drug_name,target,ChemicalStructure
(5Z)-7-Oxozeaenol,TAK1,
5-Fluorouracil,Antimetabolite (DNA & RNA),
A-443654,"AKT1, AKT2, AKT3",
A-770041,"LCK, FYN",
A-83-01,TGFB,
ACY-1215,HDAC6,
AGI-6780,IDH2(R140Q),
AICA Ribonucleotide,AMPK agonist,
AKT inhibitor VIII,"AKT1, AKT2, AKT3",
AR-42,HDAC1,CC(C)[C@H](C(=O)NC1=CC=C(C=C1)C(=O)NO)C1=CC=CC=C1
ARRY-520,KIF11,
AS601245,"JNK1, JNK2, JNK2",
AS605240,PI3Kgamma,
AST-1306,"EGFR, ERBB4",
AT-7519,"CDK1, CDK2, CDK4, CDK6, CDK9",ClC1=CC=CC(Cl)=C1C(=O)NC1=CNN=C1C(=O)NC1CCNCC1
AT7867,AKT,
AZ628,BRAF,
AZD6482,PI3Kbeta,
AZD7762,"CHEK1, CHEK2",
AZD8055,"MTORC1, MTORC2",
Afatinib,"ERBB2, EGFR",CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1
Alectinib,ALK,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=C(N1)C=C(C=C3)C#N)C2=O
Alisertib,AURKA,COC1=CC(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2OC)=CC=C1C(O)=O
Amuvatinib,"KIT, PDGFRA, FLT3",S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1
Apitolisib,"mTOR, PI3K",[H][C@@](C)(O)C(=O)N1CCN(CC2=C(C)C3=C(S2)C(=NC(=N3)C2=CNC(=N)N=C2)N2CCOCC2)CC1
Ara-G,Anti-metabolite,
Avagacestat,"Amyloid beta20, Amyloid beta40",NC(=O)[C@@H](CCC(F)(F)F)N(CC1=CC=C(C=C1F)C1=NOC=N1)S(=O)(=O)C1=CC=C(Cl)C=C1
Axitinib,"PDGFR, KIT, VEGFR",CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
BAM7,Bax activator,
BAY-61-3606,SYK,
BI-2536,"PLK1, PLK2, PLK3",
BIBF-1120,"VEGFR, PDGFR, FGFR",
BIX02189,"MEK5, ERK5",
BMS-345541,"IKK1, IKK2",
BMS-509744,ITK,
BMS-536924,"IGF1R, IR",
BMS-754807,"IGF1R, IR",C[C@]1(CCCN1C1=NN2C=CC=C2C(NC2=NNC(=C2)C2CC2)=N1)C(=O)NC1=CN=C(F)C=C1
BX-912,PDK1 (PDPK1),
BX795,"TBK1, PDK1 (PDPK1), IKK, AURKB, AURKC",
Belinostat,HDAC1,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Bexarotene,Retinioic X receptor (RXR) agonist,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C
Bicalutamide,AR,CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
Bleomycin,dsDNA break induction,C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(N)=NC(=N1)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)C1=CN=CN1)C(=O)NCCC1=NC(=CS1)C1=NC(=CS1)C(=O)NCCC[S+](C)C
Bleomycin (50 uM),dsDNA break induction,
Bortezomib,Proteasome,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
Bosutinib,"SRC, ABL, TEC",COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
"Brivanib, BMS-540215","VEGFR, PDGFR",
Bryostatin 1,PKC,
C-75,FAS,
"CAP-232, TT-232, TLN-232",Glycolysis,
CAY10566,Stearoyl-CoA desaturase,
CAY10603,"HDAC1, HDAC6",
CCT-018159,HSP90,
CCT007093,PPM1D,
CD532,AURKA,
CGP-082996,CDK4,
CGP-60474,"CDK1,CDK2,CDK5,CDK7,CDK9, PKC",
CHIR-99021,"GSK3A, GSK3B",
CI-1033,"EGFR, ERBB2, ERBB4",
CI-1040,"MEK1, MEK2",OC(=NOCC1CC1)C1=C(NC2=C(Cl)C=C(I)C=C2)C(F)=C(F)C=C1
CMK,RSK2,
CP466722,ATM,
CP724714,ERBB2,
CPI-613,"Metabo, Mitochondria",OC(=O)CCCCC(CCSCC1=CC=CC=C1)SCC1=CC=CC=C1
CUDC-101,"HDAC1-10, EGFR, ERBB2",COC1=C(OCCCCCCC(=O)NO)C=C2C(NC3=CC=CC(=C3)C#C)=NC=NC2=C1
CX-5461,RNA Polymerase 1,
Cabozantinib,"VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL",COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2
Cetuximab,EGFR,
Cisplatin,DNA crosslinker,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]
Crizotinib,"MET, ALK, ROS1",C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
Cyclopamine,SMO,
Cytarabine,Antimetabolite,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
DMOG,HIF-PH,
Dabrafenib,BRAF,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
Dacinostat,HDAC1,
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",CN1C(=O)N(C2=C1C=NC1=CC=C(C=C21)C1=CN=C2C=CC=CC2=C1)C1=CC=C(C=C1)C(C)(C)C#N
Daporinad,NAMPT,O=C(NCCCCC1CCN(CC1)C(=O)C1=CC=CC=C1)\C=C\C1=CC=CN=C1
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT",CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Docetaxel,Microtubule stabiliser,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
Doramapimod,"p38, JNK2",
Doxorubicin,Anthracycline,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O
EHT-1864,"RAC1, RAC2, RAC3",
ETP-45835,"MNK1, MNK2",
Elesclomol,HSP90,CN(NC(=O)CC(=O)NN(C)C(=S)C1=CC=CC=C1)C(=S)C1=CC=CC=C1
Embelin,XIAP,
Entinostat,"HDAC1, HDAC3",NC1=CC=CC=C1NC(=O)C1=CC=C(CNC(=O)OCC2=CN=CC=C2)C=C1
Enzastaurin,PKCB,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Epothilone B,Microtubule stabiliser,
Erlotinib,EGFR,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
Etoposide,TOP2,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
FH535,"PPARgamma, PPARdelta",
FMK,RSK,
FR-180204,"ERK1, ERK2",
FTI-277,Farnesyl-transferase (FNTA),
FTY-720,S1P,
Fedratinib,JAK2,CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)NC1=NC1=CC(=CC=C1)S(=O)(=O)NC(C)(C)C
Flavopiridol,CDK,
Foretinib,"MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR",COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=C(F)C=C(C=C3)N=C(O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C2=C1
GNF-2,BCR-ABL,
GSK1059615,PI3K,
GSK1070916,"AURKA, AURKC",
GSK1904529A,"IGF1R, IR",
GSK269962A,"ROCK1, ROCK2",
GSK319347A,IKK,
GSK429286A,"ROCK1, ROCK2",
GSK650394,"SGK2, SGK3",
GSK690693,"AKT1, AKT2, AKT3",
GW-2580,CSF1R,
GW441756,NTRK1,
GW843682X,PLK1,
Gefitinib,EGFR,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
Gemcitabine,Pyrimidine antimetabolite,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
Genentech Cpd 10,"AURKA, AURKB",
HG-5-113-01,"LOK, LTK, TRCB, ABL(T315I)",
HG-5-88-01,"EGFR, ADCK4",
HG6-64-1,BRAF,
I-BET-762,"BRD2, BRD3, BRD4",
IC-87114,PI3Kdelta,
ICL1100013,N-myristoyltransferase 1/2,
IMD-0354,IKKb,
IOX2,EGLN1,
IPA-3,PAK1,
Idelalisib,PI3Kdelta,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1
Imatinib,"ABL, KIT, PDGFR",CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Ispinesib Mesylate,KSP,
JNJ38877605,MET,
JNK Inhibitor VIII,JNK,
JNK-9L,"JNK2, JNK3",
JQ1,"BRD2, BRD3, BRD4, BRDT",
JQ12,"HDAC1, HDAC2",
JW-7-24-1,LCK,
JW-7-52-1,MTOR,
KIN001-042,GSK3B,
KIN001-236,Angiopoietin-1 receptor,
KIN001-244,PDK1 (PDPK1),
KIN001-260,IKKB,
KIN001-266,MAP3K8,
KIN001-270,CDK9,
KU-55933,ATM,
Kobe2602,RAS effector,
LCL161,"XIAP, cIAP1, cIAP2",
LDN-193189,BMP,
LFM-A13,BTK,
LGK974,PORCN,
LIMK1 inhibitor BMS4,LIMK1,
Lapatinib,"ERBB2, EGFR",CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1
Lenalidomide,CRBN,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O
Lestaurtinib,"FLT3, JAK2, NTRK1, NTRK2, NTRK3",C[C@]12O[C@H](C[C@]1(O)CO)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C3C(=O)NC4)C3=CC=CC=C3N21
Linifanib,"VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT",
Linsitinib,IGF1R,C[C@@]1(O)C[C@@H](C1)C1=NC(=C2N1C=CN=C2N)C1=CC=C2C=CC(=NC2=C1)C1=CC=CC=C1
Luminespib,HSP90,
MG-132,"Proteasome, CAPN1",
MIM1,MCL-1,
MK-2206,"AKT1, AKT2",
MPS-1-IN-1,MPS1,
Masitinib,"KIT, PDGFRA, PDGFRB",CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(N=C3NC(=CS3)C3=CN=CC=C3)=C(C)C=C2)CC1
"MetAP2 Inhibitor, A832234",MetAP2,
Methotrexate,Antimetabolite,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
Midostaurin,"PKC, PPK, FLT1, c-FGR, others",CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
Mirin,MRE11,
Mitomycin-C,DNA crosslinker,
Motesanib,"VEGFR, RET, KIT, PDGFR",CC1(C)CNC2=C1C=CC(=C2)N=C(O)C1=C(NCC2=CC=NC=C2)N=CC=C1
NG-25,"TAK1, MAP4K2",
NPK76-II-72-1,PLK3,
NSC-207895,MDM4,
NSC-87877,"SHP-1 (PTPN6), SHP-2 (PTPN11)",
NSC319726,P53 Mut specific,
NU7441,DNAPK,
NVP-BHG712,EPHB4,
NVP-TAE684,ALK,
Navitoclax,"BCL2, BCL-XL, BCL-W",[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F
Nilotinib,ABL,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F
Nutlin-3a (-),MDM2,
OSI-027,"MTORC1, MTORC2",COC1=C2NC(=CC2=CC=C1)C1=C2N(N=CN=C2N)C(=N1)[C@H]1CC[C@@H](CC1)C(O)=O
OSI-930,KIT,FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=CC=CC=C34)C=CS2)C=C1
OSU-03012,PDK1 (PDPK1),
Obatoclax Mesylate,"BCL2, BCL-XL, BCL-W, MCL1",
Olaparib,"PARP1, PARP2",OC1=NN=C(CC2=CC(C(=O)N3CCN(CC3)C(=O)C3CC3)=C(F)C=C2)C2=CC=CC=C12
Omipalisib,"PI3K (class 1), MTORC1, MTORC2",COC1=C(NS(=O)(=O)C2=C(F)C=C(F)C=C2)C=C(C=N1)C1=CC2=C(C=CN=C2C=C1)C1=CN=NC=C1
PAC-1,"Procaspase-3, Procaspase-7",OC1=C(\C=N\NC(=O)CN2CCN(CC3=CC=CC=C3)CC2)C=CC=C1CC=C
PD0325901,"MEK1, MEK2",
PD173074,"FGFR1, FGFR3",
PF-00299804,"EGFR, ERBB2, ERBB4",
PF-4708671,S6K1,
PF-562271,"FAK, FAK2",
PFI-1,BRD4,
PFI-3,"SMARCA2, SMARCA4, PB1",
PHA-665752,MET,
PHA-793887,"CDK2, CDK7, CDK5",CC(C)CC(O)=NC1=NNC2=C1CN(C(=O)C1CCN(C)CC1)C2(C)C
PI-103,"PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2",
PIK-93,PI3Kgamma,
PLX-4720,BRAF,
Paclitaxel,Microtubule stabiliser,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C
Palbociclib,"CDK4, CDK6",CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O
Panobinostat,HDAC,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Parthenolide,HDAC1,C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1
Pazopanib,"CSF1R, KIT,  PDGFRA, PDGFRB",CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pelitinib,EGFR,CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(NC1=CC(Cl)=C(F)C=C1)=C(C=N2)C#N
Pemetrexed,TYMS,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(CCC2=CNC3=C2C(O)=NC(=N)N3)C=C1)C(O)=O
Pevonedistat,NAE,[H][C@]1(O)C[C@@]([H])(C[C@@]1([H])COS(N)(=O)=O)N1C=CC2=C(N[C@@]3([H])CCC4=CC=CC=C34)N=CN=C12
Phenformin,Biguanide agent,NC(=N)NC(=N)NCCC1=CC=CC=C1
Pictilisib,PI3K (class 1),CS(=O)(=O)N1CCN(CC2=CC3=C(S2)C(=NC(=N3)C2=C3C=NNC3=CC=C2)N2CCOCC2)CC1
Pilaralisib,PI3K,COC1=CC=C(Cl)C(NC2=C(NS(=O)(=O)C3=CC(NC(=O)C(C)(C)N)=CC=C3)N=C3C=CC=CC3=N2)=C1
Piperlongumine,Induces reactive oxygen species,
Ponatinib,"ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3",CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Pyrimethamine,Dihydrofolate reductase (DHFR),CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1
QL-VIII-58,"MTOR, ATR",
QL-X-138,BTK,
QL-XI-92,DDR1,
QL-XII-47,"BTK, BMX",
QL-XII-61,"BMX, BTK",
QS11,ARFGAP1,
Quizartinib,FLT3,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
RO-3306,CDK1,
RU-SKI 43,Shh,
Rapamycin,MTORC1,
Refametinib,"MEK1, MEK2",[H][C@@](O)(CO)CC1(CC1)S(=O)(=O)NC1=C(OC)C=C(F)C(F)=C1NC1=C(F)C=C(I)C=C1
Rucaparib,"PARP1, PARP2",CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3
Ruxolitinib,"JAK1, JAK2",N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
S-Trityl-L-cysteine,KIF11,
SB216763,"GSK3A, GSK3B",
SB505124,"TGFBR1, ACVR1B, ACVR1C",
SB52334,ALK5,
SB590885,BRAF,
SGC0946,DOT1L,
SL0101,"RSK, AURKB, PIM1, PIM3",
SN-38,TOP1,
SNX-2112,HSP90,
STF-62247,Autophagy inducer,
SU11274,MET,
Salubrinal,EIF2A,
Saracatinib,"ABL, SRC",CN1CCN(CCOC2=CC3=C(C(NC4=C(Cl)C=CC5=C4OCO5)=NC=N3)C(OC3CCOCC3)=C2)CC1
Seliciclib,"CDK2, CDK7, CDK9",CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1
Selisistat,SIRT1,NC(=O)C1CCCC2=C1NC1=C2C=C(Cl)C=C1
Selumetinib,"MEK1, MEK2",CN1C=NC2=C1C=C(C(O)=NOCCO)C(NC1=C(Cl)C=C(Br)C=C1)=C2F
Sepantronium bromide,BIRC5,
Serdemetan,MDM2,C(CC1=CNC2=CC=CC=C12)NC1=CC=C(NC2=CC=NC=C2)C=C1
Shikonin,not defined,
Sorafenib,"PDGFR, KIT, VEGFR, RAF",CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sphingosine Kinase 1 Inhibitor II,Sphingosine Kinase,
Sunitinib,"PDGFR, KIT, VEGFR, FLT3, RET, CSF1R",CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
T0901317,"LXR, FXR",
TAK-715,"p38alpha, p38beta",
TGX221,PI3Kbeta,
THZ-2-102-1,CDK7,
THZ-2-49,CDK9,
TL-1-85,TAK,
TL-2-105,not defined,
TPCA-1,IKK2,
TW 37,"BCL2, BCL-XL, MCL1",
TWS119,GSK3,
Talazoparib,"PARP1, PARP2",CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1
Tamoxifen,ESR1,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tanespimycin,HSP90,[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)C(C)=C([H])[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(NCC=C)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC
Temozolomide,DNA alkylating agent,CN1N=NC2=C(N=CN2C1=O)C(N)=O
Temsirolimus,MTOR,OCC(C)(CO)C(=O)O[C@@H]1CC[C@@H](C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC
Tenovin-6,SIRT,
Thapsigargin,SERCA,
Tipifarnib,Farnesyl-transferase (FNTA),CN1C=NC=C1[C@@](N)(C1=CC=C(Cl)C=C1)C1=CC2=C(C=C1)N(C)C(=O)C=C2C1=CC(Cl)=CC=C1
Tivozanib,"VEGFR1, VEGFR2, VEGFR3",COC1=C(OC)C=C2C(OC3=CC(Cl)=C(C=C3)N=C(O)N=C3NOC(C)=C3)=CC=NC2=C1
Torin 2,mTOR,
Tozasertib,"AURKA, AURKB, AURKC, others",
Trametinib,"MEK1, MEK2",CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1
Tretinoin,Retinoic acid,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Trichostatin A,HDAC,
Tubastatin A,"HDAC1, HDAC6, HDAC8",
UNC0638,G9a and GLP methyltransferases,
UNC0642,"G9a(EHMT2), GLP(EHMT1)",
UNC1215,L3MBTL3,
VNLG/124,"HDAC,RAR",
VX-11e,ERK2,
VX-702,p38,NC(=O)N(C1=CC=C(C(N)=O)C(=N1)C1=CC=C(F)C=C1F)C1=C(F)C=CC=C1F
Veliparib,"PARP1, PARP2",C[C@@]1(CCCN1)C1=NC2=CC=CC(C(N)=O)=C2N1
Venotoclax,BCL-2 selective,
Vinblastine,Microtubule destabiliser,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vinorelbine,Microtubule destabiliser,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(CC(CC)=C2)CC2=C1NC1=CC=CC=C21)C(=O)OC
Vismodegib,SMO,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1
Vorinostat,"HDAC inhibitor Class I, IIa, IIb, IV",ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
Voxtalisib,"PI3K (class 1), DNAPK, MTOR",CCN1C(=O)C(=CC2=C(C)N=C(N)N=C12)C1=CC=NN1
WH-4-023,"SRC, LCK",
WHI-P97,JAK3,
WYE-125132,mTOR,
WZ-1-84,BMX,
WZ3105,"SRC, ROCK2, NTRK2, FLT3, IRAK1, others",
Wee1 Inhibitor,"WEE1, CHEK1",
Wnt-C59,PORCN,
XAV939,"TNKS1, TNKS2",
XMD11-85h,"BRSK2, FLT4, MARK4, PRKCD, RET, SRPK1",
XMD13-2,RIPK1,
XMD14-99,"ALK, CDK7, LTK, others",
XMD15-27,CAMK2,
XMD8-85,"ERK5, BET",
XMD8-92,MAPK7,
Y-39983,ROCK,
YK-4-279,RNA helicase A,
YM201636,PIKFYVE,
Z-LLNle-CHO,gamma-secretase,
ZG-10,JNK1,
ZM447439,"AURKA, AURKB",
ZSTK474,PI3K (class 1),
Zibotentan,Endothelin-1 receptor (EDNRA),COC1=NC(C)=CN=C1NS(=O)(=O)C1=CC=CN=C1C1=CC=C(C=C1)C1=NN=CO1
"eEF2K Inhibitor, A-484954",eEF2K,
kb NB 142-70,PKD,
rTRAIL,TRAIL receptor agonist,
'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,Bifunctional glutamate/proline--tRNA ligase,[H][C@@](C)(N)C(O)=NS(=O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,Bifunctional glutamate/proline--tRNA ligase,[H][C@]1(CCCN1)C(O)=NS(=O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate",Deoxycytidylate deaminase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C[C@@]([H])(O)N=C1O
"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",Adenosylhomocysteinase,NC1=NC=NC2=C1N=CN2[C@@H]1C=C[C@H](O)[C@H]1O
"(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)",Azurin,[O]#C[Re+]1(C#[O])(C#[O])[N]2=CC=CC3=C2C2=C(C=CC=[N]12)C=C3
(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,"Phospholipase A2, membrane associated",COC1=CC2=C(C=C1)N(CC1=CC=CC=C1)C(C)=C2CC(O)=O
"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID","Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",OC(CC1=CC=CC(=C1)C1=CC(=CC=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O
"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID","Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",OC(CC1=CC=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O
"(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",Geranylgeranyl pyrophosphate synthase,CCCCCCC(O)(P(O)(O)=O)P(O)(O)=O
"(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",Geranylgeranyl pyrophosphate synthase,CCCCCCCCC(O)(P(O)(O)=O)P(O)(O)=O
(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,Glycylpeptide N-tetradecanoyltransferase,CN1C=CN=C1C(=O)C1=C(C)C2=C(O1)C=CC=C2OCCCNCC1=CN=CC=C1
(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,Glycylpeptide N-tetradecanoyltransferase 1,CN1C=CN=C1C(=O)C1=C(C)C2=C(O1)C=CC=C2OCCCNCC1=CN=CC=C1
(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone,4-hydroxyphenylpyruvate dioxygenase,COC1=CC=C(C=C1)C1=C(C=CC(C(=O)C2=C(O)N(N=C2)C(C)(C)C)=C1C)S(C)(=O)=O
"(10E,12Z)-octadecadienoic acid",Putative aminooxidase,CCCCC\C=C/C=C/CCCCCCCCC(O)=O
"(10R)-10-Formyl-5,8,10-Trideazafolic Acid",Phosphoribosylglycinamide formyltransferase,NC1=NC(O)=C2C=C(C[C@@H](C(O)=O)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=CC2=N1
"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",MAP kinase-activated protein kinase 2,[H][C@@]1(C)CNC2=C(SC3=C2C2=C(C=C3)N=C(C=C2)C2=CN=C(C)C=C2)C(=O)N1
"(10S)-10-Formyl-5,8,10-Trideazafolic Acid",Phosphoribosylglycinamide formyltransferase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)[C@]([H])(CC1=CC2=C(NC(=N)N=C2O)C=C1)C(O)=O)C(O)=O
"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",Genome polyprotein,[H][C@]1(N(C(C)=O)C2=CC=CC(O)=C2NC2=C1C(=O)CC(C)(C)C2)C1=C(Cl)C=C(Cl)C=C1
"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,[H][C@]1(C2CCN(CC2)S(C)(=O)=O)C2=C(C=C(Cl)C=C2)C(=CC2=C1N=CC=C2)N1CCNCC1
"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",Protein farnesyltransferase subunit beta,[H][C@]1(C2CCN(CC2)S(C)(=O)=O)C2=C(C=C(Cl)C=C2)C(=CC2=C1N=CC=C2)N1CCNCC1
"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",Cyclin-dependent kinase 2,[H][C@]12CN(CCN3NC4=C(C=CC=C4C3=O)C3=NC4=C(NC3=O)C=CC=C4O1)[C@]([H])(C)C2
"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",Steroid Delta-isomerase,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@H]34)[C@@H]1CCC2=O
"(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",Carbonic anhydrase 2,[H][C@]1(CC#N)CC[C@@]2([H])[C@]3([H])CCC4=CC(OS(N)(=O)=O)=C(OC)C=C4[C@@]3([H])CC[C@]12C
"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",Serine/threonine-protein kinase B-raf,O\N=C1/CCC2=CC(=CC=C12)C1=CN(N=C1C1=CC=NC=C1)C1CCNCC1
(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid,Interleukin-2,[H][C@](NOCCS)(C(O)=O)C1=CNC2=C1C=CC=C2
"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",Liver carboxylesterase 1,[H][C@](C)(O[P@]([H])(C)=O)C(C)(C)C
"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",Platelet-activating factor acetylhydrolase IB subunit gamma,[H][C@](C)(O[P@]([H])(C)=O)C(C)(C)C
"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",Platelet-activating factor acetylhydrolase,[H][C@](C)(O[P@]([H])(C)=O)C(C)(C)C
(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid,Beta-lactamase,[H][C@@](NC(=O)CC1=CC=CS1)(B(O)O)C1=CC=CC=C1
(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE,Hepatitis B virus receptor binding protein,[H][C@@](C)(OP(O)(=O)CC1=CC=C(C=C1)N=C(C)[O-])C1=CC=CC=C1
"(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",Neutrophil collagenase,COC1=CC=C(C=C1)C1=CC=C(C=C1)S(=O)(=O)N[C@@H](C(C)C)P(O)(O)=O
(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID,Beta-lactamase TEM,[H][C@@](CC1=CC=CC(=C1)C(O)=O)(NC(=O)CC1=CC=CC=C1)B(O)O
(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,Cathepsin S,[H][C@@](CS(=O)(=O)CC1=C(OC(F)F)C=CC=C1)(OC(=O)N1CCOCC1)C(=O)NCC#N
(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,Phenylethanolamine N-methyltransferase,[H][C@](O)(CN)C1=CC=CC(=C1)C(F)(F)F
"(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE",Coagulation factor XI,[H][C@@](CNC(N)=N)(OC(=O)C1=CC=CN=C1)C1=CC=C(C=C1)B1OC[C@@]([H])(CO)O1
(1R)-3-chloro-1-phenylpropan-1-ol,Endolysin,[H][C@@](O)(CCCl)C1=CC=CC=C1
(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,Dehydrosqualene synthase,[H][C@@](CCCC1=CC=CC(OC2=CC=CC=C2)=C1)(P(O)(O)=O)S(O)(=O)=O
"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",Matrilysin,[H][C@]1(N(CCC2=CC(O)=C(OC)C=C12)S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO
(1R)-menthyl hexyl phosphonate group,Cholinesterase,CCCCCCP(O)(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C
"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene","Naphthalene 1,2-dioxygenase subunit alpha",[H][C@]1(O)C=CC2=C(C=CC=C2)[C@@]1([H])O
"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene","Naphthalene 1,2-dioxygenase subunit beta",[H][C@]1(O)C=CC2=C(C=CC=C2)[C@@]1([H])O
"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide",Cathepsin K,[H][C@@]1(CS(=O)(=O)C2=CC=C(OC)C=C2)CCCC[C@@]1([H])C(=O)NCCN
"(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL",Alpha-mannosidase 2,[H][C@@]1(O)[C@]([H])(O)[C@]([H])(NCC2=CC=CC=C2)[C@@]([H])(SC)[C@]1([H])O
"(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]",Tubby protein homolog,OCC(=O)COP(O)(=O)OC1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1O
"(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid",Beta-lactamase,[H][C@]1(CCCC[C@]1([H])C1=NNC(=S)N1)C(O)=O
"(1R,2S)-2-Phenylcyclopropanaminium",Trypsin-1,[NH3+][C@@H]1C[C@H]1C1=CC=CC=C1
"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",Nuclear receptor coactivator 1,[H][C@]1(CC[C@](C)(CCC#CC(O)(C(F)(F)F)C(F)(F)F)C1(C)C)\C=C\C=C1C[C@](O)([H])C[C@@](O)([H])C1
"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",Vitamin D3 receptor,[H][C@]1(CC[C@](C)(CCC#CC(O)(C(F)(F)F)C(F)(F)F)C1(C)C)\C=C\C=C1C[C@](O)([H])C[C@@](O)([H])C1
"(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",P-protein,[H][C@@]1(O)C=C[C@]2(C[C@]([H])(O[C@]1([H])C2)C(O)=O)C(O)=O
"(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",Chorismate mutase AroH,[H][C@@]1(O)C=C[C@]2(C[C@]([H])(O[C@]1([H])C2)C(O)=O)C(O)=O
"(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",Secreted chorismate mutase,[H][C@@]1(O)C=C[C@]2(C[C@]([H])(O[C@]1([H])C2)C(O)=O)C(O)=O
"(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",Beta-lactamase,[H][C@]1(NC(C(O)=O)=C2[C@]1([H])CCC[C@]2([H])OC)C(=C/C)\C=O
"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",DNA polymerase beta,[H][C@@]1(O)CC2=C(C=CC3=C2C2=C(C=CC=C2)C=C3)[C@@]([H])(O)[C@]1([H])O
"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",cAMP-dependent protein kinase inhibitor alpha,[H][C@@](N)(COC1=C2C=CC(=NC2=CN=C1)C1=CC=NC=C1)CC1=CNC2=C1C=CC=C2
"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](N)(COC1=C2C=CC(=NC2=CN=C1)C1=CC=NC=C1)CC1=CNC2=C1C=CC=C2
"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",Caspase-3,[H][C@@](OC(C)=O)(C(=O)NC1=CC=CC2=C1C(=O)C(=O)NC2=O)C1=CC=CC(Cl)=C1
(1S)-1-(PHENOXYMETHYL)PROPYL METHYLPHOSPHONOCHLORIDOATE,Lipase,[H][C@](CC)(COC1=CC=CC=C1)O[P@](C)(Cl)=O
(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,Aralkylamine dehydrogenase light chain,[H][C@](N)(O)CC1=CNC2=CC=CC=C12
(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,Aralkylamine dehydrogenase heavy chain,[H][C@](N)(O)CC1=CNC2=CC=CC=C12
"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",Kinesin-like protein KIF11,[H][C@](N)(C1CC1)C(=O)N1CC(=C[C@@]1([H])C1=CC=CC=C1)C1=CC(F)=CC=C1F
"(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid",Neutrophil collagenase,COC1=CC=C(C=C1)C1=CC=C(C=C1)S(=O)(=O)N[C@H](C(C)C)P(O)(O)=O
(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](N)(COC1=CN=CC(\C=C\C2=CC=NC=C2)=C1)CC1=CNC2=C1C=CC=C2
(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,cAMP-dependent protein kinase inhibitor alpha,[H][C@@](N)(COC1=CN=CC(\C=C\C2=CC=NC=C2)=C1)CC1=CNC2=C1C=CC=C2
"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",Dipeptidyl peptidase 4,[H][C@](N)(C1CCCC1)C(=O)N1[C@]([H])(CN)CC[C@]1([H])C#C
"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",Dipeptidyl peptidase 4,[H][C@](N)(C1CCCC1)C(=O)N1[C@]([H])(CN)CC[C@]1([H])C#CC
"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",Caspase-3,[H][C@@](OC(C)=O)(C(=O)NC1=CC=CC2=C1C(=O)C(=O)NC2=O)C1=CC=CC=C1
"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",Respiratory nitrate reductase 1 alpha chain,[H][C@](O)(CO)CO[P@@]([O-])(=O)OC[C@@]([H])(COC(=O)CCCC)OC(=O)CCCCCCC
"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",Respiratory nitrate reductase 1 beta chain,[H][C@](O)(CO)CO[P@@]([O-])(=O)OC[C@@]([H])(COC(=O)CCCC)OC(=O)CCCCCCC
"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",Respiratory nitrate reductase 1 gamma chain,[H][C@](O)(CO)CO[P@@]([O-])(=O)OC[C@@]([H])(COC(=O)CCCC)OC(=O)CCCCCCC
"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",Aquaporin Z,[H][C@](O)(CO)CO[P@@]([O-])(=O)OC[C@@]([H])(COC(=O)CCCC)OC(=O)CCCCCCC
(1S)-menthyl hexyl phosphonate group,Cholinesterase,CCCCCCP(O)(=O)O[C@H]1C[C@@H](C)CC[C@@H]1C(C)C
"(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid",Beta-lactamase,[H][C@@]1(C[C@@]1([H])C(=O)NC1=CC(F)=CC=C1F)C(O)=O
"(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide",Beta-glucosidase A,[H][C@@]12CO[C@@]([H])(N1C(=S)NCCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]2([H])O
"(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL",Beta-glucosidase A,O[C@H]1[C@H]2CC[C@](O)(N2)[C@@H](O)[C@@H]1O
"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",Dipeptidyl peptidase 4,[H][C@@]1(CC[C@]([H])(C2=C(F)C=C(F)C(F)=C2)[C@@]([H])(N)C1)N1CCN2C(C1)=NN=C2C(F)(F)F
"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",Lactase-phlorizin hydrolase,OC[C@H]1C[C@@H](S\C(=N/OS(O)(=O)=O)CC2=CC=CC=C2)[C@H](O)[C@@H](O)[C@@H]1O
"(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol",Alpha-mannosidase 2,[H][C@@]1(O)C(CO)=C[C@@]([H])(NCCCCCCCC)[C@]([H])(O)[C@@]1([H])O
"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",Uncharacterized protein,[H][C@]1(O)C[C@]([H])(CC[C@]1([H])C1=CC=C(C=C1)C(=O)NCCCC(O)=O)C1=CC=CC=C1
"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",Ig gamma-1 chain C region,[H][C@]1(O)C[C@]([H])(CC[C@]1([H])C1=CC=C(C=C1)C(=O)NCCCC(O)=O)C1=CC=CC=C1
"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",Ig kappa chain C region,[H][C@]1(O)C[C@]([H])(CC[C@]1([H])C1=CC=C(C=C1)C(=O)NCCCC(O)=O)C1=CC=CC=C1
"(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE",Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]12C[C@@]3([H])C[C@@](C1)(C[C@@]([H])(C2)[C@@]3([H])NC(=O)C(C)(C)OC1=CC=C(OC)C=C1)C(N)=O
"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",Disintegrin and metalloproteinase domain-containing protein 17,[H][C@@]1(C[C@@]11C[C@]([H])(NC1=O)C1=CC=C(OCC2=CC(=NC3=C2C=CC=C3)C2=CC=CC=C2)C=C1)C(O)=O
"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile",Dipeptidyl peptidase 4,[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)[C@]12C[C@@]3([H])C[C@]([H])(C[C@](O)(C3)C1)C2
"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",1-deoxypentalenic acid 11-beta-hydroxylase,[H][C@]1(C)CC[C@]2([H])C(=C[C@@]3([H])CC(C)(C)C[C@@]123)C(O)=O
"(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",Beta-lactamase,[H][C@](CC)(C=O)[C@@]1([H])NC(C(O)=O)=C2[C@@]1([H])CCC[C@@]2([H])OCCCC
"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",Phenylethanolamine N-methyltransferase,[H][C@]12CC[C@]([H])(C3=C(C=CC=C13)C(F)(F)F)[C@@]2([H])N
"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",3-dehydroquinate dehydratase,[H][C@@]1(O)C[C@@](O)(C=C(C2=CC=CC(SC3=CC=CC=C3)=C2)[C@@]1([H])O)C(O)=O
"(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",Macrophage metalloelastase,[H][C@]12CN(C[C@]([H])(O1)[C@@]([H])(O2)C(=O)NCC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)NO
"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",Liver carboxylesterase 1,[H][C@]1(O)CC(=O)O[C@@]([H])(CC[C@@]2([H])[C@@]([H])(C)C=CC3=CCC[C@]([H])(O)[C@]23[H])C1
(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE,"2,3-diketo-5-methylthiopentyl-1-phosphate enolase",CCCC(=O)C(\O)=C\OP(O)(O)=O
(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE,Amine oxidase [flavin-containing] B,[H]N=C([H])C(=C)CCC1=CC=C(F)C=C1
"(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione",Mitogen-activated protein kinase 1,[H][C@@]12C[C@]([H])(O)[C@]([H])(O)C(=O)C=CC[C@]([H])(C)OC(=O)C3=C(C=C(OC)C=C3O)[C@@]1([H])O2
(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,Stromelysin-1,CCCCOC1=CC=C(C=C1)S(=O)(=O)N1C[C@H](C[C@@H]1C(=O)NO)NS(C)(=O)=O
"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol","Apocarotenoid-15,15'-oxygenase",OC\C(C)=C\C=C\C(\C)=C/C=C/C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C
"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",Hypoxanthine-guanine-xanthine phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)N[C@@]([H])(C2=CNC3=C2N=CN=C3O)[C@]([H])(O)[C@]1([H])O
"(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol",S-methyl-5'-thioadenosine phosphorylase,[H][C@]1(CSC)N[C@@]([H])(C2=CNC3=C2N=CNC3([H])N)[C@]([H])(O)[C@]1([H])O
"(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol",5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,[H][C@]1(CSC)N[C@@]([H])(C2=CNC3=C2N=CNC3([H])N)[C@]([H])(O)[C@]1([H])O
"(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM",Geranylgeranyl pyrophosphate synthase,CCCCCCCCCCCC[P+](C)(C)CC(P(O)(O)=O)P(O)(O)=O
"(2,6-Dimethylphenoxy)acetic acid",Gag-Pol polyprotein,CC1=CC=CC(C)=C1OCC(O)=O
"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",Gag-Pol polyprotein,[H][C@@](NC1=CC(C)=CC=C1C(C)=O)(C(N)=O)C1=C(Br)C=CC=C1Br
"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",Gag-Pol polyprotein,[H][C@@](NC1=CC(C)=CC=C1C(C)=O)(C(N)=O)C1=C(Br)C=CC=C1Br
"(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE",Biotin carboxylase,NC1=NC=C(O1)C(=O)C1=CC(Br)=CC=C1
(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,Ig gamma-1 chain C region,[H][C@]12CC[C@]([H])(C1)[C@](N)(C(=O)C1=CC=CC=C1)[C@]2([H])C1=CC=CC=C1
(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE,Chymotrypsin-like elastase family member 1,NC1=CC(C=O)=C(CC(=O)OCCBr)C=C1
(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,Group IIE secretory phospholipase A2,CCCC1=CC2=C(NC(CC(N)=O)=C2)C(CC(O)=O)=C1
(2-Sulfanyl-3-Phenylpropanoyl)-Phe-Tyr,Thermolysin,[H][C@](S)(CC1=CC=CC=C1)C(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=N[C@@]([H])(CC1=CC=C(O)C=C1)C(O)=O
(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,Aldose reductase,OC(=O)COC1=CC(Cl)=CC=C1C(=O)NCC1=C(F)C=C(Br)C=C1
"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,[H][C@@]12CCN(C1=O)C1=C3C=C(OC4=C(C=CC(CN5C=NC=C5CN2)=C4)C#N)C=CC3=CC=C1
"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",Protein farnesyltransferase subunit beta,[H][C@@]12CCN(C1=O)C1=C3C=C(OC4=C(C=CC(CN5C=NC=C5CN2)=C4)C#N)C=CC3=CC=C1
"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,[H][C@]12CCN(C1=O)C1=CC=CC3=C1C=C(OC1([H])CC(CN4C=NC=C4CCN2)=CC[C@]1([H])C#N)C=C3
"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",Protein farnesyltransferase subunit beta,[H][C@]12CCN(C1=O)C1=CC=CC3=C1C=C(OC1([H])CC(CN4C=NC=C4CCN2)=CC[C@]1([H])C#N)C=C3
"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",Peptidyl-prolyl cis-trans isomerase FKBP1A,[H][C@@]12CCCCN1C(=O)C(=O)C(C)(C)COC(=O)CCCCCCCCCCCOC2=O
(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,Group IIE secretory phospholipase A2,COC1=CC(O)=C(C=C1CC=C(C)C)C(=O)\C=C\C1=CC=C(O)C=C1
(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,Penicillin-binding protein 1B,[H][C@@](CO\N=C(/CCC(O)=O)C(O)=O)(NC(=O)COC1=CC=CC=C1)C(O)=O
"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",Botulinum neurotoxin type A,ONC(=O)\C=C\C1=CC=C(Cl)C=C1Cl
"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",BoNT/A,ONC(=O)\C=C\C1=CC=C(Cl)C=C1Cl
(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,Arachidonate 15-lipoxygenase,CCCCCCC#CC1=CC=CC=C1\C=C\C(O)=O
"(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID",D-amino-acid oxidase,[H]N=C(CC1=CC(O)=C(O)C=C1)C(O)=O
"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",Peptide deformylase,OC1=CC=C(CCNC(=O)\C=C\C2=CC=C(O)C(O)=C2)C=C1
(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid,O-methyltransferase,COC1=C(O)C=C(\C=C\C(O)=O)C=C1
(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,Botulinum neurotoxin type A,ONC(=O)\C=C\C1=CC=C(Cl)C=C1
(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,BoNT/A,ONC(=O)\C=C\C1=CC=C(Cl)C=C1
"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE",Gag-Pol polyprotein,CCC1=C(C)NC(=O)C(I)=C1OC1=CC=CC(\C=C\C#N)=C1
(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,Histone deacetylase 8,CN1C=C(C=C1\C=C\C(=O)NO)C(=O)CC1=CC=CC=C1
(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,Proto-oncogene tyrosine-protein kinase Src,CN(C)C\C=C\C(=O)NC1=CC=C2N=CN=C(NC3=CC(Br)=CC=C3)C2=C1
"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",Nuclear receptor coactivator 2,COC(C)(C)CCC[C@@](C)([H])C\C=C\C(\C)=C\C(O)=O
"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",Retinoic acid receptor RXR-beta,COC(C)(C)CCC[C@@](C)([H])C\C=C\C(\C)=C\C(O)=O
"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",Oxysterols receptor LXR-alpha,COC(C)(C)CCC[C@@](C)([H])C\C=C\C(\C)=C\C(O)=O
"(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid","2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",OC(=O)C(\O)=C/C=C/C(=O)C1=CC=CC=C1
"(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID",Hyaluronate lyase,[H][C@](O)(COC(=O)CCCCCCCCCCCCCCC)[C@@]([H])(O)C(\O)=C(\O)C(O)=O
(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,Coagulation factor VII,CCOC1=CC([C@@H](NC2=CC=C(C=C2)C(N)=N)C(O)=O)=C(F)C(O[C@@H]2CCOC2)=C1
"(2R)-1-(2,6-dimethylphenoxy)propan-2-amine",Urokinase-type plasminogen activator,[H][C@](C)(N)COC1=C(C)C=CC=C1C
(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,Cyclin-dependent kinase 2,[H][C@](O)(COC1=CC=C(NC2=NC=NC(NC3=C(F)C=CC(=C3)C(F)(F)F)=C2)C=C1)CN(C)C
(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]1(C)CN(CCN1S(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)C1=CC=C(C=C1)[N+]([O-])=O
"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",Serine/threonine-protein kinase Chk1,[H][C@](C)(O)CNC1=C2C(NC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1
"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",Cyclin-dependent kinase 2,[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=NC=CC(=N1)N([H])C1=C(Cl)C=CC(Cl)=C1
"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",Cyclin-dependent kinase 2,[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=CC(=NC=N1)N([H])C1=C(F)C=CC=C1F
(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,Cyclin-dependent kinase 2,[H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=NC=C(Br)C(=N1)N([H])C1=CC=CC=C1
(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide,Cathepsin K,[H]N(C[C@@H](O)CN([H])S(=O)(=O)C1=CC=CC=N1)C(=O)[C@H](CC(C)C)C1=CC=CC(=C1)C1=CC=CC=C1
(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](CN)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,cAMP-dependent protein kinase inhibitor alpha,[H][C@@](CN)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,cAMP-dependent protein kinase catalytic subunit alpha,NC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C1=CNN=C1
(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,cAMP-dependent protein kinase inhibitor alpha,NC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C1=CNN=C1
(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,Prothrombin,C\C(=C/S(=O)(=O)N[C@@]1([H])CCN([C@](C)([H])C(=O)N2CCOCC2)C1=O)C1=CC=C(Cl)S1
(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,Coagulation factor X,C\C(=C/S(=O)(=O)N[C@@]1([H])CCN([C@](C)([H])C(=O)N2CCOCC2)C1=O)C1=CC=C(Cl)S1
(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,Pyridoxal kinase,[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(=N1)N(C)CC1=CC=CC=C1
(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,Cyclin-dependent kinase 2,[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=C(C=C2)C2=CC=CC=N2)=N1
(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,Cyclin-A2,[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=C(C=C2)C2=CC=CC=N2)=N1
"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",Matrix metalloproteinase-9,N[C@](CS(=O)(=O)C1=CC=C(OC2=CC=CC=C2)C=C1)(C(=O)NO)C(F)(F)F
(2R)-2-ETHYL-1-HEXANESULFONIC ACID,Alpha-ketoglutarate-dependent sulfate ester dioxygenase,[H][C@@](CC)(CCCC)COS(O)(=O)=O
(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE,Lanosterol 14-alpha demethylase,[H][C@](CC)(C(=O)NC1=CC=NC=C1)C1=CC=CC=C1
(2R)-2-benzyl-3-nitropropanoic acid,Carboxypeptidase A1,[H][C@@](CC1=CC=CC=C1)(C[N+]([O-])=O)C(O)=O
"(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid",D-alanyl-D-alanine carboxypeptidase,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@@]1([H])SCCC(=N1)C(O)=O
(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,Lethal factor,[H][C@@](NS(=O)(=O)C1=CC(C)=C(F)C=C1)(C1CCOCC1)C(=O)NO
"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",Cyclin-dependent kinase 2,[H][C@@](CC)(CO)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2)=N1)C(C)C
"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",Cyclin-A2,[H][C@@](CC)(CO)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2)=N1)C(C)C
"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",Photosynthetic reaction center cytochrome c subunit,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1
"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",Reaction center protein H chain,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1
"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",Reaction center protein L chain,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1
"(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",Reaction center protein M chain,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1
"(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate",Phospholipase D,[H][C@@](COC(=O)CCCCCC)(COP(O)(O)=O)OC(=O)CCCCCC
(2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate,Cathepsin K,[H][C@@](CCCC)(NC(=O)O[C@]([H])(CC1=CC=CC=C1)C(C)C)C=O
"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",Serine/threonine-protein kinase Chk1,[H][C@](O)(CO)CNC1=C2C(NC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1
(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,Chymotrypsin-like elastase family member 1,[H][C@@](O)(CNC(=O)NCC1=CC=CC=C1)C(O)=O
"(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE",Steroidogenic factor 1,CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](CO[P@](O)(=O)OC[C@H](O)CO)OC(=O)CCCCCCC\C=C/CCCCCC
"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",Carboxypeptidase A1,[H][C@@](CC1=CC=CC=C1)(CC(O)(O)C[N+]([O-])=O)C(O)=O
"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",Dipeptidyl peptidase 4,[H][C@](N)(CC(=O)N1CCCCCN1C(=O)C1=CC=CC=C1)CC1=C(F)C=C(F)C(F)=C1
"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",Dipeptidyl peptidase 4,[H][C@](N)(CC(=O)N1CCN2N=C(N=C2[C@@]1([H])C)C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,Disintegrin and metalloproteinase domain-containing protein 17,[H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO
(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE,Dipeptidyl peptidase 4,[H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1)B(O)O
(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,[H][C@](CC1=CC2=C(C=CC=C2)C=C1)(NS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1)C(=O)NO
"(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",[H]N(C(=O)C(C)(O)C(F)(F)F)C1=C(C)C=C(C=C1)S(=O)(=O)N(CC)C1=CC=CC=C1
"(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",A disintegrin and metalloproteinase with thrombospondin motifs 5,[H][C@](CC(=O)NO)(CC1=CC(O)=CC=C1)C(=O)N[C@@]1([H])C2=C(C[C@@]1([H])O)C=CC=C2
"(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE",Genome polyprotein,[H][C@](S)(NC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C([H])(C#N)C(O)=N
"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",Dipeptidyl peptidase 4,[H][C@]1(N)CN2C(C[C@]1([H])C1=C(F)C=C(F)C(F)=C1)=NC1=CC(=CC=C21)S(C)(=O)=O
"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",Disintegrin and metalloproteinase domain-containing protein 28,[H][C@@](CNC(=O)C1=NC=CS1)(C(=O)NO)[C@@]([H])(CC(C)C)C(=O)N[C@]([H])(C(=O)NC)C(C)(C)C
"(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL",Glucosylceramidase,[H][C@]1(O)CN(CCCCCCCCC)[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O
"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",Estrogen receptor,[H][C@@]1(C)C2=CC(O)=CC=C2O[C@@]([H])(C2=CC=C(OCCN3CCCC3)C=C2)[C@@]1([H])C1=CC=C(O)C=C1
"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",BAG family molecular chaperone regulator 1,[H][C@]1(CO)O[C@@]([H])(N2C(NCC3=CC=C(Cl)C(Cl)=C3)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",Heat shock cognate 71 kDa protein,[H][C@]1(CO)O[C@@]([H])(N2C(NCC3=CC=C(Cl)C(Cl)=C3)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",Gag-Pol polyprotein,[H][C@@](NC(=O)CC1=CC=CC=C1)(C(=O)NCC1=CC=CC=C1)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1
"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",Dihydrofolate reductase,[H][C@]1(CN(C)C2=CC(OC)=C(OC)C(OC)=C2)CCC2=C(C1)C(N)=N[C@]([H])(N)N2
(2S) N-acetyl-L-alanyl-αL-phenylalanyl-chloroethylketone,Chymotrypsinogen B,[H][C@@](C)(NC(C)=O)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)CCCl
"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",Genome polyprotein,[H][C@@](NC1=NC(=O)\C(S1)=C\C1=CC=C(CC)O1)(C(O)=O)C1=CC=C(F)C=C1
"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",Serine/threonine-protein kinase pim-1,[H][C@](C#N)(C1=NC2=C(S1)C=CC=C2)C1=NC(NCCC2=CC=CN=C2)=NC=C1
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,RAC-beta serine/threonine-protein kinase,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CNC2=CC=CC=C12
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,Glycogen synthase kinase-3 beta,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CNC2=CC=CC=C12
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CNC2=CC=CC=C12
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,cAMP-dependent protein kinase inhibitor alpha,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CNC2=CC=CC=C12
"(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol",Beta-secretase 1,[H][C@@](O)(COC1=C(C)C=CC(C)=C1)CN1CCOCC1
(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,cAMP-dependent protein kinase catalytic subunit alpha,[H]N([H])[C@H](COC1=CN=CC(=C1)C1=CC2=C(C=C1)C=NC=C2)CC1C=NC2=CC=CC=C12
(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine,cAMP-dependent protein kinase inhibitor alpha,[H]N([H])[C@H](COC1=CN=CC(=C1)C1=CC2=C(C=C1)C=NC=C2)CC1C=NC2=CC=CC=C12
"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](N)(COC1=CN=CC(=C1)C1=NCC2=NN=CC2=C1)CC1=C2C=CCC=C2N=C1
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol,Endolysin,[H][C@](O)(CNC(C)C)COC1=CC=CC2=C1C1=C(N2)C=CC=C1
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol,Beta-2 adrenergic receptor,[H][C@](O)(CNC(C)C)COC1=CC=CC2=C1C1=C(N2)C=CC=C1
"(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol",Cyclin-dependent kinase 2,[H]N(C1=CC=C(OC[C@@H](O)CN(C)C)C=C1)C1=NC=CC(=N1)C1=C(C)N=C2C=CC=CN12
(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,Serine/threonine-protein kinase Chk1,[H][C@](O)(CN)CNC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O
"(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",Cyclin-dependent kinase 2,[H]N(C1=CC=C(OC[C@@H](O)CN(C)C)C=C1)C1=NC=CC(=N1)N([H])C1=C(Cl)C=CC(Cl)=C1
"(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol",Cyclin-dependent kinase 2,[H]N(C1=CC=C(OC[C@@H](O)CN(C)C)C=C1)C1=CC(=NC=N1)N([H])C1=C(F)C=CC=C1F
"(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine",Probable L-lysine-epsilon aminotransferase,[H][C@](C)(C[C@@]([H])(C)C1=CC=CC=C1)C[C@]1([H])CCCCN1C
(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol,Cyclin-dependent kinase 2,[H]N(C1=CC=C(OC[C@@H](O)CN(C)C)C=C1)C1=NC=C(Br)C(=N1)N([H])C1=CC=CC=C1
(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC2=CNN=C2C=C1)CC1=C2C=CC=CC2([H])N=C1
(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](N)(COC1=CC(=CN=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CC=CC=C1
(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,cAMP-dependent protein kinase inhibitor alpha,[H][C@@](N)(COC1=CC(=CN=C1)C1=CC=C2NN=C(C)C2=C1)CC1=CC=CC=C1
(2S)-2-(1H-indol-3-yl)hexanoic acid,S-phase kinase-associated protein 1,[H][C@@](CCCC)(C(O)=O)C1=CNC2=C1C=CC=C2
(2S)-2-(1H-indol-3-yl)pentanoic acid,S-phase kinase-associated protein 1,[H][C@@](CCC)(C(O)=O)C1=CNC2=CC=CC=C12
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",Actin-related protein 2/3 complex subunit 1B,[H][C@]1(SCC(=O)N1C1=CC(Cl)=CC=C1O)C1=CC=CC(Br)=C1
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",Actin-related protein 2,[H][C@]1(SCC(=O)N1C1=CC(Cl)=CC=C1O)C1=CC=CC(Br)=C1
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",Actin-related protein 3,[H][C@]1(SCC(=O)N1C1=CC(Cl)=CC=C1O)C1=CC=CC(Br)=C1
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",Actin-related protein 2/3 complex subunit 2,[H][C@]1(SCC(=O)N1C1=CC(Cl)=CC=C1O)C1=CC=CC(Br)=C1
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",Actin-related protein 2/3 complex subunit 3,[H][C@]1(SCC(=O)N1C1=CC(Cl)=CC=C1O)C1=CC=CC(Br)=C1
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",Actin-related protein 2/3 complex subunit 4,[H][C@]1(SCC(=O)N1C1=CC(Cl)=CC=C1O)C1=CC=CC(Br)=C1
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",Actin-related protein 2/3 complex subunit 5,[H][C@]1(SCC(=O)N1C1=CC(Cl)=CC=C1O)C1=CC=CC(Br)=C1
(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,Carboxypeptidase B,[H][C@@](C[P@](O)(=O)CCCC1=CC=CC=C1)(C(O)=O)C1=CC(NC(N)=N)=CC=C1
(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,Peroxisome proliferator-activated receptor gamma,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(Cl)C=C1)C(O)=O
(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,cAMP-dependent protein kinase catalytic subunit alpha,NC[C@H](C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C1=CNN=C1
(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,cAMP-dependent protein kinase inhibitor alpha,NC[C@H](C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C1=CNN=C1
(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,Peroxisome proliferator-activated receptor gamma,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(CC)C=C1)C(O)=O
(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,Acetyl-CoA carboxylase 2,[H][C@](C)(OC1=CC=C(OC2=NC=C(C=C2Cl)C(F)(F)F)C=C1)C(O)=O
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,pH-gated potassium channel KcsA,[H][C@](CO)(COC(=O)CCCCCCCC)OC(=O)CCC
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,Ig kappa chain C region,[H][C@](CO)(COC(=O)CCCCCCCC)OC(=O)CCC
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,pH-gated potassium channel KcsA,[H][C@](CO)(COC(=O)CCCCCCCC)OC(=O)CCC
(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,Peroxisome proliferator-activated receptor gamma,[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O
(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol,Cyclin-dependent kinase 6,[H][C@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC(Cl)=CC(N)=C2)=N1)C(C)C
(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol,Cyclin homolog,[H][C@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC(Cl)=CC(N)=C2)=N1)C(C)C
"(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE",Proline iminopeptidase,[H][C@@](C)(N)C(=O)C1=NN=C(O1)C(C)(C)C
"(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL",Methionine aminopeptidase,[H][C@](N)(CCSC)C(O)(O)C1=NC=CS1
"(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate",Glutamate receptor 2,[H][C@](N)(CC1=C(ON=C1[O-])C(C)(C)C)C(O)=O
(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,Peroxisome proliferator-activated receptor gamma,[H][C@@](CC1=CC=C(OCCN2C3=C(OC4=C2C=CC=C4)C=CC=C3)C=C1)(OCC)C(O)=O
(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,2-hydroxychromene-2-carboxylate isomerase,OC(=O)[C@@]1(O)OC2=CC=CC=C2C=C1
(2S)-2-HYDROXYOCTANOIC ACID,Hydroxyacid oxidase 1,[H][C@](O)(CCCCCC)C(O)=O
(2S)-2-HYDROXYOCTANOIC ACID,(S)-mandelate dehydrogenase,[H][C@](O)(CCCCCC)C(O)=O
"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",Lanosterol 14-alpha demethylase,[H][C@@](NS(=O)(=O)C1=CC=CC2=NSN=C12)(C(=O)NC1=CC=NC=C1)C1=CC=CC=C1
"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",Beta-lactamase,[H][C@@](C)(N1C(=O)[C@@]2([H])[C@@]3([H])CC[C@]([H])(C3)[C@@]2([H])C1=O)C(O)=O
"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",Beta-lactamase,[H][C@@](C)(N1C(=O)[C@@]2([H])[C@@]3([H])CC[C@]([H])(C3)[C@@]2([H])C1=O)C(O)=O
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,Carboxypeptidase B,[H][C@@](C[P@](O)(=O)[C@@]([H])(NS(=O)(=O)C1=CC=CC=C1)C(C)C)(C(O)=O)C1=CC(CN)=CC=C1
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,Carboxypeptidase B,[H][C@@](C[P@](O)(=O)[C@@]([H])(NC(=O)OCC1=CC=CC=C1)C(C)C)(C(O)=O)C1=CC(CN)=CC=C1
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,Carboxypeptidase B,[H][C@@](C[P@](O)(=O)[C@@]([H])(NS(=O)(=O)CCCC1=CC=CC=C1)C(C)C)(C(O)=O)C1=CC(CN)=CC=C1
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,Carboxypeptidase B,[H][C@@](C[P@@](O)(=O)[C@@]([H])(NS(=O)(=O)CCC1=CC=CC=C1)C(C)C)(C(O)=O)C1=CC=CC(CN)=C1
"(2S)-2-amino-3-phenylpropane-1,1-diol",Gag-Pol polyprotein,[H][C@](N)(CC1=CC=CC=C1)C(O)O
"(2S)-2-amino-3-phenylpropane-1,1-diol",Gag-Pol polyprotein,[H][C@](N)(CC1=CC=CC=C1)C(O)O
"(2S)-2-amino-3-phenylpropane-1,1-diol",Gag-Pol polyprotein,[H][C@](N)(CC1=CC=CC=C1)C(O)O
(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,Leukotriene A-4 hydrolase,[H][C@](N)(CCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1)C(O)=O
(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,Androgen receptor,C[C@](O)(COC1=C(F)C(F)=C(F)C(F)=C1F)C(=O)NC1=CC=C(C(=C1)C(F)(F)F)[N+]([O-])=O
"(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine","Nitric oxide synthase, inducible",[H][C@]1(C)CN=C(N)C2=C(O1)C=CS2
(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,Peroxisome proliferator-activated receptor delta,[H][C@](CC)(CC1=CC(CNC(=O)C2=C(F)C=C(C=C2)C(F)(F)F)=C(OC)C=C1)C(O)=O
"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",Serine/threonine-protein kinase haspin,[H][C@](CO)(NC1=NN2C(C=C1)=NC=C2C1=CC(N)=CC=C1)C(C)C
"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",Photosynthetic reaction center cytochrome c subunit,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1
"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",Reaction center protein H chain,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1
"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",Reaction center protein L chain,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1
"(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile",Reaction center protein M chain,CCNC1=NC(Cl)=NC(NC(C)(CC)C#N)=N1
(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID,Glutamate carboxypeptidase 2,[H][C@@](CCC(O)=O)(C[P@](O)(=O)CC1=CC=C(I)C=C1)C(O)=O
"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",Nuclear receptor coactivator 1,[H][C@@](CC1=CC2=C(C=C1)N(CC1=C(C)OC(=N1)C1=C(Cl)C=CC=C1)C=C2)(OCC)C(O)=O
"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",Peroxisome proliferator-activated receptor gamma,[H][C@@](CC1=CC2=C(C=C1)N(CC1=C(C)OC(=N1)C1=C(Cl)C=CC=C1)C=C2)(OCC)C(O)=O
(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,Cytosol aminopeptidase,[H][C@@](CC1=CC=CC=C1)(C[P@](O)(=O)[C@]([H])(N)CCC1=CC=CC=C1)C(O)=O
(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,Androgen receptor,CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C=C1
"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",Kinesin-like protein KIF11,[H][C@]1(C=C(CN1C(=O)N(C)C)C1=CC(F)=CC=C1F)C1=CC=CC=C1
"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",Kinesin-like protein KIF11,[H][C@]1(C=C(CN1C(=O)N(C)C1CCNCC1)C1=CC(F)=CC=C1F)C1=CC=CC=C1
"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",Kinesin-like protein KIF11,[H][C@@]1(F)CN(C)CC[C@]1([H])N(C)C(=O)N1CC(=C[C@@]1(CO)C1=CC=CC=C1)C1=CC(F)=CC=C1F
(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,Beta-secretase 1,[H][C@]1(CN(CC2=CC=C(F)C=C2)CCN1)C(=O)NCCS
(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,Beta-secretase 1,[H][C@]1(CN(CC2=CC=C(F)C=C2)CCN1)C(=O)NCCCS
(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,Calpain-1 catalytic subunit,[H][C@@](CC(C)C)(NC(=S)NC1=CC=CC=C1)C(=O)N[C@]1([H])CO[C@]([H])(O)C1
"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,[H][C@]1(CC(=O)C2=C(O1)C=C(OC)C=C2O)C1=CC=C(O)C=C1
"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",Renin,[H][C@]1(OC2=C(C=C(C=C2)C2=C(N)N=C(N)N=C2CC)N(CCCOC)C1=O)C1=CC(F)=CC(F)=C1
(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,S-phase kinase-associated protein 1,[H][C@@](CCCCCCNC(=O)OC(C)(C)C)(C(O)=O)C1=CNC2=C1C=CC=C2
(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,Androgen receptor,C[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC1=CC=C(C#N)C(I)=C1
"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE","Glycogen phosphorylase, muscle form",[H][C@@]1(Cl)SC2=NC(=CC2=C1)C(=O)N[C@@]1([H])CC2=C(C=CC=C2)N(CC(N)=O)C1=O
(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE,Cyclin-A2,[H][C@@](C)(C(=O)\N=C1/C=C(N=N1)C1CC1)C1=CC=C(C=C1)N1CCN=C1O
(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE,Cyclin-dependent kinase 2,[H][C@@](C)(C(=O)\N=C1/C=C(N=N1)C1CC1)C1=CC=C(C=C1)N1CCN=C1O
(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid,4-hydroxymandelate synthase,[H][C@@](O)(C(O)=O)C1=CC=C(O)C=C1
"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",Adenosine deaminase,[H][C@@](C)(O)[C@@]([H])(CCCCCC)N1C=NC2=C(N)N=CN=C12
"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium",Purine nucleoside phosphorylase,[H][C@]1(CSC)N[C@@]([H])(C2=C[NH2+]C3=C2N=CN=C3O)[C@]([H])(O)[C@]1([H])O
"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium","Purine nucleotide phosphorylase, putative",[H][C@]1(CSC)N[C@@]([H])(C2=C[NH2+]C3=C2N=CN=C3O)[C@]([H])(O)[C@]1([H])O
"(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid","MIO-dependent tyrosine 2,3-aminomutase",[H][C@@](O)(C(O)=O)[C@@]([H])(O)C1=CC=C(F)C=C1
"(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE",Dipeptidyl peptidase 4,[H][C@@](N)(C(=O)N1CCC(F)(F)C1)[C@@]([H])(C(=O)N(C)C)[C@@]1([H])CC[C@@]([H])(CC1)C1=CN2N=CN=C2C=C1
"(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE",Dipeptidyl peptidase 4,[H][C@@](N)(C(=O)N1CC[C@]([H])(F)C1)[C@@]([H])(C(=O)N(C)C)[C@@]1([H])CC[C@@]([H])(CC1)C1=CC=CC2=NC=NN12
"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",Chymotrypsin-like elastase family member 1,[H][C@@](CC)(C=O)[C@@]([H])(CNS(=O)(=O)C1=CC=C(C)C=C1)C(O)=O
"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",Chymotrypsin-like elastase family member 1,[H][C@@](CC)(C=O)[C@@]([H])(CNS(=O)(=O)C1=CC=C(C=C1)[N+]([O-])=O)C(O)=O
"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",Dipeptidyl peptidase 4,[H][C@@](N)(C(F)=C1CCCC1)[C@]([H])(CC1CC1)C1=NC(=NO1)C1=CC=C(C=C1Cl)S(C)(=O)=O
"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",Dipeptidyl peptidase 4,[H][C@@](N)(C(=O)N1CCCC1)[C@]([H])(C)C1=NC(=NO1)C1=CC=C(C=C1)S(C)(=O)=O
"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",Dipeptidyl peptidase 4,[H][C@@](N)(C(=O)N1CC[C@]([H])(F)C1)[C@]([H])(CC1CC1)C1([H])N[C@]([H])(NO1)C1=C(F)C=C(C=C1)S(C)(=O)=O
"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,[H][C@](C)(\C=C(/C)\C=C\[C@]([H])(N)[C@]([H])(C)C(O)=O)[C@]([H])(CC1=CC=CC=C1)OC
"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,[H][C@](C)(\C=C(/C)\C=C\[C@]([H])(N)[C@]([H])(C)C(O)=O)[C@]([H])(CC1=CC=CC=C1)OC
"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,[H][C@](C)(\C=C(/C)\C=C\[C@]([H])(N)[C@]([H])(C)C(O)=O)[C@]([H])(CC1=CC=CC=C1)OC
"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",Genome polyprotein,[H][C@@]1(C[C@](CC(C)C)(N(C(=O)C2=CC=C(C=C2)C(C)(C)C)[C@@]1([H])C1=NC=CS1)C(O)=O)C(O)=O
"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",RNA-dependent RNA-polymerase,[H][C@@]1(C[C@](CC(C)C)(N(C(=O)C2=CC=C(C=C2)C(C)(C)C)[C@@]1([H])C1=NC=CS1)C(O)=O)C(O)=O
"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",Genome polyprotein,[H][C@@]1(C[C@](CC(C)C)(N(C(=O)C2=CC=C(C=C2)C(F)(F)F)[C@@]1([H])C1=CC=CS1)C(O)=O)C(O)=O
"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",RNA-dependent RNA-polymerase,[H][C@@]1(C[C@](CC(C)C)(N(C(=O)C2=CC=C(C=C2)C(F)(F)F)[C@@]1([H])C1=CC=CS1)C(O)=O)C(O)=O
"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide","Dihydroorotate dehydrogenase (quinone), mitochondrial",C\C(O)=C(/C#N)C(=O)NC1=CC(Cl)=C(C=C1)C1=CC=CC=C1Cl
(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,"Dihydroorotate dehydrogenase (quinone), mitochondrial",CCOC1=CC(=CC=C1)C1=CC=C(NC(=O)C(\C#N)=C(\C)O)C=C1
(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate,D-alanyl-D-alanine carboxypeptidase,[O-]C(=O)C(=C/OP(=O)=O)\C1=CC=CC=C1
"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",Cyclin-dependent kinase 2,BrC1=CC2=C(NC(=O)\C2=C2/NC3=C(C=CC=C3)C2=O)C=C1
(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,"Dihydroorotate dehydrogenase (quinone), mitochondrial",COC1=CC=CC=C1C1=CC(Cl)=C(NC(=O)C(\C#N)=C(\C)O)C=C1
(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,"Dihydroorotate dehydrogenase (quinone), mitochondrial",O\C(C1CC1)=C(\C#N)C(=O)NC1=CC=C(C=C1)C1=CC=CC=C1
(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,"Dihydroorotate dehydrogenase (quinone), mitochondrial",C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C1=CC=CC=C1
"(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}",Calcium/calmodulin-dependent protein kinase type II subunit alpha,[H][C@](O)(CO)CCO\N=C1\C(\NC2=CC=CC=C\12)=C1\C(=O)NC2=C1C=CC=C2
"(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}",Cyclin-dependent kinase 16,[H][C@](O)(CO)CCO\N=C1\C(\NC2=CC=CC=C\12)=C1\C(=O)NC2=C1C=CC=C2
"(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid","2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",OC(=O)C(\O)=C(\Cl)/C=C/C(=O)C1=CC=CC=C1
(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine,Squalene--hopene cyclase,CN(CC=C)C\C=C\COC1=CC2=C(C=C1F)C(=NN2C)C1=CC=C(Br)C=C1
"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",Cyclin-dependent kinase 2,OC1CCN(CC1)S(=O)(=O)C1=CC2=C(C=C1)NC(=O)\C2=C1/NC2=C(C=CC=C2)[C@]1(C)O
(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid,Peptide deformylase,[H][C@@](CCCC)(CN(O)C=O)C(O)=O
"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",Gag-Pol polyprotein,[H][C@](CCC1=CC=CC=C1)(C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(CCC1=CC=CC=C1)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O
"(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium",Beta-hexosaminidase subunit beta,[H][C@]1(CO)CN[C@]([H])(N=C(C)O)[C@@]([H])(O)[C@@]1([H])O
"(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium",Calcium-activated potassium channel subunit beta-2,[H][C@]1(CO)CN[C@]([H])(N=C(C)O)[C@@]([H])(O)[C@@]1([H])O
"(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran",Autoinducer 2-binding protein LsrB,[H][C@]1(O)CO[C@@](C)(O)C1(O)O
"(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol",Methionine aminopeptidase,[H][C@](N)(CCSC)C(O)(O)C1=CC=CC=N1
"(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol",Methionine aminopeptidase,[H][C@](N)(CCSC)C(O)(O)C1=CC=CC=N1
"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",Genome polyprotein,[H][C@@](CC1=CC=CC=C1)(N(CC1=CC(=CC=C1)C(F)(F)F)C(=O)C1=C(Cl)C=C(Cl)C=C1)C(O)=O
"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",Genome polyprotein,[H][C@@](CC1=CC=CC=C1)(N(CC1=CC=C(S1)C1=CC2=CC=CC=C2O1)C(=O)C1=C(Cl)C=C(Cl)C=C1)C(O)=O
(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile,Lactase-like protein,O[C@H](C#N)C1=CC=C(O)C=C1
(2s)-Pyrrolidin-2-Ylmethylamine,Dipeptidyl peptidase 4,NC[C@@H]1CCCN1
"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",Methionine aminopeptidase 2,[H][C@](N)(CCSCC)[C@]([H])(O)C(=O)N[C@@]([H])(C)C1=C2C=CC=CC2=CC=C1
"(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid","Trans-2,3-dihydro-3-hydroxyanthranilate isomerase",[H][C@]1(O)C=CC=C(C(O)=O)[C@]1([H])N
"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",Trypsin-1,[H][C@@](CCCNC(N)=N)(N=C(O)[C@]1([H])C[C@@]([H])(O)CN1C(C)=O)C(=O)C1=NC2=CC=CC=C2S1
"(2s,4s)-Alpha-Campholinic Acid",6-oxocamphor hydrolase,[H][C@@]1(C)C(=O)C[C@@]([H])(CC(O)O)C1(C)C
"(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate",D-alanyl-D-alanine carboxypeptidase,[H][C@@](CCCCC([O-])=N[C@]1([H])C(=O)N2[C@]1([H])SC(C)(C)[C@]2([H])C(O)=O)(N=C(O)CN)C(O)=O
"(2s,5s)-5-Carboxymethylproline",Carbapenam-3-carboxylate synthase,[H][C@@]1(CC(O)=O)CC[C@]([H])(N1)C(O)=O
(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,Genome polyprotein,OC(=O)C(\NC(=O)C1=CC=CC=C1)=C\C1=CC=C(OC2=CC=CC=C2Br)C=C1
"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",Corticosteroid 11-beta-dehydrogenase isozyme 1,CC1=CC=C(C=C1F)C1=NC(=CC=C1)C(=O)N1CCCC(C)(C)C1
"(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester","Glycogen phosphorylase, muscle form",[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(NP(=O)(OC)OC)[C@]1([H])O
"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",Catechol O-methyltransferase,OC1=CC=C(C(=O)C2=CC=CC=C2)C(=C1O)[N+]([O-])=O
"(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium",Gag-Pol polyprotein,OC1=CC=C(C=C1O)[As+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,Peroxisomal carnitine O-octanoyltransferase,C[N+](C)(C)C[C@H](O)CC(O)=O
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,Carnitine O-acetyltransferase,C[N+](C)(C)C[C@H](O)CC(O)=O
(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,Prostaglandin G/H synthase 1,CCCOC1=CC=C(CC(O)=O)C=C1Cl
"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE",Serine/threonine-protein kinase Chk1,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C1=CNC3=C1C=CC=N3)N2C
"(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE",CHRNA7-FAM7A fusion protein,[H][C@]12CC[C@]([H])(C[C@]([H])(C1)OC1C3=CC=CC=C3CCC3=C1C=CC=C3)[N+]2(C)C
(3-Formyl-but-3-Enyl)-Phosphonic Acid,"Glyceraldehyde-3-phosphate dehydrogenase, glycosomal",OP(O)(=O)CCC(=C)C=O
"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",Oxysterols receptor LXR-beta,OC(=O)CC1=CC(OCCCN(CC(C2=CC=CC=C2)C2=CC=CC=C2)CC2=C(Cl)C(=CC=C2)C(F)(F)F)=CC=C1
"(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE",Androgen receptor,[H][C@]12C(=O)N(C(=O)[C@@]1([H])[C@]1([H])CC[C@@]2([H])CC1)C1=CC=C(C2=CC=CC=C12)[N+]([O-])=O
"(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL",O-GlcNAcase BT_4395,[H][C@]12O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(CCC)S2
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit alpha type-1,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit alpha type-2,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit alpha type-3,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit alpha type-4,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit alpha type-5,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit alpha type-6,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit alpha type-7,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit beta type-1,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit beta type-2,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit beta type-3,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit beta type-4,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit beta type-5,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit beta type-6,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",Proteasome subunit beta type-7,[H][C@](O)([C@@]1([H])CCCC=C1)[C@]1(NC(=O)[C@]2([H])CCO[C@]12C)C=O
"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",Estrogen receptor,[H][C@@]12CC(F)(F)C[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1)C1=CC=C(O)C=C1
"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",Estrogen receptor beta,[H][C@@]12CC(F)(F)C[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1)C1=CC=C(O)C=C1
"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",Estrogen receptor,[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=CC=CC(O)=C21)C1=CC=C(O)C=C1
"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",Estrogen receptor beta,[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1COC)C1=CC=C(O)C=C1
"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",Estrogen receptor,[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1COC)C1=CC=C(O)C=C1
"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",Prothrombin,[H][C@@]12CCC[N@@]1[C@@]([H])(C1=CC=C(C=C1)C(N)=[NH2+])[C@@]1([H])C(=O)N(CC3=CC=C(F)C=C3)C(=O)[C@@]21[H]
"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE","2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",[O-]C(=O)C(=O)\C=C\CC(=O)C1=CC=CC=C1
"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE","4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase",[O-]C(=O)C(=O)\C=C\CC(=O)C1=CC=CC=C1
(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,Heat shock protein HSP 90-alpha,O=C1OCC\C1=C/NC1=CC=CC=C1
(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,Histone acetyltransferase KAT2B,CN1C=C(\C=C\C(C)=O)C2=CC=CC=C12
"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",Mitogen-activated protein kinase 10,O\N=C1\C(=O)N(CC2=C3OCOCC3=CC(F)=C2)C2=CC=C(F)C=C12
"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",Phenylethanolamine N-methyltransferase,[H][C@]1(CF)CC2=CC=C(C=C2CN1)S(=O)(=O)N1CCSCC1
"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",Phenylethanolamine N-methyltransferase,[H][C@]1(CF)CC2=CC=C(C=C2CN1)S(=O)(=O)NCCC(F)(F)F
"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",MAP kinase-activated protein kinase 2,[H][C@@]1(CN)CNC2=C(SC3=C2C=C(OC)C=C3)C(=O)N1
"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",Cyclin-dependent kinase 2,[H][C@@]1(CN)CNC2=C(SC3=C2C=C(OC)C=C3)C(=O)N1
(3R)-3-HYDROXYDODECANOIC ACID,Peroxisomal acyl-coenzyme A oxidase 1,[H][C@@](O)(CCCCCCCCC)CC(O)=O
"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine","Nitric oxide synthase, inducible",[H][C@@]1(COC2=CC=C3CCNCC3=C2)COC2=C(SC=C2)C(N)=N1
"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",Glutamate receptor 2,[H][C@@]1(CC2=CC(C)=C(C=C2S(=O)(=O)N1)S(=O)(=O)N1CCN(C)CC1)C1CCCC1
"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",Glutamate receptor 2,[H][C@@]1(CC2=C(C=C(C=C2)S(=O)(=O)N2CCN(C)CC2)S(=O)(=O)N1)C1CCCC1
(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,Chymotrypsin-like elastase family member 1,[H][C@](CC)(C(O)=O)[C@]([H])(NS(=O)(=O)C1=CC=C(C)C=C1)C(O)=O
"(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate",Acetyl-CoA acetyltransferase,[H][C@](O)(C(=O)NCCC(=O)NCCS)C(C)(C)COC(=O)C(C)(C)C
"(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID",Matrix metalloproteinase-9,[H][C@@](CC(O)=O)(C(F)F)S(=O)(=O)C1=CC=C(OC)C=C1
"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",Dipeptidyl peptidase 4,[H][C@](N)(CC(=O)N1CCCNC(=O)[C@@]1([H])C)CC1=C(F)C=C(F)C(F)=C1
"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",Beta-lactamase SHV-1,[H][C@](NC1=C(C=O)C=C2C=CC=CN12)(C(O)=O)[C@](C)(COC(=O)CC1=CC(O)=C(O)C=C1)[S@](O)=O
"(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline",Prothrombin,[H][C@]1(C)CNC2=C(C1)C=CC=C2S(=O)=O
"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",Tyrosine-protein phosphatase non-receptor type 1,[H][C@]1(CC2=C(CN1C(=O)OCC1=CC=CC=C1)C=C(NS(O)(=O)=O)C=C2)C(=O)NC
"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",Phenylethanolamine N-methyltransferase,[H][C@]1(CO)CC2=CC=C(C=C2CN1)S(=O)(=O)NC1=CC=C(Cl)C=C1
"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",Dipeptidyl peptidase 4,[H][C@]1(N)CN(CC[C@]1([H])C1=CC(F)=C(F)C=C1F)C1=NC=NC(=C1)C1=CC=CC(=C1)S(C)(=O)=O
"(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium",Purine nucleoside phosphorylase,[H]N1C=C(C[N+]2([H])C[C@H](O)[C@@H](CO)C2)C2N=CN([H])C(=O)C12
"(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium",Purine nucleoside phosphorylase,[H]N1C=C(C[N+]2([H])C[C@H](O)[C@@H](CO)C2)C2N=CN([H])C(=O)C12
"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",Dipeptidyl peptidase 4,[H][C@]1(N)CN(C[C@@]1([H])C(=O)N1CCCC1)C(=O)C1=CN=C2C=CC=CC2=N1
"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL","Glycogen phosphorylase, muscle form",[H][C@@]1(O)CN(CCCC2=CC=CC=C2)C[C@]([H])(CO)[C@@]1([H])O
"(3R,4R,5S,6R)-6-Fluoro-3,4,5-trihydroxytetrahydro-2H-pyran-2-olate",Alpha-xylosidase,[H][C@]1(F)OC([O-])[C@H](O)[C@@H](O)[C@@H]1O
"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",Dipeptidyl peptidase 4,[H][C@]1(N)CCN(C[C@@]1([H])C1=CC(C)=CC=C1)C1=CC(OC)=C(OC)C=C1
"(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL",5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,[H][C@]1(O)CN(CC2=CNC3=C(N)N=CN=C23)C[C@]1([H])CSC
"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,[H][C@]1(O)CN(CC2=CNC3=C2N=CN=C3N)C[C@]1([H])CSCC1=CC=CC=C1
"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol",5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,[H][C@]1(O)CN(CC2=CNC3=C2N=CN=C3N)C[C@]1([H])CSCCCC
"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",Dipeptidyl peptidase 4,[H][C@]1(N)CN(C[C@]1([H])C1=C(F)C=C(F)C(F)=C1)C1=CC(=NC=N1)C1=CC=C(OC)N=C1
"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",Dipeptidyl peptidase 4,[H][C@]1(N)CN(C[C@]1([H])C1=CC(F)=C(F)C=C1F)C1=CC(=NC=N1)C1=CC(=CC=C1)S(C)(=O)=O
"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",Type I polyketide synthase PikAIV,[H][C@@]1(C)C[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)O[C@]([H])(CC)[C@]([H])(C)\C=C\C1=O
"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",Mitogen-activated protein kinase 1,[H]\C1=C([H])/C2=CC(OC)=CC(O)=C2C(=O)O[C@]([H])(C)C\C([H])=C([H])/C(=O)[C@@]([H])(O)[C@@]([H])(O)C1
"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE","Nitric oxide synthase, inducible",[H][C@@]1(CCCN(CC2=CC3=C(OCO3)C=C2)C1)OC1=CC=C(C=C1)N1C=CN=C1
(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid,Beta-lactamase,[H][C@]1(CN(C(=O)C1)C1=C(O)C=CC=C1)C(O)=O
(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,Beta-lactamase,[H][C@]1(CN(C(=O)C1)C1=CC=C(C=C1)C(C)=O)C(O)=O
(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,Enoyl-[acyl-carrier-protein] reductase [NADH],[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=CC=CC=C1
"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",Enoyl-[acyl-carrier-protein] reductase [NADH],[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=CC(Cl)=CC(Cl)=C1
(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol,Disintegrin and metalloproteinase domain-containing protein 17,[H][C@]1(S)CCN(C1)S(=O)(=O)C1=CC=C(OCC#CC)C=C1
"(3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine",Beta-lactamase SHV-1,[H]\C(N[C@@]([H])(C(O)=O)[C@](C)(CN1C=CN=N1)S(=O)=O)=C(\[H])C=O
"(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine",Beta-lactamase SHV-1,[H]\C(N[C@@]([H])(C(O)=O)[C@](C)(CN1C=CN=N1)S(=O)=O)=C(/[H])C=O
"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",Glutamate receptor 2,[H][C@@]1(NC2=CC(C)=C(C=C2S(=O)(=O)N1)S(=O)(=O)N1CCN(C)CC1)C1CCCC1
"(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione",Ribosyldihydronicotinamide dehydrogenase [quinone],[H][C@@]1(O)CN(C)C2=CC(=O)C(=O)C=C12
"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",Disintegrin and metalloproteinase domain-containing protein 17,[H][C@]1(N(CCSC1(C)C)S(=O)(=O)C1=CC=C(OCC#CC)C=C1)C(=O)NO
(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,Enoyl-[acyl-carrier-protein] reductase [NADH],[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=CC=CC(Br)=C1
(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,Enoyl-[acyl-carrier-protein] reductase [NADH],[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=C(C)C(Cl)=CC=C1
(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,Enoyl-[acyl-carrier-protein] reductase [NADH],[H][C@]1(CN(C2CCCCC2)C(=O)C1)C(=O)NC1=C(C)C=CC(Cl)=C1
"(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine","Nitric oxide synthase, endothelial",[H][C@]1(CCC)COC2=C(SC=C2)C(=N)N1
"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol","Glycogen phosphorylase, muscle form",[H][C@]1(C[C@]2(ON1)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)C1=CC2=CC=CC=C2C=C1
"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol","Glycogen phosphorylase, muscle form",[H][C@]1(C[C@]2(ON1)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)C1=CC=C(C)C=C1
"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",Mycocyclosin synthase,[H][C@@]1(CC2=CC=C(O)C=C2)NC(=O)[C@]([H])(CC2=CC=C(O)C=C2)NC1=O
"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",Mitogen-activated protein kinase 10,O\N=C1/C(=O)N(CC2=C3OCOCC3=CC(F)=C2)C2=CC=CC(\C=C\C3=CC=CC=C3)=C12
"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",Mitogen-activated protein kinase 10,O\N=C1/C(=O)N(CC2=CC(F)=CC3=C2OCOC3)C2=CC=CC(=C12)C1=CC=CC=C1
"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",Serine/threonine-protein kinase Chk1,COC1=CC(=CC=C1O)C1=CC2=C(C=C1)\C(=C\C1=CC=CN1)C(=O)N2
"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",Calmodulin,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1
"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",Calcium/calmodulin-dependent protein kinase type II subunit delta,CN(C)S(=O)(=O)C1=CC=C2NC(=O)\C(=C/C3=CC4=C(CCCC4)N3)C2=C1
"(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",Beta-glucosidase A,[H][C@]12CO\C(=N/CCCCCCCC)N1[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]2([H])O
"(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol",Beta-glucosidase A,[H][C@]12CS\C(=N/CCCCCCCC)N1[C@@H](O)[C@H](O)[C@@H](O)[C@@H]2O
"(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",Beta-glucosidase A,[H][C@]12CO\C(=N/CCCCCCCC)N1[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@@]2([H])O
"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",Myosin-14,O[C@@]12CCN(C1=NC1=C(C=CC=C1)C2=O)C1=CC=CC=C1
"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",Myosin-14,CC1=C2C(=CC=C1)N=C1N(CC[C@@]1(O)C2=O)C1=CC=CC=C1
"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",Myosin-14,CC1=CC=C2C(=C1)N=C1N(CC[C@@]1(O)C2=O)C1=CC=CC=C1
"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",Estrogen receptor beta,[H][C@@]12CC(F)(F)C[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1COC)C1=CC=C(O)C=C1
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,Serine/threonine-protein kinase pim-1,OC1=CC=C(C=C1)\N=C1/C(=O)NC2=CC=CC=C12
"(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime",Glycogen synthase kinase-3 beta,O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC(Br)=C2
(3r)-1-Acetyl-3-Methylpiperidine,Peptidyl-prolyl cis-trans isomerase A,C[C@@H]1CCCN(C1)C(C)=O
(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,Streptopain,[H][C@](CC1=CC=CC=C1)([N-]C(=O)OCC1=CC=CC=C1)C(=[OH+])C[N+]#N
"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine",Peptidyl-prolyl cis-trans isomerase FKBP1A,[H][C@@](CC(C)C)(NC(=O)[C@]1([H])CSCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(O)=O
"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester",Peptidyl-prolyl cis-trans isomerase FKBP1A,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]1([H])CSCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(=O)OCC
"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",3-hydroxy-3-methylglutaryl-coenzyme A reductase,[H][C@@](O)(CC[C@@]1([H])[C@@]([H])(C)C=CC2=C[C@]([H])(C)C[C@]([H])(OC(=O)[C@@]([H])(C)CC)[C@]12[H])C[C@@]([H])(O)CC(O)=O
"(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine",Phospholipase C,[H][C@](CCP([O-])(=O)OCC[N+](C)(C)C)(COC(=O)CCCCC)OC(=O)CCCCC
"(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol",Methionine aminopeptidase,[H][C@](N)(CCCC)C(O)(O)CNC1CC1
"(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol",Methionine aminopeptidase,[H][C@](N)(CCCC)C(O)(O)CNC1CC1
"(3s)-Tetrahydrofuran-3-Yl (1r,2s)-3-[4-((1r)-2-{[(S)-Amino(Hydroxy)Methyl]Oxy}-2,3-Dihydro-1h-Inden-1-Yl)-2-Benzyl-3-Oxopyrrolidin-2-Yl]-1-Benzyl-2-Hydroxypropylcarbamate",Gag-Pol polyprotein,[H][C@](N)(O)O[C@]1([H])CC2=CC=CC=C2[C@]1([H])[C@]1([H])CN[C@@](CC2=CC=CC=C2)(C[C@]([H])(O)[C@]([H])(CC2=CC=CC=C2)N=C(O)O[C@@]2([H])CCOC2)C1=O
"(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-",Peptidyl-prolyl cis-trans isomerase A,[H]\C(CC[C@]([H])(C)[C@@]([H])(O)C[C@]1([H])O[C@@]2(N=C(O)[C@@]([H])(CC)C[C@]2([H])C)[C@@]([H])(C)[C@@]([H])(O)[C@@]1([H])C)=C(\[H])/C(/[H])=C(\C)[C@]1([H])C\C([H])=C(/[H])\C(\[H])=C([H])\[C@]([H])(O)[C@]([H])(C)[C@@]([H])(O)[C@@]([H])(CCC(C)=O)C(O)=N[C@@]([H])(C(C)C)C(O)=N[C@@]([H])(CC2=CC(O)=CC=C2)C(=O)N2CCC[C@]([H])(N2)C(=O)O1
"(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",Chitinase B,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CN=CN1)N=C2O
"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",Chitinase B,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=C(O)C=C1)NC2=O
"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",Chitinase,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=C(O)C=C1)NC2=O
"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",Squalene--hopene cyclase,CN(CC=C)CC1=CC=C(C=C1)C1=CC=C(C=C1)C(=O)C1=CC=C(Br)C=C1
"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",Cyclin-dependent kinase 2,COC1=C(C(=O)C2=CN=C(NC3CCN(CC3)S(C)(=O)=O)N=C2N)C(F)=C(F)C=C1
(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,Squalene--hopene cyclase,CN(C\C=C\COC1=CC=C(C=C1)C(=O)C1=CC=C(Br)C=C1)C1CC1
(4-ETHYLPHENYL)SULFAMIC ACID,Receptor-type tyrosine-protein phosphatase beta,CCC1=CC=C(NS(O)(=O)=O)C=C1
(4-fluorophenyl)(pyridin-4-yl)methanone,Leukotriene A-4 hydrolase,FC1=CC=C(C=C1)C(=O)C1=CC=NC=C1
(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(NC(=S)OCCC2=CSC=C2)C=C1
(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CC1=CC=C(C[Se](O)=O)C=C1)(NC(=O)OC(C)(C)C)C(=O)OC
"(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID",Receptor-type tyrosine-protein phosphatase beta,CCOC(=O)C(CCNC(=O)OC(C)(C)C)(CC1=CC=C(NS(O)(=O)=O)C=C1)C(=O)OCC
(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,Cyclin-dependent kinase 2,FC1=CC=C(NC(=O)C2=NNC=C2NC(=O)C2=CC=CC=C2)C=C1
"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",Kinesin-like protein KIF11,[H][C@@]1(CN(CC2=C1C=CC(C)=C2C)C(=O)N(C)C)C1=CC(O)=CC=C1
(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",[H][C@@]1(CC2=CC(OCCCC)=C(OC)C=C2)CNC(=O)N1
(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",[H][C@@]1(CC2=CC(OCCCC)=C(OC)C=C2)CNC(=O)N1
"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",Death-associated protein kinase 3,[H][C@@]1(C#N)C2=C(N(C)C3=C(Cl)C(Cl)=CC=C23)C(=O)NC11CCN(C)CC1
"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",Serine/threonine-protein kinase pim-1,[H][C@@]1(C#N)C2=C(N(C)C3=C(Cl)C(Cl)=CC=C23)C(=O)NC11CCN(C)CC1
"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",Serine/threonine-protein kinase pim-1,[H][C@@]1(C#N)C2=C(N(C)C3=CC(Cl)=CC=C23)C(=O)NC11CCNCC1
"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",MAP kinase-activated protein kinase 2,[H][C@]1(C)CNC(=O)C2=C1C1=CC(=CC=C1N2)C(=O)NC1=NC(=CS1)C(=O)NCCN(C)C
"(4R)-limonene 1α,2α-epoxide",Epididymal-specific lipocalin-9,CC(=C)[C@@H]1CC[C@@]2(C)O[C@H]2C1
"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@]1(CNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C[C@]([H])(CN1)OCC1=CC=C(Cl)C=C1
"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",cAMP-dependent protein kinase inhibitor alpha,[H][C@@]1(CNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C[C@]([H])(CN1)OCC1=CC=C(Cl)C=C1
"(4R,5R)-1,2-dithiane-4,5-diol",Penicillin acylase,O[C@H]1CSSC[C@@H]1O
"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",Dipeptidyl peptidase 4,[H][C@]1(N)CN(CCC2=CC=C3OCOC3=C2)C(=O)C[C@]1([H])C1=CC(F)=C(F)C=C1F
(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,Glutamate racemase,[H][C@@](N)(C[C@]([H])(CC1=CC2=CC=CC=C2C=C1)C(O)=O)C(O)=O
"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid",Peroxisome proliferator-activated receptor gamma,[H][C@](O)(CCC(O)=O)\C=C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC
"(4S,5S)-1,2-dithiane-4,5-diol","6,7-dimethyl-8-ribityllumazine synthase",[H][C@@]1(O)CSSC[C@@]1([H])O
"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",Ig kappa chain C region,[H][C@@]12C[C@]3([H])O[C@]4([H])C\C=C/[C@]([H])(O)[C@@]([H])(CO)O[C@@]4([H])C=C[C@@]3([H])O[C@@]1([H])[C@]([H])(O)[C@@]1([H])OCC=CC[C@]1([H])O2
"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",Insulin-like growth factor 1 receptor,BrC1=CC=C2C(=O)NC(=O)\C(=C/NC3=CC=C(CN4CCCC4)C=C3)C2=C1
"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",Dihydrofolate reductase,[H][C@]12C=CCC=C1C=CC1=CC(O)=CC=C1N2CC1=NC2=C(N)N=C(N)N=C2N=C1
"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",Carbonic anhydrase 2,[H][C@]12CC[C@]3(C)C(=O)N(CC4=CC=CN=C4)C(=O)C[C@@]3([H])[C@]1([H])CCC1=C2C=CC(OS(N)(=O)=O)=C1
"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",Acetylcholinesterase,[H][C@]12C[C@@]([H])(O)C=C[C@]11CCN(CCCCCCCCN3C(=O)C4=CC=CC=C4C3=O)C=C3C=CC(=[O+]C)C(O2)=C13
(4e)-4-Aminohex-4-Enoic Acid,"4-aminobutyrate aminotransferase, mitochondrial",[H]\C(C)=C(/N)CCC(O)=O
"(4e,8e,12z,16z)-N,N,4,8,13,17,21-Heptamethyldocosa-4,8,12,16,20-Pentaen-1-Amine",Squalene--hopene cyclase,CN(C)CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C
"(4r)-2-Methylpentane-2,4-Diol",Xylose isomerase,C[C@H](O)CC(C)(C)O
"(4r)-2-Methylpentane-2,4-Diol",1-pyrroline-5-carboxylate dehydrogenase,C[C@H](O)CC(C)(C)O
"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",Gag-Pol polyprotein,[H][C@]1(COC2=CC=CC=C2)N(CC2=CC=CC=C2)C(=O)N(CC2=CC=CC=C2)[C@]([H])(COC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O
"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",Thiostrepton,[H][C@@]1(CSC(=N1)C(\N)=C\C)C(O)=O
"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",50S ribosomal protein L11,[H][C@@]1(CSC(=N1)C(\N)=C\C)C(O)=O
(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate,Aspartate-semialdehyde dehydrogenase,[H][C@](O)(C[C@]([H])(N)C(O)=O)SC[C@]([H])(N)C(O)=O
(4s)-5-Fluoro-L-Leucine,Polyubiquitin-B,C[C@H](CF)C[C@H](N)C(O)=O
"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",Carbonic anhydrase 2,[H][C@]1(C)C[C@]([H])(NC)C2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O
"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",Serine/threonine-protein kinase Chk1,CN(CCO)C1=NC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1
(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,Cytochrome P450 2A6,NCC1=CC=C(O1)C1=CC=CN=C1
"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",Tryptase beta-2,NCC1=CC=C2OCC3(CCN(CC3)C(=O)C3=CC=C(O3)C#CC3=CC=CC=C3)C2=C1
(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,Aldose reductase,OC(=O)COC1=CC(Cl)=CC=C1C(=O)NCC1=CC(=CC=C1)[N+]([O-])=O
"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",Cyclin-dependent kinase 2,CS(=O)(=O)C1=CC=C(NC2=CC(Cl)=NC3=CC=NN23)C=C1
"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",Casein kinase II subunit alpha,OC(=O)CC1=C2NC(=O)C3=CC=CC=C3N2C2=C1C=CC=C2
"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",Cyclin-dependent kinase 2,OCC1=C2N=C(C=C(NCC3=CN=CC=C3)N2N=C1)C1=CC=CC=C1
"(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL",Serine/threonine-protein kinase Chk1,OCC1=NNN=C1C1=CC2=C(C=C1)C(=NN2)C1=CC2=C(N1)C=CC(CN1CCCCC1)=C2
"(5BETA)-PREGNANE-3,20-DIONE",Nuclear receptor coactivator 1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
"(5BETA)-PREGNANE-3,20-DIONE",Retinoic acid receptor RXR-alpha,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
"(5BETA)-PREGNANE-3,20-DIONE",Nuclear receptor subfamily 1 group I member 3,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
"(5BETA)-PREGNANE-3,20-DIONE",3-oxo-5-beta-steroid 4-dehydrogenase,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",Heat shock protein HSP 90-beta,OC1=CC(O)=C2C(CC(=O)CCC\C=C\CCOC2=O)=C1Cl
"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",Heat shock protein HSP 90-beta,OC1=CC(O)=C2C(CC(=O)CCCCC\C=C\CCOC2=O)=C1Cl
"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",FC1(F)OC2=C(O1)C=C(\C=C1/SC(=O)NC1=O)C=C2
"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",Prostaglandin reductase 1,[H]C(CCCC(O)=O)=C([H])CC1C(\C([H])=C(/[H])C(=O)CCCCC)C(O)CC1=O
"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",Prostaglandin reductase 2,[H]C(CCCC(O)=O)=C([H])CC1C(\C([H])=C(/[H])C(=O)CCCCC)C(O)CC1=O
"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",Peroxisome proliferator-activated receptor gamma,[H][C@]1(C\C=C\CCCC(O)=O)C=CC(=O)\C1=C/C=C/CCCCC
"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",Heat shock protein HSP 90-alpha,[H][C@]1(C\C(=N/O)C2=C(C1)N=C(N)N=C2C)C1=CC=C(F)C=C1C1=CC=CN=C1
"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",Afadin,[H][C@]1(CC2=CC=C(C=C2)C(F)(F)F)SC(S)=NC1=O
"(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one",Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]1(SC(NC2=C(F)C=CC=C2)=NC1=O)C(C)C
"(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE",3-oxoacyl-[acyl-carrier-protein] synthase 1,C\C=C\C(\C)=C\[C@@]1(C)SC(=O)C(C)=C1O
"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",Cytochrome P450 2C8,[H][C@]1(CC2=CC=C(OC[C@@]3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O
"(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE",3-oxoacyl-[acyl-carrier-protein] synthase 1,CC1=C(O)[C@](C)(SC1=O)\C=C\C=C
"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",Kinesin-like protein KIF11,[H][C@@]1(C)CCC2=C(C1)C(C(=O)N(CC)CC)=C(NC(=O)C1=CC=CS1)S2
"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid",Peroxisome proliferator-activated receptor gamma,[H][C@@](O)(CCCC(O)=O)\C=C\C=C/C\C=C/C\C=C/C\C=C/CC
"(5R,6S,7S,8S)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-A]piperidine",Beta-galactosidase,[H][C@]1(O)C2=NN=NN2[C@]([H])(CO)[C@]([H])(O)[C@]1([H])O
"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",Carboxypeptidase B,[H][C@](NC(=O)OCC1=CC=CC=C1)(C(C)C)[P@@](O)(=O)O[C@]([H])(C(O)=O)C1=CC(CN)=CC=C1
"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol","Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]2(CC(=NO2)C2=CC=CC=C2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one",Genome polyprotein,[H][C@@]1(C(C)C)N(CC2=CC=CC=C2)C(=O)C(=C1O)C1=NS(=O)(=O)C2=C1C=CC=C2
"(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",Corticosteroid 11-beta-dehydrogenase isozyme 1,CCC[C@]1(C)SC(NC2CCCCCCC2)=NC1=O
"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@](C)(NC1=NC(=O)[C@](C)(S1)C(F)(F)F)C1=C(F)C=CC=C1
"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@](C)(NC1=NC(=O)[C@@](C)(S1)C(C)(C)O)C1=CC=C(F)C=C1
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE","Cytochrome c1, heme protein, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",Cytochrome b,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE","Cytochrome b-c1 complex subunit 1, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE","Cytochrome b-c1 complex subunit 2, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE","Cytochrome b-c1 complex subunit 6, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",Cytochrome b-c1 complex subunit 8,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE","Cytochrome b-c1 complex subunit Rieske, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",Cytochrome b-c1 complex subunit 10,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",Cytochrome b-c1 complex subunit 7,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",Cytochrome b-c1 complex subunit 9,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F
"(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide",Dual specificity mitogen-activated protein kinase kinase 1,[H][C@@]1(F)C(F)=CC=C(C(=O)NOCCO)\C1=N\C1=C(F)C=C(I)C=C1
"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",Neutrophil collagenase,[H][C@@]1(CC(N)=O)CCCC2=C1C1=C(S2)N=C(NC1=O)C(=O)NCC1=CC=C2OCC(=O)NC2=C1
"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",Kinesin-like protein KIF11,CCNC(=O)N1N=C(C[C@@]1(CCCN)C1=CC=CC=C1)C1=C(F)C=CC(F)=C1
"(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE",Signal peptidase I,[H][C@](C)(OC(C)=O)[C@@]([H])(C=O)[C@@]1([H])NC(=CS1)C(=O)OCC=C
"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",Androgen receptor,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12CCOCC1=CC(F)=CC(F)=C1
"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",Heat shock protein HSP 90-beta,OC1=CC(O)=C2C(CC(=O)CCC\C=C/CCOC2=O)=C1Cl
"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",Heat shock protein HSP 90-beta,OC1=CC(O)=C2C(CC(=O)CCCC\C=C\CCOC2=O)=C1Cl
(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,UDP-N-acetylenolpyruvoylglucosamine reductase,OC1=C(C(=O)O\C1=C/C1=CC=CC2=CC=CC=C12)C1=CC=C(Cl)C=C1
"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",Cyclin-dependent kinase 2,BrC1=CC=CC(=C1)C1=NC2=[N+](NC=C2)C(NCC2=CC=NC=C2)=C1
"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",Genome polyprotein,[H][C@@](NC1=NC(=O)\C(S1)=C\C1=CC=C(CC)O1)(C1=NN=NN1)C1=CC=C(F)C=C1
"(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid",Prostacyclin synthase,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@]2([H])C[C@@]([H])(N=N2)[C@]1([H])C(\[H])=C(/[H])CCCCCC
(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,Bifunctional protein FolC,N[C@H](CO)CCCCNC(O)=O
(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,Parathion hydrolase,N[C@H](CO)CCCCNC(O)=O
(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,Isoaspartyl dipeptidase,N[C@H](CO)CCCCNC(O)=O
"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One","cGMP-inhibited 3',5'-cyclic phosphodiesterase B",[H][C@@]1(C)CC(O)=NN=C1C1=CC=C(NC2=C(CC3=CC(I)=CC=C3)C(=O)CCC2)C=C1
"(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione",Dihydropyrimidine dehydrogenase [NADP(+)],[H][C@]1(I)CN=C(O)N=C1O
"(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE",Thermolysin,[H][C@@]1(C[P@@]([H])([O-])=O)CCC2=CC(C)=CC=C2O1
"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",Gag-Pol polyprotein,CC1=CC(=CC(C)=C1OC1=C(Br)C(CO)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N
"(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE",Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,[H][C@@]12CC3=C4C(NC=C4[C@]1([H])[C@]1([H])N(C(O)=C(C(C)=O)C1=O)C2(C)C)=CC=C3
"(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)",Geranylgeranyl pyrophosphate synthase,CCCCC\C=C\CC(C\C=C\CCCCC)(P(O)(O)=O)P(O)(O)=O
"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",Beta-secretase 1,COC1=CC(=CC=C1)C1=CC(CC[C@]2(C)CC(=O)N(C)C(N)=N2)=CC=C1
(6R)-Folinic acid,Formimidoyltransferase-cyclodeaminase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@]2([H])CNC3=C(N2C=O)C(O)=NC(=N)N3)C=C1)C(O)=O
(6R)-Folinic acid,Aminomethyltransferase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@]2([H])CNC3=C(N2C=O)C(O)=NC(=N)N3)C=C1)C(O)=O
(6R)-Folinic acid,Serine hydroxymethyltransferase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@]2([H])CNC3=C(N2C=O)C(O)=NC(=N)N3)C=C1)C(O)=O
(6R)-Folinic acid,Bifunctional polymyxin resistance protein ArnA,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@]2([H])CNC3=C(N2C=O)C(O)=NC(=N)N3)C=C1)C(O)=O
(6R)-Folinic acid,Dimethylglycine oxidase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@]2([H])CNC3=C(N2C=O)C(O)=NC(=N)N3)C=C1)C(O)=O
"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",Prolyl endopeptidase,[H][C@]1(C=CC2=C(Cl)N=C(OCC3=CC=C(F)C=C3)C(=O)N12)C(=O)N1CCCC1
"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",Beta-secretase 1,COC1=CC(=CC=C1)C1=CC(=CC=C1)[C@]1(C)CC(=O)N(C)C(N)=N1
"(6S)-5,6,7,8-tetrahydrofolate",Nitric oxide synthase oxygenase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@@]2([H])CNC3=C(N2)C(O)=NC(=N)N3)C=C1)C(O)=O
"(6S)-5,6,7,8-tetrahydrofolate",Thymidylate synthase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@@]2([H])CNC3=C(N2)C(O)=NC(=N)N3)C=C1)C(O)=O
"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",Genome polyprotein,CC(C)OC1=CC=C(CC[C@]2(CC(O)=CC(=O)O2)C2CCCC2)C=C1F
"(6r,7r)-3-[(Acetyloxy)Methyl]-7-{[(6s)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Octane-2-Carboxylate",D-alanyl-D-alanine carboxypeptidase,[H][C@@](CCCCC([O-])=N[C@]1([H])C(=O)N2[C@]1([H])SC[C@@]([H])(COC(C)=O)[C@@]2([H])C(O)=O)(N=C(O)CN)C(O)=O
"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",Beta-lactamase,[H][C@]1(SCC(=NC=C1C(O)=O)C(O)=O)C1=CN2C(SC3=C2CCC3)=N1
"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",Beta-lactamase SHV-1,[H][C@]1(SCC(=NC=C1C(O)=O)C(O)=O)C1=CN2C(SC3=C2CCC3)=N1
"(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid",Beta-lactamase SHV-1,[H][C@]1(SCC(=NC=C1C(O)=O)C(O)=O)C1=CN2C(SC3=C2CCC3)=N1
"(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid","Hydroxymethylglutaryl-CoA synthase, cytoplasmic",[H]C(C(O)=O)=C(C)C(\[H])=C(/C)C[C@]([H])(C)CCCC[C@@]([H])(O)[C@@]([H])(CO)C=O
"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",Dipeptidyl peptidase 4,[H][C@]1(N)CN2C(C[C@]1([H])C1=CC(F)=C(F)C=C1F)=NC1=C2C=CN=C1
"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",Glycogen synthase kinase-3 beta,[H][C@]1(CCF)CNC(=O)C2=C1NC(=C2)C1=NC(N)=NC=C1
"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",Cell division protein ZipA,[H][C@@]12CCCC[N@]1CC(=O)C1=C2NC2=C1C=CC=C2
"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",Cell division protein ZipA,[H][C@@]12CCCC[N@]1CC(=O)C1=C2NC2=C1C=CC=C2
"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid",Peroxisome proliferator-activated receptor gamma,[H][C@](O)(C\C=C/CCCCC)\C=C\CC(=O)CCCCC(O)=O
"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid",Peroxisome proliferator-activated receptor gamma,[H][C@@](O)(CC(=O)CCCCC(O)=O)\C=C/C\C=C/CCCCC
"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",Nuclear receptor coactivator 1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C=C(CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(O)=O)C(=O)C1=CC=C(O)C=C1
"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",Bile acid receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C=C(CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(O)=O)C(=O)C1=CC=C(O)C=C1
"(8ar)-Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",Chitinase B,O=C1CNC(=O)[C@@H]2CCCN12
"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",Estrogen receptor,[H]\C(CC)=C(/[H])C1=C(O)C=C2CC[C@@]3([H])[C@]4([H])CC[C@]([H])(O)[C@@]4(C)CC[C@]3([H])C2=C1
"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",Nuclear receptor coactivator 2,[H]\C(CC)=C(/[H])C1=C(O)C=C2CC[C@@]3([H])[C@]4([H])CC[C@]([H])(O)[C@@]4(C)CC[C@]3([H])C2=C1
"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",Estrogen receptor,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])[C@@]([H])(COC)C[C@]12C
"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",Nuclear receptor coactivator 2,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])[C@@]([H])(COC)C[C@]12C
"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",Carbonic anhydrase 2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=C(C=C(OC)C(OS(N)(=O)=O)=C4)[C@@]3([H])CC[C@]12C)OS(N)(=O)=O
"(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",Glutathione S-transferase Mu 1,[H][C@](N)(CCC(=O)N[C@@]([H])(CS[C@]1([H])C2=CC=CC=C2C2=CC=CC=C2[C@@]1([H])O)C(=O)NCC(O)=O)C(O)=O
"(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",Glutathione S-transferase P,[H][C@](N)(CCC(=O)N[C@@]([H])(CS[C@]1([H])C2=CC=CC=C2C2=CC=CC=C2[C@@]1([H])O)C(=O)NCC(O)=O)C(O)=O
"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",Acetylcholinesterase,[NH3+]CCCCCCCCNC1=C2CCCCC2=[NH+]C2=CC=CC=C12
"(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid",Peroxisome proliferator-activated receptor gamma,[H][C@](O)(CCCCCCCC(O)=O)\C=C\C=C/CCCCC
"(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene",Glutathione S-transferase Mu 1,[H][C@](N)(CCC(O)=N[C@@]([H])(CS[C@@]1([H])C2=CC=CC=C2C2=CC=CC=C2[C@]1([H])O)C(O)=NCC(O)=O)C(O)=O
"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",Gag-Pol polyprotein,[H][C@]1(CC2=CC=C(OCCCCC(=O)N[C@@]([H])(C(C)C)C(=O)N1)C=C2)C(O)=O
"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid",Peroxisome proliferator-activated receptor gamma,[H][C@](O)(CCCCC)\C=C\C=C/CCCCCCCC(O)=O
"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",Estrogen receptor beta,CCCC[C@]12CC3=CC(O)=CC=C3C1=C(Br)C(=O)CC2
(C8-R)-Hydantocidin 5'-Phosphate,Adenylosuccinate synthetase,[H][C@](CCCN1C(O)=N[C@@]2(O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@@]2([H])O)C1=O)(N(O)CO)C(O)=O
(C8-S)-Hydantocidin 5'-Phosphate,Adenylosuccinate synthetase,[H][C@@](CCCN1C(O)=N[C@@]2(O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@@]2([H])O)C1=O)(N(O)CO)C(O)=O
(Carboxyhydroxyamino)Ethanoic Acid,Adenylosuccinate synthetase,ON(CC(O)=O)C(O)=O
(Carboxyhydroxyamino)Ethanoic Acid,Adenylosuccinate synthetase,ON(CC(O)=O)C(O)=O
(Diaminomethyl-Methyl-Amino)-Acetic Acid,Creatine kinase M-type,CN(CC(O)=O)C(N)N
(Diphosphono)Aminophosphonic Acid,S-adenosylmethionine synthase,OP(O)(=O)N[P@](O)(=O)OP(O)(O)=O
"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",Methionine aminopeptidase 2,[H]\C(=C(\[H])C(C)(C)C)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(OC)C(O)=N[C@@]1([H])CC[C@@]([H])(O)CN=C1O
(E)-2-Fluoro-P-Hydroxycinnamate,Tautomerase PptA,[H]\C(=C(/F)C(O)=O)C1=CC=C([O-])C=C1
"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",Gag-Pol polyprotein,COC1=C(\C=N\NC(=O)C2=CC(O)=C(O)C=C2)C2=CC=CC=C2C=C1
(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,Lethal factor,[H]\C(C1=CC=C(O1)C1=CC=C(Cl)C=C1)=C1/SC(=S)N(CCC(O)=O)C1=O
"(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol",Fibroblast growth factor receptor 1,COC1=CC(=CC=C1)C(\O)=C1/C=NC2=NC=CC(=C12)C1=CC(F)=CC(F)=C1
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Vitamin B12 transporter BtuB,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Squalene--hopene cyclase,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Outer membrane protein F,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Long-chain fatty acid transport protein,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Porin,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Outer membrane protein A,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Outer membrane protein X,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Colipase,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Pancreatic triacylglycerol lipase,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Rhodopsin,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,"Apocarotenoid-15,15'-oxygenase",CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Outer membrane protein G,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Outer membrane protein W,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Adhesin,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Porin P,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Porin D,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Porin,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Vanillate porin OpdK,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Outer membrane usher protein PapC,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Membrane protein,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,TbuX,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Membrane protein involved in aromatic hydrocarbon degradation,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Probable outer membrane protein,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Hypothetical conserved protein,CCCCCCCCOCCOCCOCCOCCO
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,Esterase EstA,CCCCCCCCOCCOCCOCCOCCO
(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,Genome polyprotein,CCOC(=O)C1=CC=C(OCCCCC2CCN(CC2)C2=NN=C(C)C=C2)C=C1
(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,Genome polyprotein,CCOC(=O)C1=CC=C(OCCCCC2CCN(CC2)C2=NN=C(C)C=C2)C=C1
(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,Genome polyprotein,CCOC(=O)C1=CC=C(OCCC2CCN(CC2)C2=NN=C(C)C=C2)C=C1
(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,Genome polyprotein,CCOC(=O)C1=CC=C(OCCC2CCN(CC2)C2=NN=C(C)C=C2)C=C1
(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,Genome polyprotein,CCOC(=O)C1=CC=C(OCCCC2CCN(CC2)C2=NN=C(C)C=C2)C=C1
(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,Genome polyprotein,CCOC(=O)C1=CC=C(OCCCC2CCN(CC2)C2=NN=C(C)C=C2)C=C1
"(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)","Sulfite oxidase, mitochondrial",NC1=NC2=C(N[C@@H]3[C@H](N2)O[C@@H](COP(O)(O)=O)C2=C3S[Mo](S)(=O)(=O)S2)C(=O)N1
(Mu-4-Sulfido)-Tetra-Nuclear Copper Ion,Oxidoreductase,[Cu]12[S@]34[Cu]5[Cu@]13[Cu@]245
(Mu-4-Sulfido)-Tetra-Nuclear Copper Ion,Nitrous-oxide reductase,[Cu]12[S@]34[Cu]5[Cu@]13[Cu@]245
(P-Iodophenylacetylamino)Methylphosphinic Acid,Beta-lactamase,[H][P@](O)(=O)CNC(=O)CC1=CC=C(I)C=C1
"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",Gag-Pol polyprotein,COC(=O)[C@@H]1CS[C@]2(N1C(=O)C1=CC=CC=C21)C1=CC=CC=C1
"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",Gag-Pol polyprotein,CC1=CC(=CC=C1)[C@]12SCCN1C(=O)C1=CC=CC=C21
"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE",Coagulation factor XI,[H][C@@]1(CO)COB(O1)C1=CC=C(CNC(N)=N)C=C1
"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE",Coagulation factor XI,[H][C@@]1(CO)COB(O1)C1=CC=C(CCNC(N)=N)C=C1
"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE",Coagulation factor XI,[H][C@@]1(CO)COB(O1)C1=CC=C(NC(N)=N)C=C1
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,Halohydrin dehalogenase,[H][C@](O)(CN=[N+]=[N-])C1=CC=C(C=C1)[N+]([O-])=O
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,Galectin-9,[H][C@](O)(CN=[N+]=[N-])C1=CC=C(C=C1)[N+]([O-])=O
(R)-1-phenylethanol,R-specific alcohol dehydrogenase,C[C@@H](O)C1=CC=CC=C1
(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE,Rhomboid protease GlpG,[H][C@@](COC(=O)CCCC)(COP(O)(O)=O)OC=O
(R)-2-Hydroxy-3-Sulfopropanoic Acid,Probable 2-phosphosulfolactate phosphatase,O[C@@H](CS(O)(=O)=O)C(O)=O
(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,Androgen receptor,C[C@](O)(CBr)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
(R)-4-Nitrostyrene oxide,Halohydrin dehalogenase,[O-][N+](=O)C1=CC=C(C=C1)[C@@H]1CO1
(R)-Atenolol,Lactotransferrin,CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1
(R)-Atenolol,Group IIE secretory phospholipase A2,CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1
(R)-Bicalutamide,Androgen receptor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
(R)-Fluoxetine,Transporter,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
(R)-Mandelic acid,Benzoylformate decarboxylase,O[C@@H](C(O)=O)C1=CC=CC=C1
(R)-Mandelic acid,Mandelate racemase,O[C@@H](C(O)=O)C1=CC=CC=C1
(R)-N-(1-Methyl-Hexyl)-Formamide,Alcohol dehydrogenase 1C,CCCCC[C@H](C)NC=O
(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,Carbonic anhydrase 2,[H]N([H])S(=O)(=O)C1=CC=C(C=C1)C(=O)N([H])C[C@@H](C)CN1C=CC2=CC=CC=C12
(R)-Propylene glycol,Isocitrate dehydrogenase [NADP],C[C@@H](O)CO
(R)-Propylene glycol,Lysozyme C,C[C@@H](O)CO
(R)-Rolipram,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",[H][C@]1(CNC(=O)C1)C1=CC(OC2CCCC2)=C(OC)C=C1
(R)-Rolipram,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",[H][C@]1(CNC(=O)C1)C1=CC(OC2CCCC2)=C(OC)C=C1
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@](C)(N)[C@@]1([H])CC[C@@]([H])(CC1)C(=O)NC1=CC=NC=C1
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,cAMP-dependent protein kinase inhibitor alpha,[H][C@](C)(N)[C@@]1([H])CC[C@@]([H])(CC1)C(=O)NC1=CC=NC=C1
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,Rho-associated protein kinase 1,[H][C@](C)(N)[C@@]1([H])CC[C@@]([H])(CC1)C(=O)NC1=CC=NC=C1
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,Rho-associated protein kinase 2,[H][C@](C)(N)[C@@]1([H])CC[C@@]([H])(CC1)C(=O)NC1=CC=NC=C1
(R)-minalrestat,Aldose reductase,[H]N1C(=O)C[C@@]2(C1=O)C(=O)N(CC1=C(F)C=C(Br)C=C1)C(=O)C1=C2C=C(F)C=C1
(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,Leukotriene A-4 hydrolase,[H][C@](O)(C1=CC=NC=C1)C1=CC=C(OCCN2CCCC2)C=C1
(R)-tacrine(10)-hupyridone,Acetylcholinesterase,O=C1NC2=C(C=C1)[C@@H](CCC2)NCCCCCCCCCCNC1=C2CCCCC2=NC2=CC=CC=C12
(R)—N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester,Interleukin-2,[H][C@@](CC1=CC=C(C=C1)C#CC1=CC=CC=C1)(N=C(O)C[C@@]1([H])CCCN(C1)C(N)=N)C(=O)OC
"(R,R)-2,3-Butanediol",Ubiquitin-conjugating enzyme E2 D2,C[C@@H](O)[C@H](C)O
"(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE",Lipase,[H][C@@](CC)(COC1=CC=CC=C1)O[P@](C)(Cl)=O
(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE],Amine oxidase [flavin-containing] B,[H][C@@](C)(\N=C\C1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O
(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@](N)(C1=CC=CC=C1)C1=CC=C(C=C1)C1=C2N=CNC2=NC=N1
(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,cAMP-dependent protein kinase inhibitor alpha,[H][C@](N)(C1=CC=CC=C1)C1=CC=C(C=C1)C1=C2N=CNC2=NC=N1
"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",Integrin alpha-L,[H][C@@](CC1=CC2=CC=CC=C2C=C1)(N1CCC(=O)N(CC2=CC3=CC=CC=C3N=C2)[C@@]([H])(CC(C)C)C1=O)C(O)=NC
(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID,Class B carbapenemase VIM-2,[H][C@](CS)(CCCC1=CC=CC=C1)C(O)=O
(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,Peptide deformylase,[H][C@@](CC(C)C)(NC(=O)[C@]([H])(CCCC)OP(O)(O)=O)C(=O)NC1=CC=C(C=C1)[N+]([O-])=O
"(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid",Glutamate receptor 2,N[C@@H](CN1C2=C(CCC2)C(=O)NC1=O)C(O)=O
"(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid",S-ribosylhomocysteine lyase,[H][C@](N)(CCSC[C@@]([H])(O)[C@@]([H])(O)C(=O)CO)C(O)=O
"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE","Glycogen phosphorylase, muscle form",[H][C@@]1(CC2=C(C=CC=C2)N(CC(=O)NCCO)C1=O)NC(=O)C1=CC2=C(N1)SC(Cl)=C2
(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@]1(C)CNCCCN1S(=O)(=O)C1=C2C(C)=CN=CC2=CC=C1
(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,cAMP-dependent protein kinase inhibitor alpha,[H][C@]1(C)CNCCCN1S(=O)(=O)C1=C2C(C)=CN=CC2=CC=C1
(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,Rho-associated protein kinase 1,[H][C@]1(C)CNCCCN1S(=O)(=O)C1=C2C(C)=CN=CC2=CC=C1
"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",Dipeptidyl peptidase 4,[H][C@](N)(CC(=O)N1CC2=CC=CC=C2C[C@@]1([H])C(N)=O)CC1=CC=CC=C1F
(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,[H][C@@](CC(O)=O)(N(C)C(=O)C1=C(NS(=O)(=O)C2=CC3=CC=CC=C3C=C2)C=CC(OS(=O)(=O)C2=CC3=CC=CC=C3C=C2)=C1)C(O)=O
(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,Peroxisome proliferator-activated receptor gamma,[H][C@@](CC1=CC=C(OCCN2C3=C(C=CC=C3)C3=C2C=CC=C3)C=C1)(OCC)C(O)=O
(S)-4-Nitrostyrene oxide,"2,3-dichloro-1-propanol dehalogenase",[O-][N+](=O)C1=CC=C(C=C1)[C@H]1CO1
(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate,Isopentenyl-diphosphate Delta-isomerase,C[C@@](O)(CBr)CCOP(O)(=O)OP(O)(O)=O
(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid,"Phospholipase A2, membrane associated",[H][C@](CCC(O)=O)(CC1=CC=C(OCC2=CC=CC=C2)C=C1)N=C(O)CCCCCCC1=CC=CC=C1
"(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole",Genome polyprotein,CC[C@H]1COC(=N1)C1=CC=C(OCCCCCCCC2=CC(C)=NO2)C=C1
(S)-AMPA,Glutamate receptor 2,CC1=C(C[C@H](N)C(O)=O)C(O)=NO1
(S)-DES-ME-AMPA,Glutamate receptor 2,N[C@@H](CC1=CONC1=O)C(O)=O
(S)-Fluoxetine,Transporter,CNCC[C@H](OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
(S)-Hmg-Coa,3-hydroxy-3-methylglutaryl-coenzyme A reductase,[H][C@](O)(C([O-])=NCCC([O-])=NCCSC(=O)C[C@@](C)(O)CC([O-])=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP([O-])([O-])=O
(S)-Hmg-Coa,3-hydroxy-3-methylglutaryl-coenzyme A reductase,[H][C@](O)(C([O-])=NCCC([O-])=NCCSC(=O)C[C@@](C)(O)CC([O-])=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP([O-])([O-])=O
(S)-Hmg-Coa,3-hydroxy-3-methylglutaryl CoA synthase,[H][C@](O)(C([O-])=NCCC([O-])=NCCSC(=O)C[C@@](C)(O)CC([O-])=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP([O-])([O-])=O
(S)-Mandelic acid,Mandelate racemase,O[C@H](C(O)=O)C1=CC=CC=C1
(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE,Mitogen-activated protein kinase 1,[H][C@](CO)(NC(=O)C1=CC(=CN1)C1=NNC=C1C1=CC=CC(Cl)=C1)C1=CC(Cl)=C(F)C=C1
(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,Carbonic anhydrase 2,[H]N([H])S(=O)(=O)C1=CC=C(C=C1)C(=O)N([H])C[C@H](C)CN1C=CC2=CC=CC=C12
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,Trypsin-1,[H][C@]1(CCCN1C(=O)CNC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,Prothrombin,[H][C@]1(CCCN1C(=O)CNC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,Trypsin-1,[H][C@]1(CCCN1C(=O)COC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,Prothrombin,[H][C@]1(CCCN1C(=O)COC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,Trypsin-1,[H][C@]1(CCCN1C(=O)CNC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,Prothrombin,[H][C@]1(CCCN1C(=O)CNC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,Trypsin-1,[H][C@]1(CCCN1C(=O)COC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,Prothrombin,[H][C@]1(CCCN1C(=O)COC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,Trypsin-1,[H][C@]1(CCCN1C(=O)CCC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,Prothrombin,[H][C@]1(CCCN1C(=O)CCC1CCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,Trypsin-1,[H][C@]1(CCCN1C(=O)CCC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,Prothrombin,[H][C@]1(CCCN1C(=O)CCC1CCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
(S)-Rolipram,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",[H][C@@]1(CNC(=O)C1)C1=CC=C(OC)C(OC2CCCC2)=C1
(S)-Rolipram,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",[H][C@@]1(CNC(=O)C1)C1=CC=C(OC)C(OC2CCCC2)=C1
(S)-atrolactic acid,Mandelate racemase,CC(O)(C(O)=O)C1=CC=CC=C1
(S)-blebbistatin,Myosin-14,CC1=CC=C2N=C3N(CC[C@@]3(O)C(=O)C2=C1)C1=CC=CC=C1
(S)-camphor,Transient receptor potential cation channel subfamily V member 1,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2
(S)-camphor,Transient receptor potential cation channel subfamily V member 3,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2
(S)-camphor,Transient receptor potential cation channel subfamily A member 1,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2
(S)-camphor,Transient receptor potential cation channel subfamily M member 8,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2
(S)-oxalosuccinic acid,Isocitrate dehydrogenase [NADP],[H][C@@](CC(O)=O)(C(O)=O)C(=O)C(O)=O
"(S)-propane-1,2-diol",Isocitrate dehydrogenase [NADP],C[C@H](O)CO
"(S)-propane-1,2-diol",Sigma factor SigB regulation protein RsbQ,C[C@H](O)CO
(S)-tacrine(10)-hupyridone,Acetylcholinesterase,O=C1NC2=C(C=C1)[C@H](CCC2)NCCCCCCCCCCNC1=C2CCCCC2=NC2=CC=CC=C12
(S)-wiskostatin,Wiskott-Aldrich syndrome protein,[H][C@](O)(CN(C)C)CN1C2=CC=C(Br)C=C2C2=C1C=CC(Br)=C2
"(S,R)-fidarestat",Aldose reductase,[H][C@]1(C[C@@]2(N=C(O)N=C2O)C2=C(O1)C=CC(F)=C2)C(O)=N
(South)-Methanocarba-Thymidine,Thymidine kinase,CC1=CN(C(=O)NC1=O)[C@]12C[C@H]1[C@H](CO)[C@@H](O)C2
(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE,Chymotrypsin-like elastase family member 1,[H][C@](C)(NC=O)NC(=O)[C@]([H])(C)NC(=O)OC(C)(C)C
(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine,Chymotrypsin-like elastase family member 1,[H][C@@](C)(N=C(O)[C@]([H])(C)N=C(O)OC(C)(C)C)C(O)=N
(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide,Protein S100-B,CN1CCN(CC1)C1=C(C\N=N/C(N)=S)C=CC=C1
(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,Glycylpeptide N-tetradecanoyltransferase 2,OC1=C(\C=C2/SC(=S)N(CC3=CC=CC=C3)C2=O)C=CC=C1[N+]([O-])=O
"(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide",Phosphatidylinositol transfer protein alpha isoform,CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC
({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,Gag-Pol polyprotein,[H][C@](CC)(C1=CC=CC(NC(=O)CNC(=O)OC(C)(C)C)=C1)C1=C(O)C2=CC=CC=C2OC1=O
"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID","Glycogen phosphorylase, muscle form",OC(=O)CO\N=C1/C2=CC=CCC2=N/C/1=C1\C(=O)N=C2CC=CC=C12
+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,Trypsin-1,[H][C@](CCC1=CC=C(C=C1)C(N)=N)(CC(=O)OC)C1=CC=CC(=C1)C(N)=N
1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID,Beta-lactamase TEM,[H][C@@](CC1=CC=CC(C(O)=O)=C1O)(NC(C)=O)B(O)O
1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid,Beta-lactamase TEM,[H][C@@](CC1=CC=CC(=C1)C(O)=O)(NC(C)=O)B(O)O
1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid,Beta-lactamase TEM,[H][C@@](CC1=CC=CC(=C1)C(O)=O)(NC(C)=O)B(O)O
"1,1'-BIPHENYL-2-SULFINIC ACID",2'-hydroxybiphenyl-2-sulfinate desulfinase,O[S@@](=O)C1=CC=CC=C1C1=CC=CC=C1
"1,1'-BIPHENYL-3,4-DIOL","1,2-dihydroxynaphthalene dioxygenase",OC1=C(O)C=C(C=C1)C1=CC=CC=C1
"1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE)",Azurin,C(CCCN1C=CN=C1)CCN1C=CN=C1
"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",Oxysterols receptor LXR-beta,OC(C1=CC=C(NCC(F)(F)F)C=C1)(C(F)(F)F)C(F)(F)F
"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",Chymotrypsinogen B,[H][C@@](CC(C)C)(NC(C)=O)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)C(F)(F)F
"1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE",Putative inactive carboxylesterase 4,CCCCCCCCSCC(=O)C(F)(F)F
"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",Chymotrypsinogen B,[H][C@@](CC1=CC=CC=C1)(NC(C)=O)C(=O)C(F)(F)F
"1,10-Phenanthroline",Methyl-accepting chemotaxis protein II,C1=CC2=CC=C3C=CC=NC3=C2N=C1
"1,10-Phenanthroline",Metallo-beta-lactamase L1,C1=CC2=CC=C3C=CC=NC3=C2N=C1
"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",Phenylethanolamine N-methyltransferase,NS(=O)(=O)C1=CC2=C(CCNC2)C=C1
"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",DNA polymerase kappa,[H][C@@]1(O)CC2=C3C=CC4=CC=CC5=CC=C(C=C2[C@@]([H])(O)[C@]1([H])O)C3=C45
"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",DNA polymerase I,[H][C@@]1(O)CC2=C3C=CC4=CC=CC5=CC=C(C=C2[C@@]([H])(O)[C@]1([H])O)C3=C45
"1,2,4-Triazole",Carbonic anhydrase 2,N1C=NC=N1
"1,2,4-Triazole-Carboxamidine","Nitric oxide synthase, endothelial",NC(=[NH2+])N1C=NC=N1
"1,2,5,8-tetrahydroxyanthracene-9,10-dione",Casein kinase II subunit alpha,OC1=C(O)C2=C(C=C1)C(=O)C1=C(O)C=CC(O)=C1C2=O
"1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE",Tyrosine-protein phosphatase non-receptor type 1,O=C1CN(C2=CC=CC=C2)S(=O)(=O)N1
"1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine",Phospholipase C,CCCCC(=O)OC[C@H](CO[P@@]([S-])(=S)OCC[N+](C)(C)C)OC(=O)CCCC
"1,2-Dichloro-Propane",Haloalkane dehalogenase,C[C@@H](Cl)CCl
"1,2-Dihydroxybenzene","Biphenyl-2,3-diol 1,2-dioxygenase",OC1=CC=CC=C1O
"1,2-Dihydroxybenzene","Catechol 1,2-dioxygenase",OC1=CC=CC=C1O
"1,2-Dipalmitoyl-Phosphatidyl-Glycerole",V-type sodium ATPase subunit K,CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC
"1,2-diacyl-sn-glycero-3-phosphoinositol",Phosphatidylinositol transfer protein alpha isoform,[H]\C(CCCCCCCC)=C(\[H])CCCCCCCC(=O)O[C@]([H])(COC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)O[C@@]1([H])[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
"1,3,2-Dioxaborolan-2-Ol",Trypsin-3,OB1OCCO1
"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,OC1=CC=C(CN2C3=C(CCN(C3)C(=O)C3=CC=C(O)C=C3)C3=CC=CC=C23)C=C1
"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",3-dehydroquinate dehydratase,[H][C@@]1(O)C[C@@](O)(C[C@]([H])(CCCOC2=CC=CC=C2)[C@@]1([H])O)C(O)=O
"1,3,5-BENZENETRICARBOXYLIC ACID",Hemoglobin subunit alpha,OC(=O)C1=CC(=CC(=C1)C(O)=O)C(O)=O
"1,3,5-BENZENETRICARBOXYLIC ACID",Hemoglobin subunit beta,OC(=O)C1=CC(=CC(=C1)C(O)=O)C(O)=O
"1,3,5-Trichloro-Benzene",Camphor 5-monooxygenase,ClC1=CC(Cl)=CC(Cl)=C1
"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",Nuclear receptor coactivator 1,C=C1\C(=C/C=C2\CCC[C@]3(C)[C@]([H])(CC[C@@]23[H])C#CC#CC(C)(O)C)C[C@](O)([H])C[C@@]1(O)[H]
"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",Vitamin D3 receptor,C=C1\C(=C/C=C2\CCC[C@]3(C)[C@]([H])(CC[C@@]23[H])C#CC#CC(C)(O)C)C[C@](O)([H])C[C@@]1(O)[H]
"1,3-DIPHENYLUREA",Epoxide hydrolase,O=C(NC1=CC=CC=C1)NC1=CC=CC=C1
"1,3-Propandiol",Haloalkane dehalogenase,OCCCO
"1,3-Propandiol",ADP-ribosylation factor 1,OCCCO
"1,4-Butanediol",Ribosomal small subunit pseudouridine synthase A,OCCCCO
"1,4-Butanediol","Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",OCCCCO
"1,4-Butanediol","Phospholipase A2, membrane associated",OCCCCO
"1,4-Butanediol",Penicillin-insensitive murein endopeptidase,OCCCCO
"1,4-Butanediol",Group IIE secretory phospholipase A2,OCCCCO
"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",Alpha-amylase,[H][C@]1(O)OC(=C)[C@@]([H])(N[C@@]2([H])C=C(C=O)C(=O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",Fibroblast growth factor 2,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O)C(O)=O
"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O)C(O)=O
"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",Annexin A5,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O)C(O)=O
"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",Fibroblast growth factor 2,[H][C@]1(O)O[C@@]([H])(C(O)=O)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O
"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",Annexin A5,[H][C@]1(O)O[C@@]([H])(C(O)=O)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O
"1,4-Diethylene Dioxide",Tumor necrosis factor ligand superfamily member 13B,C1COCCO1
"1,4-Diethylene Dioxide",Subtilisin Carlsberg,C1COCCO1
"1,4-Diethylene Dioxide",Structural polyprotein,C1COCCO1
"1,4-Diethylene Dioxide",Epsin-1,C1COCCO1
"1,4-Diethylene Dioxide",Transforming growth factor beta-3,C1COCCO1
"1,4-Dithiothreitol",Mitochondrial peptide methionine sulfoxide reductase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Retinal dehydrogenase 1,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",3-hydroxy-3-methylglutaryl-coenzyme A reductase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Maleylacetoacetate isomerase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Listeriolysin regulatory protein,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Thymidylate synthase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Spermidine/spermine N(1)-acetyltransferase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Histidinol dehydrogenase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Holo-[acyl-carrier-protein] synthase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Shikimate dehydrogenase (NADP(+)),O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Peptidyl-prolyl cis-trans isomerase B,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Amylosucrase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Unsaturated glucuronyl hydrolase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol","3-carboxy-cis,cis-muconate cycloisomerase",O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",50S ribosomal protein L27,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Organic hydroperoxide resistance protein,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Cyclic pyranopterin monophosphate synthase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",C protein alpha-antigen,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Chaperone protein TorD,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Axin-1,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Triosephosphate isomerase,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Calcium/calmodulin-dependent protein kinase type II subunit alpha,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Galectin-1,O[C@@H](CS)[C@@H](O)CS
"1,4-Dithiothreitol",Transient receptor potential cation channel subfamily M member 7,O[C@@H](CS)[C@@H](O)CS
"1,4-dithio-alpha-D-glucopyranose",Alpha-amylase 2B,[H][C@@]1(O)[C@@]([H])(O)[C@]([H])(S)[C@@]([H])(CO)O[C@]1([H])S
"1,4-dithio-beta-D-glucopyranose",Endoglucanase F,OC[C@H]1O[C@@H](S)[C@H](O)[C@@H](O)[C@@H]1S
"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol",Trypsin-1,[H]N=C(N([H])[H])C1=CC=C(O[C@@H]2CO[C@]3([H])[C@H](CO[C@]23[H])OC2=CC=CC(=C2)C(=N[H])N([H])[H])C=C1
"1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide",Cathepsin K,[H][C@@](CC(C)C)(N=C(O)OCC1=CC=CC=C1)C(O)=NNC(O)=NN=C(O)[C@]([H])(CC(C)C)N=C(O)OCC1=CC=CC=C1
"1,6-DI-O-PHOSPHONO-D-MANNITOL",Fructose-bisphosphate aldolase A,O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O
"1,6-DIHYDROXY NAPHTHALENE",Prenyltransferase,OC1=CC=C2C(O)=CC=CC2=C1
"1,6-Diaminohexane","Agmatinase, putative",NCCCCCCN
"1,6-Fructose Diphosphate (Linear Form)",Fructose-bisphosphate aldolase A,O[C@H](COP(O)(O)=O)[C@H](O)[C@H](O)C(=O)COP(O)(O)=O
"1,6-Fructose Diphosphate (Linear Form)",Fructose-bisphosphate aldolase B,O[C@H](COP(O)(O)=O)[C@H](O)[C@H](O)C(=O)COP(O)(O)=O
"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",Casein kinase II subunit alpha,OC1=CC=CC2=C1C(=O)C1=C(O)C=CC(=C1C2=O)[N+]([O-])=O
"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",Casein kinase II subunit alpha,OC1=CC=C(C2=C1C(=O)C1=C(O)C=CC=C1O2)[N+]([O-])=O
"1,N6-Ethenoadenine",Endonuclease III,N1C=NC2=C1N=CN1C=CN=C21
1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,Adenosine deaminase,[H][C@](CO)(CCN1C=CC2=C1C=C(NC(=O)CCC1=CC=CC=C1)C=C2)N1C=NC(=C1)C(N)=O
"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",Adenosine deaminase,[H][C@@](C)(O)[C@]([H])(CCC1=CC=CC2=C1OC(=N2)C1=CC=C(Cl)C=C1)N1C=NC(=C1)C(N)=O
"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",Uridine phosphorylase,OCCOCN1C(=O)NC(=O)C(CC2=CC=CC(OCC3=CC=CC=C3)=C2)=C1O
"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",Uridine phosphorylase,OCCOCN1C=C(CC2=CC=CC(OCC3=CC=CC=C3)=C2)C(=O)NC1=O
"1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE",Uridine phosphorylase,OCCOCN1C=C(SC2=CC=CC=C2)C(=O)NC1=O
"1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE",Uridine phosphorylase,OCCOCN1C=C(CC2=CC=CC=C2)C(=O)NC1=O
"1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE",Uridine phosphorylase 1,OCCOCN1C=C(CC2=CC=CC=C2)C(=O)NC1=O
"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",Tryptase alpha/beta-1,CSC1=C2C=CC=CC2=C(S1)C(=O)N1CCC2(COC3=C2C=C(CN)C=C3)CC1
"1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine",Glutaryl-CoA dehydrogenase,CN1CCN(C)C2=CC(CN)=CC=C12
"1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE",Maltose-binding periplasmic protein,CC1(C)CC(CC(C)(C)N1O)N1C(=O)CCC1=O
"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",Proto-oncogene tyrosine-protein kinase Src,CC(C)N1N=C(C2=C(N)N=CN=C12)C1=CC2=CC=CN=C2C=C1
1-(1-phenylcyclopentyl)methylamine,Dipeptidyl peptidase 4,NCC1(CCCC1)C1=CC=CC=C1
"1-(2,2'-bithiophen-5-yl)methanamine",Leukotriene A-4 hydrolase,NCC1=CC=C(S1)C1=CC=CS1
"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",Pyruvate kinase PKM,COC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)S(=O)(=O)C1=CC=C2OCCOC2=C1
"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",Ribonuclease pancreatic,[H][C@@]1(O)C[C@]([H])(O[C@@]1([H])CN1CCCC1)N1C=C(C)C(=O)NC1=O
"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",Mitogen-activated protein kinase 14,FC1=CC=C(C(F)=C1)C1=C2CNC(=O)N(C2=CC(=C1)N1CCNCC1)C1=C(Cl)C=CC=C1Cl
"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",Mitogen-activated protein kinase 14,FC1=CC=C(C(F)=C1)C1=CC(=CC2=C1CCC(=O)N2C1=C(Cl)C=CC=C1Cl)C1CCNCC1
1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,Trypsin-1,NC(=N)C1=CC=C(NC(=O)NC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1
"1-(2-CYCLOPROPYLETHYL)-3-(1,1-DIOXIDO-2H-1,2,4-BENZOTHIADIAZIN-3-YL)-6-FLUORO-4-HYDROXYQUINOLIN-2(1H)-ONE",Genome polyprotein,OC1=C(C(=O)N(CCC2CC2)C2=C1C=C(F)C=C2)C1=NC2=CC=CC=C2S(=O)(=O)N1
"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester","cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CCOC(=O)C1=C(C)N(N=C1C)C1=C(Cl)C=CC=C1
1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,Uracil-DNA glycosylase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=CC2=C(C)C=CC=C12
1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,DNA polymerase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=CC2=CC(=CC=C12)[N+]([O-])=O
"1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione",Ribonuclease pancreatic,[H][C@]1(CO)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(F)[C@]1([H])OP(O)(O)=O
1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",CCCCN1C2=C(NC(CC3=CC=C(NC(C)=O)C=C3)=N2)C(=O)N(CC2=CC=CC=C2F)C1=O
1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE,Gag-Pol polyprotein,CC1=C(SC2=CC=CC=C2)N(COCCO)C(=O)NC1=O
"1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL",Prothrombin,[H][C@]1(N)CCC([H])(CNCCN2C(Cl)=CN=C(NCC(F)(F)C3=CC=CC=N3)C2([H])O)C([H])(C)N1
"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",Cyclin-A2,CC1=NC(=NN1C1=CC(Cl)=CC(Cl)=C1)C(O)=O
"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",Cyclin-dependent kinase 2,CC1=NC(=NN1C1=CC(Cl)=CC(Cl)=C1)C(O)=O
"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",Cyclin-dependent kinase 2,CN1CCN(CC1)NC(=O)NC1=CC=CC2=C1C(=O)C1=C(NN=C21)C1=C(C)N=C(C)S1
1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,Interleukin-1 receptor-associated kinase 4,CC(C)(C)C(=O)OC1=CC=C2N(CCCO)C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)=NC2=C1
1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,Cytochrome P450 130,CC1=CC=CC(=C1)N1C=NC2=CC(N)=CC=C12
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,Angiotensin-converting enzyme,[H][C@](C)(CS)C(=O)N1CCC[C@@]1([H])C(O)=O
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,FEZ-1 protein,[H][C@](C)(CS)C(=O)N1CCC[C@@]1([H])C(O)=O
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,Carbapenem-hydrolyzing beta-lactamase BlaB-1,[H][C@](C)(CS)C(=O)N1CCC[C@@]1([H])C(O)=O
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,Metallo-beta-lactamase L1,[H][C@](C)(CS)C(=O)N1CCC[C@@]1([H])C(O)=O
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,Beta-lactamase,[H][C@](C)(CS)C(=O)N1CCC[C@@]1([H])C(O)=O
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,"Organic hydroperoxide resistance protein, putative",[H][C@](C)(CS)C(=O)N1CCC[C@@]1([H])C(O)=O
"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",Mitogen-activated protein kinase 10,COC1=CC2=C(C=C1Cl)C(=NCC2)C1=CC=CC(Br)=C1
1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea,Gag-Pol polyprotein,CN(C)CC1=CC=C(CSCCNC(=O)NC2=CC=C(C)C(Cl)=C2)O1
1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,Trypsin-1,NC(=N)C1=CC=C(NC(=O)NC2=CC=C(Cl)C=C2)C=C1
"1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester","cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CCOC(=O)C1=C(C)N(N=C1C)C1=CC=C(N)C=C1
"1-(4-CYANO-PHENYL)-3-[2-(2,6-DICHLORO-PHENYL)-1-IMINO-ETHYL]-THIOUREA",Gag-Pol polyprotein,ClC1=CC=CC(Cl)=C1CC(=N)NC(=S)NC1=CC=C(C=C1)C#N
1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE,Thyroid hormone receptor beta,CCCCCCC1=CC=C(C=C1)C(=O)C=C
1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,Prostaglandin G/H synthase 1,COC1=CC=C2N(C(=O)C3=CC=C(I)C=C3)C(C)=C(CC(O)=O)C2=C1
"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester","cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CCOC(=O)C1=C(C)N(N=C1C)C1=CC=C(OC)C=C1
1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,Trypsin-1,[H][C@](CCCNC(N)=N)(C=O)[C@]([H])(N=C(O)N1CCN(CC1)C(O)=NC(C)(C)C)C(O)=O
"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",Hepatocyte growth factor receptor,FC1=CC=C(C=C1)N1C=CC=C(C(=O)NC2=CC=C(OC3=CC=NC4=C3C=CN4)C(F)=C2)C1=O
1-(4-thiophen-2-ylphenyl)methanamine,Leukotriene A-4 hydrolase,NCC1=CC=C(C=C1)C1=CC=CS1
1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid,Orotidine 5'-phosphate decarboxylase,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C(=O)CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,Gag-Pol polyprotein,[H][C@@]1(C[C@@]1([H])C1=C(F)C=CC(C(=O)CC)=C1O)NC(=O)NC1=NC=C(Br)C=C1
"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",Serine/threonine-protein kinase Chk1,COC1=CC(OC)=C(NC(=O)NC2=NC=C(N=C2)C#N)C=C1Cl
1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,Serine/threonine-protein kinase Chk1,[H][C@](C)(CN(C)C)OC1=CN=CC(NC(=O)NC2=C(OC)C=CC(Cl)=C2)=N1
"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",3-oxoacyl-[acyl-carrier-protein] synthase 3,OC(=O)CCCCCN1C(=CC2=C1C=CC(OCC1=C(Cl)C=CC=C1Cl)=C2)C(O)=O
1-(5-Chloroindol-3-Yl)-3-Hydroxy-3-(2h-Tetrazol-5-Yl)-Propenone,Gag-Pol polyprotein,[H]\C(=C(\O)C1=NNN=N1)C(=O)C1=CNC2=C1C=C(Cl)C=C2
"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",Cyclin-dependent kinase 2,[H][C@]1(CCCN1)C1=CC(NC(=O)NC2=CC=CC3=C2[C@]2([H])CCCN2C3=O)=NN1
"1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE",Proline iminopeptidase,CNCC(=O)C1=NN=C(O1)C(C)(C)C
1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,Mitogen-activated protein kinase 14,CN1N=C(C=C1NC(=O)NC1=CC=C(Cl)C=C1)C(C)(C)C
1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,Mitogen-activated protein kinase 14,CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=C1C=CC=C2)C(C)(C)C
1-(5-phospho-D-ribosyl)-ATP,ATP phosphoribosyltransferase,O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CN(C1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O)C2=N
"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",Aurora kinase A,CN1N=CC2=C1C(NCCC1=CN=C(NC(=O)NC3=CC=CC(=C3)C(F)(F)F)S1)=NC=N2
"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE","Nitric oxide synthase, inducible",NC1=NC2(CCN(CC2)C(=O)C2=CC=C(N=C2)C#N)NC2=C(F)C=CC(F)=C12
1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,Cellular tumor antigen p53,CCN1C2=CC=C(CNC)C=C2C2=C1C=CC=C2
"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",Glycylpeptide N-tetradecanoyltransferase 2,[H][C@](O)(CNC1CCCCC1)CN1C2=C(CCCC2)C2=C1C=CC(C)=C2
1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE,Prothrombin,OCCCCCCCCNCO
"1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane",Camphor 5-monooxygenase,CCCCCC[C@](O)(CN1C=CN=C1)C1=CC=C(Cl)C=C1Cl
1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,N-(5'-phosphoribosyl)anthranilate isomerase,[H][C@@](O)(CNC1=CC=CC=C1C(O)=O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,Tryptophan biosynthesis protein TrpCF,[H][C@@](O)(CNC1=CC=CC=C1C(O)=O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,Cathepsin K,[H][C@@](CCCC)(NC(=O)OC1(CC2=CC=CC=C2)CCCC1)C=O
1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,Heme oxygenase 1,[H]C12CC3([H])CC([H])(C1)CC(C2)(C3)C(=O)CN1C=CN=C1
1-(biphenyl-4-ylmethyl)-1H-imidazole,Cytochrome P450 2B6,C(N1C=CN=C1)C1=CC=C(C=C1)C1=CC=CC=C1
"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",HTH-type transcriptional regulator EthR,O=C(CC1=CC=CS1)N1CCC(CC1)C1=NC(=NO1)C1=CC=CS1
"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",Heme oxygenase 1,ClC1=CC=C(CCC2(CN3C=CN=C3)OCCO2)C=C1
1-3 Sugar Ring of Pentamannosyl 6-Phosphate,Cation-dependent mannose-6-phosphate receptor,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O[C@@]3([H])O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]3([H])O)[C@]2([H])O)[C@]1([H])O
1-ACETYL-2-CARBOXYPIPERIDINE,"ATP synthase subunit alpha, mitochondrial",[H][C@]1(CCCCN1C(C)=O)C(O)=O
1-ACETYL-2-CARBOXYPIPERIDINE,"ATP synthase subunit beta, mitochondrial",[H][C@]1(CCCCN1C(C)=O)C(O)=O
1-ACETYL-2-CARBOXYPIPERIDINE,"ATP synthase subunit gamma, mitochondrial",[H][C@]1(CCCCN1C(C)=O)C(O)=O
1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE,Lantibiotic cinnamycin,CC(=O)OC[C@H](O)CO[P@](O)(=O)OCC[NH3+]
1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,Integrin alpha-L,CCOC1=CC=CC=C1SC1=C(C=C(C=C1)C1=CC(=NC=C1)N1CCN(CC1)C(C)=O)N(=O)=O
1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",CCCCN1C2=C(NC(CC3=CC=C(NC(C)=O)C=C3)=N2)C(=O)N(CC=C)C1=O
1-Amino-1-Carbonyl Pentane,Candidapepsin-2,[H][C@](N)(CCCC)C=O
"1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene",Cyclomaltodextrin glucanotransferase,[H][C@]1(N)C=C(CO)C[C@]([H])(O)[C@@]1([H])O
1-Amino-6-Cyclohex-3-Enylmethyloxypurine,Cyclin-dependent kinase 2,NC1=NC(OCC2CCCCC2)=C2N=CNC2=C1
1-Aminocyclopropanecarboxylic Acid,1-aminocyclopropane-1-carboxylate deaminase,NC1(CC1)C(O)=O
1-Aminocyclopropylphosphonate,1-aminocyclopropane-1-carboxylate deaminase,NC1(CC1)[P@](O)([O-])=O
1-Anilino-8-Naphthalene Sulfonate,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,OS(=O)(=O)C1=C2C(NC3=CC=CC=C3)=CC=CC2=CC=C1
1-Anilino-8-Naphthalene Sulfonate,Protein S100-A7,OS(=O)(=O)C1=C2C(NC3=CC=CC=C3)=CC=CC2=CC=C1
"1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct",3-hydroxyacyl-CoA dehydrogenase type-2,[H][C@@](N1C=NC2=NN(C=C2C1=S)[C@@]1([H])C=CN(C=C1C([O-])=N)[C@]1([H])O[C@]([H])(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])([O-])[C@]2([H])[O-])[C@@]([H])(O)[C@@]1([H])O)(C(=O)N1CCCCCC1)C1=CC=CC=C1
"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",Retinoic acid receptor RXR-alpha,COC1=CC=C(NC2=C(C(=O)N(CC3=CC=CC=C3)C2=O)C2=CC=CC=C2)C=C1
"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",Oxysterols receptor LXR-alpha,COC1=CC=C(NC2=C(C(=O)N(CC3=CC=CC=C3)C2=O)C2=CC=CC=C2)C=C1
"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",Acetylcholinesterase,[H][C@@]1(CC2CCN(CC3=CC=CC=C3)CC2)CC2=CC(OC)=C(OC)C=C2C1=O
1-Benzyl-(R)-Propylamine,Gag-Pol polyprotein,CC[C@H](N)CC1=CC=CC=C1
1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,Stromelysin-1,[H][C@@]1(CC(=O)N(CC2=CC=CC=C2)CN1S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO
"1-Beta-Ribofuranosyl-1,3-Diazepinone",Cytidine deaminase,[H][C@]1(CO)O[C@@]([H])(N2C=CC=CNC2=O)[C@]([H])(O)[C@]1([H])O
1-Bromopropane-2-Ol,Haloalkane dehalogenase,C[C@H](O)CBr
1-Butane Boronic Acid,Bacterial leucyl aminopeptidase,CCCCB(O)O
1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,Nuclear receptor coactivator 1,OC1=CC=C(C=C1)C1=CC=C2C(C=CC(O)=C2Cl)=C1
1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,Estrogen receptor beta,OC1=CC=C(C=C1)C1=CC=C2C(C=CC(O)=C2Cl)=C1
1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,Steroid hormone receptor ERR1,CC1=CC=C(C=C1)N1C=C(CNCC2CCCCC2)C2=CC=CC=C12
1-DECANE-SULFONIC-ACID,SDS hydrolase SdsA1,CCCCCCCCCCS(O)(=O)=O
1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL,Phospholipase A2,[H][C@](COCCCCCCCCCC)(COCC(F)(F)F)O[P@](O)(=O)OC
1-DODECANOL,SDS hydrolase SdsA1,CCCCCCCCCCCCO
1-DODECANOL,Fatty-acid amide hydrolase 1,CCCCCCCCCCCCO
1-Deaza-Adenosine,Adenosine deaminase,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)C=CN=C23)[C@]([H])(O)[C@]1([H])O
1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide,"Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@](N=C(C)O)(C(O)=N)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide,"Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@](N=C(O)OC)(C(O)=N)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose,"Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]([H])(N=C(O)OC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
1-Deoxy-1-Thio-Heptaethylene Glycol,Acetylcholinesterase,OCCOCCOCCOCCOCCOCCOCCS
1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol,2-dehydro-3-deoxyphosphooctonate aldolase,[H][C@@](O)(CNCP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
1-Deoxy-D-xylulose 5-phosphate,Pyridoxine 5'-phosphate synthase,CC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O
1-Deoxy-D-xylulose 5-phosphate,1-deoxy-D-xylulose 5-phosphate reductoisomerase,CC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O
1-Deoxy-Ribofuranose-5'-Phosphate,2-dehydro-3-deoxyphosphooctonate aldolase,[H][C@]1(O)CO[C@]([H])(COP(O)(O)=O)[C@]1([H])O
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE,Acetylcholinesterase,CCOCCOCCOCC
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE,Beta-hexosaminidase,CCOCCOCCOCC
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE,Phosphoenolpyruvate-protein phosphotransferase,CCOCCOCCOCC
1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,Prothrombin,[H][C@](CC1=CC=CC=C1)(NC(=O)OCC)C(=O)N1CCC[C@@]1([H])C(=O)NNCCCCN
"1-Ethyl-Pyrrolidine-2,5-Dione",Vesicle-fusing ATPase,CCN1C(=O)CCC1=O
"1-Ethyl-Pyrrolidine-2,5-Dione",ERO1-like protein beta,CCN1C(=O)CCC1=O
1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,Prothrombin,CC(C)C[C@H](NC(=O)C1=CC=C(C=C1)[N+]([O-])=O)C(=O)N1CCC[C@H]1C(=O)NCCCCN=C(N)N
1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,Prothrombin,CC(C)C[C@H](NS(=O)(=O)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)NCCCCN=C(N)N
1-Guanidinium-7-Aminoheptane,Deoxyhypusine synthase,NCCCCCCCNC(N)N
1-Hexadecanosulfonic Acid,Lipase 1,CCCCCCCCCCCCCCCCS(O)(=O)=O
1-Hexadecanosulfonic Acid,Hydrolase,CCCCCCCCCCCCCCCCS(O)(=O)=O
1-Hexadecanosulfonyl-O-L-Serine,Phospholipase A1,[H][C@](N)(COS(=O)(=O)CCCCCCCCCCCCCCCC)C(O)=O
1-Hexadecylsulfonyl Fluoride,Palmitoyl-protein thioesterase 1,CCCCCCCCCCCCCCCCS(F)(=O)=O
1-Hydroxy-1-Thio-Glycerol,Prolyl endopeptidase,OC[C@@H](O)CSO
1-Hydroxy-2-Amino-3-Cyclohexylpropane,Renin,N[C@H](CO)CC1CCCCC1
1-Hydroxy-2-Amino-3-Cyclohexylpropane,Candidapepsin-2,N[C@H](CO)CC1CCCCC1
1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane,Glutathione S-transferase Mu 4,[H][C@](CO)(COC1=CC=C(C=C1)N(=O)=O)SC[C@]([H])(N=C(O)CC[C@]([H])(N)C(O)=O)C(O)=NCC(O)=O
1-Hydroxyamine-2-Isobutylmalonic Acid,Neutrophil collagenase,CC(C)C[C@@H](C(O)=O)C(=O)NO
"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",Gag-Pol polyprotein,CC(C)OC(=O)C1=C(Cl)C=CC(NC(=O)C2=C(C)OCCS2)=C1
1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE,Gag-Pol polyprotein,CC(C)OC(=S)NC1=CC(C(=O)OC(C)C)=C(Cl)C=C1
1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,Tyrosine-protein phosphatase non-receptor type 1,CN1N=C(C=C1NS(O)(=O)=O)C1=CC=CC=C1
"1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE",Caspase-1,CN1N=C(C2=C1SC(=C2)C(=O)NCCS)C(F)(F)F
"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",Caspase-3,[H][C@@]1(COC2=CC=CC=C2)CCCN1S(=O)(=O)C1=CC2=C(C=C1)N(C)C(=O)C2=O
"1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine",Renin,CN1C(=O)CCC1(C)C
1-Methyl-2-quinolone,Uncharacterized protein,CN1C(=O)C=CC2=CC=CC=C12
"1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide",Carbonic anhydrase 2,CN1SC(=O)C2=CC(=CC=C12)S(N)(=O)=O
1-Methylcytosine,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,CN1C=CC(N)=NC1=O
1-Methylimidazole,Sensor protein FixL,CN1C=C[NH+]=C1
1-Methylimidazole,Myoglobin,CN1C=C[NH+]=C1
1-Methyloxy-4-Sulfone-Benzene,Collagenase 3,COC1=CC=C(C=C1)S(=O)=O
1-Methyloxy-4-Sulfone-Benzene,Stromelysin-1,COC1=CC=C(C=C1)S(=O)=O
1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,Lipoprotein MxiM,[H][C@](O)(COC(=O)CCCCC)COP(O)(O)=O
1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,Lipoprotein MxiM,[H][C@](O)(COC(=O)CCCCC)COP(O)(O)=O
1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,GrlR,[H][C@](O)(COC(=O)CCCCC)COP(O)(O)=O
"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",Carbonic anhydrase 2,CC1=CC(C)=[N+](CCC2=CC=C(C=C2)S(N)(=O)=O)C(C)=C1
1-N-Acetyl-Beta-D-Glucosamine,"Glycogen phosphorylase, liver form",[H][C@]1(CO)O[C@@]([H])(N=C(C)O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
1-N-Acetyl-Beta-D-Glucosamine,"Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]([H])(N=C(C)O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine,Phospholipase A2,[H][C@@](COCCCCCCCC)(COP(O)(=O)OCCN)OP(O)(=O)CCCCCCC
1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,Beta-galactosidase,[H][C@]1(CO)O[C@@]([H])(OC2=CC=CC=C2N(=O)=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide,"Phospholipase A2, membrane associated",[H][C@@](COCCCCCCCCCCCCCCCCCC)(COP(O)(=O)OCCSC)N=C(C)O
1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,Hematopoietic prostaglandin D synthase,OC(=O)C1=CN(N=C1)C1=CC=CC=C1
1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,Prostaglandin G/H synthase 2,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Br)C=C1)C(F)(F)F
"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",Androgen receptor,CC1=CC=C(C)C(CC2=NN(C3=C2C(N)=NC=N3)C(C)(C)C)=C1
"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",Tyrosine-protein kinase HCK,CC1=CC=C(C=C1)C1=NN(C2=C1C(N)=NC=N2)C(C)(C)C
"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",Proto-oncogene tyrosine-protein kinase receptor Ret,CC1=CC=C(C=C1)C1=NN(C2=C1C(N)=NC=N2)C(C)(C)C
"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",Tyrosine-protein kinase Lck,CC(C)(C)N1[NH+]=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1
"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",Tyrosine-protein kinase Lyn,CC(C)(C)N1[NH+]=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1
"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",Proto-oncogene tyrosine-protein kinase Src,CC(C)(C)N1[NH+]=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1
1-Testosterone,Androgen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C
1-Thio-Beta-D-Glucopyranose,Endoglucanase G,OC[C@H]1O[C@@H](S)[C@H](O)[C@@H](O)[C@@H]1O
"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",Pyruvate kinase PKM,FC1=CC=CC(F)=C1S(=O)(=O)N1CCN(CC1)S(=O)(=O)C1=CC=C2OCCOC2=C1
1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,Genome polyprotein,[H][C@]1(CCCN1S(=O)(=O)C1=C(N)C=C(Cl)C(C)=C1)C(O)=O
"1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol",Cyclin-dependent kinase 2,CC(C)C(=O)COC1=NC(N)=NC2=C1NC=N2
"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",Hepatocyte growth factor receptor,NC(=O)C1=CN=C2C=CN(C2=C1)S(=O)(=O)C1=CC=CC=C1[N+]([O-])=O
1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,Prothrombin,[H][C@@](N)(CC)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC(Cl)=C1
1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,Prothrombin,[H][C@@](N)(CC)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=C(C=C1)C(N)=N
"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",Cytochrome P450 130,[H][C@](CN1C=CN=C1)(OCC1=CC=C(Cl)C=C1)C1=C(Cl)C=C(Cl)C=C1
"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",Lanosterol 14-alpha demethylase,[H][C@](CN1C=CN=C1)(OCC1=CC=C(Cl)C=C1)C1=C(Cl)C=C(Cl)C=C1
"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",Serine/threonine-protein kinase Chk1,[H][C@]1(CN)CN(CCO1)C1=C(Br)C=NC2=C1C=NN2
"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",Serine/threonine-protein kinase Chk1,[H][C@]1(CN)CN(CCO1)C1=C(C=NC2=C1C=NN2)C1=CC=CC=C1
"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",Glutamate racemase,[H][C@@]1(N=C(C2=CC=CC=C2)C2=CC=CC=C2N=C1N1CC(O)C1)C1=CC=CS1
"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",Tryptase alpha/beta-1,NCC1=CC2=C(OCC22CCN(CC2)C(=O)\C=C\C2=CC=CC=C2)C=C1
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,Proto-oncogene tyrosine-protein kinase Src,CC(C)(C)C1=NN(C(NC(=O)NC2=C3C=CC=CC3=CC=C2)=C1)C1=CC=CC(N)=C1
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,Mitogen-activated protein kinase 14,CC(C)(C)C1=NN(C(NC(=O)NC2=C3C=CC=CC3=CC=C2)=C1)C1=CC=CC(N)=C1
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,Proto-oncogene tyrosine-protein kinase Src,CC(C)(C)C1=NN(C(NC(=O)NC2=CC=CC=C2)=C1)C1=CC=CC(N)=C1
1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,Gag-Pol polyprotein,[H][C@]1(C[C@]1([H])C1=C(OC)C=CC(C(C)=O)=C1O)NC(=S)NC1=NC=C(C=C1)C#N
1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,Gag-Pol polyprotein,CCOC1=C(F)C(CCNC(=S)NC2=CC=C(C)C=N2)=NC=C1
1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,Gag-Pol polyprotein,CCOC1=C(F)C(CCNC(=S)NC2=CC=C(C)C=N2)=NC=C1
1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,Dipeptidyl peptidase 4,[H][C@](N)(CC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])CN
1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,Prothrombin,[H][C@@](N)(C1CCCCC1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=C(OCC(=O)NCC)C=CC(Cl)=C1
"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",DNA polymerase kappa,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)C1=CC(C)=C(F)C=C1F
"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",Ribonuclease H,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)C1=CC(C)=C(F)C=C1F
1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,Genome polyprotein,[H][C@@](O)(COC1=CC=C(C=C1)C1CCCCC1)CN1CCN(CC1)C1=CC=CC=N1
"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",E3 ubiquitin-protein ligase XIAP,[H][C@@](C)(NC)C(=O)N[C@]([H])(C(=O)N1CCC[C@@]1([H])C(=O)N[C@]1([H])CCCC2=C1C=CC=C2)C(C)(C)C
"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",Acetylcholinesterase,CC1=C(CSCC2=CC(=CC=C2)C(O)(O)C(F)(F)F)C(N)=C2C(F)=CC=CC2=N1
1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,Urokinase-type plasminogen activator,NC(=N)NC1=CC=C(CC(=O)C2=CC=CC=C2)C=C1
"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",cAMP-dependent protein kinase catalytic subunit alpha,NCC1(CC2=CC=C(Cl)C=C2)CCN(CC1)C1=C2C=CNC2=NC=N1
"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",cAMP-dependent protein kinase inhibitor alpha,NCC1(CC2=CC=C(Cl)C=C2)CCN(CC1)C1=C2C=CNC2=NC=N1
"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",cAMP-dependent protein kinase catalytic subunit alpha,NCC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C1=CC=C(Cl)C=C1
"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",cAMP-dependent protein kinase inhibitor alpha,NCC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C1=CC=C(Cl)C=C1
"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE","Nitric oxide synthase, inducible",NCC1=CC=C(C=C1)C(=O)N1CCC2(CC1)NC1=CC=CC(F)=C1C(N)=N2
"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",Cyclin-A2,NC(=O)C1=NN(C2=C1C=CC1=C2C=NN1)C1=CC=C(C=C1)S(N)(=O)=O
"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",Cyclin-dependent kinase 2,NC(=O)C1=NN(C2=C1C=CC1=C2C=NN1)C1=CC=C(C=C1)S(N)(=O)=O
"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",Estrogen receptor,[H][C@@]12CCCCN1CCN(C2)C1=CC=C(C=C1)[C@@]1([H])N(CCC2=CC(O)=CC=C12)C1=CC=CC=C1
1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,Tyrosine-protein kinase ABL1,FC(F)(F)C1=CC(NC(=O)NC2=CC=C(OC3=CC=NC=C3)C=C2)=CC=C1
1-[4-(hydroxymethyl)phenyl]guanidine,Prostasin,NC(=N)NC1=CC=C(CO)C=C1
"1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One",Neuraminidase,CCC(CC)NC1=CC(=CC=C1N1C(=O)CCC1(CO)CO)C(O)=O
"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",Serine/threonine-protein kinase PLK1,CC1=CC(NC(=O)\N=C2\NC=C(CCNC3=NC=NC(NC4=NNC=N4)=C3)S2)=C(O1)C(F)(F)F
1-[6-(2-CHLORO-4-METHYXYPHENOXY)-HEXYL]-IMIDAZOLE,Genome polyprotein,COC1=CC(Cl)=C(OCCCCCCN2C=CN=C2)C=C1
1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol,Flavohemoprotein,[H]C(O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC[C@@]1([H])C[C@@]1([H])CCCCCC
1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID,Ig gamma-2 chain C region,OC(=O)CCCCN(CC1=CC=C(C=C1)[N+]([O-])=O)CP(O)(O)=O
"1-[Pyrrol-1-Yl-2,5-Dione-Methoxymethyl]-Pyrrole-2,5-Dione",Azurin,O=C1C=CC(=O)N1COCN1C(=O)C=CC1=O
1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,Coagulation factor X,ClC1=CC=C(\C=C\S(=O)(=O)N2CCN(CC3CCN(CC3)C3=CC=NC=C3)CC2)C=C1
"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",Vitamin D3 receptor,[H]\C(\C(\[H])=C1/CCC[C@@]2(C)[C@@]1([H])CC[C@]2([H])[C@@]([H])(C)OCCCC(O)(CC)CC)=C1/C[C@@]([H])(O)C[C@]([H])(O)C1=C
1-benzylimidazole,Glutaminyl-peptide cyclotransferase,C(N1C=CN=C1)C1=CC=CC=C1
1-biphenyl-2-ylmethanamine,Dipeptidyl peptidase 4,NCC1=C(C=CC=C1)C1=CC=CC=C1
1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,Prothrombin,[H][C@]1(CCCN1C(=O)CCC)C(=O)NCC1=CC=C(C=C1)C(N)=N
"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",Proto-oncogene tyrosine-protein kinase Src,COC1=C(OC)C=C(C=C1)C1=NN(C2CCC2)C2=NC=NC(N)=C12
"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",Proto-oncogene tyrosine-protein kinase Src,NC1=C2C(=NC=N1)N(N=C2C1=CC2=C(NC=C2)N=C1)C1CCCC1
1-deoxymannojirimycin,Alpha-mannosidase 2,[H][C@@]1(O)CN[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O
"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide","cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CCN1N=CC2=C1N=CC(C(=O)NCC1=CC=CC=C1)=C2NC1CCOCC1
"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",CN1N=C(C2=C(N)N=CN=C12)C1=CC2=CC=CC=C2C=C1
"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",Cyclin-A2,CN1N=C(C(O)=O)C2=C1C1=NC(NC3=CC=CC=C3)=NC=C1CC2
"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",Cyclin-dependent kinase 2,CN1N=C(C(O)=O)C2=C1C1=NC(NC3=CC=CC=C3)=NC=C1CC2
1-naphthaleneacetic acid,S-phase kinase-associated protein 1,OC(=O)CC1=C2C=CC=CC2=CC=C1
"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",Calcium/calmodulin-dependent protein kinase type II subunit gamma,CC1=CC(CC2=NN(C3=C2C(N)=NC=N3)C(C)(C)C)=CC=C1
"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",Adenosine deaminase,[H][C@@](C)(O)[C@@]([H])(CCOC1=CC2=C(C=CC=C2)C=C1)N1C=NC(=C1)C(N)=O
"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE","Deoxyuridine 5'-triphosphate nucleotidohydrolase, putative",[H][C@]1(F)C[C@@]([H])(O[C@]1([H])COC(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)N1C=CC(=O)NC1=O
"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE","Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",[H][C@]1(F)C[C@@]([H])(O[C@]1([H])COC(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)N1C=CC(=O)NC1=O
1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,3-phosphoinositide-dependent protein kinase 1,[H][C@](C)(C1=CC=CN1)C1=C2C=C(NC(N)=O)C=CC2=NC1=O
1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,Coagulation factor X,CC(C)N1CCC(CC1)NC(=O)C1=CC2=C(C=CC=C2)N1CC(=O)NC1=CC=C(Cl)C=C1
"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene","Phospholipase A2, membrane associated",COCCOCCOCCOC1=CC=C(C=C1)C(C)(C)CC(C)(C)C
"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",Signal peptidase I,COCCOCCOCCOC1=CC=C(C=C1)C(C)(C)CC(C)(C)C
"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid","Glycogen phosphorylase, liver form",OC(=O)C1CCN(CC1)C1=C(NC(=O)NC(=O)C2=CC(F)=C(F)C=C2Cl)C=C(F)C=C1
"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",Phenylalanine--tRNA ligase alpha subunit,O=C(NC1=NC=CS1)NC1=CC(=CC=C1)S(=O)(=O)N1CCN(CC1)C1=CC=CC=N1
"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",Phenylalanine--tRNA ligase beta subunit,O=C(NC1=NC=CS1)NC1=CC(=CC=C1)S(=O)(=O)N1CCN(CC1)C1=CC=CC=N1
1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,Prolyl endopeptidase,[H][C@]1(CCCN1C(=O)CCN1C(=O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C(=O)N1CCCC1
"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",Aurora kinase A,FC(F)(F)C1=CC=CC(NC(=O)NC2=NC=C(CCNC3=NC=NC4=C3SC=C4)S2)=C1
"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",Cathepsin K,CN1CCN(CC1)C1=CC=C(CC2=CC3=CN=C(CN)N=C3N2C2CCCCC2)C=C1
1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE,CAI-1 autoinducer synthase,CCCCCCCCCC(=O)C\N=C\C1=C(COP(O)(O)O)C=NC(C)=C1O
"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]1(C)CN(CC2(CC2)C(N)=O)CCN1S(=O)(=O)C1=CC=C(C=C1)[C@](C)(O)C(F)(F)F
1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID,Trypsin-1,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)N[C@@]([H])(CC1=CC(=CC=C1)C#N)B(O)O
1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE,Dihydrofolate reductase,NC(=N)NC(=N)SCC1=CC=CC(=C1)C(F)(F)F
"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",3-phosphoinositide-dependent protein kinase 1,COC1=CC2=NC=C3C(N)=NC4=C(C)C(N)=CC=C4C3=C2C=C1OC
"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",Aclacinomycin methylesterase RdmC,[H][C@@]1(C[C@]([H])(N(C)C)[C@]([H])(O)[C@]([H])(C)O1)O[C@@]1([H])C[C@](O)(CC)CC2=CC3=C(C(O)=C12)C(=O)C1=C(C=CC=C1O)C3=O
"10-Propargyl-5,8-Dideazafolic Acid",Thymidylate synthase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O
"10-Propargyl-5,8-Dideazafolic Acid",Thymidylate synthase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O
"10-Propargyl-5,8-Dideazafolic Acid",Thymidylate synthase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O
"10-Propargyl-5,8-Dideazafolic Acid",Ribosyldihydronicotinamide dehydrogenase [quinone],[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O
"10-Propargyl-5,8-Dideazafolic Acid",Thymidylate synthase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O
"10-Propargyl-5,8-Dideazafolic Acid",Putative dehydrogenase/reductase SDR family member 4-like 1,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(CC#C)CC1=CC=C2NC(N)=NC(=O)C2=C1)C(O)=O
"10-{4-Dimethylamino-5-[4-Hydroxy-6-Methyl-5-(6-Methyl-5-Oxo-Tetrahydro-Pyran-2-Yloxy)-Tetrahydro-Pyrane-2-Yloxy]-6-Methyl-Tetrahydro-Pyran-2-Yloxy}-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",Aclacinomycin methylesterase RdmC,[H][C@]1(O)C[C@@]([H])(O[C@]2([H])[C@]([H])(C)O[C@]([H])(C[C@]2([H])N(C)C)O[C@@]2([H])C[C@](O)(CC)CC3=CC4=C(C(O)=C23)C(=O)C2=C(C=CC=C2O)C4=O)O[C@@]([H])(C)[C@]1([H])O[C@@]1([H])CCC(=O)[C@@]([H])(C)O1
11-Deoxy-Beta-Rhodomycin,Aclacinomycin 10-hydroxylase RdmB,[H][C@]1(O)C[C@]([H])(O[C@]2([H])[C@]([H])(C)O[C@]([H])(C[C@]2([H])N(C)C)O[C@@]2([H])C[C@](O)(CC)[C@]([H])(O)C3=C2C(O)=C2C(=O)C4=C(C=CC=C4O)C(=O)C2=C3)O[C@@]([H])(C)[C@]1([H])O[C@@]1([H])CCC(=O)[C@@]([H])(C)O1
11-MERCAPTOUNDECANOIC ACID,3-oxoacyl-[acyl-carrier-protein] synthase 3,OC(=O)CCCCCCCCCCS
11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID,Putative aminooxidase,CC\C=C/C=C/C=C/CCCCCCCCCC(O)=O
11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID,3-oxoacyl-[acyl-carrier-protein] synthase 3,OC(=O)CCCCCCCCCCOC(S)=O
"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",Mitogen-activated protein kinase kinase kinase 9,CC(C)OC1=CC=C2C(CCC3=C2C2=C(C=NC2=O)C2=C3N(CCO)C3=CC=CC=C23)=C1
12-Bromododecanoic Acid,Glycodelin,OC(=O)CCCCCCCCCCCBr
12-Hydroxydodecanoic Acid,Alcohol dehydrogenase class-3,OCCCCCCCCCCCC(O)=O
12-Phenylheme,Heme oxygenase 1,CC1C(C=C)C2=CC3=C(C)C(CCC(O)=O)=C4C=C5N6C(=CC7=C(C)C(C=C)=C8N7[Fe++]6(N34)N2C1=C8C1=CC=CC=C1)C(C)=C5CCC(O)=O
13-Acetylphorbol,Protein kinase C delta type,[H][C@]12[C@]3([H])C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@]4([H])[C@@]3(O)[C@]([H])(C)[C@@]([H])(O)[C@@]1(OC(C)=O)C2(C)C
13-deoxydoxorubicin,DNA topoisomerase 2-alpha,COC1=C2C(=O)C3=C(O)C4=C(C[C@@](O)(CCO)C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(O)=C3C(=O)C2=CC=C1
"16,17-Androstene-3-Ol",Nuclear receptor subfamily 1 group I member 3,[H][C@@]12CC=C[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@]([H])(O)CC[C@]12C
16-Bromoepiandrosterone,Glucose-6-phosphate 1-dehydrogenase,[H][C@@]12C[C@@H](Br)C(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C
"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",Androgen receptor,[H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
17-METHYL-17-ALPHA-DIHYDROEQUILENIN,Estrogen receptor,[H][C@@]12CC[C@@](C)(O)[C@@]1(C)CCC1=C2C=CC2=CC(O)=CC=C12
17-METHYL-17-ALPHA-DIHYDROEQUILENIN,Nuclear receptor coactivator 2,[H][C@@]12CC[C@@](C)(O)[C@@]1(C)CCC1=C2C=CC2=CC(O)=CC=C12
17alpha-Estriol,Nuclear receptor coactivator 5,[H][C@@]12C[C@@H](O)[C@@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
17alpha-Estriol,Estrogen receptor beta,[H][C@@]12C[C@@H](O)[C@@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",Serine/threonine-protein kinase Chk1,ClC1=CC2=C(OCCCCCOC3=CN=CC(NC(=O)N2)=N3)C=C1
"19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one",Casein kinase II subunit alpha,O=C1CCCCC2=C3N=C(NC4=CC(N1)=CC=C4)N=C(NC1CC1)N3N=C2
"1D-myo-inositol 1,4,5-trisphosphate",Inositol-trisphosphate 3-kinase A,O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O
"1D-myo-inositol 1,4,5-trisphosphate",Cytohesin-2,O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O
"1D-myo-inositol 1,4,5-trisphosphate",Epsin-1,O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O
"1D-myo-inositol 1,4,5-trisphosphate","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O
"1D-myo-inositol 1,4,5-trisphosphate",Radixin,O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O
"1D-myo-inositol 1,4,5-trisphosphate","Inositol 1,4,5-trisphosphate receptor type 1",O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O
"1D-myo-inositol 1,4,5-trisphosphate","Spectrin beta chain, non-erythrocytic 1",O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O
"1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE",Acetylcholinesterase,CCC1=CC=CC=C1N=C(O)OC1=CC2=C(C=C1)N(C)C1C2(C)CCN1(C)=O
1h-Benoximidazole-2-Carboxylic Acid,Cathepsin D,OC(=O)C1=NC2=CC=CC=C2N1
"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",Nucleoside diphosphate kinase A,CC1=CN([C@@H]2O[C@H](CO[P@@](O)(=O)OP(O)(O)=O)C=C2)C(=O)NC1=O
"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",Nucleoside diphosphate kinase A,CC1=CN([C@@H]2O[C@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)C=C2)C(=O)NC1=O
"2',3'-Dideoxyadenosine-5'-Triphosphate",DNA nucleotidylexotransferase,NC1=NC=NC2=C1N=CN2[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1
"2',3'-Dideoxycytidine-5'-Monophosphate",Cytidylate kinase,NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](COP(O)(O)=O)O1
"2',3'-Dideoxythymidine-5'-Monophosphate",Thymidylate kinase,CC1=CN([C@H]2CC[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
"2',3'-O-{4-[Hydroxy(oxido)-λ5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)",Chemotaxis protein CheA,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@]4([H])OC5(O[C@@]34[H])C(=CC(C=C5[N+]([O-])=O)=[N+](O)[O-])[N+]([O-])=O)C2=NC=N1
"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",Endoglucanase 5A,[H][C@]1(CO)O[C@@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(OC3=C(C=C(C=C3)N(=O)=O)N(=O)=O)[C@]([H])(F)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,[H][C@]1(C)O[C@]([H])(C[C@]1([H])OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",Adenylate cyclase type 2,[H][C@]1(C)O[C@]([H])(C[C@]1([H])OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",Adenylate cyclase type 5,[H][C@]1(C)O[C@]([H])(C[C@]1([H])OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
"2',6'-Dichloro-Biphenyl-2,6-Diol","Biphenyl-2,3-diol 1,2-dioxygenase",OC1=CC=CC(=C1O)C1=C(Cl)C=CC=C1Cl
2'-5'dideoxyuridine,Thymidylate synthase,[H][C@]1(C)O[C@]([H])(C[C@]1([H])O)N1C=CC(O)=NC1=O
"2'-Chloro-Biphenyl-2,3-Diol","Biphenyl-2,3-diol 1,2-dioxygenase",OC1=CC=CC(=C1O)C1=C(Cl)C=CC=C1
2'-Deoxy-Thymidine-Beta-L-Rhamnose,dTDP-4-dehydrorhamnose reductase,C[C@@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H](C[C@@H]2O)N2C=C(C)C(=O)NC2=O)[C@H](O)[C@H](O)[C@H]1O
2'-Deoxy-Thymidine-Beta-L-Rhamnose,Glucose-1-phosphate thymidylyltransferase,C[C@@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H](C[C@@H]2O)N2C=C(C)C(=O)NC2=O)[C@H](O)[C@H](O)[C@H]1O
2'-Deoxycytidine,Class B acid phosphatase,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1
2'-Deoxycytidine,Deoxycytidine kinase,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1
2'-Deoxycytidine,"Thymidine kinase 2, mitochondrial",NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1
2'-Deoxycytidine 5'-triphosphate,Anaerobic ribonucleoside-triphosphate reductase,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
2'-Deoxycytidine 5'-triphosphate,Deoxycytidine triphosphate deaminase,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
2'-Deoxycytidine 5'-triphosphate,"DNA polymerase I, thermostable",NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
2'-Deoxycytidine 5'-triphosphate,Ribonucleoside-diphosphate reductase 2 subunit alpha,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",Ribonuclease pancreatic,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])CO)N1C=CC(=N)N=C1O)N1C=NC2=C(N)N=CN=C12
2'-Deoxycytidine-5'-Monophosphate,Thymidylate synthase,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1
2'-Deoxycytidine-5'-Monophosphate,Deoxycytidylate 5-hydroxymethyltransferase,NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1
2'-Deoxyguanosine-5'-Diphosphate,Nucleoside diphosphate kinase A,NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O2)C(=O)N1
2'-Deoxyguanosine-5'-Monophosphate,Thymidylate synthase,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1
2'-Deoxyguanosine-5'-Monophosphate,Deoxynucleotide monophosphate kinase,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1
2'-Deoxyguanosine-5'-Triphosphate,Anaerobic ribonucleoside-triphosphate reductase,NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)N1
2'-Deoxyguanosine-5'-Triphosphate,Nucleoside diphosphate kinase A,NC1=NC2=C(N=CN2[C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)N1
2'-Deoxyuridine,Uridine phosphorylase,OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O
2'-Deoxyuridine,Thymidylate synthase,OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O
2'-Deoxyuridine 3'-Monophosphate,Ribonuclease 4,OC[C@H]1O[C@H](C[C@@H]1OP(O)(O)=O)N1C=CC(=O)NC1=O
2'-Deoxyuridine 3'-Monophosphate,Ribonuclease pancreatic,OC[C@H]1O[C@H](C[C@@H]1OP(O)(O)=O)N1C=CC(=O)NC1=O
"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",Deoxyuridine 5'-triphosphate nucleotidohydrolase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)NP(O)(=O)OP(O)(O)=O)N1C=CC(O)=NC1=O
"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",Deoxyuridine 5'-triphosphate nucleotidohydrolase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)NP(O)(=O)OP(O)(O)=O)N1C=CC(O)=NC1=O
"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",2'-hydroxybiphenyl-2-sulfinate desulfinase,OC1=CC=CC=C1C1=CC=CC=C1[S@@](O)=O
2'-Monophosphoadenosine 5'-Diphosphoribose,"NAD(P) transhydrogenase, mitochondrial",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"Nitric oxide synthase, brain",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Aldo-keto reductase family 1 member C1,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Estradiol 17-beta-dehydrogenase 1,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Dihydrofolate reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Alcohol dehydrogenase 1B,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,3-hydroxy-3-methylglutaryl-coenzyme A reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Estradiol 17-beta-dehydrogenase 8,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"Malate dehydrogenase, cytoplasmic",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Aldo-keto reductase family 1 member C3,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Flavin reductase (NADPH),[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,NADP-dependent malic enzyme,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"C-1-tetrahydrofolate synthase, cytoplasmic",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Aldo-keto reductase family 1 member C2,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Aldose reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,L-xylulose reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Sepiapterin reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Glucose-6-phosphate 1-dehydrogenase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Quinone oxidoreductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Isocitrate dehydrogenase [NADP],[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Isocitrate dehydrogenase [NADP],[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Isocitrate dehydrogenase [NADP] cytoplasmic,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,ADP-L-glycero-D-manno-heptose-6-epimerase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Glucose-6-phosphate 1-dehydrogenase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Pteridine reductase 1,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Dihydrofolate reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Aspartate-semialdehyde dehydrogenase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,NADP-dependent isopropanol dehydrogenase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,GDP-L-fucose synthase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Shikimate dehydrogenase (NADP(+)),[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"2,4-dienoyl-CoA reductase [NADPH]",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Dihydrofolate reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,3-oxoacyl-[acyl-carrier-protein] reductase FabG,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,NAD(P) transhydrogenase subunit beta,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,NADPH--cytochrome P450 reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Protein IolS,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"2,5-diketo-D-gluconic acid reductase A",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Putative ketoacyl reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Putative pteridine reductase 2,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,NADP-dependent glyceraldehyde-3-phosphate dehydrogenase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Ferredoxin--NADP reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Sulfite reductase [NADPH] flavoprotein alpha-component,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Ferredoxin--NADP reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Dehydrogenase/reductase SDR family member 11,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Oxidoreductase YdhF,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"2,4-dienoyl-CoA reductase, mitochondrial",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"Oxidoreductase, short chain dehydrogenase/reductase family",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Prostaglandin F synthase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,General stress protein 69,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Bifunctional protein MdtA,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"Alcohol dehydrogenase, iron-containing",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,NADH-dependent butanol dehydrogenase A,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,NADP-dependent fatty aldehyde dehydrogenase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"Oxidoreductase, aldo/keto reductase family",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Prostaglandin reductase 1,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Putative dehydrogenase/reductase SDR family member 4-like 1,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Alcohol dehydrogenase [NADP(+)],[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,Aldo-keto reductase family 1 member B10,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine 5'-Diphosphoribose,"NADPH:adrenodoxin oxidoreductase, mitochondrial",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine-5'-Diphosphate,Shikimate dehydrogenase (NADP(+)),[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine-5'-Diphosphate,Dihydrofolate reductase,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-Monophosphoadenosine-5'-Diphosphate,Ribonuclease pancreatic,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-O-Acetyl Adenosine-5-Diphosphoribose,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",[H][C@]1(O)O[C@]([H])(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@@]1([H])OC(C)=O
2'-cytidylic acid,Ribonuclease pancreatic,[H][C@]1(CO)O[C@@]([H])(N2C=CC(=N)N=C2O)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),DNA polymerase kappa,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=NC2=C1N=C(NCC1=CC=CC3=C1C=CC=C3)NC2=O
"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",DUTPase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)NP(O)(O)=O)N1C=CC(O)=NC1=O
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,"dTDP-glucose 4,6-dehydratase",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)C(=O)NC1=O
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,Glucose-1-phosphate thymidylyltransferase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)C(=O)NC1=O
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,"dTDP-glucose 4,6-dehydratase",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)C(=O)NC1=O
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,"dTDP-glucose 4,6-dehydratase",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)C(=O)NC1=O
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,"dTDP-4-dehydrorhamnose 3,5-epimerase",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O2)C(=O)NC1=O
2(S)-Amino-6-Boronohexanoic Acid,Arginase-1,N[C@@H](CCCC[B-](O)(O)O)C(O)=O
"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",Serine/threonine-protein kinase Chk1,ON=C1C2=CC(OCC(O)=O)=CC=C2C2=C1C=C(OCC(O)=O)C=C2
"2,2':6',2''-Terpyridine Platinum(Ii)",Autolysin,[Cl-].[Pt++].C1=CC=C(N=C1)C1=CC=CC(=N1)C1=CC=CC=N1
"2,2':6',2''-Terpyridine Platinum(Ii)",Transposase,[Cl-].[Pt++].C1=CC=C(N=C1)C1=CC=CC(=N1)C1=CC=CC=N1
"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",Histone deacetylase 4,OC(O)(C1=CC=C(S1)C(=O)N1CCN2C(C1)=NC=C2C1=CC=CC=C1)C(F)(F)F
"2,3,-Dihydroxybenzoylserine",Neutrophil gelatinase-associated lipocalin,[H][C@@](CO)(NC(=O)C1=C(O)C(O)=CC=C1)C(O)=O
"2,3,4,5,6-Pentafluorobenzyl Alcohol",Alcohol dehydrogenase 1C,OCC1=C(F)C(F)=C(F)C(F)=C1F
"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",Galectin-3,COC1=C(F)C(F)=C(C(N)=O)C(F)=C1F
"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",Glutamate receptor 2,[H][C@@]12CCCN1C(=O)C1=C(O2)C=C2OCCOC2=C1
"2,3-Anhydro-quinic acid",3-dehydroquinate dehydratase,[H][C@@]1(O)C[C@@](O)(C=C[C@@]1([H])O)C(O)=O
"2,3-Anhydro-quinic acid",3-dehydroquinate dehydratase,[H][C@@]1(O)C[C@@](O)(C=C[C@@]1([H])O)C(O)=O
"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",Beta-lactamase IMP-1,[H][C@@](CC1=CC=C2OCOC2=C1)(C(O)=O)[C@]([H])(CC1=CC=C2OCOC2=C1)C(O)=O
"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",Beta-lactamase,[H][C@@](CC1=CC=C2OCOC2=C1)(C(O)=O)[C@]([H])(CC1=CC=C2OCOC2=C1)C(O)=O
"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",DNA topoisomerase 1,COC1=C(OC)C=C2C3=C([NH+]=CC2=C1)C1=C(C3)C=C2OCOC2=C1
"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",Fumarate reductase flavoprotein subunit,CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O
"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",Fumarate reductase iron-sulfur subunit,CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O
"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",Fumarate reductase cytochrome b subunit,CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O
"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",Tyrosine-protein kinase Lck,C(CN1CCNCC1)NC1=CC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1
"2,3-Di-O-Sulfo-Alpha-D-Glucopyranose",47 kDa membrane antigen,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(OS(O)(=O)=O)[C@@]1([H])OS(O)(=O)=O
"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium","Glycogen phosphorylase, muscle form",CC[N+]1=C(C)C(C(=O)OC(C)C)=C(C2=CC=CC=C2Cl)C(C(O)=O)=C1C(O)=O
"2,3-Didehydroalanine",Lantibiotic mersacidin,NC(=C)C(O)=O
"2,3-Difluorobenzyl Alcohol",Alcohol dehydrogenase 1C,OCC1=CC=CC(F)=C1F
"2,3-Dihydroxy-5-Oxo-Hexanedioate",Glucarate dehydratase,O[C@@H](CC(=O)C([O-])=O)[C@@H](O)C([O-])=O
"2,3-Dihydroxy-Benzoic Acid",Neutrophil gelatinase-associated lipocalin,OC(=O)C1=CC=CC(O)=C1O
"2,3-Dihydroxy-Benzoic Acid","2,3-dihydroxybenzoate-AMP ligase",OC(=O)C1=CC=CC(O)=C1O
"2,3-diphenyl-1H-indole-7-carboxylic acid",Serine/threonine-protein kinase pim-1,OC(=O)C1=CC=CC2=C1NC(=C2C1=CC=CC=C1)C1=CC=CC=C1
"2,4,6-Triaminoquinazoline",Pteridine reductase 1,NC1=CC=C2N=C(N)N=C(N)C2=C1
"2,4,6-Triaminoquinazoline",Putative dehydrogenase/reductase SDR family member 4-like 1,NC1=CC=C2N=C(N)N=C(N)C2=C1
"2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE",Gag-Pol polyprotein,[H][C@](N)(CC1=CC=CC=C1)C(O)[C@@]([H])(N)CC1=CC=CC=C1
"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",Beta-mannosidase,[H][C@]1(CO)O[C@@]([H])(OC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O)[C@@]([H])(F)[C@@]([H])(O)[C@]1([H])O
"2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid",Neuraminidase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])O[C@]([H])(C[C@]([H])(NC(N)=N)[C@@]1([H])N=C(C)O)C(O)=O
"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",Dihydrofolate reductase,COC1=CC(CC2=C[NH+]=C(N)N=C2N)=CC(OC)=C1OC
"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",Dihydrofolate reductase,COC1=CC(CC2=C[NH+]=C(N)N=C2N)=CC(OC)=C1OC
"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",Dihydrofolate reductase,COC1=CC(=CC(OC)=C1OC)N(C)CC1=C(C)C2=C(N)N=C(N)N=C2N=C1
"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine","Nitric oxide synthase, endothelial",[H][C@]1(CNC2=C(N1)C(N)=NC(N)=N2)C1=CC=CC=C1
"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",Dihydrofolate reductase,COC1=CC(CN(C)C2=CC=C3N=C(N)N=C(N)C3=C2)=C(OC)C=C1
"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",Dihydrofolate reductase,COC1=CC(CN(C)C2=CC=C3N=C(N)N=C(N)C3=C2)=C(OC)C=C1
"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",Dihydrofolate reductase,COC1=CC(CN(C)C2=CN=C3N=C(N)N=C(N)C3=C2)=CC(OC)=C1OC
"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",Dihydrofolate reductase,COC1=CC(OC)=CC(CN(C)C2=CN=C3N=C(N)N=C(N)C3=C2)=C1
"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",Dihydrofolate reductase,COC1=CC(OC)=CC(CN(C)C2=CN=C3N=C(N)N=C(N)C3=C2)=C1
"2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene",Alcohol dehydrogenase 1C,OCC1=CC=C(F)C=C1F
"2,4-Dihydroxy-3,3-Dimethyl-Butyrate",Pantothenate synthetase,CC(C)(CO)[C@@H](O)C([O-])=O
"2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One",Lactase-like protein,[H][C@@]1(O)OC2=C(C=CC(OC)=C2)N(O)C1=O
"2,4-Dihydroxy-Trans Cinnamic Acid",Chymotrypsinogen B,OC(=O)\C=C\C1=C(O)C=C(O)C=C1
"2,4-Dihydroxybenzoic Acid",p-hydroxybenzoate hydroxylase,OC(=O)C1=CC=C(O)C=C1O
"2,4-Dihydroxybenzoic Acid",p-hydroxybenzoate hydroxylase,OC(=O)C1=CC=C(O)C=C1O
"2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide",Oxygen-insensitive NAD(P)H nitroreductase,OC(=NCC(=O)C=O)C1=CC(N(CCBr)CCBr)=C(C=C1N(=O)=O)N(=O)=O
"2,4-Dinitrophenol",Pentaerythritol tetranitrate reductase,OC1=CC=C(C=C1[N+]([O-])=O)[N+]([O-])=O
"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",Beta-glucosidase A,[H][C@]1(CO)O[C@@]([H])(OC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O)[C@]([H])(F)[C@@]([H])(O)[C@]1([H])O
"2,5,7-Trihydroxynaphthoquinone",Biflaviolin synthase CYP158A2,OC1=CC2=C(C(O)=C1)C(=O)C=C(O)C2=O
"2,5,7-Trihydroxynaphthoquinone",Prenyltransferase,OC1=CC2=C(C(O)=C1)C(=O)C=C(O)C2=O
"2,5-Anhydroglucitol-1,6-Biphosphate","Fructose-1,6-bisphosphatase 1",[H][C@]1(O)[C@]([H])(O)[C@]([H])(COP(O)(O)=O)O[C@]1([H])COP(O)(O)=O
"2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE",Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,CC(C)(C)C1=CC(O)=C(C=C1O)C(C)(C)C
"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE","Fructose-1,6-bisphosphatase 1",ClC1=CC=C2OC(NS(=O)(=O)C3=CC(Cl)=CC=C3Cl)=NC2=C1
"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE","Fructose-1,6-bisphosphatase 1",COC1=CC2=C(OC(NS(=O)(=O)C3=CC(Cl)=CC=C3Cl)=N2)C(=C1)C1=CN=C(OC)C=C1
"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",Metallo-beta-lactamase L1,OC(=O)C1=C(OC(=C1C(O)=O)C1=CC=CC=C1)C1=CC=CC=C1
"2,5-Dideoxy-2,5-Imino-D-Glucitol",Xylose isomerase,OC[C@@H]1N[C@@H](CO)[C@H](O)[C@H]1O
"2,5-Dimethoxy-4-ethylthioamphetamine",5-hydroxytryptamine receptor 2A,CCSC1=CC(OC)=C(CC(C)N)C=C1OC
"2,5-Dimethoxy-4-ethylthioamphetamine",5-hydroxytryptamine receptor 2C,CCSC1=CC(OC)=C(CC(C)N)C=C1OC
"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",Trypsin-1,[H][C@]1(CO[C@]2([H])[C@]([H])(CO[C@]12[H])OC1=CC=C(C=C1)C(N)=N)OC1=CC=C(C=C1)C(N)=N
"2,5-Xylidine",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC=C(C)C(N)=C1
"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",Trypsin-1,[H][C@]1(CO[C@]2([H])[C@]([H])(CO[C@]12[H])OC1=CC=CC(=C1)C(N)=N)OC1=CC(=CC=C1)C(N)=N
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,[H][C@@](C)(CC[C@]([H])(N)[C@]([H])(C)C(O)=O)C[C@]([H])(C)[C@]([H])(CC1=CC=CC=C1)OC
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,[H][C@@](C)(CC[C@]([H])(N)[C@]([H])(C)C(O)=O)C[C@]([H])(C)[C@]([H])(CC1=CC=CC=C1)OC
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,[H][C@@](C)(CC[C@]([H])(N)[C@]([H])(C)C(O)=O)C[C@]([H])(C)[C@]([H])(CC1=CC=CC=C1)OC
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,[H][C@@](C)(CC[C@]([H])(N)[C@]([H])(C)C(O)=O)C[C@]([H])(C)[C@]([H])(CC1=CC=CC=C1)OC
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,[H][C@@](C)(CC[C@]([H])(N)[C@]([H])(C)C(O)=O)C[C@]([H])(C)[C@]([H])(CC1=CC=CC=C1)OC
"2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid",Chondroitinase (Chondroitin lyase),[H][C@]1(O)COC(=C[C@]1([H])O)C(O)=O
"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",Genome polyprotein,CC1=NC(=CO1)C1=CC(C)=C(OCCCC2=CC(C)=NO2)C(C)=C1
"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",Genome polyprotein,CN1N=NC(=N1)C1=CC(C)=C(OCCCC2=CC(C)=NO2)C(C)=C1
"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",Genome polyprotein,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)N2N=NC(C)=N2)=C1
"2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine",Purine nucleoside phosphorylase,C[C@@H](CN1C=NC2=C1N=C(N)N=C2N)OCP([O-])([O-])=O
"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",Queuine tRNA-ribosyltransferase,NC1=NC2=C(C=C(N)C=C2CSC2=NC=CN2)C(=O)N1
"2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One",Queuine tRNA-ribosyltransferase,CN(C)CCSCC1=C2N=C(N)NC(=O)C2=CC(N)=C1
"2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One",Queuine tRNA-ribosyltransferase,CCCSCC1=CC(N)=CC2=C1N=C(N)NC2=O
"2,6-Diamino-Hexanoic Acid Amide",Pituitary adenylate cyclase-activating polypeptide,N[C@@H](CCCC[NH3+])C(N)=O
"2,6-Diaminopimelic Acid","UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",N[C@@H](CCC[C@H](N)C(O)=O)C(O)=O
"2,6-Diaminopimelic Acid",Meso-diaminopimelate D-dehydrogenase,N[C@@H](CCC[C@H](N)C(O)=O)C(O)=O
"2,6-Diaminoquinazolin-4(3h)-One",Queuine tRNA-ribosyltransferase,NC1=CC2=C(C=C1)N=C(N)N=C2O
"2,6-Difluorobenzenesulfonamide",Carbonic anhydrase 2,NS(=O)(=O)C1=C(F)C=CC=C1F
"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",Mitogen-activated protein kinase 10,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2
"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",C-Jun-amino-terminal kinase-interacting protein 1,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2
"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",Mitogen-activated protein kinase 8,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2
"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",Dual specificity protein kinase TTK,O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2
"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",Queuine tRNA-ribosyltransferase,NC1=NC2=C(N1)C=C1C(=O)NC(N)=NC1=C2
"2,6-dicarboxynaphthalene",Hemoglobin subunit alpha,OC(=O)C1=CC2=CC=C(C=C2C=C1)C(O)=O
"2,6-dicarboxynaphthalene",Hemoglobin subunit beta,OC(=O)C1=CC2=CC=C(C=C2C=C1)C(O)=O
"2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium",Uridine phosphorylase,[O-][V](=O)[O+]([V](=O)O[V](=O)(=O)O[V](=O)(=O)[O+]([V]([O-])=O)[V](=O)(=O)=O)[V](=O)(=O)=O
"2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium",Cyclin-dependent kinases regulatory subunit 1,[O-][V](=O)[O+]([V](=O)O[V](=O)(=O)O[V](=O)(=O)[O+]([V]([O-])=O)[V](=O)(=O)=O)[V](=O)(=O)=O
"2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",Streptavidin,COC1=CC(=CC(OC)=C1O)\N=N\C1=CC=CC=C1C(O)=O
"2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",Streptavidin,CC1=CC(=CC(C)=C1O)\N=N\C1=CC=CC=C1C(O)=O
2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,Streptavidin,CC1=CC(=CC=C1O)\N=N\C1=CC=CC=C1C(O)=O
2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,Streptavidin,CC(C)(C)C1=CC(=CC=C1O)\N=N\C1=CC=CC=C1C(O)=O
2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID,Streptavidin,OC(=O)C1=CC=CC=C1\N=N\C1=C2C=CC=CC2=C(O)C=C1
2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID,Streptavidin,OC(=O)C1=CC=CC=C1\N=N\C1=CC=C(O)C=C1
2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",COC1=CC=CC=C1N1C(=O)C2=C(Cl)C=CC=C2N=C1CSC1=C2N=CNC2=NC=N1
2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",COC1=CC=CC=C1N1C(=O)C2=C(Cl)C=CC=C2N=C1CSC1=C2N=CNC2=NC=N1
"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",Prostaglandin G/H synthase 1,[H][C@@](C)(C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",Tyrosine-protein kinase JAK2,CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",Death-associated protein kinase 3,CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",Tyrosine-protein kinase JAK1,CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",Tyrosine-protein kinase JAK3,CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",Non-receptor tyrosine-protein kinase TYK2,CC(C)(C)C1=NC2=C3C=CC(F)=CC3=C3C(=O)NC=CC3=C2N1
"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",Glycogen synthase kinase-3 beta,COC1=C(F)C=C(CSC2=NN=C(O2)C2=CC3=C(OCO3)C=C2)C=C1
"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C2NC(=NC2=C1)C1=CSC=N1
"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",Gag-Pol polyprotein,CC(C)CCN(C[C@@H](O)[C@@H]1CC2=CC=C(OCCCC(=O)N[C@@H](CC(N)=O)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1
2-(1H-INDOL-3-YL)ACETAMIDE,Aralkylamine dehydrogenase light chain,NC(=O)CC1=CNC2=CC=CC=C12
2-(1H-INDOL-3-YL)ACETAMIDE,Aralkylamine dehydrogenase heavy chain,NC(=O)CC1=CNC2=CC=CC=C12
2-(1H-INDOL-3-YL)ETHANAMINE,Aralkylamine dehydrogenase light chain,NCCC1=CNC2=CC=CC=C12
2-(1H-INDOL-3-YL)ETHANAMINE,Aralkylamine dehydrogenase heavy chain,NCCC1=CNC2=CC=CC=C12
"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",3-phosphoinositide-dependent protein kinase 1,COCCOC1=C(OC)C=C2C(=C1)N=CC1=C(N)N=C(C=C21)N1C=CN=C1
2-(1H-pyrazol-3-yl)-1H-benzimidazole,Aurora kinase A,N1C=CC(=N1)C1=NC2=CC=CC=C2N1
"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",Heat shock protein HSP 90-alpha,OC1=CC(O)=C(C(=O)N2C=CC=C2)C(O)=C1
"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",Enoyl-[acyl-carrier-protein] reductase [NADH],OC1=CC(CC2=CC=CC=N2)=CC=C1OC1=CC=C(Cl)C=C1Cl
"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",Mitogen-activated protein kinase 14,CC(C)N1C(NC2=CC=CC=C2F)=NC2=CN=C(OC3=C(F)C=CC=C3F)N=C12
"2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE",Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]12C[C@@]3([H])C[C@@](C1)(C[C@@]([H])(C2)[C@@]3([H])NC(=O)C(C)(C)OC1=C(Cl)C=C(F)C=C1)S(C)(=O)=O
2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL,Chymotrypsin-like elastase family member 2A,[H][C@](CC=C)(C=O)[C@@]1([H])CCC[C@]1([H])O
2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,Casein kinase I isoform gamma-1,CC(C)N1C=NC2=C1NC(NCCO)=N\C2=N/C1=CC=CC(Cl)=C1
2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,Tyrosine-protein kinase Mer,CC(C)N1C=NC2=C1NC(NCCO)=N\C2=N/C1=CC=CC(Cl)=C1
"2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid",Complement C1s subcomponent,OCC(CO)(CO)NCCS(O)(=O)=O
2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,Trypsin-1,COC1=CC=C(O)C(=C1)C1=NC2=C(N1)C=CC(=C2)C(N)=[NH2+]
2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,Urokinase-type plasminogen activator,COC1=CC=C(O)C(=C1)C1=NC2=C(N1)C=CC(=C2)C(N)=[NH2+]
2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,Trypsin-1,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC=C2O)C=C1
2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine,Prothrombin,NC(=[NH2+])C1=CC2=C(C=C1)N=C(N2)C1=CC=CC=C1O
2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine,Trypsin-1,NC(=[NH2+])C1=CC2=C(C=C1)N=C(N2)C1=CC=CC=C1O
2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine,Urokinase-type plasminogen activator,NC(=[NH2+])C1=CC2=C(C=C1)N=C(N2)C1=CC=CC=C1O
2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,Trypsin-1,CC1=C(C=CC=C1)C1=CC2=C(N1)C=CC(=C2)C(N)=N
2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,Trypsin-1,CC1=CC=CC=C1C1=CC2=C(N1)C=C(C=C2)C(N)=N
"2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine",Trypsin-1,NC(=[NH2+])C1=CC2=C(NC(=N2)C2=C(O)N=CC=C2)C=C1
"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE","Glutathione reductase, mitochondrial",C1CCC2=C(P(C(=C2C1)C1=NC=CC=C1)C1=CC=CC=C1)C1=NC=CC=C1
"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",MAP kinase-activated protein kinase 2,O=C1NCCC2=C1C=C(N2)C1=CC(=NC=C1)C1=CC2=C(C=CC=C2)N=C1
"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",MAP kinase-activated protein kinase 3,O=C1NCCC2=C1C=C(N2)C1=CC(=NC=C1)C1=CC2=C(C=CC=C2)N=C1
"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",Thymidylate synthase,CC1=C2C(=O)N(C(=O)C2=CC=C1)C1=CC=NC(Cl)=C1
2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,Stromelysin-1,[H][C@@](CS)(NCC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)NCC(=O)N[C@@]([H])(C(C)C)C(=O)OC
2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol,ActVA 6 protein,COCCOCCOCCOCCOCCO
2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol,Endoribonuclease EndoA,COCCOCCOCCOCCOCCO
"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",Carbonyl reductase [NADPH] 1,CCOCCOCCOCCOCCOCCOCCOCCOCCO
"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",DevB protein,CCOCCOCCOCCOCCOCCOCCOCCOCCO
2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,Hematopoietic prostaglandin D synthase,O=C1NNC(=O)C2=CC(=CC=C12)[N+]1=NC(\C=C\C2=CC=CC=C2)=NN1C1=NC2=C(S1)C=CC=C2
2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,Poly [ADP-ribose] polymerase 1,COC1=CC=CC(=C1)C1=NC2=C(N1)C=CC=C2C(N)=O
"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",Cyclin-dependent kinase 2,CC1=CC(N2CCCS2(=O)=O)=C2OC(=C(O)C(=O)C2=C1)C1=CC=C(O)C(O)=C1
"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",Peptide deformylase,[H][C@]1(CC(=O)NO)SC2=CC=CC=C2NC1=O
"2-(3,4-Dihydroxyphenyl)Acetic Acid","3,4-dihydroxyphenylacetate 2,3-dioxygenase",OC(=O)CC1=CC(O)=C(O)C=C1
"2-(3,4-Dihydroxyphenyl)Acetic Acid","Homoprotocatechuate 2,3-dioxygenase",OC(=O)CC1=CC(O)=C(O)C=C1
"2-(3,4-Dihydroxyphenyl)Acetic Acid",Penicillin G acylase,OC(=O)CC1=CC(O)=C(O)C=C1
"2-(3,4-Dihydroxyphenyl)Acetic Acid","Protocatechuate 3,4-dioxygenase alpha chain",OC(=O)CC1=CC(O)=C(O)C=C1
"2-(3,4-Dihydroxyphenyl)Acetic Acid","Protocatechuate 3,4-dioxygenase beta chain",OC(=O)CC1=CC(O)=C(O)C=C1
"2-(3,6-DIHYDROXYPHENYL)ACETIC ACID",Penicillin G acylase,OC(=O)CC1=CC(O)=CC=C1O
"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",Aldose reductase,OC(=O)CN1C=C(CC2=NC3=C(S2)C(F)=CC(F)=C3F)C2=CC=CN=C12
"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",Heat shock protein HSP 90-beta,COC1=CC(N)=C(OC)C(CCOC(=O)C2=C(O)C=C(O)C(Cl)=C2)=C1OC
"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",Endoplasmin,COC1=CC(N)=C(OC)C(CCOC(=O)C2=C(O)C=C(O)C(Cl)=C2)=C1OC
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,Peptide deformylase,ON(CCOC1=CC=CC(=C1)C(=O)C1=CC=CC=C1)C=O
"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",Genome polyprotein,OCCNC1=CC=C2C(=O)N(C(=O)C3=CC=CC1=C23)C1=CC(Br)=CC=C1
"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",Genome polyprotein,OCCNC1=CC=C2C(=O)N(C(=O)C3=CC=CC1=C23)C1=CC(Br)=CC=C1
"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",o-succinylbenzoate synthase,[H][C@@]1(O)C=CC=C(C(=O)CCC(O)=O)[C@@]1([H])C(O)=O
"2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE",Prothrombin,[H][C@](C)(NC(=O)CC1=[N+]([O-])C(NCC(F)(F)C2=[N+]([O-])C=CC=C2)=CC=C1Cl)C1=CC=CC(Cl)=C1
"2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL",Estrogen receptor beta,OC1=CC2=C(OC(=N2)C2=CC=C(O)C(F)=C2)C(C=C)=C1
"2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL",Nuclear receptor coactivator 1,OC1=CC2=C(OC(=N2)C2=CC=C(O)C(F)=C2)C(C=C)=C1
2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID,Carboxypeptidase B,NC(N)=NC1=CC=CC(=C1)[C@@H](CS)C(O)=O
2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,Trypsin-1,CC1=CC=CC(=C1)C1=CC2=C(N1)C=CC(=C2)C(N)=N
2-(3-NITROPHENYL)ACETIC ACID,Penicillin G acylase,OC(=O)CC1=CC(=CC=C1)[N+]([O-])=O
2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE,Beta-lactamase IMP-1,[S-]CCC(=O)SCCC=O
2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,Putative enoyl-(Acyl-carrier-protein) reductase II,OC(=O)COC1=CC=C(C=C1)C1=CNC(CNC(=O)NC2=NC=C(SC3=NC=CC=C3)S2)=N1
"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",Cyclin-dependent kinase 2,NCC1CCN(CC(=O)NC2=CC=CC3=C2C(=O)C2=C(NN=C32)C2CCCCC2)CC1
2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,Proto-oncogene tyrosine-protein kinase Src,[H][C@]1(CC2=C(CN1)C=CC=C2)C1=NC(C(O)=O)=C(S1)C(C)C
2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,NmrA-like family domain-containing protein 1,OC(=O)C1=C(NC2=CC=C(Cl)C=C2)N=CC=C1
"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",Casein kinase II subunit alpha,ClC1=CC=C(CNC2=NC3=C(C=NN3C(NC3=CC=CC=C3)=N2)C#N)C=C1
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,Poly [ADP-ribose] polymerase 1,NC(=O)C1=CC=CC2=NC=C(N=C12)C1=CC=C(Cl)C=C1
2-(4-DIMETHYLAMINOPHENYL)DIAZENYLBENZOIC ACID,FMN-dependent NADH-azoreductase 1,CN(C)C1=CC=C(C=C1)\N=N\C1=CC=CC=C1C(O)=O
"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",Casein kinase II subunit alpha,CCN1CCN(CC1)C1=NC2=C(C=NN2C(NC2=CC=CC=C2)=N1)C#N
2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,Immunoglobulin heavy variable 1-2,OC(=O)CC1=CC(=C(O)C=C1)[N+]([O-])=O
2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,Ig gamma-1 chain C region,OC(=O)CC1=CC(=C(O)C=C1)[N+]([O-])=O
2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,Coagulation factor VII,NC(=N)C1=CC=C2NC(=NC2=C1)C1=NNC(=C1O)C1=CC=CC=C1
2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,Tissue factor,NC(=N)C1=CC=C2NC(=NC2=C1)C1=NNC(=C1O)C1=CC=CC=C1
2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,Estrogen receptor beta,OC1=CC=C(C=C1)C1=CC2=C(O1)C=CC(O)=C2
2-(4-METHOXYPHENYL)ACETAMIDE,Aralkylamine dehydrogenase light chain,COC1=CC=C(CC(N)=O)C=C1
2-(4-METHOXYPHENYL)ACETAMIDE,Aralkylamine dehydrogenase heavy chain,COC1=CC=C(CC(N)=O)C=C1
2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE,Thermolysin,[H][P@]([O-])(=O)CCOC1=CC=C(C)C=C1
2-(4-NITROPHENYL)ACETIC ACID,Penicillin G acylase,OC(=O)CC1=CC=C(C=C1)[N+]([O-])=O
"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",Hepatocyte growth factor receptor,FC1=CC=C(CC(=O)NC(=O)NC2=CC(F)=C(OC3=CC=NC4=C3C=CN4)C=C2)C=C1
"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",Thymidylate synthase,CC1=C2C(=O)N(C(=O)C2=CC=C1)C1=CC(=CC=C1O)C1=CC=CC=C1
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,Prothrombin,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)CCC2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,Coagulation factor X,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)CCC2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,Prothrombin,O=C([C@@](C)([H])N1CC[C@]([H])(NS(=O)(=O)\C=C\C2=CC=C(Cl)S2)C1=O)N1CCOCC1
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,Coagulation factor X,O=C([C@@](C)([H])N1CC[C@]([H])(NS(=O)(=O)\C=C\C2=CC=C(Cl)S2)C1=O)N1CCOCC1
"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",Nuclear receptor coactivator 1,OC1=CC2=C(C=C1)N=C(O2)C1=C2C=CC=C(O)C2=CC=C1
"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",Estrogen receptor beta,OC1=CC2=C(C=C1)N=C(O2)C1=C2C=CC=C(O)C2=CC=C1
"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",Prothrombin,[O-][N+]1=CC=CC=C1C(F)(F)CNC1=NC=C(Cl)N(CC(=O)NCC2=C(F)C=CC=C2)C1=O
"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",Prothrombin,CC1=C[NH+]=C(NCC(F)(F)C2=[NH+]C=CC=C2)C(=O)N1CC(=O)NCC1=C(F)C(C)=CC=N1
"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",Prothrombin,CC1=CN=C(NCC(F)(F)C2=CC=CC=N2)C(=O)N1CC(=O)NCC1=C(F)C=CC=N1
"2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE",Long-chain-fatty-acid--CoA ligase ACSBG1,OC1=CC2=C(C=C1)N=C(S2)C1=NC(=O)CS1
2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,TGF-beta receptor type-1,CC1=CC=CC(=N1)C1=NC(NC2=CC=NC=C2)=C2C=CC=CC2=N1
"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",Corticosteroid 11-beta-dehydrogenase isozyme 1,CCN(CC)C(=O)CC1=CC=CC(NS(=O)(=O)C2=C(C)C(Cl)=CC=C2)=N1
2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER,Thermolysin,[H][C@](CC(C)C)(N(O)C(C)=O)C(=O)OC
2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose,Chitotriosidase-1,[H][C@]1(O)[C@]([H])(O)[C@@]2([H])N=C(O[C@@]2([H])[C@]1([H])CO)N=C
2-(BUTYRYLOXY)-1-{[(TETRAHYDROXYPHOSPHORANYL)OXY]METHYL}ETHYL BUTYRATE,Phospholipase D,[H][C@@](COC(=O)CCC)(COP(O)(O)(O)O)OC(=O)CCC
"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole","Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]([H])(C2=NC3=C(N2)C=C(C)C=C3)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole","Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]([H])(C2=NC3=CC(C)=CC=C3S2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole","Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]([H])(C2=NN=C(C)O2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",Neutrophil collagenase,[H][C@@]1(CC2=C(CN1S(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1)C=CC=C2)C(O)=O
"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",Aldose reductase,OC(=O)CN1C(=O)C2=C(C(=CC3=CC=CC=C23)C(O)=O)S1(=O)=O
"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",Casein kinase II subunit alpha,N#CC1=C2N=C(NCC3CCCCC3)N=C(NC3=CC=CC=C3)N2N=C1
2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CC1=CC=CC=C1)(N=C(O)CCC(O)=O)C(O)=N[C@@]([H])(CC1=CC(C(O)=O)=C(OCC(O)=O)C=C1)C(O)=NCCCCC
2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,Mitogen-activated protein kinase 14,CCOCN1OC(=O)C(=C1C1=CC=NC(OC2=CC=CC=C2O)=N1)C1=CC=C(F)C=C1
2-(N-Morpholino)-Ethanesulfonic Acid,"Beta-1,4-galactosyltransferase 1",[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Corticosteroid 11-beta-dehydrogenase isozyme 1,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Acetylcholinesterase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Argininosuccinate lyase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Dihydropteridine reductase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Glutathione S-transferase P,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Chymase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Dihydrofolate reductase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Copper-containing nitrite reductase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Hydroxylamine reductase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Diaminopimelate decarboxylase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,"Limonene-1,2-epoxide hydrolase",[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Tyrosine-protein kinase transforming protein Abl,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,"Mannan endo-1,4-beta-mannosidase",[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Alpha-xylosidase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Bifunctional protein GlmU,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Glyceraldehyde-3-phosphate dehydrogenase A,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Thiol:disulfide interchange protein DsbC,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Cholinesterase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Ornithine cyclodeaminase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Biflaviolin synthase CYP158A2,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Chorismate mutase AroH,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Manganese catalase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Copper-containing nitrite reductase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,(S)-mandelate dehydrogenase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,33 kDa chaperonin,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Free methionine-R-sulfoxide reductase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,O-acetyl-ADP-ribose deacetylase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Beta-lactamase,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Lethal(3)malignant brain tumor-like protein 1,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Ribonuclease Z,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Hypothetical gliding protein,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Prolyl endopeptidase Pep,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Pulmonary surfactant-associated protein A1,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Interferon-inducible GTPase 5,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,ADP-ribosylation factor-like protein 3,[O-]S(=O)(=O)CC[NH+]1CCOCC1
2-(N-Morpholino)-Ethanesulfonic Acid,Peroxiredoxin-6,[O-]S(=O)(=O)CC[NH+]1CCOCC1
"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)NC1=C(C(O)=O)C2=C(CNCC2)S1
"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)NC1=C(C(O)=O)C2=C(COCC2)S1
"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid",Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)NC1=C(C(O)=O)C2=C(CSCC2)S1
2-(Oxalyl-Amino)-Benzoic Acid,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)NC1=C(C=CC=C1)C(O)=O
2-(Phosphonooxy)Butanoic Acid,2-dehydro-3-deoxyphosphooctonate aldolase,CC[C@@H](OP(O)(O)=O)C(O)=O
2-(Sec-Butyl)Thiazole,Epididymal-specific lipocalin-9,CC[C@@H](C)C1=NC=CS1
"2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL",Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,CC1=CC=C(C=C1)S(=O)(=O)N1N=CC2=C(C=CC=C2)B1O
2-(Thiomethylene)-4-Methylpentanoic Acid,Disintegrin and metalloproteinase domain-containing protein 28,[H][C@](CS)(CC(C)C)C(O)=O
2-(Trimethylammonium)Ethyl Thiol,NPQTN specific sortase B,C[N+](C)(C)CCS
2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose,Chondroitinase-B,[H][C@]1(O)O[C@]([H])(CO)[C@]([H])(OS(O)(=O)=O)[C@]([H])(O)[C@@]1([H])N=C(C)O
"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",Carbonic anhydrase 2,NS(=O)(=O)OC1=CC=C2C=C(CC3CCCCCC3)S(=O)(=O)C2=C1
2-(cyclohexylamino)benzoic acid,Serine/threonine-protein kinase Chk1,OC(=O)C1=CC=CC=C1NC1CCCCC1
2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,Carbonic anhydrase 2,NNC(=O)C1=C(C2=C(N1)C=CC(=C2)S(N)(=O)=O)C1=CC=CC=C1
"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",Glucokinase,CNC1=C(C=C(SC2=NN=CN2C)C=C1)C(=O)NC1=NC(C)=CS1
2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,Serine/threonine-protein kinase Chk1,CSC1=NC(O)=C(CC2=CC=CS2)N1
2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,Mitogen-activated protein kinase 8,NC(=O)C1=CC=CC=C1NC1=NC(NC2=CC(O)=CC=C2)=NC=C1
2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,Dipeptidyl peptidase 4,[H][C@@]1(N)CCCN(C1)C1=NC2=C(C=CC=C2)C(=O)N1CC1=C(C=CC=C1)C#N
"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",Coagulation factor X,[O-][N+]1=CC=CC2=C1C=C(S2)C(=O)N1CCN(CC1)S(=O)(=O)C1=CC2=CC(Cl)=CC=C2N1
2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",C(OC1=CC=C(C=C1)C1=NNC=C1CC1=CC=NC=C1)C1=NC2=CC=CC=C2C=C1
2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,Focal adhesion kinase 1,CNC(=O)C1=C(NC2=NC(NC3=CC=C(C=C3OC)N3CCOCC3)=NC=C2Cl)C=CC=C1
"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",Dipeptidyl peptidase 4,[H][C@@]1(N)CCCN(C1)C1=NC2=C(N1CC1=CC=CC=C1C#N)C(=O)N(C)C(=O)N2C
"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID","Dihydroorotate dehydrogenase (quinone), mitochondrial",OC(=O)C1=C(C=CC1)C(=O)NC1=C(F)C(F)=C(C(F)=C1F)C1=CC(OC(F)(F)F)=CC=C1
"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID","Dihydroorotate dehydrogenase (quinone), mitochondrial",OC(=O)C1=C(CCC1)C(=O)NC1=C(F)C=C(C=C1F)C1=CC=CC(OC(F)(F)F)=C1
"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",Peroxisome proliferator-activated receptor delta,OC(=O)C1=C(NC(=O)C2=CC=CC(=C2)S(=O)(=O)N2CCC3=CC=CC=C3C2)C=CC=C1
2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,Tryptophan synthase alpha chain,OP(O)(=O)OCCNS(=O)(=O)C1=CC=C(OC(F)(F)F)C=C1
2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,Tryptophan synthase beta chain,OP(O)(=O)OCCNS(=O)(=O)C1=CC=C(OC(F)(F)F)C=C1
2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,3-oxoacyl-[acyl-carrier-protein] synthase 3,CCN(CC)S(=O)(=O)C1=CC(=CC=C1Br)C(=O)NC1=CC=CC=C1C(O)=O
"2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE",Peptidoglycan recognition protein 3,C[C@@H](NC(=O)[C@H](CCC[C@@H](N)C(O)=O)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]1[C@@H](NC(C)=O)[C@@H]2OC[C@@H](O2)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)C(O)=O)C(O)=O
2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,Chymotrypsinogen B,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)NC(C)=O)C=O
2-AMINO-3-(1-HYDROPEROXY-1H-INDOL-3-YL)PROPAN-1-OL,Catalase-peroxidase,[H][C@](N)(CC1=CN(OO)C2=CC=CC=C12)C(O)=O
"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",Heat shock protein HSP 90-alpha,CCNC(=O)C1=CC2=C(N=C(N)N=C2S1)C1=C(Cl)C=C(Cl)C=C1
2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID,"3-hydroxyanthranilate 3,4-dioxygenase",NC1=C(C=CC(Cl)=C1O)C(O)=O
"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",Glucokinase,CN1C=CN=C1SC1=CC(C(=O)NC2=NC=CS2)=C(N)C=C1F
2-AMINO-4-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER,Dihydroneopterin aldolase,CCOC(=O)C1=C(O)N=C(N)N=C1
"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",Gag-Pol polyprotein,CC1=CC(=CC(C)=C1)S(=O)(=O)C1=C(C#N)C(N)=CC=C1
"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",Biotin carboxylase,NC1=NC=C(O1)C(=O)N(CC1=CC=CC=C1)CC1=CC=CC=C1
2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,Cyclin-A2,C(OC1=C2NC=NC2=NC(NC2=CC=CC=C2)=N1)C1CCCCC1
2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,Cyclin-dependent kinase 2,C(OC1=C2NC=NC2=NC(NC2=CC=CC=C2)=N1)C1CCCCC1
"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",Beta-hexosaminidase subunit beta,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1=O
"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",Chitinase B,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1=O
"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",Pyruvate synthase,CC(=O)C1=[N+](CC2=CN=C(C)N=C2N)C(C)=C(CCOP(O)(=O)OP(O)(O)=O)S1
2-Acetyl-Protoporphyrin Ix,Cytochrome c-552,CC1=C2C=C3[C@@H](C(O)=C)C(C)=C4C=C5N6C(=CC7=C(CCC(O)=O)C(C)=C8C=C([C@@H]1C=C)N2[Fe@@]6(N34)N78)C(CCC(O)=O)=C5C
2-Allyl-6-Methyl-Phenol,Endolysin,CC1=CC=CC(CC=C)=C1O
2-Allylphenol,Endolysin,OC1=CC=CC=C1CC=C
"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Estrogen receptor,CN1C(N)=NC2=NC=C(C=C12)C1=CC=CC=C1
"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",Nuclear receptor coactivator 2,CN1C(N)=NC2=NC=C(C=C12)C1=CC=CC=C1
"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",Glutamate receptor 2,N[C@@H](CC1=CCCCC2=C1C(=O)NO2)C(O)=O
2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,Glutamate receptor 2,CC(C)(C)C1=C(C[C@H](N)C(O)=O)C(OCP(O)(O)=O)=NO1
2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid,Acyl-CoA thioesterase I,[H][C@](N)(COP(=O)(OCC)OCC)C(O)=O
2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,Arylsulfatase A,[H][C@@](N)(C(O)=O)[C@@]([H])(O)OP(O)(O)=O
2-Amino-3-Ketobutyric Acid,2-amino-3-ketobutyrate coenzyme A ligase,CC(=O)[C@H](N)C(O)=O
2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One,Dipeptidyl peptidase 4,[H][C@](N)(C(C)C)C(=O)N1CCCC1
2-Amino-3-Oxo-4-Sulfo-Butyric Acid,Steryl-sulfatase,[H][C@@](N)(C(O)=O)[C@@]([H])(O)OS(O)(=O)=O
"2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid",Primary amine oxidase,NC(CC1C\C(=N/C2CC2C2=CC=CC=C2)C(O)=CC1=O)C(O)=O
"2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid",Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,[H][C@](N)(CC[C@@]1([H])C=CC([H])(N)C=C1)C(O)=O
2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid,Glutamine synthetase,C[P@@](O)(=O)CC[C@@H](N)C(O)=O
2-Amino-4-Mercapto-Butyric Acid,S-ribosylhomocysteine lyase,N[C@@H](CCS)C(O)=O
2-Amino-4-Mercapto-Butyric Acid,5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase,N[C@@H](CCS)C(O)=O
2-Amino-4-Mercapto-Butyric Acid,5-methyltetrahydrofolate S-homocysteine methyltransferase,N[C@@H](CCS)C(O)=O
2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol,Dihydroneopterin aldolase,NC1=NC(=C(Br)C(O)=N1)C1=CC=CC=C1
2-Amino-5-Hydroxy-Benzimidazole,Urokinase-type plasminogen activator,OC1=CC2=C(NC(=N)N2)C=C1
2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,Queuine tRNA-ribosyltransferase,NCC1=CC(CSC2=CC=CC=C2)=C2N=C(N)NC(=O)C2=C1
2-Amino-6-Chloropyrazine,Cyclin-dependent kinase 2,NC1=CN=CC(Cl)=N1
2-Amino-6-Oxo-Hexanoic Acid,Glutaminase-asparaginase,N[C@@H](CCCC=O)C(O)=O
"2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One",Purine nucleoside phosphorylase,NC1=NC2=C(N(CCNC(CO)CO)C=N2)C(=O)N1
2-Amino-8-Methylquinazolin-4(3h)-One,Queuine tRNA-ribosyltransferase,CC1=CC=CC2=C1NC(N)=NC2=O
"2-Amino-N,3,3-Trimethylbutanamide",Matrix metalloproteinase-9,CNC(=O)[C@@H](N)C(C)(C)C
2-Amino-P-Cresol,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC=C(O)C(N)=C1
2-Amino-Vinyl-Phosphate,Ferrichrome-iron receptor,N\C=C\OP(O)(O)=O
2-Aminobenzyl alcohol,Complement factor D,NC1=CC=CC=C1CO
2-Aminoethanimidic Acid,Cathepsin B,[H]N=C([H])CN
2-Aminophenol,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,NC1=CC=CC=C1O
2-Aminopimelic Acid,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",N[C@@H](CCCCC(O)=O)C(O)=O
2-Aminopropanedioic Acid,Arylsulfatase,NC(C(O)=O)C(O)=O
2-Aminoquinazolin-4(3h)-One,Queuine tRNA-ribosyltransferase,NC1=NC2=CC=CC=C2C(=O)N1
2-Aminothiazoline,"Nitric oxide synthase, endothelial",NC1=NCCS1
"2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate",1-aminocyclopropane-1-carboxylate deaminase,[NH3+][C@H](C=C)C([O-])=O
2-Anhydro-3-Fluoro-Quinic Acid,3-dehydroquinate dehydratase,[H][C@@]1(O)C[C@@](O)(C=C(F)[C@@]1([H])O)C(O)=O
"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",Beta-lactamase IMP-1,[H][C@@](CC1=CC=CC=C1)(C(O)=O)[C@]([H])(CC1=CC2=C(OCO2)C=C1)C(O)=O
"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",Beta-lactamase,[H][C@@](CC1=CC=CC=C1)(C(O)=O)[C@]([H])(CC1=CC2=C(OCO2)C=C1)C(O)=O
2-Benzyl-3-Iodopropanoic Acid,Carboxypeptidase A1,[H][C@@](CI)(CC1=CC=CC=C1)C(O)=O
2-Bromo-2-Propene-1-Ol,Haloalkane dehalogenase,OCC(Br)=C
2-Bromoacetyl Group,Prostaglandin G/H synthase 1,OC(=O)CBr
2-Butanol,NADP-dependent isopropanol dehydrogenase,CC[C@@H](C)O
"2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione",Queuine tRNA-ribosyltransferase,CCCCC1=NC2=C(N1)C(=O)NNC2=O
"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",Photosynthetic reaction center cytochrome c subunit,CCNC1=NC(NC(C)C)=NC(Cl)=N1
"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",Reaction center protein H chain,CCNC1=NC(NC(C)C)=NC(Cl)=N1
"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",Reaction center protein L chain,CCNC1=NC(NC(C)C)=NC(Cl)=N1
"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",Reaction center protein M chain,CCNC1=NC(NC(C)C)=NC(Cl)=N1
2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,[H][C@](OCC1=NC(Cl)=C(C=C1C1=CC(Cl)=CC=C1)C#N)(C1=CN=CN1C)C1=CC=C(C=C1)C#N
2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,Protein farnesyltransferase subunit beta,[H][C@](OCC1=NC(Cl)=C(C=C1C1=CC(Cl)=CC=C1)C#N)(C1=CN=CN1C)C1=CC=C(C=C1)C#N
"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase,CCN(CC)S(=O)(=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=C(C#N)C2=C(CCC2)S1
"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE","Glycogen phosphorylase, muscle form",[H][C@]1(CC2=C(C=CC=C2)[C@@]1([H])O)NC(=O)C1=CC2=C(N1)SC(Cl)=C2
"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE","Glycogen phosphorylase, muscle form",[H][C@]1(CC2=C(NC1=O)C=CC=C2)NC(=O)C1=CC2=C(N1)SC(Cl)=C2
2-Carboxyethylphosphonic Acid,Triosephosphate isomerase,OC(=O)CCP(O)(O)=O
2-Carboxypropyl-Coenzyme A,Methylmalonyl-CoA decarboxylase,[H][C@](C)(CSCCN=C(O)CCN=C(O)[C@]([H])(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O)C(O)=O
2-Chloro-6-Methyl-Aniline,Endolysin,CC1=CC=CC(=C)[C@H]1N
2-Chlorodideoxyadenosine,Endoplasmin,[H][C@@]1(CO)CC[C@@]([H])(O1)N1C=NC2=C1N=C(Cl)N=C2N
2-Chlorophenol,Mitogen-activated protein kinase 14,OC1=CC=CC=C1Cl
2-Cyclopropylmethylenepropanal,Renin,[H][C@](C)(CC1CC1)C=O
"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID","Glycogen phosphorylase, muscle form",[H][C@@](CC(O)=O)(OC(=O)\C=C\C1=CC=C(O)C=C1)[C@@]([H])(OC(=O)\C=C\C1=CC=C(O)C=C1)C(O)=O
2-Decenoyl N-Acetyl Cysteamine,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase,CCCCCCC\C=C/C(=O)SCCNC(C)=O
2-Decenoyl N-Acetyl Cysteamine,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase,CCCCCCC\C=C/C(=O)SCCNC(C)=O
2-Dehydropantoate,3-methyl-2-oxobutanoate hydroxymethyltransferase,CC(C)(CO)C(=O)C(O)=O
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",Neuraminidase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(O)[C@@]1([H])N=C(C)O)C(O)=O
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",Hemagglutinin-neuraminidase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(O)[C@@]1([H])N=C(C)O)C(O)=O
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",Sialidase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(O)[C@@]1([H])N=C(C)O)C(O)=O
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",Hemagglutinin-neuraminidase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(O)[C@@]1([H])N=C(C)O)C(O)=O
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",Sialidase-2,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(O)[C@@]1([H])N=C(C)O)C(O)=O
2-Deoxy-2-Amino Glucitol-6-Phosphate,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],[H][C@](N)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
2-Deoxy-2-Amino Glucitol-6-Phosphate,Glucosamine-6-phosphate isomerase 1,[H][C@](N)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
2-Deoxy-2-Amino Glucitol-6-Phosphate,Glucosamine-6-phosphate deaminase,[H][C@](N)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
2-Deoxy-2-Aminogalactose,Galectin-7,N[C@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1O
2-Deoxy-Beta-D-Galactose,Beta-galactosidase,[H][C@@]1(O)C[C@@]([H])(O)[C@@]([H])(O)[C@@]([H])(CO)O1
2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate,Inositol-3-phosphate synthase 1,OCC[C@@H](O)[C@H](O)[C@H](O)\C=C\P(O)(O)=O
2-Deoxy-Glucitol-6-Phosphate,Inositol-3-phosphate synthase 1,[H][C@@](O)(CCO)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
2-Deoxy-Glucose-6-Phosphate,"Glycogen phosphorylase, muscle form",O[C@H]1C[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1
2-Dimethylamino-Ethyl-Diphosphate,Isopentenyl-diphosphate Delta-isomerase,CN(C)CCO[P@](O)(=O)OP(O)(O)=O
"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",Pol protein,CCOCCOC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@]1(CC2=CC=CC=C2)NC=C([C@@H]2[C@@H]3OC(=O)N[C@@H]3C3=CC=CC=C23)C1=O
2-Ethoxyethanol,Alcohol dehydrogenase 1C,CCOCCO
2-Fluoro-2'-Deoxyadenosine,Purine nucleoside phosphorylase DeoD-type,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N1C=NC2=C(N)N=C(F)N=C12
2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose,Beta-galactosidase,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])F)[C@]([H])(O)[C@@]1([H])O
2-Fluoroadenosine,Purine nucleoside phosphorylase DeoD-type,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=C(F)N=C23)[C@]([H])(O)[C@]1([H])O
2-Fluoroaniline,Endolysin,NC1=CC=CC=C1F
2-Formyl-Protoporphryn Ix,Cytochrome c-552,[Fe+4].[H]\C(O)=C1/C(C)=C2[N-]/C/1=C([H])\C1=C(C)[C@@]([H])(C=C)\C([N-]1)=C([H])\C1=C(C)C(CCC(O)=O)=C([N-]1)\C([H])=C1/[N-]/C(=C\2/[H])C(C)=C1CCC(O)=O
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,Fumarate reductase flavoprotein subunit,CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,Fumarate reductase iron-sulfur subunit,CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,Fumarate reductase subunit C,CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,Fumarate reductase subunit D,CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,"Formate dehydrogenase, nitrate-inducible, major subunit",CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,"Formate dehydrogenase, nitrate-inducible, iron-sulfur subunit",CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,"Formate dehydrogenase, nitrate-inducible, cytochrome b556(Fdn) subunit",CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,Cytochrome c-type protein,CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,Cytochrome c-552,CCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
"2-HYDROXY-3,5-DIIODOBENZOIC ACID",Endothelin-1 receptor,OC(=O)C1=C(O)C(I)=CC(I)=C1
"2-HYDROXY-3,5-DIIODOBENZOIC ACID",Aldo-keto reductase family 1 member C1,OC(=O)C1=C(O)C(I)=CC(I)=C1
2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID,Caspase-3,OC(=O)C1=C(O)C=CC(=C1)S(=O)(=O)NCCS
2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE,Phenylethylamine oxidase,[H][C@](N)(CC1=CC(\N=C\CC2=CC=CC=C2)=C(O)C=C1O)C(O)=O
"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase,[H][C@]1(CO)O[C@@]([H])(SCCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",Diacylglycerol acyltransferase/mycolyltransferase Ag85C,[H][C@]1(CO)O[C@@]([H])(SCCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",Beta-1 adrenergic receptor,[H][C@]1(CO)O[C@@]([H])(SCCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",Lactase-phlorizin hydrolase,[H][C@]1(CO)O[C@@]([H])(SCCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",Histo-blood group ABO system transferase,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Cytochrome c1, heme protein, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",Cytochrome b,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Cytochrome b-c1 complex subunit 1, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Cytochrome b-c1 complex subunit 2, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Cytochrome b-c1 complex subunit 6, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",Cytochrome b-c1 complex subunit 8,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Cytochrome b-c1 complex subunit Rieske, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",Cytochrome b-c1 complex subunit 7,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",Cytochrome b-c1 complex subunit 9,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol","Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol",Histo-blood group ABO system transferase,[H][C@@]1(O)C[C@@]([H])(O)[C@]([H])(OCCCCCC)O[C@]1([H])CO
2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,Phenylethylamine oxidase,[H][C@](N)(CC1=C(O)C=C(O)C(N\C(COC2=CC=C3C=CC=CC3=C2)=C\C=O)=C1)C(O)=O
2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine,Phenylethylamine oxidase,[H]\C(C=O)=C(\COC1=CC=C(C)C=C1)NC1=C(O)C=C(O)C(C[C@]([H])(N)C(O)=O)=C1
"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",Neutrophil collagenase,OCCC1CCN(CC1)[C@@]1(C(=O)NC(O)=NC1=O)C1=CC=CC=C1
2-Hydroxy-Tryptophan,Quinohemoprotein ethanol dehydrogenase type-1,[H][C@](N)(CC1=C(O)NC2=CC=CC=C12)C(O)=O
2-Hydroxybenzalpyruvate,2-hydroxychromene-2-carboxylate isomerase,OC(=O)C(=O)\C=C\C1=CC=CC=C1O
2-Hydroxyestradiol,Adenylate cyclase,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=C(C=C(O)C(O)=C4)[C@@]3([H])CC[C@]12C
2-Hydroxyethyl Disulfide,Endolysin,OCCSSCCO
2-Hydroxyethyl Disulfide,Glutathione S-transferase A1,OCCSSCCO
"2-Hydroxymethyl-Pyrrolidine-3,4-Diol",Purine nucleoside phosphorylase,OC[C@@H]1NC[C@H](O)[C@H]1O
"2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE",Cyclin-dependent kinase 2,N=C1NC(=O)\C(S1)=C/C1=CC=CC=N1
2-Iminiopropanoate,1-aminocyclopropane-1-carboxylate deaminase,CC(=[NH2+])C([O-])=O
2-Iminobiotin,Streptavidin,[H][C@]12CS[C@@]([H])(CCCCC(O)=O)[C@@]1([H])NC(=N)N2
2-Isobutyl-3-Methoxypyrazine,Epididymal-specific lipocalin-9,COC1=NC=CN=C1CC(C)C
2-Keto-3-Deoxygluconate,2-keto-3-deoxy-gluconate kinase,OC[C@H](O)[C@@H](O)CC(=O)C(O)=O
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",Stathmin-4,[H][C@@]1(CCC2=C(C(OC)=C(OC)C(OC)=C2)C2=CC=C(OC)C(=O)C=C12)NC(=O)CS
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",Tubulin beta-2B chain,[H][C@@]1(CCC2=C(C(OC)=C(OC)C(OC)=C2)C2=CC=C(OC)C(=O)C=C12)NC(=O)CS
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",Tubulin alpha-1A chain,[H][C@@]1(CCC2=C(C(OC)=C(OC)C(OC)=C2)C2=CC=C(OC)C(=O)C=C12)NC(=O)CS
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",Tubulin alpha-1C chain,[H][C@@]1(CCC2=C(C(OC)=C(OC)C(OC)=C2)C2=CC=C(OC)C(=O)C=C12)NC(=O)CS
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",Tubulin alpha-1B chain,[H][C@@]1(CCC2=C(C(OC)=C(OC)C(OC)=C2)C2=CC=C(OC)C(=O)C=C12)NC(=O)CS
"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",Nuclear receptor coactivator 1,CC1=C(SC(=N1)C1=CC=C(C=C1)C(F)(F)F)C(=O)NCC1=CC=C(OC(C)(C)C(O)=O)C=C1
"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",Peroxisome proliferator-activated receptor alpha,CC1=C(SC(=N1)C1=CC=C(C=C1)C(F)(F)F)C(=O)NCC1=CC=C(OC(C)(C)C(O)=O)C=C1
2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,Tyrosine-protein kinase transforming protein Src,[H][C@]1(C(O)=O)[C@]([H])(C(=O)NC)[C@]1([H])C1=CC=C(OP(O)(O)=O)C=C1
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,Elongation factor Tu,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S12,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S10,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S11,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S13,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S14 type Z,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S15,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S16,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S17,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S18,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S19,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S20,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S4,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S5,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S6,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S7,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S8,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S9,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein Thx,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S17,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S20,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S2,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S3,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S9,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S19,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S2,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,30S ribosomal protein S3,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=C(SC)N=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
2-Methoxy-3-Isopropylpyrazine,Epididymal-specific lipocalin-9,COC1=NC=CN=C1C(C)C
2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol,Estrogen receptor beta,COC1=C(O)C(\C=N\C2=CC=C(C)C=C2)=CC=C1
2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol,Estrogen receptor,COC1=C(O)C(\C=N\C2=CC=C(C)C=C2)=CC=C1
2-Methoxyestradiol,Hypoxia-inducible factor 1-alpha,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3
2-Methoxyestradiol,Catechol O-methyltransferase,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3
2-Methoxyestradiol,Cytochrome P450 1A1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3
2-Methoxyestradiol,Cytochrome P450 1B1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3
2-Methoxyestradiol,Aromatase,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3
2-Methyl-2-Propanol,Calmodulin,CC(C)(C)O
2-Methyl-2-Propanol,"Biphenyl-2,3-diol 1,2-dioxygenase",CC(C)(C)O
2-Methyl-2-Propanol,Methionine aminopeptidase 2,CC(C)(C)O
2-Methyl-2-Propanol,Ribonuclease pancreatic,CC(C)(C)O
2-Methyl-2-Propanol,Triosephosphate isomerase,CC(C)(C)O
"2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate",Beta-lactamase,[H]N(C(=O)OC(C)(C)C)[C@]([H])(C(C)C)C1=NN=CO1
"2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate",Beta-lactamase,[H]N(C(=O)OC(C)(C)C)[C@@]([H])(C(C)C)C1=NN=CO1
2-Methyl-3-(2-Aminothiazolo)Propanal,Renin,[H][C@](C)(CC1=CSC(N)=N1)C=O
2-Methylbutanoic Acid,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",CC[C@@H](C)C(O)=O
2-Methylleucine,Branched-chain-amino-acid aminotransferase,CC(C)C[C@](C)(N)C(O)=O
"2-Methylpentane-1,2,4-Triol",Xylose isomerase,[H][C@@](C)(O)C[C@](C)(O)CO
2-NAPHTHALENESULFONIC ACID,Prothrombin,OS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1
2-NAPHTHALENESULFONIC ACID,Trypsin-1,OS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,"Cytochrome c1, heme protein, mitochondrial",CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,"Cytochrome b-c1 complex subunit 1, mitochondrial",CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,"Cytochrome b-c1 complex subunit 2, mitochondrial",CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,"Cytochrome b-c1 complex subunit 6, mitochondrial",CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b-c1 complex subunit 8,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b-c1 complex subunit 10,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b-c1 complex subunit 7,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b-c1 complex subunit 9,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b6,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome f,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b6-f complex iron-sulfur subunit,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b6-f complex subunit 4,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b6-f complex subunit 5,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b6-f complex subunit 6,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b6-f complex subunit 7,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,Cytochrome b6-f complex subunit 8,CCCCCCCCCC1=[N+]([O-])C2=CC=CC=C2C(O)=C1
"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",Trypsin-1,[H][C@@]1(CO[C@]2([H])[C@@]([H])(CO[C@]12[H])OC1=CC=CC(=C1)C(N)=N)OC1=CC=C(C=C1)C(N)=N
2-O-methyl fucose,Chondroitinase-B,[H][C@@]1(C)O[C@]([H])(O)[C@@]([H])(OC)[C@]([H])(O)[C@]1([H])O
2-O-methyl fucose,Chondroitinase-AC,[H][C@@]1(C)O[C@]([H])(O)[C@@]([H])(OC)[C@]([H])(O)[C@]1([H])O
2-OXOHEPTYLPHOSPHONIC ACID,Enolase-phosphatase E1,CCCCCC(=O)CP(O)(O)=O
2-OXOQUINOLINE,"2-oxo-1,2-dihydroquinoline 8-monooxygenase, oxygenase component",O=C1NC2=CC=CC=C2C=C1
2-Oxo-3-Pentenoic Acid,2-hydroxymuconate tautomerase,[H]\C(C)=C(/[H])C(=O)C(O)=O
2-Oxo-4-Methylpentanoic Acid,Deacetoxycephalosporin C synthase,CC(C)CC(=O)C(O)=O
2-Oxo-4-Methylpentanoic Acid,D-2-hydroxyisocaproate dehydrogenase,CC(C)CC(=O)C(O)=O
2-Oxobutanoic Acid,1-aminocyclopropane-1-carboxylate deaminase,CCC(=O)C(O)=O
2-Oxobutanoic Acid,Methylmalonyl-CoA carboxyltransferase 5S subunit,CCC(=O)C(O)=O
2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,Primary amine oxidase,[H][C@](N)(C[C@]1([H])C=C(NNC2=CC=CC=N2)C(O)=CC1=O)C(O)=O
2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,Cytochrome P450 1A2,O=C1C=C(OC2=C1C=CC1=CC=CC=C21)C1=CC=CC=C1
2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE,3-oxoacyl-[acyl-carrier-protein] synthase 1,CC(=O)C1=C(C)N=C(NC2=CC=CC=C2)S1
"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",Heat-labile enterotoxin B chain,O=C1NN(CCC2=CC=CC=C2)C(=O)C2=C1C=CC=C2
"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",Estrogen receptor,OC1=CC=C2[C@H](N(CCC2=C1)C1=CC=CC=C1)C1=CC=C(OCCN2CCCCC2)C=C1
2-Phenylamino-Ethanesulfonic Acid,Catabolite control protein A,OS(=O)(=O)CCNC1=CC=CC=C1
2-Phenylheme,Heme oxygenase 1,CC1=C(C=C)C2=CC3=[N+]4C(=CC5=C(C)C(CCC(O)=O)=C6N5[Fe]44N2C1=CC1=[N+]4C(C(CCC(O)=O)=C1C)=C6C1=CC=CC=C1)C(C=C)=C3C
2-Phosphoglycolic Acid,Pyruvate kinase PKLR,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Pyruvate kinase PKM,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Triosephosphate isomerase,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Glucosamine-6-phosphate deaminase 1,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,ATP-dependent 6-phosphofructokinase,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Triosephosphate isomerase,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Triosephosphate isomerase,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Methylglyoxal synthase,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,"Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-sensitive",OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Triosephosphate isomerase,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Gamma-enolase,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,2-deoxyglucose-6-phosphate phosphatase,OC(=O)COP(O)(O)=O
2-Phosphoglycolic Acid,Beta-enolase,OC(=O)COP(O)(O)=O
"2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole",Proline iminopeptidase,[H][C@]1(CCCN1)C(=O)C1=NN=C(O1)C(C)(C)C
2-Propyl-Aniline,Endolysin,CCCC1=CC=CC=C1N
2-Pyridinethiol,Cathepsin B,SC1=CC=CC=N1
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,Photosynthetic reaction center cytochrome c subunit,CCNC1=NC(NC(C)(C)C)=NC(SC)=N1
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,Reaction center protein H chain,CCNC1=NC(NC(C)(C)C)=NC(SC)=N1
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,Reaction center protein L chain,CCNC1=NC(NC(C)(C)C)=NC(SC)=N1
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,Reaction center protein M chain,CCNC1=NC(NC(C)(C)C)=NC(SC)=N1
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,Reaction center protein L chain,CCNC1=NC(NC(C)(C)C)=NC(SC)=N1
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,Reaction center protein M chain,CCNC1=NC(NC(C)(C)C)=NC(SC)=N1
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,Reaction center protein H chain,CCNC1=NC(NC(C)(C)C)=NC(SC)=N1
2-Thioethenamine,Lantibiotic mersacidin,[H]\C(N)=C(/[H])S
2-Thiomethyl-3-Phenylpropanoic Acid,Neutrophil collagenase,[H][C@](CS)(CC1=CC=CC=C1)C(O)=O
2-Tridecanoyloxy-Pentadecanoic Acid,Ferrichrome-iron receptor,[H][C@](CCCCCCCCCCCC)(CC(O)=O)OC(=O)CCCCCCCCCCCC
"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",Beta-lactamase,[H][C@](CC1=CC=C(O)C=C1)(N1C(=O)C2=C(C=C(C=C2)C(O)=O)C1=O)C(O)=O
"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",Beta-lactamase,[H][C@](CC1=CC=CC2=CC=CC=C12)(N1C(=O)C2=CC=C(C=C2C1=O)C(O)=O)C(O)=O
"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",Beta-lactamase,[H][C@](CC(O)=O)(CC1=CC=CC2=CC=CC=C12)N1C(=O)C2=CC=C(C=C2C1=O)C(O)=O
"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",Neprilysin,[H][C@](CS)(CC1=CC=CC=C1)C1=NC2=C(N1)C=C[NH+]=C2
"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",Cathepsin S,OCCOC1=C(C=CC=C1)C1=C(F)C(F)=C(F)C=C1
"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",Replicase polyprotein 1ab,CC1=CC(=C(Cl)C=C1Cl)S(=O)(=O)C1=C(C=C(C=C1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O
"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",Replicase polyprotein 1a,CC1=CC(=C(Cl)C=C1Cl)S(=O)(=O)C1=C(C=C(C=C1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O
"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",Peroxisome proliferator-activated receptor gamma,OC(=O)C1=C(NC(=O)C2=C(Cl)C=C(Cl)C=C2)C=CC(OC2=NC=CC=N2)=C1
"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",Nuclear receptor coactivator 2,OC(=O)C1=C(NC(=O)C2=C(Cl)C=C(Cl)C=C2)C=CC(OC2=NC=CC=N2)=C1
"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",Retinoic acid receptor RXR-alpha,OC(=O)C1=C(NC(=O)C2=C(Cl)C=C(Cl)C=C2)C=CC(OC2=NC=CC=N2)=C1
2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,Tryptophan synthase alpha chain,OP(O)(=O)OCCNS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1
2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,Tryptophan synthase beta chain,OP(O)(=O)OCCNS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1
"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",Dual specificity mitogen-activated protein kinase kinase 1,[H][C@@](O)(CO)CONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(I)C=C1Cl
2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,Hemoglobin subunit alpha,COC1=C(OCC2=NC=CC=C2)C=C(C)C=C1
2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,Hemoglobin subunit beta,COC1=C(OCC2=NC=CC=C2)C=C(C)C=C1
"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",Heat shock protein HSP 90-alpha,COCCNC1=CC(=CC=C1C(N)=O)N1C2=C(C3=CC=CC=C13)C(=O)CCC2
"2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol",Protein YceI,CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=CC=CC=C1O
2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid,Cystathionine gamma-lyase,[H]\C(CP(O)(O)=O)=C(\[H])/C(=N\CC1=C(COP(O)(O)=O)C=NC(C)=C1O)/C(O)=O
"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",Dual specificity mitogen-activated protein kinase kinase 1,OCCONC(=O)C1=CC=C(F)C(F)=C1NC1=CC=C(C=C1F)C#C
2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide,Macrophage metalloelastase,FC1=CC=C(C=C1)S(=O)(=O)NCC(=O)N=O
"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",Serine/threonine-protein kinase Chk1,OCCNC1=NC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1
2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide,Protein S100-B,CCCCC#CC1=CC=C(O1)C(=O)NNC(=S)NC
2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)N(C1=CC=CC=C1C(O)=O)C1=CC=CC2=CC=C(O)C=C12
"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",Serine/threonine-protein kinase PknG,NC(=O)C1=C(NC(=O)C2CC2)SC2=C1CCCC2
2-[(Dioxidophosphoranyl)oxy]benzoate,D-alanyl-D-alanine carboxypeptidase,[O-]C(=O)C1=CC=CC=C1OP([O-])=O
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase 2,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase 1,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase 2,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,Peptide deformylase,[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,"Peptide deformylase, mitochondrial",[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO
"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",Methionine aminopeptidase 2,OC(=O)C1=C2CCCCC2=CC=C1NS(=O)(=O)C1=CC=CC=C1
"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",Methionine aminopeptidase 2,CN(C)C\C=C/C1=CC(F)=CC=C1S(=O)(=O)NC1=CC=C2CCCCC2=C1C(O)=O
"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",Fumarate reductase flavoprotein subunit,[H][C@@](C)(C1=CC=C(Cl)C=C1)C1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O
"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",Fumarate reductase iron-sulfur subunit,[H][C@@](C)(C1=CC=C(Cl)C=C1)C1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O
"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",Fumarate reductase subunit C,[H][C@@](C)(C1=CC=C(Cl)C=C1)C1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O
"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",Fumarate reductase subunit D,[H][C@@](C)(C1=CC=C(Cl)C=C1)C1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O
2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide,Prostaglandin G/H synthase 1,CC[C@H](CO)NC(=O)CC1=C(C)N(C(=O)C2=CC=C(Cl)C=C2)C2=CC=C(OC)C=C12
2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide,Prostaglandin G/H synthase 1,CC[C@@H](CO)NC(=O)CC1=C(C)N(C(=O)C2=CC=C(Cl)C=C2)C2=C1C=C(OC)C=C2
"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",Succinate dehydrogenase flavoprotein subunit,CCCCCC(C)C1=C(O)C(=CC(=C1)N(=O)=O)N(=O)=O
"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",Succinate dehydrogenase iron-sulfur subunit,CCCCCC(C)C1=C(O)C(=CC(=C1)N(=O)=O)N(=O)=O
"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",Succinate dehydrogenase cytochrome b556 subunit,CCCCCC(C)C1=C(O)C(=CC(=C1)N(=O)=O)N(=O)=O
"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",Succinate dehydrogenase hydrophobic membrane anchor subunit,CCCCCC(C)C1=C(O)C(=CC(=C1)N(=O)=O)N(=O)=O
"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",Macrophage metalloelastase,[H][C@](CCN1C(=O)C2=CC=CC=C2C1=O)(CC(=O)C1=CC=C(C=C1)C1=CC=C(OCC)C=C1)C(O)=O
"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",Beta-lactamase,O=C1N(CCC2=NN=NN2)C(=O)C2=CC=CC=C12
2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide,Interleukin-2,[H][C@@](C)(N=C(O)CN=C(O)[C@]([H])(NC(N)=N)C1CCCCC1)C(O)=NCCCS
"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",MAP kinase-activated protein kinase 2,FC1=C(C=CC=C1)C1=CC(=CC=N1)C1=CC2=C(CCNC2=O)N1
"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",MAP kinase-activated protein kinase 3,FC1=C(C=CC=C1)C1=CC(=CC=N1)C1=CC2=C(CCNC2=O)N1
2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,Prothrombin,[H][C@@](CC1=CC=C(NC(N)=N)C=C1)(NC(=O)CSC1=CC=C(Cl)C=C1)C(N)=O
2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE),Coagulation factor VII,CCS(=O)(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC1=CC=C(C=C1)C(N)=N
2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE),Coagulation factor VII,CCCOC1=CC2=C(NC=C2C[C@@H](NS(=O)(=O)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC2=CC=C(C=C2)C(N)=N)C=C1
"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",Alpha-1-antitrypsin,[H][C@@](O)(CCCCCCC)C[C@@]1([H])O[C@@](CO)(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@@]([H])(O)[C@]1([H])O
"2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol","cAMP-specific 3',5'-cyclic phosphodiesterase 4D",OCC(CO)(CO)NCCCNC(CO)(CO)CO
"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",Stromelysin-1,[H][C@@](CC1=CC=CC=C1)(NC(=O)NC1=NN=C(S)S1)C(=O)NC
"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",Stromelysin-1,[H][C@@](CC1=C(F)C(F)=C(F)C(F)=C1F)(NC(=O)NC1=NN=C(S)S1)C(=O)NC
2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,Cathepsin G,CN(C1CCN(CC1)C(=O)C1=CC2=CC=CC=C2C=C1)C(=O)C1=CC2=CC=CC=C2C=C1C(=O)[C@@H](C1=CC=CC2=CC=CC=C12)P(O)(O)=O
2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,Chymase,CN(C1CCN(CC1)C(=O)C1=CC2=CC=CC=C2C=C1)C(=O)C1=CC2=CC=CC=C2C=C1C(=O)[C@@H](C1=CC=CC2=CC=CC=C12)P(O)(O)=O
"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",Acetyl-CoA carboxylase 2,[H][C@](C)(OC1=CC=C(OC2=CC=C(Cl)C=C2Cl)C=C1)C(O)=O
"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",Genome polyprotein,CCOC(=O)C1=CSC(=N1)N1CCN(CC1)C1=NC2=CC=CC=C2SC1
2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,cAMP-dependent protein kinase catalytic subunit alpha,CC1=NNC=C1C1=CC=C(CCN)C=C1
2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,cAMP-dependent protein kinase inhibitor alpha,CC1=NNC=C1C1=CC=C(CCN)C=C1
"2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone","Dihydroorotate dehydrogenase (quinone), mitochondrial",[H]C1(CCC(CC1)=C1C(O)=C(O)C2=CC=CC=C2C1=O)C1=CC=C(Cl)C=C1
"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",Thyroid hormone receptor beta,CC(C)C1=CC(OC2=C(C)C=C(C=C2C)N2N=CC(=O)NC2=O)=CC=C1O
"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",Acetylcholinesterase,CN(C)C1=CC=C(C=C1)C1=[N+](C)C2=CC=C(O)C=C2S1
"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",Gag-Pol polyprotein,[H][C@](O)(OC)C1=CC=C(CN2[C@]([H])(COC3=CC=CC=C3)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(COC3=CC=CC=C3)N(CC3=CC=C(CO)C=C3)S2(=O)=O)C=C1
"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",Hemoglobin subunit alpha,CC(C)(OC1=CC=C(NC(=O)NC2=CC(Cl)=CC(Cl)=C2)C=C1)C(O)=O
"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",Hemoglobin subunit beta,CC(C)(OC1=CC=C(NC(=O)NC2=CC(Cl)=CC(Cl)=C2)C=C1)C(O)=O
"2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid",Chymotrypsin-like elastase family member 1,[H][C@](NC(=O)C1=CC=C(C=C1)C(=O)NCC(O)=O)(C(C)C)C(=O)N1CCC[C@@]1([H])C(O)=N[C@@]([H])(C(C)C)C(=O)C(F)(F)F
2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,Gag-Pol polyprotein,ClC1=CC=C(OCC(=O)NC2=CC=CC=C2)C(=C1)C(=O)C1=CC=CC=C1
"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",Serine/threonine-protein kinase Chk1,COC1=CC=C(C=C1)C1=C(C2=C(NCCO)N=CN=C2O1)C1=CC=C(OC)C=C1
2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid,Bifunctional purine biosynthesis protein PURH,CC1=NN(C(O)=C1\N=N\C1=CC(=CC=C1C(O)=O)S(O)(=O)=O)C1=CC=C(C=C1C)S(O)(=O)=O
"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",Chymotrypsin-like elastase family member 1,[H][C@](NC(=O)CN1C(=O)C(NS(C)(=O)=O)=CN=C1C1=CC=C(N)C=C1)(C(C)C)C(=O)C(F)(F)F
"2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID",Beta-lactamase,[H][C@@](NC(=O)CC1=CC=CS1)(C(O)=O)C1=N[C@]([H])(C(O)=O)C(=C)CS1
2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,CN(CCO[P@@](O)(=O)OP(O)(O)=O)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C
2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,Geranylgeranyl transferase type-1 subunit beta,CN(CCO[P@@](O)(=O)OP(O)(O)=O)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C
2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,Prothrombin,[H][C@]1(CCCN1C(=O)OCC1=CC=CC=C1)C(=O)NNCCCCN
2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine,Cyclin-dependent kinase 2,[H][C@]1(N)CC[C@@]([H])(CC1)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C3CCCC3)C2=N1
2-[{4-[(2S)-2-{[(Allyloxy)carbonyl]amino}-3-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}amino)-3-oxopropyl]phenyl}(carboxycarbonyl)amino]benzoic acid,Tyrosine-protein phosphatase non-receptor type 1,[H]N(CCCCOC1=CC=CC(O)=C1C(=O)OC)C(=O)[C@H](CC1=CC=C(C=C1)N(C(=O)C(O)=O)C1=CC=CC=C1C(O)=O)N([H])C(=O)OCC=C
"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",Heat shock protein HSP 90-alpha,CCNC(=O)C1=CC2=C(N=C(N)N=C2S1)C1=C(Cl)C=C(Cl)C(OCCN2CCCC2)=C1
"2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",Tyrosine-protein kinase ABL1,CCN1N=CC=C1C1=CNC2=NC=C(C=C12)C1=CC(C(=O)N(C)C)=C(N)C=C1
2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,Beta-secretase 1,NC1=NC(CCC2=CC3=C(C=CN3)C=C2)=CC(=O)N1
"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",DNA ligase,NC(=O)C1=C(N)N=C2OC3=C(C=C(F)C=C3)C(=O)C2=C1
"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",Glucokinase,CN1C=NN=C1SC1=CC=C(N)C(=C1)C(=O)NC1=NC(C)=CS1
2-aminoethyl naphthalen-1-ylacetate,Gag-Pol polyprotein,NCCOC(=O)CC1=C2C=CC=CC2=CC=C1
"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",Glutamate racemase,CCCCOC1=NC(NCCN2CCOCC2)=C2N=CN(CC3=C(F)C=CC=C3F)C2=N1
"2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile",Androgen receptor,N#CC1=CC=C(\N=C2/O[C@@]([H])(C(F)(F)F)[C@]3([H])[C@](O)([H])CCN23)C(C)=C1Cl
2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC(=CC=C1Cl)[C@@]1(O)NC(=O)C2=CC=CC=C12
2-chloro-5-nitro-N-phenylbenzamide,Nuclear receptor coactivator 2,[O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=CC=CC=C1
2-chloro-5-nitro-N-phenylbenzamide,Peroxisome proliferator-activated receptor gamma,[O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=CC=CC=C1
2-chloro-5-nitro-N-phenylbenzamide,Retinoic acid receptor RXR-alpha,[O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=CC=CC=C1
2-deazo-6-thiophosphate guanosine-5'-monophosphate,Adenylosuccinate synthetase,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2[NH+]=CN=C3SP(O)(O)=O)[C@]([H])(O)[C@]1([H])O
"2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",Sulfide-quinone reductase,CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(OC)C1=O
"2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",Sulfide-quinone reductase,CCCCCCCCCCC1=C(C)C(=O)C(OC)=C(OC)C1=O
2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,Chondroitinase-B,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O
2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,Hyaluronate lyase,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O
2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,Chondroitinase-AC,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O
2-deoxy-2-acetamido-beta-D-galactose-4-sulfate,Chondroitinase (Chondroitin lyase),CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS(O)(=O)=O)[C@@H]1O
2-deoxy-2-fluoro-alpha-D-mannosyl fluoride,Alpha-mannosidase 2,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)OC([H])(F)[C@@]1([H])F
2-deoxy-2-fluoro-α-D-glucose,Exoglucanase/xylanase,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])F
2-deoxy-2-fluoro-α-D-glucose,Beta-glucosidase A,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])F
2-deoxy-2-fluoro-α-D-glucose,Cellulase B,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])F
2-deoxy-2-fluoro-α-D-glucose,Lactase-phlorizin hydrolase,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])F
2-deoxy-2-fluoro-α-D-mannose,"Mannan endo-1,4-beta-mannosidase",OC[C@H]1O[C@H](O)[C@@H](F)[C@@H](O)[C@@H]1O
2-deoxy-2-fluoro-β-D-galactose,Beta-galactosidase,[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])F
2-deoxy-2-fluoro-β-D-mannose,"Mannan endo-1,4-beta-mannosidase",OC[C@H]1O[C@@H](O)[C@@H](F)[C@@H](O)[C@@H]1O
2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,Mitogen-activated protein kinase 14,FC1=CC=C(C=C1)C1=CNN=C1C1=CC(F)=NC=C1
"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",Mitogen-activated protein kinase 8,COC1=C(NC2=NC3=C(C=CN3)C(NC3=CC=CC(F)=C3C(N)=O)=N2)C=CC(CS(C)(=O)=O)=C1
"2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid",Glutathione S-transferase,OC(=O)C(\O)=C\C=C\C(=O)C1=CC=CC=C1
"2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid","Catechol 2,3-dioxygenase",OC(=O)C(\O)=C\C=C\C(=O)C1=CC=CC=C1
"2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester",Neocarzinostatin,[H][C@]1(O)C=C[C@@]([H])(O)[C@]1([H])OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12
2-mercaptobenzothiazole,Thyroid peroxidase,S=C1NC2=C(S1)C=CC=C2
"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",Poly [ADP-ribose] polymerase 3,CC1=NC2=C(CSCC2)C(=O)N1
2-oxopropyl-CoM,"2-oxopropyl-CoM reductase, carboxylating",CC(=O)CSCCS(O)(=O)=O
2-phenyl-1H-imidazole-4-carboxylic acid,Beta-lactamase,OC(=O)C1=CNC(=N1)C1=CC=CC=C1
2-phospho-D-glyceric acid,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase",OC[C@@H](OP(O)(O)=O)C(O)=O
2-phospho-D-glyceric acid,2-dehydro-3-deoxyphosphooctonate aldolase,OC[C@@H](OP(O)(O)=O)C(O)=O
2-phospho-D-glyceric acid,Triosephosphate isomerase,OC[C@@H](OP(O)(O)=O)C(O)=O
2-phospho-D-glyceric acid,Beta-enolase,OC[C@@H](OP(O)(O)=O)C(O)=O
"2-tert-butylbenzene-1,4-diol",Hemagglutinin,CC(C)(C)C1=CC(O)=CC=C1O
"2-tert-butylbenzene-1,4-diol",Hemagglutinin,CC(C)(C)C1=CC(O)=CC=C1O
"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate","Acetolactate synthase, catabolic",[H][C@@](C)(O)[C@]12NC3=NC(C)=NC=C3CN1C(C)=C(CCOP(O)(=O)OP(O)(O)=O)S2
"2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",Beta-lactamase,[H][C@](C=O)(N=C(O)C(=N/OC)\C1=CSC(=N)N1)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1
"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",Beta-lactamase,[H][C@](N)(C(O)=N[C@]([H])(C=O)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1)C1=CC=C(O)C=C1
"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",Tyrosine-protein kinase SYK,[H][C@](C)(CO)NC(=O)C1=C(C)N=C(S1)C1=NC(NC2=CC(C)=CC(C)=C2)=NC=C1
"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",Trypsin-1,NC(=N)C1=CC2=C(NC(=N2)C2=CC=CC(C3=CC=CC=C3)=C2O)C=C1
"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",Prothrombin,NC(=N)C1=CC2=C(NC(=N2)C2=CC=CC(C3=CC=CC=C3)=C2O)C=C1
"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",Urokinase-type plasminogen activator,NC(=N)C1=CC2=C(NC(=N2)C2=CC=CC(C3=CC=CC=C3)=C2O)C=C1
"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",Prolyl endopeptidase,[H][C@]1(CC(F)(F)CN1C(=O)CCN1C(=O)C2=C(C=CC=C2)C1=O)C(=O)N1CCCC1
"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",Poly [ADP-ribose] polymerase 1,CC1=CC=CC2=C1N=C(CCCN1CCC(=CC1)C1=CC=C(F)C=C1)NC2=O
2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CC1=CC=CC=C1)(NC(O)=N[C@@]([H])(CC1=CC=C(OC(C(O)=O)C(O)=O)C=C1)C(O)=NCCCCC)C(O)=O
"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",Mitogen-activated protein kinase 10,CNC(=O)CN1CCC(CC1)NC1=NC(=CC=N1)C1=CN=C2C=CC=CN12
"2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID",Thymidylate synthase,[H][C@](NC(=O)C1=CC=C(CCC2=CNC3=C2C(=O)NC(N)=N3)C=C1)(C(C)C)C(O)=O
2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,Collagenase 3,ONC(=O)CC1(CCOCC1)S(=O)(=O)C1=CC=C(OC2=CC=C(Cl)C=C2)C=C1
2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,Cyclin-dependent kinase 2,CC(C)N1C(C)=NC=C1C1=NC(NC2=CC=C(C=C2)N2CCN(CC2)C(=O)CO)=NC=C1
2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,Mitogen-activated protein kinase 14,OCC(=O)N1CCC(CC1)C1=NNC(=C1C1=NC=NC=C1)C1=CC=C(Cl)C=C1
2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,Peroxisome proliferator-activated receptor gamma,CCCC1=C(OCCCOC2=CC3=C(C=C2)N(CC(O)=O)C=C3)C=CC2=C1C=CC(=C2)C(=O)C1=CC=CC=C1
2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,Peroxisome proliferator-activated receptor gamma,CCCC1=C2ON=C(C2=CC=C1OCCCOC1=CC2=C(C=C1)N(CC(O)=O)C=C2)C(F)(F)F
"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",4-hydroxyphenylpyruvate dioxygenase,OC(C1=CC=C(C=C1[N+]([O-])=O)C(F)(F)F)=C1C(=O)CCCC1=O
2-{N'-[2-(5-Amino-1-Phenylcarbamoyl-Pentylcarbamoyl)-Hexyl]-Hydrazinomethyl}-Hexanoic Acid(5-Amino-1-Phenylcarbamoyl-Pentyl)-Amide,Peptide deformylase,[H][C@](CCCC)(CNNC[C@]([H])(CCCC)C(O)=N[C@@]([H])(CCCCN)C(O)=NC1=CC=CC=C1)C(O)=N[C@@]([H])(CCCCN)C(O)=NC1=CC=CC=C1
"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",Tyrosine-protein kinase SYK,[H][C@]1(N)CCCC[C@@]1([H])NC1=NC(NC2=CC=CC(C)=C2)=C(C=N1)C(N)=O
2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,Genome polyprotein,OC(=O)C1=C(NC(=O)COC2=CC=C(Cl)C=C2)C=CC=C1
"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",Tyrosine-protein kinase ABL1,CCCC1=CC=C(NC(=O)C2=CC=CC=C2NCC2=CNC(=O)C=C2)C=C1C(F)(F)F
2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",CN1C=C(C(=N1)C1=CC=C(OCC2=NC3=CC=CC=C3C=C2)C=C1)C1=CC=NC=C1
2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",C(OC1=CC=C(C=C1)C1=NNC=C1C1=CC=NC=C1)C1=CC=C2C=CC=CC2=N1
2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,Tryptophan synthase alpha chain,OP(O)(=O)OCCNC(=O)C1=CC=C(OC(F)(F)F)C=C1
2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,Tryptophan synthase beta chain,OP(O)(=O)OCCNC(=O)C1=CC=C(OC(F)(F)F)C=C1
2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid,Matrix metalloproteinase-9,[H][C@@](CC(C)C)(CN(O)C=O)C(O)=O
2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,Genome polyprotein,CC(=O)C1=CC(F)=C(Cl)C=C1NCC(=O)NC1=CC=CC=C1C(O)=O
2H-Benzimidazol-2-amine,Trypsin-1,NC1N=C2C=CC=CC2=N1
"2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate","2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",[H][C@@]1(O)COP(O)(=O)OP(O)(=O)O[C@@]1(C)CO
"2s,4r-4-Methylglutamate","Glutamate receptor ionotropic, kainate 2",[H][C@@](C)(C[C@]([H])(N)C(O)=O)C([O-])=O
"3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine",Calmodulin,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)(C[C@@]22OC(=O)N(CCCl)C2=O)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
3'-1-Carboxy-1-Phosphonooxy-Ethoxy-Uridine-Diphosphate-N-Acetylglucosamine,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O[C@@](C)(OP(O)(O)=O)C(O)=O)[C@@]2([H])N=C(C)O)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
3'-Azido-3'-Deoxythymidine-5'-Diphosphate,Nucleoside diphosphate kinase A,[H][C@@]1(C[C@]([H])(N=[N+]=[N-])[C@@]([H])(COP(O)(=O)OP(O)(O)=O)O1)N1C=C(C)C(O)=NC1=O
3'-Azido-3'-Deoxythymidine-5'-Monophosphate,Thymidylate kinase,[H][C@@]1(C[C@]([H])(N=[N+]=[N-])[C@@]([H])(COP(O)(O)=O)O1)N1C=C(C)C(O)=NC1=O
3'-Azido-3'-Deoxythymidine-5'-Monophosphate,Thymidylate kinase,[H][C@@]1(C[C@]([H])(N=[N+]=[N-])[C@@]([H])(COP(O)(O)=O)O1)N1C=C(C)C(O)=NC1=O
3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,Nucleoside diphosphate kinase A,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])N
3'-O-Acetylthymidine-5'-Diphosphate,"dTDP-4-dehydrorhamnose 3,5-epimerase",[H][C@@]1(C[C@]([H])(OC(C)=O)[C@@]([H])(COP(O)(=O)OP(O)(O)=O)O1)N1C=C(C)C(O)=NC1=O
3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,Probable cysteine desulfurase,[H][C@]1(CO)O[C@@](CO)(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(OC(=O)CCCCCCC)[C@@]2([H])O)[C@@]([H])(O)[C@]1([H])O
3'-Oxo-Adenosine,Adenosylhomocysteinase,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)C1=O
3'-Phosphate-Adenosine-5'-Diphosphate,Aminoglycoside 2'-N-acetyltransferase,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
3'-Phosphate-Adenosine-5'-Diphosphate,Ribonuclease pancreatic,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
3'-Phosphate-Adenosine-5'-Phosphate Sulfate,Estrogen sulfotransferase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
3'-THIO-THYMIDINE-5'-PHOSPHATE,Type-2 restriction enzyme EcoRV,[H][C@]1(S)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(=O)NC1=O
3'-THIO-THYMIDINE-5'-PHOSPHATE,DNA topoisomerase 2-beta,[H][C@]1(S)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(=O)NC1=O
3'-Uridinemonophosphate,Ribonuclease pancreatic,[H][C@]1(CO)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
3'-beta-Sialyl-beta-lactose,Trans-sialidase,[H]N([C@@H]1[C@@H](O)C[C@@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)O[C@H](O)[C@H](O)[C@H]3O)[C@@H]2O)(O[C@@]1([H])[C@H](O)[C@H](O)CO)C(O)=O)C(C)=O
3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,Gag-Pol polyprotein,[H][C@@](C)(O)[C@@]([H])(N)CC1=CC=CC=C1
3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,Gag-Pol polyprotein,[H][C@@](C)(O)[C@@]([H])(N)CC1=CC=CC=C1
"3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid",Phosphoenolpyruvate carboxylase,OC(=O)C(CP(O)(O)=O)=C(Cl)Cl
"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",Cytochrome P450,OC(=O)C1=C(C2=CNC3=CC=CC=C23)C(=C(N1)C(O)=O)C1=CNC2=C1C=CC=C2
"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",Aldo-keto reductase family 1 member B10,OC(=O)CC1=NN(CC2=NC3=C(S2)C=CC(=C3)C(F)(F)F)C(=O)C2=C1C=CC=C2
"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",Aldose reductase,OC(=O)CC1=NN(CC2=NC3=C(S2)C=CC(=C3)C(F)(F)F)C(=O)C2=C1C=CC=C2
"3,4-Dichloroisocoumarin",Complement factor D,ClC1=C(Cl)C2=CC=CC=C2C(=O)O1
"3,4-Dihydro-2h-Pyrrolium-5-Carboxylate",D-amino-acid oxidase,[O-]C(=O)C1=[NH+]CCC1
"3,4-Dihydro-5-Methyl-Isoquinolinone",Poly [ADP-ribose] polymerase 1,CC1=CC=CC2=C1CCNC2=O
"3,4-Dihydroxy-1-Methylquinolin-2(1h)-One",Serine/threonine-protein kinase pim-1,CN1C(=O)C(O)=C(O)C2=CC=CC=C12
"3,4-Dihydroxycinnamic Acid",Photoactive yellow protein,OC(=O)\C=C\C1=CC(O)=C(O)C=C1
"3,4-Dihydroxycinnamic Acid",Tyrosine ammonia-lyase,OC(=O)\C=C\C1=CC(O)=C(O)C=C1
"3,4-Dihydroxycinnamic Acid",Macrophage migration inhibitory factor,OC(=O)\C=C\C1=CC(O)=C(O)C=C1
"3,4-Dimethylaniline",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC=C(N)C=C1C
"3,4-Dimethylphenol",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC=C(O)C=C1C
"3,4-Epoxybutyl-Alpha-D-Glucopyranoside",Beta-amylase,[H][C@]1(CCO[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)CO1
"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",Cytochrome P450,OC(=O)C1=C(C2=CNC3=C(Cl)C=CC=C23)C(=C(N1)C(O)=O)C1=CNC2=C(Cl)C=CC=C12
"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",Iron-dependent extradiol dioxygenase,[H][C@@]12CCC(=O)[C@@]1(C)CCC(=O)[C@@]2([H])CCC1=C(O)C(O)=CC=C1C
"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",Estrogen sulfotransferase,OC1=C(Cl)C=C(C=C1Cl)C1=CC(Cl)=C(O)C(Cl)=C1
"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",Methionine aminopeptidase 2,CC1=CN=C2C(=C1)C(C)=C(C)C1=C2[N+](C)=CC(C)=C1
"3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER","cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CCOC(=O)C1=C(C)N([NH+]=C1C)C1=CC=CC=C1
"3,5-Diaminophthalhydrazide",Queuine tRNA-ribosyltransferase,NC1=CC(N)=C2C(=O)NNC(=O)C2=C1
"3,5-Difluoroaniline",Endolysin,NC1=CC(F)=CC(F)=C1
"3,5-Difluorobenzenesulfonamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC(F)=CC(F)=C1
"3,5-Diiodotyrosine",cAMP-dependent protein kinase inhibitor alpha,[H][C@](N)(CC1=CC(I)=C(O)C(I)=C1)C(O)=O
"3,5-Diiodotyrosine",cAMP-dependent protein kinase catalytic subunit alpha,[H][C@](N)(CC1=CC(I)=C(O)C(I)=C1)C(O)=O
"3,5-Diiodotyrosine",Alpha-amylase G-6,[H][C@](N)(CC1=CC(I)=C(O)C(I)=C1)C(O)=O
"3,5-Diiodotyrosine",Trypsin-1,[H][C@](N)(CC1=CC(I)=C(O)C(I)=C1)C(O)=O
"3,5-Diiodotyrosine",Nickel-binding periplasmic protein,[H][C@](N)(CC1=CC(I)=C(O)C(I)=C1)C(O)=O
"3,5-Diiodotyrosine",Iodotyrosine deiodinase 1,[H][C@](N)(CC1=CC(I)=C(O)C(I)=C1)C(O)=O
"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester","cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CCOC(=O)C1=C(C)N(N=C1C)C1=CC(=CC=C1)[N+]([O-])=O
"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester","cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CCOC(=O)C1=C(C)N(N=C1C)C1=CC(=CC=C1)[N+]([O-])=O
"3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester","cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CCOC(=O)C1=C(C)NN=C1C
"3,5-Dinitrocatechol",Catechol O-methyltransferase,OC1=CC(=CC(=C1O)[N+]([O-])=O)[N+]([O-])=O
"3,6,9,12,15,18-HEXAOXAICOSANE",Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,CCOCCOCCOCCOCCOCCOCC
"3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL","Malonyl-CoA-acyl carrier protein transacylase, mitochondrial",CCOCCOCCOCCOCCOCCO
"3,6,9,12,15-PENTAOXATRICOSAN-1-OL","Dihydroorotate dehydrogenase (quinone), mitochondrial",CCCCCCCCOCCOCCOCCOCCOCCO
"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",Fatty acid oxidation complex subunit alpha,CCCCCCCCOCCOCCOCCOCCOCCO
"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",3-ketoacyl-CoA thiolase,CCCCCCCCOCCOCCOCCOCCOCCO
"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",Ferripyoverdine receptor,CCCCCCCCOCCOCCOCCOCCOCCO
"3,6,9,12,15-Pentaoxaheptadecane",Kynureninase,CCOCCOCCOCCOCCOCC
"3,6,9,12,15-Pentaoxaheptadecane",Glutamate racemase,CCOCCOCCOCCOCCOCC
"3,6,9,12,15-Pentaoxaheptadecane",Acetylcholinesterase,CCOCCOCCOCCOCCOCC
"3,6-Anhydro-D-Galactose-2-Sulfate",Iota-carrageenase,[H][C@]1(O)[C@@]2([H])CO[C@]1([H])[C@@]([H])(OS(O)(=O)=O)[C@@]([H])(O)O2
"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",Heat shock protein HSP 90-alpha,CCOC1=CC=C(C=C1)C1=C(C#N)C(N)=NC2=C1C(N)=C(S2)C(N)=O
"3,6-dihydroxy-xanthene-9-propionic acid","Glutathione reductase, mitochondrial",OC(=O)CCC1C2=CC=C(O)C=C2OC2=C1C=CC(O)=C2
"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",L-lactate dehydrogenase,OC(=O)C1=C(O)C=C2C=CC(O)=CC2=C1
"3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione","Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]2(N=C(O)N(O)C2=O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE",Casein kinase II subunit alpha,CC1=C(Br)C(=O)OC2=C(Br)C(O)=CC=C12
"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",Acetylcholinesterase,NC1=CC2=C(C=C1)C1=CC=C(N)C=C1C(C1=CC=CC=C1)=[N+]2CCCCCCC1=CN(CCNC2=C3CCCCC3=NC3=C2C=CC=C3)N=N1
"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",Acetylcholinesterase,NC1=CC2=C(C=C1)C1=CC=C(N)C=C1C(C1=CC=CC=C1)=[N+]2CCCCCCC1=CN=NN1CCNC1=C2CCCCC2=NC2=C1C=CC=C2
"3,9-Dimethyladenine",Endonuclease III,CN1C=NC2=C1[N+](C)=CN=C2N
"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",Cyclin-dependent kinase 2,CC1=C(C=CC=C1)C1=NC2=C(Br)C=NN2C(NCC2=C[N+]([O-])=CC=C2)=C1
"3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one",Genome polyprotein,CC(C)CCN1C(=O)C(C2=NS(=O)(=O)C3=CC=CC=C3N2)=C(O)C2=CC=CC=C12
3-(1-Aminoethyl)Nonanedioic Acid,ATP-dependent dethiobiotin synthetase BioD 1,[H][C@@](C)(N)[C@@]([H])(CCCCCC(O)=O)CC(O)=O
3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,Mitogen-activated protein kinase 14,NC1=C(OCC2=CC=CC3=CC=CC=C23)C=CC=N1
3-(10-methyl-9-anthryl)propanoic acid,Ig gamma-1 chain C region,CC1=C2C=CC=CC2=C(CCC(O)=O)C2=C1C=CC=C2
3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,Serine/threonine-protein kinase Chk1,N1N=C(C2=NC3=CC=CC=C3N2)C2=C1C=CC=C2
"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione",3-phosphoinositide-dependent protein kinase 1,[H]N1C=C(C2=CC=CC=C12)C1=C(C(=O)N([H])C1=O)C1=CN(CC[C@H]2CCCN2C)C2=CC=CC=C12
"3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione",cAMP-dependent protein kinase catalytic subunit alpha,[H]N1C=C(C2=CC=CC=C12)C1=C(C(=O)N([H])C1=O)C1=CN(CC[C@@H]2CCCN2C)C2=CC=CC=C12
3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one,Beta-lactamase,O=C1CCCC(NC2=NN=NN2)=C1
"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",Beta-lactamase,O=C1N(CC2=NN=NN2)C=NC2=C1C1=C(CCCC1)S2
3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,Stromelysin-1,[H][C@@](CC1=CNC2=CC=CC=C12)(NS(=O)(=O)C1=CC=C(C=C1)N1CCC(CC1)C1=CC=CC=C1)C(O)=O
"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one","High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",CSC1=NC2=CC=CC=C2C(=O)N1C1=C(F)C=CC=C1F
3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,Beta-secretase 1,CN(C1CCCCC1)C(=O)CCN1CC2=CC(=CC=C2N=C1N)C(=O)C1=CC=CC=C1
3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,Tyrosine-protein kinase Lck,CC1=CC=C(C=C1C1=CC=C2N=C(N)N=CC2=C1)C(=O)NC1=CC=CC(=C1)C(F)(F)F
3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid,Delta-aminolevulinic acid dehydratase,[H][C@](CN)(CCC(O)=O)[C@]([H])(CCN)CC(O)=O
3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,"Triosephosphate isomerase, glycosomal",OS(=O)(=O)CCCSC1=NC2=C(S1)C=CC=C2
3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,Triosephosphate isomerase,OS(=O)(=O)CCCSC1=NC2=C(S1)C=CC=C2
"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",Mitogen-activated protein kinase 14,[H][C@@](C)(NC1=NC=CC(=N1)N(C(=O)NC1=CC=CC=C1Cl)C1=CC=C(OC)C=C1)C(C)(C)O
"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",Vascular endothelial growth factor receptor 2,CC1=C(C(=O)N(C=C1)C1=CC=C2C(NCC2(C)C)=C1)C1=CC2=CN=C(N)N=C2C=C1
3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,Vascular endothelial growth factor receptor 2,CC1=C(C2=CC3=C(C=C2)N=C(N)N=C3)C(=O)N(C=C1)C1=CC(=CC=C1)C(F)(F)F
"3-(3,4-Dimethoxyphenyl)Propionic Acid",Aromatic-amino-acid aminotransferase,COC1=C(OC)C=C(CCC(O)=O)C=C1
"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",Tyrosine-protein phosphatase non-receptor type 1,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=C(C=C2)S(=O)(=O)NC1=CC=C(C=C1)S(N)(=O)=O
"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",Tyrosine-protein phosphatase non-receptor type 1,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=C(C=C2)S(=O)(=O)N(C)C
"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",Tyrosine-protein phosphatase non-receptor type 1,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=C(C=C2)S(=O)(=O)NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1
3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,Estrogen receptor beta,OC1=CC=C2C=C(C=C(C#N)C2=C1)C1=CC=C(O)C(F)=C1
3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,Nuclear receptor coactivator 1,OC1=CC=C2C=C(C=C(C#N)C2=C1)C1=CC=C(O)C(F)=C1
"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",Serine/threonine-protein kinase haspin,NC1=CC=CC(=C1)C1=C2N=C(NC3=CC=CC(Cl)=C3)C=CN2N=C1
"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",Fibroblast growth factor receptor 1,COC1=CC=CC(CC2=CNC3=C2C=CC=N3)=C1
3-(3-methylbut-2-en-1-yl)-3H-purin-6-amine,Biotin carboxylase,CC(C)=CCN1C=NC(N)=C2N=CN=C12
"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",Carbonyl reductase [NADPH] 1,CC(C)(C)N1N=C(C2=C(N)N=CN=C12)C1=CC=CC(O)=C1
"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",Genome polyprotein,CC1=CC(SC2=C(O)C[C@](CCC3=CC=C(O)C=C3)(OC2=O)C2CCCC2)=C(C=C1N)C(C)(C)C
3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid,Beta-lactamase,OB(O)C1=CC(NS(=O)(=O)C2=CC(=CS2)S(=O)(=O)C2=CC=CC=C2)=CC=C1
"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE",Prothrombin,CSC1=NN=C(N1)C1=CC=C(Cl)C=C1
"3-(4-Carbamoyl-1-Carboxy-2-Methylsulfonyl-Buta-1,3-Dienylamino)-Indolizine-2-Carboxylic Acid",Beta-lactamase,[H]\C(=C(\[H])/C(/CS(=O)=O)=C(/NC1=C(C=O)C=C2C=CC=CN12)C(O)=O)C(O)=N
3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID,Chymotrypsinogen B,CCN(CC)C1=CC(O)=C(\C=C(/C)C(O)=O)C=C1
"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",Mitogen-activated protein kinase 14,ON1C2=CC=CN=C2C(=C1C1=CC=NC=C1)C1=CC=C(F)C=C1
"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",TGF-beta receptor type-1,CC1=NC(=CC=C1)C1=NN2CCCC2=C1C1=CC=C(F)C=C1
3-(4-HYDROXY-PHENYL)PYRUVIC ACID,Prothrombin,OC(=O)C(=O)CC1=CC=C(O)C=C1
3-(4-HYDROXY-PHENYL)PYRUVIC ACID,Macrophage migration inhibitory factor,OC(=O)C(=O)CC1=CC=C(O)C=C1
3-(4-HYDROXY-PHENYL)PYRUVIC ACID,Prephenate dehydrogenase,OC(=O)C(=O)CC1=CC=C(O)C=C1
"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",HTH-type transcriptional regulator TtgR,OC1=CC=C(CCC(=O)C2=C(O)C=C(O)C=C2O)C=C1
"3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER",Macrophage migration inhibitory factor,[H][C@]1(CC(=O)OC)CC(=NO1)C1=CC=C(O)C=C1
"3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine",Primary amine oxidase,[H]N=C1C=C(C[C@]([H])(N)C(O)=O)C(=O)C=C1O
3-(4-NITRO-PHENOXY)-PROPAN-1-OL,Pol polyprotein,OCCCOC1=CC=C(C=C1)[N+]([O-])=O
3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,Beta-lactamase TEM,N#C\C(=C\NC1=CC=C(NC2=CC=CC=C2)C=C1)C1=NNN=N1
3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,Beta-lactamase TEM,N#C\C(=C\NC1=CC=C(NC2=CC=CC=C2)C=C1)C1=NNN=N1
"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",HTH-type transcriptional regulator EthR,FC1=CC=C(C=C1)C1=NN=C(N1)C1=CC=CC=C1
3-(4-nitrophenyl)-1H-pyrazole,Hematopoietic prostaglandin D synthase,[O-][N+](=O)C1=CC=C(C=C1)C1=NNC=C1
"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",Dihydroneopterin aldolase,NC1=NC2=NN(N=C2C(O)=N1)C1=CC(=CC=C1)C(O)=O
"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",Dihydroneopterin aldolase,NC1=NC2=NN(N=C2C(O)=N1)C1=CC(=CC=C1)C(=O)NCC1=CC(Cl)=CC(Cl)=C1
"3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide",Dihydroneopterin aldolase,[H]N([H])C1=NC(=O)C2=NN(N([H])C2=N1)C1=CC=CC(=C1)C(=O)N([H])CC1=CC=CC=C1SC1=CC=CC=C1CO
3-(5-amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid,Methionine aminopeptidase,[H]N=C1N=NC(N)=C1\N=N\C1=CC=CC(=C1)C(O)=O
3-(5-methoxy-1H-indol-3-yl)propanoic acid,Peroxisome proliferator-activated receptor gamma,COC1=CC=C2NC=C(CCC(O)=O)C2=C1
3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,Serine/threonine-protein kinase Chk1,NCC1CCN(CC2=CC3=C(NC(=C3)C3=NNC4=C3C=CC(=C4)C#N)C=C2)CC1
3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,Serine/threonine-protein kinase Chk1,NCC1CCN(CC2=CC3=C(NC(=C3)C3=CC4=CC=CC=C4NC3=O)C=C2)CC1
3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,CN(CC1=CC2=C(C=CC=C2)N1C)C(=O)\C=C\C1=CN=C(N)C=C1
3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,Cyclin-A2,NS(=O)(=O)C1=CC=CC(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)=C1
3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=CC(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)=C1
3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,Estrogen receptor beta,OC1=CC2=C(C=C1)C(=NO2)C1=CC2=C(C=C1)C=C(O)C=C2
3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,Nuclear receptor coactivator 1,OC1=CC2=C(C=C1)C(=NO2)C1=CC2=C(C=C1)C=C(O)C=C2
3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER,Prothrombin,CCOC(=O)C(CC1=CC2=C(C=C1)C=CC(=C2)C(N)N)C1=CC=C(OC2CCNC2)C=C1
3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid,"6,7-dimethyl-8-ribityllumazine synthase",[H][C@@](O)(CO)[C@@]([H])(O)[C@@]([H])(O)CN1C(O)=C(CCC(O)=O)N=C2C(O)=NC(=O)N=C12
"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",Wee1-like protein kinase,OC(=O)CCN1C2=C(C=C(O)C=C2)C2=C1C=C(C1=C2C(=O)NC1=O)C1=CC=CC=C1
3-(BUTYLSULPHONYL)-PROPANOIC ACID,Triosephosphate isomerase,CCCCS(=O)(=O)CCC(O)=O
3-(Benzyloxy)Pyridin-2-Amine,Mitogen-activated protein kinase 14,NC1=NC=CC=C1OCC1=CC=CC=C1
3-(Benzyloxy)Pyridin-2-Amine,Leukotriene A-4 hydrolase,NC1=NC=CC=C1OCC1=CC=CC=C1
3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN,Gag-Pol polyprotein,[H][C@](CC(=O)NC(CC)CC)(C(N)=O)C(C)(C)C
"3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID",Tyrosine-protein phosphatase non-receptor type 1,OC(=O)COC1=C(SC2=NC=CC=C12)C(O)=O
3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,Ig gamma-2 chain C region,[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)O[P@](O)(=O)C1=CC=CC=C1
"3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE",NAD(P)H dehydrogenase [quinone] 1,[H][C@@]1(C)C[N@@]1C1=CC(=O)C2=C(C(CO)=C(N2C)C2=CC=CC=C2)C1=O
3-(INDOL-3-YL) LACTATE,Hydroxyacid oxidase 1,[H][C@](O)(CC1=CNC2=C1C=CC=C2)C(O)=O
3-(INDOL-3-YL) LACTATE,(S)-mandelate dehydrogenase,[H][C@](O)(CC1=CNC2=C1C=CC=C2)C(O)=O
3-(Mercaptomethylene)Pyridine,Gag-Pol polyprotein,SCC1=CC=CN=C1
3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)NC1=CC2=C(C=CC=C2)C=C1C(O)=O
3-(P-Tolyl)Propionic Acid,Aromatic-amino-acid aminotransferase,CC1=CC=C(CCC(O)=O)C=C1
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,"Glutathione reductase, mitochondrial",S\C=C\C[S@](=O)CC=C
3-(heptyloxy)benzoic acid,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,CCCCCCCOC1=CC=CC(=C1)C(O)=O
3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID,Coagulation factor VII,CC[C@@H](C)[C@@H](NS(=O)(=O)CC1=CC(=CC=C1)C(O)=O)C(=O)N[C@@H](CCC(N)=N)C(=O)NCC1=CC=C(C=C1)C(N)=N
"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",Heat shock protein HSP 90-alpha,CC1=CC(=NC(N)=N1)C#CC1=C(CNN2C=COC2=O)C=CC=C1
3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,Cyclin-dependent kinase 2,OCCCNCCS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1
3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,Cyclin-A2,OCCCNCCS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1
"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",3-oxoacyl-[acyl-carrier-protein] synthase 2,[H][C@]12C[C@]3([H])O[C@@]1(C)C[C@@]1(C2)CCC(=O)[C@@](C)(CCC(=O)NC2=C(O)C=CC(C(O)=O)=C2O)[C@]31[H]
"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",Integrin alpha-L,NC1=CC=CC(SC2=CC=C(\C=C\C(=O)N3CCOCC3)C(=C2C(F)(F)F)C(F)(F)F)=C1
"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",Ephrin type-B receptor 4,NC(=O)C1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC=C1
"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",Ephrin type-B receptor 4,NS(=O)(=O)C1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC=C1
3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,Coagulation factor X,NC(=N)C1=CC(CN2CCN(CC2=O)S(=O)(=O)C2=CC3=C(S2)C=C(Cl)C=C3)=CC=C1
"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",Glycogen synthase kinase-3 beta,[H][C@@](O)(CO)CCONC1=C(NC2=CC=CC=C12)C1=C2C=CC=CC2=NC1=O
"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",Calcium/calmodulin-dependent protein kinase type IV,[H][C@@](O)(CO)CCONC1=C(NC2=CC=CC=C12)C1=C2C=CC=CC2=NC1=O
"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID","Dihydroorotate dehydrogenase (quinone), mitochondrial",OC(=O)C1=C(C=CS1)C(=O)NC1=C(F)C=C(C=C1F)C1=CC(OC(F)(F)F)=CC=C1
"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",Prothrombin,[H][C@]1(CCN2CC[C@@](N)(CC3=CC=CC=C3)C(=O)N12)C=O
"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",Serine/threonine-protein kinase Chk1,OCCNC1=NC=NC2=C1C(=C(N2)C1=CC=CC=C1)C1=CC=CC=C1
3-AMINO-AZACYCLOTRIDECAN-2-ONE,Neutrophil collagenase,[H][C@]1(N)CCCCCCCCCCNC1=O
3-Acetylpyridine Adenine Dinucleotide,4-hydroxy-tetrahydrodipicolinate reductase,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(C)=O)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
3-Amino-3-Oxopropanoic Acid,Malonamidase E2,NC(=O)CC(O)=O
"3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate",3-dehydroquinate dehydratase,N[C@H]1C=C(C[C@@H](O)[C@@H]1O)C([O-])=O
3-Amino-4-Oxybenzyl-2-Butanone,Cathepsin B,CC(=O)[C@@H](N)COCC1=CC=CC=C1
"3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione",Cholera enterotoxin subunit B,CCCOCCOCCOCCCNC1=C(N)C(=O)C1=O
"3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione",Cholera enterotoxin B subunit,CCCOCCOCCOCCCNC1=C(N)C(=O)C1=O
3-Amino-6-Hydroxy-Tyrosine,Primary amine oxidase,N[C@@H](CC1=CC(N)=C(O)C=C1O)C(O)=O
"3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione","Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]2(N=C(O)N(N)C2=O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
3-Amino-Alanine,Envelope glycoprotein gp160,N[C@@H](C[NH3+])C(O)=O
"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",Plasmepsin-2,CC(C)C[C@@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)NC(=O)C1=CC=C(N)C=C1
3-Aminosuccinimide,Chemotaxis protein CheY,[H][C@]1(N)CC(O)=NC1=O
3-Aminosuccinimide,Lysozyme C,[H][C@]1(N)CC(O)=NC1=O
3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,Gag-Pol polyprotein,[H][C@@](CC1=CC=CC=C1)(NC(=O)OCC1=CC=CC=C1)[C@@]([H])(O)C(O)=O
3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,Estrogen receptor beta,OC1=CC=C(C=C1)C1=C(Br)C2=C(C=C(O)C=C2)C1=O
3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,Nuclear receptor coactivator 1,OC1=CC=C(C=C1)C1=C(Br)C2=C(C=C(O)C=C2)C1=O
3-Bromo-3-buten-1-ol,Methane monooxygenase component A alpha chain,OCCC(Br)=C
3-Bromo-7-Nitroindazole,"Nitric oxide synthase, inducible",BrC1=NNC2=C1C=CC=C2N(=O)=O
3-Bromo-7-Nitroindazole,"Nitric oxide synthase, brain",BrC1=NNC2=C1C=CC=C2N(=O)=O
3-Bromo-7-Nitroindazole,"Nitric oxide synthase, endothelial",BrC1=NNC2=C1C=CC=C2N(=O)=O
3-Butylthiolane 1-Oxide,Alcohol dehydrogenase 1C,[H][C@]1(CCCC)CC[S@](=O)C1
"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",Aldo-keto reductase family 1 member C3,[H][C@@]12CC[C@@]3(CCC(C)(C)C(=O)O3)[C@@]1(C)CC[C@]1([H])C3=CC=C(C=C3CC[C@@]21[H])C(N)=O
"3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE",D-alanine--D-alanine ligase,CC(C)(CCl)C(=O)NC1=CC=C(C=C1)C(F)(F)F
3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,Estrogen receptor,OC1=CC=C(C=C1)N1N=C2C=CC(O)=CC2=C1Cl
3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,Nuclear receptor coactivator 2,OC1=CC=C(C=C1)N1N=C2C=CC(O)=CC2=C1Cl
3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,Genome polyprotein,OC(=O)C1=CC=C2C(=C1)N(CC(=O)N1CCOCC1)C(=C2C1CCCCC1)C1=CC=CC=C1
"3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium",Peroxisomal carnitine O-octanoyltransferase,[H][C@@](CC(O)=O)(C[N+](C)(C)C)OC(=O)CCCCCCC
"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",Acetylcholinesterase,[H][C@]12CC3=C(C(N)=C4C=CC(Cl)=CC4=N3)[C@]([H])(CC(CC)=C1)C2
3-Chloroalaninate,1-aminocyclopropane-1-carboxylate deaminase,[NH3+][C@H](CCl)C([O-])=O
3-Chlorophenol,Endolysin,OC1=CC=CC(Cl)=C1
3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,Thymidylate synthase,OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC3=C(C=CC1=C23)[N+]([O-])=O)C1=CC=C(O)C=C1
3-Deaza-Adenosine,IAG-nucleoside hydrolase,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C2C=CNC3=N)[C@]([H])(O)[C@]1([H])O
3-Deazacytidine,Cytidine deaminase,[H][C@]1(CO)O[C@@]([H])(N2C=CC(N)=CC2=O)[C@]([H])(O)[C@]1([H])O
"3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline",Hydroxyacid oxidase 1,CCCCCCCCCCC1=C(O)C(=O)NC1=O
3-Dehydroquinic Acid,3-dehydroquinate dehydratase,O[C@@H]1C[C@@](O)(CC(=O)[C@H]1O)C(O)=O
3-Dehydroshikimate,3-dehydroquinate dehydratase,O[C@@H]1CC(=CC(=O)[C@H]1O)C(O)=O
3-Dehydroshikimate,3-dehydroquinate dehydratase,O[C@@H]1CC(=CC(=O)[C@H]1O)C(O)=O
3-Deoxy-D-Glucosamine,Ferrichrome-iron receptor,[H][C@@]1(N)C[C@]([H])(O)[C@@]([H])(CO)O[C@]1([H])O
3-Deoxyguanosine,Purine nucleoside phosphorylase,[H][C@@]1(CO)C[C@@]([H])(O)[C@@]([H])(O1)N1C=NC2=C1NC(=N)N=C2O
3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,Estrogen receptor,CCC1=C2C=C(O)C=CC2=NN1C1=CC=C(O)C=C1
3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,Nuclear receptor coactivator 2,CCC1=C2C=C(O)C=CC2=NN1C1=CC=C(O)C=C1
3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,Methionine aminopeptidase 2,CCC1=CC=C(NS(=O)(=O)C2=CC=C(F)C=C2)C(C(O)=O)=C1C
3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,Macrophage migration inhibitory factor,OC1=CC=C(\C=N\OC(=O)C2CCCCC2)C=C1F
3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,Mitogen-activated protein kinase 14,FC1=CC(=CC(=C1)C(=O)NC1=CC=C2C=CN(CCC3=CC=NC=C3)C2=C1)N1CCOCC1
3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,Mitogen-activated protein kinase 14,FC1=CC(=CC(=C1)C(=O)NC1=CC=C2NC=C(CCC3=CC=NC=C3)C2=C1)N1CCOCC1
3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,Peroxisome proliferator-activated receptor gamma,FC1=CC=C(C=C1)N1N=C(C=C1NS(=O)(=O)C1=CC=CC(F)=C1)C1=CC=CS1
3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE,Neutrophil collagenase,[H][C@@](O)(C(=O)NO)[C@@]([H])(CC(C)C)C=O
3-Fluoro-2-(Phosphonooxy)Propanoic Acid,2-dehydro-3-deoxyphosphooctonate aldolase,[H][C@@](CF)(OP(O)(O)=O)C(O)=O
3-Fluoro-2-Methyl-Aniline,Endolysin,CC1=C(N)C=CC=C1F
"3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid",Retinoic acid receptor gamma,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C(=O)NC1=C(F)C=C(C=C1)C(O)=O
3-Fluoro-L-tyrosine,"Superoxide dismutase [Mn], mitochondrial",N[C@@H](CC1=CC(F)=C(O)C=C1)C(O)=O
"3-Hydroxy-4-(3,4,5-Trihydroxy-Tetrahydro-Pyran-2-Yloxy)-Piperidin-2-One",Exoglucanase/xylanase,[H][C@@]1(O)CO[C@@]([H])(O[C@]2([H])CCN=C(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
3-Hydroxy-Myristic Acid,Ferrichrome-iron receptor,[H][C@@](O)(CCCCCCCCCCC)CC(O)=O
3-Hydroxy-Myristic Acid,Protein TonB,[H][C@@](O)(CCCCCCCCCCC)CC(O)=O
3-Hydroxy-Myristic Acid,Lymphocyte antigen 96,[H][C@@](O)(CCCCCCCCCCC)CC(O)=O
3-Hydroxy-Myristic Acid,Toll-like receptor 4,[H][C@@](O)(CCCCCCCCCCC)CC(O)=O
3-Hydroxy-Propanoic Acid,Pimeloyl-[acyl-carrier protein] methyl ester esterase,OCCC(O)=O
3-Hydroxybutyryl-Coenzyme A,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",CC(O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
3-Hydroxyhippuric acid,Kynureninase,OC(=O)CNC(=O)C1=CC(O)=CC=C1
3-Hydroxyimino Quinic Acid,3-dehydroquinate dehydratase,[H][C@@]1(O)C[C@@](O)(C\C(=N/O)[C@@]1([H])O)C(O)=O
3-Hydroxyisoxazole-4-Carboxylic Acid,L-lactate dehydrogenase,OC(=O)C1=CON=C1O
"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol",NAD(P)H dehydrogenase [quinone] 1,CN1C(CCCO)=C(CO)C2=C1C(=O)C=C(N1CC1)C2=O
3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate,Coagulation factor XI,NC(=N)C1=CC2=C(NC(=O)C3=CC=CC(=C3)S(=O)(=O)OCCCO)C=CC=C2C=C1
3-Hydroxypyruvic Acid,Triosephosphate isomerase,OCC(=O)C(O)=O
3-Hydroxypyruvic Acid,N-acetylneuraminate lyase,OCC(=O)C(O)=O
3-Indolebutyric Acid,Aromatic-amino-acid aminotransferase,OC(=O)CCCC1=CNC2=C1C=CC=C2
3-Indolebutyric Acid,Beta-2-microglobulin,OC(=O)CCCC1=CNC2=C1C=CC=C2
3-Indolebutyric Acid,T-cell receptor alpha chain C region,OC(=O)CCCC1=CNC2=C1C=CC=C2
3-Indolebutyric Acid,T-cell receptor beta-1 chain C region,OC(=O)CCCC1=CNC2=C1C=CC=C2
3-Indolebutyric Acid,"HLA class I histocompatibility antigen, A-2 alpha chain",OC(=O)CCCC1=CNC2=C1C=CC=C2
3-Iodo-Tyrosine,Tyrosine--tRNA ligase,N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O
3-Isopropylmalic Acid,Isocitrate dehydrogenase [NADP],CC(C)C(C(O)C(O)=O)C(O)=O
3-Isopropylmalic Acid,3-isopropylmalate dehydrogenase,CC(C)C(C(O)C(O)=O)C(O)=O
3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,Genome polyprotein,COC1=NN=C(C=C1)N1CCN(CC1)C1=CC(C)=CC=C1
3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,Genome polyprotein,COC1=NN=C(C=C1)N1CCN(CC1)C1=CC(C)=CC=C1
"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",Interleukin-2,SCCC(=O)N1CCC2=C(C1)NC1=C2C=CC=C1
3-Mercuri-4-Aminobenzenesulfonamide,Carbonic anhydrase 2,NC1=CC=C(C=C1[Hg])S(N)(=O)=O
3-Methoxybenzamide,Poly [ADP-ribose] polymerase 1,COC1=CC=CC(=C1)C(N)=O
"3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole",Genome polyprotein,C[C@@H]1COC(=N1)C1=CC=C(OCCCCCCCC2=CC(C)=NO2)C=C1
3-Methyladenine,DNA-3-methyladenine glycosylase 1,CN1C=NC(N)=C2N=CN=C12
3-Methylcytosine,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,C[N+]1=C(N)C=CNC1=O
3-Methylfentanyl,Delta-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1
3-Methylfentanyl,Kappa-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1
3-Methylfentanyl,Mu-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1C)C1=CC=CC=C1
3-Methylphenylalanine,Cathepsin B,CC1=CC=CC(C[C@H](N)C(O)=O)=C1
3-Methylpyridine,Collagenase 3,CC1=CC=CN=C1
3-Methylpyridine,Stromelysin-1,CC1=CC=CN=C1
3-Methylthiofentanyl,Delta-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1
3-Methylthiofentanyl,Mu-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1
3-Methylthiofentanyl,Kappa-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1
3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(N2CCCC2=O)C(=C1)[N+]([O-])=O
3-Nitrophenylboronic Acid,Beta-lactamase,OB(O)C1=CC=CC(=C1)[N+]([O-])=O
3-O-Methylfructose in Linear Form,Xylose isomerase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(OC)C(=O)CO
3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE,Ig gamma-2 chain C region,[H][C@@]1(CCNC1=O)NC(=O)CC(=O)CCCCCCCCC
3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,Transcriptional activator protein TraR,[H][C@@]1(CCOC1=O)NC(=O)CC(=O)CCCCC
3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,Probable transcriptional activator protein TraR,[H][C@@]1(CCOC1=O)NC(=O)CC(=O)CCCCC
3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,Probable transcriptional repressor TraM,[H][C@@]1(CCOC1=O)NC(=O)CC(=O)CCCCC
3-Oxiran-2ylalanine,S-adenosylmethionine synthase isoform type-1,[H][C@](N)(C[C@@]1([H])CO1)C(O)=O
3-Oxo-Pentadecanoic Acid,Ferrichrome-iron receptor,CCCCCCCCCCCCC(=O)CC(O)=O
3-Oxo-Pentadecanoic Acid,Vitamin B12 transporter BtuB,CCCCCCCCCCCCC(=O)CC(O)=O
3-Oxo-Pentadecanoic Acid,Colicin-E3,CCCCCCCCCCCCC(=O)CC(O)=O
"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC2=C(NN=C2C)C=C1)CC1=CC=C(Br)C=C1
"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",cAMP-dependent protein kinase inhibitor alpha,[H][C@@](N)(COC1=CN=CC(=C1)C1=CC2=C(NN=C2C)C=C1)CC1=CC=C(Br)C=C1
"3-Phenyl-1,2-Propandiol",Renin,OC[C@@H](O)CC1=CC=CC=C1
3-Phenylpropylamine,Trypsin-1,NCCCC1=CC=CC=C1
3-Phenylpropylamine,Trypsin-2,NCCCC1=CC=CC=C1
3-Phosphoglycerol,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",OC[C@@H](O)COP(O)(O)=O
3-Phosphoglycerol,Triosephosphate isomerase,OC[C@@H](O)COP(O)(O)=O
3-Phosphoglycerol,Pyridoxine 5'-phosphate synthase,OC[C@@H](O)COP(O)(O)=O
3-Phosphoglycerol,Fructose-bisphosphate aldolase B,OC[C@@H](O)COP(O)(O)=O
3-Phosphono-D-alanine,Phosphoserine phosphatase,[H][C@@](N)(CP(O)(O)=O)C(O)=O
"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",Cyclin-dependent kinase 2,C1C2=C(C=CC=C2)C2=NNC(=C12)C1=CC=NC=C1
3-Thiaoctanoyl-Coenzyme A,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",[H][C@](O)(C(O)=NCCC(O)=NCCSC(=O)CSCCCCC)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
3-Trimethylsilylsuccinic Acid,Fumarate hydratase class II,C[Si](C)(C)C(CC(O)=O)C(O)=O
3-Tyrosine,Tyrosine 3-monooxygenase,N[C@@H](CC1=CC=CC(O)=C1)C(O)=O
3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid,Beta-Ala-Xaa dipeptidase,[H][C@@](C)(CP(O)(=O)[C@@]([H])(N)CC(O)=O)C(O)=O
"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",Uracil-DNA glycosylase,OC(=O)C1=CC=CC(\C=N\OCCO\N=C\C2=CC(=O)NC(=O)N2)=C1
3-[(1s)-1-(Dimethylamino)Ethyl]Phenol,Acetylcholinesterase,[H][C@@](C)(N(C)C)C1=CC(O)=CC=C1
"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",Methionine aminopeptidase 1,CC(C)(C)C(=O)NC1=C(N=CC=C1)C(=O)NC1=NC=CS1
"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",Genome polyprotein,CC(C)N(C(=O)C1=C(Cl)C=C(Cl)C=C1)C1=C(SC(=C1)C1=CC=CC=C1)C(O)=O
3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,Fibroblast growth factor receptor 1,CC1=CNC(\C=C2/C(=O)NC3=CC=CC=C23)=C1CCC(O)=O
3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid,Beta-lactamase,[H]N(C1=CC(=CC=C1)[N+]([O-])=O)S(=O)(=O)C1=C(SC=C1)C(O)=O
3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,Stromelysin-1,ONC(=O)CCOC1=CC=C(C=C1)C1=CC=C(C=C1)C#N
"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",Androgen receptor,CC(C)(C)N1N=C(CC2=CC(O)=CC=C2)C2=C1N=CN=C2N
3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID,Beta-lactamase,OC(=O)C1=C(C=CS1)S(=O)(=O)NC1=CC=C(Cl)C=C1
3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid,Beta-lactamase,OC(=O)C1=C(C=CS1)S(=O)(=O)NC1=C(O)C=C(C=C1)C(O)=O
"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",Glucokinase,CN1C=NN=C1SC1=NC(C(=O)NC2=NC(C)=CS2)=C(SC2=CC=C(F)C=C2)C=C1
"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",Kinesin-like protein KIF11,[H][C@]1(CC(=NN1C(C)=O)C1=C(Cl)C=CC=C1)C1=CC=CC(O)=C1
3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,CN(CC1=C(N)C=CC(=C1)C(=O)N(C)CC1=CC2=C(C=CC=C2)N1C)C(C)=O
"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",3-phosphoinositide-dependent protein kinase 1,NCCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2
"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",3-phosphoinositide-dependent protein kinase 1,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(CCCN)C2=C1C=CC=C2
"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",Myotonin-protein kinase,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(CCCN)C2=C1C=CC=C2
3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,Gag-Pol polyprotein,[H][C@](C(C)C)(C1=CC=C(Br)C=C1)C1=C(O)C2=C(OC1=O)C=CC=C2
"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",Gag-Pol polyprotein,CC1=CC(=CC(OC2=C(Br)C=C(CC3=NNC4=NN=CC=C34)C=C2)=C1)C#N
"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",Glycogen synthase kinase-3 beta,[H][C@@](O)(CO)CNC1=CC=CC(=C1)C1=C(C(=O)NC1=O)C1=CN(C)C2=CC=C(F)C=C12
"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",Serine/threonine-protein kinase PLK1,[H][C@@](C)(NC1=CC2=C(C=N1)C(C)=NN2C1=CC=CC(CCC(N)=O)=C1)C1=CC=CC=C1
3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,Hepatocyte growth factor receptor,CN1CCN(CC1)C1=NC2=C(C=C(C=C2N=C1)C(F)(F)F)C1=CC(O)=CC=C1
"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",Serine/threonine-protein kinase PLK1,[H][C@@](C)(NC1=CC2=C(ON=C2C2=CC(Cl)=CC(CCCO)=C2)C=N1)C1=CC=CC=C1
"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",Cyclin-dependent kinase 2,CC1=NC(C)=C(S1)C1=NC(NC2=CC=CC(O)=C2)=NC=C1
"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",Gag-Pol polyprotein,CC1=NC2=C(C=CN=C2)N1C1=CC=C(CN2C(=O)SC3=C2C=CC=C3)C=C1
3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,Carbonic anhydrase 1,NS(=O)(=O)C1=CC=C(CCC(O)=O)C=C1
3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(CCC(O)=O)C=C1
"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",CC(C)N1N=C(C2=C1N=CN=C2N)C1=CC=CC(O)=C1
"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",Proto-oncogene tyrosine-protein kinase Src,CC(C)N1N=C(C2=C1N=CN=C2N)C1=CC=CC(O)=C1
3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE,Insulin-like growth factor 1 receptor,CC1=CC(=CC2=C1N=C(N2)C1=C(NCC2=NC=CC=C2)C=CNC1=O)N1C=CN=C1
3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,Peroxisome proliferator-activated receptor gamma,CCC\C(=C\C1=CC=C(O1)C1=CC(=CC=C1)C(O)=O)[N+]([O-])=O
3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,Aldose reductase,OC(=O)CCC1=CC=C(S1)C1=CC(=CC=C1)[N+]([O-])=O
"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",Gag-Pol polyprotein,FC1=C(CC2=NNC3=NN=CC=C23)C=CC(Br)=C1OC1=CC(=CC(Cl)=C1)C#N
"3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol",Rhodopsin,[H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC
3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,Genome polyprotein,CC(C)N(C(=O)C1=CC=C(C)C=C1)C1=C(SC(=C1)C1=CC=CC=C1)C(O)=O
3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid 4-Nitro-Phenyl Ester,Cruzipain,[H][C@](CCC1=CC=CC=C1)(CCS(=O)(=O)OC1=CC=C(C=C1)N(=O)=O)N=C(O)[C@]([H])(CC1=CC=CC=C1)N=C(O)OCC1=CC=CC=C1
3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonylmethylbenzene,Cruzipain,[H][C@](CCC1=CC=CC=C1)(CCS(=O)(=O)CC1=CC=CC=C1)N=C(O)[C@]([H])(CC1=CC=CC=C1)N=C(O)OCC1=CC=CC=C1
"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",Chymotrypsin-like elastase family member 1,[H][C@](NC(=O)CN1C(=O)C(NS(=O)(=O)NC)=CC=C1C1=CC=CC=C1)(C(C)C)C(=O)C(F)(F)F
3-[[N-[4-Methyl-Piperazinyl]Carbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid Benzyloxy-Amide,Cruzipain,[H][C@](CCC1=CC=CC=C1)(CCS(=O)(=O)NOCC1=CC=CC=C1)N=C(O)[C@]([H])(CC1=CC=CC=C1)N=C(O)N1CCN(C)CC1
3-amino-5-phenylpentane,Cathepsin L2,[H][C@](N)(CCC1=CC=CC=C1)C=CS(=O)(=O)C1=CC=CC=C1
3-amino-5-phenylpentane,Cathepsin K,[H][C@](N)(CCC1=CC=CC=C1)C=CS(=O)(=O)C1=CC=CC=C1
"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",Cyclin-dependent kinase 2,BrC1=C2N=C(C=C(NCC3=CC=CN=C3)N2N=C1)C1=CC=CC=C1
"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",Cyclin-dependent kinase 2,BrC1=C2N=C(C=C(NCC3=CC=NC=C3)N2N=C1)C1=CC=CC=C1
"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",Cyclin-dependent kinase 2,BrC1=C2C=C(C=C(NCC3=CN=CN=C3)N2N=C1)C1=CC=CC=C1
"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",Cyclin-dependent kinase 2,BrC1=CN=C2N1C=C(C=C2NCC1=CN=CN=C1)C1=CC=CC=C1
"3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,OC1=C(Br)C=C(\C=N\NC(=O)C2=CC=CC(Br)=C2)C(O)=C1Br
3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,Gag-Pol polyprotein,ClC1=CC(=CC(OC2=C(Cl)C=CC(OCC3=NNC4=C3C=CC=C4)=C2)=C1)C#N
"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",Gag-Pol polyprotein,ClC1=CC(OC2=C(Cl)C=CC(OCC3=NNC4=NC=CC=C34)=C2)=CC(=C1)C#N
3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,Prothrombin,[H][C@@](N)(CC1CCCCC1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(Cl)=CC=C1
"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",Cyclin-dependent kinase 2,C(NC1=CC(=NC2=C(C=NN12)C1CC1)C1=CC=CC=C1)C1=CN=CC=C1
3-deoxy-α-D-manno-oct-2-ulopyranosonic acid,Ferrichrome-iron receptor,[H][C@@](O)(CO)[C@@]1([H])O[C@](O)(C[C@@]([H])(O)[C@@]1([H])O)C(O)=O
"3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid",Retinoic acid receptor gamma,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@H](O)C(=O)NC1=C(F)C=C(C=C1)C(O)=O
"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid","2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",OC(=O)C(\O)=C(\F)/C=C/C(=O)C1=CC=C(F)C=C1
3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,Mitogen-activated protein kinase 14,FC1=CC(=CC(=C1)C(=O)NC1=CC=C2NC=CC2=C1)N1CCOCC1
3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,Beta-lactamase,FC1=CC(=CC=C1)C(=O)NC1=CC=CC(=C1)C1=NN=NN1
3-hydroxyanthranilic acid,"Trans-2,3-dihydro-3-hydroxyanthranilate isomerase",NC1=C(O)C=CC=C1C(O)=O
3-hydroxyglutaric acid,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",OC(CC(O)=O)CC(O)=O
3-isobutyl-1-methyl-7H-xanthine,"cGMP-specific 3',5'-cyclic phosphodiesterase",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O
3-isobutyl-1-methyl-7H-xanthine,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O
3-isobutyl-1-methyl-7H-xanthine,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O
3-isobutyl-1-methyl-7H-xanthine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O
3-isobutyl-1-methyl-7H-xanthine,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O
3-isobutyl-1-methyl-7H-xanthine,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O
3-isobutyl-1-methyl-7H-xanthine,"cGMP-dependent 3',5'-cyclic phosphodiesterase",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O
3-isobutyl-1-methyl-7H-xanthine,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",CC(C)CN1C2=C(N=CN2)C(=O)N(C)C1=O
"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",Cyclin-dependent kinase 2,CC1=CN=C2N1C=CN=C2NCC1=CC=NC=C1
"3-methyl-benzene-1,2-diol","Biphenyl-2,3-diol 1,2-dioxygenase",CC1=CC=CC(O)=C1O
3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,Hematopoietic prostaglandin D synthase,N1C=CC(=N1)C1=CC(=NO1)C1=CC=CC=C1
3-phenylpropionic acid,Aspartate aminotransferase,OC(=O)CCC1=CC=CC=C1
3-phenylpropionic acid,Aromatic-amino-acid aminotransferase,OC(=O)CCC1=CC=CC=C1
3-phenylpropionic acid,Aminotransferase,OC(=O)CCC1=CC=CC=C1
3-phospho-D-glyceric acid,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase",O[C@H](COP(O)(O)=O)C(O)=O
3-phospho-D-glyceric acid,Triosephosphate isomerase,O[C@H](COP(O)(O)=O)C(O)=O
3-phospho-D-glyceric acid,Bifunctional PGK/TIM,O[C@H](COP(O)(O)=O)C(O)=O
3-phospho-D-glyceric acid,Triosephosphate isomerase,O[C@H](COP(O)(O)=O)C(O)=O
3-phospho-D-glyceric acid,Phosphoglycerate kinase 1,O[C@H](COP(O)(O)=O)C(O)=O
3-phospho-D-glyceric acid,Phosphoglycerate mutase 2,O[C@H](COP(O)(O)=O)C(O)=O
3-pyridin-4-yl-1H-indazole,cAMP-dependent protein kinase catalytic subunit alpha,N1N=C(C2=C1C=CC=C2)C1=CC=NC=C1
3-pyridin-4-yl-1H-indazole,cAMP-dependent protein kinase inhibitor alpha,N1N=C(C2=C1C=CC=C2)C1=CC=NC=C1
3-sulfino-L-alanine,"Glutathione reductase, mitochondrial",N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Carboxymethylenebutenolidase,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Beta-lactamase 2,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,S-ribosylhomocysteine lyase,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Pyridoxamine kinase,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Dimethyl sulfoxide/trimethylamine N-oxide reductase,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Chorismate mutase AroH,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Peptide deformylase,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Peroxiredoxin-2,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Malonamidase E2,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,HMG-CoA synthase,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Osmotically inducible protein C,N[C@@H](C[S@@](O)=O)C(O)=O
3-sulfino-L-alanine,Poly(A) polymerase alpha,N[C@@H](C[S@@](O)=O)C(O)=O
3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid,Beta-lactamase,[H][C@@](NC(=O)CC1=CC=CS1)(B(O)O)C1=CC(=CC=C1)C(O)=O
3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid,Beta-lactamase TEM,[H][C@@](NC(=O)CC1=CC=CS1)(B(O)O)C1=CC(=CC=C1)C(O)=O
3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid,Beta-lactamase,[H][C@@](NC(=O)CC1=CC=CS1)(B(O)O)C1=CC(=CC=C1)C(O)=O
"3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate","6,7-dimethyl-8-ribityllumazine synthase",[H][C@@](O)(CO)[C@]([H])(O)[C@]([H])(O)CN1C(=O)N(CCCOP(O)(O)=O)C2=C1N=C(O)N=C2O
"3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate","6,7-dimethyl-8-ribityllumazine synthase",[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)CN1C(=O)N(CCCOP(O)(O)=O)C2=C1N=C(O)N=C2O
"3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate","6,7-dimethyl-8-ribityllumazine synthase",OC[C@@H](O)[C@H](O)[C@@H](O)CN1C(=O)N(CCCOP(O)(O)=O)C2=C1NC(=O)NC2=O
"3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate","6,7-dimethyl-8-ribityllumazine synthase",[H][C@@](O)(CO)[C@@]([H])(O)[C@@]([H])(O)CN1C(=O)N(CCCOP(O)(O)=O)C2=C1N=C(O)N=C2O
3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL,Group IIE secretory phospholipase A2,CN(C)CC1=CNC2=C1C=CC=C2CCCO
"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",Gag-Pol polyprotein,NC1=CC=C2C(COC3=CC(OC4=CC(=CC(Cl)=C4)C#N)=C(Cl)C=C3)=NNC2=N1
"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",Trypsin-1,COC1=CC(=C([O-])C(=C1)C1=CC2=CC(=CC=C2N1)C(N)=[NH2+])C1=CC=CC=C1
3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID,Caspase-1,[H][C@@](CC(O)=O)(NC(=O)[C@@]([H])(CCCCNC(=O)C1=NC2=C(C=CC=C2O)C=C1)C1=CC=CS1)C=O
3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,Genome polyprotein,[H][C@]1(C)CC[C@@]([H])(CC1)C(=O)N(C(C)C)C1=C(SC(=C1)C1=CC=CC=C1)C(O)=O
"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",MAP kinase-activated protein kinase 2,[H][C@](C)(NC1=C(NC2=CC=NC=C2)C(=O)C1=O)C1=CC=CC=C1
3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid,Thermolysin,[H][C@](CS)(CC1=CC=CC=C1)NC(=O)CC(O)=O
3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid,Thermolysin,[H][C@](CS)(CC1=CC=CC=C1)NC(=O)CC(O)=O
"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",Cyclin-dependent kinase 2,O=C1NC2=CC=C(C=C2\C1=C\NC1=CC2=C(CS(=O)(=O)C2)C=C1)C1=CN=CO1
3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,"Dihydroorotate dehydrogenase (quinone), mitochondrial",COC1=CC=CC(=C1)C1=CC=C(NC(=O)C2=C(SC=C2)C(O)=O)C(F)=C1
3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,Lanosterol 14-alpha demethylase,CC1=CC=C(C=C1)S(=O)(=O)NCCCOC(=O)NC1=CC=NC=C1
"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",Gag-Pol polyprotein,O[C@@H]1CN(N(CC2=CC=C(O)C=C2)C(=O)N(CC2=CC=C(O)C=C2)[C@@H]1CC1=CC=CC=C1)S(=O)(=O)C1=CC(=CC=C1)C#N
"3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril",V-1 protease,O[C@@H]1CN(N(CC2=CC=C(O)C=C2)C(=O)N(CC2=CC=C(O)C=C2)[C@@H]1CC1=CC=CC=C1)S(=O)(=O)C1=CC(=CC=C1)C#N
"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",Ig gamma-1 chain C region,CN1C2=CC=CC=C2C(C#N)(C(=O)NCCC(O)=O)C2=C1C=CC=C2
"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",Ig kappa chain C region,CN1C2=CC=CC=C2C(C#N)(C(=O)NCCC(O)=O)C2=C1C=CC=C2
"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",Cyclin-dependent kinase 2,NC(=N)NS(=O)(=O)C1=CC=C(N\C=C2/C(=O)NC3=C2C=CC=C3)C=C1
3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol,Disintegrin and metalloproteinase domain-containing protein 17,CC#CCOC1=CC=C(C=C1)S(=O)(=O)CCCS
3[N-Morpholino]Propane Sulfonic Acid,Phosphoribosylglycinamide formyltransferase 2,OS(=O)(=O)CCCN1CCOCC1
3[N-Morpholino]Propane Sulfonic Acid,Alpha-xylosidase,OS(=O)(=O)CCCN1CCOCC1
3[N-Morpholino]Propane Sulfonic Acid,Granulysin,OS(=O)(=O)CCCN1CCOCC1
"3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol",Beta-hexosaminidase subunit beta,[H][C@]12O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)S2
"3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol",B-N-acetylhexosaminidase,[H][C@]12O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)S2
"3h-Indole-5,6-Diol",Lactotransferrin,OC1=C(O)C=C2C=CNC2=C1
"3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol",Hypoxanthine-guanine phosphoribosyltransferase,OC1=NC=NC2=C1N=NC2
3r-Hydroxydecanoyl-Coa,Peroxisomal multifunctional enzyme type 2,[H][C@@](O)(CCCCCCC)CC(=O)SCCN=C(O)CCN=C(O)[C@]([H])(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,"Aspartate aminotransferase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(CNOCC(O)=O)=C1O
4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,4-aminobutyrate aminotransferase GabT,CC1=NC=C(COP(O)(O)=O)C(CNOCC(O)=O)=C1O
"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",Bcl-2-like protein 1,OC(=O)C1=CC=C(C=C1)C1=CC=C(F)C=C1
4'-Hydroxyflavanone,Sex hormone-binding globulin,OC1=CC=C(C=C1)[C@@H]1CC(=O)C2=CC=CC=C2O1
4'-Phosphopantetheine,Phosphopantetheine adenylyltransferase,CC(C)(COP(O)(O)=O)[C@@H](O)C(=O)NCCC(=O)NCCS
4'-Phosphopantetheine,Phosphopantetheine adenylyltransferase,CC(C)(COP(O)(O)=O)[C@@H](O)C(=O)NCCC(=O)NCCS
4'-Phosphopantetheine,Phosphopantetheine adenylyltransferase,CC(C)(COP(O)(O)=O)[C@@H](O)C(=O)NCCC(=O)NCCS
"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",Dipeptidyl peptidase 4,[H][C@@](N)(CC1=CC(F)=CC=C1F)C1=CC=C(C=C1)C1=CC=CC(=C1)C(N)=O
"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",Uteroglobin,CS(=O)(=O)C1=CC(Cl)=C(C=C1Cl)C1=C(Cl)C=C(C(Cl)=C1)S(C)(=O)=O
"4,4'-Biphenyldiboronic Acid",Beta-lactamase,OB(O)C1=CC=C(C=C1)C1=CC=C(C=C1)B(O)O
"4,4'-DIPYRIDYL DISULFIDE",Cytochrome P450 2A6,S(SC1=CC=NC=C1)C1=CC=NC=C1
"4,4'-PROPANE-2,2-DIYLDIPHENOL",Estrogen-related receptor gamma,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
"4,4'-cyclohexane-1,1-diyldiphenol",Estrogen-related receptor gamma,OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(O)C=C1
"4,5-Dehydro-D-Glucuronic Acid",Chondroitinase-AC,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@@]1([H])O)C(O)=O
"4,5-Dehydro-L-Iduronic Acid",Chondroitinase-AC,[H][C@@]1(O)OC(C(O)=O)=C(O)[C@]([H])(O)[C@@]1([H])O
"4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid",Chondroitinase (Chondroitin lyase),O[C@H]1CO[C@@H](C[C@@H]1O)C(O)=O
"4,5-Dimethyl-1,2-Phenylenediamine",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC(N)=C(N)C=C1C
"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",COC1=CC=C(C=C1)C1=C(N=C(N1)C1=CC=CS1)C1=CC=C(OC)C=C1
"4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE",Pancreatic alpha-amylase,C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",Pancreatic alpha-amylase,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(OC[C@@]3([H])O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"4,6-Dideoxyglucose",Cyclomaltodextrin glucanotransferase,[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1
"4,6-Dideoxyglucose",Cyclomaltodextrin glucanotransferase,[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1
"4,6-Dideoxyglucose",Alpha-amylase,[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1
"4,6-Dideoxyglucose",Neopullulanase 1,[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1
"4,6-Dideoxyglucose","Glucan 1,4-alpha-maltohexaosidase",[H][C@@]1(C)C[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)O1
"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",Xanthan lyase,C[C@]1(OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O)[C@H]2O1)C(O)=O
"4,6-dideoxy-4-amino-alpha-D-glucose",Alpha-amylase 1,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N
"4,6-dideoxy-4-amino-alpha-D-glucose",Pancreatic alpha-amylase,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N
"4,6-dideoxy-4-amino-beta-D-glucopyranoside",Cyclomaltodextrin glucanotransferase,[H][C@]1(C)O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N
"4,7-Dimethyl-[1,10]Phenanthroline",Azurin,CC1=CC=NC2=C3N=CC=C(C)C3=CC=C12
"4,7-Dioxosebacic Acid",Delta-aminolevulinic acid dehydratase,OC(=O)CCC(=O)CCC(=O)CCC(O)=O
"4,7-Dioxosebacic Acid",Delta-aminolevulinic acid dehydratase,OC(=O)CCC(=O)CCC(=O)CCC(O)=O
"4,7-Dioxosebacic Acid",Delta-aminolevulinic acid dehydratase,OC(=O)CCC(=O)CCC(=O)CCC(O)=O
"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",Cyclin-dependent kinase 2,[H][C@](C)(O)[C@]([H])(N)[C@]([H])(O)C#CC1=C(F)C=CC2=C1\C(=C\C1=C(OC)C=CN1)C(=O)N2
"4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium",Trypsin-3,[NH3+]CCCCOB1OCCO1
"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE","Nitric oxide synthase, inducible",CC1=NC(OC2=CC=C(C=C2)N2C=CN=C2)=NC(OC2=CC3=C(OCO3)C=C2)=C1
"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE","Nitric oxide synthase, inducible",C1OC2=C(O1)C=C(OC1=CC=NC(OC3=CC=C(C=C3)N3C=CN=C3)=N1)C=C2
"4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid",Heat shock protein HSP 90-alpha,CCC1=C(O)C=C(O)C(=C1)C1=NNC(C(O)=O)=C1C1=CC=C2OCOC2=C1
4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid,Metabotropic glutamate receptor 1,C[C@@](N)(C(O)=O)C1=CC=C(C=C1)C(O)=O
4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,"Phospholipase A2, membrane associated",CC1=C(CC(N)=O)C2=C(C=CC(OCCCC(O)=O)=C2)N1CC1=CC=CC=C1
4-(1-methyl-1-phenylethyl)phenol,Estrogen-related receptor gamma,CC(C)(C1=CC=CC=C1)C1=CC=C(O)C=C1
4-(1H-IMIDAZOL-1-YL)PHENOL,"Nitric oxide synthase, inducible",OC1=CC=C(C=C1)N1C=CN=C1
"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",Prothrombin,[H][C@@]12CCC[N@@]1[C@@]([H])(C1=CC=C(C=C1)C(N)N)[C@@]1([H])C(=O)N(CC3=CC=C(F)C=C3)[C@]([H])(C(F)F)[C@@]21[H]
"4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole",Heat shock protein HSP 90-alpha,CCC1=C(O)C=C(O)C(=C1)C1=NNC=C1C1=CNC=N1
"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE","Tyrosine--tRNA ligase, cytoplasmic",[H][C@](N)(CC1=CC=C(CC(F)(F)F)C=C1)C(O)=O
"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",Cyclin-dependent kinase 2,CC1=NC(C)=C(S1)C1=CC=NC(NC2=CC=C(C=C2)C(F)(F)F)=N1
"4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine",Cyclin-A2,CC1=NC(C)=C(S1)C1=CC=NC(NC2=CC=C(C=C2)C(F)(F)F)=N1
"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",Cyclin-dependent kinase 2,CC1=NC(C)=C(S1)C1=NC(N)=NC=C1
"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",Cyclin-A2,CC1=NC(C)=C(S1)C1=NC(N)=NC=C1
"4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine",Heat shock protein HSP 90-alpha,NC1=NC(=C(C=N1)\N=N\C1=CC=CC=C1)C1=C(Cl)C=C(Cl)C=C1
"4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL",Prothrombin,[H][C@](N)(O)CC[C@@]([H])(N)CC1=CC=C(O)C=C1
"4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine",Cyclin-dependent kinase 2,NC1=NC=CC(=N1)C1=C(Cl)SC(Cl)=C1
"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",Casein kinase II subunit alpha,N#CC1=C2N=C(NC3=CC=CC=C3)N=C(NCCC3=CN=CN3)N2N=C1
"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",Urokinase-type plasminogen activator,CC(C)OC1=CC(NC(=O)C2=CC(Cl)=C(OCCN)C(Cl)=C2)=CC=C1
4-(2-AMINOETHYL)BENZENESULFONAMIDE,Carbonic anhydrase 2,NCCC1=CC=C(C=C1)S(N)(=O)=O
4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID,Serine--pyruvate aminotransferase,NC1=CC=CC=C1C(=O)CCC(O)=O
4-(2-Aminoethyl)Benzenesulfonyl Fluoride,Glyceraldehyde-3-phosphate dehydrogenase,NCCC1=CC=C(C=C1)S(F)(=O)=O
4-(2-Aminoethyl)Benzenesulfonyl Fluoride,"V-type proton ATPase subunit B, brain isoform",NCCC1=CC=C(C=C1)S(F)(=O)=O
4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,Tryptophan synthase alpha chain,OC1=CC=C(F)C=C1SCC\C=C\P(O)(O)=O
4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,Tryptophan synthase beta chain,OC1=CC=C(F)C=C1SCC\C=C\P(O)(O)=O
4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,Mitogen-activated protein kinase 14,OC1=C(CNC2CCN(CC2)S(=O)(=O)NC2=CC(OC3=CC=C(F)C=C3)=CC=C2)C=CC=C1
4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,Tryptophan synthase alpha chain,OC1=CC=CC=C1[S@](=O)CCCCP(O)(O)=O
4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,Tryptophan synthase beta chain,OC1=CC=CC=C1[S@](=O)CCCCP(O)(O)=O
4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID,Tryptophan synthase alpha chain,OC1=C(SCC\C=C\P(O)(O)=O)C=CC=C1
4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID,Tryptophan synthase beta chain,OC1=C(SCC\C=C\P(O)(O)=O)C=CC=C1
4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID,2-hydroxychromene-2-carboxylate isomerase,[H]\C(=C(/[H])C1=CC=CC=C1OC)C(=O)C(O)=O
"4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid",Streptavidin,[H][C@]12CS[C@@]([H])(CCCC(O)=O)[C@@]1([H])NC(=O)N2
4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,CC1=CC=C(CN2C=NC(=C2)C2=CC=CS2)C=C1
4-(2-Thienyl)Butyric Acid,Aromatic-amino-acid aminotransferase,OC(=O)CCCC1=CC=CS1
"4-(2-amino-1,3-thiazol-4-yl)phenol",Leukotriene A-4 hydrolase,NC1=NC(=CS1)C1=CC=C(O)C=C1
"4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine",Biotin carboxylase,NC1=NC(=CS1)C1=NC(N)=NC=C1
"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",Estrogen receptor,CN1C(N)=NC2=C1C=C(C=N2)C1=CC=C(O)C=C1
"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",Nuclear receptor coactivator 2,CN1C(N)=NC2=C1C=C(C=N2)C1=CC=C(O)C=C1
"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",Urokinase-type plasminogen activator,CCOC1=CC=C(OCC)C(NC(=O)C2=CC(C)=C(OCCN)C(C)=C2)=C1
"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",Urokinase-type plasminogen activator,CCOC1=C(NC(=O)C2=CC(C)=C(OCCN)C(C)=C2)C=C(C=C1Cl)N1CCCCC1
"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",Urokinase-type plasminogen activator,CC1=CC(=CC(C)=C1OCCN)C(=O)NC1=CC(Cl)=CC(=C1)N1CCCCC1
4-(2-aminoethyl)-2-cyclohexylphenol,Beta-secretase 1,NCCC1=CC=C(O)C(=C1)C1CCCCC1
4-(2-aminoethyl)-2-ethylphenol,Beta-secretase 1,CCC1=CC(CCN)=CC=C1O
"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",Wee1-like protein kinase,CN1C=C(CCO)C2=C1C=C(C1=C2C(=O)NC1=O)C1=CC=CC=C1Cl
4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine,Heat shock protein HSP 90-alpha,COCCOC1=NC(N)=NC(C)=C1
"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",Estrogen receptor beta,OC1=CC=C(CCNC2=NC(SCCCC3=CC=C(Cl)C=C3)=NC(=N2)N2CCNCC2)C=C1
"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",Gag-Pol polyprotein,CC1=C(CSCC2=CC=CO2)C(OC2=CC(C)=CC(C)=C2)=C(I)C(=O)N1
4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,TGF-beta receptor type-1,N1C=C(C(=N1)C1=NC=CC=C1)C1=C2C=CC=CC2=NC=C1
4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,Tyrosine-protein kinase JAK2,CC(C)(C)NS(=O)(=O)C1=CC=C(C=C1)C1=CC2=C(NN=C2N)C=C1
"4-(3-ethylthiophen-2-yl)benzene-1,2-diol",Methionine aminopeptidase,CCC1=C(SC=C1)C1=CC(O)=C(O)C=C1
4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,Fatty-acid amide hydrolase 1,OC(=O)N1CCC(CC2=CC(OC3=NC=C(C=C3)C(F)(F)F)=CC=C2)CC1
"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",Gag-Pol polyprotein,OC1(CCN(CCCC2(SCCS2)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,cAMP-dependent protein kinase catalytic subunit alpha,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=CNN=C1
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,cAMP-dependent protein kinase inhibitor alpha,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=CNN=C1
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,RAC-beta serine/threonine-protein kinase,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=CNN=C1
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,Glycogen synthase kinase-3 beta,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=CNN=C1
4-(4-Chlorophenyl)Imidazole,Cytochrome P450 2B6,ClC1=CC=C(C=C1)C1=CN=CN1
4-(4-FLUOROBENZYL)PIPERIDINE,Beta-secretase 1,FC1=CC=C(CC2CCNCC2)C=C1
4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,Mitogen-activated protein kinase 14,FC1=CC=C(C=C1)C1=C(N(CC2CC2)C=N1)C1=CC=NC=C1
4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,Nuclear receptor coactivator 1,O\N=C\C1=C2C=CC=CC2=C(C=C1)C1=CC=C(O)C=C1
4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,Estrogen receptor beta,O\N=C\C1=C2C=CC=CC2=C(C=C1)C1=CC=C(O)C=C1
"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",Aurora kinase A,CN1CCN(CC1)C1=CC=C(C=C1)C(=O)NC1=NNC2=CN(C=C12)C(=O)CC1=CC=CS1
"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",Serine/threonine-protein kinase PLK1,CN1CCN(CC1)C1=CC=C(C=C1)C(=O)NC1=NNC2=CN(C=C12)C(=O)CC1=CC=CS1
4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,Ig kappa chain C region,OC(=O)CCCC(=O)NC1=CC=C(\C=C\C2=CC=CC=C2)C=C1
4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,Ig gamma-1 chain C region,OC(=O)CCCC(=O)NC1=CC=C(\C=C\C2=CC=CC=C2)C=C1
4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,Immunoglobulin kappa variable 2D-28,OC(=O)CCCC(=O)NC1=CC=C(\C=C\C2=CC=CC=C2)C=C1
"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",cAMP-dependent protein kinase catalytic subunit alpha,[NH3+]C1(CC2=CC=C(Cl)C=C2)CCN(CC1)C1=C2C=CNC2=NC=N1
"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",cAMP-dependent protein kinase inhibitor alpha,[NH3+]C1(CC2=CC=C(Cl)C=C2)CCN(CC1)C1=C2C=CNC2=NC=N1
4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine,Methionine aminopeptidase,[H]N=C1N=NC(N)=C1\N=N\C1=CC=C(F)C=C1
4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one,Serine/threonine-protein kinase pim-1,CC1=CC(=CC=C1O)C1=NC(=O)N=C(C1)C1=CC=CC=C1
"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",Cyclin-dependent kinase 2,COC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1
"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",Cyclin-A2,COC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1
"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",Thymidylate synthase,CC1=C2C(=O)N(C(=O)C2=CC=C1)C1=CC=C(C=C1)C#N
"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",Cyclin-dependent kinase 2,CCCOC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1
"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",Cyclin-A2,CCCOC1=C2C(NC=C2C2=NC(N)=NC=C2)=NC=C1
"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",DNA topoisomerase 1,OC(=O)CCCN1C2=C(C(=O)C3=CC=CC=C23)C2=CC=CC=C2C1=O
4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,Prothrombin,CN1C(CC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(NS(=O)(=O)C1=CC=CC=C1)=C2
4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(C=C1)\N=N\C1=C2C=C(Br)C=CC2=NC1=O
"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",Serine/threonine-protein kinase Sgk1,OC(=O)C1=CC=C(C=C1)C1=CNC2=C1C=C(C=N2)C1=CC=CC=C1
"4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE","6,7-dimethyl-8-ribityllumazine synthase",OP(O)(=O)OCCCCC1=C(Cl)NC(=O)NC1=O
4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,Cyclin-A2,NC(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1
4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,Cyclin-dependent kinase 2,NC(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1
"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",Estrogen receptor,OC1=CC=C2C(NN=C2C2=CC=C(O)C=C2O)=C1
"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",Nuclear receptor coactivator 2,OC1=CC=C2C(NN=C2C2=CC=C(O)C=C2O)=C1
"4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL",Estrogen receptor beta,OC1=CC2=C(C=C1)C(=NO2)C1=C(O)C=C(O)C=C1
"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",Death-associated protein kinase 3,[H][C@@](CC)(CO)NC1=NN2C(C=C1)=NC=C2C1=CC=C(C=C1)C(O)=O
"4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID",Serine/threonine-protein kinase Chk1,[H][C@]1(C)CC[C@]([H])(CC1)NCC1=CC2=C(C=C1)C1=C(C2)C(=NN1)C1=CC=C(C=C1)C(O)=O
4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID,Neuraminidase,CC(=O)NC1=C(O)C=C(C=C1[N+]([O-])=O)C(O)=O
4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID,Neuraminidase,CC(=O)NC1=C(O)C=C(C=C1[N+]([O-])=O)C(O)=O
4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID,Neuraminidase,CC(=O)NC1=C(N)C=C(C=C1O)C(O)=O
4-(Acetylamino)-3-Amino Benzoic Acid,Neuraminidase,CC(=O)NC1=C(N)C=C(C=C1)C(O)=O
4-(Acetylamino)-3-Guanidinobenzoic Acid,Neuraminidase,CC(=O)NC1=CC=C(C=C1NC(N)N)C(O)=O
4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid,Neuraminidase,CC(=O)NC1=CC=C(C=C1NC(=O)C[NH3+])C(O)=O
4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid,Neuraminidase,CC(=O)NC1=CC=C(C=C1NC(=O)CO)C(O)=O
"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C(F)=C(F)C=C1
"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C=C(F)C=C1F
"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C=C(F)C=C1
"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC(F)=CC=C1F
"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC(F)=C(F)C(F)=C1
4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=C(F)C=C1
4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,Hematopoietic prostaglandin D synthase,C(CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1)CC1=NN=NN1
4-(Carboxyvin-2-Yl)Phenylboronic Acid,Beta-lactamase,OB(O)C1=CC=C(\C=C\C(O)=O)C=C1
4-(DIMETHYLAMINO)BENZOIC ACID,Replicase polyprotein 1ab,CN(C)C1=CC=C(C=C1)C(O)=O
4-(DIMETHYLAMINO)BENZOIC ACID,Orf1a polyprotein,CN(C)C1=CC=C(C=C1)C(O)=O
4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE,Histamine N-methyltransferase,CN(C)CCCCSC(N)=N
4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,Mitogen-activated protein kinase 14,NC1=NC(=CC=N1)C1=C(N=CN1CC1CC1)C1=CC=C(F)C=C1
4-(Hydroxymercury)Benzoic Acid,Carbonic anhydrase 2,O[Hg]C1=CC=C(C=C1)C(O)=O
4-(Hydroxymethyl)Benzamidine,Trypsin-3,NC(=N)C1=CC=C(CO)C=C1
4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE,Trypsin-1,CS(=O)(=O)C1=CC=C(C=C1)C(N)=N
4-(Methylsulfanyl)-2-Oxobutanoic Acid,Aminotransferase,CSCCC(=O)C(O)=O
"4-(N,N-Dimethylamino)Cinnamoyl-Coa","Enoyl-CoA hydratase, mitochondrial",[H]\C(=C(\[H])C1=CC=C(C=C1)N(C)C)C(=O)SCCN=C(O)CCN=C(O)[C@]([H])(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,Neuraminidase,CCC(CC)C(=O)NC1=CC(=CC=C1NC(C)=O)C(O)=O
4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,Cyclin-dependent kinase 2,CC(=O)NC1=CNN=C1C(=O)NC1=CC=C(F)C=C1
4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid,Beta-lactamase,OB(O)C1=CC(NS(=O)(=O)C2=CC(=CS2)S(=O)(=O)C2=CC=CC=C2)=C(C=C1)C(O)=O
4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,Fatty-acid amide hydrolase 1,OC(=O)N1CCC(CC2=CN=C3C=CC=CC3=C2)CC1
"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",[H][C@@]1(C)CN(C(=O)[C@@](C)(O)C(F)(F)F)[C@@]([H])(C)CN1C(=O)C1=CC=C(C=C1)C#N
"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",Disintegrin and metalloproteinase domain-containing protein 17,[H][C@]1(N(CCSC1(C)C)S(=O)(=O)C1=CC=C(OCC#CCN)C=C1)C(=O)NO
4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,"Nitric oxide synthase, inducible",COC1=CC=NC(NC2CCN(CC2)C(=O)C2=CC=C(C=C2)C#N)=C1
4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,Coagulation factor X,NC(=N)C1=CC=C(CN2CCN(CC2=O)S(=O)(=O)C2=CC3=C(S2)C=C(Cl)C=C3)C=C1
"4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE",Cyclin-dependent kinase 2,[H][C@]1(N)CC[C@@]([H])(CC1)NC1=NC2=NC=NN2C(NC2=CC=C(C=C2)S(N)(=O)=O)=C1
4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,Carbonic anhydrase 2,CN1CCN(CC1)NC(=S)NC1=CC=C(C=C1)S(N)(=O)=O
4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,Prothrombin,CC1=CC=CC(=C1)C(=O)C1=CC=NC(NCC2=CC=C(C=C2)C(N)=N)=C1
"4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",Histo-blood group ABO system transferase,[H][C@]1(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
"4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",Histo-blood group ABO system transferase,[H][C@]1(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCCC)[C@]1([H])O
4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,Thiamine-phosphate synthase,NC1=NC(=NC=C1CO[P@@](O)(=O)OP(O)(O)=O)C(F)(F)F
"4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE",Metallo-beta-lactamase L1,CC1=CC=CC=C1C1=NNC(=S)N1N
4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,"Fructose-1,6-bisphosphatase 1",NC1=CC=C(C=C1)S(=O)(=O)NC(=O)NCCS
"4-Acetamido-2,4-Didexoy-D-Glycero-Beta-D-Galacto-Octopyranosylphosphonic Acid",Sialidase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])O[C@]([H])(C[C@]([H])(O)[C@@]1([H])N=C(C)O)P(O)(O)=O
"4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",Neuraminidase,CCCN(C)C(=O)[C@@H]1OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O
4-Amido-4-Carbamoyl-Butyric Acid,ATP synthase subunit b,N[C@@H](CCC(O)=O)C(N)=O
4-Amino Hexanoic Acid,"4-aminobutyrate aminotransferase, mitochondrial",[H][C@@](N)(CC)CCC(O)=O
"4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid",Neuraminidase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(N)[C@@]1([H])N=C(C)O)C(O)=O
"4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium",Casein kinase I isoform gamma-3,[H]N([H])C1=C(SC(N([H])C2=CC(Cl)=CC=C2)=[N+]1[H])C(=O)C1=CC=C(F)C=C1
4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase,CC1=NC=C(CO)C(N)=N1
4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,Aminopyrimidine aminohydrolase,CC1=NC=C(CO)C(N)=N1
"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",Plasmepsin-2,CC(C)C[C@@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)NC(=O)C1=CC=CC(N)=C1
4-Aminohydrocinnamic Acid,Aromatic-amino-acid aminotransferase,NC1=CC=C(CCC(O)=O)C=C1
4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)COC1=C(SC(=C1Br)C1=CC=C(O)C=C1)C(O)=O
4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)COC1=C(SC(=C1Br)C1=CC=CC=C1)C(O)=O
4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)COC1=C(SC(=C1Br)C1=CC=CC(NC2CCCCC2)=C1)C(O)=O
4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CCC(O)=O)(N=C(O)C1=CC=CC=C1)C(O)=N[C@@]([H])(CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)C(O)=N[C@@]([H])(CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)C(O)=N
"4-Bromo-2,5-dimethoxyphenethylamine",5-hydroxytryptamine receptor 2C,COC1=CC(Br)=C(OC)C=C1CCN
"4-Bromo-2,5-dimethoxyphenethylamine",5-hydroxytryptamine receptor 2A,COC1=CC(Br)=C(OC)C=C1CCN
"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",Thymidylate synthase,OC1=C(Br)C=C(C=C1)C1(OC(=O)C2=C3C(C=CC=C13)=C(Cl)C=C2)C1=CC(Br)=C(O)C=C1
"4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",Heat shock protein HSP 90-alpha,OC1=CC(O)=C(Cl)C=C1C1=C(C=NN1)N1CCNCC1
"4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",Heat shock protein HSP 90-alpha,CS(=O)(=O)C1=CC=C(CN2CCN(CC2)C2=C(NN=C2)C2=CC(Cl)=C(O)C=C2O)C=C1
"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",Gag-Pol polyprotein,[H][C@]1(C)CN2C(=S)NC3=C2C(CN1CC=C(C)C)=CC(Cl)=C3
"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",Gag-Pol polyprotein,[H][C@]1(C)CN2C(=S)NC3=C2C(CN1CC=C(C)C)=CC(Cl)=C3
4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CCC(O)=O)(NC(=O)C1=CC2=C(C=C1)C=C(C=C2)C(F)(F)P(O)(O)=O)C(N)=O
4-Carboxy-4-Aminobutanal,Glutaminase-asparaginase,N[C@@H](CCC=O)C(O)=O
"4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole",Hydroxyacid oxidase 1,CCCCCC(CCCCC)SC1=C(N=NN1)C(O)=O
4-Carboxycinnamic Acid,Hemoglobin subunit alpha,OC(=O)\C=C\C1=CC=C(C=C1)C(O)=O
4-Carboxycinnamic Acid,Hemoglobin subunit beta,OC(=O)\C=C\C1=CC=C(C=C1)C(O)=O
4-Carboxyphenylboronic Acid,Beta-lactamase,OB(O)C1=CC=C(C=C1)C(O)=O
4-Deoxy-Alpha-D-Glucose,Cyclomaltodextrin glucanotransferase,[H][C@]1(O)C[C@@]([H])(CO)O[C@]([H])(O)[C@]1([H])O
4-Deoxy-Alpha-D-Glucose,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,[H][C@]1(O)C[C@@]([H])(CO)O[C@]([H])(O)[C@]1([H])O
4-Deoxy-D-Glucuronic Acid,Chondroitinase-B,O[C@H]1C[C@H](O[C@@H](O)[C@@H]1O)C(O)=O
4-Deoxy-D-Glucuronic Acid,Hyaluronate lyase,O[C@H]1C[C@H](O[C@@H](O)[C@@H]1O)C(O)=O
4-Deoxy-D-Glucuronic Acid,Hyaluronate lyase,O[C@H]1C[C@H](O[C@@H](O)[C@@H]1O)C(O)=O
4-Deoxy-D-Glucuronic Acid,Alginate lyase,O[C@H]1C[C@H](O[C@@H](O)[C@@H]1O)C(O)=O
4-Deoxy-D-Mannuronic Acid,AlgQ1,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@]1([H])O)C(O)=O
4-Deoxy-D-Mannuronic Acid,AlgQ2,[H][C@@]1(O)OC(=C[C@]([H])(O)[C@]1([H])O)C(O)=O
4-Deoxyglucarate,Glucarate dehydratase,[H][C@](O)(C[C@]([H])(O)[C@@]([H])(O)C([O-])=O)C([O-])=O
4-Deoxylactose,Glycosyl transferase,[H][C@@]1(CO)C[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)O1
4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide,Histone deacetylase 8,CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCC(O)=NO
4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",[H][C@@](O)(COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=CC(=N)N=C2O)[C@]([H])(O)[C@]1([H])O)[C@@](C)(O)CO
4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,4-diphosphocytidyl-2-C-methyl-D-erythritol kinase,[H][C@@](O)(COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=CC(=N)N=C2O)[C@]([H])(O)[C@]1([H])O)[C@@](C)(O)CO
4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,[H][C@@](O)(COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=CC(=N)N=C2O)[C@]([H])(O)[C@]1([H])O)[C@@](C)(O)CO
4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",[H][C@@](O)(COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=CC(=N)N=C2O)[C@]([H])(O)[C@]1([H])O)[C@](C)(CO)OP(O)(O)=O
4-Flourobenzenesulfonamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(F)C=C1
4-Fluorobenzylamine,Trypsin-1,[NH3+]CC1=CC=C(F)C=C1
4-Fluorophenethyl Alcohol,Endolysin,OCCC1=CC=C(F)C=C1
4-Guanidinobenzoic Acid,Complement factor B,NC(=N)NC1=CC=C(C=C1)C(O)=O
4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,Immunoglobulin heavy variable 1-2,OC1=C(C=C(CC(=O)NCCCCCC([O-])=O)C=C1)[N+]([O-])=O
4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,Ig lambda chain V region 4A,OC1=C(C=C(CC(=O)NCCCCCC([O-])=O)C=C1)[N+]([O-])=O
4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,Immunoglobulin heavy variable 1-2,OC1=C(C=C(CC(=O)NCCCCCC([O-])=O)C=C1I)[N+]([O-])=O
4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,Ig lambda chain V region 4A,OC1=C(C=C(CC(=O)NCCCCCC([O-])=O)C=C1I)[N+]([O-])=O
4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,Gag-Pol polyprotein,[H][C@](CC)(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=C(OC)C=C2
4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,Estrogen-related receptor gamma,CC(C)C1=CC=C(CNNC(=O)C2=CC=C(O)C=C2)C=C1
4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,Nuclear receptor-interacting protein 1,CC(C)C1=CC=C(CNNC(=O)C2=CC=C(O)C=C2)C=C1
4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,Amine oxidase [flavin-containing] B,[H][C@]1(CCC2=C1C=CC=C2O)\N=C\C=C
"4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME",Macrophage migration inhibitory factor,CC(C)(C)CC(=O)O\N=C\C1=CC=C(O)C=C1
4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,Macrophage migration inhibitory factor,OC1=CC=C(\C=N\OC(=O)C2CCCCC2)C=C1
"4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid",L-lactate dehydrogenase B chain,OC(=O)C1=NON=C1O
"4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid",L-lactate dehydrogenase,OC(=O)C1=NON=C1O
"4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid",L-lactate dehydrogenase,OC(=O)C1=NSN=C1O
4-Hydroxy-2-Butanone,Peptidyl-prolyl cis-trans isomerase FKBP1A,CC(=O)CCO
"4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One",Cytosine deaminase,[H][C@@]1(O)NC(O)=NC=C1
"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",3-oxoacyl-[acyl-carrier-protein] synthase 1,C\C(C=C)=C/[C@@]1(C)SC(=O)C(C)=C1O
"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",3-oxoacyl-[acyl-carrier-protein] synthase 1,C\C(C=C)=C/[C@@]1(C)SC(=O)C(C)=C1O
4-Hydroxy-3-Methyl Butyl Diphosphate,Isopentenyl-diphosphate Delta-isomerase,C[C@H](CO)CCO[P@](O)(=O)OP(O)(O)=O
4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,Cytochrome P450 2C9,[H][C@](CC(C)=O)(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O
4-Hydroxy-Aconitate Ion,"Aconitate hydratase, mitochondrial",[H]\C(C([O-])=O)=C(/C([O-])=O)[C@@]([H])(O)C([O-])=O
4-Hydroxy-L-Threonine-5-Monophosphate,4-hydroxythreonine-4-phosphate dehydrogenase,N[C@@H]([C@H](O)COP(O)(O)=O)C(O)=O
4-Hydroxybenzyl Coenzyme A,4-hydroxybenzoyl-CoA thioesterase,[H][C@](O)(C(O)=NCCC(O)=NCCSCC1=CC=C(O)C=C1)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
4-Hydroxybenzyl Coenzyme A,4-hydroxybenzoyl-CoA thioesterase,[H][C@](O)(C(O)=NCCC(O)=NCCSCC1=CC=C(O)C=C1)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
4-Hydroxybutan-1-Aminium,Trypsin-3,[NH3+]CCCCO
4-Hydroxyphenacyl Coenzyme A,4-hydroxybenzoyl-CoA thioesterase,[H][C@](O)(C(O)=NCCC(O)=NCCSCC(=O)C1=CC=C(O)C=C1)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
4-Hydroxyphenacyl Coenzyme A,4-hydroxybenzoyl-CoA thioesterase,[H][C@](O)(C(O)=NCCC(O)=NCCSCC(=O)C1=CC=C(O)C=C1)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
4-Imino-5-Methidyl-2-Methylpyrimidine,Thiamine-phosphate synthase,CC1=NC(=N)C(=C)C=N1
4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine,Thiamine-phosphate synthase,FC(F)(F)C1=NC(=N)C(=C)C=N1
4-Iodo-D-phenylalanine,Aminopeptidase S,[H][C@@](N)(CC1=CC=C(I)C=C1)C(O)=O
4-Iodo-L-phenylalanine,Endolysin,[H][C@](N)(CC1=CC=C(I)C=C1)C(O)=O
4-Iodo-L-phenylalanine,Pseudomonalisin,[H][C@](N)(CC1=CC=C(I)C=C1)C(O)=O
4-Iodo-L-phenylalanine,Dipeptidyl peptidase 4,[H][C@](N)(CC1=CC=C(I)C=C1)C(O)=O
4-Iodo-L-phenylalanine,Aminopeptidase S,[H][C@](N)(CC1=CC=C(I)C=C1)C(O)=O
4-Iodobenzo[B]Thiophene-2-Carboxamidine,Prothrombin,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2I
4-Iodobenzo[B]Thiophene-2-Carboxamidine,Trypsin-1,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2I
4-Iodobenzo[B]Thiophene-2-Carboxamidine,Urokinase-type plasminogen activator,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2I
4-Iodopyrazole,Alcohol dehydrogenase 1A,IC1=CNN=C1
4-Iodopyrazole,Alcohol dehydrogenase 1B,IC1=CNN=C1
4-Iodopyrazole,Alcohol dehydrogenase 1C,IC1=CNN=C1
4-Iodopyrazole,Mycocyclosin synthase,IC1=CNN=C1
4-METHYL-2H-CHROMEN-2-ONE,Endoglucanase H,CC1=CC(=O)OC2=CC=CC=C12
"4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE",Cyclin-A2,CC1=C(SC(=N)N1)C1=N\C(=N/C2=CC=C(C=C2)N2CCOCC2)N=CC1
"4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE",Cyclin-dependent kinase 2,CC1=C(SC(=N)N1)C1=N\C(=N/C2=CC=C(C=C2)N2CCOCC2)N=CC1
4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE,Cytochrome P450 2C18,CN(C1=CC=NN1C1=CC=CC=C1)S(=O)(=O)C1=CC=C(C)C=C1
"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",Genome polyprotein,CC1=CC=C(O1)\C=C1/SC(NS(=O)(=O)C2=CC=C(C)C=C2)=NC1=O
4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE,Coagulation factor XI,[H][C@@](CCCNC(N)N)(NC(=O)[C@@]([H])(NC(=O)CCC(C)C)C(C)C)C(=O)C1=NC=CS1
4-Methoxy-E-Rhodomycin T,Carminomycin 4-O-methyltransferase DnrK,[H][C@@]1(C[C@]([H])(N(C)C)[C@]([H])(O)[C@]([H])(C)O1)O[C@@]1([H])C[C@](O)(CC)[C@]([H])(C(=O)OC)C2=C(O)C3=C(C(O)=C12)C(=O)C1=C(C=CC=C1OC)C3=O
4-Methoxyamphetamine,Sodium-dependent dopamine transporter,COC1=CC=C(CC(C)N)C=C1
4-Methoxyamphetamine,Sodium-dependent serotonin transporter,COC1=CC=C(CC(C)N)C=C1
4-Methoxyamphetamine,Synaptic vesicular amine transporter,COC1=CC=C(CC(C)N)C=C1
4-Methoxyamphetamine,Alpha-1A adrenergic receptor,COC1=CC=C(CC(C)N)C=C1
4-Methoxyamphetamine,Alpha-2A adrenergic receptor,COC1=CC=C(CC(C)N)C=C1
4-Methoxyamphetamine,Amine oxidase [flavin-containing] A,COC1=CC=C(CC(C)N)C=C1
4-Methoxyamphetamine,Amine oxidase [flavin-containing] B,COC1=CC=C(CC(C)N)C=C1
4-Methyl Valeric Acid,Branched-chain-amino-acid aminotransferase,CC(C)CCC(O)=O
"4-Methyl-1,2-Benzenediol",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC=C(O)C(O)=C1
"4-Methyl-1,2-Benzenediol","Catechol 1,2-dioxygenase",CC1=CC=C(O)C(O)=C1
4-Methyl-5-Hydroxyethylthiazole,Hydroxyethylthiazole kinase,CC1=C(CCO)SC=N1
4-Methyl-5-Hydroxyethylthiazole Phosphate,Thiamine-phosphate synthase,CC1=C(CCOP(O)(O)=O)SC=N1
4-Methyl-Histidine,"Actin, alpha skeletal muscle",CN1C=NC(C[C@H](N)C(O)=O)=C1
4-Methylimidazole,Carbonic anhydrase 2,CC1=CN=CN1
4-Methylimidazole,"Carbonic anhydrase 5A, mitochondrial",CC1=CN=CN1
4-Methylimidazole,Myoglobin,CC1=CN=CN1
4-Methylpiperazin-1-Yl Carbonyl Group,Cathepsin L2,CN1CCN(CC1)C(O)=O
4-Methylpiperazin-1-Yl Carbonyl Group,Candidapepsin-2,CN1CCN(CC1)C(O)=O
4-Methylthio-Alpha-D-Mannose,Alpha-amylase 2B,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(SC)[C@]([H])(O)[C@@]1([H])O
4-Methylumbelliferyl Chitobiose,Lysozyme C,[H][C@]1(CO)O[C@@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(OC3=CC4=C(C=C3)C(C)=CC(=O)O4)[C@]([H])(N=C(C)O)[C@@]2([H])O)[C@]([H])(N=C(C)O)[C@@]([H])(O)[C@]1([H])O
4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide,Cathepsin F,[H][C@](CCC)(C=CS(=O)(=O)C1=CC=CC=C1)N=C(O)[C@]([H])(CC1=CC=CC=C1)N=C(O)N1CCC(CC1)N1CCOCC1
4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,Ig gamma-1 chain C region,OC(=O)CNC(=O)CCC[P@@](O)(=O)OCC1=CC=C(C=C1)[N+]([O-])=O
4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,Ig gamma-2 chain C region,OC(=O)CNC(=O)CCC[P@@](O)(=O)OCC1=CC=C(C=C1)[N+]([O-])=O
4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,Alpha-xylosidase,O[C@@H]1CO[C@H](SC[C@H]2O[C@@H](OC3=CC=C(C=C3)[N+]([O-])=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H]1O
4-Nitrophenyl Phosphate,Low molecular weight phosphotyrosine protein phosphatase,OP(O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O
4-Nitrophenyl Phosphate,Dual specificity protein phosphatase 23,OP(O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O
4-Nitrophenyl-Ara,Intracellular exo-alpha-(1->5)-L-arabinofuranosidase,[H][C@@]1(CO)O[C@@]([H])(OC2=CC=C(C=C2)[N+]([O-])=O)[C@]([H])(O)[C@@]1([H])O
"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",Pancreatic alpha-amylase,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose",Pancreatic alpha-amylase,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
4-O-methyl-alpha-D-glucuronic acid,"Xylan alpha-1,2-glucuronidase",[H][C@]1(O)O[C@]([H])(C(O)=O)[C@@]([H])(OC)[C@]([H])(O)[C@@]1([H])O
4-O-methyl-alpha-D-glucuronic acid,Beta-xylanase,[H][C@]1(O)O[C@]([H])(C(O)=O)[C@@]([H])(OC)[C@]([H])(O)[C@@]1([H])O
4-O-methyl-beta-D-glucuronic acid,"Xylan alpha-1,2-glucuronidase",CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1C(O)=O
"4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid",Xanthan lyase,[H][C@@]12CO[C@@](C)(O[C@@]1([H])[C@H](O)[C@H](O)[C@H](O[C@H]1[C@H](O)[C@@H](O)C(O)O[C@@H]1C(O)=O)O2)C(O)=O
"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",Prothrombin,O\N=C(/N)N1CCC(CC1)CNC(=O)[C@@H]1CC[C@H]2CN(CC(=O)N12)S(=O)(=O)CC1=CC=CC=C1
4-Oxo-Nicotinamide-Adenine Dinucleotide Phosphate,NADPH-ferredoxin reductase FprA,[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(OP(O)(O)=O)[C@]2([H])O)O[C@@]([H])([N+]2=C[C@]([H])(C(O)=N)C(=O)C=C2)[C@]([H])(O)[C@]1([H])O
4-Oxosebacic Acid,Delta-aminolevulinic acid dehydratase,OC(=O)CCCCCC(=O)CCC(O)=O
4-Oxosebacic Acid,Delta-aminolevulinic acid dehydratase,OC(=O)CCCCCC(=O)CCC(O)=O
4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,Mitogen-activated protein kinase 14,O=C(NCC1=NC=CC=C1)C1=CC=C(OC2=CC=CC=C2)C=C1
4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,Tyrosine-protein phosphatase non-receptor type 1,OP(O)(=O)OC1=CC=C(CC2=CC=C(OP(O)(O)=O)C=C2)C=C1
4-PIPERIDIN-4-YLBUTANAL,Tryptase beta-2,O=CCCCC1CCNCC1
4-PIPERIDIN-4-YLBUTANAL,Trypsin-1,O=CCCCC1CCNCC1
4-Phenyl-1h-Imidazole,Biflaviolin synthase CYP158A2,N1C=NC=C1C1=CC=CC=C1
4-Phenylbutylamine,Trypsin-1,NCCCCC1=CC=CC=C1
4-Phospho-D-Erythronohydroxamic Acid,Ribose-5-phosphate isomerase B,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)C(O)=NO
4-Piperidino-Piperidine,Liver carboxylesterase 1,C1CCN(CC1)C1CCNCC1
4-Sulfonamide-[1-(4-Aminobutane)]Benzamide,Carbonic anhydrase 2,NCCCCNC(=O)C1=CC=C(C=C1)S(N)(=O)=O
4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCCCCNCS
4-TERT-BUTYLBENZENESULFONIC ACID,Prothrombin,CC(C)(C)C1=CC=C(C=C1)S(O)(=O)=O
4-Thio-beta-D-glucopyranose,Endoglucanase 5A,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(S)[C@]([H])(O)[C@@]1([H])O
4-Thio-beta-D-glucopyranose,Endoglucanase F,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(S)[C@]([H])(O)[C@@]1([H])O
4-Thio-beta-D-glucopyranose,Endoglucanase G,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(S)[C@]([H])(O)[C@@]1([H])O
4-Thio-beta-D-glucopyranose,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(S)[C@]([H])(O)[C@@]1([H])O
"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",Growth factor receptor-bound protein 2,NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)C[C@H](\C=C\C[C@H](CNC1=O)CC1=CC=CC2=CC=CC=C12)C1=CC=C(C=C1)CP(O)(O)=O
"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",Uracil-DNA glycosylase,OC(=O)C1=CC=C(\C=N\OCCO\N=C\C2=CC(=O)NC(=O)N2)C=C1
4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,Beta-secretase 1,[H][C@@](CC1=CC(=CC=C1OC)[N+]([O-])=O)(C1=CNC(N)=N1)C1=CC=C(OC)C(F)=C1
"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",Estrogen receptor,[H][C@]12CC=C(C)[C@]([H])(C1)[C@@]([H])(OC2(C)C)C1=CC=C(O)C=C1
"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",Nuclear receptor coactivator 2,[H][C@]12CC=C(C)[C@]([H])(C1)[C@@]([H])(OC2(C)C)C1=CC=C(O)C=C1
"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",Estrogen receptor,[H][C@]1(C)C=C(C)[C@]2([H])[C@]([H])(C)[C@@]1(CO)CO[C@]2([H])C1=CC=C(O)C=C1
"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",Nuclear receptor coactivator 2,[H][C@]1(C)C=C(C)[C@]2([H])[C@]([H])(C)[C@@]1(CO)CO[C@]2([H])C1=CC=C(O)C=C1
"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",Nuclear receptor coactivator 2,[H][C@@]12C[C@@](CO)(CO[C@]1([H])C1=CC=C(O)C=C1)CC=C2C
"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",Estrogen receptor,[H][C@@]12C[C@@](CO)(CO[C@]1([H])C1=CC=C(O)C=C1)CC=C2C
"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",Estrogen receptor,[H][C@]1(C)CC[C@]2(CO)CO[C@]([H])(C3=CC=C(O)C=C3)[C@@]1([H])[C@@]2([H])C
"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",Nuclear receptor coactivator 2,[H][C@]1(C)CC[C@]2(CO)CO[C@]([H])(C3=CC=C(O)C=C3)[C@@]1([H])[C@@]2([H])C
4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM,Tyrosine-protein kinase JAK2,O=C(NC1CC1)NC1=CNN=C1C1=NC2=CC=C(C[NH+]3CCOCC3)C=C2N1
"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",Carbonic anhydrase 2,NS(=O)(=O)OC1=CC=C(CN(N2C=NN=C2)C2=CC=C(C=C2)C#N)C=C1Br
"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",CN(C)C(=O)C1=CC=C(C=C1)S(=O)(=O)C1=CC=C(NC(=O)[C@@](C)(O)C(F)(F)F)C(Cl)=C1
"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",Prothrombin,[H][C@]1(O)C[N@]2[C@@]([H])(C1)[C@]1([H])C(=O)N(CC3=CC=C4OCOC4=C3)C(=O)[C@]1([H])[C@]2([H])C1=CC=C(C=C1)C(N)=N
"4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one",Dipeptidyl peptidase 4,N[C@@H](CC(=O)N1CCCNC(=O)C1CC(F)(F)F)CC1=C(F)C=C(F)C(F)=C1
4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,Dipeptidyl peptidase 4,[H][C@@](C)(CCC1=CC=C(C=C1)C(N)=O)NCC(=O)C1=CC=C(F)C=C1
4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,Serine/threonine-protein kinase Chk1,[H][C@@]12CC[N@@](CC1)C[C@@]2([H])NC1=C(C2=NC3=CC=CC=C3N2)C(=O)NC2=C1C=C(Cl)C=C2
"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C3C=CC=CN23)C=C1
4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,Proto-oncogene tyrosine-protein kinase Src,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1
"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",Carbonic anhydrase 2,NS(=O)(=O)OC1=CC=C(CN(N2C=NN=C2)C2=CC=C(C=C2)C#N)C=C1
"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",Genome polyprotein,[H][C@]1(C)CN(C[C@@]([H])(C)C1)C(=O)C1=CC(Br)=CC=C1NC(=O)CCC(O)=O
4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE,Coagulation factor X,[H][C@@]1(CC(C)C)CN(CCN1C(=O)C1=NC=C(C=N1)C1=CC=NC=C1)S(=O)(=O)C1=CC2=CC(Cl)=CC=C2N1
"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",Cyclin-dependent kinase 2,CC(C)C1=CN=C(NC2=CC=C(C=C2)S(N)(=O)=O)S1
4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid,Genome polyprotein,OC(=O)CCC(=O)NC1=CC=C(Br)C=N1
4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,Hemoglobin subunit alpha,COC1=CC(OCC2=CC=NC=C2)=C(C)C=C1
4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,Hemoglobin subunit beta,COC1=CC(OCC2=CC=NC=C2)=C(C)C=C1
4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,ClC1=CC=CC(=C1)N1CCN(CC2=CN=CN2CC2=CC=C(C=C2)C#N)CC1=O
4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,Protein farnesyltransferase subunit beta,ClC1=CC=CC(=C1)N1CCN(CC2=CN=CN2CC2=CC=C(C=C2)C#N)CC1=O
4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,Geranylgeranyl transferase type-1 subunit beta,ClC1=CC=CC(=C1)N1CCN(CC2=CN=CN2CC2=CC=C(C=C2)C#N)CC1=O
4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,Cyclin-dependent kinase 2,NC1=NC=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=C1
4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(NC2=NC(Cl)=CN=C2)C=C1
"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",Met proto-oncogene variant,OC1=CC=C(CC2=NN=C3C=CC(=NN23)C2=CC=CC=C2)C=C1
"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",Cyclin-A2,O=C1N=C2C=CC3=C(SC=N3)C2=C1CNC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",Cyclin-dependent kinase 2,O=C1N=C2C=CC3=C(SC=N3)C2=C1CNC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",Androgen receptor,[H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=CC=C(C#N)C2=CC=CC=C12
4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE,Gag-Pol polyprotein,CC(C)C1=C(OC#CC2CC2)C2=CC(F)=CC=C2NC1=O
"4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL",Cyclin-dependent kinase 2,NC1=C(\N=N\C2=CC=C(O)C=C2)C(N)=NN1
4-[(METHYLSULFONYL)AMINO]BENZOIC ACID,Beta-lactamase,CS(=O)(=O)NC1=CC=C(C=C1)C(O)=O
"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",Biotin carboxylase,CC1=NC(=CN1CC1=C(Cl)C=CC=C1Cl)C1=NC(N)=NC=C1
"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",Estrogen receptor,OC1=CC(O)=C(C=C1)C1=NN(CC=C)C2=C1C=CC=C2C(F)(F)F
"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",Nuclear receptor coactivator 2,OC1=CC(O)=C(C=C1)C1=NN(CC=C)C2=C1C=CC=C2C(F)(F)F
"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",Poly [ADP-ribose] polymerase 3,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCCNCC1
4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL,Serine/threonine-protein kinase Chk1,COC1=CC(=CC=C1O)C1=CC2=C(C=C1)C(=NN2)C1=NC2=CC=CC=C2N1
"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid","Glycogen phosphorylase, liver form",OC(=O)C1=CC=C(NC(=O)NC(=O)C2=CC(F)=C(F)C=C2Cl)C(OC(F)(F)F)=C1
"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",Aldose reductase,OC(=O)CCCC1=NC(=NO1)C1=CC(=CC=C1)[N+]([O-])=O
4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,Prothrombin,ClC1=CC=C(C=C1)C1=NNC(=C1)C1CCNCC1
4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,Mitogen-activated protein kinase 14,FC1=CC=C(C=C1)C1=NNC=C1C1=CC=NC=C1
"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",Serine/threonine-protein kinase pim-1,NC1=NC=CC(=N1)C1=CC2=C(ON=C2C=C1)C1=CC=C(Cl)C=C1
"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)CC(=O)C1=CC=CC(=C1)N(CC1=CC=CC=C1)CC1=CC=CC=C1
4-[3-Carboxymethyl-3-(4-Phosphonooxy-Benzyl)-Ureido]-4-[(3-Cyclohexyl-Propyl)-Methyl-Carbamoyl]Butyric Acid,Tyrosine-protein kinase transforming protein Src,[H][C@@](CCC(O)=O)(N=C(O)N(CC(O)=O)CC1=CC=C(OP(O)(O)=O)C=C1)C(=O)N(C)CCCC1CCCCC1
"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",Cyclin-dependent kinase 2,COC1=CC2=NC=NC(NC3=CC(O)=CC=C3)=C2C=C1OC
"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",Mitogen-activated protein kinase 14,COC1=CC2=NC=NC(NC3=CC(SC)=CC=C3)=C2C=C1OC
"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",Retinoic acid receptor gamma,CC1(C)CCC(C)(C)C2=CC(=CC=C12)C(=O)\C=C\C1=CC=C(C=C1)C(O)=O
4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,Fibroblast growth factor receptor 2,CC(C)(N)C1=CC=C(C=C1)C1=NC(NC2=CC=C(CCN3CCOCC3)C=C2)=NC=C1Cl
"4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL",Heat shock protein HSP 90-beta,CCC1=C(O)C=C(O)C(=C1)C1=C(C(C)=NN1)C1=CC=C2OCCOC2=C1
"4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL",Heat shock protein HSP 90-alpha,CCC1=C(O)C=C(O)C(=C1)C1=C(C(C)=NN1)C1=CC=C2OCCOC2=C1
"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",Myosin light chain 6B,[H][C@](O)(CCC(O)=O)NC1=CC=C(C=C1)N1C(=O)CCC1=O
"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",Myosin regulatory light chain 12A,[H][C@](O)(CCC(O)=O)NC1=CC=C(C=C1)N1C(=O)CCC1=O
"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",Myosin-7,[H][C@](O)(CCC(O)=O)NC1=CC=C(C=C1)N1C(=O)CCC1=O
4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,Cyclin-dependent kinase 2,CNC1=NC(C)=C(S1)C1=CC=NC(NC2=CC=C(O)C=C2)=N1
"4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",COC1=CC=C(C=C1)C1=C(C)NN=C1C1=C(O)C=C(O)C=C1
"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",Gag-Pol polyprotein,NC1=NC(OC2=C(Cl)C=CC=C2Cl)=NC(NC2=CC=C(C=C2)C#N)=N1
"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",Gag-Pol polyprotein,NC1=NC(CC2=C3C=CNC3=CC=C2Cl)=NC(NC2=CC=C(C=C2)C#N)=N1
4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID,Caspase-3,[H][C@@](CC(O)=O)(NC(=O)C1=CN=CC(=C1)C1=CC=C(C=C1)C(O)=O)C=O
4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,Mitogen-activated protein kinase 14,C[S@@](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC(I)=CC=C1)C1=CC=NC=C1
4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,Mitogen-activated protein kinase 14,C[S@@](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1
4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,Mitogen-activated protein kinase 1,C[S@@](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1
"4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide",Cyclin-dependent kinase 2,CC(C)C1=C2N=C(N[C@H]3CC[C@H](N)CC3)C=C(NC3=CC=C(C=C3)S(=O)(=O)N(C)C)N2N=C1
4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,Mitogen-activated protein kinase 14,C[C@H](NC1=NC=CC(=N1)C1=C(N=C(C2CCNCC2)N1C)C1=CC(=CC=C1)C(F)(F)F)C1=CC=CC=C1
"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid","cAMP-specific 3',5'-cyclic phosphodiesterase 4A",OC(=O)C1=CC=C(C=C1)C1=NC(C2=CC=CC(=C2)[N+]([O-])=O)=C2N=CC=CC2=C1
"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid","cAMP-specific 3',5'-cyclic phosphodiesterase 4B",OC(=O)C1=CC=C(C=C1)C1=NC(C2=CC=CC(=C2)[N+]([O-])=O)=C2N=CC=CC2=C1
"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid","cAMP-specific 3',5'-cyclic phosphodiesterase 4D",OC(=O)C1=CC=C(C=C1)C1=NC(C2=CC=CC(=C2)[N+]([O-])=O)=C2N=CC=CC2=C1
4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid,Fumarylacetoacetase,C[P@@](O)(=O)CC(=O)CC(O)=O
4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,Coagulation factor X,ClC1=CC=C(\C=C\S(=O)(=O)N2CCN(CC3CCN(CC3)C3=CC=NC=C3)C(=O)C2)C=C1
4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,Vascular endothelial growth factor receptor 2,CNC(=O)C1=NC=CC(OC2=CC3=C(C=C2)N=C(NC2=CC(=C(Cl)C=C2)C(F)(F)F)N3)=C1
"4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one",Biotin carboxylase,CC1(C)CC(=O)C2=C(N)N=CN=C2C1
4-amino-N-[4-(benzyloxy)phenyl]butanamide,Leukotriene A-4 hydrolase,NCCCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1
4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,Genome polyprotein,[H][C@]1(CC2=C(Cl)C=CC=C2)CCCN1C(=O)C1=CC(Br)=CC=C1N
"4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline",Genome polyprotein,[H][C@]1(C)CN(C[C@@]([H])(C)C1)C(=O)C1=CC(Br)=CC=C1N
4-bromo-3-hydroxy-3-methyl butyl diphosphate,Isopentenyl-diphosphate Delta-isomerase,C[C@](O)(CBr)CCO[P@](O)(=O)OP(O)(O)=O
"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol",Heat shock protein HSP 90-alpha,OC1=CC2=C(C=C1)C(=NO2)C1=CC(Br)=C(O)C=C1O
"4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,OC1=C(Br)C=C(\C=N\NC(=O)C2=CC=C(Br)C=C2)C(O)=C1Br
"4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol",Heat shock protein HSP 90-alpha,OC1=CC(O)=C(Cl)C=C1C1=NOC2=C1C=C(NCCN1CCOCC1)C=C2
"4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,OC1=C(Br)C=C(\C=N\NC(=O)C2=CC=C(Cl)C=C2)C(O)=C1Br
4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,Bifunctional protein GlmU,[H][C@@]1(CCCN(CCC2=CC=CC=C2)C1)N(CCCOC)C(=O)C1=CC=C(Cl)C=C1
"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",Carbonic anhydrase 2,[H][C@]1(C)CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(=C1)S(N)(=O)=O
"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",Beta-lactamase,CCC1=C(C)NN(C1=O)C1=NN=NN1
"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",Beta-lactamase,CCC1=C(C)NN(C1=O)C1=NN=NN1
4-hydroxybenzoyl-CoA,4-chlorobenzoyl CoA dehalogenase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C1=CC=C(O)C=C1
4-hydroxybenzoyl-CoA,4-hydroxybenzoyl-CoA thioesterase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C1=CC=C(O)C=C1
4-hydroxycoumarin,Major NAD(P)H-flavin oxidoreductase,OC1=CC(=O)OC2=CC=CC=C12
4-iodo-acetamido phenylboronic acid,Beta-lactamase OXA-10,OB(O)C1=CC=CC(NC(=O)CI)=C1
4-iodo-acetamido phenylboronic acid,Beta-lactamase,OB(O)C1=CC=CC(NC(=O)CI)=C1
"4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine",Heat shock protein HSP 90-alpha,CC1=NC(N)=NC2=C1CSCC2
4-nitrophenyl-beta-D-galactoside,Galactoside O-acetyltransferase,[H][C@]1(CO)O[C@@]([H])(OC2=CC=C(C=C2)N(=O)=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
4-nitrophenyl-beta-D-galactoside,Beta-galactosidase,[H][C@]1(CO)O[C@@]([H])(OC2=CC=C(C=C2)N(=O)=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
4-phospho-D-erythronic acid,Ribose-5-phosphate isomerase B,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)C(O)=O
4-phospho-L-threonic acid,Ribose-5-phosphate isomerase,O[C@@H](COP(O)(O)=O)[C@@H](O)C(O)=O
"4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,CC(C)(C)C1=CC=C(C=C1)C(=O)N\N=C\C1=CC(Br)=C(O)C(Br)=C1O
"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",Peptide deformylase,CC(=O)OC1=CC=C(\C=C\C(=O)NCCC2=CC=CC=C2)C=C1OC(C)=O
"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid","Glycogen phosphorylase, muscle form",OC(=O)C1=C(C=C(OC2=C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)C=C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)C=C2)C=C1)C(O)=O
"4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate","6,7-dimethyl-8-ribityllumazine synthase",[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)CN1C(=O)N(CCCCOP(O)(O)=O)C2=C1N=C(O)N=C2O
"4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate","6,7-dimethyl-8-ribityllumazine synthase",OC[C@@H](O)[C@H](O)[C@@H](O)CN1C(=O)N(CCCCOP(O)(O)=O)C2=C1NC(=O)NC2=O
4-{2-(4-Fluoro-Benzyl)-6-Methyl-5-[(5-Methyl-Isoxazole-3-Carbonyl)-Amino]-4-Oxo-Heptanoylamino}-5-(2-Oxo-Pyrrolidin-3-Yl)-Pentanoic Acid Ethyl Ester,Genome polyprotein,[H][C@@](CCC(=O)OCC)(C[C@]1([H])CCN=C1O)N=C(O)[C@@]([H])(CC(=O)[C@@]([H])(NC(=O)C1=NOC(C)=C1)C(C)C)CC1=CC=C(F)C=C1
4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,"Glycogen phosphorylase, muscle form",OC(=O)C1=C(C=C(OC2=C(NC(=O)C3=CC(=CC=C3)[N+]([O-])=O)C=CC=C2)C=C1)C(O)=O
"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",Adenosine receptor A2a,NC1=NC(NCCC2=CC=C(O)C=C2)=NC2=NC(=NN12)C1=CC=CO1
4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,Cell division protein ZipA,CC1=C(Cl)C=C(NC2=NC(=CC=N2)C2=CC(=NC=C2)N2CCN(CCN)CC2)C=C1
4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,Cell division protein ZipA,CC1=C(Cl)C=C(NC2=NC(=CC=N2)C2=CC(=NC=C2)N2CCN(CCN)CC2)C=C1
"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID","Glycogen phosphorylase, muscle form",OC(=O)CCCOC1=CC=C(NC(=O)NC(=O)C2=CC=C(Cl)C=C2Cl)C(Cl)=C1
"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",Mitogen-activated protein kinase 14,CC1=C(NC2=CC=NC3=CC(=CC=C23)C2=CSC(C=O)=N2)C=C(O)C=C1
"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",Ig kappa chain C region,[H][C@@]12O[C@]1(C)CC[C@]1([H])[C@]2(C)CCC[N@+]1([O-])CC(=O)NC1=CC=C(NC(=O)CCCC(O)=O)C=C1
"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID","Glycogen phosphorylase, muscle form",CC1=C(C)C(OCCCC(O)=O)=CC=C1NC(=O)NC(=O)C1=CC=C(Cl)C=C1Cl
"4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL",Heat shock protein HSP 90-beta,NCCCOC1=CC=C(C=C1)C1=C(NN=C1)C1=CC(Cl)=C(O)C=C1O
"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",Cyclin-dependent kinase 2,C\C(C1=CC=C(O1)C1=CC=C(C=C1)S(N)(=O)=O)=C1\SC(=N)NC1=O
"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=O)NC1=O
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",Cyclin-A2,CNS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",Cyclin-dependent kinase 2,CNS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",Cyclin-A2,NS(=O)(=O)C1=CC=C(C=C1C(F)(F)F)C1=CC=C(O1)\C=C1/SC(=N)NC1=O
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(C=C1C(F)(F)F)C1=CC=C(O1)\C=C1/SC(=N)NC1=O
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",Cyclin-A2,NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",Cyclin-A2,OC(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",Cyclin-dependent kinase 2,OC(=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=C1/SC(=N)NC1=O
"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",Androgen receptor,[H][C@](O)(NC1=CC(=C(C=C1)C#N)C(F)(F)F)[C@@](C)(O)COC1=CC=C(C=C1)[N+]([O-])=O
"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",Cyclin-dependent kinase 2,[H][C@@]1(CCCNC1)NC(=O)C1=NNC=C1NC(=O)C1=C(F)C=CC=C1F
"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",Cyclin-dependent kinase 2,O=C1NC2=CC=CC=C2\C1=C\NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1
"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",Heat shock protein HSP 90-alpha,[H][C@@]1(CCCN1C(=O)C1=C(O)C=C(O)C=C1)C1=CC=CC=C1C
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,Beta-1 adrenergic receptor,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CC(=N2)C#N
4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,Bifunctional epoxide hydrolase 2,OC(=O)CCCNC(=O)NC1CCCCC1
"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",Coagulation factor X,ClC1=CC=C(S1)\C=C\S(=O)(=O)N1CCN(CC2=CC3=C(N2)C=CN=C3)C(=O)C1
"4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE)METHYL]AMINO}BUTANOIC ACID",Immunoglobulin heavy variable 3-30,OC(=O)CCCNC=C1N=C(OC1=O)C1=CC=CC=C1
"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",Collagenase 3,CN1C(=O)N(CC2=CC=C(C=C2)C(O)=O)C(=O)C2=C1C=CC(=C2)C#CCC1=CC=CC=C1
4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,Trypsin-1,CN1C(CNC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(CN1C(C)=NC3=C1C=CC=C3)=C2
4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,Cyclin-dependent kinase 2,CNS(=O)(=O)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C(C)N2C2CC2)C=C1
"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",Hematopoietic prostaglandin D synthase,CC1=CC(=CC=C1F)C1=CSC(NC2=CC=C(C(O)=O)C(O)=C2)=N1
4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,Cyclin-A2,NC(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C(N=O)C(N)=N2)C=C1
4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,Cyclin-dependent kinase 2,NC(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C(N=O)C(N)=N2)C=C1
"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",Protein-tyrosine kinase 2-beta,[H][C@]1(CCC[C@@]1([H])N(C)C)NC1=NC(NC2=CC=C(C=C2)S(=O)(=O)NC)=NC=C1C(F)(F)F
"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(NC2=CC(NC3CCCCC3)=NC3=NC=NN23)C=C1
"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(NC2=CC(OCC3CCCCC3)=NC3=NC=NN23)C=C1
"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(NC2=CC(OC3CCCCC3)=NC3=NC=NN23)C=C1
"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",Cyclin-A2,NS(=O)(=O)C1=CC=C(NC2=CC(OC3CCCCC3)=NC3=NC=NN23)C=C1
4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,Mitogen-activated protein kinase 10,CCNC(=O)N1CCC(CC1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1
4r-Fluoro-N6-Ethanimidoyl-L-Lysine,"Nitric oxide synthase, inducible",CC(=N)NCC[C@@H](F)C[C@H](N)C(O)=O
"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",Genome polyprotein,CC(=O)C1=CC=C(S1)C1=CC(NS(=O)(=O)C2=CC=C(C)C=C2C)=C(S1)C(O)=O
5'-Deoxy-5'-(Methylthio)-Tubercidin,S-methyl-5'-thioadenosine phosphorylase,[H][C@]1(CSC)O[C@@]([H])(N2C=CC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5'-Deoxy-5'-(Methylthio)-Tubercidin,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,[H][C@]1(CSC)O[C@@]([H])(N2C=CC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5'-Deoxy-5'-Methylthioadenosine,S-methyl-5'-thioadenosine phosphorylase,CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N
5'-Deoxy-5'-Methylthioadenosine,Modification methylase RsrI,CSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N
"5'-FLUORO-2',5'-DIDEOXYADENOSINE",5'-fluoro-5'-deoxy-adenosine synthase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CF)N1C=NC2=C1N=CN=C2N
5'-Fluoro-5'-Deoxyadenosine,5'-fluoro-5'-deoxy-adenosine synthase,NC1=C2N=CN([C@@H]3O[C@H](CF)[C@@H](O)[C@H]3O)C2=NC=N1
5'-Guanosine-Diphosphate-Monothiophosphate,Protein-glutamine gamma-glutamyltransferase E,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
5'-Guanosine-Diphosphate-Monothiophosphate,Cell division protein FtsZ,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
5'-Guanosine-Diphosphate-Monothiophosphate,ADP-ribosylation factor 6,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
5'-Guanosine-Diphosphate-Monothiophosphate,Ras-related protein Rab-11A,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,Bifunctional glutamate/proline--tRNA ligase,[H][C@](N)(CS)C(O)=NS(=O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,Threonine--tRNA ligase,[H][C@](N)(CO)C(O)=NS(=O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,Threonine--tRNA ligase,[H][C@](C)(O)[C@]([H])(N)C(O)=NS(=O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,Threonine--tRNA ligase,[H][C@](C)(O)[C@]([H])(N)C(O)=NS(=O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5'-O-(N-Ethyl-Sulfamoyl)Adenosine,Histidine triad nucleotide-binding protein 1,[H][C@]1(COS(=O)(=O)NCC)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5'-O-[(L-methionyl)-sulphamoyl]adenosine,Methionine--tRNA ligase,[H][C@](N)(CCSC)C(O)=NS(=O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CNC23[H])[C@]([H])(O)[C@]1([H])O
5'-S-[2-(decylamino)ethyl]-5'-thioadenosine,Hydroxymycolate synthase MmaA4,[H][C@]1(CSCCNCCCCCCCCCC)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5'-S-ethyl-5'-thioadenosine,Adenosylhomocysteinase,[H][C@]1(CSCC)O[C@@]([H])(N2C=NC3=C2N=CN=C3N)[C@]([H])(O)[C@]1([H])O
5'-deoxy-5'-piperidin-1-ylthymidine,Ribonuclease pancreatic,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CN1CCCCC1)N1C=C(C)C(=O)NC1=O
5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,S-adenosylmethionine decarboxylase proenzyme,[H][C@]1(CN(C)CCCCON)O[C@@]([H])(N2C(C=C)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"5,10-Dimethylene Tetrahydromethanopterin","5,6,7,8-tetrahydromethanopterin hydro-lyase",C[C@H]1[C@@H]2[C@@H](C)NC3=C(N2CN1C1=CC=C(C[C@@H](O)[C@@H](O)[C@H](O)CO[C@H]2O[C@H](CO[P@@](O)(=O)O[C@@H](CCC(O)=O)C(O)=O)[C@@H](O)[C@@H]2O)C=C1)C(=O)NC(N)=N3
"5,10-Methylene-6-Hydrofolic Acid",Thymidylate synthase,NC1=NC(=O)C2=C(N1)N=C[C@@H]1CN(CN21)C1=CC=C(C=C1)C(=O)N[C@H](CCC(O)=O)C(O)=O
"5,10-Methylene-6-Hydrofolic Acid",Folylpolyglutamate synthase,NC1=NC(=O)C2=C(N1)N=C[C@@H]1CN(CN21)C1=CC=C(C=C1)C(=O)N[C@H](CCC(O)=O)C(O)=O
"5,10-Methylene-6-Hydrofolic Acid",Thymidylate synthase,NC1=NC(=O)C2=C(N1)N=C[C@@H]1CN(CN21)C1=CC=C(C=C1)C(=O)N[C@H](CCC(O)=O)C(O)=O
"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",CC1(C)CC2=C(SC(=N2)N2CCOCC2)C(=O)C1
"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",Gag-Pol polyprotein,[H][C@](CC)(C1=CC=CC=C1)C1=C(O)C2=C(CCCCCC2)OC1=O
"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",Serine/threonine-protein kinase Chk1,O=C1NC=NC2=C1C1=C(CCCC1)S2
"5,6-Cyclic-Tetrahydropteridine","Nitric oxide synthase, endothelial",NC1=NC2=C(N3[C@@H](COC3=O)CN2)C(=O)N1
"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",Tyrosine-protein kinase Lck,C(CN1CCNCC1)NC1=C2C(OC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1
"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",Death-associated protein kinase 1,NC1=NN=C2C(CCC3=CC=CC=C23)=C1
"5,6-Dihydroxy-Nadp",Alcohol dehydrogenase YqhD,[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(OP(O)(O)=O)[C@]2([H])O)O[C@@]([H])(N2C=C(C[C@]([H])(O)[C@]2([H])O)C(O)=N)[C@]([H])(O)[C@]1([H])O
"5,6-Dimethylbenzimidazole",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC2=C(C=C1C)N=CN2
"5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole",Casein kinase II subunit alpha,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=CC(Cl)=C(Cl)C=C23)[C@]([H])(O)[C@]1([H])O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit alpha-1,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit alpha-2,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit alpha-3,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit alpha-4,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit alpha-5,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit alpha-6,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit gamma-1,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit gamma-2,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7,2′-trihydroxy-6,8-dimethoxyflavone",Gamma-aminobutyric acid receptor subunit gamma-3,COC1=C(O)C(OC)=C2OC(=CC(=O)C2=C1O)C1=CC=CC=C1O
"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",Serine/threonine-protein kinase pim-1,OC1=CC2=C(C(O)=C1)C(=O)C=C(O2)C1=CC(O)=C(O)C(O)=C1
"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",Casein kinase II subunit alpha,NC1=CC=C(N)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",Ribosyldihydronicotinamide dehydrogenase [quinone],COC1=C2N(C)C(=O)C=C(C)C2=C(OC)C=C1
5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate,3-phosphoshikimate 1-carboxyvinyltransferase,[H][C@]1(CC(=C[C@@]([H])(OP(O)(O)=O)[C@@]1([H])O)C(O)=O)O[C@@](C)(OP(O)(O)=O)C(O)=O
"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",Cyclin-dependent kinase 2,ClC1=C(Cl)C(=CC=C1)C1=NC2=C(SC#N)C=NN2C(NCC2=CC=NC=C2)=C1
"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",Cyclin-dependent kinase 2,ClC1=CC=CC(=C1Cl)C1=NC2=CC=NN2C(NCC2=CC=NC=C2)=C1
"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",Methionine aminopeptidase,OC(=O)C1=CC=C(O1)C1=CC(Cl)=CC=C1Cl
5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,Methionine aminopeptidase,OC(=O)C1=CC=C(O1)C1=CC=C(C=C1Cl)[N+]([O-])=O
5-(2-CHLOROBENZYL)-2-FUROIC ACID,Methionine aminopeptidase,OC(=O)C1=CC=C(CC2=CC=CC=C2Cl)O1
5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,Methionine aminopeptidase,OC(=O)C1=CC=C(O1)C1=CC=CC=C1Cl
5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,Methionine aminopeptidase 2,OC(=O)C1=CC=C(O1)C1=CC=CC=C1Cl
"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",Collagenase 3,CCOCCC1(OC2=CC=C(OC3=CC=C(F)C=C3)C=C2)C(=O)NC(=O)NC1=O
"5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid",Tyrosine-protein phosphatase non-receptor type 1,COC(=O)C1=C(O)C=CC=C1OC\C=C\C1=CC(C2=CC(=NO2)C(O)=O)=C(F)C=C1
5-(2-METHOXYPHENYL)-2-FUROIC ACID,Methionine aminopeptidase,COC1=C(C=CC=C1)C1=CC=C(O1)C(O)=O
5-(2-NITROPHENYL)-2-FUROIC ACID,Methionine aminopeptidase,OC(=O)C1=CC=C(O1)C1=C(C=CC=C1)[N+]([O-])=O
"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",Mitogen-activated protein kinase 1,NC1=NNC2=C1C=C(N=N2)C1=C2C=CC=CN2N=C1C1=CC=CC=C1
"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",Carbonic anhydrase 2,NS(=O)(=O)C1=NN=C(S1)C1=CC=CC=C1Cl
5-(2-chlorophenyl)furan-2-carbohydrazide,Methionine aminopeptidase,NNC(=O)C1=CC=C(O1)C1=CC=CC=C1Cl
"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",Cyclin-dependent kinase 2,FC1=CC=CC=C1C1=NC2=CC=NN2C(NCC2=CC=NC=C2)=C1
"5-(2-hydroxyethyl)nonane-1,9-diol",Endothelin-converting enzyme 1,OCCCCC(CCO)CCCCO
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,cAMP-dependent protein kinase catalytic subunit alpha,CC1CNCCN1S(=O)(=O)C1=C2C=CN=CC2=CC=C1
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,cAMP-dependent protein kinase inhibitor alpha,CC1CNCCN1S(=O)(=O)C1=C2C=CN=CC2=CC=C1
"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",Genome polyprotein,CC1=NOC(CCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1
"5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole",Genome polyprotein,CC1=NOC(CCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1
"5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol",S-ribosylhomocysteine lyase,N[C@@H](CCSC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O)C(O)=O
"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",Tyrosine-protein phosphatase non-receptor type 1,OC1=CC(=CC=C1)C1=CC(=O)NS1(=O)=O
5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,Tyrosine-protein phosphatase non-receptor type 1,COC(=O)C1=C(O)C=CC=C1OC\C=C\C1=CC(=CC=C1)C1=C(CO)C(=NO1)C(O)=O
"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE","Nitric oxide synthase, inducible",CCN1C2=C(F)C=CC(F)=C2C(N)=NC11CCN(CC1)C(=O)C1=CN=C(CC1)C#N
"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",Tyrosine-protein phosphatase non-receptor type 1,ClC1=C(SC=C1N1CC(=O)NS1(=O)=O)C1=CC=CC=C1
5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,Genome polyprotein,CC1=CC=CC=C1S(=O)(=O)NC1=C(SC(=C1)C1=CC=C(C=C1)C#N)C(O)=O
5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,Genome polyprotein,CC1=CC=C(C=C1)S(=O)(=O)NC1=C(SC(=C1)C1=CC=C(F)C=C1)C(O)=O
"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",Tyrosine-protein phosphatase non-receptor type 1,COC1=CC=C(C=C1N1CC(=O)NS1(=O)=O)C1=CC=CC=C1
"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",Histone deacetylase 8,CN(C)C(=O)C1=CC(=CC(NC(=O)C2=CC=C(C)C=C2)=C1)C1=CC=C(C=C1)C(=O)NO
"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",Dihydrofolate reductase,COC1=CC=C(OC2=CC=CC3=NC(N)=NC(N)=C23)C=C1
"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine","Dihydrofolate reductase, mitochondrial",COC1=CC=C(OC2=CC=CC3=NC(N)=NC(N)=C23)C=C1
"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",Dihydrofolate reductase,NC1=NC2=C(C(N)=N1)C(SC1=CC=C(C=C1)N1CCOCC1)=CC=C2
"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine","Dihydrofolate reductase, mitochondrial",NC1=NC2=C(C(N)=N1)C(SC1=CC=C(C=C1)N1CCOCC1)=CC=C2
"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",Matrix metalloproteinase-9,O=C1NC(=O)C(N2CCN(CC2)C2=NC=CC=N2)(C(=O)N1)C1=CC=C(OC2=CC=CC=C2)C=C1
"5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",Genome polyprotein,CC1=NOC(CCCCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1
"5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",Genome polyprotein,CC1=NOC(CCCCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1
"5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole",Genome polyprotein,OCCOCOCC1=NOC(CCCCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1
"5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole",Genome polyprotein,CC1=NOC(CCCCCOC2=CC=C(C=C2)C2=NCCO2)=C1
5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole,Genome polyprotein,[H][C@]1(C)COC(=N1)C1=CC=C(OCCCCCC2=CC(C)=NO2)C=C1
"5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",Genome polyprotein,CC1=NOC(CCCCCOC2=CC=C(C=C2Cl)C2=NCCO2)=C1
"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE",Heat shock protein HSP 90-alpha,CCNC(=O)C1=NNC(=C1C1=CC=C(OC)C=C1)C1=CC(Cl)=C(O)C=C1O
"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE",Heat shock protein HSP 90-alpha,CCNC(=O)C1=NOC(=C1C1=CC=C(OC)C=C1)C1=C(O)C=C(O)C(Cl)=C1
"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE",Heat shock protein HSP 90-alpha,CCNC(=O)C1=NNC(=C1N1CCNCC1)C1=CC(Cl)=C(O)C=C1O
"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",Coagulation factor X,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=NNC(=N2)C2=CC=C(Cl)S2)C1=O)C(=O)N1CCOCC1
"5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide",Heat shock protein HSP 90-alpha,CCNC(=O)C1=NOC(=C1C1=CC=C(CN2CCOCC2)C=C1)C1=C(O)C=C(O)C(Cl)=C1
"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",RAC-alpha serine/threonine-protein kinase,ClC1=CNC2=C1C(=NC=N2)N1CCC2=C(C1)N=CN2
"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",Glycogen synthase kinase-3 beta,ClC1=CNC2=C1C(=NC=N2)N1CCC2=C(C1)N=CN2
"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",Genome polyprotein,CC1=NOC(CCCCCCCOC2=CC=C(C=C2)C2=NCCO2)=C1
"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",Genome polyprotein,CC1=NOC(CCCCCCCOC2=CC=C(C=C2)C2=NCCO2)=C1
"5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole",Genome polyprotein,CC1=NOC(CCCCCCCOC2=CC=C(C=C2)C2=NCCO2)=C1
5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole,Genome polyprotein,[H][C@]1(C)COC(=N1)C1=CC=C(OCCCCCCCC2=CC(C)=NO2)C(Cl)=C1
"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",Dipeptidyl peptidase 4,COC1=CC(=CC(OC)=C1)C1=NC(=C(CN)C(N)=N1)C1=CC=C(Cl)C=C1Cl
5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),Prothrombin,CN(C)C1=C2C=CC=C(C2=CC=C1)S(O)(=O)=O
5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),Coagulation factor VII,CN(C)C1=C2C=CC=C(C2=CC=C1)S(O)(=O)=O
5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,Tissue-type plasminogen activator,CN(C)C1=C2C=CC(=CC2=CC=C1)S(O)(=O)=O
"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",Biotin/lipoyl attachment protein,[H][C@@]1(CCCCC=O)SC[C@]2([H])NC(=O)N[C@]12[H]
"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL","Pyruvate carboxylase, mitochondrial",[H][C@@]1(CCCCC=O)SC[C@]2([H])NC(=O)N[C@]12[H]
"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",Pyruvate carboxylase,[H][C@@]1(CCCCC=O)SC[C@]2([H])NC(=O)N[C@]12[H]
5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID,Ig gamma-1 chain C region,OC(=O)CCCC[P@]([O-])(=O)OC1=CC=C(C=C1)[N+]([O-])=O
"5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid",Hydroxyacid oxidase 1,CCCCCCCCCCCCSC1=C(N=NN1)C(O)=O
5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine,Hypoxanthine-guanine phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=[NH+]C3=C2N=C(O)N=C3O)[C@]([H])(O)[C@]1([H])O
5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine,Bifunctional purine biosynthesis protein PURH,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=[NH+]C3=C2N=C(O)N=C3O)[C@]([H])(O)[C@]1([H])O
"5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID",Sialidase-2,[H][C@]1(O)C=C(O[C@@]([H])(OCC(C)C)[C@]1([H])NC(C)=O)C(O)=O
5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,Ig gamma-2 chain C region,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@]([H])(CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCC(O)=O)C(C)=O
"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",Cytochrome P450 130,NC1=CC=C(SC2=CC=C(C=C2)N2C(=O)C3=C(C=C(N)C=C3)C2=O)C=C1
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",Casein kinase I isoform gamma-3,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",STE20-like serine/threonine-protein kinase,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",Calcium/calmodulin-dependent protein kinase type IV,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",Dual specificity protein kinase CLK3,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",Abelson tyrosine-protein kinase 2,NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=S)NC1=C(F)C=CC=C1F
5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID,Cathepsin D,[H][C@](N)(CC1CCCCC1)[C@@]([H])(O)C[C@@]([H])(CC(C)C)C(O)=O
5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID,Gag-Pol polyprotein,[H][C@](N)(CC1CCCCC1)[C@@]([H])(O)C[C@@]([H])(C(C)C)C(O)=O
5-AMINO-NAPHTALENE-2-MONOSULFONATE,Fibroblast growth factor 1,NC1=CC=CC2=CC(=CC=C12)S(O)(=O)=O
"5-Alpha-Androstane-3-Beta,17beta-Diol",Estrogen receptor beta,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
5-Amidino-Benzimidazole,Trypsin-1,NC(=[NH2+])C1=CC2=C(C=C1)N=CN2
"5-Amino-1h-Pyrimidine-2,4-Dione",Ribonuclease pancreatic,NC1=CNC(=O)NC1=O
5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,Cholera enterotoxin subunit B,[H][C@]1(CO)O[C@]([H])(OC2=CC(=CC(=C2)N(=O)=O)C(O)=N)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
5-Aminoimidazole Ribonucleoside,Putative sugar kinase,[H][C@]1(CO)O[C@@]([H])(N2C=NC=C2N)[C@]([H])(O)[C@]1([H])O
5-Aminoisoquinoline,Uncharacterized protein,NC1=CC=CC2=C1C=CN=C2
"5-BETA-ANDROSTANE-3,17-DIONE",Ig gamma-2 chain C region,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C
"5-BETA-ANDROSTANE-3,17-DIONE",Ig gamma-1 chain C region,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C
"5-BETA-ANDROSTANE-3,17-DIONE",Ig kappa chain C region,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C
"5-BETA-ANDROSTANE-3,17-DIONE",Ig kappa chain V-II region RPMI 6410,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)CC[C@]12C
5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,Methionine aminopeptidase 2,OC(=O)C1=C(NS(=O)(=O)C2=CC=C(Cl)C=C2)C=CC(Br)=C1
5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,Alcohol dehydrogenase 1C,[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(C3=CC(=CN=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5-Bromo-2'-Deoxyuridine-5'-Monophosphate,Thymidylate synthase ThyX,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(Br)C(O)=NC1=O
"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",Dual specificity mitogen-activated protein kinase kinase 1,[H][C@](O)(CO)CON=C(O)C1=CC(Br)=C(F)C(F)=C1NC1=C(F)C=C(I)C=C1
5-Bromonicotinamide,GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1,NC(=O)C1=CN=CC(Br)=C1
5-Bromothienyldeoxyuridine,Thymidine kinase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N1C=C(C2=CC=C(Br)S2)C(=O)NC1=O
5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,Methionine aminopeptidase 1,CC1=C(Cl)C(NCCC2=CC=CC=C2)=NC(=N1)C1=NC=CC=C1
"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",Gag-Pol polyprotein,[H][C@]1(C)CN2C(=S)NC3=C2C(CN1CC=C(C)C)=C(Cl)C=C3
"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",Coagulation factor X,[H][C@]1(CCC[C@]1([H])NC(=O)C1=CC=C(C=C1)N1C=CC=CC1=O)NC(=O)C1=CC=C(Cl)S1
5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,Coagulation factor X,ClC1=CC=C(S1)C(=O)NCCNC(=O)C1=CC=C(C=C1)N1C=CC=CC1=O
5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,Coagulation factor X,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=CC3=C(S2)C=CC(Cl)=C3)C1=O)C(=O)N1CCOCC1
"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",Coagulation factor X,[H][C@]1(F)CN(CC(=O)NC2=CC=C(C=C2F)N2C=CC=CC2=O)C[C@]1([H])NC(=O)C1=CC=C(Cl)S1
5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,Macrophage colony-stimulating factor 1 receptor,CC1CCN(CC1)C1=CC=C(CO)C=C1NC(=O)C1=CC=C(O1)C#N
"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",C-Jun-amino-terminal kinase-interacting protein 1,CCOC1=NC(=CC=C1C#N)C(=O)NCC1=CC(OC)=CC=C1OC
"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",Mitogen-activated protein kinase 8,CCOC1=NC(=CC=C1C#N)C(=O)NCC1=CC(OC)=CC=C1OC
"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid","Dihydroorotate dehydrogenase (quinone), mitochondrial",NC(=O)C1=CC(=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O
5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,"Glycogen phosphorylase, muscle form",[H][C@@](CC1=CC=C(F)C=C1)(NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2)C(=O)N1CCC(O)CC1
5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,"Glycogen phosphorylase, liver form",[H][C@@](O)(CNC(=O)C1=CC2=CC(Cl)=CC=C2N1)N(CCO)C1CCCC1
5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide,Coagulation factor X,C[C@H](N1CC[C@H](NS(=O)(=O)C2=CC3=C(N2)C=CC(Cl)=C3)C1=O)C(=O)N1CCOCC1
"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",Coagulation factor X,[H][C@]1(O)CN(CC(=O)NC2=C(F)C=C(C=C2)N2C=CC=CC2=O)C[C@]1([H])NC(=O)C1=CC=C(Cl)S1
"5-Chloryl-2,4,6-Quinazolinetriamine",Dihydrofolate reductase,NC1=C(C2=C(N)N=C(N)N=C2C=C1)[Cl](=O)=O
"5-Chloryl-2,4,6-Quinazolinetriamine","Dihydrofolate reductase, mitochondrial",NC1=C(C2=C(N)N=C(N)N=C2C=C1)[Cl](=O)=O
"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",Serine/threonine-protein kinase Chk1,CCN1C(=O)C2=C(NN=C2C)C2=C1C=CC=C2
5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE,Gag-Pol polyprotein,CCC1=C(C)NC(=O)C(N(C)CCOC)=C1CC1=CC=CC(C)=C1
5-Exo-Hydroxycamphor,Camphor 5-monooxygenase,[H][C@@]1(O)C[C@@]2(C)C(=O)C[C@]1([H])C2(C)C
"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",Poly [ADP-ribose] polymerase 1,FC1=C2C(=O)NC(=O)N(CCCCN3CCC(=CC3)C3=CC=CC=C3)C2=CC=C1
5-FLUOROINDOLE PROPANOL PHOSPHATE,Tryptophan synthase alpha chain,OP(O)(=O)OCCCC1=CNC2=C1C=C(F)C=C2
5-FLUOROINDOLE PROPANOL PHOSPHATE,Tryptophan synthase beta chain,OP(O)(=O)OCCCC1=CNC2=C1C=C(F)C=C2
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,Thymidylate synthase ThyX,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(F)C(O)=NC1=O
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,Thymidylate synthase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(F)C(O)=NC1=O
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,Thymidylate synthase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(F)C(O)=NC1=O
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,Thymidylate synthase 1,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(F)C(O)=NC1=O
"5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine",Cytosine deaminase,[H][C@@]1(O)NC(O)=NC=C1F
5-Fluorolevulinic Acid,Delta-aminolevulinic acid dehydratase,OC(=O)CCC(=O)CF
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",Cytochrome b,CCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE","Cytochrome b-c1 complex subunit Rieske, mitochondrial",CCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE","Cytochrome c1, heme protein, mitochondrial",CCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",Cytochrome b-c1 complex subunit 7,CCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",Cytochrome b-c1 complex subunit 9,CCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,Estrogen receptor beta,OC1=CC=C(C=C1)C1=CC2=C(O1)C(=CC(O)=C2)C#N
5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,Nuclear receptor coactivator 1,OC1=CC=C(C=C1)C1=CC2=C(O1)C(=CC(O)=C2)C#N
5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,3-phosphoinositide-dependent protein kinase 1,[H][C@](C)(C1=CC=CN1)C1=C2C=C(O)C=CC2=NC1=O
5-Hydroxy-N-Propargyl-1(R)-Aminoindan,Amine oxidase [flavin-containing] B,[H][C@]1(CCC2=CC=C(O)C=C12)NCC#C
5-Hydroxymethyl-Chonduritol,Alpha-amylase 1,[H][C@]1(O)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
5-Hydroxymethyl-Chonduritol,Pancreatic alpha-amylase,[H][C@]1(O)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
5-Hydroxymethyl-Chonduritol,Alpha-amylase 2B,[H][C@]1(O)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
5-Hydroxymethylene-6-Hydrofolic Acid,"Serine hydroxymethyltransferase, cytosolic",[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@@]2([H])C=NC3=C(N2CO)C(O)=NC(=N)N3)C=C1)C(O)=O
5-Hydroxymethylene-6-Hydrofolic Acid,5-formyltetrahydrofolate cyclo-ligase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC[C@@]2([H])C=NC3=C(N2CO)C(O)=NC(=N)N3)C=C1)C(O)=O
5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate,Thymidylate kinase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(CO)C(O)=NC1=O
5-IMINO-4-(2-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE,Methionine aminopeptidase,[H]N=C1N=NC(N)=C1\N=N\C1=CC=CC=C1C(F)(F)F
5-Iodo-2'-Deoxyuridine-5'-Monophosphate,Thymidine kinase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(I)C(=O)NC1=O
5-Iodouracil,Dihydropyrimidine dehydrogenase [NADP(+)],IC1=CNC(=O)NC1=O
5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,Methionine aminopeptidase 2,CC1=CC=C(NS(=O)(=O)C2=CC=CC=C2)C(=C1)C(O)=O
"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",Matrilysin,[H][C@@](CC(C)C)(CC(O)=O)C(=O)N[C@@]1([H])CC2=CN(CCCCCCNC1=O)C1=C2C=CC=C1
5-Mercapto-2-Nitro-Benzoic Acid,Interleukin-12 subunit beta,OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O
5-Mercapto-2-Nitro-Benzoic Acid,Protein ArsC,OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O
5-Mercaptoethanol-2-Decenoyl-Coenzyme A,"2,4-dienoyl-CoA reductase [NADPH]",[H]\C(C[C@]([H])(CCCCC)SCC=O)=C(\[H])C(=O)SCCN=C(O)CCN[C@]([H])(O)C(=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])([N+]2=CNC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",NAD(P)H dehydrogenase [quinone] 1,COC1=CC(=O)C2=C(C(COC3=CC=C(C=C3)[N+]([O-])=O)=C(C)N2C)C1=O
"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",NAD(P)H dehydrogenase [quinone] 1,COC1=CC(=O)C2=C(C(COC3=CC=CC=C3)=C(C)N2C)C1=O
5-Methoxybenzimidazole,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,COC1=CC2=C(C=C1)N=CN2
5-Methyl-2'-Deoxypseudouridine,Nucleoside deoxyribosyltransferase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)C1=CN(C)C(=O)N=C1O
"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",Stromelysin-1,CC1(C(=O)NC(=O)NC1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
5-Methylpyrrole,Endolysin,CC1=CNC=C1
5-Methyluridine 5'-Monophosphate,Single-stranded DNA-binding protein,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=C(C)C(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
"5-N-Acetyl-4-Amino-6-Diethylcarboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",Neuraminidase,[H][C@]1(N)C[C@@]([H])(O[C@@]([H])(C(=O)N(CC)CC)[C@]1([H])N=C(C)O)C(O)=O
5-N-Allyl-Arginine,"Nitric oxide synthase, brain",N[C@@H](CCCN\C(N)=[NH+]\CC=C)C(O)=O
"5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione","6,7-dimethyl-8-ribityllumazine synthase",[H][C@@](O)(CO)[C@@]([H])(O)[C@@]([H])(O)CNC1=C(C(O)=NC(O)=N1)N(=O)=O
"5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione","6,7-dimethyl-8-ribityllumazine synthase 2",[H][C@@](O)(CO)[C@@]([H])(O)[C@@]([H])(O)CNC1=C(C(O)=NC(O)=N1)N(=O)=O
5-Nitroindazole,"Nitric oxide synthase, inducible",O=N(=O)C1=CC=C2NN=CC2=C1
5-Nitroindazole,"Nitric oxide synthase, endothelial",O=N(=O)C1=CC=C2NN=CC2=C1
"5-Nitroso-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione","6,7-dimethyl-8-ribityllumazine synthase",[H][C@@](O)(CO)[C@@]([H])(O)[C@@]([H])(O)CNC1=C(N=O)C(O)=NC(O)=N1
5-O-phosphono-alpha-D-ribofuranosyl diphosphate,Hypoxanthine-guanine phosphoribosyltransferase,O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O
5-O-phosphono-alpha-D-ribofuranosyl diphosphate,Adenine phosphoribosyltransferase,O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O
5-O-phosphono-alpha-D-ribofuranosyl diphosphate,Orotate phosphoribosyltransferase,O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O
5-O-phosphono-alpha-D-ribofuranosyl diphosphate,Hypoxanthine-guanine phosphoribosyltransferase,O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O
5-O-phosphono-alpha-D-ribofuranosyl diphosphate,Anthranilate phosphoribosyltransferase,O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O
5-O-phosphono-alpha-D-ribofuranosyl diphosphate,Uridine-cytidine kinase-like 1,O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O
5-Oxo-L-Norleucine,Amidophosphoribosyltransferase,[H][C@](N)(CCC(C)=O)C(O)=O
5-Oxo-Pyrrolidine-2-Carbaldehyde,Acidic cytochrome c3,[H][C@]1(CCC(O)=N1)C=O
5-PENTYL-2-PHENOXYPHENOL,Enoyl-[acyl-carrier-protein] reductase [NADH],CCCCCC1=CC(O)=C(OC2=CC=CC=C2)C=C1
"5-Phenylsulfanyl-2,4-Quinazolinediamine",Dihydrofolate reductase,NC1=NC2=C(C(N)=N1)C(SC1=CC=CC=C1)=CC=C2
"5-Phenylsulfanyl-2,4-Quinazolinediamine","Dihydrofolate reductase, mitochondrial",NC1=NC2=C(C(N)=N1)C(SC1=CC=CC=C1)=CC=C2
5-Phenylvaleric Acid,Aromatic-amino-acid aminotransferase,OC(=O)CCCCC1=CC=CC=C1
5-Phospho-D-Arabinohydroxamic Acid,Glucose-6-phosphate isomerase,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)C(O)=NO
5-Phosphoarabinonic Acid,Glucose-6-phosphate isomerase,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)C(O)=O
5-Phosphoarabinonic Acid,Glucose-6-phosphate isomerase B,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)C(O)=O
5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate,Nicotinate-nucleotide pyrophosphorylase [carboxylating],[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(OP(O)(=O)CP(O)(O)=O)O[C@]1([H])COP(O)(O)=O
"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",O=C1NC(=O)\C(S1)=C\C1=CC2=C(C=C1)N=CC=N2
5-Thio-a/B-D-Mannopyranosylamine,Alpha-mannosidase 2,[H][C@]1(N)S[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",m7GpppX diphosphatase,[H][C@@](C)(OC1=C2C(N)=NC(N)=NC2=CC=C1)C1=CC(Cl)=CC=C1
5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,Cyclin-dependent kinase 2,NCCNC1=CC(C2=CC=CN2)=C2C(=O)NC3=CC=C(F)C1=C23
5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,Ephrin type-A receptor 7,CC1=C(NC2=CC(=CN=C2)C(N)=O)C=C(C=C1)C(=O)NC1=CC=CC(=C1)C(F)(F)F
"5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID",Streptavidin,[H][C@]12CS[C@]([H])(CCCCC(O)=O)[C@@]1([H])NC(=O)N2
"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@](C)(C#CC1=C(N)N=C(N)N=C1C)C1=CC(OC)=CC(=C1)C1=C(C)C=CC=C1C
"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@](C)(C#CC1=C(C)N=C(N)N=C1N)C1=CC(OC)=CC(=C1)C1=CC(C)=CC(C)=C1
"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@](C)(C#CC1=C(C)N=C(N)N=C1N)C1=CC(OC)=CC(=C1)C1=CC(C)=CC(C)=C1
"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@](C)(C#CC1=C(C)N=C(N)N=C1N)C1=CC(OC)=CC(=C1)C1=CC=C(C)C=C1
"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@](C)(C#CC1=C(C)N=C(N)N=C1N)C1=CC(OC)=CC(=C1)C1=CC=CC=C1
"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@](C)(C#CC1=C(C)N=C(N)N=C1N)C1=CC(OC)=CC(=C1)C1=CC=CC=C1
"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@@](C)(C#CC1=C(N)N=C(N)N=C1C)C1=CC(OC)=C(C=C1)C1=CC=CC=C1
"5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE",Cyclin-dependent kinase 2,[H][C@]1(N)CC[C@@]([H])(CC1)NC1=NC2=C(C=NN2C(NC(C)C)=C1)C#N
"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",Dihydrofolate reductase,CC1=CC=C(SC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1
"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine","Dihydrofolate reductase, mitochondrial",CC1=CC=C(SC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1
"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",Reverse transcriptase/RNaseH,CC1=NNC2=C1C(OC1=CC(=CC(=C1)C#N)C#N)=C(F)C=C2
"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",Calcium/calmodulin-dependent protein kinase type 1G,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(Cl)C=C3)=C1C
"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide",Serine/threonine-protein kinase Nek2,[H]N(C)C(=O)C1=C(C)N([H])C(\C=C2/C(=O)N([H])C3=C2C=C(Cl)C=C3)=C1C
"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",Carbonic anhydrase 2,NS(=O)(=O)C1=NN=C(NS(=O)(=O)C2=CC=CC=C2)S1
"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One","Troponin C, slow skeletal and cardiac muscles",[H][C@]1(C)SC(=O)NN=C1C1=CC2=C(C=C1)N(CCC2)C(=O)C1=CC(OC)=C(OC)C=C1
"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",Glycogen synthase kinase-3 beta,COC1=CC=C(C=C1)N1C=NC2=C1C=C(C=C2)C1=NNC(=S)O1
"5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid",Neuraminidase,[H][C@@](CC(C)C)(NC(C)=O)[C@]1([H])O[C@]([H])(C[C@@]1([H])C(=O)OC)C(O)=O
"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",Interleukin-2,CC(C)C[C@@H](NC(N)=N)C(=O)NCC(=O)N1CCC(CC1)C1=CC(=NN1C)C1=CC=C(OCC2=CC=C(O2)C(O)=O)C(Cl)=C1Cl
5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,Leukotriene A-4 hydrolase,C(CN1C=CC=C1)OC1=CC2=C(NC=C2)C=C1
"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",Leukotriene A-4 hydrolase,OC1=CC=C(CCC2=CC(O)=CC(O)=C2)C=C1
5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,Methionine aminopeptidase,OC(=O)C1=CC=C(O1)C1=C(OC(F)(F)F)C=CC=C1
5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,Methionine aminopeptidase,OC(=O)C1=CC=C(O1)C1=CC=CC=C1C(F)(F)F
"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",Dihydrofolate reductase,CCC1=NC(N)=NC(N)=C1C#CCC1=CC(OC)=CC=C1OC
"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",Dihydrofolate reductase,CCC1=NC(N)=NC(N)=C1C#CCC1=CC(OC)=CC=C1OC
"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",Dihydrofolate reductase,CCC1=NC(N)=NC(N)=C1C#CCC1=CC(OC)=CC=C1OC
"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",Dihydrofolate reductase,CCC1=NC(N)=NC(N)=C1C#CCC1=CC(OC)=CC=C1OC
"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",Tyrosine-protein kinase ABL1,COC1=CC=CC=C1C1=CNC2=C1C=C(C=N2)C1=CC(=CN=C1)C(=O)N(C)C
5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)COC1=C(SC(=C1Br)C1=CC=CC(NCC2=CC=CC=C2)=C1)C(O)=O
5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,Caspase-3,[H][C@@](CC(O)=O)(NC(=O)C1=CC=C(CNS(=O)(=O)C2=CC(C(O)=O)=C(O)C=C2)C=C1)C(C)=O
5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,Adenosine kinase,CN(C)C1=CC=C(C=C1)C1=C(N=CN=C1N)C#CC1=CC=C(N=C1)N1CCOCC1
"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",Dihydrofolate reductase,CC(C)(C)C1=CC=C(SC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1
"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine","Dihydrofolate reductase, mitochondrial",CC(C)(C)C1=CC=C(SC2=CC=CC3=C2C(N)=NC(N)=N3)C=C1
"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",Cyclin-A2,[H][C@](C)(OC1=C(SC(=C1)N1C=NC2=CC(OC)=C(OC)C=C12)C(N)=O)C1=CC=CC=C1Cl
"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",Cyclin-dependent kinase 2,[H][C@](C)(OC1=C(SC(=C1)N1C=NC2=CC(OC)=C(OC)C=C12)C(N)=O)C1=CC=CC=C1Cl
"5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide",Oxygen-insensitive NAD(P)H nitroreductase,NC(=O)C1=C(C=C(C(=C1)N(CCCl)CCCl)[N+]([O-])=O)[N+]([O-])=O
"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@@]1(OC2=C(OC)C(OC)=CC(CC3=C(N)N=C(N)N=C3)=C2C=C1)C1CC1
"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",Dihydrofolate reductase,[H][C@]1(OC2=C(C=C1)C(CC1=CNC(=N)NC1=N)=CC(OC)=C2OC)C1CC1
5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile,Inorganic pyrophosphatase,NC1=C(C=NN1C1=CC=C(Cl)C=C1)C#N
"5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid",Trypsin-1,NC1=C(Br)C(C(O)=O)=C(Br)C(C(O)=O)=C1Br
5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,Replicase polyprotein 1ab,[H][C@](C)(NC(=O)C1=C(C)C=CC(N)=C1)C1=CC=CC2=C1C=CC=C2
"5-benzyl-1,3-thiazol-2-amine",cAMP-dependent protein kinase catalytic subunit alpha,NC1=NC=C(CC2=CC=CC=C2)S1
"5-benzyl-1,3-thiazol-2-amine",cAMP-dependent protein kinase inhibitor alpha,NC1=NC=C(CC2=CC=CC=C2)S1
5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,Gag-Pol polyprotein,NC(=O)C1=C(C2=CC(Br)=CC=C2N1)S(=O)(=O)N1CCCC1
5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,Mitogen-activated protein kinase 10,ClC1=C(N2CCN(CC#C)CC2)C(NC(=O)C2=CC=C(Br)O2)=CC=C1
"5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile",Cyclin-dependent kinase 2,CC(C)NC1=CC(Cl)=NC2=C(C=NN12)C#N
5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,Coagulation factor X,[H][C@]1(CCN(CC(=O)NC2=C(F)C=C(C=C2)N2C=CC=CC2=O)C1)NC(=O)C1=CC=C(Cl)S1
"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide","Glycogen phosphorylase, liver form",[H][C@](O)(CO)C1=CC=C(NC(=O)C2=CC3=CC(Cl)=CC=C3N2)C=C1
"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide","cGMP-specific 3',5'-cyclic phosphodiesterase",CCCC1=NN(C)C2=C1N=C(NC2=O)C1=C(OCC)SC(=C1)S(N)(=O)=O
5-fluoro-beta-L-gulosyl fluoride,Alpha-mannosidase 2,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(O)[C@](F)(CO)OC1([H])F
5-fluorotryptophan,Glutathione S-transferase Mu 1,N[C@@H](CC1=CNC2=C1C=C(F)C=C2)C(O)=O
5-fluorotryptophan,Triosephosphate isomerase,N[C@@H](CC1=CNC2=C1C=C(F)C=C2)C(O)=O
5-fluorouridine,Uridine phosphorylase,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(F)C(=O)NC1=O
5-fluorouridine,Superoxide dismutase [Cu-Zn],OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=C(F)C(=O)NC1=O
"5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one",Genome polyprotein,COC1=CC=C2N=C(NS(=O)(=O)C2=C1)C1=C(O)C(=NN(CCC(C)C)C1=O)C1=CC=CC=C1
5-hydroxynaphthalene-1-sulfonamide,Cyclin-dependent kinase 2,NS(=O)(=O)C1=C2C=CC=C(O)C2=CC=C1
5-hydroxyvaleric acid,Delta-aminolevulinic acid dehydratase,OCCCCC(O)=O
5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,Methionine aminopeptidase,NC1=C(\N=N\C2=CC=CC(=C2)C(F)(F)F)C(=N)N=N1
5-iodotubercidin,Casein kinase I isoform gamma-2,[H][C@]1(CO)O[C@@]([H])(N2C=C(I)C3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5-iodotubercidin,Serine/threonine-protein kinase haspin,[H][C@]1(CO)O[C@@]([H])(N2C=C(I)C3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
5-iodotubercidin,Mitogen-activated protein kinase 3,[H][C@]1(CO)O[C@@]([H])(N2C=C(I)C3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"5-methoxy-N,N-dimethyltryptamine",5-hydroxytryptamine receptor 1A,COC1=CC=C2NC=C(CCN(C)C)C2=C1
"5-methoxy-N,N-dimethyltryptamine",5-hydroxytryptamine receptor 2A,COC1=CC=C2NC=C(CCN(C)C)C2=C1
"5-methyl-6-phenylquinazoline-2,4-diamine",Biotin carboxylase,CC1=C(C=CC2=NC(N)=NC(N)=C12)C1=CC=CC=C1
"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine","Dihydroorotate dehydrogenase (quinone), mitochondrial",CC1=NC2=NC=NN2C(NC2=CC=C(C=C2)C(F)(F)F)=C1
5-methylbenzimidazole,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC2=C(C=C1)N=CN2
5-methyltetrahydrofolic acid,"Aminomethyltransferase, mitochondrial",CN1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)N=C(N)N2
5-phenyl-1H-indazol-3-amine,Tyrosine-protein kinase JAK2,NC1=NNC2=CC=C(C=C12)C1=CC=CC=C1
5-phenyl-2-keto-valeric acid,Indole-3-pyruvate decarboxylase,OC(=O)C(=O)CCCC1=CC=CC=C1
"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID","Glycogen phosphorylase, muscle form",CC1=C(NC(=O)NC(=O)C2=CC=C(Cl)C=C2Cl)C=CC=C1OCCCCC(O)=O
"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE","Nitric oxide synthase, endothelial",CCC1=C(C(N)=NC(N)=N1)C1=CC=C(NCC2=CC(F)=CC(F)=C2)C=C1
"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",Renin,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(NCC2=CC(F)=CC(F)=C2)C=C1
5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone,Cyclin-dependent kinase 2,[H][C@]1(COC2=NC(=N)NC3=C2N=CN3)CCC(O)=N1
"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",Carbonic anhydrase 2,NC1=C(F)C=C(C=C1Cl)S(=O)(=O)NC1=NN=C(S1)S(N)(=O)=O
"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",m7GpppX diphosphatase,NC1=NC2=C(C(N)=N1)C(OCC1CCN(CC3=C(Cl)C(Cl)=CC=C3)CC1)=CC=C2
"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",m7GpppX diphosphatase,NC1=NC2=CC=CC(OCC3CCN(CC4=CC=CC=C4F)CC3)=C2C(N)=N1
"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",Genome polyprotein,[H][C@]1(CC2=CC=C(Cl)C(Cl)=C2)SC(=S)N(NS(=O)(=O)C2=CC=CS2)C1=O
5beta-dihydrotestosterone,3-oxo-5-beta-steroid 4-dehydrogenase,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,Mitogen-activated protein kinase 14,C([C@H]1CN(CCN1)C1=NN=C(C2=CC3=CC=CC=C3C=C2)C(=C1)C1=CC=NC=C1)C1=CC=CC=C1
"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",Gag-Pol polyprotein,CCN1C2=CC(=CC=C2N(C)C(=O)C2=C1N=CC=C2)[N+]([O-])=O
"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",Thymidylate synthase,CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC(Cl)=C(Cl)C=C1Cl
"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",Putative FAD-monooxygenase,O=C1NCC2=C3C(NC4=CC=CC=C34)=C3NC4=C(C=CC=C4)C3=C12
"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",Gag-Pol polyprotein,[H][C@](CC)(C1=CC=CC=C1)C1=C(O)C2=C(CCCCC2)OC1=O
"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",[H][C@]1(CCN(C1)C1=NC=NC2=CC(OC)=C(OC)C=C12)OC1=CC2=CC=CC=C2C=C1
"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",[H][C@]1(CCN(C1)C1=NC=NC2=CC(OC)=C(OC)C=C12)OC1=NC2=CC=CC=C2N=C1
"6,7-Dioxo-5h-8-Ribitylaminolumazine","6,7-dimethyl-8-ribityllumazine synthase",[H][C@@](O)(CO)[C@@]([H])(O)[C@@]([H])(O)CN1C(=O)C(=O)NC2=C1N=C(O)N=C2O
"6,8-DIMERCAPTO-OCTANOIC ACID AMIDE",Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,[H][C@](S)(CCS)CCCCC(N)=O
"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One","Glyceraldehyde-3-phosphate dehydrogenase, glycosomal",[H][C@]1(CC2=C(O1)C=C1OC(=O)C(=CC1=C2)C(C)(C)C=C)C(C)(C)O
"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One","Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",[H][C@]1(CC2=C(O1)C=C1OC(=O)C(=CC1=C2)C(C)(C)C=C)C(C)(C)O
"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",Renin,CCC1=C(C(N)=NC(N)=N1)C1=CC=C2OC(C)(C)C(=O)N(CCCOC)C2=C1
"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",Tyrosine-protein kinase ABL1,CN1C(=O)C(=CC2=CN=C(NC3=CC(CO)=CC=C3)N=C12)C1=C(Cl)C=CC=C1Cl
"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",Biotin carboxylase,COC1=CC=CC(OC)=C1C1=CC2=CN=C(N)N=C2N=C1N
"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",Biotin carboxylase,NC1=NC2=NC(N)=C(C=C2C=N1)C1=C(Br)C=CC=C1Br
6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE,Prothrombin,[H][C@](CCCCC(N)=N)(C=O)[C@@]1([H])CCC[C@]1([H])O
"6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid",Streptavidin,[H][C@]12CS[C@@]([H])(CCCCCC(O)=O)[C@@]1([H])NC(=O)N2
"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",Pyruvate kinase PKM,CN1C2=C(SC(C)=C2)C2=C1C(=O)N(CC1=CC=CC=C1F)N=C2
"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",Cyclin-dependent kinase 2,FC1=CC=CC=C1C1=CN2C=CN=C2C(NCC2=CC=CN=C2)=N1
"6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine",Biotin carboxylase,NC1=NC(OCCOC2=CC=CC=C2)=NC(N)=N1
"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",Gag-Pol polyprotein,CCOCN1C(=O)NC(=O)C(C(C)C)=C1CC1=CC(C)=CC(C)=C1
"6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE",Cyclin-dependent kinase 2,CCC1=NN(C2=C1C(=O)NC(CC1=CC(O)=C(O)C=C1)=N2)C1=C(Cl)C=C(Cl)C=C1Cl
6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,Cyclin-dependent kinase 2,CC(C)(C)NC1=NC(=NC2=C1C=C(C=C2)C1=CC=CC(N)=C1)C(F)(F)F
"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",Death-associated protein kinase 1,CC1=CC2=C(C=C1)N(CCCN)C1=C2C2=C(C(=O)NC2=O)C(C)=C1
"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",Heat shock protein HSP 90-alpha,NC1=NC(=NC(N)=N1)C1=CC2=CC=CC=C2C=C1Br
"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID","Glutathione reductase, mitochondrial",CC1=C(CCCCCC(O)=O)C(=O)C2=CC=CC=C2C1=O
6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,Gag-Pol polyprotein,FC1=C(CC2=NNC(=O)C=C2)C=CC(Cl)=C1OC1=CC=CC=C1
"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",Dipeptidyl peptidase 4,[H][C@@](N)(C(=O)N1CC[C@]([H])(F)C1)[C@@]([H])(C(=O)N(C)C)C1=CC=C(C=C1)C1=CN2N=CN=C2C=C1
"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",Serine/threonine-protein kinase pim-1,OC1=C(C=C(Br)C=C1)C1=CC(C2=CC=CC=C2)=C(C#N)C(=O)N1
"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OCC2=NC3=C(NC2)NC(=N)N=C3O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,Cyclin-dependent kinase 2,CC(C)C1=NC2=C(OCC3CCCCC3)N=C(N)N=C2N1
6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C1=CC2=C(C=C1)C=C(C=C2)C(F)(F)P(O)(O)=O
6-(Dihydroxy-Isobutyl)-Thymine,Thymidine kinase,CC1=C(CC(CO)CO)NC(=O)NC1=O
6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid,"Glycine cleavage system H protein, mitochondrial",[H][C@](CCCCC(O)=O)(CCSCN)SSCCO
6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,Urokinase-type plasminogen activator,NC(=N)C1=CC=C2C=C(C=CC2=C1)C(=O)NC1=CC=CC=C1
"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",Dihydrofolate reductase,[H][C@@]12CCN(C[C@@]3([H])CC[C@]4([H])N[C@@]([H])(N)N[C@@]([H])(N)[C@]4([H])C3)[C@@]1([H])CCCC2
"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",Dihydrofolate reductase,[H][C@@]12CCN(C[C@@]3([H])CC[C@]4([H])N[C@@]([H])(N)N[C@@]([H])(N)[C@]4([H])C3)[C@@]1([H])CCCC2
6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)NC1=CC2=C(C=CN2)C=C1C(O)=O
6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,Cathepsin K,CN1CCN(CCN2C=NC3=C(NC4CCCCC4)N=C(N=C23)C#N)CC1
"6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione",Gag-Pol polyprotein,CCOCN1C(=O)NC(=O)C(C(C)C)=C1SC1CCCCC1
"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",Queuine tRNA-ribosyltransferase,NC1=NC2=CC3=C(C=C2C(=O)N1)N=CN3
"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",Queuine tRNA-ribosyltransferase,COC1=CC=C(CCC2=C3N=CNC3=CC3=C2N=C(N)NC3=O)C=C1
"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",Queuine tRNA-ribosyltransferase,CC1=CC=C(CCC2=C3N=CNC3=CC3=C2N=C(N)NC3=O)C=C1
"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",Poly [ADP-ribose] polymerase 1,NC1=CC=C2C(=O)NC(=O)C3=CC=CC1=C23
6-Amino-1-Methylpurine,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,C[N+]1=CNC2=NC=NC2=C1N
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",Cyclomaltodextrin glucanotransferase,[H][C@]1(N)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",Cyclomaltodextrin glucanotransferase,[H][C@]1(N)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",Alpha-amylase,[H][C@]1(N)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",Neopullulanase 1,[H][C@]1(N)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol","Glucan 1,4-alpha-maltohexaosidase",[H][C@]1(N)C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"6-Aminohexyl-Uridine-C1,5'-Diphosphate","Beta-1,4-galactosyltransferase 1",[H][C@]1(COP(O)(=O)OP(O)(=O)OCCCCCCN)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,Gag-Pol polyprotein,CC(C)C1=C(CC2=CC=CC=C2)N(COCC2=CC=CC=C2)C(=O)NC1=O
"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",Cyclin-dependent kinase 2,BrC1=C2NCCCNS(=O)(=O)C3=CC=CC(NC(N=C1)=N2)=C3
6-Bromo-1-hexanol,Methane monooxygenase component A alpha chain,OCCCCCCBr
6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,Prothrombin,[H][C@](CCCCC(N)=N)(C(O)=O)[C@@]1([H])C2=C(C[C@]1([H])O)C=C(C=C2)C1=CC(OC)=CC=C1
6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,Prothrombin,[H][C@](CCCCC(N)=N)(C(O)=O)[C@@]1([H])C2=C(C[C@]1([H])O)C=CC(=C2)C1=CC=C(O)C=C1
6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,Coagulation factor XI,COC(=O)C1=CC2=CC=C(C=C2C(NC(=O)C2=CC=CC(O)=C2C)=C1)C(N)=N
"6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL",Prothrombin,[H][C@]1(CCN=C2NC[C@]([H])(Cl)N(CCNCC3=CSC4=C3C=C(Cl)C=C4)C2([H])O)CCCCN1
"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",Gag-Pol polyprotein,[H][C@@](C)(SC1=NC(N)=CC(Cl)=N1)C1=NC=C2OC=CC2=C1
6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE,Macrophage colony-stimulating factor 1 receptor,CC1=NOC(=C1)C1=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",Carbonic anhydrase 2,[H][C@]1(NC2=CC(Cl)=C(C=C2S(=O)(=O)N1)S(N)(=O)=O)C(Cl)Cl
6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,Gag-Pol polyprotein,CC(C)C1=C(OC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O
6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,Gag-Pol polyprotein,CCCC1=C(OC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O
6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,Gag-Pol polyprotein,CCCC1=C(SC2CCCCC2)C2=CC(Cl)=CC=C2NC1=O
6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,Gag-Pol polyprotein,CCCC1=C(C2=C(C=CC(Cl)=C2)N=C1O)[S@](=O)C1CCCCC1
"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",C-Jun-amino-terminal kinase-interacting protein 1,CN1N=C(C)C2=C1N(O)C1=C(C=C(Cl)C=C1)C2=O
"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",Mitogen-activated protein kinase 8,CN1N=C(C)C2=C1N(O)C1=C(C=C(Cl)C=C1)C2=O
6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,Coagulation factor X,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=CC3=CC=C(Cl)C=C3C=C2)C1=O)C(=O)N1CCOCC1
6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,Coagulation factor X,[H][C@@](C)(N1CC[C@]([H])(NS(=O)(=O)C2=CC3=C(S2)C=C(Cl)C=C3)C1=O)C(=O)N1CCOCC1
6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,Cyclin-A2,ClC1=CC=CC(NC2=NC(OCC3CCCCC3)=C3NC=NC3=N2)=C1
6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,Cyclin-dependent kinase 2,ClC1=CC=CC(NC2=NC(OCC3CCCCC3)=C3NC=NC3=N2)=C1
6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,Cyclin-A2,OC1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1
6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,Cyclin-dependent kinase 2,OC1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1
"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",Cyclin-dependent kinase 2,NC1=NC(N)=C(N=O)C(OCC2CCCCC2)=N1
6-Carboxymethyluracil,Dihydropyrimidine dehydrogenase [NADP(+)],OC(=O)CC1=CC(=O)NC(=O)N1
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,Prothrombin,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC(=C2O)C2=CC=CC=C2)C=C1Cl
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,Trypsin-1,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC(=C2O)C2=CC=CC=C2)C=C1Cl
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,Urokinase-type plasminogen activator,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC(=C2O)C2=CC=CC=C2)C=C1Cl
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,Serine protease hepsin,NC(=[NH2+])C1=CC2=C(NC(=C2)C2=CC=CC(=C2O)C2=CC=CC=C2)C=C1Cl
"6-Chloropurine Riboside, 5'-Monophosphate",Inosine-5'-monophosphate dehydrogenase 2,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(Cl)[NH+]=CN=C23)[C@]([H])(O)[C@]1([H])O
"6-Chloropurine Riboside, 5'-Monophosphate",Inosine-5'-monophosphate dehydrogenase 1,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(Cl)[NH+]=CN=C23)[C@]([H])(O)[C@]1([H])O
6-Deoxyerythronolide B,6-deoxyerythronolide B hydroxylase,[H][C@@]1(C)C[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)O[C@]([H])(CC)[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C1=O
"6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE",Thymidylate synthase,CCC1=NC(N)=NC(N)=C1C1=CC=CC=C1
"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",Renin,CCC1=NC(N)=NC(N)=C1C1=CC2=C(C=C1)C1=CC=CC=C1N2CCCOC
6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,Urokinase-type plasminogen activator,[H][C@]1(C)CCCC[C@]1([H])OC1=C(O)C(=CC=C1)C1=CC2=CC(C(N)=N)=C(F)C=C2N1
"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",Carbonic anhydrase 2,NS(=O)(=O)C1=NC2=C(S1)C=C(O)C=C2
"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",Macrophage migration inhibitory factor,NS(=O)(=O)C1=NC2=C(S1)C=C(O)C=C2
"6-Hydroxy-1,6-Dihydro Purine Nucleoside",Adenosine deaminase,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C2[NH+]=CN[C@@]3([H])O)[C@]([H])(O)[C@]1([H])O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione","Cytochrome c1, heme protein, mitochondrial",CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",Cytochrome b,CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione","Cytochrome b-c1 complex subunit 1, mitochondrial",CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione","Cytochrome b-c1 complex subunit 2, mitochondrial",CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione","Cytochrome b-c1 complex subunit 6, mitochondrial",CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",Cytochrome b-c1 complex subunit 8,CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione","Cytochrome b-c1 complex subunit Rieske, mitochondrial",CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",Cytochrome b-c1 complex subunit 10,CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",Cytochrome b-c1 complex subunit 7,CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
"6-Hydroxy-5-undecyl-4,7-benzothiazoledione",Cytochrome b-c1 complex subunit 9,CCCCCCCCCCCC1=C(O)C(=O)C2=C(N=CS2)C1=O
6-Hydroxy-6-Methyl-Heptan-3-One,Epididymal-specific lipocalin-9,CCC(=O)CCC(C)(C)O
"6-Hydroxy-7,8-Dihydro Purine Nucleoside",Adenosine deaminase,[H][C@]1(CO)O[C@@]([H])(N2CNC3=C2N=CN=C3O)[C@]([H])(O)[C@]1([H])O
"6-Hydroxymethyl-7,8-Dihydropterin",Dihydroneopterin aldolase,NC1=NC2=C(N=C(CO)CN2)C(=O)N1
"6-Hydroxymethyl-7,8-Dihydropterin",2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,NC1=NC2=C(N=C(CO)CN2)C(=O)N1
6-Hydroxymethylpterin,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,NC1=NC2=NC=C(CO)N=C2C(=O)N1
6-Hydroxypropylthymine,Thymidine kinase,CC1=C(CCCO)NC(=O)NC1=O
6-Hydroxyuridine-5'-Phosphate,Orotidine 5'-phosphate decarboxylase,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C(O)=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
6-Hydroxyuridine-5'-Phosphate,Uridine 5'-monophosphate synthase,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C(O)=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL","2,4-dienoyl-CoA reductase, mitochondrial",CCCS(=O)(=O)N1N=CC2=C(C=C(C)S2)B1O
"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,CCCS(=O)(=O)N1N=CC2=C(C=C(C)S2)B1O
6-MORPHOLIN-4-YL-9H-PURINE,Serine/threonine-protein kinase Chk1,C1CN(CCO1)C1=C2N=CNC2=NC=N1
6-Methyl-Formycin A,Purine nucleoside phosphorylase DeoD-type,[H][C@]1(CO)O[C@@]([H])(C2=C3NC=[N+](C)C(N)=C3N=N2)[C@]([H])(O)[C@]1([H])O
6-Methylamino-5-Nitroisocytosine,Dihydropteroate synthase,CNC1=C(C(=O)NC(N)=N1)[N+]([O-])=O
6-Methylpurine,Purine nucleoside phosphorylase DeoD-type,CC1=C2NC=NC2=NC=N1
6-Nitroindazole,"Nitric oxide synthase, inducible",O=N(=O)C1=CC2=NNC=C2C=C1
6-Nitroindazole,"Nitric oxide synthase, endothelial",O=N(=O)C1=CC2=NNC=C2C=C1
6-O-Cyclohexylmethyl Guanine,Cyclin-dependent kinase 2,NC1=NC(OCC2CCCCC2)=C2N=CNC2=N1
6-O-Cyclohexylmethyl Guanine,Cyclin-A2,NC1=NC(OCC2CCCCC2)=C2N=CNC2=N1
6-O-Phosphoryl Inosine Monophosphate,Adenylosuccinate synthetase isozyme 1,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=CN=C3OP(O)(O)=O)[C@]([H])(O)[C@]1([H])O
6-O-Phosphoryl Inosine Monophosphate,Adenylosuccinate synthetase,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=CN=C3OP(O)(O)=O)[C@]([H])(O)[C@]1([H])O
"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",Cyclin-dependent-like kinase 5,CCCCC1=C(NC2=NC=CN=C12)C1=CC=C(O)C=C1
"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",Cyclin-dependent kinase 5 activator 1,CCCCC1=C(NC2=NC=CN=C12)C1=CC=C(O)C=C1
6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid,"Phospholipase A2, membrane associated",[H][C@](CCC(O)=O)(CCC1=CC=CC=C1)N=C(O)CCCCCCC1=CC=CC=C1
6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,Aldose reductase,CC1=C(OC2=CC=C(Cl)C=C12)S(=O)(=O)C1=NNC(=O)C=C1
6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,Urokinase-type plasminogen activator,NC(=N)C1=CC2=CC=C(C=C2C=C1)C(=O)NC1=CC=CC(OC2CCCC2)=C1
6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,Urokinase-type plasminogen activator,NCC1=CC=C(NC(=O)C2=CC(NC3=NC=CC=N3)=C3C=C(C=CC3=C2)C(N)=N)C=C1
"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",Retinoic acid receptor RXR-beta,CC1=CC2=C(C=C1C1(CC1)C1=CC=C(C=N1)C(O)=O)C(C)(C)CCC2(C)C
6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,Beta-secretase 1,NC1=NC(CCC2=CC=C3C=CNC3=C2)=CC=C1
6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,Beta-secretase 1,COC1=CC=CC(=C1)C1=CC(CCC2=CC=CC(N)=N2)=CC=C1
"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",Tumor necrosis factor receptor superfamily member 1A,[O-][N+](=O)C1=CC(=CC=C1)C1=CC2=C(S1)C=C1N2C(=S)N(CCCN2CCOCC2)C1=O
"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",Mitogen-activated protein kinase 14,CC(C)NC1=NC2=C(S1)C=C(C=C2)C1=C(N=CO1)C1=CC=CC=C1F
"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",Activin receptor type-1,C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1
"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",Peptidyl-prolyl cis-trans isomerase FKBP1A,C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1
"6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid",Streptavidin,[H][C@@]1(CCCCC(=O)NCCCCCC(O)=O)SC[C@]2([H])NC(=O)N[C@]12[H]
"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",Urokinase-type plasminogen activator,[H][C@]1(NCCC2=C1C=C(NC(=O)C1=CC=C3C=C(C=CC3=C1)C(N)=N)C=C2)C(C)C
"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",Urokinase-type plasminogen activator,CC(C)C1=NCCC2=C1C=C(NC(=O)C1=CC=C3C=C(C=CC3=C1)C(N)=N)C=C2
6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,Urokinase-type plasminogen activator,NCC1=CC=C(NC(=O)C2=CC=C3C=C(C=CC3=C2)C(N)=N)C=C1
"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",Urokinase-type plasminogen activator,[H][C@]1(CC)CNCC2=C1C=C(NC(=O)C1=CC=C3C=C(C=CC3=C1)C(N)=N)C=C2
"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",Queuine tRNA-ribosyltransferase,NC1=NC2=CC3=C(C=C2C(=O)N1)N=C(NCC1=CC=CC2=CC=CC=C12)N3
"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",Queuine tRNA-ribosyltransferase,NC1=NC2=C(C=C3N=C(NCCN4CCOCC4)NC3=C2)C(=O)N1
"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",Queuine tRNA-ribosyltransferase,NC1=NC2=CC3=C(NC(NCC4=CC=CS4)=N3)C=C2C(=O)N1
"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",Queuine tRNA-ribosyltransferase,CC1=NC2=C(N1)C=C1C(=O)NC(N)=NC1=C2
"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",Queuine tRNA-ribosyltransferase,NC1=NC2=C(C=C3NC=NC3=C2CCC2=CC=CC=C2)C(=O)N1
"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",Vascular endothelial growth factor receptor 2,FC(F)(F)C1=CC(NC2=NOC3=C(C(=O)NC4=CN=CN=C4)C(Cl)=CC=C23)=CC=C1
6-deoxy-2-O-methyl-alpha-L-galactopyranose,Chondroitinase-B,[H][C@@]1(C)O[C@@]([H])(O)[C@@]([H])(OC)[C@]([H])(O)[C@]1([H])O
"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",Renin,[H][C@]1(CCC2=CC=C(C=C2N1CCCOC)C1=C(N)N=C(N)N=C1CC)C1=CC=CC=C1
6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine,Urokinase-type plasminogen activator,CC(C)COC1=C(O)C(=CC=C1)C1=NC2=CC(C(N)=N)=C(F)C=C2N1
6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine,Trypsin-1,CC(C)COC1=C(O)C(=CC=C1)C1=NC2=CC(C(N)=N)=C(F)C=C2N1
6-hydroxy-D-norleucine,L-asparaginase,[H][C@@](N)(CCCCO)C(O)=O
6-hydroxy-L-norleucine,L-asparaginase,N[C@@H](CCCCO)C(O)=O
6-hydroxydopa quinone,Membrane primary amine oxidase,N[C@@H](CC1=CC(=O)C(O)=CC1=O)C(O)=O
6-hydroxydopa quinone,Primary amine oxidase,N[C@@H](CC1=CC(=O)C(O)=CC1=O)C(O)=O
6-hydroxydopa quinone,Phenylethylamine oxidase,N[C@@H](CC1=CC(=O)C(O)=CC1=O)C(O)=O
"6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one",Ribosyldihydronicotinamide dehydrogenase [quinone],COC1=CC(=O)N(C)C2=C1C=CC1=C2OCO1
"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",Dihydrofolate reductase,COC1=CC(=CC(OC)=C1OC)C(C)(C)C#CC1=C(C)N=C(N)N=C1N
6-phospho-D-gluconic acid,Glucose-6-phosphate isomerase,O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O
6-phospho-D-gluconic acid,Thermoresistant gluconokinase,O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O
6-phospho-D-gluconic acid,"6-phosphogluconate dehydrogenase, decarboxylating",O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O
6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,cAMP-dependent protein kinase catalytic subunit alpha,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=C2N=CNC2=NC=N1
6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,cAMP-dependent protein kinase inhibitor alpha,ClC1=CC=C(C=C1)C1(CCNCC1)C1=CC=C(C=C1)C1=C2N=CNC2=NC=N1
6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,Ig gamma-1 chain C region,OC(=O)CCCCCNC(=O)CCC[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O
6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,Bifunctional epoxide hydrolase 2,OC(=O)CCCCCNC(=O)NC1CCCCC1
"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",Hepatocyte growth factor receptor,CN1C=C(C=N1)C1=NN2C(SC3=CC=C4N=CC=CC4=C3)=NN=C2C=C1
"6S-5,6,7,8-Tetrahydrobiopterin","Nitric oxide synthase, endothelial",[H][C@](C)(O)[C@@]([H])(O)[C@@]1([H])CNC2=C(N1)C(O)=NC(=N)N2
"7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane",Pseudoazurin,OC(=O)CN(CCN(CC(O)=O)CC(=O)NCCS)CCN(CC(O)=O)CC(=O)NCCS
"7,8-Diamino-Nonanoic Acid",ATP-dependent dethiobiotin synthetase BioD 1,C[C@H](N)[C@H](N)CCCCCC(O)=O
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Phenylethanolamine N-methyltransferase,ClC1=CC=C2CCNCC2=C1Cl
"7,8-Dihydro-7,7-Dimethyl-6-Hydroxypterin",2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,CC1(C)NC2=C(N=C1O)C(=O)NC(N)=N2
"7,8-Dihydroneopterin",Dihydroneopterin aldolase,NC1=NC2=C(N=C(CN2)[C@H](O)[C@H](O)CO)C(=O)N1
"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",Beta-lactamase type II,[H][C@]1(C)CC2=C(C(=O)C3=C(O2)C=C(O)C(O)=C3C(O)=O)[C@]([H])(OC)O1
"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,C[C@@]1(CCC2=CC=CC=C2)NC2=C(N=C1CO)C(=O)NC(N)=N2
"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",Catechol O-methyltransferase,OC1=CC=C2C(OC(=O)C=C2C2=CC=CC=C2)=C1O
"7,9-Dimethylguanine",Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,[H][C@@]1(N)NC2=C([N+](C)=CN2C)[C@]([H])(O)N1
7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,Beta-lactamase OXA-10,CO[C@]1(NC(=O)[C@H](C(O)=O)C2=CC=C(O)C=C2)[C@H]2OCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O
"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",Tyrosine-protein phosphatase non-receptor type 1,[H][C@@]1(COC2=NS(=O)(=O)C3=C2C=CC=C3)OCCC2=C1SC(NC(=O)C(O)=O)=C2C(O)=O
"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE","Dihydrofolate reductase, mitochondrial",CCC(CC)N1C=CC2=C1C=CC1=C2C(N)=NC(N)=N1
"7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem",Beta-lactamase,[H][C@@]1(SC=C(NC=C1C=O)C(O)=O)C1=CN(C)N=N1
"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",Biotin carboxylase,NC1=NC2=C(C=N1)C=C(C1=CC=CC=C1)C(=N2)N1CC=CC1
7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,Beta-lactamase,N[C@@H](C(=O)N[C@@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1
"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",Adenosine kinase,[H][C@]1(C)O[C@@]([H])(N2C=C(I)C3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
7-(Carboxyamino)-8-Amino-Nonanoic Acid,ATP-dependent dethiobiotin synthetase BioD 1,C[C@H](N)[C@@H](CCCCCC(O)=O)NC(O)=O
7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,Dipeptidyl peptidase 4,CN1C=NC2=CC(C#N)=C(C(CN)=C12)C1=C(Cl)C=CC=C1
7-AMINO-4-METHYL-CHROMEN-2-ONE,Peptidyl-prolyl cis-trans isomerase A,CC1=CC(=O)OC2=C1C=CC(N)=C2
7-AMINO-4-METHYL-CHROMEN-2-ONE,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",CC1=CC(=O)OC2=C1C=CC(N)=C2
7-AMINO-4-METHYL-CHROMEN-2-ONE,Histone deacetylase 8,CC1=CC(=O)OC2=C1C=CC(N)=C2
7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=NC(=N)NC=C23)[C@]([H])(O)[C@]1([H])O
7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=NC=NC=C23)[C@]([H])(O)[C@]1([H])O
"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",Dipeptidyl peptidase 4,CN1C2=C(N(CC3=CC=CC=C3)C(=N2)N2CC[NH2+]CC2)C(=O)N(C)C1=O
7-Deaza-7-Aminomethyl-Guanine,Queuine tRNA-ribosyltransferase,NCC1=CNC2=C1C(=O)NC(N)=N2
7-Deaza-7-Cyano-Guanine,Queuine tRNA-ribosyltransferase,OC1=NC(=N)NC2=C1C(=CN2)C#N
7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,Profilin-1,CC1=C(CCO)C(=O)OC2=CC(O)=CC=C12
7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,Macrophage migration inhibitory factor,CCOC(=O)C1=CC2=CC=C(O)C=C2OC1=O
7-Hydroxystaurosporine,3-phosphoinositide-dependent protein kinase 1,[H][C@]1(O)N=C(O)C2=C3C4=CC=CC=C4N4C3=C3N(C5=CC=CC=C5C3=C12)[C@@]1(C)O[C@]4([H])C[C@@]([H])(NC)[C@@]1([H])OC
"7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline",Phenylethanolamine N-methyltransferase,IC1=CC2=C(CCNC2)C=C1
7-Keto-8-Aminopelargonic Acid,Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,[H][C@@](C)(N)C(=O)CCCCCC(O)=O
7-METHOXY-1-METHYL-9H-BETA-CARBOLINE,Amine oxidase [flavin-containing] A,COC1=CC=C2C(NC3=C2C=CN=C3C)=C1
7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,Urokinase-type plasminogen activator,COC1=CC=C2C=CC(=CC2=C1C1=CN(N=C1)S(C)(=O)=O)C(N)=N
7-Methyl-Guanosine-5'-Triphosphate,Eukaryotic translation initiation factor 4E,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=[N+](C)C3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
7-Methylguanosine,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,CN1C=[N+]([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C2=C1C(=O)N=C(N)N2
7-Nitroindazole,"Nitric oxide synthase, inducible",O=N(=O)C1=CC=CC2=CNN=C12
7-Nitroindazole,"Nitric oxide synthase, endothelial",O=N(=O)C1=CC=CC2=CNN=C12
7-Nitroindazole-2-Carboxamidine,"Nitric oxide synthase, endothelial",NC(=N)N1C=C2C=CC=C(C2=N1)[N+]([O-])=O
"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",Focal adhesion kinase 1,COC1=CC(NC2=NC=C3C=CN(C3=N2)C2=CC=CC=N2)=CC(OC)=C1OC
7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,Amine oxidase [flavin-containing] B,ClC1=CC=CC(COC2=CC=C3C(OC(=O)C=C3C=O)=C2)=C1
7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,Amine oxidase [flavin-containing] B,CNCC1=CC(=O)OC2=C1C=CC(OCC1=CC=CC(Cl)=C1)=C2
"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE","Dihydrofolate reductase, mitochondrial",COCC(COC)N1C=CC2=C1C=CC1=NC(N)=NC(N)=C21
"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",Histone deacetylase 8,ONC(=O)\C=C\C(\C)=C\[C@](C)([H])C(=O)C1=CC=C(N(C)C)C=C1
"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",Acetoin utilization protein,ONC(=O)\C=C\C(\C)=C\[C@](C)([H])C(=O)C1=CC=C(N(C)C)C=C1
"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",Histone deacetylase 7,ONC(=O)\C=C\C(\C)=C\[C@](C)([H])C(=O)C1=CC=C(N(C)C)C=C1
"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",DNA ligase,CC(C)(C)C1=NC(N2CCN(CC2)C2=NC=CC=N2)=C2C=C(C(N)=O)C(N)=NC2=N1
"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",DNA ligase,CC(C)(C)C1=NC2=NC(N)=C(C=C2C(NCCC2=CNC=N2)=N1)C(N)=O
"7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole",Putative FAD-monooxygenase,OC(=O)C1=C2C(=C(O)N1)C1=C(NC3=C1C=CC=C3)C1=C2C2=C(N1)C=CC=C2
7-ethyl-10-hydroxycamptothecin,DNA topoisomerase 1,CCC1=C2C=C(O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O
7-methyl-GpppA,Eukaryotic translation initiation factor 4E,CN1C=[N+]([C@@H]2O[C@H](CO[P@](O)(=O)O[P@](O)(=O)O[P@](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N3C=NC4=C(N)N=CN=C34)[C@@H](O)[C@H]2O)C2=C1C(=O)N=C(N)N2
7-methyl-GpppA,m7GpppX diphosphatase,CN1C=[N+]([C@@H]2O[C@H](CO[P@](O)(=O)O[P@](O)(=O)O[P@](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N3C=NC4=C(N)N=CN=C34)[C@@H](O)[C@H]2O)C2=C1C(=O)N=C(N)N2
7-methyl-guanosine-5'-triphosphate-5'-guanosine,m7GpppX diphosphatase,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=[N+](C)C4=C3NC(=N)N=C4O)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
7-methyl-guanosine-5'-triphosphate-5'-guanosine,RNA-directed RNA polymerase lambda-3,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=[N+](C)C4=C3NC(=N)N=C4O)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
7-thionicotinamide-adenine-dinucleotide phosphate,"NAD(P) transhydrogenase, mitochondrial",[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C([S-])=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID","Glycogen phosphorylase, muscle form",OC(=O)CCCCCCOC1=C(Cl)C=C(NC(=O)NC(=O)C2=CC=CC=C2Cl)C=C1Cl
7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID,Bifunctional epoxide hydrolase 2,OC(=O)CCCCCCNC(=O)NC1CCCCC1
"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",Integrin alpha-L,ClC1=CC(=CC(Cl)=C1)C1=C(C#N)[C@@]2(CC3=CC=C(C=C3)C#N)CCCN2C1=O
7n-Methyl-8-Hydroguanosine-5'-Diphosphate,Eukaryotic translation initiation factor 4E,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(O)=O)N1CN(C)C2=C1NC(=N)N=C2O
7n-Methyl-8-Hydroguanosine-5'-Diphosphate,m7GpppX diphosphatase,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(O)=O)N1CN(C)C2=C1NC(=N)N=C2O
7n-Methyl-8-Hydroguanosine-5'-Diphosphate,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(O)=O)N1CN(C)C2=C1NC(=N)N=C2O
7n-Methyl-8-Hydroguanosine-5'-Triphosphate,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1CN(C)C2=C1NC(=N)N=C2O
"8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One","Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]2(N=C(S)N=C2O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione","Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]2(N=C(O)N(C)C2=O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
"8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine",Phenylethanolamine N-methyltransferase,ClC1=CC=C2CCCNCC2=C1Cl
"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",Heat shock protein HSP 90-alpha,COC1=CC(CC2=NC3=C(N)N=C(F)N=C3N2CCCC#C)=C(OC)C=C1
"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",Heat shock protein HSP 90-alpha,COC1=CC(CC2=NC3=NC(F)=NC(N)=C3N2)=C(OC)C=C1
"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",Mitogen-activated protein kinase 14,CCN1C(NC2=CC=CC=C2Cl)=NC2=C1N=C(NC1=C(F)C=CC=C1F)N=C2
"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",Heat shock protein HSP 90-alpha,COC1=C(OC)C(OC)=C(Cl)C(CC2=NC3=C(N)N=C(F)N=C3N2CCCC#C)=C1
"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",Heat shock protein HSP 90-alpha,COC1=C(OC)C(OC)=C(Cl)C(CC2=NC3=C(N)N=CN=C3N2CCCC#C)=C1
"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",Heat shock protein HSP 90-beta,CC(C)NCCCN1C(SC2=C(Br)C=C3OCOC3=C2)=NC2=C1N=CN=C2N
"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",Heat shock protein HSP 90-alpha,CC(C)NCCCN1C(SC2=C(Br)C=C3OCOC3=C2)=NC2=C1N=CN=C2N
8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,Urokinase-type plasminogen activator,NC(=N)C1=CC2=C(C=CC=C2NC2=NC=CC=N2)C=C1
"8-Amino-1,3-Dimethyl-3,7-Dihydropurine-2,6-Dione",Dihydroneopterin aldolase,CN1C2=C(NC(=N)N2)C(=O)N(C)C1=O
8-Azaxanthine,Uric acid degradation bifunctional protein,OC1=NC2=C(N=NN2)C(O)=N1
"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",Heat shock protein HSP 90-alpha,CCCCN1C(CC2=CC3=C(OCO3)C=C2)=NC2=C(N)N=CN=C12
"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",Heat shock protein HSP 90-alpha,CCCCN1C(CC2=CC3=C(OCO3)C=C2)=NC2=C(N)N=C(F)N=C12
8-Bromo-Adenosine-5'-Monophosphate,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C(Br)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
8-Bromo-Adenosine-5'-Monophosphate,Histidine triad nucleotide-binding protein 1,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C(Br)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
8-Bromoadenosine-5'-Diphosphate,S-adenosylmethionine synthase,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C(Br)=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
8-Demethyl-8-Dimethylamino-Flavin-Adenine-Dinucleotide,p-hydroxybenzoate hydroxylase,[H][C@@](O)(COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)[C@@]([H])(O)[C@@]([H])(O)CN1C2=C(C=C(C)C(=C2)N(C)C)N=C2C(O)=NC(=O)N=C12
8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,Thiostrepton,[H][C@@](C)(O)C1=CC(=NC2=C1C=CC[C@]2([H])O)C(O)=O
8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,50S ribosomal protein L11,[H][C@@](C)(O)C1=CC(=NC2=C1C=CC[C@]2([H])O)C(O)=O
8-Iodo-Guanine,Purine nucleoside phosphorylase,OC1=NC(=N)NC2=C1N=C(I)N2
8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate,8-oxo-dGTP diphosphatase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C(O)=NC2=C1NC(=N)N=C2O
8-azaguanine,Purine nucleoside phosphorylase,NC1=NC2=C(NN=N2)C(O)=N1
"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",Wee1-like protein kinase,CN1C2=C(C(Br)=C1C(=O)NCCO)C1=C(C(=O)NC1=O)C(=C2)C1=C(Cl)C=CC=C1
8-chlorotheophylline,Adenosine receptor A2a,CN1C2=C(NC(Cl)=N2)C(=O)N(C)C1=O
"8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one",Aurora kinase A,CCN1C(=O)C(C)(C)C2=CC3=C(C=C12)C1=C(N3)C2=C(CCC1)C(C)=NN2
"9,10-Deepithio-9,10-Didehydroacanthifolicin",Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,[H]\C(=C(\[H])[C@@]1([H])CC[C@@]2(CC[C@@]3([H])O[C@@]([H])(C(=C)[C@@]([H])(O)[C@]3([H])O2)[C@@]([H])(O)C[C@]([H])(C)[C@@]2([H])O[C@@]3(CCCCO3)CC[C@@]2([H])C)O1)[C@@]([H])(C)[C@]1([H])CC(C)=C[C@@]2(O[C@]([H])(C[C@@](C)(O)C(O)=O)CC[C@@]2([H])O)O1
"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",Histone deacetylase-like amidohydrolase,FC(F)(F)C(=O)CCCCCCC(=O)NC1=CC=CC=C1
9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine,Purine nucleoside phosphorylase DeoD-type,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N1C=NC2=C(C)N=CN=C12
9-(2-carboxyethyl)-10-methylanthracene endoperoxide,Ig gamma-1 chain C region,C[C@@]12OO[C@@](CCC(O)=O)(C3=C1C=CC=C3)C1=C2C=CC=C1
"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",Cholinesterase,IC1=CC=CC(CNC2=C3CCCCC3=NC3=C2C=CC=C3)=C1
"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",Mitogen-activated protein kinase 10,OC1=CC=C(C=C1)C1=CC2=C(C=CC3=C2C=NC=C3)N=C1
9-(4-hydroxybutyl)-N2-phenylguanine,Thymidine kinase,OCCCCN1C=NC2=C1N=C(NC1=CC=CC=C1)NC2=O
"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",Purine nucleoside phosphorylase,NC1=NC2=C(N=CN2CCCCC(F)(F)P(O)(O)=O)C(=O)N1
9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine,Purine nucleoside phosphorylase DeoD-type,[H][C@@](C)(O)[C@@]1([H])O[C@@]([H])(N2C=NC3=C(C)N=CN=C23)[C@]([H])(O)[C@]1([H])O
9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine,Purine nucleoside phosphorylase DeoD-type,[H][C@](C)(O)[C@@]1([H])O[C@@]([H])(N2C=NC3=C(C)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",CREB-binding protein,CC(=O)N1C2=CC=CC=C2C2=C1C(=O)CCC2
"9-Amino-2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",Neuraminidase,[H][C@@](O)(CN)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(O)[C@@]1([H])N=C(C)O)C(O)=O
9-Aminophenanthrene,6-deoxyerythronolide B hydroxylase,NC1=CC2=C(C=CC=C2)C2=C1C=CC=C2
9-Beta-D-Xylofuranosyl-Adenine,Purine nucleoside phosphorylase DeoD-type,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@@]1([H])O
"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",Heat shock protein HSP 90-alpha,CCCCN1C(CC2=C(OC)C=CC(OC)=C2)=NC2=C(N)N=C(F)N=C12
"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",Heat shock protein HSP 90-alpha,CCCCN1C(CC2=CC(OC)=CC=C2OC)=NC2=C(N)N=CN=C12
"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",Heat shock protein HSP 90-alpha,CCCCN1C(CC2=CC(OC)=C(OC)C(OC)=C2Cl)=NC2=C(N)N=CN=C12
"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",Heat shock protein HSP 90-beta,CCCCN1C(CC2=CC(OC)=C(OC)C(OC)=C2)=NC2=C(N)N=CN=C12
"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",Heat shock protein HSP 90-alpha,CCCCN1C(CC2=CC(OC)=C(OC)C(OC)=C2)=NC2=C(N)N=CN=C12
9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,Heat shock protein HSP 90-alpha,CCCCN1C(CC2=CC=CC(OC)=C2)=NC2=C(N)N=CN=C12
9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,Heat shock protein HSP 90-alpha,CCCCN1C(CC2=CC=C(OC)C=C2)=NC2=C(N)N=CN=C12
9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,Cathepsin K,N#CC1=NC2=C(N=CN2C2CCCC2)C(NC2=CC=CC=C2OCCCN2C=CN=C2)=N1
"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",Purine nucleoside phosphorylase,OC[C@H]1O[C@H]([C@@H]2O[C@H](CP(O)(O)=O)O[C@H]12)C1=CNC2=C1NC=NC2=O
9-Deazaadenine,Adenine phosphoribosyltransferase,N=C1NC=NC2=C1NC=C2
9-Deazaguanine,Hypoxanthine-guanine phosphoribosyltransferase,OC1=NC(=N)NC2=C1NC=C2
9-Deazahypoxanthine,Purine nucleoside phosphorylase,OC1=NC=NC2=C1NC=C2
9-Deazainosine,Purine nucleoside phosphorylase,[H][C@]1(CO)O[C@@]([H])(C2=CNC3=C2N=CN=C3O)[C@]([H])(O)[C@]1([H])O
"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",Wee1-like protein kinase,OC1=CC2=C(NC3=CC(=C4C(=O)NC(=O)C4=C23)C2=CC=CC=C2)C=C1
"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",Wee1-like protein kinase,COC1=CC=CC=C1C1=CC2=C(C3=C(C=CC(O)=C3)N2CCCO)C2=C1C(=O)NC2=O
"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",Group IIE secretory phospholipase A2,COC1=C(O)C=CC2=C1C=C(C1=C2C2=C(OCO2)C=C1C(O)=O)[N+]([O-])=O
9-Methylguanine,Dihydroneopterin aldolase,CN1C=NC2=C1N=C(N)N=C2O
9-N-Phenylmethylamino-Tacrine,Cholinesterase,C(NC1=C2C=CC=CC2=NC2=C1CCCC2)C1=CC=CC=C1
"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",Cyclin-dependent kinase 2,NC1=NC=CC(=N1)C1=C2C=CN=C(N)N2C2=NC=CC(O)=C12
"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",Cyclin-A2,NC1=NC=CC(=N1)C1=C2C=CN=C(N)N2C2=NC=CC(O)=C12
99mTc-14 F7 Mab,"Lactosylceramide alpha-2,3-sialyltransferase",
9H-CARBAZOLE,Ferredoxin CarAc,N1C2=CC=CC=C2C2=CC=CC=C12
9H-CARBAZOLE,Terminal oxygenase component of carbazole,N1C2=CC=CC=C2C2=CC=CC=C12
A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,Stromelysin-1,[H][C@@](CCCO)(C(=O)NO)[C@@]([H])(CC(C)C)C(=O)N[C@@]1([H])CCCCN(CCOC)C1=O
A-98881,Gag-Pol polyprotein,[H][C@@]1(O)CN(CC2=CC=CC=C2)N(CC2=CC(OC)=C(O)C=C2)C(=O)N(CC2=CC(OC)=C(O)C=C2)[C@]1([H])CC1=CC=CC=C1
ABT-341,Dipeptidyl peptidase 4,[H][C@]1(N)CC(=CC[C@]1([H])C1=CC(F)=C(F)C=C1F)C(=O)N1CCN2C(C1)=NN=C2C(F)(F)F
ABT-510,Vascular endothelial growth factor A,CCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN(C)C(C)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC
ABT-510,Interleukin-8,CCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN(C)C(C)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC
ABT-510,Fibroblast growth factor 2,CCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN(C)C(C)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC
ABT-510,Hepatocyte growth factor,CCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN(C)C(C)=O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC
ABT-869,Vascular endothelial growth factor receptor 3,
ABT-869,Vascular endothelial growth factor receptor 1,
ABT-869,Receptor-type tyrosine-protein kinase FLT3,
ABT-869,Vascular endothelial growth factor receptor 2,
ABT-869,Mast/stem cell growth factor receptor Kit,
ABT-869,Macrophage colony-stimulating factor 1 receptor,
ABX-PTH,Parathyroid hormone,
AC-(D)PHE-PRO-BOROHOMOLYS-OH,Prothrombin,[H][C@@](CCCCCN)(NC(=O)[C@]1([H])CCCN1C(=O)[C@@]([H])(CC1=CC=CC=C1)NC(C)=O)B(O)O
AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH,Prothrombin,[H][C@@](CCCN)(NC(=O)[C@]1([H])CCCN1C(=O)[C@@]([H])(CC1=CC=CC=C1)NC(C)=O)B(O)O
AC-(D)PHE-PRO-BOROLYS-OH,Prothrombin,[H][C@@](CCCCN)(NC(=O)[C@]1([H])CCCN1C(=O)[C@@]([H])(CC1=CC=CC=C1)NC(C)=O)B(O)O
ACA 125,Tyrosine-protein kinase transforming protein Abl,
ACETOPHENONE,R-specific alcohol dehydrogenase,CC(=O)C1=CC=CC=C1
ACP-104,Muscarinic acetylcholine receptor M1,
ACP-104,D(3) dopamine receptor,
ACP-104,D(2) dopamine receptor,
ADL 10-0101,Kappa-type opioid receptor,
ADL5859,Delta-type opioid receptor,
ADX-10061,Neuron-specific vesicular protein calcyon,
ADX10059,Metabotropic glutamate receptor 5,
AE-941,Matrix metalloproteinase-9,
AE-941,72 kDa type IV collagenase,
AE-941,Macrophage metalloelastase,
AEG35156,E3 ubiquitin-protein ligase XIAP,
AER001,Interleukin-4 receptor subunit alpha,
AER001,Interleukin-13 receptor subunit alpha-2,
AGRO100,NF-kappa-B essential modulator,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)O[C@@]1([H])C[C@@]([H])(O[C@]1([H])COP(O)(=O)OC1([H])CC([H])(OC1([H])CO)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O
AHA047,Gag-Pol polyprotein,[H][C@@]1(O)[C@@]([H])(O)[C@@]([H])(COC2=CC=CC=C2)N(CC2=CC(=CC=C2)C(O)=NC)S(=O)(=O)N(CC2=CC=CC=C2)[C@]1([H])COC1=CC=CC=C1
AICA ribonucleotide,Bifunctional purine biosynthesis protein PURH,NC(=O)C1=C(N)N(C=N1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
AL4623,Carbonic anhydrase 2,[H][C@@]1(CN(CCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O)NCC
AL5300,Carbonic anhydrase 2,[H][C@]1(O)CN(CC2=CC=CS2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
AL5424,Carbonic anhydrase 2,[H][C@]1(O)CN(C2=CC=C(OC)C=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
AL5927,Carbonic anhydrase 2,COC1=CC=C(CNS(=O)(=O)C2=CC=C(S2)S(N)(=O)=O)C=C1
AL6528,Carbonic anhydrase 2,COC1=CC(=CC=C1)N1C=CC2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O
AL7089A,Carbonic anhydrase 2,CN[C@H]1CN(C2=CC(OC)=CC=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
AL7099A,Carbonic anhydrase 2,CN[C@@H]1CN(C2=CC(OC)=CC=C2)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
AL7182,Carbonic anhydrase 2,COC1=CC(=CC=C1)N1CCC2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O
ALKS 27,Muscarinic acetylcholine receptor M3,
ALKS 27,Muscarinic acetylcholine receptor M1,
ALKS 27,Muscarinic acetylcholine receptor M5,
ALKS 27,Muscarinic acetylcholine receptor M4,
ALKS 27,Muscarinic acetylcholine receptor M2,
"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",Gag-Pol polyprotein,[H][C@@](NC1=C(C=CC(C)=C1)C(C)=O)(C(N)=O)C1=C(Cl)C=CC=C1Cl
"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",Gag-Pol polyprotein,[H][C@@](NC1=C(C=CC(C)=C1)C(C)=O)(C(N)=O)C1=C(Cl)C=CC=C1Cl
ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,Protein farnesyltransferase subunit beta,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)C[C@@]([H])(O)P(O)(O)=O
ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)C[C@@]([H])(O)P(O)(O)=O
AM103,Arachidonate 5-lipoxygenase-activating protein,
AMD-070,C-C chemokine receptor type 5,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@H]1CCCC2=C1N=CC=C2
AMD-070,C-X-C chemokine receptor type 4,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@H]1CCCC2=C1N=CC=C2
AME-527,Tumor necrosis factor,
AMG-131,Peroxisome proliferator-activated receptor gamma,ClC1=CC=C(C(Cl)=C1)S(=O)(=O)NC1=CC(Cl)=C(OC2=CN=C3C=CC=CC3=C2)C(Cl)=C1
AMG-208,Met proto-oncogene variant,COC1=CC2=NC=CC(OCC3=NN=C4C=CC(=NN34)C3=CC=CC=C3)=C2C=C1
AMG-222,Dipeptidyl peptidase 4,[H][C@](C)(CC1(C2=NNN=N2)C2=CC=C(C=C2CCC2=CC(=CC=C12)C(=O)N(C)C)C(=O)N(C)C)NCC(=O)N1CCC[C@@]1([H])C#N
AMGN-0007,Tumor necrosis factor ligand superfamily member 11,
AMPCPR,ADP-ribose pyrophosphatase,[H][C@]1(O)O[C@]([H])(COP(O)(=O)CP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@@]1([H])O
AMPCPR,MutT/nudix family protein,[H][C@]1(O)O[C@]([H])(COP(O)(=O)CP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@@]1([H])O
ANA380,Protein P,
ANA971,Toll-like receptor 7,
"ANDROSTA-1,4-DIENE-3,17-DIONE",Pentaerythritol tetranitrate reductase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
ANX-510,Thymidylate synthase,
ANZ-100,KiSS-1 receptor,
AP1081,Estrogen receptor,
AP1903,Serine/threonine-protein kinase mTOR,
APD668,Glucose-dependent insulinotropic receptor,
APD791,5-hydroxytryptamine receptor 2A,
AR-9281,Bifunctional epoxide hydrolase 2,CC(=O)N1CCC(CC1)NC(=O)NC12CC3CC(CC(C3)C1)C2
AS-8112,D(2) dopamine receptor,[H]N(C)C1=C(Br)C=C(C(=O)N([H])[C@@H]2CN(C)CCN(CC)C2)C(OC)=C1
AS-8112,D(3) dopamine receptor,[H]N(C)C1=C(Br)C=C(C(=O)N([H])[C@@H]2CN(C)CCN(CC)C2)C(OC)=C1
AS-8112,5HT3 serotonin receptor,[H]N(C)C1=C(Br)C=C(C(=O)N([H])[C@@H]2CN(C)CCN(CC)C2)C(OC)=C1
AT-7519,Cyclin-dependent kinase 2,ClC1=CC=CC(Cl)=C1C(=O)NC1=CNN=C1C(=O)NC1CCNCC1
AT-7519,Cyclin-dependent kinase 1,ClC1=CC=CC(Cl)=C1C(=O)NC1=CNN=C1C(=O)NC1CCNCC1
AT1391,Insulin receptor,
AT2220,Lysosomal alpha-glucosidase,
AT9283,Aurora kinase A,
AT9283,Aurora kinase B,
ATG003,Neuronal acetylcholine receptor subunit alpha-10,
ATG003,Neuronal acetylcholine receptor subunit alpha-9,
ATL1101,Insulin-like growth factor 1 receptor,
ATL1102,Integrin alpha-4,
ATP,Tyrosine-protein kinase ABL1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Beta-adrenergic receptor kinase 2,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,ATP-binding cassette sub-family A member 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,AFG3-like protein 2,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,NEDD8-activating enzyme E1 regulatory subunit,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,ATP-binding cassette sub-family C member 8,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Asparagine synthetase [glutamine-hydrolyzing],NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Cytosolic purine 5'-nucleotidase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Activin receptor type-1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Adenylate cyclase type 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Apoptotic protease-activating factor 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Beta-adrenergic receptor kinase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,"Acetyl-coenzyme A synthetase, cytoplasmic",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,ALK tyrosine kinase receptor,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,RAC-alpha serine/threonine-protein kinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Serine/threonine-protein kinase A-Raf,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Abelson tyrosine-protein kinase 2,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Cyclin-dependent kinase 15,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Serine/threonine-protein kinase receptor R3,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,ATP-binding cassette sub-family C member 9,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,ADP/ATP translocase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Long-chain-fatty-acid--CoA ligase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Activin receptor type-1B,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Argininosuccinate synthase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Anti-Muellerian hormone type-2 receptor,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,5'-AMP-activated protein kinase catalytic subunit alpha-1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Bile salt export pump,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,ATPase ASNA1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Activated CDC42 kinase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Multidrug resistance protein 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Canalicular multispecific organic anion transporter 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,ATP-binding cassette sub-family G member 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Multidrug resistance-associated protein 6,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Multidrug resistance-associated protein 4,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Multidrug resistance-associated protein 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Cystic fibrosis transmembrane conductance regulator,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Casein kinase II subunit alpha,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Casein kinase II subunit beta,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,P2Y purinoceptor 11,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
ATP,Serine/threonine-protein phosphatase 5,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
AUROVERTIN B,"ATP synthase subunit alpha, mitochondrial",[H][C@]1(CC)O[C@]2(C)[C@]([H])(OC(C)=O)[C@@]1(C)O[C@@]([H])(\C=C\C=C\C=C\C1=C(C)C(OC)=CC(=O)O1)[C@]2([H])O
AUROVERTIN B,"ATP synthase subunit beta, mitochondrial",[H][C@]1(CC)O[C@]2(C)[C@]([H])(OC(C)=O)[C@@]1(C)O[C@@]([H])(\C=C\C=C\C=C\C1=C(C)C(OC)=CC(=O)O1)[C@]2([H])O
AUROVERTIN B,"ATP synthase subunit gamma, mitochondrial",[H][C@]1(CC)O[C@]2(C)[C@]([H])(OC(C)=O)[C@@]1(C)O[C@@]([H])(\C=C\C=C\C=C\C1=C(C)C(OC)=CC(=O)O1)[C@]2([H])O
AV-412,Receptor tyrosine-protein kinase erbB-2,CC1=CC=C(C=C1)S(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.CN1CCN(CC1)C(C)(C)C#CC1=C(NC(=O)C=C)C=C2C(NC3=CC=C(F)C(Cl)=C3)=NC=NC2=C1
AV-412,Epidermal growth factor receptor,CC1=CC=C(C=C1)S(O)(=O)=O.CC1=CC=C(C=C1)S(O)(=O)=O.CN1CCN(CC1)C(C)(C)C#CC1=C(NC(=O)C=C)C=C2C(NC3=CC=C(F)C(Cl)=C3)=NC=NC2=C1
AV608,Substance-P receptor,
AVE-1625,Cannabinoid receptor 1,
AVE9633,Myeloid cell surface antigen CD33,
AVI-4557,Hepatocyte nuclear factor 4-alpha,
AZD 3355,Cellular tumor antigen p53,
AZD-7325,Gamma-aminobutyric acid receptor subunit alpha-3,CCCNC(=O)C1=C(N)C2=CC=CC(=C2N=N1)C1=C(F)C=CC=C1OC
AZD-7325,Gamma-aminobutyric acid receptor subunit alpha-2,CCCNC(=O)C1=C(N)C2=CC=CC(=C2N=N1)C1=C(F)C=CC=C1OC
AZD-8330,Mitogen-activated protein kinase kinase kinase 1,CN1C(=O)C(C)=CC(C(=O)NOCCO)=C1NC1=CC=C(I)C=C1F
AZD-9684,Carboxypeptidase B2,
AZD3409,Protein farnesyltransferase subunit beta,
AZD3409,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,
Abacavir,Reverse transcriptase/RNaseH,NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1
Abacavir,"HLA class I histocompatibility antigen, B-57 alpha chain",NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1
Abaloparatide,Parathyroid hormone/parathyroid hormone-related peptide receptor,
Abarelix,Gonadotropin-releasing hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
Abatacept,T-lymphocyte activation antigen CD86,
Abatacept,T-lymphocyte activation antigen CD80,
Abciximab,Integrin beta-3,
Abciximab,Integrin alpha-IIb,
Abciximab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Abciximab,Complement C1r subcomponent,
Abciximab,Complement C1q subcomponent subunit A,
Abciximab,Complement C1q subcomponent subunit B,
Abciximab,Complement C1q subcomponent subunit C,
Abciximab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Abciximab,Complement C1s subcomponent,
Abciximab,High affinity immunoglobulin gamma Fc receptor I,
Abciximab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Abciximab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Abciximab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Abciximab,Vitronectin,
Abemaciclib,Cyclin-dependent kinase 4,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
Abemaciclib,Cyclin-dependent kinase 6,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
Abequose,Tail fiber protein,[H][C@@]1(O)C[C@@]([H])(O)[C@@]([H])(O)O[C@]1([H])C
Abexinostat,Histone deacetylase 1,CN(C)CC1=C(OC2=CC=CC=C12)C(=O)NCCOC1=CC=C(C=C1)C(=O)NO
Abiraterone,"Steroid 17-alpha-hydroxylase/17,20 lyase",[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C
Acalabrutinib,Tyrosine-protein kinase BTK,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
Acamprosate,Gamma-aminobutyric acid receptor subunit alpha-1,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit alpha-2,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit alpha-3,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit alpha-4,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit alpha-5,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit alpha-6,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit beta-1,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit beta-2,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit beta-3,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit delta,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit epsilon,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit gamma-1,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit gamma-2,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit gamma-3,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit pi,CC(=O)NCCCS(O)(=O)=O
Acamprosate,Gamma-aminobutyric acid receptor subunit theta,CC(=O)NCCCS(O)(=O)=O
Acamprosate,"Glutamate receptor ionotropic, NMDA 1",CC(=O)NCCCS(O)(=O)=O
Acamprosate,"Glutamate receptor ionotropic, NMDA 2A",CC(=O)NCCCS(O)(=O)=O
Acamprosate,"Glutamate receptor ionotropic, NMDA 2B",CC(=O)NCCCS(O)(=O)=O
Acamprosate,"Glutamate receptor ionotropic, NMDA 2C",CC(=O)NCCCS(O)(=O)=O
Acamprosate,"Glutamate receptor ionotropic, NMDA 2D",CC(=O)NCCCS(O)(=O)=O
Acamprosate,"Glutamate receptor ionotropic, NMDA 3A",CC(=O)NCCCS(O)(=O)=O
Acamprosate,"Glutamate receptor ionotropic, NMDA 3B",CC(=O)NCCCS(O)(=O)=O
Acamprosate,Metabotropic glutamate receptor 5,CC(=O)NCCCS(O)(=O)=O
Acarbose,"Maltase-glucoamylase, intestinal",[H][C@@](O)(CO)[C@@]([H])(O[C@@]1([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(C)[C@@]([H])(N[C@@]3([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O)[C@]([H])(O)[C@@]([H])(O)C=O
Acarbose,Lysosomal alpha-glucosidase,[H][C@@](O)(CO)[C@@]([H])(O[C@@]1([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(C)[C@@]([H])(N[C@@]3([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O)[C@]([H])(O)[C@@]([H])(O)C=O
Acarbose,"Sucrase-isomaltase, intestinal",[H][C@@](O)(CO)[C@@]([H])(O[C@@]1([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(C)[C@@]([H])(N[C@@]3([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O)[C@]([H])(O)[C@@]([H])(O)C=O
Acarbose,Pancreatic alpha-amylase,[H][C@@](O)(CO)[C@@]([H])(O[C@@]1([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(C)[C@@]([H])(N[C@@]3([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O)[C@]([H])(O)[C@@]([H])(O)C=O
Acarbose Derived Hexasaccharide,Maltogenic alpha-amylase,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(OC[C@@]3([H])O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
Acarbose Derived Hexasaccharide,Pancreatic alpha-amylase,[H][C@]1(C)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(OC[C@@]3([H])O[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
Acebutolol,Beta-1 adrenergic receptor,CCCC(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)C)C=C1
Acebutolol,Beta-2 adrenergic receptor,CCCC(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)C)C=C1
Aceclofenac,Prostaglandin G/H synthase 2,OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Aceclofenac,Prostaglandin G/H synthase 1,OC(=O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Aceglutamide,o-succinylbenzoate synthase,CC(=O)N[C@@H](CCC(N)=O)C(O)=O
Acemetacin,Prostaglandin G/H synthase 1,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O
Acemetacin,Prostaglandin G/H synthase 2,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O
Acenocoumarol,Vitamin K epoxide reductase complex subunit 1,CC(=O)CC(C1=CC=C(C=C1)[N+]([O-])=O)C1=C(O)C2=CC=CC=C2OC1=O
Acepromazine,D(2) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O
Acepromazine,D(1A) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O
Acepromazine,5-hydroxytryptamine receptor 2A,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O
Acepromazine,5-hydroxytryptamine receptor 1A,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O
Acepromazine,Alpha-1A adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O
Acepromazine,Alpha-1B adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O
Aceprometazine,Histamine H1 receptor,CC(CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O)N(C)C
Acetamide,Aliphatic amidase expression-regulating protein,CC(N)=O
Acetaminophen,Prostaglandin G/H synthase 1,CC(=O)NC1=CC=C(O)C=C1
Acetaminophen,Prostaglandin G/H synthase 2,CC(=O)NC1=CC=C(O)C=C1
Acetaminophen,Fatty-acid amide hydrolase 1,CC(=O)NC1=CC=C(O)C=C1
Acetaminophen,Transient receptor potential cation channel subfamily V member 1,CC(=O)NC1=CC=C(O)C=C1
Acetaminophen,Glutathione S-transferase P,CC(=O)NC1=CC=C(O)C=C1
Acetazolamide,Carbonic anhydrase 1,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
Acetazolamide,Carbonic anhydrase 2,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
Acetazolamide,Carbonic anhydrase 4,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
Acetazolamide,Carbonic anhydrase 12,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
Acetazolamide,Carbonic anhydrase 14,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
Acetazolamide,Carbonic anhydrase 3,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
Acetazolamide,Carbonic anhydrase 7,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
Acetazolamide,Aquaporin-1,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
Acetic Acid Salicyloyl-Amino-Ester,Prostaglandin G/H synthase 1,CC(=O)ONC(=O)C1=C(O)C=CC=C1
Acetoacetic Acid,Fumarylacetoacetase,CC(=O)CC(O)=O
Acetoacetyl-CoA,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Acetoacetyl-CoA,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Acetoacetyl-CoA,Acetyl-CoA acetyltransferase,CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Acetoacetyl-CoA,"1,4-dihydroxy-2-naphthoyl-CoA synthase",CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Acetoacetyl-CoA,3-hydroxy-3-methylglutaryl CoA synthase,CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Acetoacetyl-CoA,HMG-CoA synthase,CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Acetoacetyl-CoA,"Acyl-CoA dehydrogenase, short-chain specific",CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Acetoacetyl-CoA,"Enoyl-CoA hydratase, mitochondrial",CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Acetohexamide,ATP-sensitive inward rectifier potassium channel 1,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Acetohydroxamic acid,Urease subunit alpha,CC(=O)NO
Acetohydroxamic acid,Macrophage metalloelastase,CC(=O)NO
Acetophenazine,D(2) dopamine receptor,CC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1
Acetophenazine,D(1A) dopamine receptor,CC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1
Acetophenazine,Androgen receptor,CC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1
Acetyl Dithranol,ActVA 6 protein,OC(=O)CC1=C(O)C2=C(CC3=C(C(O)=CC=C3)C2=O)C=C1
Acetyl sulfisoxazole,Dihydropteroate synthase,CC(=O)N(C1=C(C)C(C)=NO1)S(=O)(=O)C1=CC=C(N)C=C1
Acetylamino-Acetic Acid,Glycine oxidase,CC(=O)NCC(O)=O
Acetylcholine,Acetylcholinesterase,CC(=O)OCC[N+](C)(C)C
Acetylcholine,Muscarinic acetylcholine receptor M1,CC(=O)OCC[N+](C)(C)C
Acetylcholine,Muscarinic acetylcholine receptor M2,CC(=O)OCC[N+](C)(C)C
Acetylcholine,Muscarinic acetylcholine receptor M3,CC(=O)OCC[N+](C)(C)C
Acetylcholine,Muscarinic acetylcholine receptor M4,CC(=O)OCC[N+](C)(C)C
Acetylcholine,Neuronal acetylcholine receptor subunit alpha-7,CC(=O)OCC[N+](C)(C)C
Acetylcysteine,Glutathione synthetase,CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,Cystine/glutamate transporter,CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,Aminoacylase-1,CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,Inhibitor of nuclear factor kappa-B kinase subunit beta,CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,"Glutamate receptor ionotropic, NMDA 2B",CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,"Glutamate receptor ionotropic, NMDA 1",CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,"Glutamate receptor ionotropic, NMDA 2A",CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,"Glutamate receptor ionotropic, NMDA 2D",CC(=O)N[C@@H](CS)C(O)=O
Acetylcysteine,"Glutamate receptor ionotropic, NMDA 3A",CC(=O)N[C@@H](CS)C(O)=O
Acetyldigitoxin,Sodium/potassium-transporting ATPase subunit alpha-1,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1
Acetylphosphate,GDP-L-fucose synthase,CC(=O)OP(O)(O)=O
Acetylphosphate,Phosphate acetyltransferase,CC(=O)OP(O)(O)=O
Acetylsalicylic acid,Prostaglandin G/H synthase 1,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Prostaglandin G/H synthase 2,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Aldo-keto reductase family 1 member C1,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,5'-AMP-activated protein kinase catalytic subunit alpha-1,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,5'-AMP-activated protein kinase catalytic subunit alpha-2,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,5'-AMP-activated protein kinase subunit beta-1,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,5'-AMP-activated protein kinase subunit beta-2,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,5'-AMP-activated protein kinase subunit gamma-1,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,5'-AMP-activated protein kinase subunit gamma-2,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,5'-AMP-activated protein kinase subunit gamma-3,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Endothelin-1 receptor,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Cellular tumor antigen p53,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,78 kDa glucose-regulated protein,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Ribosomal protein S6 kinase alpha-3,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,NF-kappa-B inhibitor alpha,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Tumor necrosis factor-inducible gene 6 protein,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Caspase-1,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Caspase-3,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Inhibitor of nuclear factor kappa-B kinase subunit beta,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,G1/S-specific cyclin-D1,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Myc proto-oncogene protein,CC(=O)OC1=CC=CC=C1C(O)=O
Acetylsalicylic acid,Proliferating cell nuclear antigen,CC(=O)OC1=CC=CC=C1C(O)=O
Acifluorfen,Protoporphyrinogen oxidase,OC(=O)C1=C(C=CC(OC2=CC=C(C=C2Cl)C(F)(F)F)=C1)[N+]([O-])=O
Acifluorfen,Protoporphyrinogen oxidase,OC(=O)C1=C(C=CC(OC2=CC=C(C=C2Cl)C(F)(F)F)=C1)[N+]([O-])=O
Acitretin,Retinoic acid receptor RXR-alpha,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
Acitretin,Retinoic acid receptor alpha,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
Acitretin,Retinoic acid receptor beta,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
Acitretin,Retinoic acid receptor gamma,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
Acitretin,Retinoic acid receptor RXR-beta,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
Acitretin,Retinoic acid receptor RXR-gamma,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
Acitretin,Retinol-binding protein 1,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1
Aclidinium,Muscarinic acetylcholine receptor M1,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
Aclidinium,Muscarinic acetylcholine receptor M2,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
Aclidinium,Muscarinic acetylcholine receptor M3,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
Aclidinium,Muscarinic acetylcholine receptor M4,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
Aclidinium,Muscarinic acetylcholine receptor M5,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
Aconitate Ion,Aconitate hydratase B,[O-]C(=O)C\C(=C\C([O-])=O)C([O-])=O
Aconitate Ion,"Aconitate hydratase, mitochondrial",[O-]C(=O)C\C(=C\C([O-])=O)C([O-])=O
Acrivastine,Histamine H1 receptor,[H]\C(CN1CCCC1)=C(\C1=CC=C(C)C=C1)C1=CC=CC(=N1)C(\[H])=C(/[H])C(O)=O
Acrylic Acid,Beta-lactamase SHV-1,OC(=O)C=C
Actelion-1,Endothelin-1 receptor,
Acyclovir,DNA polymerase catalytic subunit,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2
Acyclovir,DNA polymerase catalytic subunit,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2
Acyclovir,Thymidine kinase,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2
Acylated Ceftazidime,Beta-lactamase,[H][C@](C=O)(N=C(O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(=N)N1)[C@@]1([H])SCC(=C)C(=N1)C(O)=O
Acylated Ceftazidime,Regulatory protein BlaR1,[H][C@](C=O)(N=C(O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(=N)N1)[C@@]1([H])SCC(=C)C(=N1)C(O)=O
Adalimumab,Tumor necrosis factor,
Adamantane,Camphor 5-monooxygenase,C1C2CC3CC1CC(C2)C3
Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide,Camphor 5-monooxygenase,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCCNC(=O)C12CC3CC(CC(C3)C1)C2
Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide,Camphor 5-monooxygenase,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCCCCCCNC(=O)C12CC3CC(CC(C3)C1)C2
Adamantanone,Camphor 5-monooxygenase,O=C1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2
Adapalene,Retinoic acid receptor gamma,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2
Adapalene,Retinoic acid receptor beta,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2
Adapalene,Retinoic acid receptor RXR-gamma,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2
Adapalene,Retinoic acid receptor RXR-beta,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2
Adapalene,Retinoic acid receptor alpha,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2
Adapalene,Retinoic acid receptor RXR-alpha,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2
Adapalene,Prostaglandin G/H synthase 2,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2
Adefovir,Protein P,NC1=C2N=CN(CCOCP(O)(O)=O)C2=NC=N1
Adefovir dipivoxil,Protein P,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C
Ademetionine,S-adenosylmethionine decarboxylase proenzyme,[H][C@](N)(CC[S+](C)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C([O-])=O
Ademetionine,S-adenosylmethionine synthase isoform type-2,[H][C@](N)(CC[S+](C)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C([O-])=O
Ademetionine,Cystathionine beta-synthase,[H][C@](N)(CC[S+](C)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C([O-])=O
Ademetionine,Glycine N-methyltransferase,[H][C@](N)(CC[S+](C)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C([O-])=O
Ademetionine,S-adenosylmethionine synthase isoform type-1,[H][C@](N)(CC[S+](C)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C([O-])=O
Ademetionine,Catechol O-methyltransferase,[H][C@](N)(CC[S+](C)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C([O-])=O
Ademetionine,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,[H][C@](N)(CC[S+](C)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C([O-])=O
Ademetionine,Arsenite methyltransferase,[H][C@](N)(CC[S+](C)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C([O-])=O
Adenine,Adenine phosphoribosyltransferase,NC1=C2NC=NC2=NC=N1
Adenine,Acetyl-CoA carboxylase 2,NC1=C2NC=NC2=NC=N1
Adenine,S-methyl-5'-thioadenosine phosphorylase,NC1=C2NC=NC2=NC=N1
Adenine,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,NC1=C2NC=NC2=NC=N1
Adenine,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,NC1=C2NC=NC2=NC=N1
Adenine,Nucleoside 2-deoxyribosyltransferase,NC1=C2NC=NC2=NC=N1
Adenine,Adenine DNA glycosylase,NC1=C2NC=NC2=NC=N1
Adenine,Peroxisomal trans-2-enoyl-CoA reductase,NC1=C2NC=NC2=NC=N1
Adenine,Holliday junction ATP-dependent DNA helicase RuvB,NC1=C2NC=NC2=NC=N1
Adenine,Low molecular weight phosphotyrosine protein phosphatase,NC1=C2NC=NC2=NC=N1
Adenine,SRSF protein kinase 2,NC1=C2NC=NC2=NC=N1
Adenosine,Adenosine receptor A2a,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine,Adenosine receptor A2b,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine,Adenosine receptor A3,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine,Adenosine receptor A1,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine 5'-[γ-thio]triphosphate,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Synapsin-1,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Mismatch repair endonuclease PMS2,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Protein RecA,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Protein RecA,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Protein RecA,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Chloramphenicol 3-O phosphotransferase,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Phosphoribosylglycinamide formyltransferase 2,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,ATP-dependent DNA helicase RecQ,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,DNA polymerase III subunit tau,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Serine/threonine-protein kinase PknB,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-[γ-thio]triphosphate,Cag alpha,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine 5'-phosphosulfate,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O
Adenosine 5'-phosphosulfate,ATP sulfurylase (Sulfate adenylyltransferase),NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O
Adenosine Monotungstate,Bis(5'-adenosyl)-triphosphatase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[W](O)(O)=O)[C@H](O)[C@H]1O
Adenosine Phosphonoacetic Acid,Nucleoside diphosphate kinase A,[H][C@]1(COC(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine phosphate,"Glycogen phosphorylase, liver form",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,5'-AMP-activated protein kinase subunit beta-1,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,Adenylate cyclase type 1,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,"Acetyl-coenzyme A synthetase, cytoplasmic",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,Long-chain-fatty-acid--CoA ligase 1,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,5'-AMP-activated protein kinase catalytic subunit alpha-1,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,5'-AMP-activated protein kinase subunit beta-2,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,Cyclic AMP-responsive element-binding protein 1,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,Serine/threonine-protein kinase pim-1,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,Histidine triad nucleotide-binding protein 1,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,"Fructose-1,6-bisphosphatase 1",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine phosphate,Adenosine kinase,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-2'-5'-Diphosphate,Eosinophil cationic protein,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
Adenosine-2'-5'-Diphosphate,Non-secretory ribonuclease,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
Adenosine-2'-5'-Diphosphate,Ribonuclease pancreatic,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
Adenosine-3'-5'-Diphosphate,Bile salt sulfotransferase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Sulfotransferase 1A1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Estrogen sulfotransferase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Sulfotransferase family cytosolic 2B member 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Non-secretory ribonuclease,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,DNA topoisomerase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Holo-[acyl-carrier-protein] synthase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Sulfotransferase family cytosolic 1B member 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Ribonuclease pancreatic,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-3'-5'-Diphosphate,Heparan sulfate glucosamine 3-O-sulfotransferase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O
Adenosine-5'-(Dithio)Phosphate,Nuclease P1,[H][C@]1(COP(O)(S)=S)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)C([H])(O)[C@]1([H])O
"Adenosine-5'-Diphosphate-2',3'-Vanadate",Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)OP(O)(O)=O)[C@H]2O[V](=O)(=O)O[C@H]12
Adenosine-5'-Ditungstate,Histidine triad nucleotide-binding protein 1,[H]N([H])C1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO[W](O)(=O)O[W](O)(O)=O)[C@@H](O)[C@H]1O
Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,ADP-L-glycero-D-manno-heptose-6-epimerase,NC1=C2N=CN([C@@H]3O[C@H](CO[P@](O)(=O)O[P@](O)(=O)O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5'-Pentaphosphate,Diadenosine hexaphosphate hydrolase,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@](O)(=O)O[P@@](O)(=O)O[P@@](O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5'-Propylphosphate,Acetyl-coenzyme A synthetase,[H][C@]1(COP(O)(=O)OCCC)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine-5'-Rp-Alpha-Thio-Triphosphate,Adenylate cyclase,[H][C@]1(CO[P@@](O)(=S)OP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",Folylpolyglutamate synthase,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Insulin receptor,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Pyridoxal kinase,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",UDP-N-acetylmuramate--L-alanine ligase,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Chemotaxis protein CheA,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Thermoresistant gluconokinase,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Folylpolyglutamate synthase,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Phosphoribosylglycinamide formyltransferase 2,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Serine/threonine-protein kinase PknB,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Ribokinase,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Probable butyrate kinase 2,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Kinesin-like protein KIF1A,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Putative sugar kinase,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",Phosphoglycerate kinase 1,[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Adenosine-5-Diphosphoribose,Glyceraldehyde-3-phosphate dehydrogenase,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,ADP-ribose pyrophosphatase,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,p-hydroxybenzoate hydroxylase,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,"CDP-glucose 4,6-dehydratase",NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,Lactaldehyde reductase,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,ADP-ribose pyrophosphatase,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,MutT/nudix family protein,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,ADP compounds hydrolase NudE,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,Elongation factor 2,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenosine-5-Diphosphoribose,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]4O[C@H](O)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)C2=NC=N1
Adenylosuccinic acid,Adenylosuccinate synthetase isozyme 1,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C(N[C@@H](CC(O)=O)C(O)=O)N=CN=C12
Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,Diphtheria toxin,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Adinazolam,Gamma-aminobutyric acid receptor subunit alpha-1,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit alpha-2,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit alpha-3,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit alpha-5,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit gamma-1,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit gamma-2,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit gamma-3,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit beta-1,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit beta-2,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit beta-3,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit delta,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit epsilon,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit pi,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit rho-1,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit rho-2,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adinazolam,Gamma-aminobutyric acid receptor subunit rho-3,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Adipiplon,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Adipiplon,Gamma-aminobutyric acid receptor subunit alpha-2,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Adipiplon,Gamma-aminobutyric acid receptor subunit alpha-3,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Adipiplon,Gamma-aminobutyric acid receptor subunit alpha-4,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Adipiplon,Gamma-aminobutyric acid receptor subunit alpha-5,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Adipiplon,Gamma-aminobutyric acid receptor subunit alpha-6,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Adipiplon,Gamma-aminobutyric acid receptor subunit gamma-1,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Adipiplon,Gamma-aminobutyric acid receptor subunit gamma-2,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Adipiplon,Gamma-aminobutyric acid receptor subunit gamma-3,CCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12
Ado-P-Ch2-P-Ps-Ado,Bis(5'-adenosyl)-triphosphatase,[H][C@]1(COP(O)(=O)CP(O)(=O)O[P@](O)(=S)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Aeruginosin 98-B,Trypsin-1,[H][C@@](O)(CC1=CC=C(O)C=C1)C(O)=N[C@@]([H])(C(=O)N1[C@@]([H])(C[C@]2([H])CC[C@]([H])(C[C@]12[H])OS(O)(=O)=O)C(O)=NCCCCNC(N)=N)[C@]([H])(C)CC
Aetiocholanolone,Bile salt sulfotransferase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@]([H])(O)CC[C@]12C
Aetiocholanolone,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@]([H])(O)CC[C@]12C
Aetiocholanolone,Estradiol 17-beta-dehydrogenase 11,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@]([H])(O)CC[C@]12C
Aetiocholanolone,Ig gamma-2 chain C region,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@]([H])(O)CC[C@]12C
Afamelanotide,Melanocyte-stimulating hormone receptor,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O
Afatinib,Epidermal growth factor receptor,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1
Afatinib,Receptor tyrosine-protein kinase erbB-2,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1
Afatinib,Receptor tyrosine-protein kinase erbB-4,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1
Afegostat,Endoglucanase 5A,OC[C@H]1CNC[C@@H](O)[C@@H]1O
Afegostat,Beta-glucosidase A,OC[C@H]1CNC[C@@H](O)[C@@H]1O
Afegostat,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",OC[C@H]1CNC[C@@H](O)[C@@H]1O
Afelimomab,Tumor necrosis factor,
Afimoxifene,Estrogen receptor,CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Afimoxifene,Estrogen receptor beta,CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Afimoxifene,Estrogen-related receptor gamma,CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Afimoxifene,Trefoil factor 1,CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Afimoxifene,Steroid hormone receptor ERR1,CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Afimoxifene,Nuclear receptor subfamily 1 group I member 2,CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Afimoxifene,Sex hormone-binding globulin,CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Aflibercept,Vascular endothelial growth factor A,
Aflibercept,Placenta growth factor,
Aflibercept,Vascular endothelial growth factor B,
Agkistrodon piscivorus antivenin,Group 10 secretory phospholipase A2,
Agmatine,Alpha-2C adrenergic receptor,NCCCCNC(N)=N
Agmatine,Nischarin,NCCCCNC(N)=N
Agmatine,Acetylcholine receptor subunit alpha,NCCCCNC(N)=N
Agmatine,"Glutamate receptor ionotropic, NMDA 1",NCCCCNC(N)=N
Agmatine,ATP-sensitive inward rectifier potassium channel 1,NCCCCNC(N)=N
Agmatine,Voltage-dependent N-type calcium channel subunit alpha-1B,NCCCCNC(N)=N
Agmatine,Acid-sensing ion channel 3,NCCCCNC(N)=N
Agomelatine,5-hydroxytryptamine receptor 2C,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
Agomelatine,Melatonin receptor type 1A,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
Agomelatine,Melatonin receptor type 1B,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1
Ajmaline,Sodium channel protein type 5 subunit alpha,CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)C5=CC=CC=C5[C@]44C[C@@H](C2[C@H]4O)N3[C@@H]1O
"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",Carbonic anhydrase 2,NS(=O)(=O)C1=CC2=C(S1)S(=O)(=O)N(C(CN1CCOCC1)=C2)C1=CC(O)=CC=C1
"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",Carbonic anhydrase 2,COC1=CC=CC(=C1)N1C(CN2CCOCC2)=CC2=C(SC(=C2)S(N)(=O)=O)S1(=O)=O
Alanosine,Adenylosuccinate synthetase isozyme 2,N[C@@H](CN(O)N=O)C(O)=O
Alanosine,Adenylosuccinate synthetase isozyme 1,N[C@@H](CN(O)N=O)C(O)=O
Alanosine,Aspartate carbamoyltransferase catalytic subunit,N[C@@H](CN(O)N=O)C(O)=O
Albendazole,Tubulin beta-2 chain,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2
Albendazole,Tubulin alpha-1A chain,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2
Albendazole,Tubulin beta-4B chain,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2
Albendazole,Fumarate reductase flavoprotein subunit,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2
Albiglutide,Glucagon-like peptide 1 receptor,
Albutrepenonacog alfa,Coagulation factor X,
Alcaftadine,Histamine H1 receptor,CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=CC=CC=C12
Alclofenac,Prostaglandin G/H synthase 2,OC(=O)CC1=CC(Cl)=C(OCC=C)C=C1
Alclometasone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C
Aldesleukin,Interleukin-2 receptor subunit beta,
Aldesleukin,Interleukin-2 receptor subunit alpha,
Aldesleukin,Cytokine receptor common subunit gamma,
Aldosterone,Mineralocorticoid receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@H](O)C[C@]12C=O)C(=O)CO
Aldosterone,Glucocorticoid receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@H](O)C[C@]12C=O)C(=O)CO
Aldoxorubicin,DNA topoisomerase 2-alpha,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]4C[C@H](N)[C@H](O)[C@H](C)O4)C(\CO)=N\NC(=O)CCCCCN4C(=O)C=CC4=O)C(O)=C3C(=O)C2=CC=C1
Alectinib,ALK tyrosine kinase receptor,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=C(N1)C=C(C=C3)C#N)C2=O
Alefacept,T-cell surface antigen CD2,
Alefacept,Complement C1r subcomponent,
Alefacept,Complement C1q subcomponent subunit A,
Alefacept,Complement C1q subcomponent subunit B,
Alefacept,Complement C1q subcomponent subunit C,
Alefacept,Low affinity immunoglobulin gamma Fc region receptor III-A,
Alefacept,High affinity immunoglobulin gamma Fc receptor I,
Alefacept,Low affinity immunoglobulin gamma Fc region receptor II-a,
Alefacept,Low affinity immunoglobulin gamma Fc region receptor II-b,
Alefacept,Low affinity immunoglobulin gamma Fc region receptor II-c,
Alefacept,Low affinity immunoglobulin gamma Fc region receptor III-B,
Aleglitazar,Peroxisome proliferator-activated receptor alpha,CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O
Aleglitazar,Peroxisome proliferator-activated receptor gamma,CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O
Aleglitazar,Nuclear receptor coactivator 1,CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O
Alemtuzumab,CAMPATH-1 antigen,
Alemtuzumab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Alemtuzumab,Complement C1r subcomponent,
Alemtuzumab,Complement C1q subcomponent subunit A,
Alemtuzumab,Complement C1q subcomponent subunit B,
Alemtuzumab,Complement C1q subcomponent subunit C,
Alemtuzumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Alemtuzumab,High affinity immunoglobulin gamma Fc receptor I,
Alemtuzumab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Alemtuzumab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Alemtuzumab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Alendronic acid,Farnesyl pyrophosphate synthase,NCCCC(O)(P(O)(O)=O)P(O)(O)=O
Alendronic acid,Tyrosine-protein phosphatase non-receptor type 4,NCCCC(O)(P(O)(O)=O)P(O)(O)=O
Alendronic acid,Receptor-type tyrosine-protein phosphatase S,NCCCC(O)(P(O)(O)=O)P(O)(O)=O
Alendronic acid,Receptor-type tyrosine-protein phosphatase epsilon,NCCCC(O)(P(O)(O)=O)P(O)(O)=O
Alendronic acid,V-type proton ATPase catalytic subunit A,NCCCC(O)(P(O)(O)=O)P(O)(O)=O
Alfacalcidol,Vitamin D3 receptor,CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C
Alfacalcidol,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C
Alfacalcidol,Retinoic acid receptor RXR-alpha,CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C
Alfentanil,Mu-type opioid receptor,CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)C2=CC=CC=C2)C1=O
Alfimeprase,Fibrinogen alpha chain,
Alfimeprase,Fibrinogen beta chain,
Alfuzosin,Alpha-1A adrenergic receptor,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1
Alfuzosin,Alpha-1B adrenergic receptor,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1
Alfuzosin,Alpha-1D adrenergic receptor,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1
Alfuzosin,Potassium voltage-gated channel subfamily H member 2,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1
Alglucosidase alfa,Cation-dependent mannose-6-phosphate receptor,
Alimemazine,Histamine H1 receptor,CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=CC=C12
Alirocumab,Proprotein convertase subtilisin/kexin type 9,
Alisertib,Aurora kinase A,COC1=CC(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2OC)=CC=C1C(O)=O
Aliskiren,Renin,COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1
Alitretinoin,Retinoic acid receptor alpha,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alitretinoin,Retinoic acid receptor RXR-alpha,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alitretinoin,Retinoic acid receptor beta,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alitretinoin,Retinoic acid receptor RXR-beta,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alitretinoin,Retinoic acid receptor gamma,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alitretinoin,Retinoic acid receptor RXR-gamma,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alitretinoin,Insulin-like growth factor-binding protein 3,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alitretinoin,Pregnancy-specific beta-1-glycoprotein 5,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alitretinoin,Cytochrome P450 26C1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
Alizapride,D(2) dopamine receptor,COC1=CC2=NNN=C2C=C1C(=O)NCC1CCCN1CC=C
Allantoate,Allantoate amidohydrolase,NC(=O)NC(NC(N)=O)C([O-])=O
Allolactose,Beta-galactosidase,OC[C@H]1O[C@@H](OC[C@H]2OC(O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O
Allopurinol,Xanthine dehydrogenase/oxidase,O=C1N=CN=C2NNC=C12
Allosamidin,Chitinase B,CN(C)C1=N[C@@H]2[C@@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]4NC(C)=O)[C@@H](O)[C@H]3NC(C)=O)[C@@H](CO)[C@@H]2O1
Allosamidin,Chitinase A,CN(C)C1=N[C@@H]2[C@@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]4NC(C)=O)[C@@H](O)[C@H]3NC(C)=O)[C@@H](CO)[C@@H]2O1
Allosamizoline,Chitotriosidase-1,[H][C@]1(O)[C@]([H])(O)[C@@]2([H])N=C(O[C@@]2([H])[C@]1([H])CO)N(C)C
Allosamizoline,Chitinase B,[H][C@]1(O)[C@]([H])(O)[C@@]2([H])N=C(O[C@@]2([H])[C@]1([H])CO)N(C)C
Allosamizoline,Chitinase A,[H][C@]1(O)[C@]([H])(O)[C@@]2([H])N=C(O[C@@]2([H])[C@]1([H])CO)N(C)C
Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,Squalene--hopene cyclase,CN(CC=C)C\C=C\COC1=CC2=C(C=C1)C(=CO2)C1=CC=C(Br)C=C1
Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin,Squalene--hopene cyclase,CN(CCCCCCOC1=CC=C2C(OC=C2C2=CC=C(Br)C=C2)=C1)CC=C
Allylestrenol,Progesterone receptor,[H][C@@]12CC[C@@](O)(CC=C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
Allylestrenol,Estrogen receptor,[H][C@@]12CC[C@@](O)(CC=C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
Almitrine,Sodium/potassium-transporting ATPase subunit alpha-1,FC1=CC=C(C=C1)C(N1CCN(CC1)C1=NC(NCC=C)=NC(NCC=C)=N1)C1=CC=C(F)C=C1
Almotriptan,5-hydroxytryptamine receptor 1D,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2
Almotriptan,5-hydroxytryptamine receptor 1B,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2
Alogliptin,Dipeptidyl peptidase 4,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O
Alosetron,5-hydroxytryptamine receptor 3A,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2
Alpelisib,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",Pantothenate synthetase,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",NH(3)-dependent NAD(+) synthetase,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",Adenylate cyclase,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",NTPase P4,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",Cyclase,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",Carbapenam-3-carboxylate synthase,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Alpha-1-proteinase inhibitor,Neutrophil elastase,
Alpha-Adenosine Monophosphate,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=NC=NC(N)=C23)[C@]([H])(O)[C@]1([H])O
Alpha-Aminobutyric Acid,"Glycine amidinotransferase, mitochondrial",CC[C@@H](N)C(O)=O
Alpha-Aminobutyric Acid,Gag-Pol polyprotein,CC[C@@H](N)C(O)=O
Alpha-Aminobutyric Acid,Pro-epidermal growth factor,CC[C@@H](N)C(O)=O
Alpha-Aminobutyric Acid,Lantibiotic mersacidin,CC[C@@H](N)C(O)=O
Alpha-Aminoisobutyric Acid,Corticoliberin,CC(C)(N)C(O)=O
Alpha-Aminoisobutyric Acid,Pro-neuropeptide Y,CC(C)(N)C(O)=O
Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,Prostatic acid phosphatase,[H][C@](NCC1=CC=CC=C1)(C1=CC=CC=C1)P(O)(O)=O
Alpha-Cyclodextrin (Cyclohexa-Amylose),Cyclomaltodextrin glucanotransferase,[H][C@]1(CO)O[C@]2([H])O[C@]3([H])[C@@]([H])(CO)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O[C@]6([H])[C@@]([H])(CO)O[C@]([H])(O[C@]7([H])[C@@]([H])(CO)O[C@]([H])(O[C@@]1([H])[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]7([H])O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O
Alpha-D-Fucose,Lactotransferrin,C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O
Alpha-D-Fucose,L-arabinose-binding periplasmic protein,C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O
Alpha-D-Galactose-1-Phosphate,Beta-phosphoglucomutase,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@H]1O
Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide,"Glycogen phosphorylase, muscle form",[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(C(O)=N)[C@]1([H])O
"Alpha-D-Glucose 1,6-Bisphosphate",Beta-phosphoglucomutase,O[C@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H](OP(O)(O)=O)[C@@H]1O
"Alpha-D-Glucose 1,6-Bisphosphate",Phosphoglucomutase-1,O[C@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H](OP(O)(O)=O)[C@@H]1O
Alpha-D-Glucose-1-Phosphate-6-Vanadate,Phosphoglucomutase-1,O[C@@H]1[C@@H](O)[C@H](CO[V](O)(=O)=O)O[C@H](OP(O)(O)=O)[C@H]1O
Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex,"Citrate synthase, mitochondrial",[H][C@](F)(CCN=C(O)CCN=C(O)[C@]([H])(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,Phenylalanine dehydrogenase,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L10-like,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L13a,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L23,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L15,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L19,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L23a,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,Probable ribosome biogenesis protein RLP24,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L26-like 1,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L8,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L37,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L3,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,60S ribosomal protein L11,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,NHP2-like protein 1,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,Carboxypeptidase A1,[H][C@](O)(CC1=CC=CC=C1)C(O)=O
Alpha-Ketomalonic Acid,"NAD-dependent malic enzyme, mitochondrial",OC(=O)C(=O)C(O)=O
Alpha-L-Arabinose,L-arabinose-binding periplasmic protein,OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O
Alpha-L-Arabinose,Arabinose operon regulatory protein,OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O
Alpha-L-Arabinose,Aldose 1-epimerase,OC[C@@H]1O[C@@H](O)[C@H](O)[C@H]1O
Alpha-L-Fucose,Genome polyprotein,C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O
Alpha-L-Fucose,Genome polyprotein,C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O
Alpha-L-Fucose,Ig gamma-1 chain C region,C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O
Alpha-L-Fucose,Envelope glycoprotein gp160,C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O
Alpha-Linolenic Acid,Fatty acid desaturase 1,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Sodium/calcium exchanger 1,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Transient receptor potential cation channel subfamily V member 1,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Fatty acid desaturase 2,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Elongation of very long chain fatty acids protein 4,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Peroxisome proliferator-activated receptor alpha,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Bile acid receptor,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Peroxisome proliferator-activated receptor delta,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Peroxisome proliferator-activated receptor gamma,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Linolenic Acid,Retinoic acid receptor RXR-alpha,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O
Alpha-Methyl-N-Acetyl-D-Glucosamine,Mannose-binding protein C,[H][C@]1(CO)O[C@@]([H])(OC)[C@]([H])(NC(C)=O)[C@@]([H])(O)[C@]1([H])O
Alpha-Methylene Adenosine Monophosphate,Ribose-phosphate pyrophosphokinase,[H][C@]1(COP(C)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Alpha-Methylisocitric Acid,"Aconitate hydratase, mitochondrial",C[C@@](O)([C@H](CC(O)=O)C(O)=O)C(O)=O
Alpha-N-Dichloroacetyl-P-Aminophenylserinol,Chloramphenicol 3-O phosphotransferase,[H][C@](CO)(NC(=O)C(Cl)Cl)[C@]([H])(O)C1=CC=C(N)C=C1
Alpha-Ribazole-5'-Phosphate,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC2=C(C=C1C)N(C=N2)[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Alpha-Ribazole-5'-Phosphate Derivative,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=CC=CC=C23)[C@]([H])(O)[C@]1([H])O
Alprazolam,Translocator protein,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-6,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-2,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-3,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-4,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-5,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-6,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit beta-1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit beta-2,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit beta-3,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit delta,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit epsilon,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit gamma-1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit gamma-2,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit gamma-3,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit pi,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit theta,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-3,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-4,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-5,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprazolam,Gamma-aminobutyric acid receptor subunit alpha-2,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12
Alprenolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC=C1CC=C
Alprenolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC=C1CC=C
Alprenolol,5-hydroxytryptamine receptor 1A,CC(C)NCC(O)COC1=CC=CC=C1CC=C
Alprenolol,Beta-3 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC=C1CC=C
Alprostadil,Prostaglandin E2 receptor EP1 subtype,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
Alprostadil,Prostaglandin E2 receptor EP2 subtype,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
Alprostadil,Prostaglandin D2 receptor 2,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
Alrestatin,Aldose reductase,OC(=O)CN1C(=O)C2=CC=CC3=CC=CC(C1=O)=C23
Alsterpaullone,Cyclin-dependent-like kinase 5,[O-][N+](=O)C1=CC2=C(NC3=C2CC(=O)NC2=C3C=CC=C2)C=C1
Alsterpaullone,Glycogen synthase kinase-3 beta,[O-][N+](=O)C1=CC2=C(NC3=C2CC(=O)NC2=C3C=CC=C2)C=C1
Alsterpaullone,Cyclin-dependent kinase 1,[O-][N+](=O)C1=CC2=C(NC3=C2CC(=O)NC2=C3C=CC=C2)C=C1
Alteplase,Plasminogen,
Alteplase,Fibrinogen alpha chain,
Alteplase,Urokinase plasminogen activator surface receptor,
Alteplase,Plasminogen activator inhibitor 1,
Altropane,Sodium-dependent dopamine transporter,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)C1=CC=C(F)C=C1)C(=O)OC)N2C\C=C\I
Aluminium,Serotransferrin,[Al]
Aluminium,Sodium/potassium-transporting ATPase subunit alpha-1,[Al]
Aluminium,Kallikrein-1,[Al]
Aluminium,Amyloid beta A4 protein,[Al]
Aluminium monostearate,"Troponin C, slow skeletal and cardiac muscles",CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O
Aluminium monostearate,Voltage-dependent anion-selective channel protein 1,CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O
Aluminium monostearate,Voltage-dependent anion-selective channel protein 2,CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O
Aluminium monostearate,Voltage-dependent anion-selective channel protein 3,CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O
Aluminium phosphate,Serotransferrin,[Al+3].[O-]P([O-])([O-])=O
Aluminium phosphate,Sodium/potassium-transporting ATPase subunit alpha-1,[Al+3].[O-]P([O-])([O-])=O
Aluminium phosphate,Kallikrein-1,[Al+3].[O-]P([O-])([O-])=O
Aluminium phosphate,Amyloid beta A4 protein,[Al+3].[O-]P([O-])([O-])=O
Aluminum acetate,Serotransferrin,[Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O
Aluminum acetate,Sodium/potassium-transporting ATPase subunit alpha-1,[Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O
Aluminum acetate,Kallikrein-1,[Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O
Aluminum acetate,Amyloid beta A4 protein,[Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O
Aluminum chloride,"Glutamate dehydrogenase 1, mitochondrial",Cl[Al](Cl)Cl
Alverine,5-hydroxytryptamine receptor 1A,CCN(CCCC1=CC=CC=C1)CCCC1=CC=CC=C1
Alvespimycin,Heat shock protein HSP 90-alpha,[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)\C(C)=C([H])\[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(NCCN(C)C)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC
Alvimopan,Mu-type opioid receptor,C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1
Alvimopan,Kappa-type opioid receptor,C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1
Alvimopan,Delta-type opioid receptor,C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1
Alvocidib,Epidermal growth factor receptor,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,Cyclin-dependent-like kinase 5,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,"Glycogen phosphorylase, muscle form",CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,Cyclin-dependent kinase 2,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,Cyclin-dependent kinase 1,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,Cyclin-dependent kinase 7,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,Cyclin-dependent kinase 9,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,Cyclin-dependent kinase 6,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,Cyclin-dependent kinase 4,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,Cyclin-dependent kinase 8,CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,"Glycogen phosphorylase, brain form",CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Alvocidib,"Glycogen phosphorylase, liver form",CN1CC[C@@H]([C@H](O)C1)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=CC=CC=C1Cl
Amantadine,Matrix protein 2,NC12CC3CC(CC(C3)C1)C2
Amantadine,"Glutamate receptor ionotropic, NMDA 3A",NC12CC3CC(CC(C3)C1)C2
Amantadine,D(2) dopamine receptor,NC12CC3CC(CC(C3)C1)C2
Amantadine,Neuronal acetylcholine receptor subunit alpha-7,NC12CC3CC(CC(C3)C1)C2
Amantadine,Neuronal acetylcholine receptor subunit alpha-4,NC12CC3CC(CC(C3)C1)C2
Amantadine,Neuronal acetylcholine receptor subunit alpha-3,NC12CC3CC(CC(C3)C1)C2
Amatuximab,Mesothelin,
Ambenonium,Acetylcholinesterase,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl
Ambrisentan,Endothelin-1 receptor,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1
Ambrisentan,Endothelin B receptor,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1
Amcinonide,Glucocorticoid receptor,[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Amcinonide,Annexin A1,[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Amdinocillin,Penicillin-binding protein 2a,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1
Amdinocillin,Penicillin-binding protein 2,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1
Amdinocillin,Penicillin-binding protein 3,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1
Amdinocillin,Penicillin-binding protein 1A,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1
Amdinocillin,Penicillin-binding protein 2B,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1
Amdinocillin,Penicillin-binding protein 1b,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])N1CCCCCC1
Amelubant,Leukotriene B4 receptor 2,CCOC(=O)NC(=N)C1=CC=C(OCC2=CC=CC(COC3=CC=C(C=C3)C(C)(C)C3=CC=C(O)C=C3)=C2)C=C1
Amelubant,Leukotriene B4 receptor 1,CCOC(=O)NC(=N)C1=CC=C(OCC2=CC=CC(COC3=CC=C(C=C3)C(C)(C)C3=CC=C(O)C=C3)=C2)C=C1
Amibegron,Beta-3 adrenergic receptor,CCOC(=O)COC1=CC=C2CC[C@@H](CC2=C1)NC[C@H](O)C1=CC=CC(Cl)=C1
Amido Phenyl Pyruvic Acid,Tryptase beta-2,NC(=N)C1=CC=C(CC(=O)C(O)=O)C=C1
Amifampridine,Potassium voltage-gated channel subfamily A member 1,NC1=CNC=CC1=N
Amifostine,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,NCCCNCCSP(O)(O)=O
Amifostine,"Alkaline phosphatase, placental-like",NCCCNCCSP(O)(O)=O
Amikacin,30S ribosomal protein S12,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
Amiloride,Amiloride-sensitive sodium channel subunit alpha,NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amiloride,Amiloride-sensitive sodium channel subunit beta,NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amiloride,Amiloride-sensitive sodium channel subunit gamma,NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amiloride,Amiloride-sensitive sodium channel subunit delta,NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amiloride,Amiloride-sensitive amine oxidase [copper-containing],NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amiloride,Acid-sensing ion channel 2,NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amiloride,Acid-sensing ion channel 1,NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amiloride,Sodium/hydrogen exchanger 1,NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amiloride,Urokinase-type plasminogen activator,NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1
Amineptine,Sodium-dependent noradrenaline transporter,OC(=O)CCCCCCNC1C2=CC=CC=C2CCC2=CC=CC=C12
Amineptine,Sodium-dependent serotonin transporter,OC(=O)CCCCCCNC1C2=CC=CC=C2CCC2=CC=CC=C12
Aminobenzoic acid,p-hydroxybenzoate hydroxylase,NC1=CC=C(C=C1)C(O)=O
Aminobenzoic acid,p-hydroxybenzoate hydroxylase,NC1=CC=C(C=C1)C(O)=O
Aminocaproic Acid,Plasminogen,NCCCCCC(O)=O
Aminocaproic Acid,Tissue-type plasminogen activator,NCCCCCC(O)=O
Aminocaproic Acid,Apolipoprotein(a),NCCCCCC(O)=O
Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide,Carbonic anhydrase 2,NCCOCCOCCNC(=O)C1=CC=C(C=C1)S(N)(=O)=O
Aminoglutethimide,Aromatase,CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1
Aminoglutethimide,"Cholesterol side-chain cleavage enzyme, mitochondrial",CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1
Aminolevulinic acid,Delta-aminolevulinic acid dehydratase,NCC(=O)CCC(O)=O
Aminomethylcyclohexane,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,[NH3+]CC1CCCCC1
Aminomethylcyclohexane,Trypsin-1,[NH3+]CC1CCCCC1
Aminooxyacetic acid,Serine--pyruvate aminotransferase,NOCC(O)=O
Aminophosphonic Acid-Guanylate Ester,Cell division control protein 42 homolog,[H][C@]1(COP(O)(=O)OP(N)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
Aminophylline,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O
Aminophylline,Adenosine receptor A1,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O
Aminophylline,Adenosine receptor A3,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O
Aminophylline,Histone deacetylase 2,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O
Aminoquinuride,Lethal factor,CC1=NC2=CC=C(NC(=O)NC3=CC4=C(C=C3)N=C(C)C=C4N)C=C2C(N)=C1
Aminosalicylic Acid,Prostaglandin G/H synthase 2,NC1=CC(O)=C(C=C1)C(O)=O
Aminosalicylic Acid,Inhibitor of nuclear factor kappa-B kinase subunit alpha,NC1=CC(O)=C(C=C1)C(O)=O
Aminosalicylic Acid,Arachidonate 5-lipoxygenase,NC1=CC(O)=C(C=C1)C(O)=O
Aminosalicylic Acid,Group IIE secretory phospholipase A2,NC1=CC(O)=C(C=C1)C(O)=O
Aminosalicylic Acid,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,NC1=CC(O)=C(C=C1)C(O)=O
Amiodarone,Potassium voltage-gated channel subfamily H member 2,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
Amiodarone,Beta-1 adrenergic receptor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
Amiodarone,Voltage-dependent T-type calcium channel subunit alpha-1H,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
Amiodarone,Voltage-dependent calcium channel subunit alpha-2/delta-2,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
Amiodarone,Thyroid hormone receptor alpha,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
Amiodarone,Thyroid hormone receptor beta,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
Amiodarone,Peroxisome proliferator-activated receptor gamma,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2
Amisulpride,D(3) dopamine receptor,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC
Amisulpride,D(2) dopamine receptor,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC
Amisulpride,5-hydroxytryptamine receptor 7,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC
Amisulpride,5-hydroxytryptamine receptor 2A,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC
Amitifadine,Sodium-dependent noradrenaline transporter,[H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1
Amitifadine,Sodium-dependent serotonin transporter,[H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1
Amitifadine,D(2) dopamine receptor,[H][C@]12C[C@]1(CNC2)C1=CC(Cl)=C(Cl)C=C1
Amitriptyline,Sodium-dependent noradrenaline transporter,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Sodium-dependent serotonin transporter,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,5-hydroxytryptamine receptor 2A,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,5-hydroxytryptamine receptor 1A,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Delta-type opioid receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Kappa-type opioid receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,High affinity nerve growth factor receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,BDNF/NT-3 growth factors receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Alpha-1A adrenergic receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Alpha-1D adrenergic receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Alpha-2A adrenergic receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Histamine H1 receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Potassium voltage-gated channel subfamily KQT member 2,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Potassium voltage-gated channel subfamily A member 1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Histamine H2 receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Histamine H4 receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Sigma non-opioid intracellular receptor 1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,5-hydroxytryptamine receptor 2C,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Alpha-1B adrenergic receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,5-hydroxytryptamine receptor 7,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,5-hydroxytryptamine receptor 1D,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Mu-type opioid receptor,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,5-hydroxytryptamine receptor 1B,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,5-hydroxytryptamine receptor 6,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Potassium voltage-gated channel subfamily KQT member 3,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,5-hydroxytryptamine receptor 2C,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Muscarinic acetylcholine receptor M1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Muscarinic acetylcholine receptor M2,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Muscarinic acetylcholine receptor M3,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Muscarinic acetylcholine receptor M4,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amitriptyline,Muscarinic acetylcholine receptor M5,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Amlexanox,Protein S100-A12,CC(C)C1=CC2=C(OC3=NC(N)=C(C=C3C2=O)C(O)=O)C=C1
Amlexanox,Protein S100-A13,CC(C)C1=CC2=C(OC3=NC(N)=C(C=C3C2=O)C(O)=O)C=C1
Amlexanox,Interleukin-3,CC(C)C1=CC2=C(OC3=NC(N)=C(C=C3C2=O)C(O)=O)C=C1
Amlexanox,Fibroblast growth factor 1,CC(C)C1=CC2=C(OC3=NC(N)=C(C=C3C2=O)C(O)=O)C=C1
Amlodipine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit beta-1,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent N-type calcium channel subunit alpha-1B,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent calcium channel subunit alpha-2/delta-3,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Carbonic anhydrase 1,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Sphingomyelin phosphodiesterase,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent calcium channel gamma-1 subunit,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent calcium channel subunit alpha-2/delta-1,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent calcium channel subunit alpha-2/delta-2,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent calcium channel subunit alpha-2/delta-3,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit alpha-1D,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit alpha-1F,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit alpha-1S,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit beta-1,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit beta-2,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit beta-3,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent L-type calcium channel subunit beta-4,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent N-type calcium channel subunit alpha-1B,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent T-type calcium channel subunit alpha-1G,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent T-type calcium channel subunit alpha-1H,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent T-type calcium channel subunit alpha-1I,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amlodipine,Voltage-dependent T-type calcium channel subunit alpha-1I,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
Amobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,Neuronal acetylcholine receptor subunit alpha-4,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,Neuronal acetylcholine receptor subunit alpha-7,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,Glutamate receptor 2,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amobarbital,"Glutamate receptor ionotropic, kainate 2",CCC1(CCC(C)C)C(=O)NC(=O)NC1=O
Amodiaquine,Histamine N-methyltransferase,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
Amonafide,DNA topoisomerase 2-alpha,CN(C)CCN1C(=O)C2=CC=CC3=CC(N)=CC(C1=O)=C23
Amonafide,DNA topoisomerase 2-beta,CN(C)CCN1C(=O)C2=CC=CC3=CC(N)=CC(C1=O)=C23
Amoxapine,Sodium-dependent noradrenaline transporter,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Sodium-dependent serotonin transporter,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,D(2) dopamine receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,D(1A) dopamine receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Alpha-2A adrenergic receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Alpha-1A adrenergic receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Muscarinic acetylcholine receptor M1,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit alpha-1,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,5-hydroxytryptamine receptor 2A,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,5-hydroxytryptamine receptor 2C,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,5-hydroxytryptamine receptor 6,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,5-hydroxytryptamine receptor 7,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,D(3) dopamine receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,D(4) dopamine receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Histamine H1 receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Alpha-1A adrenergic receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Alpha-1B adrenergic receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Alpha-1D adrenergic receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Muscarinic acetylcholine receptor M1,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Muscarinic acetylcholine receptor M2,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Muscarinic acetylcholine receptor M3,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Muscarinic acetylcholine receptor M4,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Muscarinic acetylcholine receptor M5,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,5-hydroxytryptamine receptor 2B,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,5-hydroxytryptamine receptor 3A,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,5-hydroxytryptamine receptor 1A,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,5-hydroxytryptamine receptor 1B,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Alpha-2A adrenergic receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Alpha-2B adrenergic receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Alpha-2C adrenergic receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Histamine H4 receptor,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit alpha-1,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit alpha-2,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit alpha-3,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit alpha-4,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit alpha-5,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit alpha-6,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit beta-1,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit beta-2,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit beta-3,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit delta,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit epsilon,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit gamma-1,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit gamma-2,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit gamma-3,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit pi,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Gamma-aminobutyric acid receptor subunit theta,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxapine,Sodium-dependent dopamine transporter,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
Amoxicillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O
Amperozide,5-hydroxytryptamine receptor 2A,[H]N(CC)C(=O)N1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1
Amphetamine,Synaptic vesicular amine transporter,CC(N)CC1=CC=CC=C1
Amphetamine,Sodium-dependent dopamine transporter,CC(N)CC1=CC=CC=C1
Amphetamine,Cocaine- and amphetamine-regulated transcript protein,CC(N)CC1=CC=CC=C1
Amphetamine,Trace amine-associated receptor 1,CC(N)CC1=CC=CC=C1
Amphetamine,Sodium-dependent noradrenaline transporter,CC(N)CC1=CC=CC=C1
Amphetamine,Alpha-1A adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Alpha-1B adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Alpha-1D adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Alpha-2A adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Alpha-2B adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Alpha-2C adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Beta-1 adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Beta-2 adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Beta-3 adrenergic receptor,CC(N)CC1=CC=CC=C1
Amphetamine,D(2) dopamine receptor,CC(N)CC1=CC=CC=C1
Amphetamine,Amine oxidase [flavin-containing] B,CC(N)CC1=CC=CC=C1
Amphetamine,Sodium-dependent serotonin transporter,CC(N)CC1=CC=CC=C1
Amphetamine,Amine oxidase [flavin-containing] A,CC(N)CC1=CC=CC=C1
Amphetamine,Amine oxidase [flavin-containing] B,CC(N)CC1=CC=CC=C1
Amphetamine,Vesicle monoamine transporter type 2,CC(N)CC1=CC=CC=C1
Ampicillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Ampicillin,Penicillin-binding protein 1b,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Ampicillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Ampicillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Ampicillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Ampicillin,Solute carrier family 15 member 1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Ampicillin,Solute carrier family 15 member 2,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Ampicillin,Angiopoietin-1 receptor,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Amprenavir,Pol polyprotein,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1
Amrinone,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",NC1=CC(=CNC1=O)C1=CC=NC=C1
Amrinone,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",NC1=CC(=CNC1=O)C1=CC=NC=C1
Amrinone,Tumor necrosis factor,NC1=CC(=CNC1=O)C1=CC=NC=C1
Amrubicin,DNA topoisomerase 2-alpha,[H][C@@]1(C[C@@](N)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O)O[C@H]1C[C@H](O)[C@H](O)CO1
Amsacrine,DNA topoisomerase 2-alpha,COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
Amsacrine,Potassium voltage-gated channel subfamily H member 2,COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
Amsacrine,Alpha-1-acid glycoprotein 1,COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
Amsacrine,Serum albumin,COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
Amuvatinib,Receptor-type tyrosine-protein kinase FLT3,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1
Amuvatinib,Mast/stem cell growth factor receptor Kit,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1
Amuvatinib,Platelet-derived growth factor receptor alpha,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1
Amuvatinib,Hepatocyte growth factor receptor,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1
Amuvatinib,Proto-oncogene tyrosine-protein kinase receptor Ret,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1
Amuvatinib,DNA repair protein RAD51 homolog 1,S=C(NCC1=CC=C2OCOC2=C1)N1CCN(CC1)C1=NC=NC2=C1OC1=C2C=CC=C1
Amyl Nitrite,Atrial natriuretic peptide receptor 1,CCCCCON=O
Amylamine,Trypsin-1,CCCCCN
Anagrelide,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl
Anakinra,Interleukin-1 receptor type 1,
Analogue of Indinavir Drug,Gag-Pol polyprotein,[H][C@@](O)(CN1CCN(CC2=CC3=C(OCO3)C=C2)C[C@@]1([H])C(O)=NC(C)(C)C)C[C@]([H])(C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O)[C@]([H])(C)C1=CC=CC=C1
Anastrozole,Aromatase,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N
Anatibant,B2 bradykinin receptor,CC1=CC(C)=C2C=CC=C(OCC3=C(Cl)C=CC(=C3Cl)S(=O)(=O)N3CCC[C@H]3C(=O)NCCCNC(=O)C3=CC=C(C=C3)C(N)=N)C2=N1
Ancestim,Mast/stem cell growth factor receptor Kit,
Ancrod,Fibrinogen alpha chain,
Andexanet alfa,Tissue factor pathway inhibitor,
Andrographolide,Tumor necrosis factor,[H]\C(C[C@]1([H])C(=C)CC[C@]2([H])[C@](C)(CO)[C@]([H])(O)CC[C@@]12C)=C1/C(=O)OC[C@@]1([H])O
Andrographolide,Interleukin-6,[H]\C(C[C@]1([H])C(=C)CC[C@]2([H])[C@](C)(CO)[C@]([H])(O)CC[C@@]12C)=C1/C(=O)OC[C@@]1([H])O
Andrographolide,Interleukin-1 beta,[H]\C(C[C@]1([H])C(=C)CC[C@]2([H])[C@](C)(CO)[C@]([H])(O)CC[C@@]12C)=C1/C(=O)OC[C@@]1([H])O
Andrographolide,Nuclear factor NF-kappa-B p105 subunit,[H]\C(C[C@]1([H])C(=C)CC[C@]2([H])[C@](C)(CO)[C@]([H])(O)CC[C@@]12C)=C1/C(=O)OC[C@@]1([H])O
Andrographolide,Nuclear factor NF-kappa-B p100 subunit,[H]\C(C[C@]1([H])C(=C)CC[C@]2([H])[C@](C)(CO)[C@]([H])(O)CC[C@@]12C)=C1/C(=O)OC[C@@]1([H])O
Androstanedione,Estradiol 17-beta-dehydrogenase 1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Androstanedione,Steroid Delta-isomerase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Androstenedione,Estradiol 17-beta-dehydrogenase 1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Androstenedione,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Androstenedione,6-deoxyerythronolide B hydroxylase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Androstenedione,Aldo-keto reductase family 1 member C3,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Angiotensin II,Type-1 angiotensin II receptor,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O
Anidulafungin,"1,3-beta-glucan synthase component FKS1",[H][C@]1(NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)[C@H](C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C1=O)NC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@@H](C)O
Anileridine,Mu-type opioid receptor,CCOC(=O)C1(CCN(CCC2=CC=C(N)C=C2)CC1)C1=CC=CC=C1
Aniline,Kallikrein-1,NC1=CC=CC=C1
Aniline,Serum albumin,NC1=CC=CC=C1
Aniracetam,5-hydroxytryptamine receptor 2A,COC1=CC=C(C=C1)C(=O)N1CCCC1=O
Aniracetam,D(2) dopamine receptor,COC1=CC=C(C=C1)C(=O)N1CCCC1=O
Aniracetam,Glutamate receptor 2,COC1=CC=C(C=C1)C(=O)N1CCCC1=O
Aniracetam,Glutamate receptor 3,COC1=CC=C(C=C1)C(=O)N1CCCC1=O
Anisindione,Vitamin K-dependent gamma-carboxylase,COC1=CC=C(C=C1)C1C(=O)C2=CC=CC=C2C1=O
Anisomycin,60S ribosomal protein L10-like,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L13a,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L23,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L15,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L19,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L23a,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,Probable ribosome biogenesis protein RLP24,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L26-like 1,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L8,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L37,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L3,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,60S ribosomal protein L11,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisomycin,NHP2-like protein 1,[H][C@]1(O)CN[C@]([H])(CC2=CC=C(OC)C=C2)[C@]1([H])OC(C)=O
Anisotropine methylbromide,Muscarinic acetylcholine receptor M3,[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C
Anisotropine methylbromide,Muscarinic acetylcholine receptor M1,[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C
Anisotropine methylbromide,Muscarinic acetylcholine receptor M2,[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C
Anistreplase,Plasminogen,
Anistreplase,Fibrinogen alpha chain,
Anistreplase,Urokinase plasminogen activator surface receptor,
Anistreplase,Plasminogen activator inhibitor 1,
Annamycin,DNA topoisomerase 2-alpha,C[C@@H]1O[C@@H](O[C@H]2C[C@@](O)(CC3=C2C(O)=C2C(=O)C4=CC=CC=C4C(=O)C2=C3O)C(=O)CO)[C@H](I)[C@H](O)[C@H]1O
Antazoline,Histamine H1 receptor,C(N(CC1=CC=CC=C1)C1=CC=CC=C1)C1=NCCN1
Anthralin,"Keratin, type II cytoskeletal 2 epidermal",OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2
Anthralin,C-Jun-amino-terminal kinase-interacting protein 1,OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2
Anthralin,"Keratin, type I cytoskeletal 12",OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2
Anthranilic acid,D-amino-acid oxidase,NC1=CC=CC=C1C(O)=O
Anthranilic acid,L-amino-acid oxidase,NC1=CC=CC=C1C(O)=O
Anthrax immune globulin human,Protective antigen,
Anti-inhibitor coagulant complex,Coagulation factor X,
Anti-inhibitor coagulant complex,Prothrombin,
Anti-inhibitor coagulant complex,Fibrinogen alpha chain,
Anti-inhibitor coagulant complex,Fibrinogen beta chain,
Anti-inhibitor coagulant complex,Coagulation factor XIII A chain,
Anti-inhibitor coagulant complex,Coagulation factor V,
Anti-inhibitor coagulant complex,Coagulation factor VIII,
Anti-inhibitor coagulant complex,Coagulation factor VII,
"Antihemophilic Factor (Recombinant), PEGylated",von Willebrand factor,
Antihemophilic factor human,Coagulation factor IX,
Antihemophilic factor human,Coagulation factor X,
"Antihemophilic factor, human recombinant",Coagulation factor X,
"Antihemophilic factor, human recombinant",Coagulation factor IX,
"Antihemophilic factor, human recombinant",von Willebrand factor,
"Antihemophilic factor, human recombinant","Phytanoyl-CoA dioxygenase, peroxisomal",
"Antihemophilic factor, human recombinant",Asialoglycoprotein receptor 2,
"Antihemophilic factor, human recombinant",78 kDa glucose-regulated protein,
"Antihemophilic factor, human recombinant",Calreticulin,
"Antihemophilic factor, human recombinant",Calnexin,
"Antihemophilic factor, human recombinant",Protein ERGIC-53,
"Antihemophilic factor, human recombinant",Prolow-density lipoprotein receptor-related protein 1,
"Antihemophilic factor, human recombinant",Multiple coagulation factor deficiency protein 2,
Antipyrine,Prostaglandin G/H synthase 2,CN1N(C(=O)C=C1C)C1=CC=CC=C1
Antipyrine,Prostaglandin G/H synthase 1,CN1N(C(=O)C=C1C)C1=CC=CC=C1
Antithrombin Alfa,Prothrombin,
Antithrombin Alfa,Coagulation factor X,
Antithrombin III human,Antithrombin-III,
Antithymocyte immunoglobulin (rabbit),T-cell surface glycoprotein CD1a,
Antithymocyte immunoglobulin (rabbit),Major histocompatibility complex class I-related gene protein,
Antithymocyte immunoglobulin (rabbit),Integrin alpha-L,
Antithymocyte immunoglobulin (rabbit),T-lymphocyte activation antigen CD86,
Antithymocyte immunoglobulin (rabbit),Low affinity immunoglobulin gamma Fc region receptor II-b,
Antithymocyte immunoglobulin (rabbit),T-cell surface glycoprotein CD4,
Antithymocyte immunoglobulin (rabbit),Integrin beta-1,
Antithymocyte immunoglobulin (rabbit),Integrin alpha-V,
Antithymocyte immunoglobulin (rabbit),Integrin beta-3,
Antrafenine,Prostaglandin G/H synthase 1,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCOC(=O)C2=CC=CC=C2NC2=C3C=CC(=CC3=NC=C2)C(F)(F)F)CC1
Antrafenine,Prostaglandin G/H synthase 2,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCOC(=O)C2=CC=CC=C2NC2=C3C=CC(=CC3=NC=C2)C(F)(F)F)CC1
Apadenoson,Adenosine receptor A2a,CCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=C(N=C2N)C#CC[C@H]1CC[C@@H](CC1)C(=O)OC
Apalutamide,Androgen receptor,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit alpha-1,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit alpha-2,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit alpha-3,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit alpha-4,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit alpha-5,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit alpha-6,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit beta-1,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit beta-2,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit beta-3,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit delta,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit epsilon,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit gamma-1,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit gamma-2,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit gamma-3,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit pi,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apalutamide,Gamma-aminobutyric acid receptor subunit theta,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
Apatorsen,Heat shock protein beta-1,COCCOC1C(O)C(COP(O)(=S)OC2C(COP(O)(=S)OC3C(COP(O)(=S)OC4C(COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5CC(OC5COP(O)(=S)OC5C(COP(O)(=S)OC6C(COP(O)(=S)OC7C(COP(O)(=S)OC8C(CO)OC(C8OCCOC)N8C=NC9=C8NC(=N)N=C9O)OC(C7OCCOC)N7C=NC8=C7NC(=N)N=C8O)OC(C6OCCOC)N6C=NC7=C6NC(=N)N=C7O)OC(C5OCCOC)N5C=NC6=C(N)N=CN=C56)N5C=C(C)C(=N)N=C5O)N5C=NC6=C5NC(=N)N=C6O)N5C=C(C)C(=N)N=C5O)N5C=NC6=C5NC(=N)N=C6O)N5C=NC6=C5NC(=N)N=C6O)N5C=C(C)C(=N)N=C5O)N5C=NC6=C5NC(=N)N=C6O)N5C=C(C)C(=N)N=C5O)N5C=C(C)C(O)=NC5=O)N5C=C(C)C(=N)N=C5O)N5C=NC6=C5NC(=N)N=C6O)N5C=NC6=C5NC(=N)N=C6O)OC(C4OCCOC)N4C=C(C)C(O)=NC4=O)OC(C3OCCOC)N3C=C(C)C(=N)N=C3O)OC(C2OCCOC)N2C=NC3=C(N)N=CN=C23)OC1N1C=C(C)C(O)=NC1=O
Apigenin,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,OC1=CC=C(C=C1)C1=CC(=O)C2=C(O1)C=C(O)C=C2O
Apixaban,Coagulation factor X,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O
Aplaviroc,C-C chemokine receptor type 5,[H][C@@]1(NC(=O)C2(CCN(CC3=CC=C(OC4=CC=C(C=C4)C(O)=O)C=C3)CC2)N(CCCC)C1=O)[C@H](O)C1CCCCC1
Aplyronine A,"Actin, alpha skeletal muscle",COC[C@H](N(C)C)C(=O)O[C@@H]1C\C=C\C=C\C(=O)O[C@@H](C\C=C\[C@H](OC)C[C@H](C)C\C=C(C)\[C@@H](OC)CC[C@@H](C)[C@@H](O)[C@@H]1C)[C@@H](C)[C@@H](O)[C@@H](C)CC[C@@H](OC(=O)[C@H](C)N(C)C)[C@H](C)[C@H](OC(C)=O)[C@H](C)\C=C\N(C)C=O
Apomorphine,D(3) dopamine receptor,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,D(4) dopamine receptor,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,D(2) dopamine receptor,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,Alpha-2C adrenergic receptor,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,Alpha-2B adrenergic receptor,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,5-hydroxytryptamine receptor 2C,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,D(1B) dopamine receptor,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,5-hydroxytryptamine receptor 1A,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,5-hydroxytryptamine receptor 2A,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,5-hydroxytryptamine receptor 2B,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,Alpha-2A adrenergic receptor,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,D(1A) dopamine receptor,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,5-hydroxytryptamine receptor 1D,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,5-hydroxytryptamine receptor 1B,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apomorphine,Neuron-specific vesicular protein calcyon,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
Apoptone,Apoptosis regulator Bcl-2,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C
Apraclonidine,Alpha-2A adrenergic receptor,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1
Apraclonidine,Alpha-1A adrenergic receptor,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1
Apraclonidine,Alpha-2B adrenergic receptor,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1
Apremilast,"Nitric oxide synthase, endothelial",[H][C@](CS(C)(=O)=O)(N1C(=O)C2=C(C1=O)C(=CC=C2)N=C(C)O)C1=CC(OCC)=C(OC)C=C1
Apremilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",[H][C@](CS(C)(=O)=O)(N1C(=O)C2=C(C1=O)C(=CC=C2)N=C(C)O)C1=CC(OCC)=C(OC)C=C1
Apremilast,Tumor necrosis factor,[H][C@](CS(C)(=O)=O)(N1C(=O)C2=C(C1=O)C(=CC=C2)N=C(C)O)C1=CC(OCC)=C(OC)C=C1
Apremilast,Interferon gamma,[H][C@](CS(C)(=O)=O)(N1C(=O)C2=C(C1=O)C(=CC=C2)N=C(C)O)C1=CC(OCC)=C(OC)C=C1
Apremilast,Interleukin-2,[H][C@](CS(C)(=O)=O)(N1C(=O)C2=C(C1=O)C(=CC=C2)N=C(C)O)C1=CC(OCC)=C(OC)C=C1
Apremilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",[H][C@](CS(C)(=O)=O)(N1C(=O)C2=C(C1=O)C(=CC=C2)N=C(C)O)C1=CC(OCC)=C(OC)C=C1
Apremilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",[H][C@](CS(C)(=O)=O)(N1C(=O)C2=C(C1=O)C(=CC=C2)N=C(C)O)C1=CC(OCC)=C(OC)C=C1
Aprepitant,Substance-P receptor,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
Apricitabine,Reverse transcriptase/RNaseH,NC1=NC(=O)N(C=C1)[C@H]1CO[C@@H](CO)S1
Aprindine,Sodium channel protein type 5 subunit alpha,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C1=CC=CC=C1
Aprindine,Calmodulin,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C1=CC=CC=C1
Aprinocarsen,Protein kinase C alpha type,[H]C1(O)CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])COP(O)(=S)OC1([H])CC([H])(OC1([H])CO)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=C(C)C(O)=NC1=O)N1C=CC(=N)N=C1O)N1C=C(C)C(O)=NC1=O)N1C=CC(=N)N=C1O)N1C=NC2=C1NC(=N)N=C2O)N1C=CC(=N)N=C1O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=NC2=C1NC(=N)N=C2O)N1C=NC2=C(N)N=CN=C12)N1C=NC2=C1NC(=N)N=C2O)N1C=C(C)C(O)=NC1=O)N1C=C(C)C(O)=NC1=O)N1C=C(C)C(O)=NC1=O)N1C=CC(=N)N=C1O)N1C=NC2=C(N)N=CN=C12
Aprobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,Neuronal acetylcholine receptor subunit alpha-4,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,Neuronal acetylcholine receptor subunit alpha-7,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,Glutamate receptor 2,CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprobarbital,"Glutamate receptor ionotropic, kainate 2",CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Aprotinin,Plasminogen,
Aprotinin,Kallikrein-1,
Aprotinin,Trypsin-1,
Aprotinin,Chymotrypsinogen B,
Apstatin,Xaa-Pro aminopeptidase,C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(N)=O
"Ara-Alpha(1,3)-Xyl",Intracellular exo-alpha-(1->5)-L-arabinofuranosidase,[H][C@@]1(CO)O[C@@]([H])(O[C@@]2([H])[C@]([H])(O)CO[C@@]([H])(O)[C@]2([H])O)[C@]([H])(O)[C@@]1([H])O
Arabinose-5-phosphate,2-dehydro-3-deoxyphosphooctonate aldolase,[H][C@@](O)(CO)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
Arabinose-5-phosphate,Ribose-5-phosphate isomerase A,[H][C@@](O)(CO)[C@]([H])(O)[C@]([H])(O)COP(O)(O)=O
Arachidonic Acid,Prostaglandin G/H synthase 1,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Arachidonic Acid,14 kDa fatty acid-binding protein,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Arachidonic Acid,Peroxisome proliferator-activated receptor alpha,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Arachidonic Acid,Bile acid receptor,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Arachidonic Acid,Retinoic acid receptor RXR-alpha,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Aracytidine 5'-monophosphate,Cytidylate kinase,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=CC(=N)N=C2O)[C@@]([H])(O)[C@]1([H])O
Aranidipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Voltage-dependent L-type calcium channel subunit alpha-1F,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Alpha-1A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Alpha-1B adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Alpha-1D adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Alpha-2A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Alpha-2B adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Aranidipine,Alpha-2C adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)=O
Arbaclofen,Gamma-aminobutyric acid type B receptor subunit 1,[H][C@@](CN)(CC(O)=O)C1=CC=C(Cl)C=C1
Arbaclofen,Gamma-aminobutyric acid type B receptor subunit 2,[H][C@@](CN)(CC(O)=O)C1=CC=C(Cl)C=C1
Arbaclofen Placarbil,Gamma-aminobutyric acid type B receptor subunit 1,CC(C)[C@H](OC(=O)NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1)OC(=O)C(C)C
Arbaclofen Placarbil,Gamma-aminobutyric acid type B receptor subunit 2,CC(C)[C@H](OC(=O)NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1)OC(=O)C(C)C
Arbekacin,30S ribosomal protein S12,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
Arbutamine,Beta-1 adrenergic receptor,O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1
Arbutamine,Beta-2 adrenergic receptor,O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1
Arbutamine,Beta-3 adrenergic receptor,O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1
Arbutin,Tyrosinase,OC[C@H]1O[C@@H](OC2=CC=C(O)C=C2)[C@H](O)[C@@H](O)[C@@H]1O
Archexin,RAC-alpha serine/threonine-protein kinase,
Ardeparin,Antithrombin-III,
Ardeparin,Heparin cofactor 2,
Arecoline,Muscarinic acetylcholine receptor M1,COC(=O)C1=CCCN(C)C1
Arecoline,Muscarinic acetylcholine receptor M3,COC(=O)C1=CCCN(C)C1
Arformoterol,Beta-2 adrenergic receptor,COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1
Argadin,Chitotriosidase-1,CC(=O)NC(=N)NCCC[C@@H]1NC(=O)[C@H](CCCC(O)=O)NC(=O)[C@H](CC2=CNC=N2)N2[C@H](O)C[C@H](NC(=O)[C@H]3CCCN3C1=O)C2=O
Argadin,Endochitinase B1,CC(=O)NC(=N)NCCC[C@@H]1NC(=O)[C@H](CCCC(O)=O)NC(=O)[C@H](CC2=CNC=N2)N2[C@H](O)C[C@H](NC(=O)[C@H]3CCCN3C1=O)C2=O
Argatroban,Prothrombin,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2
Argifin,Chitotriosidase-1,[H][C@]1(C)N=C(O)C[C@]([H])(N=C(O)C[C@]([H])(N=C(O)[C@]([H])(CC2=CC=CC=C2)N(C)C(=O)[C@]([H])(CCCNC(=N)NC(O)=NC)N=C1O)C(O)=O)C(O)=O
Argifin,Endochitinase B1,[H][C@]1(C)N=C(O)C[C@]([H])(N=C(O)C[C@]([H])(N=C(O)[C@]([H])(CC2=CC=CC=C2)N(C)C(=O)[C@]([H])(CCCNC(=N)NC(O)=NC)N=C1O)C(O)=O)C(O)=O
Arginineamide,Potassium voltage-gated channel subfamily A member 4,N[C@@H](CCCNC(N)=[NH2+])C(N)=O
Argininosuccinate,Argininosuccinate lyase,N[C@@H](CCCNC(=N)N[C@H](CC(O)=O)C(O)=O)C(O)=O
Argininosuccinate,Argininosuccinate synthase,N[C@@H](CCCNC(=N)N[C@H](CC(O)=O)C(O)=O)C(O)=O
Arhalofenate,Peroxisome proliferator-activated receptor gamma,CC(=O)NCCOC(=O)[C@H](OC1=CC=CC(=C1)C(F)(F)F)C1=CC=C(Cl)C=C1
Arimoclomol,Superoxide dismutase [Cu-Zn],O[C@@H](CON=C(Cl)C1=C[N+]([O-])=CC=C1)CN1CCCCC1
Aripiprazole,5-hydroxytryptamine receptor 1A,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,5-hydroxytryptamine receptor 2A,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,D(3) dopamine receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,5-hydroxytryptamine receptor 1D,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,5-hydroxytryptamine receptor 7,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Alpha-1A adrenergic receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Alpha-1B adrenergic receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Alpha-2A adrenergic receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Alpha-2C adrenergic receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Histamine H1 receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,5-hydroxytryptamine receptor 1B,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,5-hydroxytryptamine receptor 2C,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,5-hydroxytryptamine receptor 3A,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,5-hydroxytryptamine receptor 6,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,D(1A) dopamine receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,D(4) dopamine receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Alpha-2B adrenergic receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,5-hydroxytryptamine receptor 1E,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,D(2) dopamine receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,D(1B) dopamine receptor,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Muscarinic acetylcholine receptor M1,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Muscarinic acetylcholine receptor M2,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Muscarinic acetylcholine receptor M3,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Muscarinic acetylcholine receptor M4,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole,Muscarinic acetylcholine receptor M5,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
Aripiprazole lauroxil,D(2) dopamine receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 1A,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 2A,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 1B,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 1D,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 1E,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,D(1A) dopamine receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,D(1B) dopamine receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,D(3) dopamine receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,D(4) dopamine receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 2C,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 3A,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 6,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,5-hydroxytryptamine receptor 7,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Histamine H1 receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Alpha-1A adrenergic receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Alpha-1B adrenergic receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Alpha-2A adrenergic receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Alpha-2B adrenergic receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Alpha-2C adrenergic receptor,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Muscarinic acetylcholine receptor M1,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Muscarinic acetylcholine receptor M2,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Muscarinic acetylcholine receptor M3,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Muscarinic acetylcholine receptor M4,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Aripiprazole lauroxil,Muscarinic acetylcholine receptor M5,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
Armodafinil,Sodium-dependent dopamine transporter,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1
Arotinoid acid,Retinoic acid receptor beta,C\C(=C/C1=CC=C(C=C1)C(O)=O)C1=CC=C2C(=C1)C(C)(C)CCC2(C)C
Arotinolol,Beta-1 adrenergic receptor,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O
Arotinolol,Beta-2 adrenergic receptor,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O
Arotinolol,Alpha-1A adrenergic receptor,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O
Arotinolol,Alpha-1B adrenergic receptor,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O
Arotinolol,Alpha-1D adrenergic receptor,CC(C)(C)NCC(O)CSC1=NC(=CS1)C1=CC=C(S1)C(N)=O
Arsanilic acid,Lysozyme C,NC1=CC=C(C=C1)[As](O)(O)=O
Arsenic trioxide,Inhibitor of nuclear factor kappa-B kinase subunit beta,O=[As]O[As]=O
Arsenic trioxide,"Thioredoxin reductase 1, cytoplasmic",O=[As]O[As]=O
Arsenic trioxide,Transcription factor AP-1,O=[As]O[As]=O
Arsenic trioxide,G1/S-specific cyclin-D1,O=[As]O[As]=O
Arsenic trioxide,Mitogen-activated protein kinase 3,O=[As]O[As]=O
Arsenic trioxide,Mitogen-activated protein kinase 1,O=[As]O[As]=O
Arsenic trioxide,RAC-alpha serine/threonine-protein kinase,O=[As]O[As]=O
Arsenic trioxide,Cyclin-dependent kinase inhibitor 1,O=[As]O[As]=O
Arsenic trioxide,Histone deacetylase 1,O=[As]O[As]=O
Arsenic trioxide,Protein PML,O=[As]O[As]=O
Arsenous acid,Arsenate reductase,O[As](O)O
Arsenous acid,Arsenical pump-driving ATPase,O[As](O)O
Artenimol,"Actin, cytoplasmic 2",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Alpha-aminoadipic semialdehyde dehydrogenase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Annexin A2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"ATP synthase subunit alpha, mitochondrial",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"ATP synthase subunit g, mitochondrial",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"ATP synthase subunit O, mitochondrial",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Calpastatin,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,T-complex protein 1 subunit gamma,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Cofilin-1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Chloride intracellular channel protein 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Cysteine and glycine-rich protein 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Dihydropyrimidinase-related protein 2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Desmoplakin,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Elongation factor 1-alpha 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Alpha-enolase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Filamin-A,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Alpha-ketoglutarate-dependent dioxygenase FTO,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Glucose-6-phosphate 1-dehydrogenase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Glucose-6-phosphate isomerase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Heterogeneous nuclear ribonucleoproteins A2/B1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Heterogeneous nuclear ribonucleoprotein D0,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Heterogeneous nuclear ribonucleoprotein K,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Heterochromatin protein 1-binding protein 3,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Heat shock protein beta-1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Ras GTPase-activating-like protein IQGAP1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Far upstream element-binding protein 2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,L-lactate dehydrogenase A chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,L-lactate dehydrogenase B chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Galectin-1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Microtubule-associated protein 4,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Malate dehydrogenase, cytoplasmic",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Puromycin-sensitive aminopeptidase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Profilin-1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Phosphoglycerate kinase 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Pyruvate kinase PKM,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Peptidyl-prolyl cis-trans isomerase A,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Peroxiredoxin-1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L10,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L14,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L18,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L23a,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L35,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L4,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S13,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S17,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S18,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S19,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S28,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S5,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S6,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S8,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S9,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Splicing factor 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Splicing factor, proline- and glutamine-rich",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Small nuclear ribonucleoprotein Sm D2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Signal recognition particle 14 kDa protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Serine/arginine-rich splicing factor 4,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Transgelin,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Transgelin-2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Triosephosphate isomerase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Tropomyosin alpha-1 chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Tubulin alpha-1A chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Vimentin,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Zyxin,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Heat shock cognate 71 kDa protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Tubulin beta-6 chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Tubulin beta-4A chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Tubulin beta chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Fructose-bisphosphate aldolase A,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Glyceraldehyde-3-phosphate dehydrogenase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Cytochrome c,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Phosphoglycerate mutase 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Myosin-9,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Protein disulfide-isomerase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Probable ATP-dependent RNA helicase DDX5,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Serine hydroxymethyltransferase, mitochondrial",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Spliceosome RNA helicase DDX39B,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Nucleophosmin,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Translationally-controlled tumor protein homolog,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,P-type Ca2+-transporting ATPase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Ornithine aminotransferase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Elongation factor 1-alpha,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Multidrug resistance protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Elongation factor 2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Actin-1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Glyceraldehyde-3-phosphate dehydrogenase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Fructose-bisphosphate aldolase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Cell division cycle protein 48 homologue,putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Heat shock protein 90,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Eukaryotic initiation factor 4A,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Pyruvate kinase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,L-lactate dehydrogenase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Protein disulfide-isomerase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Thioredoxin-related protein, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Spermidine synthase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Probable ATP-dependent 6-phosphofructokinase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Glutamate dehydrogenase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Endoplasmin homolog, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Enolase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S3,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Non-SERCA-type Ca2+-transporting P-ATPase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Tubulin alpha chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Knob-associated histidine-rich protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,S-adenosylmethionine synthase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"V-type H(+)-translocating pyrophosphatase, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L4,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Phosphoethanolamine N-methyltransferase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S3a,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Conserved Plasmodium membrane protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L3,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,High molecular weight rhoptry protein 2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Serine repeat antigen 5,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S19,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Glycophorin-binding protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Calcium-transporting ATPase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,V-type proton ATPase catalytic subunit A,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Acyl-CoA synthetase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Plasmepsin IV,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Plasmepsin-1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Chloroquine resistance transporter,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,14-3-3 protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Isoleucine--tRNA ligase, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Plasmodium exported protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Tubulin beta chain,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L27,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Sec62, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Autophagy-related protein 18, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Mature parasite-infected erythrocyte surface antigen,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Importin-7, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Peptidyl-prolyl cis-trans isomerase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"DnaJ protein, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Merozoite surface protein 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Glutamate--tRNA ligase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,T-complex protein 1 subunit eta,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Plasmepsin-2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Chaperone, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Rhoptry neck protein 3,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"40S ribosomal protein S5, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Skeleton-binding protein 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Purine nucleotide phosphorylase, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Adenosylhomocysteinase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Adenosine deaminase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Methionine--tRNA ligase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Carbamoyl phosphate synthetase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Aspartate carbamoyltransferase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Signal recognition particle receptor, beta subunit",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Parasite-infected erythrocyte surface protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Coatomer alpha subunit, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Hexokinase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Proteasome subunit alpha type,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Haloacid dehalogenase-like hydrolase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Insulinase, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,40S ribosomal protein S21,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Ubiquitin-conjugating enzyme E2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Eukaryotic translation initiation factor 3 subunit C,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"60S ribosomal protein L24, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L23,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"60S ribosomal protein L17, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,HAP protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Heat shock protein 110, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"60S ribosomal protein L10, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Lysophospholipase, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Polyadenylate-binding protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Ubiquitin-60S ribosomal protein L40,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Thioredoxin peroxidase 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Protein transport protein SEC31,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Dipeptidyl aminopeptidase 1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Ring-infected erythrocyte surface antigen,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,ATP-dependent RNA helicase UAP56,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Calcium-dependent protein kinase 4,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,GTP-binding nuclear protein Ran,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Nucleoside transporter 2,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Anamorsin homolog,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Glutamine synthetase, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"60S ribosomal protein L30e, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Casein kinase 2, alpha subunit",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Threonine--tRNA ligase,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,cAMP-dependent protein kinase regulatory subunit,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"Elongation factor 1-gamma, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Thioredoxin-like protein,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,60S ribosomal protein L21,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"60S ribosomal protein L14, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Inner membrane complex sub-compartment protein 3,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,"HSP40, subfamily A, putative",[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Pyridoxal 5'-phosphate synthase subunit Pdx1,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artenimol,Serum albumin,[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4
Artesunate,Malaria protein EXP-1,[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4
Arundic acid,Protein S100-B,CCCCCC[C@@H](CCC)C(O)=O
Arylacenamide,"HCG20471, isoform CRA_c",Cl.CCN(C\C=C/C1=CC(Cl)=C(C=C1)C1CCCCC1)C1CCCCC1
Arzoxifene,Estrogen receptor,COC1=CC=C(C=C1)C1=C(OC2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
Arzoxifene,Estrogen receptor beta,COC1=CC=C(C=C1)C1=C(OC2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
Ascorbic acid,Prolyl 4-hydroxylase subunit alpha-1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Dopamine beta-hydroxylase,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Solute carrier family 23 member 1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Xylose isomerase,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Hyaluronate lyase,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,"Phytanoyl-CoA dioxygenase, peroxisomal",[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Gamma-butyrobetaine dioxygenase,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Peptidyl-glycine alpha-amidating monooxygenase,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Prolyl 3-hydroxylase 1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,DNA oxidative demethylase ALKBH2,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Prolyl 3-hydroxylase 2,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Prolyl 3-hydroxylase 3,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Prolyl 3-hydroxylase OGFOD1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Egl nine homolog 2,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Lysine-specific demethylase 5D,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Egl nine homolog 1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Egl nine homolog 3,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,"Trimethyllysine dioxygenase, mitochondrial",[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Transmembrane prolyl 4-hydroxylase,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Ascorbic acid,Lactase-phlorizin hydrolase,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO
Asenapine,D(2) dopamine receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,5-hydroxytryptamine receptor 2A,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,5-hydroxytryptamine receptor 1A,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,5-hydroxytryptamine receptor 1B,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,5-hydroxytryptamine receptor 2B,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,5-hydroxytryptamine receptor 2C,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,5-hydroxytryptamine receptor 5A,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,5-hydroxytryptamine receptor 6,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,5-hydroxytryptamine receptor 7,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,Alpha-2A adrenergic receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,Alpha-2B adrenergic receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,Alpha-2C adrenergic receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,Alpha-1A adrenergic receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,D(1A) dopamine receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,D(3) dopamine receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,D(4) dopamine receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,Histamine H1 receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,Histamine H2 receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,Beta-1 adrenergic receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asenapine,Beta-2 adrenergic receptor,OC(=O)\C=C/C(O)=O.CN1CC2C(C1)C1=C(OC3=CC=CC=C23)C=CC(Cl)=C1
Asfotase alfa,Sphingosine 1-phosphate receptor 1,
Asimadoline,Kappa-type opioid receptor,CN([C@H](CN1CC[C@H](O)C1)C1=CC=CC=C1)C(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
Asoprisnil,Progesterone receptor,[H]\C(=N/O)C1=CC=C(C=C1)[C@@]1([H])C[C@@]2(C)[C@@]([H])(CC[C@]2(COC)OC)[C@]2([H])CCC3=CC(=O)CCC3=C12
Asparagine,Asparagine synthetase [glutamine-hydrolyzing],N[C@@H](CC(N)=O)C(O)=O
Asparagine,Neutral amino acid transporter B(0),N[C@@H](CC(N)=O)C(O)=O
Asparagine,Sodium-coupled neutral amino acid transporter 3,N[C@@H](CC(N)=O)C(O)=O
Asparagine,"Asparagine--tRNA ligase, cytoplasmic",N[C@@H](CC(N)=O)C(O)=O
Asparagine,Isoaspartyl peptidase/L-asparaginase,N[C@@H](CC(N)=O)C(O)=O
Asparagine,"Probable asparagine--tRNA ligase, mitochondrial",N[C@@H](CC(N)=O)C(O)=O
Aspartame,Taste receptor type 1 member 2,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O
Aspartame,Transient receptor potential cation channel subfamily V member 1,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O
Aspartame,Taste receptor type 1 member 3,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O
Aspartate Beryllium Trifluoride,Sugar phosphatase YbiV,N[C@@H](C[C@H](O)O[Be](F)(F)F)C(O)=O
Aspartate Beryllium Trifluoride,Chemotaxis protein CheY,N[C@@H](C[C@H](O)O[Be](F)(F)F)C(O)=O
Aspartate Beryllium Trifluoride,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,N[C@@H](C[C@H](O)O[Be](F)(F)F)C(O)=O
Aspartate Semialdehyde,Aspartate-semialdehyde dehydrogenase,[H][C@@](N)(CC=O)C(O)=O
Aspartic Acid-4-Carboxymethyl Ester,(S)-2-haloacid dehalogenase,N[C@@H](CC(=O)OCC(O)=O)C(O)=O
Aspartic acid,Aspartoacylase,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Asparagine synthetase [glutamine-hydrolyzing],N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Calcium-binding mitochondrial carrier protein Aralar1,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Calcium-binding mitochondrial carrier protein Aralar2,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,"Aspartate aminotransferase, mitochondrial",N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Aminoacylase-1,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Aspartyl/asparaginyl beta-hydroxylase,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,"Aspartate aminotransferase, cytoplasmic",N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Argininosuccinate synthase,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,"Aspartate--tRNA ligase, cytoplasmic",N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,"Argininosuccinate synthetase, isoform CRA_a",N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Excitatory amino acid transporter 3,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Aspartate aminotransferase,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Multifunctional protein ADE2,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,CAD protein,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Adenylosuccinate synthetase isozyme 2,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,"Aspartate--tRNA ligase, mitochondrial",N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Isoaspartyl peptidase/L-asparaginase,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Adenylosuccinate synthetase isozyme 1,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming),N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Ribonuclease pancreatic,N[C@@H](CC(O)=O)C(O)=O
Aspartic acid,Lysozyme C,N[C@@H](CC(O)=O)C(O)=O
Aspartyl-Adenosine-5'-Monophosphate,Aspartate--tRNA(Asp) ligase,[H][C@](N)(CC(O)=O)C(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Astaxanthin,NF-kappa-B inhibitor alpha,C\C(\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C(=O)[C@@H](O)CC1(C)C
Astemizole,Histamine H1 receptor,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1
Astemizole,Potassium voltage-gated channel subfamily H member 2,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1
Astemizole,Potassium voltage-gated channel subfamily H member 1,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1
Astemizole,Microtubule-associated protein tau,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1
Astodrimer,Envelope glycoprotein gp160,
Atazanavir,Pol polyprotein,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
Atenolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1
Atenolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1
Atezolizumab,Programmed cell death 1 ligand 1,
Atiprimod,Tumor necrosis factor,CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1
Atiprimod,Interleukin-6,CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1
Atl146e,Adenosine receptor A2a,
Atomoxetine,Sodium-dependent noradrenaline transporter,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,Sodium-dependent serotonin transporter,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,"Glutamate receptor ionotropic, NMDA 1",CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,"Glutamate receptor ionotropic, NMDA 2A",CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,"Glutamate receptor ionotropic, NMDA 2B",CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,"Glutamate receptor ionotropic, NMDA 2C",CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,"Glutamate receptor ionotropic, NMDA 2D",CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,"Glutamate receptor ionotropic, NMDA 3A",CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,"Glutamate receptor ionotropic, NMDA 3B",CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,G protein-activated inward rectifier potassium channel 1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atomoxetine,Kappa-type opioid receptor,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
Atorvastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
Atorvastatin,Dipeptidyl peptidase 4,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
Atorvastatin,Aryl hydrocarbon receptor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1
Atosiban,Oxytocin receptor,[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
Atosiban,Vasopressin V1a receptor,[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
Atosiban,Vasopressin V1b receptor,[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
Atosiban,Vasopressin V2 receptor,[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O
Atovaquone,Cytochrome b,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O
Atovaquone,"Dihydroorotate dehydrogenase (quinone), mitochondrial",OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O
Atovaquone,"Dihydroorotate dehydrogenase (quinone), mitochondrial",OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O
Atpenin A5,Succinate dehydrogenase flavoprotein subunit,[H][C@](C)(C[C@]([H])(C)[C@@]([H])(Cl)CCl)C(=O)C1=C(O)C(OC)=C(NC1=O)OC
Atpenin A5,Succinate dehydrogenase iron-sulfur subunit,[H][C@](C)(C[C@]([H])(C)[C@@]([H])(Cl)CCl)C(=O)C1=C(O)C(OC)=C(NC1=O)OC
Atpenin A5,Succinate dehydrogenase cytochrome b556 subunit,[H][C@](C)(C[C@]([H])(C)[C@@]([H])(Cl)CCl)C(=O)C1=C(O)C(OC)=C(NC1=O)OC
Atpenin A5,Succinate dehydrogenase hydrophobic membrane anchor subunit,[H][C@](C)(C[C@]([H])(C)[C@@]([H])(Cl)CCl)C(=O)C1=C(O)C(OC)=C(NC1=O)OC
Atracurium besylate,Neuronal acetylcholine receptor subunit alpha-2,[O-]S(=O)(=O)C1=CC=CC=C1.[O-]S(=O)(=O)C1=CC=CC=C1.COC1=CC2=C(C=C1OC)C(CC1=CC(OC)=C(OC)C=C1)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCC3=C(C=C(OC)C(OC)=C3)C1CC1=CC(OC)=C(OC)C=C1)CC2
Atrasentan,Endothelin-1 receptor,CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C1=CC=C(OC)C=C1)C(O)=O)C1=CC2=C(OCO2)C=C1
Atropine,Muscarinic acetylcholine receptor M1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Atropine,Muscarinic acetylcholine receptor M2,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Atropine,Muscarinic acetylcholine receptor M3,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Atropine,Muscarinic acetylcholine receptor M4,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Atropine,Muscarinic acetylcholine receptor M5,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Atropine,Glycine receptor subunit alpha-1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Atropine,Neuronal acetylcholine receptor subunit alpha-4,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Atropine,Neuronal acetylcholine receptor subunit beta-2,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Auranofin,"Peroxiredoxin-5, mitochondrial",CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O
Auranofin,Inhibitor of nuclear factor kappa-B kinase subunit beta,CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O
Aurodox,Elongation factor Tu-B,[H]\C(C)=C(/[H])\C(\[H])=C(/[H])[C@]1([H])O[C@](O)([C@]([H])(CC)C(O)=NC\C([H])=C(/[H])\C(\[H])=C(/C)[C@@]([H])(OC)[C@@]([H])(C)[C@]2([H])O[C@]([H])(C(\[H])=C(/[H])\C(\[H])=C(/[H])\C(\[H])=C(/C)C(=O)C3=C(O)C=CN(C)C3=O)[C@]([H])(O)[C@]2([H])O)[C@]([H])(O)[C@]([H])(O)C1(C)C
Aurothioglucose,Adenylate cyclase type 1,OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
Aurothioglucose,Adenylate cyclase type 2,OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
Aurothioglucose,Adenylate cyclase type 5,OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O
Avanafil,"cGMP-specific 3',5'-cyclic phosphodiesterase",COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1
Avasimibe,Liver carboxylesterase 1,CC(C)C1=CC(C(C)C)=C(CC(=O)NS(=O)(=O)OC2=C(C=CC=C2C(C)C)C(C)C)C(=C1)C(C)C
Avatrombopag,ATP-binding cassette sub-family G member 2,OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1
Avatrombopag,Thrombopoietin receptor,OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1
Avatrombopag,Solute carrier family 22 member 8,OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1
Avelumab,Programmed cell death 1 ligand 1,
Avibactam,Beta-lactamase TEM,[H]OS(=O)(=O)ON1C(=O)N2C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])C(=O)N([H])[H]
Avibactam,Beta-lactamase SHV-1,[H]OS(=O)(=O)ON1C(=O)N2C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])C(=O)N([H])[H]
Avibactam,Beta-lactamase SHV-2,[H]OS(=O)(=O)ON1C(=O)N2C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])C(=O)N([H])[H]
Avibactam,Beta-lactamase SHV-1,[H]OS(=O)(=O)ON1C(=O)N2C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])C(=O)N([H])[H]
Avibactam,Class D OXA-48 carbapenemase,[H]OS(=O)(=O)ON1C(=O)N2C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])C(=O)N([H])[H]
Avibactam,Carbapenem-hydrolyzing beta-lactamase KPC,[H]OS(=O)(=O)ON1C(=O)N2C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])C(=O)N([H])[H]
Avibactam,Beta-lactamase UOE-1,[H]OS(=O)(=O)ON1C(=O)N2C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])C(=O)N([H])[H]
Avibactam,Extended-spectrum beta-lactamase PER-1,[H]OS(=O)(=O)ON1C(=O)N2C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])C(=O)N([H])[H]
Axicabtagene ciloleucel,B-lymphocyte antigen CD19,
Axitinib,Vascular endothelial growth factor receptor 3,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
Axitinib,Vascular endothelial growth factor receptor 1,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
Axitinib,Vascular endothelial growth factor receptor 2,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
Azacitidine,DNA (cytosine-5)-methyltransferase 1,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Azatadine,Histamine H1 receptor,CN1CCC(CC1)=C1C2=CC=CC=C2CCC2=C1N=CC=C2
Azathioprine,Hypoxanthine-guanine phosphoribosyltransferase,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O
Azathioprine,Ras-related C3 botulinum toxin substrate 1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O
Azelaic acid,Thioredoxin reductase,OC(=O)CCCCCCCC(O)=O
Azelaic acid,3-oxo-5-beta-steroid 4-dehydrogenase,OC(=O)CCCCCCCC(O)=O
Azelaic acid,3-oxo-5-alpha-steroid 4-dehydrogenase 2,OC(=O)CCCCCCCC(O)=O
Azelaic acid,Tyrosinase,OC(=O)CCCCCCCC(O)=O
Azelaic acid,DNA polymerase I,OC(=O)CCCCCCCC(O)=O
Azelastine,Histamine H1 receptor,CN1CCCC(CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=CC=CC=C2C1=O
Azelnidipine,Voltage-dependent L-type calcium channel subunit beta-1,CC(C)OC(=O)C1=C(C)NC(N)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1
Azidocillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O
Azidocillin,Penicillin-binding protein 1b,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O
Azidocillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O
Azidocillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O
Azidocillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N=[N+]=[N-])C1=CC=CC=C1)C(O)=O
Azilsartan medoxomil,Type-1 angiotensin II receptor,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1
Azimilide,Potassium voltage-gated channel subfamily H member 2,CN1CCN(CCCCN2C(=O)CN(N=CC3=CC=C(O3)C3=CC=C(Cl)C=C3)C2=O)CC1
Azimilide,Potassium voltage-gated channel subfamily E member 1,CN1CCN(CCCCN2C(=O)CN(N=CC3=CC=C(O3)C3=CC=C(Cl)C=C3)C2=O)CC1
Azimilide,Potassium voltage-gated channel subfamily KQT member 1,CN1CCN(CCCCN2C(=O)CN(N=CC3=CC=C(O3)C3=CC=C(Cl)C=C3)C2=O)CC1
Azithromycin,Protein-arginine deiminase type-4,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
Azlocillin,Penicillin-binding protein 1A,[H][C@](NC(=O)N1CCNC1=O)(C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@]12[H])C1=CC=CC=C1
Aztreonam,Penicillin-binding protein 3,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
Aztreonam,Beta-lactamase,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
B-2-Octylglucoside,Protein-glutamine gamma-glutamyltransferase E,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-2-Octylglucoside,"DNA polymerase I, thermostable",[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-2-Octylglucoside,Aquaporin Z,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-2-Octylglucoside,H subunit of photosynthetic reaction center complex,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-2-Octylglucoside,Aquaporin Z,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-2-Octylglucoside,Cytochrome b,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-2-Octylglucoside,Ubiquinol-cytochrome c reductase iron-sulfur subunit,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-2-Octylglucoside,Cytochrome c1,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-2-Octylglucoside,Rhodopsin,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OCCCCCCCC
B-nonylglucoside,Cytochrome c oxidase subunit 1,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Cytochrome c oxidase subunit 2,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Cytochrome c oxidase polypeptide 2A,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Rhodopsin,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Aquaporin-1,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Colipase,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Pancreatic triacylglycerol lipase,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Cytochrome c oxidase subunit 1,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Cytochrome c oxidase subunit 2,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Lens fiber major intrinsic protein,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Rhomboid protease GlpG,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,G protein-activated inward rectifier potassium channel 1,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Putative inward rectifier potassium channel,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
B-nonylglucoside,Arginine/agmatine antiporter,CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
BENZOTHIAZOLE,Prothrombin,[H][C@](N)(CCCNC(N)=N)C(=O)C1=NC2=CC=CC=C2S1
BENZOTHIAZOLE,Aryl hydrocarbon receptor,[H][C@](N)(CCCNC(N)=N)C(=O)C1=NC2=CC=CC=C2S1
"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",Collagenase 3,O=C(OCC1=CC=CC=C1)C1=CN2C(S1)=CC(=O)N(CC1=CC=CC=C1)C2=O
"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",Cathepsin B,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)NCCC)C(=O)N1CCC[C@@]1([H])C(=O)OCC1=CC=CC=C1
BETA-METHYLLACTOSIDE,Histo-blood group ABO system transferase,CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
BIA,Catechol O-methyltransferase,OC1=CC(=CC(=C1O)[N+]([O-])=O)C(=O)CCN1CCN(CC1)C1=CC(=CC=C1)C(F)(F)F
BIOTINOL-5-AMP,Bifunctional ligase/repressor BirA,NC1=C2N=CN([C@@H]3O[C@H](CO[P@@](O)(=O)OCCCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)[C@@H](O)[C@H]3O)C2=NC=N1
"BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE",Serum amyloid P-component,[H][C@@]1(CO[C@](C)(OC1)C(O)=O)OC(O)=NCCN=C(O)O[C@@]1([H])CO[C@](C)(OC1)C(O)=O
"BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE",Serum amyloid P-component,[H][C@@]1(CO[C@](C)(OC1)C(O)=O)OC(=O)N1CCN(CC1)C(=O)O[C@@]1([H])CO[C@](C)(OC1)C(O)=O
BL-1020,5-hydroxytryptamine receptor 2A,
BL-1020,D(2) dopamine receptor,
BMS-488043,Free fatty acid receptor 4,COC1=C2C(NC=C2C(=O)C(=O)N2CCN(CC2)C(=O)C2=CC=CC=C2)=C(OC)N=C1
BMS-564929,Androgen receptor,[H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=C(C)C(Cl)=C(C=C1)C#N
BMS184394,Retinoic acid receptor gamma,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)[C@@H](O)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O
BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA,D-alanyl-D-alanine carboxypeptidase DacA,C[C@@H](NC(=O)[C@H](CCCCNC(=O)OCC1=CC=CC=C1)NC(=O)CC[C@H](NC(=O)OC(C)(C)C)C(O)=O)B(O)O
BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA,D-alanyl-D-alanine carboxypeptidase DacA,C[C@@H](NC(=O)[C@H](CCCCNC(=O)OCC1=CC=CC=C1)NC(=O)CC[C@H](NC(=O)OC(C)(C)C)C(O)=O)B(O)O
BTA9881,Fusion glycoprotein F0,
"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",Neutrophil collagenase,ClC1=CC=C(C=C1)C1=NN\C(SC1)=N\CCC=C
BV1,Cholera enterotoxin subunit B,[H]C1(CO)OC([H])(OC2=CC(=CC(=C2)N(=O)=O)C(O)=NCCCN2CCN(CCCNC3=C(NCCCN4CCN(CCCN=C(O)C5=CC(=CC(O[C@@]6([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]6([H])O)=C5)N(=O)=O)CC4)C(=O)C3=O)CC2)C([H])(O)C([H])(O)C1([H])O
BV2,Cholera enterotoxin subunit B,[H]C(N)(COC(O)=NCCCN1CCN(CCCN=C(O)C2=CC(=CC(OC3([H])OC([H])(CO)C([H])(O)C([H])(O)C3([H])O)=C2)N(=O)=O)CC1)COC(O)=NCCCN1CCN(CCCN=C(O)C2=CC(=CC(O[C@@]3([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]3([H])O)=C2)N(=O)=O)CC1
BV3,Cholera enterotoxin subunit B,[H]C(N)(COC(O)=NCCNC1=C(NCCCN2CCN(CCCN=C(O)C3=CC(=CC(OC4([H])OC([H])(CO)C([H])(O)C([H])(O)C4([H])O)=C3)N(=O)=O)CC2)C(=O)C1=O)COC(O)=NCCNC1=C(NCCCN2CCN(CCCN=C(O)C3=CC(=CC(O[C@@]4([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]4([H])O)=C3)N(=O)=O)CC2)C(=O)C1=O
BV4,Cholera enterotoxin subunit B,[H]C(N)(COC(O)=NCCCOCCOCCOCCCNC1=C(NCCCN2CCN(CCCN=C(O)C3=CC(=CC(OC4([H])OC([H])(CO)C([H])(O)C([H])(O)C4([H])O)=C3)N(=O)=O)CC2)C(=O)C1=O)COC(O)=NCCCOCCOCCOCCCNC1=C(NCCCN2CCN(CCCN=C(O)C3=CC(=CC(O[C@@]4([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]4([H])O)=C3)N(=O)=O)CC2)C(=O)C1=O
Bacampicillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OC(C)OC(=O)OCC
Bacitracin,Insulin-degrading enzyme,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC
Bacitracin,Alpha-2-macroglobulin,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC
Baclofen,Gamma-aminobutyric acid type B receptor subunit 1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1
Baclofen,Gamma-aminobutyric acid type B receptor subunit 2,NCC(CC(O)=O)C1=CC=C(Cl)C=C1
Bacteriochlorophyll A,Bacteriochlorophyll a protein,[H][C@]1(CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)\C2=C\C3=C(C)C(C(C)=O)=C4\C=C5/N=C(/C=C6\N([Mg]N34)C3=C([C@@H](C(=O)OC)C(=O)C3=C6C)C1=N2)[C@H](CC)[C@H]5C
Bacteriochlorophyll A,Bacteriochlorophyll a protein,[H][C@]1(CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)\C2=C\C3=C(C)C(C(C)=O)=C4\C=C5/N=C(/C=C6\N([Mg]N34)C3=C([C@@H](C(=O)OC)C(=O)C3=C6C)C1=N2)[C@H](CC)[C@H]5C
Bafilomycin A1,V-type proton ATPase catalytic subunit A,CO[C@H]1\C=C\C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O)[C@H](C)[C@H](O1)C(C)C
Bafilomycin B1,V-type proton ATPase catalytic subunit A,CO[C@H]1\C=C/C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(\C)/C=C(OC)\C(=O)OC1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](OC(=O)\C=C\C(=O)NC2=C(O)CCC2=O)[C@H](C)[C@H](O1)C(C)C
Balanol,cAMP-dependent protein kinase catalytic subunit alpha,OC(=O)C1=CC=CC(O)=C1C(=O)C1=C(O)C=C(C=C1O)C(=O)O[C@@H]1CCCNC[C@@H]1NC(=O)C1=CC=C(O)C=C1
Balanol Analog 1,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@]1(CNCCC[C@@]1([H])OC(=O)C1=CC=C(O)C=C1)NC(=O)C1=CC=C(O)C=C1
Balanol Analog 2,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@]1(CNCCC[C@@]1([H])OC(=O)C1=CC=C(C=C1)C(=O)C1=CC=CC=C1O)NC(=O)C1=CC=C(O)C=C1
Balanol Analog 8,cAMP-dependent protein kinase catalytic subunit alpha,[H][C@](C)(CC)C1=C(O)C=CC(=C1)C(O)=N[C@]1([H])CNCCC[C@@]1([H])OC(=O)C1=CC=C(C=C1)C(=O)C1=C(O)C=CC(OC)=C1
Balsalazide,Peroxisome proliferator-activated receptor gamma,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
Balsalazide,Prostaglandin G/H synthase 2,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
Balsalazide,Prostaglandin G/H synthase 1,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
Balsalazide,Arachidonate 5-lipoxygenase,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
Bambuterol,Beta-2 adrenergic receptor,CN(C)C(=O)OC1=CC(=CC(OC(=O)N(C)C)=C1)C(O)CNC(C)(C)C
Banoxantrone,DNA topoisomerase 2-alpha,C[N+](C)([O-])CCNC1=CC=C(NCC[N+](C)(C)[O-])C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O
Barbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,Neuronal acetylcholine receptor subunit alpha-4,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,Neuronal acetylcholine receptor subunit alpha-7,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,Glutamate receptor 2,CCC1(CC)C(=O)NC(=O)NC1=O
Barbital,"Glutamate receptor ionotropic, kainate 2",CCC1(CC)C(=O)NC(=O)NC1=O
Barbituric acid derivative,Gamma-aminobutyric acid receptor subunit alpha-1,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,Gamma-aminobutyric acid receptor subunit alpha-2,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,Gamma-aminobutyric acid receptor subunit alpha-3,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,Gamma-aminobutyric acid receptor subunit alpha-4,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,Gamma-aminobutyric acid receptor subunit alpha-5,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,Gamma-aminobutyric acid receptor subunit alpha-6,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,Neuronal acetylcholine receptor subunit alpha-4,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,Neuronal acetylcholine receptor subunit alpha-7,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,Glutamate receptor 2,FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Barbituric acid derivative,"Glutamate receptor ionotropic, kainate 2",FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1
Bardoxolone,Caspase-8,CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C1[C@@]2(C)C=C(C#N)C(=O)C(C)(C)[C@@H]2CC[C@@]31C)C(O)=O
Bardoxolone methyl,NF-kappa-B inhibitor alpha,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2
Baricitinib,Tyrosine-protein kinase JAK1,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
Baricitinib,Tyrosine-protein kinase JAK2,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
Baricitinib,Protein-tyrosine kinase 2-beta,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
Baricitinib,Tyrosine-protein kinase JAK3,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
Barnidipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@H]1CCN(CC2=CC=CC=C2)C1
Basifungin,Inositol phosphorylceramide synthase,CC[C@@H](C)[C@@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)C(NC1=O)C(C)C)[C@H](C)C(C)C
Basiliximab,Interleukin-2 receptor subunit alpha,
Basiliximab,Interleukin-2 receptor subunit beta,
Basiliximab,High affinity immunoglobulin gamma Fc receptor I,
Basiliximab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Basiliximab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Basiliximab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Basiliximab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Basiliximab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Basiliximab,Complement C1s subcomponent,
Basiliximab,Complement C1r subcomponent,
Basiliximab,Complement C1q subcomponent subunit A,
Basiliximab,Complement C1q subcomponent subunit B,
Basiliximab,Complement C1q subcomponent subunit C,
Batimastat,Neutrophil collagenase,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)[C@]([H])(CSC1=CC=CS1)C(=O)NO)C(=O)NC
Batimastat,Macrophage metalloelastase,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)[C@]([H])(CSC1=CC=CS1)C(=O)NO)C(=O)NC
Batimastat,Matrix metalloproteinase-16,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)[C@]([H])(CSC1=CC=CS1)C(=O)NO)C(=O)NC
Batimastat,Disintegrin and metalloproteinase domain-containing protein 28,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)[C@]([H])(CSC1=CC=CS1)C(=O)NO)C(=O)NC
Batimastat,A disintegrin and metalloproteinase with thrombospondin motifs 5,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)[C@]([H])(CSC1=CC=CS1)C(=O)NO)C(=O)NC
Bazedoxifene,Estrogen receptor,CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1
Bazedoxifene,Estrogen receptor beta,CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1
Bb-3497,Peptide deformylase,[H][C@@](CCCC)(CN(O)C=O)C(=O)N[C@]([H])(C(=O)N(C)C)C(C)(C)C
Bb-3497,"Peptide deformylase, mitochondrial",[H][C@@](CCCC)(CN(O)C=O)C(=O)N[C@]([H])(C(=O)N(C)C)C(C)(C)C
Becaplermin,Platelet-derived growth factor receptor beta,
Becaplermin,Platelet-derived growth factor receptor alpha,
Becaplermin,Alpha-2-macroglobulin,
Becatecarin,DNA topoisomerase 2-alpha,CCN(CC)CCN1C(=O)C2=C(C1=O)C1=C(N([C@@H]3O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]3O)C3=C(Cl)C=CC=C13)C1=C2C2=C(N1)C(Cl)=CC=C2
Becatecarin,DNA topoisomerase 2-beta,CCN(CC)CCN1C(=O)C2=C(C1=O)C1=C(N([C@@H]3O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]3O)C3=C(Cl)C=CC=C13)C1=C2C2=C(N1)C(Cl)=CC=C2
Beclomethasone dipropionate,Glucocorticoid receptor,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Becocalcidiol,Mediator of RNA polymerase II transcription subunit 1,CC[C@@](C)([H])[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1/C[C@](O)([H])C(=C)[C@]([H])(O)C1
Becocalcidiol,Vitamin D3 receptor,CC[C@@](C)([H])[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1/C[C@](O)([H])C(=C)[C@]([H])(O)C1
Bedaquiline,ATP synthase subunit c,COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C1=CC=CC=C1)[C@@](O)(CCN(C)C)C1=CC=CC2=C1C=CC=C2
Bedoradrine,Beta-2 adrenergic receptor,CN(C)C(=O)COC1=CC=C2CC[C@@H](CC2=C1)NC[C@H](O)C1=CC=C(O)C(CCO)=C1
Befunolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC2=C1OC(=C2)C(C)=O
Befunolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC2=C1OC(=C2)C(C)=O
Belatacept,T-lymphocyte activation antigen CD86,
Belatacept,T-lymphocyte activation antigen CD80,
Belimumab,Tumor necrosis factor ligand superfamily member 13B,
Belinostat,Histone deacetylase 1,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 10,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 11,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 2,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 3,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 4,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 5,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 6,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 7,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 8,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Belinostat,Histone deacetylase 9,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
Bemiparin,Coagulation factor X,
Bemiparin,Antithrombin-III,
Bemiparin,Heparin cofactor 2,
Benazepril,Angiotensin-converting enzyme,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC
Bendazac,Prostaglandin G/H synthase 1,OC(=O)COC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12
Bendazac,Prostaglandin G/H synthase 2,OC(=O)COC1=NN(CC2=CC=CC=C2)C2=CC=CC=C12
Bendroflumethiazide,Solute carrier family 12 member 3,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
Bendroflumethiazide,Calcium-activated potassium channel subunit alpha-1,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
Bendroflumethiazide,Carbonic anhydrase 1,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
Bendroflumethiazide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
Bendroflumethiazide,Carbonic anhydrase 4,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
Benidipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent L-type calcium channel subunit alpha-1F,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent L-type calcium channel subunit beta-1,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent L-type calcium channel subunit beta-2,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent L-type calcium channel subunit beta-3,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent L-type calcium channel subunit beta-4,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent N-type calcium channel subunit alpha-1B,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent T-type calcium channel subunit alpha-1G,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent T-type calcium channel subunit alpha-1H,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benidipine,Voltage-dependent T-type calcium channel subunit alpha-1I,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1
Benralizumab,Interleukin-5 receptor subunit alpha,
Benralizumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Benserazide,Aromatic-L-amino-acid decarboxylase,NC(CO)C(=O)NNCC1=C(O)C(O)=C(O)C=C1
Bentiromide,Serine protease hepsin,OC(=O)C1=CC=C(NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)C2=CC=CC=C2)C=C1
Benzamidine,Urokinase-type plasminogen activator,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Casein kinase II subunit alpha,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Trypsin-3,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Kallikrein-6,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Trypsin,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Suppressor of tumorigenicity 14 protein,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Trypsin-1,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,"Enoyl-CoA delta isomerase 1, mitochondrial",NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Copper transport protein ATOX1,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Trypsin-2,NC(=[NH2+])C1=CC=CC=C1
Benzamidine,Kallikrein-1,NC(=[NH2+])C1=CC=CC=C1
Benzatropine,Muscarinic acetylcholine receptor M1,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
Benzatropine,Sodium-dependent dopamine transporter,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
Benzatropine,Histamine H1 receptor,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
Benzatropine,Sodium-dependent serotonin transporter,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
Benzatropine,Sodium-dependent noradrenaline transporter,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
Benzbromarone,Cytochrome P450 2C9,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1
Benzbromarone,Cytochrome P450 2C19,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1
Benzene Hexacarboxylic Acid,Phosphoglycerate mutase 2,OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O
Benzenesulfinic acid,Oxysterols receptor LXR-beta,O[S@@](=O)C1=CC=CC=C1
Benzimidazole,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,N1C=NC2=CC=CC=C12
Benzo[B]Thiophene-2-Boronic Acid,Beta-lactamase,OB(O)C1=CC2=C(S1)C=CC=C2
Benzo[B]Thiophene-2-Carboxamidine,Trypsin-1,NC(=[NH2+])C1=CC2=C(S1)C=CC=C2
Benzocaine,Sodium channel protein type 10 subunit alpha,CCOC(=O)C1=CC=C(N)C=C1
Benzofuran,Endolysin,O1C=CC2=C1C=CC=C2
Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,Cathepsin K,[H][C@@](CC(C)C)(N=C(O)C1=CC2=CC=CC=C2O1)C(O)=N[C@@]1([H])CCCN(CC1=O)S(=O)(=O)C1=CC=CC=N1
Benzoic Acid,"Peroxiredoxin-5, mitochondrial",OC(=O)C1=CC=CC=C1
Benzoic Acid,Cocaine esterase,OC(=O)C1=CC=CC=C1
Benzoic Acid,Heat-labile enterotoxin B chain,OC(=O)C1=CC=CC=C1
Benzoic Acid,Tautomerase PptA,OC(=O)C1=CC=CC=C1
Benzoic Acid,Ribonuclease UK114,OC(=O)C1=CC=CC=C1
Benzoic Acid,HTH-type transcriptional regulator MalT,OC(=O)C1=CC=CC=C1
Benzoic Acid,Ras-related protein Rab-9A,OC(=O)C1=CC=CC=C1
Benzoic Acid,"Chlorocatechol 1,2-dioxygenase",OC(=O)C1=CC=CC=C1
Benzoic Acid,Hydrogen peroxide-inducible genes activator,OC(=O)C1=CC=CC=C1
Benzoic Acid,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",OC(=O)C1=CC=CC=C1
Benzoic Acid,Oxygen-insensitive NAD(P)H nitroreductase,OC(=O)C1=CC=CC=C1
Benzoic Acid,Non-heme chloroperoxidase,OC(=O)C1=CC=CC=C1
Benzoic Acid,"Hydroxyquinol 1,2-dioxygenase",OC(=O)C1=CC=CC=C1
Benzoic Acid,Replication protein,OC(=O)C1=CC=CC=C1
Benzoic Acid,D-amino-acid oxidase,OC(=O)C1=CC=CC=C1
Benzoic Acid,Solute carrier family 15 member 1,OC(=O)C1=CC=CC=C1
Benzonatate,Sodium channel protein type 5 subunit alpha,CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC
Benzophenone,Estrogen receptor,O=C(C1=CC=CC=C1)C1=CC=CC=C1
Benzophenone,Estrogen receptor beta,O=C(C1=CC=CC=C1)C1=CC=CC=C1
Benzoyl-Arginine-Alanine-Methyl Ketone,Cruzipain,[H][C@@](C)(N=C(O)[C@]([H])(CCCNC(N)N)N=C(O)OCC1=CC=CC=C1)C(=O)CF
Benzoyl-Arginine-Alanine-Methyl Ketone,Cathepsin F,[H][C@@](C)(N=C(O)[C@]([H])(CCCNC(N)N)N=C(O)OCC1=CC=CC=C1)C(=O)CF
Benzoylformic Acid,Hydroxyacid oxidase 1,OC(=O)C(=O)C1=CC=CC=C1
Benzphetamine,Synaptic vesicular amine transporter,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
Benzphetamine,Alpha-2A adrenergic receptor,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
Benzphetamine,Alpha-1A adrenergic receptor,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
Benzphetamine,Sodium-dependent dopamine transporter,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1
Benzquinamide,Histamine H1 receptor,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O
Benzquinamide,Muscarinic acetylcholine receptor M4,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O
Benzquinamide,Muscarinic acetylcholine receptor M1,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O
Benzquinamide,Muscarinic acetylcholine receptor M5,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O
Benzquinamide,Muscarinic acetylcholine receptor M2,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O
Benzquinamide,Muscarinic acetylcholine receptor M3,CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O
Benzthiazide,Solute carrier family 12 member 3,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
Benzthiazide,Carbonic anhydrase 1,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
Benzthiazide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
Benzthiazide,Carbonic anhydrase 4,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
Benzthiazide,Carbonic anhydrase 9,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
Benzthiazide,Carbonic anhydrase 12,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O
Benzylamine,Trypsin-1,NCC1=CC=CC=C1
Benzylamine,Trypsin-2,NCC1=CC=CC=C1
Benzylcysteine,Methylated-DNA--protein-cysteine methyltransferase,N[C@@H](CSCC1=CC=CC=C1)C(O)=O
Benzylpenicillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O
Benzylpenicillin,Beta-lactamase TEM,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O
Benzylpenicillin,Solute carrier family 22 member 8,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O
Benzylpenicillin,Solute carrier family 15 member 1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O
Benzylpenicillin,Solute carrier family 15 member 2,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O
Benzylpenicilloyl Polylysine,High affinity immunoglobulin epsilon receptor subunit alpha,
Benzylpenicilloyl Polylysine,High affinity immunoglobulin epsilon receptor subunit gamma,
Benzylsulfinic Acid,Chymase,OS(=O)(=O)CC1=CC=CC=C1
Benzylsulfinic Acid,Subtilisin BPN',OS(=O)(=O)CC1=CC=CC=C1
Benzylsulfinic Acid,Sigma factor SigB regulation protein RsbQ,OS(=O)(=O)CC1=CC=CC=C1
Benzylsulfinic Acid,Serine protease hepsin,OS(=O)(=O)CC1=CC=CC=C1
Benzylsulfinic Acid,Extracellular subtilisin-like serine proteinase,OS(=O)(=O)CC1=CC=CC=C1
Benzylsulfinic Acid,Carboxylesterase 2,OS(=O)(=O)CC1=CC=CC=C1
Benzylsulfinic Acid,"Superoxide dismutase [Mn], mitochondrial",OS(=O)(=O)CC1=CC=CC=C1
Bepotastine,Histamine H1 receptor,OC(=O)CCCN1CCC(CC1)OC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
Bepridil,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,Voltage-dependent T-type calcium channel subunit alpha-1H,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,Voltage-dependent calcium channel subunit alpha-2/delta-2,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,Sodium/potassium-transporting ATPase subunit alpha-1,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,Potassium voltage-gated channel subfamily KQT member 1,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,"Troponin C, slow skeletal and cardiac muscles",CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,Calmodulin,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Bepridil,Potassium voltage-gated channel subfamily H member 2,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1
Beraprost,Prostacyclin receptor,[Na+].[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C1=CC=CC(CCCC([O-])=O)=C1O2
Berberine,HTH-type transcriptional regulator QacR,COC1=CC=C2C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=CC2=C1OC
Berberine,Baculoviral IAP repeat-containing protein 5,COC1=CC=C2C=C3C4=CC5=C(OCO5)C=C4CC[N+]3=CC2=C1OC
Besifloxacin,DNA topoisomerase 4 subunit A,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O
Besifloxacin,DNA topoisomerase 4 subunit A,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O
Besifloxacin,DNA gyrase subunit A,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O
Besifloxacin,DNA gyrase subunit A,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O
Besilesomab,Carcinoembryonic antigen,
Beta(2-Thienyl)Alanine,Phenylalanine-4-hydroxylase,N[C@@H](CC1=CC=CS1)C(O)=O
Beta-(2-Naphthyl)-Alanine,"Tyrosine--tRNA ligase, cytoplasmic",[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(O)=O
Beta-(2-Naphthyl)-Alanine,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(O)=O
Beta-(2-Naphthyl)-Alanine,Prothrombin,[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(O)=O
Beta-3-Cysteine,Envelope glycoprotein gp160,[H][C@](N)(CS)CC(O)=O
Beta-3-Serine,Envelope glycoprotein gp160,[H][C@](CN)(CO)C(O)=O
Beta-Alanine,Pantothenate synthetase,NCCC(O)=O
Beta-Cyclohexyl-Alanine,Zinc finger Y-chromosomal protein,N[C@@H](CC1CCCCC1)C(O)=O
Beta-D-Fructopyranose,Fucose-binding lectin PA-IIL,OC[C@]1(O)OC[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Fucose,L-arabinose-binding periplasmic protein,C[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
Beta-D-Fucose,Arabinose operon regulatory protein,C[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
Beta-D-Glucopyranose Spirohydantoin,"Glycogen phosphorylase, muscle form",OC[C@H]1O[C@]2(NC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Glycogen phosphorylase, liver form",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Prostaglandin G/H synthase 1,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Glycogen phosphorylase, muscle form",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Interferon beta,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Galectin-7,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Glucokinase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Pulmonary surfactant-associated protein D,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Hexokinase-1,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Endoglucanase 5A,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Xylose isomerase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Cyclomaltodextrin glucanotransferase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Botulinum neurotoxin type B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Tail fiber protein,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Ferrichrome-iron receptor,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Chondroitinase-B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Xylose isomerase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Endoglucanase F,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Exoglucanase/xylanase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Cyclomaltodextrin glucanotransferase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Alpha-amylase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Neopullulanase 1,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Glucan 1,4-alpha-maltohexaosidase",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Tetanus toxin,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Neopullulanase 2,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Dimethyl sulfoxide/trimethylamine N-oxide reductase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Cholera enterotoxin subunit B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Glucan 1,4-alpha-maltotetraohydrolase",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Endoglucanase G,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Glucose--fructose oxidoreductase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Glucosamine-6-phosphate isomerase 1,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Alpha-amylase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Beta-glucanase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Alpha-amylase 1,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Maltodextrin phosphorylase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Quinoprotein glucose dehydrogenase B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Alpha-amylase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Cyclomaltodextrin glucanotransferase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Shiga-like toxin 1 subunit B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Beta-amylase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"ADP-ribose pyrophosphatase, mitochondrial",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Enterotoxin type B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Maltose-binding periplasmic protein,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Endoglucanase A,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,D-galactose-binding periplasmic protein,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Cellulose 1,4-beta-cellobiosidase (reducing end) CelS",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Cellulase B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Aspartate ammonia-lyase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Diacetyl reductase [(S)-acetoin forming],OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Pancreatic alpha-amylase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Amylase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Glucokinase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Fucose-binding lectin PA-IIL,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,BH0236 protein,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Laminarinase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Endo-1,4-beta-xylanase A",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Cellulase B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Endoglucanase C,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Adenine DNA glycosylase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Amylosucrase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Aldose 1-epimerase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Ecotin,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Malto-oligosyltrehalose trehalohydrolase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Putative monooxygenase MoxC,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Endo-1,4-beta-xylanase",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Beta-xylanase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Orf protein,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Capsid protein VP1,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Maltoporin,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Endoglucanase E1,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,D-galactose-binding periplasmic protein,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Neopullulanase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Endo-1,4-beta-xylanase A",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Maltoporin,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Hexokinase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Galectin-2,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Inorganic polyphosphate/ATP-glucomannokinase,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Endoglucanase C307,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,"Endo-1,4-beta glucanase EngF",OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Endoglucanase E-4,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Lactase-like protein,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Alpha-amylase 2B,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Myoglobin,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Keratin-associated protein 5-3,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Keratin-associated protein 5-2,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Glycosyltransferase 6 domain-containing protein 1,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Neurocan core protein,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Beta-D-Glucose,Sialoadhesin,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
"Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor",Bifunctional purine biosynthesis protein PURH,[H]\C(=C(\[H])C1=C(N=CN1[C@]1([H])O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@@]1([H])O)C(O)=N)C(=O)N(CC1=NC2=C(NC(=N)N=C2O)C=C1)C1=CC=C(C=C1)C(=O)N[C@@]([H])(CCC(O)=O)C(O)=O
Beta-Hydroxyaspartic Acid,Beta-lactamase TEM,N[C@@H]([C@@H](O)C(O)=O)C(O)=O
Beta-L-Arabinose,L-arabinose-binding periplasmic protein,OC[C@@H]1O[C@H](O)[C@H](O)[C@H]1O
Betadex,Neopullulanase 2,[H][C@]1(CO)O[C@]2([H])O[C@]3([H])[C@@]([H])(CO)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O[C@]6([H])[C@@]([H])(CO)O[C@]([H])(O[C@]7([H])[C@@]([H])(CO)O[C@]([H])(O[C@]8([H])[C@@]([H])(CO)O[C@]([H])(O[C@@]1([H])[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]8([H])O)[C@]([H])(O)[C@@]7([H])O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O
Betadex,Maltose-binding periplasmic protein,[H][C@]1(CO)O[C@]2([H])O[C@]3([H])[C@@]([H])(CO)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O[C@]6([H])[C@@]([H])(CO)O[C@]([H])(O[C@]7([H])[C@@]([H])(CO)O[C@]([H])(O[C@]8([H])[C@@]([H])(CO)O[C@]([H])(O[C@@]1([H])[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]8([H])O)[C@]([H])(O)[C@@]7([H])O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O
Betadex,Maltogenic amylase,[H][C@]1(CO)O[C@]2([H])O[C@]3([H])[C@@]([H])(CO)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O[C@]6([H])[C@@]([H])(CO)O[C@]([H])(O[C@]7([H])[C@@]([H])(CO)O[C@]([H])(O[C@]8([H])[C@@]([H])(CO)O[C@]([H])(O[C@@]1([H])[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]8([H])O)[C@]([H])(O)[C@@]7([H])O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O
Betahistine,Histamine H1 receptor,CNCCC1=CC=CC=N1
Betahistine,Histamine H3 receptor,CNCCC1=CC=CC=N1
Betamethasone,Glucocorticoid receptor,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Betaxolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1
Betaxolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1
Betazole,Histamine H2 receptor,NCCC1=CC=NN1
Bethanechol,Muscarinic acetylcholine receptor M2,CC(C[N+](C)(C)C)OC(N)=O
Bethanechol,Muscarinic acetylcholine receptor M1,CC(C[N+](C)(C)C)OC(N)=O
Bethanechol,Muscarinic acetylcholine receptor M3,CC(C[N+](C)(C)C)OC(N)=O
Bethanechol,Muscarinic acetylcholine receptor M4,CC(C[N+](C)(C)C)OC(N)=O
Bethanidine,Alpha-2A adrenergic receptor,CN\C(NCC1=CC=CC=C1)=N/C
Bethanidine,Alpha-2B adrenergic receptor,CN\C(NCC1=CC=CC=C1)=N/C
Bethanidine,Alpha-2C adrenergic receptor,CN\C(NCC1=CC=CC=C1)=N/C
Bethanidine,ATP-sensitive inward rectifier potassium channel 1,CN\C(NCC1=CC=CC=C1)=N/C
Bethanidine,Beta-1 adrenergic receptor,CN\C(NCC1=CC=CC=C1)=N/C
Bethanidine,Beta-2 adrenergic receptor,CN\C(NCC1=CC=CC=C1)=N/C
Bethanidine,Beta-3 adrenergic receptor,CN\C(NCC1=CC=CC=C1)=N/C
Betrixaban,Coagulation factor X,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1
Bevacizumab,Vascular endothelial growth factor A,
Bevacizumab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Bevacizumab,Complement C1r subcomponent,
Bevacizumab,Complement C1q subcomponent subunit A,
Bevacizumab,Complement C1q subcomponent subunit B,
Bevacizumab,Complement C1q subcomponent subunit C,
Bevacizumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Bevacizumab,High affinity immunoglobulin gamma Fc receptor I,
Bevacizumab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Bevacizumab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Bevacizumab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Bevantolol,Beta-1 adrenergic receptor,COC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1
Bevantolol,Beta-2 adrenergic receptor,COC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1
Bevantolol,Alpha-1A adrenergic receptor,COC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1
Bevasiranib,Vascular endothelial growth factor A,
Bevirimat,Gag-Pol polyprotein,[H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O)C(C)=C
Bexarotene,Retinoic acid receptor RXR-alpha,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C
Bexarotene,Retinoic acid receptor RXR-beta,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C
Bexarotene,Retinoic acid receptor RXR-gamma,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C
Bezafibrate,Peroxisome proliferator-activated receptor alpha,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
Bezafibrate,Peroxisome proliferator-activated receptor delta,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
Bezafibrate,Peroxisome proliferator-activated receptor gamma,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
Bezafibrate,Nuclear receptor subfamily 1 group I member 2,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
Bezafibrate,Retinoic acid receptor RXR-alpha,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
Bezafibrate,Retinoic acid receptor RXR-beta,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
Bezafibrate,Retinoic acid receptor RXR-gamma,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
Bezlotoxumab,Toxin B,
Bicalutamide,Androgen receptor,CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
Bicifadine,Sodium-dependent noradrenaline transporter,CC1=CC=C(C=C1)C12CC1CNC2
Bicifadine,Sodium-dependent serotonin transporter,CC1=CC=C(C=C1)C12CC1CNC2
Bicifadine,D(2) dopamine receptor,CC1=CC=C(C=C1)C12CC1CNC2
Bicine,Plasminogen,OCCN(CCO)CC(O)=O
Bicine,Membrane-bound lytic murein transglycosylase B,OCCN(CCO)CC(O)=O
Bicine,UDP-galactopyranose mutase,OCCN(CCO)CC(O)=O
Bictegravir,Reverse transcriptase/RNaseH,OC1=C2N(C[C@H]3O[C@@H]4CC[C@@H](C4)N3C2=O)C=C(C(=O)NCC2=C(F)C=C(F)C=C2F)C1=O
Bictegravir,Integrase,OC1=C2N(C[C@H]3O[C@@H]4CC[C@@H](C4)N3C2=O)C=C(C(=O)NCC2=C(F)C=C(F)C=C2F)C1=O
Bifeprunox,5-hydroxytryptamine receptor 1A,O=C1NC2=C(O1)C(=CC=C2)N1CCN(CC2=CC(=CC=C2)C2=CC=CC=C2)CC1
Bifeprunox,D(2) dopamine receptor,O=C1NC2=C(O1)C(=CC=C2)N1CCN(CC2=CC(=CC=C2)C2=CC=CC=C2)CC1
Bifonazole,Lanosterol 14-alpha demethylase,C1=CN(C=N1)C(C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=CC=C1
Bifonazole,Cytochrome P450 2B6,C1=CN(C=N1)C(C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=CC=C1
Bilastine,Histamine H1 receptor,CCOCCN1C(=NC2=CC=CC=C12)C1CCN(CCC2=CC=C(C=C2)C(C)(C)C(O)=O)CC1
Bilh 434,Regulatory protein E2,[H][C@]1(O[C@@]2(C(=O)C3=C(C=C(C)C=C3)C2=O)[C@]([H])(C(O)=O)[C@]1([H])C(=O)NC1=CC=C(C=C1)C1=CSN=N1)C1=CC(Cl)=C(Cl)C=C1
Biliverdine IX Alpha,Flavin reductase (NADPH),CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(N1)\C=C1/N=C(/C=C2\NC(=O)C(C=C)=C2C)C(C)=C1CCC(O)=O
Biliverdine IX Alpha,Heme oxygenase 1,CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(N1)\C=C1/N=C(/C=C2\NC(=O)C(C=C)=C2C)C(C)=C1CCC(O)=O
Biliverdine IX Alpha,Myoglobin,CC1=C(C=C)\C(NC1=O)=C\C1=C(C)C(CCC(O)=O)=C(N1)\C=C1/N=C(/C=C2\NC(=O)C(C=C)=C2C)C(C)=C1CCC(O)=O
Bimatoprost,Prostaglandin E2 receptor EP1 subtype,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1
Bimatoprost,Prostaglandin F2-alpha receptor,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1
Bimatoprost,Prostaglandin E2 receptor EP3 subtype,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1
Bimoclomol,Heat shock factor protein 1,OC(CO\N=C(/Cl)C1=CN=CC=C1)CN1CCCCC1
Binimetinib,Tumor necrosis factor,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
Binimetinib,Interleukin-6,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
Binimetinib,Interleukin-1 beta,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
Binimetinib,Mitogen-activated protein kinase kinase kinase 1,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
Binimetinib,Dual specificity mitogen-activated protein kinase kinase 2,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
Binodenoson,Adenosine receptor A2a,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=C(N\N=C\C3CCCCC3)N=C12
Bioallethrin,Sodium channel protein,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent T-type calcium channel subunit alpha-1G,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent T-type calcium channel subunit alpha-1H,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent T-type calcium channel subunit alpha-1I,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent L-type calcium channel subunit alpha-1C,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent L-type calcium channel subunit alpha-1D,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent L-type calcium channel subunit alpha-1F,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent L-type calcium channel subunit alpha-1S,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent L-type calcium channel subunit beta-1,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent L-type calcium channel subunit beta-2,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent L-type calcium channel subunit beta-3,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Bioallethrin,Voltage-dependent L-type calcium channel subunit beta-4,CC(C)=C[C@@H]1[C@@H](C(=O)OC2CC(=O)C(CC=C)=C2C)C1(C)C
Biopterin,Dihydrofolate reductase,C[C@@H](O)[C@@H](O)C1=CN=C2N=C(N)NC(=O)C2=N1
Biopterin,Sepiapterin reductase,C[C@@H](O)[C@@H](O)C1=CN=C2N=C(N)NC(=O)C2=N1
Biopterin,6-pyruvoyl tetrahydrobiopterin synthase,C[C@@H](O)[C@@H](O)C1=CN=C2N=C(N)NC(=O)C2=N1
Biotin,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial",[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotin,Sodium-dependent multivitamin transporter,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotin,Biotin--protein ligase,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotin,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial",[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotin,"Propionyl-CoA carboxylase alpha chain, mitochondrial",[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotin,"Propionyl-CoA carboxylase beta chain, mitochondrial",[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotin,Acetyl-CoA carboxylase 1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotin,"Pyruvate carboxylase, mitochondrial",[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotin,Acetyl-CoA carboxylase 2,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
Biotinyl P-Nitroaniline,Streptavidin,[H][C@@]1(CCCCC(=O)NC2=CC=C(C=C2)[N+]([O-])=O)SC[C@]2([H])NC(=O)N[C@]12[H]
Biperiden,Muscarinic acetylcholine receptor M1,OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1
Biperiden,Neuronal acetylcholine receptor subunit alpha-2,OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1
"Biphenyl-2,3-Diol","Biphenyl-2,3-diol 1,2-dioxygenase",OC1=C(O)C(=CC=C1)C1=CC=CC=C1
"Biphenyl-2,3-Diol","Biphenyl-2,3-diol 1,2-dioxygenase",OC1=C(O)C(=CC=C1)C1=CC=CC=C1
"Biphenyl-2,3-Diol","1,2-dihydroxynaphthalene dioxygenase",OC1=C(O)C(=CC=C1)C1=CC=CC=C1
Biphenylalanine,Envelope glycoprotein gp160,[H][C@](N)(CC1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O
Biphenylalanine,Ig gamma-1 chain C region,[H][C@](N)(CC1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O
Biricodar,Multidrug resistance-associated protein 1,COC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)OC(CCCC1=CN=CC=C1)CCCC1=CN=CC=C1
Biricodar,ATP-binding cassette sub-family G member 2,COC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)OC(CCCC1=CN=CC=C1)CCCC1=CN=CC=C1
Biricodar,ATP-binding cassette sub-family B member 5,COC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)OC(CCCC1=CN=CC=C1)CCCC1=CN=CC=C1
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,Trypsin-1,NC(=N)C1=CC2=C(C=C1)N=C(N2)C(=O)C1=NC2=C(N1)C=CC(=C2)C([NH3+])=[NH2+]
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,Trypsin-1,NC(=N)C1=CC2=C(C=C1)N=C(N2)C(O)(O)C1=NC2=C(N1)C=C(C=C2)C([NH3+])=[NH2+]
Bis(5-Amidino-2-Benzimidazolyl)Methanone,Trypsin-1,NC(=N)C1=CC2=C(C=C1)N=C(N2)C(=O)C1=NC2=C(N1)C=CC(=C2)C(N)=N
Bis(5-Amidino-Benzimidazolyl)Methane,Botulinum neurotoxin type B,NC(=[NH2+])C1=CC2=C(C=C1)N=C(CC1=NC3=C(N1)C=C(C=C3)C([NH3+])=[NH2+])N2
Bis(5-Amidino-Benzimidazolyl)Methane,Trypsin-1,NC(=[NH2+])C1=CC2=C(C=C1)N=C(CC1=NC3=C(N1)C=C(C=C3)C([NH3+])=[NH2+])N2
Bis(5-Amidino-Benzimidazolyl)Methane Zinc,Trypsin-1,[H]N=C(N)C1=CC2=C(C=C1)N1[Zn]N3C(CC1=[NH+]2)=[NH+]C1=C3C=CC(=C1)C(N)=N[H]
Bis(5-Amidino-Benzimidazolyl)Methanone Zinc,Trypsin-1,NC(N)C1=CC2=C(C=C1)[N+]1=C(N2)C(=O)C2=[N+]([Zn]1)C1=C(N2)C=C(C=C1)C(N)N
Bis(Adenosine)-5'-Pentaphosphate,Adenylate kinase,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Bis(Adenosine)-5'-Pentaphosphate,Adenylate kinase,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Bis(Adenosine)-5'-Pentaphosphate,Adenylate kinase,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Bis(Adenosine)-5'-Pentaphosphate,Adenylate kinase,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Bis(Adenosine)-5'-Pentaphosphate,Adenylate kinase isoenzyme 1,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Bis(Adenosine)-5'-Pentaphosphate,"Adenylate kinase 2, mitochondrial",[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Bis(Adenosine)-5'-Pentaphosphate,Adenylate kinase 8,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Bis(Adenosine)-5'-Triphosphate,Dephospho-CoA kinase,[H][C@]1(COP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Bis-Benzamidine,Trypsin-1,[H][C@@]1(CC2=CC=C(C=C2)C(N)=N)CCCC[C@@]([H])(CC2=CC=C(C=C2)C(N)=N)C1=O
Bis-Napthyl Beta-Ketophosphonic Acid,Cathepsin G,[H][C@](C(=O)C1=CC2=CC=CC=C2C=C1)(C1=CC=CC2=CC=CC=C12)P(O)(O)=O
Bisegliptin,Dipeptidyl peptidase 4,[H][C@@]1(F)CN(C(=O)CNC23CCC(CC2)(CC3)C(=O)OCC)[C@@]([H])(C1)C#N
"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",Oxygen-insensitive NAD(P)H nitroreductase,[H][C@@]1(C[C@@]2([H])C(=O)OC3=C(C=CC=C3)C2=O)C(=O)OC2=CC=CC=C2C1=O
"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",NAD(P)H dehydrogenase [quinone] 1,[H][C@@]1(C[C@@]2([H])C(=O)OC3=C(C=CC=C3)C2=O)C(=O)OC2=CC=CC=C2C1=O
"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",FMN-dependent NADH-azoreductase,[H][C@@]1(C[C@@]2([H])C(=O)OC3=C(C=CC=C3)C2=O)C(=O)OC2=CC=CC=C2C1=O
Bismuth subcitrate potassium,ATP-dependent Clp protease ATP-binding subunit ClpX,[K+].[K+].[K+].[K+].[K+].[Bi+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O
Bisoprolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1
Bisoprolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1
Bitolterol,Beta-2 adrenergic receptor,CC1=CC=C(C=C1)C(=O)OC1=C(OC(=O)C2=CC=C(C)C=C2)C=C(C=C1)C(O)CNC(C)(C)C
Bivalirudin,Prothrombin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O
Bivatuzumab,CD44 antigen,
Bleomycin,DNA ligase 1,C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(N)=NC(=N1)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)C1=CN=CN1)C(=O)NCCC1=NC(=CS1)C1=NC(=CS1)C(=O)NCCC[S+](C)C
Bleomycin,DNA ligase 3,C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(N)=NC(=N1)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)C1=CN=CN1)C(=O)NCCC1=NC(=CS1)C1=NC(=CS1)C(=O)NCCC[S+](C)C
Blinatumomab,B-lymphocyte antigen CD19,
Blinatumomab,T-cell surface glycoprotein CD3 delta chain,
Blonanserin,D(2) dopamine receptor,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
Blonanserin,D(3) dopamine receptor,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
Blonanserin,5-hydroxytryptamine receptor 2A,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
Bmsc-0013,Cholera enterotoxin subunit B,[H][C@]1(CO)O[C@@]([H])(N=C(O)CCCCCN=C(O)OC)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Boceprevir,Genome polyprotein,[H][C@]12CN([C@H](C(=O)NC(CC3CCC3)C(=O)C(N)=O)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C
Boldenone,Androgen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Boldenone undecylenate,Androgen receptor,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C
Bopindolol,Beta-1 adrenergic receptor,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
Bopindolol,Beta-2 adrenergic receptor,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
Bopindolol,5-hydroxytryptamine receptor 1A,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
Bopindolol,5-hydroxytryptamine receptor 1B,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
Bopindolol,Beta-3 adrenergic receptor,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1
Bortezomib,Proteasome subunit beta type-5,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
Bortezomib,Proteasome subunit beta type-1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
Bosentan,Endothelin B receptor,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1
Bosentan,Endothelin-1 receptor,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1
Bosutinib,Breakpoint cluster region protein,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Tyrosine-protein kinase ABL1,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Tyrosine-protein kinase Lyn,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Tyrosine-protein kinase HCK,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Proto-oncogene tyrosine-protein kinase Src,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Cyclin-dependent kinase 2,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Dual specificity mitogen-activated protein kinase kinase 1,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Dual specificity mitogen-activated protein kinase kinase 2,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Mitogen-activated protein kinase kinase kinase 2,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Bosutinib,Calcium/calmodulin-dependent protein kinase type II subunit gamma,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
Botulinum Toxin Type B,Vesicle-associated membrane protein 2,
Botulinum Toxin Type B,Vesicle-associated membrane protein 1,
Botulinum Toxin Type B,Synaptotagmin-2,
Botulinum toxin type A,Synaptosomal-associated protein 25,
Botulinum toxin type A,Rho-related GTP-binding protein RhoB,
Bradanicline,Alpha-7 nicotinic cholinergic receptor subunit,[H][C@@]1(CC2=CC=CN=C2)N2CCC(CC2)[C@@]1([H])NC(=O)C1=CC2=C(O1)C=CC=C2
Brasofensine,D(2) dopamine receptor,[H][C@@]12CC[C@@]([H])(N1C)[C@]([H])(\C=N\OC)[C@H](C2)C1=CC(Cl)=C(Cl)C=C1
Brecanavir,Pol polyprotein,[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](CC1=CC=C(OCC2=CSC(C)=N2)C=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC2=C(OCO2)C=C1
Brefeldin A,Cytohesin-2,[H][C@]1(O)C[C@@]2([H])\C=C\CCC[C@]([H])(C)OC(=O)\C=C\[C@@]([H])(O)[C@]2([H])C1
Brefeldin A,ADP-ribosylation factor 1,[H][C@]1(O)C[C@@]2([H])\C=C\CCC[C@]([H])(C)OC(=O)\C=C\[C@@]([H])(O)[C@]2([H])C1
Bremelanotide,Melanocyte-stimulating hormone receptor,CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O
Bremelanotide,Adrenocorticotropic hormone receptor,CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O
Brentuximab vedotin,Tumor necrosis factor receptor superfamily member 8,
Brequinar,"Dihydroorotate dehydrogenase (quinone), mitochondrial",CC1=C(N=C2C=CC(F)=CC2=C1C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1F
Brequinar Analog,"Dihydroorotate dehydrogenase (quinone), mitochondrial",CC1=C(N=C2C=CC(F)=CC2=C1C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1
Bretylium,Sodium/potassium-transporting ATPase subunit alpha-1,CC[N+](C)(C)CC1=CC=CC=C1Br
Brexanolone,Gamma-aminobutyric acid receptor subunit alpha-1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit alpha-2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit alpha-3,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit alpha-4,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit alpha-5,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit alpha-6,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit beta-1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit beta-2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit beta-3,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit delta,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit epsilon,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit gamma-1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit gamma-2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit gamma-3,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit pi,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexanolone,Gamma-aminobutyric acid receptor subunit theta,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
Brexpiprazole,5-hydroxytryptamine receptor 1A,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1
Brexpiprazole,D(2) dopamine receptor,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1
Brexpiprazole,5-hydroxytryptamine receptor 2A,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1
Brexpiprazole,Alpha-2C adrenergic receptor,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1
Brexpiprazole,Alpha-1B adrenergic receptor,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1
Briakinumab,Interleukin-12 subunit beta,
Briakinumab,Interleukin-23 subunit alpha,
Brigatinib,ALK tyrosine kinase receptor,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brigatinib,Epidermal growth factor receptor,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brigatinib,Tyrosine-protein kinase ABL1,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brigatinib,Insulin-like growth factor 1 receptor,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brigatinib,Receptor-type tyrosine-protein kinase FLT3,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brigatinib,Insulin receptor,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brigatinib,Hepatocyte growth factor receptor,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brigatinib,Receptor tyrosine-protein kinase erbB-4,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brigatinib,Receptor tyrosine-protein kinase erbB-2,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Brimonidine,Alpha-2A adrenergic receptor,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
Brimonidine,Alpha-2C adrenergic receptor,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
Brimonidine,Alpha-2B adrenergic receptor,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12
Brinzolamide,Carbonic anhydrase 2,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Brinzolamide,Carbonic anhydrase 1,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Brinzolamide,Carbonic anhydrase 4,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Brinzolamide,"Carbonic anhydrase 5A, mitochondrial",CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Brinzolamide,Carbonic anhydrase 3,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Brivaracetam,Synaptic vesicle glycoprotein 2A,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 1 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 10 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 11 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 2 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 3 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 4 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 5 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 7 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 8 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel protein type 9 subunit alpha,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel subunit beta-1,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel subunit beta-2,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel subunit beta-3,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivaracetam,Sodium channel subunit beta-4,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Brivudine,Thymidine kinase,[H]\C(Br)=C(\[H])C1=CN(C(=O)N=C1O)[C@@]1([H])C[C@]([H])(O)[C@@]([H])(CO)O1
Brivudine monophosphate,Thymidine kinase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=C(\C=C\Br)C(=O)NC1=O
"Brodimoprim-4,6-Dicarboxylate",Dihydrofolate reductase,COC1=CC(CC2=C[NH+]=C(N)N=C2N)=CC(OCCC[C@@H](CCC([O-])=O)C([O-])=O)=C1Br
Brofaromine,Amine oxidase [flavin-containing] A,COC1=CC2=C(OC(=C2)C2CCNCC2)C(Br)=C1
Bromamphenicol,Dr hemagglutinin structural subunit,[H][C@](CO)(NC(=O)C(Br)Br)[C@]([H])(O)C1=CC=C(C=C1)[N+]([O-])=O
Bromazepam,Gamma-aminobutyric acid receptor subunit alpha-1,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit alpha-2,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit alpha-3,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit alpha-4,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit alpha-5,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit alpha-6,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit beta-1,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit beta-2,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit beta-3,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit gamma-1,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit gamma-2,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit gamma-3,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit delta,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit epsilon,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit pi,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit rho-1,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit rho-2,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit rho-3,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromazepam,Gamma-aminobutyric acid receptor subunit theta,BrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Bromfenac,Prostaglandin G/H synthase 2,NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1
Bromfenac,Prostaglandin G/H synthase 1,NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1
Bromo-WR99210,Dihydrofolate reductase,CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC=C(Br)C=C1
Bromo-Willardiine,Glutamate receptor 2,N[C@@H](CN1C=C(Br)C(=O)NC1=O)C(O)=O
Bromocriptine,D(2) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,D(3) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,5-hydroxytryptamine receptor 1D,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,Alpha-2A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,5-hydroxytryptamine receptor 1A,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,Alpha-2C adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,Alpha-2B adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,5-hydroxytryptamine receptor 2B,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,D(4) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,5-hydroxytryptamine receptor 2A,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,5-hydroxytryptamine receptor 1B,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,5-hydroxytryptamine receptor 2C,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,D(1B) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,D(1A) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,Alpha-1A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,Alpha-1B adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,Alpha-1D adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromocriptine,5-hydroxytryptamine receptor 7,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C
Bromodiphenhydramine,Histamine H1 receptor,CN(C)CCOC(C1=CC=CC=C1)C1=CC=C(Br)C=C1
Bromopride,D(2) dopamine receptor,CCN(CC)CCN=C(O)C1=C(OC)C=C(N)C(Br)=C1
Bromopurine,Nucleoside 2-deoxyribosyltransferase,BrC1=C2N=CN=C2NC=N1
Brompheniramine,Histamine H1 receptor,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
Brompheniramine,Muscarinic acetylcholine receptor M1,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
Brompheniramine,Muscarinic acetylcholine receptor M2,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
Brompheniramine,Muscarinic acetylcholine receptor M3,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
Brompheniramine,Muscarinic acetylcholine receptor M4,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
Brompheniramine,Muscarinic acetylcholine receptor M5,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
Buclizine,Muscarinic acetylcholine receptor M1,CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1
Buclizine,Histamine H1 receptor,CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1
Budesonide,Glucocorticoid receptor,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Bufexamac,Prostaglandin G/H synthase 1,CCCCOC1=CC=C(CC(=O)NO)C=C1
Bufexamac,Prostaglandin G/H synthase 2,CCCCOC1=CC=C(CC(=O)NO)C=C1
Bufexamac,Histone deacetylase 6,CCCCOC1=CC=C(CC(=O)NO)C=C1
Bufexamac,Histone deacetylase 10,CCCCOC1=CC=C(CC(=O)NO)C=C1
Bufuralol,Beta-1 adrenergic receptor,CCC1=CC=CC2=C1OC(=C2)C(O)CNC(C)(C)C
Bufuralol,Beta-2 adrenergic receptor,CCC1=CC=CC2=C1OC(=C2)C(O)CNC(C)(C)C
Bufuralol,Beta-3 adrenergic receptor,CCC1=CC=CC2=C1OC(=C2)C(O)CNC(C)(C)C
Bulgecin A,Membrane-bound lytic murein transglycosylase B,[H][C@]1(C[C@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(OS(O)(=O)=O)[C@]([H])(O)[C@@]2([H])N=C(C)O)[C@@]([H])(CO)N1)C(O)=[NH+]CCS(O)(=O)=O
Bulgecin A,Soluble lytic murein transglycosylase,[H][C@]1(C[C@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(OS(O)(=O)=O)[C@]([H])(O)[C@@]2([H])N=C(C)O)[C@@]([H])(CO)N1)C(O)=[NH+]CCS(O)(=O)=O
Bumetanide,Solute carrier family 12 member 1,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
Bumetanide,Solute carrier family 12 member 2,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
Bumetanide,Solute carrier family 12 member 4,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
Bumetanide,Solute carrier family 12 member 5,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
Bumetanide,Cystic fibrosis transmembrane conductance regulator,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
Bupivacaine,Sodium channel protein type 10 subunit alpha,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
Bupivacaine,Prostaglandin E2 receptor EP1 subtype,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
Bupranolol,Beta-1 adrenergic receptor,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1
Bupranolol,Beta-2 adrenergic receptor,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1
Bupranolol,Beta-3 adrenergic receptor,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1
Buprenorphine,Kappa-type opioid receptor,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4
Buprenorphine,Mu-type opioid receptor,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4
Buprenorphine,Delta-type opioid receptor,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4
Buprenorphine,Nociceptin receptor,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4
Bupropion,Sodium-dependent dopamine transporter,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
Bupropion,Sodium-dependent noradrenaline transporter,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
Bupropion,Neuronal acetylcholine receptor subunit alpha-3,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
Bupropion,5-hydroxytryptamine receptor 3A,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
Burosumab,Fibroblast growth factor 23,
Buserelin,Lutropin-choriogonadotropic hormone receptor,
Buserelin,Gonadotropin-releasing hormone receptor,
Buspirone,5-hydroxytryptamine receptor 1A,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
Buspirone,D(2) dopamine receptor,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1
Butabarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit beta-1,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit beta-2,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit beta-3,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit delta,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit epsilon,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit gamma-1,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit gamma-2,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit gamma-3,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit pi,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Gamma-aminobutyric acid receptor subunit theta,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Neuronal acetylcholine receptor subunit alpha-4,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Neuronal acetylcholine receptor subunit alpha-7,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,Glutamate receptor 2,CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butabarbital,"Glutamate receptor ionotropic, kainate 2",CCC(C)C1(CC)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-2,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-3,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-4,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-5,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-6,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Neuronal acetylcholine receptor subunit alpha-4,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Neuronal acetylcholine receptor subunit alpha-7,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Glutamate receptor 2,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,"Glutamate receptor ionotropic, kainate 2",CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-2,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-3,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-4,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-5,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit alpha-6,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit beta-1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit beta-2,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit beta-3,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit delta,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit epsilon,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit gamma-1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit gamma-2,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit gamma-3,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit pi,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butalbital,Gamma-aminobutyric acid receptor subunit theta,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
Butamben,Voltage-dependent calcium channel gamma-1 subunit,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent calcium channel subunit alpha-2/delta-1,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent calcium channel subunit alpha-2/delta-2,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent calcium channel subunit alpha-2/delta-3,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent L-type calcium channel subunit alpha-1C,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent L-type calcium channel subunit alpha-1D,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent L-type calcium channel subunit alpha-1F,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent L-type calcium channel subunit alpha-1S,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent L-type calcium channel subunit beta-1,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent L-type calcium channel subunit beta-2,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent L-type calcium channel subunit beta-3,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent L-type calcium channel subunit beta-4,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent N-type calcium channel subunit alpha-1B,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent T-type calcium channel subunit alpha-1G,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent T-type calcium channel subunit alpha-1H,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,Voltage-dependent T-type calcium channel subunit alpha-1I,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,ATP-sensitive inward rectifier potassium channel 1,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,ATP-sensitive inward rectifier potassium channel 10,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,ATP-sensitive inward rectifier potassium channel 11,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,ATP-sensitive inward rectifier potassium channel 12,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,ATP-sensitive inward rectifier potassium channel 14,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,ATP-sensitive inward rectifier potassium channel 15,CCCCOC(=O)C1=CC=C(N)C=C1
Butamben,ATP-sensitive inward rectifier potassium channel 8,CCCCOC(=O)C1=CC=C(N)C=C1
Butenafine,Squalene monooxygenase,CN(CC1=CC=C(C=C1)C(C)(C)C)CC1=CC=CC2=CC=CC=C12
Butobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,Neuronal acetylcholine receptor subunit alpha-4,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,Neuronal acetylcholine receptor subunit alpha-7,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,Glutamate receptor 2,CCCCC1(CC)C(=O)NC(=O)NC1=O
Butobarbital,"Glutamate receptor ionotropic, kainate 2",CCCCC1(CC)C(=O)NC(=O)NC1=O
Butorphanol,Kappa-type opioid receptor,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1
Butorphanol,Delta-type opioid receptor,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1
Butorphanol,Mu-type opioid receptor,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1
Butriptyline,Sodium-dependent serotonin transporter,
Butriptyline,Histamine H1 receptor,
Butriptyline,5-hydroxytryptamine receptor 2A,
Butyl alcohol,Haloalkane dehalogenase,CCCCO
Butylamine,Candidapepsin-2,CCCCN
Butylphosphonate,Lipase,CCCCP(O)(O)=O
Butylscopolamine,Muscarinic acetylcholine receptor M3,CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Butylscopolamine,Muscarinic acetylcholine receptor M2,CCCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Butyramide,Aliphatic amidase expression-regulating protein,CCCC(N)=O
Butyric Acid,(S)-2-haloacid dehalogenase,CCCC(O)=O
Butyric Acid,Cholinesterase,CCCC(O)=O
Butyric Acid,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",CCCC(O)=O
Butyrylthiocholine,Cholinesterase,CCCC(=O)SCC[N+](C)(C)C
C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide,"Glycogen phosphorylase, muscle form",[H]C(N)(O)[C@]1(O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O)N=[N+]=[N-]
C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide,"Glycogen phosphorylase, muscle form",[H][C@]1(O)[C@]([H])(O)[C@@]([H])(O)[C@@](O)(O[C@]1([H])CO)C(O)=N
C-1027 Aromatized Chromophore,Antitumor antibiotic C-1027 apoprotein,[H][C@@]12OC3=C(Cl)C=C(C=C3O)[C@@]([H])([NH3+])CC(=O)OC[C@]([H])(OC(=O)C3=C4N=C(O)C(=C)OC4=CC(OC)=C3)C3=CC(=C1C=C3)C1=CC=C[C@]21O[C@]1([H])OC(C)(C)[C@@]([H])(N(C)C)[C@@]([H])(O)[C@@]1([H])O
C16-Fatty-Acyl-Substrate-Mimic,Enoyl-[acyl-carrier-protein] reductase [NADH],CCCCCCCCCCCCCCCC(=O)SCCNC(C)=O
C31G,Gag-Pol polyprotein,CCCCCCCCCCCC[N+](C)(C)[O-].CCCCCCCCCCCC[N+](C)(C)CC([O-])=O
C31G,CD9 antigen,CCCCCCCCCCCC[N+](C)(C)[O-].CCCCCCCCCCCC[N+](C)(C)CC([O-])=O
CA4P,Tubulin beta chain,COC1=CC(=CC(OC)=C1OC)[C@@H](O)CC1=CC(O)=C(OC)C=C1
CAD106,Amyloid beta A4 protein,
CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,Pro-cathepsin H,[H][C@@](O)(COC)[C@]([H])(CC(C)C)NC(=O)[C@]([H])(CC(C)C)NC(=O)OCC1=CC=CC=C1
CAT-213,Eotaxin,
CBZ-LEU-LEU-TYR-CH2F,Calpain-1 catalytic subunit,[H][C@@](CC(C)C)(N=C(O)OCC1=CC=CC=C1)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CC1=CC=C(O)C=C1)C(=O)CF
CCR5 mAb,C-C chemokine receptor type 5,
CCX915,C-C chemokine receptor type 2,
CD564,Retinoic acid receptor gamma,CC1(C)CCC(C)(C)C2=C1C=CC(=C2)C(=O)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O
CDP323,Integrin alpha-4,
CEP-1347,Mitogen-activated protein kinase 12,[H][C@@]12C[C@H](C(=O)OOC)[C@](C)(O1)N1C3=C(C=C(CSCC)C=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC(CSCC)=C5)N2C4=C13
CGP 4832,Ferrichrome-iron receptor,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)CC(=O)OCC3CCCN(C)C3)[C@@H]1C)=C(N1CCOCC1)C2=O
CHF 4227,Estrogen receptor,
CHF 4227,Estrogen receptor beta,
CHGN111,Dual specificity protein kinase CLK1,
"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",Phenylethanolamine N-methyltransferase,[H][C@]1(N)CCC2=CC=CC=C2[C@@]1([H])O
CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE,Lanosterol 14-alpha demethylase,[H][C@@](CCSC)(NC(=O)[C@]1([H])CC[C@]([H])(C)CC1)C(=O)NC1=CC=NC=C1
CLX-0921,Peroxisome proliferator-activated receptor gamma,
CMLVAX100,BCR/ABL p210 fusion protein,
CNS-5161,"Glutamate receptor ionotropic, NMDA 1",CSC1=CC(\N=C(/N)N(C)C2=CC(SC)=CC=C2)=C(Cl)C=C1
CP-122721,Substance-P receptor,COC1=CC=C(OC(F)(F)F)C=C1CN[C@H]1CCCN[C@H]1C1=CC=CC=C1
CP-271485,Macrophage metalloelastase,[H][C@@]1(CN(CC2=CC=CC=C2)C(=O)CO1)C1=CC2=C(C=C1)N(C)S(=O)(=O)C2
CP-526423,"Glycogen phosphorylase, liver form",ClC1=CC2=C(NC(=C2)C(=O)NCCOCCOCCNC(=O)C2=CC3=C(N2)C=CC(Cl)=C3)C=C1
CP-945598,Cannabinoid receptor 1,
CPG 10101,Toll-like receptor 9,
CPI-1205,Histone-lysine N-methyltransferase EZH2,COC1=C(CNC(=O)C2=C(C)N([C@H](C)C3CCN(CC(F)(F)F)CC3)C3=CC=CC=C23)C(=O)NC(C)=C1
CR002,Platelet-derived growth factor D,
CR665,Kappa-type opioid receptor,CCCC[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC1=CC=NC=C1
CRA_10433,Trypsin-1,NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(OC2CCCC2)=C1[O-]
CRA_10655,Trypsin-1,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC=CC(OC2CCCC2)=C1[O-]
CRA_10655,Urokinase-type plasminogen activator,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC=CC(OC2CCCC2)=C1[O-]
CRA_10656,Trypsin-1,CC(C)COC1=C([O-])C(=CC=C1)C1=NC2=CC(=CC=C2N1)C(N)=[NH2+]
CRA_10762,Trypsin-1,NC(=N)C1=CC2=C(NC(=N2)C2=CC=CC(C3=CC=CC=C3)=C2O)C=C1Cl
CRA_10972,Trypsin-1,CC(C)COC1=CC=CC(C2=NC3=C(N2)C=C(Cl)C(=C3)C(N)=N)=C1O
CRA_10991,Trypsin-1,NC(=[NH2+])C1=C(Cl)C=C2NC(=CC2=C1)C1=CC=CC(OC2CCCC2)=C1[O-]
CRA_11092,Trypsin-1,[H][C@]1(C)CCCC[C@]1([H])OC1=CC=CC(C2=NC3=C(N2)C=C(F)C(=C3)C(N)=N)=C1O
CRA_1144,Trypsin-1,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC=CC=C1[O-]
CRA_1144,Serine protease hepsin,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC=CC=C1[O-]
CRA_16847,Trypsin-1,[H][C@](CC([O-])=O)(C(O)=O)C1=CC(C2=NC3=C(N2)C=C(C=C3)C(N)=N)=C([O-])C(Br)=C1
CRA_17312,Trypsin-1,[H][C@](CC([O-])=O)(C(O)=O)C1=CC(=C([O-])C(=C1)C1=NC2=C(N1)C=C(C=C2)C(N)=N)C1=CC=CC=C1OC
CRA_17693,Trypsin-1,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC(=CC(=C1[O-])C1=C(F)C=CC=C1)[C@@H](CC([O-])=O)C([O-])=O
CRA_1801,Trypsin-1,NC(=N)C1=CC2=C(C=C1)N=C(N2)C1=C(O)C=CC=N1
CRA_1802,Trypsin-1,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC(F)=CC=C1[O-]
CRA_23653,Trypsin-1,NC(=N)C1=CC2=C(C=C1)N=C(N2)C1=CC(CC[NH3+])=CC(=C1O)C1=CC=CC=C1
CRA_8696,Prothrombin,NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(=C1[O-])C1=CC=CC=C1
CRA_8696,Trypsin-1,NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(=C1[O-])C1=CC=CC=C1
CRA_8696,Urokinase-type plasminogen activator,NC(=[NH2+])C1=CC=C2NC(=CC2=C1)C1=CC=CC(=C1[O-])C1=CC=CC=C1
CRA_9076,Trypsin-1,CC1=CC(Br)=C([O-])C(=C1)C1=CC2=CC(=CC=C2N1)C(N)=[NH2+]
CRA_9334,Trypsin-1,CC1=CC(Br)=C([O-])C(=C1)C1=NC2=CC(=CC=C2N1)C(N)=[NH2+]
CRA_9678,Trypsin-1,NC(=N)C1=CC2=C(NC(=C2)C2=C(O)C(Br)=CC(CC([O-])=O)=C2)C=C1
CRA_9785,Trypsin-1,NC(=[NH2+])C1=CC=C2NC(=NC2=C1)C1=CC(OC(F)(F)F)=CC=C1[O-]
CRx-119,Sodium-dependent noradrenaline transporter,
CRx-119,Sodium-dependent serotonin transporter,
CRx-139,Tumor necrosis factor,
CRx-139,C-reactive protein,
CRx-139,Interleukin-6,
CRx-139,Interleukin-10,
CT-011,Programmed cell death protein 1,
CTA018,Vitamin D3 receptor,
CTA018,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",
CTCE-0214,Stromal cell-derived factor 1,
CTS-1027,Collagenase 3,ONC(=O)C1(CS(=O)(=O)C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2)CCOCC1
CTS-21166,Beta-secretase 1,
CVT-6883,Adenosine receptor A2b,CCCN1C(=O)N(CC)C2=C(NC(=N2)C2=CN(CC3=CC=CC(=C3)C(F)(F)F)N=C2)C1=O
CX157,Amine oxidase [flavin-containing] A,
CX516,Glutamate receptor 1,O=C(N1CCCCC1)C1=CC2=C(C=C1)N=CC=N2
CX717,Glutamate receptor 1,O=C(N1CCOCC1)C1=CC2=NON=C2C=C1
CX717,Glutamate receptor 2,O=C(N1CCOCC1)C1=CC2=NON=C2C=C1
CX717,Glutamate receptor 4,O=C(N1CCOCC1)C1=CC2=NON=C2C=C1
CX717,Glutamate receptor 3,O=C(N1CCOCC1)C1=CC2=NON=C2C=C1
CX717,Brain-derived neurotrophic factor,O=C(N1CCOCC1)C1=CC2=NON=C2C=C1
CYC116,Vascular endothelial growth factor receptor 2,
CYC116,Aurora kinase A,
"CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE",Cathepsin D,[H][C@](N)(CC1CCCCC1)[C@@]([H])(O)[C@@]([H])(O)CC(C)C
CYT006-AngQb,Type-1 angiotensin II receptor,
CYT006-AngQb,Type-2 angiotensin II receptor,
CYT007-TNFQb,Tumor necrosis factor,
CYT997,Tubulin beta-1 chain,
CYT997,Tubulin beta chain,
CYT997,Tubulin alpha-1B chain,
CYT997,Tubulin alpha-1A chain,
CYT997,Tubulin beta-4B chain,
CYT997,Tubulin alpha-1C chain,
CYT997,Tubulin alpha-4A chain,
CYT997,Tubulin beta-4A chain,
CYT997,Tubulin beta-3 chain,
CYT997,Tubulin alpha-3C/D chain,
CYT997,Tubulin alpha-3E chain,
CYT997,Putative tubulin-like protein alpha-4B,
CYT997,Tubulin beta-2A chain,
CYT997,Tubulin beta-2B chain,
CYT997,Tubulin beta-6 chain,
CZEN 002,Melanocyte-stimulating hormone receptor,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NC(CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O
Cabazitaxel,Tubulin alpha-4A chain,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C
Cabazitaxel,Tubulin beta-1 chain,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C
Cabergoline,D(2) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,5-hydroxytryptamine receptor 2B,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,D(3) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,5-hydroxytryptamine receptor 2A,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,Alpha-2B adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,5-hydroxytryptamine receptor 1D,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,D(4) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,Alpha-2A adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,5-hydroxytryptamine receptor 1A,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,Alpha-2C adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,D(1B) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,D(1A) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,5-hydroxytryptamine receptor 1B,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,5-hydroxytryptamine receptor 2C,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,5-hydroxytryptamine receptor 7,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,Alpha-1A adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,Alpha-1B adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,Alpha-1D adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,Beta-1 adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,Beta-2 adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,D(1A) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabergoline,D(1B) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC
Cabozantinib,Hepatocyte growth factor receptor,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2
Cabozantinib,Vascular endothelial growth factor receptor 2,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2
Cabozantinib,Proto-oncogene tyrosine-protein kinase receptor Ret,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2
Cacodylic acid,"Nitric oxide synthase, endothelial",C[As](C)(O)=O
Cacodylic acid,Aldose reductase,C[As](C)(O)=O
Cacodylic acid,Gag-Pol polyprotein,C[As](C)(O)=O
Cacodylic acid,Guanine nucleotide-binding protein G(t) subunit alpha-1,C[As](C)(O)=O
Caffeine,Adenosine receptor A1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,Adenosine receptor A2a,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,Ryanodine receptor 1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cGMP-dependent 3',5'-cyclic phosphodiesterase",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"cGMP-specific 3',5'-cyclic phosphodiesterase",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,DNA-dependent protein kinase catalytic subunit,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Inositol 1,4,5-trisphosphate receptor type 1",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Inositol 1,4,5-trisphosphate receptor type 2",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,"Inositol 1,4,5-trisphosphate receptor type 3",CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Caffeine,Serine-protein kinase ATM,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Calanolide A,Gag-Pol polyprotein,CCCC1=CC(=O)OC2=C1C1=C(C=CC(C)(C)O1)C1=C2[C@@H](O)[C@H](C)[C@@H](C)O1
Calcifediol,Vitamin D3 receptor,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Calcipotriol,Vitamin D3 receptor,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1
Calcitriol,Vitamin D3 receptor,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C
Calcitriol,Homeobox protein Hox-A10,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C
Calcium,Voltage-dependent L-type calcium channel subunit alpha-1C,[Ca]
Calcium,Calcium-transporting ATPase type 2C member 1,[Ca]
Calcium,"Troponin C, skeletal muscle",[Ca]
Calcium,"Troponin C, slow skeletal and cardiac muscles",[Ca]
Calcium,"Spectrin beta chain, non-erythrocytic 1",[Ca]
Calcium,Protein S100-B,[Ca]
Calcium,Calpastatin,[Ca]
Calcium,Cartilage oligomeric matrix protein,[Ca]
Calcium,Calmodulin,[Ca]
Calcium,Amiloride-sensitive amine oxidase [copper-containing],[Ca]
Calcium,Protein S100-A13,[Ca]
Calcium,"Alkaline phosphatase, placental type",[Ca]
Calcium,Protein S100-A8,[Ca]
Calcium,Protein S100-A9,[Ca]
Calcium,Protein S100-A2,[Ca]
Calcium,Ceruloplasmin,[Ca]
Calcium,Bone morphogenetic protein 4,[Ca]
Calcium,Matrix Gla protein,[Ca]
Calcium,Protocadherin-19,[Ca]
Calcium,Programmed cell death protein 6,[Ca]
Calcium Chloride,Protein S100-A13,[Cl-].[Cl-].[Ca++]
Calcium Citrate,Extracellular calcium-sensing receptor,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calreticulin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calcium and integrin-binding protein 1,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Programmed cell death protein 6,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Sorcin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calcineurin B homologous protein 1,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,SPARC,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calnexin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Fibrillin-2,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Protein S100-B,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calsequestrin-2,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Regucalcin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Peflin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Protein S100-A6,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Translationally-controlled tumor protein,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calcium and integrin-binding family member 2,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Protein S100-A13,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calsequestrin-1,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Nucleobindin-1,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Nucleobindin-2,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calmodulin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Fibrillin-3,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Grancalcin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calcium-dependent secretion activator 1,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calmodulin-2,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calmodulin-3,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Protein S100-A16,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calretinin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calcyphosin,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calcium-dependent secretion activator 2,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Calreticulin-3,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Neurexin-1,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Citrate,Neuronal calcium sensor 1,[Ca++].[Ca++].[Ca++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Calcium Phosphate,Extracellular calcium-sensing receptor,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calreticulin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calcium and integrin-binding protein 1,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Programmed cell death protein 6,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Sorcin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calcineurin B homologous protein 1,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,SPARC,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calnexin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Fibrillin-2,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Protein S100-B,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calsequestrin-2,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Regucalcin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Peflin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Protein S100-A6,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Translationally-controlled tumor protein,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calcium and integrin-binding family member 2,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Protein S100-A13,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calsequestrin-1,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Nucleobindin-1,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Nucleobindin-2,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calmodulin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Fibrillin-3,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Grancalcin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calcium-dependent secretion activator 1,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calmodulin-2,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calmodulin-3,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Protein S100-A16,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calretinin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calcyphosin,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calcium-dependent secretion activator 2,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Calreticulin-3,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Neurexin-1,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium Phosphate,Neuronal calcium sensor 1,[Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
Calcium carbimide,Aldehyde dehydrogenase family 3 member B2,[Ca++].[N-]=C=[N-]
Calcium levulinate,Calmodulin,[Ca++].CC(=O)CCC([O-])=O.CC(=O)CCC([O-])=O
Calcium levulinate,Calsequestrin-1,[Ca++].CC(=O)CCC([O-])=O.CC(=O)CCC([O-])=O
Calcium levulinate,Calretinin,[Ca++].CC(=O)CCC([O-])=O.CC(=O)CCC([O-])=O
Calcium phosphate dihydrate,Extracellular calcium-sensing receptor,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calreticulin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calcium and integrin-binding protein 1,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Programmed cell death protein 6,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Sorcin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calcineurin B homologous protein 1,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,SPARC,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calnexin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Fibrillin-2,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Protein S100-B,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calsequestrin-2,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Regucalcin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Peflin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Protein S100-A6,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Translationally-controlled tumor protein,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calcium and integrin-binding family member 2,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Protein S100-A13,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calsequestrin-1,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Nucleobindin-1,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Nucleobindin-2,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calmodulin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Fibrillin-3,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Grancalcin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calcium-dependent secretion activator 1,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calmodulin-2,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calmodulin-3,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Protein S100-A16,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calretinin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calcyphosin,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calcium-dependent secretion activator 2,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Calreticulin-3,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Neurexin-1,O.O.[Ca++].OP([O-])([O-])=O
Calcium phosphate dihydrate,Neuronal calcium sensor 1,O.O.[Ca++].OP([O-])([O-])=O
Caldaret,Sodium/calcium exchanger 1,CC1=CC=C(N2CCNCC2)C(=C1)S(O)(=O)=O
Calusterone,Androgen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](C)CC2=CC(=O)CC[C@]12C
Calyculin A,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,[H][C@@]1(O[C@]2(C[C@@H](O)[C@H](C)[C@H](C\C=C\C3=COC(=N3)[C@@H](C)CCNC(=O)[C@@H](O)[C@@H](O)[C@H](COC)N(C)C)O2)C(C)(C)[C@H]1OP(O)(O)=O)[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C(\C)=C\C=C\C(\C)=C/C#N)OC
Camphane,Camphor 5-monooxygenase,[H][C@]12CC[C@](C)(CC1)C2(C)C
Camphor,Camphor 5-monooxygenase,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C
Camphor,Transient receptor potential cation channel subfamily V member 1,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C
Camphor,Transient receptor potential cation channel subfamily V member 3,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C
Camphor,Transient receptor potential cation channel subfamily A member 1,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C
Camphor,Transient receptor potential cation channel subfamily M member 8,[H][C@@]12CC[C@@](C)(C(=O)C1)C2(C)C
Camptothecin,DNA topoisomerase 1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=CC=CC=C4N=C13)C2=O
Canagliflozin,Sodium/glucose cotransporter 2,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1
Canakinumab,Interleukin-1 beta,
Canaline,"Ornithine aminotransferase, mitochondrial",NOCC[C@H](N)C(O)=O
Candesartan,Type-1 angiotensin II receptor,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1
Candesartan cilexetil,Type-1 angiotensin II receptor,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1
Candoxatril,Neprilysin,COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(=O)OC1=CC2=C(CCC2)C=C1
Candoxatril,Angiotensin-converting enzyme,COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(=O)OC1=CC2=C(CCC2)C=C1
Candoxatrilat,Neprilysin,COCCOC[C@H](CC1(CCCC1)C(=O)N[C@H]1CC[C@H](CC1)C(O)=O)C(O)=O
Canertinib,Epidermal growth factor receptor,FC1=C(Cl)C=C(NC2=NC=NC3=CC(OCCCN4CCOCC4)=C(NC(=O)C=C)C=C23)C=C1
Canfosfamide,Glutathione S-transferase P,[H][C@](N)(CCC(O)=N[C@@]([H])(CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)C(O)=N[C@@]([H])(C(O)=O)C1=CC=CC=C1)C(O)=O
Cangrelor,P2Y purinoceptor 12,CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1
Cannabidiol,Cannabinoid receptor 1,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Cannabinoid receptor 2,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,G-protein coupled receptor 12,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Glycine receptor subunit alpha-1,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Glycine receptor subunit alpha-1,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Glycine receptor subunit beta,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Glycine receptor subunit alpha-3,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,N-arachidonyl glycine receptor,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,G-protein coupled receptor 55,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,5-hydroxytryptamine receptor 1A,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,5-hydroxytryptamine receptor 2A,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Neuronal acetylcholine receptor subunit alpha-7,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Delta-type opioid receptor,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Mu-type opioid receptor,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Peroxisome proliferator-activated receptor gamma,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Transient receptor potential cation channel subfamily V member 1,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Voltage-dependent T-type calcium channel subunit alpha-1G,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Voltage-dependent T-type calcium channel subunit alpha-1H,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Voltage-dependent T-type calcium channel subunit alpha-1I,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Transient receptor potential cation channel subfamily A member 1,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Transient receptor potential cation channel subfamily M member 8,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Transient receptor potential cation channel subfamily V member 2,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Transient receptor potential cation channel subfamily V member 3,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Transient receptor potential cation channel subfamily V member 4,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Voltage-dependent anion-selective channel protein 1,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,5-hydroxytryptamine receptor 3A,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidiol,Adenosine receptor A1,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Cannabidivarin,Transient receptor potential cation channel subfamily V member 1,[H][C@]1(CCC(C)=C[C@H]1C1=C(O)C=C(CCC)C=C1O)C(C)=C
Cannabidivarin,Transient receptor potential cation channel subfamily V member 2,[H][C@]1(CCC(C)=C[C@H]1C1=C(O)C=C(CCC)C=C1O)C(C)=C
Cannabidivarin,Transient receptor potential cation channel subfamily A member 1,[H][C@]1(CCC(C)=C[C@H]1C1=C(O)C=C(CCC)C=C1O)C(C)=C
Cannabidivarin,Sn1-specific diacylglycerol lipase alpha,[H][C@]1(CCC(C)=C[C@H]1C1=C(O)C=C(CCC)C=C1O)C(C)=C
Cantharidin,Aryl hydrocarbon receptor,[H][C@]12CC[C@]([H])(O1)[C@]1(C)C(=O)OC(=O)[C@]21C
Capecitabine,Thymidylate synthase,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O
Caplacizumab,von Willebrand factor,
Capravirine,Gag-Pol polyprotein,CC(C)C1=C(SC2=CC(Cl)=CC(Cl)=C2)N(CC2=CC=NC=C2)C(COC(N)=O)=N1
Capric acid,3-oxoacyl-[acyl-carrier-protein] synthase 1,CCCCCCCCCC(O)=O
Capric acid,Furin,CCCCCCCCCC(O)=O
Capric acid,Peptostreptococcal albumin-binding protein,CCCCCCCCCC(O)=O
Capric acid,Glycolipid transfer protein,CCCCCCCCCC(O)=O
Capric acid,Octanoyltransferase,CCCCCCCCCC(O)=O
Capric acid,Putative uncharacterized protein tcp14,CCCCCCCCCC(O)=O
Capric acid,Peroxisome proliferator-activated receptor gamma,CCCCCCCCCC(O)=O
Capromab pendetide,Glutamate carboxypeptidase 2,
Caprylic acid,3-oxoacyl-[acyl-carrier-protein] synthase 1,CCCCCCCC(O)=O
Caprylic acid,Acyl-CoA thioesterase I,CCCCCCCC(O)=O
Caprylic acid,Peroxisome proliferator-activated receptor alpha,CCCCCCCC(O)=O
Capsaicin,Transient receptor potential cation channel subfamily V member 1,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
Capsaicin,Prohibitin-2,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
Capsicum oleoresin,Transient receptor potential cation channel subfamily V member 1,
Captodiame,5-hydroxytryptamine receptor 2C,CCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1
Captodiame,Sigma non-opioid intracellular receptor 1,CCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1
Captodiame,D(3) dopamine receptor,CCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1
Captopril,Angiotensin-converting enzyme,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
Captopril,72 kDa type IV collagenase,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
Captopril,Matrix metalloproteinase-9,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
Captopril,Leukotriene A-4 hydrolase,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
Captopril,B1 bradykinin receptor,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
Carba-Nicotinamide-Adenine-Dinucleotide,Poly [ADP-ribose] polymerase 1,[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)C[C@@]([H])([N+]2=CC=CC(=C2)C(O)=N)[C@]([H])(O)[C@]1([H])O
Carbamazepine,Sodium channel protein type 5 subunit alpha,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12
Carbamazepine,Neuronal acetylcholine receptor subunit alpha-4,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12
Carbamazepine,Neuronal acetylcholine receptor subunit beta-2,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12
Carbamazepine,Nuclear receptor subfamily 1 group I member 2,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12
Carbamic Acid,Beta-lactamase,NC(O)=O
Carbamoylcholine,Muscarinic acetylcholine receptor M1,C[N+](C)(C)CCOC(N)=O
Carbamoylcholine,Muscarinic acetylcholine receptor M2,C[N+](C)(C)CCOC(N)=O
Carbamoylcholine,Neuronal acetylcholine receptor subunit alpha-2,C[N+](C)(C)CCOC(N)=O
Carbamoylcholine,Acetylcholinesterase,C[N+](C)(C)CCOC(N)=O
Carbamoylcholine,Muscarinic acetylcholine receptor M3,C[N+](C)(C)CCOC(N)=O
Carbamoylcholine,Muscarinic acetylcholine receptor M4,C[N+](C)(C)CCOC(N)=O
Carbaphosphonate,3-dehydroquinate synthase,[H][C@@]1(O)C[C@@](O)(C[C@]([H])(CP(O)(O)=O)[C@@]1([H])O)C(O)=O
Carbenicillin,D-alanyl-D-alanine carboxypeptidase DacA,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O
Carbenicillin,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O
Carbenicillin,D-alanyl-D-alanine carboxypeptidase DacC,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O
Carbenicillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O
Carbenicillin,Penicillin-binding protein 1B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O
Carbenicillin,Penicillin-binding protein 2,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O
Carbenicillin,Peptidoglycan synthase FtsI,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(O)=O)C1=CC=CC=C1)C(O)=O
Carbenoxolone,Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]1(CC[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@]2([H])C(=O)C=C2[C@]4([H])C[C@](C)(CC[C@]4(C)CC[C@@]32C)C(O)=O)C1(C)C)OC(=O)CCC(O)=O
Carbenoxolone,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase,[H][C@@]1(CC[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@]2([H])C(=O)C=C2[C@]4([H])C[C@](C)(CC[C@]4(C)CC[C@@]32C)C(O)=O)C1(C)C)OC(=O)CCC(O)=O
Carbetocin,Oxytocin receptor,[H][C@]1(NC(=O)[C@H](CC2=CC=C(OC)C=C2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)[C@@H](C)CC
Carbidopa,Aromatic-L-amino-acid decarboxylase,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O
Carbimazole,Thyroid peroxidase,CCOC(=O)N1C=CN(C)C1=S
Carbinoxamine,Histamine H1 receptor,CN(C)CCOC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome,Tolloid-like protein 2,[H][C@@](C)(NP(O)(=O)[C@]([H])(CC1=CC=CC=C1)N=C(O)[C@]([H])(CCCC[NH3+])N=C(O)[C@]1([H])CCCN1C(=O)OCC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)OC
Carbocisteine,Glutathione S-transferase P,N[C@@H](CSCC(O)=O)C(O)=O
Carbon monoxide,Myoglobin,
Carboprost tromethamine,Prostaglandin E2 receptor EP1 subtype,OCC([NH3+])(CO)CO.CCCCC[C@@](O)(C)\C=C\[C@H]1[C@@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)[O-]
Carboxin,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",CC1=C(SCCO1)C(=O)NC1=CC=CC=C1
Carboxyatractyloside,ADP/ATP translocase 1,CC(C)CC(=O)O[C@H]1[C@@H](O[C@@H]2C[C@]3(C)[C@H]4CC[C@@H]5C[C@@]4(CC[C@H]3C(C2)(C(O)=O)C(O)=O)[C@@H](O)C5=C)O[C@@H](COO)[C@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O
Carboxylic PRPP,Pur operon repressor,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(C[C@]1([H])COP(O)(O)=O)OP(O)(=O)OP(O)(O)=O
Carboxylic PRPP,Xanthine phosphoribosyltransferase,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(C[C@]1([H])COP(O)(O)=O)OP(O)(=O)OP(O)(O)=O
Carboxylic PRPP,Amidophosphoribosyltransferase,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(C[C@]1([H])COP(O)(O)=O)OP(O)(=O)OP(O)(O)=O
Carboxymethylcellulose,"Solute carrier family 2, facilitated glucose transporter member 1",
"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",Cystathionine gamma-lyase,OC(=O)CSC1=NC(=NO1)C1=CC=CC(Cl)=C1
Carboxymycobactin S,Neutrophil gelatinase-associated lipocalin,C[C@H]1C[C@H](O)N[C@@H]2CCCCN(O[Fe@@]34O[C@@H](\C=C\CCCCCCC(O)=O)[N@](CCCC[C@H](NC(=O)[C@H]5COC(=N5)C5=CC=CC=C5O3)C(=O)O1)O4)C2=O
Carboxymycobactin T,Neutrophil gelatinase-associated lipocalin,OC(=O)CCCCCC\C=C/[C@@H]1O[Fe@]23ON1CCCC[C@@H](NC(=O)[C@@H]1CO[C@H](N1)C1=CC=CC=C1O2)C(=O)OCCC(=O)N[C@@H]1CCCCN(O3)C1=O
Cardarine,Peroxisome proliferator-activated receptor delta,CC1=C(CSC2=CC(C)=C(OCC(O)=O)C=C2)SC(=N1)C1=CC=C(C=C1)C(F)(F)F
Cardarine,Peroxisome proliferator-activated receptor alpha,CC1=C(CSC2=CC(C)=C(OCC(O)=O)C=C2)SC(=N1)C1=CC=C(C=C1)C(F)(F)F
Carfentanil,Mu-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)OC
Carfentanil,Delta-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)OC
Carfentanil,Kappa-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)OC
Carfilzomib,Proteasome subunit beta type-5,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
Carfilzomib,Proteasome subunit beta type-8,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
Carfilzomib,Proteasome subunit beta type-1,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
Carfilzomib,Proteasome subunit beta type-9,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
Carfilzomib,Proteasome subunit beta type-2,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
Carfilzomib,Proteasome subunit beta type-10,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
Carglumic acid,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",NC(=O)N[C@@H](CCC(O)=O)C(O)=O
Carindacillin,D-alanyl-D-alanine carboxypeptidase DacA,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O
Carindacillin,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O
Carindacillin,D-alanyl-D-alanine carboxypeptidase DacC,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O
Carindacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O
Carindacillin,Penicillin-binding protein 1B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O
Carindacillin,Penicillin-binding protein 2,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O
Carindacillin,Peptidoglycan synthase FtsI,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C(=O)OC1=CC2=C(CCC2)C=C1)C1=CC=CC=C1)C(O)=O
Cariporide,Sodium/hydrogen exchanger 1,CC(C)C1=CC=C(C=C1S(C)(=O)=O)C(=O)NC(N)=N
Cariprazine,D(3) dopamine receptor,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
Cariprazine,D(2) dopamine receptor,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
Cariprazine,5-hydroxytryptamine receptor 1A,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
Cariprazine,5-hydroxytryptamine receptor 2B,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
Cariprazine,5-hydroxytryptamine receptor 2A,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
Cariprazine,Histamine H1 receptor,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
Carisoprodol,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC(C)(COC(N)=O)COC(=O)NC(C)C
Carisoprodol,Gamma-aminobutyric acid receptor subunit beta-2,CCCC(C)(COC(N)=O)COC(=O)NC(C)C
Carisoprodol,Gamma-aminobutyric acid receptor subunit gamma-2,CCCC(C)(COC(N)=O)COC(=O)NC(C)C
Carisoprodol,Gamma-aminobutyric acid receptor subunit alpha-5,CCCC(C)(COC(N)=O)COC(=O)NC(C)C
Carisoprodol,Gamma-aminobutyric acid receptor subunit alpha-3,CCCC(C)(COC(N)=O)COC(=O)NC(C)C
Carmustine,"Glutathione reductase, mitochondrial",ClCCNC(=O)N(CCCl)N=O
Carotuximab,Endoglin,
Carphenazine,D(2) dopamine receptor,CCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1
Carphenazine,D(1A) dopamine receptor,CCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1
Carphenazine,D(1B) dopamine receptor,CCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1
Carprofen,Prostaglandin G/H synthase 2,CC(C(O)=O)C1=CC2=C(C=C1)C1=C(N2)C=CC(Cl)=C1
Carprofen,Prostaglandin G/H synthase 1,CC(C(O)=O)C1=CC2=C(C=C1)C1=C(N2)C=CC(Cl)=C1
Carteolol,Beta-1 adrenergic receptor,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2
Carteolol,Beta-2 adrenergic receptor,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2
Carvedilol,Beta-1 adrenergic receptor,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Alpha-1A adrenergic receptor,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,NADH dehydrogenase [ubiquinone] 1 subunit C2,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Beta-2 adrenergic receptor,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Vascular endothelial growth factor A,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Natriuretic peptides B,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Gap junction alpha-1 protein,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Potassium voltage-gated channel subfamily H member 2,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Vascular cell adhesion protein 1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Alpha-1D adrenergic receptor,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Alpha-1B adrenergic receptor,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Alpha-2C adrenergic receptor,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Alpha-2B adrenergic receptor,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Alpha-2A adrenergic receptor,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,E-selectin,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Hypoxia-inducible factor 1-alpha,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Carvedilol,Inward rectifier potassium channel 4,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
Casopitant,Cytochrome P450 3A4,C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=CC=C(F)C=C1C)N1CCN(CC1)C(C)=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
Casopitant,Substance-P receptor,C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=CC=C(F)C=C1C)N1CCN(CC1)C(C)=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
Caspofungin,"1,3-beta-glucan synthase component FKS1",CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN
Castanospermine,"Glucan 1,3-beta-glucosidase",[H][C@]1(O)CCN2C[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@@]12[H]
Castor oil,Prostaglandin E2 receptor EP3 subtype,
Castor oil,Prostaglandin E2 receptor EP4 subtype,
Catridecacog,Coagulation factor XIII B chain,
Catumaxomab,Epithelial cell adhesion molecule,
Catumaxomab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Catumaxomab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Catumaxomab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Catumaxomab,T-cell surface glycoprotein CD3 epsilon chain,
Catumaxomab,High affinity immunoglobulin gamma Fc receptor I,
Cediranib,Vascular endothelial growth factor receptor 2,COC1=CC2=C(C=C1OCCCN1CCCC1)N=CN=C2OC1=C(F)C2=C(NC(C)=C2)C=C1
Cefacetrile,Penicillin-binding protein 1A,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC#N)C(O)=O
Cefacetrile,Penicillin-binding protein 1B,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC#N)C(O)=O
Cefaclor,Penicillin-binding protein 3,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Cefaclor,Penicillin-binding protein 1A,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Cefadroxil,Penicillin-binding protein 3,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O
Cefadroxil,Penicillin-binding protein 1A,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O
Cefadroxil,Penicillin-binding protein 1b,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O
Cefadroxil,Penicillin-binding protein 2B,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O
Cefalotin,D-alanyl-D-alanine carboxypeptidase,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O
Cefalotin,Penicillin-binding protein 1A,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O
Cefalotin,Penicillin-binding protein 1b,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O
Cefalotin,Penicillin-binding protein 3,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O
Cefalotin,Penicillin-binding protein 2a,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O
Cefalotin,Penicillin-binding protein 2B,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O
Cefalotin,Penicillin-binding protein 1A,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O
Cefalotin,Beta-lactamase,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CS1)C(O)=O
Cefamandole,Penicillin-binding protein 2,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O
Cefapirin,Penicillin-binding protein 1A,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CSC1=CC=NC=C1)C(O)=O
Cefazolin,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O
Cefazolin,Penicillin-binding protein 1B,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O
Cefazolin,Penicillin-binding protein 1C,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O
Cefazolin,Penicillin-binding protein 2,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O
Cefazolin,Peptidoglycan synthase FtsI,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O
Cefazolin,Serum paraoxonase/arylesterase 1,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O
Cefazolin,Interleukin-15,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O
Cefazolin,Interleukin-2,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O
Cefdinir,Penicillin-binding protein 2,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O
Cefdinir,PBP3,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O
Cefdinir,Myeloperoxidase,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O
Cefditoren,Penicillin-binding protein 2B,[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefditoren,Penicillin-binding protein 1A,[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefepime,Penicillin-binding protein 2,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1
Cefepime,Peptidoglycan synthase FtsI,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1
Cefepime,Cell division protein,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1
Cefepime,Penicillin-binding protein 2,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1
Cefixime,Penicillin-binding protein 2,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC(O)=O)\C1=CSC(N)=N1)C(O)=O
Cefmenoxime,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefmenoxime,Peptidoglycan synthase FtsI,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefmetazole,Penicillin binding protein 2a,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O
Cefmetazole,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O
Cefmetazole,Penicillin-binding protein 1B,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O
Cefmetazole,Peptidoglycan synthase FtsI,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O
Cefmetazole,D-alanyl-D-alanine carboxypeptidase DacA,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O
Cefmetazole,D-alanyl-D-alanine carboxypeptidase DacC,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=O
Cefonicid,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O
Cefonicid,Peptidoglycan synthase FtsI,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O
Cefonicid,Penicillin-binding protein 1B,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O
Cefonicid,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O
Cefonicid,Penicillin-binding protein 2,[H][C@]12SCC(CSC3=NN=NN3CS(O)(=O)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](O)C1=CC=CC=C1)C(O)=O
Cefoperazone,Peptidoglycan synthase FtsI,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Cefoperazone,Penicillin-binding protein 1B,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Cefoperazone,Penicillin-binding protein 2,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Cefoperazone,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Cefoperazone,Penicillin-binding protein 1B,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Cefoperazone,D-alanyl-D-alanine carboxypeptidase DacC,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Cefoperazone,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Cefoperazone,D-alanyl-D-alanine carboxypeptidase DacA,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Cefoperazone,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O
Ceforanide,Penicillin-binding protein 2,[H][C@]12SCC(CSC3=NN=NN3CC(O)=O)=C(N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1CN)C(O)=O
Cefotaxime,Penicillin-binding protein 1b,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Penicillin-binding protein 2a,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Penicillin-binding protein 3,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Penicillin-binding protein 1A,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Penicillin-binding protein 2B,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Solute carrier family 22 member 6,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Solute carrier family 22 member 8,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Solute carrier family 22 member 11,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Solute carrier family 22 member 7,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Solute carrier family 15 member 1,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Serum albumin,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Beta-lactamase,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotaxime,Solute carrier family 15 member 2,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefotetan,Penicillin-binding protein 3,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O
Cefotiam,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=NN3CCN(C)C)=C(N1C(=O)[C@H]2NC(=O)CC1=CSC(N)=N1)C(O)=O
Cefoxitin,D-alanyl-D-alanine carboxypeptidase DacC,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,D-alanyl-D-alanine carboxypeptidase DacA,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,D-alanyl-D-alanine endopeptidase,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,Penicillin-binding protein 1A,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,Penicillin-binding protein 1B,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,Peptidoglycan synthase FtsI,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,Penicillin-binding protein 3,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,Penicillin-binding protein 1b,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,Penicillin-binding protein 2a,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,Penicillin-binding protein 1A,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefoxitin,Penicillin-binding protein 2B,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O
Cefpiramide,Peptidoglycan synthase FtsI,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O
Cefpiramide,Penicillin-binding protein 1B,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O
Cefpiramide,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O
Cefpiramide,Penicillin-binding protein 1B,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O
Cefpiramide,D-alanyl-D-alanine carboxypeptidase DacC,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O
Cefpiramide,Penicillin-binding protein 1A,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O
Cefpiramide,Penicillin binding protein 2a,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](NC(=O)C1=C(O)C=C(C)N=C1)C1=CC=C(O)C=C1)C(O)=O
Cefpodoxime,Peptidoglycan synthase FtsI,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefprozil,Penicillin-binding protein 1A,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O
Cefprozil,Penicillin-binding protein 2x,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O
Cefprozil,Penicillin-binding protein 2B,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O
Cefradine,Penicillin-binding protein 1A,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CCC=CC1)C(O)=O
Cefroxadine,Penicillin-binding protein 1B,[H][C@]12SCC(OC)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CCC=CC1)C(O)=O
Ceftazidime,Peptidoglycan synthase FtsI,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftazidime,Penicillin-binding protein 3,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftazidime,Penicillin-binding protein 1A,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftazidime,Penicillin-binding protein 1A,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftazidime,Penicillin-binding protein 1B,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftazidime,Penicillin-binding protein 1B,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftazidime,Penicillin-binding protein 2,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftazidime,Penicillin-binding protein 2,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftazidime,D-alanyl-D-alanine endopeptidase,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
Ceftibuten,Peptidoglycan synthase FtsI,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O
Ceftibuten,Penicillin-binding protein 1A,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O
Ceftibuten,Penicillin-binding protein 1B,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O
Ceftibuten,Penicillin-binding protein 2,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=C/CC(O)=O)\C1=CSC(N)=N1)C(O)=O
Ceftizoxime,MecA PBP2' (penicillin binding protein 2'),[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Ceftizoxime,Penicillin-binding protein 1A,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Ceftizoxime,Penicillin-binding protein 1B,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Ceftizoxime,Peptidoglycan synthase FtsI,[H][C@]12SCC=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Ceftobiprole,MecA,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCNC1
Ceftobiprole,Penicillin-binding protein 2x,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCNC1
Ceftobiprole,Peptidoglycan synthase FtsI,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCNC1
Ceftolozane,Penicillin-binding protein 1B,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,Cell division protein,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,D-alanyl-D-alanine carboxypeptidase DacA,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,D-alanyl-D-alanine carboxypeptidase DacB,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,D-alanyl-D-alanine carboxypeptidase DacC,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,Penicillin-binding protein 1A,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,Penicillin-binding protein 1B,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,Penicillin-binding protein 2,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,Peptidoglycan synthase FtsI,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,Penicillin-binding protein 1C,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftolozane,Penicillin-binding protein 2,CN1C(N)=C(NC(=O)NCCN)C=[N+]1CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=NSC(N)=N1)C2=O)C([O-])=O
Ceftriaxone,Penicillin-binding protein 2B,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Ceftriaxone,Solute carrier family 22 member 11,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Ceftriaxone,Solute carrier family 22 member 6,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Ceftriaxone,Solute carrier family 22 member 8,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Ceftriaxone,Solute carrier family 15 member 1,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O
Cefuroxime,Penicillin-binding protein 1A,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O
Celecoxib,Prostaglandin G/H synthase 2,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
Celecoxib,3-phosphoinositide-dependent protein kinase 1,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
Celecoxib,Carbonic anhydrase 2,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
Celecoxib,Carbonic anhydrase 3,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
Celecoxib,ATP-binding cassette sub-family B member 5,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
Celecoxib,ATP-binding cassette sub-family G member 2,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
Celecoxib,Multidrug resistance protein 1,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
Celiprolol,Beta-1 adrenergic receptor,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O
Celiprolol,Beta-2 adrenergic receptor,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O
Celiprolol,Beta-3 adrenergic receptor,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O
Celiprolol,Alpha-2A adrenergic receptor,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O
Celiprolol,Alpha-2B adrenergic receptor,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O
Celiprolol,Alpha-2C adrenergic receptor,CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O
Cellobiose,Endoglucanase 5A,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Cellobiose,Endoglucanase,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Cellobiose,Endoglucanase G,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Cellotetraose,Glucanase,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@@]([H])(O[C@]4([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
Cemiplimab,Programmed cell death protein 1,
Cenegermin,High affinity nerve growth factor receptor,
Cenisertib,Aurora kinase A,[H][C@@]12C[C@@]([H])(C=C1)[C@@H]([C@@H]2NC1=C(F)C=NC(NC2=CC=C(N3CCN(C)CC3)C(C)=C2)=N1)C(N)=O
Cephalexin,Penicillin-binding protein 3,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Cephalexin,Penicillin-binding protein 2a,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Cephalexin,Penicillin-binding protein 1b,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Cephalexin,Penicillin-binding protein 2B,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Cephalexin,Penicillin-binding protein 1A,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Cephaloglycin,Multimodular transpeptidase-transglycosylase / Penicillin-binding protein 1A/1B (PBP1),[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O
Cephalosporin Analog,D-alanyl-D-alanine carboxypeptidase,[H][C@](C)(N=C(O)[C@@]([H])(C)N=C(O)[C@]([H])(CCC1=C(N[C@]([H])(SC1)[C@]([H])(N=C(O)CC1=CC=CC=C1)C(O)=O)C(O)=O)N=C(O)CC[C@@]([H])(N=C(C)O)C(O)=O)C(O)=O
Cephalosporin C,D-alanyl-D-alanine carboxypeptidase,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N=C(O)CCC[C@@H](N)C(O)=O)C2=O)C(O)=O
Cephalosporin C,Penicillin-binding protein 1b,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N=C(O)CCC[C@@H](N)C(O)=O)C2=O)C(O)=O
Cephalosporin C,Penicillin-binding protein 1A,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N=C(O)CCC[C@@H](N)C(O)=O)C2=O)C(O)=O
Cephalosporin C,Penicillin-binding protein 2B,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N=C(O)CCC[C@@H](N)C(O)=O)C2=O)C(O)=O
Cephalosporin C,Penicillin-binding protein 2a,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N=C(O)CCC[C@@H](N)C(O)=O)C2=O)C(O)=O
Cephalosporin C,Penicillin-binding protein 3,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N=C(O)CCC[C@@H](N)C(O)=O)C2=O)C(O)=O
Cephalothin Group,Beta-lactamase Toho-1,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@]1([H])NC(C(O)=O)=C(CC(=O)OC)CS1
Cephalothin Group,D-alanyl-D-alanine carboxypeptidase,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@]1([H])NC(C(O)=O)=C(CC(=O)OC)CS1
Ceritinib,ALK tyrosine kinase receptor,CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1
Cerivastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(C(C)C)N=C1C(C)C
Cerliponase alfa,Cation-independent mannose-6-phosphate receptor,
Certolizumab pegol,Tumor necrosis factor,
Cerulenin,3-oxoacyl-[acyl-carrier-protein] synthase 1,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O
Cerulenin,3-oxoacyl-[acyl-carrier-protein] synthase 2,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O
Cerulenin,3-oxoacyl-[acyl-carrier-protein] synthase 3,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O
Cerulenin,Fatty acid synthase,[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O
Ceruletide,Cholecystokinin receptor type A,[H][C@](NC(=O)[C@H](CC1=CC=C(OS(O)(=O)=O)C=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O
Cetilistat,Pancreatic triacylglycerol lipase,CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1
Cetirizine,Histamine H1 receptor,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Cetrimonium,Cyclopropane mycolic acid synthase MmaA2,CCCCCCCCCCCCCCCC[N+](C)(C)C
Cetrimonium,Cyclopropane mycolic acid synthase 1,CCCCCCCCCCCCCCCC[N+](C)(C)C
Cetrorelix,Lutropin-choriogonadotropic hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
Cetrorelix,Gonadotropin-releasing hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
Cetuximab,Epidermal growth factor receptor,
Cetuximab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Cetuximab,Complement C1r subcomponent,
Cetuximab,Complement C1q subcomponent subunit A,
Cetuximab,Complement C1q subcomponent subunit B,
Cetuximab,Complement C1q subcomponent subunit C,
Cetuximab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Cetuximab,Complement C1s subcomponent,
Cetuximab,High affinity immunoglobulin gamma Fc receptor I,
Cetuximab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Cetuximab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Cetuximab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Cevimeline,Muscarinic acetylcholine receptor M3,CC1O[C@@]2(CS1)CN1CCC2CC1
Cevimeline,Muscarinic acetylcholine receptor M1,CC1O[C@@]2(CS1)CN1CCC2CC1
Chenodeoxycholic acid,Bile acid receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
Chenodeoxycholic acid,Nuclear receptor subfamily 1 group I member 2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
Chenodeoxycholic acid,G-protein coupled bile acid receptor 1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
Chenodeoxycholic acid,Aldo-keto reductase family 1 member C2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
Chitotriose,Lysozyme C,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])N=C(C)O)[C@]([H])(O)[C@@]2([H])N=C(C)O)[C@]([H])(O)[C@@]1([H])N=C(C)O
Chloramphenicol,50S ribosomal protein L16,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
Chloramphenicol,Dr hemagglutinin structural subunit,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
Chloramphenicol,Complement decay-accelerating factor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
Chloramphenicol succinate,Dr hemagglutinin structural subunit,O[C@@H]([C@@H](COC(=O)CCC(O)=O)NC(=O)C(Cl)Cl)C1=CC=C(C=C1)[N+]([O-])=O
Chlorcyclizine,Histamine H1 receptor,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit alpha-1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit alpha-2,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit alpha-3,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit alpha-4,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit alpha-5,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit alpha-6,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit beta-1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit beta-2,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit beta-3,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit delta,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit epsilon,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit gamma-1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit gamma-2,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit gamma-3,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit pi,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlordiazepoxide,Gamma-aminobutyric acid receptor subunit theta,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1
Chlormerodrin,"Succinate-semialdehyde dehydrogenase, mitochondrial",COC(CNC(N)=O)C[Hg]Cl
Chlormerodrin,Solute carrier family 12 member 1,COC(CNC(N)=O)C[Hg]Cl
Chlormezanone,Translocator protein,CN1C(C2=CC=C(Cl)C=C2)S(=O)(=O)CCC1=O
Chlorobutanol,Potassium voltage-gated channel subfamily H member 2,CC(C)(O)C(Cl)(Cl)Cl
Chlorophyll A,Beta-lactamase 2,CCC1=C(C)\C2=C\C3=C(C=C)C(C)=C4\C=C5/N=C([C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@@H]5C)C5=C6N([Mg]N34)\C(=C/C1=N2)C(C)=C6C(=O)[C@@H]5C(=O)OC
Chloroprocaine,Sodium channel protein type 10 subunit alpha,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1
Chloroprocaine,"Glutamate receptor ionotropic, NMDA 3A",CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1
Chloroprocaine,Neuronal acetylcholine receptor subunit alpha-10,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1
Chloroprocaine,5-hydroxytryptamine receptor 3A,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1
Chloroprocaine,Sodium-dependent dopamine transporter,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1
Chloropyramine,Histamine H1 receptor,CN(C)CCN(CC1=CC=C(Cl)C=C1)C1=CC=CC=N1
Chloroquine,Glutathione S-transferase A2,CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1
Chloroquine,Tumor necrosis factor,CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1
Chloroquine,Toll-like receptor 9,CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1
Chloroquine,Glutathione S-transferase,CCN(CC)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1
Chlorothiazide,Carbonic anhydrase 1,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1
Chlorothiazide,Carbonic anhydrase 2,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1
Chlorothiazide,Solute carrier family 12 member 3,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1
Chlorotrianisene,Estrogen receptor,COC1=CC=C(C=C1)C(Cl)=C(C1=CC=C(OC)C=C1)C1=CC=C(OC)C=C1
Chlorphenamine,Histamine H1 receptor,CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
Chlorphenamine,Sodium-dependent serotonin transporter,CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
Chlorphenamine,Sodium-dependent noradrenaline transporter,CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
Chlorphenamine,Sodium-dependent dopamine transporter,CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
Chlorpromazine,D(2) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,D(1A) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,5-hydroxytryptamine receptor 1A,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,5-hydroxytryptamine receptor 2A,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-1A adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-1B adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Histamine H1 receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Potassium voltage-gated channel subfamily H member 2,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,D(1A) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,D(1B) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,D(3) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,D(4) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,D(1B) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,5-hydroxytryptamine receptor 2C,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,5-hydroxytryptamine receptor 2A,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,5-hydroxytryptamine receptor 2B,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,5-hydroxytryptamine receptor 2C,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-1A adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-1B adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-1D adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-2A adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-2B adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-2C adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Muscarinic acetylcholine receptor M1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Muscarinic acetylcholine receptor M3,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Sphingomyelin phosphodiesterase,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Calmodulin,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-1-acid glycoprotein 1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Alpha-1-acid glycoprotein 2,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,5-hydroxytryptamine receptor 6,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,5-hydroxytryptamine receptor 7,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpromazine,Histamine H4 receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
Chlorpropamide,ATP-binding cassette sub-family C member 8,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1
Chlorprothixene,D(2) dopamine receptor,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,D(1A) dopamine receptor,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,D(3) dopamine receptor,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,5-hydroxytryptamine receptor 2A,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,5-hydroxytryptamine receptor 2B,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,5-hydroxytryptamine receptor 2C,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,Histamine H1 receptor,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,Muscarinic acetylcholine receptor M1,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,Muscarinic acetylcholine receptor M2,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,Muscarinic acetylcholine receptor M3,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,Muscarinic acetylcholine receptor M4,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlorprothixene,Muscarinic acetylcholine receptor M5,CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
Chlortetracycline,30S ribosomal protein S3,[H][C@]12C[C@@]3([H])[C@]([H])(N(C)C)C(O)=C(C(O)=N)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C(O)C=CC(Cl)=C1[C@@]2(C)O
Chlortetracycline,30S ribosomal protein S8,[H][C@]12C[C@@]3([H])[C@]([H])(N(C)C)C(O)=C(C(O)=N)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C(O)C=CC(Cl)=C1[C@@]2(C)O
Chlortetracycline,30S ribosomal protein S19,[H][C@]12C[C@@]3([H])[C@]([H])(N(C)C)C(O)=C(C(O)=N)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C(O)C=CC(Cl)=C1[C@@]2(C)O
Chlortetracycline,30S ribosomal protein S14,[H][C@]12C[C@@]3([H])[C@]([H])(N(C)C)C(O)=C(C(O)=N)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C(O)C=CC(Cl)=C1[C@@]2(C)O
Chlortetracycline,30S ribosomal protein S7,[H][C@]12C[C@@]3([H])[C@]([H])(N(C)C)C(O)=C(C(O)=N)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C(O)C=CC(Cl)=C1[C@@]2(C)O
Chlorthalidone,Solute carrier family 12 member 1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12
Chlorthalidone,Carbonic anhydrase 1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12
Chlorzoxazone,Calcium-activated potassium channel subunit alpha-1,ClC1=CC2=C(OC(=O)N2)C=C1
Cholecalciferol,Vitamin D3 receptor,CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Cholecystokinin,Cholecystokinin receptor type A,
Cholecystokinin,RAF proto-oncogene serine/threonine-protein kinase,
Cholecystokinin,Mitogen-activated protein kinase 3,
Cholecystokinin,Pro-epidermal growth factor,
Cholecystokinin,Protein kinase C beta type,
Cholecystokinin,Gastrin/cholecystokinin type B receptor,
Cholesterol,Nuclear receptor ROR-alpha,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C
Cholesterol,Nuclear receptor subfamily 1 group I member 3,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C
Cholesterol,Vitamin D3 receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C
Cholesterol,C-type lectin domain family 4 member E,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C
Cholesterol sulfate,Nuclear receptor ROR-alpha,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OS(O)(=O)=O)[C@H](C)CCCC(C)C
Cholesteryl Linoleate,Lipase 3,CCCCC\C=C/C\C=C/CCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@]3([H])[C@]4([H])CC[C@]([H])([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@]23[H])C1
Cholic Acid,"Ferrochelatase, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Alcohol dehydrogenase 1C,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Estrogen-related receptor gamma,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Gastrotropin,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Cytochrome c oxidase subunit 1,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Cytochrome c oxidase subunit 2,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Cytochrome c oxidase subunit 3,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,"Cytochrome c oxidase subunit 5A, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,"Cytochrome c oxidase subunit 5B, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Cytochrome c oxidase subunit 6C,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,"Cytochrome c oxidase subunit 7B, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,"Cytochrome c oxidase subunit 7C, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,"Cytochrome c oxidase subunit 8A, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,"Cytochrome c oxidase subunit 6A2, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Cytochrome c oxidase subunit 6B1,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,"Cytochrome c oxidase subunit 7A1, mitochondrial",[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Phospholipase A2,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Liver carboxylesterase 1,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Ferrochelatase,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Choloylglycine hydrolase,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,Bile acid receptor,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Cholic Acid,G-protein coupled bile acid receptor 1,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
Choline,Acetylcholinesterase,C[N+](C)(C)CCO
Choline,Choline-phosphate cytidylyltransferase B,C[N+](C)(C)CCO
Choline,Choline-phosphate cytidylyltransferase A,C[N+](C)(C)CCO
Choline,Phospholipase D2,C[N+](C)(C)CCO
Choline,Cholinesterase,C[N+](C)(C)CCO
Choline,Phospholipase D1,C[N+](C)(C)CCO
Choline,Phosphoethanolamine/phosphocholine phosphatase,C[N+](C)(C)CCO
Choline,Neuronal acetylcholine receptor subunit alpha-7,C[N+](C)(C)CCO
Choline alfoscerate,Ganglioside GM2 activator,[H][C@@](O)(CO)COP([O-])(=O)OCC[N+](C)(C)C
Choline magnesium trisalicylate,Prostaglandin G/H synthase 1,[Mg++].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O
Choline magnesium trisalicylate,Prostaglandin G/H synthase 2,[Mg++].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O
Choline salicylate,Choline-phosphate cytidylyltransferase B,C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O
Choline salicylate,Acetylcholinesterase,C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O
Choline salicylate,Choline-phosphate cytidylyltransferase A,C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O
Choline salicylate,Phospholipase D2,C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O
Choline salicylate,Cholinesterase,C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O
Choline salicylate,Phospholipase D1,C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O
Choline salicylate,Phosphoethanolamine/phosphocholine phosphatase,C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O
Choline salicylate,Neuronal acetylcholine receptor subunit alpha-7,C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O
Chondroitin sulfate,Brain-derived neurotrophic factor,
Chondroitin sulfate,Glial cell line-derived neurotrophic factor,
Chondroitin sulfate,Vascular endothelial growth factor A,
Chondroitin sulfate,C-C motif chemokine 2,
Choriogonadotropin alfa,Lutropin-choriogonadotropic hormone receptor,
Choriogonadotropin alfa,Follicle-stimulating hormone receptor,
Chorionic Gonadotropin (Human),Lutropin-choriogonadotropic hormone receptor,
Chromic chloride,Insulin receptor,[Cl-].[Cl-].[Cl-].[Cr+3]
Chromic citrate,Cytochrome b5,[Cr+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Chromic nitrate,Cytochrome b5,[Cr+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
Chromium,Cytochrome b5,[Cr]
Chromium gluconate,Cytochrome b5,[Cr+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O
Chromium nicotinate,Cytochrome b5,[Cr+3].[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1
Chromous sulfate,Cytochrome b5,[Cr++].[O-]S([O-])(=O)=O
Chymopapain,Bone marrow proteoglycan,
Chymostatin,Peptide amidase,[H][C@](CC1=CC=CC=C1)(C=O)N=C(O)[C@]([H])(CC(C)C)N=C(O)[C@@]([H])(NC(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=O)[C@]1([H])CCNC(=N)N1
Cibacron Blue,Glutathione S-transferase P,NC1=C(C=C(NC2=CC=C(NC3=NC(Cl)=NC(NC4=CC=CC=C4S(O)(=O)=O)=N3)C(=C2)S(O)(=O)=O)C2=C1C(=O)C1=CC=CC=C1C2=O)S(O)(=O)=O
Cibacron Blue,NAD(P)H dehydrogenase [quinone] 1,NC1=C(C=C(NC2=CC=C(NC3=NC(Cl)=NC(NC4=CC=CC=C4S(O)(=O)=O)=N3)C(=C2)S(O)(=O)=O)C2=C1C(=O)C1=CC=CC=C1C2=O)S(O)(=O)=O
Ciclesonide,Glucocorticoid receptor,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C
Ciclopirox,Sodium/potassium-transporting ATPase subunit alpha-1,CC1=CC(=O)N(O)C(=C1)C1CCCCC1
Ciclosporin,Calcium signal-modulating cyclophilin ligand,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
Ciclosporin,Calcineurin subunit B type 2,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
Ciclosporin,Peptidyl-prolyl cis-trans isomerase A,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
Ciclosporin,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
Cidofovir,DNA polymerase catalytic subunit,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1
Ciglitazone,Peroxisome proliferator-activated receptor gamma,CC1(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)CCCCC1
Cilansetron,5-hydroxytryptamine receptor 3A,CC1=NC=CN1C[C@H]1CCC2=C(C3=CC=CC4=C3N2CCC4)C1=O
Cilastatin,Dipeptidase 1,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O
Cilazapril,Angiotensin-converting enzyme,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O
Cilnidipine,Voltage-dependent N-type calcium channel subunit alpha-1B,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilnidipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilnidipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilnidipine,Voltage-dependent L-type calcium channel subunit alpha-1F,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilnidipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilnidipine,Voltage-dependent L-type calcium channel subunit beta-1,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilnidipine,Voltage-dependent L-type calcium channel subunit beta-2,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilnidipine,Voltage-dependent L-type calcium channel subunit beta-3,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilnidipine,Voltage-dependent L-type calcium channel subunit beta-4,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1
Cilomilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",[H][C@@]1(CC[C@](CC1)(C#N)C1=CC(OC2CCCC2)=C(OC)C=C1)C(O)=O
Cilomilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",[H][C@@]1(CC[C@](CC1)(C#N)C1=CC(OC2CCCC2)=C(OC)C=C1)C(O)=O
Cilostazol,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
Ciluprevir,Genome polyprotein,COC1=CC2=C(C=C1)C(O[C@H]1CN3C(=O)[C@H](CCCCC\C=C/[C@]4([H])C[C@@]4(C(O)=O)NC(=O)[C@]3([H])C1)NC(=O)OC1CCCC1)=CC(=N2)C1=CSC(NC(C)C)=N1
Cimetidine,Histamine H2 receptor,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N
Cimicoxib,Prostaglandin G/H synthase 2,COC1=C(F)C=C(C=C1)C1=C(Cl)N=CN1C1=CC=C(C=C1)S(N)(=O)=O
Cinacalcet,Extracellular calcium-sensing receptor,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
Cinalukast,Cysteinyl leukotriene receptor 1,CCC(CC)(CC(=O)NC1=CC(\C=C\C2=NC(=CS2)C2CCC2)=CC=C1)C(O)=O
Cinchocaine,Sodium channel protein type 10 subunit alpha,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
Cinchocaine,Sodium channel protein type 5 subunit alpha,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
Cinchocaine,Calmodulin,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
Cinitapride,5-hydroxytryptamine receptor 1A,CCOC1=CC(N)=C(C=C1C(=O)NC1CCN(CC2CCC=CC2)CC1)[N+]([O-])=O
Cinitapride,5-hydroxytryptamine receptor 2A,CCOC1=CC(N)=C(C=C1C(=O)NC1CCN(CC2CCC=CC2)CC1)[N+]([O-])=O
Cinitapride,5-hydroxytryptamine receptor 4,CCOC1=CC(N)=C(C=C1C(=O)NC1CCN(CC2CCC=CC2)CC1)[N+]([O-])=O
Cinnarizine,Histamine H1 receptor,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Voltage-dependent L-type calcium channel subunit alpha-1C,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Voltage-dependent L-type calcium channel subunit alpha-1D,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Voltage-dependent L-type calcium channel subunit alpha-1F,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Voltage-dependent L-type calcium channel subunit alpha-1S,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Voltage-dependent T-type calcium channel subunit alpha-1G,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Voltage-dependent T-type calcium channel subunit alpha-1I,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Voltage-dependent T-type calcium channel subunit alpha-1H,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,D(2) dopamine receptor,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,D(1A) dopamine receptor,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,D(1B) dopamine receptor,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Muscarinic acetylcholine receptor M1,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Muscarinic acetylcholine receptor M2,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Muscarinic acetylcholine receptor M3,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Muscarinic acetylcholine receptor M4,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinnarizine,Muscarinic acetylcholine receptor M5,C(C=CC1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cinolazepam,Gamma-aminobutyric acid receptor subunit alpha-1,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit alpha-2,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit alpha-3,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit alpha-5,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit gamma-1,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit gamma-2,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit gamma-3,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit beta-1,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit beta-2,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit beta-3,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit delta,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit epsilon,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit pi,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit rho-1,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit rho-2,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinolazepam,Gamma-aminobutyric acid receptor subunit rho-3,OC1N=C(C2=CC=CC=C2F)C2=C(C=CC(Cl)=C2)N(CCC#N)C1=O
Cinoxacin,DNA gyrase subunit A,CCN1N=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12
Cintredekin Besudotox,Interleukin-13,
Ciprofibrate,Peroxisome proliferator-activated receptor alpha,CC(C)(OC1=CC=C(C=C1)C1CC1(Cl)Cl)C(O)=O
Ciprofloxacin,DNA topoisomerase 4 subunit A,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,DNA gyrase subunit A,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,DNA topoisomerase 2-alpha,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,Potassium voltage-gated channel subfamily H member 2,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,DNA gyrase subunit A,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,DNA topoisomerase 4 subunit A,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,DNA topoisomerase 4 subunit B,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,DNA gyrase subunit A,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,Multidrug resistance protein MdtK,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,Gyrase A,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Ciprofloxacin,DNA gyrase subunit A,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O
Cirazoline,Alpha-1A adrenergic receptor,[H]N1CCN=C1COC1=CC=CC=C1C1CC1
Cirazoline,Alpha-1B adrenergic receptor,[H]N1CCN=C1COC1=CC=CC=C1C1CC1
Cirazoline,Alpha-1D adrenergic receptor,[H]N1CCN=C1COC1=CC=CC=C1C1CC1
Cirazoline,Alpha-2A adrenergic receptor,[H]N1CCN=C1COC1=CC=CC=C1C1CC1
Cirazoline,Alpha-2B adrenergic receptor,[H]N1CCN=C1COC1=CC=CC=C1C1CC1
Cirazoline,Alpha-2C adrenergic receptor,[H]N1CCN=C1COC1=CC=CC=C1C1CC1
"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",E3 ubiquitin-protein ligase Mdm2,[H][C@]1(N=C(N(C(=O)N2CCN(CCO)CC2)[C@]1([H])C1=CC=C(Br)C=C1)C1=C(OCC)C=C(OC)C=C1)C1=CC=C(Br)C=C1
"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",E3 ubiquitin-protein ligase Mdm2,[H][C@]1(N=C(N(C(=O)N2CCNCC2)[C@]1([H])C1=CC=C(Cl)C=C1)C1=C(OC(C)C)C=C(OC)C=C1)C1=CC=C(Cl)C=C1
Cisapride,5-hydroxytryptamine receptor 4,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC
Cisapride,5-hydroxytryptamine receptor 3A,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC
Cisapride,5-hydroxytryptamine receptor 2A,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC
Cisapride,Potassium voltage-gated channel subfamily H member 2,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC
Cisatracurium,Neuronal acetylcholine receptor subunit alpha-2,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2
Cisplatin,DNA-3-methyladenine glycosylase,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]
Cisplatin,Alpha-2-macroglobulin,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]
Cisplatin,Serotransferrin,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]
Cisplatin,Copper transport protein ATOX1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H]
Citalopram,Sodium-dependent serotonin transporter,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
Citalopram,Histamine H1 receptor,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
Citicoline,LicC protein,C[N+](C)(C)CCOP([O-])(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O
Citraconic acid,Fumarate reductase flavoprotein subunit,C\C(=C\C(O)=O)C(O)=O
Citric acid,Adenine phosphoribosyltransferase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,"cGMP-specific 3',5'-cyclic phosphodiesterase",OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Glycine N-methyltransferase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Aldose reductase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,"Malate dehydrogenase, mitochondrial",OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Proto-oncogene tyrosine-protein kinase Src,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Betaine--homocysteine S-methyltransferase 1,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Eosinophil cationic protein,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Tumor necrosis factor ligand superfamily member 13B,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Angiogenin,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Tryptophan--tRNA ligase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Cell division protein FtsZ,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Beta-lactamase 2,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Uridine-cytidine kinase 2,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Beta-lactamase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Isocitrate dehydrogenase [NADP],OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,1-deoxy-D-xylulose 5-phosphate reductoisomerase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Oxygen-insensitive NAD(P)H nitroreductase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Molybdenum cofactor guanylyltransferase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Tryptophan synthase alpha chain,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Macrophage migration inhibitory factor,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Gag-Pro-Pol polyprotein,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Fumarate hydratase class II,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Sialidase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,6-phosphogluconolactonase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,KHG/KDPG aldolase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Glucose-1-phosphate thymidylyltransferase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,GMP synthase [glutamine-hydrolyzing],OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Riboflavin biosynthesis protein,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Glutamine synthetase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Glutamine synthetase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Nicotinate-nucleotide adenylyltransferase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Glyoxalase family protein,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Citrate synthase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,2-methylcitrate synthase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Laccase domain protein YfiH,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Cytochrome c peroxidase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Intron-associated endonuclease 1,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Prostaglandin F synthase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Invasin,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Short tail fiber protein gp12,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,N5-carboxyaminoimidazole ribonucleotide mutase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,50S ribosomal protein L4,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Carboxypeptidase B,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Hexon protein,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Beta-fructosidase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Putative stringent starvation protein A,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,RNA 3'-terminal phosphate cyclase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Pleckstrin homology domain-containing family A member 1,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Fe(3+)-binding periplasmic protein,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Signal recognition particle receptor FtsY,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,N utilization substance protein B homolog,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Complement component C8 gamma chain,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Ribonucleoside-diphosphate reductase subunit beta,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Ribose-5-phosphate isomerase A,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Lysozyme,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Glycerol uptake operon antiterminator regulatory protein,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,"3-carboxy-cis,cis-muconate cycloisomerase",OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Pyruvate decarboxylase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Ribonuclease pancreatic,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,U6 snRNA-associated Sm-like protein LSm6,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Inosine triphosphate pyrophosphatase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,"Citrate synthase, mitochondrial",OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,L-amino-acid oxidase,OC(=O)CC(O)(CC(O)=O)C(O)=O
Citric acid,Hepatocyte growth factor-regulated tyrosine kinase substrate,OC(=O)CC(O)(CC(O)=O)C(O)=O
Cixutumumab,Insulin-like growth factor 1 receptor,
Cladribine,Ribonucleoside-diphosphate reductase large subunit,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Cladribine,Ribonucleoside-diphosphate reductase subunit M2,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Cladribine,Ribonucleoside-diphosphate reductase subunit M2 B,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Cladribine,DNA polymerase alpha catalytic subunit,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Cladribine,DNA polymerase epsilon catalytic subunit A,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Cladribine,DNA polymerase epsilon subunit 2,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Cladribine,DNA polymerase epsilon subunit 3,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Cladribine,DNA polymerase epsilon subunit 4,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Cladribine,Purine nucleoside phosphorylase,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
Clarithromycin,50S ribosomal protein L10,[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)OC
Clarithromycin,Potassium voltage-gated channel subfamily H member 2,[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)OC
Clarithromycin,Solute carrier organic anion transporter family member 1B1,[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)OC
Clarithromycin,Solute carrier organic anion transporter family member 1B3,[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)OC
Clavulanic acid,Beta-lactamase,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)\C(O2)=C\CO
Clazosentan,Endothelin-1 receptor,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C)C=N2)N=C(N=C1OCCO)C1=CC=NC(=C1)C1=NN=NN1
Clemastine,Histamine H1 receptor,CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Clenbuterol,Beta-2 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1
Clenbuterol,Beta-1 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1
Clenbuterol,Beta-3 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1
Clenbuterol,Beta-nerve growth factor,CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1
Clenbuterol,Tumor necrosis factor,CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1
Clenoliximab,T-cell surface glycoprotein CD4,
Clevidipine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
Clevidipine,Voltage-dependent L-type calcium channel subunit alpha-1S,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
Clevidipine,Voltage-dependent L-type calcium channel subunit alpha-1F,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
Clevidipine,Voltage-dependent L-type calcium channel subunit alpha-1D,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
Clidinium,Muscarinic acetylcholine receptor M1,C[N@@+]12CC[C@@H](CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Clindamycin,50S ribosomal protein L10,CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O
Clinofibrate,Peroxisome proliferator-activated receptor alpha,CCC(C)(OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(OC(C)(CC)C(O)=O)C=C1)C(O)=O
Clinofibrate,Peroxisome proliferator-activated receptor gamma,CCC(C)(OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(OC(C)(CC)C(O)=O)C=C1)C(O)=O
Clinofibrate,Peroxisome proliferator-activated receptor delta,CCC(C)(OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(OC(C)(CC)C(O)=O)C=C1)C(O)=O
Clobazam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit alpha-4,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit alpha-6,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit beta-1,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit beta-2,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit beta-3,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit delta,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit epsilon,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit gamma-1,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit gamma-2,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit gamma-3,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit pi,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobazam,Gamma-aminobutyric acid receptor subunit theta,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
Clobetasol propionate,Glucocorticoid receptor,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Clobetasone,Glucocorticoid receptor,[H][C@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]2(C)[C@@]1(O)C(=O)CCl
Clocortolone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Clodronic acid,ADP/ATP translocase 1,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O
Clodronic acid,ADP/ATP translocase 2,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O
Clodronic acid,ADP/ATP translocase 3,OP(O)(=O)C(Cl)(Cl)P(O)(O)=O
Clofarabine,Ribonucleoside-diphosphate reductase large subunit,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12
Clofarabine,DNA polymerase alpha catalytic subunit,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12
Clofazimine,Uncharacterized oxidoreductase CzcO-like,CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1
Clofazimine,Bile salt export pump,CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1
Clofedanol,Histamine H1 receptor,CN(C)CCC(O)(C1=CC=CC=C1)C1=CC=CC=C1Cl
Clofibrate,Peroxisome proliferator-activated receptor alpha,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
Clomethiazole,Gamma-aminobutyric acid receptor subunit alpha-1,CC1=C(CCCl)SC=N1
Clomifene,Estrogen receptor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
Clomifene,Sex hormone-binding globulin,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1
Clomipramine,Sodium-dependent serotonin transporter,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2
Clomipramine,5-hydroxytryptamine receptor 2A,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2
Clomipramine,5-hydroxytryptamine receptor 2B,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2
Clomipramine,5-hydroxytryptamine receptor 2C,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2
Clomipramine,Sodium-dependent noradrenaline transporter,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2
Clomipramine,Glutathione S-transferase P,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2
Clomocycline,30S ribosomal protein S4,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(=O)NCO)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O
Clomocycline,30S ribosomal protein S9,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(=O)NCO)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC(Cl)=C1[C@@]3(C)O
Clonazepam,Gamma-aminobutyric acid receptor subunit alpha-1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit alpha-2,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit alpha-3,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit alpha-4,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit alpha-5,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit alpha-6,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit beta-1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit beta-2,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit beta-3,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit delta,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit epsilon,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit gamma-1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit gamma-2,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit gamma-3,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit pi,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Gamma-aminobutyric acid receptor subunit theta,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Translocator protein,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonazepam,Nuclear receptor subfamily 1 group I member 2,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1
Clonidine,Alpha-2A adrenergic receptor,ClC1=CC=CC(Cl)=C1NC1=NCCN1
Clonidine,Alpha-2B adrenergic receptor,ClC1=CC=CC(Cl)=C1NC1=NCCN1
Clonidine,Alpha-2C adrenergic receptor,ClC1=CC=CC(Cl)=C1NC1=NCCN1
Clonidine,Alpha-1A adrenergic receptor,ClC1=CC=CC(Cl)=C1NC1=NCCN1
Clonidine,Alpha-1B adrenergic receptor,ClC1=CC=CC(Cl)=C1NC1=NCCN1
Clonidine,Alpha-1D adrenergic receptor,ClC1=CC=CC(Cl)=C1NC1=NCCN1
Clopidogrel,P2Y purinoceptor 12,[H][C@@](N1CCC2=C(C1)C=CS2)(C(=O)OC)C1=CC=CC=C1Cl
Clorazepic acid,Gamma-aminobutyric acid receptor subunit alpha-1,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit alpha-2,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit alpha-3,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit alpha-4,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit alpha-5,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit alpha-6,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit beta-1,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit beta-2,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit beta-3,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit delta,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit epsilon,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit gamma-1,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit gamma-2,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit gamma-3,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit pi,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Gamma-aminobutyric acid receptor subunit theta,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorazepic acid,Translocator protein,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Clorgiline,Amine oxidase [flavin-containing] A,CN(CCCOC1=CC=C(Cl)C=C1Cl)CC#C
Clorobiocin,DNA gyrase subunit B,CO[C@@H]1[C@@H](OC(=O)C2=CC=C(C)N2)[C@@H](O)[C@H](OC2=C(Cl)C3=C(C=C2)C(O)=C(NC(=O)C2=CC(CC=C(C)C)=C(O)C=C2)C(=O)O3)OC1(C)C
Clotiazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit gamma-1,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit gamma-3,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit beta-1,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit beta-2,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit beta-3,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit delta,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit epsilon,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit pi,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit rho-1,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit rho-2,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotiazepam,Gamma-aminobutyric acid receptor subunit rho-3,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl
Clotrimazole,Lanosterol 14-alpha demethylase,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Clotrimazole,Intermediate conductance calcium-activated potassium channel protein 4,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Clotrimazole,Nuclear receptor subfamily 1 group I member 2,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Clotrimazole,Hydroxycarboxylic acid receptor 2,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Clove oil,Vascular cell adhesion protein 1,
Clove oil,C-X-C motif chemokine 10,
Clove oil,Collagen alpha-1(I) chain,
Clove oil,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,
Cloxacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O
Cloxacillin,Beta-lactamase,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O
Cloxacillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O
Cloxacillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O
Cloxacillin,Cell division protein,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O
Cloxacillin,D-alanyl-D-alanine carboxypeptidase DacA,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl)C(O)=O
Clozapine,D(2) dopamine receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 2A,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,D(1A) dopamine receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,D(3) dopamine receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,D(4) dopamine receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 1A,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 1B,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 1D,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 1E,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 2C,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 3A,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 6,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,5-hydroxytryptamine receptor 7,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Histamine H1 receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Histamine H4 receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Alpha-1A adrenergic receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Alpha-1B adrenergic receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Alpha-2A adrenergic receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Alpha-2B adrenergic receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Alpha-2C adrenergic receptor,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Muscarinic acetylcholine receptor M1,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Muscarinic acetylcholine receptor M2,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Muscarinic acetylcholine receptor M3,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Muscarinic acetylcholine receptor M4,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Muscarinic acetylcholine receptor M5,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Neuron-specific vesicular protein calcyon,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Clozapine,Glutathione S-transferase P,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
Cmp-2-Keto-3-Deoxy-Octulosonic Acid,3-deoxy-manno-octulosonate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)O[C@]2(C[C@@H](O)[C@@H](O)[C@H](O2)[C@H](O)CO)C(O)=O)[C@@H](O)[C@H]1O
Cmp-2-Keto-3-Deoxy-Octulosonic Acid,3-deoxy-manno-octulosonate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)O[C@]2(C[C@@H](O)[C@@H](O)[C@H](O2)[C@H](O)CO)C(O)=O)[C@@H](O)[C@H]1O
Coa-S-Acetyl 5-Bromotryptamine,Serotonin N-acetyltransferase,[H][C@](O)(C(O)=NCCC(O)=NCCSCC(O)=NCCC1=CNC2=C1C=C(Br)C=C2)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Coa-S-Acetyl Tryptamine,Serotonin N-acetyltransferase,[H][C@](O)(C(O)=NCCC(O)=NCCSCC(O)=NCCC1=CNC2=CC=CC=C12)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Coa-S-Trimethylene-Acetyl-Tryptamine,Serotonin N-acetyltransferase,[H][C@](O)(C(O)=NCCC(O)=NCCSCCCCC(O)=NCCC1=CNC2=CC=CC=C12)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Coagulation Factor IX (Recombinant),Coagulation factor X,
Coagulation Factor IX (Recombinant),Coagulation factor XI,
Coagulation Factor IX (Recombinant),Coagulation factor VII,
Coagulation Factor IX (Recombinant),Coagulation factor VIII,
Coagulation Factor IX (Recombinant),Prothrombin,
Coagulation Factor IX (Recombinant),Prolow-density lipoprotein receptor-related protein 1,
Coagulation Factor IX (Recombinant),Vitamin K-dependent gamma-carboxylase,
Coagulation Factor IX Human,Coagulation factor X,
Coagulation Factor IX Human,Coagulation factor XI,
Coagulation Factor IX Human,Coagulation factor VII,
Coagulation Factor IX Human,Coagulation factor VIII,
Coagulation Factor IX Human,Prothrombin,
Coagulation Factor IX Human,Prolow-density lipoprotein receptor-related protein 1,
Coagulation Factor IX Human,Vitamin K-dependent gamma-carboxylase,
Coagulation factor VII human,Tissue factor,
Coagulation factor VII human,Coagulation factor X,
Coagulation factor VII human,Coagulation factor IX,
Coagulation factor VIIa Recombinant Human,Coagulation factor X,
Coagulation factor VIIa Recombinant Human,Coagulation factor VII,
Coagulation factor VIIa Recombinant Human,Vitamin K-dependent gamma-carboxylase,
Coagulation factor VIIa Recombinant Human,Tissue factor pathway inhibitor,
Coagulation factor VIIa Recombinant Human,Tissue factor,
Coagulation factor VIIa Recombinant Human,Serine protease hepsin,
Cobalt Hexammine Ion,Chorismate synthase,[NH3+][Co-3]([NH3+])([NH3+])([NH3+])([NH3+])[NH3+]
Cobalt Hexammine Ion,Outer membrane protein TolC,[NH3+][Co-3]([NH3+])([NH3+])([NH3+])([NH3+])[NH3+]
Cobimetinib,Dual specificity mitogen-activated protein kinase kinase 1,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1
Cobiprostone,Chloride channel protein 2,CC[C@H](C)CC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(O)=O)O1
Cocaine,Sodium-dependent dopamine transporter,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Sodium-dependent noradrenaline transporter,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Sodium-dependent serotonin transporter,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Sodium channel protein type 5 subunit alpha,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Sodium channel protein type 10 subunit alpha,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Sodium channel protein type 11 subunit alpha,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Muscarinic acetylcholine receptor M1,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Muscarinic acetylcholine receptor M2,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Sigma non-opioid intracellular receptor 1,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocaine,Liver carboxylesterase 1,[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
Cocarboxylase,Benzoylformate decarboxylase,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Cocarboxylase,Pyruvate oxidase,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Cocarboxylase,"Acetolactate synthase, catabolic",CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Cocarboxylase,Pyruvate dehydrogenase E1 component,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Cocarboxylase,Pyruvate synthase,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Cocarboxylase,Indole-3-pyruvate decarboxylase,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Cocarboxylase,N(2)-(2-carboxyethyl)arginine synthase,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Cocarboxylase,Transketolase 1,CC1=C(CCO[P@](O)(=O)O[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Coccidioides immitis spherule,"HLA class I histocompatibility antigen, A-2 alpha chain",
Coccidioides immitis spherule,"HLA class I histocompatibility antigen, A-3 alpha chain",
Coccidioides immitis spherule,"HLA class I histocompatibility antigen, B-27 alpha chain",
Codeine,Mu-type opioid receptor,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC
Codeine,Kappa-type opioid receptor,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC
Codeine,Delta-type opioid receptor,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC
Coenzyme A,Carnitine O-acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,3-oxoacyl-[acyl-carrier-protein] synthase 3,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,3-hydroxy-3-methylglutaryl-coenzyme A reductase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Streptogramin A acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Pantothenate kinase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Formyl-CoA:oxalate CoA-transferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,"Acetyl-CoA acetyltransferase, cytosolic",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Fatty acid metabolism regulator protein,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Galactoside O-acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Acetyl-CoA acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,L-carnitine CoA-transferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Spermidine/spermine N(1)-acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Formate acetyltransferase 1,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Malate synthase G,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Phosphopantetheine adenylyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Holo-[acyl-carrier-protein] synthase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,3-hydroxy-3-methylglutaryl-coenzyme A reductase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Formyl-CoA:oxalate CoA-transferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Acetyl-coenzyme A synthetase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Gentamicin 3-N-acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Bifunctional protein GlmU,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Aminoglycoside 2'-N-acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,4-hydroxybenzoyl-CoA thioesterase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Acetyl transferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Uncharacterized N-acetyltransferase YvbK,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Aminoglycoside N(6')-acetyltransferase type 1,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Acyl-CoA hydrolase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Uncharacterized acyl-CoA thioester hydrolase HI_0827,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,3-oxoacyl-[acyl-carrier-protein] synthase 3,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Mycothiol acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Acyl-CoA hydrolase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Histone acetyltransferase KAT2B,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,"1,4-dihydroxy-2-naphthoyl-CoA synthase",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Citrate synthase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Aac(6')-Ii protein,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,4'-phosphopantetheinyl transferase sfp,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Uncharacterized protein,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Serine acetyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,2-methylcitrate synthase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,"Citrate synthase, mitochondrial",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Acyl-CoA-binding protein,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Histone acetyltransferase KAT5,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme A,Histone acetyltransferase KAT2A,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Coenzyme a Persulfide,"Isovaleryl-CoA dehydrogenase, mitochondrial",[H][C@](O)(C(O)=NCCC(O)=NCCSS)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Colchicine,Tubulin beta-1 chain,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1C(CC2)NC(C)=O
Colchicine,Tubulin beta chain,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1C(CC2)NC(C)=O
Colforsin,Adenylate cyclase type 2,[H][C@]1(O)CCC(C)(C)[C@]2([H])[C@]([H])(O)[C@]([H])(OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]12C)C=C
Colforsin,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,[H][C@]1(O)CCC(C)(C)[C@]2([H])[C@]([H])(O)[C@]([H])(OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]12C)C=C
Colforsin,Adenylate cyclase type 5,[H][C@]1(O)CCC(C)(C)[C@]2([H])[C@]([H])(O)[C@]([H])(OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]12C)C=C
Colforsin,Cystic fibrosis transmembrane conductance regulator,[H][C@]1(O)CCC(C)(C)[C@]2([H])[C@]([H])(O)[C@]([H])(OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]12C)C=C
Collagenase clostridium histolyticum,Collagen alpha-1(I) chain,
Collagenase clostridium histolyticum,Collagen alpha-1(III) chain,
Collagenase clostridium histolyticum,Collagen alpha-1(II) chain,
Collagenase clostridium histolyticum,Collagen alpha-2(I) chain,
Coltuximab ravtansine,B-lymphocyte antigen CD19,
"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CC1=CC=C(N(C(=O)C(O)=O)C2=CC=CC=C2C(O)=O)C2=CC=CC=C12)(N=C(C)O)C(O)=NCCCCC
Compound 18,Estrogen receptor,[H][C@](C)(COC1=CC=C(C=C1)[C@]1([H])OC2=C(S[C@]1([H])C1=CC=C(O)C=C1)C=C(O)C=C2)N1CCCC1
Compound 19,Estrogen receptor,[H][C@@](C)(COC1=CC=C(C=C1)[C@]1([H])OC2=C(S[C@]1([H])C1=CC=C(O)C=C1)C=C(O)C=C2)N1CCCC1
Compound 19,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](C)(COC1=CC=C(C=C1)[C@]1([H])OC2=C(S[C@]1([H])C1=CC=C(O)C=C1)C=C(O)C=C2)N1CCCC1
Compound 4-D,Estrogen receptor,[H][C@]1(OC2=C(S[C@]1([H])C1=CC=C(O)C=C1)C=C(O)C=C2)C1=CC=C(OCCN2CCCCC2)C=C1
"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)N(C1=CC=CC=C1C(O)=O)C1=CC=CC2=C1C=CC=C2
Concanamycin A,Multidrug resistance protein 1,[H][C@@]1(OC(=O)\C(OC)=C\C(\C)=C\[C@@H](C)[C@@H](O)[C@@H](CC)[C@@H](O)[C@H](C)C\C(C)=C\C=C\[C@@H]1OC)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O[C@H]2C[C@@H](O)[C@H](OC(N)=O)[C@@H](C)O2)[C@H](C)[C@H](O1)\C=C\C
Conestat alfa,Complement C1r subcomponent,
Conestat alfa,Complement C1s subcomponent,
Conestat alfa,Plasma kallikrein,
Conestat alfa,Coagulation factor XII,
Conestat alfa,Prothrombin,
Conestat alfa,Coagulation factor XI,
Conestat alfa,Tissue-type plasminogen activator,
Conivaptan,Vasopressin V1a receptor,CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1
Conivaptan,Vasopressin V2 receptor,CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1
Conjugated estrogens,Estrogen receptor,
Conjugated estrogens,Estrogen receptor beta,
Contulakin-G,Voltage-dependent N-type calcium channel subunit alpha-1B,
Copanlisib,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21
Copanlisib,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21
Copper,Amyloid beta A4 protein,[Cu]
Copper,Adenosylhomocysteinase,[Cu]
Copper,Histone H2B type 1-C/E/F/G/I,[Cu]
Copper,Glyceraldehyde-3-phosphate dehydrogenase,[Cu]
Copper,Nucleoside diphosphate kinase A,[Cu]
Copper,Histone H1.4,[Cu]
Copper,Peroxiredoxin-1,[Cu]
Copper,Protein S100-A8,[Cu]
Copper,40S ribosomal protein SA,[Cu]
Copper,"Actin, cytoplasmic 2",[Cu]
Copper,Alpha-enolase,[Cu]
Copper,Elongation factor 1-alpha 1,[Cu]
Copper,"Keratin, type II cytoskeletal 8",[Cu]
Copper,Protein disulfide-isomerase,[Cu]
Copper,Protein disulfide-isomerase A3,[Cu]
Copper,"60 kDa heat shock protein, mitochondrial",[Cu]
Copper,Heat shock 70 kDa protein 13,[Cu]
Copper,78 kDa glucose-regulated protein,[Cu]
Copper,Endoplasmin,[Cu]
Copper,Serotransferrin,[Cu]
Copper,Cell growth-regulating nucleolar protein,[Cu]
Copper,40S ribosomal protein S2,[Cu]
Copper,Serine/arginine-rich splicing factor 1,[Cu]
Copper,Heterogeneous nuclear ribonucleoproteins A2/B1,[Cu]
Copper,Heterogeneous nuclear ribonucleoprotein H,[Cu]
Copper,Heterogeneous nuclear ribonucleoprotein H3,[Cu]
Copper,Cobalt-precorrin-5B C(1)-methyltransferase,[Cu]
Copper,Heterogeneous nuclear ribonucleoprotein L,[Cu]
Copper,"Splicing factor, proline- and glutamine-rich",[Cu]
Copper,Splicing factor 3A subunit 2,[Cu]
Copper,Receptor of activated protein C kinase 1,[Cu]
Copper,Alpha-actinin-1,[Cu]
Copper,Aminoacylase-1,[Cu]
Copper,Annexin A4,[Cu]
Copper,Annexin A5,[Cu]
Copper,Calreticulin,[Cu]
Copper,Pyruvate kinase PKM,[Cu]
Copper,Alcohol dehydrogenase [NADP(+)],[Cu]
Copper,NADH-cytochrome b5 reductase 3,[Cu]
Copper,"Glutathione reductase, mitochondrial",[Cu]
Copper,Transketolase,[Cu]
Copper,Peroxiredoxin-2,[Cu]
Copper,Peroxiredoxin-6,[Cu]
Copper,Peptidyl-prolyl cis-trans isomerase A,[Cu]
Copper,Heat shock cognate 71 kDa protein,[Cu]
Copper,Heat shock protein HSP 90-alpha,[Cu]
Copper,Prostaglandin E synthase 3,[Cu]
Copper,Stress-induced-phosphoprotein 1,[Cu]
Copper,Translation elongation factor 1 alpha 1-like 14,[Cu]
Copper,Eukaryotic translation initiation factor 6,[Cu]
Copper,Eukaryotic initiation factor 4A-I,[Cu]
Copper,Glucose-6-phosphate isomerase,[Cu]
Copper,L-lactate dehydrogenase A chain,[Cu]
Copper,Phosphoglycerate kinase 1,[Cu]
Copper,Tubulin alpha-3C/D chain,[Cu]
Copper,Tubulin beta chain,[Cu]
Copper,Cofilin-1,[Cu]
Copper,14-3-3 protein beta/alpha,[Cu]
Copper,"Aspartate aminotransferase, cytoplasmic",[Cu]
Copper,Glutathione synthetase,[Cu]
Copper,Hepatoma-derived growth factor,[Cu]
Copper,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",[Cu]
Copper,Chloride intracellular channel protein 1,[Cu]
Copper,Proteasome activator complex subunit 1,[Cu]
Copper,Phosphatidylethanolamine-binding protein 1,[Cu]
Copper,Phosphoglycerate mutase 1,[Cu]
Copper,Ran-specific GTPase-activating protein,[Cu]
Copper,UDP-glucose 6-dehydrogenase,[Cu]
Copper,Beta-2-microglobulin,[Cu]
Copper,"Protein SCO1 homolog, mitochondrial",[Cu]
Copper,Alternative prion protein,[Cu]
Copper,Glycine receptor subunit alpha-1,[Cu]
Copper,Huntingtin,[Cu]
Copper,Endonuclease 8-like 1,[Cu]
Copper,Endonuclease 8-like 2,[Cu]
Copper,Hephaestin-like protein 1,[Cu]
Copper,Plasminogen activator inhibitor 1,[Cu]
Copper,Protein S100-A2,[Cu]
Copper,Protein S100-A4,[Cu]
Copper,Alpha-synuclein,[Cu]
Copper,Brain-derived neurotrophic factor,[Cu]
Copper,Protein deglycase DJ-1,[Cu]
Copper,Islet amyloid polypeptide,[Cu]
Copper,Tachykinin-3,[Cu]
Copper,Alpha-1B-glycoprotein,[Cu]
Copper,Afamin,[Cu]
Copper,Angiotensinogen,[Cu]
Copper,Alpha-2-HS-glycoprotein,[Cu]
Copper,Serum amyloid P-component,[Cu]
Copper,Apolipoprotein A-I,[Cu]
Copper,Apolipoprotein A-II,[Cu]
Copper,Apolipoprotein A-IV,[Cu]
Copper,Apolipoprotein B receptor,[Cu]
Copper,Apolipoprotein C-II,[Cu]
Copper,Apolipoprotein C-III,[Cu]
Copper,Apolipoprotein D,[Cu]
Copper,Apolipoprotein E,[Cu]
Copper,Beta-2-glycoprotein 1,[Cu]
Copper,Zinc-alpha-2-glycoprotein,[Cu]
Copper,Complement C1q subcomponent subunit C,[Cu]
Copper,Complement C1s subcomponent,[Cu]
Copper,Complement C3,[Cu]
Copper,Complement C4-B,[Cu]
Copper,C4b-binding protein alpha chain,[Cu]
Copper,Complement C5,[Cu]
Copper,Complement component C8 beta chain,[Cu]
Copper,Complement component C9,[Cu]
Copper,Complement factor H,[Cu]
Copper,Complement factor I,[Cu]
Copper,Tetranectin,[Cu]
Copper,Clusterin,[Cu]
Copper,Prothrombin,[Cu]
Copper,"Complement component 1 Q subcomponent-binding protein, mitochondrial",[Cu]
Copper,Gelsolin,[Cu]
Copper,Hemoglobin subunit alpha,[Cu]
Copper,Hemoglobin subunit beta,[Cu]
Copper,Chromobox protein homolog 5,[Cu]
Copper,Haptoglobin-related protein,[Cu]
Copper,Insulin-like growth factor-binding protein complex acid labile subunit,[Cu]
Copper,Ig gamma-1 chain C region,[Cu]
Copper,Ig gamma-4 chain C region,[Cu]
Copper,Ig kappa chain V-III region GOL,[Cu]
Copper,Immunoglobulin lambda-like polypeptide 1,[Cu]
Copper,Inter-alpha-trypsin inhibitor heavy chain H2,[Cu]
Copper,Kininogen-1,[Cu]
Copper,"Keratin, type II cytoskeletal 1",[Cu]
Copper,"Keratin, type I cytoskeletal 10",[Cu]
Copper,"Keratin, type II cytoskeletal 2 epidermal",[Cu]
Copper,"Keratin, type I cytoskeletal 9",[Cu]
Copper,Leucine-rich alpha-2-glycoprotein,[Cu]
Copper,Lumican,[Cu]
Copper,N-acetylmuramoyl-L-alanine amidase,[Cu]
Copper,Plasminogen,[Cu]
Copper,Serum paraoxonase/arylesterase 1,[Cu]
Copper,Platelet basic protein,[Cu]
Copper,Alpha-1-antitrypsin,[Cu]
Copper,Kallistatin,[Cu]
Copper,Corticosteroid-binding globulin,[Cu]
Copper,Thyroxine-binding globulin,[Cu]
Copper,Antithrombin-III,[Cu]
Copper,Heparin cofactor 2,[Cu]
Copper,Pigment epithelium-derived factor,[Cu]
Copper,Alpha-2-antiplasmin,[Cu]
Copper,Plasma protease C1 inhibitor,[Cu]
Copper,Transthyretin,[Cu]
Copper,Vitronectin,[Cu]
Copper,Amyloid-like protein 1,[Cu]
Coprogen,Iron(3+)-hydroxamate-binding protein FhuD,[Fe+3].[H]\C(=C(\C)CCO)C(=O)N([O-])CCC[C@]([H])(N=C(C)O)C(=O)OCC\C(C)=C(/[H])C(=O)N([O-])CCC[C@]1([H])N=C(O)[C@]([H])(CCCN([O-])C(=O)C(\[H])=C(/C)CCO)N=C1O
Coproporphyrin I,Uroporphyrinogen decarboxylase,CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(CCC(O)=O)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(CCC(O)=O)=C4C)/C(CCC(O)=O)=C3C
Coproporphyrinogen III,Uroporphyrinogen decarboxylase,CC1=C2CC3=C(C)C(CCC(O)=O)=C(CC4=C(CCC(O)=O)C(C)=C(CC5=C(CCC(O)=O)C(C)=C(CC(N2)=C1CCC(O)=O)N5)N4)N3
Cordycepin Triphosphate,Poly(A) polymerase alpha,[H][C@@]1(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C[C@@]([H])(O)[C@@]([H])(O1)N1C=NC2=C(N)N=CN=C12
Corifollitropin alfa,Follicle-stimulating hormone receptor,
Corticorelin ovine triflutate,Corticotropin-releasing factor receptor 1,CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(N)=O
Corticosterone,Mineralocorticoid receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO
Corticosterone,Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO
Corticosterone,Nuclear receptor coactivator 1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(O)C[C@]12C)C(=O)CO
Corticotropin,Adrenocorticotropic hormone receptor,
Corticotropin,Corticoliberin,
Cortisone acetate,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Cortivazol,Glucocorticoid receptor,C[C@@H]1C[C@H]2[C@@H]3C=C(C)C4=CC5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O)C=NN5C1=CC=CC=C1
Cositecan,DNA topoisomerase 1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C(CC[Si](C)(C)C)C4=CC=CC=C4N=C13)C2=O
Coumarin,Cytochrome P450 2A6,O=C1OC2=CC=CC=C2C=C1
"Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine",Sorbitol dehydrogenase,CN(C)S(=O)(=O)N1CCN(CC1)C1=CC=NC(CO)=N1
"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate","Glycogen phosphorylase, liver form",[H][C@@](CC1=CC=CC=C1)(NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2)C(=O)N1CC(C1)C(O)=O
Cpad,Alcohol dehydrogenase 1C,NC(=O)C1=NC(=CC=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O
Crc200 (Chiron-Behring),Trypsin-1,[H][C@@](CC(O)=O)(NS(=O)(=O)C1=C(C)C=C(OC)C(C)=C1C)C(O)=N[C@]([H])(CC1=CC=C(C=C1)C(N)=N)C(=O)N1CCCCC1
Creatine,Creatine kinase M-type,CN(CC(O)=O)C(N)=N
Creatine,"Creatine kinase U-type, mitochondrial",CN(CC(O)=O)C(N)=N
Creatine,Creatine kinase B-type,CN(CC(O)=O)C(N)=N
Creatine,"Creatine kinase S-type, mitochondrial",CN(CC(O)=O)C(N)=N
Creatine,Sodium- and chloride-dependent creatine transporter 1,CN(CC(O)=O)C(N)=N
Creatine,Guanidinoacetate N-methyltransferase,CN(CC(O)=O)C(N)=N
Crisaborole,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2
Crisaborole,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2
Crisaborole,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2
Crisaborole,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2
Crizotinib,ALK tyrosine kinase receptor,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
Crizotinib,Hepatocyte growth factor receptor,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
Crofelemer,Cystic fibrosis transmembrane conductance regulator,
Crofelemer,Anoctamin-1,
Cromoglicic acid,Calcium-activated potassium channel subunit alpha-1,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O
Cromoglicic acid,Protein S100-P,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O
Crotalus adamanteus antivenin,Group 10 secretory phospholipase A2,
Crotonaldehyde,"Aldehyde dehydrogenase, mitochondrial",C\C=C\C=O
Cryptenamine,Muscarinic acetylcholine receptor M2,
Cryptenamine,Muscarinic acetylcholine receptor M1,
Cryptenamine,Muscarinic acetylcholine receptor M3,
Cryptenamine,Muscarinic acetylcholine receptor M4,
Cryptenamine,Muscarinic acetylcholine receptor M5,
Cu-Cyclam,Lysozyme C,[Cu].C1CNCCNCCCNCCNC1
Cupric Chloride,Vitamin K-dependent protein C,Cl[Cu]Cl
Cupric Chloride,Cystatin-B,Cl[Cu]Cl
Curcumin,Peroxisome proliferator-activated receptor gamma,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O
Curcumin,Vitamin D3 receptor,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O
Curcumin,Multidrug resistance-associated protein 5,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O
Curcumin,Carbonyl reductase [NADPH] 1,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O
Curcumin,Glutathione S-transferase P,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O
Curcumin sulfate,Peroxisome proliferator-activated receptor gamma,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(OS(O)(=O)=O)C(OC)=C2)=CC=C1O
Curcumin sulfate,Vitamin D3 receptor,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(OS(O)(=O)=O)C(OC)=C2)=CC=C1O
Curcumin sulfate,Multidrug resistance-associated protein 5,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(OS(O)(=O)=O)C(OC)=C2)=CC=C1O
Curcumin sulfate,Carbonyl reductase [NADPH] 1,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(OS(O)(=O)=O)C(OC)=C2)=CC=C1O
Curcumin sulfate,Glutathione S-transferase P,COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(OS(O)(=O)=O)C(OC)=C2)=CC=C1O
Custirsen,Estrogen receptor,
Custirsen,Nuclear factor NF-kappa-B p105 subunit,
Custirsen,Nuclear factor NF-kappa-B p100 subunit,
Cyanamide,Carbonic anhydrase 2,NC#N
Cyanamide,Cathepsin K,NC#N
Cyanocobalamin,Methionine synthase,[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N+]([Co-3]456(N7C8=C(C9=[N+]4C(C([C@@H]9CCC(N)=O)(C)C)=CC4=[N+]5C(=C(C5=[N+]6[C@@]([C@]7([C@@H]([C@@]8(C)CCC(=O)NC[C@@]([H])(C)OP([O-])(=O)O2)CC(N)=O)[H])([C@@]([C@@H]5CCC(N)=O)(C)CC(N)=O)C)C)[C@@]([C@@H]4CCC(N)=O)(C)CC(N)=O)C)C#N)=C3)C)O1)O)CO
Cyanocobalamin,"Methylmalonyl-CoA mutase, mitochondrial",[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N+]([Co-3]456(N7C8=C(C9=[N+]4C(C([C@@H]9CCC(N)=O)(C)C)=CC4=[N+]5C(=C(C5=[N+]6[C@@]([C@]7([C@@H]([C@@]8(C)CCC(=O)NC[C@@]([H])(C)OP([O-])(=O)O2)CC(N)=O)[H])([C@@]([C@@H]5CCC(N)=O)(C)CC(N)=O)C)C)[C@@]([C@@H]4CCC(N)=O)(C)CC(N)=O)C)C#N)=C3)C)O1)O)CO
Cyanocobalamin,Methionine synthase reductase,[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N+]([Co-3]456(N7C8=C(C9=[N+]4C(C([C@@H]9CCC(N)=O)(C)C)=CC4=[N+]5C(=C(C5=[N+]6[C@@]([C@]7([C@@H]([C@@]8(C)CCC(=O)NC[C@@]([H])(C)OP([O-])(=O)O2)CC(N)=O)[H])([C@@]([C@@H]5CCC(N)=O)(C)CC(N)=O)C)C)[C@@]([C@@H]4CCC(N)=O)(C)CC(N)=O)C)C#N)=C3)C)O1)O)CO
Cyanocobalamin,"Methylmalonic aciduria type A protein, mitochondrial",[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N+]([Co-3]456(N7C8=C(C9=[N+]4C(C([C@@H]9CCC(N)=O)(C)C)=CC4=[N+]5C(=C(C5=[N+]6[C@@]([C@]7([C@@H]([C@@]8(C)CCC(=O)NC[C@@]([H])(C)OP([O-])(=O)O2)CC(N)=O)[H])([C@@]([C@@H]5CCC(N)=O)(C)CC(N)=O)C)C)[C@@]([C@@H]4CCC(N)=O)(C)CC(N)=O)C)C#N)=C3)C)O1)O)CO
Cyanocobalamin,Methylmalonic aciduria and homocystinuria type C protein,[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N+]([Co-3]456(N7C8=C(C9=[N+]4C(C([C@@H]9CCC(N)=O)(C)C)=CC4=[N+]5C(=C(C5=[N+]6[C@@]([C@]7([C@@H]([C@@]8(C)CCC(=O)NC[C@@]([H])(C)OP([O-])(=O)O2)CC(N)=O)[H])([C@@]([C@@H]5CCC(N)=O)(C)CC(N)=O)C)C)[C@@]([C@@H]4CCC(N)=O)(C)CC(N)=O)C)C#N)=C3)C)O1)O)CO
Cyanocobalamin,Methylenetetrahydrofolate reductase,[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N+]([Co-3]456(N7C8=C(C9=[N+]4C(C([C@@H]9CCC(N)=O)(C)C)=CC4=[N+]5C(=C(C5=[N+]6[C@@]([C@]7([C@@H]([C@@]8(C)CCC(=O)NC[C@@]([H])(C)OP([O-])(=O)O2)CC(N)=O)[H])([C@@]([C@@H]5CCC(N)=O)(C)CC(N)=O)C)C)[C@@]([C@@H]4CCC(N)=O)(C)CC(N)=O)C)C#N)=C3)C)O1)O)CO
Cyclacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O
Cyclacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O
Cyclacillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O
Cyclacillin,Penicillin binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1(N)CCCCC1)C(O)=O
Cyclandelate,Voltage-dependent calcium channel subunit alpha-2/delta-1,CC1CC(CC(C)(C)C1)OC(=O)C(O)C1=CC=CC=C1
Cyclandelate,Liver carboxylesterase 1,CC1CC(CC(C)(C)C1)OC(=O)C(O)C1=CC=CC=C1
"Cyclic 3',5'-thymidine monophosphate","5'(3')-deoxyribonucleotidase, mitochondrial",[H][C@]1(COP(O)(O)=O)O[C@]([H])(C=C1)N1C=C(C)C(=O)NC1=O
Cyclic GMP,"cGMP-dependent 3',5'-cyclic phosphodiesterase",NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(O)(=O)O[C@H]3[C@H]2O)C(=O)N1
Cyclic GMP,cAMP-dependent protein kinase type I-alpha regulatory subunit,NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(O)(=O)O[C@H]3[C@H]2O)C(=O)N1
Cyclic GMP,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(O)(=O)O[C@H]3[C@H]2O)C(=O)N1
Cyclic adenosine monophosphate,cAMP-activated global transcriptional regulator CRP,NC1=C2N=CN([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1
Cyclic adenosine monophosphate,Adenylate cyclase,NC1=C2N=CN([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1
Cyclic adenosine monophosphate,Cyclic nucleotide-gated potassium channel mll3241,NC1=C2N=CN([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1
Cyclic adenosine monophosphate,cAMP-dependent protein kinase type I-alpha regulatory subunit,NC1=C2N=CN([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1
Cyclic adenosine monophosphate,cAMP-dependent protein kinase type II-beta regulatory subunit,NC1=C2N=CN([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1
Cyclic adenosine monophosphate,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,NC1=C2N=CN([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1
Cyclizine,Histamine H1 receptor,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cyclizine,Estrogen sulfotransferase,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Cyclo-Tetrametavanadate,Mono-ADP-ribosyltransferase C3,[O-][V]1(=O)O[V]([O-])(=O)O[V]([O-])(=O)O[V]([O-])(=O)O1
Cyclobenzaprine,5-hydroxytryptamine receptor 2A,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12
Cyclohexane Propionic Acid,Aromatic-amino-acid aminotransferase,OC(=O)CCC1CCCCC1
Cyclohexanol,Alcohol dehydrogenase 1B,OC1CCCCC1
Cyclohexanone,Pentaerythritol tetranitrate reductase,O=C1CCCCC1
Cyclohexyl-Hexyl-Beta-D-Maltoside,Beta-lactamase SHV-1,[H][C@]1(CO)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(OCCCCCCC3CCCCC3)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Cyclohexyl-Hexyl-Beta-D-Maltoside,Beta-lactamase SHV-2,[H][C@]1(CO)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(OCCCCCCC3CCCCC3)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Cyclohexyl-pentyl-maltoside,Cytochrome P450 2B6,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OCCCCCC3CCCCC3)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",Mitogen-activated protein kinase 10,CCCN1C(=NC(=C1C1=CC=NC(NC2CCCCC2)=N1)C1=CC=C(Cl)C(Cl)=C1)C1CCNCC1
Cyclohexylammonium Ion,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,[NH3+]C1CCCCC1
Cyclohexylformamide,Alcohol dehydrogenase 4,O=CNC1CCCCC1
Cyclohexylformamide,Alcohol dehydrogenase 1C,O=CNC1CCCCC1
Cycloleucine,"Glutamate receptor ionotropic, NMDA 1",NC1(CCCC1)C(O)=O
Cyclopentolate,Muscarinic acetylcholine receptor M1,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1
Cyclophosphamide,Nuclear receptor subfamily 1 group I member 2,ClCCN(CCCl)P1(=O)NCCCO1
"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",Mitogen-activated protein kinase 10,CCCN1C(=NC(=C1C1=CC=NC(NC2CC2)=N1)C1=CC=C(Cl)C(Cl)=C1)C1CCN(C)CC1
Cycloserine,D-alanine--D-alanine ligase A,N[C@@H]1CONC1=O
Cycloserine,Alanine racemase,N[C@@H]1CONC1=O
Cyclotheonamide A,Trypsin-1,[H]\C1=C([H])/[C@]([H])(CC2=CC=C(O)C=C2)N=C(O)[C@@]([H])(CC2=CC=CC=C2)NC(=O)C(=O)[C@]([H])(CCCNC(N)=N)N=C(O)[C@]2([H])CCCN2C(=O)[C@]([H])(CN=C1O)N=CO
Cyclothiazide,Sodium/potassium-transporting ATPase subunit gamma,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2
Cyclothiazide,Carbonic anhydrase 1,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2
Cyclothiazide,Carbonic anhydrase 2,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2
Cyclothiazide,Carbonic anhydrase 4,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2
Cyclothiazide,Secreted frizzled-related protein 4,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C1CC2CC1C=C2
Cyclouridine,Uridine phosphorylase,OC[C@H]1O[C@@H]2[C@@H](OC3=NC(=O)C=CN23)[C@@H]1O
Cycrimine,Muscarinic acetylcholine receptor M1,OC(CCN1CCCCC1)(C1CCCC1)C1=CC=CC=C1
Cyproheptadine,Histamine H1 receptor,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
Cyproheptadine,5-hydroxytryptamine receptor 2A,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
Cyproheptadine,5-hydroxytryptamine receptor 2C,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
Cyproheptadine,Muscarinic acetylcholine receptor M1,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
Cyproheptadine,Muscarinic acetylcholine receptor M2,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
Cyproheptadine,Muscarinic acetylcholine receptor M3,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
Cyproheptadine,5-hydroxytryptamine receptor 7,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
Cyproterone acetate,Androgen receptor,[H][C@@]12C[C@]1([H])[C@@]1(C)C(=CC2=O)C(Cl)=C[C@@]2([H])[C@]3([H])CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@]12[H]
Cyproterone acetate,Prostate-specific antigen,[H][C@@]12C[C@]1([H])[C@@]1(C)C(=CC2=O)C(Cl)=C[C@@]2([H])[C@]3([H])CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@]12[H]
Cysteamine,Somatostatin,NCCS
Cysteamine,Neuropeptide Y receptor type 2,NCCS
Cystein-S-Yl Cacodylate,Gag-Pol polyprotein,[H][C@](N)(CS[As](C)(C)=O)C(O)=O
Cystein-S-Yl Cacodylate,"Proteinase inhibitor I4, serpin",[H][C@](N)(CS[As](C)(C)=O)C(O)=O
Cysteine-S-Acetamide,Ribonuclease pancreatic,N[C@@H](CSCC(N)=O)C(O)=O
Cysteine-S-Acetamide,2'-5'-oligoadenylate synthase 1,N[C@@H](CSCC(N)=O)C(O)=O
Cysteinesulfonic Acid,3-oxoacyl-[acyl-carrier-protein] synthase 3,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Tyrosine-protein phosphatase non-receptor type 1,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Penicillin acylase,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,S-ribosylhomocysteine lyase,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,M-phase inducer phosphatase 2,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Deoxynucleotide monophosphate kinase,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Cathepsin L1,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Methylaspartate ammonia-lyase,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Beta-lactamase VIM-2,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Ribose 5-phosphate isomerase B,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,1-cys peroxiredoxin,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Peptide deformylase,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Golgi-associated plant pathogenesis-related protein 1,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Uncharacterized protein,N[C@@H](CS(O)(=O)=O)C(O)=O
Cysteinesulfonic Acid,Peptide deformylase,N[C@@H](CS(O)(=O)=O)C(O)=O
Cystine,Cystine/glutamate transporter,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O
Cystine,Cystinosin,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O
Cystine,Neutral and basic amino acid transport protein rBAT,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O
Cystine,"b(0,+)-type amino acid transporter 1",N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O
Cytarabine,DNA polymerase beta,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Cytidine,Uridine-cytidine kinase 2,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Cytidine 3'-monophosphate,Ribonuclease pancreatic,[H][C@]1(CO)O[C@@]([H])(N2C=CC(=N)N=C2O)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Cytidine 5'-Diphosphoglycerol,Glycerol-3-phosphate cytidylyltransferase,[H][C@](O)(CO)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=CC(=N)N=C2O)[C@]([H])(O)[C@]1([H])O
Cytidine-5'-Diphosphate,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Diphosphate,3-deoxy-manno-octulosonate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Diphosphate,Cytidylate kinase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Diphosphate,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Diphosphate,N-acylneuraminate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Diphosphate,CDP-paratose 2-epimerase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Diphospho-Beta-D-Xylose,"CDP-glucose 4,6-dehydratase",[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])OC[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)O[C@@]([H])(N2C=CC(=N)N=C2O)[C@]([H])(O)[C@]1([H])O
Cytidine-5'-Monophosphate,UMP-CMP kinase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate,Uridine-cytidine kinase 2,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate,3-deoxy-manno-octulosonate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate,Cytidylate kinase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate,Bifunctional enzyme IspD/IspF,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate,Coenzyme A biosynthesis bifunctional protein CoaBC,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate,"Alpha-2,3-/2,8-sialyltransferase",NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,N-acylneuraminate cytidylyltransferase,[H][C@]1(O[C@](C[C@H](O)[C@H]1NC(C)=O)(OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O)C(O)=O)[C@H](O)[C@H](O)CO
Cytidine-5'-Triphosphate,Uridine-cytidine kinase 2,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Triphosphate,3-deoxy-manno-octulosonate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Triphosphate,Glycerol-3-phosphate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Triphosphate,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Triphosphate,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Triphosphate,Coenzyme A biosynthesis bifunctional protein CoaBC,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Triphosphate,CCA-adding enzyme,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytidine-5'-Triphosphate,Glucose-1-phosphate cytidylyltransferase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O
Cytisine,Neuronal acetylcholine receptor subunit alpha-4,O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12
Cytisine,Neuronal acetylcholine receptor subunit alpha-7,O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12
Cytisine,Neuronal acetylcholine receptor subunit alpha-3,O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12
Cytisine,Neuronal acetylcholine receptor subunit alpha-6,O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12
Cytisine,Neuronal acetylcholine receptor subunit beta-2,O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12
"D-1,4-dithiothreitol","6,7-dimethyl-8-ribityllumazine synthase",O[C@H](CS)[C@H](O)CS
D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,Chymotrypsinogen B,[H]N(C(C)=O)[C@]([H])(CC1=CC=C(Cl)C=C1)[B-](O)(O)O
D-1-naphthyl-2-acetamido-ethane boronic acid,Chymotrypsinogen B,[H]N(C(C)=O)[C@]([H])(CC1=C2C=CC=CC2=CC=C1)[B-](O)(O)O
D-Alanine,Thermolysin,C[C@@H](N)C(O)=O
D-Alanine,D-alanyl-D-alanine carboxypeptidase,C[C@@H](N)C(O)=O
D-Allopyranose,D-allose-binding periplasmic protein,OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O
D-Arginine,Creatine kinase M-type,N[C@H](CCCNC(N)=N)C(O)=O
D-Aspartic Acid,Thermolysin,N[C@H](CC(O)=O)C(O)=O
D-Aspartic Acid,L-asparaginase,N[C@H](CC(O)=O)C(O)=O
D-Cysteine,Carboxypeptidase A1,N[C@H](CS)C(O)=O
D-Dethiobiotin,ATP-dependent dethiobiotin synthetase BioD 1,[H][C@@]1(C)NC(=O)N[C@]1([H])CCCCCC(O)=O
D-Dethiobiotin,Biotin synthase,[H][C@@]1(C)NC(=O)N[C@]1([H])CCCCCC(O)=O
D-Dethiobiotin,ATP-dependent dethiobiotin synthetase BioD,[H][C@@]1(C)NC(=O)N[C@]1([H])CCCCCC(O)=O
D-Eritadenine,Adenosylhomocysteinase,[H][C@@](O)(CN1C=NC2=C(N)N=CN=C12)[C@@]([H])(O)C(O)=O
D-Galctopyranosyl-1-On,Beta-galactosidase,[H][C@]1(O)C(=O)O[C@]([H])(CO)[C@]([H])(O)[C@]1([H])O
"D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",[H][C@]1(O)[C@]([H])(O)[C@]([H])(CP(O)(O)=O)O[C@]1([H])COP(O)(O)=O
D-Glutamic Acid,Thermolysin,N[C@H](CCC(O)=O)C(O)=O
D-Glutamine,Glutamate racemase,N[C@H](CCC(N)=O)C(O)=O
D-Glycero-D-Mannopyranose-7-Phosphate,Phosphoheptose isomerase,[H][C@@](O)(COP(O)(O)=O)[C@@]1([H])O[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)[C@]1([H])O
D-Lactic acid,(S)-2-haloacid dehalogenase,C[C@@H](O)C(O)=O
D-Levofloxacin,Autolysin,C[C@@H]1COC2=C(N3CCN(C)CC3)C(F)=CC3=C2N1C=C(C(O)=O)C3=O
D-Lysine,"Alanine racemase, catabolic",[H][C@@](N)(CCCCN)C(O)=O
D-Lysine,Diaminopimelate decarboxylase,[H][C@@](N)(CCCCN)C(O)=O
D-Mannose 1-Phosphate,Phosphomannomutase/phosphoglucomutase,OC[C@H]1OC(OP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O
D-Mannuronic Acid,AlgQ1,[H][C@]1(O)O[C@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
D-Mannuronic Acid,AlgQ2,[H][C@]1(O)O[C@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
D-Methionine,Methionine aminopeptidase 2,CSCC[C@@H](N)C(O)=O
D-Methionine,"Transcriptional regulator, HTH_3 family",CSCC[C@@H](N)C(O)=O
"D-Myo-Inositol-1,4-Bisphosphate","Type II inositol 1,4,5-trisphosphate 5-phosphatase",O[C@H]1[C@@H](O)[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1OP(O)(O)=O
D-Myo-Inositol-Hexasulphate,Myo-inositol hexaphosphate phosphohydrolase,[H][C@]1(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@@]([H])(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@]1([H])OS(O)(=O)=O
D-Myo-Inositol-Hexasulphate,Follistatin,[H][C@]1(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@@]([H])(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@]([H])(OS(O)(=O)=O)[C@]1([H])OS(O)(=O)=O
D-Phenylalanine,Kynurenine--oxoglutarate transaminase 1,N[C@H](CC1=CC=CC=C1)C(O)=O
D-Phenylalanine,Corticoliberin,N[C@H](CC1=CC=CC=C1)C(O)=O
D-Serine,"Glutamate receptor ionotropic, NMDA 1",N[C@H](CO)C(O)=O
D-Serine,Glycine receptor subunit alpha-1,N[C@H](CO)C(O)=O
D-Serine,Head decoration protein,N[C@H](CO)C(O)=O
D-Serine,Serpin B3,N[C@H](CO)C(O)=O
D-Threonine,Thermolysin,C[C@@H](O)[C@@H](N)C(O)=O
D-Treitol,Formate acetyltransferase 1,OC[C@H](O)[C@@H](O)CO
D-Tryptophan,D-amino-acid oxidase,N[C@H](CC1=CNC2=CC=CC=C12)C(O)=O
D-Xylulose,Xylose isomerase,OC[C@H](O)[C@H](O)C(=O)CO
D-[(Amino)Carbonyl]Phenylalanine,N-carbamoyl-D-amino acid hydrolase,[H][C@@](CC1=CC=CC=C1)(NC(N)=O)C(O)=O
D-[(Amino)Carbonyl]Phenylalanine,Carboxypeptidase A1,[H][C@@](CC1=CC=CC=C1)(NC(N)=O)C(O)=O
D-[(N-Hydroxyamino)Carbonyl]Phenylalanine,Carboxypeptidase A1,[H]N(O)C(=O)N([H])[C@H](CC1=CC=CC=C1)C(O)=O
"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",Alanine racemase,CC1=NC=C(COP(O)(O)=O)C(CN[C@@H]2CONC2=O)=C1O
"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide","2,2-dialkylglycine decarboxylase",CC1=NC=C(COP(O)(O)=O)C(CN[C@@H]2CONC2=O)=C1O
"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(CN[C@@H]2CONC2=O)=C1O
"D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide",Aminodeoxychorismate lyase,CC1=NC=C(COP(O)(O)=O)C(CN[C@@H]2CONC2=O)=C1O
D-alpha-Tocopherol acetate,SEC14-like protein 4,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,SEC14-like protein 3,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,SEC14-like protein 2,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,Nuclear receptor subfamily 1 group I member 2,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,Protein kinase C beta type,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,Arachidonate 5-lipoxygenase,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,Protein kinase C alpha type,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,Diacylglycerol kinase alpha,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-alpha-Tocopherol acetate,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1
D-glucitol 6-phosphate,Glucose-6-phosphate isomerase,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O
"D-gluconhydroximo-1,5-lactam",Lactase-phlorizin hydrolase,[H][C@]1(O)C(NO)=N[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,Prothrombin,[H][C@@](N)(CC(C)C)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(Cl)=CC=C1
D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,Prothrombin,[H][C@@](N)(CC(C)C)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=C(C=C1)C(N)=N
D-naphthyl-1-acetamido boronic acid alanine,Subtilisin Carlsberg,CC(=O)N[C@H](CC1=CC=CC2=C1C=CC=C2)[B-](O)(O)OC[C@H](N)C(O)=O
D-norleucine,Phenylalanine-4-hydroxylase,CCCC[C@@H](N)C(O)=O
D-norleucine,Parathyroid hormone,CCCC[C@@H](N)C(O)=O
D-norleucine,Hepatocyte nuclear factor 1-alpha,CCCC[C@@H](N)C(O)=O
D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,Prothrombin,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(Cl)=CC=C1
D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,Prothrombin,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC(F)=C1
D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,Prothrombin,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC(C)=CC=C1
D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide,Prothrombin,[H][C@@]([NH3+])(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(O)=N[C@@]([H])(CCCNC(N)=N)[C@]([H])(O)CCl
D-phenylalanyl-N-benzyl-L-prolinamide,Prothrombin,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=CC=C1
D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,Prothrombin,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCC1=CC=C(C=C1)C(N)=[NH2+]
D-tartaric acid,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,"2,3-diketo-L-gulonate reductase",O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,Triggering receptor expressed on myeloid cells 1,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,Probable ATP-dependent RNA helicase DDX6,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,Cytochrome P450,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,Hypoxia-inducible factor 1-alpha inhibitor,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,D-3-phosphoglycerate dehydrogenase,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,"dTDP-4-dehydrorhamnose 3,5-epimerase",O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,Uncharacterized protein,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,Phosphonoacetate hydrolase,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,Uncharacterized protein,O[C@@H]([C@H](O)C(O)=O)C(O)=O
D-tartaric acid,V-type proton ATPase subunit C 1,O[C@@H]([C@H](O)C(O)=O)C(O)=O
DAS-431 IV,Neuron-specific vesicular protein calcyon,
DDP-225,5-hydroxytryptamine receptor 3A,O.Cl.CC1=CC2=C(N=C(N=C2S1)N1CCNCC1)C1=CC=CC=C1F
DDP-225,Sodium-dependent noradrenaline transporter,O.Cl.CC1=CC2=C(N=C(N=C2S1)N1CCNCC1)C1=CC=CC=C1F
DDP733,5-hydroxytryptamine receptor 3A,
DEAMINO-METHYL-PHENYLALANINE,Thermolysin,[H][C@](C)(CC1=CC=CC=C1)C(O)=O
DECANE-1-THIOL,3-oxoacyl-[acyl-carrier-protein] synthase 3,CCCCCCCCCCS
DECYL FORMATE,3-oxoacyl-[acyl-carrier-protein] synthase 3,CCCCCCCCCCOC=O
DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID,Arginase-1,N[C@@H](CC\C=C\[B-](O)(O)O)C(O)=O
DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),Aklanonic acid methyl ester cyclase AcmA,[H][C@](O)(CC)C[C@@]([H])(O)C1=C(O)C2=C(C=C1CC(=O)OC)C(=O)C1=CC=CC(O)=C1C2=O
DG031,Arachidonate 5-lipoxygenase-activating protein,
DG051,Leukotriene A-4 hydrolase,
"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",Estrogen receptor,[H][C@]12O[C@]([H])(C(=C1C1=CC=C(O)C=C1)C1=CC=C(O)C=C1)[C@]([H])(C(=O)OCC)[C@]2([H])C(=O)OCC
"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",Nuclear receptor coactivator 2,[H][C@]12O[C@]([H])(C(=C1C1=CC=C(O)C=C1)C1=CC=C(O)C=C1)[C@]([H])(C(=O)OCC)[C@]2([H])C(=O)OCC
DIETHYL 4-METHOXYPHENYL PHOSPHATE,Phosphotriesterase,CCOP(=O)(OCC)OC1=CC=C(OC)C=C1
"DIETHYL PROPANE-1,3-DIYLBISCARBAMATE",Shiga-like toxin 1 subunit B,CCOC(=O)NCCCNC(=O)OCC
DIMETHYL THIOPHOSPHATE,Phosphotriesterase,COP(O)(=S)OC
"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",Casein kinase II subunit alpha,CN(C)C1=NC2=C(Br)C(Br)=C(Br)C(Br)=C2N1
DL-Methylephedrine,Beta-1 adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Alpha-2A adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Alpha-1A adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Alpha-1B adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Alpha-1D adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Alpha-2A adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Alpha-2B adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Alpha-2C adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Beta-1 adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Beta-2 adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DL-Methylephedrine,Beta-3 adrenergic receptor,C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C
DMP450,Gag-Pol polyprotein,[H][C@]1(CC2=CC=CC=C2)N(CC2=CC(N)=CC=C2)C(=O)N(CC2=CC(N)=CC=C2)[C@]([H])(CC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O
DODECANESULFONATE ION,Cholinesterase,CCCCCCCCCCCCS([O-])(=O)=O
DPI59,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](O)(C1=CC=CC2=CC=CC=C12)P(O)(O)=O
Dabigatran etexilate,Prothrombin,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1
Dabrafenib,Serine/threonine-protein kinase B-raf,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
Dabrafenib,RAF proto-oncogene serine/threonine-protein kinase,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
Dabrafenib,Serine/threonine-protein kinase SIK1,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
Dabrafenib,Serine/threonine-protein kinase Nek11,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
Dabrafenib,LIM domain kinase 1,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
Dacarbazine,DNA polymerase alpha subunit B,CN(C)\N=N\C1=C(N=CN1)C(N)=O
Dacarbazine,"6-phosphogluconate dehydrogenase, decarboxylating",CN(C)\N=N\C1=C(N=CN1)C(N)=O
Dacetuzumab,Tumor necrosis factor receptor superfamily member 5,
Daclizumab,Interleukin-2 receptor subunit alpha,
Daclizumab,Interleukin-2 receptor subunit beta,
Daclizumab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Daclizumab,Complement C1r subcomponent,
Daclizumab,Complement C1q subcomponent subunit A,
Daclizumab,Complement C1q subcomponent subunit B,
Daclizumab,Complement C1q subcomponent subunit C,
Daclizumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Daclizumab,High affinity immunoglobulin gamma Fc receptor I,
Daclizumab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Daclizumab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Daclizumab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Dacomitinib,Epidermal growth factor receptor,COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
Dactinomycin,DNA topoisomerase 2-alpha,[H][C@@]12CCCN1C(=O)[C@H](NC(=O)[C@@H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@]3([H])CCCN3C(=O)[C@H](NC1=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C
Dactinomycin,DNA topoisomerase 2-beta,[H][C@@]12CCCN1C(=O)[C@H](NC(=O)[C@@H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@]3([H])CCCN3C(=O)[C@H](NC1=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C
Daglutril,Neprilysin,CCOC(=O)[C@H](CCC1=CC=CC=C1)CC1(CCCC1)C(=O)N[C@H]1CCC2=CC=CC=C2N(CC(O)=O)C1=O
Daidzin,"Aldehyde dehydrogenase, mitochondrial",[H][C@]1(CO)O[C@@]([H])(OC2=CC=C3C(=O)C(=COC3=C2)C2=CC=C(O)C=C2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Dalfampridine,Potassium voltage-gated channel subfamily A member 1,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily A member 2,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily A member 3,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily A member 4,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily A member 5,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily A member 6,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily A member 7,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily A member 10,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily B member 1,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily B member 2,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily C member 1,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily C member 2,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily C member 3,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily D member 1,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily D member 2,NC1=CC=NC=C1
Dalfampridine,Potassium voltage-gated channel subfamily D member 3,NC1=CC=NC=C1
Dalfopristin,Streptogramin A acetyltransferase,[H]\C1=C(\[H])/C(/C)=C([H])/[C@@]([H])(O)CC(=O)CC2=NC(=CO2)C(=O)N2CC[C@]([H])([C@]2([H])C(=O)O[C@]([H])(C(C)C)[C@]([H])(C)\C([H])=C([H])\C(O)=NC1)S(=O)(=O)CCN(CC)CC
Dalteparin,Antithrombin-III,
Dalteparin,Vascular endothelial growth factor A,
Dalteparin,Tissue factor pathway inhibitor,
Dalteparin,P-selectin,
Damoctocog alfa pegol,Coagulation factor VIII,
Danaparoid,Antithrombin-III,
Danazol,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
Danazol,Androgen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
Danazol,Progesterone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
Danazol,Gonadotropin-releasing hormone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
Danazol,Putative gonadotropin-releasing hormone II receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
Danazol,C-C motif chemokine 2,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
Danoprevir,Genome polyprotein,CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)OC(=O)N1CC2=CC=CC(F)=C2C1)C(=O)NS(=O)(=O)C1CC1
Dansylamide,Carbonic anhydrase 2,CN(C)C1=C2C=CC=C(C2=CC=C1)S(N)(=O)=O
Dansyllysine,Ig alpha-2 chain C region,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCC[C@H](N)C(O)=O
Dantrolene,Ryanodine receptor 1,[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)C=NN1CC(=O)NC1=O
Dapagliflozin,Sodium/glucose cotransporter 2,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1
Dapiprazole,Alpha-1A adrenergic receptor,CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1
Dapiprazole,Alpha-1D adrenergic receptor,CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1
Dapiprazole,Alpha-1B adrenergic receptor,CC1=CC=CC=C1N1CCN(CCC2=NN=C3CCCCN23)CC1
Dapivirine,Gag-Pol polyprotein,CC1=CC(C)=C(NC2=NC(NC3=CC=C(C=C3)C#N)=NC=C2)C(C)=C1
Daporinad,Nicotinamide phosphoribosyltransferase,O=C(NCCCCC1CCN(CC1)C(=O)C1=CC=CC=C1)\C=C\C1=CC=CN=C1
Dapoxetine,5-hydroxytryptamine receptor 1A,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C12)C1=CC=CC=C1
Dapoxetine,5-hydroxytryptamine receptor 2C,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C12)C1=CC=CC=C1
Dapoxetine,5-hydroxytryptamine receptor 1B,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C12)C1=CC=CC=C1
Dapsone,Dihydropteroate synthase,NC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(N)C=C1
Dapsone,Inactive dihydropteroate synthase 2,NC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(N)C=C1
Darapladib,Cytosolic phospholipase A2,CCN(CC)CCN(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C2=C(CCC2)C(=O)N=C1SCC1=CC=C(F)C=C1
Daratumumab,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,
Darbepoetin alfa,Erythropoietin receptor,
Darglitazone,Peroxisome proliferator-activated receptor gamma,CC1=C(CCC(=O)C2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1
Darifenacin,Muscarinic acetylcholine receptor M3,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
Darifenacin,Muscarinic acetylcholine receptor M1,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
Darifenacin,Muscarinic acetylcholine receptor M2,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
Darifenacin,Muscarinic acetylcholine receptor M4,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
Darifenacin,Muscarinic acetylcholine receptor M5,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
Darunavir,Pol polyprotein,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1
Darusentan,Endothelin-1 receptor,COC1=CC(OC)=NC(O[C@H](C(O)=O)C(OC)(C2=CC=CC=C2)C2=CC=CC=C2)=N1
Dasabuvir,Nonstructural protein 5b,COC1=C(C=C(C=C1C1=CC2=CC=C(NS(C)(=O)=O)C=C2C=C1)N1C=CC(=O)NC1=O)C(C)(C)C
Dasatinib,Tyrosine-protein kinase ABL1,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Proto-oncogene tyrosine-protein kinase Src,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Ephrin type-A receptor 2,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Tyrosine-protein kinase Lck,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Tyrosine-protein kinase Yes,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Mast/stem cell growth factor receptor Kit,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Platelet-derived growth factor receptor beta,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Signal transducer and activator of transcription 5B,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Abelson tyrosine-protein kinase 2,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Tyrosine-protein kinase Fyn,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Tyrosine-protein kinase BTK,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Nuclear receptor subfamily 4 group A member 3,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Breakpoint cluster region protein,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Tyrosine-protein kinase CSK,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Ephrin type-A receptor 5,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Ephrin type-B receptor 4,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Tyrosine-protein kinase Fgr,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Tyrosine-protein kinase FRK,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Heat shock cognate 71 kDa protein,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Tyrosine-protein kinase Lyn,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Mitogen-activated protein kinase kinase kinase MLT,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Mitogen-activated protein kinase 14,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasatinib,Amidophosphoribosyltransferase,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
Dasotraline,Sodium-dependent noradrenaline transporter,N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12
Dasotraline,Sodium-dependent dopamine transporter,N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12
Dasotraline,Sodium-dependent serotonin transporter,N[C@@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C12
Daunorubicin,DNA topoisomerase 2-alpha,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O
Daunorubicin,DNA topoisomerase 2-beta,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O
Daxalipram,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CCCOC1=CC(=CC=C1OC)[C@]1(C)CNC(=O)O1
Dazoxiben,Thromboxane-A synthase,OC(=O)C1=CC=C(OCCN2C=CN=C2)C=C1
"Dcka, 5,7-Dichlorokynurenic Acid","Glutamate receptor ionotropic, NMDA 1",OC(=O)C1=NC2=CC(Cl)=CC(Cl)=C2C(O)=C1
Deacetoxycephalosporin-C,Deacetoxycephalosporin C synthase,[H][C@@](N)(CCCC(O)=N[C@]1([H])C(=O)N2C(C(O)=O)=C(C)CS[C@]12[H])C(O)=O
Deamido-Nad+,NH(3)-dependent NAD(+) synthetase,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[N+]4=CC=CC(=C4)C(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Deamido-Nad+,NH(3)-dependent NAD(+) synthetase,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[N+]4=CC=CC(=C4)C(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Deamido-Nad+,Nicotinate-nucleotide adenylyltransferase,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[N+]4=CC=CC(=C4)C(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Deamido-Nad+,NH(3)-dependent NAD(+) synthetase,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[N+]4=CC=CC(=C4)C(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Deamido-Nad+,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[N+]4=CC=CC(=C4)C(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Deamido-Nad+,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)[N+]4=CC=CC(=C4)C(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1
Debrisoquine,Sodium-dependent noradrenaline transporter,NC(=N)N1CCC2=CC=CC=C2C1
Debromohymenialdisine,Activated CDC42 kinase 1,OC1=NC(=N)N\C1=C1\CCN=C(O)C2=C1C=CN2
Debromohymenialdisine,Dual specificity protein kinase CLK1,OC1=NC(=N)N\C1=C1\CCN=C(O)C2=C1C=CN2
Decamethonium,Acetylcholinesterase,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
Decamethonium,Neuronal acetylcholine receptor subunit alpha-2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
Decamethonium,Neuronal acetylcholine receptor subunit alpha-4,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
Decamethonium,Neuronal acetylcholine receptor subunit beta-2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
Decitabine,DNA (cytosine-5)-methyltransferase 1,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1
Declopramide,DNA topoisomerase 2-alpha,CCN(CC)CCNC(=O)C1=CC=C(N)C(Cl)=C1
Declopramide,DNA topoisomerase 2-beta,CCN(CC)CCNC(=O)C1=CC=C(N)C(Cl)=C1
Decyl(dimethyl)phosphine oxide,Amine oxidase [flavin-containing] A,CCCCCCCCCCP(C)(C)=O
"Decylamine-N,N-Dimethyl-N-Oxide","Dihydroorotate dehydrogenase (quinone), mitochondrial",CCCCCCCCCC[N+](C)(C)[O-]
"Decylamine-N,N-Dimethyl-N-Oxide",Ferrichrome-iron receptor,CCCCCCCCCC[N+](C)(C)[O-]
"Decylamine-N,N-Dimethyl-N-Oxide",Autolysin,CCCCCCCCCC[N+](C)(C)[O-]
"Decylamine-N,N-Dimethyl-N-Oxide",Pancreatic lipase-related protein 2,CCCCCCCCCC[N+](C)(C)[O-]
Decyloxy-Methanol,Ribosome-recycling factor,CCCCCCCCCCOCO
Decyloxy-Methanol,Ribosome-recycling factor,CCCCCCCCCCOCO
Deferoxamine,Amyloid beta A4 protein,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
Defibrotide,Adenosine receptor A1,
Defibrotide,Adenosine receptor A2b,
Defibrotide,Adenosine receptor A2a,
Deflazacort,Glucocorticoid receptor,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O
Degarelix,Gonadotropin-releasing hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
Degraded Cephaloridine,Beta-lactamase,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@]1([H])NC(C(O)=O)=C(C)CS1
Degraded Cephaloridine,Penicillin-binding protein 1A,[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@]1([H])NC(C(O)=O)=C(C)CS1
Delafloxacin,DNA topoisomerase 4 subunit A,NC1=NC(N2C=C(C(O)=O)C(=O)C3=CC(F)=C(N4CC(O)C4)C(Cl)=C23)=C(F)C=C1F
Delafloxacin,DNA gyrase subunit A,NC1=NC(N2C=C(C(O)=O)C(=O)C3=CC(F)=C(N4CC(O)C4)C(Cl)=C23)=C(F)C=C1F
Delavirdine,Reverse transcriptase/RNaseH,CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2
Delta-2-Albomycin A1,Ferrichrome-iron receptor,O1N2C(=[O+][Fe-3]1134ON(C(=[O+]1)C)CCC[C@](C(=O)N[C@@](C(=O)N[C@@](C(O)=O)([C@@]([C@]1(S[C@@](N5C=C\C(=N\C(N)=O)N(C5=O)C)([C@@]([C@]1([H])O)([H])O)[H])[H])([H])O)[H])([H])CO)([H])NC([C@@]([H])(CCCN(O3)C(=[O+]4)C)NC([C@]([H])(N)CCC2)=O)=O)C
Delta-2-Albomycin A1,Iron(3+)-hydroxamate-binding protein FhuD,O1N2C(=[O+][Fe-3]1134ON(C(=[O+]1)C)CCC[C@](C(=O)N[C@@](C(=O)N[C@@](C(O)=O)([C@@]([C@]1(S[C@@](N5C=C\C(=N\C(N)=O)N(C5=O)C)([C@@]([C@]1([H])O)([H])O)[H])[H])([H])O)[H])([H])CO)([H])NC([C@@]([H])(CCCN(O3)C(=[O+]4)C)NC([C@]([H])(N)CCC2)=O)=O)C
Delta-Amino Valeric Acid,Delta-aminolevulinic acid dehydratase,[NH3+]CCCCC(O)=O
Delta-Amino Valeric Acid,"Glycine amidinotransferase, mitochondrial",[NH3+]CCCCC(O)=O
Demecarium,Acetylcholinesterase,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C
Demecarium,Cholinesterase,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C
Demeclocycline,30S ribosomal protein S9,[H][C@]12C[C@@]3([H])[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C([C@H]2O)C(Cl)=CC=C1O
Demeclocycline,30S ribosomal protein S4,[H][C@]12C[C@@]3([H])[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C(=O)C1=C([C@H]2O)C(Cl)=CC=C1O
Demegestone,Progesterone receptor,[H][C@@]12CC[C@](C)(C(C)=O)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H]
Denibulin,Vascular endothelial growth factor receptor 3,[H][C@@](C)(N)C(=O)NC1=CC=C(SC2=CC3=C(C=C2)N=C(N3)N=C(O)OC)C=C1
Denibulin,Vascular endothelial growth factor receptor 1,[H][C@@](C)(N)C(=O)NC1=CC=C(SC2=CC3=C(C=C2)N=C(N3)N=C(O)OC)C=C1
Denibulin,Vascular endothelial growth factor A,[H][C@@](C)(N)C(=O)NC1=CC=C(SC2=CC3=C(C=C2)N=C(N3)N=C(O)OC)C=C1
Denileukin diftitox,Interleukin-2 receptor subunit alpha,
Denileukin diftitox,Interleukin-2 receptor subunit beta,
Denileukin diftitox,Cytokine receptor common subunit gamma,
Denosumab,Tumor necrosis factor ligand superfamily member 11,
Denufosol,P2Y purinoceptor 2,[H]N([H])C1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)N([H])C2=O)O1
Deoxy-2-fluoro-beta-D-cellotrioside,Endoglucanase 5A,[H][C@]1(F)[C@@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@@H]1O
Deoxycholic Acid,Steroid Delta-isomerase,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Cytochrome C,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Elongation factor Tu GTP-binding domain-containing protein 1,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Choloylglycine hydrolase,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Lactaldehyde dehydrogenase,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Multidrug efflux pump subunit AcrB,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Cytochrome c oxidase subunit 1,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Cytochrome c oxidase subunit 2,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Bile acid receptor,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,Glutathione S-transferase P,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxycholic Acid,G-protein coupled bile acid receptor 1,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
Deoxyguanidinoproclavaminic acid,Clavaminate synthase 1,[H][C@@](CCCNC(N)=N)(N1CCC1=O)C(O)=O
Deoxyuridine monophosphate,Thymidylate synthase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine monophosphate,Deoxyuridine 5'-triphosphate nucleotidohydrolase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine monophosphate,Deoxyuridine 5'-triphosphate nucleotidohydrolase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine monophosphate,Pol polyprotein,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine monophosphate,Thymidylate synthase ThyX,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine monophosphate,Thymidylate synthase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine monophosphate,Thymidylate synthase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine monophosphate,Thymidylate synthase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Diphosphate,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Diphosphate,Deoxyuridine 5'-triphosphate nucleotidohydrolase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Diphosphate,Deoxyuridine 5'-triphosphate nucleotidohydrolase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Diphosphate,Deoxyuridine triphosphatase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Diphosphate,Pol polyprotein,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Triphosphate,Deoxyuridine 5'-triphosphate nucleotidohydrolase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Triphosphate,Deoxyuridine 5'-triphosphate nucleotidohydrolase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Triphosphate,Pol polyprotein,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Triphosphate,Deoxycytidine triphosphate deaminase,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Deoxyuridine-5'-Triphosphate,Septum formation protein Maf,O[C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Depatuxizumab mafodotin,Epidermal growth factor receptor,[H][C@](C)(CC)[C@]([H])(N(C)C(=O)[C@@]([H])(N=C(O)[C@]([H])(C(C)C)N(C)C(=O)CCCCCN1C(=O)C=CC1=O)C(C)C)[C@@]([H])(CC(=O)N1CCC[C@@]1([H])C([H])(OC)[C@@]([H])(C)C(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=O)OC
Depatuxizumab mafodotin,Tubulin beta chain,[H][C@](C)(CC)[C@]([H])(N(C)C(=O)[C@@]([H])(N=C(O)[C@]([H])(C(C)C)N(C)C(=O)CCCCCN1C(=O)C=CC1=O)C(C)C)[C@@]([H])(CC(=O)N1CCC[C@@]1([H])C([H])(OC)[C@@]([H])(C)C(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=O)OC
Dephospho Coenzyme A,Phosphopantetheine adenylyltransferase,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS
Dequalinium,HTH-type transcriptional regulator QacR,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2
Dequalinium,Multidrug efflux pump subunit AcrB,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2
Dequalinium,E3 ubiquitin-protein ligase XIAP,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2
Dequalinium,cGMP-gated cation channel alpha-1,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2
Dequalinium,Calcium-activated potassium channel subunit alpha-1,CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C(C)C=C(N)C2=C1C=CC=C2
Deramciclane,5-hydroxytryptamine receptor 2A,[H][C@]12CC[C@](C)(C1(C)C)[C@@](C2)(OCCN(C)C)C1=CC=CC=C1
Deramciclane,5-hydroxytryptamine receptor 2C,[H][C@]12CC[C@](C)(C1(C)C)[C@@](C2)(OCCN(C)C)C1=CC=CC=C1
Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine,Arginase-1,N\C(NO)=N/CCC[NH3+]
Deserpidine,Synaptic vesicular amine transporter,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Desflurane,Gamma-aminobutyric acid receptor subunit alpha-1,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit alpha-2,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit alpha-3,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit alpha-4,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit alpha-5,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit alpha-6,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit beta-1,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit beta-2,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit beta-3,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit delta,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit epsilon,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit gamma-1,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit gamma-2,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit gamma-3,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit pi,FC(F)OC(F)C(F)(F)F
Desflurane,Gamma-aminobutyric acid receptor subunit theta,FC(F)OC(F)C(F)(F)F
Desflurane,Glycine receptor subunit alpha-1,FC(F)OC(F)C(F)(F)F
Desflurane,Glutamate receptor 1,FC(F)OC(F)C(F)(F)F
Desflurane,Potassium voltage-gated channel subfamily A member 1,FC(F)OC(F)C(F)(F)F
Desflurane,Calcium-transporting ATPase type 2C member 1,FC(F)OC(F)C(F)(F)F
Desflurane,"ATP synthase subunit delta, mitochondrial",FC(F)OC(F)C(F)(F)F
Desflurane,NADH-ubiquinone oxidoreductase chain 1,FC(F)OC(F)C(F)(F)F
Desipramine,Sodium-dependent noradrenaline transporter,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Sodium-dependent serotonin transporter,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,5-hydroxytryptamine receptor 2A,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Beta-2 adrenergic receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Beta-1 adrenergic receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Sphingomyelin phosphodiesterase,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Histamine H1 receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Alpha-1A adrenergic receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Alpha-1B adrenergic receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Alpha-1D adrenergic receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Muscarinic acetylcholine receptor M1,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Muscarinic acetylcholine receptor M2,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Muscarinic acetylcholine receptor M3,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Muscarinic acetylcholine receptor M4,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Muscarinic acetylcholine receptor M5,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,5-hydroxytryptamine receptor 1A,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,5-hydroxytryptamine receptor 2C,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,D(2) dopamine receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Alpha-2A adrenergic receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Alpha-2B adrenergic receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Desipramine,Alpha-2C adrenergic receptor,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Deslanoside,Sodium/potassium-transporting ATPase subunit alpha-1,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1
Desloratadine,Histamine H1 receptor,ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(CC2)C=CC=N1
Desmethylsertraline,Multidrug resistance protein 1,[H][C@]1(N)CC[C@@]([H])(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
Desmopressin,Vasopressin V2 receptor,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
Desmopressin,Vasopressin V1a receptor,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
Desmopressin,Vasopressin V1b receptor,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
Desmoteplase,Plasminogen,
Desogestrel,Progesterone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
Desogestrel,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
Desonide,Glucocorticoid receptor,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Desoximetasone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Desoxycorticosterone acetate,Mineralocorticoid receptor,[H][C@@]12CC[C@H](C(=O)COC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Desoxycorticosterone pivalate,Mineralocorticoid receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)COC(=O)C(C)(C)C
Desulfo-Coenzyme A,Chloramphenicol acetyltransferase,[H][C@](O)(C(O)=NCCC(O)=NCC)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Desvancosaminyl Vancomycin,dTDP-epi-vancosaminyltransferase,[H][C@](CC(C)C)(NC)C(O)=N[C@@]1([H])C(O)=N[C@@]([H])(CC(O)=N)C(O)=N[C@]2([H])C3=CC(OC4=C(Cl)C=C(C=C4)[C@@]1([H])O)=C(O[C@]1([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O)C(OC1=C(Cl)C=C(C=C1)[C@@]([H])(O)[C@]1([H])N=C(O)[C@]([H])(N=C2O)C2=CC(=C(O)C=C2)C2=C(C=C(O)C=C2O)[C@]([H])(N=C1O)C(O)=O)=C3
Desvancosaminyl Vancomycin,Desvancosaminyl-vancomycin vancosaminetransferase,[H][C@](CC(C)C)(NC)C(O)=N[C@@]1([H])C(O)=N[C@@]([H])(CC(O)=N)C(O)=N[C@]2([H])C3=CC(OC4=C(Cl)C=C(C=C4)[C@@]1([H])O)=C(O[C@]1([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O)C(OC1=C(Cl)C=C(C=C1)[C@@]([H])(O)[C@]1([H])N=C(O)[C@]([H])(N=C2O)C2=CC(=C(O)C=C2)C2=C(C=C(O)C=C2O)[C@]([H])(N=C1O)C(O)=O)=C3
Desvenlafaxine,Sodium-dependent noradrenaline transporter,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
Desvenlafaxine,Sodium-dependent serotonin transporter,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
Desvenlafaxine,Sodium-dependent dopamine transporter,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
Deutetrabenazine,Synaptic vesicular amine transporter,[2H]C([2H])([2H])OC1=CC2=C(C=C1OC([2H])([2H])[2H])[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2
Dexamethasone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Dexamethasone,Nuclear receptor subfamily 0 group B member 1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Dexamethasone,Annexin A1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Dexamethasone,"Nitric oxide synthase, inducible",[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Dexamethasone,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Dexanabinol,Tumor necrosis factor,CCCCCCC(C)(C)C1=CC(O)=C2[C@H]3CC(CO)=CC[C@@H]3C(C)(C)OC2=C1
Dexbrompheniramine,Histamine H1 receptor,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C1=CC=CC=N1
Dexchlorpheniramine maleate,Histamine H1 receptor,OC(=O)\C=C/C(O)=O.CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1
Dexfenfluramine,Sodium-dependent serotonin transporter,CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F
Dexfenfluramine,5-hydroxytryptamine receptor 2C,CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F
Dexfosfoserine,"Glycogen phosphorylase, liver form",N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Lithostathine-1-alpha,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,"Glycogen phosphorylase, muscle form",N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,3-phosphoinositide-dependent protein kinase 1,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Cystic fibrosis transmembrane conductance regulator,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Rhodopsin,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Serine/threonine-protein kinase pim-1,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Phosphomannomutase/phosphoglucomutase,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Protein kinase C theta type,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Fimbrial protein,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Alkaline phosphatase,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Anti-sigma F factor antagonist,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Siroheme synthase,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Glutaminase 1,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,"Endo-1,4-beta-xylanase Y",N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Potassium voltage-gated channel subfamily C member 4,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Phosphocarrier protein HPr,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,cAMP-dependent protein kinase catalytic subunit alpha,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Mothers against decapentaplegic homolog 2,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Serpin B3,N[C@@H](COP(O)(O)=O)C(O)=O
Dexfosfoserine,Serine/threonine-protein kinase TAO2,N[C@@H](COP(O)(O)=O)C(O)=O
Dexibuprofen,Prostaglandin G/H synthase 2,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Prostaglandin G/H synthase 1,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Apoptosis regulator Bcl-2,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Thrombomodulin,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Tissue-type plasminogen activator,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,"Fatty acid-binding protein, intestinal",CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Peroxisome proliferator-activated receptor gamma,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Cystic fibrosis transmembrane conductance regulator,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Solute carrier family 15 member 1,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Peroxisome proliferator-activated receptor alpha,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Platelet glycoprotein Ib alpha chain,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexibuprofen,Protein S100-A7,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
Dexketoprofen,Prostaglandin G/H synthase 1,[H][C@@](C)(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1
Dexketoprofen,Prostaglandin G/H synthase 2,[H][C@@](C)(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1
Dexlansoprazole,Potassium-transporting ATPase alpha chain 1,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1
Dexlansoprazole,Potassium-transporting ATPase subunit beta,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1
Dexlansoprazole,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1
Dexloxiglumide,Cholecystokinin receptor type A,CCCCCN(CCCOC)C(=O)[C@@H](CCC(O)=O)NC(=O)C1=CC(Cl)=C(Cl)C=C1
Dexmedetomidine,Alpha-2A adrenergic receptor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
Dexmethylphenidate,Sodium-dependent dopamine transporter,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1
Dexmethylphenidate,Sodium-dependent noradrenaline transporter,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1
Dexmethylphenidate,Sodium-dependent serotonin transporter,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1
Dexniguldipine,Multidrug resistance protein 1,[H]N1C(C)=C([C@@H](C2=CC(=CC=C2)[N+]([O-])=O)C(C(=O)OCCCN2CCC(CC2)(C2=CC=CC=C2)C2=CC=CC=C2)=C1C)C(=O)OC
Dexrazoxane,DNA topoisomerase 2-alpha,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1
Dexrazoxane,DNA topoisomerase 2-beta,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1
Dextroamphetamine,Synaptic vesicular amine transporter,C[C@H](N)CC1=CC=CC=C1
Dextroamphetamine,Sodium-dependent noradrenaline transporter,C[C@H](N)CC1=CC=CC=C1
Dextroamphetamine,Sodium-dependent dopamine transporter,C[C@H](N)CC1=CC=CC=C1
Dextroamphetamine,Trace amine-associated receptor 1,C[C@H](N)CC1=CC=CC=C1
Dextroamphetamine,Alpha-1A adrenergic receptor,C[C@H](N)CC1=CC=CC=C1
Dextroamphetamine,Alpha-1B adrenergic receptor,C[C@H](N)CC1=CC=CC=C1
Dextromethorphan,Sigma non-opioid intracellular receptor 1,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,"HCG20471, isoform CRA_c",[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,"Glutamate receptor ionotropic, NMDA 3A",[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neuronal acetylcholine receptor subunit alpha-2,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Sodium-dependent serotonin transporter,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Membrane-associated progesterone receptor component 1,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neuronal acetylcholine receptor subunit alpha-3,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neuronal acetylcholine receptor subunit alpha-4,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neuronal acetylcholine receptor subunit beta-4,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neuronal acetylcholine receptor subunit beta-2,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neuronal acetylcholine receptor subunit alpha-7,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Mu-type opioid receptor,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Delta-type opioid receptor,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Kappa-type opioid receptor,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Cytochrome b-245 heavy chain,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Cytochrome b-245 light chain,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neutrophil cytosol factor 1,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neutrophil cytosol factor 2,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Neutrophil cytosol factor 4,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Ras-related C3 botulinum toxin substrate 1,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Ras-related C3 botulinum toxin substrate 2,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextromethorphan,Sodium-dependent noradrenaline transporter,[H][C@]12CC3=C(C=C(OC)C=C3)[C@@]3(CCCC[C@]13[H])CCN2C
Dextropropoxyphene,Delta-type opioid receptor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
Dextropropoxyphene,Kappa-type opioid receptor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
Dextropropoxyphene,Mu-type opioid receptor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
Dextropropoxyphene,Liver carboxylesterase 1,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
Dextrothyroxine,Thyroid hormone receptor alpha,N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
Dextrothyroxine,Thyroid hormone receptor beta,N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
Dextrothyroxine,Thyroid peroxidase,N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
Dexverapamil,Multidrug resistance protein 1,COC1=CC=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1OC
Dezocine,Mu-type opioid receptor,[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N
Dezocine,Kappa-type opioid receptor,[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N
Di(N-Acetyl-D-Glucosamine),"Beta-1,4-galactosyltransferase 1",[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])N=C(C)O)[C@]([H])(O)[C@@]1([H])N=C(C)O
Di(N-Acetyl-D-Glucosamine),Chitobiase,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])N=C(C)O)[C@]([H])(O)[C@@]1([H])N=C(C)O
Di(N-Acetyl-D-Glucosamine),Lysozyme C,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])N=C(C)O)[C@]([H])(O)[C@@]1([H])N=C(C)O
Di-Linoleoyl-3-Sn-Phosphatidylcholine,Phosphatidylcholine transfer protein,CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC
Di-Stearoyl-3-Sn-Phosphatidylcholine,ADP/ATP translocase 1,[H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC
Di-Stearoyl-3-Sn-Phosphatidylcholine,Bactericidal permeability-increasing protein,[H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COP(O)(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC
Di-Stearoyl-3-Sn-Phosphatidylethanolamine,Prosaposin,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCCCC
Diacerein,Oxysterols receptor LXR-alpha,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Oxysterols receptor LXR-beta,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Arachidonate 5-lipoxygenase,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Cytochrome P450 1A2,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Cytochrome P450 3A4,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Cytochrome P450 3A43,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Cytochrome P450 3A5,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Cytochrome P450 3A7,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Cytochrome P450 2E1,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Cytochrome P450 2C9,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diacerein,Cytochrome P450 2D6,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C=C1C2=O)C(O)=O
Diamorphine,Mu-type opioid receptor,[H][C@@]12C=C[C@H](OC(C)=O)[C@@H]3OC4=C(OC(C)=O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5
Diamorphine,Kappa-type opioid receptor,[H][C@@]12C=C[C@H](OC(C)=O)[C@@H]3OC4=C(OC(C)=O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5
Diamorphine,Delta-type opioid receptor,[H][C@@]12C=C[C@H](OC(C)=O)[C@@H]3OC4=C(OC(C)=O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5
Diamorphine,Liver carboxylesterase 1,[H][C@@]12C=C[C@H](OC(C)=O)[C@@H]3OC4=C(OC(C)=O)C=CC5=C4[C@]13CCN(C)[C@@H]2C5
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit beta-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit beta-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit beta-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit gamma-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit gamma-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit delta,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit epsilon,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit pi,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit rho-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit rho-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit rho-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit theta,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Translocator protein,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-4,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit alpha-6,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit beta-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit beta-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit beta-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit delta,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit epsilon,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit gamma-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit gamma-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit pi,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazepam,Gamma-aminobutyric acid receptor subunit theta,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Diazoxide,ATP-sensitive inward rectifier potassium channel 11,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2
Diazoxide,Carbonic anhydrase 1,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2
Diazoxide,Carbonic anhydrase 2,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2
Diazoxide,Sodium/potassium-transporting ATPase subunit alpha-1,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2
Diazoxide,Calcium-activated potassium channel subunit alpha-1,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2
Diazoxide,Solute carrier family 12 member 3,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2
Dibotermin alfa,Bone morphogenetic protein receptor type-2,
Dibotermin alfa,Bone morphogenetic protein receptor type-1A,
Dibromothymoquinone,Cytochrome b6,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O
Dibromothymoquinone,Cytochrome b6-f complex subunit 4,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O
Dibromothymoquinone,Cytochrome b6-f complex iron-sulfur subunit,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O
Dibromothymoquinone,Cytochrome f,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O
Dibromothymoquinone,Cytochrome b6-f complex subunit 5,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O
Dibromothymoquinone,Cytochrome b6-f complex subunit 6,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O
Dibromothymoquinone,Cytochrome b6-f complex subunit 7,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O
Dibromothymoquinone,Cytochrome b6-f complex subunit 8,CC(C)C1=C(Br)C(=O)C(C)=C(Br)C1=O
Dibromotyrosine,Erythropoietin receptor,[H][C@](N)(CC1=CC(Br)=C(O)C(Br)=C1)C(O)=O
Dichloroacetic acid,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",OC(=O)C(Cl)Cl
Dichloroacetic acid,Maleylacetoacetate isomerase,OC(=O)C(Cl)Cl
Dichlorobenzyl alcohol,Sodium channel protein type 1 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 10 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 11 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 2 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 3 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 4 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 5 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 7 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 8 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel protein type 9 subunit alpha,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel subunit beta-1,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel subunit beta-2,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel subunit beta-3,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorobenzyl alcohol,Sodium channel subunit beta-4,OCC1=C(Cl)C=C(Cl)C=C1
Dichlorvos,Serotransferrin,COP(=O)(OC)OC=C(Cl)Cl
Dichlorvos,Cholinesterase,COP(=O)(OC)OC=C(Cl)Cl
Diclofenac,Prostaglandin G/H synthase 2,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Diclofenac,Prostaglandin G/H synthase 1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Diclofenac,Arachidonate 5-lipoxygenase,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Diclofenac,Sodium channel protein type 4 subunit alpha,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Diclofenac,Acid-sensing ion channel 1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Diclofenac,Potassium voltage-gated channel subfamily KQT member 2,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Diclofenac,Potassium voltage-gated channel subfamily KQT member 3,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Diclofenac,"Phospholipase A2, membrane associated",OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
Diclofenamide,Carbonic anhydrase 1,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O
Diclofenamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O
Diclofenamide,Carbonic anhydrase 4,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O
Diclofenamide,Carbonic anhydrase 7,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O
Diclofenamide,Carbonic anhydrase 3,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O
Dicloxacillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O
Dicloxacillin,Penicillin-binding protein 1b,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O
Dicloxacillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O
Dicloxacillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O
Dicloxacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O
Dicloxacillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl)C(O)=O
Dicoumarol,Vitamin K epoxide reductase complex subunit 1,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2
Dicoumarol,NAD(P)H dehydrogenase [quinone] 1,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2
Dicoumarol,Quinone oxidoreductase,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=C1C=CC=C2
Dicyclomine,Muscarinic acetylcholine receptor M1,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
Dicyclomine,Muscarinic acetylcholine receptor M2,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
Didanosine,Reverse transcriptase/RNaseH,OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O
Didanosine,Purine nucleoside phosphorylase,OC[C@@H]1CC[C@@H](O1)N1C=NC2=C1NC=NC2=O
Didecyldimethylammonium,Cyclopropane mycolic acid synthase 2,CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
Dienestrol,Estrogen receptor,[H]\C(C)=C(/C(=C(\[H])C)/C1=CC=C(O)C=C1)\C1=CC=C(O)C=C1
Dienestrol,Sex hormone-binding globulin,[H]\C(C)=C(/C(=C(\[H])C)/C1=CC=C(O)C=C1)\C1=CC=C(O)C=C1
Dienogest,Progesterone receptor,[H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H]
Dienogest,Androgen receptor,[H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H]
Diethyl 4-Methylbenzylphosphonate,Parathion hydrolase,CCOP(=O)(CC1=CC=C(C)C=C1)OCC
Diethyl 4-Methylbenzylphosphonate,Parathion hydrolase,CCOP(=O)(CC1=CC=C(C)C=C1)OCC
Diethylcarbamazine,Arachidonate 5-lipoxygenase,CCN(CC)C(=O)N1CCN(C)CC1
Diethylcarbamazine,Prostaglandin G/H synthase 1,CCN(CC)C(=O)N1CCN(C)CC1
Diethylphosphono Group,Diacylglycerol acyltransferase/mycolyltransferase Ag85C,CCOP(=O)OCC
Diethylphosphono Group,Cholinesterase,CCOP(=O)OCC
Diethylpropion,Sodium-dependent noradrenaline transporter,CCN(CC)C(C)C(=O)C1=CC=CC=C1
Diethylpropion,Sodium-dependent dopamine transporter,CCN(CC)C(C)C(=O)C1=CC=CC=C1
Diethylstilbestrol,Estrogen receptor,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diethylstilbestrol,Estrogen-related receptor gamma,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diethylstilbestrol,Estrogen receptor beta,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diethylstilbestrol,Steroid hormone receptor ERR1,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diethylstilbestrol,Steroid hormone receptor ERR2,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diethylstilbestrol,Nuclear receptor coactivator 2,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diethylstilbestrol,Nuclear receptor subfamily 1 group I member 2,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diethylstilbestrol,Androgen receptor,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diethylstilbestrol,Sex hormone-binding globulin,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
Diflorasone,Glucocorticoid receptor,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Diflunisal,Prostaglandin G/H synthase 2,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
Diflunisal,Prostaglandin G/H synthase 1,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1
Difluocortolone,Annexin A3,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Difluocortolone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Difluoromethionine,Methionine--tRNA ligase,N[C@@H](CCSC(F)F)C(O)=O
Difluprednate,Glucocorticoid receptor,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Digitoxin,Sodium/potassium-transporting ATPase subunit alpha-1,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1
Diglyme,Endoplasmin,COCCOCCOC
Digoxin,Sodium/potassium-transporting ATPase subunit alpha-1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1
Diguanosine-5'-Triphosphate,mRNA-capping enzyme,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2NC(N)=NC3=O)[C@@H](O)[C@H]1O
Dihomo-gamma-linolenic acid,Prostaglandin G/H synthase 1,CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O
Dihomo-gamma-linolenic acid,Prostaglandin G/H synthase 2,CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O
Dihydrexidine,D(1A) dopamine receptor,OC1=C(O)C=C2[C@H]3[C@H](CCC2=C1)NCC1=CC=CC=C31
Dihydro-alpha-ergocryptine,D(2) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydro-alpha-ergocryptine,D(1A) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydro-alpha-ergocryptine,D(1B) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydro-alpha-ergocryptine,D(3) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 1A,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 1B,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 1D,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 1E,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 1F,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 2A,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 2B,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 2C,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 3A,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 3B,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 3C,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 3D,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 3E,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 4,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 6,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,5-hydroxytryptamine receptor 7,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Beta-1 adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Beta-2 adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Beta-3 adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Alpha-1A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Alpha-1B adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Alpha-1D adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Alpha-2A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Alpha-2B adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocornine,Alpha-2C adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](C(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 1A,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 1B,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 1D,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 1E,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 1F,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 2A,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 2B,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 2C,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 3A,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 3B,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 3C,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 3D,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 3E,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 4,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 6,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,5-hydroxytryptamine receptor 7,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Beta-1 adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Beta-2 adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Beta-3 adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Alpha-1A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Alpha-1B adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Alpha-1D adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Alpha-2A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Alpha-2B adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,Alpha-2C adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,D(1A) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,D(1B) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,D(2) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,D(3) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergocristine,D(4) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N1C(=O)[C@@](O[C@@]21O)(N=C(O)[C@@]1([H])CN(C)[C@]2([H])CC3=CNC4=CC=CC(=C34)[C@@]2([H])C1)C(C)C
Dihydroergotamine,5-hydroxytryptamine receptor 1D,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
Dihydroergotamine,5-hydroxytryptamine receptor 1B,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
Dihydroergotamine,Alpha-2A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
Dihydroergotamine,5-hydroxytryptamine receptor 2B,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
Dihydrofolic Acid,Dihydrofolate reductase,NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CN2)C(=O)N1
Dihydrofolic Acid,Putative pteridine reductase 2,NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CN2)C(=O)N1
Dihydrogenphosphate,L-xylulose reductase,[H]OP([O-])(=O)O[H]
Dihydrogenphosphate,Phosphate-binding protein PstS,[H]OP([O-])(=O)O[H]
Dihydrolipoic Acid,Aminomethyltransferase,[H][C@](S)(CCS)CCCCC(O)=O
Dihydrolipoic Acid,"Glycine cleavage system H protein, mitochondrial",[H][C@](S)(CCS)CCCCC(O)=O
Dihydrolipoic Acid,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",[H][C@](S)(CCS)CCCCC(O)=O
Dihydrolipoic Acid,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",[H][C@](S)(CCS)CCCCC(O)=O
Dihydromorphine,Mu-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O
Dihydromorphine,Delta-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O
Dihydromorphine,Kappa-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O
Dihydromorphine,E3 ubiquitin-protein ligase TRIM13,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O
Dihydromorphine,Pro-opiomelanocortin,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CC[C@@H]2O
Dihydroorotic Acid,Dihydroorotase,OC(=O)[C@@H]1CC(=O)NC(=O)N1
Dihydroquinidine barbiturate,Gamma-aminobutyric acid receptor subunit alpha-1,
Dihydrotachysterol,Vitamin D3 receptor,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1/C[C@@H](O)CC[C@@H]1C
Dihydroxy(oxo)molybdenum(6+),Sensor histidine kinase CitA,O[Mo+6](O)=O
Dihydroxyacetone,Dihydroxyacetone kinase,OCC(=O)CO
Dihydroxyacetone phosphate,Fructose-bisphosphate aldolase A,OCC(=O)COP(O)(O)=O
Dihydroxyacetone phosphate,L-fuculose phosphate aldolase,OCC(=O)COP(O)(O)=O
Dihydroxyacetone phosphate,Triosephosphate isomerase,OCC(=O)COP(O)(O)=O
Dihydroxyacetone phosphate,Fructose-bisphosphate aldolase B,OCC(=O)COP(O)(O)=O
Diisopropylphosphono Group,Dipeptidyl peptidase 4,CC(C)OP(=O)OC(C)C
Diisopropylphosphono Group,Subtilisin BPN',CC(C)OP(=O)OC(C)C
Diisopropylphosphono Group,Complement factor B,CC(C)OP(=O)OC(C)C
Diisopropylphosphono Group,Esterase EstB,CC(C)OP(=O)OC(C)C
Dilmapimod,Tumor necrosis factor,CC1=CC(F)=CC=C1C1=C2C=CC(=O)N(C2=NC(NC(CO)CO)=N1)C1=C(F)C=CC=C1F
Dilmapimod,Interleukin-1 beta,CC1=CC(F)=CC=C1C1=C2C=CC(=O)N(C2=NC(NC(CO)CO)=N1)C1=C(F)C=CC=C1F
Dilmapimod,Interleukin-6,CC1=CC(F)=CC=C1C1=C2C=CC(=O)N(C2=NC(NC(CO)CO)=N1)C1=C(F)C=CC=C1F
Diltiazem,Voltage-dependent calcium channel gamma-1 subunit,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
Diltiazem,Voltage-dependent L-type calcium channel subunit alpha-1C,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O
Dimenhydrinate,Histamine H1 receptor,CN1C2=C([N-]C(Cl)=N2)C(=O)N(C)C1=O.C[NH+](C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
Dimercaprol,Amyloid beta A4 protein,OCC(S)CS
Dimetacrine,Acetylcholinesterase,CN(C)CCCN1C2=CC=CC=C2C(C)(C)C2=CC=CC=C12
Dimethyl Propionate Ester Heme,Cytochrome b5,COC(=O)CCC1=C(C)C2=CC3=C(C=C)C(C)=C4C=C5N6C(=CC7=C(C)C(CCC(=O)OC)=C8C=C1N2[Fe@@]6(N78)N34)C(C)=C5C=C
Dimethyl fumarate,Kelch-like ECH-associated protein 1,[H]\C(=C(\[H])C(=O)OC)C(=O)OC
Dimethyl fumarate,Transcription factor p65,[H]\C(=C(\[H])C(=O)OC)C(=O)OC
Dimethylallyl Diphosphate,Farnesyl pyrophosphate synthase,CC(C)=CCO[P@](O)(=O)OP(O)(O)=O
Dimethylallyl Diphosphate,Isopentenyl-diphosphate Delta-isomerase 1,CC(C)=CCO[P@](O)(=O)OP(O)(O)=O
Dimethylallyl Diphosphate,4-hydroxy-3-methylbut-2-enyl diphosphate reductase,CC(C)=CCO[P@](O)(=O)OP(O)(O)=O
Dimethylallyl S-Thiolodiphosphate,Farnesyl diphosphate synthase,CC(C)CCS[P@](O)(=O)OP(O)(O)=O
Dimethylallyl S-Thiolodiphosphate,Adenylate dimethylallyltransferase,CC(C)CCS[P@](O)(=O)OP(O)(O)=O
Dimethylallyl S-Thiolodiphosphate,tRNA dimethylallyltransferase,CC(C)CCS[P@](O)(=O)OP(O)(O)=O
Dimethylcurcumin,Androgen receptor,COC1=CC=C(\C=C\C(\O)=C\C(=O)\C=C\C2=CC(OC)=C(OC)C=C2)C=C1OC
Dimethylthiambutene,Delta-type opioid receptor,CC(C=C(C1=CC=CS1)C1=CC=CS1)N(C)C
Dimethylthiambutene,Mu-type opioid receptor,CC(C=C(C1=CC=CS1)C1=CC=CS1)N(C)C
Dimethyltryptamine,5-hydroxytryptamine receptor 6,CN(C)CCC1=CNC2=CC=CC=C12
Dimethyltryptamine,5-hydroxytryptamine receptor 2A,CN(C)CCC1=CNC2=CC=CC=C12
Dimethyltryptamine,Sigma non-opioid intracellular receptor 1,CN(C)CCC1=CNC2=CC=CC=C12
Dimetindene,Histamine H1 receptor,CC(C1=C(CCN(C)C)CC2=CC=CC=C12)C1=CC=CC=N1
Dimetindene,Muscarinic acetylcholine receptor M2,CC(C1=C(CCN(C)C)CC2=CC=CC=C12)C1=CC=CC=N1
Diminazene,"Peroxiredoxin-5, mitochondrial",NC(=N)C1=CC=C(N\N=N\C2=CC=C(C=C2)C(N)=N)C=C1
Diminazene,HTH-type transcriptional regulator QacR,NC(=N)C1=CC=C(N\N=N\C2=CC=C(C=C2)C(N)=N)C=C1
Diminazene,Trypsin-1,NC(=N)C1=CC=C(N\N=N\C2=CC=C(C=C2)C(N)=N)C=C1
Diminazene,Amiloride-sensitive amine oxidase [copper-containing],NC(=N)C1=CC=C(N\N=N\C2=CC=C(C=C2)C(N)=N)C=C1
Dinitrochlorobenzene,Methylated-DNA--protein-cysteine methyltransferase,ClC1=C(C=C(C=C1)N(=O)=O)N(=O)=O
Dinitrochlorobenzene,Glutathione S-transferase P,ClC1=C(C=C(C=C1)N(=O)=O)N(=O)=O
Dinitrophenylene,"Mannan endo-1,4-beta-mannosidase",[O-][N+](=O)C1=CC(=CC=C1)[N+]([O-])=O
Dinoprost,Prostaglandin D2 receptor 2,[H]\C(CCCC(O)=O)=C(/[H])C[C@@]1([H])[C@@]([H])(O)C[C@@]([H])(O)[C@]1([H])C(\[H])=C(/[H])[C@@]([H])(O)CCCCC
Dinoprost tromethamine,Prostaglandin F2-alpha receptor,NC(CO)(CO)CO.CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
Dinoprost tromethamine,Prostacyclin receptor,NC(CO)(CO)CO.CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
Dinoprostone,Prostaglandin E2 receptor EP2 subtype,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
Dinoprostone,Prostaglandin E2 receptor EP1 subtype,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
Dinoprostone,Prostaglandin E2 receptor EP3 subtype,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
Dinoprostone,Prostaglandin E2 receptor EP4 subtype,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
Dinoprostone,Prostaglandin D2 receptor 2,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
Dinor-N(Omega)-Hydroxy-L-Arginine,Arginase-1,N[C@@H](C\N=C(/N)NO)C(O)=O
Diosmin,Aryl hydrocarbon receptor,COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O)C=C(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)C=C2O1
Dioxybenzone,Sex hormone-binding globulin,COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1O
Dioxyselenocysteine,Subtilisin BPN',[H][C@](N)(C[SeH](=O)=O)C(O)=O
Diphemanil,Muscarinic acetylcholine receptor M3,C[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1
Diphenhydramine,Histamine H1 receptor,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
Diphenhydramine,Muscarinic acetylcholine receptor M2,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
Diphenidol,Muscarinic acetylcholine receptor M3,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
Diphenidol,Muscarinic acetylcholine receptor M1,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
Diphenidol,Muscarinic acetylcholine receptor M2,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
Diphenoxylate,Mu-type opioid receptor,CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1
Diphenoxylate,Delta-type opioid receptor,CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1
Diphenylacetic Acid,Cathepsin B,OC(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
Diphenylpyraline,Histamine H1 receptor,CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
Diphenylpyraline,Sodium-dependent dopamine transporter,CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1
Diphthamide,Elongation factor 2,C[N+](C)(C)[C@@H](CCC1=NC(C[C@H](N)C(O)=O)=CN1)C(N)=O
Dipicolinic Acid,4-hydroxy-tetrahydrodipicolinate reductase,OC(=O)C1=CC=CC(=N1)C(O)=O
Dipicolinic Acid,4-hydroxy-tetrahydrodipicolinate reductase,OC(=O)C1=CC=CC(=N1)C(O)=O
Dipivefrin,Alpha-1A adrenergic receptor,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
Dipivefrin,Alpha-2A adrenergic receptor,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
Dipivefrin,Beta-2 adrenergic receptor,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
Dipivefrin,Cholinesterase,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
Dipivefrin,Acetylcholinesterase,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1
Dipraglurant,Metabotropic glutamate receptor 5,FC1=CN2C=C(CCC#CC3=CC=CC=N3)N=C2C=C1
Diprenorphine,Mu-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@H](C1)C(C)(C)O
Diprenorphine,Delta-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@H](C1)C(C)(C)O
Diprenorphine,Kappa-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@H](C1)C(C)(C)O
Diprenorphine,E3 ubiquitin-protein ligase TRIM13,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]11CC[C@@]2(OC)[C@H](C1)C(C)(C)O
Dipyridamole,"cGMP-specific 3',5'-cyclic phosphodiesterase",OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1
Dipyridamole,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1
Dipyridamole,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1
Dipyridamole,Adenosine deaminase,OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1
Dipyridamole,Calcipressin-1,OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1
Dipyridamole,Alpha-1-acid glycoprotein 1,OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1
Dipyrithione,"Nitric oxide synthase, inducible",[O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-]
Dipyrithione,Prostaglandin G/H synthase 2,[O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-]
Dipyrromethane Cofactor,Porphobilinogen deaminase,CC1=C(CC(O)=O)C(CCC(O)=O)=C(CC2=C(CC(O)=O)C(CCC(O)=O)=CN2)N1
Disopyramide,Sodium channel protein type 5 subunit alpha,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
Disopyramide,Muscarinic acetylcholine receptor M1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
Disopyramide,Muscarinic acetylcholine receptor M2,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
Disopyramide,Muscarinic acetylcholine receptor M3,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
Disopyramide,Potassium voltage-gated channel subfamily D member 2,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
Disopyramide,Potassium voltage-gated channel subfamily D member 3,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
Disopyramide,Potassium voltage-gated channel subfamily H member 2,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
Disopyramide,Alpha-1-acid glycoprotein 2,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
Disulfiram,"Aldehyde dehydrogenase, mitochondrial",CCN(CC)C(=S)SSC(=S)N(CC)CC
Disulfiram,Dopamine beta-hydroxylase,CCN(CC)C(=S)SSC(=S)N(CC)CC
Dithioerythritol,Listeriolysin regulatory protein,[H][C@](O)(CS)[C@]([H])(O)CS
Dithioerythritol,"Thymidine kinase, cytosolic",[H][C@](O)(CS)[C@]([H])(O)CS
Dithioerythritol,"6,7-dimethyl-8-ribityllumazine synthase",[H][C@](O)(CS)[C@]([H])(O)CS
Dobutamine,Beta-1 adrenergic receptor,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1
Dobutamine,Beta-2 adrenergic receptor,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1
Dobutamine,Alpha-1A adrenergic receptor,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1
Dobutamine,Alpha-1B adrenergic receptor,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1
Dobutamine,Alpha-1D adrenergic receptor,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1
Dobutamine,Estrogen receptor,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1
Docetaxel,Tubulin beta-1 chain,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
Docetaxel,Apoptosis regulator Bcl-2,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
Docetaxel,Microtubule-associated protein 2,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
Docetaxel,Microtubule-associated protein 4,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
Docetaxel,Microtubule-associated protein tau,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
Docetaxel,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
Doconexent,Peroxisome proliferator-activated receptor alpha,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O
Doconexent,Peroxisome proliferator-activated receptor gamma,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O
Doconexent,Retinoic acid receptor RXR-alpha,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O
Doconexent,Retinoic acid receptor RXR-beta,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O
Doconexent,Retinoic acid receptor RXR-gamma,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O
Doconexent,Sterol regulatory element-binding protein 1,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O
Docosanol,Envelope glycoprotein GP350,CCCCCCCCCCCCCCCCCCCCCCO
Docosanol,Envelope glycoprotein GP340,CCCCCCCCCCCCCCCCCCCCCCO
Dodecane-Trimethylamine,Tyrosine-protein phosphatase non-receptor type 11,CCCCCCCCCCCC[N+](C)(C)C
Dodecyl sulfate,Lysozyme C,CCCCCCCCCCCCOS(O)(=O)=O
Dodecyl sulfate,Lipid A palmitoyltransferase PagP,CCCCCCCCCCCCOS(O)(=O)=O
Dodecyl-Alpha-D-Maltoside,Retinoic acid receptor gamma,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(O[C@@]2([H])[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(OCCCCCCCCCCCC)O[C@]2([H])CO)[C@]1([H])O
Dodecyl-Coa,3-oxoacyl-[acyl-carrier-protein] synthase 3,CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C(N)N=CN=C12
Dodecyl-Coa,Fatty acid metabolism regulator protein,CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C(N)N=CN=C12
Dofequidar,ATP-binding cassette sub-family B member 5,OC(COC1=CC=CC2=C1C=CC=N2)CN1CCN(CC1)C(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
Dofequidar,Multidrug resistance protein 1,OC(COC1=CC=CC2=C1C=CC=N2)CN1CCN(CC1)C(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
Dofetilide,Potassium voltage-gated channel subfamily H member 2,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1
Dofetilide,Potassium channel subfamily K member 2,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1
Dofetilide,ATP-sensitive inward rectifier potassium channel 12,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1
Dolasetron,5-hydroxytryptamine receptor 3A,[H][C@@]1(C[C@@]2([H])C[C@]3([H])C[C@@]([H])(C1)N2CC3=O)OC(=O)C1=CNC2=C1C=CC=C2
Dolutegravir,Integrase,[H][C@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N1[C@H](C)CCO2
Domoic Acid,"Glutamate receptor ionotropic, kainate 2",[H]\C(\C(\[H])=C(\C)[C@@]1([H])CN[C@]([H])(C(O)=O)[C@@]1([H])CC(O)=O)=C(\[H])[C@@]([H])(C)C(O)=O
Domperidone,D(2) dopamine receptor,ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=CC=CC=C34)CC1)C(=O)N2
Domperidone,D(3) dopamine receptor,ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=CC=CC=C34)CC1)C(=O)N2
Donepezil,Acetylcholinesterase,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1
Donepezil,5-hydroxytryptamine receptor 2A,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1
Dopamine,D(2) dopamine receptor,NCCC1=CC(O)=C(O)C=C1
Dopamine,D(1A) dopamine receptor,NCCC1=CC(O)=C(O)C=C1
Dopamine,D(1B) dopamine receptor,NCCC1=CC(O)=C(O)C=C1
Dopamine,D(3) dopamine receptor,NCCC1=CC(O)=C(O)C=C1
Dopamine,D(4) dopamine receptor,NCCC1=CC(O)=C(O)C=C1
Dopamine,Sodium-dependent dopamine transporter,NCCC1=CC(O)=C(O)C=C1
Dopamine,Dopamine beta-hydroxylase,NCCC1=CC(O)=C(O)C=C1
Dopamine,5-hydroxytryptamine receptor 1A,NCCC1=CC(O)=C(O)C=C1
Dopamine,5-hydroxytryptamine receptor 7,NCCC1=CC(O)=C(O)C=C1
Dopamine,D(1A) dopamine receptor,NCCC1=CC(O)=C(O)C=C1
Dopamine,D(1B) dopamine receptor,NCCC1=CC(O)=C(O)C=C1
Dopamine,Sodium-dependent noradrenaline transporter,NCCC1=CC(O)=C(O)C=C1
Dopamine,Sodium-dependent serotonin transporter,NCCC1=CC(O)=C(O)C=C1
Dopamine,5-hydroxytryptamine receptor 3A,NCCC1=CC(O)=C(O)C=C1
Dopamine,5-hydroxytryptamine receptor 3B,NCCC1=CC(O)=C(O)C=C1
Dopamine,Superoxide dismutase [Cu-Zn],NCCC1=CC(O)=C(O)C=C1
Dopamine,Synaptic vesicular amine transporter,NCCC1=CC(O)=C(O)C=C1
Doravirine,Reverse transcriptase/RNaseH,CN1C(O)=NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F
Doripenem,Penicillin-binding protein 1A,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Doripenem,Penicillin-binding protein 1B,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Doripenem,Penicillin-binding protein 2,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Doripenem,Cell division protein,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Doripenem,Penicillin-binding protein 4,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Dorzolamide,Carbonic anhydrase 2,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Dorzolamide,Carbonic anhydrase 4,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Dorzolamide,Carbonic anhydrase 1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Dorzolamide,Carbonic anhydrase 3,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
Dosulepin,5-hydroxytryptamine receptor 1A,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,5-hydroxytryptamine receptor 2A,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Histamine H1 receptor,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Muscarinic acetylcholine receptor M1,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Muscarinic acetylcholine receptor M2,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Muscarinic acetylcholine receptor M3,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Muscarinic acetylcholine receptor M4,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Muscarinic acetylcholine receptor M5,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Alpha-2A adrenergic receptor,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Alpha-2B adrenergic receptor,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Alpha-2C adrenergic receptor,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Alpha-1A adrenergic receptor,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Alpha-1B adrenergic receptor,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Alpha-1D adrenergic receptor,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Sodium-dependent noradrenaline transporter,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dosulepin,Sodium-dependent serotonin transporter,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
Dotarizine,5-hydroxytryptamine receptor 1A,C(CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)CC1(OCCO1)C1=CC=CC=C1
Dotarizine,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,C(CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)CC1(OCCO1)C1=CC=CC=C1
Dotarizine,5-hydroxytryptamine receptor 2A,C(CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)CC1(OCCO1)C1=CC=CC=C1
Dotarizine,5-hydroxytryptamine receptor 2C,C(CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1)CC1(OCCO1)C1=CC=CC=C1
Dotatate gallium Ga-68,Somatostatin receptor type 2,[Ga+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O
Dovitinib,Nuclear receptor subfamily 1 group I member 2,CN1CCN(CC1)C1=CC=C2N=C(NC2=C1)C1=C(N)C2=C(NC1=O)C=CC=C2F
Doxacurium,Neuronal acetylcholine receptor subunit alpha-2,COC1=CC(CC2C3=C(OC)C(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C(OC)=C3C2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
Doxacurium,Muscarinic acetylcholine receptor M2,COC1=CC(CC2C3=C(OC)C(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C(OC)=C3C2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
Doxapram,Potassium channel subfamily K member 3,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1
Doxapram,Potassium channel subfamily K member 9,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1
Doxazosin,Alpha-1A adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1
Doxazosin,Alpha-1B adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1
Doxazosin,Alpha-1D adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1
Doxazosin,Potassium voltage-gated channel subfamily H member 2,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1
Doxazosin,Potassium voltage-gated channel subfamily H member 6,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1
Doxazosin,Potassium voltage-gated channel subfamily H member 7,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1
Doxepin,Histamine H1 receptor,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Histamine H2 receptor,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Sodium-dependent noradrenaline transporter,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Sodium-dependent serotonin transporter,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,5-hydroxytryptamine receptor 2A,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,5-hydroxytryptamine receptor 2B,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,5-hydroxytryptamine receptor 2C,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Muscarinic acetylcholine receptor M1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Muscarinic acetylcholine receptor M2,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Muscarinic acetylcholine receptor M3,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Muscarinic acetylcholine receptor M4,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Muscarinic acetylcholine receptor M5,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Alpha-1A adrenergic receptor,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Alpha-1B adrenergic receptor,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Alpha-1D adrenergic receptor,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,5-hydroxytryptamine receptor 1A,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,5-hydroxytryptamine receptor 6,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Histamine H4 receptor,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxepin,Potassium voltage-gated channel subfamily H member 2,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
Doxercalciferol,Vitamin D3 receptor,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C
Doxofylline,"Phosphodiesterase 2A, cGMP-stimulated",CN1C2=C(N(CC3OCCO3)C=N2)C(=O)N(C)C1=O
Doxofylline,Adenosine receptor A2a,CN1C2=C(N(CC3OCCO3)C=N2)C(=O)N(C)C1=O
Doxofylline,Beta-2 adrenergic receptor,CN1C2=C(N(CC3OCCO3)C=N2)C(=O)N(C)C1=O
Doxorubicin,DNA topoisomerase 2-alpha,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O
Doxorubicin,Nucleolar and coiled-body phosphoprotein 1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O
Doxylamine,Muscarinic acetylcholine receptor M1,CN(C)CCOC(C)(C1=CC=CC=C1)C1=CC=CC=N1
Doxylamine,Histamine H1 receptor,CN(C)CCOC(C)(C1=CC=CC=C1)C1=CC=CC=N1
Doxylamine,Nuclear receptor subfamily 1 group I member 3,CN(C)CCOC(C)(C1=CC=CC=C1)C1=CC=CC=N1
Dpb-T,"5'(3')-deoxyribonucleotidase, mitochondrial",[H][C@]1(C[C@]2([H])O[C@@](OC[C@]2([H])O1)(C1=CC=CC=C1)P(O)(O)=O)N1C=C(C)C(=O)NC1=O
Dronabinol,Cannabinoid receptor 1,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1
Dronabinol,Cannabinoid receptor 2,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1
Dronedarone,Alpha-1A adrenergic receptor,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Alpha-1B adrenergic receptor,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Alpha-1D adrenergic receptor,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Alpha-2A adrenergic receptor,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Alpha-2B adrenergic receptor,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Alpha-2C adrenergic receptor,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Beta-1 adrenergic receptor,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Potassium voltage-gated channel subfamily H member 2,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1C,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1D,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1F,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1S,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Voltage-dependent L-type calcium channel subunit beta-1,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Voltage-dependent L-type calcium channel subunit beta-2,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Voltage-dependent L-type calcium channel subunit beta-3,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Voltage-dependent L-type calcium channel subunit beta-4,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Sodium channel protein type 1 subunit alpha,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Dronedarone,Potassium channel subfamily K member 2,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
Droperidol,D(2) dopamine receptor,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12
Droperidol,Alpha-1A adrenergic receptor,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12
Drospirenone,Progesterone receptor,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21
Drospirenone,Mineralocorticoid receptor,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21
Drospirenone,Androgen receptor,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21
Drostanolone,Androgen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C
Drotaverine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CCOC1=C(OCC)C=C(\C=C2/NCCC3=CC(OCC)=C(OCC)C=C23)C=C1
Drotaverine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCOC1=C(OCC)C=C(\C=C2/NCCC3=CC(OCC)=C(OCC)C=C23)C=C1
Drotrecogin alfa,Coagulation factor VIII,
Drotrecogin alfa,Coagulation factor V,
Drotrecogin alfa,Prothrombin,
Drotrecogin alfa,Plasminogen activator inhibitor 1,
Drotrecogin alfa,Vitamin K-dependent gamma-carboxylase,
Drotrecogin alfa,Vitamin K-dependent protein S,
Drotrecogin alfa,Platelet factor 4,
Drotrecogin alfa,Ceruloplasmin,
Drotrecogin alfa,Thrombomodulin,
Drotrecogin alfa,Endothelial protein C receptor,
Drotrecogin alfa,Plasma serine protease inhibitor,
Drotrecogin alfa,Serpin B6,
Droxicam,Prostaglandin G/H synthase 1,CN1C2=C(OC(=O)N(C2=O)C2=CC=CC=N2)C2=CC=CC=C2S1(=O)=O
Droxicam,Prostaglandin G/H synthase 2,CN1C2=C(OC(=O)N(C2=O)C2=CC=CC=N2)C2=CC=CC=C2S1(=O)=O
Droxidopa,Alpha-1A adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Alpha-1B adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Alpha-1D adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Alpha-2A adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Alpha-2B adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Alpha-2C adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Beta-1 adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Beta-2 adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Beta-3 adrenergic receptor,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Droxidopa,Phenylalanine-4-hydroxylase,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
Dulaglutide,Glucagon-like peptide 1 receptor,
Duloxetine,Sodium-dependent serotonin transporter,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
Duloxetine,Sodium-dependent noradrenaline transporter,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
Duloxetine,Sodium-dependent dopamine transporter,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
Dupilumab,Interleukin-4 receptor subunit alpha,
Duroquinone,NAD(P)H dehydrogenase [quinone] 1,CC1=C(C)C(=O)C(C)=C(C)C1=O
Durvalumab,Programmed cell death 1 ligand 1,
Durvalumab,T-lymphocyte activation antigen CD80,
Dutasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F
Dutasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F
Dutogliptin,Dipeptidyl peptidase 4,OB(O)[C@@H]1CCCN1C(=O)CN[C@@H]1CCNC1
Duvelisib,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1
Duvelisib,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1
Duvoglustat,Xylose isomerase,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O
Duvoglustat,Cyclomaltodextrin glucanotransferase,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O
Duvoglustat,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O
Duvoglustat,"Mannosyl-oligosaccharide alpha-1,2-mannosidase",OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O
Duvoglustat,Beta-glucosidase A,OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O
Dyclonine,Sodium channel protein type 10 subunit alpha,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1
Dydrogesterone,Progesterone receptor,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C
Dyphylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
Dyphylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
Dyphylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
Dyphylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
Dyphylline,Adenosine receptor A1,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
Dyphylline,Adenosine receptor A2a,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
Dyphylline,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
Dyphylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
E-2012,Gamma-secretase subunit APH-1A,[H]\C(C1=CC(OC)=C(C=C1)N1C=NC(C)=C1)=C1\CCCN(C1=O)[C@@]([H])(C)C1=CC=C(F)C=C1
E-2012,Gamma-secretase subunit PEN-2,[H]\C(C1=CC(OC)=C(C=C1)N1C=NC(C)=C1)=C1\CCCN(C1=O)[C@@]([H])(C)C1=CC=C(F)C=C1
E5531,Toll-like receptor 4,[H]\C(CCCCCC)=C(/[H])CCCC(=O)O[C@]([H])(CCCCCCC)CCO[C@@]1([H])[C@]([H])(OP(O)(O)=O)[C@@]([H])(COC)O[C@@]([H])(OC[C@@]2([H])O[C@]([H])(OP(O)(O)=O)[C@]([H])(N=C(O)CC(=O)CCCCCCCCCCC)[C@@]([H])(OCC[C@]([H])(O)CCCCCCC)[C@]2([H])O)[C@]1([H])N=C(O)CC(=O)CCCCCCCCCCC
EM-1745,Estradiol 17-beta-dehydrogenase 1,[H][C@]1(CCCCCCCCC(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)C[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])O
ENMD-1198,Hypoxia-inducible factor 1-alpha,COC1=C(C=C2CC[C@H]3[C@@H]4CC=C[C@@]4(C)CC[C@@H]3C2=C1)C(N)=O
ENMD-1198,Tumor necrosis factor receptor superfamily member 11A,COC1=C(C=C2CC[C@H]3[C@@H]4CC=C[C@@]4(C)CC[C@@H]3C2=C1)C(N)=O
ENMD-1198,Signal transducer and activator of transcription 3,COC1=C(C=C2CC[C@H]3[C@@H]4CC=C[C@@]4(C)CC[C@@H]3C2=C1)C(N)=O
EP-2104R,Fibrinogen alpha chain,
ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE,Lactase-phlorizin hydrolase,CCS\C(CC1=CC=CC=C1)=N/OS(O)(=O)=O
ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,Carbonic anhydrase 1,CCOC(=O)CCC1=CC=C(C=C1)S(N)(=O)=O
ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,Carbonic anhydrase 2,CCOC(=O)CCC1=CC=C(C=C1)S(N)(=O)=O
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,"Nitric oxide synthase, inducible",CCOC(=O)N1CCC(CC1)NC1=NC=CC(Cl)=C1
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,"Nitric oxide synthase, inducible",CCOC(=O)N1CCC(CC1)NC1=NC=CC(C)=C1
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,"Nitric oxide synthase, endothelial",CCOC(=O)N1CCC(CC1)NC1=NC=CC(C)=C1
ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE,Cholinesterase,CCO[P@](O)(=O)N(CC)CC
EVT-101,Retinoic acid receptor RXR-alpha,Cl.Cl.CC1=NC=CN1CC1=CC(=CN=N1)C1=CC=C(F)C(=C1)C(F)F
EVT-101,"Glutamate receptor ionotropic, NMDA 2B",Cl.Cl.CC1=NC=CN1CC1=CC(=CN=N1)C1=CC=C(F)C(=C1)C(F)F
Ebselen,Bifunctional epoxide hydrolase 2,O=C1N([Se]C2=CC=CC=C12)C1=CC=CC=C1
Ecabet,NADPH oxidase organizer 1,[H][C@@]12CCC3=CC(C(C)C)=C(C=C3[C@@]1(C)CCC[C@@]2(C)C(O)=O)S(O)(=O)=O
Ecabet,Urease subunit alpha,[H][C@@]12CCC3=CC(C(C)C)=C(C=C3[C@@]1(C)CCC[C@@]2(C)C(O)=O)S(O)(=O)=O
Ecallantide,Plasma kallikrein,
Echothiophate,Cholinesterase,CCOP(=O)(OCC)SCC[N+](C)(C)C
Econazole,Lanosterol 14-alpha demethylase,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Econazole,Nuclear receptor subfamily 1 group I member 2,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Eculizumab,Complement C5,
Edonerpic,Amyloid beta A4 protein,OC1CN(CCCOCCC2=CC3=C(SC=C3)C=C2)C1
Edotecarin,DNA topoisomerase 1,OCC(CO)NN1C(=O)C2=C3C(NC4=C3C=CC(O)=C4)=C3N([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C4=C(C=CC(O)=C4)C3=C2C1=O
Edoxaban,Coagulation factor X,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=NC=C(Cl)C=C2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1
Edoxudine,DNA polymerase,CCC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
Edrophonium,Acetylcholinesterase,CC[N+](C)(C)C1=CC(O)=CC=C1
Edrophonium,Cholinesterase,CC[N+](C)(C)C1=CC(O)=CC=C1
Efalizumab,Integrin alpha-L,
Efalizumab,High affinity immunoglobulin gamma Fc receptor I,
Efalizumab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Efalizumab,Complement C1r subcomponent,
Efalizumab,Complement C1q subcomponent subunit A,
Efalizumab,Complement C1q subcomponent subunit B,
Efalizumab,Complement C1q subcomponent subunit C,
Efalizumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Efalizumab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Efalizumab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Efalizumab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Efaproxiral,Hemoglobin subunit alpha,CC1=CC(NC(=O)CC2=CC=C(OC(C)(C)C(O)=O)C=C2)=CC(C)=C1
Efaproxiral,Hemoglobin subunit beta,CC1=CC(NC(=O)CC2=CC=C(OC(C)(C)C(O)=O)C=C2)=CC(C)=C1
Efavirenz,Reverse transcriptase/RNaseH,FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1
Efinaconazole,Lanosterol 14-alpha demethylase,C[C@@H](N1CCC(=C)CC1)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1
Eflornithine,Ornithine decarboxylase,NCCCC(N)(C(F)F)C(O)=O
Efmoroctocog alfa,von Willebrand factor,
Efonidipine,Voltage-dependent T-type calcium channel subunit alpha-1I,CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1
Efonidipine,Voltage-dependent L-type calcium channel subunit alpha-1C,CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1
Egaptivon pegol,Platelet glycoprotein Ib alpha chain,
Egaptivon pegol,von Willebrand factor,
Elacestrant,Estrogen receptor,CCNCCC1=CC=C(CN(CC)C2=C(C=CC(OC)=C2)[C@@H]2CCC3=CC(O)=CC=C3C2)C=C1
Elacridar,Multidrug resistance protein 1,COC1=CC=CC2=C1NC1=C(C=CC=C1C(=O)NC1=CC=C(CCN3CCC4=CC(OC)=C(OC)C=C4C3)C=C1)C2=O
Elacytarabine,Deoxycytidine kinase,[H]\C(CCCCCCCC)=C(\[H])CCCCCCCC(=O)OC[C@@]1([H])O[C@@]([H])(N2C=CC(=N)N=C2O)[C@@]([H])(O)[C@]1([H])O
Elafibranor,Peroxisome proliferator-activated receptor alpha,CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1
Elafibranor,Peroxisome proliferator-activated receptor gamma,CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1
Elafibranor,Peroxisome proliferator-activated receptor delta,CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1
Elafin,Neutrophil elastase,
Elafin,Myeloblastin,
Elagolix,Gonadotropin-releasing hormone receptor,COC1=C(F)C(=CC=C1)C1=C(C)N(CC2=C(C=CC=C2F)C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C2=CC=CC=C2)C1=O
Elaidoylamide,"Phospholipase A2, membrane associated",CCCCCCCC\C=C\CCCCCCCC(N)=O
Eldecalcitol,Vitamin D3 receptor,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)[C@@H](OCCCO)[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
Eldelumab,C-X-C motif chemokine 10,
Eletriptan,5-hydroxytryptamine receptor 1D,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
Eletriptan,5-hydroxytryptamine receptor 1B,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
Eletriptan,5-hydroxytryptamine receptor 1F,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
Eletriptan,5-hydroxytryptamine receptor 1A,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
Eletriptan,5-hydroxytryptamine receptor 1E,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
Eletriptan,5-hydroxytryptamine receptor 2B,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
Eletriptan,5-hydroxytryptamine receptor 7,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
Eliglustat,Ceramide glucosyltransferase,[H][C@](CN1CCCC1)(N=C(O)CCCCCCC)[C@]([H])(O)C1=CC2=C(OCCO2)C=C1
Elinogrel,P2Y purinoceptor 12,CNC1=C(F)C=C2C(NC(=O)N(C2=O)C2=CC=C(NC(=O)NS(=O)(=O)C3=CC=C(Cl)S3)C=C2)=C1
Ellagic Acid,Carbonic anhydrase 1,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Carbonic anhydrase 2,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Carbonic anhydrase 3,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Carbonic anhydrase 4,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,"Carbonic anhydrase 5A, mitochondrial",OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,"Carbonic anhydrase 5B, mitochondrial",OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Carbonic anhydrase 6,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Carbonic anhydrase 7,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Carbonic anhydrase 9,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Carbonic anhydrase 12,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Carbonic anhydrase 14,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Casein kinase II subunit alpha,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,cAMP-dependent protein kinase catalytic subunit alpha,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Protein kinase C alpha type,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Protein kinase C beta type,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Tyrosine-protein kinase SYK,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Ellagic Acid,Squalene monooxygenase,OC1=C(O)C2=C3C(=C1)C(=O)OC1=C3C(=CC(O)=C1O)C(=O)O2
Elocalcitol,Vitamin D3 receptor,CCC(O)(CC)\C=C\C[C@H](C)C1=CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@@](F)([H])C1=C
Elotuzumab,SLAM family member 7,
Elsamitrucin,DNA topoisomerase 2-alpha,CO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](OC3=CC=CC4=C3C3=C5C(C(=O)OC6=C5C(=C(C)C=C6)C(=O)O3)=C4O)O[C@H](C)[C@H](O)[C@]2(C)O)O[C@H](C)[C@@H]1O
Elsamitrucin,DNA topoisomerase 1,CO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](OC3=CC=CC4=C3C3=C5C(C(=O)OC6=C5C(=C(C)C=C6)C(=O)O3)=C4O)O[C@H](C)[C@H](O)[C@]2(C)O)O[C@H](C)[C@@H]1O
Eltrombopag,Thrombopoietin receptor,CC1=NN(C(=O)\C1=N/NC1=C(O)C(=CC=C1)C1=CC=CC(=C1)C(O)=O)C1=CC=C(C)C(C)=C1
Eluxadoline,Mu-type opioid receptor,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O
Eluxadoline,Delta-type opioid receptor,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O
Eluxadoline,Kappa-type opioid receptor,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O
Elvitegravir,Integrase,[H][C@@](CO)(C(C)C)N1C=C(C(O)=O)C(=O)C2=C1C=C(OC)C(CC1=C(F)C(Cl)=CC=C1)=C2
Emapalumab,Interferon gamma,
Emedastine,Histamine H1 receptor,CCOCCN1C(=NC2=CC=CC=C12)N1CCCN(C)CC1
Emicizumab,Coagulation factor IX,
Emicizumab,Coagulation factor X,
Emivirine,Gag-Pol polyprotein,CCOCN1C(=O)NC(=O)C(C(C)C)=C1CC1=CC=CC=C1
Emodin,Casein kinase II subunit alpha,CC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1
Emodin,Putative ketoacyl reductase,CC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1
Emodin,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,CC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1
Emodin,Aryl hydrocarbon receptor,CC1=CC(O)=C2C(=O)C3=C(C=C(O)C=C3O)C(=O)C2=C1
Emopamil,Multidrug resistance protein 1,CC(C)C(CCCN(C)CCC1=CC=CC=C1)(C#N)C1=CC=CC=C1
Empagliflozin,Sodium/glucose cotransporter 2,[H][C@@]1(CCOC1)OC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)C=C1
Emricasan,Caspase-1,C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC1=C(F)C(F)=CC(F)=C1F
Emricasan,Caspase-3,C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC1=C(F)C(F)=CC(F)=C1F
Emricasan,Caspase-7,C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC1=C(F)C(F)=CC(F)=C1F
Emtricitabine,Reverse transcriptase/RNaseH,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1
Enalapril,Angiotensin-converting enzyme,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O
Enalaprilat,Angiotensin-converting enzyme,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O
Enalaprilat,B1 bradykinin receptor,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O
Enalkiren,Renin,COC1=CC=C(C[C@H](NC(=O)CC(C)(C)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)[C@@H](O)CC(C)C)C=C1
Enasidenib,"Isocitrate dehydrogenase [NADP], mitochondrial",CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F
Encainide,Sodium channel protein type 5 subunit alpha,COC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1C
Encenicline,Neuronal acetylcholine receptor subunit alpha-7,ClC1=C2SC(=CC2=CC=C1)C(=O)N[C@H]1CN2CCC1CC2
Encorafenib,Serine/threonine-protein kinase B-raf,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C
Encorafenib,G1/S-specific cyclin-D1,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C
Endostatin,Matrix metalloproteinase-9,
Endostatin,72 kDa type IV collagenase,
Endostatin,Collagenase 3,
Endostatin,E-selectin,
Endostatin,Focal adhesion kinase 1,
Enflurane,Gamma-aminobutyric acid receptor subunit alpha-1,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit alpha-2,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit alpha-3,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit alpha-4,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit alpha-5,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit alpha-6,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit beta-1,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit beta-2,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit beta-3,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit delta,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit epsilon,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit gamma-1,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit gamma-2,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit gamma-3,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit pi,FC(F)OC(F)(F)C(F)Cl
Enflurane,Gamma-aminobutyric acid receptor subunit theta,FC(F)OC(F)(F)C(F)Cl
Enflurane,Glycine receptor subunit alpha-1,FC(F)OC(F)(F)C(F)Cl
Enflurane,Glycine receptor subunit beta,FC(F)OC(F)(F)C(F)Cl
Enflurane,Intermediate conductance calcium-activated potassium channel protein 4,FC(F)OC(F)(F)C(F)Cl
Enflurane,Potassium voltage-gated channel subfamily A member 1,FC(F)OC(F)(F)C(F)Cl
Enflurane,Calcium-transporting ATPase type 2C member 1,FC(F)OC(F)(F)C(F)Cl
Enflurane,"ATP synthase subunit delta, mitochondrial",FC(F)OC(F)(F)C(F)Cl
Enflurane,Glutamate receptor 1,FC(F)OC(F)(F)C(F)Cl
Enfuvirtide,Envelope glycoprotein,
Eniluracil,Dihydropyrimidine dehydrogenase [NADP(+)],O=C1NC=C(C#C)C(=O)N1
Eniluracil,Aldehyde oxidase,O=C1NC=C(C#C)C(=O)N1
Eniluracil,Xanthine dehydrogenase/oxidase,O=C1NC=C(C#C)C(=O)N1
Enoxacin,DNA gyrase subunit A,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1
Enoxacin,DNA topoisomerase 4 subunit A,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1
Enoxacin,DNA topoisomerase 2-alpha,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N=C12)N1CCNCC1
Enoxaparin,Antithrombin-III,
Enoxaparin,Coagulation factor X,
Enoximone,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",CSC1=CC=C(C=C1)C(=O)C1=C(C)NC(=O)N1
Enprofylline,Adenosine receptor A2b,CCCN1C2=C(NC=N2)C(=O)NC1=O
Enprofylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CCCN1C2=C(NC=N2)C(=O)NC1=O
Enprofylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CCCN1C2=C(NC=N2)C(=O)NC1=O
Enprofylline,Adenosine receptor A1,CCCN1C2=C(NC=N2)C(=O)NC1=O
Enprofylline,Adenosine receptor A2a,CCCN1C2=C(NC=N2)C(=O)NC1=O
Enprofylline,Adenosine receptor A3,CCCN1C2=C(NC=N2)C(=O)NC1=O
Enrasentan,Endothelin-1 receptor,CCCOC1=CC=C2[C@@H]([C@H]([C@@H](C2=C1)C1=CC=C(OC)C=C1OCCO)C(O)=O)C1=CC=C2OCOC2=C1
Enrasentan,Endothelin B receptor,CCCOC1=CC=C2[C@@H]([C@H]([C@@H](C2=C1)C1=CC=C(OC)C=C1OCCO)C(O)=O)C1=CC=C2OCOC2=C1
Entacapone,Catechol O-methyltransferase,CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N
Enzacamene,Progesterone receptor,CC1=CC=C(\C=C2/C3CCC(C)(C2=O)C3(C)C)C=C1
Enzacamene,Androgen receptor,CC1=CC=C(\C=C2/C3CCC(C)(C2=O)C3(C)C)C=C1
Enzacamene,Estrogen receptor beta,CC1=CC=C(\C=C2/C3CCC(C)(C2=O)C3(C)C)C=C1
Enzacamene,Estrogen receptor,CC1=CC=C(\C=C2/C3CCC(C)(C2=O)C3(C)C)C=C1
Enzalutamide,Androgen receptor,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F
Enzastaurin,RAC-alpha serine/threonine-protein kinase,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Enzastaurin,Cyclin-dependent kinase 15,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Enzastaurin,Protein kinase C beta type,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Enzastaurin,Phosphatidylinositol 3-kinase regulatory subunit alpha,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Enzastaurin,Aurora kinase A,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Enzastaurin,Serine/threonine-protein kinase Chk2,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Enzastaurin,Serine/threonine-protein kinase Chk1,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Enzastaurin,Aurora kinase B,CN1C=C(C2=CC=CC=C12)C1=C(C(=O)NC1=O)C1=CN(C2CCN(CC3=CC=CC=N3)CC2)C2=CC=CC=C12
Ephedra sinica root,Sodium-dependent dopamine transporter,
Ephedra sinica root,Sodium-dependent noradrenaline transporter,
Ephedra sinica root,Alpha-2A adrenergic receptor,
Ephedra sinica root,Alpha-2B adrenergic receptor,
Ephedra sinica root,Alpha-2C adrenergic receptor,
Ephedra sinica root,Amine oxidase [flavin-containing] A,
Ephedra sinica root,Amine oxidase [flavin-containing] B,
Ephedra sinica root,Beta-1 adrenergic receptor,
Ephedra sinica root,Beta-2 adrenergic receptor,
Ephedra sinica root,Beta-3 adrenergic receptor,
Ephedra sinica root,Sodium-dependent serotonin transporter,
Ephedra sinica root,Synaptic vesicular amine transporter,
Ephedra sinica root,Chromaffin granule amine transporter,
Ephedrine,Sodium-dependent noradrenaline transporter,CN[C@@H](C)[C@H](O)C1=CC=CC=C1
Ephedrine,Alpha-1A adrenergic receptor,CN[C@@H](C)[C@H](O)C1=CC=CC=C1
Ephedrine,Synaptic vesicular amine transporter,CN[C@@H](C)[C@H](O)C1=CC=CC=C1
Ephedrine,Acetylcholinesterase,CN[C@@H](C)[C@H](O)C1=CC=CC=C1
Epibatidine,CHRNA7-FAM7A fusion protein,[H][C@@]12CC[C@@]([H])(N1)[C@]([H])(C2)C1=CC=C(Cl)N=C1
Epibatidine,Neuronal acetylcholine receptor subunit alpha-7,[H][C@@]12CC[C@@]([H])(N1)[C@]([H])(C2)C1=CC=C(Cl)N=C1
Epibatidine,Neuronal acetylcholine receptor subunit beta-2,[H][C@@]12CC[C@@]([H])(N1)[C@]([H])(C2)C1=CC=C(Cl)N=C1
Epibatidine,Neuronal acetylcholine receptor subunit alpha-2,[H][C@@]12CC[C@@]([H])(N1)[C@]([H])(C2)C1=CC=C(Cl)N=C1
Epibatidine,Neuronal acetylcholine receptor subunit alpha-3,[H][C@@]12CC[C@@]([H])(N1)[C@]([H])(C2)C1=CC=C(Cl)N=C1
Epibatidine,Neuronal acetylcholine receptor subunit alpha-4,[H][C@@]12CC[C@@]([H])(N1)[C@]([H])(C2)C1=CC=C(Cl)N=C1
Epibatidine,Neuronal acetylcholine receptor subunit beta-4,[H][C@@]12CC[C@@]([H])(N1)[C@]([H])(C2)C1=CC=C(Cl)N=C1
Epicept NP-1,Alpha-2A adrenergic receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,Alpha-2C adrenergic receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,5-hydroxytryptamine receptor 2B,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,Histamine H1 receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,5-hydroxytryptamine receptor 2A,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,Alpha-1A adrenergic receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,5-hydroxytryptamine receptor 2C,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,Alpha-2B adrenergic receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,Alpha-1B adrenergic receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,Alpha-1D adrenergic receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,Mu-type opioid receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicept NP-1,Nociceptin receptor,CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O
Epicriptine,D(1A) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])([C@H](C)CC)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Epicriptine,D(1B) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])([C@H](C)CC)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Epicriptine,D(2) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])([C@H](C)CC)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Epicriptine,D(3) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])([C@H](C)CC)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Epicriptine,D(4) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@]([H])([C@H](C)CC)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
Epigallocatechin gallate,Aryl hydrocarbon receptor,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1
Epigallocatechin gallate,DNA (cytosine-5)-methyltransferase 1,OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1
Epigallocatechin gallate,"Dihydrofolate reductase, mitochondrial",OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C1=CC(O)=C(O)C(O)=C1
Epinastine,Histamine H1 receptor,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21
Epinastine,Histamine H2 receptor,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21
Epinastine,Alpha-1A adrenergic receptor,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21
Epinastine,Alpha-2A adrenergic receptor,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21
Epinastine,5-hydroxytryptamine receptor 2A,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21
Epinastine,5-hydroxytryptamine receptor 7,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21
Epinephrine,Alpha-1A adrenergic receptor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
Epinephrine,Alpha-1B adrenergic receptor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
Epinephrine,Beta-1 adrenergic receptor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
Epinephrine,Alpha-2A adrenergic receptor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
Epinephrine,Beta-2 adrenergic receptor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
Epinephrine,Alpha-2B adrenergic receptor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
Epinephrine,Alpha-1D adrenergic receptor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
Epinephrine,Tumor necrosis factor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
Epirubicin,Chromodomain-helicase-DNA-binding protein 1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O
Epirubicin,DNA topoisomerase 2-alpha,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O
Epitestosterone,Aldo-keto reductase family 1 member C1,[H][C@@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
Epitestosterone,Aldo-keto reductase family 1 member C2,[H][C@@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
Eplerenone,Mineralocorticoid receptor,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC
Eplivanserin,5-hydroxytryptamine receptor 2A,CN(C)CCO\N=C(\C=C\C1=CC=C(O)C=C1)/C1=CC=CC=C1F
Eplivanserin,5-hydroxytryptamine receptor 2C,CN(C)CCO\N=C(\C=C\C1=CC=C(O)C=C1)/C1=CC=CC=C1F
Epoprostenol,P2Y purinoceptor 12,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O
Epoprostenol,Prostacyclin receptor,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O
Epoprostenol,Prostacyclin synthase,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O
Epothilone D,Tubulin beta-1 chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin beta chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin alpha-1B chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin alpha-1A chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin alpha-8 chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin beta-4B chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin alpha-1C chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin alpha-4A chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin beta-4A chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin beta-3 chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epothilone D,Tubulin alpha-3C/D chain,[H]\C(=C(\C)[C@]1([H])C\C([H])=C(C)/CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Epratuzumab,B-cell receptor CD22,
Eprosartan,Type-1 angiotensin II receptor,CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O
Eprotirome,Thyroid hormone receptor beta,CC(C)C1=CC(OC2=C(Br)C=C(NC(=O)CC(O)=O)C=C2Br)=CC=C1O
Eprotirome,Thyroid hormone receptor alpha,CC(C)C1=CC(OC2=C(Br)C=C(NC(=O)CC(O)=O)C=C2Br)=CC=C1O
Eptifibatide,Integrin beta-3,
Eptinezumab,Calcitonin gene-related peptide 1,
Eptinezumab,Calcitonin gene-related peptide 2,
Equilenin,Steroid Delta-isomerase,[H][C@@]12CCC(=O)[C@@]1(C)CCC1=C2C=CC2=C1C=CC(O)=C2
Equilenin,Steroid Delta-isomerase,[H][C@@]12CCC(=O)[C@@]1(C)CCC1=C2C=CC2=C1C=CC(O)=C2
Equilin,Estradiol 17-beta-dehydrogenase 1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC=C21)C=C(O)C=C3
Equilin,Estrogen receptor,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC=C21)C=C(O)C=C3
Equine Botulinum Neurotoxin A Immune FAB2,Botulinum neurotoxin type A,
Equine Botulinum Neurotoxin B Immune FAB2,Botulinum neurotoxin type B,
Equine Botulinum Neurotoxin C Immune FAB2,Botulinum neurotoxin type C1,
Equine Botulinum Neurotoxin D Immune FAB2,Botulinum neurotoxin type D,
Equine Botulinum Neurotoxin E Immune FAB2,Botulinum neurotoxin type E,
Equine Botulinum Neurotoxin F Immune FAB2,Botulinum neurotoxin type F,
Equine Botulinum Neurotoxin G Immune FAB2,Botulinum neurotoxin type G,
Equol,Estrogen receptor beta,OC1=CC=C(C=C1)[C@H]1COC2=C(C1)C=CC(O)=C2
Equol,Sex hormone-binding globulin,OC1=CC=C(C=C1)[C@H]1COC2=C(C1)C=CC(O)=C2
Eravacycline,30S ribosomal protein S4,[H][C@@]12CC3=C(C(O)=C(NC(=O)CN4CCCC4)C=C3F)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@]([H])(N(C)C)[C@]1([H])C2
Erdafitinib,Fibroblast growth factor receptor 1,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,Fibroblast growth factor receptor 2,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,Fibroblast growth factor receptor 3,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,Fibroblast growth factor receptor 4,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,RET proto-oncogene,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,Macrophage colony-stimulating factor 1 receptor,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,Platelet-derived growth factor receptor alpha,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,Platelet-derived growth factor receptor beta,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,Mast/stem cell growth factor receptor Kit,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erdafitinib,Vascular endothelial growth factor receptor 2,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Erenumab,Calcitonin gene-related peptide type 1 receptor,
Ergocalciferol,Vitamin D3 receptor,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent calcium channel gamma-1 subunit,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent calcium channel subunit alpha-2/delta-1,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent calcium channel subunit alpha-2/delta-2,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent calcium channel subunit alpha-2/delta-3,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent L-type calcium channel subunit alpha-1C,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent L-type calcium channel subunit alpha-1D,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent L-type calcium channel subunit alpha-1F,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent L-type calcium channel subunit alpha-1S,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent L-type calcium channel subunit beta-1,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent L-type calcium channel subunit beta-2,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent L-type calcium channel subunit beta-3,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent L-type calcium channel subunit beta-4,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent N-type calcium channel subunit alpha-1B,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent T-type calcium channel subunit alpha-1G,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent T-type calcium channel subunit alpha-1H,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergocalciferol,Voltage-dependent T-type calcium channel subunit alpha-1I,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Ergoloid mesylate,D(1A) dopamine receptor,
Ergoloid mesylate,D(1B) dopamine receptor,
Ergoloid mesylate,D(2) dopamine receptor,
Ergoloid mesylate,D(3) dopamine receptor,
Ergoloid mesylate,D(4) dopamine receptor,
Ergoloid mesylate,Alpha-1A adrenergic receptor,
Ergoloid mesylate,Alpha-1B adrenergic receptor,
Ergoloid mesylate,Alpha-1D adrenergic receptor,
Ergoloid mesylate,Alpha-2A adrenergic receptor,
Ergoloid mesylate,Alpha-2B adrenergic receptor,
Ergoloid mesylate,Alpha-2C adrenergic receptor,
Ergoloid mesylate,Beta-1 adrenergic receptor,
Ergoloid mesylate,Beta-2 adrenergic receptor,
Ergoloid mesylate,Beta-3 adrenergic receptor,
Ergoloid mesylate,5-hydroxytryptamine receptor 1A,
Ergoloid mesylate,5-hydroxytryptamine receptor 1B,
Ergoloid mesylate,5-hydroxytryptamine receptor 1D,
Ergoloid mesylate,5-hydroxytryptamine receptor 1E,
Ergoloid mesylate,5-hydroxytryptamine receptor 1F,
Ergoloid mesylate,5-hydroxytryptamine receptor 2A,
Ergoloid mesylate,5-hydroxytryptamine receptor 2B,
Ergoloid mesylate,5-hydroxytryptamine receptor 2C,
Ergoloid mesylate,5-hydroxytryptamine receptor 3A,
Ergoloid mesylate,5-hydroxytryptamine receptor 3B,
Ergoloid mesylate,5-hydroxytryptamine receptor 3C,
Ergoloid mesylate,5-hydroxytryptamine receptor 3D,
Ergoloid mesylate,5-hydroxytryptamine receptor 3E,
Ergoloid mesylate,5-hydroxytryptamine receptor 4,
Ergoloid mesylate,5-hydroxytryptamine receptor 6,
Ergoloid mesylate,5-hydroxytryptamine receptor 7,
Ergometrine,Alpha-1A adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](C)CO
Ergotamine,5-hydroxytryptamine receptor 1D,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,5-hydroxytryptamine receptor 1B,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,5-hydroxytryptamine receptor 2A,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,D(2) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,Alpha-1A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,Alpha-1B adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,Alpha-1D adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,Alpha-2A adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,Alpha-2B adrenergic receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,Sodium-dependent noradrenaline transporter,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,D(1A) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,D(1B) dopamine receptor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,5-hydroxytryptamine receptor 1A,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,5-hydroxytryptamine receptor 1F,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,5-hydroxytryptamine receptor 2C,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Ergotamine,5-hydroxytryptamine receptor 2B,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Eribaxaban,Coagulation factor X,[H][C@@]1(CN(C(=O)NC2=CC=C(Cl)C=C2)[C@]([H])(C1)C(=O)NC1=CC=C(C=C1F)N1C=CC=CC1=O)OC
Eribulin,Tubulin beta-1 chain,[H][C@@]12O[C@@]3([H])CCC4CC(=O)C[C@H]5[C@H](C[C@H]6O[C@H](C[C@@H](C)C6=C)CC[C@@H]6O[C@H](CC6=C)CC[C@@]67C[C@@H](O[C@H]1[C@@H](O6)[C@@]3([H])O4)[C@@H]2O7)O[C@H](C[C@H](O)CN)[C@@H]5OC
Eribulin,Apoptosis regulator Bcl-2,[H][C@@]12O[C@@]3([H])CCC4CC(=O)C[C@H]5[C@H](C[C@H]6O[C@H](C[C@@H](C)C6=C)CC[C@@H]6O[C@H](CC6=C)CC[C@@]67C[C@@H](O[C@H]1[C@@H](O6)[C@@]3([H])O4)[C@@H]2O7)O[C@H](C[C@H](O)CN)[C@@H]5OC
Eritoran,Toll-like receptor 4,[H]\C(CCCCCC)=C(/[H])CCCCCCCCCC(O)=N[C@@]1([H])[C@]([H])(OC[C@@]2([H])O[C@]([H])(OP(O)(O)=O)[C@]([H])(N=C(O)CC(=O)CCCCCCCCCCC)[C@@]([H])(OCCCCCCCCCC)[C@]2([H])O)O[C@]([H])(COC)[C@@]([H])(OP(O)(O)=O)[C@]1([H])OCC[C@@]([H])(CCCCCCC)OC
Erlotinib,Epidermal growth factor receptor,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
Erlotinib,Nuclear receptor subfamily 1 group I member 2,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
Ertapenem,Penicillin-binding protein 2,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Ertapenem,Penicillin-binding protein 2,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Ertapenem,Peptidoglycan synthase FtsI,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Ertapenem,Peptidoglycan synthase FtsI,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Ertapenem,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Ertapenem,Penicillin-binding protein 1A,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Ertapenem,Penicillin-binding protein 1B,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Ertapenem,D-alanyl-D-alanine carboxypeptidase DacC,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Erteberel,Estrogen receptor beta,[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1)C1=CC=C(O)C=C1
Erteberel,Estrogen receptor,[H][C@@]12CCC[C@]1([H])[C@@]([H])(OC1=C2C=C(O)C=C1)C1=CC=C(O)C=C1
Ertiprotafib,Peroxisome proliferator-activated receptor alpha,CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1
Ertiprotafib,Peroxisome proliferator-activated receptor gamma,CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1
Ertiprotafib,Tyrosine-protein phosphatase non-receptor type 1,CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1
Ertiprotafib,Inhibitor of nuclear factor kappa-B kinase subunit beta,CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1
Ertugliflozin,Sodium/glucose cotransporter 2,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1
Erythose-4-Phosphate,Glucose-6-phosphate isomerase,O[C@H](COP(O)(O)=O)[C@@H](O)C=O
Erythose-4-Phosphate,2-dehydro-3-deoxyphosphooctonate aldolase,O[C@H](COP(O)(O)=O)[C@@H](O)C=O
Erythose-4-Phosphate,Phospho-2-dehydro-3-deoxyheptonate aldolase,O[C@H](COP(O)(O)=O)[C@@H](O)C=O
Erythrityl tetranitrate,Atrial natriuretic peptide receptor 1,[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@H](CO[N+]([O-])=O)O[N+]([O-])=O
Erythrityl tetranitrate,Atrial natriuretic peptide receptor 2,[O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@H](CO[N+]([O-])=O)O[N+]([O-])=O
Erythromycin,Potassium voltage-gated channel subfamily H member 2,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
Erythromycin,Motilin receptor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
Erythropoietin,Erythropoietin receptor,
Escitalopram,Sodium-dependent serotonin transporter,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
Escitalopram,Sodium-dependent dopamine transporter,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
Escitalopram,Sodium-dependent noradrenaline transporter,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
Escitalopram,Alpha-1A adrenergic receptor,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
Escitalopram,Muscarinic acetylcholine receptor M1,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
Escitalopram,Histamine H1 receptor,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
Esculin,Androgen receptor,OC[C@H]1O[C@@H](OC2=C(O)C=C3OC(=O)C=CC3=C2)[C@H](O)[C@@H](O)[C@@H]1O
Esketamine,"Glutamate receptor ionotropic, NMDA 1",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,"Glutamate receptor ionotropic, NMDA 2A",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,"Glutamate receptor ionotropic, NMDA 2B",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,"Glutamate receptor ionotropic, NMDA 2C",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,"Glutamate receptor ionotropic, NMDA 2D",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,"Glutamate receptor ionotropic, NMDA 3A",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,"Glutamate receptor ionotropic, NMDA 3B",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,"Glutamate receptor ionotropic, NMDA 2B",CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,Elongation factor 2,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,Brain-derived neurotrophic factor,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Esketamine,BDNF/NT-3 growth factors receptor,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Eslicarbazepine,P2X purinoceptor 4,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2
Eslicarbazepine acetate,P2X purinoceptor 4,CC(=O)O[C@H]1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C12
Esmirtazapine,Histamine H1 receptor,[H][C@]12CN(C)CCN1C1=C(CC3=CC=CC=C23)C=CC=N1
Esmirtazapine,5-hydroxytryptamine receptor 2A,[H][C@]12CN(C)CCN1C1=C(CC3=CC=CC=C23)C=CC=N1
Esmirtazapine,5-hydroxytryptamine receptor 2B,[H][C@]12CN(C)CCN1C1=C(CC3=CC=CC=C23)C=CC=N1
Esmirtazapine,5-hydroxytryptamine receptor 2C,[H][C@]12CN(C)CCN1C1=C(CC3=CC=CC=C23)C=CC=N1
Esmirtazapine,Alpha-2A adrenergic receptor,[H][C@]12CN(C)CCN1C1=C(CC3=CC=CC=C23)C=CC=N1
Esmirtazapine,Alpha-2B adrenergic receptor,[H][C@]12CN(C)CCN1C1=C(CC3=CC=CC=C23)C=CC=N1
Esmirtazapine,Alpha-2C adrenergic receptor,[H][C@]12CN(C)CCN1C1=C(CC3=CC=CC=C23)C=CC=N1
Esmolol,Beta-1 adrenergic receptor,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1
Esomeprazole,Potassium-transporting ATPase alpha chain 1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1
Esomeprazole,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-1,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-2,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-3,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-5,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit gamma-1,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit gamma-2,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit gamma-3,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit beta-1,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit beta-2,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit beta-3,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit delta,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit epsilon,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit pi,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit rho-1,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit rho-2,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit rho-3,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-1,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-2,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-3,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-4,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-5,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit alpha-6,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit beta-1,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit beta-2,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit beta-3,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit delta,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit epsilon,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit gamma-1,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit gamma-2,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit gamma-3,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit pi,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estazolam,Gamma-aminobutyric acid receptor subunit theta,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1
Estradiol,Estrogen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,Estrogen receptor beta,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,Neuronal acetylcholine receptor subunit alpha-4,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,Nuclear receptor coactivator 2,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,G-protein coupled estrogen receptor 1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,ATP synthase subunit a,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,Beclin-1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,Estradiol 17-beta-dehydrogenase 2,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol,Estrogen-related receptor gamma,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol acetate,Estrogen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,Estrogen receptor beta,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,Neuronal acetylcholine receptor subunit alpha-4,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,Nuclear receptor coactivator 2,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,G-protein coupled estrogen receptor 1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,ATP synthase subunit a,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,Beclin-1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,Estradiol 17-beta-dehydrogenase 2,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol acetate,Estrogen-related receptor gamma,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]
Estradiol benzoate,Estrogen receptor,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,Nuclear receptor subfamily 1 group I member 2,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,Estrogen receptor beta,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,Neuronal acetylcholine receptor subunit alpha-4,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,Nuclear receptor coactivator 2,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,G-protein coupled estrogen receptor 1,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,ATP synthase subunit a,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,Beclin-1,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,Estradiol 17-beta-dehydrogenase 2,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol benzoate,Estrogen-related receptor gamma,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C
Estradiol cypionate,Estrogen receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,Nuclear receptor subfamily 1 group I member 2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,Estrogen receptor beta,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,Neuronal acetylcholine receptor subunit alpha-4,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,Nuclear receptor coactivator 2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,G-protein coupled estrogen receptor 1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,ATP synthase subunit a,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,Beclin-1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,Estradiol 17-beta-dehydrogenase 2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol cypionate,Estrogen-related receptor gamma,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1
Estradiol dienanthate,Estrogen receptor,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,Nuclear receptor subfamily 1 group I member 2,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,Estrogen receptor beta,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,Neuronal acetylcholine receptor subunit alpha-4,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,Nuclear receptor coactivator 2,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,G-protein coupled estrogen receptor 1,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,ATP synthase subunit a,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,Beclin-1,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,Estradiol 17-beta-dehydrogenase 2,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol dienanthate,Estrogen-related receptor gamma,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Estradiol valerate,Estrogen receptor,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,Estrogen receptor beta,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,Neuronal acetylcholine receptor subunit alpha-4,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,Nuclear receptor coactivator 2,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,G-protein coupled estrogen receptor 1,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,ATP synthase subunit a,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,Beclin-1,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,Estradiol 17-beta-dehydrogenase 2,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estradiol valerate,Estrogen-related receptor gamma,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estramustine,Estrogen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H]
Estramustine,Estrogen receptor beta,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H]
Estramustine,Microtubule-associated protein 2,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H]
Estramustine,Microtubule-associated protein 1A,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(=O)N(CCCl)CCCl)C=C3CC[C@@]21[H]
Estriol,Estrogen receptor,[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estriol,Estrogen receptor beta,[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estriol,Sex hormone-binding globulin,[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estriol tripropionate,Estrogen receptor,[H][C@]1(C[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)CC)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])OC(=O)CC)OC(=O)CC
Estriol tripropionate,Estrogen receptor beta,[H][C@]1(C[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)CC)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])OC(=O)CC)OC(=O)CC
Estriol tripropionate,Sex hormone-binding globulin,[H][C@]1(C[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)CC)=CC=C4[C@@]3([H])CC[C@]2(C)[C@@]1([H])OC(=O)CC)OC(=O)CC
Estrone,Estrogen receptor,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estrone,Estrogen receptor beta,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estrone,Androgen receptor,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estrone,Aromatase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estrone,Sex hormone-binding globulin,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Estrone sulfate,Estrogen receptor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(OS(O)(=O)=O)=C4)[C@@H]1CCC2=O
Estrone sulfate,Estrogen receptor beta,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(OS(O)(=O)=O)=C4)[C@@H]1CCC2=O
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-2,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-5,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-3,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-2,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-3,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-4,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-5,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit alpha-6,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit beta-1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit beta-2,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit beta-3,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit delta,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit epsilon,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit gamma-1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit gamma-2,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit gamma-3,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit pi,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Eszopiclone,Gamma-aminobutyric acid receptor subunit theta,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Etacrynic acid,Solute carrier family 12 member 1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
Etacrynic acid,Sodium/potassium-transporting ATPase subunit alpha-1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
Etacrynic acid,Lymphoid enhancer-binding factor 1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
Etacrynic acid,Glutathione S-transferase P,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1
Etafedrine,Beta-2 adrenergic receptor,CCN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1
Etanercept,Tumor necrosis factor,
Etanercept,Tumor necrosis factor receptor superfamily member 1B,
Etanercept,High affinity immunoglobulin gamma Fc receptor I,
Etanercept,Low affinity immunoglobulin gamma Fc region receptor III-A,
Etanercept,Low affinity immunoglobulin gamma Fc region receptor II-a,
Etanercept,Low affinity immunoglobulin gamma Fc region receptor II-b,
Etanercept,Low affinity immunoglobulin gamma Fc region receptor II-c,
Etanercept,Lymphotoxin-alpha,
Etanercept,Low affinity immunoglobulin gamma Fc region receptor III-B,
Etanercept,Complement C1s subcomponent,
Etanercept,Complement C1r subcomponent,
Etanercept,Complement C1q subcomponent subunit A,
Etanercept,Complement C1q subcomponent subunit B,
Etanercept,Complement C1q subcomponent subunit C,
Etelcalcetide,Extracellular calcium-sensing receptor,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O
Ethambutol,Probable arabinosyltransferase C,CC[C@@H](CO)NCCN[C@@H](CC)CO
Ethambutol,Probable arabinosyltransferase B,CC[C@@H](CO)NCCN[C@@H](CC)CO
Ethambutol,Probable arabinosyltransferase A,CC[C@@H](CO)NCCN[C@@H](CC)CO
Ethanesulfonic Acid,Platelet basic protein,CCS(O)(=O)=O
Ethanesulfonic Acid,Phosphonoacetaldehyde hydrolase,CCS(O)(=O)=O
Ethanol,Glycine receptor subunit alpha-1,CCO
Ethanol,"Glutamate receptor ionotropic, NMDA 3A",CCO
Ethanol,Glycine receptor subunit alpha-2,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit alpha-1,CCO
Ethanol,Voltage-dependent L-type calcium channel subunit beta-1,CCO
Ethanol,5-hydroxytryptamine receptor 3A,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit alpha-2,CCO
Ethanol,Neuronal acetylcholine receptor subunit alpha-10,CCO
Ethanol,Voltage-dependent L-type calcium channel subunit alpha-1C,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit alpha-5,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit alpha-4,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit alpha-3,CCO
Ethanol,Glutamate receptor 1,CCO
Ethanol,Voltage-dependent calcium channel gamma-1 subunit,CCO
Ethanol,Neuronal acetylcholine receptor subunit alpha-2,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit alpha-6,CCO
Ethanol,Glutamate receptor 2,CCO
Ethanol,Glutamate receptor 4,CCO
Ethanol,Glutamate receptor 3,CCO
Ethanol,Neuronal acetylcholine receptor subunit alpha-4,CCO
Ethanol,Neuronal acetylcholine receptor subunit beta-2,CCO
Ethanol,G protein-activated inward rectifier potassium channel 1,CCO
Ethanol,G protein-activated inward rectifier potassium channel 2,CCO
Ethanol,Vascular cell adhesion protein 1,CCO
Ethanol,Equilibrative nucleoside transporter 1,CCO
Ethanol,G protein-activated inward rectifier potassium channel 4,CCO
Ethanol,Neuronal acetylcholine receptor subunit alpha-7,CCO
Ethanol,Neuronal acetylcholine receptor subunit alpha-9,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit beta-1,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit beta-3,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit beta-2,CCO
Ethanol,Voltage-dependent L-type calcium channel subunit alpha-1S,CCO
Ethanol,Voltage-dependent L-type calcium channel subunit alpha-1D,CCO
Ethanol,Neuronal acetylcholine receptor subunit beta-4,CCO
Ethanol,Neuronal acetylcholine receptor subunit alpha-3,CCO
Ethanol,Neuronal acetylcholine receptor subunit alpha-5,CCO
Ethanol,Neuronal acetylcholine receptor subunit alpha-6,CCO
Ethanol,Neuronal acetylcholine receptor subunit beta-3,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit gamma-1,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit gamma-3,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit epsilon,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit pi,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit theta,CCO
Ethanol,Gamma-aminobutyric acid receptor subunit delta,CCO
Ethanol,Equilibrative nucleoside transporter 2,CCO
Ethanol,5-hydroxytryptamine receptor 3E,CCO
Ethanol,5-hydroxytryptamine receptor 3B,CCO
Ethanol,5-hydroxytryptamine receptor 3D,CCO
Ethanol,5-hydroxytryptamine receptor 3C,CCO
Ethanol,Voltage-dependent calcium channel gamma-2 subunit,CCO
Ethanol,G protein-activated inward rectifier potassium channel 3,CCO
Ethanol,Neural cell adhesion molecule L1,CCO
Ethanolamine,Surface protein A,NCCO
Ethanolamine,Annexin A3,NCCO
Ethanolamine oleate,Coagulation factor XII,NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit alpha-1,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit alpha-2,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit alpha-3,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit alpha-4,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit alpha-5,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit alpha-6,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit beta-1,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit beta-2,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit beta-3,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit delta,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit epsilon,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit gamma-1,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit gamma-2,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit gamma-3,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit pi,CCC(O)(\C=C\Cl)C#C
Ethchlorvynol,Gamma-aminobutyric acid receptor subunit theta,CCC(O)(\C=C\Cl)C#C
Etheno-Nad,L-lactate dehydrogenase A chain,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C2N=CN2C=CN=C32)[C@]([H])(O)[C@]1([H])O
Etheno-Nad,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C2N=CN2C=CN=C32)[C@]([H])(O)[C@]1([H])O
Etheno-Nadp,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,[H][C@@]1(O)O[C@]([H])(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C3N=CN3C=CN=C43)[C@]([H])(OP(O)(O)=O)[C@]2([H])O)[C@@]([H])(O)[C@@]1([H])O
Ethinamate,Carbonic anhydrase 1,NC(=O)OC1(CCCCC1)C#C
Ethinamate,Carbonic anhydrase 2,NC(=O)OC1(CCCCC1)C#C
Ethinylestradiol,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Ethinylestradiol,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Ethinylestradiol,Sex hormone-binding globulin,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
Ethionamide,Enoyl-[acyl-carrier-protein] reductase [NADH],CCC1=NC=CC(=C1)C(N)=S
Ethionamide,Catalase-peroxidase,CCC1=NC=CC(=C1)C(N)=S
Ethosuximide,Voltage-dependent T-type calcium channel subunit alpha-1G,CCC1(C)CC(=O)NC1=O
Ethotoin,Sodium channel protein type 5 subunit alpha,CCN1C(=O)NC(C1=O)C1=CC=CC=C1
Ethotoin,Nuclear receptor subfamily 1 group I member 2,CCN1C(=O)NC(C1=O)C1=CC=CC=C1
Ethoxzolamide,Carbonic anhydrase 1,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
Ethoxzolamide,Carbonic anhydrase 2,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
Ethoxzolamide,Carbonic anhydrase 4,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
Ethoxzolamide,Carbonic anhydrase 7,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
Ethoxzolamide,Carbonic anhydrase 3,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
Ethyl Dihydrogen Phosphate,Parathion hydrolase,CCOP(O)(O)=O
Ethyl Dihydrogen Phosphate,Cholinesterase,CCOP(O)(O)=O
Ethyl Isocyanide,Myoglobin,CC[N+]#C
Ethyl Oxo(Piperidin-1-Yl)Acetate,Peptidyl-prolyl cis-trans isomerase A,CCOC(=O)C(=O)N1CCCCC1
Ethyl pyruvate,Tumor necrosis factor,CCOC(=O)C(C)=O
Ethyl pyruvate,High mobility group protein B1,CCOC(=O)C(C)=O
Ethyl-Carbamic Acid Methyl Ester,Shiga-like toxin 1 subunit B,CCNC(=O)OC
Ethyl-Trimethyl-Silane,Tetanus toxin,CC[Si](C)(C)C
Ethylaminobenzylmethylcarbonyl Group,Candidapepsin-2,[H][C@@](CCCC)(N1CCN[C@]([H])(CC2=CC=CC=C2)C1=O)C(O)=O
Ethylene Dichloride,Haloalkane dehalogenase,ClCCCl
Ethylmercurithiosalicylic acid,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",CC[Hg]SC1=CC=CC=C1C(O)=O
Ethylmercurithiosalicylic acid,Sensor histidine kinase,CC[Hg]SC1=CC=CC=C1C(O)=O
Ethylmorphine,Mu-type opioid receptor,[H][C@@]12OC3=C(OCC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
Ethynodiol diacetate,Progesterone receptor,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H]
Ethynodiol diacetate,Estrogen receptor,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H]
Etidronic acid,Receptor-type tyrosine-protein phosphatase S,CC(O)(P(O)(O)=O)P(O)(O)=O
Etidronic acid,V-type proton ATPase catalytic subunit A,CC(O)(P(O)(O)=O)P(O)(O)=O
Etiprednol dicloacetate,Interleukin-1 beta,[H][C@@]12CC[C@](OC(=O)C(Cl)Cl)(C(=O)OCC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Etizolam,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl
Etizolam,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl
Etizolam,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl
Etizolam,Gamma-aminobutyric acid receptor subunit gamma-2,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl
Etizolam,Platelet-activating factor receptor,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl
Etodolac,Prostaglandin G/H synthase 2,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1
Etodolac,Prostaglandin G/H synthase 1,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1
Etodolac,Retinoic acid receptor RXR-alpha,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit alpha-1,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Alpha-2B adrenergic receptor,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit alpha-1,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit alpha-2,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit alpha-3,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit alpha-4,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit alpha-5,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit alpha-6,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit beta-1,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit beta-2,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit beta-3,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit delta,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit epsilon,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit gamma-1,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit gamma-2,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit gamma-3,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit pi,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etomidate,Gamma-aminobutyric acid receptor subunit theta,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1
Etonogestrel,Progesterone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Etonogestrel,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Etoperidone,Alpha-1A adrenergic receptor,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Alpha-1B adrenergic receptor,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Alpha-1D adrenergic receptor,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Alpha-2A adrenergic receptor,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Alpha-2B adrenergic receptor,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Alpha-2C adrenergic receptor,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,D(2) dopamine receptor,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Muscarinic acetylcholine receptor M1,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Muscarinic acetylcholine receptor M2,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Muscarinic acetylcholine receptor M3,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Muscarinic acetylcholine receptor M4,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,Muscarinic acetylcholine receptor M5,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,5-hydroxytryptamine receptor 2A,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoperidone,5-hydroxytryptamine receptor 2C,CCN1C(=O)N(CCCN2CCN(CC2)C2=CC=CC(Cl)=C2)N=C1CC
Etoposide,DNA topoisomerase 2-alpha,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
Etoposide,DNA topoisomerase 2-beta,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O
Etoricoxib,Prostaglandin G/H synthase 2,CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O
Etorphine,Mu-type opioid receptor,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3
Etorphine,Delta-type opioid receptor,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3
Etorphine,Kappa-type opioid receptor,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3
Etorphine,Nociceptin receptor,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3
Etorphine,E3 ubiquitin-protein ligase TRIM13,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3
Etorphine,Pro-opiomelanocortin,[H][C@]12CC3=C4C(OC5[C@@]4(CCN1C)[C@]21CC(C(C)(O)CCC)C5(OC)C=C1)=C(O)C=C3
Etravirine,Gag-Pol polyprotein,CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N
Etravirine,Gag-Pol polyprotein,CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N
Etretinate,Retinoic acid receptor alpha,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
Etretinate,Retinoic acid receptor RXR-alpha,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
Etretinate,Retinoic acid receptor beta,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
Etretinate,Retinoic acid receptor RXR-gamma,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
Etretinate,Retinoic acid receptor RXR-beta,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
Etretinate,Retinoic acid receptor gamma,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
Eugenol,Estrogen receptor,COC1=C(O)C=CC(CC=C)=C1
Eugenol,Estrogen receptor beta,COC1=C(O)C=CC(CC=C)=C1
Eugenol,Androgen receptor,COC1=C(O)C=CC(CC=C)=C1
Eugenol,Transient receptor potential cation channel subfamily V member 3,COC1=C(O)C=CC(CC=C)=C1
Everolimus,Serine/threonine-protein kinase mTOR,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC
Exemestane,Aromatase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C
Exenatide,Glucagon-like peptide 1 receptor,
Exisulind,"cGMP-specific 3',5'-cyclic phosphodiesterase",CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O
Exisulind,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O
Exisulind,"cGMP-dependent 3',5'-cyclic phosphodiesterase",CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O
Exisulind,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O
Exisulind,Glutathione S-transferase P,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O
Exisulind,Aldose reductase,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O
Exisulind,Aldo-keto reductase family 1 member B10,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O
Ezatiostat,Glutathione S-transferase P,CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCC1=CC=CC=C1)C(=O)N[C@@H](C(=O)OCC)C1=CC=CC=C1
Ezetimibe,Sterol O-acyltransferase 1,O[C@@H](CC[C@@H]1[C@H](N(C1=O)C1=CC=C(F)C=C1)C1=CC=C(O)C=C1)C1=CC=C(F)C=C1
Ezetimibe,Niemann-Pick C1-like protein 1,O[C@@H](CC[C@@H]1[C@H](N(C1=O)C1=CC=C(F)C=C1)C1=CC=C(O)C=C1)C1=CC=C(F)C=C1
Ezetimibe,Aminopeptidase N,O[C@@H](CC[C@@H]1[C@H](N(C1=O)C1=CC=C(F)C=C1)C1=CC=C(O)C=C1)C1=CC=C(F)C=C1
Ezogabine,Potassium voltage-gated channel subfamily KQT member 2,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
Ezogabine,Potassium voltage-gated channel subfamily KQT member 3,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
Ezogabine,Potassium voltage-gated channel subfamily KQT member 4,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
Ezogabine,Potassium voltage-gated channel subfamily KQT member 5,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
F-Loop of Vitamin B12,Glutamate mutase sigma subunit,C[C@H](O)C[NH3+]
FAMOXADONE,"Cytochrome c1, heme protein, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,Cytochrome b,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,"Cytochrome b-c1 complex subunit 1, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,"Cytochrome b-c1 complex subunit 2, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,"Cytochrome b-c1 complex subunit 6, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,Cytochrome b-c1 complex subunit 8,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,Cytochrome b-c1 complex subunit 10,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,Cytochrome b-c1 complex subunit 7,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FAMOXADONE,Cytochrome b-c1 complex subunit 9,C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1
FG-2216,Egl nine homolog 1,OC(=O)CNC(=O)C1=C(O)C2=CC=CC=C2C(Cl)=N1
FG-2216,Hypoxia-inducible factor 1-alpha,OC(=O)CNC(=O)C1=C(O)C2=CC=CC=C2C(Cl)=N1
FG-9041,Glutamate receptor 2,[O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)[N+]([O-])=O
FKB-001,Peptidyl-prolyl cis-trans isomerase FKBP1A,COC1=CC(=CC(OC)=C1OC)C(F)(F)C(=O)N1CCCC[C@H]1C(=O)O[C@@H](CCCC1=CC=CC=C1)CCCC1=CN=CC=C1
FLUORESCIN,Ig gamma-1 chain C region,OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=C1C=CC(O)=C2
FM-VP4,Multidrug resistance protein 1,
FR117016,Adenosine deaminase,NC(N)=NC1=NC(=CS1)C1=CC=C(CNC2=NC3=C(N2)C=CC=C3)S1
FR221647,Adenosine deaminase,[H][C@](CO)(CCC1=CC=CC=C1)N1C=NC(=C1)C(N)=O
FR230513,Adenosine deaminase,[H][C@](CO)(CCC1=CC=CC2=C1C=CC=C2)N1C=NC(=C1)C(N)=O
FR233623,Adenosine deaminase,[H][C@@](C)(O)[C@@]([H])(CCC1=CC=CC2=C1C=CC=C2)N1C=NC(=C1)C(N)=O
FR236913,Adenosine deaminase,[H][C@](CO)(CCN1C=CC2=C1C=C(NC(=O)NCC1=CC=CC=C1)C=C2)N1C=NC(=C1)C(N)=O
FR239087,Adenosine deaminase,[H][C@@](C)(O)[C@@]([H])(CCC1=CC=CC(Cl)=C1Cl)N1C=NC(=C1)C(N)=O
FX06,Cadherin-5,
Factor IIIm,5-methyltetrahydrofolate--homocysteine S-methyltransferase,COC1=CC=C2N(C=NC2=C1)[C@H]1O[C@H](CO)[C@@H](O[P@]([OH-])(=O)O[C@H](C)CNC(=O)CC[C@]2(C)[C@@H](CC(N)=O)C3=[N+]4C2=C(C)C2=[N+]5C(=CC6=[N+]7C(=C(C)C8=[N+]([C@]3(C)[C@@](C)(CC(N)=O)[C@@H]8CCC(N)=O)[Co]457)[C@@](C)(CC(N)=O)[C@@H]6CCC(N)=O)C(C)(C)[C@@H]2CCC(N)=O)[C@H]1O
Famciclovir,DNA polymerase catalytic subunit,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O
Famciclovir,DNA polymerase catalytic subunit,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O
Famotidine,Histamine H2 receptor,NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1
Farletuzumab,Folate receptor alpha,
Farnesol,Amine oxidase [flavin-containing] B,CC(C)=CCC\C(C)=C/CC\C(C)=C/CO
Farnesol,Bile acid receptor,CC(C)=CCC\C(C)=C/CC\C(C)=C/CO
Farnesyl diphosphate,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,Protein farnesyltransferase subunit beta,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,GTPase KRas,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,Farnesyl pyrophosphate synthase,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,Lantibiotic nisin-Z,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,Geranylgeranyl pyrophosphate synthase,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,"(2Z,6E)-farnesyl diphosphate synthase",CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,Geranylgeranyl transferase type-2 subunit alpha,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl diphosphate,Geranylgeranyl transferase type-2 subunit beta,CC(C)=CCC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O
Farnesyl thiopyrophosphate,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",[H]\C(CC\C(C)=C(/[H])CSP(O)(=O)OP(O)(O)=O)=C(\C)CCC=C(C)C
Farnesyl thiopyrophosphate,Geranylgeranyl pyrophosphate synthase,[H]\C(CC\C(C)=C(/[H])CSP(O)(=O)OP(O)(O)=O)=C(\C)CCC=C(C)C
Farnesyl thiopyrophosphate,Mevalonate kinase,[H]\C(CC\C(C)=C(/[H])CSP(O)(=O)OP(O)(O)=O)=C(\C)CCC=C(C)C
Farnesyl thiopyrophosphate,Dehydrosqualene synthase,[H]\C(CC\C(C)=C(/[H])CSP(O)(=O)OP(O)(O)=O)=C(\C)CCC=C(C)C
Faropenem medoxomil,Penicillin-binding protein 2B,[H][C@]12SC(=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCC1=C(C)OC(=O)O1)[C@@]1([H])CCCO1
Faropenem medoxomil,Penicillin-binding protein 1A,[H][C@]12SC(=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCC1=C(C)OC(=O)O1)[C@@]1([H])CCCO1
Faropenem medoxomil,"Peptidoglycan D,D-transpeptidase FtsI",[H][C@]12SC(=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(=O)OCC1=C(C)OC(=O)O1)[C@@]1([H])CCCO1
Fasudil,cAMP-dependent protein kinase inhibitor alpha,O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
Fasudil,cAMP-dependent protein kinase catalytic subunit alpha,O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
Fasudil,Rho-associated protein kinase 1,O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
Fasudil,Rho-associated protein kinase 2,O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
FavId,Granulocyte colony-stimulating factor receptor,
Febuxostat,Xanthine dehydrogenase/oxidase,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N
Felbamate,"Glutamate receptor ionotropic, NMDA 2B",NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
Felbamate,"Glutamate receptor ionotropic, NMDA 3A",NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
Felbamate,"Glutamate receptor ionotropic, NMDA 2A",NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
Felbinac,Cathepsin L1,OC(=O)CC1=CC=C(C=C1)C1=CC=CC=C1
Felodipine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,Voltage-dependent calcium channel subunit alpha-2/delta-1,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,Voltage-dependent L-type calcium channel subunit beta-2,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,Voltage-dependent L-type calcium channel subunit alpha-1D,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,Voltage-dependent L-type calcium channel subunit alpha-1S,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,Voltage-dependent T-type calcium channel subunit alpha-1H,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,Voltage-dependent calcium channel subunit alpha-2/delta-2,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,Calmodulin,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,Mineralocorticoid receptor,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,"Troponin C, skeletal muscle",CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felodipine,"Troponin C, slow skeletal and cardiac muscles",CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC
Felypressin,Vasopressin V1a receptor,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
Fencamfamin,Sodium-dependent dopamine transporter,CCNC1C2CCC(C2)C1C1=CC=CC=C1
Fenfluramine,Sodium-dependent serotonin transporter,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
Fenfluramine,5-hydroxytryptamine receptor 2B,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
Fenfluramine,5-hydroxytryptamine receptor 2C,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
Fenfluramine,5-hydroxytryptamine receptor 2A,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F
Fenofibrate,Peroxisome proliferator-activated receptor alpha,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
Fenofibrate,Matrix metalloproteinase-25,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
Fenofibrate,Peroxisome proliferator-activated receptor gamma,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
Fenofibrate,Peroxisome proliferator-activated receptor delta,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
Fenofibrate,Nuclear receptor subfamily 1 group I member 2,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
Fenofibric acid,Peroxisome proliferator-activated receptor alpha,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
Fenofibric acid,Matrix metalloproteinase-25,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
Fenofibric acid,Peroxisome proliferator-activated receptor gamma,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
Fenofibric acid,Peroxisome proliferator-activated receptor delta,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
Fenofibric acid,Nuclear receptor subfamily 1 group I member 2,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O
Fenoldopam,D(1A) dopamine receptor,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
Fenoldopam,D(1B) dopamine receptor,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
Fenoldopam,Alpha-2A adrenergic receptor,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
Fenoldopam,Alpha-2C adrenergic receptor,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
Fenoldopam,Alpha-2B adrenergic receptor,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
Fenoldopam,Alpha-1B adrenergic receptor,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
Fenoldopam,Alpha-1D adrenergic receptor,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
Fenoldopam,Alpha-1A adrenergic receptor,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
Fenoprofen,Prostaglandin G/H synthase 1,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1
Fenoprofen,Prostaglandin G/H synthase 2,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1
Fenoprofen,Peroxisome proliferator-activated receptor alpha,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1
Fenoprofen,Peroxisome proliferator-activated receptor gamma,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1
Fenoterol,Beta-2 adrenergic receptor,CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1
Fenoterol,Beta-1 adrenergic receptor,CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1
Fenoterol,Beta-3 adrenergic receptor,CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1
Fenoxaprop-ethyl,"Nitric oxide synthase, inducible",CCOC(=O)C(C)OC1=CC=C(OC2=NC3=C(O2)C=C(Cl)C=C3)C=C1
Fentanyl,Mu-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
Fentanyl,Delta-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
Fentanyl,Kappa-type opioid receptor,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
Fentanyl,Multidrug resistance protein 1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1
Ferric cation,Iron(3+)-hydroxamate-binding protein FhuD,[Fe+3]
Ferric cation,Transferrin receptor protein 1,[Fe+3]
Ferric pyrophosphate,Ferritin light chain,[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O
Ferric pyrophosphate,Hemoglobin subunit alpha,[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O
Ferric pyrophosphate,Hemoglobin subunit beta,[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O
Ferric pyrophosphate citrate,Ferritin light chain,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Ferric pyrophosphate citrate,Ferritin heavy chain,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Ferric pyrophosphate citrate,Hemoglobin subunit alpha,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Ferric pyrophosphate citrate,Hemoglobin subunit beta,[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP(O)(=O)OP(O)(O)=O.OP(O)(=O)OP(O)(O)=O.OP([O-])(=O)OP([O-])([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Ferricrocin-Iron,Ferrichrome-iron receptor,[H][C@]1(CO)NC(=O)CNC(=O)[C@]2([H])CCCN3O[Fe-3]456(ON(CCC[C@]([H])(NC(=O)CNC1=O)C(=O)N[C@@]([H])(CCCN(O4)C(C)=[O+]5)C(=O)N2)C(C)=[O+]6)[O+]=C3C
Ferrous ascorbate,Transferrin receptor protein 1,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Egl nine homolog 1,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Histone deacetylase 8,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Alpha-hemoglobin-stabilizing protein,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Hemoglobin subunit alpha,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,"Frataxin, mitochondrial",[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Ferritin heavy chain,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Flap endonuclease 1,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Endonuclease 8-like 1,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Endonuclease 8-like 2,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,DNA polymerase beta,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Ceruloplasmin,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous ascorbate,Serotransferrin,[Fe++].[H][C@](O)(CO)[C@@]1([H])OC(=O)C(O)=C1O.[H][C@](O)(CO)[C@@]1([H])OC(=O)C([O-])=C1[O-]
Ferrous fumarate,Transferrin receptor protein 1,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Egl nine homolog 1,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Histone deacetylase 8,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Alpha-hemoglobin-stabilizing protein,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Hemoglobin subunit alpha,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,"Frataxin, mitochondrial",[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Ferritin heavy chain,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Flap endonuclease 1,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Endonuclease 8-like 1,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Endonuclease 8-like 2,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,DNA polymerase beta,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Ceruloplasmin,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous fumarate,Serotransferrin,[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=O
Ferrous gluconate,Transferrin receptor protein 1,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Egl nine homolog 1,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Histone deacetylase 8,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Alpha-hemoglobin-stabilizing protein,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Hemoglobin subunit alpha,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,"Frataxin, mitochondrial",[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Ferritin heavy chain,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Flap endonuclease 1,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Endonuclease 8-like 1,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Endonuclease 8-like 2,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,DNA polymerase beta,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Ceruloplasmin,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous gluconate,Serotransferrin,[Fe++].[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O.[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C([O-])=O
Ferrous glycine sulfate,Transferrin receptor protein 1,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Egl nine homolog 1,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Histone deacetylase 8,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Alpha-hemoglobin-stabilizing protein,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Hemoglobin subunit alpha,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,"Frataxin, mitochondrial",[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Ferritin heavy chain,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Flap endonuclease 1,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Endonuclease 8-like 1,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Endonuclease 8-like 2,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,DNA polymerase beta,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Ceruloplasmin,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous glycine sulfate,Serotransferrin,[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O
Ferrous succinate,Transferrin receptor protein 1,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Egl nine homolog 1,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Histone deacetylase 8,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Alpha-hemoglobin-stabilizing protein,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Hemoglobin subunit alpha,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,"Frataxin, mitochondrial",[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Ferritin heavy chain,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Flap endonuclease 1,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Endonuclease 8-like 1,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Endonuclease 8-like 2,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,DNA polymerase beta,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Ceruloplasmin,[Fe++].[O-]C(=O)CCC([O-])=O
Ferrous succinate,Serotransferrin,[Fe++].[O-]C(=O)CCC([O-])=O
Ferulic acid,"Endo-1,4-beta-xylanase Y",COC1=CC(\C=C\C(O)=O)=CC=C1O
Ferulic acid,"Endo-1,4-beta-xylanase Z",COC1=CC(\C=C\C(O)=O)=CC=C1O
Ferulic acid,Est1e,COC1=CC(\C=C\C(O)=O)=CC=C1O
Ferulic acid,O-methyltransferase,COC1=CC(\C=C\C(O)=O)=CC=C1O
Feruloyl Coenzyme A,Catechol O-methyltransferase domain-containing protein 1,COC1=CC(\C=C\C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO[P@@](=O)(O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2OP(O)(O)=O)N2C=NC3=C(N)N=CN=C23)=CC(O)=C1O
Fesoterodine,Muscarinic acetylcholine receptor M3,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
Fesoterodine,Muscarinic acetylcholine receptor M4,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
Fesoterodine,Muscarinic acetylcholine receptor M1,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
Fesoterodine,Muscarinic acetylcholine receptor M2,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
Fesoterodine,Muscarinic acetylcholine receptor M5,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
Fexaramine,Bile acid receptor,COC(=O)\C=C\C1=CC(=CC=C1)N(CC1=CC=C(C=C1)C1=CC=C(C=C1)N(C)C)C(=O)C1CCCCC1
Fexofenadine,Histamine H1 receptor,CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Fiboflapon,Arachidonate 5-lipoxygenase-activating protein,CCOC1=CC=C(C=N1)C1=CC=C(CN2C(CC(C)(C)C(O)=O)=C(SC(C)(C)C)C3=CC(OCC4=CC=C(C)C=N4)=CC=C23)C=C1
Fibrinolysin,Plasminogen activator inhibitor 1,
Fibrinolysin,Urokinase-type plasminogen activator,
Fica,Caspase-7,FC1=CC2=C(NC(=C2)C(=O)NCCS)C=C1
Fidarestat,Aldose reductase,[H][C@]1(C[C@]2(N=C(O)N=C2O)C2=C(O1)C=CC(F)=C2)C(O)=N
Fidarestat,Aldo-keto reductase family 1 member B10,[H][C@]1(C[C@]2(N=C(O)N=C2O)C2=C(O1)C=CC(F)=C2)C(O)=N
Fidaxomicin,RNA polymerase sigma factor SigA,CC[C@H]1\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)C3=C(CC)C(Cl)=C(O)C(Cl)=C3O)[C@H](O)[C@@H]2OC)\C(=O)OC(C\C=C(/C)\C=C(C)\[C@@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O)[C@@H](C)O
Filaminast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",COC1=CC=C(C=C1OC1CCCC1)C(\C)=N\OC(N)=O
Filanesib,Kinesin-like protein KIF11,CON(C)C(=O)N1N=C(S[C@@]1(CCCN)C1=CC=CC=C1)C1=CC(F)=CC=C1F
Filgrastim,Neutrophil elastase,
Filgrastim,Granulocyte colony-stimulating factor receptor,
Fimasartan,Type-1 angiotensin II receptor,CCCCC1=NC(C)=C(CC(=S)N(C)C)C(=O)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1
Finafloxacin,DNA gyrase subunit A,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O
Finafloxacin,DNA topoisomerase 4 subunit A,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O
Finafloxacin,DNA topoisomerase 2-alpha,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O
Finasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 2,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
Finasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 1,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
Finasteride,3-oxo-5-beta-steroid 4-dehydrogenase,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C
Fingolimod,Sphingosine 1-phosphate receptor 5,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
Fingolimod,Histone deacetylase 1,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
Firocoxib,Prostaglandin G/H synthase 2,CC1(C)OC(=O)C(OCC2CC2)=C1C1=CC=C(C=C1)S(C)(=O)=O
Fisetin,Cyclin homolog,OC1=CC2=C(C=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Fisetin,Cyclin-dependent kinase 6,OC1=CC2=C(C=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Fish oil,Diacylglycerol O-acyltransferase 2,
Fish oil,Prostaglandin G/H synthase 2,
Fish oil,Free fatty acid receptor 4,
Fish oil,Voltage-dependent L-type calcium channel subunit alpha-1C,
Fish oil,Voltage-dependent L-type calcium channel subunit alpha-1D,
Fish oil,Voltage-dependent L-type calcium channel subunit alpha-1F,
Fish oil,Voltage-dependent L-type calcium channel subunit alpha-1S,
Fish oil,Voltage-dependent L-type calcium channel subunit beta-1,
Fish oil,Voltage-dependent L-type calcium channel subunit beta-2,
Fish oil,Voltage-dependent L-type calcium channel subunit beta-3,
Fish oil,Voltage-dependent L-type calcium channel subunit beta-4,
Fish oil,Nuclear factor NF-kappa-B p100 subunit,
Fish oil,Nuclear factor NF-kappa-B p105 subunit,
Fish oil,Sterol regulatory element-binding protein 1,
Fish oil,Peroxisome proliferator-activated receptor alpha,
Fish oil,Peroxisome proliferator-activated receptor gamma,
Fish oil,Peroxisome proliferator-activated receptor delta,
Flavin adenine dinucleotide,"Nitric oxide synthase, brain",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,D-lactate dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,NADH-cytochrome b5 reductase 3,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Ribosyldihydronicotinamide dehydrogenase [quinone],CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Glutathione reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Isovaleryl-CoA dehydrogenase, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Isobutyryl-CoA dehydrogenase, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Glutathione reductase, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Dihydrolipoyl dehydrogenase, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Dihydropyrimidine dehydrogenase [NADP(+)],CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Apoptosis-inducing factor 1, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,NAD(P)H dehydrogenase [quinone] 1,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Cholesterol oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Monomeric sarcosine oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Pyruvate oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,NADPH-ferredoxin reductase FprA,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Thymidylate synthase ThyX,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Fumarate reductase flavoprotein subunit,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,p-hydroxybenzoate hydroxylase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,p-hydroxybenzoate hydroxylase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Cholesterol oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Trypanothione reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Glycine oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Flavohemoprotein,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,UDP-galactopyranose mutase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"2-oxopropyl-CoM reductase, carboxylating",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Bifunctional protein PutA,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Glutaryl-CoA dehydrogenase, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"2,4-dienoyl-CoA reductase [NADPH]",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Deoxyribodipyrimidine photo-lyase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Thioredoxin reductase 1, cytoplasmic",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Fumarate reductase flavoprotein subunit,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"5,10-methylenetetrahydrofolate reductase",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Thioredoxin reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Amine oxidase [flavin-containing] B,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Amine oxidase [flavin-containing] A,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Xanthine dehydrogenase/oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,NADPH--cytochrome P450 reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Ferredoxin reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,NADH peroxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Dihydrolipoyl dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Phenol 2-hydroxylase component B,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Oxidoreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Fumarate reductase flavoprotein subunit,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Flavohemoprotein,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Acyl-CoA dehydrogenase, short-chain specific",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Dimethylglycine oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Ferredoxin--NADP reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Sulfite reductase [NADPH] flavoprotein alpha-component,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Ferredoxin--NADP reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Dihydrolipoyl dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Amine oxidase, flavin-containing protein",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Deoxyribodipyrimidine photo-lyase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Deoxyribodipyrimidine photo-lyase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,L-aspartate oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Cryptochrome DASH,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,UDP-N-acetylenolpyruvoylglucosamine reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,UDP-N-acetylenolpyruvoylglucosamine reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Methylenetetrahydrofolate reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Putidaredoxin reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,NAD(P)H dehydrogenase (quinone),CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,UDP-galactopyranose mutase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-Delta-isomerase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,4-cresol dehydrogenase [hydroxylating] flavoprotein subunit,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Alkyl hydroperoxide reductase subunit F,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Dihydrolipoyl dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Glutathione reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Phenylacetone monooxygenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"Benzoate 1,2-dioxygenase electron transfer component",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Putative acyl-CoA dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,FkbI,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Dihydrolipoyl dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Alkyl hydroperoxide reductase subunit F,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Ferredoxin--NADP reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Ferredoxin--NADP reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Mersacidin decarboxylase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,Peroxisomal acyl-coenzyme A oxidase 1,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,D-amino-acid oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"NADPH:adrenodoxin oxidoreductase, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,NADH-cytochrome b5 reductase 1,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,L-amino-acid oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,ERO1-like protein beta,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,FAD-linked sulfhydryl oxidase ALR,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin adenine dinucleotide,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,"Nitric oxide synthase, brain",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Pyridoxine-5'-phosphate oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Riboflavin kinase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,"Dihydroorotate dehydrogenase (quinone), mitochondrial",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Flavin reductase (NADPH),CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Oxygen-insensitive NADPH nitroreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Dihydropyrimidine dehydrogenase [NADP(+)],CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Major NAD(P)H-flavin oxidoreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Dihydroorotate dehydrogenase (quinone),CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Oxygen-insensitive NAD(P)H nitroreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Flavodoxin,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Chorismate synthase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,"2,4-dienoyl-CoA reductase [NADPH]",CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Dihydroorotate dehydrogenase A (fumarate),CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Pyridoxine/pyridoxamine 5'-phosphate oxidase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,NADPH--cytochrome P450 reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Pentaerythritol tetranitrate reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Riboflavin biosynthesis protein,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Nitric oxide reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,FMN-dependent NADH-azoreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,NADPH-flavin oxidoreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Flavodoxin,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Ferredoxin-dependent glutamate synthase 2,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Phenazine biosynthesis protein,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,FMN-dependent NADH-azoreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Epidermin decarboxylase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Chorismate synthase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Flavodoxin,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Flavodoxin,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Uncharacterized protein,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Putative monooxygenase MoxC,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,tRNA-dihydrouridine synthase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Protein NrdI,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Probable UbiX-like flavin prenyltransferase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,(S)-mandelate dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,FMN-dependent NADPH-azoreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Flavodoxin,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Oxygen-insensitive NAD(P)H nitroreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Isopentenyl-diphosphate delta-isomerase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Trimethylamine dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Rubredoxin-oxygen oxidoreductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Morphinone reductase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Phenazine biosynthesis protein PhzG,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,NAD(P)H dehydrogenase (quinone),CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Flavodoxin-1,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Isopentenyl-diphosphate delta-isomerase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,NADH dehydrogenase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,FMN-binding protein,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Nitroreductase family protein,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Phosphopantothenoylcysteine decarboxylase,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Hydroxyacid oxidase 1,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Serine/threonine-protein kinase Sgk1,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Hydroxyacid oxidase 2,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin mononucleotide,Ribosomal protein S6 kinase alpha-4,CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2
Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone,D-amino-acid oxidase,[H][C@@](O)(COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])([N+]2=CN=C3C2=NC=NC3=N)[C@]([H])(O)[C@]1([H])O)[C@@]([H])(O)[C@@]([H])(O)CN1C2=C(C=C(C)C(C)=C2)N(C(=O)C(C)C)C2=C1N=C(O)N=C2[O-]
Flavin-N7 Protonated-Adenine Dinucleotide,Cholesterol oxidase,[H][C@@](O)(COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C([NH3+])N=CN=C23)[C@]([H])(O)[C@]1([H])O)[C@@]([H])(O)[C@@]([H])(O)CN1C2=C(C=C(C)C(C)=C2)N=C2C(O)=NC(=O)N=C12
Flavone,Neocarzinostatin,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1
Flavone,Steroid hormone receptor ERR1,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1
Flavone,Steroid hormone receptor ERR2,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1
Flavone,Cytochrome P450 1B1,O=C1C=C(OC2=CC=CC=C12)C1=CC=CC=C1
Flavoxate,Muscarinic acetylcholine receptor M1,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1
Flavoxate,Muscarinic acetylcholine receptor M2,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1
Flecainide,Sodium channel protein type 5 subunit alpha,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
Flecainide,Sodium channel protein type 4 subunit alpha,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
Flecainide,Potassium voltage-gated channel subfamily H member 2,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
Fleroxacin,DNA topoisomerase 2-alpha,CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O
Fleroxacin,DNA gyrase subunit A,CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O
Fleroxacin,DNA topoisomerase 4 subunit A,CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O
Flibanserin,5-hydroxytryptamine receptor 1A,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
Flibanserin,D(4) dopamine receptor,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
Flibanserin,5-hydroxytryptamine receptor 2A,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
Florbetaben (18F),Amyloid beta A4 protein,CNC1=CC=C(\C=C\C2=CC=C(OCCOCCOCC[18F])C=C2)C=C1
Florbetapir (18F),Amyloid beta A4 protein,[H]N(C1=C([H])C([H])=C(\C([H])=C(/[H])C2=C([H])N=C(OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])[18F])C([H])=C2[H])C([H])=C1[H])C([H])([H])[H]
Flovagatran,Prothrombin,COCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)B(O)O
Floxuridine,Thymidylate synthase,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O
Fluciclovine (18F),Neutral amino acid transporter B(0),N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),Y+L amino acid transporter 1,N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),Cationic amino acid transporter 3,N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),"Glutamate receptor ionotropic, NMDA 1",N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),"Glutamate receptor ionotropic, NMDA 2A",N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),"Glutamate receptor ionotropic, NMDA 2B",N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),"Glutamate receptor ionotropic, NMDA 2C",N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),"Glutamate receptor ionotropic, NMDA 2D",N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),"Glutamate receptor ionotropic, NMDA 3A",N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),"Glutamate receptor ionotropic, NMDA 3B",N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),Glutamate receptor 1,N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),Glutamate receptor 2,N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),Glutamate receptor 3,N[C@]1(C[C@H]([18F])C1)C(O)=O
Fluciclovine (18F),Glutamate receptor 4,N[C@]1(C[C@H]([18F])C1)C(O)=O
Flucloxacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl)C(O)=O
Fluconazole,Lanosterol 14-alpha demethylase,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1
Flucytosine,DNA (cytosine-5)-methyltransferase 1,NC1=C(F)C=NC(=O)N1
Flucytosine,Thymidylate synthase,NC1=C(F)C=NC(=O)N1
Fludarabine,Ribonucleoside-diphosphate reductase large subunit,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Fludarabine,DNA polymerase alpha catalytic subunit,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Fludarabine,Deoxycytidine kinase,NC1=NC(F)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Fludiazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit gamma-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit gamma-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit beta-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit beta-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit beta-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit delta,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit epsilon,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit pi,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit rho-1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit rho-2,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludiazepam,Gamma-aminobutyric acid receptor subunit rho-3,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Fludrocortisone,Mineralocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Fludrocortisone,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Fludrocortisone,Androgen receptor,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Flufenamic Acid,Prostaglandin G/H synthase 2,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
Flufenamic Acid,Prostaglandin G/H synthase 1,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
Flufenamic Acid,Aldo-keto reductase family 1 member C3,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
Flufenamic Acid,Androgen receptor,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
Flufenamic Acid,Peroxisome proliferator-activated receptor alpha,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
Flufenamic Acid,Peroxisome proliferator-activated receptor gamma,OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
Flumazenil,Gamma-aminobutyric acid receptor subunit alpha-1,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit gamma-2,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit alpha-5,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit alpha-1,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit alpha-2,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit alpha-3,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit alpha-4,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit alpha-5,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit alpha-6,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit beta-1,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit beta-2,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit beta-3,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit delta,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit epsilon,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit gamma-1,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit gamma-2,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit gamma-3,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit pi,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumazenil,Gamma-aminobutyric acid receptor subunit theta,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Flumethasone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Flunarizine,Voltage-dependent T-type calcium channel subunit alpha-1G,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
Flunarizine,Voltage-dependent T-type calcium channel subunit alpha-1H,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
Flunarizine,Voltage-dependent T-type calcium channel subunit alpha-1I,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
Flunarizine,Histamine H1 receptor,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
Flunarizine,Calmodulin,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
Flunisolide,Glucocorticoid receptor,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
Flunitrazepam,Translocator protein,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Flunitrazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Flunitrazepam,Gamma-aminobutyric acid receptor subunit alpha-4,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Flunitrazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Flunitrazepam,Gamma-aminobutyric acid receptor subunit alpha-6,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Flunitrazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Flunitrazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Flunitrazepam,Gamma-aminobutyric acid receptor subunit beta-3,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Flunitrazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1F
Fluocinolone acetonide,Glucocorticoid receptor,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
Fluocinolone acetonide,Annexin A1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
Fluocinolone acetonide,Annexin A2,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
Fluocinolone acetonide,Annexin A3,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
Fluocinolone acetonide,Annexin A4,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
Fluocinolone acetonide,Annexin A5,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO
Fluocinonide,Glucocorticoid receptor,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O
Fluocinonide,Smoothened homolog,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O
Fluorescein,Ig kappa chain V-II region RPMI 6410,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1
Fluoro-Willardiine,Glutamate receptor 2,N[C@@H](CN1C=C(F)C(=O)NC1=O)C(O)=O
Fluorometholone,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
Fluorouracil,Thymidylate synthase,FC1=CNC(=O)NC1=O
Fluoxetine,Sodium-dependent serotonin transporter,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
Fluoxetine,Potassium voltage-gated channel subfamily H member 2,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
Fluoxetine,5-hydroxytryptamine receptor 2C,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
Fluoxetine,Cyclin-dependent kinases regulatory subunit 1,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
Fluoxetine,Neuronal acetylcholine receptor subunit alpha-2,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
Fluoxetine,Neuronal acetylcholine receptor subunit alpha-3,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
Fluoxetine,Neuronal acetylcholine receptor subunit beta-4,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
Fluoxymesterone,Androgen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Fluoxymesterone,Estrogen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Fluoxymesterone,Prolactin receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Fluoxymesterone,Glucocorticoid receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Fluoxymesterone,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Flupentixol,D(2) dopamine receptor,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Flupentixol,5-hydroxytryptamine receptor 2A,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Flupentixol,D(1A) dopamine receptor,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Flupentixol,Alpha-1A adrenergic receptor,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Flupentixol,Muscarinic acetylcholine receptor M1,[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Fluphenazine,D(2) dopamine receptor,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Fluphenazine,D(1A) dopamine receptor,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Fluphenazine,Calmodulin,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Fluphenazine,Androgen receptor,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Fluphenazine,5-hydroxytryptamine receptor 2A,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Fluphenazine,5-hydroxytryptamine receptor 2C,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Flupirtine,Alpha-2A adrenergic receptor,CCOC(=O)NC1=C(N)N=C(NCC2=CC=C(F)C=C2)C=C1
Flurandrenolide,Glucocorticoid receptor,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
Flurazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit alpha-4,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit alpha-6,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit beta-1,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit beta-2,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit beta-3,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit gamma-1,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit gamma-3,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit delta,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit epsilon,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit pi,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit rho-1,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit rho-2,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit rho-3,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurazepam,Gamma-aminobutyric acid receptor subunit theta,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Flurbiprofen,Prostaglandin G/H synthase 1,CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
Flurbiprofen,Prostaglandin G/H synthase 2,CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
Flurbiprofen Methyl Ester,Prostaglandin G/H synthase 1,COC(=O)[C@@H](C)C1=CC=C(C(F)=C1)C1=CC=CC=C1
Fluspirilene,D(2) dopamine receptor,FC1=CC=C(C=C1)C(CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1)C1=CC=C(F)C=C1
Fluspirilene,5-hydroxytryptamine receptor 2A,FC1=CC=C(C=C1)C(CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1)C1=CC=C(F)C=C1
Fluspirilene,Voltage-dependent calcium channel gamma-1 subunit,FC1=CC=C(C=C1)C(CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1)C1=CC=C(F)C=C1
Flutamide,Androgen receptor,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
Flutamide,Aryl hydrocarbon receptor,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
Flutamide,Nuclear receptor subfamily 1 group I member 2,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
Flutemetamol (18F),Amyloid beta A4 protein,CNC1=C([18F])C=C(C=C1)C1=NC2=CC=C(O)C=C2S1
Fluticasone,Glucocorticoid receptor,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF
Fluticasone,Progesterone receptor,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF
Fluticasone,Cytosolic phospholipase A2,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF
Fluticasone,Mineralocorticoid receptor,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF
Fluticasone furoate,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Fluticasone furoate,Progesterone receptor,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Fluticasone furoate,Mineralocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Fluticasone propionate,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Fluticasone propionate,Progesterone receptor,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Fluticasone propionate,Cytosolic phospholipase A2,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Fluticasone propionate,Mineralocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Fluvastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=CC=C(F)C=C2)C2=CC=CC=C12
Fluvoxamine,Sodium-dependent serotonin transporter,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
Fluvoxamine,Potassium voltage-gated channel subfamily H member 2,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
Folic acid,Folate receptor beta,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1
Folic acid,Folate receptor gamma,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1
Folic acid,Folate receptor alpha,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1
Follitropin,Follicle-stimulating hormone receptor,
Fomepizole,Alcohol dehydrogenase 1A,CC1=CNN=C1
Fomepizole,Alcohol dehydrogenase 1B,CC1=CNN=C1
Fomepizole,Alcohol dehydrogenase 1C,CC1=CNN=C1
Fomepizole,Catalase,CC1=CNN=C1
Fomivirsen,30 kDa immediate-early protein 2,
Fomivirsen,45 kDa immediate-early protein 2,
Fondaparinux,Antithrombin-III,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O
Fondaparinux,Coagulation factor X,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O
Fontolizumab,Interferon gamma,
Forasartan,Type-1 angiotensin II receptor,CCCCC1=NN(CC2=CN=C(C=C2)C2=CC=CC=C2C2=NNN=N2)C(CCCC)=N1
Foreskin fibroblast (neonatal),Interleukin-6,
Foreskin fibroblast (neonatal),Vascular endothelial growth factor receptor 1,
Foreskin fibroblast (neonatal),Interleukin-1 receptor type 1,
Foreskin fibroblast (neonatal),TGF-beta receptor type-2,
Foreskin fibroblast (neonatal),Fibroblast growth factor 1,
Foreskin fibroblast (neonatal),Interferon gamma,
Foreskin fibroblast (neonatal),Fibroblast growth factor receptor 2,
Foreskin fibroblast (neonatal),Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,
Foreskin fibroblast (neonatal),Platelet-derived growth factor receptor beta,
Foreskin fibroblast (neonatal),Transforming growth factor beta-1,
Foreskin fibroblast (neonatal),Tumor necrosis factor,
Foreskin keratinocyte (neonatal),Fibroblast growth factor 1,
Foreskin keratinocyte (neonatal),Epidermal growth factor receptor,
Foreskin keratinocyte (neonatal),Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,
Foreskin keratinocyte (neonatal),Interleukin-1 beta,
Foreskin keratinocyte (neonatal),Interleukin-6,
Foreskin keratinocyte (neonatal),Interferon gamma,
Foreskin keratinocyte (neonatal),Fibroblast growth factor receptor 2,
Foreskin keratinocyte (neonatal),Platelet-derived growth factor receptor alpha,
Foreskin keratinocyte (neonatal),TGF-beta receptor type-2,
Foreskin keratinocyte (neonatal),Transforming growth factor beta-1,
Foreskin keratinocyte (neonatal),Tumor necrosis factor,
Foreskin keratinocyte (neonatal),Vascular endothelial growth factor A,
Foretinib,Vascular endothelial growth factor receptor 2,COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=C(F)C=C(C=C3)N=C(O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C2=C1
Foretinib,Hepatocyte growth factor,COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=C(F)C=C(C=C3)N=C(O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C2=C1
Formaldehyde,D-alanyl-D-alanine carboxypeptidase,[H]C([H])=O
Formebolone,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C(C=O)=C[C@]12C
Formic Acid Benzyl Ester,Thermolysin,O=COCC1=CC=CC=C1
Formic acid,"Nitric oxide synthase, brain",OC=O
Formic acid,Carbonic anhydrase 2,OC=O
Formic acid,Aminodeoxychorismate synthase component 1,OC=O
Formic acid,Fibroblast growth factor 1,OC=O
Formic acid,Heme oxygenase 1,OC=O
Formic acid,Delta-aminolevulinic acid dehydratase,OC=O
Formic acid,Putative hydroxypyruvate isomerase YgbM,OC=O
Formic acid,3-phosphoshikimate 1-carboxyvinyltransferase,OC=O
Formic acid,Subtilisin Carlsberg,OC=O
Formic acid,Peptide deformylase,OC=O
Formic acid,Dihydroorotate dehydrogenase (quinone),OC=O
Formic acid,(S)-2-haloacid dehalogenase,OC=O
Formic acid,Streptavidin,OC=O
Formic acid,Beta-lactamase OXA-2,OC=O
Formic acid,Signal recognition particle protein,OC=O
Formic acid,Methylglyoxal synthase,OC=O
Formic acid,6-phosphogluconolactonase,OC=O
Formic acid,Catalase,OC=O
Formic acid,Hypoxanthine-guanine phosphoribosyltransferase,OC=O
Formic acid,C-terminal-binding protein 1,OC=O
Formic acid,Citrate lyase subunit beta-like protein,OC=O
Formic acid,Peripheral plasma membrane protein CASK,OC=O
Formic acid,Guanylate kinase,OC=O
Formic acid,Probable butyrate kinase 2,OC=O
Formic acid,Uncharacterized protein,OC=O
Formic acid,Arginine N-succinyltransferase subunit alpha,OC=O
Formic acid,Putative mannose-6-phosphate isomerase YvyI,OC=O
Formic acid,"Mannoside ABC transport system, sugar-binding protein",OC=O
Formic acid,Probable phosphatase YcdX,OC=O
Formic acid,Phenazine biosynthesis protein PhzD,OC=O
Formic acid,Oxalate decarboxylase OxdC,OC=O
Formic acid,Putative ketoacyl reductase,OC=O
Formic acid,Gephyrin,OC=O
Formic acid,Glyoxalase family protein,OC=O
Formic acid,Cytohesin-2,OC=O
Formic acid,Glutaconyl-CoA decarboxylase subunit alpha,OC=O
Formic acid,"Transcriptional regulator, IclR family",OC=O
Formic acid,Catalase,OC=O
Formic acid,Putative L-rhamnose mutarotase,OC=O
Formic acid,Glutathione S-transferase,OC=O
Formic acid,Glutaminase 1,OC=O
Formic acid,Glutaminase 1,OC=O
Formic acid,Molybdopterin synthase catalytic subunit,OC=O
Formic acid,"Aminotransferase, putative",OC=O
Formic acid,Iron ABC transporter substrate-binding protein,OC=O
Formic acid,DNA gyrase subunit B,OC=O
Formic acid,Ribonuclease pancreatic,OC=O
Formic acid,Parvalbumin alpha,OC=O
Formic acid,Acylphosphatase-2,OC=O
Formic acid,Gamma-glutamylaminecyclotransferase,OC=O
Formoterol,Beta-2 adrenergic receptor,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
Formoterol,Beta-1 adrenergic receptor,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
Formoterol,Beta-3 adrenergic receptor,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
Formycin,S-methyl-5'-thioadenosine phosphorylase,[H][C@]1(CO)O[C@@]([H])(C2=C3N=CN=C(N)C3=NN2)[C@]([H])(O)[C@]1([H])O
Formycin,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,[H][C@]1(CO)O[C@@]([H])(C2=C3N=CN=C(N)C3=NN2)[C@]([H])(O)[C@]1([H])O
Formycin B,Purine nucleoside phosphorylase DeoD-type,[H][C@]1(CO)O[C@@]([H])(C2=C3N=CNC(=O)C3=NN2)[C@]([H])(O)[C@]1([H])O
Formycin B,Hypoxanthine-guanine phosphoribosyltransferase,[H][C@]1(CO)O[C@@]([H])(C2=C3N=CNC(=O)C3=NN2)[C@]([H])(O)[C@]1([H])O
Formycin-5'-Monophosphate,AMP nucleosidase,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(C2=C3N=CN=C(N)C3=NN2)[C@]([H])(O)[C@]1([H])O
Forodesine,Purine nucleoside phosphorylase,OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1=CNC2=C1N=CNC2=O
Fosamprenavir,Pol polyprotein,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1
Foscarnet,DNA polymerase catalytic subunit,OC(=O)P(O)(O)=O
Foscarnet,DNA polymerase catalytic subunit,OC(=O)P(O)(O)=O
Fosfomycin,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,C[C@@H]1O[C@@H]1P(O)(O)=O
Fosinopril,Angiotensin-converting enzyme,CCC(=O)O[C@@H](O[P@](=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C
Fosmidomycin,1-deoxy-D-xylulose 5-phosphate reductoisomerase,ON(CCCP(O)(O)=O)C=O
Fosphenytoin,Sodium channel protein type 5 subunit alpha,OP(O)(=O)OCN1C(=O)NC(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1
Fospropofol,Gamma-aminobutyric acid receptor subunit beta-2,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O
Fospropofol,Gamma-aminobutyric acid receptor subunit beta-3,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O
Fostamatinib,Tyrosine-protein kinase SYK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Adenosine receptor A3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Vesicle monoamine transporter type 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Fatty-acid amide hydrolase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Equilibrative nucleoside transporter 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,UDP-glucuronosyltransferase 1-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"cGMP-specific 3',5'-cyclic phosphodiesterase",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Arachidonate 5-lipoxygenase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cathepsin S,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cathepsin L1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase ABL1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium-dependent protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PknB,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ribosomal protein S6 kinase alpha-6,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Non-receptor tyrosine-protein kinase TYK2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Atypical kinase COQ8A, mitochondrial",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase JAK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Hepatocyte growth factor receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase NIM1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 26,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,cAMP-dependent protein kinase catalytic subunit alpha,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 24,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Tec,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 33,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 35,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 36,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 38,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 38-like,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,STE20/SPS1-related proline-alanine-rich protein kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase TAO1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase TAO2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase TAO3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase TBK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Angiopoietin-1 receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity testis-specific protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,TGF-beta receptor type-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,TGF-beta receptor type-2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase receptor Tie-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase tousled-like 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase tousled-like 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,TRAF2 and NCK-interacting protein kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Non-receptor tyrosine-protein kinase TNK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Activated CDC42 kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase TNNI3K,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Testis-specific serine/threonine-protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity protein kinase TTK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase TXK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase receptor TYRO3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase ULK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase ULK2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase ULK3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Wee1-like protein kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Yes,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 19,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase MLT,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase ZAP-70,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,AP2-associated protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Abelson tyrosine-protein kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Activin receptor type-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Activin receptor type-1B,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Atypical kinase COQ8B, mitochondrial",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,ALK tyrosine kinase receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ankyrin repeat and protein kinase domain-containing protein 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Aurora kinase A,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Aurora kinase B,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Aurora kinase C,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase receptor UFO,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Blk,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,BMP-2-inducible protein kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Bone morphogenetic protein receptor type-1B,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Bone morphogenetic protein receptor type-2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cytoplasmic tyrosine-protein kinase BMX,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase B-raf,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase BTK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase type 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase type 1D,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase type 1G,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase type II subunit alpha,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase type II subunit beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase type II subunit delta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase type II subunit gamma,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Calcium/calmodulin-dependent protein kinase kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Peripheral plasma membrane protein CASK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Kappa-casein,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cyclin-dependent kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase MRCK gamma,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cyclin-dependent kinase 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cyclin-dependent kinase-like 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cyclin-dependent kinase-like 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Chk1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Chk2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Citron Rho-interacting kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity protein kinase CLK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity protein kinase CLK2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity protein kinase CLK3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity protein kinase CLK4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Macrophage colony-stimulating factor 1 receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase CSK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Casein kinase I isoform alpha,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Casein kinase II subunit alpha,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Casein kinase II subunit alpha',COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Death-associated protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Death-associated protein kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Death-associated protein kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase DCLK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase DCLK2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase DCLK3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Epithelial discoidin domain-containing receptor 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Discoidin domain-containing receptor 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Epidermal growth factor receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Eukaryotic translation initiation factor 2-alpha kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Interferon-induced, double-stranded RNA-activated protein kinase",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,eIF-2-alpha kinase GCN2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-A receptor 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-A receptor 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-A receptor 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-A receptor 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-A receptor 5,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-A receptor 6,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-A receptor 7,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-A receptor 8,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-B receptor 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-B receptor 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-B receptor 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ephrin type-B receptor 6,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Receptor tyrosine-protein kinase erbB-2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Receptor tyrosine-protein kinase erbB-4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase/endoribonuclease IRE1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Fer,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Fes/Fps,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Fibroblast growth factor receptor 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Fibroblast growth factor receptor 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Fibroblast growth factor receptor 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Fgr,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Vascular endothelial growth factor receptor 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Receptor-type tyrosine-protein kinase FLT3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Vascular endothelial growth factor receptor 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase mTOR,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase FRK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Fyn,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cyclin-G-associated kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Glycogen synthase kinase-3 alpha,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Glycogen synthase kinase-3 beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase HCK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Homeodomain-interacting protein kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Homeodomain-interacting protein kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase ICK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Inhibitor of nuclear factor kappa-B kinase subunit beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Insulin receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Insulin receptor-related protein,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Interleukin-1 receptor-associated kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Interleukin-1 receptor-associated kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Interleukin-1 receptor-associated kinase 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase ITK/TSK,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase JAK2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase JAK3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Vascular endothelial growth factor receptor 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase SIK3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mast/stem cell growth factor receptor Kit,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase LATS1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Lck,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,LIM domain kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,LIM domain kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Leucine-rich repeat serine/threonine-protein kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Leukocyte tyrosine kinase receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Lyn,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity mitogen-activated protein kinase kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity mitogen-activated protein kinase kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity mitogen-activated protein kinase kinase 5,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Dual specificity mitogen-activated protein kinase kinase 6,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 10,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 11,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 12,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 13,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 15,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 6,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase 9,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase kinase 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase kinase kinase kinase 5,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase 10,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase 13,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase 14,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase 15,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase 7,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Mitogen-activated protein kinase 9,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,MAP kinase-activated protein kinase 5,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase MARK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase MARK2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,MAP/microtubule affinity-regulating kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,MAP/microtubule affinity-regulating kinase 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,CLIP-associating protein 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Microtubule-associated serine/threonine-protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Megakaryocyte-associated tyrosine-protein kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Maternal embryonic leucine zipper kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Mer,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Misshapen-like kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,MAP kinase-interacting serine/threonine-protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,MAP kinase-interacting serine/threonine-protein kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Macrophage-stimulating protein receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Muscle, skeletal receptor tyrosine-protein kinase",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Myosin light chain kinase, smooth muscle",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Myosin light chain kinase 2, skeletal/cardiac muscle",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Myosin light chain kinase 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Myosin light chain kinase family member 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Myosin-IIIa,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Nek1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Nek11,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Nek2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Nek3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Nek4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Nek5,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Nek9,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,High affinity nerve growth factor receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,BDNF/NT-3 growth factors receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,NT-3 growth factor receptor,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,NUAK family SNF1-like kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,NUAK family SNF1-like kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase OSR1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PAK 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PAK 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PAK 3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PAK 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PAK 6,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PAK 5,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cyclin-dependent kinase 16,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cyclin-dependent kinase 17,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Platelet-derived growth factor receptor alpha,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Platelet-derived growth factor receptor beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,3-phosphoinositide-dependent protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Cyclin-dependent kinase 15,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Phosphatidylinositol 4-kinase beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase pim-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase pim-3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase N1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase N2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PLK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PLK2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PLK3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PLK4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,5'-AMP-activated protein kinase catalytic subunit alpha-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,5'-AMP-activated protein kinase catalytic subunit alpha-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,5'-AMP-activated protein kinase catalytic subunit alpha-2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,5'-AMP-activated protein kinase subunit beta-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,5'-AMP-activated protein kinase subunit beta-2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,5'-AMP-activated protein kinase subunit gamma-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,5'-AMP-activated protein kinase subunit gamma-2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,5'-AMP-activated protein kinase subunit gamma-3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,cAMP-dependent protein kinase catalytic subunit beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Protein kinase C delta type,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Protein kinase C epsilon type,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Protein kinase C gamma type,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Protein kinase C iota type,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Protein kinase C theta type,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase D1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,cGMP-dependent protein kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase PRP4 homolog,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Focal adhesion kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Protein-tyrosine kinase 2-beta,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Protein-tyrosine kinase 6,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,RAF proto-oncogene serine/threonine-protein kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Proto-oncogene tyrosine-protein kinase receptor Ret,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase RIO1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase RIO2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase RIO3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Receptor-interacting serine/threonine-protein kinase 1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Receptor-interacting serine/threonine-protein kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Receptor-interacting serine/threonine-protein kinase 4,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Rho-associated protein kinase 2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Proto-oncogene tyrosine-protein kinase ROS,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ribosomal protein S6 kinase alpha-1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Ribosomal protein S6 kinase alpha-3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase SBK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Uncharacterized serine/threonine-protein kinase SBK3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase Sgk3,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase SIK1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase SIK2,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,STE20-like serine/threonine-protein kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,SNF-related serine/threonine-protein kinase,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Proto-oncogene tyrosine-protein kinase Src,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Tyrosine-protein kinase Srms,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 10,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 16,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 17A,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 17B,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fostamatinib,Serine/threonine-protein kinase 32A,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Fotemustine,"Thioredoxin reductase 1, cytoplasmic",CCOP(=O)(OCC)[C@@H](C)NC(=O)N(CCCl)N=O
Fradafiban,Integrin alpha-IIb,NC(=N)C1=CC=C(C=C1)C1=CC=C(OC[C@@H]2C[C@@H](CC(O)=O)C(=O)N2)C=C1
Fradafiban,Integrin beta-3,NC(=N)C1=CC=C(C=C1)C1=CC=C(OC[C@@H]2C[C@@H](CC(O)=O)C(=O)N2)C=C1
Framycetin,30S ribosomal protein S12,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O
Framycetin,C-X-C chemokine receptor type 4,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O
Fremanezumab,Calcitonin gene-related peptide 1,
Fremanezumab,Calcitonin gene-related peptide 2,
Freselestat,Neutrophil elastase,CC(C)[C@@H](NC(=O)CN1C(=O)C(N)=CN=C1C1=CC=CC=C1)[C@@H](O)C1=NN=C(O1)C(C)(C)C
Freselestat,Chymotrypsin-like elastase family member 1,CC(C)[C@@H](NC(=O)CN1C(=O)C(N)=CN=C1C1=CC=CC=C1)[C@@H](O)C1=NN=C(O1)C(C)(C)C
Frovatriptan,5-hydroxytryptamine receptor 1D,CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O
Frovatriptan,5-hydroxytryptamine receptor 1B,CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O
Fructose,Bis(5'-adenosyl)-triphosphatase,OC[C@@H]1O[C@@](O)(CO)[C@H](O)[C@H]1O
Fructose,Maltoporin,OC[C@@H]1O[C@@](O)(CO)[C@H](O)[C@H]1O
Fructose -6-Phosphate,Glucosamine-6-phosphate deaminase 1,OCC(=O)[C@@H](O)[C@@H](O)[C@H](O)COP(O)(O)=O
Fructose-6-Phosphate,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O
Fructose-6-Phosphate,Glucose-6-phosphate isomerase,OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O
Fructose-6-Phosphate,ATP-dependent 6-phosphofructokinase,OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O
Fructose-6-Phosphate,"Fructose-1,6-bisphosphatase 1",OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O
Fructose-6-Phosphate,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O
Fucitol,L-fucose isomerase,[H][C@@](C)(O)[C@@]([H])(O)[C@@]([H])(O)[C@]([H])(O)CO
Fudp,Nucleoside diphosphate kinase A,[H][C@]1(F)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(O)=O)N1C=CC(O)=NC1=O
Fulvestrant,Estrogen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
Fumagillin,Methionine aminopeptidase 2,CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O
Fumaric Acid,"NAD-dependent malic enzyme, mitochondrial",OC(=O)\C=C\C(O)=O
Fumaric Acid,Malate dehydrogenase,OC(=O)\C=C\C(O)=O
Fumaric Acid,Fumarate reductase flavoprotein subunit,OC(=O)\C=C\C(O)=O
Fumaric Acid,Fumarate reductase flavoprotein subunit,OC(=O)\C=C\C(O)=O
Fumaric Acid,Fumarylacetoacetase,OC(=O)\C=C\C(O)=O
"Furo[2,3d]Pyrimidine Antifolate",Dihydrofolate reductase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)N(C)CC1=COC2=NC(N)=NC(N)=C12)C(O)=O
Furosemide,Solute carrier family 12 member 1,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O
Furosemide,Carbonic anhydrase 2,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O
Furoyl-Leucine,Disintegrin and metalloproteinase domain-containing protein 28,[H][C@@](CC(C)C)(NC(=O)C1=CC=CO1)C(O)=O
Fusicoccin,14-3-3 protein epsilon,[H]\C1=C2/[C@@]([H])(COC)CC[C@@]2([H])[C@@]([H])(C)[C@@]([H])(O)[C@]([H])(O[C@@]2([H])O[C@]([H])(COC(C)(C)C=C)[C@@]([H])(O)[C@]([H])(OC(C)=O)[C@@]2([H])O)C2=C(C[C@]([H])(O)[C@]12C)[C@]([H])(C)COC(C)=O
Fusidic acid,Elongation factor G,O[C@@H]1CC[C@@]2(C)[C@@]([H])(CC[C@@]3(C)[C@@]2([H])[C@H](O)C[C@@]2([H])\C([C@@H](OC(=O)C)C[C@]32C)=C(/CCC=C(C)C)C(O)=O)[C@@H]1C
Fusidic acid,Chloramphenicol acetyltransferase,O[C@@H]1CC[C@@]2(C)[C@@]([H])(CC[C@@]3(C)[C@@]2([H])[C@H](O)C[C@@]2([H])\C([C@@H](OC(=O)C)C[C@]32C)=C(/CCC=C(C)C)C(O)=O)[C@@H]1C
Fusidic acid,Chloramphenicol acetyltransferase 3,O[C@@H]1CC[C@@]2(C)[C@@]([H])(CC[C@@]3(C)[C@@]2([H])[C@H](O)C[C@@]2([H])\C([C@@H](OC(=O)C)C[C@]32C)=C(/CCC=C(C)C)C(O)=O)[C@@H]1C
GALACTOSE GREASE,Histo-blood group ABO system transferase,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCCCC(=O)OC)[C@]1([H])O
GC-24,Thyroid hormone receptor beta,CC1=CC(OCC(O)=O)=CC(C)=C1CC1=CC=C(O)C(CC2=CC=CC=C2)=C1
GE-2270A,Elongation factor Tu,[H][C@](O)(C1=CC=CC=C1)[C@]1([H])N=C(O)CN=C(O)C2=C(COC)SC(=N2)[C@@]([H])(N=C(O)C2=C(C)SC(=N2)[C@]([H])(CC(O)=NC)N=C(O)C2=CSC(=N2)C2=C(N=C(C=C2)C2=NC(=CS2)C2=N[C@@]([H])(CO2)C(=O)N2CCC[C@@]2([H])C(O)=N)C2=CSC(=N2)C2=CSC1=N2)C(C)C
GEM-231,cAMP-dependent protein kinase type II-alpha regulatory subunit,
GEM-231,cAMP-dependent protein kinase type I-alpha regulatory subunit,
GIBBERELLIN A4,Arylacetamide deacetylase-like 2,[H][C@@]12C[C@@]3(CC1=C)[C@@]([H])(CC2)[C@@]12CC[C@]([H])(O)[C@@](C)(C(=O)O1)[C@@]2([H])[C@]3([H])C(O)=O
GLUTATHIONE SULFINATE,Glutathione S-transferase kappa 1,N[C@@H](CCC(=O)N[C@@H](C[S@](O)=O)C(=O)NCC(O)=O)C(O)=O
GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,Prolyl tripeptidyl peptidase,[H][C@@](C)(NC(=O)CN)C(=O)N1CCC[C@@]1([H])C(=O)NC1=CC=C2C=CC=CC2=C1
GM6001,Lethal factor,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(=O)NC
GM6001,Disintegrin and metalloproteinase domain-containing protein 28,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(=O)NC
GM6001,Aggrecan core protein,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(=O)NC
GMX1777,Nicotinamide phosphoribosyltransferase,
GPI-1485,Peptidyl-prolyl cis-trans isomerase FKBP1A,CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(O)=O
GSHNA,Glutathione S-transferase A3,[H][C@](N)(CCC(O)=N[C@@]([H])(CS[C@@]1([H])C[C@]([H])(O)O[C@]1([H])CCCCC)C(O)=NCC(O)=O)C(O)=O
GSK-364735,Gag-Pol polyprotein,CN1C(=O)C(C(=O)NCCO)=C(O)C2=NC=C(CC3=CC=C(F)C=C3)C=C12
GSK-923295,Centromere-associated protein E,
GTI 2040,Ribonucleoside-diphosphate reductase subunit M2,
GTS-21,Neuronal acetylcholine receptor subunit alpha-7,[H]\C(=C1\CCCN=C1C1=CN=CC=C1)C1=C(OC)C=C(OC)C=C1
"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",Purine nucleoside phosphorylase,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](CO)[C@H]2O[C@@H](CP(O)(O)=O)O[C@@H]12
"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",Purine nucleoside phosphorylase,NC1=NC(=O)C2=C(N1)N(C=N2)[C@@H]1O[C@H](CO)[C@H]2O[C@@H](O[C@@H]12)P(O)(O)=O
GW 468816,Glycine receptor subunit alpha-1,
GW 597599,Substance-P receptor,
Gabaculine,"Ornithine aminotransferase, mitochondrial",NC1=CC=CC(=C1)C(O)=O
Gabaculine,"Glutamate-1-semialdehyde 2,1-aminomutase",NC1=CC=CC(=C1)C(O)=O
Gabapentin,Voltage-dependent calcium channel subunit alpha-2/delta-1,NCC1(CC(O)=O)CCCCC1
Gabapentin,Voltage-dependent calcium channel subunit alpha-2/delta-2,NCC1(CC(O)=O)CCCCC1
Gabapentin,Voltage-dependent N-type calcium channel subunit alpha-1B,NCC1(CC(O)=O)CCCCC1
Gabapentin,Adenosine receptor A1,NCC1(CC(O)=O)CCCCC1
Gabapentin,"Glutamate receptor ionotropic, NMDA 1",NCC1(CC(O)=O)CCCCC1
Gabapentin,"Glutamate receptor ionotropic, NMDA 2A",NCC1(CC(O)=O)CCCCC1
Gabapentin,"Glutamate receptor ionotropic, NMDA 2B",NCC1(CC(O)=O)CCCCC1
Gabapentin,"Glutamate receptor ionotropic, NMDA 2C",NCC1(CC(O)=O)CCCCC1
Gabapentin,"Glutamate receptor ionotropic, NMDA 2D",NCC1(CC(O)=O)CCCCC1
Gabapentin,"Glutamate receptor ionotropic, NMDA 3A",NCC1(CC(O)=O)CCCCC1
Gabapentin,"Glutamate receptor ionotropic, NMDA 3B",NCC1(CC(O)=O)CCCCC1
Gabapentin,Gamma-aminobutyric acid type B receptor subunit 1,NCC1(CC(O)=O)CCCCC1
Gabapentin,Gamma-aminobutyric acid type B receptor subunit 2,NCC1(CC(O)=O)CCCCC1
Gabapentin enacarbil,Voltage-dependent calcium channel subunit alpha-2/delta-1,CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1
Gabapentin enacarbil,Voltage-dependent calcium channel subunit alpha-2/delta-2,CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1
Gabexate,Plasma kallikrein,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1
Gabexate,Prothrombin,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1
Gabexate,Plasminogen,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1
Gadopentetic acid,"6-phosphogluconate dehydrogenase, decarboxylating",[Gd+3].OC(=O)CN(CCN(CCN(CC(O)=O)CC([O-])=O)CC([O-])=O)CC([O-])=O
Galactose-uridine-5'-diphosphate,Histo-blood group ABO system transferase,OC[C@H]1O[C@H](O[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@H]1O
Galactose-uridine-5'-diphosphate,"Beta-1,4-galactosyltransferase 1",OC[C@H]1O[C@H](O[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@H]1O
Galactose-uridine-5'-diphosphate,UDP-glucose 4-epimerase,OC[C@H]1O[C@H](O[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@H]1O
Galantamine,Acetylcholinesterase,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Acetylcholine receptor subunit alpha,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Acetylcholine receptor subunit beta,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Acetylcholine receptor subunit delta,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Acetylcholine receptor subunit gamma,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Acetylcholine receptor subunit epsilon,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit alpha-2,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit alpha-3,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit alpha-4,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit alpha-5,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit alpha-6,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit alpha-7,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit alpha-9,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit alpha-10,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit beta-2,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit beta-3,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Neuronal acetylcholine receptor subunit beta-4,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galantamine,Cholinesterase,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
Galcanezumab,Calcitonin gene-related peptide 1,
Galcanezumab,Calcitonin gene-related peptide 2,
Galiximab,T-lymphocyte activation antigen CD80,
Gallamine Triethiodide,Muscarinic acetylcholine receptor M2,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
Gallamine Triethiodide,Acetylcholinesterase,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
Gallamine Triethiodide,Neuronal acetylcholine receptor subunit alpha-2,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
Gallamine Triethiodide,Muscarinic acetylcholine receptor M1,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
Gallamine Triethiodide,Muscarinic acetylcholine receptor M5,[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
Gallichrome,Iron(3+)-hydroxamate-binding protein FhuD,CC1=[O][Ga]2345ON1CCC[C@H]1NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCN(O2)C(C)=[O]3)NC(=O)C(CCCN(O4)C(C)=[O]5)NC1=O
Gallium maltolate,Ribonucleoside-diphosphate reductase large subunit,[Ga+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1
Gallium nitrate,Ribonucleoside-diphosphate reductase subunit M2,[Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
Gallium nitrate,"V-type proton ATPase subunit B, brain isoform",[Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
Gallium nitrate,Osteocalcin,[Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
Gallium nitrate,Protein-tyrosine-phosphatase,[Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
Gallium nitrate,Interleukin-1 beta,[Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
Galsulfase,Perilipin-3,
"Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate",NH(3)-dependent NAD(+) synthetase,[H][C@]1(COP(O)(=O)OP(O)(=O)C[As](O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
"Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate",Glycerol kinase,[H][C@]1(COP(O)(=O)OP(O)(=O)C[As](O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Gamma-Carboxy-Glutamic Acid,Prothrombin,N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O
Gamma-Carboxy-Glutamic Acid,Coagulation factor X,N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O
Gamma-Carboxy-Glutamic Acid,Osteocalcin,N[C@@H](CC(C(O)=O)C(O)=O)C(O)=O
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,"cGMP-specific 3',5'-cyclic phosphodiesterase",[H][C@](N)(CCC(O)=N[C@@]([H])(CSCC1=CC=CC=C1I)C(O)=NCC(O)=O)C(O)=O
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,Glutathione S-transferase Mu 4,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCC1=CC=CC=C1I)C(O)=NCC(O)=O)C(O)=O
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",[H][C@](N)(CCC(O)=N[C@@]([H])(CSCC1=CC=CC=C1I)C(O)=NCC(O)=O)C(O)=O
Ganaxolone,Gamma-aminobutyric acid receptor subunit alpha-2,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C
Ganaxolone,Gamma-aminobutyric acid receptor subunit alpha-5,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C
Ganaxolone,Gamma-aminobutyric acid receptor subunit alpha-4,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C
Ganaxolone,Gamma-aminobutyric acid receptor subunit alpha-3,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C
Ganaxolone,Gamma-aminobutyric acid receptor subunit alpha-6,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C
Ganaxolone,Gamma-aminobutyric acid receptor subunit alpha-1,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@](C)(O)CC[C@]12C
Ganciclovir,DNA polymerase catalytic subunit,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1
Ganciclovir,Thymidine kinase,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1
Ganirelix,Gonadotropin-releasing hormone receptor,CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
Ganstigmine,Acetylcholinesterase,CCC1=C(NC(=O)OC2=CC3=C(C=C2)N(C)[C@H]2ON(C)CC[C@@]32C)C=CC=C1
Gantacurium,Neuronal acetylcholine receptor subunit alpha-3,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N@@+]2(C)CCCOC(=O)C(\Cl)=C\C(=O)OCCC[N@@+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@@H]2C2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
Gatifloxacin,DNA gyrase subunit A,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1
Gatifloxacin,DNA gyrase subunit B,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1
Gatifloxacin,DNA topoisomerase 4 subunit A,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1
Gatifloxacin,DNA topoisomerase 4 subunit B,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1
Gavestinel,"Glutamate receptor ionotropic, NMDA 1",OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1
Gavestinel,"Glutamate receptor ionotropic, NMDA 2A",OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1
Gavestinel,"Glutamate receptor ionotropic, NMDA 2B",OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1
Gavestinel,"Glutamate receptor ionotropic, NMDA 2C",OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1
Gavestinel,"Glutamate receptor ionotropic, NMDA 2D",OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1
Gavestinel,"Glutamate receptor ionotropic, NMDA 3A",OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1
Gavestinel,"Glutamate receptor ionotropic, NMDA 3B",OC(=O)C1=C(\C=C\C(=O)NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1
Gefitinib,Epidermal growth factor receptor,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
Geldanamycin,Heat shock protein HSP 90-alpha,[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)\C(C)=C([H])\[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(OC)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC
Geldanamycin,Heat shock protein HSP 90-beta,[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)\C(C)=C([H])\[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(OC)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC
Geldanamycin,Endoplasmin,[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)\C(C)=C([H])\[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(OC)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC
Gemcitabine,Ribonucleoside-diphosphate reductase large subunit,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
Gemcitabine,Thymidylate synthase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
Gemcitabine,UMP-CMP kinase,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
Gemeprost,Prostaglandin E2 receptor EP2 subtype,CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(=O)OC
Gemeprost,Prostaglandin E2 receptor EP3 subtype,CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(=O)OC
Gemfibrozil,Peroxisome proliferator-activated receptor alpha,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
Gemifloxacin,DNA gyrase subunit A,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O
Gemifloxacin,DNA topoisomerase 4 subunit A,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O
Gemtuzumab ozogamicin,Myeloid cell surface antigen CD33,
Gemtuzumab ozogamicin,High affinity immunoglobulin gamma Fc receptor I,
Gemtuzumab ozogamicin,Low affinity immunoglobulin gamma Fc region receptor III-B,
Gemtuzumab ozogamicin,Complement C1s subcomponent,
Gemtuzumab ozogamicin,Complement C1r subcomponent,
Gemtuzumab ozogamicin,Complement C1q subcomponent subunit A,
Gemtuzumab ozogamicin,Complement C1q subcomponent subunit B,
Gemtuzumab ozogamicin,Complement C1q subcomponent subunit C,
Gemtuzumab ozogamicin,Low affinity immunoglobulin gamma Fc region receptor III-A,
Gemtuzumab ozogamicin,Low affinity immunoglobulin gamma Fc region receptor II-a,
Gemtuzumab ozogamicin,Low affinity immunoglobulin gamma Fc region receptor II-b,
Gemtuzumab ozogamicin,Low affinity immunoglobulin gamma Fc region receptor II-c,
Geneticin,Ornithine decarboxylase,[H][C@](C)(O)[C@@]1([H])O[C@]([H])(O[C@]2([H])[C@@]([H])(N)C[C@@]([H])(N)[C@]([H])(O[C@@]3([H])OC[C@](C)(O)[C@]([H])(NC)[C@@]3([H])O)[C@@]2([H])O)[C@]([H])(N)[C@@]([H])(O)[C@]1([H])O
Genistein,DNA topoisomerase 2-alpha,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Estrogen receptor beta,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Protein-tyrosine kinase 2-beta,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Nuclear receptor coactivator 1,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Estrogen receptor,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Nuclear receptor coactivator 2,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Steroid hormone receptor ERR2,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Steroid hormone receptor ERR1,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Nuclear receptor subfamily 1 group I member 2,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,RAC-alpha serine/threonine-protein kinase,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,G-protein coupled estrogen receptor 1,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Cytochrome P450 1B1,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Genistein,Sex hormone-binding globulin,OC1=CC=C(C=C1)C1=COC2=C(C(O)=CC(O)=C2)C1=O
Gentamicin,30S ribosomal protein S12,CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1
Gentamicin,Low-density lipoprotein receptor-related protein 2,CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1
Gentamicin,NH(3)-dependent NAD(+) synthetase,CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1
Gentamicin,Dihydrofolate reductase,CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1
Gentamicin C1a,30S ribosomal protein S12,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O
Genz-10850,Enoyl-[acyl-carrier-protein] reductase [NADH],O=C(N1CCN(CC1)C1C2=CC=CC=C2C2=CC=CC=C12)C1=CC2=C(NC=C2)C=C1
Geranyl Diphosphate,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O
Geranyl Diphosphate,Bifunctional enzyme IspD/IspF,CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O
Geranyl Diphosphate,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O
Geranyl Diphosphate,Farnesyl pyrophosphate synthase,CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O
Geranyl Diphosphate,Prenyltransferase,CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O
Geranyl Diphosphate,Geranylgeranyl pyrophosphate synthase,CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O
Geranyl Diphosphate,"(2Z,6E)-farnesyl diphosphate synthase",CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O
Geranyl Diphosphate,Decaprenyl diphosphate synthase,CC(C)=CCC\C(C)=C\CO[P@@](=O)(O)OP(=O)(O)O
Geranylgeranyl diphosphate,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O
Geranylgeranyl diphosphate,Geranylgeranyl transferase type-1 subunit beta,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O
Geranylgeranyl diphosphate,Protein farnesyltransferase subunit beta,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O
Geranylgeranyl diphosphate,Geranylgeranyl pyrophosphate synthase,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O
Geranylgeranyl diphosphate,Farnesyl pyrophosphate synthase,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O
Geranylgeranyl diphosphate,Geranylgeranyl transferase type-2 subunit alpha,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O
Geranylgeranyl diphosphate,Geranylgeranyl transferase type-2 subunit beta,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O
Gestodene,Progesterone receptor,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C
Gestrinone,Sex hormone-binding globulin,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Gestrinone,Progesterone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Gestrinone,Glucocorticoid receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Gestrinone,Androgen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Gestrinone,Gonadotropin-releasing hormone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Gestrinone,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Gevokizumab,Interleukin-1 beta,
Ghavamiol,Alpha-mannosidase 2,[H][C@@](O)(CN1C[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])CO)C([H])(CO)OS([O-])([O-])[O-]
Gibberellic acid,Arylacetamide deacetylase-like 2,[H][C@@]12CC[C@]3(O)C[C@]1(CC3=C)[C@@H](C(O)=O)[C@]1([H])[C@@]3(C)[C@@H](O)C=C[C@@]21OC3=O
Gilteritinib,Receptor-type tyrosine-protein kinase FLT3,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 1A,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 1B,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 1D,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 1E,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 1F,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 2A,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 2B,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 2C,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 3A,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 3B,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 3C,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 3D,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 3E,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 4,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 6,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,5-hydroxytryptamine receptor 7,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,Tyrosine-protein kinase receptor UFO,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gilteritinib,ALK tyrosine kinase receptor,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
Gimeracil,Dihydropyrimidine dehydrogenase [NADP(+)],OC1=CC(=O)NC=C1Cl
Ginkgo biloba,Sodium-dependent noradrenaline transporter,
Ginkgo biloba,Glycine receptor subunit alpha-1,
Ginkgo biloba,"Phospholipase A2, membrane associated",
Ginkgo biloba,Gamma-aminobutyric acid receptor subunit alpha-1,
Ginkgo biloba,Gamma-aminobutyric acid receptor subunit beta-2,
Ginkgo biloba,Gamma-aminobutyric acid receptor subunit gamma-2,
Ginseng,Prostaglandin G/H synthase 2,
Ginseng,Interleukin-6,
Ginseng,Aryl hydrocarbon receptor,
Ginsenoside Rb1,Solute carrier organic anion transporter family member 1B3,[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)C(C)(CCC=C(C)C)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O
Ginsenoside Rg1,Solute carrier organic anion transporter family member 1B3,CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@H](C[C@@]21C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Girentuximab,Interleukin-2,
Girentuximab,Carbonic anhydrase 9,
Glasdegib,Smoothened homolog,CN1CC[C@H](C[C@@H]1C1=NC2=CC=CC=C2N1)NC(=O)NC1=CC=C(C=C1)C#N
Glatiramer,"HLA class II histocompatibility antigen, DRB1-1 beta chain",
Glecaprevir,NS3 protease,CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC\C=C\C(F)(F)C2=NC3=C(C=CC=C3)N=C2O[C@@H]2C[C@H](N(C2)C1=O)C(=O)N[C@@]1(C[C@H]1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1
Glembatumumab vedotin,Transmembrane glycoprotein NMB,
Gliclazide,ATP-binding cassette sub-family C member 8,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1
Gliclazide,Vascular endothelial growth factor A,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1
Glimepiride,ATP-sensitive inward rectifier potassium channel 11,[H][C@]1(C)CC[C@@]([H])(CC1)N=C(O)NS(=O)(=O)C1=CC=C(CCN=C(O)N2CC(C)=C(CC)C2=O)C=C1
Glimepiride,ATP-sensitive inward rectifier potassium channel 1,[H][C@]1(C)CC[C@@]([H])(CC1)N=C(O)NS(=O)(=O)C1=CC=C(CCN=C(O)N2CC(C)=C(CC)C2=O)C=C1
Glimepiride,ATP-binding cassette sub-family C member 8,[H][C@]1(C)CC[C@@]([H])(CC1)N=C(O)NS(=O)(=O)C1=CC=C(CCN=C(O)N2CC(C)=C(CC)C2=O)C=C1
Glipizide,ATP-binding cassette sub-family C member 8,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glipizide,Peroxisome proliferator-activated receptor gamma,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Gliquidone,ATP-binding cassette sub-family C member 8,COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O
Gliquidone,ATP-sensitive inward rectifier potassium channel 8,COC1=CC2=C(C=C1)C(C)(C)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C2=O
Glisoxepide,ATP-sensitive inward rectifier potassium channel 8,CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1
Glucagon,Glucagon receptor,
Glucagon,Glucagon-like peptide 1 receptor,
Glucagon,Glucagon-like peptide 2 receptor,
Glucaric acid,Glucarate dehydratase,O[C@@H]([C@H](O)[C@@H](O)C(O)=O)[C@H](O)C(O)=O
Gluconolactone,Lactase-phlorizin hydrolase,OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O
Glucosamine,Matrix metalloproteinase-9,N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O
Glucosamine,Nuclear factor NF-kappa-B p100 subunit,N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O
Glucosamine,Tumor necrosis factor,N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O
Glucosamine,Interferon gamma,N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O
Glucosamine,Chitosanase,N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O
Glucosamine 1-Phosphate,Ferrichrome-iron receptor,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(O)=O
Glucosamine 4-Phosphate,Ferrichrome-iron receptor,N[C@H]1[C@H](O)O[C@H](CO)[C@@H](OP(O)(O)=O)[C@@H]1O
Glucosamine 6-Phosphate,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],N[C@H]1[C@@H](O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O
Glucosamine 6-Phosphate,N-acetylglucosamine-6-phosphate deacetylase,N[C@H]1[C@@H](O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O
Glucosaminyl-(Alpha-6)-D-Myo-Inositol,1-phosphatidylinositol phosphodiesterase,N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1O
Glucose-6-Phosphate,Glucose-6-phosphate isomerase,O[C@H](COP(O)(O)=O)[C@H](O)[C@H](O)[C@@H](O)C=O
Glucose-6-Phosphate,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],O[C@H](COP(O)(O)=O)[C@H](O)[C@H](O)[C@@H](O)C=O
Glutamic Acid,"Glutaminase liver isoform, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Cystine/glutamate transporter,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate--cysteine ligase catalytic subunit,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate dehydrogenase 1, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Bifunctional glutamate/proline--tRNA ligase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Asparagine synthetase [glutamine-hydrolyzing],N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"4-aminobutyrate aminotransferase, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,GMP synthase [glutamine-hydrolyzing],N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, kainate 1",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, NMDA 1",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate decarboxylase 1,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Aspartate aminotransferase, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, NMDA 2D",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Vitamin K-dependent gamma-carboxylase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, NMDA 2B",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, NMDA 2C",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Branched-chain-amino-acid aminotransferase, cytosolic",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Aspartate aminotransferase, cytoplasmic",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, NMDA 3B",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate carboxypeptidase 2,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate decarboxylase 2,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Phosphoserine aminotransferase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate--cysteine ligase regulatory subunit,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate receptor 1,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, NMDA 3A",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Alanine aminotransferase 1,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Tyrosine aminotransferase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Folylpolyglutamate synthase, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Branched-chain-amino-acid aminotransferase, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate dehydrogenase 2, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, NMDA 2A",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Formimidoyltransferase-cyclodeaminase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Delta-1-pyrroline-5-carboxylate synthase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Metabotropic glutamate receptor 1,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutaminase kidney isoform, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, kainate 2",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, kainate 4",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, kainate 5",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate receptor 2,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate receptor 4,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamate receptor 3,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, kainate 3",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Metabotropic glutamate receptor 4,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Metabotropic glutamate receptor 7,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Metabotropic glutamate receptor 8,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Excitatory amino acid transporter 2,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Excitatory amino acid transporter 3,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Excitatory amino acid transporter 1,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Aspartate aminotransferase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Kynurenine--oxoglutarate transaminase 3,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Alanine aminotransferase 2,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Phosphoribosylformylglycinamidine synthase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamine synthetase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamine-dependent NAD(+) synthetase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Excitatory amino acid transporter 5,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,5-oxoprolinase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, delta-2",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Excitatory amino acid transporter 4,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Glutamyl aminopeptidase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Probable glutamate--tRNA ligase, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Lengsin,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"N-acetylglutamate synthase, mitochondrial",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Mitochondrial glutamate carrier 2,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Mitochondrial glutamate carrier 1,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Aspartyl aminopeptidase,N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,"Glutamate receptor ionotropic, delta-1",N[C@@H](CCC(O)=O)C(O)=O
Glutamic Acid,Carboxypeptidase Q,N[C@@H](CCC(O)=O)C(O)=O
Glutamine hydroxamate,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],N[C@@H](CCC(=O)NO)C(O)=O
Glutamine t-butyl ester,Glutaminyl-peptide cyclotransferase,CC(C)(C)OC(=O)[C@@H](N)CCC(N)=O
Glutaric Acid,Aspartate aminotransferase,OC(=O)CCCC(O)=O
Glutaric Acid,Branched-chain-amino-acid aminotransferase,OC(=O)CCCC(O)=O
Glutaric Acid,Glutamate decarboxylase alpha,OC(=O)CCCC(O)=O
Glutathione,Glutathione synthetase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,"Glutathione reductase, mitochondrial",N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase Mu 1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase kappa 1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase A3,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase Mu 3,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase A4,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase Mu 4,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase A5,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase P,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase omega-1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione peroxidase 1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione peroxidase 2,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase theta-1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Maleylacetoacetate isomerase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Epididymal secretory glutathione peroxidase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione peroxidase 3,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Gamma-glutamyltranspeptidase 1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Lactoylglutathione lyase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Leukotriene C4 synthase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Hematopoietic prostaglandin D synthase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase Mu 2,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,"Hydroxyacylglutathione hydrolase, mitochondrial",N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase A2,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Microsomal glutathione S-transferase 3,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Thioredoxin domain-containing protein 12,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase A1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Microsomal glutathione S-transferase 1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,S-formylglutathione hydrolase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutaredoxin-1,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase Mu 5,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione peroxidase 6,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione peroxidase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Probable glutathione peroxidase 8,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione peroxidase 7,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Microsomal glutathione S-transferase 2,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Glutathione S-transferase omega-2,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,"Glutaredoxin-2, mitochondrial",N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Aldose reductase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Matrix metalloproteinase-9,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione,Cytochrome P450 3A4,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
Glutathione Sulfonic Acid,Glutathione S-transferase Mu 4,[H][C@](N)(CCC(O)=N[C@@]([H])(CS(O)(=O)=O)C(O)=NCC(O)=O)C(O)=O
Glutathione Sulfonic Acid,Glutathione S-transferase P,[H][C@](N)(CCC(O)=N[C@@]([H])(CS(O)(=O)=O)C(O)=NCC(O)=O)C(O)=O
Glutathione Sulfonic Acid,Glutathione S-transferase GstA,[H][C@](N)(CCC(O)=N[C@@]([H])(CS(O)(=O)=O)C(O)=NCC(O)=O)C(O)=O
Glutathione Sulfonic Acid,Glutathione S-transferase A1,[H][C@](N)(CCC(O)=N[C@@]([H])(CS(O)(=O)=O)C(O)=NCC(O)=O)C(O)=O
Glutathione disulfide,"Glutathione reductase, mitochondrial",N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O
Glutathione disulfide,Glutathione S-transferase Mu 2,N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O
Glutathionylspermidine Disulfide,"Glutathione reductase, mitochondrial",[H][C@@](N)(CCC(O)=N[C@@]([H])(CSSC[C@]([H])(N=C(O)CC[C@@]([H])(N)C(O)=O)C(O)=NCC(O)=NCCCNCCCCN)C(O)=NCC(O)=NCCCNCCCCN)C(O)=O
Glutethimide,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit beta-1,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit beta-2,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit beta-3,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit delta,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit epsilon,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit gamma-1,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit gamma-2,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit gamma-3,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit pi,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glutethimide,Gamma-aminobutyric acid receptor subunit theta,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1
Glyburide,ATP-binding cassette sub-family C member 8,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,ATP-sensitive inward rectifier potassium channel 11,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,G protein-activated inward rectifier potassium channel 4,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,ATP-binding cassette sub-family C member 9,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,Bile salt export pump,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,ATP-binding cassette sub-family A member 1,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,Cystic fibrosis transmembrane conductance regulator,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,ATP-sensitive inward rectifier potassium channel 11,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,ATP-sensitive inward rectifier potassium channel 8,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyburide,"Carnitine O-palmitoyltransferase 1, liver isoform",COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Glyceraldehyde-3-Phosphate,Glyceraldehyde-3-phosphate dehydrogenase A,O[C@H](COP(O)(O)=O)C=O
Glyceraldehyde-3-Phosphate,Glyceraldehyde-3-phosphate dehydrogenase,O[C@H](COP(O)(O)=O)C=O
Glyceraldehyde-3-Phosphate,NADP-dependent glyceraldehyde-3-phosphate dehydrogenase,O[C@H](COP(O)(O)=O)C=O
Glycerin,Peroxisome proliferator-activated receptor delta,OCC(O)CO
Glycerin,Hematopoietic prostaglandin D synthase,OCC(O)CO
Glycerin,Glutathione S-transferase P,OCC(O)CO
Glycerin,Endoglucanase G,OCC(O)CO
Glycerin,Group IIE secretory phospholipase A2,OCC(O)CO
Glycerin,Inositol-3-phosphate synthase 1,OCC(O)CO
Glycerin,C4-dicarboxylate transport transcriptional regulatory protein DctD,OCC(O)CO
Glycerin,Alcohol dehydrogenase 1B,OCC(O)CO
Glycerin,"Inositol 1,4,5-trisphosphate receptor type 1",OCC(O)CO
Glycerin,Glycodelin,OCC(O)CO
Glycerin,Alpha-N-acetylgalactosaminidase,OCC(O)CO
Glycerin,Cytochrome c4,OCC(O)CO
Glycerin,Bacterioferritin,OCC(O)CO
Glycerin,TGF-beta receptor type-2,OCC(O)CO
Glycerin,Argininosuccinate synthase,OCC(O)CO
Glycerin,Enolase,OCC(O)CO
Glycerin,ADP-ribosylation factor 1,OCC(O)CO
Glycerin,Multidrug resistance protein MexA,OCC(O)CO
Glycerin,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,OCC(O)CO
Glycerin,Histidinol dehydrogenase,OCC(O)CO
Glycerin,DNA mismatch repair protein MutL,OCC(O)CO
Glycerin,Glycerol uptake facilitator protein,OCC(O)CO
Glycerin,Ribonucleoside-diphosphate reductase 1 subunit beta,OCC(O)CO
Glycerin,Adenine DNA glycosylase,OCC(O)CO
Glycerin,tRNA (cytosine(38)-C(5))-methyltransferase,OCC(O)CO
Glycerol-2-Phosphate,Triosephosphate isomerase,OCC(CO)OP(O)(O)=O
Glycinamid,Neutrophil collagenase,NCC(N)=O
Glycinamide Ribonucleotide,Trifunctional purine biosynthetic protein adenosine-3,NCC(=O)NC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Glycinamide Ribonucleotide,Phosphoribosylglycinamide formyltransferase,NCC(=O)NC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Glycinamide Ribonucleotide,Phosphoribosylglycinamide formyltransferase 2,NCC(=O)NC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O
Glycine,Glycine receptor subunit beta,NCC(O)=O
Glycine,"Alanine--glyoxylate aminotransferase 2, mitochondrial",NCC(O)=O
Glycine,Glutathione synthetase,NCC(O)=O
Glycine,"Serine hydroxymethyltransferase, mitochondrial",NCC(O)=O
Glycine,Serine--pyruvate aminotransferase,NCC(O)=O
Glycine,"Serine hydroxymethyltransferase, cytosolic",NCC(O)=O
Glycine,"Glycine amidinotransferase, mitochondrial",NCC(O)=O
Glycine,Glycine N-methyltransferase,NCC(O)=O
Glycine,"5-aminolevulinate synthase, nonspecific, mitochondrial",NCC(O)=O
Glycine,Glycine receptor subunit alpha-3,NCC(O)=O
Glycine,Glycine receptor subunit alpha-1,NCC(O)=O
Glycine,"Glutamate receptor ionotropic, NMDA 2C",NCC(O)=O
Glycine,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",NCC(O)=O
Glycine,"Glutamate receptor ionotropic, NMDA 3B",NCC(O)=O
Glycine,Proton-coupled amino acid transporter 1,NCC(O)=O
Glycine,"Glycine dehydrogenase (decarboxylating), mitochondrial",NCC(O)=O
Glycine,Glycine receptor subunit alpha-2,NCC(O)=O
Glycine,"Glutamate receptor ionotropic, NMDA 2A",NCC(O)=O
Glycine,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",NCC(O)=O
Glycine,Sodium- and chloride-dependent glycine transporter 1,NCC(O)=O
Glycine,Glycine--tRNA ligase,NCC(O)=O
Glycine,Serine hydroxymethyltransferase,NCC(O)=O
Glycine,"Glycine cleavage system H protein, mitochondrial",NCC(O)=O
Glycine,Bile acid-CoA:amino acid N-acyltransferase,NCC(O)=O
Glycine,N-arachidonyl glycine receptor,NCC(O)=O
Glycine,Glycine N-acyltransferase,NCC(O)=O
Glycine,Glycine N-acyltransferase-like protein 2,NCC(O)=O
Glycine,Glycine N-acyltransferase-like protein 1,NCC(O)=O
Glycine,Vesicular inhibitory amino acid transporter,NCC(O)=O
Glycine,Peroxisomal sarcosine oxidase,NCC(O)=O
Glycine,Sodium- and chloride-dependent glycine transporter 2,NCC(O)=O
Glycine betaine,Apoptosis regulator Bcl-2,C[N+](C)(C)CC([O-])=O
Glycochenodeoxycholic Acid,7-alpha-hydroxysteroid dehydrogenase,C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Glycocholic acid,Gastrotropin,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCC([O-])=O
Glycocyamine,Guanidinoacetate N-methyltransferase,NC(=N)NCC(O)=O
Glycol salicylate,Prostaglandin G/H synthase 1,OCCOC(=O)C1=CC=CC=C1O
Glycol salicylate,Prostaglandin G/H synthase 2,OCCOC(=O)C1=CC=CC=C1O
Glycolic acid,Glucose-6-phosphate 1-dehydrogenase,OCC(O)=O
Glycolic acid,Glycine oxidase,OCC(O)=O
Glycoluril,Streptavidin,O=C1N[C@@H]2NC(=O)N[C@@H]2N1
Glycopyrronium,Muscarinic acetylcholine receptor M1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
Glycopyrronium,Muscarinic acetylcholine receptor M3,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
Glycopyrronium,Muscarinic acetylcholine receptor M2,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine,D-alanyl-D-alanine carboxypeptidase,[H][C@](C)(N=C(O)CCCC[C@]([H])(N=C(O)CN)C(O)=O)C(O)=O
Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-Alanine,D-alanyl-D-alanine carboxypeptidase,[H][C@](C)(N=C(O)[C@@]([H])(C)N=C(O)CCCC[C@]([H])(N=C(O)CN)C(O)=O)C(O)=O
Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate,D-alanyl-D-alanine carboxypeptidase,[H][C@](C)(N=C([O-])CCCC[C@]([H])(N=C(O)CN)C(O)=O)P(O)(O)=O
Glycyrrhizic acid,Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
Glycyrrhizic acid,Tumor necrosis factor,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
Glycyrrhizic acid,Caspase-3,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
Glycyrrhizic acid,Nuclear factor NF-kappa-B p100 subunit,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
Glycyrrhizic acid,Nuclear factor NF-kappa-B p105 subunit,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
Glycyrrhizic acid,Lipoprotein lipase,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
Glymidine,ATP-sensitive inward rectifier potassium channel 1,COCCOC1=CN=C(NS(=O)(=O)C2=CC=CC=C2)N=C1
Glymidine,ATP-binding cassette sub-family C member 8,COCCOC1=CN=C(NS(=O)(=O)C2=CC=CC=C2)N=C1
Glyoxylic acid,Malate synthase G,OC(=O)C=O
Glyoxylic acid,Putative 4-hydroxy-4-methyl-2-oxoglutarate aldolase,OC(=O)C=O
Glyoxylic acid,Malate synthase G,OC(=O)C=O
Glyoxylic acid,Isocitrate lyase,OC(=O)C=O
Glyphosate,3-phosphoshikimate 1-carboxyvinyltransferase,OC(=O)C[NH2+]CP(O)(O)=O
Glyphosate,3-phosphoshikimate 1-carboxyvinyltransferase,OC(=O)C[NH2+]CP(O)(O)=O
Glyphosate,Aromatase,OC(=O)C[NH2+]CP(O)(O)=O
Golimumab,Tumor necrosis factor,
Golotimod,Toll-like receptor 7,N[C@H](CCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O)C(O)=O
Golotimod,Toll-like receptor 2,N[C@H](CCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O)C(O)=O
Golotimod,Toll-like receptor 9,N[C@H](CCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O)C(O)=O
Golotimod,Toll-like receptor 4,N[C@H](CCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O)C(O)=O
Gonadorelin,Gonadotropin-releasing hormone receptor,CC(C)CC(NC(=O)CNC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CN=CN1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(N)=O
Gonadorelin,Putative gonadotropin-releasing hormone II receptor,CC(C)CC(NC(=O)CNC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CN=CN1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(N)=O
Goserelin,Lutropin-choriogonadotropic hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O
Goserelin,Gonadotropin-releasing hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O
Gosogliptin,Dipeptidyl peptidase 4,[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCC(F)(F)C1)N1CCN(CC1)C1=NC=CC=N1
Gossypol,Bcl-2-like protein 1,CC(C)C1=C2C=C(C)C(=C(O)C2=C(C=O)C(O)=C1O)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C
Gpi-1046,Peptidyl-prolyl cis-trans isomerase FKBP1A,[H][C@]1(CCCN1C(=O)C(=O)C(C)(C)CC)C(=O)OCCCC1=CN=CC=C1
Granisetron,5-hydroxytryptamine receptor 3A,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2
Grapiprant,Prostaglandin E2 receptor EP4 subtype,CCC1=NC2=C(C)N=C(C)C=C2N1C1=CC=C(CCNC(=O)NS(=O)(=O)C2=CC=C(C)C=C2)C=C1
Grazoprevir,Genome polyprotein,[H][C@@]12C[C@@]1([H])OC(O)=N[C@]([H])(C(=O)N1C[C@@]([H])(C[C@@]1([H])C(O)=N[C@@]1(C[C@@]1([H])C=C)C(O)=NS(=O)(=O)C1CC1)OC1=C(CCCCC2)N=C2C=CC(OC)=CC2=N1)C(C)(C)C
Grepafloxacin,DNA gyrase subunit A,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O
Grepafloxacin,DNA topoisomerase 4 subunit A,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O
Griseofulvin,Tubulin beta chain,COC1=CC(OC)=C(Cl)C2=C1C(=O)[C@]1(O2)[C@H](C)CC(=O)C=C1OC
Griseofulvin,Tubulin alpha chain,COC1=CC(OC)=C(Cl)C2=C1C(=O)[C@]1(O2)[C@H](C)CC(=O)C=C1OC
Griseofulvin,"Keratin, type I cytoskeletal 12",COC1=CC(OC)=C(Cl)C2=C1C(=O)[C@]1(O2)[C@H](C)CC(=O)C=C1OC
Grn163l,Telomerase reverse transcriptase,
Grn163l,Telomerase-binding protein EST1A,
Grn163l,N-terminal kinase-like protein,
Grn163l,Prostaglandin E synthase 3,
Guaiacol,Serum albumin,COC1=C(O)C=CC=C1
Guaifenesin,"Glutamate receptor ionotropic, NMDA 1",COC1=CC=CC=C1OCC(O)CO
Guaifenesin,"Glutamate receptor ionotropic, NMDA 2A",COC1=CC=CC=C1OCC(O)CO
Guaifenesin,"Glutamate receptor ionotropic, NMDA 2B",COC1=CC=CC=C1OCC(O)CO
Guaifenesin,"Glutamate receptor ionotropic, NMDA 2C",COC1=CC=CC=C1OCC(O)CO
Guaifenesin,"Glutamate receptor ionotropic, NMDA 2D",COC1=CC=CC=C1OCC(O)CO
Guaifenesin,"Glutamate receptor ionotropic, NMDA 3A",COC1=CC=CC=C1OCC(O)CO
Guaifenesin,"Glutamate receptor ionotropic, NMDA 3B",COC1=CC=CC=C1OCC(O)CO
Guanabenz,Alpha-2A adrenergic receptor,NC(N)=NN=CC1=C(Cl)C=CC=C1Cl
Guanabenz,Alpha-2B adrenergic receptor,NC(N)=NN=CC1=C(Cl)C=CC=C1Cl
Guanadrel,Sodium-dependent noradrenaline transporter,NC(N)=NCC1COC2(CCCCC2)O1
Guanethidine,Sodium-dependent noradrenaline transporter,NC(N)=NCCN1CCCCCCC1
Guanfacine,Alpha-2A adrenergic receptor,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
Guanfacine,Alpha-2B adrenergic receptor,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl
Guanidine,"Aldehyde dehydrogenase, mitochondrial",NC(N)=N
Guanidine,Guanidinoacetate N-methyltransferase,NC(N)=N
Guanidine,Endolysin,NC(N)=N
Guanidine,Argininosuccinate synthase,NC(N)=N
Guanidine,Arginase,NC(N)=N
Guanidine,Ribonuclease pancreatic,NC(N)=N
Guanidine,Disks large homolog 4,NC(N)=N
Guanidine-3-Propanol,Trypsin-3,NC(=[NH2+])NCCCO
Guanidinoethylmercaptosuccinic acid,Carboxypeptidase D,NC(=N)NCCS[C@@H](CC(O)=O)C(O)=O
Guanine,Purine nucleoside phosphorylase,NC1=NC(=O)C2=C(N1)N=CN2
Guanine,GTP cyclohydrolase 1,NC1=NC(=O)C2=C(N1)N=CN2
Guanine,Purine nucleoside phosphorylase 2,NC1=NC(=O)C2=C(N1)N=CN2
Guanine,Xanthine phosphoribosyltransferase,NC1=NC(=O)C2=C(N1)N=CN2
Guanine,Purine nucleoside phosphorylase,NC1=NC(=O)C2=C(N1)N=CN2
Guanosine,Purine nucleoside phosphorylase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine,DNA polymerase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine,Purine nucleoside phosphorylase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine 3'-monophosphate,Ribonuclease,NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]2O)C(=O)N1
Guanosine 3'-monophosphate,Bifunctional protein PyrR,NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]2O)C(=O)N1
"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",GDP-mannose 6-dehydrogenase,[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])O[C@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,Adenylosuccinate synthetase,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]2([H])OP(O)(=O)O[C@]12[H]
Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,Bifunctional (p)ppGpp synthase/hydrolase RelA,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]2([H])OP(O)(=O)O[C@]12[H]
"Guanosine-2',3'-Cyclophosphorothioate",Guanyl-specific ribonuclease Sa,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]2([H])O[P@@](O)(=S)O[C@]12[H]
Guanosine-2'-Monophosphate,Guanyl-specific ribonuclease Sa,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
Guanosine-3'-Monophosphate-5'-Diphosphate,ADP-ribosylation factor 1,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
"Guanosine-5',3'-Tetraphosphate",GTPase Obg,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])OP(O)(=O)OP(O)(O)=O
"Guanosine-5',3'-Tetraphosphate",Xanthine phosphoribosyltransferase,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])OP(O)(=O)OP(O)(O)=O
Guanosine-5'-Diphosphate,Protein-glutamine gamma-glutamyltransferase 2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,GTPase HRas,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Ras-related C3 botulinum toxin substrate 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Transforming protein RhoA,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Protein-glutamine gamma-glutamyltransferase E,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Cell division protein FtsZ,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Adenylosuccinate synthetase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Bifunctional (p)ppGpp synthase/hydrolase RelA,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Ras-related protein Rab-9A,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Elongation factor Tu-B,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,GDP-mannose mannosyl hydrolase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Signal recognition particle protein,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Elongation factor G,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Probable GTP-binding protein EngB,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Ras-related protein Rap-2a,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,GTPase Der,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Elongation factor Tu,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Adenylosuccinate synthetase isozyme 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Adenylosuccinate synthetase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Nucleoside diphosphate kinase A,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,ADP-ribosylation factor 4,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,"GDP-mannose 4,6 dehydratase",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Elongation factor Tu,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,GTPase (Rab6),NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Nucleoside diphosphate kinase B,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,"GDP-mannose 4,6-dehydratase",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Putative ribosome biogenesis GTPase RsgA,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,ADP-ribosylation factor-like protein 5A,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,ADP-ribosylation factor 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Guanine nucleotide-binding protein G(t) subunit alpha-1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Elongation factor Tu GTP-binding domain-containing protein 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,ADP-ribosylation factor 6,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Elongation factor 2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Ras-related protein Rab-8B,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Ras-related protein Rab-7a,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Guanine nucleotide-binding protein G(i) subunit alpha-1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Elongation factor 1-alpha 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Ras-related protein Rab-5A,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,ADP-ribosylation factor-like protein 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,"Elongation factor Tu, mitochondrial",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Ras-related protein Rab-11A,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,GTP-binding nuclear protein Ran,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Ras-related protein Ral-A,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,GTP-binding protein Rheb,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Cell division control protein 42 homolog,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,ADP-ribosylation factor-like protein 5B,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,GTP-binding protein SAR1b,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Interferon-inducible GTPase 5,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,Eukaryotic translation initiation factor 2 subunit 3,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate,ADP-ribosylation factor-like protein 3,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Diphosphate-Rhamnose,"GDP-mannose 4,6 dehydratase",C[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2NC(N)=NC3=O)[C@@H](O)[C@@H](O)[C@@H]1O
Guanosine-5'-Monophosphate,"cGMP-specific 3',5'-cyclic phosphodiesterase",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Bifunctional purine biosynthesis protein PURH,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Protein-glutamine gamma-glutamyltransferase E,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Response regulator PleD,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,DNA polymerase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Amidophosphoribosyltransferase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,GMP reductase 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Histidine triad nucleotide-binding protein 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Bifunctional protein PyrR,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Xanthine phosphoribosyltransferase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Amidophosphoribosyltransferase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Guanylate kinase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Bifunctional adenosylcobalamin biosynthesis protein CobU,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Monophosphate,Disks large homolog 4,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,"Glutamate dehydrogenase 1, mitochondrial",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,GTPase HRas,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,RNA-directed RNA polymerase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Genome polyprotein,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Genome polyprotein,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Molybdenum cofactor guanylyltransferase,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,"Ornithine decarboxylase, inducible",NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Genome polyprotein,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,GTP cyclohydrolase 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,mRNA-capping enzyme,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Probable GTP-binding protein EngB,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Ras-related protein Rap-2a,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Adenylosuccinate synthetase isozyme 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,ADP-ribosylation factor 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Ras-related protein Rab-5A,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Uridine-cytidine kinase-like 1,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,GTP-binding protein Rheb,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guanosine-5'-Triphosphate,Rho-related GTP-binding protein RhoE,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1
Guselkumab,Interleukin-23 subunit alpha,
Guvacine,Sodium- and chloride-dependent GABA transporter 2,OC(=O)C1=CCCNC1
Guvacine,Sodium- and chloride-dependent GABA transporter 1,OC(=O)C1=CCCNC1
Guvacine,Sodium- and chloride-dependent GABA transporter 3,OC(=O)C1=CCCNC1
Guvacine,Sodium- and chloride-dependent betaine transporter,OC(=O)C1=CCCNC1
H TYPE I TRISACCHARIDE,Histo-blood group ABO system transferase,[H][C@@]1(C)O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[C@@]3([H])[C@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(O)[C@]3([H])N=C(C)O)O[C@]([H])(CO)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
H TYPE II TRISACCHARIDE,Histo-blood group ABO system transferase,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@H]2[C@H](O)[C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)[C@@H](O)[C@H](O)[C@@H]1O
H3B-8800,Splicing factor 3B subunit 1,C[C@H](\C=C\C=C(/C)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(=O)N2CCN(C)CC2)\C=C\[C@@H]1C)C1=CC=CC=N1
HE3286,Nuclear factor NF-kappa-B p105 subunit,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@]2(O)C#C)[C@@H](O)C=C1C[C@@H](O)CC[C@]31C
HE3286,Nuclear factor NF-kappa-B p100 subunit,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@]2(O)C#C)[C@@H](O)C=C1C[C@@H](O)CC[C@]31C
HGS-TR2J,Tumor necrosis factor receptor superfamily member 10B,
HM-30181,Multidrug resistance protein 1,[H]N(C(=O)C1=CC(=O)C2=CC=CC=C2O1)C1=CC(OC)=C(OC)C=C1C1=NN(N=N1)C1=CC=C(CCN2CCC3=CC(OC)=C(OC)C=C3C2)C=C1
HOMOPHENYLALANINYLMETHANE,Cathepsin F,[H][C@](N)(CCC1=CC=CC=C1)C(C)=O
HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,Thermolysin,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)C(=O)NO)C(=O)NCC(=O)NC1=CC=C(C=C1)[N+]([O-])=O
HY10275,Histamine H1 receptor,
HY10275,5-hydroxytryptamine receptor 2A,
"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",Cyclin-A2,O=N(=O)C1=CC=CC(=C1)\N=C1\N=CCC(=N1)C1=CC=CC(CN2C=NC=N2)=C1
"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",Cyclin-dependent kinase 2,O=N(=O)C1=CC=CC(=C1)\N=C1\N=CCC(=N1)C1=CC=CC(CN2C=NC=N2)=C1
HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE,Peptide deformylase,CC1=NC(CCCN(O)C=O)=CC=C1
HZT-501,Histamine H2 receptor,
Hadacidin,Adenylosuccinate synthetase,ON(CC(O)=O)C=O
Hadacidin,Adenylosuccinate synthetase isozyme 1,ON(CC(O)=O)C=O
Hadacidin,Adenylosuccinate synthetase,ON(CC(O)=O)C=O
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-1,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-2,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-3,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-5,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit gamma-1,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit gamma-2,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit gamma-3,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit beta-1,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit beta-2,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit beta-3,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit delta,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit epsilon,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit pi,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit rho-1,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit rho-2,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit rho-3,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-1,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-2,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-3,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-4,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-5,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit alpha-6,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit beta-1,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit beta-2,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit beta-3,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit delta,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit epsilon,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit gamma-1,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit gamma-2,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit gamma-3,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit pi,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halazepam,Gamma-aminobutyric acid receptor subunit theta,FC(F)(F)CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Halcinonide,Smoothened homolog,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Halofantrine,Potassium voltage-gated channel subfamily H member 2,CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F
Halofantrine,Plasmepsin-2,CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F
Halofuginone,Collagen alpha-1(I) chain,[H][C@]1(O)CCCN[C@]1([H])CC(=O)CN1C=NC2=C(C=C(Cl)C(Br)=C2)C1=O
Halofuginone,72 kDa type IV collagenase,[H][C@]1(O)CCCN[C@]1([H])CC(=O)CN1C=NC2=C(C=C(Cl)C(Br)=C2)C1=O
Haloperidol,D(1A) dopamine receptor,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
Haloperidol,"Glutamate receptor ionotropic, NMDA 2B",OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
Haloperidol,D(2) dopamine receptor,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
Haloperidol,5-hydroxytryptamine receptor 2A,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
Haloperidol,D(3) dopamine receptor,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
Haloperidol,Melanin-concentrating hormone receptor 1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
Haloperidol,Synaptic vesicular amine transporter,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
Halothane,Potassium channel subfamily K member 3,[H]C(Cl)(Br)C(F)(F)F
Halothane,Potassium channel subfamily K member 9,[H]C(Cl)(Br)C(F)(F)F
Halothane,Calcium-activated potassium channel subunit alpha-1,[H]C(Cl)(Br)C(F)(F)F
Halothane,"Glutamate receptor ionotropic, NMDA 3A",[H]C(Cl)(Br)C(F)(F)F
Halothane,"Glutamate receptor ionotropic, NMDA 3B",[H]C(Cl)(Br)C(F)(F)F
Halothane,"Glutamate receptor ionotropic, NMDA 2A",[H]C(Cl)(Br)C(F)(F)F
Halothane,Glycine receptor subunit alpha-1,[H]C(Cl)(Br)C(F)(F)F
Halothane,Rhodopsin,[H]C(Cl)(Br)C(F)(F)F
Halothane,G protein-activated inward rectifier potassium channel 2,[H]C(Cl)(Br)C(F)(F)F
Halothane,G protein-activated inward rectifier potassium channel 1,[H]C(Cl)(Br)C(F)(F)F
Halothane,NADH-ubiquinone oxidoreductase chain 1,[H]C(Cl)(Br)C(F)(F)F
Halothane,Intermediate conductance calcium-activated potassium channel protein 4,[H]C(Cl)(Br)C(F)(F)F
Halothane,"ATP synthase subunit delta, mitochondrial",[H]C(Cl)(Br)C(F)(F)F
Halothane,Calcium-transporting ATPase type 2C member 1,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit alpha-1,[H]C(Cl)(Br)C(F)(F)F
Halothane,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,[H]C(Cl)(Br)C(F)(F)F
Halothane,Neuropeptide S receptor,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit alpha-1,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit alpha-2,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit alpha-3,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit alpha-4,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit alpha-5,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit alpha-6,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit beta-1,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit beta-2,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit beta-3,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit delta,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit epsilon,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit gamma-1,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit gamma-2,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit gamma-3,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit pi,[H]C(Cl)(Br)C(F)(F)F
Halothane,Gamma-aminobutyric acid receptor subunit theta,[H]C(Cl)(Br)C(F)(F)F
Harmaline,Histamine N-methyltransferase,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NCC1
Heme C,Cytochrome c,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Nitrite reductase,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c'',CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,High-molecular-weight cytochrome c,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c4,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Nitrite reductase,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Quinohemoprotein ethanol dehydrogenase type-1,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c-552,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Group 1 truncated hemoglobin GlbN,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome P450 2C9,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Nine-heme cytochrome c,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c3,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c-553,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c2,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c3,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c-550,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c-552,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c-551,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c3,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Split-Soret cytochrome c,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,"Cytochrome c3, 13 kDa",CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c551 peroxidase,CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme C,Cytochrome c',CC(S)C1=C2C=C3C(C)=C(C(C)S)C4=[N+]3[Fe--]35N6C(=C4)C(C)=C(CCC(O)=O)C6=CC4=[N+]3C(=CC(N25)=C1C)C(C)=C4CCC(O)=O
Heme D,Nitrite reductase,CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5[N+]6=C(C=C7N8C(C=C1N2[Fe]68N34)=C([O-])[C@]7(C)CC(O)=O)C(=O)[C@]5(C)CC(O)=O
Heme D,Nitrite reductase,CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5[N+]6=C(C=C7N8C(C=C1N2[Fe]68N34)=C([O-])[C@]7(C)CC(O)=O)C(=O)[C@]5(C)CC(O)=O
Hemi-Babim,Trypsin-1,NC(=N)C1=CC2=C(NC(CC3=NC4=C(N3)C=CC=C4)=N2)C=C1
Hemi-Babim,Prothrombin,NC(=N)C1=CC2=C(NC(CC3=NC4=C(N3)C=CC=C4)=N2)C=C1
Heparin,Antithrombin-III,
Heparin,Coagulation factor X,
Heparin,P-selectin,
Heparin,Fibroblast growth factor receptor 4,
Heparin,Fibroblast growth factor 4,
Heparin,Fibroblast growth factor 19,
Heparin,Fibroblast growth factor receptor 1,
Heparin,Fibroblast growth factor 1,
Heparin,Fibroblast growth factor receptor 2,
Heparin,Fibroblast growth factor 2,
Heparin,Platelet factor 4,
Heparin,Hepatocyte growth factor,
Heparin Disaccharide I-S,C-C motif chemokine 5,[H][C@]1(O)O[C@]([H])(COS([O-])(=O)=O)[C@@]([H])(O[C@]2([H])OC(=C[C@]([H])(O)[C@@]2([H])OS([O-])(=O)=O)C([O-])=O)[C@]([H])(O)[C@@]1([H])NS([O-])(=O)=O
Heparin Disaccharide Iii-S,C-C motif chemokine 5,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@]2([H])OC(=C[C@]([H])(O)[C@@]2([H])OS([O-])(=O)=O)C([O-])=O)[C@]([H])(O)[C@@]1([H])NS([O-])(=O)=O
Hepatitis B Immune Globulin,HBsAg,
Heptabarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,Neuronal acetylcholine receptor subunit alpha-4,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,Neuronal acetylcholine receptor subunit alpha-7,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,Glutamate receptor 2,CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptabarbital,"Glutamate receptor ionotropic, kainate 2",CCC1(C(=O)NC(=O)NC1=O)C1=CCCCCC1
Heptaethylene glycol,Carbonyl reductase [NADPH] 1,OCCOCCOCCOCCOCCOCCOCCO
Heptamolybdate,Sensor histidine kinase CitA,O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo]
Heptanamide,"Limonene-1,2-epoxide hydrolase",CCCCCCC(N)=O
"Heptane-1,2,3-Triol",Rhodopsin,[H][C@@](O)(CO)[C@]([H])(O)CCCC
"Heptane-1,2,3-Triol",Fimbrial protein,[H][C@@](O)(CO)[C@]([H])(O)CCCC
"Heptane-1,2,3-Triol",Fe(3+) dicitrate transport protein FecA,[H][C@@](O)(CO)[C@]([H])(O)CCCC
Heptanoic Acid,Phospholipase A2,CCCCCCC(O)=O
Heptulose-2-Phosphate,"Glycogen phosphorylase, muscle form",C[C@]1(OP(O)(O)=O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Heptyl 1-Thiohexopyranoside,Rhodopsin,[H][C@]1(CO)O[C@@]([H])(SCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Heptyl 1-Thiohexopyranoside,NADPH:ferredoxin reductase,[H][C@]1(CO)O[C@@]([H])(SCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Heptyl 1-Thiohexopyranoside,Acyl carrier protein,[H][C@]1(CO)O[C@@]([H])(SCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Heptyl 1-Thiohexopyranoside,Biotin biosynthesis cytochrome P450,[H][C@]1(CO)O[C@@]([H])(SCCCCCCC)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Heptyl-Beta-D-Glucopyranoside,Peroxisome proliferator-activated receptor delta,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCC)[C@]1([H])O
Heptyl-Beta-D-Glucopyranoside,Peptidyl-prolyl cis-trans isomerase FKBP1A,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCC)[C@]1([H])O
Hesperetin,Sterol O-acyltransferase 1,COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1
Hesperetin,Microsomal triglyceride transfer protein large subunit,COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1
Hesperetin,Sterol O-acyltransferase 2,COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1
Hesperetin,Sex hormone-binding globulin,COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1
Hesperidin,Aurora kinase B,COC1=CC=C(C=C1O)[C@@H]1CC(=O)C2=C(O1)C=C(O[C@@H]1O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]1O)C=C2O
Hetacillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O
Hetacillin,Penicillin-binding protein 1b,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O
Hetacillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O
Hetacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O
Hetacillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N1C(=O)[C@H](NC1(C)C)C1=CC=CC=C1)C(O)=O
Hexachlorophene,D-lactate dehydrogenase,OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl
Hexachlorophene,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl
Hexachlorophene,"Glutamate dehydrogenase 1, mitochondrial",OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl
Hexachlorophene,Estrogen receptor,OC1=C(CC2=C(O)C(Cl)=CC(Cl)=C2Cl)C(Cl)=C(Cl)C=C1Cl
Hexadecanal,Rhodopsin,CCCCCCCCCCCCCCCC=O
Hexadecanal,Acyl-CoA-binding protein,CCCCCCCCCCCCCCCC=O
Hexadecyl Octanoate,HTH-type transcriptional regulator EthR,CCCCCCCCCCCCCCCOC(=O)CCCCCCC
Hexafluronium,Cholinesterase,C[N+](C)(CCCCCC[N+](C)(C)C1C2=C(C=CC=C2)C2=C1C=CC=C2)C1C2=C(C=CC=C2)C2=C1C=CC=C2
Hexamethonium,Neuronal acetylcholine receptor subunit alpha-2,C[N+](C)(C)CCCCCC[N+](C)(C)C
Hexamidine,HTH-type transcriptional regulator QacR,NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
Hexamidine,HTH-type transcriptional regulator QacR,NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
"Hexane-1,6-Diol",Glucocorticoid receptor,OCCCCCCO
"Hexane-1,6-Diol",GTPase HRas,OCCCCCCO
"Hexane-1,6-Diol",Endolysin,OCCCCCCO
"Hexane-1,6-Diol",Holliday junction ATP-dependent DNA helicase RuvB,OCCCCCCO
"Hexane-1,6-Diol","Chain A, Red Copper Protein Nitrosocyanin",OCCCCCCO
"Hexane-1,6-Diol",Phospholipase A2,OCCCCCCO
Hexanoyl-CoA,"Enoyl-CoA hydratase, mitochondrial",CCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Hexatantalum Dodecabromide,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Br.Br.Br.Br.Br.Br.Br.Br.Br.Br.Br.[Br-].[Ta].[Ta].[Ta].[Ta].[Ta].[Ta+]
Hexatantalum Dodecabromide,Ubiquitin-like modifier-activating enzyme 1,Br.Br.Br.Br.Br.Br.Br.Br.Br.Br.Br.[Br-].[Ta].[Ta].[Ta].[Ta].[Ta].[Ta+]
Hexestrol,Aldo-keto reductase family 1 member C1,[H][C@](CC)(C1=CC=C(O)C=C1)[C@]([H])(CC)C1=CC=C(O)C=C1
Hexestrol,Estrogen receptor,[H][C@](CC)(C1=CC=C(O)C=C1)[C@]([H])(CC)C1=CC=C(O)C=C1
Hexestrol,Nuclear receptor subfamily 1 group I member 2,[H][C@](CC)(C1=CC=C(O)C=C1)[C@]([H])(CC)C1=CC=C(O)C=C1
Hexestrol,Nuclear receptor subfamily 1 group I member 3,[H][C@](CC)(C1=CC=C(O)C=C1)[C@]([H])(CC)C1=CC=C(O)C=C1
Hexobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,Neuronal acetylcholine receptor subunit alpha-4,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,Neuronal acetylcholine receptor subunit alpha-7,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,Glutamate receptor 2,CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexobarbital,"Glutamate receptor ionotropic, kainate 2",CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1
Hexocyclium,Muscarinic acetylcholine receptor M1,C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
Hexocyclium,Muscarinic acetylcholine receptor M2,C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
Hexocyclium,Muscarinic acetylcholine receptor M3,C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
Hexocyclium,Muscarinic acetylcholine receptor M4,C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
Hexylcaine,Sodium channel protein type 10 subunit alpha,CC(CNC1CCCCC1)OC(=O)C1=CC=CC=C1
Hexylcaine,Sodium channel protein type 5 subunit alpha,CC(CNC1CCCCC1)OC(=O)C1=CC=CC=C1
Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester,Lipase,CCCCCCP(O)(=O)OC[C@H](C)CC1=CC=CC=C1
Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester,Lipase,CCCCCCP(O)(=O)OC[C@@H](C)CC1=CC=CC=C1
Hexylresorcinol,DNA topoisomerase 1,CCCCCCC1=C(O)C=C(O)C=C1
Hexylresorcinol,Protein-glutamine gamma-glutamyltransferase 2,CCCCCCC1=C(O)C=C(O)C=C1
Hexylresorcinol,Tyrosinase,CCCCCCC1=C(O)C=C(O)C=C1
"Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide","cGMP-inhibited 3',5'-cyclic phosphodiesterase B",[H][C@](O)(CO)[C@]([H])(O)[C@]([H])(O)[C@]([H])(O)CN(CCO)C(=O)CCCCCCCC
Histamine,Histamine H1 receptor,NCCC1=CNC=N1
Histamine,Histamine H2 receptor,NCCC1=CNC=N1
Histamine,Histamine H3 receptor,NCCC1=CNC=N1
Histamine,Histamine H4 receptor,NCCC1=CNC=N1
Histamine,Synaptic vesicular amine transporter,NCCC1=CNC=N1
Histidine,Histidine decarboxylase,N[C@@H](CC1=CN=CN1)C(O)=O
Histidine,Histidine ammonia-lyase,N[C@@H](CC1=CN=CN1)C(O)=O
Histidine,Sodium-coupled neutral amino acid transporter 3,N[C@@H](CC1=CN=CN1)C(O)=O
Histidine,"Histidine--tRNA ligase, cytoplasmic",N[C@@H](CC1=CN=CN1)C(O)=O
Histidinol,Histidinol dehydrogenase,[H][C@@]([NH3+])(CO)CC1=CN=CN1
Histidinol,Histidine--tRNA ligase,[H][C@@]([NH3+])(CO)CC1=CN=CN1
Histidyl-Adenosine Monophosphate,Histidine--tRNA ligase,[H][C@](N)(CC1=CN=CN1)C(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Histidyl-Adenosine Monophosphate,Histidine--tRNA ligase,[H][C@](N)(CC1=CN=CN1)C(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Histrelin,Gonadotropin-releasing hormone receptor,CC(O)=O.CC(O)=O.[H][C@@](CO)(N=C(O)[C@]([H])(CC1=CNC2=CC=CC=C12)N=C(O)[C@]([H])(CC1=CN=CN1)N=C(O)[C@]1([H])CCC(O)=N1)C(O)=N[C@@]([H])(CC1=CC=C(O)C=C1)C(O)=N[C@]([H])(CC1=CN(CC2=CC=CC=C2)C=N1)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CCCNC(N)=N)C(=O)N1CCC[C@@]1([H])C(O)=NCC
Homatropine,Muscarinic acetylcholine receptor M1,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C
Homatropine,Muscarinic acetylcholine receptor M2,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C
Homatropine,Muscarinic acetylcholine receptor M3,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C
Homatropine,Muscarinic acetylcholine receptor M4,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C
Homatropine,Muscarinic acetylcholine receptor M5,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C
Homatropine methylbromide,Muscarinic acetylcholine receptor M3,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1
Homatropine methylbromide,Muscarinic acetylcholine receptor M1,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1
Homatropine methylbromide,Muscarinic acetylcholine receptor M5,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1
Homatropine methylbromide,Muscarinic acetylcholine receptor M4,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1
Homatropine methylbromide,Muscarinic acetylcholine receptor M2,[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1
Homosalate,Progesterone receptor,
Homosalate,Androgen receptor,
Homosalate,Estrogen receptor,
Homoserine Lactone,Sodium/hydrogen exchanger 1,N[C@@H]1CCOC1=O
Human C1-esterase inhibitor,Complement C1r subcomponent,
Human C1-esterase inhibitor,Complement C1s subcomponent,
Human C1-esterase inhibitor,Plasma kallikrein,
Human C1-esterase inhibitor,Coagulation factor XII,
Human C1-esterase inhibitor,Prothrombin,
Human C1-esterase inhibitor,Coagulation factor XI,
Human C1-esterase inhibitor,Tissue-type plasminogen activator,
Human Rho(D) immune globulin,Rhesus blood group D antigen,
Human Thrombin,Coagulation factor V,
Human Thrombin,Coagulation factor VIII,
Human Thrombin,Coagulation factor XI,
Human Thrombin,Coagulation factor XIII A chain,
Human Thrombin,Coagulation factor XIII B chain,
Human Thrombin,Fibrinogen alpha chain,
Human Thrombin,Fibrinogen beta chain,
Human Thrombin,Fibrinogen gamma chain,
Human calcitonin,Alpha-actinin-1,
Huperzine A,Acetylcholinesterase,[H][C@@]12CC3=C(C=CC(=O)N3)[C@@](N)(CC(C)=C1)\C2=C\C
Huperzine B,Acetylcholinesterase,[H][C@@]12CC3=C(C=CC(O)=N3)[C@]3(CC(C)=C1)NCCC[C@]23[H]
Hyaluronic acid,CD44 antigen,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Intercellular adhesion molecule 1,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Hyaluronan mediated motility receptor,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Neurocan core protein,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Versican core protein,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,"Complement component 1 Q subcomponent-binding protein, mitochondrial",CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Hyaluronan and proteoglycan link protein 1,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Hyaluronan and proteoglycan link protein 3,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Hyaluronan and proteoglycan link protein 4,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Hyaluronan-binding protein 2,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Layilin,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Stabilin-2,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Tumor necrosis factor-inducible gene 6 protein,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Interphotoreceptor matrix proteoglycan 2,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronic acid,Intracellular hyaluronan-binding protein 4,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Hyaluronidase (ovine),Transforming growth factor beta-1,
Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe),Soluble cytochrome b562,CCC1=C2C=C3N4C(=CC5=C(C)C(CCC(O)=O)=C6C=C7N8C(=CC(N2[Fe]48N56)=C1C)C(C)=C7CCC(O)=O)C(C=C)=C3C
Hycanthone,Multidrug resistance protein 1,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(CO)C=C1
Hydantocidin-5'-Phosphate,Adenylosuccinate synthetase,[H][C@]1(COP(O)(O)=O)O[C@@]2(N=C(O)N=C2O)[C@]([H])(O)[C@]1([H])O
Hydralazine,Prolyl 4-hydroxylase subunit alpha-1,NNC1=NN=CC2=CC=CC=C12
Hydralazine,Membrane primary amine oxidase,NNC1=NN=CC2=CC=CC=C12
Hydrochlorothiazide,Solute carrier family 12 member 3,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
Hydrochlorothiazide,Carbonic anhydrase 1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
Hydrochlorothiazide,Carbonic anhydrase 2,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
Hydrochlorothiazide,Calcium-activated potassium channel subunit alpha-1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1
Hydrocodone,Delta-type opioid receptor,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O
Hydrocodone,Mu-type opioid receptor,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O
Hydrocortamate,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CN(CC)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone,Annexin A1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone aceponate,Annexin A1,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone aceponate,Glucocorticoid receptor,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone aceponate,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone aceponate,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone acetate,Annexin A1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone acetate,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone acetate,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone acetate,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone butyrate,Annexin A1,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone butyrate,Glucocorticoid receptor,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone butyrate,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone butyrate,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone cypionate,Annexin A1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone cypionate,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone cypionate,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone cypionate,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone phosphate,Annexin A1,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone phosphate,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone phosphate,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone phosphate,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone probutate,Annexin A1,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone probutate,Glucocorticoid receptor,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone probutate,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone probutate,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone valerate,Annexin A1,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone valerate,Glucocorticoid receptor,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone valerate,Corticosteroid 11-beta-dehydrogenase isozyme 2,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydrocortisone valerate,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydroflumethiazide,Solute carrier family 12 member 1,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
Hydroflumethiazide,Carbonic anhydrase 1,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
Hydroflumethiazide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
Hydroflumethiazide,Carbonic anhydrase 4,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
Hydroflumethiazide,Carbonic anhydrase 9,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
Hydroflumethiazide,Carbonic anhydrase 12,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
Hydroflumethiazide,Sodium/potassium-transporting ATPase subunit alpha-1,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
Hydroflumethiazide,Calcium-activated potassium channel subunit alpha-1,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F
Hydrogenobyrinic Acid,Precorrin-8X methylmutase,[H][C@]12N=C(\C(C)=C3/N=C(/C=C4\N=C(\C(\C)=C5/N[C@]1(C)[C@@](C)(CC(O)=O)[C@@H]5CCC(O)=O)[C@@](C)(CC(O)=O)[C@@H]4CCC(O)=O)C(C)(C)[C@@H]3CCC(O)=O)[C@](C)(CCC(O)=O)[C@H]2CC(O)=O
Hydrolyzed Cephalothin,Beta-lactamase,[H][C@@](NC(=O)CC1=CC=CS1)(C(O)=O)[C@@]1([H])NC(C(O)=O)=C(C)CS1
Hydromorphone,Mu-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O
Hydromorphone,Delta-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O
Hydromorphone,Kappa-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O
Hydroquinone,Tyrosinase,OC1=CC=C(O)C=C1
Hydroxocobalamin,Methionine synthase,[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
Hydroxocobalamin,"Methylmalonyl-CoA mutase, mitochondrial",[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
Hydroxocobalamin,Methionine synthase reductase,[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
Hydroxocobalamin,"Methylmalonic aciduria type A protein, mitochondrial",[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
Hydroxocobalamin,Transcobalamin-1,[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
Hydroxocobalamin,Protein amnionless,[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
Hydroxocobalamin,Cubilin,[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
Hydroxocobalamin,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
Hydroxocobalamin,Methylmalonic aciduria and homocystinuria type C protein,[N+]1=2[Co-3]345([N+]6=C7[C@H]([C@@](CC(=O)N)(C)[C@@]6([C@@]6(N3C(=C(C)C3=[N+]4C(C(C)(C)[C@@H]3CCC(=O)N)=CC3=[N+]5C(=C7C)[C@@](CC(=O)N)([C@@H]3CCC(=O)N)C)[C@@](C)([C@H]6CC(=O)N)CCC(NC[C@@H](C)OP(=O)(O[C@@H]3[C@H](O[C@H](N(C4=CC(=C(C=C14)C)C)C=2)[C@@H]3O)CO)[O-])=O)[H])C)CCC(=O)N)O[H]
"Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium",Acetylcholinesterase,[H][C@](OCC[As+](C)(C)C)(C1=CC=CC=C1[N+](O)=O)C(F)(F)F
Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester,Liver carboxylesterase 1,[H][C@](O)(C(=O)O[C@@]1([H])C[C@]2([H])CC[C@]([H])(C1)N2C)C1=CC=CC=C1
Hydroxyaminovaline,Collagenase 3,CC(C)[C@@H](N)C(=O)NO
Hydroxyaminovaline,Stromelysin-1,CC(C)[C@@H](N)C(=O)NO
Hydroxychloroquine,Toll-like receptor 7,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1
Hydroxychloroquine,Toll-like receptor 9,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1
Hydroxyethylcysteine,Gag-Pro-Pol polyprotein,N[C@@H](CSCCO)C(O)=O
Hydroxyfasudil,Rho-associated protein kinase 1,OC1=C2C=CC=C(C2=CC=N1)S(=O)(=O)N1CCCNCC1
Hydroxyfasudil,cAMP-dependent protein kinase catalytic subunit alpha,OC1=C2C=CC=C(C2=CC=N1)S(=O)(=O)N1CCCNCC1
Hydroxyfasudil,cAMP-dependent protein kinase inhibitor alpha,OC1=C2C=CC=C(C2=CC=N1)S(=O)(=O)N1CCCNCC1
Hydroxyphenyl Propionic Acid,Tyrosine phenol-lyase,OC(=O)CCC1=CC=C(O)C=C1
Hydroxyphenyl Propionic Acid,Tyrosine phenol-lyase,OC(=O)CCC1=CC=C(O)C=C1
Hydroxyphenyl Propionic Acid,Prephenate dehydrogenase,OC(=O)CCC1=CC=C(O)C=C1
Hydroxyprogesterone caproate,Progesterone receptor,[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Hydroxyurea,Ribonucleoside-diphosphate reductase large subunit,NC(=O)NO
Hydroxyzine,Histamine H1 receptor,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Hymecromone,Arylsulfate sulfotransferase AssT,CC1=CC(=O)OC2=C1C=CC(O)=C2
Hymenialdisine,Cyclin-dependent-like kinase 5,[H][C@@]12C=C(Br)N=C1C(=O)NCC[C@]2([H])C1=NC(N)=NC1=O
Hymenialdisine,Cyclin-dependent kinase 2,[H][C@@]12C=C(Br)N=C1C(=O)NCC[C@]2([H])C1=NC(N)=NC1=O
Hymenialdisine,Cyclin-dependent kinase 1,[H][C@@]12C=C(Br)N=C1C(=O)NCC[C@]2([H])C1=NC(N)=NC1=O
Hyoscyamine,Muscarinic acetylcholine receptor M1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
Hyoscyamine,Muscarinic acetylcholine receptor M2,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
Hyoscyamine,Muscarinic acetylcholine receptor M3,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
Hyoscyamine,Muscarinic acetylcholine receptor M4,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
Hyperforin,Prostaglandin G/H synthase 1,CC(C)C(=O)[C@@]12C(O)=C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O
Hyperforin,Arachidonate 5-lipoxygenase,CC(C)C(=O)[C@@]12C(O)=C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O
Hyperforin,Nuclear receptor subfamily 1 group I member 2,CC(C)C(=O)[C@@]12C(O)=C(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O
Hypericin,Glutathione S-transferase A1,CC1=CC(O)=C2C(=O)C3=C(O)C=C(O)C4=C3C3=C2C1=C1C(C)=CC(O)=C2C(=O)C5=C(O)C=C(O)C4=C5C3=C12
Hypericin,Glutathione S-transferase P,CC1=CC(O)=C2C(=O)C3=C(O)C=C(O)C4=C3C3=C2C1=C1C(C)=CC(O)=C2C(=O)C5=C(O)C=C(O)C4=C5C3=C12
Hypophosphite,Thiosulfate sulfurtransferase,[O-]P=O
Hypoxanthine,Purine nucleoside phosphorylase,OC1=NC=NC2=C1NC=N2
Hypromellose,Epithelial cell adhesion molecule,
IC261,Casein kinase I isoform gamma-2,COC1=CC(OC)=C(\C=C2\C(=O)NC3=CC=CC=C23)C(OC)=C1
ICA-105665,Potassium voltage-gated channel subfamily KQT member 1,
ICA-105665,Potassium voltage-gated channel subfamily KQT member 2,
ICA-105665,Potassium voltage-gated channel subfamily KQT member 3,
ICA-105665,Potassium voltage-gated channel subfamily KQT member 4,
ICA-105665,Potassium voltage-gated channel subfamily KQT member 5,
IDD552,Aldose reductase,OC(=O)COC1=CC(F)=CC=C1C(=O)NCC1=NC2=C(S1)C(F)=CC(F)=C2F
IDD594,Aldose reductase,OC(=O)COC1=CC(F)=CC=C1C(=S)NCC1=CC=C(Br)C=C1F
IGN311,Receptor tyrosine-protein kinase erbB-2,
IGN311,Epidermal growth factor receptor,
IMC-1C11,Vascular endothelial growth factor receptor 3,
IMC-1C11,Vascular endothelial growth factor receptor 1,
IMC-1C11,Vascular endothelial growth factor receptor 2,
IMIDAZOPYRIDAZIN 1,Serine/threonine-protein kinase pim-1,CC(=O)C1=CC=CC(=C1)C1=CN=C2C=CC(NCC3CC3)=NN12
"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",Methionine aminopeptidase,NNC(=O)C1=CN2C=CC3=C(C=CC=C3)C2=N1
INCB-9471,C-C chemokine receptor type 5,CCO[C@@H]1CC2=CC(=CC=C2[C@H]1N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C(F)(F)F
INCB13739,Corticosteroid 11-beta-dehydrogenase isozyme 1,
INCB3284,C-C chemokine receptor type 2,
INCB7839,Disintegrin and metalloproteinase domain-containing protein 9,
ING-1,Epithelial cell adhesion molecule,
INHIBITOR Q8467 OF DUPONT MERCK,Gag-Pol polyprotein,O[C@@H]1[C@@H](O)[C@@H](CC2=CC=CC=C2)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)C(=O)N(CC2CC2)[C@@H]1CC1=CC=CC=C1
INS 316,P2Y purinoceptor 2,
IRL-1620,Endothelin B receptor,
ISIS 113715,Tyrosine-protein phosphatase non-receptor type 1,
ISO24,Proto-oncogene tyrosine-protein kinase Src,CCC1=CC=C(NC(=O)P(O)(O)=O)C=C1
ISOPENTENYL PYROPHOSPHATE,Farnesyl pyrophosphate synthase,CC(=C)CCO[P@](O)(=O)OP(O)(O)=O
ISOPENTENYL PYROPHOSPHATE,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",CC(=C)CCO[P@](O)(=O)OP(O)(O)=O
ISOPENTENYL PYROPHOSPHATE,Geranylgeranyl pyrophosphate synthase,CC(=C)CCO[P@](O)(=O)OP(O)(O)=O
ISOPENTENYL PYROPHOSPHATE,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",CC(=C)CCO[P@](O)(=O)OP(O)(O)=O
ISOPENTENYL PYROPHOSPHATE,Decaprenyl diphosphate synthase,CC(=C)CCO[P@](O)(=O)OP(O)(O)=O
ISOPENTENYL PYROPHOSPHATE,4-hydroxy-3-methylbut-2-enyl diphosphate reductase,CC(=C)CCO[P@](O)(=O)OP(O)(O)=O
"ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE",Gag-Pol polyprotein,[H][C@@]1(CC)N(C(=O)OC(C)C)C2=CC(F)=CC=C2NC1=O
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,cAMP-dependent protein kinase catalytic subunit alpha,ClC1=CC=C(COCCNCCNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C=C1
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,cAMP-dependent protein kinase inhibitor alpha,ClC1=CC=C(COCCNCCNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C=C1
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,RAC-beta serine/threonine-protein kinase,ClC1=CC=C(COCCNCCNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C=C1
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,Glycogen synthase kinase-3 beta,ClC1=CC=C(COCCNCCNS(=O)(=O)C2=CC=CC3=CN=CC=C23)C=C1
ISOTHIAZOLIDINONE ANALOG,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CC1=CC=C(C=C1)[C@]1([H])CC(=O)NS1(=O)=O)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(C)=O)C(N)=O
ISS-1018,Toll-like receptor 9,
Ibalizumab,T-cell surface glycoprotein CD4,
Ibalizumab,C-C chemokine receptor type 5,
Ibalizumab,C-X-C chemokine receptor type 4,
Ibandronate,Farnesyl pyrophosphate synthase,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O
Ibritumomab tiuxetan,B-lymphocyte antigen CD20,
Ibritumomab tiuxetan,Low affinity immunoglobulin gamma Fc region receptor III-B,
Ibritumomab tiuxetan,Complement C1r subcomponent,
Ibritumomab tiuxetan,Complement C1q subcomponent subunit A,
Ibritumomab tiuxetan,Complement C1q subcomponent subunit B,
Ibritumomab tiuxetan,Complement C1q subcomponent subunit C,
Ibritumomab tiuxetan,Low affinity immunoglobulin gamma Fc region receptor III-A,
Ibritumomab tiuxetan,Complement C1s subcomponent,
Ibritumomab tiuxetan,High affinity immunoglobulin gamma Fc receptor I,
Ibritumomab tiuxetan,Low affinity immunoglobulin gamma Fc region receptor II-a,
Ibritumomab tiuxetan,Low affinity immunoglobulin gamma Fc region receptor II-b,
Ibritumomab tiuxetan,Low affinity immunoglobulin gamma Fc region receptor II-c,
Ibrutinib,Tyrosine-protein kinase BTK,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1
Ibudilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C
Ibudilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C
Ibudilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C
Ibudilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C
Ibudilast,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C
Ibuprofen,Prostaglandin G/H synthase 2,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,Prostaglandin G/H synthase 1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,Apoptosis regulator Bcl-2,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,Thrombomodulin,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,"Fatty acid-binding protein, intestinal",CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,Peroxisome proliferator-activated receptor gamma,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,Cystic fibrosis transmembrane conductance regulator,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,Peroxisome proliferator-activated receptor alpha,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,Platelet glycoprotein Ib alpha chain,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibuprofen,Protein S100-A7,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O
Ibutilide,Voltage-dependent L-type calcium channel subunit alpha-1C,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,Voltage-dependent L-type calcium channel subunit beta-1,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,Potassium voltage-gated channel subfamily H member 2,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,Voltage-dependent calcium channel subunit alpha-2/delta-1,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,Voltage-dependent calcium channel gamma-1 subunit,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,Potassium channel subfamily K member 1,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,Potassium channel subfamily K member 6,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,Potassium voltage-gated channel subfamily H member 6,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,Potassium voltage-gated channel subfamily H member 7,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Ibutilide,ATP-sensitive inward rectifier potassium channel 11,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Icaridin,Odorant binding protein,CCC(C)OC(=O)N1CCCCC1CCO
Icatibant,Aminopeptidase N,[H][C@]12CC(N(C(=O)C3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CS3)NC(=O)CNC(=O)C3C[C@@H](O)CN3C(=O)C3CCCN3C(=O)C(CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)[C@@]1([H])CCCC2)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Icatibant,B2 bradykinin receptor,[H][C@]12CC(N(C(=O)C3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CS3)NC(=O)CNC(=O)C3C[C@@H](O)CN3C(=O)C3CCCN3C(=O)C(CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)[C@@]1([H])CCCC2)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Iclaprim,Dihydrofolate reductase,COC1=CC(CC2=CN=C(N)N=C2N)=C2C=CC(OC2=C1OC)C1CC1
Icosapent,Prostaglandin G/H synthase 2,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Prostaglandin G/H synthase 1,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Peroxisome proliferator-activated receptor gamma,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Peroxisome proliferator-activated receptor delta,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Fatty acid desaturase 1,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Long-chain-fatty-acid--CoA ligase 4,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Long-chain-fatty-acid--CoA ligase 3,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Free fatty acid receptor 1,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Sodium/calcium exchanger 1,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Transient receptor potential cation channel subfamily V member 1,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icosapent,Peroxisome proliferator-activated receptor alpha,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
Icotinib,Epidermal growth factor receptor,C#CC1=CC=CC(NC2=NC=NC3=CC4=C(OCCOCCOCCO4)C=C23)=C1
Idarubicin,DNA topoisomerase 2-alpha,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O
Idoxuridine,Thymidine kinase,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(I)C(=O)NC1=O
Idraparinux,Coagulation factor X,
Idronoxil,Ecto-NOX disulfide-thiol exchanger 2,OC1=CC=C(C=C1)C1=CC2=C(OC1)C=C(O)C=C2
Idursulfase,Perilipin-3,
Ifenprodil,"Glutamate receptor ionotropic, NMDA 1",CC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1
Ifenprodil,"Glutamate receptor ionotropic, NMDA 2B",CC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1
Ifosfamide,Nuclear receptor subfamily 1 group I member 2,ClCCNP1(=O)OCCCN1CCCl
Iloperidone,5-hydroxytryptamine receptor 2A,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,D(2) dopamine receptor,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,D(1A) dopamine receptor,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,D(3) dopamine receptor,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,D(4) dopamine receptor,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,5-hydroxytryptamine receptor 1A,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,5-hydroxytryptamine receptor 6,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,5-hydroxytryptamine receptor 7,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,Alpha-1A adrenergic receptor,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,Histamine H1 receptor,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloperidone,Alpha-2C adrenergic receptor,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
Iloprost,Prostacyclin receptor,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
Iloprost,Prostaglandin E2 receptor EP1 subtype,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
Iloprost,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
Iloprost,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
Iloprost,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
Iloprost,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
Iloprost,Tissue-type plasminogen activator,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
Iloprost,Prostaglandin D2 receptor 2,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
Imatinib,BCR/ABL fusion protein isoform X9,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imatinib,Mast/stem cell growth factor receptor Kit,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imatinib,RET proto-oncogene,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imatinib,High affinity nerve growth factor receptor,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imatinib,Macrophage colony-stimulating factor 1 receptor,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imatinib,Platelet-derived growth factor receptor alpha,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imatinib,Epithelial discoidin domain-containing receptor 1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imatinib,Tyrosine-protein kinase ABL1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imatinib,Platelet-derived growth factor receptor beta,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
Imexon,Ribonucleoside-diphosphate reductase large subunit,NC1=NC(=O)N2CC12
Imexon,Ribonucleoside-diphosphate reductase subunit M2,NC1=NC(=O)N2CC12
Imidacloprid,CHRNA7-FAM7A fusion protein,[O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1
Imidafenacin,Muscarinic acetylcholine receptor M1,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1
Imidafenacin,Muscarinic acetylcholine receptor M2,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1
Imidafenacin,Muscarinic acetylcholine receptor M3,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1
Imidazole,"Nitric oxide synthase, inducible",N1C=CN=C1
Imidazole,Cytochrome c,N1C=CN=C1
Imidazole,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,N1C=CN=C1
Imidazole,Serine/threonine-protein kinase pim-1,N1C=CN=C1
Imidazole,Monomeric sarcosine oxidase,N1C=CN=C1
Imidazole,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",N1C=CN=C1
Imidazole,Isopentenyl-diphosphate Delta-isomerase,N1C=CN=C1
Imidazole,Circadian clock protein KaiB,N1C=CN=C1
Imidazole,Sensor protein FixL,N1C=CN=C1
Imidazole,Leukotriene A-4 hydrolase,N1C=CN=C1
Imidazole,Histidinol dehydrogenase,N1C=CN=C1
Imidazole,Acyl carrier protein,N1C=CN=C1
Imidazole,Acyl-CoA thioesterase I,N1C=CN=C1
Imidazole,Gephyrin,N1C=CN=C1
Imidazole,Adenine DNA glycosylase,N1C=CN=C1
Imidazole,"Endo-1,4-beta-xylanase A",N1C=CN=C1
Imidazole,Bacterial hemoglobin,N1C=CN=C1
Imidazole,YopE regulator,N1C=CN=C1
Imidazole,Guanine deaminase,N1C=CN=C1
Imidazole,Molybdenum cofactor biosynthesis protein B,N1C=CN=C1
Imidazole,Uracil-DNA glycosylase inhibitor,N1C=CN=C1
Imidazole,Recombination protein RecR,N1C=CN=C1
Imidazole,Meiotic recombination protein DMC1/LIM15 homolog,N1C=CN=C1
Imidazole,Myoglobin,N1C=CN=C1
Imidazole,"Adenylate kinase 2, mitochondrial",N1C=CN=C1
Imidazole,Unconventional myosin-Ie,N1C=CN=C1
Imidazole-Derived Cellobiose,Endoglucanase 5A,[H][C@]1(CO)O[C@@]([H])(O[C@]2([H])[C@@]([H])(CO)N3C=CN=C3[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Imino-Tryptophan,D-amino-acid oxidase,[H]N=C(CC1=CNC2=CC=CC=C12)C(O)=O
Imipenem,Penicillin-binding protein 2,[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Imipenem,Penicillin-binding protein 1B,[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Imipenem,Penicillin-binding protein 1A,[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Imipenem,Penicillin-binding protein 3,[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Imipenem,Beta-lactamase,[H][C@]12CC(SCC\N=C\N)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
Imipramine,5-hydroxytryptamine receptor 2A,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Sodium-dependent noradrenaline transporter,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Sodium-dependent serotonin transporter,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Histamine H1 receptor,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Alpha-1A adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Alpha-1D adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Muscarinic acetylcholine receptor M3,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Muscarinic acetylcholine receptor M1,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Muscarinic acetylcholine receptor M4,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Muscarinic acetylcholine receptor M2,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Muscarinic acetylcholine receptor M5,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Potassium voltage-gated channel subfamily D member 2,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Potassium voltage-gated channel subfamily D member 3,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,5-hydroxytryptamine receptor 2C,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Alpha-1B adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,5-hydroxytryptamine receptor 7,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,D(1A) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,D(1B) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,D(2) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Potassium voltage-gated channel subfamily H member 2,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Sodium-dependent dopamine transporter,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,5-hydroxytryptamine receptor 1A,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,5-hydroxytryptamine receptor 6,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Potassium voltage-gated channel subfamily H member 1,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imipramine,Alpha-1-acid glycoprotein 2,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
Imiquimod,Toll-like receptor 7,CC(C)CN1C=NC2=C1C1=CC=CC=C1N=C2N
Imiquimod,Toll-like receptor 8,CC(C)CN1C=NC2=C1C1=CC=CC=C1N=C2N
Immucillin-G,Purine nucleoside phosphorylase,[H][C@]1(CO)N[C@@]([H])(C2=CNC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
Immune Globulin Human,High affinity immunoglobulin gamma Fc receptor I,
Immune Globulin Human,High affinity immunoglobulin gamma Fc receptor IB,
Immune Globulin Human,Low affinity immunoglobulin gamma Fc region receptor II-a,
Immune Globulin Human,Low affinity immunoglobulin gamma Fc region receptor II-b,
Immune Globulin Human,Low affinity immunoglobulin gamma Fc region receptor II-c,
Immune Globulin Human,Low affinity immunoglobulin gamma Fc region receptor III-A,
Immune Globulin Human,Low affinity immunoglobulin gamma Fc region receptor III-B,
Immune Globulin Human,Complement C3,
Immune Globulin Human,Complement C4-A,
Immune Globulin Human,Complement C5,
Immune Globulin Human,Complement C4-B,
Implitapide,Microsomal triglyceride transfer protein large subunit,CC1=NC2=C(C3=CC=CC=C3N2CC2=CC(=CC=C2)[C@H](C2CCCC2)C(=O)N[C@@H](CO)C2=CC=CC=C2)C(C)=C1
Indacaterol,Beta-2 adrenergic receptor,CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1
Indapamide,Solute carrier family 12 member 3,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
Indecainide,Sodium channel protein type 5 subunit alpha,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12
Indeglitazar,Nuclear receptor coactivator 1,COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12
Indeglitazar,Peroxisome proliferator-activated receptor alpha,COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12
Indeglitazar,Peroxisome proliferator-activated receptor delta,COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12
Indeglitazar,Peroxisome proliferator-activated receptor gamma,COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12
Indigotindisulfonic Acid,Aryl hydrocarbon receptor,OS(=O)(=O)C1=CC2=C(N\C(C2=O)=C2\NC3=C(C=C(C=C3)S(O)(=O)=O)C2=O)C=C1
Indigotindisulfonic Acid,Alpha-1A adrenergic receptor,OS(=O)(=O)C1=CC2=C(N\C(C2=O)=C2\NC3=C(C=C(C=C3)S(O)(=O)=O)C2=O)C=C1
Indigotindisulfonic Acid,Alpha-1B adrenergic receptor,OS(=O)(=O)C1=CC2=C(N\C(C2=O)=C2\NC3=C(C=C(C=C3)S(O)(=O)=O)C2=O)C=C1
Indigotindisulfonic Acid,Alpha-1D adrenergic receptor,OS(=O)(=O)C1=CC2=C(N\C(C2=O)=C2\NC3=C(C=C(C=C3)S(O)(=O)=O)C2=O)C=C1
Indigotindisulfonic Acid,Alpha-2A adrenergic receptor,OS(=O)(=O)C1=CC2=C(N\C(C2=O)=C2\NC3=C(C=C(C=C3)S(O)(=O)=O)C2=O)C=C1
Indigotindisulfonic Acid,Alpha-2B adrenergic receptor,OS(=O)(=O)C1=CC2=C(N\C(C2=O)=C2\NC3=C(C=C(C=C3)S(O)(=O)=O)C2=O)C=C1
Indigotindisulfonic Acid,Alpha-2C adrenergic receptor,OS(=O)(=O)C1=CC2=C(N\C(C2=O)=C2\NC3=C(C=C(C=C3)S(O)(=O)=O)C2=O)C=C1
Indinavir,Pol polyprotein,CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12
Indirubin,Cytochrome P450 1A1,O=C1NC2=CC=CC=C2\C1=C1/NC2=CC=CC=C2C1=O
Indirubin,Aryl hydrocarbon receptor,O=C1NC2=CC=CC=C2\C1=C1/NC2=CC=CC=C2C1=O
Indirubin-3'-Monoxime,Cyclin-dependent-like kinase 5,O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2
Indirubin-3'-Monoxime,Glycogen synthase kinase-3 beta,O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2
Indirubin-3'-Monoxime,Cyclin-dependent kinase 1,O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2
Indirubin-3'-Monoxime,Cyclin-dependent kinase 5 activator 1,O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2
Indirubin-3'-Monoxime,Cyclin-dependent kinase 2,O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2
Indirubin-3'-Monoxime,Aryl hydrocarbon receptor,O\N=C1\C(\NC2=C\1C=CC=C2)=C1\C(=O)NC2=C1C=CC=C2
Indirubin-5-Sulphonate,"Glycogen phosphorylase, muscle form",OS(=O)(=O)C1=CC=C2NC(=O)\C(=C3/NC4=CC=CC=C4C3=O)C2=C1
Indirubin-5-Sulphonate,Cell division control protein 2 homolog,OS(=O)(=O)C1=CC=C2NC(=O)\C(=C3/NC4=CC=CC=C4C3=O)C2=C1
Indole,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,N1C=CC2=C1C=CC=C2
Indole,Endolysin,N1C=CC2=C1C=CC=C2
Indole Naphthyridinone,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,CN(CC1=CN(C)C2=CC=CC=C12)C(=O)\C=C\C1=CN=C2NC(=O)CCC2=C1
Indole-3-Glycerol Phosphate,Tryptophan synthase alpha chain,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)C1=CNC2=C1C=CC=C2
Indole-3-Glycerol Phosphate,Tryptophan synthase beta chain,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)C1=CNC2=C1C=CC=C2
Indole-3-Propanol Phosphate,Tryptophan synthase alpha chain,OP(O)(=O)OCCCC1=CNC2=C1C=CC=C2
Indole-3-Propanol Phosphate,Tryptophan synthase alpha chain,OP(O)(=O)OCCCC1=CNC2=C1C=CC=C2
Indole-3-Propanol Phosphate,Tryptophan synthase beta chain,OP(O)(=O)OCCCC1=CNC2=C1C=CC=C2
Indoleacetic acid,Group IIE secretory phospholipase A2,OC(=O)CC1=CNC2=CC=CC=C12
Indoleacetic acid,S-phase kinase-associated protein 1,OC(=O)CC1=CNC2=CC=CC=C12
Indoleacetic acid,Kynurenine--oxoglutarate transaminase 1,OC(=O)CC1=CNC2=CC=CC=C12
Indolylpropionic Acid,Aspartate aminotransferase,OC(=O)CCC1=CNC2=CC=CC=C12
Indolylpropionic Acid,Aromatic-amino-acid aminotransferase,OC(=O)CCC1=CNC2=CC=CC=C12
Indolylpropionic Acid,Group IIE secretory phospholipase A2,OC(=O)CCC1=CNC2=CC=CC=C12
Indometacin,Prostaglandin G/H synthase 1,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indometacin,Prostaglandin G/H synthase 2,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indometacin,"Phospholipase A2, membrane associated",COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indometacin,Prostaglandin reductase 2,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indometacin,Peroxisome proliferator-activated receptor gamma,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indometacin,Lactoylglutathione lyase,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indometacin,Prostaglandin D2 receptor 2,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indometacin,Peroxisome proliferator-activated receptor alpha,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indometacin,Aldo-keto reductase family 1 member C3,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
Indoramin,Alpha-1A adrenergic receptor,OC(=NC1CCN(CCC2=CNC3=CC=CC=C23)CC1)C1=CC=CC=C1
Inecalcitol,Vitamin D3 receptor,[H][C@@]1(CC[C@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)CC#CC(C)(C)O
Infliximab,Tumor necrosis factor,
Ingenol mebutate,Protein kinase C alpha type,[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(\C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C
Ingenol mebutate,Protein kinase C delta type,[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(\C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C
Inhibitor BEA369,Gag-Pol polyprotein,[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@]1([H])CO[C@]([H])(CO)C1
Inhibitor BEA369,Gag-Pol polyprotein,[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@]1([H])CO[C@]([H])(CO)C1
Inhibitor Bea322,Gag-Pol polyprotein,[H][C@](C)(CC)[C@]([H])(N=C(O)[C@]([H])(OCC1=CC=CC=C1)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@]([H])(C(O)=NC)[C@@]([H])(C)CC)C(O)=NC
Inhibitor Bea388,Gag-Pol polyprotein,[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC
Inhibitor Bea403,Gag-Pol polyprotein,[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=CC=C1F)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O)[C@@]([H])(OCC1=CC=CC=C1F)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O
Inhibitor Bea409,Gag-Pol polyprotein,[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=C(C=C1)C1=CSC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC)[C@@]([H])(OCC1=CC=C(C=C1)C1=CSC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC
Inhibitor Bea425,Gag-Pol polyprotein,[H][C@](C[C@@]([H])(O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O)(OCC1=CC=CC=C1)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O
Inhibitor Bea428,Gag-Pol polyprotein,[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=C(C=C1)C1=CN=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC)[C@@]([H])(OCC1=CC=C(C=C1)C1=CN=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NC
Inhibitor Idd 384,Aldose reductase,CC1=CC=CC=C1CC(=O)NC1=CC(C)=C(C(C)=C1)S(=O)(=O)NCC(O)=O
Inhibitor Msa367,Gag-Pol polyprotein,[H][C@@](O)([C@@]([H])(O)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NCC1=CC=CC=N1)[C@@]([H])(OCC1=CC=CC=C1)C(O)=N[C@@]([H])(C(C)C)C(O)=NCC1=CC=CC=N1
Inhibitor of P38 Kinase,Mitogen-activated protein kinase 14,C(CC1=CC=NC=C1)C1=CNC2=CC=CC=C12
Iniparib,Poly [ADP-ribose] polymerase 1,NC(=O)C1=CC(=C(I)C=C1)[N+]([O-])=O
Inosine,Purine nucleoside phosphorylase,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1NC=NC2=O
Inosine,Purine nucleoside phosphorylase DeoD-type,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1NC=NC2=O
Inosine,IAG-nucleoside hydrolase,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1NC=NC2=O
Inosinic Acid,Inosine-5'-monophosphate dehydrogenase 2,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O
Inosinic Acid,"Glycogen phosphorylase, muscle form",O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O
Inosinic Acid,Adenylosuccinate synthetase,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O
Inosinic Acid,Adenylosuccinate synthetase,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O
Inosinic Acid,Inosine-5'-monophosphate dehydrogenase,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O
Inosinic Acid,Hypoxanthine phosphoribosyltransferase,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O
Inosinic Acid,Adenylosuccinate synthetase isozyme 1,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O
Inosinic Acid,Hypoxanthine-guanine phosphoribosyltransferase,O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O
"Inositol 1,3,4,5-Tetrakisphosphate",RAC-alpha serine/threonine-protein kinase,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
"Inositol 1,3,4,5-Tetrakisphosphate",Pleckstrin homology domain-containing family A member 4,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
"Inositol 1,3,4,5-Tetrakisphosphate",Tyrosine-protein kinase BTK,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
"Inositol 1,3,4,5-Tetrakisphosphate",Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
"Inositol 1,3,4,5-Tetrakisphosphate",Inositol-trisphosphate 3-kinase A,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
"Inositol 1,3,4,5-Tetrakisphosphate",Cytohesin-2,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
"Inositol 1,3,4,5-Tetrakisphosphate",Cytohesin-3,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
"Inositol 1,3,4,5-Tetrakisphosphate",3-phosphoinositide-dependent protein kinase 1,O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O
"Inositol 1,3-Bisphosphate",Early endosome antigen 1,O[C@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](OP(O)(O)=O)[C@@H]1O
"Inositol 2,4,5-trisphosphate","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",O[C@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]1OP(O)(O)=O
Inositol nicotinate,Hydroxycarboxylic acid receptor 3,O=C(O[C@H]1[C@H](OC(=O)C2=CC=CN=C2)[C@@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@@H]1OC(=O)C1=CC=CN=C1)C1=CC=CN=C1
Inositol nicotinate,Hydroxycarboxylic acid receptor 2,O=C(O[C@H]1[C@H](OC(=O)C2=CC=CN=C2)[C@@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C2=CC=CN=C2)[C@@H]1OC(=O)C1=CC=CN=C1)C1=CC=CN=C1
"Inositol-(1,3,4,5,6)-Pentakisphosphate",Cytohesin-3,[H][C@]1(O)[C@]([H])(OP(O)(O)=O)[C@@]([H])(OP(O)(O)=O)[C@@]([H])(OP(O)(O)=O)[C@]([H])(OP(O)(O)=O)[C@@]1([H])OP(O)(O)=O
Inotuzumab ozogamicin,B-cell receptor CD22,
Insulin Aspart,Insulin receptor,
Insulin Aspart,Insulin-like growth factor 1 receptor,
Insulin Degludec,Insulin receptor,
Insulin Degludec,Insulin-like growth factor 1 receptor,
Insulin Detemir,Insulin receptor,
Insulin Detemir,Insulin-like growth factor 1 receptor,
Insulin Glulisine,Insulin receptor,
Insulin Glulisine,Insulin-like growth factor 1 receptor,
Insulin Human,Insulin receptor,
Insulin Human,Insulin-like growth factor 1 receptor,
Insulin Human,Retinoblastoma-associated protein,
Insulin Lispro,Insulin receptor,
Insulin Lispro,Insulin-like growth factor 1 receptor,
Insulin Pork,Insulin receptor,
Insulin Pork,Insulin-like growth factor 1 receptor,
Insulin Pork,Insulin-degrading enzyme,
Insulin Pork,"HLA class II histocompatibility antigen, DQ alpha 2 chain",
Insulin Pork,"HLA class II histocompatibility antigen, DQ beta 1 chain",
Insulin Pork,Retinoblastoma-associated protein,
Insulin Pork,Cathepsin D,
Insulin Pork,Carboxypeptidase E,
Insulin Pork,Neuroendocrine convertase 2,
Insulin Pork,Neuroendocrine convertase 1,
Insulin Pork,Protein NOV homolog,
Insulin Pork,Low-density lipoprotein receptor-related protein 2,
Insulin Pork,Insulin-like growth factor-binding protein 7,
Insulin Pork,Synaptotagmin-like protein 4,
Insulin glargine,Insulin receptor,
Insulin glargine,Insulin-like growth factor 1 receptor,
"Interferon Alfa-2a, Recombinant",Interferon alpha/beta receptor 2,
"Interferon Alfa-2a, Recombinant",Interferon alpha/beta receptor 1,
Interferon alfa,Interferon alpha/beta receptor 1,
Interferon alfa-2b,Interferon alpha/beta receptor 2,
Interferon alfa-2b,Interferon alpha/beta receptor 1,
Interferon alfa-n1,Interferon alpha/beta receptor 2,
Interferon alfa-n1,Interferon alpha/beta receptor 1,
Interferon alfa-n3,Interferon alpha/beta receptor 2,
Interferon alfa-n3,Interferon alpha/beta receptor 1,
Interferon alfacon-1,Interferon alpha/beta receptor 2,
Interferon alfacon-1,Interferon alpha/beta receptor 1,
Interferon beta-1a,Interferon alpha/beta receptor 1,
Interferon beta-1a,Interferon alpha/beta receptor 2,
Interferon beta-1b,Interferon alpha/beta receptor 2,
Interferon beta-1b,Interferon alpha/beta receptor 1,
Interferon gamma-1b,Interferon gamma receptor 2,
Interferon gamma-1b,Interferon gamma receptor 1,
Inulin,Cycloinulo-oligosaccharide fructanotransferase,OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(OC[C@@]%12(OC[C@@]%13(OC[C@@]%14(OC[C@@]%15(OC[C@@]%16(OC[C@@]%17(OC[C@@]%18(OC[C@@]%19(OC[C@@]%20(OC[C@@]%21(OC[C@@]%22(OC[C@@]%23(OC[C@@]%24(OC[C@@]%25(OC[C@@]%26(OC[C@@]%27(OC[C@@]%28(OC[C@@]%29(OC[C@@]%30(OC[C@@]%31(OC[C@@]%32(OC[C@@]%33(OC[C@@]%34(OC[C@@]%35(OC[C@@]%36(OC[C@@]%37(O[C@H]%38O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%38O)O[C@H](CO)[C@@H](O)[C@@H]%37O)O[C@H](CO)[C@@H](O)[C@@H]%36O)O[C@H](CO)[C@@H](O)[C@@H]%35O)O[C@H](CO)[C@@H](O)[C@@H]%34O)O[C@H](CO)[C@@H](O)[C@@H]%33O)O[C@H](CO)[C@@H](O)[C@@H]%32O)O[C@H](CO)[C@@H](O)[C@@H]%31O)O[C@H](CO)[C@@H](O)[C@@H]%30O)O[C@H](CO)[C@@H](O)[C@@H]%29O)O[C@H](CO)[C@@H](O)[C@@H]%28O)O[C@H](CO)[C@@H](O)[C@@H]%27O)O[C@H](CO)[C@@H](O)[C@@H]%26O)O[C@H](CO)[C@@H](O)[C@@H]%25O)O[C@H](CO)[C@@H](O)[C@@H]%24O)O[C@H](CO)[C@@H](O)[C@@H]%23O)O[C@H](CO)[C@@H](O)[C@@H]%22O)O[C@H](CO)[C@@H](O)[C@@H]%21O)O[C@H](CO)[C@@H](O)[C@@H]%20O)O[C@H](CO)[C@@H](O)[C@@H]%19O)O[C@H](CO)[C@@H](O)[C@@H]%18O)O[C@H](CO)[C@@H](O)[C@@H]%17O)O[C@H](CO)[C@@H](O)[C@@H]%16O)O[C@H](CO)[C@@H](O)[C@@H]%15O)O[C@H](CO)[C@@H](O)[C@@H]%14O)O[C@H](CO)[C@@H](O)[C@@H]%13O)O[C@H](CO)[C@@H](O)[C@@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O
Iodine,NADH-ubiquinone oxidoreductase chain 5,II
Iodo-Willardiine,Glutamate receptor 2,N[C@@H](CN1C=C(I)C(=O)NC1=O)C(O)=O
Iodophenyl,Endoglucanase F,IC1=CC=CC=C1
Iopodic acid,Thyroxine 5-deiodinase,CN(C)C=NC1=C(I)C=C(I)C(CCC(O)=O)=C1I
Ipilimumab,Cytotoxic T-lymphocyte protein 4,
Ipratropium,Muscarinic acetylcholine receptor M1,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
Ipratropium,Muscarinic acetylcholine receptor M2,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
Ipratropium,Muscarinic acetylcholine receptor M3,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
Irbesartan,Type-1 angiotensin II receptor,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1
Irbesartan,Transcription factor AP-1,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1
Irinotecan,"DNA topoisomerase I, mitochondrial",CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
Irinotecan,DNA topoisomerase 1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
Irofulven,Far upstream element-binding protein 1,CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1
Iron,Transferrin receptor protein 1,[Fe]
Iron,Egl nine homolog 1,[Fe]
Iron,Histone deacetylase 8,[Fe]
Iron,Alpha-hemoglobin-stabilizing protein,[Fe]
Iron,Hemoglobin subunit alpha,[Fe]
Iron,"Frataxin, mitochondrial",[Fe]
Iron,Ferritin heavy chain,[Fe]
Iron,Flap endonuclease 1,[Fe]
Iron,Endonuclease 8-like 1,[Fe]
Iron,Endonuclease 8-like 2,[Fe]
Iron,DNA polymerase beta,[Fe]
Iron,Ceruloplasmin,[Fe]
Iron,Serotransferrin,[Fe]
Iron Dextran,Ferritin light chain,
Iron Dextran,Hemoglobin subunit alpha,
Iron Dextran,Ferritin heavy chain,
Iron Dextran,Hemoglobin subunit beta,
Iron saccharate,Hemoglobin subunit alpha,O.O.O.[OH-].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Irosustat,Carbonic anhydrase 2,NS(=O)(=O)OC1=CC=C2C3=C(CCCCC3)C(=O)OC2=C1
Irosustat,Steryl-sulfatase,NS(=O)(=O)OC1=CC=C2C3=C(CCCCC3)C(=O)OC2=C1
Isatin,Amine oxidase [flavin-containing] B,O=C1NC2=CC=CC=C2C1=O
Isatoribine,Toll-like receptor 7,NC1=NC(=O)C2=C(N1)N([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C(=O)S2
Isavuconazole,Lanosterol 14-alpha demethylase,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,Potassium voltage-gated channel subfamily H member 2,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,Voltage-dependent L-type calcium channel subunit alpha-1C,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,G protein-activated inward rectifier potassium channel 2,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,G protein-activated inward rectifier potassium channel 3,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,ATP-sensitive inward rectifier potassium channel 11,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,Potassium voltage-gated channel subfamily A member 5,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,Potassium voltage-gated channel subfamily D member 3,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,Potassium voltage-gated channel subfamily KQT member 1,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isavuconazole,Sodium channel protein type 5 subunit alpha,C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1
Isoamyl alcohol,Renin,CC(C)CCO
Isobutyric acid,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",CC(C)C(O)=O
Isocarboxazid,Amine oxidase [flavin-containing] B,CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1
Isocarboxazid,Amine oxidase [flavin-containing] A,CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1
Isochorismic Acid,Phenazine biosynthesis protein PhzD,[H][C@]1(O)C(=CC=C[C@]1([H])OC(=C)C([O-])=O)C([O-])=O
Isocitric Acid,Isocitrate dehydrogenase [NADP],O[C@@H]([C@H](CC(O)=O)C(O)=O)C(O)=O
Isocitric Acid,Isocitrate dehydrogenase [NADP],O[C@@H]([C@H](CC(O)=O)C(O)=O)C(O)=O
Isocitric Acid,Isocitrate dehydrogenase [NADP] cytoplasmic,O[C@@H]([C@H](CC(O)=O)C(O)=O)C(O)=O
Isocitric Acid,2-methylisocitrate lyase,O[C@@H]([C@H](CC(O)=O)C(O)=O)C(O)=O
Isocitric Acid,"Aconitate hydratase, mitochondrial",O[C@@H]([C@H](CC(O)=O)C(O)=O)C(O)=O
Isocitric Acid,"Isocitrate dehydrogenase [NADP], mitochondrial",O[C@@H]([C@H](CC(O)=O)C(O)=O)C(O)=O
Isoetarine,Beta-1 adrenergic receptor,CCC(NC(C)C)C(O)C1=CC(O)=C(O)C=C1
Isoetarine,Beta-2 adrenergic receptor,CCC(NC(C)C)C(O)C1=CC(O)=C(O)C=C1
Isoflavone,Peroxisome proliferator-activated receptor alpha,O=C1C(=COC2=CC=CC=C12)C1=CC=CC=C1
Isoflavone,Peroxisome proliferator-activated receptor gamma,O=C1C(=COC2=CC=CC=C12)C1=CC=CC=C1
Isoflurane,Gamma-aminobutyric acid receptor subunit alpha-1,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Calcium-transporting ATPase type 2C member 1,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Glycine receptor subunit alpha-1,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Glutamate receptor 1,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Potassium voltage-gated channel subfamily A member 1,FC(F)OC(Cl)C(F)(F)F
Isoflurane,"ATP synthase subunit delta, mitochondrial",FC(F)OC(Cl)C(F)(F)F
Isoflurane,Calmodulin,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit alpha-1,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit alpha-2,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit alpha-3,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit alpha-4,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit alpha-5,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit alpha-6,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit beta-1,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit beta-2,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit beta-3,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit delta,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit epsilon,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit gamma-1,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit gamma-2,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit gamma-3,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit pi,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Gamma-aminobutyric acid receptor subunit theta,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Neuronal acetylcholine receptor subunit alpha-4,FC(F)OC(Cl)C(F)(F)F
Isoflurane,Neuronal acetylcholine receptor subunit beta-2,FC(F)OC(Cl)C(F)(F)F
Isoflurophate,Acetylcholinesterase,CC(C)OP(F)(=O)OC(C)C
Isoflurophate,Cholinesterase,CC(C)OP(F)(=O)OC(C)C
Isoflurophate,Serotransferrin,CC(C)OP(F)(=O)OC(C)C
Isoleucine,"Isoleucine--tRNA ligase, cytoplasmic",CC[C@H](C)[C@H](N)C(O)=O
Isoleucine,"Branched-chain-amino-acid aminotransferase, cytosolic",CC[C@H](C)[C@H](N)C(O)=O
Isoleucine,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",CC[C@H](C)[C@H](N)C(O)=O
Isoleucine,"Branched-chain-amino-acid aminotransferase, mitochondrial",CC[C@H](C)[C@H](N)C(O)=O
Isoleucine,"Isoleucine--tRNA ligase, mitochondrial",CC[C@H](C)[C@H](N)C(O)=O
Isoluminol,Queuine tRNA-ribosyltransferase,NC1=CC=C2C(=O)NNC(=O)C2=C1
Isometheptene,Alpha-1A adrenergic receptor,CNC(C)CCC=C(C)C
Isometheptene,Synaptic vesicular amine transporter,CNC(C)CCC=C(C)C
Isoniazid,Enoyl-[acyl-carrier-protein] reductase [NADH],NNC(=O)C1=CC=NC=C1
Isoniazid,Catalase-peroxidase,NNC(=O)C1=CC=NC=C1
Isoniazid,Cytochrome P450 2C8,NNC(=O)C1=CC=NC=C1
Isoniazid,Cytochrome P450 1A2,NNC(=O)C1=CC=NC=C1
Isoniazid,Cytochrome P450 3A4,NNC(=O)C1=CC=NC=C1
Isoniazid,Cytochrome P450 2C19,NNC(=O)C1=CC=NC=C1
Isoniazid,Dihydrofolate reductase,NNC(=O)C1=CC=NC=C1
Isopentyl Pyrophosphate,Farnesyl diphosphate synthase,CC(C)CCO[P@](O)(=O)OP(O)(O)=O
Isopentyl Pyrophosphate,Farnesyl pyrophosphate synthase,CC(C)CCO[P@](O)(=O)OP(O)(O)=O
Isopentyl Pyrophosphate,Pentaerythritol tetranitrate reductase,CC(C)CCO[P@](O)(=O)OP(O)(O)=O
Isopentyl Pyrophosphate,Geranyltranstransferase (Farnesyldiphosphate synthase),CC(C)CCO[P@](O)(=O)OP(O)(O)=O
Isoprenaline,Beta-1 adrenergic receptor,CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isoprenaline,Beta-2 adrenergic receptor,CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isoprenaline,Beta-3 adrenergic receptor,CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isoprenaline,Mitogen-activated protein kinase 1,CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isoprenaline,Phosphatidylinositol 3-kinase regulatory subunit alpha,CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isoprenaline,Phosphatidylinositol 3-kinase regulatory subunit beta,CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isoprenaline,Phosphatidylinositol 3-kinase regulatory subunit gamma,CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isoprenaline,CAMP phosphodiesterase,CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isoprenaline,Superoxide dismutase [Cu-Zn],CC(C)NCC(O)C1=CC(O)=C(O)C=C1
Isopropamide,Muscarinic acetylcholine receptor M3,CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C
Isopropamide,Muscarinic acetylcholine receptor M4,CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C
Isopropyl alcohol,Tumor necrosis factor,CC(C)O
Isopropyl alcohol,L-xylulose reductase,CC(C)O
Isopropyl alcohol,GTP cyclohydrolase 1,CC(C)O
Isopropyl alcohol,Chitotriosidase-1,CC(C)O
Isopropyl alcohol,Thermolysin,CC(C)O
Isopropyl alcohol,Subtilisin BPN',CC(C)O
Isopropyl alcohol,Ganglioside GM2 activator,CC(C)O
Isopropyl alcohol,Aldehyde oxidoreductase,CC(C)O
Isopropyl alcohol,DNA mismatch repair protein MutL,CC(C)O
Isopropyl alcohol,"Phospholipase A2, membrane associated",CC(C)O
Isopropyl alcohol,Adenosylhomocysteinase,CC(C)O
Isopropyl alcohol,Gag-Pro-Pol polyprotein,CC(C)O
Isopropyl alcohol,Endolysin,CC(C)O
Isopropyl alcohol,Glucarate dehydratase,CC(C)O
Isopropyl alcohol,FMN-dependent NADH-azoreductase,CC(C)O
Isopropyl alcohol,Transcription termination/antitermination protein NusG,CC(C)O
Isopropyl alcohol,Growth/differentiation factor 5,CC(C)O
Isopropyl alcohol,Ig kappa chain V-IV region Len,CC(C)O
Isopropyl alcohol,Pectate lyase,CC(C)O
Isopropyl alcohol,Gag polyprotein,CC(C)O
Isopropyl alcohol,Scaffolding dockerin binding protein A,CC(C)O
Isopropyl alcohol,Alr1529 protein,CC(C)O
Isopropyl alcohol,Putative deoxyribonuclease YcfH,CC(C)O
Isopropyl alcohol,Ribonuclease pancreatic,CC(C)O
Isopropyl alcohol,mRNA-capping enzyme,CC(C)O
Isopropyl alcohol,Tartrate-resistant acid phosphatase type 5,CC(C)O
Isopropyl alcohol,Trypsin-2,CC(C)O
Isopropyl alcohol,Spliceosome RNA helicase DDX39B,CC(C)O
Isopropyl alcohol,"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase",CC(C)O
Isopropyl alcohol,Peroxiredoxin-6,CC(C)O
Isopropyl beta-D-thiogalactopyranoside,Galactoside O-acetyltransferase,[H][C@]1(CO)O[C@@]([H])(SC(C)C)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Isopropyl beta-D-thiogalactopyranoside,Beta-galactosidase,[H][C@]1(CO)O[C@@]([H])(SC(C)C)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Isopropyl beta-D-thiogalactopyranoside,Lactose operon repressor,[H][C@]1(CO)O[C@@]([H])(SC(C)C)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Isosorbide,Apoptosis regulator Bcl-2,[H][C@]1(O)CO[C@]2([H])[C@]([H])(O)CO[C@]12[H]
Isosorbide,Bcl-2-like protein 1,[H][C@]1(O)CO[C@]2([H])[C@]([H])(O)CO[C@]12[H]
Isosorbide,Induced myeloid leukemia cell differentiation protein Mcl-1,[H][C@]1(O)CO[C@]2([H])[C@]([H])(O)CO[C@]12[H]
Isosorbide Mononitrate,Guanylate cyclase soluble subunit alpha-2,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O
Isosorbide dinitrate,Atrial natriuretic peptide receptor 1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O
Isothipendyl,Histamine H1 receptor,CC(CN1C2=CC=CC=C2SC2=C1N=CC=C2)N(C)C
Isotretinoin,Retinoic acid receptor alpha,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
Isotretinoin,Retinoic acid receptor gamma,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O
Isovaleric Acid,Aspartate aminotransferase,CC(C)CC(O)=O
Isovaleric Acid,Pseudomonalisin,CC(C)CC(O)=O
Isovaleric Acid,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",CC(C)CC(O)=O
Isradipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
Isradipine,Voltage-dependent calcium channel subunit alpha-2/delta-1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
Isradipine,Voltage-dependent L-type calcium channel subunit beta-2,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
Isradipine,Voltage-dependent T-type calcium channel subunit alpha-1H,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
Isradipine,Voltage-dependent calcium channel subunit alpha-2/delta-2,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
Isradipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
Isradipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C
Istaroxime,Sodium/potassium-transporting ATPase subunit alpha-1,C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C\C(CC[C@]34C)=N\OCCN)[C@@H]1CCC2=O
Istaroxime,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4C\C(CC[C@]34C)=N\OCCN)[C@@H]1CCC2=O
Itopride,Acetylcholinesterase,COC1=CC=C(C=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1
Itopride,D(2) dopamine receptor,COC1=CC=C(C=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1
Itraconazole,Lanosterol 14-alpha demethylase,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Itraconazole,Lanosterol 14-alpha demethylase,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Ivabradine,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
Ivacaftor,Cystic fibrosis transmembrane conductance regulator,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C
Ivermectin,Glycine receptor subunit alpha-3,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@H]1[C@H](C)O[C@H](C[C@@H]1OC)O[C@H]1[C@@H](C)\C=C\C=C2/CO[C@@H]3[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]4C[C@@H](C\C=C1/C)O[C@@]1(CC[C@H](C)[C@@H](C(C)C)O1)C4)[C@]23O.CC[C@@H](C)[C@H]1O[C@@]2(CC[C@@H]1C)O[C@@H]1C\C=C(C)\[C@@H](O[C@@H]3O[C@@H](C)[C@H](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](OC)C4)[C@@H](OC)C3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O[C@@H](C1)C2)[C@]34O
Ivermectin,Gamma-aminobutyric acid receptor subunit beta-3,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@H]1[C@H](C)O[C@H](C[C@@H]1OC)O[C@H]1[C@@H](C)\C=C\C=C2/CO[C@@H]3[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]4C[C@@H](C\C=C1/C)O[C@@]1(CC[C@H](C)[C@@H](C(C)C)O1)C4)[C@]23O.CC[C@@H](C)[C@H]1O[C@@]2(CC[C@@H]1C)O[C@@H]1C\C=C(C)\[C@@H](O[C@@H]3O[C@@H](C)[C@H](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](OC)C4)[C@@H](OC)C3)[C@@H](C)\C=C\C=C3/CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O[C@@H](C1)C2)[C@]34O
Ivosidenib,Isocitrate dehydrogenase [NADP] cytoplasmic,[H][C@@](N(C(=O)[C@]1([H])CCC(=O)N1C1=NC=CC(=C1)C#N)C1=CC(F)=CN=C1)(C(=O)NC1CC(F)(F)C1)C1=C(Cl)C=CC=C1
Ixabepilone,Tubulin beta-3 chain,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1
Ixekizumab,Interleukin-17A,
JNJ-37822681,D(2) dopamine receptor,FC1=C(F)C=C(CN2CCC(CC2)NC2=CC=C(N=N2)C(F)(F)F)C=C1
Jaspisamide A,"Actin, alpha skeletal muscle",[H]\C(C[C@@]([H])(OC)[C@@]([H])(C)C(=O)CC[C@]([H])(C)[C@]([H])(C[C@]1([H])OC(=O)C[C@@]([H])(O)C[C@]([H])(O)CC(=O)[C@]([H])(C)[C@]([H])(OC)C2=COC(=N2)C2=COC(=N2)C2=COC(=N2)\C([H])=C([H])\CC[C@@]1([H])C)OC)=C(\[H])N(C)CO
"Je-2147, Ag1776, Kni-764",Gag-Pol polyprotein,[H][C@@](O)(C(=O)N1CSC(C)(C)[C@@]1([H])C(O)=NCC1=CC=CC=C1C)[C@]([H])(CC1=CC=CC=C1)N=C(O)C1=C(C)C(O)=CC=C1
Josamycin,50S ribosomal protein L4,CO[C@H]1[C@@H](CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C)OC(C)=O
K-252a,Hepatocyte growth factor receptor,[H][C@]12C[C@](O)(C(=O)OC)[C@](C)(O1)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13
K-252a,Dual specificity mitogen-activated protein kinase kinase 1,[H][C@]12C[C@](O)(C(=O)OC)[C@](C)(O1)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13
K201,Annexin A5,COC1=CC2=C(SCCN(C2)C(=O)CCN2CCC(CC3=CC=CC=C3)CC2)C=C1
KAI-1455,Protein kinase C epsilon type,
KB-141,Thyroid hormone receptor beta,CC(C)C1=CC(OC2=C(Cl)C=C(CC(O)=O)C=C2Cl)=CC=C1O
KB-141,Thyroid hormone receptor alpha,CC(C)C1=CC(OC2=C(Cl)C=C(CC(O)=O)C=C2Cl)=CC=C1O
KB001,Low calcium response locus protein V,
KB002,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,
KB002,Granulocyte-macrophage colony-stimulating factor,
KB002,GM-CSF receptor alpha subunit,
KC706,Mitogen-activated protein kinase 14,
KC706,Mitogen-activated protein kinase 12,
KC706,Mitogen-activated protein kinase 11,
KC706,Mitogen-activated protein kinase 13,
KD3010,Peroxisome proliferator-activated receptor delta,CC1=CC=C(C=C1)S(O)(=O)=O.[H]C1(CC2=C(C1)C(=CC=C2)S(=O)(=O)N1[C@@]([H])(C)CN(C[C@@]1([H])C)C1=CC=C(OC(F)(F)F)C=C1)C(O)=O
KD7040,"Nitric oxide synthase, inducible",
KP-1461,Gag-Pol polyprotein,CCCCCCCOC(=O)NC1=NC(=O)N(CN1)[C@H]1C[C@H](O)[C@@H](CO)O1
KX-01,Proto-oncogene tyrosine-protein kinase Src,O=C(CC1=CC=C(C=N1)C1=CC=C(OCCN2CCOCC2)C=C1)NCC1=CC=CC=C1
Kabiramide C,"Actin, alpha skeletal muscle",[H]\C(=C(\[H])[C@@]([H])(C)[C@@]([H])(OC)[C@@]([H])(C)C(=O)CC[C@]([H])(C)[C@]([H])(C[C@]1([H])OC(=O)C[C@]([H])(C[C@]([H])(C)C[C@]([H])(O)[C@]([H])(C)[C@@]([H])(OC)C2=COC(=N2)C2=COC(=N2)C2=COC(=N2)\C([H])=C([H])\C[C@]([H])(OC)[C@@]1([H])C)O[C@]([H])(N)O)OC)N(C)CO
Kaempherol,UDP-glucuronosyltransferase 3A1,OC1=CC=C(C=C1)C1=C(O)C(=O)C2=C(O1)C=C(O)C=C2O
Kanamycin,30S ribosomal protein S12,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
Kappadione,Prothrombin,[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1
Kappadione,Coagulation factor VII,[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1
Kappadione,Coagulation factor IX,[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1
Kappadione,Coagulation factor X,[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1
Kappadione,Vitamin K-dependent protein C,[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1
Kappadione,Vitamin K-dependent gamma-carboxylase,[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1
Kappadione,Vitamin K-dependent protein S,[Na+].[Na+].[Na+].[Na+].CC1=C(OP([O-])([O-])=O)C2=CC=CC=C2C(OP([O-])([O-])=O)=C1
Ketamine,"Glutamate receptor ionotropic, NMDA 3A",CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Substance-P receptor,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,D(2) dopamine receptor,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Delta-type opioid receptor,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Sodium-dependent noradrenaline transporter,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Kappa-type opioid receptor,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Mu-type opioid receptor,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Muscarinic acetylcholine receptor M1,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Muscarinic acetylcholine receptor M2,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Muscarinic acetylcholine receptor M3,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Muscarinic acetylcholine receptor M4,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Muscarinic acetylcholine receptor M5,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 2A,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 2B,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 2C,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 1A,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 1B,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 1D,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 1E,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 1F,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,5-hydroxytryptamine receptor 3A,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Alpha-7 nicotinic cholinergic receptor subunit,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,Cholinesterase,CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketamine,"Nitric oxide synthase, brain",CNC1(CCCCC1=O)C1=CC=CC=C1Cl
Ketanserin,5-hydroxytryptamine receptor 2A,FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1
Ketazolam,Translocator protein,CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1
Ketazolam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1
Ketazolam,Gamma-aminobutyric acid receptor subunit beta-1,CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1
Ketazolam,Gamma-aminobutyric acid receptor subunit gamma-1,CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1
Ketazolam,Gamma-aminobutyric acid receptor subunit delta,CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1
Ketazolam,Gamma-aminobutyric acid receptor subunit epsilon,CN1C2=C(C=C(Cl)C=C2)C2(OC(C)=CC(=O)N2CC1=O)C1=CC=CC=C1
Ketobemidone,Mu-type opioid receptor,CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,Kappa-type opioid receptor,CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,Delta-type opioid receptor,CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,"Glutamate receptor ionotropic, NMDA 1",CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,"Glutamate receptor ionotropic, NMDA 2A",CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,"Glutamate receptor ionotropic, NMDA 2B",CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,"Glutamate receptor ionotropic, NMDA 2C",CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,"Glutamate receptor ionotropic, NMDA 2D",CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,"Glutamate receptor ionotropic, NMDA 3A",CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketobemidone,"Glutamate receptor ionotropic, NMDA 3B",CCC(=O)C1(CCN(C)CC1)C1=CC(O)=CC=C1
Ketoconazole,Lanosterol 14-alpha demethylase,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Ketoconazole,Androgen receptor,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Ketoconazole,Steroid 21-hydroxylase,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Ketoconazole,Aromatase,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Ketoconazole,Potassium voltage-gated channel subfamily H member 2,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Ketoconazole,Nuclear receptor subfamily 1 group I member 2,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Ketoconazole,Nuclear receptor subfamily 1 group I member 3,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Ketoprofen,Prostaglandin G/H synthase 1,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1
Ketoprofen,Prostaglandin G/H synthase 2,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1
Ketoprofen,C-X-C chemokine receptor type 1,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1
Ketorolac,Prostaglandin G/H synthase 2,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
Ketorolac,Prostaglandin G/H synthase 1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1
Ketotifen,Histamine H1 receptor,CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=CC=CC=C12
Ketotifen,"6-phosphogluconate dehydrogenase, decarboxylating",CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=CC=CC=C12
Kifunensine,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",[H][C@]12NC(=O)C(=O)N1[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O
Kifunensine,"Mannosyl-oligosaccharide alpha-1,2-mannosidase",[H][C@]12NC(=O)C(=O)N1[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O
Kifunensine,Alpha-mannosidase 2,[H][C@]12NC(=O)C(=O)N1[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O
Kynurenic Acid,Aryl hydrocarbon receptor,OC(=O)C1=CC(=O)C2=CC=CC=C2N1
Kynurenic Acid,G-protein coupled receptor 35,OC(=O)C1=CC(=O)C2=CC=CC=C2N1
L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid,Chymotrypsinogen B,[H]N([C@@H](CC1=CC=C(Cl)C=C1)[B-](O)(O)O)C(C)=O
L-1-naphthyl-2-acetamido-ethane boronic acid,Chymotrypsinogen B,[H]N([C@@H](CC1=CC=CC2=CC=CC=C12)[B-](O)(O)O)C(C)=O
"L-2,4-diaminobutyric acid",Envelope glycoprotein gp160,NCC[C@H](N)C(O)=O
L-2-Amino-4-(Guanidinooxy)Butyric Acid,"Nitric oxide synthase, endothelial",N[C@@H](CCONC(N)=N)C(O)=O
L-2-Amino-6-Methylene-Pimelic Acid,Meso-diaminopimelate D-dehydrogenase,N[C@@H](CCCC(=C)C(O)=O)C(O)=O
L-2-amino-3-butynoic acid,Cystathionine gamma-lyase,N[C@@H](C#C)C(O)=O
L-2-amino-3-butynoic acid,Cysteine desulfurase,N[C@@H](C#C)C(O)=O
L-2-amino-4-methoxy-cis-but-3-enoic acid,S-adenosylmethionine synthase isoform type-1,[H]\C(OC)=C(/[H])[C@]([H])(N)C(O)=O
"L-709,587",Peptidyl-prolyl cis-trans isomerase FKBP1A,[H]\C(=C(\C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@]([H])(C[C@@]2([H])C)OC)[C@]([H])(C[C@@]([H])(C)[C@]([H])(O)\C(C)=C([H])\[C@@]([H])(CC)C(=O)C[C@]([H])(O)[C@@]1([H])C)OC)[C@]1([H])CC[C@@]([H])(OC2=CC=C3N(C)C=CC3=C2)[C@@]([H])(C1)OC
"L-756,423",Gag-Pol polyprotein,[H][C@@](O)(CN1CCN(CC2=CC3=CC=CC=C3O2)C[C@@]1([H])C(O)=NC(C)(C)C)C[C@@]([H])(CC1=CC=CC=C1)C(O)=N[C@@]1([H])C2=CC=CC=C2C[C@@]1([H])O
L-Alanine,"Alanine--glyoxylate aminotransferase 2, mitochondrial",C[C@H](N)C(O)=O
L-Alanine,"Cysteine desulfurase, mitochondrial",C[C@H](N)C(O)=O
L-Alanine,"4-aminobutyrate aminotransferase, mitochondrial",C[C@H](N)C(O)=O
L-Alanine,"Alanine--tRNA ligase, cytoplasmic",C[C@H](N)C(O)=O
L-Alanine,Serine--pyruvate aminotransferase,C[C@H](N)C(O)=O
L-Alanine,Kynureninase,C[C@H](N)C(O)=O
L-Alanine,Neutral amino acid transporter A,C[C@H](N)C(O)=O
L-Alanine,Proton-coupled amino acid transporter 1,C[C@H](N)C(O)=O
L-Alanine,Alanine aminotransferase 1,C[C@H](N)C(O)=O
L-Alanine,Large neutral amino acids transporter small subunit 2,C[C@H](N)C(O)=O
L-Alanine,5-phosphohydroxy-L-lysine phospho-lyase,C[C@H](N)C(O)=O
L-Alanine,Alanine aminotransferase 2,C[C@H](N)C(O)=O
L-Alanine,"Alanine--tRNA ligase, mitochondrial",C[C@H](N)C(O)=O
L-Alpha-Glycerophosphorylethanolamine,Annexin A5,NCCO[P@@](O)(=O)OC[C@@H](O)CO
L-Alpha-Glycerophosphorylserine,Annexin A5,[H][C@@](O)(CO)COP(O)(=O)OC[C@]([H])(N)C(O)=O
L-Arginine,"Nitric oxide synthase, inducible",N[C@@H](CCCNC(N)=N)C(O)=O
L-Arginine,Cationic amino acid transporter 4,N[C@@H](CCCNC(N)=N)C(O)=O
L-Arginine,Cationic amino acid transporter 3,N[C@@H](CCCNC(N)=N)C(O)=O
L-Arginine,High affinity cationic amino acid transporter 1,N[C@@H](CCCNC(N)=N)C(O)=O
L-Arginine,"Nitric oxide synthase, endothelial",N[C@@H](CCCNC(N)=N)C(O)=O
L-Arginine,Antizyme inhibitor 2,N[C@@H](CCCNC(N)=N)C(O)=O
L-Arginine,Argininosuccinate lyase,N[C@@H](CCCNC(N)=N)C(O)=O
L-Arginine,Argininosuccinate synthase,N[C@@H](CCCNC(N)=N)C(O)=O
L-Arginine,"Arginase-2, mitochondrial",N[C@@H](CCCNC(N)=N)C(O)=O
L-BENZYLSUCCINIC ACID,Carboxypeptidase A1,[H][C@](CC(O)=O)(CC1=CC=CC=C1)C(O)=O
L-BENZYLSUCCINIC ACID,Thermolysin,[H][C@](CC(O)=O)(CC1=CC=CC=C1)C(O)=O
L-BENZYLSUCCINIC ACID,Retinoid-inducible serine carboxypeptidase,[H][C@](CC(O)=O)(CC1=CC=CC=C1)C(O)=O
L-CYSTEIN-S-1-(IMINOMETHYL)-L-ORNITHINE,Arginine deiminase,[H][C@](N)(CSC(=N)NCCC[C@]([H])([NH3+])C(O)=O)C(O)=O
L-Citrulline,"Nitric oxide synthase, inducible",N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,"Nitric oxide synthase, brain",N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,"Nitric oxide synthase, endothelial",N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,"Ornithine carbamoyltransferase, mitochondrial",N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2",N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,Argininosuccinate synthase,N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,"Argininosuccinate synthetase, isoform CRA_a",N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,Protein-arginine deiminase type-4,N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,Protein-arginine deiminase type-6,N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,Protein-arginine deiminase type-1,N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,Protein-arginine deiminase type-3,N[C@@H](CCCNC(N)=O)C(O)=O
L-Citrulline,Protein-arginine deiminase type-2,N[C@@H](CCCNC(N)=O)C(O)=O
L-Cysteine,Cysteine sulfinic acid decarboxylase,N[C@@H](CS)C(O)=O
L-Cysteine,"Cysteine desulfurase, mitochondrial",N[C@@H](CS)C(O)=O
L-Cysteine,Glutamate--cysteine ligase catalytic subunit,N[C@@H](CS)C(O)=O
L-Cysteine,Glutathione synthetase,N[C@@H](CS)C(O)=O
L-Cysteine,Cystathionine beta-synthase,N[C@@H](CS)C(O)=O
L-Cysteine,"Aspartate aminotransferase, cytoplasmic",N[C@@H](CS)C(O)=O
L-Cysteine,Cysteine dioxygenase type 1,N[C@@H](CS)C(O)=O
L-Cysteine,Glutamate--cysteine ligase regulatory subunit,N[C@@H](CS)C(O)=O
L-Cysteine,"Cysteine--tRNA ligase, cytoplasmic",N[C@@H](CS)C(O)=O
L-Cysteine,Cystathionine gamma-lyase,N[C@@H](CS)C(O)=O
L-Cysteine,Thiamine transporter 2,N[C@@H](CS)C(O)=O
L-Cysteine,Methylated-DNA--protein-cysteine methyltransferase,N[C@@H](CS)C(O)=O
L-Cysteine,"Probable cysteine--tRNA ligase, mitochondrial",N[C@@H](CS)C(O)=O
L-Eflornithine,Ornithine decarboxylase,NCCC[C@@](N)(C(F)F)C(O)=O
L-Gluconic Acid,Beta-glucosidase A,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O
L-Glutamine,Amidophosphoribosyltransferase,N[C@@H](CCC(N)=O)C(O)=O
L-Glutamine,CTP synthase 1,N[C@@H](CCC(N)=O)C(O)=O
L-Glutamine,Glutamine synthetase,N[C@@H](CCC(N)=O)C(O)=O
L-Glycero-D-Manno-Heptopyranose,Ferrichrome-iron receptor,[H][C@](O)(CO)[C@@]1([H])O[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)[C@]1([H])O
L-Histidine Beta Naphthylamide,Hut operon positive regulatory protein,[H][C@@](N)(CC1=CN=CN1)C(=O)NC1=CC=C2C=CC=CC2=C1
L-Homoarginine,"Nitric oxide synthase, endothelial",N[C@@H](CCCCNC(N)=N)C(O)=O
L-Leucine,"Probable leucine--tRNA ligase, mitochondrial",CC(C)C[C@H](N)C(O)=O
L-Leucine,Leucine carboxyl methyltransferase 1,CC(C)C[C@H](N)C(O)=O
L-Leucine,"Branched-chain-amino-acid aminotransferase, cytosolic",CC(C)C[C@H](N)C(O)=O
L-Leucine,tRNA wybutosine-synthesizing protein 4,CC(C)C[C@H](N)C(O)=O
L-Leucine,"Branched-chain-amino-acid aminotransferase, mitochondrial",CC(C)C[C@H](N)C(O)=O
L-Leucine,"Leucine--tRNA ligase, cytoplasmic",CC(C)C[C@H](N)C(O)=O
L-Leucyl-Hydroxylamine,Thermolysin,CC(C)C[C@H](N)C(=O)NO
L-Lysine,Cationic amino acid transporter 4,NCCCC[C@H](N)C(O)=O
L-Lysine,Cationic amino acid transporter 3,NCCCC[C@H](N)C(O)=O
L-Lysine,Lysine--tRNA ligase,NCCCC[C@H](N)C(O)=O
L-Lysine,High affinity cationic amino acid transporter 1,NCCCC[C@H](N)C(O)=O
L-Lysine,Cationic amino acid transporter 2,NCCCC[C@H](N)C(O)=O
L-Myo-Inositol-1-Phosphate,Inositol monophosphatase 1,[H][C@]1(O)[C@]([H])(O)[C@]([H])(O)[C@]([H])(OP([O-])([O-])=O)[C@@]([H])(O)[C@]1([H])O
"L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide","Nitric oxide synthase, brain",[H][C@](N)(CCCNC(=N)NN(=O)=O)C(O)=N[C@@]([H])(CCN)C(O)=N
"L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide","Nitric oxide synthase, endothelial",[H][C@](N)(CCCNC(=N)NN(=O)=O)C(O)=N[C@@]([H])(CCN)C(O)=N
L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,"Nitric oxide synthase, brain",N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(=O)N[C@H]1CN[C@@H](C1)C(N)=O
L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide,"Nitric oxide synthase, endothelial",N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(=O)N[C@H]1CN[C@@H](C1)C(N)=O
L-Phenylalanine,"Phenylalanine--tRNA ligase, mitochondrial",N[C@@H](CC1=CC=CC=C1)C(O)=O
L-Phenylalanine,Phenylalanine--tRNA ligase alpha subunit,N[C@@H](CC1=CC=CC=C1)C(O)=O
L-Phenylalanine,Phenylalanine--tRNA ligase beta subunit,N[C@@H](CC1=CC=CC=C1)C(O)=O
L-Phenylalanine,Tyrosine 3-monooxygenase,N[C@@H](CC1=CC=CC=C1)C(O)=O
L-Phenylalanine,Tyrosine aminotransferase,N[C@@H](CC1=CC=CC=C1)C(O)=O
L-Phenylalanine,Phenylalanine-4-hydroxylase,N[C@@H](CC1=CC=CC=C1)C(O)=O
L-Phenylalanine,Large neutral amino acids transporter small subunit 2,N[C@@H](CC1=CC=CC=C1)C(O)=O
L-Phospholactate,Pyruvate kinase PKM,C[C@@H](OP(O)(O)=O)C(O)=O
L-Rhamnitol,L-rhamnose isomerase,[H][C@@](C)(O)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)CO
L-Thiocitrulline,"Nitric oxide synthase, inducible",N[C@@H](CCC\N=C(/N)S)C(O)=O
L-Threonine,"Threonine--tRNA ligase, cytoplasmic",C[C@@H](O)[C@H](N)C(O)=O
L-Threonine,Threonine synthase-like 1,C[C@@H](O)[C@H](N)C(O)=O
L-Threonine,"Threonine--tRNA ligase, mitochondrial",C[C@@H](O)[C@H](N)C(O)=O
L-Threonohydroxamate 4-Phosphate,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,[H][C@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)NO
L-Tryptophan,"Tryptophan--tRNA ligase, cytoplasmic",N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O
L-Tryptophan,Tryptophan--tRNA ligase,N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O
L-Tryptophan,"Tryptophan--tRNA ligase, mitochondrial",N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O
L-Tryptophanamide,Tryptophan--tRNA ligase,[H][C@](N)(CC1=CNC2=C1C=CC=C2)C(N)=O
L-Tryptophanamide,"Tryptophan--tRNA ligase, cytoplasmic",[H][C@](N)(CC1=CNC2=C1C=CC=C2)C(N)=O
L-Valine,Valine--tRNA ligase,CC(C)[C@H](N)C(O)=O
L-Valine,"Branched-chain-amino-acid aminotransferase, cytosolic",CC(C)[C@H](N)C(O)=O
L-Valine,"Propionyl-CoA carboxylase beta chain, mitochondrial",CC(C)[C@H](N)C(O)=O
L-Xylopyranose,Xylose isomerase,O[C@H]1COC(O)[C@@H](O)[C@@H]1O
L-Xylulose 5-Phosphate,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,[H][C@](O)(COP(O)(O)=O)[C@@]([H])(O)C(=O)CO
L-[(N-Hydroxyamino)Carbonyl]Phenylalanine,Carboxypeptidase A1,[H]N(O)C(=O)N([H])[C@@H](CC1=CC=CC=C1)C(O)=O
"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",Kallikrein-7,[H][C@@](C)(N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC1=CC=CC=C1)[C@@]([H])(C)O
L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal,Calpain-3,CCOC(OCC)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)CCC(=O)N[C@H](CC([O-])=O)C[N+](C)(C)C
"L-erythro-7,8-dihydrobiopterin","Nitric oxide synthase, inducible",[H][C@@](C)(O)[C@]([H])(O)C1=NC2=C(NC1)NC(=N)N=C2O
"L-erythro-7,8-dihydrobiopterin",Tyrosine 3-monooxygenase,[H][C@@](C)(O)[C@]([H])(O)C1=NC2=C(NC1)NC(=N)N=C2O
"L-erythro-7,8-dihydrobiopterin",Phenylalanine-4-hydroxylase,[H][C@@](C)(O)[C@]([H])(O)C1=NC2=C(NC1)NC(=N)N=C2O
"L-erythro-7,8-dihydrobiopterin",Dihydroneopterin aldolase,[H][C@@](C)(O)[C@]([H])(O)C1=NC2=C(NC1)NC(=N)N=C2O
"L-erythro-7,8-dihydrobiopterin",Pteridine reductase 1,[H][C@@](C)(O)[C@]([H])(O)C1=NC2=C(NC1)NC(=N)N=C2O
"L-erythro-7,8-dihydrobiopterin",Pterin-4-alpha-carbinolamine dehydratase,[H][C@@](C)(O)[C@]([H])(O)C1=NC2=C(NC1)NC(=N)N=C2O
L-gulonic acid 6-phosphate,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,O[C@@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O
L-histidinol phosphate,Histidinol-phosphate aminotransferase,N[C@H](COP(O)(O)=O)CC1=CNC=N1
L-histidinol phosphate,Histidinol-phosphate aminotransferase,N[C@H](COP(O)(O)=O)CC1=CNC=N1
L-methionine (R)-S-oxide,Catalase,C[S@@](=O)CC[C@H](N)C(O)=O
L-methionine (R)-S-oxide,Protease,C[S@@](=O)CC[C@H](N)C(O)=O
L-methionine (R)-S-oxide,Amyloid beta A4 protein,C[S@@](=O)CC[C@H](N)C(O)=O
L-methionine (S)-S-oxide,Thymidylate synthase,[H]C([H])([H])[S@](=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H]
L-methionine (S)-S-oxide,Cellulase B,[H]C([H])([H])[S@](=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H]
L-methionine (S)-S-oxide,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",[H]C([H])([H])[S@](=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H]
L-methionine (S)-S-oxide,Amicyanin,[H]C([H])([H])[S@](=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H]
L-methionine (S)-S-oxide,Aminopeptidase S,[H]C([H])([H])[S@](=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H]
L-methionine (S)-S-oxide,Ras-related protein Rab-5A,[H]C([H])([H])[S@](=O)C([H])([H])C([H])([H])[C@@]([H])(C([O-])=O)[N+]([H])([H])[H]
L-naphthyl-1-acetamido boronic acid alanine,Subtilisin Carlsberg,[H][C@](N)(CO[B-](O)(O)[C@]([H])(CC1=CC=CC2=CC=CC=C12)N=C(C)O)C(O)=O
L-proline betaine,Glycine betaine-binding periplasmic protein,C[N+]1(C)CCC[C@H]1C([O-])=O
L-thioproline,Annexin A5,[H][C@]1(CSCN1)C(O)=O
L-tyrosinamide,Pro-neuropeptide Y,[H][C@](N)(CC1=CC=C(O)C=C1)C(N)=O
L-tyrosinamide,Valacyclovir hydrolase,[H][C@](N)(CC1=CC=C(O)C=C1)C(N)=O
L-xylitol 5-phosphate,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,OC[C@@H](O)[C@H](O)[C@@H](O)COP(O)(O)=O
LATRUNCULIN B,"Actin, alpha skeletal muscle",[H][C@]1(CSC(=O)N1)[C@@]1(O)C[C@@]2([H])C[C@@]([H])(CC[C@]([H])(C)\C=C/CC\C(C)=C/C(=O)O2)O1
LATRUNCULIN B,MKL/myocardin-like protein 1,[H][C@]1(CSC(=O)N1)[C@@]1(O)C[C@@]2([H])C[C@@]([H])(CC[C@]([H])(C)\C=C/CC\C(C)=C/C(=O)O2)O1
LATRUNCULIN B,Protein spire homolog 2,[H][C@]1(CSC(=O)N1)[C@@]1(O)C[C@@]2([H])C[C@@]([H])(CC[C@]([H])(C)\C=C/CC\C(C)=C/C(=O)O2)O1
LAX-101,Caspase-1,
LAX-101,Phospholipase D1,
LErafAON,RAF proto-oncogene serine/threonine-protein kinase,
LFA703,Integrin alpha-L,[H][C@](C)(CC)C(=O)O[C@@]1([H])C[C@@]([H])(C)C=C2C=C[C@]([H])(C)[C@]([H])(CC[C@@]3([H])C[C@@]([H])(O)CC(=O)N3CC3=CC4=C(C=C3)C(CO)=C(OC)C=C4)[C@@]12[H]
LGD-1550,Retinoic acid receptor gamma,
LGD-1550,Retinoic acid receptor beta,
LGD-1550,Retinoic acid receptor alpha,
LGD-1550,Transcription factor AP-1,
LGD-2226,Androgen receptor,FC(F)(F)CN(CC(F)(F)F)C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1
LGD2941,Androgen receptor,C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1
LI-301,5-hydroxytryptamine receptor 1A,
LI-301,Mu-type opioid receptor,
LJP 1082,Beta-2-glycoprotein 1,NC(CCC(=O)NC(CSCO)C(=O)NCC(O)=O)C(O)=O
LLL-3348,Interleukin-10,
LM-609,Integrin beta-3,
LX1031,Tryptophan 5-hydroxylase 1,
LY-294002,Serine/threonine-protein kinase pim-1,O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1
LY-294002,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",O=C1C=C(OC2=C1C=CC=C2C1=CC=CC=C1)N1CCOCC1
LY-517717,Coagulation factor X,CN1CCC(CC1)N1CCN(CC1)C(=O)[C@H](NC(=O)C1=CC=C2C=CNC2=C1)C1=CC=CC=C1
LY2140023,Metabotropic glutamate receptor 2,
LY2140023,Metabotropic glutamate receptor 3,
LY2181308,Baculoviral IAP repeat-containing protein 5,
LY2275796,Eukaryotic translation initiation factor 4E,
LY231514 Tetra Glu,Thymidylate synthase,[H][C@@](CCC(O)=N[C@@]([H])(CCC(O)=N[C@@]([H])(CCC(O)=NC([H])(CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)(NC(=O)C1=CC=C(CCC2=CNC3=C2C(O)=NC(=N)N3)C=C1)C(O)=O
LY249543,"C-1-tetrahydrofolate synthase, cytoplasmic",[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(CC[C@]2([H])CNC3=C(C2)C(O)=NC(=N)N3)C=C1)C(O)=O
LY341770,Thymidylate synthase,[H][C@@](CCC1=NNN=N1)(NC(=O)C1=CC=C(CCC2=CNC3=C2C(O)=NC(=N)N3)C=C1)C(O)=O
LY374571,"C-1-tetrahydrofolate synthase, cytoplasmic",[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(NC(O)=NC2=C(N)C(O)=NC(=N)N2)C=C1)C(O)=O
Labetalol,Beta-1 adrenergic receptor,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
Labetalol,Beta-2 adrenergic receptor,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
Labetalol,Alpha-1A adrenergic receptor,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
Labetalol,Alpha-1B adrenergic receptor,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
Labetalol,Alpha-1D adrenergic receptor,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
Labetuzumab,Carcinoembryonic antigen,
Labradimil,B2 bradykinin receptor,COC1=CC=C(C[C@@H](CN[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CS2)NC(=O)CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCNC(N)=N)C=C1
Lacidipine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC
Lacidipine,Voltage-dependent L-type calcium channel subunit alpha-1D,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC
Lacidipine,Voltage-dependent L-type calcium channel subunit alpha-1F,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC
Lacidipine,Voltage-dependent L-type calcium channel subunit alpha-1S,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC
Lacidipine,Voltage-dependent L-type calcium channel subunit beta-1,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC
Lacidipine,Voltage-dependent L-type calcium channel subunit beta-2,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC
Lacidipine,Voltage-dependent L-type calcium channel subunit beta-3,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC
Lacidipine,Voltage-dependent L-type calcium channel subunit beta-4,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C)C(=O)OCC
Lacosamide,Sodium channel protein type 10 subunit alpha,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
Lacosamide,Sodium channel protein type 9 subunit alpha,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
Lacosamide,Sodium channel protein type 3 subunit alpha,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
Lactic acid,Bifunctional protein PutA,CC(O)C(O)=O
Lactic acid,NimA-related protein,CC(O)C(O)=O
Lactose,Tetanus toxin,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactose,Beta-galactosidase,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactose,Glycolipid transfer protein,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactose,Sialidase,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactose,Enterotoxin type B,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactose,"Endo-1,4-beta-xylanase A",OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactose,Beta-xylanase,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactose,Glycosyltransferase 6 domain-containing protein 1,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactose,Galectin-3,OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
Lactulose,Evolved beta-galactosidase subunit alpha,OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O
Laevulinic Acid,Delta-aminolevulinic acid dehydratase,CC(=O)CCC(O)=O
"Lambda-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C9-Adamantane Ruthenium (II)",Camphor 5-monooxygenase,CC1=CC2=C3C=C(CCCCCCCCC(=O)N[C@H]4[C@H]5C[C@@H]6C[C@@H](C[C@H]4C6)C5)C=CN3[Ru++]34(N5C=CC=CC5=C5C=CC=CN35)(N3C=CC=CC3=C3C=CC=CN43)N2C=C1
Lamivudine,Reverse transcriptase/RNaseH,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1
Lamivudine,Protein P,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1
Lamotrigine,Voltage-dependent R-type calcium channel subunit alpha-1E,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Sodium channel protein type 2 subunit alpha,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Adenosine receptor A1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Adenosine receptor A2a,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Alpha-1A adrenergic receptor,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Alpha-2A adrenergic receptor,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Beta-1 adrenergic receptor,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,D(1A) dopamine receptor,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,D(1B) dopamine receptor,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,D(2) dopamine receptor,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-2,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-3,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-4,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-5,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-6,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit beta-1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit beta-2,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit beta-3,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit delta,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit epsilon,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit gamma-1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit gamma-2,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit gamma-3,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit pi,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit theta,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-2,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-3,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-4,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-5,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit alpha-6,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit gamma-1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit gamma-2,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Gamma-aminobutyric acid receptor subunit gamma-3,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Histamine H1 receptor,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Kappa-type opioid receptor,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Muscarinic acetylcholine receptor M1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Muscarinic acetylcholine receptor M2,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Muscarinic acetylcholine receptor M3,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Muscarinic acetylcholine receptor M4,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,Muscarinic acetylcholine receptor M5,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,5-hydroxytryptamine receptor 2A,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lamotrigine,5-hydroxytryptamine receptor 3A,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1
Lanadelumab,Plasma kallikrein,
Lanosterol,Lanosterol synthase,[H][C@@]1(CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@]1([H])CC3)[C@H](C)CCC=C(C)C
Lanoteplase,Coagulation factor X,
Lanoteplase,Fibrinogen alpha chain,
Lanoteplase,Urokinase plasminogen activator surface receptor,
Lanoteplase,Plasminogen activator inhibitor 2,
Lanoteplase,Calnexin,
Lanoteplase,Kallikrein-1,
Lanoteplase,Annexin A2,
Lanoteplase,Fibronectin,
Lanoteplase,Laminin subunit alpha-5,
Lanoteplase,Tetranectin,
Lanoteplase,"Keratin, type II cytoskeletal 8",
Lanoteplase,Laminin subunit beta-1,
Lanoteplase,Laminin subunit gamma-1,
Lanoteplase,Laminin subunit alpha-1,
Lanoteplase,Calreticulin,
Lanoteplase,Prolow-density lipoprotein receptor-related protein 1,
Lanoteplase,Laminin subunit alpha-3,
Lanreotide,Somatostatin receptor type 2,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H]
Lanreotide,Somatostatin receptor type 5,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H]
Lansoprazole,Potassium-transporting ATPase alpha chain 1,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1
Lansoprazole,Microtubule-associated protein tau,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1
Lapachone,Retinol-binding protein 3,CC1(C)CCC2=C(O1)C1=CC=CC=C1C(=O)C2=O
Lapatinib,Receptor tyrosine-protein kinase erbB-2,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1
Lapatinib,Epidermal growth factor receptor,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1
Larotrectinib,High affinity nerve growth factor receptor,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1
Larotrectinib,BDNF/NT-3 growth factors receptor,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1
Larotrectinib,NT-3 growth factor receptor,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1
Lasofoxifene,Estrogen receptor,[H][C@@]1(CCC2=CC(O)=CC=C2[C@@]1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1
Lasofoxifene,Estrogen receptor beta,[H][C@@]1(CCC2=CC(O)=CC=C2[C@@]1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1
Lasofoxifene,Cannabinoid receptor 2,[H][C@@]1(CCC2=CC(O)=CC=C2[C@@]1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1
Latamoxef,Penicillin-binding protein 3,[H][C@]12OCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C(C(O)=O)C1=CC=C(O)C=C1)OC)C(O)=O
Latamoxef,Penicillin-binding protein 1A,[H][C@]12OCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C(C(O)=O)C1=CC=C(O)C=C1)OC)C(O)=O
Latamoxef,Penicillin-binding protein 1B,[H][C@]12OCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C(C(O)=O)C1=CC=C(O)C=C1)OC)C(O)=O
Latamoxef,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]12OCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C(C(O)=O)C1=CC=C(O)C=C1)OC)C(O)=O
Latanoprost,Prostaglandin F2-alpha receptor,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1
Latanoprostene Bunod,Prostaglandin F2-alpha receptor,O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O)CCC1=CC=CC=C1
Latrunculin A,"Actin, alpha skeletal muscle",[H]\C1=C(\[H])/C(/[H])=C([H])\[C@@]([H])(C)CC[C@]2([H])C[C@]([H])(C[C@@](O)(O2)[C@]2([H])CSC(O)=N2)OC(=O)\C([H])=C(C)/CC1
Latrunculin A,Gelsolin,[H]\C1=C(\[H])/C(/[H])=C([H])\[C@@]([H])(C)CC[C@]2([H])C[C@]([H])(C[C@@](O)(O2)[C@]2([H])CSC(O)=N2)OC(=O)\C([H])=C(C)/CC1
Latrunculin A,Iota toxin component Ia,[H]\C1=C(\[H])/C(/[H])=C([H])\[C@@]([H])(C)CC[C@]2([H])C[C@]([H])(C[C@@](O)(O2)[C@]2([H])CSC(O)=N2)OC(=O)\C([H])=C(C)/CC1
Lauric acid,Alcohol dehydrogenase class-3,CCCCCCCCCCCC(O)=O
Lauric acid,3-oxoacyl-[acyl-carrier-protein] synthase 1,CCCCCCCCCCCC(O)=O
Lauric acid,Ferrichrome-iron receptor,CCCCCCCCCCCC(O)=O
Lauric acid,Ganglioside GM2 activator,CCCCCCCCCCCC(O)=O
Lauric acid,3-oxoacyl-[acyl-carrier-protein] synthase 3,CCCCCCCCCCCC(O)=O
Lauric acid,Genome polyprotein,CCCCCCCCCCCC(O)=O
Lauric acid,Genome polyprotein,CCCCCCCCCCCC(O)=O
Lauric acid,Genome polyprotein,CCCCCCCCCCCC(O)=O
Lauric acid,Hepatocyte nuclear factor 4-alpha,CCCCCCCCCCCC(O)=O
Lauric acid,"Phospholipase A2, membrane associated",CCCCCCCCCCCC(O)=O
Lauric acid,Very low-density lipoprotein receptor,CCCCCCCCCCCC(O)=O
Lauric acid,Glycolipid transfer protein,CCCCCCCCCCCC(O)=O
Lauric acid,3-oxoacyl-[acyl-carrier-protein] synthase 2,CCCCCCCCCCCC(O)=O
Lauric acid,Lactotransferrin,CCCCCCCCCCCC(O)=O
Lauric acid,Protein TonB,CCCCCCCCCCCC(O)=O
Lauric acid,Complement component C8 gamma chain,CCCCCCCCCCCC(O)=O
Lauric acid,Group IID secretory phospholipase A2,CCCCCCCCCCCC(O)=O
Lauric acid,Acyl-homoserine lactone acylase PvdQ,CCCCCCCCCCCC(O)=O
Lauric acid,Lymphocyte antigen 96,CCCCCCCCCCCC(O)=O
Lauric acid,Toll-like receptor 4,CCCCCCCCCCCC(O)=O
Lauric acid,Peroxisome proliferator-activated receptor alpha,CCCCCCCCCCCC(O)=O
Lauryl Dimethylamine-N-Oxide,Long-chain fatty acid transport protein,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Fe(3+) dicitrate transport protein FecA,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Lipid A palmitoyltransferase PagP,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Acyl-CoA thioesterase 2,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Amine oxidase [flavin-containing] B,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein L chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein M chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein H chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Cytochrome c oxidase subunit 1-beta,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Cytochrome c oxidase subunit 2,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Ig kappa chain V-I region Bi,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Ig heavy chain V-III region 23,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Photosynthetic reaction center cytochrome c subunit,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein H chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein L chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein M chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,H subunit of photosynthetic reaction center complex,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Destrin,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Rhodopsin,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Cytochrome c2,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Nuclear factor erythroid 2-related factor 1,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Squalene--hopene cyclase,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Vitamin B12 transporter BtuB,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Colicin-E3,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Fe(3+)-pyochelin receptor,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Myelin P2 protein,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Outer membrane protein W,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Light-harvesting protein B-800/850 alpha chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Light-harvesting protein B-800/850 beta chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Protein TonB,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Colicin I receptor,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Colicin-Ia,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Cofilin-1,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Rhomboid protease GlpG,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Outer membrane protein G,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Outer membrane usher protein PapC,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Probable N-acetylneuraminic acid outer membrane channel protein NanC,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein H chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein L chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Reaction center protein M chain,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Outer membrane protein II,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Cyclic nucleotide-gated potassium channel mll3241,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Ammonia channel,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,Penicillin-binding protein 2,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,"Dihydroorotate dehydrogenase (quinone), mitochondrial",CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,TraO protein,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,TraF protein,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,TraN protein,CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl Dimethylamine-N-Oxide,"Outer membrane porin, OprD family",CCCCCCCCCCCC[N+](C)(C)[O-]
Lauryl alcohol diphosphonic acid,Geranylgeranyl pyrophosphate synthase,CCCCCCCCCCCC(O)(P(O)(O)=O)P(O)(O)=O
Lebrikizumab,Interleukin-13,
Lebrikizumab,IL13 protein,
Ledipasvir,Nonstructural protein 5A,[H][C@](N=C(O)OC)(C(C)C)C(=O)N1CC2(CC2)C[C@@]1([H])C1=NC=C(N1)C1=CC2=C(C=C1)C1=C(C=C(C=C1)C1=CC3=C(C=C1)N=C(N3)[C@@]1([H])N(C(=O)[C@@]([H])(N=C(O)OC)C(C)C)[C@]3([H])CC[C@@]1([H])C3)C2(F)F
Leflunomide,"Dihydroorotate dehydrogenase (quinone), mitochondrial",CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
Leflunomide,Aryl hydrocarbon receptor,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
Leflunomide,Protein-tyrosine kinase 2-beta,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
Lefradafiban,Integrin alpha-IIb,COC(=O)C[C@@H]1C[C@@H](COC2=CC=C(C=C2)C2=CC=C(C=C2)C(\N)=N\C(=O)OC)NC1=O
Lefradafiban,Integrin beta-3,COC(=O)C[C@@H]1C[C@@H](COC2=CC=C(C=C2)C2=CC=C(C=C2)C(\N)=N\C(=O)OC)NC1=O
Lenalidomide,Protein cereblon,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O
Lenalidomide,Tumor necrosis factor ligand superfamily member 11,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O
Lenalidomide,Cadherin-5,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O
Lenalidomide,Prostaglandin G/H synthase 2,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O
Lenograstim,Granulocyte colony-stimulating factor receptor,
Lenvatinib,Vascular endothelial growth factor receptor 1,COC1=C(C=C2C(OC3=CC(Cl)=C(NC(O)=NC4CC4)C=C3)=CC=NC2=C1)C(O)=N
Lenvatinib,Vascular endothelial growth factor receptor 2,COC1=C(C=C2C(OC3=CC(Cl)=C(NC(O)=NC4CC4)C=C3)=CC=NC2=C1)C(O)=N
Lenvatinib,Vascular endothelial growth factor receptor 3,COC1=C(C=C2C(OC3=CC(Cl)=C(NC(O)=NC4CC4)C=C3)=CC=NC2=C1)C(O)=N
Lenvatinib,Fibroblast growth factor receptor 1,COC1=C(C=C2C(OC3=CC(Cl)=C(NC(O)=NC4CC4)C=C3)=CC=NC2=C1)C(O)=N
Lenvatinib,Fibroblast growth factor receptor 2,COC1=C(C=C2C(OC3=CC(Cl)=C(NC(O)=NC4CC4)C=C3)=CC=NC2=C1)C(O)=N
Lenvatinib,Fibroblast growth factor receptor 3,COC1=C(C=C2C(OC3=CC(Cl)=C(NC(O)=NC4CC4)C=C3)=CC=NC2=C1)C(O)=N
Lenvatinib,Fibroblast growth factor receptor 4,COC1=C(C=C2C(OC3=CC(Cl)=C(NC(O)=NC4CC4)C=C3)=CC=NC2=C1)C(O)=N
Lenvatinib,Mast/stem cell growth factor receptor Kit,COC1=C(C=C2C(OC3=CC(Cl)=C(NC(O)=NC4CC4)C=C3)=CC=NC2=C1)C(O)=N
Lepirudin,Prothrombin,
Leptin,Leptin receptor,
Lercanidipine,Voltage-dependent calcium channel gamma-1 subunit,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1
Leronlimab,C-C chemokine receptor type 5,
Lesinurad,Solute carrier family 22 member 12,OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2
Lesinurad,Solute carrier family 22 member 11,OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2
Lesopitron,5-hydroxytryptamine receptor 1A,ClC1=CN(CCCCN2CCN(CC2)C2=NC=CC=N2)N=C1
Lestaurtinib,Receptor-type tyrosine-protein kinase FLT3,C[C@]12O[C@H](C[C@]1(O)CO)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C3C(=O)NC4)C3=CC=CC=C3N21
Letermovir,Tripartite terminase subunit 1,COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=CC(=CC=C1OC)C(F)(F)F
Letermovir,Tripartite terminase subunit 2,COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=CC(=CC=C1OC)C(F)(F)F
Letermovir,Tripartite terminase subunit 3,COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=CC(=CC=C1OC)C(F)(F)F
Letrozole,Aromatase,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N
Leucine - Reduced Carbonyl,Serine protease inhibitor Kazal-type 6,CC(C)C[C@@H](C)N
Leucine Phosphonic Acid,Bacterial leucyl aminopeptidase,CC(C)C[C@H](N)P(O)(O)=O
Leucine Phosphonic Acid,Cytosol aminopeptidase,CC(C)C[C@H](N)P(O)(O)=O
Leukotriene B4,Leukotriene B4 receptor 1,CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O
Leukotriene B4,Leukotriene B4 receptor 2,CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O
Leukotriene B4,Peroxisome proliferator-activated receptor alpha,CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O
Leukotriene C4,Cysteinyl leukotriene receptor 1,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O
Leukotriene C4,Cysteinyl leukotriene receptor 2,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O
Leukotriene C4,Multidrug resistance-associated protein 1,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O
Leukotriene D4,Cysteinyl leukotriene receptor 1,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O
Leukotriene D4,Cysteinyl leukotriene receptor 2,CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O
Leuprolide,Gonadotropin-releasing hormone receptor,
Levacetylmethadol,Mu-type opioid receptor,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Levacetylmethadol,Neuronal acetylcholine receptor subunit beta-4,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Levacetylmethadol,Neuronal acetylcholine receptor subunit alpha-3,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Levallorphan,Mu-type opioid receptor,[H][C@@]12CCCC[C@@]11CCN(CC=C)[C@@H]2CC2=C1C=C(O)C=C2
Levamisole,Neuronal acetylcholine receptor subunit alpha-3,C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1
Levamisole,"Alkaline phosphatase, placental-like",C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1
Levamisole,Acetylcholine receptor subunit alpha-type unc-38,C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1
Levamisole,Acetylcholine receptor subunit alpha-type unc-63,C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1
Levamisole,Acetylcholine receptor subunit beta-type lev-1,C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1
Levamisole,Acetylcholine receptor subunit beta-type unc-29,C1CN2C[C@@H](N=C2S1)C1=CC=CC=C1
Levamlodipine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=CC=CC=C1Cl)C(=O)OC
Levamlodipine,"Nitric oxide synthase, endothelial",CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=CC=CC=C1Cl)C(=O)OC
Levamlodipine,"Nitric oxide synthase, inducible",CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=CC=CC=C1Cl)C(=O)OC
Levetiracetam,Synaptic vesicle glycoprotein 2A,CC[C@H](N1CCCC1=O)C(N)=O
Levetiracetam,Voltage-dependent N-type calcium channel subunit alpha-1B,CC[C@H](N1CCCC1=O)C(N)=O
Levobetaxolol,Beta-1 adrenergic receptor,CC(C)NC[C@H](O)COC1=CC=C(CCOCC2CC2)C=C1
Levobunolol,Beta-1 adrenergic receptor,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O
Levobunolol,Beta-2 adrenergic receptor,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O
Levobupivacaine,Sodium channel protein type 10 subunit alpha,CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
Levocabastine,Histamine H1 receptor,C[C@@H]1CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@H]1CC[C@](CC1)(C#N)C1=CC=C(F)C=C1
Levocabastine,Neurotensin receptor type 2,C[C@@H]1CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@H]1CC[C@](CC1)(C#N)C1=CC=C(F)C=C1
Levocarnitine,Mitochondrial basic amino acids transporter,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,Solute carrier family 22 member 5,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,"Carnitine O-palmitoyltransferase 2, mitochondrial",C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,Peroxisomal carnitine O-octanoyltransferase,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,"Carnitine O-palmitoyltransferase 1, liver isoform",C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,Carnitine O-acetyltransferase,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,Mitochondrial carnitine/acylcarnitine carrier protein,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,Solute carrier family 22 member 4,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,Xanthine dehydrogenase/oxidase,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,Liver carboxylesterase 1,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocarnitine,Myeloperoxidase,C[N+](C)(C)C[C@H](O)CC([O-])=O
Levocetirizine,Histamine H1 receptor,OC(=O)COCCN1CCN(CC1)[C@H](C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Levodopa,D(1A) dopamine receptor,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
Levodopa,D(1B) dopamine receptor,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
Levodopa,D(2) dopamine receptor,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
Levodopa,D(3) dopamine receptor,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
Levodopa,D(4) dopamine receptor,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
Levofloxacin,DNA gyrase subunit A,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1
Levofloxacin,DNA topoisomerase 4 subunit A,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1
Levofloxacin,DNA topoisomerase 2-alpha,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1
Levoketoconazole,"Cytochrome P450 11B1, mitochondrial",CC(=O)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Levoketoconazole,Lanosterol 14-alpha demethylase,CC(=O)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
Levoleucovorin,Serine hydroxymethyltransferase,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1
Levoleucovorin,Dihydrofolate reductase,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1
Levomenthol,Transient receptor potential cation channel subfamily M member 8,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Transient receptor potential cation channel subfamily A member 1,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Transient receptor potential cation channel subfamily V member 3,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Kappa-type opioid receptor,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Voltage-dependent L-type calcium channel subunit alpha-1C,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Voltage-dependent L-type calcium channel subunit alpha-1D,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Voltage-dependent L-type calcium channel subunit alpha-1F,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Voltage-dependent L-type calcium channel subunit alpha-1S,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Voltage-dependent L-type calcium channel subunit beta-1,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Voltage-dependent L-type calcium channel subunit beta-2,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Voltage-dependent L-type calcium channel subunit beta-3,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomenthol,Voltage-dependent L-type calcium channel subunit beta-4,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
Levomilnacipran,Sodium-dependent serotonin transporter,CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1
Levomilnacipran,Sodium-dependent noradrenaline transporter,CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1
Levonordefrin,Alpha-2A adrenergic receptor,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1
Levonordefrin,Alpha-2B adrenergic receptor,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1
Levonordefrin,Alpha-2C adrenergic receptor,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1
Levonorgestrel,Progesterone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Levonorgestrel,3-oxo-5-alpha-steroid 4-dehydrogenase 1,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Levonorgestrel,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Levonorgestrel,Androgen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Levonorgestrel,Sex hormone-binding globulin,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Levorphanol,Mu-type opioid receptor,[H][C@@]12CCCC[C@@]11CCN(C)[C@@H]2CC2=C1C=C(O)C=C2
Levorphanol,Delta-type opioid receptor,[H][C@@]12CCCC[C@@]11CCN(C)[C@@H]2CC2=C1C=C(O)C=C2
Levorphanol,Kappa-type opioid receptor,[H][C@@]12CCCC[C@@]11CCN(C)[C@@H]2CC2=C1C=C(O)C=C2
Levosalbutamol,Beta-2 adrenergic receptor,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1
Levosimendan,ATP-sensitive inward rectifier potassium channel 11,C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
Levosimendan,"Troponin C, slow skeletal and cardiac muscles",C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
Levosimendan,ATP-sensitive inward rectifier potassium channel 8,C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
Levosimendan,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1
Levothyroxine,Thyroid hormone receptor beta,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
Levothyroxine,Thyroid hormone receptor alpha,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
Levothyroxine,Integrin alpha-V,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
Levothyroxine,Integrin beta-3,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
Lexatumumab,Tumor necrosis factor receptor superfamily member 10B,
Licofelone,Arachidonate 5-lipoxygenase,CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Licofelone,Prostaglandin G/H synthase 2,CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Licofelone,Group IIE secretory phospholipase A2,CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Lidocaine,Sodium channel protein type 10 subunit alpha,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
Lidocaine,Sodium channel protein type 9 subunit alpha,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
Lidocaine,Sodium channel protein type 5 subunit alpha,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
Lidocaine,Epidermal growth factor receptor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
Lidocaine,Sodium channel protein type 4 subunit alpha,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
Lidocaine,Alpha-1-acid glycoprotein 1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
Lidocaine,Alpha-1-acid glycoprotein 2,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
Lifitegrast,Integrin alpha-L,CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C3=CC=C4C=COC4=C3)C=C2Cl)C(O)=O)=CC=C1
Ligandrol,Androgen receptor,O[C@H]([C@H]1CCCN1C1=CC=C(C#N)C(=C1)C(F)(F)F)C(F)(F)F
Limaprost,Prostaglandin E2 receptor EP1 subtype,CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O
Limaprost,Prostaglandin E2 receptor EP2 subtype,CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O
Limaprost,Prostaglandin E2 receptor EP3 subtype,CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O
Limaprost,Prostaglandin E2 receptor EP4 subtype,CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O
Linaclotide,Heat-stable enterotoxin receptor,[H][C@]1(CSSC[C@]2([H])NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N3)NC2=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
Linagliptin,Dipeptidyl peptidase 4,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1
Lincomycin,50S ribosomal protein L10,[H][C@](C)(O)[C@@]([H])(N=C(O)[C@]1([H])C[C@@]([H])(CCC)CN1C)[C@@]1([H])O[C@]([H])(SC)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Lindane,Gamma-aminobutyric acid receptor subunit beta-1,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Glycine receptor subunit alpha-1,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Glycine receptor subunit alpha-2,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Glycine receptor subunit alpha-3,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Glycine receptor subunit beta,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Gamma-aminobutyric acid receptor subunit beta-3,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Gamma-aminobutyric acid receptor subunit rho-1,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Progesterone receptor,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Estrogen receptor,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Lindane,Nuclear receptor subfamily 1 group I member 2,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
Linsitinib,Insulin-like growth factor 1 receptor,C[C@@]1(O)C[C@@H](C1)C1=NC(=C2N1C=CN=C2N)C1=CC=C2C=CC(=NC2=C1)C1=CC=CC=C1
Lintitript,Cholecystokinin receptor type A,OC(=O)CN1C(=CC2=CC=CC=C12)C(=O)NC1=NC(=CS1)C1=CC=CC=C1Cl
Liothyronine,Thyroid hormone receptor alpha,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
Liothyronine,Thyroid hormone receptor beta,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
Liothyronine,Proliferating cell nuclear antigen,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O
Liotrix,Thyroid hormone receptor alpha,[Na+].[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C([O-])=O.N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O
Liotrix,Thyroid hormone receptor beta,[Na+].[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C([O-])=O.N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O
Lipegfilgrastim,Granulocyte colony-stimulating factor receptor,
Lipoic Acid,"Lipoyltransferase 1, mitochondrial",OC(=O)CCCC[C@@H]1CCSS1
Lipoic Acid,Sodium-dependent multivitamin transporter,OC(=O)CCCC[C@@H]1CCSS1
Lipoic Acid,"Lipoyl synthase, mitochondrial",OC(=O)CCCC[C@@H]1CCSS1
Liraglutide,Glucagon-like peptide 1 receptor,
Lisdexamfetamine,Trace amine-associated receptor 1,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN
Lisinopril,Angiotensin-converting enzyme,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O
Lisuride,D(2) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,D(3) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,D(4) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,D(1A) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,D(1B) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,5-hydroxytryptamine receptor 1A,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,5-hydroxytryptamine receptor 1D,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,5-hydroxytryptamine receptor 2B,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,5-hydroxytryptamine receptor 2A,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,5-hydroxytryptamine receptor 2C,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,5-hydroxytryptamine receptor 1B,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,Alpha-2A adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,Alpha-2B adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,Alpha-2C adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lisuride,5-hydroxytryptamine receptor 7,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Lithium carbonate,Inositol monophosphatase 2,[Li+].[Li+].[O-]C([O-])=O
Lithium carbonate,Inositol monophosphatase 1,[Li+].[Li+].[O-]C([O-])=O
Lithium carbonate,Glycogen synthase kinase-3 beta,[Li+].[Li+].[O-]C([O-])=O
Lithium carbonate,Glutamate receptor 3,[Li+].[Li+].[O-]C([O-])=O
Lithium cation,Glycogen synthase kinase-3 beta,[Li+]
Lithium cation,Inositol monophosphatase 1,[Li+]
Lithium cation,Inositol monophosphatase 2,[Li+]
Lithium cation,Glutamate receptor 3,[Li+]
Lithium citrate,Inositol monophosphatase 2,[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Lithium citrate,Inositol monophosphatase 1,[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Lithium citrate,Glycogen synthase kinase-3 beta,[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Lithium citrate,Glutamate receptor 3,[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Lithium succinate,Inositol monophosphatase 2,[Li+].[Li+].[O-]C(=O)CCC([O-])=O
Lithium succinate,Inositol monophosphatase 1,[Li+].[Li+].[O-]C(=O)CCC([O-])=O
Lithium succinate,Glycogen synthase kinase-3 beta,[Li+].[Li+].[O-]C(=O)CCC([O-])=O
Lithium succinate,Glutamate receptor 3,[Li+].[Li+].[O-]C(=O)CCC([O-])=O
Lixisenatide,Glucagon-like peptide 1 receptor,[V].[H][C@](C)(O)[C@]([H])(N=C(O)CN=C(O)[C@]([H])(CCC(O)=O)N=C(O)CN=C(O)[C@@]([H])(N)CC1=CN=CN1)C(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=N[C@]([H])(C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CC(O)=O)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=N[C@@]([H])(CCSC)C(O)=N[C@@]([H])(CCC(O)=O)C(O)=N[C@@]([H])(CCC(O)=O)C(O)=N[C@@]([H])(CCC(O)=O)C(O)=N[C@@]([H])(C)C(O)=N[C@@]([H])(C(C)C)C(O)=N[C@@]([H])(CCCNC(N)=N)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=N[C@]([H])(C(O)=N[C@@]([H])(CCC(O)=O)C(O)=N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CC(O)=N)C(O)=NCC(O)=NCC(=O)N1CCC[C@@]1([H])C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CO)C(O)=NCC(O)=N[C@@]([H])(C)C(=O)N1CCC[C@@]1([H])C(=O)N1CCC[C@@]1([H])C(O)=N[C@@]([H])(CO)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@@]([H])(CCCCN)C(O)=N)[C@@]([H])(C)CC)[C@@]([H])(C)O
Lobeglitazone,Peroxisome proliferator-activated receptor gamma,COC1=CC=C(OC2=NC=NC(=C2)N(C)CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1
Lobeline,Neuronal acetylcholine receptor subunit alpha-10,CN1[C@H](C[C@H](O)C2=CC=CC=C2)CCC[C@@H]1CC(=O)C1=CC=CC=C1
Lobeline,Neuronal acetylcholine receptor subunit alpha-9,CN1[C@H](C[C@H](O)C2=CC=CC=C2)CCC[C@@H]1CC(=O)C1=CC=CC=C1
Lobeline,Neuronal acetylcholine receptor subunit alpha-7,CN1[C@H](C[C@H](O)C2=CC=CC=C2)CCC[C@@H]1CC(=O)C1=CC=CC=C1
Lofexidine,Alpha-2A adrenergic receptor,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
Lofexidine,Alpha-1A adrenergic receptor,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
Lofexidine,5-hydroxytryptamine receptor 1A,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
Lofexidine,5-hydroxytryptamine receptor 7,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
Lofexidine,5-hydroxytryptamine receptor 2C,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
Lofexidine,5-hydroxytryptamine receptor 1D,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
Lomefloxacin,DNA gyrase subunit A,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12
Lomefloxacin,DNA topoisomerase 4 subunit A,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12
Lomefloxacin,DNA topoisomerase 2-alpha,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12
Lomerizine,Multidrug resistance protein 1,COC1=CC=C(CN2CCN(CC2)C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(OC)=C1OC
Lometrexol,Dihydrofolate reductase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(CC[C@@]2([H])CNC3=C(C2)C(O)=NC(=N)N3)C=C1)C(O)=O
Lomitapide,Microsomal triglyceride transfer protein large subunit,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12
Lomustine,Stathmin-4,ClCCN(N=O)C(=O)NC1CCCCC1
Lonafarnib,Insulin-like growth factor-binding protein 3,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3=C(CCC4=C2C(Br)=CC(Cl)=C4)C=C(Br)C=N3)CC1
Lonafarnib,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3=C(CCC4=C2C(Br)=CC(Cl)=C4)C=C(Br)C=N3)CC1
Lonidamine,Hexokinase-1,OC(=O)C1=NN(CC2=C(Cl)C=C(Cl)C=C2)C2=C1C=CC=C2
Lonidamine,Cystic fibrosis transmembrane conductance regulator,OC(=O)C1=NN(CC2=C(Cl)C=C(Cl)C=C2)C2=C1C=CC=C2
Lonoctocog alfa,Coagulation factor X,
Lonoctocog alfa,"Phytanoyl-CoA dioxygenase, peroxisomal",
Lonoctocog alfa,Coagulation factor IX,
Lonoctocog alfa,Asialoglycoprotein receptor 2,
Lonoctocog alfa,78 kDa glucose-regulated protein,
Lonoctocog alfa,Calreticulin,
Lonoctocog alfa,Calnexin,
Lonoctocog alfa,Protein ERGIC-53,
Lonoctocog alfa,Prolow-density lipoprotein receptor-related protein 1,
Lonoctocog alfa,Multiple coagulation factor deficiency protein 2,
Lonoctocog alfa,von Willebrand factor,
Loperamide,Mu-type opioid receptor,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Loperamide,Delta-type opioid receptor,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Loperamide,Kappa-type opioid receptor,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Loperamide,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Loperamide,Pro-opiomelanocortin,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Loperamide,Calmodulin,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Loperamide,Nuclear receptor subfamily 1 group I member 3,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1
Lopinavir,Pol polyprotein,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)CC1=CC=CC=C1
Loracarbef,Penicillin-binding protein 3,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1
Loracarbef,Penicillin-binding protein 1A,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1
Loratadine,Histamine H1 receptor,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2
Loratadine,Potassium voltage-gated channel subfamily H member 2,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit alpha-1,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit alpha-2,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit alpha-3,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit alpha-4,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit alpha-5,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit alpha-6,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit beta-1,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit beta-2,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit beta-3,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit delta,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit epsilon,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit gamma-1,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit gamma-2,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit gamma-3,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit pi,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Gamma-aminobutyric acid receptor subunit theta,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorazepam,Translocator protein,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2
Lorcaserin,5-hydroxytryptamine receptor 2C,C[C@H]1CNCCC2=CC=C(Cl)C=C12
Lorlatinib,ALK tyrosine kinase receptor,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2
Lormetazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl
Lormetazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl
Lormetazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl
Lormetazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl
Lormetazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1Cl
Lornoxicam,Prostaglandin G/H synthase 1,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O
Lornoxicam,Prostaglandin G/H synthase 2,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O
Lorpiprazole,5-hydroxytryptamine receptor 2A,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,5-hydroxytryptamine receptor 2C,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,Alpha-1A adrenergic receptor,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,Alpha-1B adrenergic receptor,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,Alpha-1D adrenergic receptor,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,Alpha-2A adrenergic receptor,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,Alpha-2B adrenergic receptor,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,Alpha-2C adrenergic receptor,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,Histamine H1 receptor,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Lorpiprazole,Sodium-dependent serotonin transporter,[H][C@@]12CCC[C@]1([H])C1=NN=C(CCN3CCN(CC3)C3=CC=CC(=C3)C(F)(F)F)N1C2
Losartan,Type-1 angiotensin II receptor,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1
Loteprednol etabonate,Glucocorticoid receptor,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Lovastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
Lovastatin,Integrin alpha-L,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
Lovastatin,Histone deacetylase 2,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
Loxapine,D(1A) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,D(2) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 2A,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 2C,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 1A,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 1B,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 1D,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 1E,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 3A,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 5A,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 6,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,5-hydroxytryptamine receptor 7,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Alpha-1A adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Alpha-1B adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Alpha-2A adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Alpha-2B adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Alpha-2C adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Beta-1 adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Muscarinic acetylcholine receptor M1,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Muscarinic acetylcholine receptor M2,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Muscarinic acetylcholine receptor M3,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Muscarinic acetylcholine receptor M4,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Muscarinic acetylcholine receptor M5,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,D(1A) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,D(1B) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,D(3) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,D(4) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,D(1B) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Histamine H1 receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Histamine H2 receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Histamine H4 receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Sodium-dependent serotonin transporter,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Sodium-dependent noradrenaline transporter,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxapine,Sodium-dependent dopamine transporter,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
Loxicodegol,Mu-type opioid receptor,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CC[C@]2([H])OCCOCCOCCOCCOCCOCCOC
Loxicodegol,Delta-type opioid receptor,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CC[C@]2([H])OCCOCCOCCOCCOCCOCCOC
Loxicodegol,Kappa-type opioid receptor,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CC[C@]2([H])OCCOCCOCCOCCOCCOCCOC
Loxoprofen,Prostaglandin G/H synthase 2,CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1
Loxoprofen,Prostaglandin G/H synthase 1,CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1
Lpc-Ether,Ganglioside GM2 activator,CCCCCCCCCCCCCCCCCCOC[C@@H](O)CO[P@@](O)(=O)OCC[N+](C)(C)C
Lpc-Ether,Phospholipase A2,CCCCCCCCCCCCCCCCCCOC[C@@H](O)CO[P@@](O)(=O)OCC[N+](C)(C)C
Lubiprostone,Chloride channel protein 2,[H][C@@]12CC(=O)[C@H](CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC
Lucanthone,DNA topoisomerase 2-alpha,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1
Lucanthone,DNA topoisomerase 1,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1
Lucanthone,DNA-(apurinic or apyrimidinic site) lyase,CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1
Lucatumumab,Tumor necrosis factor receptor superfamily member 5,
Luliconazole,Lanosterol 14-alpha demethylase,ClC1=CC(Cl)=C(C=C1)[C@@H]1CS\C(S1)=C(\C#N)N1C=CN=C1
Lumacaftor,Cystic fibrosis transmembrane conductance regulator,CC1=CC=C(NC(=O)C2(CC2)C2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC(=CC=C1)C(O)=O
Lumateperone,5-hydroxytryptamine receptor 2A,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C
Lumateperone,D(2) dopamine receptor,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C
Lumichrome,Flavin reductase (NADPH),CC1=CC2=NC3=C(N=C2C=C1C)C(=O)NC(=O)N3
Lumichrome,Riboflavin biosynthesis protein,CC1=CC2=NC3=C(N=C2C=C1C)C(=O)NC(=O)N3
Lumiliximab,Low affinity immunoglobulin epsilon Fc receptor,
Lumiracoxib,Prostaglandin G/H synthase 1,CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1
Lumiracoxib,Prostaglandin G/H synthase 2,CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(O)=O)=C1
Lurasidone,D(2) dopamine receptor,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Lurasidone,5-hydroxytryptamine receptor 2A,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Lurasidone,5-hydroxytryptamine receptor 7,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Lurasidone,5-hydroxytryptamine receptor 1A,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Lurasidone,Alpha-2C adrenergic receptor,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Lurasidone,Alpha-2A adrenergic receptor,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Lusutrombopag,Thrombopoietin receptor,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1
Lutetium Lu 177 dotatate,Somatostatin receptor type 2,[177Lu+3].[H][C@](C)(O)[C@]([H])(N=C(O)[C@]1([H])CSSC[C@]([H])(N=C(O)[C@@]([H])(CC2=CC=CC=C2)N=C([O-])CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC([O-])=O)CC2)C(O)=N[C@@]([H])(CC2=CC=C([O-])C=C2)C(O)=N[C@]([H])(CC2=CNC3=CC=CC=C23)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@]([H])(C(O)=N1)[C@@]([H])(C)O)C(O)=O
Lutetium Lu 177 dotatate,Somatostatin receptor type 1,[177Lu+3].[H][C@](C)(O)[C@]([H])(N=C(O)[C@]1([H])CSSC[C@]([H])(N=C(O)[C@@]([H])(CC2=CC=CC=C2)N=C([O-])CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC([O-])=O)CC2)C(O)=N[C@@]([H])(CC2=CC=C([O-])C=C2)C(O)=N[C@]([H])(CC2=CNC3=CC=CC=C23)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@]([H])(C(O)=N1)[C@@]([H])(C)O)C(O)=O
Lutetium Lu 177 dotatate,Somatostatin receptor type 3,[177Lu+3].[H][C@](C)(O)[C@]([H])(N=C(O)[C@]1([H])CSSC[C@]([H])(N=C(O)[C@@]([H])(CC2=CC=CC=C2)N=C([O-])CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC([O-])=O)CC2)C(O)=N[C@@]([H])(CC2=CC=C([O-])C=C2)C(O)=N[C@]([H])(CC2=CNC3=CC=CC=C23)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@]([H])(C(O)=N1)[C@@]([H])(C)O)C(O)=O
Lutetium Lu 177 dotatate,Somatostatin receptor type 4,[177Lu+3].[H][C@](C)(O)[C@]([H])(N=C(O)[C@]1([H])CSSC[C@]([H])(N=C(O)[C@@]([H])(CC2=CC=CC=C2)N=C([O-])CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC([O-])=O)CC2)C(O)=N[C@@]([H])(CC2=CC=C([O-])C=C2)C(O)=N[C@]([H])(CC2=CNC3=CC=CC=C23)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@]([H])(C(O)=N1)[C@@]([H])(C)O)C(O)=O
Lutetium Lu 177 dotatate,Somatostatin receptor type 5,[177Lu+3].[H][C@](C)(O)[C@]([H])(N=C(O)[C@]1([H])CSSC[C@]([H])(N=C(O)[C@@]([H])(CC2=CC=CC=C2)N=C([O-])CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC([O-])=O)CC2)C(O)=N[C@@]([H])(CC2=CC=C([O-])C=C2)C(O)=N[C@]([H])(CC2=CNC3=CC=CC=C23)C(O)=N[C@@]([H])(CCCCN)C(O)=N[C@]([H])(C(O)=N1)[C@@]([H])(C)O)C(O)=O
Lutropin alfa,Lutropin-choriogonadotropic hormone receptor,
Lyme disease vaccine (recombinant OspA),Toll-like receptor 2,
Lymecycline,30S ribosomal protein S4,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C
Lymecycline,30S ribosomal protein S9,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C
Lypressin,Vasopressin V1a receptor,[H]N([H])C(=O)C[C@]1([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)NC([H])(CCCCN)C(=O)NCC(N)=O
Lypressin,Vasopressin V2 receptor,[H]N([H])C(=O)C[C@]1([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)NC([H])(CCCCN)C(=O)NCC(N)=O
Lypressin,Vasopressin V1b receptor,[H]N([H])C(=O)C[C@]1([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)NC([H])(CCCCN)C(=O)NCC(N)=O
Lysergic acid diethylamide,5-hydroxytryptamine receptor 1A,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC
Lysergic acid diethylamide,5-hydroxytryptamine receptor 2B,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC
Lysergic acid diethylamide,5-hydroxytryptamine receptor 6,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC
Lysine Nz-Carboxylic Acid,Cyclin-dependent kinase 2,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,UDP-N-acetylmuramoylalanine--D-glutamate ligase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Beta-lactamase OXA-10,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Alanine racemase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Dihydroorotase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Folylpolyglutamate synthase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Parathion hydrolase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Methylmalonyl-CoA carboxyltransferase 5S subunit,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,D-hydantoinase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,D-hydantoinase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Beta-lactamase OXA-1,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,L-hydantoinase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Beta-lactamase OXA-2,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Isoaspartyl dipeptidase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,"Alanine racemase, catabolic",N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,"Alpha-L-fucosidase, putative",N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Endonuclease III,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysine Nz-Carboxylic Acid,Hydrolase,N[C@@H](CCCCNC(O)=O)C(O)=O
Lysophosphotidylserine,Prothrombin,[H][C@@](O)(CO[C@@]([H])(O)CCCCCCCCCCCCCC)COP(O)(=O)OC[C@]([H])(N)C(O)=O
"M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene",Acetylcholinesterase,C[N+](C)(C)C1=CC=CC(=C1)C(O)(O)C(F)(F)F
M-Aminophenylboronic Acid,Beta-lactamase,NC1=CC=CC(=C1)B(O)O
M-Cresol,Insulin,CC1=CC=CC(O)=C1
M0002,Vasopressin V2 receptor,
MB-07803,"Fructose-1,6-bisphosphatase 1",CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)C1=CC=C(O1)C1=C(SC(N)=N1)C(=O)C(C)(C)C
MB07811,Thyroid hormone receptor beta,
MCC,"Apoptosis-inducing factor 1, mitochondrial",
MDX-018,Interleukin-8,
MDX-1303,Anthrax toxin receptor 2,
MDX-1303,Anthrax toxin receptor 1,
MEM 1414,CAMP phosphodiesterase,
METHOXYUNDECYLPHOSPHINIC ACID,Colipase,CCCCCCCCCCC[P@@](O)(=O)OC
METHOXYUNDECYLPHOSPHINIC ACID,Pancreatic triacylglycerol lipase,CCCCCCCCCCC[P@@](O)(=O)OC
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,"Cytochrome c1, heme protein, mitochondrial",CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,Cytochrome b,CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,"Cytochrome b-c1 complex subunit 1, mitochondrial",CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,"Cytochrome b-c1 complex subunit 2, mitochondrial",CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,"Cytochrome b-c1 complex subunit 6, mitochondrial",CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,Cytochrome b-c1 complex subunit 8,CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,Cytochrome b-c1 complex subunit 10,CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,Cytochrome b-c1 complex subunit 7,CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,Cytochrome b-c1 complex subunit 9,CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=NC=NC(OC2=CC=CC=C2C#N)=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,"Cytochrome c1, heme protein, mitochondrial",CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,Cytochrome b,CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,"Cytochrome b-c1 complex subunit 1, mitochondrial",CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,"Cytochrome b-c1 complex subunit 2, mitochondrial",CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,"Cytochrome b-c1 complex subunit 6, mitochondrial",CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,Cytochrome b-c1 complex subunit 8,CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,Cytochrome b-c1 complex subunit 10,CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,Cytochrome b-c1 complex subunit 7,CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,Cytochrome b-c1 complex subunit 9,CO\C=C(\C(=O)OC)C1=C(\C=C\C2=CC=CC=C2)C=CC=C1
METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE,"Polyhydroxybutyrate depolymerase, putative",[H][C@](C)(O)CC(=O)O[C@]([H])(C)CC(=O)O[C@]([H])(C)CC(=O)OC
"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",Putative dehydrogenase/reductase SDR family member 4-like 1,COC(=O)C1CCN(CC1)C(=O)C1=CC=C(C=C1)N(C)CC1=NC2=C(N)N=C(N)N=C2N=C1
"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",Putative dehydrogenase/reductase SDR family member 4-like 1,COC(=O)C1CCN(CC1)C(=O)C1=CC=C(NCC2=NC3=C(N=C2)N=C(N)N=C3N)C=C1
"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",Heat shock protein HSP 90-beta,COC(=O)C1=C(CCC(=O)NC2=C(O)C=C(OC)C(O)=C2)C(Cl)=C(O)C=C1O
"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",Endoplasmin,COC(=O)C1=C(CCC(=O)NC2=C(O)C=C(OC)C(O)=C2)C(Cl)=C(O)C=C1O
"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",Dipeptidyl peptidase 4,[H][C@]1(CNC(=O)NC2=CC=C(C=C2)C(=O)OC)CC[C@]([H])(N1)C(=O)N1CCC[C@@]1([H])CN
"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",Cathepsin B,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)NCCC)C(=O)N1CCC[C@@]1([H])C(=O)OC
"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",Methionine aminopeptidase,[H][C@@](C)(NC(=O)[C@@]([H])(O)[C@]([H])(N)C1=CC=C(C=C1)C(C)C)C(=O)N[C@]([H])(CC(C)C)C(=O)OC
"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",Methionine aminopeptidase,[H][C@@](C)(NC(=O)[C@@]([H])(O)[C@]([H])(N)C1=CC=C(C)C=C1)C(=O)N[C@]([H])(CC(C)C)C(=O)OC
METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE,Chymotrypsin-like elastase family member 1,[H][C@](OC(C)=O)(C(=O)OC)C1=CC=C(N)C=C1C(O)=O
METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE,Prothrombin,[H][C@](CC1=CC=CC=C1)(NC)C(=O)N1CCC[C@@]1([H])C(O)=NC[C@@]1([H])CC[C@]([H])(N)CC1
METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,Ig kappa chain C region,C[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O
METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,"Alkaline phosphatase, placental type",C[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O
METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,Interstitial collagenase,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)NC
METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,Neutrophil collagenase,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(=O)NC
MF101,Estrogen receptor beta,
MF268,Acetylcholinesterase,[H][C@]1(C)CN(CCCCCCCCNC=O)C[C@@]([H])(C)O1
MIV-701,Cathepsin K,
MK-0354,G-protein coupled estrogen receptor 1,C1CC2=C(C1)C(=NN2)C1=NNN=N1
MK-1775,Wee1-like protein kinase,CN1CCN(CC1)C1=CC=C(NC2=NC=C3C(=O)N(CC=C)N(C3=N2)C2=NC(=CC=C2)C(C)(C)O)C=C1
MLN-977,Arachidonate 5-lipoxygenase,[H][C@@]1(COC2=CC=C(F)C=C2)CC[C@]([H])(O1)C#CCCN(O)C(O)=N
MLN0415,Inhibitor of nuclear factor kappa-B kinase subunit beta,
MLN2222,Complement factor B,
MLN8054,Aurora kinase A,OC(=O)C1=CC=C(NC2=NC=C3CN=C(C4=C(C=CC(Cl)=C4)C3=N2)C2=C(F)C=CC=C2F)C=C1
MMDA,5-hydroxytryptamine receptor 2A,COC1=CC(CC(C)N)=CC2=C1OCO2
MMDA,Sodium-dependent dopamine transporter,COC1=CC(CC(C)N)=CC2=C1OCO2
MMDA,Sodium-dependent serotonin transporter,COC1=CC(CC(C)N)=CC2=C1OCO2
MMDA,Sodium-dependent noradrenaline transporter,COC1=CC(CC(C)N)=CC2=C1OCO2
MMDA,Synaptic vesicular amine transporter,COC1=CC(CC(C)N)=CC2=C1OCO2
MMDA,Chromaffin granule amine transporter,COC1=CC(CC(C)N)=CC2=C1OCO2
MMDA,Amine oxidase [flavin-containing] A,COC1=CC(CC(C)N)=CC2=C1OCO2
MMDA,Amine oxidase [flavin-containing] B,COC1=CC(CC(C)N)=CC2=C1OCO2
MMI-175,Beta-secretase 1,[H][C@@](C)(C[C@]([H])(O)[C@]([H])(CC(C)C)N=C(O)[C@]1([H])CC(O)=NCCCCCCOC(O)=N[C@@]([H])(C(C)C)C(O)=N1)C(O)=N[C@@]([H])(C(C)C)C(O)=NCC1=CC=CC=C1
MN-305,5-hydroxytryptamine receptor 1A,Cl.C(CNC[C@H]1COC2=CC=CC=C2O1)COC1=CC2=C(OCO2)C=C1
MONOGALACTOSYL-DIACYLGLYCEROL,Photosystem II protein D1 1,CCCCCCCCCCCCCCCC(=O)O[C@@H](CO[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1O)COC(=O)CCCCCCCCCCCC
MOXALACTAM (HYDROLYZED),Metallo-beta-lactamase L1,CO[C@](NC(=O)[C@H](C(O)=O)C1=CC=C(O)C=C1)([C@H]1OCC(=C)C(=N1)C(O)=O)C(O)=O
MPI-674,Aromatase,
MYO-029,Growth/differentiation factor 8,
Macimorelin,Growth hormone secretagogue receptor type 1,CC(C)(N)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)NC=O
Macitentan,Endothelin-1 receptor,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1
Macitentan,Endothelin B receptor,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1
Mafenide,Carbonic anhydrase 6,NCC1=CC=C(C=C1)S(N)(=O)=O
Magnesium acetate,Sodium/potassium-transporting ATPase subunit alpha-1,[Mg++].CC([O-])=O.CC([O-])=O
Magnesium acetate tetrahydrate,"Glutamate receptor ionotropic, NMDA 1",O.O.O.O.[Mg++].CC([O-])=O.CC([O-])=O
Magnesium acetate tetrahydrate,"Glutamate receptor ionotropic, NMDA 2A",O.O.O.O.[Mg++].CC([O-])=O.CC([O-])=O
Magnesium acetate tetrahydrate,"Glutamate receptor ionotropic, NMDA 2B",O.O.O.O.[Mg++].CC([O-])=O.CC([O-])=O
Magnesium acetate tetrahydrate,"Glutamate receptor ionotropic, NMDA 2C",O.O.O.O.[Mg++].CC([O-])=O.CC([O-])=O
Magnesium acetate tetrahydrate,"Glutamate receptor ionotropic, NMDA 2D",O.O.O.O.[Mg++].CC([O-])=O.CC([O-])=O
Magnesium acetate tetrahydrate,"Glutamate receptor ionotropic, NMDA 3A",O.O.O.O.[Mg++].CC([O-])=O.CC([O-])=O
Magnesium acetate tetrahydrate,"Glutamate receptor ionotropic, NMDA 3B",O.O.O.O.[Mg++].CC([O-])=O.CC([O-])=O
Magnesium carbonate,"Glutamate receptor ionotropic, NMDA 1",[Mg++].[O-]C([O-])=O
Magnesium carbonate,"Glutamate receptor ionotropic, NMDA 2A",[Mg++].[O-]C([O-])=O
Magnesium carbonate,"Glutamate receptor ionotropic, NMDA 2B",[Mg++].[O-]C([O-])=O
Magnesium carbonate,"Glutamate receptor ionotropic, NMDA 2C",[Mg++].[O-]C([O-])=O
Magnesium carbonate,"Glutamate receptor ionotropic, NMDA 2D",[Mg++].[O-]C([O-])=O
Magnesium carbonate,"Glutamate receptor ionotropic, NMDA 3A",[Mg++].[O-]C([O-])=O
Magnesium carbonate,"Glutamate receptor ionotropic, NMDA 3B",[Mg++].[O-]C([O-])=O
Magnesium cation,Sodium/potassium-transporting ATPase subunit alpha-1,[Mg++]
Magnesium lactate,Sodium/potassium-transporting ATPase subunit alpha-1,[Mg+4].CC([O-])C([O-])=O.CC([O-])C([O-])=O
Magnesium levulinate,Sodium/potassium-transporting ATPase subunit alpha-1,[Mg++].CC(=O)CCC([O-])=O.CC(=O)CCC([O-])=O
Magnesium salicylate,Prostaglandin G/H synthase 2,[Mg++].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O
Magnesium salicylate,Prostaglandin G/H synthase 1,[Mg++].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O
Magnesium sulfate,Voltage-dependent L-type calcium channel subunit beta-1,[Mg++].[O-]S([O-])(=O)=O
Magnesium sulfate,Voltage-dependent L-type calcium channel subunit alpha-1C,[Mg++].[O-]S([O-])(=O)=O
Magnesium sulfate,Voltage-dependent calcium channel gamma-1 subunit,[Mg++].[O-]S([O-])(=O)=O
Magnesium sulfate,Voltage-dependent calcium channel subunit alpha-2/delta-1,[Mg++].[O-]S([O-])(=O)=O
Magnesium sulfate,Voltage-dependent L-type calcium channel subunit beta-2,[Mg++].[O-]S([O-])(=O)=O
Magnesium sulfate,Voltage-dependent L-type calcium channel subunit alpha-1S,[Mg++].[O-]S([O-])(=O)=O
Malachite Green,HTH-type transcriptional regulator QacR,CN(C)C1=CC=C(C=C1)C(C1=CC=CC=C1)=C1C=CC(C=C1)=[N+](C)C
Malate Ion,"NAD-dependent malic enzyme, mitochondrial",O[C@H](CC(O)=O)C(O)=O
Malate Ion,Circadian clock protein KaiB,O[C@H](CC(O)=O)C(O)=O
Malate Ion,Malate synthase G,O[C@H](CC(O)=O)C(O)=O
Malate Ion,Fumarate hydratase class II,O[C@H](CC(O)=O)C(O)=O
Malate Ion,Capsule biosynthesis protein,O[C@H](CC(O)=O)C(O)=O
Malate Ion,"Citrate synthase, mitochondrial",O[C@H](CC(O)=O)C(O)=O
Malate Like Intermediate,Fumarate reductase flavoprotein subunit,O[C@H](\C=C(/O)[O-])C([O-])=O
Malathion,Cholinesterase,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC
Maleic Acid,"Aspartate aminotransferase, cytoplasmic",OC(=O)\C=C/C(O)=O
Maleic Acid,Aspartate aminotransferase,OC(=O)\C=C/C(O)=O
Maleic Acid,Aromatic-amino-acid aminotransferase,OC(=O)\C=C/C(O)=O
Maleic Acid,Aspartate aminotransferase,OC(=O)\C=C/C(O)=O
Maleic Acid,Trypanothione reductase,OC(=O)\C=C/C(O)=O
Malonaldehyde,Beta-lactamase SHV-1,O=CCC=O
Malonate Ion,Chorismate mutase AroH,[O-]C(=O)CC([O-])=O
Malonate Ion,Stromal cell-derived factor 2,[O-]C(=O)CC([O-])=O
Malonic acid,Proto-oncogene tyrosine-protein kinase Src,OC(=O)CC(O)=O
Malonic acid,Aspartate 1-decarboxylase,OC(=O)CC(O)=O
Malonic acid,Sigma factor SigB regulation protein RsbQ,OC(=O)CC(O)=O
Malonic acid,Acetyl transferase,OC(=O)CC(O)=O
Malonic acid,Malonamidase E2,OC(=O)CC(O)=O
Malonic acid,Biflaviolin synthase CYP158A2,OC(=O)CC(O)=O
Malonic acid,U1 small nuclear ribonucleoprotein A,OC(=O)CC(O)=O
Malonyl-CoA,3-oxoacyl-[acyl-carrier-protein] synthase 3,CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O
Maltose,Cyclomaltodextrin glucanotransferase,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Maltose,Maltogenic alpha-amylase,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Maltose,Maltodextrin phosphorylase,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Maltose,Beta-amylase,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Maltose,Maltose-binding periplasmic protein,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Maltose,Alpha-glucosidase,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Maltose,Malto-oligosyltrehalose trehalohydrolase,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Maltose,Maltose binding protein,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
Maltose,Alpha-amylase 2B,OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O
"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",Pancreatic alpha-amylase,[H][C@]1(CO)O[C@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@]([H])(O[C@]3([H])[C@@]([H])(CO)N=C(NO)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Maltotetraose,Neopullulanase 2,OC[C@@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C=O
Maltotetraose,"Glucan 1,4-alpha-maltotetraohydrolase",OC[C@@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C=O
Managlinat dialanetil,"Fructose-1,6-bisphosphatase 1",[H][C@@](C)(NP(=O)(N[C@@]([H])(C)C(=O)OCC)C1=CC=C(O1)C1=C(CC(C)C)SC(=N)N1)C(=O)OCC
Manganese,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",[Mn++]
Manganese,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",[Mn++]
Manganese,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,[Mn++]
Manganese,Arginase-1,[Mn++]
Manganese,Serotransferrin,[Mn++]
Manidipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent L-type calcium channel subunit alpha-1F,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent L-type calcium channel subunit beta-1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent L-type calcium channel subunit beta-2,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent L-type calcium channel subunit beta-3,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent L-type calcium channel subunit beta-4,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent T-type calcium channel subunit alpha-1G,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent T-type calcium channel subunit alpha-1H,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manidipine,Voltage-dependent T-type calcium channel subunit alpha-1I,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1
Manitimus,"Dihydroorotate dehydrogenase (quinone), mitochondrial",O\C(CCC#C)=C(\C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F
Mant-Adp,Myosin-14,[H][C@@]1(C[C@]([H])(OC(=O)C2=CC=CC=C2NC)[C@@]([H])(COP(O)(=O)OP(O)(O)=O)O1)N1C=NC2=C(N)N=CN=C12
Maprotiline,Sodium-dependent noradrenaline transporter,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Muscarinic acetylcholine receptor M1,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Histamine H1 receptor,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Muscarinic acetylcholine receptor M2,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Muscarinic acetylcholine receptor M3,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Muscarinic acetylcholine receptor M4,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Muscarinic acetylcholine receptor M5,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Alpha-1A adrenergic receptor,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Alpha-1B adrenergic receptor,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Alpha-1D adrenergic receptor,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,5-hydroxytryptamine receptor 2A,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,5-hydroxytryptamine receptor 2C,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,5-hydroxytryptamine receptor 7,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,D(2) dopamine receptor,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Alpha-2A adrenergic receptor,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Alpha-2B adrenergic receptor,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maprotiline,Alpha-2C adrenergic receptor,CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
Maraviroc,C-C chemokine receptor type 5,CC(C)C1=NN=C(C)N1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1
Maribavir,Serine/threonine protein kinase UL97,CC(C)NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O
Maribavir,Serine/threonine protein kinase UL97,CC(C)NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O
Marimastat,Interstitial collagenase,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,72 kDa type IV collagenase,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Stromelysin-1,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrilysin,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Neutrophil collagenase,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-9,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Stromelysin-2,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Stromelysin-3,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Macrophage metalloelastase,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Collagenase 3,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-14,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-15,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-16,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-17,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-19,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-20,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-21,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-23,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-24,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-26,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-27,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Marimastat,Matrix metalloproteinase-28,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Masoprocol,Arachidonate 5-lipoxygenase,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1
Masoprocol,Sex hormone-binding globulin,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1
Matairesinol,Dehydrogenase/reductase SDR family member 4-like 2,[H][C@]1(CC2=CC=C(O)C(OC)=C2)COC(=O)[C@]1([H])CC1=CC=C(O)C(OC)=C1
Matuzumab,Epidermal growth factor receptor,
Mazindol,Sodium-dependent noradrenaline transporter,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
Mazindol,Sodium-dependent dopamine transporter,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
Mazindol,Sodium-dependent serotonin transporter,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
Mazindol,Synaptic vesicular amine transporter,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1
"Mdl 101,146",Neutrophil elastase,CC(C)[C@@H](NC(=O)C1=CC=C(C=C1)C(=O)N1CCOCC1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(C)C)C(=O)C(F)(F)C(F)(F)F
"Mdl 101,146",Chymotrypsin-like elastase family member 1,CC(C)[C@@H](NC(=O)C1=CC=C(C=C1)C(=O)N1CCOCC1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(C)C)C(=O)C(F)(F)C(F)(F)F
Mdl-29951,"Fructose-1,6-bisphosphatase 1",OC(=O)CCC1=C(NC2=C1C(Cl)=CC(Cl)=C2)C(O)=O
Mebendazole,Tubulin alpha-1A chain,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C1=CC=CC=C1
Mebendazole,Tubulin beta-4B chain,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C1=CC=CC=C1
Mecamylamine,Neuronal acetylcholine receptor subunit alpha-2,CNC1(C)C2CCC(C2)C1(C)C
Mecamylamine,Neuronal acetylcholine receptor subunit alpha-7,CNC1(C)C2CCC(C2)C1(C)C
Mecamylamine,Neuronal acetylcholine receptor subunit alpha-4,CNC1(C)C2CCC(C2)C1(C)C
Mecamylamine,Neuronal acetylcholine receptor subunit beta-2,CNC1(C)C2CCC(C2)C1(C)C
Mecasermin,Insulin-like growth factor 1 receptor,
Mecasermin,Insulin-like growth factor-binding protein 3,
Mecasermin,Insulin receptor,
Mecasermin,Cation-independent mannose-6-phosphate receptor,
Mecasermin rinfabate,Insulin-like growth factor 1 receptor,
Mecasermin rinfabate,Insulin receptor,
Mecasermin rinfabate,Cation-independent mannose-6-phosphate receptor,
Meclizine,Histamine H1 receptor,CC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1
Meclizine,Nuclear receptor subfamily 1 group I member 3,CC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1
Meclocycline,30S ribosomal protein S7,CN(C)[C@H]1[C@@H]2[C@@H](O)[C@@H]3C(=C)C4=C(Cl)C=CC(O)=C4C(=O)C3=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O
Meclofenamic acid,Prostaglandin G/H synthase 1,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1
Meclofenamic acid,Arachidonate 5-lipoxygenase,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1
Meclofenamic acid,Prostaglandin G/H synthase 2,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1
Meclofenamic acid,Potassium voltage-gated channel subfamily KQT member 2,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1
Meclofenamic acid,Potassium voltage-gated channel subfamily KQT member 3,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1
Medical Cannabis,Cannabinoid receptor 1,
Medical Cannabis,Cannabinoid receptor 2,
Medical Cannabis,G-protein coupled receptor 12,
Medical Cannabis,Glycine receptor subunit alpha-1,
Medical Cannabis,Glycine receptor subunit alpha-1,
Medical Cannabis,Glycine receptor subunit beta,
Medical Cannabis,Glycine receptor subunit alpha-3,
Medical Cannabis,N-arachidonyl glycine receptor,
Medical Cannabis,G-protein coupled receptor 55,
Medical Cannabis,5-hydroxytryptamine receptor 1A,
Medical Cannabis,5-hydroxytryptamine receptor 2A,
Medical Cannabis,Neuronal acetylcholine receptor subunit alpha-7,
Medical Cannabis,Delta-type opioid receptor,
Medical Cannabis,Mu-type opioid receptor,
Medical Cannabis,Peroxisome proliferator-activated receptor gamma,
Medical Cannabis,Transient receptor potential cation channel subfamily V member 1,
Medical Cannabis,Voltage-dependent T-type calcium channel subunit alpha-1G,
Medical Cannabis,Voltage-dependent T-type calcium channel subunit alpha-1H,
Medical Cannabis,Voltage-dependent T-type calcium channel subunit alpha-1I,
Medical Cannabis,Transient receptor potential cation channel subfamily A member 1,
Medical Cannabis,Transient receptor potential cation channel subfamily M member 8,
Medical Cannabis,Transient receptor potential cation channel subfamily V member 2,
Medical Cannabis,Transient receptor potential cation channel subfamily V member 3,
Medical Cannabis,Transient receptor potential cation channel subfamily V member 4,
Medical Cannabis,Voltage-dependent anion-selective channel protein 1,
Medrogestone,Progesterone receptor,[H][C@@]12CC[C@](C)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
Medroxyprogesterone acetate,Progesterone receptor,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
Medroxyprogesterone acetate,Estrogen receptor,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
Medrysone,Glucocorticoid receptor,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
Mefenamic acid,Prostaglandin G/H synthase 1,CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1
Mefenamic acid,Prostaglandin G/H synthase 2,CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1
Mefloquine,Hemoglobin subunit alpha,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F
Mefloquine,Adenosine receptor A2a,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F
Megestrol acetate,Progesterone receptor,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
Megestrol acetate,Glucocorticoid receptor,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C
Meglutol,3-hydroxy-3-methylglutaryl-coenzyme A reductase,CC(O)(CC(O)=O)CC(O)=O
Melatonin,Melatonin receptor type 1A,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Melatonin receptor type 1B,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Estrogen receptor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Nuclear receptor ROR-beta,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Calmodulin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Myeloperoxidase,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Eosinophil peroxidase,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Calreticulin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Acetylserotonin O-methyltransferase,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Melatonin,Ribosyldihydronicotinamide dehydrogenase [quinone],COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
Meloxicam,Prostaglandin G/H synthase 2,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O
Meloxicam,Prostaglandin G/H synthase 1,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O
Melperone,D(2) dopamine receptor,CC1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1
Memantine,5-hydroxytryptamine receptor 3A,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Alpha-7 nicotinic cholinergic receptor subunit,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,D(2) dopamine receptor,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,"Glutamate receptor ionotropic, NMDA 1",CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,"Glutamate receptor ionotropic, NMDA 1",CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,"Glutamate receptor ionotropic, NMDA 2A",CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,"Glutamate receptor ionotropic, NMDA 2B",CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,"Glutamate receptor ionotropic, NMDA 2C",CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,"Glutamate receptor ionotropic, NMDA 2D",CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,"Glutamate receptor ionotropic, NMDA 3A",CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,"Glutamate receptor ionotropic, NMDA 3B",CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit alpha-1,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit alpha-2,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit alpha-3,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit alpha-4,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit alpha-5,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit alpha-6,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit beta-1,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit beta-2,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit beta-3,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit delta,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit epsilon,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit gamma-1,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit gamma-2,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit gamma-3,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit pi,CC12CC3CC(C)(C1)CC(N)(C3)C2
Memantine,Gamma-aminobutyric acid receptor subunit theta,CC12CC3CC(C)(C1)CC(N)(C3)C2
Menadione,Vitamin K-dependent gamma-carboxylase,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Vitamin K epoxide reductase complex subunit 1,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Vitamin K epoxide reductase complex subunit 1-like protein 1,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Prothrombin,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Coagulation factor VII,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Coagulation factor IX,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Coagulation factor X,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Vitamin K-dependent protein C,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Vitamin K-dependent protein S,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Vitamin K-dependent protein Z,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Ribosyldihydronicotinamide dehydrogenase [quinone],CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,NAD(P)H dehydrogenase [quinone] 1,CC1=CC(=O)C2=CC=CC=C2C1=O
Menadione,Osteocalcin,CC1=CC(=O)C2=CC=CC=C2C1=O
Menotropins,Lutropin-choriogonadotropic hormone receptor,
Menotropins,Follicle-stimulating hormone receptor,
Menthyl salicylate,Prostaglandin G/H synthase 1,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O
Menthyl salicylate,Prostaglandin G/H synthase 2,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O
Mepenzolate,Muscarinic acetylcholine receptor M1,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Mepenzolate,Muscarinic acetylcholine receptor M3,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Meperidine,Kappa-type opioid receptor,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,"Glutamate receptor ionotropic, NMDA 1",CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,"Glutamate receptor ionotropic, NMDA 2B",CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,"Glutamate receptor ionotropic, NMDA 2A",CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,"Glutamate receptor ionotropic, NMDA 2C",CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,"Glutamate receptor ionotropic, NMDA 2D",CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Muscarinic acetylcholine receptor M1,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Muscarinic acetylcholine receptor M2,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Muscarinic acetylcholine receptor M3,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Muscarinic acetylcholine receptor M4,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Muscarinic acetylcholine receptor M5,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Mu-type opioid receptor,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Sodium-dependent dopamine transporter,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Sodium-dependent noradrenaline transporter,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Sodium-dependent serotonin transporter,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Meperidine,Liver carboxylesterase 1,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1
Mephentermine,Alpha-1A adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephentermine,Alpha-1B adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephentermine,Alpha-1D adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephentermine,Alpha-2A adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephentermine,Alpha-2B adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephentermine,Alpha-2C adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephentermine,Beta-1 adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephentermine,Beta-2 adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephentermine,Beta-3 adrenergic receptor,CNC(C)(C)CC1=CC=CC=C1
Mephenytoin,Sodium channel protein type 5 subunit alpha,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1
Mephenytoin,Nuclear receptor subfamily 1 group I member 2,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1
Mepivacaine,Sodium channel protein type 10 subunit alpha,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
Mepolizumab,Interleukin-5,
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-2,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-5,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-4,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-3,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-6,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-2,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-3,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-4,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-5,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit alpha-6,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit beta-1,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit beta-2,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit beta-3,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit delta,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit epsilon,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit gamma-1,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit gamma-2,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit gamma-3,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit pi,CCCC(C)(COC(N)=O)COC(N)=O
Meprobamate,Gamma-aminobutyric acid receptor subunit theta,CCCC(C)(COC(N)=O)COC(N)=O
Mepyramine,Histamine H1 receptor,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=C2)C=C1
Mequitazine,Histamine H1 receptor,C(C1CN2CCC1CC2)N1C2=CC=CC=C2SC2=CC=CC=C12
Mercaptocarboxylate Inhibitor,Beta-lactamase IMP-1,[H][C@](CS)(CCC1=CC=CC=C1)C(=O)N=C(C(O)=O)C1=CC=C(CN2C=NN=N2)S1
Mercaptoethanol,Pyridoxine-5'-phosphate oxidase,OCCS
Mercaptoethanol,Alpha-1-antitrypsin,OCCS
Mercaptoethanol,Lactoylglutathione lyase,OCCS
Mercaptoethanol,Endolysin,OCCS
Mercaptoethanol,Glucose--fructose oxidoreductase,OCCS
Mercaptoethanol,Pyridoxine/pyridoxamine 5'-phosphate oxidase,OCCS
Mercaptoethanol,Endonuclease III,OCCS
Mercaptoethanol,Protein ninB,OCCS
Mercaptoethanol,Galectin-1,OCCS
Mercaptoethanol,Polycomb protein SCMH1,OCCS
Mercaptomethyl Phosphonate,Alkaline phosphatase,[O-]P([O-])(=O)CS
Mercaptopurine,Hypoxanthine-guanine phosphoribosyltransferase,S=C1N=CNC2=C1NC=N2
Mercaptopurine,Amidophosphoribosyltransferase,S=C1N=CNC2=C1NC=N2
Mercaptopurine,Inosine-5'-monophosphate dehydrogenase 1,S=C1N=CNC2=C1NC=N2
Mercaptopurine,Inosine-5'-monophosphate dehydrogenase 2,S=C1N=CNC2=C1NC=N2
Mercuribenzoic Acid,Carbonic anhydrase 2,OC(=O)C1=CC=C([Hg])C=C1
Mercuribenzoic Acid,Divalent-cation tolerance protein CutA,OC(=O)C1=CC=C([Hg])C=C1
Mercuric iodide,Bile salt sulfotransferase,I[Hg]I
Merimepodib,Inosine-5'-monophosphate dehydrogenase,COC1=C(C=CC(NC(=O)NC2=CC=CC(CNC(=O)O[C@H]3CCOC3)=C2)=C1)C1=CN=CO1
Meropenem,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H]
Mersalyl,"Alkaline phosphatase, tissue-nonspecific isozyme",COC(CNC(=O)C1=CC=CC=C1OCC(O)=O)C[Hg]O
Mersalyl,Aquaporin-1,COC(CNC(=O)C1=CC=CC=C1OCC(O)=O)C[Hg]O
Mersalyl,Monocarboxylate transporter 1,COC(CNC(=O)C1=CC=CC=C1OCC(O)=O)C[Hg]O
Mesalazine,Prostaglandin G/H synthase 2,NC1=CC(C(O)=O)=C(O)C=C1
Mesalazine,Prostaglandin G/H synthase 1,NC1=CC(C(O)=O)=C(O)C=C1
Mesalazine,Arachidonate 5-lipoxygenase,NC1=CC(C(O)=O)=C(O)C=C1
Mesalazine,Peroxisome proliferator-activated receptor gamma,NC1=CC(C(O)=O)=C(O)C=C1
Mesalazine,Inhibitor of nuclear factor kappa-B kinase subunit alpha,NC1=CC(C(O)=O)=C(O)C=C1
Mesalazine,Inhibitor of nuclear factor kappa-B kinase subunit beta,NC1=CC(C(O)=O)=C(O)C=C1
Mesalazine,Myeloperoxidase,NC1=CC(C(O)=O)=C(O)C=C1
Mesalazine,Arylamine N-acetyltransferase,NC1=CC(C(O)=O)=C(O)C=C1
Meso-Erythritol,5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase,OC[C@H](O)[C@H](O)CO
Mesobiliverdin Iv Alpha,Flavin reductase (NADPH),[H]\C(C1=C(C)C(CCC(O)=O)=C(N1)C(\[H])=C1/N=C(O)C(C)=C1CC)=C1\N=C(\C(\[H])=C2/N=C(O)C(C)=C2CC)C(CCC(O)=O)=C1C
Mesoridazine,5-hydroxytryptamine receptor 2A,CN1CCCCC1CCN1C2=C(SC3=C1C=C(C=C3)S(C)=O)C=CC=C2
Mesoridazine,D(2) dopamine receptor,CN1CCCCC1CCN1C2=C(SC3=C1C=C(C=C3)S(C)=O)C=CC=C2
Mestranol,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3
Meta-Nitro-Tyrosine,"Glutathione reductase, mitochondrial",N[C@@H](CC1=CC=C(O)C(=C1)[N+]([O-])=O)C(O)=O
Metamfetamine,Sodium-dependent dopamine transporter,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Sodium-dependent serotonin transporter,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Sodium-dependent noradrenaline transporter,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Synaptic vesicular amine transporter,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Chromaffin granule amine transporter,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Trace amine-associated receptor 1,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Alpha-2A adrenergic receptor,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Alpha-2B adrenergic receptor,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Alpha-2C adrenergic receptor,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Amine oxidase [flavin-containing] A,CN[C@@H](C)CC1=CC=CC=C1
Metamfetamine,Amine oxidase [flavin-containing] B,CN[C@@H](C)CC1=CC=CC=C1
Metamizole,Prostaglandin G/H synthase 1,CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1
Metanitrophenyl-Alpha-D-Galactoside,Heat-labile enterotoxin B chain,[H][C@]1(CO)O[C@]([H])(OC2=CC=CC(=C2)N(=O)=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Metanitrophenyl-Alpha-D-Galactoside,Cholera enterotoxin subunit B,[H][C@]1(CO)O[C@]([H])(OC2=CC=CC(=C2)N(=O)=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Metaraminol,Alpha-1A adrenergic receptor,C[C@H](N)[C@H](O)C1=CC(O)=CC=C1
Metergoline,Sodium channel protein type 2 subunit alpha,[H][C@]1(CN=C(O)OCC2=CC=CC=C2)CN(C)[C@]2([H])CC3=CN(C)C4=CC=CC(=C34)[C@@]2([H])C1
Metformin,5'-AMP-activated protein kinase subunit beta-1,CN(C)C(=N)NC(N)=N
Metformin,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",CN(C)C(=N)NC(N)=N
Methacholine,Muscarinic acetylcholine receptor M3,CC(C[N+](C)(C)C)OC(C)=O
Methacrylyl-Coenzyme A,"Isobutyryl-CoA dehydrogenase, mitochondrial",CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Methadone,Mu-type opioid receptor,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Methadone,"Glutamate receptor ionotropic, NMDA 3A",CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Methadone,Neuronal acetylcholine receptor subunit alpha-10,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Methadone,Delta-type opioid receptor,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Methadone,5-hydroxytryptamine receptor 3A,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Methadone,Lymphocyte antigen 96,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Methadone,Alpha-1-acid glycoprotein 2,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Methadyl acetate,Mu-type opioid receptor,CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1
Methantheline,Muscarinic acetylcholine receptor M1,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12
Methantheline,Histamine H2 receptor,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Neuronal acetylcholine receptor subunit alpha-4,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Neuronal acetylcholine receptor subunit alpha-7,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Glutamate receptor 2,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,"Glutamate receptor ionotropic, kainate 2",CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit beta-1,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit beta-2,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit beta-3,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit delta,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit epsilon,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit gamma-1,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit gamma-2,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit gamma-3,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit pi,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Metharbital,Gamma-aminobutyric acid receptor subunit theta,CCC1(CC)C(=O)NC(=O)N(C)C1=O
Methazolamide,Carbonic anhydrase 1,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
Methazolamide,Carbonic anhydrase 2,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
Methazolamide,Carbonic anhydrase 4,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
Methazolamide,Carbonic anhydrase 7,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
Methazolamide,Carbonic anhydrase 3,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
Methdilazine,Histamine H1 receptor,CN1CCC(CN2C3=CC=CC=C3SC3=CC=CC=C23)C1
Methicillin Acyl-Serine,Beta-lactam-inducible penicillin-binding protein,[H][C@](N)(COC(=O)[C@@]([H])(N=C([O-])C1=C(OC)C=CC=C1OC)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1)C([O-])=O
Methimazole,Thyroid peroxidase,CN1C=CNC1=S
Methionine,Methionine synthase,CSCC[C@H](N)C(O)=O
Methionine,Methionine synthase reductase,CSCC[C@H](N)C(O)=O
Methionine,Betaine--homocysteine S-methyltransferase 1,CSCC[C@H](N)C(O)=O
Methionine,Methionine aminopeptidase 2,CSCC[C@H](N)C(O)=O
Methionine,S-methylmethionine--homocysteine S-methyltransferase BHMT2,CSCC[C@H](N)C(O)=O
Methionine Phosphinate,Methionine--tRNA ligase,CSCC[C@H](N)P(O)=O
Methionine Phosphinate,Methionine aminopeptidase,CSCC[C@H](N)P(O)=O
Methionine Phosphonate,Methionine--tRNA ligase,CSCC[C@H](N)P(O)(O)=O
Methionine Phosphonate,Methionine aminopeptidase,CSCC[C@H](N)P(O)(O)=O
Methocarbamol,Carbonic anhydrase 1,COC1=C(OCC(O)COC(N)=O)C=CC=C1
Methohexital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O
Methotrexate,Dihydrofolate reductase,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
Methotrimeprazine,D(2) dopamine receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,D(1A) dopamine receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,D(1B) dopamine receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,D(3) dopamine receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,D(4) dopamine receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,5-hydroxytryptamine receptor 2A,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,5-hydroxytryptamine receptor 2C,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Histamine H1 receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Muscarinic acetylcholine receptor M1,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Muscarinic acetylcholine receptor M2,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Muscarinic acetylcholine receptor M3,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Muscarinic acetylcholine receptor M4,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Muscarinic acetylcholine receptor M5,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Alpha-1A adrenergic receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Alpha-1B adrenergic receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Alpha-1D adrenergic receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Alpha-2A adrenergic receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Alpha-2B adrenergic receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methotrimeprazine,Alpha-2C adrenergic receptor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Methoxamine,Alpha-1A adrenergic receptor,COC1=CC(C(O)C(C)N)=C(OC)C=C1
Methoxamine,Alpha-1B adrenergic receptor,COC1=CC(C(O)C(C)N)=C(OC)C=C1
Methoxamine,Alpha-1D adrenergic receptor,COC1=CC(C(O)C(C)N)=C(OC)C=C1
Methoxy arachidonyl fluorophosphonate,Fatty-acid amide hydrolase 1,[H]\C(CCCCC)=C(/[H])C\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])CCCC[P@](F)(=O)OC
Methoxy polyethylene glycol-epoetin beta,Erythropoietin receptor,
Methoxyflurane,Gamma-aminobutyric acid receptor subunit alpha-1,COC(F)(F)C(Cl)Cl
Methoxyflurane,Glutamate receptor 1,COC(F)(F)C(Cl)Cl
Methoxyflurane,Glycine receptor subunit alpha-1,COC(F)(F)C(Cl)Cl
Methoxyflurane,Calcium-transporting ATPase type 2C member 1,COC(F)(F)C(Cl)Cl
Methoxyflurane,Potassium voltage-gated channel subfamily A member 1,COC(F)(F)C(Cl)Cl
Methoxyflurane,"ATP synthase subunit delta, mitochondrial",COC(F)(F)C(Cl)Cl
Methoxyflurane,NADH-ubiquinone oxidoreductase chain 1,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit alpha-1,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit alpha-2,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit alpha-3,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit alpha-4,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit alpha-5,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit alpha-6,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit beta-1,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit beta-2,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit beta-3,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit delta,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit epsilon,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit gamma-1,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit gamma-2,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit gamma-3,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit pi,COC(F)(F)C(Cl)Cl
Methoxyflurane,Gamma-aminobutyric acid receptor subunit theta,COC(F)(F)C(Cl)Cl
Methscopolamine bromide,Muscarinic acetylcholine receptor M1,[Br-].[H][C@]12C[C@@H](C[C@@]([H])(C3OC13)[N+]2(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1
Methscopolamine bromide,Muscarinic acetylcholine receptor M2,[Br-].[H][C@]12C[C@@H](C[C@@]([H])(C3OC13)[N+]2(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1
Methscopolamine bromide,Muscarinic acetylcholine receptor M3,[Br-].[H][C@]12C[C@@H](C[C@@]([H])(C3OC13)[N+]2(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1
Methsuximide,Voltage-dependent T-type calcium channel subunit alpha-1G,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1
Methyclothiazide,Solute carrier family 12 member 1,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O
Methyclothiazide,Carbonic anhydrase 1,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O
Methyclothiazide,Carbonic anhydrase 2,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O
Methyclothiazide,Carbonic anhydrase 4,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O
"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside",Serum amyloid P-component,[H][C@@]12CO[C@](C)(O[C@]1([H])[C@H](O)[C@@H](O)[C@H](OC)O2)C(O)=O
Methyl Isocyanide,Myoglobin,C[N+]#[C-]
Methyl Methylsulfinylmethyl Sulfide,Peptidyl-prolyl cis-trans isomerase FKBP1A,CSC[S@](C)=O
Methyl Nonanoate (Ester),Neutrophil gelatinase-associated lipocalin,CCCCCCCCC(=O)OC
Methyl Nonanoate (Ester),Ig gamma-1 chain C region,CCCCCCCCC(=O)OC
"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",DNA-directed RNA polymerase subunit alpha,[H]\C(CCC[C@@]([H])(C)C1=CC(=O)C([H])(C(=O)C(\C)=C(/[H])\C(\[H])=C(/C)CCC)C(=O)O1)=N/C(=O)OC
"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",DNA-directed RNA polymerase subunit beta,[H]\C(CCC[C@@]([H])(C)C1=CC(=O)C([H])(C(=O)C(\C)=C(/[H])\C(\[H])=C(/C)CCC)C(=O)O1)=N/C(=O)OC
"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",DNA-directed RNA polymerase subunit beta',[H]\C(CCC[C@@]([H])(C)C1=CC(=O)C([H])(C(=O)C(\C)=C(/[H])\C(\[H])=C(/C)CCC)C(=O)O1)=N/C(=O)OC
"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",DNA-directed RNA polymerase subunit omega,[H]\C(CCC[C@@]([H])(C)C1=CC(=O)C([H])(C(=O)C(\C)=C(/[H])\C(\[H])=C(/C)CCC)C(=O)O1)=N/C(=O)OC
"Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",RNA polymerase sigma factor SigA,[H]\C(CCC[C@@]([H])(C)C1=CC(=O)C([H])(C(=O)C(\C)=C(/[H])\C(\[H])=C(/C)CCC)C(=O)O1)=N/C(=O)OC
Methyl alpha-D-mannoside,Mannose-binding protein C,CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O
Methyl aminolevulinate,High affinity immunoglobulin gamma Fc receptor I,COC(=O)CCC(=O)CN
Methyl vanillate,"Endo-1,4-beta-xylanase Y",COC(=O)C1=CC(OC)=C(O)C=C1
"Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside",Hemagglutinin-neuraminidase,[H][C@@]1(O)[C@@]([H])(O)[C@]([H])(OC)O[C@]([H])(C=S)[C@]1([H])O
Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",[H][C@]1(CO)O[C@]([H])(OC)[C@@]([H])(S[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@]1([H])O
Methyl-Carbamic Acid Ethyl Ester,Shiga-like toxin 1 subunit B,CCOC(=O)NC
Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester,Squalene--hopene cyclase,CN([C@H]1CC[C@@H](CC1)C1=CC=C(CN2CCCCC2)C=C1)C(=O)OC1=CC=C(Cl)C=C1
Methylamine,Ammonia channel,CN
Methylcobalamin,Methionine synthase,C1(CC[C@@]2([C@@H](CC(N)=O)[C@@]3([C@@]4([N+]5=C([C@H]([C@@]4(CC(N)=O)C)CCC(N)=O)C(C)=C4[N+]6=C(C=C7[N+]8=C([C@H](C7(C)C)CCC(N)=O)C(C)=C2N3[Co-3]568([N+]2=CN([C@H]3O[C@@H]([C@@H](OP(O[C@@H](CN1)C)([O-])=O)[C@H]3O)CO)C1=CC(C)=C(C=C21)C)C)[C@H]([C@@]4(CC(N)=O)C)CCC(N)=O)C)[H])C)=O
Methyldiazene,Quinoprotein glucose dehydrogenase B,[H]N=NC
Methyldopa,Alpha-2A adrenergic receptor,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O
Methyldopa,Aromatic-L-amino-acid decarboxylase,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O
Methylecgonine,Ig gamma-2 chain C region,[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@@]([H])(O)C2
Methylecgonine,Ig kappa chain C region,[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@@]([H])(O)C2
Methylene blue,Guanylate cyclase soluble subunit alpha-2,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1
Methylene blue,"Nitric oxide synthase, brain",[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1
Methylergometrine,D(1A) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
Methylergometrine,5-hydroxytryptamine receptor 2B,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO
Methylethylamine,Myoglobin,CCNC
Methylmalonic Acid,Methylmalonyl-CoA carboxyltransferase 12S subunit,CC(C(O)=O)C(O)=O
Methylmalonyl-Coenzyme A,Methylmalonyl-CoA carboxyltransferase 12S subunit,[H][C@@](C)(C(O)=O)C(=O)SCCN=C(O)CCN=C(O)[C@]([H])(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Methylnaltrexone,Mu-type opioid receptor,C[N@+]1(CC2CC2)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35
Methylnaltrexone,Kappa-type opioid receptor,C[N@+]1(CC2CC2)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35
Methylphenidate,Sodium-dependent noradrenaline transporter,COC(=O)C(C1CCCCN1)C1=CC=CC=C1
Methylphenidate,Sodium-dependent dopamine transporter,COC(=O)C(C1CCCCN1)C1=CC=CC=C1
Methylphenidate,5-hydroxytryptamine receptor 1A,COC(=O)C(C1CCCCN1)C1=CC=CC=C1
Methylphenobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Neuronal acetylcholine receptor subunit alpha-4,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Neuronal acetylcholine receptor subunit alpha-7,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Glutamate receptor 2,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,"Glutamate receptor ionotropic, kainate 2",CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphenobarbital,Nuclear receptor subfamily 1 group I member 2,CCC1(C(=O)NC(=O)N(C)C1=O)C1=CC=CC=C1
Methylphosphinic Acid,Esterase,CP(O)=O
Methylphosphinic Acid,Cholinesterase,CP(O)=O
Methylphosphinic Acid,Acetylcholinesterase,CP(O)=O
Methylphosphonic Acid Diisopropyl Ester,Parathion hydrolase,CC(C)OP(C)(=O)OC(C)C
Methylphosphonic Acid Diisopropyl Ester,Parathion hydrolase,CC(C)OP(C)(=O)OC(C)C
Methylphosphonic Acid Ester Group,Acetylcholinesterase,CP([O-])=O
Methylprednisolone,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C
Methyltestosterone,Androgen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Methyltestosterone,Estrogen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Methylthioinosine,Purine nucleoside phosphorylase DeoD-type,CSC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Methylthioninium,Acetylcholinesterase,CN(C)C1=CC2=[S+]C3=CC(=CC=C3N=C2C=C1)N(C)C
Methylthioninium,Transcriptional regulator,CN(C)C1=CC2=[S+]C3=CC(=CC=C3N=C2C=C1)N(C)C
Methylumbelliferyl Chitotriose,Lysozyme C,[H][C@]1(CO)O[C@@]([H])(O[C@]2([H])[C@@]([H])(CO)O[C@@]([H])(O[C@]3([H])[C@@]([H])(CO)O[C@]([H])(OC4=CC5=C(C=C4)C(C)=CC(=O)O5)[C@]([H])(N=C(C)O)[C@@]3([H])O)[C@]([H])(N=C(C)O)[C@@]2([H])O)[C@]([H])(N=C(C)O)[C@@]([H])(O)[C@]1([H])O
Methylumbelliferyl Sialic Acid,Trans-sialidase,[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])O[C@@](C[C@]([H])(O)[C@@]1([H])N=C(C)O)(OC1=CC2=C(C=C1)C(C)=CC(=O)O2)C(O)=O
Methyprylon,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit beta-1,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit beta-2,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit beta-3,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit delta,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit epsilon,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit gamma-1,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit gamma-2,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit gamma-3,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit pi,CCC1(CC)C(=O)NCC(C)C1=O
Methyprylon,Gamma-aminobutyric acid receptor subunit theta,CCC1(CC)C(=O)NCC(C)C1=O
Methysergide,5-hydroxytryptamine receptor 2B,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
Methysergide,5-hydroxytryptamine receptor 2C,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
Methysergide,5-hydroxytryptamine receptor 2A,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
Methysergide,5-hydroxytryptamine receptor 1A,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
Methysergide,5-hydroxytryptamine receptor 7,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
Methysergide,5-hydroxytryptamine receptor 1B,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
Methysergide,5-hydroxytryptamine receptor 1F,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
Methysergide,5-hydroxytryptamine receptor 1E,[H][C@@]12CC3=CN(C)C4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)NC(CC)CO
Metiamide,Histamine H2 receptor,CNC(=S)NCCSCC1=C(C)NC=N1
Meticillin,MecA PBP2' (penicillin binding protein 2'),[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O
Meticillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O
Meticillin,Penicillin-binding protein 1b,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O
Meticillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O
Meticillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O
Meticillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OC)C=CC=C1OC)C(O)=O
Metipranolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1
Metipranolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1
Metixene,Muscarinic acetylcholine receptor M1,CN1CCCC(CC2C3=CC=CC=C3SC3=CC=CC=C23)C1
Metixene,Muscarinic acetylcholine receptor M4,CN1CCCC(CC2C3=CC=CC=C3SC3=CC=CC=C23)C1
Metixene,Muscarinic acetylcholine receptor M5,CN1CCCC(CC2C3=CC=CC=C3SC3=CC=CC=C23)C1
Metixene,Muscarinic acetylcholine receptor M2,CN1CCCC(CC2C3=CC=CC=C3SC3=CC=CC=C23)C1
Metixene,Muscarinic acetylcholine receptor M3,CN1CCCC(CC2C3=CC=CC=C3SC3=CC=CC=C23)C1
Metoclopramide,Muscarinic acetylcholine receptor M1,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC
Metoclopramide,D(2) dopamine receptor,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC
Metoclopramide,5-hydroxytryptamine receptor 4,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC
Metoclopramide,5-hydroxytryptamine receptor 3A,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC
Metoclopramide,Acetylcholinesterase,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC
Metocurine,Muscarinic acetylcholine receptor M2,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3
Metocurine,Neuronal acetylcholine receptor subunit alpha-2,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3
Metocurine Iodide,Neuronal acetylcholine receptor subunit alpha-2,[I-].[I-].[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CC[N+]1(C)C)C2=C6)=C(OC)C=C5)=CC(OC)=C4OC)C=C3
Metolazone,Solute carrier family 12 member 3,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O
Metoprine,Histamine N-methyltransferase,CC1=C(C(N)=NC(N)=N1)C1=CC(Cl)=C(Cl)C=C1
Metoprolol,Beta-1 adrenergic receptor,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1
Metoprolol,Beta-2 adrenergic receptor,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1
Metreleptin,Leptin receptor,
Metribolone,Progesterone receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Metribolone,Androgen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Metribolone,Nuclear receptor coactivator 2,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Metribolone,Mineralocorticoid receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
Metronidazole,Oxygen-insensitive NADPH nitroreductase,CC1=NC=C(N1CCO)[N+]([O-])=O
Metronidazole,Iron hydrogenase 1,CC1=NC=C(N1CCO)[N+]([O-])=O
Metronidazole,Lanosterol 14-alpha demethylase,CC1=NC=C(N1CCO)[N+]([O-])=O
Metyrapone,"Cytochrome P450 11B1, mitochondrial",CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1
Metyrapone,Camphor 5-monooxygenase,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1
Metyrosine,Tyrosine 3-monooxygenase,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O
Mevalonic acid,3-hydroxy-3-methylglutaryl-coenzyme A reductase,C[C@@](O)(CCO)CC(O)=O
Mevastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,[H][C@]12[C@H](CCC=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC
Mexiletine,Sodium channel protein type 5 subunit alpha,CC(N)COC1=C(C)C=CC=C1C
Mexiletine,Aryl hydrocarbon receptor,CC(N)COC1=C(C)C=CC=C1C
Mezlocillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)C1=CC=CC=C1)C(O)=O
Mezlocillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)C1=CC=CC=C1)C(O)=O
Mezlocillin,Penicillin-binding protein 2,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)C1=CC=CC=C1)C(O)=O
Mianserin,Alpha-2A adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,5-hydroxytryptamine receptor 2A,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,5-hydroxytryptamine receptor 2C,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Histamine H1 receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Sodium-dependent noradrenaline transporter,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Sodium-dependent serotonin transporter,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Histamine H4 receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,5-hydroxytryptamine receptor 1A,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Alpha-2C adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,5-hydroxytryptamine receptor 2B,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,5-hydroxytryptamine receptor 1F,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Alpha-2B adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,D(3) dopamine receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Kappa-type opioid receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Sodium-dependent dopamine transporter,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,5-hydroxytryptamine receptor 7,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,D(2) dopamine receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,5-hydroxytryptamine receptor 6,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Alpha-1A adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Alpha-1B adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,Alpha-1D adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,D(1A) dopamine receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mianserin,D(1B) dopamine receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Mibefradil,Voltage-dependent T-type calcium channel subunit alpha-1G,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent T-type calcium channel subunit alpha-1H,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent L-type calcium channel subunit alpha-1C,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent L-type calcium channel subunit alpha-1D,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent L-type calcium channel subunit alpha-1F,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent T-type calcium channel subunit alpha-1I,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent L-type calcium channel subunit alpha-1S,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent L-type calcium channel subunit beta-1,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent L-type calcium channel subunit beta-2,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent L-type calcium channel subunit beta-3,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibefradil,Voltage-dependent L-type calcium channel subunit beta-4,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=CC=CC=C3N2)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
Mibolerone,Androgen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H]
Micafungin,"1,3-beta-glucan synthase component FKS1",CCCCCOC1=CC=C(C=C1)C1=CC(=NO1)C1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC(OS(O)(=O)=O)=C(O)C=C1)[C@H](O)CC(N)=O
Miconazole,Lanosterol 14-alpha demethylase,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,"Nitric oxide synthase, endothelial",ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,"Nitric oxide synthase, inducible",ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Calcium-activated potassium channel subunit alpha-1,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Calcium-activated potassium channel subunit beta-1,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Calcium-activated potassium channel subunit beta-2,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Calcium-activated potassium channel subunit beta-3,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Calcium-activated potassium channel subunit beta-4,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Intermediate conductance calcium-activated potassium channel protein 4,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Small conductance calcium-activated potassium channel protein 1,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Small conductance calcium-activated potassium channel protein 2,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Potassium voltage-gated channel subfamily H member 2,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Potassium voltage-gated channel subfamily H member 6,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Potassium voltage-gated channel subfamily H member 7,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Small conductance calcium-activated potassium channel protein 3,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Miconazole,Nuclear receptor subfamily 1 group I member 2,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Midazolam,Gamma-aminobutyric acid receptor subunit alpha-1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12
Midazolam,Gamma-aminobutyric acid receptor subunit alpha-2,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12
Midazolam,Gamma-aminobutyric acid receptor subunit alpha-5,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12
Midazolam,Gamma-aminobutyric acid receptor subunit alpha-4,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12
Midazolam,Gamma-aminobutyric acid receptor subunit alpha-3,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12
Midazolam,Gamma-aminobutyric acid receptor subunit alpha-6,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12
Midodrine,Alpha-1A adrenergic receptor,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1
Midodrine,Alpha-1B adrenergic receptor,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1
Midodrine,Alpha-1D adrenergic receptor,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1
Midomafetamine,Sodium-dependent serotonin transporter,CNC(C)CC1=CC2=C(OCO2)C=C1
Midomafetamine,Synaptic vesicular amine transporter,CNC(C)CC1=CC2=C(OCO2)C=C1
Midomafetamine,Sodium-dependent dopamine transporter,CNC(C)CC1=CC2=C(OCO2)C=C1
Midomafetamine,5-hydroxytryptamine receptor 2A,CNC(C)CC1=CC2=C(OCO2)C=C1
Midomafetamine,5-hydroxytryptamine receptor 2B,CNC(C)CC1=CC2=C(OCO2)C=C1
Midomafetamine,5-hydroxytryptamine receptor 2C,CNC(C)CC1=CC2=C(OCO2)C=C1
Midomafetamine,Sodium-dependent noradrenaline transporter,CNC(C)CC1=CC2=C(OCO2)C=C1
Midostaurin,Receptor-type tyrosine-protein kinase FLT3,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
Midostaurin,Platelet-derived growth factor receptor beta,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
Midostaurin,Vascular endothelial growth factor receptor 2,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
Midostaurin,Mast/stem cell growth factor receptor Kit,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
Midostaurin,Platelet-derived growth factor receptor alpha,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
Midostaurin,Protein kinase C alpha type,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
Mifamurtide,Toll-like receptor 4,O.[Na+].CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]([C@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC
Mifamurtide,Nucleotide-binding oligomerization domain-containing protein 2,O.[Na+].CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]([C@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC
Mifepristone,Progesterone receptor,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
Mifepristone,Glucocorticoid receptor,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
Mifepristone,Prostate-specific antigen,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
Mifepristone,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
Migalastat,Alpha-galactosidase A,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
Miglitol,"Maltase-glucoamylase, intestinal",OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
Miglitol,Lysosomal alpha-glucosidase,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
Miglitol,Neutral alpha-glucosidase AB,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
Miglitol,Neutral alpha-glucosidase C,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
Miglustat,Ceramide glucosyltransferase,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
Milataxel,Tubulin beta-1 chain,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CO4)C(C)=C([C@@H](O)C(=O)[C@]12C)C3(C)C
Milataxel,Tubulin beta chain,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CO4)C(C)=C([C@@H](O)C(=O)[C@]12C)C3(C)C
Milnacipran,Sodium-dependent noradrenaline transporter,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milnacipran,Sodium-dependent serotonin transporter,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milnacipran,"Glutamate receptor ionotropic, NMDA 1",CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milnacipran,"Glutamate receptor ionotropic, NMDA 2A",CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milnacipran,"Glutamate receptor ionotropic, NMDA 2B",CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milnacipran,"Glutamate receptor ionotropic, NMDA 2C",CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milnacipran,"Glutamate receptor ionotropic, NMDA 2D",CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milnacipran,"Glutamate receptor ionotropic, NMDA 3A",CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milnacipran,"Glutamate receptor ionotropic, NMDA 3B",CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
Milrinone,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1
Miltefosine,Multidrug resistance protein 1,CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
Mimosine,Tyrosinase,N[C@@H](CN1C=CC(=O)C(O)=C1)C(O)=O
Mimosine,"Serine hydroxymethyltransferase, cytosolic",N[C@@H](CN1C=CC(=O)C(O)=C1)C(O)=O
Mimosine,C-C motif chemokine 2,N[C@@H](CN1C=CC(=O)C(O)=C1)C(O)=O
Minaprine,Amine oxidase [flavin-containing] A,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minaprine,5-hydroxytryptamine receptor 2B,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minaprine,5-hydroxytryptamine receptor 2A,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minaprine,5-hydroxytryptamine receptor 2C,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minaprine,Acetylcholinesterase,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minaprine,Sodium-dependent serotonin transporter,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minaprine,D(1A) dopamine receptor,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minaprine,D(2) dopamine receptor,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minaprine,Muscarinic acetylcholine receptor M1,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
Minocycline,30S ribosomal protein S9,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minocycline,30S ribosomal protein S4,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minocycline,Interleukin-1 beta,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minocycline,Arachidonate 5-lipoxygenase,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minocycline,Matrix metalloproteinase-9,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minocycline,Vascular endothelial growth factor A,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minocycline,Caspase-1,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minocycline,Caspase-3,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minocycline,Cytochrome c,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
Minodronic acid,Farnesyl pyrophosphate synthase,OC(CC1=CN=C2C=CC=CN12)(P(O)(O)=O)P(O)(O)=O
Minodronic acid,Geranylgeranyl pyrophosphate synthase,OC(CC1=CN=C2C=CC=CN12)(P(O)(O)=O)P(O)(O)=O
Minoxidil,Prostaglandin G/H synthase 1,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1
Minoxidil,ATP-sensitive inward rectifier potassium channel 1,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1
Minoxidil,Renin,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1
Mirabegron,Beta-3 adrenergic receptor,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1
Mirococept,Complement C3,
Mirtazapine,Alpha-2A adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Mirtazapine,Histamine H1 receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Mirtazapine,5-hydroxytryptamine receptor 2A,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Mirtazapine,5-hydroxytryptamine receptor 2C,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Mirtazapine,Kappa-type opioid receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Mirtazapine,5HT3 serotonin receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Mirtazapine,Alpha-1A adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Mirtazapine,Alpha-1B adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Mirtazapine,Alpha-1D adrenergic receptor,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1
Misoprostol,Prostaglandin E2 receptor EP3 subtype,CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
Misoprostol,Prostaglandin E2 receptor EP2 subtype,CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
Misoprostol,Prostaglandin E2 receptor EP4 subtype,CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
Mitemcinal,Motilin receptor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C(C)C)[C@@]2(C)CC(C)=C(O2)[C@H](C)C(=O)[C@]1(C)OC
Mitiglinide,ATP-binding cassette sub-family C member 8,[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O
Mitiglinide,Peroxisome proliferator-activated receptor gamma,[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O
Mito-4509,Amyloid beta A4 protein,
Mitotane,"Adrenodoxin, mitochondrial",ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl
Mitotane,"Cytochrome P450 11B1, mitochondrial",ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl
Mitotane,Estrogen receptor,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl
Mitotane,Progesterone receptor,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl
Mitotane,Androgen receptor,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl
Mitoxantrone,DNA topoisomerase 2-alpha,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(C(O)=CC=C1O)C2=O
Mivacurium,Neuronal acetylcholine receptor subunit alpha-2,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
Mivacurium,Muscarinic acetylcholine receptor M2,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
Mivacurium,Muscarinic acetylcholine receptor M3,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
Mivacurium,Cholinesterase,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC
"Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid",ATP-dependent dethiobiotin synthetase BioD 1,C[C@H](N)[C@@H](CCCCCC(O)=O)NC(=O)OP(O)(O)=O
Mocetinostat,Histone deacetylase 1,NC1=CC=CC=C1NC(=O)C1=CC=C(CNC2=NC=CC(=N2)C2=CC=CN=C2)C=C1
Mocetinostat,Histone deacetylase 2,NC1=CC=CC=C1NC(=O)C1=CC=C(CNC2=NC=CC(=N2)C2=CC=CN=C2)C=C1
Mocetinostat,Histone deacetylase 3,NC1=CC=CC=C1NC(=O)C1=CC=C(CNC2=NC=CC(=N2)C2=CC=CN=C2)C=C1
Moclobemide,Amine oxidase [flavin-containing] A,ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
Moclobemide,Amine oxidase [flavin-containing] A,ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
Moclobemide,Amine oxidase [flavin-containing] B,ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
Moclobemide,Amine oxidase [flavin-containing] B,ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
Modafinil,Alpha-1B adrenergic receptor,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
Modafinil,Sodium-dependent dopamine transporter,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
Modified Acarbose Pentasaccharide,4-alpha-glucanotransferase,[H][C@]1(C)O[C@]([H])(O[C@]2([H])C(CO)=C[C@]([H])(N[C@]3([H])[C@@]([H])(C)O[C@]([H])(O[C@]4([H])[C@@]([H])(CO)O[C@]([H])(O[C@]5([H])[C@@]([H])(CO)O[C@]([H])(O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
Modified Ribosylated Glutamyl Ester,Nucleoside 2-deoxyribosyltransferase,[H][C@](N)(CCC(=O)O[C@@]1([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]1(O)F)C(O)=O
Moexipril,Angiotensin-converting enzyme,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O
Moexipril,Angiotensin-converting enzyme 2,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O
Mogamulizumab,C-X-C chemokine receptor type 4,
Molindone,D(2) dopamine receptor,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
Molindone,5-hydroxytryptamine receptor 1A,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
Molindone,5-hydroxytryptamine receptor 2A,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
Molindone,Muscarinic acetylcholine receptor M1,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
Molsidomine,Guanylate cyclase soluble subunit alpha-2,CCOC(=O)[N-]C1=C[N+](=NO1)N1CCOCC1
Molybdenum cofactor,Aldehyde oxidoreductase,O=[Mo++]=O.NC1=NC2=C(N[C@@H]3[C@H](N2)O[C@H](COP([O-])([O-])=O)C([S-])=C3[S-])C(=O)N1
Mometasone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Mometasone,Progesterone receptor,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Mometasone furoate,Glucocorticoid receptor,[H][C@@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)CCl
Mometasone furoate,Progesterone receptor,[H][C@@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)CCl
Monastrol,Kinesin-like protein KIF11,[H][C@]1(NC(=S)NC(C)=C1C(=O)OCC)C1=CC=CC(O)=C1
"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=C2C=CC(C)=C3)[C@]([H])(O)[C@]1([H])O
Monobenzone,Tyrosinase,OC1=CC=C(OCC2=CC=CC=C2)C=C1
Monofluorophosphate ion,"Glycogen phosphorylase, muscle form",[O-]P([O-])(F)=O
Monoisopropylphosphorylserine,Acetylcholinesterase,[H][C@](N)(COP(O)(=O)OC(C)C)C(O)=O
Monoisopropylphosphorylserine,Subtilisin BPN',[H][C@](N)(COP(O)(=O)OC(C)C)C(O)=O
Monoisopropylphosphorylserine,Trypsin-1,[H][C@](N)(COP(O)(=O)OC(C)C)C(O)=O
Monoisopropylphosphorylserine,Trypsin-2,[H][C@](N)(COP(O)(=O)OC(C)C)C(O)=O
Monothioglycerol,Prolyl endopeptidase,OC[C@@H](O)CS
Montelukast,Arachidonate 5-lipoxygenase,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1
Montelukast,Cysteinyl leukotriene receptor 1,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1
Moricizine,Sodium channel protein type 5 subunit alpha,CCOC(=O)NC1=CC2=C(SC3=CC=CC=C3N2C(=O)CCN2CCOCC2)C=C1
Morniflumate,Arachidonate 5-lipoxygenase,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OCCN2CCOCC2)=CC=C1
Morniflumate,Prostaglandin G/H synthase 2,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OCCN2CCOCC2)=CC=C1
Morniflumate,Leukotriene B4 receptor 1,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OCCN2CCOCC2)=CC=C1
Morniflumate,Thromboxane A2 receptor,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OCCN2CCOCC2)=CC=C1
Moroctocog alfa,Coagulation factor X,
Moroctocog alfa,"Phytanoyl-CoA dioxygenase, peroxisomal",
Moroctocog alfa,Coagulation factor IX,
Moroctocog alfa,Asialoglycoprotein receptor 2,
Moroctocog alfa,78 kDa glucose-regulated protein,
Moroctocog alfa,Calreticulin,
Moroctocog alfa,Calnexin,
Moroctocog alfa,Protein ERGIC-53,
Moroctocog alfa,Prolow-density lipoprotein receptor-related protein 1,
Moroctocog alfa,Multiple coagulation factor deficiency protein 2,
Moroctocog alfa,von Willebrand factor,
Morphine,Mu-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
Morphine,Kappa-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
Morphine,Delta-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
Morphine,Lymphocyte antigen 96,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
Morphine glucuronide,Delta-type opioid receptor,[H][C@]12C=C[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4O
Morphine glucuronide,Kappa-type opioid receptor,[H][C@]12C=C[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4O
Morphine glucuronide,Mu-type opioid receptor,[H][C@]12C=C[C@H](O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4O
Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,Cathepsin S,C(C)(C)C[C@H](C(=O)N[C@H](CCC1=CC=CC=C1)\C=C\S(=O)(=O)C1=CC=CC=C1)NC(=O)N1CCOCC1
Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,Cathepsin S,[H][C@@](CSCC1=CC=CC=C1)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C=O
Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,Cathepsin S,[H][C@@](COCC1=CC=CC=C1)(NC(=O)[C@]([H])(CC(C)C)NC(=O)N1CCOCC1)C#N
Motuporin,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,[H]N1[C@H](CCC(=O)N(C)\C(=C/C)C(=O)N([H])[C@H]([C@H](C)C(=O)N([H])[C@@H](C(C)C)C(=O)N([H])[C@@H](\C=C\C(\C)=C\[C@H](C)[C@H](CC2=CC=CC=C2)OC)[C@H](C)C1=O)C(O)=O)C(O)=O
Moxalactam Derivative,Beta-lactamase,[H][C@@](C(O)=O)(C(O)=N[C@](OC)(C=O)[C@@]1([H])OCC(=C)C(=N1)C(O)=O)C1=CC=C(O)C=C1
Moxetumomab Pasudotox,B-cell receptor CD22,
Moxetumomab Pasudotox,Elongation factor 2,
Moxidectin,Glutamate-gated chloride channel,[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O
Moxifloxacin,DNA gyrase subunit A,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O
Moxifloxacin,DNA topoisomerase 4 subunit A,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O
Moxifloxacin,DNA topoisomerase 2-alpha,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O
Moxisylyte,Alpha-1A adrenergic receptor,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1
Moxisylyte,Alpha-1B adrenergic receptor,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1
Moxisylyte,Alpha-1D adrenergic receptor,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1
Moxisylyte,Alpha-2A adrenergic receptor,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1
Moxisylyte,Alpha-2B adrenergic receptor,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1
Moxisylyte,Alpha-2C adrenergic receptor,CC(C)C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1
Moxonidine,Alpha-2A adrenergic receptor,COC1=NC(C)=NC(Cl)=C1NC1=NCCN1
Moxonidine,Nischarin,COC1=NC(C)=NC(Cl)=C1NC1=NCCN1
Mupirocin,Isoleucine--tRNA ligase,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O
Muraglitazar,Peroxisome proliferator-activated receptor alpha,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C3=CC=CC=C3)C=C2)C=C1
Muraglitazar,Peroxisome proliferator-activated receptor gamma,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C3=CC=CC=C3)C=C2)C=C1
Muromonab,T-cell surface glycoprotein CD3 delta chain,
Muromonab,T-cell surface glycoprotein CD3 epsilon chain,
Muromonab,T-cell surface glycoprotein CD3 gamma chain,
Muromonab,T-cell surface glycoprotein CD3 zeta chain,
Muromonab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Muromonab,Complement C1r subcomponent,
Muromonab,Complement C1q subcomponent subunit A,
Muromonab,Complement C1q subcomponent subunit B,
Muromonab,Complement C1q subcomponent subunit C,
Muromonab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Muromonab,Complement C1s subcomponent,
Muromonab,High affinity immunoglobulin gamma Fc receptor I,
Muromonab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Muromonab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Muromonab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Muscimol,Gamma-aminobutyric acid receptor subunit alpha-1,NCC1=CC(O)=NO1
Muscimol,Gamma-aminobutyric acid receptor subunit beta-3,NCC1=CC(O)=NO1
Muscimol,Gamma-aminobutyric acid receptor subunit gamma-2,NCC1=CC(O)=NO1
Mycophenolate mofetil,Inosine-5'-monophosphate dehydrogenase 1,COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C
Mycophenolate mofetil,Inosine-5'-monophosphate dehydrogenase 2,COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C
Mycophenolic acid,Inosine-5'-monophosphate dehydrogenase 2,COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C
Mycophenolic acid,Inosine-5'-monophosphate dehydrogenase 1,COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C
Myricetin,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C(O)=C2)=C1
Myricetin,Tyrosine-protein kinase JAK1,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C(O)=C2)=C1
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,cAMP-dependent protein kinase inhibitor alpha,CCCCCCCCCCCCCC(O)=O
Myristic acid,cAMP-dependent protein kinase catalytic subunit alpha,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Fatty acid metabolism regulator protein,CCCCCCCCCCCCCC(O)=O
Myristic acid,"Enoyl-CoA delta isomerase 2, mitochondrial",CCCCCCCCCCCCCC(O)=O
Myristic acid,Recoverin,CCCCCCCCCCCCCC(O)=O
Myristic acid,Calmodulin,CCCCCCCCCCCCCC(O)=O
Myristic acid,Non-fluorescent flavoprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Tyrosine-protein kinase ABL1,CCCCCCCCCCCCCC(O)=O
Myristic acid,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Hepatocyte nuclear factor 4-alpha,CCCCCCCCCCCCCC(O)=O
Myristic acid,Nuclear receptor coactivator 1,CCCCCCCCCCCCCC(O)=O
Myristic acid,Protein Nef,CCCCCCCCCCCCCC(O)=O
Myristic acid,Ferrichrome-iron receptor,CCCCCCCCCCCCCC(O)=O
Myristic acid,Peptidyl-prolyl cis-trans isomerase FKBP1A,CCCCCCCCCCCCCC(O)=O
Myristic acid,Calcineurin subunit B type 1,CCCCCCCCCCCCCC(O)=O
Myristic acid,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,CCCCCCCCCCCCCC(O)=O
Myristic acid,Alpha-pyrone synthesis polyketide synthase-like Pks18,CCCCCCCCCCCCCC(O)=O
Myristic acid,Gag-Pol polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Trafficking protein particle complex subunit 3,CCCCCCCCCCCCCC(O)=O
Myristic acid,Insulin,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Genome polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Ganglioside GM2 activator,CCCCCCCCCCCCCC(O)=O
Myristic acid,ADP-ribosylation factor 6,CCCCCCCCCCCCCC(O)=O
Myristic acid,Lymphocyte antigen 96,CCCCCCCCCCCCCC(O)=O
Myristic acid,Protein TonB,CCCCCCCCCCCCCC(O)=O
Myristic acid,Gag polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,Gag-Pol polyprotein,CCCCCCCCCCCCCC(O)=O
Myristic acid,ADP-ribosylation factor 1,CCCCCCCCCCCCCC(O)=O
Myristic acid,Guanylyl cyclase-activating protein 1,CCCCCCCCCCCCCC(O)=O
Myristic acid,R2-like ligand binding oxidase,CCCCCCCCCCCCCC(O)=O
Myristic acid,Poliovirus receptor,CCCCCCCCCCCCCC(O)=O
Myristic acid,Toll-like receptor 4,CCCCCCCCCCCCCC(O)=O
Myristic acid,Peroxisome proliferator-activated receptor alpha,CCCCCCCCCCCCCC(O)=O
Myristoyl-Coa,Glycylpeptide N-tetradecanoyltransferase,CCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Myristoyl-Coa,Glycylpeptide N-tetradecanoyltransferase 2,CCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Myrrh,Bile acid receptor,
Myrrh,Nuclear receptor subfamily 1 group I member 2,
Myrrh,Peroxisome proliferator-activated receptor alpha,
Myxopyronin B,DNA-directed RNA polymerase subunit alpha,CCCC\C(C)=C\C=C(/C)C(=O)C1=C(O)C=C(CCC\C=C\NC(=O)OC)OC1=O
Myxopyronin B,DNA-directed RNA polymerase subunit beta,CCCC\C(C)=C\C=C(/C)C(=O)C1=C(O)C=C(CCC\C=C\NC(=O)OC)OC1=O
Myxopyronin B,DNA-directed RNA polymerase subunit beta',CCCC\C(C)=C\C=C(/C)C(=O)C1=C(O)C=C(CCC\C=C\NC(=O)OC)OC1=O
Myxopyronin B,DNA-directed RNA polymerase subunit omega,CCCC\C(C)=C\C=C(/C)C(=O)C1=C(O)C=C(CCC\C=C\NC(=O)OC)OC1=O
Myxopyronin B,RNA polymerase sigma factor SigA,CCCC\C(C)=C\C=C(/C)C(=O)C1=C(O)C=C(CCC\C=C\NC(=O)OC)OC1=O
Myxothiazol,"Cytochrome b-c1 complex subunit 1, mitochondrial",CO[C@@H](\C=C\C1=CSC(=N1)C1=CSC(=N1)[C@@H](C)\C=C\C=C\C(C)C)[C@@H](C)C(\OC)=C/C(N)=O
"N''-{3-[(3s,8ar)-1,4-Dioxooctahydropyrrolo[1,2-a]Pyrazin-3-Yl]Propyl}Guanidine",Chitinase B,[H][C@@]12CCCN1C(=O)[C@]([H])(CCCNC(N)=N)N=C2O
"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",Methionine aminopeptidase 2,[H][C@@](N)(CCSC(C)C)[C@]([H])(O)C(=O)NNC(=O)C1=CC(Cl)=CC=C1
"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",Methionine aminopeptidase 2,[H][C@@](N)(CC1CCCCC1)[C@]([H])(O)C(=O)NNC1=CC=C(C)C=C1
"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",Ephrin type-B receptor 4,COC1=CC(NC2=NC=NC(NC3=CC(Cl)=C(OC)C=C3)=N2)=CC(OC)=C1OC
"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",Ephrin type-B receptor 4,COC1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC(OC)=C1OC
"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",Ephrin type-B receptor 4,ClC1=C(NC2=NC(NC3=CC(=CC=C3)N3CCOCC3)=NC=C2)C2=C(OCO2)C=C1
N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,"Branched-chain-amino-acid aminotransferase, cytosolic",FC(F)(F)C1=CC=CC=C1S(=O)(=O)NNC(=O)C1=CC2=CC(Cl)=CC=C2O1
"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",Ephrin type-B receptor 4,CS(=O)(=O)C1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC=C1
"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",Vascular endothelial growth factor receptor 2,CC1=CC=C(C=C1C(=O)NC1=CN=C(N)C=C1)C(=O)NCCC1CCCC1
"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",Cyclin-dependent kinase 2,[H][C@]12CCCN1C(=O)C1=C2C(NC(=O)NC2=CC=CC=N2)=CC=C1
N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine,Threonine--tRNA ligase,[H][C@](N)(CO)C(O)=N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]1([H])O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Kynurenine--oxoglutarate transaminase 1,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Serine--pyruvate aminotransferase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Ornithine decarboxylase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,"Glycogen phosphorylase, muscle form",[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Aspartate aminotransferase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,L-allo-threonine aldolase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Aspartate aminotransferase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Methionine gamma-lyase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Cystathionine gamma-synthase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
N'-Pyridoxyl-Lysine-5'-Monophosphate,Tyrosine aminotransferase,[H]\C(=N/CCCC[C@]([H])(N)C(O)=O)C1=C(COP(O)(O)=O)C=NC(C)=C1O
"N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE",3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,OC1=C(Br)C=C(\C=N\NC(=O)C2=CN=CC=C2)C(O)=C1Br
"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide",3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,COC1=CC=C(C=C1)C(=O)N\N=C\C1=CC(Br)=C(O)C(Br)=C1O
"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide",3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,OC1=C(Br)C=C(\C=N\NC(=O)C2=CC=C3C=CC=CC3=C2)C(O)=C1Br
"N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium",Tyrosine-protein phosphatase YopH,OC1=CC=C(C=C1OS(O)(=O)=O)[N+]([O-])=O
"N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium",Arylsulfatase A,OC1=CC=C(C=C1OS(O)(=O)=O)[N+]([O-])=O
"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",Mitogen-activated protein kinase 14,CNC(=O)C1=CC(NC2=C3C=NN(C3=NC=N2)C2=CC=CC=C2)=C(C)C=C1
"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",GTPase HRas,CN(CCN(C)C1=CC=C(C2=NON=C12)[N+]([O-])=O)C(C)=O
"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",Casein kinase II subunit alpha,N(C1=CC=CC=C1)C1=NC2=CC=NN2C(NC2=CC=CC=C2)=N1
"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",Glutamate receptor 2,[H][C@](C)(CNS(C)(=O)=O)C1=CC=C(C=C1)C1=CC=C(C=C1)[C@@]([H])(C)CNS(C)(=O)=O
"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",C-reactive protein,C[N+](C)(C)CCOP(O)(O)=O
"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",Gamma-hemolysin component B,C[N+](C)(C)CCOP(O)(O)=O
"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",Epididymal sperm-binding protein 1,C[N+](C)(C)CCOP(O)(O)=O
"N,N,N-trimethylglycinium",Circadian clock protein KaiB,C[N+](C)(C)CC(O)=O
"N,N,N-trimethylglycinium",Glycine betaine-binding periplasmic protein,C[N+](C)(C)CC(O)=O
"N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide",Peroxisome proliferator-activated receptor alpha,[H][C@@](C)(CCC(=O)N(CCCN=C(O)[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO)CCCN=C(O)[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO)[C@@]1([H])CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
"N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide",Insulin-like growth factor I,[H][C@@](C)(CCC(=O)N(CCCN=C(O)[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO)CCCN=C(O)[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO)[C@@]1([H])CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",Beta-lactamase TEM,ClC1=CC=C(CN(CC2=CC=C(Cl)C=C2)C2=NNN=N2)C=C1
"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",Beta-lactamase TEM,ClC1=CC=C(CN(CC2=CC=C(Cl)C=C2)C2=NNN=N2)C=C1
"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",Kinesin-like protein KIF11,CCN(CC)C(=O)C1=C(NC(=O)C2=CC=CS2)SC2=C1CCCC2
"N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE",Cytochrome P450 2A6,CN(C)CC1=CC=C(O1)C1=CC=CN=C1
"N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE",Mitogen-activated protein kinase 1,CN(C)C(=O)C1=CC(=CN1)C1=NNC=C1C1=CC=CC=C1
"N,N-dimethylarginine","Nitric oxide synthase, inducible",N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O
"N,N-dimethylarginine","Nitric oxide synthase, endothelial",N[C@@H](CCC\N=C(/N)N(C)C)C(O)=O
"N,N-dimethylformamide",Renin,CN(C)C=O
"N,N-dimethylformamide",Chymotrypsin-like elastase family member 1,CN(C)C=O
"N,N-dimethylglycine",Monomeric sarcosine oxidase,CN(C)CC(O)=O
"N,O-Didansyl-L-Tyrosine",Thymidylate synthase,[H][C@@](CC1=CC=C(OS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C)C=C1)(NS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C)C(O)=O
"N,O6-Disulfo-Glucosamine",Fibroblast growth factor 1,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O
"N,O6-Disulfo-Glucosamine",Fibroblast growth factor 2,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O
"N,O6-Disulfo-Glucosamine",Hepatocyte growth factor,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O
"N,O6-Disulfo-Glucosamine",Complement control protein C3,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O
"N,O6-Disulfo-Glucosamine",Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O
"N,O6-Disulfo-Glucosamine",Annexin A5,[H][C@]1(O)O[C@]([H])(COS(O)(=O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])NS(O)(=O)=O
"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",Coagulation factor X,[H][C@]1(CCCC[C@@]1([H])NC(=O)C1=NC2=C(CN(C)CC2)S1)NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2
"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",Coagulation factor X,[H][C@@]1(CCCC[C@@]1([H])NC(=O)C1=NC2=C(CN(C)CC2)S1)NC(=O)C1=CC2=C(N1)C=CC(Cl)=C2
"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",Cyclin-dependent kinase 2,CCC1=C2N=C(C=C(NCC3=CN=C(N)N=C3)N2N=C1)C1=C(F)C=CC=C1F
"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",3-dehydroquinate dehydratase,O=C1C2=CC=CC=C2OC2=C1C=C(C=C2)S(=O)(=O)N=C1NN=NN1
N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea,Urokinase-type plasminogen activator,[H]C12CC3([H])CC([H])(C1)CC(C2)(C3)NC(=O)NCC1=CC=C(NC(N)=N)C=C1
"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",Chymotrypsinogen B,[H][C@@](CC1=CC=CC=C1)(NC(C)=O)C(O)(O)C(F)(F)F
"N-(1-Benzyl-3-{[3-(1,3-Dioxo-1,3-Dihydro-Isoindol-2-Yl)-Propionyl]-[2-(Hexahydro-Benzo[1,3]Dioxol-5-Yl)-Ethyl]-Amino}-2-Hydroxy-Propyl)-4-Benzyloxy-3,5-Dimethoxy-Benzamide",Plasmepsin-2,[H][C@](O)(CN(CC[C@]1([H])CCC2([H])OCOC2([H])C1)C(=O)CCN1C(=O)C2=CC=CC=C2C1=O)[C@]([H])(CC1=CC=CC=C1)N=C(O)C1=CC(OC)=C(OCC2=CC=CC=C2)C(OC)=C1
"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",Cathepsin S,[H][C@@](CS(=O)(=O)C[C@]1([H])CCC(=O)N1)(N[C@@]([H])(C1=CC=C(F)C=C1)C(F)(F)F)C(=O)NC1(CC1)C#N
N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine,Elastase,[H][C@@](CCC1=CC=CC=C1)(N[C@@]([H])(CC1=CC=CC=C1)C(O)=N[C@@]([H])(CC(O)=O)C(O)=N)C(O)=O
N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,Coagulation factor X,COC1=CC(CN2C(=CC3=C2C=CC=C3)C(=O)NC2CCN(CC2)C(C)C)=CC=C1
N-(1-PHENYL-PROPYL)-FORMAMIDE,Capsid scaffolding protein,[H][C@](CC)(NC=O)C1=CC=CC=C1
N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide,Beta-secretase 1,SCCCC(=O)NC1CCN(CC2=CC=CC=C2)CC1
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",Oxysterols receptor LXR-beta,OC(C1=CC=C(C=C1)N(CC(F)(F)F)S(=O)(=O)C1=CC=CC=C1)(C(F)(F)F)C(F)(F)F
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",Nuclear receptor coactivator 2,OC(C1=CC=C(C=C1)N(CC(F)(F)F)S(=O)(=O)C1=CC=CC=C1)(C(F)(F)F)C(F)(F)F
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",Retinoic acid receptor RXR-beta,OC(C1=CC=C(C=C1)N(CC(F)(F)F)S(=O)(=O)C1=CC=CC=C1)(C(F)(F)F)C(F)(F)F
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",Oxysterols receptor LXR-alpha,OC(C1=CC=C(C=C1)N(CC(F)(F)F)S(=O)(=O)C1=CC=CC=C1)(C(F)(F)F)C(F)(F)F
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",Nuclear receptor coactivator 1,OC(C1=CC=C(C=C1)N(CC(F)(F)F)S(=O)(=O)C1=CC=CC=C1)(C(F)(F)F)C(F)(F)F
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",Nuclear receptor subfamily 1 group I member 2,OC(C1=CC=C(C=C1)N(CC(F)(F)F)S(=O)(=O)C1=CC=CC=C1)(C(F)(F)F)C(F)(F)F
"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C(F)=C(F)C(F)=C1F
"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC(F)=C1F
"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=C(F)C=CC=C1F
"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",Tyrosine-protein kinase Lck,CC1=CC=CC(C)=C1NC1=NC=C(N2C=NC=C12)C1=CC=CC=C1
N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,Coagulation factor X,ClC1=CN=C(NS(=O)(=O)C2=C(NC(=O)C3=CC=C(C=C3)N3C=CC=CC3=O)C=CC=C2)C=C1
N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",CC(C)C1=CC=C(COC2=C(Cl)C=C(CC(=O)NCCN)C=C2)C=C1
"N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",Cathepsin K,[H][C@@](CC(C)C)(N[C@@]([H])(C1=CC=C(C=C1)C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F)C(=O)NCCN
N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE,Amine oxidase [flavin-containing] B,OCCNC(=O)C1=CC=C(Cl)C=C1
N-(2-Acetamido)Iminodiacetic Acid,Peptide deformylase,NC(=O)CN(CC(O)=O)CC(O)=O
N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide,Casein kinase I isoform gamma-2,NCCNS(=O)(=O)C1=CC=C(Cl)C2=C1C=NC=C2
N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,"Glycogen phosphorylase, liver form",COC1=CC=C(O)C=C1NC(=O)NC(=O)C1=CC=C(F)C=C1Cl
N-(2-Ferrocenylethyl)Maleimide,Camphor 5-monooxygenase,N1(C(=O)C=CC1=O)CCC12[Fe]3456789%10C%11C3C4C5C6%11.C7(C8C19)C2%10
N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC=C1F
N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,Cyclin-dependent kinase 2,COCCNS(=O)(=O)C1=CC=C(NC2=NC(=CC=N2)C2=CN=C(C)N2C(C)C)C=C1
"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",Heat-labile enterotoxin B chain,[H][C@]1(CO)O[C@]([H])(OC2=CC(=CC(=C2)N(=O)=O)C(O)=NC(CN2CCOCC2)CN2CCOCC2)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE,Regulatory protein SdiA,[H][C@@]1(CCOC1=O)NC(=O)CCCCCCC
"N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide",Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(S1)S(=O)(=O)NCC1=CC=CS1
"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",Tyrosine-protein kinase Lck,[H][C@]1(C)CN(CCN1)C1=CC=C2N=C(NC3=C(C)C=CC=C3Cl)C3=CN=CN3C2=C1
"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",Tyrosine-protein kinase Lck,ClC1=C(NC2=NC=C(N3C=NC=C23)C2=CC=CC=C2)C=CC=C1
"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",Tyrosine-protein kinase SYK,CN1C=C(C2=CC3=CC=CN=C3N2)C2=CC(=CC=C12)C(=O)NC(C)(C)CO
"N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine",5-hydroxytryptamine receptor 2A,COC1=CC(C#N)=C(OC)C=C1CCNCC1=C(O)C=CC=C1
"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",Thymidylate synthase,COC1=CC(OC)=CC(NC(=N)NC(N)=N)=C1
"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",Casein kinase II subunit alpha,CC(=O)NC1=CC=CC(NC2=NC3=C(C=NN3C(NC3=CC=CC=C3)=N2)C#N)=C1
N-(3-(Aminomethyl)Benzyl)Acetamidine,"Nitric oxide synthase, endothelial",CC(=N)NCC1=CC=CC(CN)=C1
N-(3-(Aminomethyl)Benzyl)Acetamidine,"Nitric oxide synthase, inducible",CC(=N)NCC1=CC=CC(CN)=C1
N-(3-(Aminomethyl)Benzyl)Acetamidine,"Nitric oxide synthase, brain",CC(=N)NCC1=CC=CC(CN)=C1
N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,Histone acetyltransferase KAT2B,NCCCNC1=CC=CC=C1[N+]([O-])=O
"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",Gag-Pol polyprotein,OC1=C([C@@H](C2CC2)C2=CC=CC(NS(=O)(=O)C3=CC=CC=C3)=C2)C(=O)OC2=C1CCCCCC2
N-(3-MERCAPTOPROPANOYL)-D-ALANINE,Metallo-beta-lactamase L1,[H][C@](C)(NC(=O)CCS)C(O)=O
N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE,Cyclin-dependent kinase 2,CC(C)=CCNC1=C2N=CNC2=NC=N1
N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine,Neprilysin,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@]([H])(S)CC1=CC=CC=C1)C(O)=O
N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,Cathepsin B,[H][C@](O)(CC(=O)N[C@]([H])(C(=O)N1CCC[C@@]1([H])C(O)=O)[C@@]([H])(C)CC)C(=O)NCCC
N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,Mitogen-activated protein kinase 14,CC(C)(C)C1=NNC(NC(=O)NC2=CC=C(Cl)C(COC3=CC=CN=C3)=C2)=C1
N-(3-carboxypropanoyl)-L-norvaline,Putative ornithine carbamoyltransferase,[H][C@@](CCC)(NC(=O)CCC(O)=O)C(O)=O
N-(3-carboxypropanoyl)-L-norvaline,N-acetylornithine carbamoyltransferase,[H][C@@](CCC)(NC(=O)CCC(O)=O)C(O)=O
N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,Prothrombin,[H][C@]1(CCCN1C(=O)CCC(C)C)C(=O)NCC1=CC(Cl)=CC=C1
"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",Hepatocyte growth factor receptor,CN(C1=CC(Cl)=CC=C1)S(=O)(=O)C1=CC2=C(CC3=C(C)C(C)=C(C)N3)C(=O)N=C2C=C1
"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",Mitogen-activated protein kinase 10,FC1=CC=CC=C1C(=O)NC1=C(C#N)C2=C(CCCC2)S1
"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",Mitogen-activated protein kinase 14,CC1=NN=C(O1)C1=CC=C(C)C(=C1)C1=CC=C(C=C1)C(=O)NC1=CC(=CC=C1)C#N
N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,Cyclin-A2,O=C(CC1=CC2=C(C=CC=C2)C=C1)NC1=CC(=NN1)C1CC1
N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,Cyclin-dependent kinase 2,O=C(CC1=CC2=C(C=CC=C2)C=C1)NC1=CC(=NN1)C1CC1
N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,"Nitric oxide synthase, inducible",ClC1=CC=CC(CNCCC2=CC=C(NC(=N)C3=CC=CS3)C=C2)=C1
N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,"Nitric oxide synthase, brain",ClC1=CC=CC(CNCCC2=CC=C(NC(=N)C3=CC=CS3)C=C2)=C1
"N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",Heat shock protein HSP 90-alpha,CC(=O)C1=CC=C(NC(=O)C2=C(NN=C2)C2=CC(Cl)=C(O)C=C2O)C=C1
"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",C-Jun-amino-terminal kinase-interacting protein 1,CCOC1=NC(NC(=O)CC2=CC(OC)=C(Br)C=C2OC)=CC(N)=C1C#N
"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",Mitogen-activated protein kinase 8,CCOC1=NC(NC(=O)CC2=CC(OC)=C(Br)C=C2OC)=CC(N)=C1C#N
N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine,Glutathione S-transferase A1,[H][C@@](CSCC1=CC=C(OC)C=C1)(N=C(O)CCCN)C(O)=NCC(O)=O
N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,Urokinase-type plasminogen activator,CC1=CC(I)=C(O)C(=C1)C(=O)NC1=CC(Cl)=C(C=C1)C(N)=N
"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",Phenylethanolamine N-methyltransferase,ClC1=CC=C(NS(=O)(=O)C2=CC=C3CCNCC3=C2)C=C1
N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,Fructose-bisphosphate aldolase A,OP(O)(=O)OC1=C(C=C2C=CC=CC2=C1)C(=O)NC1=CC=C(Cl)C=C1
N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,Enoyl-[acyl-carrier-protein] reductase [NADH],CC1=CC=C(C=C1)C(=O)N1CCC(CC2=CC=CC=C2)CC1
N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID,Proteasome subunit alpha,[H][C@@](CC(C)C)(NC(=O)[C@@]([H])(CC1=C2C=CC=CC2=CC=C1)NC(=O)N1CCOCC1)B(O)O
N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID,Proteasome subunit beta,[H][C@@](CC(C)C)(NC(=O)[C@@]([H])(CC1=C2C=CC=CC2=CC=C1)NC(=O)N1CCOCC1)B(O)O
"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",Glycogen synthase kinase-3 beta,COC1=CC=C(CNC(=O)NC2=NC=C(S2)[N+]([O-])=O)C=C1
"N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE",Serine/threonine-protein kinase Chk1,CC(=O)NC1=NC2=C(S1)C(=O)NCCC2
N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,Proto-oncogene tyrosine-protein kinase Src,C=CC(=O)NC1=CC=C2N=CN=C(NC3=CC=CC=C3)C2=C1
"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",Genome polyprotein,[H][C@]1(C)CN(C[C@@]([H])(C)C1)C(=O)C1=C(NC(=O)CCC(=O)N2CCOCC2)C=CC(Br)=C1
N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,Prothrombin,[H][C@]1(CCCN1C(=O)CCC1=CC=CC=C1)C(=O)NCC1=CC=C(C=C1)C(N)=N
N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,Prothrombin,[H][C@]1(CCCN1C(=O)CCC(C)C)C(=O)NCC1=CC=C(C=C1)C(N)=N
"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",Carbonic anhydrase 13,CN(CC1=CC=C(Cl)C=C1)S(=O)(=O)C1=CC=C(C=C1)S(N)(=O)=O
N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,Vascular endothelial growth factor receptor 1,ClC1=CC=C(NC(=O)C2=C(NCC3=CC=NC=C3)C=CC=C2)C=C1
N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,Vascular endothelial growth factor receptor 2,O=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)C1=C(NCC2=CC=NC=C2)N=CC=C1
N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(NC(=O)C2=NNC3=C2C=CC=C3)C=C1
"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",Vascular endothelial growth factor receptor 2,COC1=CC=C(C=C1)C1=C(C2=C(N)N=CN=C2O1)C1=CC=C(NC(O)=NC2=C(F)C=CC(=C2)C(F)(F)F)C=C1
N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,Cyclin-dependent kinase 2,[H][C@@]1(CCN(C1)C(=O)C1=CC=C(NC2=NC(C3=CN=C(C)N3C(C)C)=C(F)C=N2)C=C1)N(C)C
"N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide",Gag-Pol polyprotein,NC(=N)NCCCCNC(=O)C1=CSC(=N1)C1=CSC=N1
N-(5'-Phosphopyridoxyl)-D-Alanine,Alanine racemase,C[C@@H](NCC1=C(O)C(C)=NC=C1COP(O)(O)=O)C(O)=O
N-(5'-phosphopyridoxyl)-L-alanine,Aspartate aminotransferase,[H][C@@](C)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O
N-(5'-phosphopyridoxyl)-L-alanine,Alanine racemase,[H][C@@](C)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O
N-(5'-phosphopyridoxyl)-L-alanine,L-cysteine/cystine lyase C-DES,[H][C@@](C)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O
"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",Serine/threonine-protein kinase Chk1,OC(=O)CNC1=NC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1
N-(5-Amino-5-Carboxypentyl)Glutamic Acid,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",N[C@@H](CCCCN[C@@H](CCC(O)=O)C(O)=O)C(O)=O
N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,Prothrombin,[H][C@@]1(Cl)CN=C(NCCC2=NC=CC=C2)[C@]([H])(O)N1CC(=O)NCC1=CSC2=CC=C(Cl)C=C12
N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,Cyclin-dependent kinase 2,O=C(NC1=CC(=NN1)C1CC1)C1=CC=CC=C1
N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE,Cyclin-dependent kinase 2,CC(C)C1=CN\C(S1)=N\C(=O)CC1=CC=CN=C1
N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,Calcium/calmodulin-dependent protein kinase type 1D,CC1=CC(NC2=C3C=CC=CC3=NC(=N2)C2=CC=CC=C2)=NN1
"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",Ephrin type-B receptor 4,COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(NC3=C(Cl)C=CC4=C3OCO4)C2=C1
"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",Dual specificity mitogen-activated protein kinase kinase 1,NCCNC1=NN=C(O1)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1
"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",[H]N(CCO)S(=O)(=O)C1=C(Cl)C=CC(=C1)C1=C(C)N=C(S1)N([H])C(C)=O
"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide",Phosphatidylinositol 3-kinase catalytic subunit type 3,[H]N(CCO)S(=O)(=O)C1=C(Cl)C=CC(=C1)C1=C(C)N=C(S1)N([H])C(C)=O
N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,[H][C@@](CCN)(C(=O)NC1=CC=C2NN=C(NC(=O)C3=CC=CC=C3)C2=C1)C1=CC(Cl)=CC=C1
"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",Outer membrane protein F,CC(=O)NC1=CC=C2OCCOCCOC3=C(OCCOCCOC2=C1)C=CC=C3
N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,Calmodulin,NCCCCCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2Cl
N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,"Troponin C, slow skeletal and cardiac muscles",NCCCCCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2Cl
N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,"Troponin I, cardiac muscle",NCCCCCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2Cl
"N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine",Squalene--hopene cyclase,CN(CCCCCCOC1=CC=C2C(SN=C2C2=CC=C(Br)C=C2)=C1)CC=C
N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,Coagulation factor XI,CC1=C(O)C=CC=C1C(=O)NC1=C2C=C(C=CC2=CC=C1)C(N)=N
"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",Vascular endothelial growth factor receptor 2,COC1=CC=C(C=C1NC1=NC=C(O1)C1=CC(=CC=C1)C1=CN=CC=C1)S(=O)(=O)NCC1CC1
N-(Chlorophenyl)-N'-Hydroxyguanidine,"Nitric oxide synthase, endothelial",ONC(=N)NC1=CC=C(Cl)C=C1
N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,Ig gamma-1 chain C region,OC(=O)C\N=C(\NC(C1=CC=CC=C1)C1=CC=CC=C1)NC1=CC=C(C=C1)C#N
N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,Ig kappa chain C region,OC(=O)CCCC(=O)NC1=CC=C(CC[N+]2([O-])CCCCC2)C=C1
N-(Phosphonoacetyl)-L-Ornithine,"Ornithine carbamoyltransferase, mitochondrial",N[C@@H](CCCNC(=O)CP(O)(O)=O)C(O)=O
N-(QUINOLIN-8-YL)METHANESULFONAMIDE,Methionine aminopeptidase,CS(=O)(=O)NC1=CC=CC2=C1N=CC=C2
N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),Plasmepsin-2,CCCCCC1=CC=C(C=C1)C(=O)N(CC1=CC=C(C=C1)C1=CC=C(CC(=O)OC)C=C1)C1CCN(CC2=NC=CN2)CC1
N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,Lethal factor,[H][C@@](CCSC)(NC(=O)[C@]1([H])CCCN1C(=O)[C@]([H])(CC1=CC=C(O)C=C1)NC(=O)CS)C(N)=O
"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",Oxysterols receptor LXR-alpha,CC1=CC(=CC(C)=C1)C(=O)N(NC(=O)C1=C(C)C2=C(OCCO2)C=C1)C(C)(C)C
"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",Retinoic acid receptor RXR-beta,CC1=CC(=CC(C)=C1)C(=O)N(NC(=O)C1=C(C)C2=C(OCCO2)C=C1)C(C)(C)C
N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,Immunoglobulin heavy variable 3-30,CN(CCCCC(O)=O)C1=CC=C(\C=C\C2=CC=C(C=C2)[N+]([O-])=O)C=C1
"N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE",Dipeptidyl peptidase 4,[H][C@@](N)(C(=O)N1CC[C@]([H])(F)C1)[C@@]([H])(C)[C@@]1([H])CC[C@@]([H])(CC1)N(C)C(C)=O
N-(biphenyl-4-ylsulfonyl)-D-leucine,Macrophage metalloelastase,[H][C@](CC(C)C)(NS(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O
N-(carboxycarbonyl)-D-phenylalanine,Hypoxia-inducible factor 1-alpha inhibitor,[H][C@](CC1=CC=CC=C1)(NC(=O)C(O)=O)C(O)=O
"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",Mitogen-activated protein kinase 14,CC1=NN=C(O1)C1=CC=C(C)C(=C1)C1=CC=C(C=C1)C(=O)NCC1CC1
"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",Macrophage metalloelastase,[H][C@](NS(=O)(=O)C1=CC2=C(C=C1)C1=CC=CC=C1S2)(C(C)C)C(O)=O
N-(pyridin-3-ylmethyl)aniline,Inorganic pyrophosphatase,C(NC1=CC=CC=C1)C1=CC=CN=C1
N-(pyridin-3-ylmethyl)aniline,Leukotriene A-4 hydrolase,C(NC1=CC=CC=C1)C1=CC=CN=C1
N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,Mitogen-activated protein kinase 10,CC(C)(C)NS(=O)(=O)C1=CC=C(C=C1)C1=CN=C2C=CC=C(NC3=CC=CC=N3)C2=C1
N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,Glutamate carboxypeptidase 2,[H][C@@](CCC(O)=O)(NC(=O)N[C@@]([H])(CSCC1=CC=C(F)C=C1)C(O)=O)C(O)=O
N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,Dipeptidyl peptidase 4,[H][C@](N)(CC(=O)N1CCC[C@@]1([H])CNC(=O)C1=CC=CC=C1)CC1=C(F)C=CC=C1
N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,Dipeptidyl peptidase 4,[H][C@](N)(CC(=O)N1CCC[C@@]1([H])CNC(=O)C1=CC=CC(=C1)S(C)(=O)=O)CC1=CC(Cl)=CC=C1
"N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE",Cathepsin B,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)NCC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(O)=O
"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",Gag-Pol polyprotein,[H][C@]1(COCC2=CC=CC=C2)CNC[C@]1([H])CN(CC(C)C)S(=O)(=O)C1=CC=CC=C1
"N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid",Trifunctional purine biosynthetic protein adenosine-3,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)[C@@]([H])(CCCC1([H])C(O)=N[C@]([H])(N)N[C@]1([H])N)C(O)(O)C(F)(F)F)C(O)=O
N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,Hepatocyte growth factor receptor,NC1=NC=CC(OC2=C(F)C=C(NC(=O)NC(=O)CC3=CC=C(F)C=C3)C=C2)=C1
N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,UDP-N-acetylmuramoylalanine--D-glutamate ligase,[H][C@](CCC(O)=O)(NS(=O)(=O)C1=CC2=C(C=C1)C=C(OCC1=C(F)C=C(C=C1)C#N)C=C2)C(O)=O
N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,UDP-N-acetylmuramoylalanine--D-glutamate ligase,[H][C@](CCC(O)=O)(NS(=O)(=O)C1=CC2=C(C=C1)C=C(OCC1=CC=C(C=C1)C#N)C=C2)C(O)=O
N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,Carbonic anhydrase 2,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1=CC=C(C=C1)S(N)(=O)=O
"N-1,10-phenanthrolin-5-ylacetamide",Soluble cytochrome b562,CC(=O)NC1=C2C=CC=NC2=C2N=CC=CC2=C1
"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine","Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(N[C@]4([H])CCCC5=CC=CC=C45)N=CN=C23)[C@]([H])(N=C(O)C2=CC(OC)=CC(OC)=C2)[C@]1([H])O
N-1-Methylheptylformamide,Alcohol dehydrogenase 1C,[H][C@@](C)(CCCCCC)N=CO
"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",Gag-Pol polyprotein,N(C1=NC=CN1)C1=CC=C(NC2=CC=C(NC3=NC=CN3)C=C2)C=C1
N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,TGF-beta receptor type-1,CC1=CC=CC(=N1)C1=NC(NC2=CC=C3NN=CC3=C2)=C2C=CC=CC2=N1
N-2-Thiophen-2-Yl-Acetamide Boronic Acid,Beta-lactamase,OB(O)CNC(=O)CC1=CC=CS1
N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE,Transcriptional activator protein LasR,[H][C@@]1(CCOC1=O)NC(=O)CC(=O)CCCCCCCCC
N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(C)=O)C(N)=O
N-ACETYLHISTAMINE,Glutaminyl-peptide cyclotransferase,CC(=O)NCCC1=CN=CN1
N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,Prothrombin,NC(=N)NOCCCOC1=CC(Cl)=CC(=C1)C(=O)N(CC=C)C1CCCC1
N-Acetyl-D-Allosamine,Chitotriosidase-1,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@@]([H])(O)[C@@]1([H])N=C(C)O
N-Acetyl-D-Allosamine,Chitinase B,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@@]([H])(O)[C@@]1([H])N=C(C)O
N-Acetyl-D-Allosamine,Chitinase A,[H][C@@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@@]([H])(O)[C@@]1([H])N=C(C)O
N-Acetyl-D-Galactosamine 6-Sulfate,Hyaluronate lyase,CC(=O)N[C@H]1[C@H](O)O[C@H](COS(O)(=O)=O)[C@H](O)[C@@H]1O
N-Acetyl-D-Galactosamine 6-Sulfate,Chondroitinase-AC,CC(=O)N[C@H]1[C@H](O)O[C@H](COS(O)(=O)=O)[C@H](O)[C@@H]1O
N-Acetyl-L-Citrulline,N-acetylornithine carbamoyltransferase,CC(=O)N[C@@H](CCCNC(N)=O)C(O)=O
N-Acetyl-L-Glutamate,Acetylglutamate kinase,CC(=O)N[C@@H](CCC(O)=O)C(O)=O
N-Acetyl-L-Glutamate,Acetylglutamate kinase,CC(=O)N[C@@H](CCC(O)=O)C(O)=O
N-Acetyl-N'-Beta-D-Glucopyranosyl Urea,"Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]([H])(N=C(O)N=C(C)O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
N-Acetyl-P-Nitrophenylserinol,Chloramphenicol 3-O phosphotransferase,[H][C@@](O)(C1=CC=C(C=C1)N(=O)=O)[C@@]([H])(CO)N=C(C)O
N-Acetyl-Serine,Coagulation factor XIII A chain,CC(=O)N[C@@H](CO)C(O)=O
N-Acetylalanine,Aldose reductase,C[C@H](NC(C)=O)C(O)=O
N-Acetylglucosamine,N-acylglucosamine 2-epimerase,[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
N-Acetylglucosamine,"Beta-1,4-galactosyltransferase 1",[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
N-Acetylglucosamine,Alpha-N-acetylglucosaminidase,[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
N-Acetylglucosamine,"Beta-1,4-galactosyltransferase 3",[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
N-Acetylglucosamine,"Beta-1,4-galactosyltransferase 4",[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
N-Acetylglucosamine,"Beta-1,4-galactosyltransferase 2",[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
N-Acetylglucosamine,N-acetyl-D-glucosamine kinase,[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
N-Acetylglucosamine,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
N-Acetylmannosaminitol,Capsule biosynthesis protein,[H][C@@](C)(O)N[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO
N-Acetylmethionine,o-succinylbenzoate synthase,CSCC[C@H](NC(C)=O)C(O)=O
N-Acetylmethionine,Rhodopsin,CSCC[C@H](NC(C)=O)C(O)=O
N-Acetylproline,(5R)-carbapenem-3-carboxylate synthase,[H][C@]1(CCCN1C(C)=O)C(O)=O
N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine,Squalene--hopene cyclase,CN(CCCCCCOC1=CC2=C(C=C1)C(=NN2C)C1=CC=C(Br)C=C1)CC=C
N-Allyl-Aniline,Endolysin,C=CCNC1=CC=CC=C1
N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,Trypsin-1,CC(=O)N1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(N)=N)NS(=O)(=O)C1=CC=C2C=CC=CC2=C1
N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,Trypsin-1,COC(=O)C1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(N)=N)NS(=O)(=O)C1=CC=C2C=CC=CC2=C1
N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,Trypsin-1,[H][C@@](CC1=CC(=CC=C1)C(N)=N)(NS(=O)(=O)C1=CC2=CC=CC=C2C=C1)C(=O)N1CCCC[C@]1([H])C(O)=O
"N-Alpha-Acetyl-3,5-Diiodotyrosylglycine",Peptidyl-glycine alpha-amidating monooxygenase,CC(=O)N[C@@H](CC1=CC(I)=C(O)C(I)=C1)C(=O)NCC(O)=O
N-Alpha-L-Acetyl-Arginine,Clavaminate synthase 1,CC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
N-Aminoethylmorpholine,Cathepsin D,NCCN1CCOCC1
N-BENZOYL-D-ALANINE,Penicillin-binding protein 1b,[H][C@](C)(NC(=O)C1=CC=CC=C1)C(O)=O
N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,Mitogen-activated protein kinase 1,ClC1=CC(=CC=C1)C1=CNN=C1C1=CNC(=C1)C(=O)NCC1=CC=CC=C1
N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,Mitogen-activated protein kinase 10,ClC1=CC(=CC=C1)C1=CNN=C1C1=CNC(=C1)C(=O)NCC1=CC=CC=C1
N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,Subtilisin DY,[H][C@](C)(O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@]1([H])CCCN1C(=O)[C@]([H])(C)NC(=O)OCC1=CC=CC=C1
N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,Genome polyprotein,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(O)=O
N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,Genome polyprotein,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(O)=O
N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,Genome polyprotein,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(O)=O
N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,"Glycogen phosphorylase, muscle form",[H][C@]1(CO)O[C@@]([H])(N=C(O)N=C(O)C2=CC=CC=C2)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide,Heat-labile enterotoxin B chain,[H][C@]1(CO)O[C@]([H])(OC2=CC=CC(=C2)C(=O)NCC2=CC=CC=C2)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
N-Benzyl-4-Sulfamoyl-Benzamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)C(=O)NCC1=CC=CC=C1
N-Benzylformamide,Alcohol dehydrogenase 1B,O=CNCC1=CC=CC=C1
N-Bromoacetyl-Aminoethyl Phosphate,Glucose-6-phosphate isomerase B,CC(=O)N(Br)CCOP(O)(O)=O
N-Butyl Isocyanide,Camphor 5-monooxygenase,CCCC[N+]#[C-]
N-Butyl Isocyanide,Cytochrome c',CCCC[N+]#[C-]
N-Butyl Isocyanide,Group 1 truncated hemoglobin GlbN,CCCC[N+]#[C-]
N-Butyl Isocyanide,Myoglobin,CCCC[N+]#[C-]
"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",Estrogen receptor beta,[H][C@]1(O)CC[C@@]2([H])[C@]3([H])[C@]([H])(CCCCCCCCCCC(=O)N(C)CCCC)CC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C
N-Butyl-N'-Hydroxyguanidine,"Nitric oxide synthase, brain",CCCCNC(=N)NO
N-Carbamoyl-Alanine,Peroxiredoxin-2,C[C@@H](NC(N)=O)C(O)=O
N-Carbamoyl-L-Aspartate,Dihydroorotase,NC(=O)N[C@@H](CC(O)=O)C(O)=O
N-Carbamyl-D-Methionine,N-carbamoyl-D-amino acid hydrolase,CSCC[C@@H](NC(N)=O)C(O)=O
N-Carbamyl-D-Valine,N-carbamoyl-D-amino acid hydrolase,CC(C)[C@@H](NC(N)=O)C(O)=O
N-Carboxymethionine,Thymidylate synthase,[H][C@@](CCSC)(NC(O)=O)C(O)=O
N-Carboxymethionine,Urease subunit alpha,[H][C@@](CCSC)(NC(O)=O)C(O)=O
N-Carboxymethionine,Urease subunit beta,[H][C@@](CCSC)(NC(O)=O)C(O)=O
N-Carboxymethionine,Urease subunit gamma,[H][C@@](CCSC)(NC(O)=O)C(O)=O
N-Carboxymethionine,Light-harvesting protein B-800/850 alpha chain,[H][C@@](CCSC)(NC(O)=O)C(O)=O
N-Carboxymethionine,Light-harvesting protein B-800/850 beta chain,[H][C@@](CCSC)(NC(O)=O)C(O)=O
N-Carboxymethionine,Ribosomal RNA small subunit methyltransferase F,[H][C@@](CCSC)(NC(O)=O)C(O)=O
N-Cyclohexyl-N'-(4-Iodophenyl)Urea,Bifunctional epoxide hydrolase 2,IC1=CC=C(NC(=O)NC2CCCCC2)C=C1
N-Cyclohexyl-N'-(Propyl)Phenyl Urea,Bifunctional epoxide hydrolase 2,O=C(NCCCC1=CC=CC=C1)NC1CCCCC1
N-Cyclohexyl-N'-Decylurea,Bifunctional epoxide hydrolase 2,CCCCCCCCCCNC(=O)NC1CCCCC1
N-Cyclopentyl-N-Cyclobutylformamide,Alcohol dehydrogenase 1A,O=CN(C1CCC1)C1CCCC1
N-DODECANOYL-L-TYROSINE,Long-chain N-acyl amino acid synthase,[H][C@@](CC1=CC=C(O)C=C1)(NC(=O)CCCCCCCCCCC)C(O)=O
"N-DODECYL-N,N-DIMETHYLGLYCINATE",AppA protein,CCCCCCCCCCCC[N+](C)(C)CC([O-])=O
"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",Penton protein,CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O
"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",Insulin-like growth factor I,CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O
"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",Amine oxidase [flavin-containing] B,CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O
N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,Prothrombin,[H][C@](C)(COC1=CC(=CC(C)=C1)C(=O)N(CC)C(C)C)NC1=CC=NC=C1
N-Ethyl-5'-Carboxamido Adenosine,Endoplasmin,CCNC(=O)[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N
N-Ethylmaleimide,Galectin-10,CCN1C(=O)C=CC1=O
N-Formylmethionine,Glutamate--cysteine ligase,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Ribonuclease pancreatic,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Geranylgeranyl transferase type-2 subunit alpha,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Geranylgeranyl transferase type-2 subunit beta,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Photosynthetic reaction center cytochrome c subunit,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Reaction center protein H chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Reaction center protein L chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Reaction center protein M chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Light-harvesting protein B-800/820 alpha chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Light-harvesting protein B-800/820 beta chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Light-harvesting protein B-800/850 alpha chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Light-harvesting protein B-800/850 beta chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Antithrombin-III,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Beta-2-microglobulin,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,NADH-ubiquinone oxidoreductase chain 1,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"HLA class I histocompatibility antigen, B-27 alpha chain",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Respiratory nitrate reductase 1 alpha chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Respiratory nitrate reductase 1 beta chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Respiratory nitrate reductase 1 gamma chain,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Protein S100-G,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Rubredoxin,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Cytochrome c oxidase subunit 1,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Cytochrome c oxidase subunit 2,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Cytochrome c oxidase subunit 3,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"Cytochrome c oxidase subunit 5A, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"Cytochrome c oxidase subunit 5B, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Cytochrome c oxidase subunit 6C,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"Cytochrome c oxidase subunit 7B, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"Cytochrome c oxidase subunit 7C, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"Cytochrome c oxidase subunit 8A, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"Cytochrome c oxidase subunit 6A2, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Cytochrome c oxidase subunit 6B1,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,"Cytochrome c oxidase subunit 7A1, mitochondrial",[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Methionyl-tRNA formyltransferase,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Streptavidin,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Protein S100-B,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Delta-hemolysin,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Polyubiquitin-C,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,AtpH,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Probable L-ascorbate-6-phosphate lactonase UlaG,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylmethionine,Immunoglobulin G-binding protein G,[H][C@@](CCSC)(NC=O)C(O)=O
N-Formylpiperidine,Alcohol dehydrogenase 1C,O=CN1CCCCC1
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,Macrophage metalloelastase,[H][C@](C(C)C)(N(CC1=CC=CN=C1)S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,Interstitial collagenase,[H][C@](C(C)C)(N(CC1=CC=CN=C1)S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO
N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,Interstitial collagenase,ONC(=O)CC1(CCOCC1)S(=O)(=O)C1=CC=C(OC2=CC=CC=C2)C=C1
N-Heptylformamide,Alcohol dehydrogenase 1B,CCCCCCCNC=O
N-Hexadecanoylglycine,Bifunctional cytochrome P450/NADPH--P450 reductase,CCCCCCCCCCCCCCCC(=O)NCC(O)=O
"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",Stromelysin-1,CON[C@H]1C[C@@H](N(C1)S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO
N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,Stromelysin-1,[H][C@@]1(CN(CCN1S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)OCC1=CC=CC=C1)C(=O)NO
N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,Histone deacetylase 8,CN(C1=CC=C(C=C1)C(=O)NO)S(=O)(=O)C1=CC=C(S1)C1=NC=CC=C1
N-Hydroxy-4-Phosphono-Butanamide,Triosephosphate isomerase,ONC(=O)CCCP([O-])([O-])=O
"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",Stromelysin-1,[H][C@@]1(N(CCCSC1(C)C)S(=O)(=O)C1=CC=C(OC)C=C1)C(=O)NO
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,Stromelysin-2,COC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C)CC(=O)NO
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,Macrophage metalloelastase,COC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C)CC(=O)NO
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,Stromelysin-1,COC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C)CC(=O)NO
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,Matrix metalloproteinase-20,COC1=CC=C(C=C1)S(=O)(=O)N(CC(C)C)CC(=O)NO
N-Isopropyl-N'-Hydroxyguanidine,"Nitric oxide synthase, brain",CC(C)NC(=N)NO
N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,Cytochrome P450 2A6,CNCC1=CC=C(O1)C1=CC=CN=C1
N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,cAMP-dependent protein kinase catalytic subunit alpha,CNCC1=CC=C(C=C1)C1=NC=NC2=C1N=CN2
N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,cAMP-dependent protein kinase inhibitor alpha,CNCC1=CC=C(C=C1)C1=NC=NC2=C1N=CN2
"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",Cyclin-dependent kinase 2,CNS(=O)(=O)C1=CC=C(N\C=C2/C(=O)NC3=C2C=CC=C3)C=C1
N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE,Amine oxidase [flavin-containing] B,[H][C@@](C)(CC1=CC=CC=C1)N(C)CC=C
"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",Cyclin-dependent kinase 2,CNS(=O)(=O)CC1=CC=C(N\N=C2/C(=O)NC3=C2C2=C(C=C3)N=CS2)C=C1
"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",E3 ubiquitin-protein ligase XIAP,CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C12)OC1=CC=CC=C1)C(C)(C)C
"N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide",Signal peptidase I,[H][C@](C)(N=C(O)[C@@]([H])(CO)N(C)C(=O)CCCCCCCCC(C)C)C(O)=NCC(=O)N(C)[C@@]1([H])C2=CC(=C(O)C=C2)C2=C(O)C=CC(C[C@]([H])(N=C(O)[C@]([H])(C)N=C1O)C(O)=O)=C2
N-Methyl-N-(Methylbenzyl)Formamide,Renin,[H][C@@](C)(N(C)C=O)C1=CC=CC=C1
N-Methyl-N-Propargyl-1(R)-Aminoindan,Amine oxidase [flavin-containing] B,[H][C@]1(CCC2=C1C=CC=C2)N(C)CC#C
"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",Cell division protein ZipA,CN(C(C)=O)C1=CC=CC(=C1)C1=NN=C2C=CC(=NN12)C1=CC=CC=C1
"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",Cell division protein ZipA,CN(C(C)=O)C1=CC=CC(=C1)C1=NN=C2C=CC(=NN12)C1=CC=CC=C1
N-Methyl-Pyridoxal-5'-Phosphate,Aspartate aminotransferase,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=[N+]1C
N-Methylleucine,C-X-C motif chemokine 10,CN[C@H](CC(C)C)C(O)=O
N-Methylmesoporphyrin,Ferrochelatase,CCC1=C(C)C2=CC3=C(CC)C(C)=C(C=C4N=C(C=C5N\C(=C/C1=N2)C(C)=C5CCC(O)=O)C(CCC(O)=O)=C4C)N3C
N-Methylmesoporphyrin Containing Copper,Ferrochelatase,CCC1=C2C=C3N4C(=CC5=[N+]6C(=CC7=[N]8(C)C(=CC(N2[Cu-]468)=C1C)C(CC)=C7C)C(C)=C5CCC(O)=O)C(CCC(O)=O)=C3C
N-Methylnaloxonium,Liver carboxylesterase 1,C[N@@+]1(CC=C)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35
"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine","Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(NCC4=CC=CC5=CC=CC=C45)N=CN=C23)[C@]([H])(N=C(O)C2=CC(OC)=CC(OC)=C2)[C@]1([H])O
"N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate",Penicillin-binding protein 2X,[H][C@]1(COC(=O)CCCCCCC)O[C@@](CO)(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@@]([H])(O)[C@]1([H])O
N-Octyl-2-Hydroxyethyl Sulfoxide,Ferrichrome-iron receptor,CCCCCCCC[S@@](=O)CCO
N-Octyl-2-Hydroxyethyl Sulfoxide,Colicin I receptor,CCCCCCCC[S@@](=O)CCO
N-Octyl-2-Hydroxyethyl Sulfoxide,Membrane protein,CCCCCCCC[S@@](=O)CCO
N-Omega-Hydroxy-L-Arginine,"Nitric oxide synthase, inducible",N[C@@H](CCCNC(=N)NO)C(O)=O
N-Omega-Hydroxy-L-Arginine,"Nitric oxide synthase, brain",N[C@@H](CCCNC(=N)NO)C(O)=O
N-Omega-Hydroxy-L-Arginine,"Nitric oxide synthase, endothelial",N[C@@H](CCCNC(=N)NO)C(O)=O
N-Omega-Hydroxy-L-Arginine,Arginase-1,N[C@@H](CCCNC(=N)NO)C(O)=O
N-Omega-Hydroxy-L-Arginine,Nitric oxide synthase oxygenase,N[C@@H](CCCNC(=N)NO)C(O)=O
N-Omega-Propyl-L-Arginine,"Nitric oxide synthase, inducible",CCCNC(=[NH2+])NCCC[C@H](N)C(O)=O
N-Omega-Propyl-L-Arginine,"Nitric oxide synthase, brain",CCCNC(=[NH2+])NCCC[C@H](N)C(O)=O
N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE,Aspartate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(CN[C@@](C)(CCC(O)=O)C(O)=O)=C1O
N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE,Aspartate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(CN[C@H](CCC(O)=O)C(O)=O)=C1O
N-Propargyl-1(S)-Aminoindan,Amine oxidase [flavin-containing] B,[H][C@@]1(CCC2=C1C=CC=C2)NCC#C
N-Propyl Isocyanide,Myoglobin,CCC[N+]#[C-]
N-Propyl-Tartramic Acid,Prostatic acid phosphatase,[H][C@](O)(C(O)=O)[C@@]([H])(O)C(O)=NCCC
N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate,"2,2-dialkylglycine decarboxylase",CC1=NC=C(COP(O)(O)=O)C(CNC2(CC2)C(O)=O)=C1O
N-Pyridoxyl-2-Methylalanine-5-Phosphate,"2,2-dialkylglycine decarboxylase",CC1=NC=C(COP(O)(O)=O)C(CNC(C)(C)C(O)=O)=C1O
N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate,8-amino-7-oxononanoate synthase,[H][C@@](C)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(=O)CCCCCC(O)=O
N-Pyridoxyl-Glycine-5-Monophosphate,"Serine hydroxymethyltransferase, cytosolic",CC1=NC=C(COP(O)(O)=O)C(CNCC(O)=O)=C1O
N-Pyridoxyl-Glycine-5-Monophosphate,Ornithine decarboxylase,CC1=NC=C(COP(O)(O)=O)C(CNCC(O)=O)=C1O
N-Pyridoxyl-Glycine-5-Monophosphate,Serine hydroxymethyltransferase,CC1=NC=C(COP(O)(O)=O)C(CNCC(O)=O)=C1O
N-Pyridoxyl-Glycine-5-Monophosphate,L-allo-threonine aldolase,CC1=NC=C(COP(O)(O)=O)C(CNCC(O)=O)=C1O
N-Pyridoxyl-Threonine-5-Monophosphate,L-allo-threonine aldolase,CC(O)C(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O
N-Succinyl Methionine,o-succinylbenzoate synthase,[H][C@](CCSC)(NC(=O)CCC(O)=O)C(O)=O
N-Succinyl Phenylglycine,o-succinylbenzoate synthase,[H][C@](NC(=O)CCC(O)=O)(C(O)=O)C1=CC=CC=C1
N-Sulfo-Flavin Mononucleotide,Hydroxyacid oxidase 1,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@@]([H])(O)CN1C2=C(C=C(C)C(C)=C2)[N+](=C2C(O)=NC(=O)N=C12)S([O-])(=O)=O
N-Tridecanoic Acid,"Phospholipase A2, membrane associated",CCCCCCCCCCCCC(O)=O
N-Tridecanoic Acid,Phospholipase A2,CCCCCCCCCCCCC(O)=O
N-Tridecanoic Acid,Group IIE secretory phospholipase A2,CCCCCCCCCCCCC(O)=O
N-Trimethyllysine,Calmodulin,[H][C@](N)(CCCC[N+](C)(C)C)C(O)=O
N-Trimethyllysine,Cytochrome c,[H][C@](N)(CCCC[N+](C)(C)C)C(O)=O
N-Valeric Acid,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",CCCCC(O)=O
"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",Genome polyprotein,CC(C)(NC(=O)C1=CC=C2C(=C1)N1CCOC3=C(C=CC=C3)C1=C2C1CCCCC1)C(O)=O
N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Estrogen receptor,[H][C@@](C)(CCC1=CC=C(O)C=C1)NC(=O)CC1=C(NC2=C1C=CC=C2)C1=CC=CC=C1
"N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide",Neutral ceramidase,[H][C@@](O)(\C=C\CCCCCCCCCCCCC)[C@@]([H])(CO)NC(C)=O
N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE,Protein-arginine deiminase type-4,[H][C@@](CCCNC(C)=N)(NC(=O)C1=CC=CC=C1)C(N)=O
"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",Cathepsin S,C\C=C\C[C@]([H])(C(C)=O)N1N=NC(=C1)[C@](C)(C(C)C)NC(=O)C1=CC=CC=C1
"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",cAMP-dependent protein kinase catalytic subunit alpha,[H][C@@](CN)(CC1=C(Cl)C=C(Cl)C=C1)NC(=O)C1=CC=C(S1)C1=CC=NC(NC)=N1
N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,Cathepsin S,[H][C@@](CC1CCCCC1)(NC(=O)N1CCOCC1)C(=O)NC1(CCN(C)CC1)C#N
"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",RAC-beta serine/threonine-protein kinase,[H][C@](CN)(NC(=O)C1=CC=C(S1)C1=C2C=CNC2=NC=C1)C1=CC=CC=C1
"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",Glycogen synthase kinase-3 beta,[H][C@](CN)(NC(=O)C1=CC=C(S1)C1=C2C=CNC2=NC=C1)C1=CC=CC=C1
N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,Lanosterol 14-alpha demethylase,[H][C@](NC(=O)C1CCCCC1)(C(C)C)C(=O)NC1=CC=NC=C1
N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,Cathepsin S,[H][C@@](CC1CCCCC1)(NC(=O)N1CCOCC1)C(=O)N[C@@](C)(COCC1=CC=CC=C1)C#N
N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide,Protease 1,[H][C@@](CCCCN)(NS(=O)(=O)C1=CC=C(C)C=C1)C(=O)CCl
N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,Heat shock protein HSP 90-alpha,CC1=NC(N)=NC(CNS(=O)(=O)C2=CC(N\C=C3/CCOC3=O)=CC=C2)=C1
N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine,Leukotriene A-4 hydrolase,[H][C@@](C)(NC(=O)[C@@]([H])(CC(=O)NO)CC1=CC=CC=C1)C(O)=O
"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",Peptide deformylase,[H][C@@](CCCC)(CN(O)C=O)C(=O)N1CCC[C@@]1([H])C1=NC2=C(O1)C=CC=C2
"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",Carbonic anhydrase 2,[H][C@]1(CC2=C(C1)C=C(C=C2)S(N)(=O)=O)NC(=O)C(CCC)CCC
"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",Genome polyprotein,[H][C@](NC(=O)NC1CCCC1)(C(C)C)C(=O)N1CC[C@]([H])(NC(=O)C2CC2)[C@@]1([H])C1(CCC1)C=O
"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",NS3 protease,[H][C@](NC(=O)NC1CCCC1)(C(C)C)C(=O)N1CC[C@]([H])(NC(=O)C2CC2)[C@@]1([H])C1(CCC1)C=O
"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",Prothrombin,[H][C@](N)(CC1=CC=CC=C1)[C@]([H])(O)CNS(=O)(=O)C1=C(C)C=C(OC)C(C)=C1C
"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",Prothrombin,[H][C@](N)(CC1=CC=CC=C1)[C@]([H])(O)CNS(=O)(=O)C1=CC=C2C=CC=CC2=C1
"N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide",Penicillin G acylase,[H][C@@]1(NC(=O)CC2=CC=CC=C2)C(=O)[N@]2[C@]1([H])[S@@]([H])(O)C(C)(C)[C@]2([H])C(O)=O
"N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea",Mitogen-activated protein kinase 14,CC(C)(C)C1=C\C(=N/C(=O)NC2=CC=C(Cl)C=C2)N(N1)C1=CC=CC=C1
N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE,Egl nine homolog 1,OC(=O)CNC(=O)C1=C(O)C2=CC=CC(I)=C2C=N1
N-[(4-methoxyphenyl)sulfonyl]-D-alanine,Macrophage metalloelastase,[H][C@](C)(NS(=O)(=O)C1=CC=C(OC)C=C1)C(O)=O
"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",Beta-secretase 1,[H][C@@]1(C)CCC2=CC(C[C@@](C)(N)C(=O)OCC3=CC(CC1)=NC(=C3)N(C)S(C)(=O)=O)=CC=C2
"N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide","Glycogen phosphorylase, muscle form",CC(=O)NN1C(=O)N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O
N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid,UDP-N-acetylmuramoylalanine--D-glutamate ligase,CCCCOC1=CC2=CC=C(C=C2C=C1)S(=O)(=O)N[C@H](CCC(O)=O)C(O)=O
N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid,UDP-N-acetylmuramoylalanine--D-glutamate ligase,CCCCOC1=CC2=CC=C(C=C2C=C1)S(=O)(=O)N[C@@H](CCC(O)=O)C(O)=O
N-[(Aminooxy)Carbonyl]Aniline,Chitinase B,NOC(=O)NC1=CC=CC=C1
N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE,Metallo-beta-lactamase L1,[H][C@@](CS)(NC(=O)OCC1=CC=CC=C1)C(=O)NCC(O)=O
N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,Bifunctional epoxide hydrolase 2,OC(=O)CNC(=O)NC1CCCCC1
N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,Disintegrin and metalloproteinase domain-containing protein 28,[H][C@@](CC(C)C)(NC(=O)C1=CC=CO1)C(=O)N[C@@]([H])(CC1=CNC2=C1C=CC=C2)P(O)(O)=O
"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",Beta-secretase 1,COC1=CC=CC(OC)=C1CN1CCC(CC1)NC(=O)CCCS
N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID,Coagulation factor VII,CCCS(=O)(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCSC)C(=O)NCC1=CC=C(C=C1)C(N)=N
"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",Beta-secretase 1,COC1=C(OC)C(CN2CCC(CC2)NC(=O)CCCS)=CC(Br)=C1
"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",Cathepsin S,[H][C@@](CS(=O)(=O)CC1=CC=CC=C1)(N[C@@]([H])(C1=CC=C(O)C=C1)C(F)(F)F)C(=O)NC1(CN)CC1
"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",Cathepsin S,[H][C@@](CS(=O)(=O)N1CCOCC1)(N[C@@]([H])(C1=CC=C(F)C=C1)C(F)(F)F)C(=O)NC1(CN)CC1
N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,Cathepsin B,[H][C@](O)(CC(O)=O)C(=O)N[C@@]([H])(CC(C)C)C(=O)NCCC(C)C
N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,Pro-cathepsin H,[H][C@](O)(CC(O)=O)C(=O)N[C@@]([H])(CC(C)C)C(=O)NCCC(C)C
N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine,Bifunctional cytochrome P450/NADPH--P450 reductase,[H][C@@](CC(C)C)(NC(=O)CCCCCCCCCCCN1C=CN=C1)C(O)=O
N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID,Tryptophan synthase alpha chain,[H][C@@](CC(O)=O)(NC(=O)CC1=CNC2=CC=CC=C12)C(O)=O
N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID,Tryptophan synthase beta chain,[H][C@@](CC(O)=O)(NC(=O)CC1=CNC2=CC=CC=C12)C(O)=O
N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,Tryptophan synthase alpha chain,OC(=O)CNC(=O)CC1=CNC2=C1C=CC=C2
N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,Tryptophan synthase beta chain,OC(=O)CNC(=O)CC1=CNC2=C1C=CC=C2
N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,Tryptophan synthase alpha chain,[H][C@](NC(=O)CC1=CNC2=CC=CC=C12)(C(C)C)C(O)=O
N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,Tryptophan synthase beta chain,[H][C@](NC(=O)CC1=CNC2=CC=CC=C12)(C(C)C)C(O)=O
N-[2(S)-Cyclopentyl-1(R)-Hydroxy-3(R)Methyl]-5-[(2(S)-Tertiary-Butylamino-Carbonyl)-4-(N1-(2)-(N-Methylpiperazinyl)-3-Chloro-Pyrazinyl-5-Carbonyl)-Piperazino]-4(S)-Hydroxy-2(R)-Phenylmethyl-Pentanamide,Gag-Pol polyprotein,[H][C@@](O)(CN1CCN(C[C@@]1([H])C(O)=NC(C)(C)C)C(=O)C1=NC(Cl)=C(N=C1)N1CCN(C)CC1)C[C@@]([H])(CC1=CC=CC=C1)C(O)=N[C@@]1([H])[C@@]([H])(C)CC[C@@]1([H])O
"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE","Nitric oxide synthase, inducible",[H][C@@]1(CCCN1C1=NC(=NC(C)=C1)N1C=CN=C1)C(=O)NCCC1=CC2=C(OCO2)C=C1
N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,Chymotrypsin-like elastase family member 1,O=C[C@@]([H])(C(C)C)[C@]1([H])N(CC[C@@]1([H])NS(=O)(=O)C)C(=O)\C=C\CN1CCCCC1
N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,Phosphate-binding protein PstS,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)N\C=C/N1C(=O)CCC1=O)C(=O)O2
N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,Carbonic anhydrase 2,[H][C@@](CC)(CNC(=O)C1=CC=C(C=C1)S(N)(=O)=O)C1=CC2=C(NC=C2)C=C1
"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",DNA ligase,CC(C)(CNC(=O)C1=CC=C(OC2=CC=CC=C2)C=C1)C1=NC2=NC(N)=NC(N)=C2C=C1
"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",DNA ligase,CC(C)(CNC(=O)C1=CC=C(OC2=CC=CC=C2)C=C1)C1=NC2=NC(N)=NC(N)=C2C=C1
N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,Ribosyldihydronicotinamide dehydrogenase [quinone],COC1=CC=C2NC(I)=C(CCNC(C)=O)C2=C1
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,Actin-related protein 2/3 complex subunit 1B,CC1=C(CCNC(=O)C2=CC=CS2)C2=CC=CC=C2N1
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,Actin-related protein 2,CC1=C(CCNC(=O)C2=CC=CS2)C2=CC=CC=C2N1
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,Actin-related protein 3,CC1=C(CCNC(=O)C2=CC=CS2)C2=CC=CC=C2N1
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,Actin-related protein 2/3 complex subunit 2,CC1=C(CCNC(=O)C2=CC=CS2)C2=CC=CC=C2N1
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,Actin-related protein 2/3 complex subunit 3,CC1=C(CCNC(=O)C2=CC=CS2)C2=CC=CC=C2N1
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,Actin-related protein 2/3 complex subunit 4,CC1=C(CCNC(=O)C2=CC=CS2)C2=CC=CC=C2N1
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,Actin-related protein 2/3 complex subunit 5,CC1=C(CCNC(=O)C2=CC=CS2)C2=CC=CC=C2N1
"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE","Nitric oxide synthase, inducible",[H][C@@]1(CCNC(=O)C2=COC=C2)NC2=C(F)C=CC(F)=C2C(N)=N1
N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,cAMP-dependent protein kinase catalytic subunit alpha,BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1
N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,cAMP-dependent protein kinase inhibitor alpha,BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1
N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,Serine/threonine-protein kinase haspin,BrC1=CC=C(\C=C\CNCCNS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C=C1
"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",RAC-alpha serine/threonine-protein kinase,CC1=NN=C(N1)C1=CC=CC=C1NC1=NC=NC2=C1C=CN2
"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",Glycogen synthase kinase-3 beta,CC1=NN=C(N1)C1=CC=CC=C1NC1=NC=NC2=C1C=CN2
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,"Nitric oxide synthase, inducible",CC1=CC(N)=NC(CCNC(=O)C2=CC=C(C=C2)C#N)=C1
N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,cAMP-dependent protein kinase catalytic subunit alpha,CNCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2
N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,cAMP-dependent protein kinase inhibitor alpha,CNCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2
"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",Prothrombin,NC(=N)NOCCNC(=O)CC1=C(C=CC(NCC(F)(F)C2=NC=CC=C2)=C1F)C#N
"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",Prothrombin,NC(=N)NOCCNC(=O)CC1=C(Cl)C=CC(NCC(F)(F)C2=CC=CC=C2)=C1F
"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",Gag-Pol polyprotein,CC(C)CCN(C[C@@H](O)[C@@H]1CC2=CC=C(OCCCC(=O)N[C@@H](C(C)C)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1
N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,Thymidylate synthase,NC(=N)NC(=N)NC1=C(Cl)C=CC(=C1)C(F)(F)F
"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",Mitogen-activated protein kinase 14,[H][C@@](C)(CC)NC1=NC=C(S1)C(=O)NC1=C(C)C=CC(=C1)C(=O)NC
N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,Aurora kinase A,O=C(NC1=CNN=C1C1=NC2=C(N1)C=CC=C2)C1=CC=CC=C1
N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,Cyclin-dependent kinase 2,O=C(NC1=CNN=C1C1=NC2=C(N1)C=CC=C2)C1=CC=CC=C1
"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",Caspase-3,FCCOC1=CC=CC(NC(=O)CCC(=O)NC2=CC=C3C(=O)NC(=O)C(=O)C3=C2)=C1
N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,Interstitial collagenase,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]([H])(CC1=CC=C(OC)C=C1)C(=O)NC
"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",Neprilysin,[H][C@@](C)(N)[P@](O)(=O)C[C@@]([H])(CC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)N[C@@]([H])(C)C(O)=O
"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",Leukotriene A-4 hydrolase,[H][C@@](C)(N)[P@](O)(=O)C[C@@]([H])(CC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)N[C@@]([H])(C)C(O)=O
"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",Ephrin type-B receptor 4,CS(=O)(=O)NC1=CC(NC2=NC(NC3=C(Cl)C=CC4=C3OCO4)=CC=N2)=CC=C1
"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",Cyclin-dependent kinase 2,CN(C)C1=CC=C(NC2=NC(=CC=N2)C2=C(C)N=C(C)S2)C=C1
"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",Cyclin-A2,CN(C)C1=CC=C(NC2=NC(=CC=N2)C2=C(C)N=C(C)S2)C=C1
"N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide",Cyclin-dependent kinase 2,CC1=NC(C)=C(S1)C1=CC=NC(N\C=N/O)=N1
"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",Wee1-like protein kinase,ClC1=CC=CC=C1C1=CC2=C(C3=C(N2)C=CC(NC=O)=C3)C2=C1C(=O)NC2=O
"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",Cyclin-dependent kinase 2,CC(=O)NC1=NC(=CC=N1)C1=C(C)N=C2C=CC=CN12
N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](CO)(N=C(O)CCN=C(O)CBr)C(O)=NCCC1=CC=C(C=C1)N=C(O)C(O)=O
N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,Proto-oncogene tyrosine-protein kinase Src,BrC1=CC=CC(NC2=C3C=C(NC(=O)C=C)C=CC3=NC=N2)=C1
N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,Epidermal growth factor receptor,BrC1=CC=CC(NC2=C3C=C(NC(=O)C=C)C=CC3=NC=N2)=C1
N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine,Ig gamma-1 chain C region,[H][C@](C)(N=C(O)CCCP(O)(=O)OC1=CC=C(C=C1)N(=O)=O)C(O)=O
N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine,Ig gamma-1 chain C region,[H][C@@](C)(NC(=O)CCC[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O)C(O)=O
N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,TGF-beta receptor type-1,CC(=O)NC1=NC(=C(N1)C1=CC=C2N=CC=NC2=C1)C1=NC(C)=C(F)C=C1
"N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",Heat shock protein HSP 90-alpha,NS(=O)(=O)C1=CC=C(CNC(=O)C2=C(NN=C2)C2=CC(Cl)=C(O)C=C2O)C=C1
N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(NC(=O)C2=CC=CC=C2S)C=C1
N-[4-(benzyloxy)phenyl]glycinamide,Leukotriene A-4 hydrolase,NCC(=O)NC1=CC=C(OCC2=CC=CC=C2)C=C1
N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE,Beta-lactamase IMP-1,CN(C)C1=C2C=CC=C(C2=CC=C1)S(=O)(=O)NCCCCNC(=O)CCS
N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,Mitogen-activated protein kinase 14,[H][C@@]1(F)C[C@]([H])(CC(=C1)C(=O)NC1=CC=C(Cl)C(COC2=CN=CC=C2)=C1)N1CCOCC1
N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,Tyrosine-protein kinase transforming protein Abl,CC1=CC=C(NC(=O)C2=CC=CN=C2)C=C1NC1=NC=CC(=N1)C1=CC=CN=C1
N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,Tyrosine-protein kinase ABL1,CC1=CC=C(NC(=O)C2=CC=CN=C2)C=C1NC1=NC=CC(=N1)C1=CC=CN=C1
"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",Pancreatic alpha-amylase,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",Amylase,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
"N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside",Alpha-amylase 2B,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])N[C@@]1([H])C=C(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide,Phosphoribosylglycinamide formyltransferase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)[C@](O)(CNCC(O)=N[C@]1([H])O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@@]1([H])O)CC1=CC2=C(NC(=N)N=C2O)C=C1)C(O)=O
"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",Cyclin-dependent kinase 2,O=C(CC1=CC=C(C=C1)N1CCCCC1)NC1=NNC2=C1C=C(C=C2)N1CCCS1(=O)=O
"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",Vascular endothelial growth factor receptor 2,CCS(=O)(=O)C1=CC=C(OC)C(NC2=NC=C(O2)C2=CC=CC(=C2)C2=CC=CC=N2)=C1
"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE","Fructose-1,6-bisphosphatase 1",COC1=CC2=C(OC(NS(=O)(=O)C3=CC(Cl)=CC=C3Cl)=N2)C(=C1)C1=CC(N)=CC=C1
N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,Isoleucine--tRNA ligase,[H][C@](C)(CC)[C@]([H])(N)C(O)=NS(=O)(=O)NC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine,NPQTN specific sortase B,CC(C)C[C@H](NC(=O)[C@@H](O)CC(O)=O)C(=O)NCCCCNC(N)=[NH2+]
N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine,Calpain-1 catalytic subunit,CC(C)C[C@H](NC(=O)[C@@H](O)CC(O)=O)C(=O)NCCCCNC(N)=[NH2+]
N-[O-Phosphono-Pyridoxyl]-Isoleucine,"Branched-chain-amino-acid aminotransferase, mitochondrial",[H][C@](C)(CC)[C@@]([H])(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O
N-[Tosyl-D-Prolinyl]Amino-Ethanethiol,Thymidylate synthase,[H][C@@]1(CCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(=O)NCCS
N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,Stromelysin-1,[H][C@](CC(C)C)(N(CC1=CC=CC=C1)[P@](C)(=O)C1=CC=CC=C1)C(=O)NO
N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA,Gag-Pol polyprotein,CCOC1=C(F)C(CCNC(=S)NC2=NC=C(Cl)C=C2)=NC=C1
N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA,Gag-Pol polyprotein,CCOC1=C(F)C(CCNC(=S)NC2=NC=C(C=C2)C#N)=NC=C1
"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",Beta-secretase 1,NC(=N)NC(=O)CN1C(=CC=C1C1=CC=CC=C1)C1=CC=CC=C1
N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,Beta-secretase 1,CCCOC1=CC=C(C=C1)C1=CSC(=C1CC(=O)NC(N)=N)C1=CC=CC=C1Cl
N-acetyl-D-glucosamine-6-phosphate,Glucosamine-6-phosphate isomerase 1,CC(=O)N[C@H]1C(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O
N-acetyl-D-glucosamine-6-phosphate,Glucosamine-6-phosphate deaminase,CC(=O)N[C@H]1C(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O
N-acetyl-alpha-D-glucosamine,Angiotensin-converting enzyme,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-D-glucosamine,Acetylcholinesterase,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-D-glucosamine,Glucosylceramidase,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-D-glucosamine,Sialic acid-binding Ig-like lectin 7,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-D-glucosamine,Hemagglutinin-neuraminidase,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-D-glucosamine,Peptidoglycan-N-acetylmuramic acid deacetylase PdaA,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-D-glucosamine,Fucose-binding lectin PA-IIL,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-D-glucosamine,Ig gamma-1 chain C region,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-D-glucosamine,Envelope glycoprotein gp160,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])N=C(C)O
N-acetyl-alpha-neuraminic acid,Lithostathine-1-alpha,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,E-selectin,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,P-selectin,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Botulinum neurotoxin type B,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Tetanus toxin,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Cholera enterotoxin subunit B,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,3-deoxy-manno-octulosonate cytidylyltransferase,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Neuraminidase,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Enterotoxin type B,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Hemagglutinin-neuraminidase,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Endo-N-acetylneuraminidase,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Liver carboxylesterase 1,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Zinc-alpha-2-glycoprotein,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Fiber,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Capsid protein VP1,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Fiber,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Mannose-binding protein C,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-alpha-neuraminic acid,Sialoadhesin,[H][C@]1(O[C@](O)(C[C@H](O)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
N-acetyl-beta-neuraminic acid,Tetanus toxin,CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O
N-acetyl-beta-neuraminic acid,Hemagglutinin-neuraminidase,CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O
N-acetyl-beta-neuraminic acid,Sialidase,CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O
N-acetyl-beta-neuraminic acid,Endo-N-acetylneuraminidase,CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O
N-acetylserotonin,Sepiapterin reductase,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2
"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine","Dihydroorotate dehydrogenase (quinone), mitochondrial",CC1=NC2=NC=NN2C(NC2=CC3=CC4=CC=CC=C4C=C3C=C2)=C1
N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,Leukotriene A-4 hydrolase,[H][C@]1(COC2=CC=C(NCC3=CC=CC=C3)C=C2)CCCN1
N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,Aurora kinase A,CCCCNC(=O)C1=CC=CC(NC(=O)CCCCCNC2=C3N=CNC3=NC=N2)=C1
N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,Trypsin-1,[H][C@]1(CCCN1C(=O)CNC1CCCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,Prothrombin,[H][C@]1(CCCN1C(=O)CNC1CCCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",Serine/threonine-protein kinase pim-1,FC(F)(F)C1=CC=CC(=C1)C1=NN=C2C=CC(NC3CCCCC3)=NN12
"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",Mitogen-activated protein kinase 10,CN(C1CCCCC1)C1=NC(=CC=N1)C1=CN=C2C=CC=CN12
N-cyclohexyltaurine,Sulfotransferase family cytosolic 2B member 1,OS(=O)(=O)CCNC1CCCCC1
N-cyclohexyltaurine,Nitrite reductase,OS(=O)(=O)CCNC1CCCCC1
N-cyclohexyltaurine,Cyanovirin-N,OS(=O)(=O)CCNC1CCCCC1
N-cyclohexyltaurine,Ribonuclease PH,OS(=O)(=O)CCNC1CCCCC1
N-cyclohexyltaurine,Phosphoprotein,OS(=O)(=O)CCNC1CCCCC1
N-cyclohexyltaurine,Homeobox protein engrailed-2,OS(=O)(=O)CCNC1CCCCC1
N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,Prothrombin,[H][C@]1(CCCN1C(=O)CNC1CCCCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,Trypsin-1,[H][C@]1(CCCN1C(=O)CNC1CCCCCCC1)C(=O)NCC1=CC=C(C=C1)C(N)=N
"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",Mitogen-activated protein kinase 14,CC1=NN=C(O1)C1=CC=C(C(C)=C1)C1=CC(=CC=C1C)C(=O)NC1CC1
"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",Mitogen-activated protein kinase 14,CN1C2=C(C=NN2C2=C(F)C=C(F)C=C2)C(NC2=C(C)C=CC(=C2)C(=O)NC2CC2)=CC1=O
N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,Mitogen-activated protein kinase 14,CC1=CC=CC=C1C1=NN=CC2=C1C=CC(=C2)C1=C(C)C=CC(=C1)C(=O)NC1CC1
N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,Mitogen-activated protein kinase 14,CC1=CC=C(C=C1C1=CC2=C(C=C1)N=C(NCCN1CCOCC1)N=C2)C(=O)NC1CC1
"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",Cyclin-A2,C1CC1NC1=NC(=CC=N1)C1=C2C=CC=NN2N=C1
"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",Cyclin-dependent kinase 2,C1CC1NC1=NC(=CC=N1)C1=C2C=CC=NN2N=C1
"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",Vascular endothelial growth factor receptor 2,COC1=C(OC)C=C2C(OC3=CC4=CC=CC(C(=O)NC5CC5)=C4C=C3)=CC=NC2=C1
"N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]1(CC[C@@]([H])(CC1)C1=CC=CN=C1)N(C1CC1)C(=O)C1=CC=C(C=C1)[C@](C)(O)C(F)(F)F
"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",Mitogen-activated protein kinase 14,CCNC(=O)C1=CN2N=CN=C(NC3=CC(=CC=C3C)C(=O)NOC)C2=C1C
"N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine",Diamine acetyltransferase 1,CCCNCCCNCCCNCC
N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,A disintegrin and metalloproteinase with thrombospondin motifs 5,ONC(=O)C1(CCOCC1)S(=O)(=O)C1=CC=C(OC2=CC=C(C=C2)C(F)(F)F)C=C1
"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",Histone deacetylase 4,ONC(=O)C1=CC=C(S1)C(=O)N1CCN2C(C1)=NC=C2C1=CC=CC=C1
N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,Leukotriene A-4 hydrolase,CNCC1=CC=CC=C1C1=CC=CS1
N-oxo-2-(phenylsulfonylamino)ethanamide,Macrophage metalloelastase,O=NC(=O)CNS(=O)(=O)C1=CC=CC=C1
N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,Macrophage metalloelastase,O=NC(=O)CNS(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1
N-phenyl-1H-pyrazole-3-carboxamide,Cyclin-dependent kinase 2,O=C(NC1=CC=CC=C1)C1=NNC=C1
"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",Serine/threonine-protein kinase pim-1,N(C1=CNC2=NC=CC=C12)C1=CC=CC=C1
"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,[H][C@](C)(O)[C@]([H])(NC(=O)C1=CC=C(C=C1)C#CC1=CC=C(CN2CCOCC2)C=C1)C(=O)NO
N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine,Aminopeptidase N,[H][C@@](C)(N)[P@@](O)(=O)C[C@@]([H])(CC1=CC=CC=C1)C(=O)N[C@@]([H])(CC1=CC=CC=C1)C(O)=O
"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine","Nitric oxide synthase, brain",[H][C@]1(CC2=NC(N)=CC(C)=C2)CNC[C@]1([H])NCCNCC1=CC(Cl)=CC=C1
"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine","Nitric oxide synthase, endothelial",[H][C@]1(CC2=NC(N)=CC(C)=C2)CNC[C@]1([H])NCCNCC1=CC(Cl)=CC=C1
"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE","Nitric oxide synthase, brain",[H][C@]1(CC2=NC(N)=CC(C)=C2)CNC[C@@]1([H])NCCNCC1=CC=C(Cl)C=C1
"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE","Nitric oxide synthase, endothelial",[H][C@]1(CC2=NC(N)=CC(C)=C2)CNC[C@@]1([H])NCCNCC1=CC=C(Cl)C=C1
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine,"Nitric oxide synthase, brain",NCCNC[C@@H](N)CCCNC(=N)N[N+]([O-])=O
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine,"Nitric oxide synthase, endothelial",NCCNC[C@@H](N)CCCNC(=N)N[N+]([O-])=O
"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",Corticosteroid 11-beta-dehydrogenase isozyme 1,C[C@](O)(C1=CC=C(C=C1)C(=O)N(C1CC1)C1CCN(CC2(CC2)C(N)=O)CC1)C(F)(F)F
N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid,Tyrosine-protein phosphatase non-receptor type 1,[H]C(CS)(N=C(O)CCCCCN=C(O)[C@]([H])(CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)N=C(O)C([H])(CC(O)=O)N=C(O)CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)C(O)=N
"N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE",Mitogen-activated protein kinase 10,[H][C@@]1(CC[C@@]([H])(CC1)C(=O)NC1=CC(=CC=N1)C1=CC(NC2=CC=C(F)C=C2)=NC=C1)OC
"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",Prothrombin,[H][C@@]1(CCCCN1)C(F)(F)CNC1=NC=CC2=C1N=C(CC1=CC=CC=C1N1C=NC=N1)O2
"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",Serine/threonine-protein kinase B-raf,CCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CN=CC=C2)=C1F
"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",Neutrophil collagenase,CN(CCOC1=CC=C(C=C1)C1=CC=C(C=C1)C#N)C(=O)NO
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,Carbonic anhydrase 1,CC(=O)NCCC1=CC=C(C=C1)S(N)(=O)=O
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,Carbonic anhydrase 2,CC(=O)NCCC1=CC=C(C=C1)S(N)(=O)=O
"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",Renin,CCC1=NC(N)=NC(N)=C1C1=CC=C2SC(C)(C)C(=O)N(CCNC(C)=O)C2=C1
"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",Renin,CCC1=NC(N)=NC(N)=C1C1=CC2=C(OC(C)(C)C(=O)N2CCNC(C)=O)C=C1
N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,Beta-secretase 1,CC1=CC=C(NC2=CC(=NC=N2)C2=CC=CC=C2)C=C1NS(C)(=O)=O
N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,Prothrombin,CC1=CC(OCCNC2=CC=[NH+]C=C2)=CC(NS(=O)(=O)C2=CC=CC=C2)=C1
N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,Aurora kinase A,FC(F)(F)C1=CC=CC(NC2=NC(NC3=CC(NC(=O)C4CC4)=CC=C3)=NC=C2)=C1
"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",Serine/threonine-protein kinase B-raf,CCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(Cl)C=C23)=C(F)C=C1
"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",Cell division protein ZipA,[H][C@@]12CCCC[N@]1CC(=O)C1=C2N(CCCNS(=O)(=O)C(C)C)C2=C1C=CC=C2
"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",Cell division protein ZipA,[H][C@@]12CCCC[N@]1CC(=O)C1=C2N(CCCNS(=O)(=O)C(C)C)C2=C1C=CC=C2
N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid,Gag-Pol polyprotein,CC1=C(C=CO1)C(=S)NC1=CC(\C=N\OC(C)(C)C)=C(Cl)C=C1
"N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-(2-Thiophen-2-Yl-Acetylamino)-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",Cholera enterotoxin subunit B,[H][C@]1(CO)O[C@]([H])(OC2=CC(=CC(=C2)N=C(O)CC2=CC=CS2)C(O)=NCCCN2CCN(CCCN)CC2)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide,Cholera enterotoxin subunit B,[H][C@]1(CO)O[C@]([H])(OC2=CC(=CC(=C2)N(=O)=O)C(O)=NCCCN2CCN(CCCN)CC2)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide,Cholera enterotoxin subunit B,[H][C@]1(CO)O[C@@]([H])(OC2=CC(=CC(=C2)N(=O)=O)C(O)=NCCCN2CCN(CCCN)CC2)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
"N-{3-[4-hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide",Genome polyprotein,CC(C)CCN1N2C=CC=C2C(O)=C(C1=O)C1=NC2=C(C=C(NS(C)(=O)=O)C=C2)S(=O)(=O)N1
"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",Mitogen-activated protein kinase 9,O=C(NC1=CC(=CC=C1)C1=NNC2=CC=C(C=C12)C1=NNC=N1)C1=CC=CO1
"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",Catechol O-methyltransferase,[H]\C(CN=C(O)C1=C(O)C(O)=CC(=C1)N(=O)=O)=C(\[H])[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,Angiopoietin-1 receptor,CC1=CC=C(NC(=O)C2=CC=CC(=C2)C(F)(F)F)C=C1NC1=NC=CC=C1C1=CC=NC=N1
"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",Serine/threonine-protein kinase Chk1,CN1CCN(CC1)C1=CC=C(C=C1)C1=CC2=C(NC=C2NC(=O)C2=CN=CC=C2)N=C1
"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-",Cathepsin B,[H][C@](C)(O)[C@]([H])(N=C(O)[C@@]1([H])O[C@]1([H])C(=O)OCC)C(O)=N[C@]([H])(C(O)=O)[C@@]([H])(C)CC
"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE",Cathepsin B,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)OCC)C(O)=O
"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE",Cathepsin B,[H][C@@](C)(NC(=O)[C@@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)OCC)[C@@]([H])(C)CC)C(O)=O
"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE",Cathepsin B,[H][C@](C)(CC)[C@]([H])(NC(=O)[C@@]([H])(NC(=O)[C@@]1([H])O[C@]1([H])C(=O)OCC)[C@@]([H])(C)CC)C(O)=O
N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE,Ig gamma-1 chain C region,[H][C@](CC1=CC=CC=C1)(NC(=O)CCCC(O)=O)[P@](O)(=O)OCC(=O)NCCC1=CC=CC=C1
N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,Disintegrin and metalloproteinase domain-containing protein 17,[H][C@](CC1=CNC2=C1C=C(C)C=C2)(NS(=O)(=O)C1=CC=C(OCC#CC)C=C1)C(O)=O
N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,UDP-N-acetylmuramoylalanine--D-glutamate ligase,[H][C@](CCC(O)=O)(NS(=O)(=O)C1=CC2=C(C=C1)C=C(OCCCCC)C=C2)C(O)=O
"N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane","Nitric oxide synthase, endothelial",CS\C(N)=N\CCCCCCCCCCCCCC\N=C(/N)SC
"N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",Casein kinase II subunit alpha,CN1CCN2C1=NC1=C(Br)C(Br)=C(Br)C(Br)=C21
N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,Pro-cathepsin H,[H][C@@](CC1=CC=CC=C1)(NC(=O)C(=O)CC(=O)NCCC1=NC=CC=C1)C(=O)N(C)C
"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE","ATP synthase subunit alpha, mitochondrial",[H][C@](N)(CC(C)C)CN1CCC[N@@]2CCC[C@@]12[H]
"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE","ATP synthase subunit beta, mitochondrial",[H][C@](N)(CC(C)C)CN1CCC[N@@]2CCC[C@@]12[H]
"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE","ATP synthase subunit gamma, mitochondrial",[H][C@](N)(CC(C)C)CN1CCC[N@@]2CCC[C@@]12[H]
N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE,Methionine aminopeptidase,O=C(NC1CCCC1)C(=O)NC1=NC=CS1
N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,Cathepsin K,[H][C@@](CCCC)(NC(=O)[C@]([H])(CC(C)C)NC(=O)OCC1=CC=C(Br)C=C1)C=O
N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide,Cathepsin K,[H]N([C@@H](CC(C)C)C(=O)N([H])[C@@H]1CN(CC1=O)C(=O)[C@H](CC(C)C)N([H])C(=O)OCC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1
N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,Cathepsin K,[H][C@@](CC(C)C)(NC(=O)OCC1=CC=CC=C1)C(=O)N[C@]1([H])CCN(C1)C#N
"N3, N4-Dimethylarginine",Haloalkane dehalogenase,CN\C(NCCC[C@H](N)C(O)=O)=N/C
"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",Prothrombin,NC(=N)NNC(=O)N(C1=CC=CC=C1)C1=CC=CC=C1
"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",Matrilysin,[H][C@@](CC(C)C)(CC(=O)NO)C(=O)N[C@@]1([H])CC2=CN(CCCCCCNC1=O)C1=C2C=CC=C1
N5-(1-Imino-3-Butenyl)-L-Ornithine,"Nitric oxide synthase, brain",[H][C@]([NH3+])(CCCNC(=N)CCC)C(O)=O
N5-Iminoethyl-L-Ornithine,"Nitric oxide synthase, endothelial",[H][C@](N)(CCCNC(C)=N)C(O)=O
N5-Methylglutamine,Release factor glutamine methyltransferase,CNC(=O)CC[C@H](N)C(O)=O
"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",Dihydrofolate reductase,COC1=CC(CN(C)C2=CC3=C(N=C2)N=C(N)N=C3N)=C(OC)C=C1
N6-Benzyl Adenosine-5'-Diphosphate,Proto-oncogene tyrosine-protein kinase Src,[H][C@]1(COP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(NCC4=CC=CC=C4)N=CN=C23)[C@]([H])(O)[C@]1([H])O
N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,"Tyrosine--tRNA ligase, cytoplasmic",[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2N=CN=C3NCCC(C)C)[C@]([H])(O)[C@]1([H])O
"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",Prothrombin,CCCCNC1=CC(C)=NC2=NC(NC3=CC(Cl)=CC=C3C)=NN12
N7-Methyl-Formycin A,Purine nucleoside phosphorylase DeoD-type,[H][C@]1(CO)O[C@@]([H])(C2=C3N=CN=C(NC)C3=NN2)[C@]([H])(O)[C@]1([H])O
N7-Methyl-Guanosine-5'-Monophosphate,m7GpppX diphosphatase,C[N+]1=CN([C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O)C2=C1C(O)=NC(=N)N2
NADH,Estradiol 17-beta-dehydrogenase 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NAD(P) transhydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Alcohol dehydrogenase class-3,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Aminomethyltransferase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,7-dehydrocholesterol reductase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,L-lactate dehydrogenase B chain,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Methylsterol monooxygenase 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,L-lactate dehydrogenase A-like 6B,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Aldo-keto reductase family 1 member C1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Corticosteroid 11-beta-dehydrogenase isozyme 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Aldehyde dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Alpha-aminoadipic semialdehyde dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NAD-dependent malic enzyme, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,L-lactate dehydrogenase C chain,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Succinate-semialdehyde dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH-cytochrome b5 reductase 3,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,D-3-phosphoglycerate dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"2-oxoglutarate dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Cytochrome c oxidase subunit NDUFA4,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 subunit C2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Glutamate dehydrogenase 1, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,3-keto-steroid reductase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Aldehyde dehydrogenase family 3 member B2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Estradiol 17-beta-dehydrogenase 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH-ubiquinone oxidoreductase chain 3,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Ribosyldihydronicotinamide dehydrogenase [quinone],NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Pyrroline-5-carboxylate reductase 1, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Alcohol dehydrogenase 1A,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Tyrosinase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Trifunctional enzyme subunit alpha, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH-ubiquinone oxidoreductase chain 4L,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,4-trimethylaminobutyraldehyde dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,L-lactate dehydrogenase A-like 6A,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Sorbitol dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,3-hydroxyacyl-CoA dehydrogenase type-2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADP-dependent malic enzyme, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Corticosteroid 11-beta-dehydrogenase isozyme 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Dihydrofolate reductase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Testosterone 17-beta-dehydrogenase 3,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Steroid 17-alpha-hydroxylase/17,20 lyase",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH-ubiquinone oxidoreductase chain 6,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,GDH/6PGL endoplasmic bifunctional protein,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Alcohol dehydrogenase 4,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Alcohol dehydrogenase 1B,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Peroxisomal multifunctional enzyme type 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Cytochrome P450 4A11,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,L-lactate dehydrogenase A chain,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Aldo-keto reductase family 1 member C4,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Aldehyde dehydrogenase family 3 member B1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Alcohol dehydrogenase 1C,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Aldehyde dehydrogenase X, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH-ubiquinone oxidoreductase chain 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Retinal dehydrogenase 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Alcohol dehydrogenase class 4 mu/sigma chain,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Dihydropteridine reductase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Glyceraldehyde-3-phosphate dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Acyl carrier protein, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH-ubiquinone oxidoreductase chain 4,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,15-hydroxyprostaglandin dehydrogenase [NAD(+)],NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Retinal dehydrogenase 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Cysteine dioxygenase type 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,11-cis retinol dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,3-hydroxy-3-methylglutaryl-coenzyme A reductase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Estradiol 17-beta-dehydrogenase 8,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH-ubiquinone oxidoreductase chain 5,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Aldehyde dehydrogenase family 1 member A3,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Peroxisomal bifunctional enzyme,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Heme oxygenase 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Malate dehydrogenase, cytoplasmic",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Aldo-keto reductase family 1 member C3,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Flavin reductase (NADPH),NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Fatty aldehyde dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADP-dependent malic enzyme,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"C-1-tetrahydrofolate synthase, cytoplasmic",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Aldo-keto reductase family 1 member C2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,UDP-glucose 6-dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Glutathione reductase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH-ubiquinone oxidoreductase chain 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,GDP-L-fucose synthase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Aldehyde dehydrogenase, dimeric NADP-preferring",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Inosine-5'-monophosphate dehydrogenase 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Pyrroline-5-carboxylate reductase 2,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Heme oxygenase 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Dihydrolipoyl dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Biliverdin reductase A,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Aldose reductase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Glutamate dehydrogenase 2, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,Inosine-5'-monophosphate dehydrogenase 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NADH,"Malate dehydrogenase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,Replicase polyprotein 1ab,[H][C@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)C(=O)CCO
NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,Replicase polyprotein 1a,[H][C@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)C(=O)CCO
NAM NAPTHYLAMINOALANINE,Pol polyprotein,[H][C@](N)(CC1=CC=CC2=C1C=CC=C2)C(N)=O
NAPHTHALEN-2-YL-3-ALANINE,Periplasmic oligopeptide-binding protein,[H][C@](N)(CC1=CC=CC2=C1C=CC=C2)C(O)=O
NAPHTHALEN-2-YL-3-ALANINE,Pol polyprotein,[H][C@](N)(CC1=CC=CC2=C1C=CC=C2)C(O)=O
"NAPHTHALENE-1,2-DIOL","1,2-dihydroxynaphthalene dioxygenase",OC1=CC=C2C=CC=CC2=C1O
NAPHTHYLOXYACETIC ACID,Gag-Pol polyprotein,OC(=O)COC1=CC=CC2=CC=CC=C12
NAPHTHYLOXYACETIC ACID,Gag-Pol polyprotein,OC(=O)COC1=CC=CC2=CC=CC=C12
NCX 950,Beta-2 adrenergic receptor,
ND7001,"cGMP-dependent 3',5'-cyclic phosphodiesterase",
ND7001,"Phosphodiesterase 2A, cGMP-stimulated",
NF-kappaB Decoy,Nuclear factor NF-kappa-B p100 subunit,
NF-kappaB Decoy,Nuclear factor NF-kappa-B p105 subunit,
NGX267,Muscarinic acetylcholine receptor M1,CC[C@@H]1SC2(CCN(C)CC2)NC1=O
NM-702,Thromboxane-A synthase,
NN344,Insulin receptor,
NOX-700,Nuclear factor NF-kappa-B p105 subunit,
NOX-700,Nuclear factor NF-kappa-B p100 subunit,
NP-50301,Estrogen receptor,
NPI 32101,Cytokine receptor common subunit beta,
NPS-2143,Extracellular calcium-sensing receptor,CC(C)(CC1=CC=C2C=CC=CC2=C1)NC[C@@H](O)COC1=CC=CC(Cl)=C1C#N
NRP409,Ketimine reductase mu-crystallin,
NRP409,Thyroid hormone receptor alpha,
NS-398,Cyclooxygenase 2,CS(=O)(=O)NC1=CC=C(C=C1OC1CCCCC1)[N+]([O-])=O
NU1025,Poly [ADP-ribose] polymerase 1,CC1=NC2=C(C=CC=C2O)C(=O)N1
NXN-188,"Nitric oxide synthase, brain",
NXN-188,5-hydroxytryptamine receptor 1D,
NXN-188,5-hydroxytryptamine receptor 1B,
Nabilone,Cannabinoid receptor 1,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC
Nabilone,Cannabinoid receptor 2,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC
Nabiximols,Cannabinoid receptor 1,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Cannabinoid receptor 2,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,G-protein coupled receptor 12,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Glycine receptor subunit alpha-1,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Glycine receptor subunit alpha-1,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Glycine receptor subunit beta,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Glycine receptor subunit alpha-3,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,N-arachidonyl glycine receptor,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,G-protein coupled receptor 55,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,5-hydroxytryptamine receptor 1A,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,5-hydroxytryptamine receptor 2A,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Neuronal acetylcholine receptor subunit alpha-7,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Delta-type opioid receptor,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Mu-type opioid receptor,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Peroxisome proliferator-activated receptor gamma,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Transient receptor potential cation channel subfamily V member 1,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Voltage-dependent T-type calcium channel subunit alpha-1G,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Voltage-dependent T-type calcium channel subunit alpha-1H,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Voltage-dependent T-type calcium channel subunit alpha-1I,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Transient receptor potential cation channel subfamily A member 1,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Transient receptor potential cation channel subfamily M member 8,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Transient receptor potential cation channel subfamily V member 2,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Transient receptor potential cation channel subfamily V member 3,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Transient receptor potential cation channel subfamily V member 4,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabiximols,Voltage-dependent anion-selective channel protein 1,[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C
Nabumetone,Prostaglandin G/H synthase 2,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
Nabumetone,Prostaglandin G/H synthase 1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
Nadolol,Beta-1 adrenergic receptor,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2
Nadolol,Beta-2 adrenergic receptor,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,Dihydropyrimidine dehydrogenase [NADP(+)],NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,Glucose-6-phosphate 1-dehydrogenase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,Pteridine reductase 1,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,Glucose--fructose oxidoreductase,NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,"Thioredoxin reductase 1, cytoplasmic",NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@@H](O)[C@H]1O
Nadroparin,Antithrombin-III,
Nadroparin,P-selectin,
Nadroparin,Proto-oncogene c-Fos,
Nadroparin,Myc proto-oncogene protein,
Nafamostat,Prothrombin,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
Nafamostat,Coagulation factor X,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
Nafamostat,Coagulation factor XII,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
Nafamostat,Trypsin-1,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
Nafamostat,Kallikrein-1,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
Nafamostat,Intercellular adhesion molecule 1,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N
Nafarelin,Gonadotropin-releasing hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
Nafarelin,Putative gonadotropin-releasing hormone II receptor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
Nafcillin,Penicillin-binding protein 1b,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O
Nafcillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O
Nafcillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O
Nafcillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O
Nafcillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(OCC)C=CC2=CC=CC=C12)C(O)=O
Naftifine,Squalene monooxygenase,CN(CC=CC1=CC=CC=C1)CC1=CC=CC2=CC=CC=C12
Nalbuphine,Delta-type opioid receptor,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5
Nalbuphine,Kappa-type opioid receptor,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5
Nalbuphine,Mu-type opioid receptor,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5
Naldemedine,Mu-type opioid receptor,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O
Naldemedine,Delta-type opioid receptor,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O
Naldemedine,Kappa-type opioid receptor,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O
Nalmefene,Mu-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C
Nalmefene,Kappa-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C
Nalmefene,Delta-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C
Naloxegol,Mu-type opioid receptor,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5
Naloxone,Mu-type opioid receptor,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
Naloxone,Delta-type opioid receptor,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
Naloxone,Kappa-type opioid receptor,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
Naloxone,Cyclic AMP-responsive element-binding protein 1,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
Naloxone,Estrogen receptor,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
Naloxone,Toll-like receptor 4,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
Naloxone,Liver carboxylesterase 1,OC1=CC=C2C[C@H]3N(CC=C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",Trypsin-1,[H][C@@](CC1=CC=CC(=C1)C(N)=N)(NC(=O)CNS(=O)(=O)C1=CC=C(C)C=C1)C(=O)OC
Naltrexone,Delta-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
Naltrexone,Kappa-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
Naltrexone,Mu-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
Naltrexone,"HCG20471, isoform CRA_c",[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O
Naluzotan,5-hydroxytryptamine receptor 1A,CC(=O)NC1=CC=CC(=C1)N1CCN(CCCCNS(=O)(=O)CC2CCCCC2)CC1
Namn,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,[H][C@]1(COP(O)([O-])=O)O[C@@]([H])([N+]2=CC=CC(=C2)C(O)=O)[C@]([H])(O)[C@]1([H])O
Namn,Nicotinate-nucleotide pyrophosphorylase [carboxylating],[H][C@]1(COP(O)([O-])=O)O[C@@]([H])([N+]2=CC=CC(=C2)C(O)=O)[C@]([H])(O)[C@]1([H])O
Nanaomycin D,ActVA 6 protein,[H][C@]12CC(=O)O[C@]1([H])C1=C(C(=O)C3=C(C=CC=C3O)C1=O)[C@]([H])(C)O2
Nandrolone decanoate,Androgen receptor,CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C
Nandrolone phenpropionate,Androgen receptor,[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Naphazoline,Alpha-2A adrenergic receptor,C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
Naphazoline,Alpha-1A adrenergic receptor,C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
Naphthalene Trisulfonate,Fibroblast growth factor 1,[O-]S(=O)(=O)C1=CC2=C(C=C1)C(=CC(=C2)S([O-])(=O)=O)S([O-])(=O)=O
"Naphthalene-2,6-disulfonic acid",L-lactate dehydrogenase,OS(=O)(=O)C1=CC2=CC=C(C=C2C=C1)S(O)(=O)=O
"Naphthalene-2,6-disulfonic acid",Bacterioferritin comigratory protein,OS(=O)(=O)C1=CC2=CC=C(C=C2C=C1)S(O)(=O)=O
Naphthyridine Inhibitor,TGF-beta receptor type-1,CC1=CC=CC(=N1)C1=C(CNN1)C1=CC=C2N=CC=CC2=N1
Naproxen,Prostaglandin G/H synthase 1,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
Naproxen,Prostaglandin G/H synthase 2,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
Naproxen,Peptostreptococcal albumin-binding protein,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
Naratriptan,5-hydroxytryptamine receptor 1F,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1
Naratriptan,5-hydroxytryptamine receptor 1D,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1
Naratriptan,5-hydroxytryptamine receptor 1B,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1
Naratriptan,5-hydroxytryptamine receptor 1A,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1
Naringenin,HTH-type transcriptional regulator TtgR,[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Naringenin,Estrogen receptor,[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Naringenin,Aldo-keto reductase family 1 member C1,[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Naringenin,Cytochrome P450 1B1,[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Naringenin,KAT8 regulatory NSL complex subunit 3,[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Naringenin,Sex hormone-binding globulin,[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Naringenin,Aromatase,[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Naringenin,Estrogen receptor beta,[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1
Naronapride,5-hydroxytryptamine receptor 4,CO[C@H]1CN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)CC[C@H]1NC(=O)C1=C(OC)C=C(N)C(Cl)=C1
Natalizumab,Integrin alpha-4,
Natalizumab,High affinity immunoglobulin gamma Fc receptor I,
Natalizumab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Natalizumab,Intercellular adhesion molecule 1,
Natalizumab,Complement C1r subcomponent,
Natalizumab,Complement C1q subcomponent subunit A,
Natalizumab,Complement C1q subcomponent subunit B,
Natalizumab,Complement C1q subcomponent subunit C,
Natalizumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Natalizumab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Natalizumab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Natalizumab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Nateglinide,ATP-binding cassette sub-family C member 8,[H][C@](CC1=CC=CC=C1)(N=C(O)[C@@]1([H])CC[C@@]([H])(CC1)C(C)C)C(O)=O
Nateglinide,Peroxisome proliferator-activated receptor gamma,[H][C@](CC1=CC=CC=C1)(N=C(O)[C@@]1([H])CC[C@@]([H])(CC1)C(C)C)C(O)=O
Naveglitazar,Peroxisome proliferator-activated receptor gamma,CO[C@@H](CC1=CC=C(OCCCOC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1)C(O)=O
Navitoclax,Apoptosis regulator Bcl-2,[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F
Navitoclax,Bcl-2-like protein 2,[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F
Navitoclax,Bcl2-associated agonist of cell death,[H][C@@](CCN1CCOCC1)(CSC1=CC=CC=C1)NC1=C(C=C(C=C1)S(=O)(=O)NC(=O)C1=CC=C(C=C1)N1CCN(CC2=C(CCC(C)(C)C2)C2=CC=C(Cl)C=C2)CC1)S(=O)(=O)C(F)(F)F
Naxifylline,Adenosine receptor A1,[H][C@]12O[C@@]1([H])[C@@]1([H])C[C@]2([H])C[C@@H]1C1=NC2=C(N1)N(CCC)C(=O)C(CCC)C2=O
Ncs-Chromophore,Neocarzinostatin,[H]\C1=C2\C(=C[C@@]([H])(OC(=O)C3=C(O)C=CC4=C3C=C(OC)C=C4C)[C@]2([H])O[C@@]2([H])O[C@]([H])(C)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])NC)C#C[C@@]2(O[C@]2([H])C#C1)[C@@]1([H])COC(=O)O1
Nd1-Phosphonohistidine,Phosphocarrier protein HPr,N[C@@H](CC1=C[NH+]=CN1P(O)(O)=O)C(O)=O
Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine,Ornithine carbamoyltransferase chain I,[H][C@](N)(CCCN[P@@](N)(=O)NS(O)(=O)=O)C(O)=O
Nebivolol,Beta-1 adrenergic receptor,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2
Nebivolol,Beta-2 adrenergic receptor,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2
Nebularine,Adenosine deaminase,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=CN=CN=C23)[C@]([H])(O)[C@]1([H])O
Necitumumab,Epidermal growth factor receptor,
Nedocromil,Cysteinyl leukotriene receptor 1,CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O
Nedocromil,Cysteinyl leukotriene receptor 2,CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O
Nedocromil,fMet-Leu-Phe receptor,CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O
Nedocromil,Prostaglandin D2 receptor,CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O
Nedocromil,Heat shock protein HSP 90-alpha,CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O
Nefazodone,5-hydroxytryptamine receptor 2A,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,5-hydroxytryptamine receptor 2C,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,Sodium-dependent serotonin transporter,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,5-hydroxytryptamine receptor 1A,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,Sodium-dependent noradrenaline transporter,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,Sodium-dependent dopamine transporter,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,Alpha-1B adrenergic receptor,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,Alpha-2A adrenergic receptor,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,Alpha-1A adrenergic receptor,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Nefazodone,Potassium voltage-gated channel subfamily H member 2,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1
Neflamapimod,Mitogen-activated protein kinase 14,FC1=CC(F)=C(SC2=NN3C=NC(=O)C(=C3C=C2)C2=C(Cl)C=CC=C2Cl)C=C1
Nelarabine,DNA polymerase alpha catalytic subunit,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Nelfinavir,HIV-1 protease,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C
Nelipepimut-S,"HLA class I histocompatibility antigen, A-2 alpha chain",
Nelipepimut-S,"HLA class I histocompatibility antigen, A-3 alpha chain",
Nelotanserin,5-hydroxytryptamine receptor 2A,COC1=CC=C(NC(=O)NC2=CC=C(F)C=C2F)C=C1C1=C(Br)C=NN1C
Neomycin,30S ribosomal protein S12,
Neomycin,Extracellular calcium-sensing receptor,
Neostigmine,Acetylcholinesterase,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
Nepafenac,Prostaglandin G/H synthase 1,NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N
Nepafenac,Prostaglandin G/H synthase 2,NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N
Neramexane,"Glutamate receptor ionotropic, NMDA 3A",CC1(C)CC(C)(C)CC(C)(N)C1
Neratinib,Epidermal growth factor receptor,CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N
Nesbuvir,Genome polyprotein,CNC(=O)C1=C(OC2=CC(N(CCO)S(C)(=O)=O)=C(C=C12)C1CC1)C1=CC=C(F)C=C1
Nesbuvir,Genome polyprotein,CNC(=O)C1=C(OC2=CC(N(CCO)S(C)(=O)=O)=C(C=C12)C1CC1)C1=CC=C(F)C=C1
Nesiritide,Atrial natriuretic peptide receptor 1,
Nesiritide,Atrial natriuretic peptide receptor 2,
Nesiritide,Atrial natriuretic peptide receptor 3,
Netarsudil,Rho-associated protein kinase 1,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1
Netarsudil,Rho-associated protein kinase 2,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1
Netilmicin,30S ribosomal protein S12,CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O
Netupitant,Substance-P receptor,CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=C(C=C1C1=CC=CC=C1C)N1CCN(C)CC1
Nevirapine,Reverse transcriptase/RNaseH,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1
Niacin,Hydroxycarboxylic acid receptor 3,OC(=O)C1=CN=CC=C1
Niacin,Hydroxycarboxylic acid receptor 2,OC(=O)C1=CN=CC=C1
Niacin,Nicotinate-nucleotide pyrophosphorylase [carboxylating],OC(=O)C1=CN=CC=C1
Niacin,Nicotinamide N-methyltransferase,OC(=O)C1=CN=CC=C1
Nialamide,Amine oxidase [flavin-containing] B,O=C(CCNNC(=O)C1=CC=NC=C1)NCC1=CC=CC=C1
Nialamide,Amine oxidase [flavin-containing] A,O=C(CCNNC(=O)C1=CC=NC=C1)NCC1=CC=CC=C1
Nialamide,Catechol O-methyltransferase,O=C(CCNNC(=O)C1=CC=NC=C1)NCC1=CC=CC=C1
Nicardipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Voltage-dependent L-type calcium channel subunit beta-2,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Voltage-dependent calcium channel subunit alpha-2/delta-1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Alpha-1A adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Alpha-1B adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Alpha-1D adrenergic receptor,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Muscarinic acetylcholine receptor M1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Muscarinic acetylcholine receptor M2,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Muscarinic acetylcholine receptor M3,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Muscarinic acetylcholine receptor M4,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Muscarinic acetylcholine receptor M5,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicardipine,Calmodulin,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Nicergoline,Alpha-1A adrenergic receptor,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)[C@]1(C[C@@H](COC(=O)C1=CN=CC(Br)=C1)CN2C)OC
Nicorandil,ATP-binding cassette sub-family C member 9,[O-][N+](=O)OCCNC(=O)C1=CC=CN=C1
Nicotinamide,L-lactate dehydrogenase A chain,NC(=O)C1=CC=CN=C1
Nicotinamide,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,NC(=O)C1=CC=CN=C1
Nicotinamide,Poly [ADP-ribose] polymerase 1,NC(=O)C1=CC=CN=C1
Nicotinamide,Exotoxin A,NC(=O)C1=CC=CN=C1
Nicotinamide,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",NC(=O)C1=CC=CN=C1
Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,"6-phosphogluconate dehydrogenase, decarboxylating",[H][C@]1(COP([O-])(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C(Br)=NC3=C(N)N=CN=C23)[C@]([H])(OP(O)(O)=O)[C@]1([H])O
Nicotinamide Mononucleotide,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@@H](COP(O)(O)=O)[C@H](O)[C@H]1O
Nicotinamide Mononucleotide,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@@H](COP(O)(O)=O)[C@H](O)[C@H]1O
Nicotinamide Mononucleotide,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3,NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@@H](COP(O)(O)=O)[C@H](O)[C@H]1O
Nicotinamide Mononucleotide,DNA ligase,NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@@H](COP(O)(O)=O)[C@H](O)[C@H]1O
Nicotine,Neuronal acetylcholine receptor subunit alpha-4,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit alpha-7,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit beta-2,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit alpha-2,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit alpha-3,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit alpha-5,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit alpha-6,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit alpha-9,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit alpha-10,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit beta-3,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Neuronal acetylcholine receptor subunit beta-4,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Aromatase,CN1CCC[C@H]1C1=CN=CC=C1
Nicotine,Choline O-acetyltransferase,CN1CCC[C@H]1C1=CN=CC=C1
Nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Nifedipine,Voltage-dependent calcium channel subunit alpha-2/delta-1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Nifedipine,Voltage-dependent L-type calcium channel subunit beta-2,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Nifedipine,Calmodulin,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Nifedipine,Potassium voltage-gated channel subfamily A member 1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Nifedipine,Voltage-dependent T-type calcium channel subunit alpha-1H,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Nifedipine,Nuclear receptor subfamily 1 group I member 2,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC
Niflumic acid,Phospholipase A2,OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1
Niflumic acid,Prostaglandin G/H synthase 2,OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1
Niflumic acid,Chloride channel protein ClC-Ka,OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1
Niflumic acid,Prostaglandin G/H synthase 1,OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1
Niflumic acid,Cytosolic phospholipase A2,OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1
Niflumic acid,UDP-glucuronosyltransferase 1-9,OC(=O)C1=C(NC2=CC=CC(=C2)C(F)(F)F)N=CC=C1
Niguldipine,Alpha-1A adrenergic receptor,[H]N1C(C)=C([C@H](C2=CC(=CC=C2)[N+]([O-])=O)C(C(=O)OCCCN2CCC(CC2)(C2=CC=CC=C2)C2=CC=CC=C2)=C1C)C(=O)OC
Nilotinib,Tyrosine-protein kinase ABL1,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F
Nilotinib,Mast/stem cell growth factor receptor Kit,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F
Nilutamide,Androgen receptor,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
Nilvadipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
Nilvadipine,Voltage-dependent calcium channel subunit alpha-2/delta-1,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
Nilvadipine,Voltage-dependent L-type calcium channel subunit beta-2,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
Nilvadipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
Nilvadipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
Nilvadipine,Voltage-dependent calcium channel subunit alpha-2/delta-3,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
Nimesulide,Prostaglandin G/H synthase 2,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O
Nimesulide,Group IIE secretory phospholipase A2,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O
Nimesulide,Lactotransferrin,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O
Nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1F,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Voltage-dependent L-type calcium channel subunit beta-1,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Voltage-dependent L-type calcium channel subunit beta-2,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Voltage-dependent L-type calcium channel subunit beta-3,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Voltage-dependent L-type calcium channel subunit beta-4,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Mineralocorticoid receptor,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nimodipine,Aryl hydrocarbon receptor,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C
Nintedanib,Vascular endothelial growth factor receptor 1,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Vascular endothelial growth factor receptor 2,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Vascular endothelial growth factor receptor 3,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Fibroblast growth factor receptor 1,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Fibroblast growth factor receptor 2,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Fibroblast growth factor receptor 3,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Receptor-type tyrosine-protein kinase FLT3,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Tyrosine-protein kinase Lck,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Tyrosine-protein kinase Lyn,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Nintedanib,Proto-oncogene tyrosine-protein kinase Src,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
Niraparib,Poly [ADP-ribose] polymerase 1,NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1
Niraparib,Poly [ADP-ribose] polymerase 2,NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1
Nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C
Nisoldipine,Voltage-dependent calcium channel subunit alpha-2/delta-1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C
Nisoldipine,Voltage-dependent L-type calcium channel subunit beta-2,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C
Nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C
Nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1S,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C
Nisoxetine,Sodium-dependent serotonin transporter,CNCCC(OC1=CC=CC=C1OC)C1=CC=CC=C1
Nitazoxanide,Pyruvate synthase,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O
Nitisinone,4-hydroxyphenylpyruvate dioxygenase,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O
Nitrazepam,Gamma-aminobutyric acid receptor subunit alpha-1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit alpha-2,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit alpha-3,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit alpha-4,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit alpha-5,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit alpha-6,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit beta-1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit beta-2,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit beta-3,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit gamma-1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit gamma-2,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit gamma-3,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit delta,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit epsilon,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit pi,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit rho-1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit rho-2,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit rho-3,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Gamma-aminobutyric acid receptor subunit theta,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrazepam,Sodium channel protein type 1 subunit alpha,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1
Nitrendipine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
Nitrendipine,Voltage-dependent calcium channel subunit alpha-2/delta-1,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
Nitrendipine,Voltage-dependent L-type calcium channel subunit beta-2,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
Nitrendipine,Voltage-dependent calcium channel gamma-1 subunit,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
Nitrendipine,Voltage-dependent L-type calcium channel subunit alpha-1D,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
Nitrendipine,Voltage-dependent L-type calcium channel subunit alpha-1S,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
Nitrendipine,Voltage-dependent calcium channel subunit alpha-2/delta-2,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
Nitrendipine,Voltage-dependent T-type calcium channel subunit alpha-1H,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC
Nitric Oxide,Guanylate cyclase soluble subunit alpha-2,[N]=O
Nitric Oxide,Metallothionein-1A,[N]=O
Nitric Oxide,"Indoleamine 2,3-dioxygenase 1",[N]=O
Nitrilotriacetic Acid,Lactotransferrin,OC(=O)CN(CC(O)=O)CC(O)=O
Nitroarginine,"Nitric oxide synthase, brain",N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O
Nitroarginine,"Nitric oxide synthase, endothelial",N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O
Nitroaspirin,Prostaglandin G/H synthase 1,CC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC(CO[N+]([O-])=O)=C1
Nitrocefin Acyl-Serine,Beta-lactam-inducible penicillin-binding protein,[H]\C(=C(\[H])C1=C(C=C(C=C1)N(=O)=O)N(=O)=O)C1=C(N[C@]([H])(SC1)[C@]([H])(N=C([O-])CC1=CC=CS1)C(=O)OC[C@]([H])(N)C([O-])=O)C(O)=O
Nitrofural,Malate dehydrogenase,NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O
Nitrofural,Glutathione reductase,NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O
Nitrofural,Pyruvate dehydrogenase [ubiquinone],NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O
Nitrofural,[Citrate [pro-3S]-lyase] ligase,NC(=O)N\N=C\C1=CC=C(O1)[N+]([O-])=O
Nitrofurantoin,Probable pyruvate-flavodoxin oxidoreductase,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O
Nitrofurantoin,Oxygen-insensitive NADPH nitroreductase,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O
Nitrofurantoin,30S ribosomal protein S10,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O
Nitroglycerin,Atrial natriuretic peptide receptor 1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O
Nitromethyldethia Coenzyme A,"Citrate synthase, mitochondrial",[H][C@](O)(C(O)=NCCC(O)=NCCCN(=O)=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Nitroprusside,Atrial natriuretic peptide receptor 1,O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N
Nitrosoethane,Myoglobin,CCN=O
Nitrous acid,Hemoglobin subunit alpha,ON=O
Nitrous acid,Hemoglobin subunit beta,ON=O
Nitrous acid,Myoglobin,ON=O
Nitroxoline,Methionine aminopeptidase 2,OC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O
Nivolumab,Programmed cell death protein 1,
Nizatidine,Histamine H2 receptor,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O
Nogalaviketone,Nogalonic acid methyl ester cyclase,COC(=O)C1=C(C)CC(=O)C2=C(O)C3=C(C=C12)C(=O)C1=CC=CC(O)=C1C3=O
Nojirimycine Tetrazole,"Glycogen phosphorylase, muscle form",[H][C@]1(O)C2=NN=NN2[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O
Nojirimycine Tetrazole,Lactase-like protein,[H][C@]1(O)C2=NN=NN2[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O
Nojirimycine Tetrazole,Lactase-phlorizin hydrolase,[H][C@]1(O)C2=NN=NN2[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])O
Nomifensine,Sodium-dependent noradrenaline transporter,CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2
Nomifensine,Sodium-dependent dopamine transporter,CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2
Nomifensine,Amine oxidase [flavin-containing] B,CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2
Nomifensine,Amine oxidase [flavin-containing] A,CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2
Nomifensine,Myeloperoxidase,CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2
Nomifensine,Sodium-dependent serotonin transporter,CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2
Nomifensine,Synaptic vesicular amine transporter,CN1CC(C2=CC=CC=C2)C2=C(C1)C(N)=CC=C2
Nonacog beta pegol,Coagulation factor VII,
Nonacog beta pegol,Coagulation factor VIII,
Nonacog beta pegol,Coagulation factor X,
Nonan-1-Ol,"ATP synthase subunit c, sodium ion specific",CCCCCCCCCO
Nonivamide,Transient receptor potential cation channel subfamily V member 1,CCCCCCCCC(=O)NCC1=CC(OC)=C(O)C=C1
Norcamphor,Camphor 5-monooxygenase,[H][C@]12CC[C@]([H])(C1)C(=O)C2
Norelgestromin,Progesterone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Norelgestromin,Serum albumin,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Norelgestromin,Androgen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Norepinephrine,Alpha-1A adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Alpha-1B adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Alpha-1D adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Alpha-2A adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Alpha-2B adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Beta-1 adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Alpha-2C adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Beta-2 adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Beta-3 adrenergic receptor,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Phenylalanine-4-hydroxylase,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Synaptic vesicular amine transporter,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norepinephrine,Chromaffin granule amine transporter,NC[C@H](O)C1=CC(O)=C(O)C=C1
Norethisterone,Progesterone receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Norethynodrel,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3
Norethynodrel,Androgen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3
Norethynodrel,Sex hormone-binding globulin,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3
Norfloxacin,DNA gyrase subunit A,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1
Norfloxacin,DNA topoisomerase 4 subunit A,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1
Norfloxacin,DNA topoisomerase 2-alpha,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1
Norgestimate,Estrogen receptor,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O
Norgestimate,Progesterone receptor,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O
Norgestimate,Androgen receptor,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O
Norgestrel,Progesterone receptor,CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C
Norgestrel,3-oxo-5-alpha-steroid 4-dehydrogenase 1,CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C
Norgestrel,Androgen receptor,CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C
Norleucine Phosphonate,Methionine aminopeptidase,CCCC[C@H](N)P(O)(O)=O
Nortriptyline,Sodium-dependent noradrenaline transporter,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Sodium-dependent serotonin transporter,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,5-hydroxytryptamine receptor 2A,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,5-hydroxytryptamine receptor 1A,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Histamine H1 receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Alpha-1A adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Alpha-1D adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Muscarinic acetylcholine receptor M1,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Muscarinic acetylcholine receptor M2,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Muscarinic acetylcholine receptor M3,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Muscarinic acetylcholine receptor M4,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Muscarinic acetylcholine receptor M5,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,5-hydroxytryptamine receptor 2C,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,5-hydroxytryptamine receptor 6,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Alpha-1B adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Alpha-2A adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Alpha-2B adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Alpha-2C adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Beta-1 adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Beta-2 adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Beta-3 adrenergic receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,D(2) dopamine receptor,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Membrane-associated progesterone receptor component 1,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,Sigma non-opioid intracellular receptor 1,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Nortriptyline,5-hydroxytryptamine receptor 2C,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12
Norvaline,"Ornithine carbamoyltransferase, mitochondrial",CCC[C@H](N)C(O)=O
Norvaline,"Glycine amidinotransferase, mitochondrial",CCC[C@H](N)C(O)=O
Noscapine,Sigma non-opioid intracellular receptor 1,[H][C@@]1(OC(=O)C2=C1C=CC(OC)=C2OC)[C@]1([H])N(C)CCC2=CC3=C(OCO3)C(OC)=C12
Novo Nordisk a/S Compound,Tyrosine-protein phosphatase non-receptor type 1,OC(=O)C(=O)NC1=C(C=C(I)C=C1)C(O)=O
Novobiocin,DNA gyrase subunit B,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C
Novobiocin,DNA topoisomerase 1,CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=CC=C(O)C(CC=C(C)C)=C2)C(=O)O3)OC1(C)C
Nusinersen,Survival motor neuron protein,
Nylidrin,Voltage-dependent T-type calcium channel subunit alpha-1I,CC(CCC1=CC=CC=C1)NC(C)C(O)C1=CC=C(O)C=C1
Nylidrin,Interferon alpha/beta receptor 2,CC(CCC1=CC=CC=C1)NC(C)C(O)C1=CC=C(O)C=C1
Nz-(1-Carboxyethyl)-Lysine,4-hydroxy-tetrahydrodipicolinate synthase,C[C@@H](NCCCC[C@H](N)C(O)=O)C(O)=O
Nz-(Dicarboxymethyl)Lysine,Transaldolase B,N[C@@H](CCCCNC(C(O)=O)C(O)=O)C(O)=O
Nz2-Tryptophan,Endolysin,[H][C@](N)(CC1=CNC2=C1C=CC=N2)C(O)=O
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",Exotoxin A,CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",Elongation factor 2,CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",Cholix toxin,CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",Poly [ADP-ribose] polymerase 3,CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",Poly [ADP-ribose] polymerase 15,CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1
N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide,Stromelysin-1,OCCN(CC(=O)NO)S(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1
"N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",Cathepsin S,[H][C@@](CC1CCCCC1)(NC1=NC2=CC=CC=C2O1)C(=O)NCCNC1=CC=C(OC)C=C1
"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",Serine/threonine-protein kinase/endoribonuclease IRE1,C1CC1C1=NNC(NC2=CC=NC(NC3=CC4=C(NC=N4)C=C3)=N2)=C1
N~2~-Succinylarginine,N-succinylarginine dihydrolase,[H][C@@](CCCNC(N)=N)(N=C(O)CCC(O)=O)C(O)=O
N~2~-Succinylornithine,N-succinylarginine dihydrolase,NCCC[C@H](NC(=O)CCC(O)=O)C(O)=O
"N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",ATP-dependent Clp protease proteolytic subunit,[H][C@@](C)(O)[C@]([H])(CC1=CC=C(O)C=C1)NC(=O)[C@]([H])(CC(C)C)NC(=O)OCC1=CC=CC=C1
"N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",Beta-secretase 1,NC1=NC=CC=C1NCC1=CC=CC(=C1)C1=CN=CC=C1
"N~3~-BENZYLPYRIDINE-2,3-DIAMINE",Beta-secretase 1,NC1=NC=CC=C1NCC1=CC=CC=C1
"N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",Beta-secretase 1,NC1=NC=CC=C1NCC1=CC=CC(=C1)C1=CC2=C(C=CN2)C=C1
"N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",Beta-secretase 1,COC1=CN=CC(=C1)C1=CC(CNC2=CC=CN=C2N)=CC=C1
"N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",Beta-secretase 1,NC1=NC=CC=C1NCC1=C(OCC2=NC=CC=C2)C=CC(=C1)C1=CC2=C(C=CN2)C=C1
"N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",Mitogen-activated protein kinase 14,CC1=CC=C(C=C1C1=CC=C(C=C1)C(=O)NCC1CC1)C(=O)NC1CC1
"N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",Vascular endothelial growth factor receptor 2,COC1=CC(NC2=NC=CC(NC3=CC=C4C(C)=NNC4=C3)=N2)=CC(OC)=C1OC
"N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",Vascular endothelial growth factor receptor 2,COC1=CC(NC2=NC(=CC=N2)N(C)C2=CC3=C(C=C2)C(C)=NN3)=CC(OC)=C1OC
"N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",Aurora kinase B,C1CCC(CC1)NC1=C2N=CNC2=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1
"N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",Inner centromere protein,C1CCC(CC1)NC1=C2N=CNC2=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1
Nα-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide,Stromelysin-3,[H]N([H])C(=O)[C@H](CC1=CN([H])C2=CC=CC=C12)N([H])C(=O)[C@H](CCCC1=CC=CC=C1)CP(O)(=O)[C@@H](CC1=CC=CC=C1)N([H])C(=O)OCC1=CC=CC=C1
Nα-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide,Cathepsin F,[H][C@@](C)(N=C(O)[C@]([H])(CC1=CC=C(O)C=C1)N=C(O)OCC1=CC=CC=C1)C(=O)CF
"O,O-DIETHYL HYDROGEN THIOPHOSPHATE",Phosphotriesterase,CCOP(O)(=S)OCC
O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,Carboxypeptidase A1,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(=O)NC[P@](O)(=O)O[C@@]([H])(CC1=CC=CC=C1)C(O)=O
O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,Carboxypeptidase A1,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@]([H])(C)[P@](O)(=O)O[C@@]([H])(CC1=CC=CC=C1)C(O)=O
O-Benzylsulfonyl-Serine,Subtilisin Savinase,N[C@@H](COS(=O)(=O)CC1=CC=CC=C1)C(O)=O
O-Benzylsulfonyl-Serine,Carboxymethylenebutenolidase,N[C@@H](COS(=O)(=O)CC1=CC=CC=C1)C(O)=O
O-Benzylsulfonyl-Serine,Capsid scaffolding protein,N[C@@H](COS(=O)(=O)CC1=CC=CC=C1)C(O)=O
O-Benzylsulfonyl-Serine,Alkaline protease,N[C@@H](COS(=O)(=O)CC1=CC=CC=C1)C(O)=O
O-Benzylsulfonyl-Serine,Trypsin-2,N[C@@H](COS(=O)(=O)CC1=CC=CC=C1)C(O)=O
O-Decyl Hydrogen Thiocarbonate,3-oxoacyl-[acyl-carrier-protein] synthase 3,CCCCCCCCCCOC(S)=O
O-Succinylbenzoate,o-succinylbenzoate synthase,OC(=O)CCC(=O)C1=C(C=CC=C1)C(O)=O
O-Succinylbenzoate,o-succinylbenzoate synthase,OC(=O)CCC(=O)C1=C(C=CC=C1)C(O)=O
O-Succinylbenzoate,o-succinylbenzoate synthase,OC(=O)CCC(=O)C1=C(C=CC=C1)C(O)=O
"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",Gag-Pol polyprotein,BrC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1
"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",Gag-Pol polyprotein,ClC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1
"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",Gag-Pol polyprotein,IC1=CC=C(NC(=S)OCCN2C(=O)C3=C(C=CC=C3)C2=O)C=C1
O-acetyl-L-serine,Prostaglandin G/H synthase 1,CC(=O)OC[C@H](N)C(O)=O
O1-Pentyl-Mannose,Cyanovirin-N,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(OCCCCC)[C@@]1([H])O
O2-Sulfo-Glucuronic Acid,Fibroblast growth factor 1,[H][C@@]1(O)O[C@@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O
O2-Sulfo-Glucuronic Acid,Hepatocyte growth factor,[H][C@@]1(O)O[C@@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O
O2-Sulfo-Glucuronic Acid,Complement control protein C3,[H][C@@]1(O)O[C@@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O
O2-Sulfo-Glucuronic Acid,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,[H][C@@]1(O)O[C@@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])OS(O)(=O)=O
O3-Sulfonylgalactose,Mannose-binding protein C,[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(OS(O)(=O)=O)[C@@]1([H])O
O4-Sulfonylgalactose,Mannose-binding protein C,[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(OS(O)(=O)=O)[C@]([H])(O)[C@@]1([H])O
"O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine",L-carnitine CoA-transferase,[H][C@@](O)(CC(=O)SCCN=C(O)CCN=C(O)[C@]([H])(O)C(C)(C)COP([O-])(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O)C[N+](C)(C)C
"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",Pyridoxal kinase,[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(OCC2=CC=CC=C2)=N1
O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,Cyclin-A2,NS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1
O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(NC2=NC(OCC3CCCCC3)=C3N=CNC3=N2)C=C1
OBE101,Histamine H1 receptor,
OBE101,Histamine H3 receptor,
"OCTANE-1,3,5,7-TETRACARBOXYLIC ACID",Carboxypeptidase A1,[H][C@](C)(C[C@]([H])(C[C@@]([H])(CCC(O)=O)C(O)=O)C(O)=O)C(O)=O
OLOMOUCINE II,Cyclin-dependent kinase 2,[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=CC=C2O)=N1
OMS-103HP,Interleukin-1 receptor type 1,
OMS-103HP,Tumor necrosis factor,
ONT-093,Multidrug resistance protein 1,[H]\C(COCC)=C(\[H])C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=C(NC(C)C)C=C1)C1=CC=C(NC(C)C)C=C1
OPC-14523,Sodium-dependent serotonin transporter,COC1=CC=CC2=C1CCC(=O)N2CCCN1CCN(CC1)C1=CC=CC(Cl)=C1
OPC-28326,Alpha-2C adrenergic receptor,O.Cl.CCC(=O)NC1=C(C)C=C(C=C1C)C(=O)N1CCC(CC1)N(C)CCC1=CC=CC=C1
OPC-28326,5-hydroxytryptamine receptor 2B,O.Cl.CCC(=O)NC1=C(C)C=C(C=C1C)C(=O)N1CCC(CC1)N(C)CCC1=CC=CC=C1
OPC-28326,Alpha-2B adrenergic receptor,O.Cl.CCC(=O)NC1=C(C)C=C(C=C1C)C(=O)N1CCC(CC1)N(C)CCC1=CC=CC=C1
OPC-51803,Vasopressin V2 receptor,CC(C)NC(=O)C[C@H]1CCCN(C(=O)C2=C(Cl)C=C(C=C2)N2CCCC2)C2=CC=CC=C12
ORE-1001,Carboxypeptidase N catalytic chain,[H][C@@](CC(C)C)(N[C@@]([H])(CC1=CN=CN1CC1=CC(Cl)=CC(Cl)=C1)C(O)=O)C(O)=O
ORE-1001,Carboxypeptidase N subunit 2,[H][C@@](CC(C)C)(N[C@@]([H])(CC1=CN=CN1CC1=CC(Cl)=CC(Cl)=C1)C(O)=O)C(O)=O
ORG-34517,Glucocorticoid receptor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1=CC=C2OCOC2=C1
ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,Lactose operon repressor,[H][C@]1(C)O[C@@]([H])(OC2=CC=CC=C2[N+]([O-])=O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
OSI-461,"cGMP-specific 3',5'-cyclic phosphodiesterase",
OSI-7904L,Thymidylate synthase,
OSI-930,Vascular endothelial growth factor receptor 1,FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=CC=CC=C34)C=CS2)C=C1
OSI-930,Mast/stem cell growth factor receptor Kit,FC(F)(F)OC1=CC=C(NC(=O)C2=C(NCC3=CC=NC4=CC=CC=C34)C=CS2)C=C1
Obatoclax,Apoptosis regulator Bcl-2,COC1=CC(=N\C1=C/C1=C(C)C=C(C)N1)C1=CC2=CC=CC=C2N1
Obeticholic acid,Bile acid receptor,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)[C@]([H])(CC)[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
Obinepitide,Neuropeptide Y receptor type 4,CC[C@H](C)[C@H](N=C(O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@H](CCCNC(N)=N)N=C(O)[C@H](CCCNC(N)=N)N=C(O)[C@H](CC(C)C)N=C(O)[C@H](CC(O)=O)N=C(O)[C@H](C)N=C(O)[C@H](C)N=C(O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@H](CCC(O)=N)N=C(O)[C@H](C)N=C(O)[C@H](CCSC)N=C(O)[C@H](CCC(O)=N)N=C(O)[C@H](CCC(O)=O)N=C(O)[C@@H]1CCCN1C(=O)[C@@H](N=C(O)[C@H](C)N=C(O)[C@H](CC(O)=N)N=C(O)[C@H](CC(O)=O)N=C(O)CN=C(O)[C@@H]1CCCN1C(=O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@@H](N=C(O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)N=C(O)[C@H](CC(C)C)N=C(O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(O)=N[C@@H](CC(O)=N)C(O)=N[C@@H](CCSC)C(O)=N[C@@H](CC(C)C)C(O)=N[C@@H]([C@@H](C)O)C(O)=N[C@@H](CCCNC(N)=N)C(O)=N[C@@H](CCC(O)=N)C(O)=N[C@@H](CCCNC(N)=N)C(O)=N[C@@H](CC1=CC=C(O)C=C1)C(O)=N
Obinepitide,Neuropeptide Y receptor type 2,CC[C@H](C)[C@H](N=C(O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@H](CCCNC(N)=N)N=C(O)[C@H](CCCNC(N)=N)N=C(O)[C@H](CC(C)C)N=C(O)[C@H](CC(O)=O)N=C(O)[C@H](C)N=C(O)[C@H](C)N=C(O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@H](CCC(O)=N)N=C(O)[C@H](C)N=C(O)[C@H](CCSC)N=C(O)[C@H](CCC(O)=N)N=C(O)[C@H](CCC(O)=O)N=C(O)[C@@H]1CCCN1C(=O)[C@@H](N=C(O)[C@H](C)N=C(O)[C@H](CC(O)=N)N=C(O)[C@H](CC(O)=O)N=C(O)CN=C(O)[C@@H]1CCCN1C(=O)[C@H](CC1=CC=C(O)C=C1)N=C(O)[C@@H](N=C(O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)N=C(O)[C@H](CC(C)C)N=C(O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(O)=N[C@@H](CC(O)=N)C(O)=N[C@@H](CCSC)C(O)=N[C@@H](CC(C)C)C(O)=N[C@@H]([C@@H](C)O)C(O)=N[C@@H](CCCNC(N)=N)C(O)=N[C@@H](CCC(O)=N)C(O)=N[C@@H](CCCNC(N)=N)C(O)=N[C@@H](CC1=CC=C(O)C=C1)C(O)=N
Obinutuzumab,B-lymphocyte antigen CD20,
Ocaperidone,Alpha-2A adrenergic receptor,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,Alpha-2C adrenergic receptor,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,5-hydroxytryptamine receptor 2B,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,Histamine H1 receptor,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,5-hydroxytryptamine receptor 2A,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,Alpha-1A adrenergic receptor,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,5-hydroxytryptamine receptor 2C,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,Alpha-2B adrenergic receptor,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,Alpha-1B adrenergic receptor,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,Alpha-1D adrenergic receptor,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocaperidone,D(2) dopamine receptor,CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12
Ocrelizumab,B-lymphocyte antigen CD20,
Ocriplasmin,Fibronectin,
Ocriplasmin,Alpha-2-macroglobulin,
Ocriplasmin,Alpha-2-antiplasmin,
Octanoyl-Coenzyme A,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Octanoyl-Coenzyme A,"Enoyl-CoA delta isomerase 1, mitochondrial",CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Octanoyl-Coenzyme A,"Enoyl-CoA hydratase, mitochondrial",CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Octocrylene,Estrogen receptor,
Octocrylene,Estrogen receptor beta,
Octreotide,Somatostatin receptor type 1,[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)[C@H](N)CC1=CC=CC=C1)[C@@H](C)O
Octreotide,Somatostatin receptor type 5,[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)[C@H](N)CC1=CC=CC=C1)[C@@H](C)O
Octreotide,Somatostatin receptor type 2,[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)[C@H](N)CC1=CC=CC=C1)[C@@H](C)O
Octylphenoxy polyethoxyethanol,"Troponin C, skeletal muscle",CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1
Odanacatib,Cathepsin K,CC(C)(F)C[C@H](N[C@@H](C1=CC=C(C=C1)C1=CC=C(C=C1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N
Ofatumumab,B-lymphocyte antigen CD20,
Ofloxacin,DNA gyrase subunit A,CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1
Ofloxacin,DNA topoisomerase 4 subunit A,CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1
Ofloxacin,DNA topoisomerase 2-alpha,CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1
Olanzapine,5-hydroxytryptamine receptor 2A,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,D(2) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,D(1A) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,D(1B) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,D(4) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,D(3) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,5-hydroxytryptamine receptor 2C,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,5-hydroxytryptamine receptor 3A,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,5-hydroxytryptamine receptor 6,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Histamine H1 receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Alpha-1A adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Alpha-1B adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Muscarinic acetylcholine receptor M1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Muscarinic acetylcholine receptor M2,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Muscarinic acetylcholine receptor M3,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Muscarinic acetylcholine receptor M4,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,D(1A) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,D(1B) dopamine receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Beta-1 adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Beta-2 adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Beta-3 adrenergic receptor,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,5-hydroxytryptamine receptor 1A,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,5-hydroxytryptamine receptor 1B,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,5-hydroxytryptamine receptor 1D,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,5-hydroxytryptamine receptor 1E,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,5-hydroxytryptamine receptor 1F,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit alpha-1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit alpha-2,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit alpha-3,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit alpha-4,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit alpha-5,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit alpha-6,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit gamma-1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit gamma-2,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olanzapine,Gamma-aminobutyric acid receptor subunit gamma-3,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Olaparib,Poly [ADP-ribose] polymerase 1,OC1=NN=C(CC2=CC(C(=O)N3CCN(CC3)C(=O)C3CC3)=C(F)C=C2)C2=CC=CC=C12
Olaparib,Poly [ADP-ribose] polymerase 2,OC1=NN=C(CC2=CC(C(=O)N3CCN(CC3)C(=O)C3CC3)=C(F)C=C2)C2=CC=CC=C12
Olaparib,Poly [ADP-ribose] polymerase 3,OC1=NN=C(CC2=CC(C(=O)N3CCN(CC3)C(=O)C3CC3)=C(F)C=C2)C2=CC=CC=C12
Olaratumab,Platelet-derived growth factor receptor alpha,
Olcegepant,Calcitonin gene-related peptide 1,[H][C@@](CCCCN)(N=C(O)[C@@]([H])(CC1=CC(Br)=C(O)C(Br)=C1)N=C(O)N1CCC(CC1)N1CC2=CC=CC=C2N=C1O)C(=O)N1CCN(CC1)C1=CC=NC=C1
Olcegepant,Calcitonin gene-related peptide type 1 receptor,[H][C@@](CCCCN)(N=C(O)[C@@]([H])(CC1=CC(Br)=C(O)C(Br)=C1)N=C(O)N1CCC(CC1)N1CC2=CC=CC=C2N=C1O)C(=O)N1CCN(CC1)C1=CC=NC=C1
Oleic Acid,14 kDa fatty acid-binding protein,CCCCCCCC\C=C\CCCCCCCC(O)=O
Oleic Acid,Glycolipid transfer protein,CCCCCCCC\C=C\CCCCCCCC(O)=O
Oleic Acid,Myelin P2 protein,CCCCCCCC\C=C\CCCCCCCC(O)=O
Oleic Acid,Peroxisome proliferator-activated receptor alpha,CCCCCCCC\C=C\CCCCCCCC(O)=O
Oleic Acid,Peroxisome proliferator-activated receptor delta,CCCCCCCC\C=C\CCCCCCCC(O)=O
Oleic Acid,Retinoic acid receptor RXR-alpha,CCCCCCCC\C=C\CCCCCCCC(O)=O
Oleic Acid,Peroxisome proliferator-activated receptor gamma,CCCCCCCC\C=C\CCCCCCCC(O)=O
Olmesartan,Type-1 angiotensin II receptor,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O
Olmutinib,Epidermal growth factor receptor,CN1CCN(CC1)C1=CC=C(NC2=NC(OC3=CC=CC(NC(=O)C=C)=C3)=C3SC=CC3=N2)C=C1
Olodaterol,Beta-2 adrenergic receptor,COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1
Olomoucine,Cyclin-dependent-like kinase 5,CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1
Olomoucine,Cyclin-dependent kinase 2,CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1
Olomoucine,Cyclin-dependent kinase 1,CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1
Olomoucine,Mitogen-activated protein kinase 1,CN1C=NC2=C1N=C(NCCO)N=C2NCC1=CC=CC=C1
Olopatadine,Histamine H1 receptor,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
Olopatadine,Histamine H2 receptor,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
Olopatadine,Histamine H3 receptor,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
Olopatadine,Protein S100-A1,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
Olopatadine,Protein S100-A12,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
Olopatadine,Protein S100-B,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
Olopatadine,Protein S100-A13,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
Olopatadine,Protein S100-A2,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
Olsalazine,Thiopurine S-methyltransferase,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(O)C(=C1)C(O)=O
Olsalazine,Interferon gamma,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(O)C(=C1)C(O)=O
Omacetaxine mepesuccinate,50S ribosomal protein L2,[H][C@@]1(OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@]23CCCN2CCC2=CC4=C(OCO4)C=C2[C@]13[H]
Omacetaxine mepesuccinate,60S ribosomal protein L3,[H][C@@]1(OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@]23CCCN2CCC2=CC4=C(OCO4)C=C2[C@]13[H]
Omadacycline,30S ribosomal protein S3,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Omadacycline,30S ribosomal protein S7,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Omadacycline,30S ribosomal protein S8,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Omadacycline,30S ribosomal protein S19,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Omadacycline,30S ribosomal protein S14,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Omalizumab,High affinity immunoglobulin epsilon receptor subunit alpha,
Omalizumab,High affinity immunoglobulin epsilon receptor subunit beta,
Omapatrilat,Angiotensin-converting enzyme,[H][C@]12CCC[C@H](N1C(=O)[C@H](CCS2)NC(=O)[C@@H](S)CC1=CC=CC=C1)C(O)=O
Omapatrilat,Neprilysin,[H][C@]12CCC[C@H](N1C(=O)[C@H](CCS2)NC(=O)[C@@H](S)CC1=CC=CC=C1)C(O)=O
Ombitasvir,Nonstructural protein 5A,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C(C=C1)[C@@H]1CC[C@H](N1C1=CC=C(C=C1)C(C)(C)C)C1=CC=C(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)C=C1
Omega-3 fatty acids,Peroxisome proliferator-activated receptor gamma,
Omega-3 fatty acids,Peroxisome proliferator-activated receptor alpha,
Omega-3 fatty acids,Sterol regulatory element-binding protein 1,
Omega-3-acid ethyl esters,Sterol regulatory element-binding protein 1,
Omega-3-carboxylic acids,Diacylglycerol O-acyltransferase 2,
Omega-3-carboxylic acids,3-hydroxyacyl-CoA dehydrogenase type-2,
Omega-3-carboxylic acids,"Enoyl-CoA hydratase, mitochondrial",
Omega-3-carboxylic acids,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",
Omega-3-carboxylic acids,Elongation of very long chain fatty acids protein 4,
Omega-3-carboxylic acids,Lipoprotein lipase,
Omeprazole,Potassium-transporting ATPase alpha chain 1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
Omeprazole,Aryl hydrocarbon receptor,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C
Onapristone,Glucocorticoid receptor,CN(C)C1=CC=C(C=C1)[C@H]1C[C@]2(C)[C@@H](CC[C@]2(O)CCCO)[C@@H]2CCC3=CC(=O)CCC3=C12
Onapristone,Adhesion G-protein coupled receptor D1,CN(C)C1=CC=C(C=C1)[C@H]1C[C@]2(C)[C@@H](CC[C@]2(O)CCCO)[C@@H]2CCC3=CC(=O)CCC3=C12
Ondansetron,5-hydroxytryptamine receptor 3A,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
Ondansetron,5-hydroxytryptamine receptor 4,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
Ondansetron,Mu-type opioid receptor,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
Ondansetron,5-hydroxytryptamine receptor 1A,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
Ondansetron,5-hydroxytryptamine receptor 1B,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2
Onercept,Tumor necrosis factor,
Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate,Deoxyribose-phosphate aldolase,[H][C@](O)(CCO)[C@]([H])(O)COP(O)(O)=O
Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate,Deoxyribose-phosphate aldolase,[H][C@](O)(CCO)[C@]([H])(O)COP(O)(O)=O
Opicapone,Catechol O-methyltransferase,CC1=C(C2=NOC(=N2)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl
Opium,Delta-type opioid receptor,
Opium,Kappa-type opioid receptor,
Opium,Mu-type opioid receptor,
Oportuzumab monatox,Epithelial cell adhesion molecule,
Oprelvekin,Interleukin-11 receptor subunit alpha,
Orciprenaline,Beta-2 adrenergic receptor,CC(C)NCC(O)C1=CC(O)=CC(O)=C1
Oregovomab,Mucin-16,
Orlistat,Pancreatic triacylglycerol lipase,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
Orlistat,Gastric triacylglycerol lipase,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
Orlistat,Fatty acid synthase,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
Ornithine,Cationic amino acid transporter 4,NCCC[C@H](N)C(O)=O
Ornithine,Cationic amino acid transporter 3,NCCC[C@H](N)C(O)=O
Ornithine,Mitochondrial ornithine transporter 1,NCCC[C@H](N)C(O)=O
Ornithine,High affinity cationic amino acid transporter 1,NCCC[C@H](N)C(O)=O
Ornithine,Mitochondrial ornithine transporter 2,NCCC[C@H](N)C(O)=O
Ornithine,Arginase-1,NCCC[C@H](N)C(O)=O
Ornithine,"Ornithine carbamoyltransferase, mitochondrial",NCCC[C@H](N)C(O)=O
Ornithine,"Glycine amidinotransferase, mitochondrial",NCCC[C@H](N)C(O)=O
Ornithine,Ornithine decarboxylase antizyme 1,NCCC[C@H](N)C(O)=O
Ornithine,"Ornithine aminotransferase, mitochondrial",NCCC[C@H](N)C(O)=O
Ornithine,Cationic amino acid transporter 2,NCCC[C@H](N)C(O)=O
Ornithine,"Arginase-2, mitochondrial",NCCC[C@H](N)C(O)=O
Ornithine,Ornithine decarboxylase antizyme 2,NCCC[C@H](N)C(O)=O
Ornithine,Ornithine decarboxylase antizyme 3,NCCC[C@H](N)C(O)=O
Orotic Acid,"Dihydroorotate dehydrogenase (quinone), mitochondrial",OC(=O)C1=CC(=O)NC(=O)N1
Orotic Acid,Dihydroorotase,OC(=O)C1=CC(=O)NC(=O)N1
Orotic Acid,Dihydroorotate dehydrogenase (quinone),OC(=O)C1=CC(=O)NC(=O)N1
Orotic Acid,Orotate phosphoribosyltransferase,OC(=O)C1=CC(=O)NC(=O)N1
Orotic Acid,Dihydroorotate dehydrogenase A (fumarate),OC(=O)C1=CC(=O)NC(=O)N1
Orphenadrine,"Glutamate receptor ionotropic, NMDA 2D",CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C
Orphenadrine,"Glutamate receptor ionotropic, NMDA 1",CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C
Orphenadrine,"Glutamate receptor ionotropic, NMDA 3B",CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C
Orphenadrine,"Glutamate receptor ionotropic, NMDA 3A",CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C
Orphenadrine,Histamine H1 receptor,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C
Orphenadrine,Sodium-dependent noradrenaline transporter,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C
Orphenadrine,Sodium channel protein type 10 subunit alpha,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C
Osanetant,Neuromedin-K receptor,CN(C(C)=O)C1(CCN(CCC[C@@]2(CCCN(C2)C(=O)C2=CC=CC=C2)C2=CC(Cl)=C(Cl)C=C2)CC1)C1=CC=CC=C1
Oseltamivir,Neuraminidase,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
Oseltamivir,Liver carboxylesterase 1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
Oseltamivir,Sialidase-1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
Oseltamivir,Sialidase-2,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
Oseltamivir acid,Neuraminidase,CCC(CC)O[C@@H]1C=C(C[C@H](N)[C@H]1NC(C)=O)C(O)=O
Osimertinib,Epidermal growth factor receptor,COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
Ospemifene,Estrogen receptor,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
Otamixaban,Coagulation factor X,COC(=O)[C@H](CC1=CC(=CC=C1)C(N)=N)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC=[N+]([O-])C=C1
Ouabain,Sodium/potassium-transporting ATPase subunit alpha-1,[H][C@@]12CC[C@]3(O)C[C@H](C[C@@H](O)[C@]3(CO)[C@@]1([H])[C@H](O)C[C@]1(C)[C@H](CC[C@]21O)C1=CC(=O)OC1)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O
Ouabain,Sodium/potassium-transporting ATPase subunit alpha-2,[H][C@@]12CC[C@]3(O)C[C@H](C[C@@H](O)[C@]3(CO)[C@@]1([H])[C@H](O)C[C@]1(C)[C@H](CC[C@]21O)C1=CC(=O)OC1)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O
Ouabain,Sodium/potassium-transporting ATPase subunit alpha-3,[H][C@@]12CC[C@]3(O)C[C@H](C[C@@H](O)[C@]3(CO)[C@@]1([H])[C@H](O)C[C@]1(C)[C@H](CC[C@]21O)C1=CC(=O)OC1)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O
Ovalicin,Methionine aminopeptidase 2,[H][C@]1(CC=C(C)C)O[C@]1(C)[C@@]1(O)[C@]([H])(OC)C(=O)CC[C@@]1(C)O
Ovalicin,Methionine aminopeptidase 1,[H][C@]1(CC=C(C)C)O[C@]1(C)[C@@]1(O)[C@]([H])(OC)C(=O)CC[C@@]1(C)O
Oxacillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxacillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxacillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxacillin,Penicillin-binding protein 1b,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxacillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxacillin,Solute carrier family 15 member 1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxacillin,Penicillin-binding protein 2,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxacillin,Solute carrier family 15 member 2,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C1=C(C)ON=C1C1=CC=CC=C1)C(O)=O
Oxalic Acid,Proto-oncogene tyrosine-protein kinase Src,OC(=O)C(O)=O
Oxaloacetate Ion,Sepiapterin reductase,OC(=O)C(=O)CC([O-])=O
Oxaloacetate Ion,Methylmalonyl-CoA carboxyltransferase 5S subunit,OC(=O)C(=O)CC([O-])=O
Oxaloacetate Ion,Malate dehydrogenase,OC(=O)C(=O)CC([O-])=O
Oxaloacetate Ion,Citrate lyase subunit beta-like protein,OC(=O)C(=O)CC([O-])=O
Oxaloacetate Ion,"Citrate synthase, mitochondrial",OC(=O)C(=O)CC([O-])=O
Oxamic Acid,L-lactate dehydrogenase B chain,NC(=O)C(O)=O
Oxamic Acid,L-lactate dehydrogenase A chain,NC(=O)C(O)=O
Oxamic Acid,L-lactate dehydrogenase,NC(=O)C(O)=O
Oxamic Acid,L-lactate dehydrogenase,NC(=O)C(O)=O
Oxamic Acid,Formate acetyltransferase 1,NC(=O)C(O)=O
Oxamic Acid,D-lactate dehydrogenase,NC(=O)C(O)=O
Oxandrolone,Androgen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12C
Oxaprozin,Prostaglandin G/H synthase 1,OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
Oxaprozin,Prostaglandin G/H synthase 2,OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-1,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-2,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-3,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-4,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-5,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-6,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit beta-1,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit beta-2,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit beta-3,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit gamma-1,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit gamma-2,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit gamma-3,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit delta,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit epsilon,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit pi,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit rho-1,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit rho-2,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit rho-3,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit theta,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-1,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-2,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-3,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-4,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-5,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit alpha-6,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit beta-1,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit beta-2,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit beta-3,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit delta,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit epsilon,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit gamma-1,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit gamma-2,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit gamma-3,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit pi,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxazepam,Gamma-aminobutyric acid receptor subunit theta,OC1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2
Oxcarbazepine,Sodium channel protein type 5 subunit alpha,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2
Oxetacaine,Gastrin,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1
Oxibendazole,Tubulin beta-4B chain,CCCOC1=CC2=C(C=C1)N=C(NC(=O)OC)N2
Oxiconazole,Lanosterol 14-alpha demethylase,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1
Oxiconazole,Lanosterol synthase,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1
Oxiconazole,Nuclear receptor subfamily 1 group I member 2,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1
Oxidized Acetyl Dithranol,ActVA 6 protein,OC(=O)CC1=C(O)C2=C(C=C1)C(=O)C1=C(C(O)=CC=C1)C2=O
Oxidized Coenzyme A,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,[H][C@](O)(C(O)=NCCC(O)=NCCSO)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Oxidized Coenzyme A,Formyl-CoA:oxalate CoA-transferase,[H][C@](O)(C(O)=NCCC(O)=NCCSO)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Oxiranpseudoglucose,Cyclomaltodextrin glucanotransferase,[H][C@@]12C[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@]1(CO)O2
Oxitriptan,Tryptophan--tRNA ligase 2,N[C@@H](CC1=CNC2=C1C=C(O)C=C2)C(O)=O
Oxogluric acid,Aspartate aminotransferase,OC(=O)CCC(=O)C(O)=O
Oxprenolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC=C1OCC=C
Oxprenolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC=C1OCC=C
Oxprenolol,Beta-3 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC=C1OCC=C
Oxtriphylline,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O
Oxtriphylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O
Oxtriphylline,Adenosine receptor A2a,C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O
Oxtriphylline,Adenosine receptor A1,C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O
Oxtriphylline,Histone deacetylase 2,C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O
Oxybenzone,Progesterone receptor,COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1
Oxybenzone,Androgen receptor,COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1
Oxybenzone,Estrogen receptor,COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1
Oxybenzone,Estrogen receptor beta,COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1
Oxybuprocaine,Sodium channel protein type 10 subunit alpha,CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC
Oxybutynin,Muscarinic acetylcholine receptor M3,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
Oxybutynin,Muscarinic acetylcholine receptor M2,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
Oxybutynin,Muscarinic acetylcholine receptor M1,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
Oxycodone,Delta-type opioid receptor,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O
Oxycodone,Kappa-type opioid receptor,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O
Oxycodone,Mu-type opioid receptor,[H][C@@]12OC3=C(OC)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O
Oxygen,Cytochrome c oxidase subunit 1,O=O
Oxygen,NADPH oxidase 1,O=O
Oxygen,Hemoglobin subunit alpha,O=O
Oxygen,Hemoglobin subunit beta,O=O
Oxymetazoline,Alpha-2A adrenergic receptor,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
Oxymetazoline,Alpha-1A adrenergic receptor,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
Oxymetazoline,Alpha-2C adrenergic receptor,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
Oxymetazoline,Alpha-2B adrenergic receptor,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
Oxymetazoline,Alpha-1B adrenergic receptor,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
Oxymetazoline,Alpha-1D adrenergic receptor,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C
Oxymetholone,Androgen receptor,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O
Oxymetholone,Natriuretic peptides B,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O
Oxymorphone,Mu-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O
Oxymorphone,Delta-type opioid receptor,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O
Oxyphenbutazone,Group IIE secretory phospholipase A2,CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1
Oxyphencyclimine,Muscarinic acetylcholine receptor M3,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
Oxyphencyclimine,Muscarinic acetylcholine receptor M1,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
Oxyphencyclimine,Muscarinic acetylcholine receptor M2,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
Oxyphenonium,Muscarinic acetylcholine receptor M1,CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
Oxypurinol,Xanthine dehydrogenase/oxidase,O=C1NC(=O)C2=CNNC2=N1
Oxytetracycline,30S ribosomal protein S9,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C
Oxytetracycline,30S ribosomal protein S4,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C
Oxytocin,Oxytocin receptor,
Oxytocin,Oxytocin-neurophysin 1,
Ozenoxacin,DNA gyrase subunit A,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O
Ozenoxacin,DNA topoisomerase 4 subunit A,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O
P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,Prostaglandin G/H synthase 1,[H][C@@](C)(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=C(I)S1
P-Aminophenyl-Alpha-D-Galactopyranoside,Heat-labile enterotoxin B chain,[H][C@]1(CO)O[C@]([H])(OC2=CC=C(N)C=C2)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
P-Anisic Acid,Group IIE secretory phospholipase A2,COC1=CC=C(C=C1)C(O)=O
P-Anisic Acid,Phospholipase A2,COC1=CC=C(C=C1)C(O)=O
P-Cresol,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,CC1=CC=C(O)C=C1
P-Hydroxybenzoic Acid,Chorismate pyruvate-lyase,OC(=O)C1=CC=C(O)C=C1
P-Hydroxybenzoic Acid,p-hydroxybenzoate hydroxylase,OC(=O)C1=CC=C(O)C=C1
P-Hydroxybenzoic Acid,p-hydroxybenzoate hydroxylase,OC(=O)C1=CC=C(O)C=C1
P-Hydroxybenzoic Acid,4-hydroxybenzoyl-CoA thioesterase,OC(=O)C1=CC=C(O)C=C1
P-Nitrophenol,Sulfotransferase 1A1,OC1=CC=C(C=C1)[N+]([O-])=O
P-Nitrophenol,Alpha-amylase 2B,OC1=CC=C(C=C1)[N+]([O-])=O
P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate,Thymidylate kinase,[H][C@@]1(C[C@]([H])(N=[N+]=[N-])[C@@]([H])(COP([O-])(=O)OP([O-])(=O)OP(O)(=O)OP([O-])(=O)OP([O-])(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)O1)N1C=C(C)C([O-])=NC1=O
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,Thymidylate kinase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)N1C=C(C)C(O)=NC1=O
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,Thymidylate kinase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)N1C=C(C)C(O)=NC1=O
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,Thymidine kinase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)N1C=C(C)C(O)=NC1=O
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,Thymidine kinase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)N1C=C(C)C(O)=NC1=O
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,Thymidylate kinase,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)N1C=C(C)C(O)=NC1=O
P54,Nuclear factor NF-kappa-B p105 subunit,
P54,Nuclear factor NF-kappa-B p100 subunit,
PA-1050040,Gag polyprotein,
PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID,Acetyl-CoA acetyltransferase,[H][C@](O)(C(=O)NCCC(=O)NCCO)C(C)(C)COC(=O)C(C)(C)C
PARA-(BENZOYL)-PHENYLALANINE,Tyrosine-protein phosphatase non-receptor type 1,[H][C@](N)(CC1=CC=C(C=C1)C(=O)C1=CC=CC=C1)C(O)=O
PARA-(BENZOYL)-PHENYLALANINE,"Tyrosine--tRNA ligase, cytoplasmic",[H][C@](N)(CC1=CC=C(C=C1)C(=O)C1=CC=CC=C1)C(O)=O
PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,Ig gamma-1 chain C region,OC(=O)CNC(=O)CCCC(=O)NCC1=CC=C(C=C1)[N+]([O-])=O
PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,Lactase-like protein,[H][C@]1(CO)O[C@@]([H])(SC2=CC=C(C=C2)[N+]([O-])=O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,Ig gamma-1 chain C region,OC(=O)CNC(=O)CCC[P@](O)(=O)OC1=CC=C(C=C1)[N+]([O-])=O
PAS219,Proto-oncogene tyrosine-protein kinase Src,O[P@@](=O)(OCC1CCCCC1)OC1=C(C=O)C=CC=C1
PASBN,Proto-oncogene tyrosine-protein kinase Src,O[P@@](=O)(OCC1=CC=CC=C1)OC1=C(C=O)C=CC=C1
PCL-016,E3 ubiquitin-protein ligase UBR4,
PCL-016,Zinc finger Y-chromosomal protein,
PCNOTAXIME Group,Penicillin-binding protein 1A,[H][C@](C=O)(N=C(O)C(=N/OC)\C1=CSC(=N)N1)[C@@]1([H])SCC(=C)C(=N1)C(O)=O
PCNOTAXIME Group,Beta-lactamase Toho-1,[H][C@](C=O)(N=C(O)C(=N/OC)\C1=CSC(=N)N1)[C@@]1([H])SCC(=C)C(=N1)C(O)=O
PCNOTAXIME Group,Beta-lactamase,[H][C@](C=O)(N=C(O)C(=N/OC)\C1=CSC(=N)N1)[C@@]1([H])SCC(=C)C(=N1)C(O)=O
PD-0325901,Dual specificity mitogen-activated protein kinase kinase 1,[H][C@@](O)(CO)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1
PD150606,Calpain small subunit 1,[H][C@](S)(CC1=CC=C(I)C=C1)C(O)=O
PD173955,Tyrosine-protein kinase transforming protein Abl,CSC1=CC=CC(NC2=NC=C3C=C(C(=O)N(C)C3=N2)C2=C(Cl)C=CC=C2Cl)=C1
PEG-uricase,Uric acid degradation bifunctional protein,
PF-00356231,Macrophage metalloelastase,[H][C@](CC(O)=O)(NC(=O)C1=CC(=CS1)C1=CC=C(C=C1)C1=CC=NC=C1)C1=CC=CC=C1
PG-530742,Matrix metalloproteinase-9,
PH-284,Vasopressin V1a receptor,
PH-284,Vasopressin V1b receptor,
PH-797804,Mitogen-activated protein kinase 14,CNC(=O)C1=CC=C(C)C(=C1)N1C(C)=CC(OCC2=C(F)C=C(F)C=C2)=C(Br)C1=O
"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",Hematopoietic prostaglandin D synthase,N1C=CC(=N1)C1=CN=C(S1)C1=CC=CC=C1
PHENYLALANINE BORONIC ACID,Alpha-lytic protease,[H][C@](N)(CC1=CC=CC=C1)B(O)O
PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE,Carbonic anhydrase 2,[H][C@](N)(CC1=CC=CC=C1)C(=O)NCCOCCOCCNC(=O)C1=CC=C(C=C1)S(N)(=O)=O
"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",Cyclin-dependent kinase 2,NS(=O)(=O)C1=CC=C(NC2=CN3C=C(C=CC3=N2)C(=O)C2=C(Cl)C=CC=C2Cl)C=C1
PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE,Ig kappa chain C region,[H][C@@](CCCC)(NC(=O)CCC(O)=O)[P@](O)(=O)OC1=CC=CC=C1
PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER,Phospholipase A2,[H][C@@](CCCC)(CO[P@](O)(=O)OCCO)NC(=O)CCCCCCCCCCC
PICEATANNOL,"ATP synthase subunit alpha, mitochondrial",OC1=CC(\C=C\C2=CC=C(O)C(O)=C2)=CC(O)=C1
PICEATANNOL,"ATP synthase subunit beta, mitochondrial",OC1=CC(\C=C\C2=CC=C(O)C(O)=C2)=CC(O)=C1
PICEATANNOL,"ATP synthase subunit gamma, mitochondrial",OC1=CC(\C=C\C2=CC=C(O)C(O)=C2)=CC(O)=C1
PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE,Gag-Pol polyprotein,[H][C@]1(CCCCN1)C(=O)NC(C)(C)C
PLATENSIMYCIN,3-oxoacyl-[acyl-carrier-protein] synthase 2,[H][C@]12C[C@]3([H])O[C@@]1(C)C[C@@]1(C2)C=CC(=O)[C@@](C)(CCC(=O)NC2=C(O)C(=CC=C2O)C(O)=O)[C@]31[H]
PN0621,Tumor necrosis factor,
PNU177836,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@](O)(N[C@@]([H])(CC1=CC=CC=C1)[C@]([H])(O)N[C@@]([H])(CC1=CC(C(O)=O)=C(OCC(O)=O)C=C1)[C@@]([H])(O)NCCCCC)OC(C)(C)C
PPI-2458,Methionine aminopeptidase 2,[H][C@@]1([C@H](OC)[C@@H](CC[C@]11CO1)OC(=O)N[C@H](C(C)C)C(N)=O)[C@@]1(C)O[C@@H]1CC=C(C)C
PPL-100,Alpha-1-antitrypsin,COC(=O)N[C@@H](C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1
PPL-100,Plasma serine protease inhibitor,COC(=O)N[C@@H](C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1
PPL-100,Plasma protease C1 inhibitor,COC(=O)N[C@@H](C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1
PR-104,Tumor necrosis factor,CS(=O)(=O)OCCN(CCBr)C1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)C(=O)NCCOP(O)(O)=O
PREPHENIC ACID,Chorismate mutase AroH,[H][C@]1(O)C=C[C@](CC(=O)C(O)=O)(C=C1)C(O)=O
PRLX 93936,Voltage-dependent anion-selective channel protein 2,
PRLX 93936,Voltage-dependent anion-selective channel protein 3,
PRO-542,Free fatty acid receptor 4,
PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,Ig gamma-2 chain C region,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@]([H])(C[C@]12C)OC(=O)CCC(O)=O)C(C)=O
PRX-07034,5-hydroxytryptamine receptor 6,Cl.COC1=C(OC)C(=CC(Cl)=C1)C(C)NC1=CC(=CC=C1S(C)(=O)=O)N1CCNCC1
PRX-08066,5-hydroxytryptamine receptor 2B,OC(=O)\C=C\C(O)=O.FC1=C(C=C(CN2CCC(CC2)NC2=C3C=C(Cl)SC3=NC=N2)C=C1)C#N
PSN357,"Glycogen phosphorylase, liver form",
PSN9301,Dipeptidyl peptidase 4,
PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,60S ribosomal protein L37,CN(C)C1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](N)[C@H]1O
PX-12,"Thioredoxin reductase 1, cytoplasmic",CCC(C)SSC1=NC=CN1
PX-478,Hypoxia-inducible factor 1-alpha,Cl.Cl.N[C@@H](CC1=CC=C(C=C1)[N+]([O-])(CCCl)CCCl)C(O)=O
"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",Collagenase 3,CC1=CC(CNC(=O)C2=CC(=NC=N2)C(=O)NCC2=CC=CC(C)=C2)=CC=C1
"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",Collagenase 3,CC1=C(F)C=CC(CNC(=O)C2=CC(=NC=N2)C(=O)NCC2=CC(C)=C(F)C=C2)=C1
"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",Collagenase 3,O=C(NCC1=CC=CN=C1)C1=CC(=NC=N1)C(=O)NCC1=CN=CC=C1
Paclitaxel,Tubulin beta-1 chain,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C
Paclitaxel,Apoptosis regulator Bcl-2,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C
Paclitaxel,Microtubule-associated protein 4,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C
Paclitaxel,Microtubule-associated protein 2,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C
Paclitaxel,Microtubule-associated protein tau,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C
Paclitaxel,Nuclear receptor subfamily 1 group I member 2,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C
Paclitaxel docosahexaenoic acid,Apoptosis regulator Bcl-2,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@@]3([H])[C@@](C)([C@@H](O)C[C@@]4([H])OC[C@@]34OC(=O)C)C(=O)[C@H](OC(=O)C)C(=C1C)C2(C)C)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1
Pagoclone,Gamma-aminobutyric acid receptor subunit alpha-2,CC(C)CCC(=O)CC1N(C(=O)C2=CC=CC=C12)C1=NC2=C(C=CC(Cl)=N2)C=C1
Pagoclone,Gamma-aminobutyric acid receptor subunit alpha-3,CC(C)CCC(=O)CC1N(C(=O)C2=CC=CC=C12)C1=NC2=C(C=CC(Cl)=N2)C=C1
Palbociclib,Cyclin-dependent kinase 4,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O
Palbociclib,Cyclin-dependent kinase 6,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O
Palifermin,Fibroblast growth factor receptor 2,
Palifermin,Basement membrane-specific heparan sulfate proteoglycan core protein,
Palifermin,Fibroblast growth factor receptor 4,
Palifermin,Neuropilin-1,
Palifermin,Fibroblast growth factor receptor 1,
Palifermin,Fibroblast growth factor receptor 3,
Palifosfamide,DNA (cytosine-5)-methyltransferase 1,OP(=O)(NCCCl)NCCCl
Paliperidone,5-hydroxytryptamine receptor 2A,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,D(2) dopamine receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,Histamine H1 receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,Alpha-1A adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,Alpha-1B adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,D(4) dopamine receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,5-hydroxytryptamine receptor 1D,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,D(3) dopamine receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,5-hydroxytryptamine receptor 2C,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,Alpha-2A adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,Alpha-2B adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,Alpha-2C adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,5-hydroxytryptamine receptor 1A,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,D(1A) dopamine receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Paliperidone,5-hydroxytryptamine receptor 7,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
Palivizumab,Fusion glycoprotein F0,
Palivizumab,High affinity immunoglobulin gamma Fc receptor I,
Palivizumab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Palivizumab,Complement C1r subcomponent,
Palivizumab,Complement C1q subcomponent subunit A,
Palivizumab,Complement C1q subcomponent subunit B,
Palivizumab,Complement C1q subcomponent subunit C,
Palivizumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Palivizumab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Palivizumab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Palivizumab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Palmitic Acid,SEC14-like protein 2,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Rhodopsin,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Cytochrome P450 2C8,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Hepatocyte nuclear factor 4-gamma,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Lipid binding protein,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Trafficking protein particle complex subunit 3,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Fatty acid-binding protein TM_1468,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Glycodelin,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Myelin P2 protein,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Palmitoyl-protein thioesterase 1,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Alpha-lactalbumin,CCCCCCCCCCCCCCCC(O)=O
Palmitic Acid,Peroxisome proliferator-activated receptor alpha,CCCCCCCCCCCCCCCC(O)=O
Palmitoleic Acid,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,CCCCCC\C=C/CCCCCCCC(O)=O
Palmitoleic Acid,Bifunctional cytochrome P450/NADPH--P450 reductase,CCCCCC\C=C/CCCCCCCC(O)=O
Palmitoleic Acid,Fatty-acid peroxygenase,CCCCCC\C=C/CCCCCCCC(O)=O
Palmitoyl-Linoleoyl Phosphatidylcholine,Phosphatidylcholine transfer protein,CCCCCCCCCCCCCCCC(=O)OC[C@]([H])(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC
Palonosetron,5-hydroxytryptamine receptor 3A,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2
Pamidronic acid,Farnesyl pyrophosphate synthase,NCCC(O)(P(O)(O)=O)P(O)(O)=O
Pancuronium,Neuronal acetylcholine receptor subunit alpha-2,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1
Pancuronium,Muscarinic acetylcholine receptor M2,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1
Pancuronium,Muscarinic acetylcholine receptor M3,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1
Panitumumab,Epidermal growth factor receptor,
Panobinostat,Histone deacetylase 1,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 10,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 11,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 2,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 3,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 4,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 5,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 6,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 7,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 8,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Panobinostat,Histone deacetylase 9,[H]\C(=C(\[H])C1=CC=C(CNCCC2=C(C)NC3=CC=CC=C23)C=C1)C(O)=NO
Pantoprazole,Potassium-transporting ATPase alpha chain 1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1
Pantoprazole,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1
Pantothenic acid,Pantothenate kinase,CC(C)(CO)C(O)C(=O)NCCC(O)=O
Pantothenoylaminoethenethiol,Phosphopantothenoylcysteine decarboxylase,[H]\C(S)=C(/[H])N=C(O)CCN=C(O)[C@]([H])(O)C(C)(C)CO
Pantothenyl-Aminoethanol-Acetate Pivalic Acid,Acetyl-CoA acetyltransferase,CC(=O)OCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)C(C)(C)C
Pantoyl Adenylate,Pantothenate synthetase,[H][C@](O)(C(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C(C)(C)CO
Papain,Toll-like receptor 4,
Papaverine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",COC1=C(OC)C=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1
Papaverine,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",COC1=C(OC)C=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1
Para-Bromobenzyl Alcohol,Alcohol dehydrogenase 1C,OCC1=CC=C(Br)C=C1
Para-Iodo-D-Phenylalanine Hydroxamic Acid,Bacterial leucyl aminopeptidase,[H][C@@](N)(CC1=CC=C(I)C=C1)C(=O)NO
Para-Isopropylaniline,Chymotrypsin-like elastase family member 1,CC(C)C1=CC=C(N)C=C1
Para-Mercury-Benzenesulfonic Acid,Estrogen receptor beta,OS(=O)(=O)C1=CC=C([Hg])C=C1
Para-Mercury-Benzenesulfonic Acid,Galectin-10,OS(=O)(=O)C1=CC=C([Hg])C=C1
Para-Toluene Sulfonate,Lysozyme C,CC1=CC=C(C=C1)S(O)(=O)=O
Para-Toluene Sulfonate,Pro-cathepsin H,CC1=CC=C(C=C1)S(O)(=O)=O
Parachlorophenol,Sodium channel protein type 4 subunit alpha,OC1=CC=C(Cl)C=C1
Paramethadione,Voltage-dependent T-type calcium channel subunit alpha-1I,CCC1(C)OC(=O)N(C)C1=O
Paramethasone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Parathyroid hormone,Parathyroid hormone/parathyroid hormone-related peptide receptor,
Parathyroid hormone,Parathyroid hormone 2 receptor,
Pardoprunox,5-hydroxytryptamine receptor 1A,CN1CCN(CC1)C1=C2OC(=O)NC2=CC=C1
Pardoprunox,D(4) dopamine receptor,CN1CCN(CC1)C1=C2OC(=O)NC2=CC=C1
Pardoprunox,D(3) dopamine receptor,CN1CCN(CC1)C1=C2OC(=O)NC2=CC=C1
Pardoprunox,D(2) dopamine receptor,CN1CCN(CC1)C1=C2OC(=O)NC2=CC=C1
Parecoxib,Prostaglandin G/H synthase 2,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1
Parecoxib,Lactotransferrin,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1
Pargyline,Amine oxidase [flavin-containing] B,CN(CC#C)CC1=CC=CC=C1
Pargyline,Amine oxidase [flavin-containing] A,CN(CC#C)CC1=CC=CC=C1
Paricalcitol,Vitamin D3 receptor,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O
Paritaprevir,Genome polyprotein,[H][C@@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](CN1C(=O)[C@H](CCCCC\C=C/2)NC(=O)C1=CN=C(C)C=N1)OC1=NC2=C(C=CC=C2)C2=C1C=CC=C2)C(=O)NS(=O)(=O)C1CC1
Paromomycin,30S ribosomal protein S10,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O
Paroxetine,Sodium-dependent serotonin transporter,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
Paroxetine,Sodium-dependent noradrenaline transporter,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
Paroxetine,5-hydroxytryptamine receptor 2A,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
Paroxetine,Muscarinic acetylcholine receptor M1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
Paroxetine,Muscarinic acetylcholine receptor M2,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
Paroxetine,Muscarinic acetylcholine receptor M3,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
Paroxetine,Muscarinic acetylcholine receptor M4,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
Paroxetine,Muscarinic acetylcholine receptor M5,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1
Pascolizumab,Interleukin-4,
Pasireotide,Somatostatin receptor type 1,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
Pasireotide,Somatostatin receptor type 5,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
Pasireotide,Somatostatin receptor type 2,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
Pasireotide,Somatostatin receptor type 3,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
Patent Blue,Serum albumin,CCN(CC)C1=CC=C(C=C1)C(=C1C=CC(C=C1)=[N+](CC)CC)C1=C(C=C(C(O)=C1)S(O)(=O)=O)S(O)(=O)=O
Patupilone,Tubulin beta-1 chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin beta chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin alpha-1B chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin alpha-1A chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin alpha-8 chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin beta-4B chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin alpha-1C chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin alpha-4A chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin beta-4A chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin beta-3 chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Patupilone,Tubulin alpha-3C/D chain,[H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1
Pavinetant,Neuromedin-K receptor,CC[C@H](NC(=O)C1=C(NS(C)(=O)=O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C1=CC=CC=C1
Pazopanib,Vascular endothelial growth factor receptor 3,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,Vascular endothelial growth factor receptor 1,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,Platelet-derived growth factor receptor beta,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,Vascular endothelial growth factor receptor 2,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,Mast/stem cell growth factor receptor Kit,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,Platelet-derived growth factor receptor alpha,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,Fibroblast growth factor receptor 3,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,Tyrosine-protein kinase ITK/TSK,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,Fibroblast growth factor 1,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pazopanib,SH2B adapter protein 3,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
Pefloxacin,DNA topoisomerase 4 subunit A,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1
Pefloxacin,DNA gyrase subunit A,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1
Pefloxacin,DNA topoisomerase 2-alpha,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1
Pefloxacin,DNA topoisomerase 1,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1
Pegademase,Growth factor receptor-bound protein 2,
Pegaptanib,Neuropilin-1,
Pegdinetanib,Vascular endothelial growth factor receptor 2,
Pegfilgrastim,Neutrophil elastase,
Pegfilgrastim,Granulocyte colony-stimulating factor receptor,
Peginesatide,Erythropoietin receptor,
Peginterferon alfa-2a,Interferon alpha/beta receptor 2,
Peginterferon alfa-2a,Interferon alpha/beta receptor 1,
Peginterferon alfa-2b,Interferon alpha/beta receptor 2,
Peginterferon alfa-2b,Interferon alpha/beta receptor 1,
Pegpleranib,Platelet-derived growth factor subunit B,
Pegvisomant,Growth hormone receptor,
Peldesine,Purine nucleoside phosphorylase,NC1=NC(=O)C2=C(N1)C(CC1=CN=CC=C1)=CN2
Pelitinib,Epidermal growth factor receptor,CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(NC1=CC(Cl)=C(F)C=C1)=C(C=N2)C#N
Pembrolizumab,Programmed cell death protein 1,
Pemetrexed,Thymidylate synthase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(CCC2=CNC3=C2C(O)=NC(=N)N3)C=C1)C(O)=O
Pemetrexed,Bifunctional purine biosynthesis protein PURH,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(CCC2=CNC3=C2C(O)=NC(=N)N3)C=C1)C(O)=O
Pemetrexed,Dihydrofolate reductase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(CCC2=CNC3=C2C(O)=NC(=N)N3)C=C1)C(O)=O
Pemetrexed,Trifunctional purine biosynthetic protein adenosine-3,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(CCC2=CNC3=C2C(O)=NC(=N)N3)C=C1)C(O)=O
Penbutolol,Beta-1 adrenergic receptor,CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1
Penbutolol,Beta-2 adrenergic receptor,CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1
Penbutolol,5-hydroxytryptamine receptor 1A,CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1
Penbutolol,5-hydroxytryptamine receptor 1B,CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1
Penciclovir,DNA polymerase catalytic subunit,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2
Penciclovir,Thymidine kinase,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2
Penicillin G Acyl-Serine,Regulatory protein BlaR1,[H][C@](N)(COC(=O)[C@@]([H])(N=C([O-])CC1=CC=CC=C1)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1)C([O-])=O
Penicillin G Acyl-Serine,Beta-lactam-inducible penicillin-binding protein,[H][C@](N)(COC(=O)[C@@]([H])(N=C([O-])CC1=CC=CC=C1)[C@]1([H])N[C@@]([H])(C(O)=O)C(C)(C)S1)C([O-])=O
Pentaerythritol tetranitrate,Hemoglobin subunit alpha,[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O
Pentaerythritol tetranitrate,Hemoglobin subunit beta,[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O
Pentagastrin,Gastrin/cholecystokinin type B receptor,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O
Pentaglyme,Profilin-2,COCCOCCOCCOCCOCCOC
Pentaglyme,Restriction endonuclease R.BpuJI,COCCOCCOCCOCCOCCOC
Pentaglyme,Cytochrome c-552,COCCOCCOCCOCCOCCOC
Pentaglyme,Uncharacterized protein,COCCOCCOCCOCCOCCOC
Pentaglyme,"Sensor cyclic diguanylate phosphodiesterase, GAF and GAF domain-containing",COCCOCCOCCOCCOCCOC
Pentaglyme,Uncharacterized protein,COCCOCCOCCOCCOCCOC
Pentaglyme,"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase",COCCOCCOCCOCCOCCOC
Pentaglyme,Adenylosuccinate synthetase,COCCOCCOCCOCCOCCOC
Pentaglyme,Hypothetical cytosolic protein,COCCOCCOCCOCCOCCOC
Pentaglyme,"EDD domain protein, DegV family",COCCOCCOCCOCCOCCOC
Pentaglyme,Uncharacterized protein,COCCOCCOCCOCCOCCOC
Pentamidine,tRNA (cytosine(38)-C(5))-methyltransferase,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
Pentanal,cAMP-dependent protein kinase catalytic subunit alpha,CCCCC=O
"Pentane-1,5-Diamine",2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,NCCCCCN
Pentasulfide-Sulfur,Sulfide dehydrogenase,[S-]SSS[S-]
Pentazocine,Kappa-type opioid receptor,C[C@H]1[C@H]2CC3=CC=C(O)C=C3[C@]1(C)CCN2CC=C(C)C
Pentazocine,Mu-type opioid receptor,C[C@H]1[C@H]2CC3=CC=C(O)C=C3[C@]1(C)CCN2CC=C(C)C
Pentazocine,Sigma non-opioid intracellular receptor 1,C[C@H]1[C@H]2CC3=CC=C(O)C=C3[C@]1(C)CCN2CC=C(C)C
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Neuronal acetylcholine receptor subunit alpha-4,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Neuronal acetylcholine receptor subunit alpha-7,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Glutamate receptor 2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,"Glutamate receptor ionotropic, kainate 2",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit beta-1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit beta-2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit beta-3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit delta,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit epsilon,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit gamma-1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit gamma-2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit gamma-3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit pi,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Gamma-aminobutyric acid receptor subunit theta,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,"Glutamate receptor ionotropic, NMDA 1",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,"Glutamate receptor ionotropic, NMDA 2A",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,"Glutamate receptor ionotropic, NMDA 2B",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,"Glutamate receptor ionotropic, NMDA 2C",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,"Glutamate receptor ionotropic, NMDA 2D",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,"Glutamate receptor ionotropic, NMDA 3A",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,"Glutamate receptor ionotropic, NMDA 3B",CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentobarbital,Nuclear receptor subfamily 1 group I member 2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
Pentolinium,Neuronal acetylcholine receptor subunit alpha-10,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1
Pentolinium,Neuronal acetylcholine receptor subunit alpha-3,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1
Pentolinium,Neuronal acetylcholine receptor subunit beta-4,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1
Pentosan Polysulfate,Fibroblast growth factor 2,O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O
Pentosan Polysulfate,Fibroblast growth factor 1,O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O
Pentosan Polysulfate,Fibroblast growth factor 4,O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O
Pentostatin,Adenosine deaminase,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC[C@H]2O
Pentoxifylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
Pentoxifylline,Adenosine receptor A1,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
Pentoxifylline,"cGMP-specific 3',5'-cyclic phosphodiesterase",CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
Pentoxifylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
Pentoxifylline,Adenosine receptor A2a,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
Pentoxifylline,5'-nucleotidase,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
Pentoxyverine,Sigma non-opioid intracellular receptor 1,CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1
Pentoxyverine,Potassium voltage-gated channel subfamily H member 2,CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1
Pentoxyverine,Kappa-type opioid receptor,CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1
Pentoxyverine,Mu-type opioid receptor,CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1
Peptide YY (3-36),Neuropeptide Y receptor type 4,
Peptide YY (3-36),Neuropeptide Y receptor type 2,
Peptide YY (3-36),Neuropeptide Y receptor type 1,
Peptide YY (3-36),Neuropeptide Y receptor type 5,
Peramivir,Neuraminidase,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O
Peramivir,Neuraminidase,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O
Peramivir,Neuraminidase,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O
Perampanel,Glutamate receptor 1,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1
Perchlorate,Protein ArsC,[O-][Cl](=O)(=O)=O
Pergolide,D(2) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,D(3) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,D(4) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,5-hydroxytryptamine receptor 1A,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,5-hydroxytryptamine receptor 2B,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,5-hydroxytryptamine receptor 2A,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,5-hydroxytryptamine receptor 1D,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,Alpha-2B adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,Alpha-2A adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,Alpha-2C adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,D(1B) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,D(1A) dopamine receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,5-hydroxytryptamine receptor 1B,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,5-hydroxytryptamine receptor 2C,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,Alpha-1A adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,Alpha-1B adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pergolide,Alpha-1D adrenergic receptor,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Perhexiline,"Carnitine O-palmitoyltransferase 1, liver isoform",C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1
Perhexiline,"Carnitine O-palmitoyltransferase 2, mitochondrial",C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1
Perhexiline,Potassium voltage-gated channel subfamily H member 2,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1
Periciazine,D(1A) dopamine receptor,OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1
Periciazine,Alpha-2A adrenergic receptor,OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1
Periciazine,Alpha-1B adrenergic receptor,OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1
Periciazine,Androgen receptor,OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1
Perifosine,RAC-alpha serine/threonine-protein kinase,CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1
Perifosine,Mitogen-activated protein kinase 1,CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1
Perifosine,Protein kinase C alpha type,CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1
Perindopril,Angiotensin-converting enzyme,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O
Perindopril,Secreted frizzled-related protein 4,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O
Permethrin,Sodium channel protein type 1 subunit alpha,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC(OC2=CC=CC=C2)=CC=C1
Permethrin,Estrogen receptor,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC(OC2=CC=CC=C2)=CC=C1
Permethrin,Nuclear receptor subfamily 1 group I member 2,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC(OC2=CC=CC=C2)=CC=C1
Perospirone,5-hydroxytryptamine receptor 2A,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Perospirone,D(2) dopamine receptor,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Perospirone,5-hydroxytryptamine receptor 1A,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Perospirone,Histamine H1 receptor,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Perospirone,D(4) dopamine receptor,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Perospirone,Alpha-1A adrenergic receptor,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Perospirone,Alpha-1B adrenergic receptor,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Perospirone,Alpha-1D adrenergic receptor,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
Perphenazine,D(2) dopamine receptor,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Perphenazine,D(1A) dopamine receptor,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Perphenazine,Calmodulin,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Pertuzumab,Receptor tyrosine-protein kinase erbB-2,
Phenacemide,Sodium channel protein type 1 subunit alpha,NC(=O)NC(=O)CC1=CC=CC=C1
Phenacetin,Prostaglandin G/H synthase 1,CCOC1=CC=C(NC(C)=O)C=C1
Phenazopyridine,Sodium channel protein type 1 subunit alpha,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1
Phencyclidine,Sigma non-opioid intracellular receptor 1,C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1
Phencyclidine,"Glutamate receptor ionotropic, NMDA 3A",C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1
Phendimetrazine,Alpha-1A adrenergic receptor,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1
Phendimetrazine,Sodium-dependent noradrenaline transporter,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1
Phendimetrazine,Alpha-1B adrenergic receptor,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1
Phenelzine,Amine oxidase [flavin-containing] A,NNCCC1=CC=CC=C1
Phenelzine,Amine oxidase [flavin-containing] B,NNCCC1=CC=CC=C1
Phenelzine,Membrane primary amine oxidase,NNCCC1=CC=CC=C1
Phenelzine,"4-aminobutyrate aminotransferase, mitochondrial",NNCCC1=CC=CC=C1
Phenelzine,Alanine aminotransferase 1,NNCCC1=CC=CC=C1
Phenelzine,Alanine aminotransferase 2,NNCCC1=CC=CC=C1
Phenelzine,Glutamic acid decarboxylase,NNCCC1=CC=CC=C1
Phenethyl Isothiocyanate,"Actin, aortic smooth muscle",S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,"Actin, cytoplasmic 1",S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,"ATP synthase subunit beta, mitochondrial",S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,"ATP synthase subunit e, mitochondrial",S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,"ATP synthase subunit g, mitochondrial",S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Cytochrome b5 type B,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,"Diablo homolog, mitochondrial",S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,F-box only protein 41,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Heterogeneous nuclear ribonucleoprotein F,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Heterogeneous nuclear ribonucleoprotein K,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Heat shock 70 kDa protein 4,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Heat shock protein beta-1,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,"10 kDa heat shock protein, mitochondrial",S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Heat shock protein 105 kDa,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,NADH-ubiquinone oxidoreductase chain 1,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Nuclear migration protein nudC,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Pappalysin-1,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Proteasome subunit alpha type-3,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,26S protease regulatory subunit 6A,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Ran-specific GTPase-activating protein,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Protein S100-A10,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Splicing factor 3A subunit 3,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,"Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial",S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tumor protein D54,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tropomyosin alpha-1 chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tropomyosin alpha-3 chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tropomyosin alpha-4 chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tubulin alpha-1A chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tubulin alpha-3C/D chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tubulin alpha-4A chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tubulin beta-1 chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tubulin beta-2A chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tubulin beta-3 chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Tubulin beta-4B chain,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Thioredoxin,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Ubiquitin carboxyl-terminal hydrolase isozyme L1,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Ubiquitin carboxyl-terminal hydrolase 14,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Transitional endoplasmic reticulum ATPase,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,Vimentin,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,14-3-3 protein beta/alpha,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,14-3-3 protein epsilon,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,14-3-3 protein eta,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,14-3-3 protein theta,S=C=NCCC1=CC=CC=C1
Phenethyl Isothiocyanate,14-3-3 protein zeta/delta,S=C=NCCC1=CC=CC=C1
Phenethylamine,Primary amine oxidase,NCCC1=CC=CC=C1
Phenethylamine,Trypsin-1,NCCC1=CC=CC=C1
Phenethylamine,Trypsin-2,NCCC1=CC=CC=C1
Phenformin,5'-AMP-activated protein kinase catalytic subunit alpha-1,NC(=N)NC(=N)NCCC1=CC=CC=C1
Phenformin,ATP-sensitive inward rectifier potassium channel 8,NC(=N)NC(=N)NCCC1=CC=CC=C1
Phenindamine,Histamine H1 receptor,CN1CCC2=C(C1)C(C1=CC=CC=C21)C1=CC=CC=C1
Phenindione,Vitamin K epoxide reductase complex subunit 1,O=C1C(C(=O)C2=CC=CC=C12)C1=CC=CC=C1
Pheniramine,Histamine H1 receptor,CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=N1
Pheniramine,Nuclear receptor subfamily 1 group I member 3,CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=N1
Phenmetrazine,Sodium-dependent noradrenaline transporter,CC1NCCOC1C1=CC=CC=C1
Phenmetrazine,Sodium-dependent dopamine transporter,CC1NCCOC1C1=CC=CC=C1
Phenobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,Neuronal acetylcholine receptor subunit alpha-4,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,Neuronal acetylcholine receptor subunit alpha-7,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,Glutamate receptor 2,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,"Glutamate receptor ionotropic, kainate 2",CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,"Glutamate receptor ionotropic, NMDA 1",CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,"Glutamate receptor ionotropic, NMDA 2A",CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,"Glutamate receptor ionotropic, NMDA 2B",CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,"Glutamate receptor ionotropic, NMDA 2C",CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,"Glutamate receptor ionotropic, NMDA 2D",CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,"Glutamate receptor ionotropic, NMDA 3A",CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,"Glutamate receptor ionotropic, NMDA 3B",CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenobarbital,Nuclear receptor subfamily 1 group I member 2,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1
Phenol,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,OC1=CC=CC=C1
Phenol,Endolysin,OC1=CC=CC=C1
Phenol,Thermolysin,OC1=CC=CC=C1
Phenol,Serum albumin,OC1=CC=CC=C1
Phenolphthalein,UDP-glucuronosyltransferase 1-9,OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC=C12)C1=CC=C(O)C=C1
Phenolphthalein,Nuclear receptor subfamily 1 group I member 2,OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC=C12)C1=CC=C(O)C=C1
Phenolphthalein,Nuclear receptor subfamily 1 group I member 3,OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC=C12)C1=CC=C(O)C=C1
Phenolphthalein,Estrogen receptor,OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC=C12)C1=CC=C(O)C=C1
Phenolphthalein,Sex hormone-binding globulin,OC1=CC=C(C=C1)C1(OC(=O)C2=CC=CC=C12)C1=CC=C(O)C=C1
Phenothiazine,Androgen receptor,N1C2=CC=CC=C2SC2=CC=CC=C12
Phenoxybenzamine,Alpha-1A adrenergic receptor,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
Phenoxybenzamine,Alpha-2A adrenergic receptor,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
Phenoxybenzamine,Alpha-2C adrenergic receptor,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
Phenoxybenzamine,Calmodulin,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
Phenoxybenzamine,Alpha-2B adrenergic receptor,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
Phenoxybenzamine,Beta-2 adrenergic receptor,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
Phenoxybenzamine,Alpha-1B adrenergic receptor,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
Phenoxybenzamine,Alpha-1D adrenergic receptor,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1
Phenoxymethylpenicillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O
Phenoxymethylpenicillin,MecA PBP2' (penicillin binding protein 2'),[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O
Phenoxymethylpenicillin,D-alanyl-D-alanine carboxypeptidase DacB,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O
Phenoxymethylpenicillin,Penicillin acylase,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O
Phenoxymethylpenicillin,Solute carrier family 15 member 1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)COC1=CC=CC=C1)C(O)=O
Phenprocoumon,Vitamin K epoxide reductase complex subunit 1,CCC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2
Phenserine,Acetylcholinesterase,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC3=CC=CC=C3)=C1)N2C
Phenserine,Cholinesterase,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC3=CC=CC=C3)=C1)N2C
Phenserine,Amyloid beta A4 protein,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC3=CC=CC=C3)=C1)N2C
Phentermine,Sodium-dependent noradrenaline transporter,CC(C)(N)CC1=CC=CC=C1
Phentermine,Sodium-dependent serotonin transporter,CC(C)(N)CC1=CC=CC=C1
Phentermine,Sodium-dependent dopamine transporter,CC(C)(N)CC1=CC=CC=C1
Phentermine,Amine oxidase [flavin-containing] A,CC(C)(N)CC1=CC=CC=C1
Phentermine,Amine oxidase [flavin-containing] B,CC(C)(N)CC1=CC=CC=C1
Phentermine,Pro-neuropeptide Y,CC(C)(N)CC1=CC=CC=C1
Phentolamine,Alpha-2A adrenergic receptor,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
Phentolamine,Alpha-1A adrenergic receptor,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
Phentolamine,Alpha-1B adrenergic receptor,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
Phentolamine,Alpha-1D adrenergic receptor,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1
Phenyl Boronic Acid,Cocaine esterase,OB(O)C1=CC=CC=C1
Phenyl salicylate,Prostaglandin G/H synthase 1,OC1=CC=CC=C1C(=O)OC1=CC=CC=C1
Phenyl salicylate,Prostaglandin G/H synthase 2,OC1=CC=CC=C1C(=O)OC1=CC=CC=C1
Phenyl-Uridine-5'-Diphosphate,UDP-glucose 4-epimerase,[H][C@]1(COP(O)(=O)OP(O)(=O)OC2=CC=CC=C2)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
Phenylacetaldehyde,Primary amine oxidase,O=CCC1=CC=CC=C1
Phenylalanine Amide,Genome polyprotein,[H][C@](N)(CC1=CC=CC=C1)C(N)=O
Phenylalanine Amide,Genome polyprotein,[H][C@](N)(CC1=CC=CC=C1)C(N)=O
Phenylalanine Amide,D-Amino acid amidase,[H][C@](N)(CC1=CC=CC=C1)C(N)=O
Phenylalanine-N-Sulfonamide,Carboxypeptidase A1,[H][C@@](CC1=CC=CC=C1)(NS(N)(=O)=O)C(O)=O
Phenylalanylmethylchloride,Chymotrypsinogen B,[H][C@](N)(CC1=CC=CC=C1)C(=O)CCl
Phenylbutazone,Prostacyclin synthase,CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
Phenylbutazone,Prostaglandin G/H synthase 2,CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
Phenylbutazone,Prostaglandin G/H synthase 1,CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
Phenylbutyric acid,Aromatic-amino-acid aminotransferase,OC(=O)CCCC1=CC=CC=C1
Phenylbutyric acid,Thermolysin,OC(=O)CCCC1=CC=CC=C1
Phenylephrine,Alpha-1A adrenergic receptor,CNC[C@H](O)C1=CC(O)=CC=C1
Phenylephrine,Alpha-1B adrenergic receptor,CNC[C@H](O)C1=CC(O)=CC=C1
Phenylephrine,Alpha-1D adrenergic receptor,CNC[C@H](O)C1=CC(O)=CC=C1
Phenylethane Boronic Acid,Chymotrypsinogen B,OB(O)CCC1=CC=CC=C1
Phenylethyl alcohol,Parathion hydrolase,OCCC1=CC=CC=C1
Phenylferricrocin-Iron,Ferrichrome-iron receptor,[H][C@]1(CC2=CC=CC=C2)NC(=O)CNC(=O)[C@]2([H])CCCN3O[Fe-3]456(ON(CCC[C@]([H])(NC(=O)CNC1=O)C(=O)N[C@@]([H])(CCCN(O4)C(C)=[O+]5)C(=O)N2)C(C)=[O+]6)[O+]=C3C
Phenylphosphate,Proto-oncogene tyrosine-protein kinase Src,OP(O)(=O)OC1=CC=CC=C1
Phenylpropanolamine,D(1A) dopamine receptor,[H][C@@](C)(N)[C@]([H])(O)C1=CC=CC=C1
Phenylpropanolamine,Beta-1 adrenergic receptor,[H][C@@](C)(N)[C@]([H])(O)C1=CC=CC=C1
Phenylpropanolamine,Beta-2 adrenergic receptor,[H][C@@](C)(N)[C@]([H])(O)C1=CC=CC=C1
Phenylpropanolamine,Alpha-2A adrenergic receptor,[H][C@@](C)(N)[C@]([H])(O)C1=CC=CC=C1
Phenylpropanolamine,Alpha-2B adrenergic receptor,[H][C@@](C)(N)[C@]([H])(O)C1=CC=CC=C1
Phenylpropanolamine,Alpha-2C adrenergic receptor,[H][C@@](C)(N)[C@]([H])(O)C1=CC=CC=C1
Phenylpyruvic acid,Phenylalanine dehydrogenase,OC(=O)C(=O)CC1=CC=CC=C1
Phenylpyruvic acid,Hydroxyacid oxidase 1,OC(=O)C(=O)CC1=CC=CC=C1
Phenylpyruvic acid,Indole-3-pyruvate decarboxylase,OC(=O)C(=O)CC1=CC=CC=C1
Phenylpyruvic acid,Putative uncharacterized protein,OC(=O)C(=O)CC1=CC=CC=C1
Phenylpyruvic acid,Bacilysin biosynthesis protein BacB,OC(=O)C(=O)CC1=CC=CC=C1
Phenylpyruvic acid,Probable chorismate mutase,OC(=O)C(=O)CC1=CC=CC=C1
Phenyltoloxamine,Histamine H1 receptor,CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1
Phenytoin,Sodium channel protein type 5 subunit alpha,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
Phenytoin,Sodium channel protein type 1 subunit alpha,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
Phenytoin,Nuclear receptor subfamily 1 group I member 2,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
Phenytoin,Sodium channel subunit beta-1,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
Phenytoin,Sodium channel protein type 3 subunit alpha,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
Pholcodine,Mu-type opioid receptor,[H][C@@]12OC3=C(OCCN4CCOCC4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
Pholcodine,Kappa-type opioid receptor,[H][C@@]12OC3=C(OCCN4CCOCC4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
Pholcodine,Delta-type opioid receptor,[H][C@@]12OC3=C(OCCN4CCOCC4)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O
Phosphatidyl ethanol,Steroidogenic factor 1,[H]\C(CCCCCC)=C(/[H])CCCCCCCC(=O)O[C@@]([H])(COC(=O)CCCCCCC\C([H])=C(\[H])CCCCCCCC)COP(O)(=O)OCCO
Phosphatidyl serine,Scavenger receptor class B member 1,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Phosphatidylserine decarboxylase proenzyme,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Phospholipid-transporting ATPase IA,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Phosphatidylserine synthase 1,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Protein kinase C alpha type,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Diacylglycerol kinase gamma,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Diacylglycerol kinase delta,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Phosphatidylserine synthase 2,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Sphingomyelin phosphodiesterase 4,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidyl serine,Sphingomyelin phosphodiesterase 3,CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O
Phosphatidylethanolamine,Endothelial protein C receptor,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC
Phosphatidylethanolamine,Bacteriorhodopsin,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC
Phosphatidylethanolamine,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC
Phosphoaminophosphonic Acid Guanylate Ester,Ras-related protein Rab-8B,[H][C@]1(COP(O)(=O)OP(O)(=O)NP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
Phosphoaminophosphonic Acid-Adenylate Ester,Glutathione synthetase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,DNA gyrase subunit B,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Ephrin type-A receptor 2,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Tyrosine-protein kinase Lck,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Insulin-like growth factor 1 receptor,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Glycogen synthase kinase-3 beta,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Mitogen-activated protein kinase 10,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Hexokinase-1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Cystic fibrosis transmembrane conductance regulator,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Casein kinase II subunit alpha,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Thymidylate kinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,UDP-N-acetylmuramate--L-alanine ligase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Serine/threonine-protein kinase pim-1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Pantothenate kinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Dihydroxyacetone kinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Chemotaxis protein CheA,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Argininosuccinate synthase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,S-adenosylmethionine synthase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Phosphoribosylglycinamide formyltransferase 2,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,DNA mismatch repair protein MutL,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,4-diphosphocytidyl-2-C-methyl-D-erythritol kinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Acetylglutamate kinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Inositol-trisphosphate 3-kinase A,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Death-associated protein kinase 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Aminoglycoside 3'-phosphotransferase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Arsenical pump-driving ATPase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Osmolarity sensor protein EnvZ,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,"Actin, alpha skeletal muscle",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,DNA repair protein RAD51 homolog 1,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,DNA topoisomerase 2-beta,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Mitogen-activated protein kinase 12,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Protein RecA,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,TrwB,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Kinesin-like protein KIF1A,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,ATP-dependent protease ATPase subunit HslU,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Rod shape-determining protein MreB,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Chaperone protein ClpB,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Type II secretion system protein E,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Sensor protein PhoQ,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,DNA topoisomerase 4 subunit B,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Galactokinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Potassium-transporting ATPase ATP-binding subunit,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,SRSF protein kinase 2,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Ephrin type-B receptor 2,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,T-complex protein 1 subunit gamma,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Transitional endoplasmic reticulum ATPase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Kinesin-like protein KIF2C,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaminophosphonic Acid-Adenylate Ester,Transient receptor potential cation channel subfamily M member 7,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O
Phosphoaspartate,Nitrogen regulation protein NR(I),N[C@@H](CC(=O)OP(O)(O)=O)C(O)=O
Phosphoaspartate,Beta-phosphoglucomutase,N[C@@H](CC(=O)OP(O)(O)=O)C(O)=O
Phosphocreatine,Guanidinoacetate N-methyltransferase,CN(CC(O)=O)C(=N)NP(O)(O)=O
Phosphocreatine,Sodium- and chloride-dependent creatine transporter 1,CN(CC(O)=O)C(=N)NP(O)(O)=O
Phosphocreatine,Creatine kinase M-type,CN(CC(O)=O)C(=N)NP(O)(O)=O
Phosphocreatine,"Creatine kinase U-type, mitochondrial",CN(CC(O)=O)C(=N)NP(O)(O)=O
Phosphocreatine,"Creatine kinase S-type, mitochondrial",CN(CC(O)=O)C(=N)NP(O)(O)=O
Phosphocreatine,Creatine kinase B-type,CN(CC(O)=O)C(=N)NP(O)(O)=O
Phosphoenolpyruvate,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",OC(=O)C(=C)OP(O)(O)=O
Phosphoenolpyruvate,2-dehydro-3-deoxyphosphooctonate aldolase,OC(=O)C(=C)OP(O)(O)=O
Phosphoenolpyruvate,2-dehydro-3-deoxyphosphooctonate aldolase,OC(=O)C(=C)OP(O)(O)=O
Phosphoenolpyruvate,Phospho-2-dehydro-3-deoxyheptonate aldolase,OC(=O)C(=C)OP(O)(O)=O
Phosphoenolpyruvate,"Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-sensitive",OC(=O)C(=C)OP(O)(O)=O
Phosphoenolpyruvate,Capsule biosynthesis protein,OC(=O)C(=C)OP(O)(O)=O
Phosphoenolpyruvate,Beta-enolase,OC(=O)C(=C)OP(O)(O)=O
Phosphoglycolohydroxamic Acid,Rhamnulose-1-phosphate aldolase,ONC(=O)COP(O)(O)=O
Phosphoglycolohydroxamic Acid,Methylglyoxal synthase,ONC(=O)COP(O)(O)=O
Phosphoglycolohydroxamic Acid,L-fuculose phosphate aldolase,ONC(=O)COP(O)(O)=O
Phosphoglycolohydroxamic Acid,Triosephosphate isomerase,ONC(=O)COP(O)(O)=O
Phosphoglycolohydroxamic Acid,"D-tagatose-1,6-bisphosphate aldolase subunit KbaY",ONC(=O)COP(O)(O)=O
Phosphoglycolohydroxamic Acid,Fructose-bisphosphate aldolase class 2,ONC(=O)COP(O)(O)=O
Phosphomethylphosphonic Acid Adenosyl Ester,Ribose-phosphate pyrophosphokinase,[H][C@]1(COP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Phosphomethylphosphonic Acid Adenosyl Ester,MutT/nudix family protein,[H][C@]1(COP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Phosphomethylphosphonic Acid Adenosyl Ester,Protein UshA,[H][C@]1(COP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Phosphomethylphosphonic Acid Guanosyl Ester,Soluble calcium-activated nucleotidase 1,[H][C@]1(COP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
Phosphomethylphosphonic Acid Guanylate Ester,Cell division protein FtsZ,[H][C@]1(COP(O)(=O)CP(O)(=O)OP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
Phosphomethylphosphonic Acid-Guanylate Ester,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",[H][C@]1(COP(O)(=O)OP(O)(=O)CP(O)(O)=O)O[C@@]([H])(N2C=NC3=C2NC(=N)N=C3O)[C@]([H])(O)[C@]1([H])O
Phosphonoacetaldehyde,Phosphonoacetaldehyde hydrolase,OP(O)(=O)CC=O
Phosphonoacetic Acid,Alkaline phosphatase,OC(=O)CP(O)(O)=O
Phosphonoacetohydroxamic Acid,Beta-enolase,ONC(=O)CP(O)(O)=O
Phosphonopyruvate,"Pyruvate, phosphate dikinase",OC(=O)C(=O)CP(O)(O)=O
Phosphonothreonine,Mitogen-activated protein kinase 1,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,Aurora kinase A,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,Rhodopsin,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,Protein kinase C theta type,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,Threonine-phosphate decarboxylase,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,Cyclin-dependent kinase 7,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,Protein S100-A11,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,Mitogen-activated protein kinase 12,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,cAMP-dependent protein kinase catalytic subunit alpha,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonothreonine,cAMP-dependent protein kinase catalytic subunit beta,C[C@H](OP(O)(O)=O)[C@@H](N)C(O)=O
Phosphonotyrosine,Mast/stem cell growth factor receptor Kit,N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(O)=O
Phosphonotyrosine,Proto-oncogene tyrosine-protein kinase Src,N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(O)=O
Phosphonotyrosine,Tyrosine-protein kinase HCK,N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(O)=O
Phosphoramidon,Neprilysin,[H][C@@](CC(C)C)(NP(O)(=O)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O)C(O)=N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(O)=O
Phosphoramidon,Kell blood group glycoprotein,[H][C@@](CC(C)C)(NP(O)(=O)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O)C(O)=N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(O)=O
"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=NC(O)=NC=C23)[C@]([H])(O)[C@]1([H])O
"Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",Thymidylate kinase,[H][C@]1(N)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(O)=NC1=O
"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester",Thymidylate kinase,[H][C@]1(F)C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(=O)NC1=O
Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,Ribonuclease pancreatic,[H][C@]1(CO)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C3NC(=N)N=C4O)[C@]([H])(O)[C@]2([H])O)[C@]1([H])O
Phosphorylated Dihydropteroate,Bifunctional protein FolC,NC1=NC2=NC=C(CNC3=CC=C(C=C3)C(=O)OP(O)(O)=O)N=C2C(=O)N1
Phosphorylcolamine,Protein kinase C beta type,NCCOP(O)(O)=O
Phosphorylisopropane,Trypsin-1,CC(C)OP(O)(O)=O
Phosphorylisopropane,Capsid scaffolding protein,CC(C)OP(O)(O)=O
Phosphorylisopropane,Chymotrypsinogen B,CC(C)OP(O)(O)=O
Phosphorylisopropane,Trypsin-2,CC(C)OP(O)(O)=O
"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,[H][C@]1(COP(O)(O)=O)O[C@]([H])(N2C=NC3=C2C=CC(OC)=C3)[C@]([H])(O)[C@]1([H])O
Phthalic Acid,Nicotinate-nucleotide pyrophosphorylase [carboxylating],OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Estrogen receptor,OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Progesterone receptor,OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Estrogen receptor beta,OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Peroxisome proliferator-activated receptor alpha,OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Peroxisome proliferator-activated receptor delta,OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Peroxisome proliferator-activated receptor gamma,OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Retinoic acid receptor RXR-alpha,OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Retinoic acid receptor RXR-beta,OC(=O)C1=CC=CC=C1C(O)=O
Phthalic Acid,Retinoic acid receptor RXR-gamma,OC(=O)C1=CC=CC=C1C(O)=O
Phylloquinone,Vitamin K-dependent gamma-carboxylase,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O
Phylloquinone,Osteocalcin,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=C(C)C(=O)C2=C(C=CC=C2)C1=O
Physostigmine,Acetylcholinesterase,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C
Physostigmine,Neuronal acetylcholine receptor subunit alpha-4,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C
Physostigmine,Neuronal acetylcholine receptor subunit beta-2,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C
Piboserod,5-hydroxytryptamine receptor 4,CCCCN1CCC(CNC(=O)C2=C3OCCCN3C3=CC=CC=C23)CC1
Piclamilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",COC1=CC=C(C=C1OC1CCCC1)C(=O)NC1=C(Cl)C=NC=C1Cl
Piclamilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",COC1=CC=C(C=C1OC1CCCC1)C(=O)NC1=C(Cl)C=NC=C1Cl
Piclamilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",COC1=CC=C(C=C1OC1CCCC1)C(=O)NC1=C(Cl)C=NC=C1Cl
Piclamilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",COC1=CC=C(C=C1OC1CCCC1)C(=O)NC1=C(Cl)C=NC=C1Cl
Piclidenoson,Adenosine receptor A3,CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(NCC3=CC(I)=CC=C3)N=CN=C12
Picric acid,Pentaerythritol tetranitrate reductase,OC1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O
Picrotoxin,Gamma-aminobutyric acid receptor subunit rho-1,[H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O
Picrotoxin,Gamma-aminobutyric acid receptor subunit alpha-1,[H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O
Picrotoxin,Glycine receptor subunit alpha-2,[H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O
Picrotoxin,Glycine receptor subunit alpha-3,[H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O
Picrotoxin,Glycine receptor subunit alpha-1,[H][C@@]12OC(=O)[C@@]34OC3C[C@@](O)(C3[C@@H](C1OC3=O)C(C)=C)[C@@]24C.[H][C@@]12C[C@@]3(O)C4[C@@H](C(OC4=O)[C@@]4([H])OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O
Pidolic Acid,Vascular endothelial growth factor A,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Angiogenin,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Chondroitinase-B,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Alpha-amylase 1,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Pancreatic alpha-amylase,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Copper-containing nitrite reductase,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Cytochrome c2,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Ig lambda chain V-II region MGC,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,"Endo-1,4-beta-xylanase",OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,C-C motif chemokine 8,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Cytochrome c',OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Disintegrin and metalloproteinase domain-containing protein 28,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Orexin,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Alpha-amylase 2B,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Trefoil factor 2,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Ig lambda-1 chain C regions,OC(=O)[C@@H]1CCC(=O)N1
Pidolic Acid,Keratin-associated protein 5-2,OC(=O)[C@@H]1CCC(=O)N1
Pilaralisib,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",COC1=CC=C(Cl)C(NC2=C(NS(=O)(=O)C3=CC(NC(=O)C(C)(C)N)=CC=C3)N=C3C=CC=CC3=N2)=C1
Pilocarpine,Muscarinic acetylcholine receptor M3,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
Pilocarpine,Muscarinic acetylcholine receptor M1,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
Pilocarpine,Muscarinic acetylcholine receptor M2,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
Pilocarpine,Muscarinic acetylcholine receptor M4,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
Pimagedine,"Nitric oxide synthase, inducible",NNC(N)=N
Pimagedine,Aldose reductase,NNC(N)=N
Pimagedine,Metalloproteinase inhibitor 3,NNC(N)=N
Pimavanserin,5-hydroxytryptamine receptor 2A,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1
Pimavanserin,D(2) dopamine receptor,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1
Pimecrolimus,Serine/threonine-protein kinase mTOR,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC
Pimecrolimus,Peptidyl-prolyl cis-trans isomerase FKBP1A,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC
Pimelic Acid,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",OC(=O)CCCCCC(O)=O
Pimozide,D(2) dopamine receptor,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1
Pimozide,D(3) dopamine receptor,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1
Pimozide,Potassium voltage-gated channel subfamily H member 2,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1
Pimozide,Calmodulin,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1
Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate,Beta-lactamase,CC(C)(O\N=C(/C(=O)NCB(O)O)C1=CSC(N)=N1)C(O)=O
Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate,Beta-lactamase TEM,CC(C)(O\N=C(/C(=O)NCB(O)O)C1=CSC(N)=N1)C(O)=O
Pinaverium,Voltage-dependent L-type calcium channel subunit alpha-1S,COC1=C(OC)C=C(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)C(Br)=C1
Pindolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
Pindolol,5-hydroxytryptamine receptor 1A,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
Pindolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
Pindolol,5-hydroxytryptamine receptor 1B,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
Pindolol,Beta-3 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2
Pioglitazone,Peroxisome proliferator-activated receptor gamma,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1
Pioglitazone,Peroxisome proliferator-activated receptor delta,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1
Pioglitazone,Peroxisome proliferator-activated receptor alpha,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1
Pioglitazone,Amine oxidase [flavin-containing] B,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1
Pipamperone,D(2) dopamine receptor,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,5-hydroxytryptamine receptor 2A,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,Alpha-1A adrenergic receptor,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,Alpha-1B adrenergic receptor,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,Alpha-1D adrenergic receptor,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,D(4) dopamine receptor,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,D(1A) dopamine receptor,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,D(3) dopamine receptor,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,5-hydroxytryptamine receptor 2B,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipamperone,Alpha-2A adrenergic receptor,NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1
Pipecuronium,Neuronal acetylcholine receptor subunit alpha-2,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1
Pipecuronium,Muscarinic acetylcholine receptor M2,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1
Pipecuronium,Muscarinic acetylcholine receptor M3,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1
Pipendoxifene,"Integrase, catalytic core",CC1=C(N(CC2=CC=C(OCCN3CCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1
Piperacillin,Penicillin-binding protein 3,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O
Piperacillin,Penicillin-binding protein 2B,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O
Piperacillin,Penicillin-binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O
Piperacillin,Penicillin-binding protein 1b,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=CC=C1)C(O)=O
Piperazine,Gamma-aminobutyric acid receptor subunit beta-3,C1CNCCN1
Piperine,Nuclear receptor subfamily 1 group I member 2,O=C(\C=C\C=C\C1=CC2=C(OCO2)C=C1)N1CCCCC1
Pipotiazine,D(2) dopamine receptor,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1
Pipotiazine,D(1A) dopamine receptor,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1
Pipotiazine,5-hydroxytryptamine receptor 2A,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1
Pipotiazine,5-hydroxytryptamine receptor 1A,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCC(CCO)CC2)C=C1
Pipradrol,D(1A) dopamine receptor,[H]N1CCCCC1C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Pipradrol,D(1B) dopamine receptor,[H]N1CCCCC1C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Pirbuterol,Beta-2 adrenergic receptor,CC(C)(C)NCC(O)C1=NC(CO)=C(O)C=C1
Pirbuterol,Beta-1 adrenergic receptor,CC(C)(C)NCC(O)C1=NC(CO)=C(O)C=C1
Pirenzepine,Muscarinic acetylcholine receptor M1,CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
Piretanide,Solute carrier family 12 member 1,NS(=O)(=O)C1=CC(=CC(N2CCCC2)=C1OC1=CC=CC=C1)C(O)=O
Pirfenidone,Furin,CC1=CN(C(=O)C=C1)C1=CC=CC=C1
Piribedil,D(2) dopamine receptor,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
Piribedil,D(3) dopamine receptor,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
Piritrexim,Dihydrofolate reductase,COC1=CC(CC2=C(C)C3=C(N=C2)N=C(N)N=C3N)=C(OC)C=C1
Pirlindole,Amine oxidase [flavin-containing] A,CC1=CC=C2N3CCNC4CCCC(=C34)C2=C1
Pirlindole,5-hydroxytryptamine receptor 1A,CC1=CC=C2N3CCNC4CCCC(=C34)C2=C1
Pirlindole,Alpha-2A adrenergic receptor,CC1=CC=C2N3CCNC4CCCC(=C34)C2=C1
Piroxicam,Prostaglandin G/H synthase 2,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O
Piroxicam,Prostaglandin G/H synthase 1,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O
Pitavastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O
Pitolisant,Histamine H3 receptor,ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
Pitolisant,Potassium voltage-gated channel subfamily H member 2,ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
Pivampicillin,Penicillin-binding protein 1A,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OCOC(=O)C(C)(C)C
Pivmecillinam,Penicillin-binding protein 1A,[H]C(=N[C@@H]1C(=O)N2[C@@H](C(=O)OCOC(=O)C(C)(C)C)C(C)(C)S[C@]12[H])N1CCCCCC1
Pizotifen,Muscarinic acetylcholine receptor M1,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Muscarinic acetylcholine receptor M2,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Muscarinic acetylcholine receptor M3,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,5-hydroxytryptamine receptor 2A,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,5-hydroxytryptamine receptor 2B,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,5-hydroxytryptamine receptor 2C,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,5-hydroxytryptamine receptor 1A,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,5-hydroxytryptamine receptor 1B,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,5-hydroxytryptamine receptor 1D,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Histamine H1 receptor,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Alpha-1A adrenergic receptor,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Alpha-1B adrenergic receptor,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Alpha-1D adrenergic receptor,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Alpha-2A adrenergic receptor,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Alpha-2B adrenergic receptor,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Pizotifen,Alpha-2C adrenergic receptor,CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
Platelet Activating Factor,Ganglioside GM2 activator,CCCCCCCCCCCCCCCCOC[C@H](CO[P@@]([O-])(=O)OCC[N+](C)(C)C)OC(C)=O
Platelet Activating Factor,Platelet-activating factor receptor,CCCCCCCCCCCCCCCCOC[C@H](CO[P@@]([O-])(=O)OCC[N+](C)(C)C)OC(C)=O
Plazomicin,30S ribosomal protein S14,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O
Plazomicin,30S ribosomal protein S11,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O
Plecanatide,Guanylate cyclase soluble subunit alpha-2,[H][C@](C)(O)[C@]1([H])N=C(O)[C@]2([H])CSSC[C@]([H])(N=C(O)[C@]([H])(CCC(O)=O)N=C(O)[C@]([H])(CC(O)=O)N=C(O)[C@@]([H])(N)CC(O)=N)C(O)=N[C@@]([H])(CCC(O)=O)C(O)=N[C@@]([H])(CC(C)C)C(O)=N[C@@]([H])(CSSC[C@]([H])(N=C(O)CN=C1O)C(O)=N[C@@]([H])(CC(C)C)C(O)=O)C(O)=N[C@@]([H])(C(C)C)C(O)=N[C@@]([H])(CC(O)=N)C(O)=N[C@@]([H])(C(C)C)C(O)=N[C@@]([H])(C)C(O)=N2
Pleconaril,Genome polyprotein,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C2=NOC(=N2)C(F)(F)F)=C1
Plerixafor,C-X-C chemokine receptor type 4,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1
Plinabulin,Tumor necrosis factor,CC(C)(C)C1=C(\C=C2/NC(=O)\C(NC2=O)=C\C2=CC=CC=C2)N=CN1
Plozalizumab,C-C chemokine receptor type 2,
"Pmp-Hydroxyisoxazole, Pyridoxamine-5-Phosphate-Hydroxyisoxazole",Alanine racemase,CC1=NC=C(COP(O)(O)=O)C(CNC2=CON=C2O)=C1O
Podofilox,DNA topoisomerase 2-alpha,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O
Podofilox,Tubulin alpha-4A chain,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O
Podofilox,Tubulin beta chain,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O
Polaprezinc,Tumor necrosis factor,[Zn++].[H][C@@](CC1=CN=CN1)([N-]C(=O)CCN)C([O-])=O
Polaprezinc,Interleukin-6,[Zn++].[H][C@@](CC1=CN=CN1)([N-]C(=O)CCN)C([O-])=O
Polaprezinc,Interleukin-3,[Zn++].[H][C@@](CC1=CN=CN1)([N-]C(=O)CCN)C([O-])=O
Polaprezinc,Vascular endothelial growth factor receptor 1,[Zn++].[H][C@@](CC1=CN=CN1)([N-]C(=O)CCN)C([O-])=O
Polaprezinc,Beta-nerve growth factor,[Zn++].[H][C@@](CC1=CN=CN1)([N-]C(=O)CCN)C([O-])=O
Polaprezinc,Platelet-derived growth factor receptor beta,[Zn++].[H][C@@](CC1=CN=CN1)([N-]C(=O)CCN)C([O-])=O
Polaprezinc,Heat shock protein HSP 90-alpha,[Zn++].[H][C@@](CC1=CN=CN1)([N-]C(=O)CCN)C([O-])=O
Polaprezinc,Heat shock protein HSP 90-beta,[Zn++].[H][C@@](CC1=CN=CN1)([N-]C(=O)CCN)C([O-])=O
Polatuzumab vedotin,B-cell antigen receptor complex-associated protein beta chain,
Polyestradiol phosphate,Estrogen receptor,
Polyethylene glycol 400,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,
Polyethylene glycol 400,Oxidoreductase HTATIP2,
Polythiazide,Solute carrier family 12 member 3,CN1C(CSCC(F)(F)F)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O
Pomalidomide,Protein cereblon,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
Pomalidomide,Tumor necrosis factor,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
Pomalidomide,Prostaglandin G/H synthase 2,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
Ponatinib,Tyrosine-protein kinase ABL1,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Breakpoint cluster region protein,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Mast/stem cell growth factor receptor Kit,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Proto-oncogene tyrosine-protein kinase receptor Ret,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Angiopoietin-1 receptor,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Receptor-type tyrosine-protein kinase FLT3,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Fibroblast growth factor receptor 1,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Fibroblast growth factor receptor 2,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Fibroblast growth factor receptor 3,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Fibroblast growth factor receptor 4,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Tyrosine-protein kinase Lck,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Proto-oncogene tyrosine-protein kinase Src,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Tyrosine-protein kinase Lyn,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Vascular endothelial growth factor receptor 2,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Ponatinib,Platelet-derived growth factor receptor alpha,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
Porfimer sodium,Low-density lipoprotein receptor,
Porfimer sodium,High affinity immunoglobulin gamma Fc receptor I,
Porphobilinogen,Delta-aminolevulinic acid dehydratase,NCC1=C(CC(O)=O)C(CCC(O)=O)=CN1
Porphyrin Fe(III),Myoglobin,C1=CC2=CC3=CC=C4C=C5C=CC6=CC7=CC=C8C=C1N2[Fe](N78)(N34)N56
Posaconazole,Lanosterol 14-alpha demethylase,[H][C@@](C)(O)[C@]([H])(CC)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@]2([H])CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1
Posizolid,Amine oxidase [flavin-containing] A,OC[C@H](O)C(=O)N1CCC(=CC1)C1=C(F)C=C(C=C1F)N1C[C@H](COC2=NOC=C2)OC1=O
Potassium acetate,Sodium/potassium-transporting ATPase subunit alpha-1,[K+].CC([O-])=O
Potassium cation,Sodium/potassium-transporting ATPase subunit alpha-1,[K+]
Potassium chloride,Solute carrier family 12 member 5,[Cl-].[K+]
Potassium chloride,Solute carrier family 12 member 6,[Cl-].[K+]
Potassium chloride,Solute carrier family 12 member 7,[Cl-].[K+]
Potassium chloride,Solute carrier family 12 member 2,[Cl-].[K+]
Potassium chloride,Solute carrier family 12 member 1,[Cl-].[K+]
Potassium chloride,Solute carrier family 12 member 4,[Cl-].[K+]
Potassium nitrate,Potassium voltage-gated channel subfamily H member 2,[K+].[O-][N+]([O-])=O
Potassium perchlorate,Sodium/iodide cotransporter,[K+].[O-][Cl](=O)(=O)=O
Potassium sulfate,Sodium/potassium-transporting ATPase subunit alpha-1,[K+].[K+].[O-]S([O-])(=O)=O
Pozanicline,Neuronal acetylcholine receptor subunit alpha-4,CC1=C(OC[C@@H]2CCCN2)C=CC=N1
Pozanicline,Neuronal acetylcholine receptor subunit beta-2,CC1=C(OC[C@@H]2CCCN2)C=CC=N1
Pracinostat,Histone deacetylase 1,CCCCC1=NC2=CC(\C=C\C(=O)NO)=CC=C2N1CCN(CC)CC
Pracinostat,Histone deacetylase 2,CCCCC1=NC2=CC(\C=C\C(=O)NO)=CC=C2N1CCN(CC)CC
Pracinostat,Histone deacetylase 3,CCCCC1=NC2=CC(\C=C\C(=O)NO)=CC=C2N1CCN(CC)CC
Pracinostat,Histone deacetylase 6,CCCCC1=NC2=CC(\C=C\C(=O)NO)=CC=C2N1CCN(CC)CC
Practolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1
Pradefovir Mesylate,Cytochrome P450 3A4,CS(O)(=O)=O.NC1=C2N=CN(CCOC[P@@]3(=O)OCC[C@H](O3)C3=CC(Cl)=CC=C3)C2=NC=N1
Pralatrexate,Dihydrofolate reductase,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1
Pralatrexate,Thymidylate synthase,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1
Pralidoxime,Acetylcholinesterase,C[N+]1=C(\C=N\O)C=CC=C1
Pralidoxime,Cholinesterase,C[N+]1=C(\C=N\O)C=CC=C1
Pralnacasan,Caspase-1,CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2N1C(=O)[C@H](CCC2=O)NC(=O)C1=NC=CC2=CC=CC=C12
Pramipexole,D(3) dopamine receptor,CCCN[C@H]1CCC2=C(C1)SC(N)=N2
Pramipexole,D(2) dopamine receptor,CCCN[C@H]1CCC2=C(C1)SC(N)=N2
Pramipexole,D(4) dopamine receptor,CCCN[C@H]1CCC2=C(C1)SC(N)=N2
Pramipexole,5-hydroxytryptamine receptor 1A,CCCN[C@H]1CCC2=C(C1)SC(N)=N2
Pramipexole,Alpha-2A adrenergic receptor,CCCN[C@H]1CCC2=C(C1)SC(N)=N2
Pramlintide,Calcitonin receptor,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O
Pramlintide,Receptor activity-modifying protein 1,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O
Pramlintide,Receptor activity-modifying protein 2,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O
Pramlintide,Receptor activity-modifying protein 3,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O
Pranlukast,Cysteinyl leukotriene receptor 1,O=C(NC1=C2OC(=CC(=O)C2=CC=C1)C1=NNN=N1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
Pranlukast,Tumor necrosis factor,O=C(NC1=C2OC(=CC(=O)C2=CC=C1)C1=NNN=N1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
Pranlukast,Interleukin-5,O=C(NC1=C2OC(=CC(=O)C2=CC=C1)C1=NNN=N1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
Pranlukast,Eosinophil cationic protein,O=C(NC1=C2OC(=CC(=O)C2=CC=C1)C1=NNN=N1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
Pranlukast,Nuclear factor NF-kappa-B p105 subunit,O=C(NC1=C2OC(=CC(=O)C2=CC=C1)C1=NNN=N1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
Pranlukast,Mucin-2,O=C(NC1=C2OC(=CC(=O)C2=CC=C1)C1=NNN=N1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1
Prasterone,Estrogen receptor,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Estrogen receptor beta,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit alpha-1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit alpha-2,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit alpha-3,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit alpha-4,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit alpha-5,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit alpha-6,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit beta-1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit beta-2,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit beta-3,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit delta,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit epsilon,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit gamma-1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit gamma-2,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit gamma-3,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit pi,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Gamma-aminobutyric acid receptor subunit theta,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,"Glutamate receptor ionotropic, NMDA 1",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,"Glutamate receptor ionotropic, NMDA 2A",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,"Glutamate receptor ionotropic, NMDA 2B",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,"Glutamate receptor ionotropic, NMDA 2C",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,"Glutamate receptor ionotropic, NMDA 2D",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,"Glutamate receptor ionotropic, NMDA 3A",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,"Glutamate receptor ionotropic, NMDA 3B",[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Androgen receptor,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Estradiol 17-beta-dehydrogenase 1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Bile salt sulfotransferase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Sulfotransferase family cytosolic 2B member 1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Peroxisome proliferator-activated receptor alpha,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Sigma non-opioid intracellular receptor 1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Nuclear receptor subfamily 1 group I member 3,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Steroid Delta-isomerase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasterone,Cholesterol oxidase,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Prasugrel,P2Y purinoceptor 12,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1
Pravastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-1,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-2,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-3,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-5,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit gamma-1,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit gamma-2,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit gamma-3,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit beta-1,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit beta-2,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit beta-3,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit delta,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit epsilon,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit pi,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit rho-1,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit rho-2,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit rho-3,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-1,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-2,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-3,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-4,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-5,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit alpha-6,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit beta-1,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit beta-2,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit beta-3,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit delta,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit epsilon,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit gamma-1,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit gamma-2,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit gamma-3,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit pi,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazepam,Gamma-aminobutyric acid receptor subunit theta,ClC1=CC2=C(C=C1)N(CC1CC1)C(=O)CN=C2C1=CC=CC=C1
Prazosin,Alpha-1A adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prazosin,Alpha-1B adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prazosin,Alpha-1D adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prazosin,Potassium voltage-gated channel subfamily H member 2,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prazosin,Alpha-2A adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prazosin,Alpha-2B adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prazosin,Alpha-1A adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prazosin,Alpha-1B adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prazosin,Alpha-1D adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1
Prednicarbate,Glucocorticoid receptor,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Prednisolone,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Prednisone,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Prednisone,Corticosteroid 11-beta-dehydrogenase isozyme 1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Pregabalin,Voltage-dependent calcium channel subunit alpha-2/delta-1,CC(C)C[C@H](CN)CC(O)=O
Pregnenolone,Sulfotransferase family cytosolic 2B member 1,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C
Pregnenolone,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C
Prenylamine,Calmodulin,CC(CC1=CC=CC=C1)NCCC(C1=CC=CC=C1)C1=CC=CC=C1
Prenylamine,"Myosin light chain kinase 2, skeletal/cardiac muscle",CC(CC1=CC=CC=C1)NCCC(C1=CC=CC=C1)C1=CC=CC=C1
Prilocaine,Sodium channel protein type 5 subunit alpha,CCCNC(C)C(=O)NC1=CC=CC=C1C
Primaquine,"Keratin, type II cytoskeletal 7",COC1=CC(NC(C)CCCN)=C2N=CC=CC2=C1
Primaquine,Ribosyldihydronicotinamide dehydrogenase [quinone],COC1=CC(NC(C)CCCN)=C2N=CC=CC2=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Neuronal acetylcholine receptor subunit alpha-4,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Neuronal acetylcholine receptor subunit alpha-7,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Glutamate receptor 2,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,"Glutamate receptor ionotropic, kainate 2",CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-3,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-4,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-5,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit alpha-6,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit beta-1,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit beta-2,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit beta-3,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit delta,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit epsilon,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit gamma-1,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit gamma-2,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit gamma-3,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit pi,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Primidone,Gamma-aminobutyric acid receptor subunit theta,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1
Probenecid,Solute carrier family 22 member 6,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
Probenecid,Solute carrier family 22 member 11,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
Probenecid,Solute carrier family 22 member 8,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
Probenecid,Pannexin-1,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
Probenecid,Taste receptor type 2 member 16,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
Probucol,ATP-binding cassette sub-family A member 1,CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C
Probucol,Liver carboxylesterase 1,CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C
Procainamide,Sodium channel protein type 5 subunit alpha,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
Procainamide,DNA (cytosine-5)-methyltransferase 1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
Procainamide,Potassium voltage-gated channel subfamily H member 2,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
Procaine,Sodium channel protein type 10 subunit alpha,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,5-hydroxytryptamine receptor 3A,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,"Glutamate receptor ionotropic, NMDA 3A",CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Sodium-dependent dopamine transporter,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Neuronal acetylcholine receptor subunit alpha-2,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Calcium-activated potassium channel subunit alpha-1,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Calcium-activated potassium channel subunit beta-1,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Calcium-activated potassium channel subunit beta-2,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Calcium-activated potassium channel subunit beta-3,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Calcium-activated potassium channel subunit beta-4,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Intermediate conductance calcium-activated potassium channel protein 4,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Small conductance calcium-activated potassium channel protein 1,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Small conductance calcium-activated potassium channel protein 2,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Small conductance calcium-activated potassium channel protein 3,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Amine oxidase [flavin-containing] A,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procaine,Amine oxidase [flavin-containing] B,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
Procarbazine,Amine oxidase [flavin-containing] A,CNNCC1=CC=C(C=C1)C(=O)NC(C)C
Procarbazine,Amine oxidase [flavin-containing] B,CNNCC1=CC=C(C=C1)C(=O)NC(C)C
Procaterol,Beta-2 adrenergic receptor,CC[C@H](NC(C)C)[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1
Prochlorperazine,D(2) dopamine receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Prochlorperazine,Histamine H1 receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Prochlorperazine,Alpha-1A adrenergic receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Prochlorperazine,Alpha-1B adrenergic receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Prochlorperazine,Alpha-1D adrenergic receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Prochlorperazine,Alpha-2A adrenergic receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Prochlorperazine,Alpha-2B adrenergic receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Prochlorperazine,Alpha-2C adrenergic receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Procyclidine,Muscarinic acetylcholine receptor M1,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
Procyclidine,Muscarinic acetylcholine receptor M4,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
Procyclidine,Muscarinic acetylcholine receptor M2,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
Procyclidine,Muscarinic acetylcholine receptor M3,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
Profenamine,Muscarinic acetylcholine receptor M1,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12
Profenamine,"Glutamate receptor ionotropic, NMDA 3A",CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12
Profenamine,Muscarinic acetylcholine receptor M2,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12
Proflavine,Prothrombin,NC1=CC2=NC3=C(C=CC(N)=C3)C=C2C=C1
Proflavine,HTH-type transcriptional regulator QacR,NC1=CC2=NC3=C(C=CC(N)=C3)C=C2C=C1
Proflavine,TetR family transcriptional regulator,NC1=CC2=NC3=C(C=CC(N)=C3)C=C2C=C1
Progabide,Gamma-aminobutyric acid type B receptor subunit 1,OC(=N)CCC\N=C(\C1=CC=C(Cl)C=C1)C1=C(O)C=CC(F)=C1
Progabide,Gamma-aminobutyric acid receptor subunit alpha-1,OC(=N)CCC\N=C(\C1=CC=C(Cl)C=C1)C1=C(O)C=CC(F)=C1
Progesterone,Progesterone receptor,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,Estrogen receptor,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,Mineralocorticoid receptor,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,"Steroid 17-alpha-hydroxylase/17,20 lyase",[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,Kappa-type opioid receptor,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,Alpha-1-acid glycoprotein 1,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,Glucocorticoid receptor,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,Androgen receptor,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,Sex hormone-binding globulin,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Progesterone,Estrogen receptor beta,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Proguanil,Dihydrofolate reductase,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
Proguanil,Bifunctional dihydrofolate reductase-thymidylate synthase,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
Proline,Prolyl 4-hydroxylase subunit alpha-1,OC(=O)[C@@H]1CCCN1
Proline,Bifunctional glutamate/proline--tRNA ligase,OC(=O)[C@@H]1CCCN1
Proline,"Pyrroline-5-carboxylate reductase 1, mitochondrial",OC(=O)[C@@H]1CCCN1
Proline,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),OC(=O)[C@@H]1CCCN1
Proline,Sodium-dependent proline transporter,OC(=O)[C@@H]1CCCN1
Proline,Pyrroline-5-carboxylate reductase 2,OC(=O)[C@@H]1CCCN1
Proline,Peptidyl-prolyl cis-trans isomerase A,OC(=O)[C@@H]1CCCN1
Proline,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",OC(=O)[C@@H]1CCCN1
Proline,Proline synthase co-transcribed bacterial homolog protein,OC(=O)[C@@H]1CCCN1
Proline,Prolyl 3-hydroxylase 1,OC(=O)[C@@H]1CCCN1
Proline,Prolyl 3-hydroxylase 2,OC(=O)[C@@H]1CCCN1
Proline,Prolyl 3-hydroxylase 3,OC(=O)[C@@H]1CCCN1
Proline,Prolyl 4-hydroxylase subunit alpha-2,OC(=O)[C@@H]1CCCN1
Proline,"Proline dehydrogenase 1, mitochondrial",OC(=O)[C@@H]1CCCN1
Proline,Peptidyl-prolyl cis-trans isomerase H,OC(=O)[C@@H]1CCCN1
Proline,Peptidyl-prolyl cis-trans isomerase B,OC(=O)[C@@H]1CCCN1
Proline,Peptidyl-prolyl cis-trans isomerase C,OC(=O)[C@@H]1CCCN1
Proline,Peptidyl-prolyl cis-trans isomerase G,OC(=O)[C@@H]1CCCN1
Proline,Pyrroline-5-carboxylate reductase,OC(=O)[C@@H]1CCCN1
Proline,"Probable proline--tRNA ligase, mitochondrial",OC(=O)[C@@H]1CCCN1
Proline,Trans-3-hydroxy-L-proline dehydratase,OC(=O)[C@@H]1CCCN1
Proline,Pyrroline-5-carboxylate reductase 3,OC(=O)[C@@H]1CCCN1
Promazine,D(2) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,5-hydroxytryptamine receptor 2A,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,5-hydroxytryptamine receptor 2C,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,D(1A) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,D(4) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Muscarinic acetylcholine receptor M4,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Muscarinic acetylcholine receptor M2,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Muscarinic acetylcholine receptor M3,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Muscarinic acetylcholine receptor M1,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Alpha-1B adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Muscarinic acetylcholine receptor M5,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Alpha-1A adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Histamine H1 receptor,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promazine,Alpha-1D adrenergic receptor,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
Promethazine,Histamine H1 receptor,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,D(2) dopamine receptor,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,Muscarinic acetylcholine receptor M1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,Muscarinic acetylcholine receptor M2,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,Muscarinic acetylcholine receptor M3,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,Muscarinic acetylcholine receptor M4,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,Muscarinic acetylcholine receptor M5,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,Alpha-1A adrenergic receptor,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,5-hydroxytryptamine receptor 2A,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,Calmodulin,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Promethazine,Histamine H2 receptor,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
Propacetamol,Prostaglandin G/H synthase 1,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1
Propacetamol,Prostaglandin G/H synthase 2,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1
Propacetamol,Transient receptor potential cation channel subfamily V member 1,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1
Propacetamol,Cannabinoid receptor 1,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1
Propafenone,Sodium channel protein type 5 subunit alpha,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
Propafenone,Potassium voltage-gated channel subfamily H member 2,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
Propafenone,Beta-1 adrenergic receptor,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
Propafenone,Beta-2 adrenergic receptor,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1
Propanoic acid,Alanine racemase,CCC(O)=O
Propanoic acid,Non-heme chloroperoxidase,CCC(O)=O
Propanoic acid,Gephyrin,CCC(O)=O
Propanoic acid,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",CCC(O)=O
Propanoyl-CoA,Propionyl-CoA carboxylase complex B subunit,CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N
Propantheline,Muscarinic acetylcholine receptor M1,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12)C(C)C
Proparacaine,Sodium channel protein type 10 subunit alpha,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC
Propentofylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CCCN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
Propidium,Acetylcholinesterase,CC[N+](C)(CC)CCC[N+]1=C(C2=CC=CC=C2)C2=C(C=CC(N)=C2)C2=C1C=C(N)C=C2
Propiomazine,Histamine H1 receptor,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,5-hydroxytryptamine receptor 2A,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,5-hydroxytryptamine receptor 2C,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,D(2) dopamine receptor,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,D(1A) dopamine receptor,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,D(4) dopamine receptor,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,Alpha-1A adrenergic receptor,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,Alpha-1B adrenergic receptor,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,Alpha-1D adrenergic receptor,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,Muscarinic acetylcholine receptor M3,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,Muscarinic acetylcholine receptor M5,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,Muscarinic acetylcholine receptor M2,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,Muscarinic acetylcholine receptor M4,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiomazine,Muscarinic acetylcholine receptor M1,CCC(=O)C1=CC2=C(SC3=CC=CC=C3N2CC(C)N(C)C)C=C1
Propiverine,Muscarinic acetylcholine receptor M1,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Propiverine,Muscarinic acetylcholine receptor M2,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Propiverine,Muscarinic acetylcholine receptor M3,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Propiverine,Muscarinic acetylcholine receptor M4,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Propiverine,Muscarinic acetylcholine receptor M5,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Propiverine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Propiverine,Alpha-1A adrenergic receptor,CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Propofol,Gamma-aminobutyric acid receptor subunit beta-2,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit beta-3,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Sodium channel protein type 4 subunit alpha,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Sodium channel protein type 2 subunit alpha,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit alpha-1,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit alpha-2,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit alpha-3,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit alpha-4,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit alpha-5,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit alpha-6,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit beta-1,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit beta-2,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit beta-3,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit delta,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit epsilon,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit gamma-1,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit gamma-2,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit gamma-3,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit pi,CC(C)C1=CC=CC(C(C)C)=C1O
Propofol,Gamma-aminobutyric acid receptor subunit theta,CC(C)C1=CC=CC(C(C)C)=C1O
Propranolol,Beta-1 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2
Propranolol,Beta-2 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2
Propranolol,Beta-3 adrenergic receptor,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2
Propranolol,5-hydroxytryptamine receptor 1A,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2
Propranolol,5-hydroxytryptamine receptor 1B,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2
Propyl Gallate,Estrogen receptor,CCCOC(=O)C1=CC(O)=C(O)C(O)=C1
Propyl acetate,Carboxylesterase,CCCOC(C)=O
Propyl alcohol,Lysozyme C,CCCO
Propylene glycol,Coagulation factor XIII A chain,CC(O)CO
Propylene glycol,Haloalkane dehalogenase,CC(O)CO
Propylene glycol,Clavaminate synthase 1,CC(O)CO
Propylene glycol,Lactaldehyde reductase,CC(O)CO
Propylene glycol,B12-independent glycerol dehydratase,CC(O)CO
Propylhexedrine,Synaptic vesicular amine transporter,CNC(C)CC1CCCCC1
Propylhexedrine,Trace amine-associated receptor 1,CNC(C)CC1CCCCC1
Propylthiouracil,Thyroid peroxidase,CCCC1=CC(=O)NC(=S)N1
Prostaglandin D2,Aldo-keto reductase family 1 member C3,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O
Prostaglandin D2,Prostaglandin D2 receptor 2,[H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O
Prostaglandin G2,Prostaglandin G/H synthase 2,[H][C@@](CCCCC)(OO)\C=C\[C@@]1([H])[C@@]2([H])C[C@]([H])(OO2)[C@]1([H])C\C=C/CCCC(O)=O
Protamine sulfate,Coagulation factor X,
Protamine sulfate,Antithrombin-III,
Protein S human,Coagulation factor V,
Protein S human,Coagulation factor X,
Protein S human,Vitamin K-dependent protein C,
Prothrombin,Fibrinogen alpha chain,
Prothrombin,Fibrinogen beta chain,
Prothrombin,Coagulation factor XIII A chain,
Prothrombin,Carboxypeptidase B2,
Protirelin,Thyrotropin-releasing hormone receptor,[H][C@@](CC1=CN=CN1)(NC(=O)[C@]1([H])CCC(=O)N1)C(=O)N1CCC[C@@]1([H])C(N)=O
Protokylol,Beta-2 adrenergic receptor,CC(CC1=CC=C2OCOC2=C1)NCC(O)C1=CC=C(O)C(O)=C1
Protoporphyrin,Ferritin light chain,CC1=C(CCC(O)=O)/C2=C/C3=N/C(=C\C4=C(C)C(C=C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C=C)=C4C)/C(C)=C3CCC(O)=O
Protoporphyrin Ix Containing Co,Prostaglandin G/H synthase 1,CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5N6C(=CC7=C(C=C)C(C)=C8C=C1N2[Co]6(N34)N78)C(C)=C5C=C
Protoporphyrin Ix Containing Co,Cytochrome c,CC1=C(CCC(O)=O)C2=CC3=C(CCC(O)=O)C(C)=C4C=C5N6C(=CC7=C(C=C)C(C)=C8C=C1N2[Co]6(N34)N78)C(C)=C5C=C
Protoporphyrin Ix Containing Zn,Cytochrome c,CC1=C(CCC(O)=O)C2=CC3=[N]4C(=CC5=C(C)C(C=C)=C6C=C7C(C)=C(C=C)C8=[N]7[Zn]4(N2C1=C8)N56)C(C)=C3CCC(O)=O
Protriptyline,Sodium-dependent noradrenaline transporter,CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12
Protriptyline,Sodium-dependent serotonin transporter,CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12
Prucalopride,5-hydroxytryptamine receptor 4,COCCCN1CCC(CC1)NC(=O)C1=C2OCCC2=C(N)C(Cl)=C1
Pseudoephedrine,Sodium-dependent noradrenaline transporter,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Sodium-dependent dopamine transporter,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Alpha-1A adrenergic receptor,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Alpha-2A adrenergic receptor,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Sodium-dependent serotonin transporter,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Beta-2 adrenergic receptor,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Beta-1 adrenergic receptor,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,"Nuclear factor of activated T-cells, cytoplasmic 1",CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Tumor necrosis factor,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Cyclic AMP-dependent transcription factor ATF-1,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Cyclic AMP-dependent transcription factor ATF-2,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Cyclic AMP-dependent transcription factor ATF-3,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Cyclic AMP-dependent transcription factor ATF-4,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Cyclic AMP-dependent transcription factor ATF-5,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Cyclic AMP-dependent transcription factor ATF-6 alpha,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Cyclic AMP-dependent transcription factor ATF-7,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Jun dimerization protein 2,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Proto-oncogene c-Fos,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Transcription factor AP-1,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pseudoephedrine,Interleukin-2,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pterin Cytosine Dinucleotide,Aldehyde oxidoreductase,[H][C@]12NC3=C(N[C@@]1([H])C(S)=C(S)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O)O2)C(=O)NC(N)=N3
Pterin-6-Yl-Methyl-Monophosphate,Dihydropteroate synthase,NC1=NC2=NC=C(COP(O)(O)=O)N=C2C(=O)N1
Pterin-6-Yl-Methyl-Monophosphate,Dihydropteroate synthase,NC1=NC2=NC=C(COP(O)(O)=O)N=C2C(=O)N1
Pteroic Acid,Dihydropteroate synthase,NC1=NC2=C(N=C(CNC3=CC=C(C=C3)C(O)=O)C=N2)C(O)=N1
Purine Riboside-5'-Monophosphate,Ribonuclease pancreatic,[H][C@]1(COP(O)(O)=O)O[C@@]([H])(N2C=NC3=CN=CN=C23)[C@]([H])(O)[C@]1([H])O
Puromycin,60S ribosomal protein L10-like,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L13a,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L23,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L15,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L19,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L23a,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,Probable ribosome biogenesis protein RLP24,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L26-like 1,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L8,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L37,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L3,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,60S ribosomal protein L11,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Puromycin,Leucyl/phenylalanyl-tRNA--protein transferase,[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@]1([H])[C@@]([H])(CO)O[C@@]([H])(N2C=NC3=C(N=CN=C23)N(C)C)[C@]1([H])O
Purvalanol,Mitogen-activated protein kinase 1,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C
Purvalanol,Mitogen-activated protein kinase 3,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C
Purvalanol,Cyclin-dependent kinase 2,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C
Purvalanol,Cell division control protein 2 homolog,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C
Purvalanol,Cyclin-dependent kinase 4,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C
Purvalanol,SRSF protein kinase 2,[H][C@@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC=C(C(O)=O)C(Cl)=C2)=N1)C(C)C
Purvalanol A,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](CO)(NC1=NC(NC2=CC=CC(Cl)=C2)=C2N=CN(C(C)C)C2=N1)C(C)C
Purvalanol A,Casein kinase I isoform gamma-3,[H][C@@](CO)(NC1=NC(NC2=CC=CC(Cl)=C2)=C2N=CN(C(C)C)C2=N1)C(C)C
Purvalanol A,Ribosomal protein S6 kinase alpha-1,[H][C@@](CO)(NC1=NC(NC2=CC=CC(Cl)=C2)=C2N=CN(C(C)C)C2=N1)C(C)C
Putrescine,S-adenosylmethionine decarboxylase proenzyme,NCCCCN
Putrescine,Ornithine decarboxylase,NCCCCN
Putrescine,Putrescine-binding periplasmic protein,NCCCCN
Putrescine,Beta-1 adrenergic receptor,NCCCCN
Putrescine,Beta-2 adrenergic receptor,NCCCCN
Pyrantel,G-protein coupled receptor 35,[H]\C(=C(\[H])C1=NCCCN1C)C1=CC=CS1
Pyrantel,Muscarinic acetylcholine receptor M1,[H]\C(=C(\[H])C1=NCCCN1C)C1=CC=CS1
Pyrazole,Alcohol dehydrogenase 1C,N1C=CC=N1
Pyrazole,Estrogen receptor,N1C=CC=N1
Pyrazole,Estrogen receptor beta,N1C=CC=N1
Pyrethrum extract,Nuclear receptor subfamily 1 group I member 2,
Pyridostigmine,Acetylcholinesterase,CN(C)C(=O)OC1=C[N+](C)=CC=C1
Pyridostigmine,Cholinesterase,CN(C)C(=O)OC1=C[N+](C)=CC=C1
Pyridostigmine,Serum albumin,CN(C)C(=O)OC1=C[N+](C)=CC=C1
Pyridoxal,Pyridoxal kinase,CC1=NC=C(CO)C(C=O)=C1O
Pyridoxal phosphate,"Alanine--glyoxylate aminotransferase 2, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Glutamate decarboxylase 1,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Cystathionine beta-synthase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Kynureninase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Serine hydroxymethyltransferase, cytosolic",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Cysteine desulfurase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Aspartate aminotransferase, cytoplasmic",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Ornithine aminotransferase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Ornithine decarboxylase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"4-aminobutyrate aminotransferase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Pyridoxine-5'-phosphate oxidase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Sphingosine-1-phosphate lyase 1,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Tyrosine aminotransferase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Kynurenine--oxoglutarate transaminase 1,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Threonine synthase-like 1,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Glycogen phosphorylase, liver form",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Serine palmitoyltransferase 2,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Cysteine sulfinic acid decarboxylase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Histidine decarboxylase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Antizyme inhibitor 2,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,L-serine dehydratase/L-threonine deaminase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Glycine dehydrogenase (decarboxylating), mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Alanine aminotransferase 1,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Phosphoserine aminotransferase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"5-aminolevulinate synthase, nonspecific, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Serine--pyruvate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Pyridoxal phosphate phosphatase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Serine palmitoyltransferase 1,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Cystathionine gamma-lyase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Branched-chain-amino-acid aminotransferase, cytosolic",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Branched-chain-amino-acid aminotransferase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Proline synthase co-transcribed bacterial homolog protein,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Formimidoyltransferase-cyclodeaminase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Aspartate aminotransferase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Glycogen phosphorylase, brain form",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Glycogen phosphorylase, muscle form",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Aromatic-L-amino-acid decarboxylase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Aspartate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Serine hydroxymethyltransferase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Selenocysteine lyase variant,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Alpha-1,4 glucan phosphorylase",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Ornithine aminotransferase variant,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,5-aminolevulinate synthase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Glutamate decarboxylase 2 (Pancreatic islets and brain, 65kDa)",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,DDC protein,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Pyridoxal-dependent decarboxylase domain-containing protein 1,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Kynurenine--oxoglutarate transaminase 3,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Acidic amino acid decarboxylase GADL1,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Selenocysteine lyase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Immunoglobulin superfamily member 10,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,5-phosphohydroxy-L-lysine phospho-lyase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Glutamate decarboxylase 1 (Brain, 67kDa)",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"Serine hydroxymethyltransferase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Alanine aminotransferase 2,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Molybdenum cofactor sulfurase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Serine dehydratase-like,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,P-selectin cytoplasmic tail-associated protein (PCAP),CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Hepatic peroxysomal alanine:glyoxylate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Serine racemase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,O-phosphoseryl-tRNA(Sec) selenium transferase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Serine palmitoyltransferase 3,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Glutamic acid decarboxylase,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal phosphate,Alanine-glyoxylate aminotransferase homolog,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
Pyridoxal-5'-Phosphate-N-Oxide,Aspartate aminotransferase,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=[N+]1[O-]
Pyridoxamine-5'-Phosphate,Kynurenine--oxoglutarate transaminase 1,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,"Branched-chain-amino-acid aminotransferase, mitochondrial",CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,Alanine racemase,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,Histidinol-phosphate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,Aspartate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,Histidinol-phosphate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,D-alanine aminotransferase,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,4-aminobutyrate aminotransferase GabT,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase,CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxamine-5'-Phosphate,"Glutamate-1-semialdehyde 2,1-aminomutase",CC1=NC=C(COP(O)(O)=O)C(CN)=C1O
Pyridoxine,Pyridoxal kinase,CC1=C(O)C(CO)=C(CO)C=N1
Pyridoxine phosphate,Ornithine decarboxylase,CC1=NC=C(COP(O)(O)=O)C(CO)=C1O
Pyridoxine phosphate,Pyridoxine 5'-phosphate synthase,CC1=NC=C(COP(O)(O)=O)C(CO)=C1O
Pyridoxyl-Glutamic Acid-5'-Monophosphate,Histidinol-phosphate aminotransferase,[H][C@@](CCC(O)=O)(NCC1=C(COP(O)(O)=O)C=[NH+]C(C)=C1O)C(O)=O
Pyridoxyl-Glutamic Acid-5'-Monophosphate,Branched-chain-amino-acid aminotransferase,[H][C@@](CCC(O)=O)(NCC1=C(COP(O)(O)=O)C=[NH+]C(C)=C1O)C(O)=O
Pyrimethamine,Dihydrofolate reductase,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1
Pyrimethamine,Bifunctional dihydrofolate reductase-thymidylate synthase,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1
Pyrimethamine,Beta-hexosaminidase subunit beta,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1
Pyrithiamine Pyrophosphate,Thiamin pyrophosphokinase 1,CC1=NC=C(C[N+]2=CC=CC(CCO[P@](O)(=O)OP(O)(O)=O)=C2C)C(N)=N1
Pyromellitic Acid,Fumarate hydratase class II,OC(=O)C1=CC(C(O)=O)=C(C=C1C(O)=O)C(O)=O
Pyrophosphoric acid,Thymidylate kinase,OP(O)(=O)OP(O)(O)=O
Pyrophosphoric acid,Ferrichrome-iron receptor,OP(O)(=O)OP(O)(O)=O
Pyrophosphoric acid,NH(3)-dependent NAD(+) synthetase,OP(O)(=O)OP(O)(O)=O
Pyrophosphoric acid,Isopentenyl-diphosphate Delta-isomerase,OP(O)(=O)OP(O)(O)=O
Pyrophosphoric acid,Farnesyl diphosphate synthase,OP(O)(=O)OP(O)(O)=O
Pyrophosphoric acid,Adenylosuccinate synthetase,OP(O)(=O)OP(O)(O)=O
Pyrrole-2-Carboxylate,Monomeric sarcosine oxidase,OC(=O)C1=CC=CN1
Pyrroloquinoline Quinone,Quinoprotein glucose dehydrogenase B,OC(=O)C1=CC2=C(N1)C1=C(N=C(C=C1C(O)=O)C(O)=O)C(=O)C2=O
Pyrroloquinoline Quinone,Quinohemoprotein ethanol dehydrogenase type-1,OC(=O)C1=CC2=C(N1)C1=C(N=C(C=C1C(O)=O)C(O)=O)C(=O)C2=O
Pyrroloquinoline Quinone,Quinohemoprotein alcohol dehydrogenase ADH IIB,OC(=O)C1=CC2=C(N1)C1=C(N=C(C=C1C(O)=O)C(O)=O)C(=O)C2=O
Pyrroloquinoline Quinone,Pyrroloquinoline-quinone synthase,OC(=O)C1=CC2=C(N1)C1=C(N=C(C=C1C(O)=O)C(O)=O)C(=O)C2=O
Pyrroloquinoline Quinone,Quinoprotein ethanol dehydrogenase,OC(=O)C1=CC2=C(N1)C1=C(N=C(C=C1C(O)=O)C(O)=O)C(=O)C2=O
Pyruvaldehyde,Phospholipase A2,CC(=O)C=O
Pyruvic acid,Pyruvate kinase PKLR,CC(=O)C(O)=O
Pyruvic acid,Pyruvate kinase PKM,CC(=O)C(O)=O
Pyruvic acid,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",CC(=O)C(O)=O
Pyruvic acid,"Alanine--glyoxylate aminotransferase 2, mitochondrial",CC(=O)C(O)=O
Pyruvic acid,Monocarboxylate transporter 7,CC(=O)C(O)=O
Pyruvic acid,Monocarboxylate transporter 8,CC(=O)C(O)=O
Pyruvic acid,Monocarboxylate transporter 5,CC(=O)C(O)=O
Pyruvic acid,"4-aminobutyrate aminotransferase, mitochondrial",CC(=O)C(O)=O
Pyruvic acid,Monocarboxylate transporter 3,CC(=O)C(O)=O
Pyruvic acid,Monocarboxylate transporter 6,CC(=O)C(O)=O
Pyruvic acid,Monocarboxylate transporter 2,CC(=O)C(O)=O
Pyruvic acid,Monocarboxylate transporter 4,CC(=O)C(O)=O
Pyruvic acid,Monocarboxylate transporter 1,CC(=O)C(O)=O
Pyruvic acid,"Pyruvate carboxylase, mitochondrial",CC(=O)C(O)=O
QR-333,Aldose reductase,
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-1,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-2,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-3,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-5,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit gamma-1,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit gamma-2,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit gamma-3,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit beta-1,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit beta-3,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit delta,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit epsilon,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit pi,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit rho-1,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit rho-2,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit rho-3,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-1,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-2,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-3,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-4,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-5,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit alpha-6,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit beta-1,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit beta-2,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit beta-3,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit delta,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit epsilon,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit gamma-1,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit gamma-2,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit gamma-3,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit pi,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quazepam,Gamma-aminobutyric acid receptor subunit theta,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2
Quercetin,Tyrosine-protein kinase HCK,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,UDP-glucuronosyltransferase 3A1,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,"ATP synthase subunit alpha, mitochondrial",OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,"ATP synthase subunit beta, mitochondrial",OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,"ATP synthase subunit gamma, mitochondrial",OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Serine/threonine-protein kinase pim-1,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,HTH-type transcriptional regulator TtgR,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial",OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Serine/threonine-protein kinase 17B,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Estrogen receptor,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Estrogen receptor beta,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Ribosyldihydronicotinamide dehydrogenase [quinone],OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Aryl hydrocarbon receptor,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Cytochrome P450 1B1,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,"Actin, cytoplasmic 1",OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Casein kinase II subunit alpha,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Casein kinase II subunit beta,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Eukaryotic translation initiation factor 3 subunit F,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Heat shock protein HSP 90-alpha,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Heat shock-related 70 kDa protein 2,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,RuvB-like 2,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Splicing factor 3B subunit 3,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Ubiquitin-like modifier-activating enzyme 1,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Sex hormone-binding globulin,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Carbonyl reductase [NADPH] 1,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,CCAAT/enhancer-binding protein beta,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quercetin,Nuclear receptor subfamily 1 group I member 2,OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C1=CC=C(O)C(O)=C1
Quetiapine,5-hydroxytryptamine receptor 2A,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,D(2) dopamine receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,5-hydroxytryptamine receptor 1A,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,5-hydroxytryptamine receptor 1B,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,5-hydroxytryptamine receptor 1D,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,5-hydroxytryptamine receptor 1E,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,5-hydroxytryptamine receptor 2C,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,5-hydroxytryptamine receptor 3A,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,5-hydroxytryptamine receptor 6,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,5-hydroxytryptamine receptor 7,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,D(1A) dopamine receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,D(1B) dopamine receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,D(3) dopamine receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,D(4) dopamine receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Histamine H1 receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Alpha-1A adrenergic receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Alpha-1B adrenergic receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Alpha-1D adrenergic receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Alpha-2A adrenergic receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Alpha-2B adrenergic receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Alpha-2C adrenergic receptor,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Muscarinic acetylcholine receptor M1,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Muscarinic acetylcholine receptor M2,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Muscarinic acetylcholine receptor M3,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Muscarinic acetylcholine receptor M4,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quetiapine,Muscarinic acetylcholine receptor M5,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
Quinacrine,85/88 kDa calcium-independent phospholipase A2,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2
Quinacrine,Cytosolic phospholipase A2,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2
Quinacrine,Inactive phospholipase C-like protein 1,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2
Quinacrine mustard,Trypanothione reductase,COC1=CC2=C(NC(C)CCCN(CCCl)CCCl)C3=CC=C(Cl)C=C3N=C2C=C1
Quinagolide,D(2) dopamine receptor,[H][C@]12C[C@@H](CN(CCC)[C@]1([H])CC1=CC=CC(O)=C1C2)NS(=O)(=O)N(CC)CC
Quinagolide,D(1A) dopamine receptor,[H][C@]12C[C@@H](CN(CCC)[C@]1([H])CC1=CC=CC(O)=C1C2)NS(=O)(=O)N(CC)CC
Quinagolide,D(1B) dopamine receptor,[H][C@]12C[C@@H](CN(CCC)[C@]1([H])CC1=CC=CC(O)=C1C2)NS(=O)(=O)N(CC)CC
Quinaldic Acid,Gag-Pol polyprotein,OC(=O)C1=NC2=C(C=CC=C2)C=C1
Quinapril,Angiotensin-converting enzyme,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O
Quinestrol,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC1CCCC1)C=C3
Quinethazone,Carbonic anhydrase 1,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O
Quinethazone,Carbonic anhydrase 2,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O
Quinethazone,Solute carrier family 12 member 1,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O
Quinethazone,Solute carrier family 12 member 2,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O
Quinethazone,Solute carrier family 12 member 3,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O
Quinidine,Sodium channel protein type 5 subunit alpha,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1
Quinidine,Potassium channel subfamily K member 1,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1
Quinidine,Potassium channel subfamily K member 6,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1
Quinidine,Potassium voltage-gated channel subfamily H member 2,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1
Quinidine,Alpha-1A adrenergic receptor,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1
Quinidine,Alpha-1B adrenergic receptor,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1
Quinidine,Alpha-1D adrenergic receptor,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1
Quinidine barbiturate,Gamma-aminobutyric acid receptor subunit alpha-1,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C
Quinidine barbiturate,Gamma-aminobutyric acid receptor subunit alpha-2,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C
Quinidine barbiturate,Sodium channel protein type 5 subunit alpha,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C
Quinidine barbiturate,Potassium channel subfamily K member 1,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C
Quinidine barbiturate,Glutamate receptor 2,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1.COC1=CC2=C(C=CN=C2C=C1)C(O)C1CC2CCN1CC2C=C
Quinine,Platelet glycoprotein IX,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12
Quinine,Intermediate conductance calcium-activated potassium channel protein 4,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12
Quinolinic Acid,Nicotinate-nucleotide pyrophosphorylase [carboxylating],OC(=O)C1=CC=CN=C1C(O)=O
Quinolinic Acid,Nicotinate-nucleotide pyrophosphorylase [carboxylating],OC(=O)C1=CC=CN=C1C(O)=O
"Quinonoid 7,8-Tetrahydrobiopterin",Phenylalanine-4-hydroxylase,[H][C@@]1(CN=C2NC(N)=NC(=O)C2=N1)[C@@H](O)[C@H](C)O
Quinupristin,50S ribosomal protein L10,[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1
Quinupristin,50S ribosomal protein L22,[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)[C@]([H])(CS[C@@H]3CN4CCC3CC4)CN1C(=O)[C@H](CC1=CC=C(C=C1)N(C)C)N(C)C2=O)C1=CC=CC=C1
Quisqualate,"Glutamate receptor ionotropic, kainate 2",N[C@@H](CN1OC(=O)NC1=O)C(O)=O
Quisqualate,Glutamate receptor 2,N[C@@H](CN1OC(=O)NC1=O)C(O)=O
Quizartinib,Receptor-type tyrosine-protein kinase FLT3,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
R-1487,Mitogen-activated protein kinase 14,CN1C(=O)C(OC2=CC=C(F)C=C2F)=CC2=C1N=C(NC1CCOCC1)N=C2
"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",Stromelysin-1,[H][C@](CC#CCOC)(NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(OC)C=C1)C(O)=O
R-348,Tyrosine-protein kinase JAK3,CCC(=O)NS(=O)(=O)C1=CC(NC2=NC=C(F)C(NC3=CC=C(OCC#C)C=C3)=N2)=CC=C1C
R-9-(2-hydroxypropyl)adenine,Thymidine kinase,C[C@@H](O)CN1C=NC2=C1N=CN=C2N
R-Styrene Oxide,Halohydrin dehalogenase,C1O[C@@H]1C1=CC=CC=C1
R048-8071,Lanosterol synthase,CN(CCCCCCOC1=CC=C(C(=O)C2=CC=C(Br)C=C2)C(F)=C1)CC=C
R1295,Integrin alpha-4,
R1295,Integrin beta-4,
R1295,Integrin beta-7,
R1626,RNA-dependent RNA-polymerase,
R411,Integrin alpha-4,
R450,Alpha-1A adrenergic receptor,
R450,Alpha-1B adrenergic receptor,
R450,Alpha-1D adrenergic receptor,
R667,Retinoic acid receptor gamma,
R673,Substance-P receptor,
RAF-265,Vascular endothelial growth factor receptor 2,CN1C(NC2=CC=C(C=C2)C(F)(F)F)=NC2=CC(OC3=CC=NC(=C3)C3=NC=C(N3)C(F)(F)F)=CC=C12
RAF-265,Serine/threonine-protein kinase B-raf,CN1C(NC2=CC=C(C=C2)C(F)(F)F)=NC2=CC(OC3=CC=NC(=C3)C3=NC=C(N3)C(F)(F)F)=CC=C12
RALOXIFENE CORE,Estrogen receptor,OC1=CC=C(C=C1)C1=CC2=C(S1)C=C(O)C=C2
RALOXIFENE CORE,Nuclear receptor coactivator 2,OC1=CC=C(C=C1)C1=CC2=C(S1)C=C(O)C=C2
RB106,Thermolysin,[H][C@](S)(CC1=CC=CC=C1)C(=O)NCC(=O)N1[C@@]([H])(CC[C@]1([H])C1=CC=CC=C1)C(O)=O
RB106,Thermolysin,[H][C@](S)(CC1=CC=CC=C1)C(=O)NCC(=O)N1[C@@]([H])(CC[C@]1([H])C1=CC=CC=C1)C(O)=O
RDEA806,Gag-Pol polyprotein,
"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",Serine/threonine-protein kinase Chk1,[H][C@]12CC[C@]([H])(O1)N1C3=C(C=CC=C3)C3=C4C(=O)NC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13
REP8839,Methionine--tRNA ligase,
REV131,Histamine H4 receptor,
RH-1,NAD(P)H dehydrogenase [quinone] 1,CC1=C(N2CC2)C(=O)C(CO)=C(N2CC2)C1=O
RI 624,Beta-nerve growth factor,
ROX-888,C-C motif chemokine 3,
RPI-78M,Neuronal acetylcholine receptor subunit alpha-10,
RPI-78M,Neuronal acetylcholine receptor subunit alpha-2,
RPI-78M,Neuronal acetylcholine receptor subunit alpha-4,
RPI-78M,Neuronal acetylcholine receptor subunit beta-2,
RPI-78M,Neuronal acetylcholine receptor subunit alpha-7,
RPI-78M,Neuronal acetylcholine receptor subunit alpha-9,
RPR128515,Trypsin-1,COC(=O)[C@H](CC1=CC=CC(=C1)C(N)=N)[C@@H](C)NC(=O)C1=CC=C(C=C1)C1=CC=CC(CN)=C1
RPR131247,Trypsin-1,NC(=N)C1=CC=C(O)C(CN2CC[C@H](NS(=O)(=O)C3=CC4=C(S3)C=CC=N4)C2=O)=C1
RTA 744,DNA topoisomerase 2-alpha,
RU78191,Proto-oncogene tyrosine-protein kinase Src,OC(=O)C(C(O)=O)C1=CC=CC=C1
RU78262,Proto-oncogene tyrosine-protein kinase Src,OP(O)(=O)OC1=C(C=O)C=CC=C1
RU78299,Proto-oncogene tyrosine-protein kinase Src,CC1=CC(C=O)=C(OP(O)(O)=O)C(C=O)=C1
RU78300,Proto-oncogene tyrosine-protein kinase Src,COC1=CC=CC(C=O)=C1OP(O)(O)=O
RU78783,Proto-oncogene tyrosine-protein kinase Src,OP(O)(=O)C(C1=CC=CC=C1)P(O)(O)=O
RU79072,Proto-oncogene tyrosine-protein kinase Src,OP(O)(=O)OC1=CC=CC2=CC=C(N=C12)C#N
RU79073,Proto-oncogene tyrosine-protein kinase Src,OP(O)(=O)OC1=C2NCCCC2=CC=C1
RU79256,Proto-oncogene tyrosine-protein kinase Src,[H][C@](C(O)=O)(C1=CC=CC=C1)S(O)(=O)=O
RU81843,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](CC1=CC=C(OP(O)(O)=O)C=C1)(N=C(C)O)C(O)=N[C@@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O
RU82129,Proto-oncogene tyrosine-protein kinase Src,[H]\C(=C(\N=C(C)O)C(O)=N[C@@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O)C1=CC(C=O)=C(CC(O)=O)C=C1
RU82197,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](CC1=CC(C=O)=C(C=C1)C(O)=O)(N=C(C)O)C(O)=N[C@@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O
RU82209,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)(N=C(C)O)C(O)=N[C@@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O
RU83876,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](CC1=CC(=C(C=C1)P(O)(O)=O)P(O)(O)=O)(N=C(C)O)C(O)=N[C@@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O
RU84687,Proto-oncogene tyrosine-protein kinase Src,CC(=O)N[C@@H](CC1=CC=C(OP(O)(O)=O)C(C=O)=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O
RU85053,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](CC1=CC(C(O)=O)=C(CC(O)=O)C=C1)(N=C(C)O)C(O)=N[C@@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O
RU85493,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](CC1=CC(=C(OCC(O)=O)C=C1)P(O)(O)=O)(N=C(C)O)C(O)=N[C@@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O
RU90395,Proto-oncogene tyrosine-protein kinase Src,[H][C@@](CC1=CC(C(=O)OC)=C(C=C1)C(F)(C(O)=O)C(O)=O)(N=C(C)O)C(O)=N[C@@]1([H])CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O
RWJ-51084,Trypsin-1,[H][C@@](CCCNC(N)=N)(NC(=O)C1CCCC1)C(=O)C1=NC2=C(S1)C=CC=C2
Rabeprazole,Potassium-transporting ATPase alpha chain 1,COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1
Racepinephrine,Alpha-1A adrenergic receptor,
Racepinephrine,Alpha-1B adrenergic receptor,
Racepinephrine,Alpha-2A adrenergic receptor,
Racepinephrine,Alpha-2B adrenergic receptor,
Racepinephrine,Alpha-2C adrenergic receptor,
Racepinephrine,Beta-1 adrenergic receptor,
Racepinephrine,Beta-2 adrenergic receptor,
Racepinephrine,Alpha-1D adrenergic receptor,
Racepinephrine,Beta-3 adrenergic receptor,
Raclopride,D(2) dopamine receptor,[H][C@@]1(CN=C(O)C2=C(O)C(Cl)=CC(Cl)=C2OC)CCCN1CC
Ractopamine,Estrogen receptor,CC(CCC1=CC=C(O)C=C1)NCC(O)C1=CC=C(O)C=C1
Radezolid,Ribosome-binding protein 1,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C(F)=C1)C1=CC=C(CNCC2=CN=NN2)C=C1
Radezolid,60S ribosome subunit biogenesis protein NIP7 homolog,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C(F)=C1)C1=CC=C(CNCC2=CN=NN2)C=C1
Radicicol,Heat shock protein HSP 90-beta,[H]/C1=C([H])\C(=O)CC2=C(C(O)=CC(O)=C2Cl)C(=O)O[C@]([H])(C)C[C@@]2([H])O[C@]2([H])/C([H])=C\1/[H]
Radicicol,Endoplasmin,[H]/C1=C([H])\C(=O)CC2=C(C(O)=CC(O)=C2Cl)C(=O)O[C@]([H])(C)C[C@@]2([H])O[C@]2([H])/C([H])=C\1/[H]
Radicicol,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",[H]/C1=C([H])\C(=O)CC2=C(C(O)=CC(O)=C2Cl)C(=O)O[C@]([H])(C)C[C@@]2([H])O[C@]2([H])/C([H])=C\1/[H]
Radicicol,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",[H]/C1=C([H])\C(=O)CC2=C(C(O)=CC(O)=C2Cl)C(=O)O[C@]([H])(C)C[C@@]2([H])O[C@]2([H])/C([H])=C\1/[H]
Radicicol,Virulence sensor histidine kinase PhoQ,[H]/C1=C([H])\C(=O)CC2=C(C(O)=CC(O)=C2Cl)C(=O)O[C@]([H])(C)C[C@@]2([H])O[C@]2([H])/C([H])=C\1/[H]
Radotinib,Tyrosine-protein kinase ABL1,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=N3)=C2)=CC(=C1)C(F)(F)F
Ragaglitazar,Peroxisome proliferator-activated receptor alpha,CCO[C@H](CC1=CC=C(OCCN2C3=CC=CC=C3OC3=C2C=CC=C3)C=C1)C(O)=O
Ragaglitazar,Peroxisome proliferator-activated receptor gamma,CCO[C@H](CC1=CC=C(OCCN2C3=CC=CC=C3OC3=C2C=CC=C3)C=C1)C(O)=O
Raloxifene,Estrogen receptor,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
Raloxifene,Estrogen receptor beta,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
Raloxifene,Serpin B9,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
Raloxifene,Trefoil factor 1,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
Raltegravir,Integrase,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1
Raltitrexed,Thymidylate synthase,CN(CC1=CC2=C(NC(C)=NC2=O)C=C1)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
Raltitrexed,"Folylpolyglutamate synthase, mitochondrial",CN(CC1=CC2=C(NC(C)=NC2=O)C=C1)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
Ramatroban,Prostaglandin D2 receptor 2,[H][C@]1(CCC2=C(C1)C1=CC=CC=C1N2CCC(O)=O)NS(=O)(=O)C1=CC=C(F)C=C1
Ramelteon,Melatonin receptor type 1B,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2
Ramelteon,Melatonin receptor type 1A,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2
Ramipril,Angiotensin-converting enzyme,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC
Ramipril,B1 bradykinin receptor,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC
Ramosetron,5-hydroxytryptamine receptor 3A,CN1C=C(C(=O)[C@@H]2CCC3=C(C2)N=CN3)C2=C1C=CC=C2
Ramucirumab,Vascular endothelial growth factor receptor 2,
Ranibizumab,Vascular endothelial growth factor A,
Ranirestat,Aldose reductase,FC1=C(CN2C(=O)C3=CC=CN3[C@@]3(CC(=O)NC3=O)C2=O)C=CC(Br)=C1
Ranitidine,Histamine H2 receptor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O
Ranitidine,Acetylcholinesterase,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O
Ranitidine,Cholinesterase,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O
Ranolazine,Voltage-dependent L-type calcium channel subunit alpha-1C,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Voltage-dependent L-type calcium channel subunit alpha-1D,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Voltage-dependent L-type calcium channel subunit alpha-1F,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Voltage-dependent L-type calcium channel subunit alpha-1S,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Voltage-dependent L-type calcium channel subunit beta-1,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Voltage-dependent L-type calcium channel subunit beta-2,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Voltage-dependent L-type calcium channel subunit beta-3,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Voltage-dependent L-type calcium channel subunit beta-4,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Alpha-1A adrenergic receptor,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Alpha-1B adrenergic receptor,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Alpha-1D adrenergic receptor,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Ranolazine,Beta-1 adrenergic receptor,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Rapacuronium,Muscarinic acetylcholine receptor M2,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1
Rasagiline,Amine oxidase [flavin-containing] B,C#CCN[C@@H]1CCC2=CC=CC=C12
Rasagiline,Apoptosis regulator Bcl-2,C#CCN[C@@H]1CCC2=CC=CC=C12
Rauwolfia serpentina root,Synaptic vesicular amine transporter,
Ravulizumab,Complement C5,
Raxibacumab,Protective antigen,
Rbt205 Inhibitor,Serine/threonine-protein kinase pim-1,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2
Rbt205 Inhibitor,3-phosphoinositide-dependent protein kinase 1,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2
Rbt205 Inhibitor,Protein kinase C iota type,CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2
Reboxetine,Sodium-dependent noradrenaline transporter,[H][C@@](OC1=CC=CC=C1OCC)(C1=CC=CC=C1)[C@@]1([H])CNCCO1
Recombinant alpha 1-antitrypsin,Alpha-1-antitrypsin,
Regadenoson,Adenosine receptor A2a,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1
Reglitazar,Peroxisome proliferator-activated receptor alpha,CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C1=CC=CC=C1
Reglitazar,Peroxisome proliferator-activated receptor gamma,CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C1=CC=CC=C1
Regorafenib,Vascular endothelial growth factor receptor 1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Vascular endothelial growth factor receptor 2,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Vascular endothelial growth factor receptor 3,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Mast/stem cell growth factor receptor Kit,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Platelet-derived growth factor receptor alpha,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Platelet-derived growth factor receptor beta,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Fibroblast growth factor receptor 1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Fibroblast growth factor receptor 2,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Angiopoietin-1 receptor,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Discoidin domain-containing receptor 2,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,High affinity nerve growth factor receptor,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Ephrin type-A receptor 2,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,RAF proto-oncogene serine/threonine-protein kinase,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Serine/threonine-protein kinase B-raf,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Mitogen-activated protein kinase 11,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Tyrosine-protein kinase FRK,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Tyrosine-protein kinase ABL1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regorafenib,Proto-oncogene tyrosine-protein kinase receptor Ret,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
Regramostim,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,
Regramostim,GM-CSF receptor alpha subunit,
Regrelor,P2Y purinoceptor 12,[H][C@]12O[C@@H](O[C@@]1([H])[C@@H](O[C@@H]2COP(O)(O)=O)N1C=NC2=C1N=CN=C2NC(=O)NCC)\C=C\C1=CC=CC=C1
Reidispongiolide A,"Actin, alpha skeletal muscle",CO[C@H](C\C=C\N(C)C=O)[C@@H](C)C(=O)CC[C@H](C)[C@H](OC)[C@H](C)[C@H]1OC(=O)\C=C\C=C(C)\C[C@H](CC2=CC(=O)O[C@H](C2)[C@H](C)[C@H](C[C@H](OC)\C=C\[C@H](C)[C@H](C[C@@H](OC)\C=C\[C@@H]1C)OC)OC)OC
Reidispongiolide C,"Actin, alpha skeletal muscle",[H]/C1=C([H])\C(=O)O[C@]([H])([C@@]([H])(C)[C@@]([H])(OC)[C@@]([H])(C)CCC(=O)[C@]([H])(C)[C@@]([H])(CCC(O)=O)OC)[C@@]([H])(C)\C([H])=C([H])\[C@@]([H])(C[C@]([H])(OC)[C@@]([H])(C)\C([H])=C([H])\[C@]([H])(C[C@]([H])(OC)[C@@]([H])(C)[C@@]2([H])CC(C[C@@]([H])(C\C(C)=C\1/[H])OC)=CC(=O)O2)OC)OC
Relacatib,Cathepsin K,CC(C)C[C@H](NC(=O)C1=CC2=CC=CC=C2O1)C(=O)N[C@H]1CC[C@@H](C)N(CC1=O)S(=O)(=O)C1=CC=CC=N1
Relcovaptan,Oxytocin receptor,COC1=CC=C(C=C1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(C2=CC(Cl)=CC=C12)C1=CC=CC=C1Cl
Relcovaptan,Vasopressin V1a receptor,COC1=CC=C(C=C1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(C2=CC(Cl)=CC=C12)C1=CC=CC=C1Cl
Remifentanil,Mu-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC
Remifentanil,Delta-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC
Remifentanil,Kappa-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC
Remikiren,Renin,[H][C@@](CC1=CC=CC=C1)(CS(=O)(=O)C(C)(C)C)C(O)=N[C@@]([H])(CC1=CN=CN1)C(O)=N[C@@]([H])(CC1CCCCC1)[C@@]([H])(O)[C@@]([H])(O)C1CC1
Remoxipride,D(2) dopamine receptor,CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC
Remoxipride,D(4) dopamine receptor,CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC
Remoxipride,D(3) dopamine receptor,CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC
Remoxipride,5-hydroxytryptamine receptor 2A,CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC
Remoxipride,Sigma non-opioid intracellular receptor 1,CCN1CCC[C@H]1CNC(=O)C1=C(OC)C=CC(Br)=C1OC
Renzapride,5-hydroxytryptamine receptor 4,COC1=C(C=CC(N)=C1Cl)C(=O)NC1CCN2CCCC1C2
Renzapride,5-hydroxytryptamine receptor 3A,COC1=C(C=CC(N)=C1Cl)C(=O)NC1CCN2CCCC1C2
Repaglinide,ATP-binding cassette sub-family C member 8,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O
Repaglinide,Peroxisome proliferator-activated receptor gamma,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O
Repinotan,5-hydroxytryptamine receptor 1A,O=C1N(CCCCNC[C@H]2CCC3=CC=CC=C3O2)S(=O)(=O)C2=CC=CC=C12
Resatorvid,Cytokine receptor common subunit gamma,[H][C@]1(CCCC=C1C(=O)OCC)S(=O)(=O)NC1=C(Cl)C=C(F)C=C1
Resatorvid,Cytokine receptor common subunit beta,[H][C@]1(CCCC=C1C(=O)OCC)S(=O)(=O)NC1=C(Cl)C=C(F)C=C1
Rescinnamine,Angiotensin-converting enzyme,[H][C@]12C[C@@H](OC(=O)C=CC3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
Reserpine,Synaptic vesicular amine transporter,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
Reserpine,Chromaffin granule amine transporter,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
Reserpine,Baculoviral IAP repeat-containing protein 5,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2
Resiniferatoxin,Transient receptor potential cation channel subfamily V member 1,[H][C@]12O[C@]3(CC4=CC=CC=C4)O[C@]1(C[C@@]([H])(C)[C@]1(O3)[C@]3([H])C=C(C)C(=O)[C@@]3(O)CC(COC(=O)CC3=CC(OC)=C(O)C=C3)=C[C@@]21[H])C(C)=C
Resiquimod,Toll-like receptor 7,CCOCC1=NC2=C(N1CC(C)(C)O)C1=CC=CC=C1NC2=N
Resiquimod,Toll-like receptor 8,CCOCC1=NC2=C(N1CC(C)(C)O)C1=CC=CC=C1NC2=N
Reslizumab,Interleukin-5,
Resorcinol,Thyroid peroxidase,OC1=CC(O)=CC=C1
Resveratrol,Ribosyldihydronicotinamide dehydrogenase [quinone],OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Casein kinase II subunit alpha,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Prostaglandin G/H synthase 1,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Prostaglandin G/H synthase 2,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Arachidonate 15-lipoxygenase,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Arachidonate 5-lipoxygenase,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Aryl hydrocarbon receptor,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Phosphatidylinositol 4-kinase type 2-beta,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Integrin alpha-5,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Integrin beta-3,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Amyloid beta A4 protein,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Alpha-synuclein,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Estrogen receptor,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Melatonin receptor type 1A,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Melatonin receptor type 1B,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,C-type lectin domain family 14 member A,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Nuclear receptor subfamily 1 group I member 2,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Nuclear receptor subfamily 1 group I member 3,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,"Solute carrier family 2, facilitated glucose transporter member 1",OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Carbonyl reductase [NADPH] 1,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Peroxisome proliferator-activated receptor alpha,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Peroxisome proliferator-activated receptor gamma,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,RAC-alpha serine/threonine-protein kinase,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,Far upstream element-binding protein 2,OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Resveratrol,"Tyrosine--tRNA ligase, cytoplasmic",OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1
Retapamulin,50S ribosomal protein L3,[H][C@]12CC[C@]([H])(C[C@]([H])(C1)SCC(=O)O[C@]1([H])C[C@@](C)(C=C)[C@@]([H])(O)[C@]([H])(C)[C@]34CCC(=O)[C@@]3([H])[C@@]1(C)[C@]([H])(C)CC4)N2C
Reteplase,Plasminogen,
Reteplase,Fibrinogen alpha chain,
Reteplase,Urokinase plasminogen activator surface receptor,
Reteplase,Plasminogen activator inhibitor 1,
Revefenacin,Muscarinic acetylcholine receptor M1,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
Revefenacin,Muscarinic acetylcholine receptor M2,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
Revefenacin,Muscarinic acetylcholine receptor M3,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
Revefenacin,Muscarinic acetylcholine receptor M4,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
Revefenacin,Muscarinic acetylcholine receptor M5,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
Reversin 121,Multidrug resistance protein 1,CC(C)(C)OC(=O)N[C@@H](CC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](CCCCNC(=O)OCC1=CC=CC=C1)C(=O)OC(C)(C)C
Rhamnose,L-rhamnose isomerase,[H][C@@](C)(O)[C@]([H])(O)[C@@]([H])(O)[C@@]([H])(O)C=O
Rhein,Oxysterols receptor LXR-alpha,OC(=O)C1=CC2=C(C(O)=C1)C(=O)C1=C(C=CC=C1O)C2=O
Rhein,Oxysterols receptor LXR-beta,OC(=O)C1=CC2=C(C(O)=C1)C(=O)C1=C(C=CC=C1O)C2=O
Rhein,Arachidonate 5-lipoxygenase,OC(=O)C1=CC2=C(C(O)=C1)C(=O)C1=C(C=CC=C1O)C2=O
Rhodamine 6G,HTH-type transcriptional regulator QacR,[Cl-].CCNC1=CC2=[O+]C3=C(C=C(C)C(NCC)=C3)C(C3=CC=CC=C3C(=O)OCC)=C2C=C1C
Rhodamine 6G,Multidrug efflux pump subunit AcrB,[Cl-].CCNC1=CC2=[O+]C3=C(C=C(C)C(NCC)=C3)C(C3=CC=CC=C3C(=O)OCC)=C2C=C1C
Ribavirin,Inosine-5'-monophosphate dehydrogenase 1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Ribavirin,RNA-directed RNA polymerase L,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Ribavirin,Inosine-5'-monophosphate dehydrogenase 2,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Ribavirin,RNA-directed RNA polymerase catalytic subunit,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Ribavirin,Cytosolic purine 5'-nucleotidase,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Ribavirin,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Ribavirin,Genome polyprotein,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Ribociclib,Cyclin-dependent kinase 4,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=N3)N3CCNCC3)N=C2N1C1CCCC1
Ribociclib,Cyclin-dependent kinase 6,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=N3)N3CCNCC3)N=C2N1C1CCCC1
Riboflavin,Riboflavin kinase,CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1
Riboflavin,Riboflavin synthase,CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1
Riboflavin,Flavin reductase (NADPH),CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1
Ribose-1-Phosphate,Purine nucleoside phosphorylase,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O
Ribose-1-Phosphate,Uridine phosphorylase,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O
Ribose-5-phosphate,2-dehydro-3-deoxyphosphooctonate aldolase,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@@]([H])(O)C=O
Ribose-5-phosphate,Ribose-5-phosphate isomerase A,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@@]([H])(O)C=O
Ribose-5-phosphate,ADP-ribose pyrophosphatase,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@@]([H])(O)C=O
Ribostamycin,30S ribosomal protein S12,[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@@H](O)[C@H]1O
Ribostamycin,Protein disulfide-isomerase,[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@@H](O)[C@H]1O
Ribostamycin,Aminoglycoside 2'-N-acetyltransferase,[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@@H](O)[C@H]1O
Ribostamycin,Aminoglycoside N(6')-acetyltransferase type 1,[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@@H](O)[C@H]1O
Ribulose-5-Phosphate,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,OCC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O
Ricinoleic Acid,Cannabinoid receptor 1,[H]\C(CCCCCCCC(O)=O)=C(/[H])C[C@]([H])(O)CCCCCC
Ricinoleic Acid,Cannabinoid receptor 2,[H]\C(CCCCCCCC(O)=O)=C(/[H])C[C@]([H])(O)CCCCCC
Ricinoleic Acid,Transient receptor potential cation channel subfamily V member 1,[H]\C(CCCCCCCC(O)=O)=C(/[H])C[C@]([H])(O)CCCCCC
Ridaforolimus,Serine/threonine-protein kinase mTOR,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O
Ridogrel,Thromboxane A2 receptor,OC(=O)CCCCO\N=C(\C1=CN=CC=C1)C1=CC(=CC=C1)C(F)(F)F
Ridogrel,Thromboxane-A synthase,OC(=O)CCCCO\N=C(\C1=CN=CC=C1)C1=CC(=CC=C1)C(F)(F)F
Rifabutin,DNA-directed RNA polymerase subunit alpha,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21
Rifabutin,DNA-directed RNA polymerase subunit beta,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21
Rifabutin,DNA-directed RNA polymerase subunit beta',CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21
Rifabutin,Heat shock protein HSP 90-alpha,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21
Rifabutin,Endoplasmin,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21
Rifalazil,DNA-directed RNA polymerase subunit beta,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1OC5=C(N=C1C4=C3C2=O)C(O)=CC(=C5)N1CCN(CC(C)C)CC1
Rifampicin,DNA-directed RNA polymerase subunit beta,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifampicin,DNA-directed RNA polymerase subunit beta',CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifampicin,Nuclear receptor subfamily 1 group I member 2,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifampicin,Solute carrier organic anion transporter family member 1B1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifampicin,Solute carrier organic anion transporter family member 1A2,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifampicin,Solute carrier organic anion transporter family member 1B3,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifampicin,Lanosterol 14-alpha demethylase,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifampicin,Serum albumin,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifampicin,Solute carrier organic anion transporter family member 2B1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C
Rifamycin,DNA-directed RNA polymerase subunit beta,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C2O
Rifamycin,DNA-directed RNA polymerase subunit alpha,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C2O
Rifamycin,DNA-directed RNA polymerase subunit beta',CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C2O
Rifapentine,DNA-directed RNA polymerase subunit beta',CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O
Rifaximin,DNA-directed RNA polymerase subunit beta,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C1=C(N=C5C=C(C)C=CN15)C4=C3C2=O
Rifaximin,Nuclear receptor subfamily 1 group I member 2,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C1=C(N=C5C=C(C)C=CN15)C4=C3C2=O
Rilapladib,Platelet-activating factor acetylhydrolase,COCCN1CCC(CC1)N(CC1=CC=C(C=C1)C1=CC=C(C=C1)C(F)(F)F)C(=O)CN1C(SCC2=C(F)C(F)=CC=C2)=CC(=O)C2=C1C=CC=C2
Rilmenidine,Alpha-2A adrenergic receptor,C1CC1C(NC1=NCCO1)C1CC1
Rilonacept,Interleukin-1 beta,
Rilonacept,Interleukin-1 alpha,
Rilonacept,Interleukin-1 receptor antagonist protein,
Rilpivirine,Reverse transcriptase/RNaseH,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1
Rilpivirine,Nuclear receptor subfamily 1 group I member 2,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1
Riluzole,Sodium channel protein type 5 subunit alpha,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
Riluzole,Cystine/glutamate transporter,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
Rimantadine,Matrix protein 2,CC(N)C12CC3CC(CC(C3)C1)C2
Rimexolone,Glucocorticoid receptor,[H][C@@]12C[C@@H](C)[C@](C)(C(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Rimonabant,Cannabinoid receptor 1,CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=C(Cl)C=C(Cl)C=C1)C1=CC=C(Cl)C=C1
Rimonabant,G-protein coupled receptor 55,CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=C(Cl)C=C(Cl)C=C1)C1=CC=C(Cl)C=C1
Rindopepimut,Epidermal growth factor receptor,
Riociguat,Guanylate cyclase soluble subunit alpha-2,COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2
Ripasudil,Rho-associated protein kinase 1,C[C@H]1CNCCCN1S(=O)(=O)C1=C2C(F)=CN=CC2=CC=C1
Ripasudil,Rho-associated protein kinase 2,C[C@H]1CNCCCN1S(=O)(=O)C1=C2C(F)=CN=CC2=CC=C1
Risankizumab,Interleukin-12 subunit beta,
Risankizumab,Interleukin-23 subunit alpha,
Risedronic acid,Farnesyl pyrophosphate synthase,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O
Risperidone,5-hydroxytryptamine receptor 2A,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,D(2) dopamine receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,D(3) dopamine receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,D(4) dopamine receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,Alpha-1A adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,Alpha-1B adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,5-hydroxytryptamine receptor 1D,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,Histamine H1 receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,Alpha-2A adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,Alpha-2B adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,Alpha-2C adrenergic receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,5-hydroxytryptamine receptor 2C,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,5-hydroxytryptamine receptor 1A,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,D(1A) dopamine receptor,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Risperidone,5-hydroxytryptamine receptor 7,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1
Ritanserin,5-hydroxytryptamine receptor 2A,CC1=C(CCN2CCC(CC2)=C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(=O)N2C=CSC2=N1
Ritodrine,Beta-2 adrenergic receptor,C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C1=CC=C(O)C=C1
Ritonavir,Pol polyprotein,CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1
Ritonavir,Nuclear receptor subfamily 1 group I member 2,CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1
Rituximab,B-lymphocyte antigen CD20,
Rivanicline,Neuronal acetylcholine receptor subunit beta-2,CNCC\C=C\C1=CN=CC=C1
Rivanicline,Interleukin-8,CNCC\C=C\C1=CN=CC=C1
Rivaroxaban,Coagulation factor X,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O
Rivastigmine,Acetylcholinesterase,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
Rivastigmine,Cholinesterase,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
Rizatriptan,5-hydroxytryptamine receptor 1F,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
Rizatriptan,5-hydroxytryptamine receptor 1D,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
Rizatriptan,5-hydroxytryptamine receptor 1B,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
Robalzotan,5-hydroxytryptamine receptor 1A,NC(=O)C1=C2C[C@H](COC2=C(F)C=C1)N(C1CCC1)C1CCC1
Robenacoxib,Cyclooxygenase 2,CCC1=CC(CC(O)=O)=C(NC2=C(F)C(F)=CC(F)=C2F)C=C1
Rociverine,Muscarinic acetylcholine receptor M1,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1
Rociverine,Muscarinic acetylcholine receptor M2,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1
Rociverine,Muscarinic acetylcholine receptor M3,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1
Rociverine,Muscarinic acetylcholine receptor M4,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1
Rociverine,Muscarinic acetylcholine receptor M5,CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1
Rocuronium,Muscarinic acetylcholine receptor M2,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1
Rocuronium,Neuronal acetylcholine receptor subunit alpha-2,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1
Rocuronium,5-hydroxytryptamine receptor 3A,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1
Rofecoxib,Prostaglandin G/H synthase 2,CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1
Rofecoxib,Elastin,CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1
Roflumilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
Roflumilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
Roflumilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
Roflumilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
Rolicyclidine,"Glutamate receptor ionotropic, NMDA 3A",C1CCN(C1)C1(CCCCC1)C1=CC=CC=C1
Rolicyclidine,D(2) dopamine receptor,C1CCN(C1)C1(CCCCC1)C1=CC=CC=C1
Rolipram,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",COC1=C(OC2CCCC2)C=C(C=C1)C1CN=C(O)C1
Rolipram,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",COC1=C(OC2CCCC2)C=C(C=C1)C1CN=C(O)C1
Rolitetracycline,30S ribosomal protein S9,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCN1CCCC1)=C(O)[C@H]2N(C)C
Rolofylline,Adenosine receptor A1,CCCN1C2=C(NC(=N2)C23C[C@@H]4CC2C[C@H](C3)C4)C(=O)N(CCC)C1=O
Romidepsin,Histone deacetylase 1,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C
Romidepsin,Histone deacetylase 2,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C
Romidepsin,Histone deacetylase 4,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C
Romidepsin,Histone deacetylase 6,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C
Romidepsin,Multidrug resistance-associated protein 1,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C
Romiplostim,Thrombopoietin receptor,
Ronacaleret,Extracellular calcium-sensing receptor,CC(C)(CC1CC2=C(C1)C=CC=C2)NC[C@@H](O)COC1=CC(CCC(O)=O)=CC(F)=C1F
Ronacaleret,Adhesion G-protein coupled receptor F1,CC(C)(CC1CC2=C(C1)C=CC=C2)NC[C@@H](O)COC1=CC(CCC(O)=O)=CC(F)=C1F
Ropinirole,D(3) dopamine receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropinirole,D(4) dopamine receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropinirole,D(2) dopamine receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropinirole,Alpha-1A adrenergic receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropinirole,Alpha-1B adrenergic receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropinirole,Alpha-1D adrenergic receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropinirole,Alpha-2A adrenergic receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropinirole,Alpha-2B adrenergic receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropinirole,Alpha-2C adrenergic receptor,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
Ropivacaine,Sodium channel protein type 10 subunit alpha,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C
Rosiglitazone,Peroxisome proliferator-activated receptor gamma,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
Rosiglitazone,Long-chain-fatty-acid--CoA ligase 4,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
Rosiglitazone,Peroxisome proliferator-activated receptor alpha,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
Rosiglitazone,Peroxisome proliferator-activated receptor delta,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
Rosiglitazone,Retinoic acid receptor RXR-alpha,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
Rosiglitazone,Retinoic acid receptor RXR-beta,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
Rosiglitazone,Retinoic acid receptor RXR-gamma,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
Rosoxacin,DNA gyrase subunit B,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(C=C2)C1=CC=NC=C1
Rosoxacin,DNA topoisomerase 4 subunit A,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(C=C2)C1=CC=NC=C1
Rosuvastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O
Rotigotine,D(3) dopamine receptor,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
Rotigotine,D(4) dopamine receptor,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
Rotigotine,D(1B) dopamine receptor,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
Rotigotine,D(2) dopamine receptor,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
Rotigotine,D(1A) dopamine receptor,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
Rotigotine,5-hydroxytryptamine receptor 1A,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
Rotigotine,Alpha-2B adrenergic receptor,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
Roxadustat,Egl nine homolog 2,CC1=NC(C(=O)NCC(O)=O)=C(O)C2=CC=C(OC3=CC=CC=C3)C=C12
Roxadustat,Egl nine homolog 1,CC1=NC(C(=O)NCC(O)=O)=C(O)C2=CC=C(OC3=CC=CC=C3)C=C12
Roxadustat,Egl nine homolog 3,CC1=NC(C(=O)NCC(O)=O)=C(O)C2=CC=C(OC3=CC=CC=C3)C=C12
Roxatidine acetate,Histamine H2 receptor,CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
Roxithromycin,50S ribosomal protein L10,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
Roxithromycin,Multidrug resistance protein 1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
Rozrolimupab,Rhesus blood group D antigen,
Rubitecan,DNA topoisomerase 1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(C1=C3)[N+]([O-])=O)C2=O
Rucaparib,Poly [ADP-ribose] polymerase 1,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3
Rucaparib,Poly [ADP-ribose] polymerase 2,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3
Rucaparib,Poly [ADP-ribose] polymerase 3,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3
Rufinamide,Metabotropic glutamate receptor 5,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
Rufinamide,Sodium channel protein type 9 subunit alpha,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
Rupatadine,Platelet-activating factor receptor,CC1=CC(CN2CCC(CC2)=C2C3=CC=C(Cl)C=C3CCC3=C2N=CC=C3)=CN=C1
Rupatadine,Histamine H1 receptor,CC1=CC(CN2CCC(CC2)=C2C3=CC=C(Cl)C=C3CCC3=C2N=CC=C3)=CN=C1
Rupintrivir,Genome polyprotein,CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@H](C(C)C)NC(=O)C1=NOC(C)=C1)CC1=CC=C(F)C=C1
Ruplizumab,CD40 ligand,
Rutin,Aldo-keto reductase family 1 member C3,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C3=CC(O)=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
Rutin,Carbonyl reductase [NADPH] 1,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C3=CC(O)=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
Ruxolitinib,Tyrosine-protein kinase JAK1,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
Ruxolitinib,Tyrosine-protein kinase JAK2,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
"S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea","Nitric oxide synthase, endothelial",NC(=N)SCCC1=CC(CCSC(N)=N)=CC=C1
"S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea","Nitric oxide synthase, endothelial",NC(=N)SCCC1=CC=C(CCSC(N)=N)C=C1
"S,S-(2-Hydroxyethyl)Thiocysteine",Arginase-1,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Thymidylate synthase,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine","cAMP-specific 3',5'-cyclic phosphodiesterase 4B",N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Serine/threonine-protein kinase pim-1,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Beta-galactosidase,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Thymidylate synthase,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Isocitrate dehydrogenase [NADP],N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Serpin B5,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Maltose-binding periplasmic protein,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Delta-aminolevulinic acid dehydratase,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Cytohesin-2,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine","dTDP-4-dehydrorhamnose 3,5-epimerase",N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine","Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Transcription antiterminator LicT,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",cAMP-dependent protein kinase catalytic subunit alpha,N[C@@H](CSSCCO)C(O)=O
"S,S-(2-Hydroxyethyl)Thiocysteine",Sorting nexin-3,N[C@@H](CSSCCO)C(O)=O
"S,S-Propylthiocysteine",Listeriolysin regulatory protein,[H][C@](N)(CSSCCC)C=O
"S,S-Propylthiocysteine",Thermonuclease,[H][C@](N)(CSSCCC)C=O
"S-(2,4-dinitrophenyl)glutathione",Glutathione S-transferase Mu 1,[H][C@](N)(CCC(=O)N[C@@]([H])(CSC1=C(C=C(C=C1)N(=O)=O)N(=O)=O)C(=O)NCC(O)=O)C(O)=O
"S-(2,4-dinitrophenyl)glutathione",Glutathione S-transferase Mu 2,[H][C@](N)(CCC(=O)N[C@@]([H])(CSC1=C(C=C(C=C1)N(=O)=O)N(=O)=O)C(=O)NCC(O)=O)C(O)=O
S-(2-Oxo)Pentadecylcoa,Glycylpeptide N-tetradecanoyltransferase 2,[H][C@@](O)(C(O)=NCCC(O)=NCCSCC(=O)CCCCCCCCCCCCC)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE",Acyl carrier protein,[H][C@](O)(C(=O)NCCC(=O)NCCSC(=O)CCCCCC)C(C)(C)CO[P@]([H])(O)=O
"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE",Acyl carrier protein,[H][C@](O)(C(=O)NCCC(=O)NCCSC(=O)CCCCC)C(C)(C)CO[P@]([H])(O)=O
S-(4-BROMOBENZYL)CYSTEINE,Glutathione S-transferase P,[H][C@](N)(CSCC1=CC=C(Br)C=C1)C(O)=O
S-(D-Carboxybutyl)-L-Homocysteine,Betaine--homocysteine S-methyltransferase 1,N[C@@H](CCSCCCCC(O)=O)C(O)=O
S-(Dimethylarsenic)Cysteine,"Nitric oxide synthase, endothelial",[H][C@](N)(CS[As](C)C)C(O)=O
S-(Dimethylarsenic)Cysteine,Toll-like receptor 2,[H][C@](N)(CS[As](C)C)C(O)=O
S-(Dimethylarsenic)Cysteine,Gag-Pol polyprotein,[H][C@](N)(CS[As](C)C)C(O)=O
S-(Dimethylarsenic)Cysteine,Capsid scaffolding protein,[H][C@](N)(CS[As](C)C)C(O)=O
S-(Dimethylarsenic)Cysteine,DNA repair protein XRCC4,[H][C@](N)(CS[As](C)C)C(O)=O
S-(Dimethylarsenic)Cysteine,Coatomer subunit gamma-1,[H][C@](N)(CS[As](C)C)C(O)=O
S-(Dimethylarsenic)Cysteine,Genome polyprotein,[H][C@](N)(CS[As](C)C)C(O)=O
S-(Dimethylarsenic)Cysteine,Peptide methionine sulfoxide reductase MsrA,[H][C@](N)(CS[As](C)C)C(O)=O
S-(Methylmercury)-L-Cysteine,Elongation factor Tu GTP-binding domain-containing protein 1,C[Hg]SC[C@@H](N)C(O)=O
S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione,"Hydroxyacylglutathione hydrolase, mitochondrial",[H][C@](N)(CCC(O)=N[C@@]([H])(CS[C@]([H])(O)N(O)C1=CC=C(Br)C=C1)C(O)=NCC(O)=O)C(O)=O
S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione,Lactoylglutathione lyase,[H][C@](N)(CCC(O)=N[C@@]([H])(CS[C@@]([H])(O)N(O)C1=CC=C(I)C=C1)C(O)=NCC(O)=O)C(O)=O
S-(P-Nitrobenzyl)Glutathione,Glutathione S-transferase P,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCC1=CC=C(C=C1)N(=O)=O)C(O)=NCC(O)=O)C(O)=O
S-2-(Boronoethyl)-L-Cysteine,Arginase-1,[H][C@](N)(CSCC[B-](O)(O)O)C(O)=O
S-2-(Boronoethyl)-L-Cysteine,"Arginase-2, mitochondrial",[H][C@](N)(CSCC[B-](O)(O)O)C(O)=O
S-23,Androgen receptor,C[C@](O)(COC1=CC=C(Cl)C(F)=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,Androgen receptor,C[C@](O)(COC1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
S-4-Nitrobutyryl-Coa,"Glutaryl-CoA dehydrogenase, mitochondrial",[H][C@](O)(C(O)=NCCC(O)=NCCSC(=O)CCCN(=O)=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
S-9-(2-hydroxypropyl)adenine,Thymidine kinase,[H][C@@](C)(O)CN1C=NC2=C(N)N=CN=C12
S-Acetyl-Cysteine,3-oxoacyl-[acyl-carrier-protein] synthase 3,[H][C@](N)(CSC(C)=O)C(O)=O
S-Acetyl-Cysteine,Acetyl-CoA acetyltransferase,[H][C@](N)(CSC(C)=O)C(O)=O
S-Acetyl-Cysteine,3-hydroxy-3-methylglutaryl CoA synthase,[H][C@](N)(CSC(C)=O)C(O)=O
S-Acetyl-Cysteine,Histone acetyltransferase KAT5,[H][C@](N)(CSC(C)=O)C(O)=O
"S-Adenosyl-1,8-Diamino-3-Thiooctane",Polyamine aminopropyltransferase,[H][C@]1(CSC(CCCCCN)=CCN)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
S-Adenosyl-L-Homoselenocysteine,tRNA (cmo5U34)-methyltransferase,[H][C@](N)(CC[Se]C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O)C(O)=O
S-Arsonocysteine,Arsenate reductase,N[C@@H](CS[As](O)(O)=O)C(O)=O
S-Arsonocysteine,Protein ArsC,N[C@@H](CS[As](O)(O)=O)C(O)=O
S-Arsonocysteine,3-mercaptopyruvate sulfurtransferase,N[C@@H](CS[As](O)(O)=O)C(O)=O
S-Benzyl-Glutathione,Lactoylglutathione lyase,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCC1=CC=CC=C1)C(O)=NCC(O)=O)C(O)=O
S-Benzyl-Glutathione,Glutathione S-transferase A1,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCC1=CC=CC=C1)C(O)=NCC(O)=O)C(O)=O
S-Butyryl-Cystein,Acetyl-CoA acetyltransferase,[H][C@](N)(CSC(=O)CCC)C(O)=O
S-Dioxymethionine,Catalase,CS(=O)(=O)CC[C@H](N)C(O)=O
S-Ethyl-N-Phenyl-Isothiourea,"Nitric oxide synthase, endothelial",CCS\C(N)=N\C1=CC=CC=C1
S-Ethyl-N-Phenyl-Isothiourea,"Nitric oxide synthase, brain",CCS\C(N)=N\C1=CC=CC=C1
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,"Nitric oxide synthase, brain",CCS\C(N)=N\C1=CC=C(C=C1)C(F)(F)F
S-Ethylisothiourea,"Nitric oxide synthase, inducible",CCSC(N)=N
S-Ethylisothiourea,"Nitric oxide synthase, endothelial",CCSC(N)=N
S-Ethylisothiourea,Nitric oxide synthase oxygenase,CCSC(N)=N
S-Hexylglutathione,Glutathione S-transferase Mu 4,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCCCCCC)C(O)=NCC(O)=O)C(O)=O
S-Hexylglutathione,Glutathione S-transferase P,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCCCCCC)C(O)=NCC(O)=O)C(O)=O
S-Hexylglutathione,Lactoylglutathione lyase,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCCCCCC)C(O)=NCC(O)=O)C(O)=O
S-Hexylglutathione,Glutathione S-transferase A1,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCCCCCC)C(O)=NCC(O)=O)C(O)=O
S-Hexylglutathione,Glutathione S-transferase,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCCCCCC)C(O)=NCC(O)=O)C(O)=O
S-Hexylglutathione,Glutathione S-transferase theta-2,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCCCCCC)C(O)=NCC(O)=O)C(O)=O
S-Hydroxycysteine,Glutathione S-transferase P,N[C@@H](CSO)C(O)=O
S-Hydroxycysteine,"Acetyl-CoA acetyltransferase, cytosolic",N[C@@H](CSO)C(O)=O
S-Hydroxycysteine,Azurin,N[C@@H](CSO)C(O)=O
S-Hydroxycysteine,Subtilisin BPN',N[C@@H](CSO)C(O)=O
S-Hydroxycysteine,Acetyl-CoA acetyltransferase,N[C@@H](CSO)C(O)=O
S-Hydroxycysteine,Glutathione S-transferase A1,N[C@@H](CSO)C(O)=O
S-Hydroxycysteine,Complement C3,N[C@@H](CSO)C(O)=O
S-Hydroxycysteine,Myelin P2 protein,N[C@@H](CSO)C(O)=O
S-Hydroxymethyl Glutathione,Alcohol dehydrogenase class-3,N[C@@H](CCC(=O)N[C@@H](CSCO)C(=O)NCC(O)=O)C(O)=O
S-Isopropyl-Isothiourea,"Nitric oxide synthase, endothelial",CC(C)SC(N)=N
"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",Casein kinase II subunit alpha,CSC1=NC2=C(N1)C(Br)=C(Br)C(Br)=C2Br
S-METHYL-GLUTATHIONE,Glutathione S-transferase Mu 2,CSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O
S-Mercaptocysteine,Cysteine desulfurase,N[C@@H](CSS)C(O)=O
S-Mercaptocysteine,Thiosulfate sulfurtransferase GlpE,N[C@@H](CSS)C(O)=O
S-Mercaptocysteine,Hydroxylamine reductase,N[C@@H](CSS)C(O)=O
S-Mercaptocysteine,3-mercaptopyruvate sulfurtransferase,N[C@@H](CSS)C(O)=O
S-Mercaptocysteine,L-cysteine/cystine lyase C-DES,N[C@@H](CSS)C(O)=O
S-Mercaptocysteine,3-mercaptopyruvate sulfurtransferase,N[C@@H](CSS)C(O)=O
S-Mercaptocysteine,Hydroxylamine reductase,N[C@@H](CSS)C(O)=O
S-Mercaptocysteine,Sulfurtransferase,N[C@@H](CSS)C(O)=O
S-Mercaptocysteine,Thiosulfate sulfurtransferase,N[C@@H](CSS)C(O)=O
S-Methyl Phosphocysteine,Chemotaxis protein CheY,N[C@@H](CSCP(O)(O)=O)C(O)=O
S-Methyl Thiocysteine Group,Endoglucanase G,[H][C@](N)(CSSC)C(O)=O
S-Methylcysteine,Cathepsin D,CSC[C@H](N)C(O)=O
S-Methylcysteine,Methylated-DNA--protein-cysteine methyltransferase,CSC[C@H](N)C(O)=O
S-NONYL-CYSTEINE,Glutathione S-transferase P,[H][C@](N)(CSCCCCCCCCC)C(O)=O
S-Octylglutathione,Glutathione S-transferase Mu 4,[H][C@](N)(CCC(O)=N[C@@]([H])(CSCCCCCCCC)C(O)=NCC(O)=O)C(O)=O
S-P-Nitrobenzyloxycarbonylglutathione,Lactoylglutathione lyase,[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CSC(O)OCC1=CC=C(C=C1)[N+]([O-])=O)C(=O)N([H])CC(O)=O)C(O)=O
S-PALMITOYL-L-CYSTEINE,Trafficking protein particle complex subunit 6A,[H][C@](N)(CSC(=O)CCCCCCCCCCCCCCC)C(O)=O
S-PALMITOYL-L-CYSTEINE,Trafficking protein particle complex subunit 3,[H][C@](N)(CSC(=O)CCCCCCCCCCCCCCC)C(O)=O
S-PALMITOYL-L-CYSTEINE,Trafficking protein particle complex subunit 6B,[H][C@](N)(CSC(=O)CCCCCCCCCCCCCCC)C(O)=O
S-PALMITOYL-L-CYSTEINE,Trafficking protein particle complex subunit 5,[H][C@](N)(CSC(=O)CCCCCCCCCCCCCCC)C(O)=O
S-PALMITOYL-L-CYSTEINE,Trafficking protein particle complex subunit 4,[H][C@](N)(CSC(=O)CCCCCCCCCCCCCCC)C(O)=O
S-PALMITOYL-L-CYSTEINE,Trafficking protein particle complex subunit 1,[H][C@](N)(CSC(=O)CCCCCCCCCCCCCCC)C(O)=O
S-Phosphocysteine,"N,N'-diacetylchitobiose-specific phosphotransferase enzyme IIB component",N[C@@H](CSP(O)(O)=O)C(O)=O
S-Phosphocysteine,2-iminobutanoate/2-iminopropanoate deaminase,N[C@@H](CSP(O)(O)=O)C(O)=O
S-Selanyl Cysteine,Cysteine desulfurase,N[C@@H](CS[SeH])C(O)=O
"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",Eukaryotic translation initiation factor 4E,CC1(C)C=C(CSS(C)(=O)=O)C(C)(C)N1O
"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",Possible exported protein,CC1(C)C=C(CSS(C)(=O)=O)C(C)(C)N1O
"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",Carcinoembryonic antigen-related cell adhesion molecule 5,CC1(C)C=C(CSS(C)(=O)=O)C(C)(C)N1O
"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",Afimbrial adhesin AFA-III,CC1(C)C=C(CSS(C)(=O)=O)C(C)(C)N1O
"S-[(1-Hydroxy-2,2,5,5-tetramethyl-4-phenyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate",Endolysin,CC1(C)N(O)C(C)(C)C(=C1CSS(C)(=O)=O)C1=CC=CC=C1
"S-[(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] TRIHYDROGENTHIODIPHOSPHATE",Prenyltransferase,[H]\C(CSP(O)(=O)OP(O)(O)=O)=C(\C)CCC=C(C)C
"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate",Actinorhodin polyketide synthase acyl carrier protein,[H][C@@](O)(C(=O)NCCC(=O)NCCSC(=O)CCCCC)C(C)(C)COP(O)(O)=O
"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate",Actinorhodin polyketide synthase acyl carrier protein,[H][C@@](O)(C(=O)NCCC(=O)NCCSC(=O)CCCCCCC)C(C)(C)COP(O)(O)=O
"S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE",Sortase,[H][C@](N)(CSCCC(=O)C1=CC=C(Cl)C(Cl)=C1)C(O)=O
"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",Replicase polyprotein 1ab,FC(F)(F)C1=NN=C(N1)SC(=O)C1=CC=C(O1)C#CC1=CC=CC=C1
"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",Replicase polyprotein 1a,FC(F)(F)C1=NN=C(N1)SC(=O)C1=CC=C(O1)C#CC1=CC=CC=C1
S-adenosyl-L-homocysteine,Glycine N-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Guanidinoacetate N-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Phenylethanolamine N-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Cyclopropane mycolic acid synthase 2,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Genome polyprotein,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Cobalt-precorrin-4 C(11)-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Modification methylase RsrI,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Carminomycin 4-O-methyltransferase DnrK,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Release factor glutamine methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Histamine N-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Cyclopropane mycolic acid synthase MmaA2,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Release factor glutamine methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Ribosomal RNA small subunit methyltransferase H,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,rRNA adenine N-6-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,tRNA (cytosine(38)-C(5))-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,tRNA (cytidine(34)-2'-O)-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Modification methylase PvuII,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,DNA adenine methylase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Cyclopropane mycolic acid synthase 3,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Siroheme synthase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Modification methylase HhaI,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Histone-lysine N-methyltransferase SETD7,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,tRNA (guanine-N(1)-)-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Aclacinomycin 10-hydroxylase RdmB,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,tRNA (guanine-N(1)-)-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Uroporphyrinogen-III C-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Uncharacterized protein,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Chemotaxis protein methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Modification methylase TaqI,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Protein-L-isoaspartate O-methyltransferase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Diphthine methyl ester synthase,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Protein arginine N-methyltransferase 3,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Catechol O-methyltransferase domain-containing protein 1,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-adenosyl-L-homocysteine,Protein arginine N-methyltransferase 1,N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O
S-oxy-L-cysteine,Aspartate 1-decarboxylase,[H][C@](N)(CS=O)C(O)=O
S-oxy-L-cysteine,Prolyl endopeptidase,[H][C@](N)(CS=O)C(O)=O
S-oxy-L-cysteine,Superoxide dismutase [Cu-Zn],[H][C@](N)(CS=O)C(O)=O
S-oxy-L-cysteine,NADH peroxidase,[H][C@](N)(CS=O)C(O)=O
S-oxy-L-cysteine,Exopolyphosphatase,[H][C@](N)(CS=O)C(O)=O
S-oxy-L-cysteine,Conserved protein,[H][C@](N)(CS=O)C(O)=O
S-oxy-L-cysteine,Probable thiol peroxidase,[H][C@](N)(CS=O)C(O)=O
S-propylamine-L-cysteine,Arginase-1,NCCCSC[C@H](N)CO
"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",Gag-Pol polyprotein,CC1=CC2=C(C=C1)N(CCC2)C(=O)SCC(=O)NC1=C(Cl)C=C(C=C1)S(N)(=O)=O
S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine,Arginase-1,[H][C@](N)(CSCCS(N)(=O)=O)C(O)=O
S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,Epidermal growth factor receptor,[H][C@](N)(CSCCC(=O)NC1=CC2=C(C=C1)N=CN=C2NC1=CC=CC=C1)C(O)=O
SALOPHEN-10-PROPIONATE IRON CHELATE,Heme oxygenase,[Fe+4].[H]\C(=N/C1=C(C=C(CCC(O)=O)C=C1)/N=C(\[H])C1=CC=CC=C1[O-])C1=CC=CC=C1[O-]
SB-269970,5-hydroxytryptamine receptor 7,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)C2=CC=CC(O)=C2)CC1
SB-409513,Glycogen synthase kinase-3 beta,OC(=O)C1=CC(NC2=C(C(=O)NC2=O)C2=CC(Cl)=CC=C2)=CC=C1Cl
SB-559448,Thrombopoietin receptor,
SB220025,Mitogen-activated protein kinase 14,NC1=NC=CC(=N1)C1=C(N=CN1C1CCNCC1)C1=CC=C(F)C=C1
SB220025,Mitogen-activated protein kinase 1,NC1=NC=CC(=N1)C1=C(N=CN1C1CCNCC1)C1=CC=C(F)C=C1
SC-236,Cyclooxygenase 2,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Cl)C=C1)C(F)(F)F
SC-236,Nuclear factor NF-kappa-B p100 subunit,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Cl)C=C1)C(F)(F)F
SC-236,Nuclear factor NF-kappa-B p105 subunit,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Cl)C=C1)C(F)(F)F
SC-236,Transcription factor p65,NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(Cl)C=C1)C(F)(F)F
SC-74020,72 kDa type IV collagenase,CCCCCC1=CC=C(C=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)N(CCN1CCOCC1)[C@H](C(C)C)C(=O)NO
SC12267,"Dihydroorotate dehydrogenase (quinone), mitochondrial",
SD118,Interleukin-1 receptor type 1,
SD118,Tumor necrosis factor,
SD146,Gag-Pol polyprotein,[H][C@]1(CC2=CC=CC=C2)N(CC2=CC(=CC=C2)C(O)=NC2=NC3=CC=CC=C3N2)C(=O)N(CC2=CC(=CC=C2)C(O)=NC2=NC3=CC=CC=C3N2)[C@]([H])(CC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O
SEBACIC ACID,Hemoglobin subunit alpha,OC(=O)CCCCCCCCC(O)=O
SEBACIC ACID,Hemoglobin subunit beta,OC(=O)CCCCCCCCC(O)=O
SF1126,Phosphatidylinositol 3-kinase regulatory subunit alpha,
SF1126,Phosphatidylinositol 3-kinase regulatory subunit beta,
SF1126,Phosphatidylinositol 3-kinase regulatory subunit gamma,
SF1126,DNA-dependent protein kinase catalytic subunit,
SF1126,Serine/threonine-protein kinase mTOR,
SGN-30,Nuclear factor NF-kappa-B p105 subunit,
SGN-30,Nuclear factor NF-kappa-B p100 subunit,
SGS-742,Gamma-aminobutyric acid type B receptor subunit 1,CCCCP(O)(=O)CCCN
SGS-742,Gamma-aminobutyric acid type B receptor subunit 2,CCCCP(O)(=O)CCCN
SGS518,5-hydroxytryptamine receptor 6,
SGX-523,Hepatocyte growth factor receptor,CN1C=C(C=N1)C1=NN2C(SC3=CC=C4N=CC=CC4=C3)=NN=C2C=C1
SINAPINATE,"Endo-1,4-beta-xylanase Y",COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O
SLV319,Cannabinoid receptor 1,
SLx-4090,Microsomal triglyceride transfer protein large subunit,COC1=CC=CC(C(O)=NC2=CC=C3CN(CCC3=C2)C(=O)OC2=CC=CC=C2)=C1C1=CC=C(C=C1)C(F)(F)F
SNS-032,Vascular endothelial growth factor A,CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1
SNS-032,Cyclin-dependent kinase 7,CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1
SNS-314,Aurora kinase A,ClC1=CC=CC(NC(=O)NC2=NC=C(CCNC3=C4SC=CC4=NC=N3)S2)=C1
SNS-314,Aurora kinase C,ClC1=CC=CC(NC(=O)NC2=NC=C(CCNC3=C4SC=CC4=NC=N3)S2)=C1
SNX-5422,Heat shock protein HSP 90-alpha,CC1(C)CC2=C(C(=NN2C2=CC(N[C@H]3CC[C@@H](CC3)OC(=O)CN)=C(C=C2)C(N)=O)C(F)(F)F)C(=O)C1
SNX-5422,Heat shock protein HSP 90-beta,CC1(C)CC2=C(C(=NN2C2=CC(N[C@H]3CC[C@@H](CC3)OC(=O)CN)=C(C=C2)C(N)=O)C(F)(F)F)C(=O)C1
SO-101,Histamine H1 receptor,
SOT-107,Glioma pathogenesis-related protein 1,
SP1049C,DNA topoisomerase 2-alpha,
SP2456,Interleukin-2,[H][C@@](NC(N)=N)(C1CCCCC1)C(O)=NCC(=O)N1CCC(CC1)C1=CC(=NN1)C1=C(Cl)C(Cl)=CC=C1
SP4160,Interleukin-2,CC(C)C[C@@H](N=C(N)N)C(=O)NCC(=O)N1CCC(CC1)C1=CC(=NN1C)C1=C(Cl)C(Cl)=C(OCC2=CC=C(NC(C)=O)C=C2)C=C1
SPP 301,Endothelin-1 receptor,
SPP1148,Renin,
SPP1148,Angiotensin-converting enzyme 2,
SR 121463,Vasopressin V1b receptor,
SR 140333,Substance-P receptor,[Cl-].CC(C)OC1=CC=CC(CC(=O)N2CCC[C@](CC[N+]34CCC(CC3)(CC4)C3=CC=CC=C3)(C2)C2=CC(Cl)=C(Cl)C=C2)=C1
SR-123781A,Antithrombin-III,
SR-123781A,Proteinase-activated receptor 1,
SR-9009,Nuclear receptor subfamily 1 group D member 1,CCOC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC2=CC=C(Cl)C=C2)C1
SR-9009,Nuclear receptor subfamily 1 group D member 2,CCOC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC2=CC=C(Cl)C=C2)C1
SR-9011,Nuclear receptor subfamily 1 group D member 2,CCCCCNC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC2=CC=C(Cl)C=C2)C1
SR-9011,Nuclear receptor subfamily 1 group D member 1,CCCCCNC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC2=CC=C(Cl)C=C2)C1
SR11254,Retinoic acid receptor gamma,CC1(C)CCC(C)(C)C2=CC(=CC=C12)C(=N/O)\C1=CC=C2C=C(C=CC2=C1)C(O)=O
SR12813,Nuclear receptor subfamily 1 group I member 2,CCOP(=O)(OCC)C(=CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)P(=O)(OCC)OCC
SRT501,NAD-dependent protein deacetylase sirtuin-1,
SSR-126517E,Coagulation factor X,
SU4984,Fibroblast growth factor receptor 2,OC1=NC2=CC=CC=C2C1CC1=CC=C(C=C1)N1CCN(CC1)C=O
SU4984,Fibroblast growth factor receptor 1,OC1=NC2=CC=CC=C2C1CC1=CC=C(C=C1)N1CCN(CC1)C=O
SU9516,Cyclin-dependent-like kinase 5,COC1=CC=C2NC(=O)\C(=C/C3=CN=CN3)C2=C1
SU9516,Cyclin-dependent kinase 2,COC1=CC=C2NC(=O)\C(=C/C3=CN=CN3)C2=C1
SU9516,Cyclin-dependent kinase 1,COC1=CC=C2NC(=O)\C(=C/C3=CN=CN3)C2=C1
"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",Steroid Delta-isomerase,[H][C@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)OC(=O)CCC(O)=O
SUVN-502,5-hydroxytryptamine receptor 6,COC1=CC=C2N(C=C(CN3CCN(C)CC3)C2=C1)S(=O)(=O)C1=CC=CC=C1Br
SYRINGATE,"Endo-1,4-beta-xylanase Y",COC(=O)C1=CC(OC)=C(O)C(OC)=C1
Saccharin,Carbonic anhydrase 3,O=C1NS(=O)(=O)C2=C1C=CC=C2
Sacubitril,Neprilysin,[H][C@@](CC1=CC=C(C=C1)C1=CC=CC=C1)(C[C@@]([H])(C)C(=O)OCC)NC(=O)CCC(O)=O
Safinamide,Amine oxidase [flavin-containing] B,C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O
Salbutamol,Beta-2 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1
Salbutamol,Beta-1 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1
Salbutamol,Beta-3 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1
Salicylic acid,Prostaglandin G/H synthase 1,OC(=O)C1=CC=CC=C1O
Salicylic acid,Prostaglandin G/H synthase 2,OC(=O)C1=CC=CC=C1O
Salicylic acid,Aldo-keto reductase family 1 member C1,OC(=O)C1=CC=CC=C1O
Salmeterol,Beta-2 adrenergic receptor,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
Salmeterol,Beta-1 adrenergic receptor,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
Salmeterol,Beta-3 adrenergic receptor,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
Salmon Calcitonin,Calcitonin receptor,
Salophen iron chelate,Heme oxygenase,[Fe+4].[H]\C(=N/C1=CC=CC=C1\N=C(/[H])C1=CC=CC=C1[O-])C1=CC=CC=C1[O-]
Salophen-10-carboxylate iron chelate,Heme oxygenase,[Fe+4].[H]\C(=N/C1=C(C=C(C=C1)C(O)=O)/N=C(\[H])C1=CC=CC=C1[O-])C1=CC=CC=C1[O-]
Salsalate,Prostaglandin G/H synthase 2,OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O
Salsalate,Prostaglandin G/H synthase 1,OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O
Saprisartan,Type-1 angiotensin II receptor,CCC1=NC(C2CC2)=C(N1CC1=CC2=C(OC(=C2Br)C2=CC=CC=C2NS(=O)(=O)C(F)(F)F)C=C1)C(N)=O
Sapropterin,Phenylalanine-4-hydroxylase,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O
Sapropterin,"Nitric oxide synthase, endothelial",[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O
Sapropterin,Tyrosine 3-monooxygenase,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O
Sapropterin,Tryptophan 5-hydroxylase 1,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O
Saquinavir,Pol polyprotein,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=NC3=C(C=CC=C3)C=C1)[C@@H](C2)C(=O)NC(C)(C)C
Saredutant,Substance-K receptor,CN(C[C@@H](CCN1CCC(CC1)(NC(C)=O)C1=CC=CC=C1)C1=CC=C(Cl)C(Cl)=C1)C(=O)C1=CC=CC=C1
Sargramostim,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,
Sargramostim,Interleukin-3 receptor subunit alpha,
Sargramostim,Cytokine receptor common subunit beta,
Sargramostim,Syndecan-2,
Sargramostim,Bone marrow proteoglycan,
Sarilumab,Interleukin-6 receptor subunit alpha,
Sarilumab,High affinity immunoglobulin gamma Fc receptor I,
Sarilumab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Sarilumab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Sarilumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Sarilumab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Sarizotan,5-hydroxytryptamine receptor 1A,FC1=CC=C(C=C1)C1=CN=CC(CNC[C@H]2CCC3=CC=CC=C3O2)=C1
Sarizotan,D(2) dopamine receptor,FC1=CC=C(C=C1)C1=CN=CC(CNC[C@H]2CCC3=CC=CC=C3O2)=C1
Sarizotan,D(3) dopamine receptor,FC1=CC=C(C=C1)C1=CN=CC(CNC[C@H]2CCC3=CC=CC=C3O2)=C1
Sarpogrelate,5-hydroxytryptamine receptor 2C,COC1=CC(CCC2=CC=CC=C2OCC(CN(C)C)OC(=O)CCC(O)=O)=CC=C1
Sarpogrelate,5-hydroxytryptamine receptor 2A,COC1=CC(CCC2=CC=CC=C2OCC(CN(C)C)OC(=O)CCC(O)=O)=CC=C1
Saxagliptin,Dipeptidyl peptidase 4,N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2
Scopolamine,Muscarinic acetylcholine receptor M1,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Scopolamine,"Sucrase-isomaltase, intestinal",CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Scopolamine,Muscarinic acetylcholine receptor M2,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Scopolamine,Muscarinic acetylcholine receptor M3,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Scopolamine,Muscarinic acetylcholine receptor M4,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Scopolamine,Muscarinic acetylcholine receptor M5,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Scopolamine,Neuronal acetylcholine receptor subunit alpha-4,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Scopolamine,Neuronal acetylcholine receptor subunit beta-2,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Se-Ethyl-Isoselenourea,"Nitric oxide synthase, endothelial",CC[Se]C(N)=N
Secobarbital,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,Gamma-aminobutyric acid receptor subunit alpha-2,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,Gamma-aminobutyric acid receptor subunit alpha-3,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,Gamma-aminobutyric acid receptor subunit alpha-4,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,Gamma-aminobutyric acid receptor subunit alpha-5,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,Gamma-aminobutyric acid receptor subunit alpha-6,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,Neuronal acetylcholine receptor subunit alpha-4,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,Neuronal acetylcholine receptor subunit alpha-7,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,Glutamate receptor 2,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,"Glutamate receptor ionotropic, kainate 2",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,"Glutamate receptor ionotropic, NMDA 1",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,"Glutamate receptor ionotropic, NMDA 2A",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,"Glutamate receptor ionotropic, NMDA 2B",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,"Glutamate receptor ionotropic, NMDA 2C",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,"Glutamate receptor ionotropic, NMDA 2D",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,"Glutamate receptor ionotropic, NMDA 3A",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secobarbital,"Glutamate receptor ionotropic, NMDA 3B",CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Secretin human,Secretin receptor,
Secukinumab,Interleukin-17A,
Segesterone acetate,Progesterone receptor,[H][C@@]12CC(=C)[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Segesterone acetate,Androgen receptor,[H][C@@]12CC(=C)[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Segesterone acetate,Glucocorticoid receptor,[H][C@@]12CC(=C)[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
Selegiline,Amine oxidase [flavin-containing] B,C[C@H](CC1=CC=CC=C1)N(C)CC#C
Selegiline,Amine oxidase [flavin-containing] A,C[C@H](CC1=CC=CC=C1)N(C)CC#C
Selenazole-4-Carboxyamide-Adenine Dinucleotide,Inosine-5'-monophosphate dehydrogenase 2,[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(C3=NC(=C[Se]3)C(O)=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Selenocysteine,Formate dehydrogenase H,N[C@@H](C[SeH])C(O)=O
Selenocysteine,Cysteine desulfurase,N[C@@H](C[SeH])C(O)=O
Selenocysteine,Nucleoside diphosphate kinase A,N[C@@H](C[SeH])C(O)=O
Selenocysteine,Cathelicidin antimicrobial peptide,N[C@@H](C[SeH])C(O)=O
Selenoinosine,Nucleoside 2-deoxyribosyltransferase,[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C2N=CN=C3[SeH])[C@]([H])(O)[C@]1([H])O
Seletracetam,Synaptic vesicle glycoprotein 2A,CC[C@H](N1C[C@@H](CC1=O)C=C(F)F)C(N)=O
Seletracetam,Voltage-dependent N-type calcium channel subunit alpha-1B,CC[C@H](N1C[C@@H](CC1=O)C=C(F)F)C(N)=O
Seletracetam,Glycine receptor subunit alpha-1,CC[C@H](N1C[C@@H](CC1=O)C=C(F)F)C(N)=O
Seletracetam,Glycine receptor subunit beta,CC[C@H](N1C[C@@H](CC1=O)C=C(F)F)C(N)=O
Selexipag,Prostacyclin receptor,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(N=C1)C1=CC=CC=C1
Seliciclib,Mitogen-activated protein kinase 1,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1
Seliciclib,Mitogen-activated protein kinase 3,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1
Seliciclib,Cyclin-dependent kinase 2,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1
Seliciclib,Cyclin-dependent kinase 1,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1
Seliciclib,Cyclin-dependent kinase 7,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1
Seliciclib,Cyclin-dependent kinase 9,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1
Seliciclib,Casein kinase I isoform epsilon,CC[C@H](CO)NC1=NC(NCC2=CC=CC=C2)=C2N=CN(C(C)C)C2=N1
Selisistat,NAD-dependent protein deacetylase sirtuin-1,NC(=O)C1CCCC2=C1NC1=C2C=C(Cl)C=C1
Semaglutide,Glucagon-like peptide 1 receptor,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O
Semaxanib,Vascular endothelial growth factor receptor 2,CC1=CC(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12
Sennosides,Reverse transcriptase/RNaseH,
Seocalcitol,Vitamin D3 receptor,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\C=C\C(O)(CC)CC
Seractide acetate,Adrenocorticotropic hormone receptor,
Seratrodast,Thromboxane A2 receptor,CC1=C(C)C(=O)C(C(CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
Serine,"Serine--tRNA ligase, cytoplasmic",N[C@@H](CO)C(O)=O
Serine,L-serine dehydratase/L-threonine deaminase,N[C@@H](CO)C(O)=O
Serine,Serine--pyruvate aminotransferase,N[C@@H](CO)C(O)=O
Serine,Cystathionine beta-synthase,N[C@@H](CO)C(O)=O
Serine,Serine racemase,N[C@@H](CO)C(O)=O
Serine,Serine palmitoyltransferase 1,N[C@@H](CO)C(O)=O
Serine,Serine palmitoyltransferase 2,N[C@@H](CO)C(O)=O
Serine vanadate,Alkaline phosphatase,N[C@@H](CO[V](O)([O-])([O-])[O-])C(O)=O
Sermorelin,Growth hormone-releasing hormone receptor,
Serotonin,Sodium-dependent serotonin transporter,NCCC1=CNC2=CC=C(O)C=C12
Serotonin,5-hydroxytryptamine receptor 2A,NCCC1=CNC2=CC=C(O)C=C12
Serotonin,5-hydroxytryptamine receptor 3A,NCCC1=CNC2=CC=C(O)C=C12
Serotonin,5-hydroxytryptamine receptor 3B,NCCC1=CNC2=CC=C(O)C=C12
Serotonin,Synaptic vesicular amine transporter,NCCC1=CNC2=CC=C(O)C=C12
Sertaconazole,Lanosterol 14-alpha demethylase,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=CSC2=C1C=CC=C2Cl
Sertindole,D(2) dopamine receptor,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
Sertindole,5-hydroxytryptamine receptor 2A,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
Sertindole,5-hydroxytryptamine receptor 2C,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
Sertindole,5-hydroxytryptamine receptor 6,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
Sertindole,Potassium voltage-gated channel subfamily H member 2,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
Sertindole,Alpha-1A adrenergic receptor,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
Sertindole,Alpha-1B adrenergic receptor,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
Sertindole,Alpha-1D adrenergic receptor,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2
Sertraline,Sodium-dependent serotonin transporter,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
Sertraline,Sodium-dependent dopamine transporter,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
Sertraline,Membrane-associated progesterone receptor component 1,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
Sertraline,Sigma non-opioid intracellular receptor 1,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12
Setiptiline,Alpha-2A adrenergic receptor,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,Alpha-2B adrenergic receptor,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,Alpha-2C adrenergic receptor,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 1A,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 1B,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 1D,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 1E,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 1F,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 2A,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 2B,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 2C,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 3A,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 3B,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 3C,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 3D,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 3E,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 4,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 6,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Setiptiline,5-hydroxytryptamine receptor 7,CN1CCC2=C(C1)C1=CC=CC=C1CC1=CC=CC=C21
Sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Glycine receptor subunit alpha-1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Glutamate receptor 1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Potassium voltage-gated channel subfamily A member 1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Calcium-transporting ATPase type 2C member 1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,"ATP synthase subunit delta, mitochondrial",FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,NADH-ubiquinone oxidoreductase chain 1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-2,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-3,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-4,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-5,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-6,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit beta-1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit beta-2,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit beta-3,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit delta,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit epsilon,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit gamma-1,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit gamma-2,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit gamma-3,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit pi,FCOC(C(F)(F)F)C(F)(F)F
Sevoflurane,Gamma-aminobutyric acid receptor subunit theta,FCOC(C(F)(F)F)C(F)(F)F
Shikimate-3-Phosphate,3-phosphoshikimate 1-carboxyvinyltransferase,O[C@@H]1CC(=C[C@@H](OP(O)(O)=O)[C@H]1O)C(O)=O
Shikimate-3-Phosphate,3-phosphoshikimate 1-carboxyvinyltransferase,O[C@@H]1CC(=C[C@@H](OP(O)(O)=O)[C@H]1O)C(O)=O
Sibrotuzumab,Prolyl endopeptidase FAP,
Sibutramine,Sodium-dependent noradrenaline transporter,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
Sibutramine,Sodium-dependent serotonin transporter,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
Sibutramine,Sodium-dependent dopamine transporter,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
Sifalimumab,Interferon alpha-2,
Sildenafil,"cGMP-specific 3',5'-cyclic phosphodiesterase",CCCC1=NN(C)C2=C1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(C)CC1
Sildenafil,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",CCCC1=NN(C)C2=C1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(C)CC1
Sildenafil,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",CCCC1=NN(C)C2=C1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(C)CC1
Silicon dioxide,Macrophage receptor MARCO,O=[Si]=O
Silodosin,Alpha-1A adrenergic receptor,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
Silodosin,Alpha-1B adrenergic receptor,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
Silodosin,Alpha-1D adrenergic receptor,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
Siltuximab,Interleukin-6,
Silver,Metal regulatory transcription factor 1,[Ag]
Silver,Metallothionein 1H-like protein 1,[Ag]
Silver,Metallothionein-1A,[Ag]
Silver,Metallothionein-1B,[Ag]
Silver,Metallothionein-1E,[Ag]
Silver,Metallothionein-1F,[Ag]
Silver,Metallothionein-1G,[Ag]
Silver,Metallothionein-1H,[Ag]
Silver,Metallothionein-1L,[Ag]
Silver,Metallothionein-1M,[Ag]
Silver,Metallothionein-1X,[Ag]
Silver,Metallothionein-2,[Ag]
Silver,Metallothionein-3,[Ag]
Silver,Metallothionein-4,[Ag]
Silver,Putative metallothionein MT1DP,[Ag]
Silver,Tesmin,[Ag]
Silver,Ceruloplasmin,[Ag]
Silver,Serum albumin,[Ag]
Silver,Alpha-2-macroglobulin,[Ag]
Simeprevir,NS3 protease,[H]\C1=C([H])\[C@]2([H])C[C@]2(N=C(O)[C@]2([H])C[C@]([H])(C[C@@]2([H])C(=O)N(C)CCCC1)OC1=C2C=CC(OC)=C(C)C2=NC(=C1)C1=NC(=CS1)C(C)C)C(O)=NS(=O)(=O)C1CC1
Simoctocog alfa,von Willebrand factor,
Simvastatin,3-hydroxy-3-methylglutaryl-coenzyme A reductase,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC
Simvastatin,Integrin beta-2,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC
Simvastatin,Integrin alpha-L,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC
Sinapoyl Coenzyme A,Catechol O-methyltransferase domain-containing protein 1,[H]\C(=C(\[H])C1=CC(OC)=C(O)C(OC)=C1)C(=O)SCCN=C(O)CCN=C(O)C1(O)[C@]([H])(OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@@]([H])(O)[C@]2([H])OP(O)(O)=O)C1(C)C
Sinefungin,Modification methylase RsrI,[H][C@](N)(CC[C@]([H])(N)C(O)=O)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Sinefungin,rRNA adenine N-6-methyltransferase,[H][C@](N)(CC[C@]([H])(N)C(O)=O)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Sinefungin,Aclacinomycin 10-hydroxylase RdmB,[H][C@](N)(CC[C@]([H])(N)C(O)=O)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Sinefungin,Modification methylase TaqI,[H][C@](N)(CC[C@]([H])(N)C(O)=O)C[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Siplizumab,T-cell surface antigen CD2,
Siponimod,Sphingosine 1-phosphate receptor 5,CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F
Siponimod,Sphingosine 1-phosphate receptor 1,CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F
Sipuleucel-T,Prostatic acid phosphatase,
Siroheme,Sulfite reductase [NADPH] hemoprotein beta-component,C[C@@]1(CC(O)=O)C2=CC3=C(CC(O)=O)C(CCC(O)=O)=C4C=C5N6C(=CC7=C(CCC(O)=O)[C@](C)(CC(O)=O)C8=CC(N2[Fe@]6(N34)N78)=C1CCC(O)=O)C(CC(O)=O)=C5CCC(O)=O
Sirolimus,Serine/threonine-protein kinase mTOR,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC
Sirolimus,Peptidyl-prolyl cis-trans isomerase FKBP1A,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC
Sirolimus,Fibroblast growth factor 2,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC
Sitagliptin,Dipeptidyl peptidase 4,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F
Sitaxentan,Endothelin-1 receptor,CC1=NOC(NS(=O)(=O)C2=C(SC=C2)C(=O)CC2=CC3=C(OCO3)C=C2C)=C1Cl
Sitaxentan,Endothelin B receptor,CC1=NOC(NS(=O)(=O)C2=C(SC=C2)C(=O)CC2=CC3=C(OCO3)C=C2C)=C1Cl
Skf 107457,Gag-Pol polyprotein,[H][C@@](C)(N)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC1=CC=CC=C1)[C@@]([H])(O)CCC(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)OC
Sobetirome,"Thyroid hormone receptor, alpha isoform 1 variant",CC(C)C1=C(O)C=CC(CC2=C(C)C=C(OCC(O)=O)C=C2C)=C1
Sobetirome,Thyroid hormone receptor beta,CC(C)C1=C(O)C=CC(CC2=C(C)C=C(OCC(O)=O)C=C2C)=C1
Sodium Tetradecyl Sulfate,Vitamin K-dependent protein C,[Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O
Sodium Tetradecyl Sulfate,Vitamin K-dependent protein S,[Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O
Sodium carbonate,Carbonic anhydrase 1,[Na+].[Na+].[O-]C([O-])=O
Sodium carbonate,Carbonic anhydrase 2,[Na+].[Na+].[O-]C([O-])=O
Sodium carbonate,Carbonic anhydrase 4,[Na+].[Na+].[O-]C([O-])=O
Sodium carbonate,Carbonic anhydrase 9,[Na+].[Na+].[O-]C([O-])=O
Sodium ferric gluconate complex,Ferritin light chain,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sodium ferric gluconate complex,Hemoglobin subunit alpha,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sodium ferric gluconate complex,Hemoglobin subunit beta,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sodium stibogluconate,DNA topoisomerase 1,O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[H][C@@]1(O[Sb]2(O)(O[Sb]34([O-])O[C@@H](C([O-])=O)[C@@]([H])(O3)[C@]([H])(O4)[C@H](O)CO)O[C@@H](C([O-])=O)[C@@]1([H])O2)[C@H](O)CO
Sodium sulfate,Carbonic anhydrase 2,[Na+].[Na+].[O-]S([O-])(=O)=O
Sodium sulfate,Carbonic anhydrase 1,[Na+].[Na+].[O-]S([O-])(=O)=O
Sofosbuvir,RNA-dependent RNA-polymerase,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1
Solabegron,Beta-3 adrenergic receptor,[H][C@](O)(CNCCNC1=CC(=CC=C1)C1=CC(=CC=C1)C(O)=O)C1=CC=CC(Cl)=C1
Solifenacin,Muscarinic acetylcholine receptor M3,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
Solifenacin,Muscarinic acetylcholine receptor M1,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
Solifenacin,Muscarinic acetylcholine receptor M2,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
Solifenacin,Muscarinic acetylcholine receptor M4,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
Solifenacin,Muscarinic acetylcholine receptor M5,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
Solriamfetol,Sodium-dependent dopamine transporter,N[C@@H](COC(N)=O)CC1=CC=CC=C1
Solriamfetol,Sodium-dependent noradrenaline transporter,N[C@@H](COC(N)=O)CC1=CC=CC=C1
Somatostatin,Somatostatin receptor type 1,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O
Somatostatin,Somatostatin receptor type 2,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O
Somatostatin,Somatostatin receptor type 3,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O
Somatostatin,Somatostatin receptor type 4,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O
Somatostatin,Somatostatin receptor type 5,C[C@@H](O)[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O
Somatotropin,Growth hormone receptor,
Somatotropin,Prolactin receptor,
Somatrem,Growth hormone receptor,
Somatrem,Insulin-like growth factor 1 receptor,
Soneclosan,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,OC1=C(OC2=CC=C(Cl)C=C2)C=CC(Cl)=C1
Sonidegib,Smoothened homolog,[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=CC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=N1
Sorafenib,Vascular endothelial growth factor receptor 3,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,RAF proto-oncogene serine/threonine-protein kinase,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,Vascular endothelial growth factor receptor 2,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,Serine/threonine-protein kinase B-raf,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,Receptor-type tyrosine-protein kinase FLT3,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,Platelet-derived growth factor receptor beta,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,Mast/stem cell growth factor receptor Kit,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,Fibroblast growth factor receptor 1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,Proto-oncogene tyrosine-protein kinase receptor Ret,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Sorafenib,Vascular endothelial growth factor receptor 1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Soraphen A,Acetyl-CoA carboxylase 2,[H]\C1=C([H])/[C@@]([H])(OC)[C@]([H])(CCCC[C@]([H])(OC(=O)[C@@]([H])(C)[C@@]2(O)O[C@]([H])([C@@]([H])(C)[C@]([H])(O)[C@@]2([H])OC)[C@@]1([H])C)C1=CC=CC=C1)OC
Sorbinil,Aldose reductase,FC1=CC=C2OCC[C@]3(NC(=O)NC3=O)C2=C1
Sorbitol,Xylose isomerase,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Sorbitol,Malate synthase G,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Sorbitol,Xylose isomerase,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Sorbitol,Xylose isomerase,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Sotalol,Potassium voltage-gated channel subfamily H member 2,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Sotalol,Beta-1 adrenergic receptor,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Sotalol,Beta-2 adrenergic receptor,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1
Sotatercept,Activin receptor type-2A,
Soybean oil,Peroxisome proliferator-activated receptor alpha,
Sp-722,Thymidylate synthase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)S(=O)(=O)N1CCC[C@]1([H])C(O)=O)C(O)=O
Sp-876,Thymidylate synthase,[H][C@@](CCC(O)=O)(NC(=O)C1=CC=C(C=C1)S(=O)(=O)N1CCC[C@]1([H])C(O)=NCCC(O)=O)C(O)=O
"Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate",cAMP-dependent protein kinase type I-alpha regulatory subunit,[H][C@@]12CO[P@@](O)(=S)O[C@@]1([H])[C@@]([H])(O)[C@@]([H])(O2)N1C=NC2=C(N)N=CN=C12
Sp7343-Sp7964,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@]1(CC[C@]([H])(CC1)C(O)=NCCSSCCN=C(C)O)N=C(O)C1=C(N=CC=N1)C(O)=O
Spaglumic Acid,Glutamate carboxypeptidase 2,CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O
Sparfloxacin,DNA gyrase subunit A,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O
Sparfloxacin,DNA topoisomerase 4 subunit A,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O
Sparfloxacin,DNA topoisomerase 2-alpha,C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O
Sparfosic acid,Aspartate carbamoyltransferase catalytic chain,[H][C@@](CC(O)=O)(N=C(O)CP(O)(O)=O)C(O)=O
Sparfosic acid,CAD protein,[H][C@@](CC(O)=O)(N=C(O)CP(O)(O)=O)C(O)=O
Sparsentan,Endothelin-1 receptor,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C(COCC)=C1)C1=CC=CC=C1S(=O)(=O)NC1=NOC(C)=C1C
Sparsentan,Angiotensinogen,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C(COCC)=C1)C1=CC=CC=C1S(=O)(=O)NC1=NOC(C)=C1C
Spectinomycin,30S ribosomal protein S12,[H][C@@]12O[C@H](C)CC(=O)[C@]1(O)O[C@]1([H])[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@@]1([H])O2
Spermidine,Gentamicin 3-N-acetyltransferase,NCCCCNCCCN
Spermidine,"Thioredoxin reductase 1, cytoplasmic",NCCCCNCCCN
Spermidine,Spermidine/putrescine-binding periplasmic protein,NCCCCNCCCN
Spermidine,Beta-1 adrenergic receptor,NCCCCNCCCN
Spermidine,Beta-2 adrenergic receptor,NCCCCNCCCN
Spermine,Spermine synthase,NCCCNCCCCNCCCN
Spermine,Spermine oxidase,NCCCNCCCCNCCCN
Spermine,Ornithine decarboxylase,NCCCNCCCCNCCCN
Spermine,Extracellular calcium-sensing receptor,NCCCNCCCCNCCCN
Spermine,Beta-1 adrenergic receptor,NCCCNCCCCNCCCN
Spermine,Beta-2 adrenergic receptor,NCCCNCCCCNCCCN
Sphingosine,Glycolipid transfer protein,[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@@]([H])(O)[C@@]([H])(N)CO
Sphingosine,Genome polyprotein,[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@@]([H])(O)[C@@]([H])(N)CO
Sphingosine,Genome polyprotein,[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@@]([H])(O)[C@@]([H])(N)CO
Sphingosine,Genome polyprotein,[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@@]([H])(O)[C@@]([H])(N)CO
Sphingosine,Genome polyprotein,[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@@]([H])(O)[C@@]([H])(N)CO
Sphingosine,Poliovirus receptor,[H]\C(CCCCCCCCCCCCC)=C(\[H])[C@@]([H])(O)[C@@]([H])(N)CO
Sphinxolide B,"Actin, alpha skeletal muscle",CO[C@H](C\C=C\N(C)C=O)[C@@H](C)C(=O)CC[C@H](C)[C@H](OC)[C@H](C)[C@H]1OC(=O)\C=C\C=C(C)/C[C@H](CC2=CC(=O)O[C@H]([C@H]2O)[C@H](C)[C@H](C[C@H](OC)\C=C\[C@H](C)[C@@H](O)C[C@@H](OC)\C=C\[C@@H]1C)OC)OC
Spiramycin,50S ribosomal protein L3,[H]\C1=C(\[H])/C(/[H])=C([H])/[C@]([H])(O[C@@]2([H])CC[C@]([H])(N(C)C)[C@]([H])(C)O2)[C@]([H])(C)C[C@]([H])(CC=O)[C@]([H])(O[C@]2([H])O[C@]([H])(C)[C@@]([H])(O[C@@]3([H])C[C@@](C)(O)[C@@]([H])(O)[C@]([H])(C)O3)[C@]([H])(N(C)C)[C@@]2([H])O)[C@@]([H])(OC)[C@]([H])(O)CC(=O)O[C@]([H])(C)C1
Spirapril,Angiotensin-converting enzyme,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2
Spironolactone,Mineralocorticoid receptor,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Androgen receptor,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Progesterone receptor,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Glucocorticoid receptor,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,"Cytochrome P450 11B2, mitochondrial",[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,3-oxo-5-alpha-steroid 4-dehydrogenase 1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,3-oxo-5-alpha-steroid 4-dehydrogenase 2,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Polyprenol reductase,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Sex hormone-binding globulin,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent calcium channel gamma-1 subunit,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent calcium channel subunit alpha-2/delta-1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent calcium channel subunit alpha-2/delta-2,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent calcium channel subunit alpha-2/delta-3,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent L-type calcium channel subunit alpha-1C,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent L-type calcium channel subunit alpha-1D,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent L-type calcium channel subunit alpha-1F,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent L-type calcium channel subunit alpha-1S,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent L-type calcium channel subunit beta-1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent L-type calcium channel subunit beta-2,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent L-type calcium channel subunit beta-3,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent L-type calcium channel subunit beta-4,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent N-type calcium channel subunit alpha-1B,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent T-type calcium channel subunit alpha-1G,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent T-type calcium channel subunit alpha-1H,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Voltage-dependent T-type calcium channel subunit alpha-1I,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Spironolactone,Nuclear receptor subfamily 1 group I member 2,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
Sri-9439,Dihydrofolate reductase,CC1=C(CNC2=CC=CC3=NC=CC=C23)C=NC2=NC(N)=NC(N)=C12
Sri-9662,Dihydrofolate reductase,COC1=CC(\C=C/C2=C(C)C3=C(N)N=C(N)N=C3N=C2)=C(OC)C=C1
Stannsoporfin,Heme oxygenase 2,[Cl-].[Cl-].[Sn+4].CCC1=C2[N-]C(\C=C3/N=C(/C=C4\[N-]\C(=C/C5=N/C(=C\2)/C(C)=C5CC)C(C)=C4CCC(O)=O)C(CCC(O)=O)=C3C)=C1C
Stannsoporfin,Heme oxygenase 1,[Cl-].[Cl-].[Sn+4].CCC1=C2[N-]C(\C=C3/N=C(/C=C4\[N-]\C(=C/C5=N/C(=C\2)/C(C)=C5CC)C(C)=C4CCC(O)=O)C(CCC(O)=O)=C3C)=C1C
Stanolone,Androgen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Stanolone,Estradiol 17-beta-dehydrogenase 1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Stanolone,Estrogen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Stanolone,Mineralocorticoid receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Stanolone acetate,Androgen receptor,[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Stanolone acetate,Estradiol 17-beta-dehydrogenase 1,[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Stanolone acetate,Estrogen receptor,[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Stanolone acetate,Mineralocorticoid receptor,[H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
Staurosporine,Tyrosine-protein kinase Lck,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Glycogen synthase kinase-3 beta,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Cyclin-dependent kinase 2,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,3-phosphoinositide-dependent protein kinase 1,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Serine/threonine-protein kinase pim-1,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Tyrosine-protein kinase ZAP-70,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Tyrosine-protein kinase SYK,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Tyrosine-protein kinase ITK/TSK,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Tyrosine-protein kinase CSK,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,MAP kinase-activated protein kinase 2,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Protein kinase C theta type,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Staurosporine,Muscarinic acetylcholine receptor M1,[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
Stavudine,Reverse transcriptase/RNaseH,CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O
Stearic acid,Group IID secretory phospholipase A2,CCCCCCCCCCCCCCCCCC(O)=O
Stearic acid,Peroxisome proliferator-activated receptor alpha,CCCCCCCCCCCCCCCCCC(O)=O
Stiripentol,Gamma-aminobutyric acid receptor subunit alpha-1,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit alpha-2,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit alpha-3,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit alpha-4,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit alpha-5,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit alpha-6,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit beta-1,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit beta-2,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit beta-3,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit delta,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit epsilon,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit gamma-1,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit gamma-2,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit gamma-3,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit pi,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,Gamma-aminobutyric acid receptor subunit theta,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,L-lactate dehydrogenase A chain,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Stiripentol,L-lactate dehydrogenase B chain,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
Streptokinase,Plasminogen,
Streptokinase,Proteinase-activated receptor 1,
Streptomycin,30S ribosomal protein S12,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O
Streptomycin,Protein-arginine deiminase type-4,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O
Streptozocin,"Solute carrier family 2, facilitated glucose transporter member 2",CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
Streptozocin,O-GlcNAcase BT_4395,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
Streptozocin,Protein O-GlcNAcase,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
Succinamide-Coa,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",[H][C@](O)(C(O)=NCCC(O)=NCCN=C(O)CCC(O)=O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Succinic acid,Solute carrier family 13 member 1,OC(=O)CCC(O)=O
Succinic acid,Prolyl 4-hydroxylase subunit alpha-1,OC(=O)CCC(O)=O
Succinic acid,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",OC(=O)CCC(O)=O
Succinic acid,"Succinate-semialdehyde dehydrogenase, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,"Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,Solute carrier family 13 member 2,OC(=O)CCC(O)=O
Succinic acid,Aspartyl/asparaginyl beta-hydroxylase,OC(=O)CCC(O)=O
Succinic acid,Solute carrier family 13 member 3,OC(=O)CCC(O)=O
Succinic acid,17-beta-hydroxysteroid dehydrogenase type 6,OC(=O)CCC(O)=O
Succinic acid,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",OC(=O)CCC(O)=O
Succinic acid,Gamma-butyrobetaine dioxygenase,OC(=O)CCC(O)=O
Succinic acid,Prolyl 3-hydroxylase 1,OC(=O)CCC(O)=O
Succinic acid,Prolyl 3-hydroxylase 2,OC(=O)CCC(O)=O
Succinic acid,Prolyl 3-hydroxylase 3,OC(=O)CCC(O)=O
Succinic acid,"Trimethyllysine dioxygenase, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,Prolyl 4-hydroxylase subunit alpha-2,OC(=O)CCC(O)=O
Succinic acid,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,"Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,Succinate receptor 1,OC(=O)CCC(O)=O
Succinic acid,"Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,"Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial",OC(=O)CCC(O)=O
Succinic acid,Mitochondrial dicarboxylate carrier,OC(=O)CCC(O)=O
Succinobucol,Vascular cell adhesion protein 1,CC(C)(C)C1=CC(SC(C)(C)SC2=CC(=C(OC(=O)CCC(O)=O)C(=C2)C(C)(C)C)C(C)(C)C)=CC(=C1O)C(C)(C)C
Succinyl-Coenzyme A,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O
Succinylcholine,Neuronal acetylcholine receptor subunit alpha-10,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Succinylcholine,Alpha-7 nicotinic cholinergic receptor subunit,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Succinylcholine,Muscarinic acetylcholine receptor M1,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Succinylcholine,Muscarinic acetylcholine receptor M2,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Succinylcholine,Muscarinic acetylcholine receptor M3,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Sucralfate,Fibroblast growth factor 2,O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O
Sucralfate,Pro-epidermal growth factor,O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O
Sucralfate,Fibrinogen alpha chain,O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O
Sucralfate,Fibrinogen beta chain,O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O
Sucralfate,Fibrinogen gamma chain,O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O
Sucrose,Beta-lactamase,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Nitric oxide synthase oxygenase,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Septum formation protein Maf,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,GDP-mannose 6-dehydrogenase,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,"Actin, alpha skeletal muscle",OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Beta-lactamase,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Levansucrase,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Beta-glucosidase,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Amylosucrase,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Heme oxygenase,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Copper transport protein ATOX1,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Orange carotenoid-binding protein,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Sucrose porin,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Lysozyme C,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,tRNA-splicing ligase RtcB homolog,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrose,Taste receptor type 1 member 2,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O
Sucrosofate,Fibroblast growth factor 1,OS(=O)(=O)OC[C@H]1O[C@@](COS(O)(=O)=O)(O[C@H]2O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O
Sucrosofate,Fibroblast growth factor receptor 2,OS(=O)(=O)OC[C@H]1O[C@@](COS(O)(=O)=O)(O[C@H]2O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H]1OS(O)(=O)=O
Sufentanil,Mu-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
Sufentanil,Delta-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
Sufentanil,Kappa-type opioid receptor,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
Sufugolix,Gonadotropin-releasing hormone receptor,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)CC2=CC=CC=C2)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=CC=C1
Sulbactam,Beta-lactamase,[H][C@@]12CC(=O)N1[C@@]([H])(C(O)=O)C(C)(C)S2(=O)=O
Sulfacetamide,Dihydropteroate synthase,CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
Sulfacetamide,Dihydropteroate synthase type-1,CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
Sulfacetamide,Folic acid synthesis protein FOL1,CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
Sulfacytine,Dihydropteroate synthase,CCN1C=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC1=O
Sulfadiazine,Dihydropteroate synthetase,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1
Sulfadoxine,Dihydropteroate synthetase,COC1=NC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1OC
Sulfadoxine,Bifunctional dihydrofolate reductase-thymidylate synthase,COC1=NC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1OC
Sulfamerazine,Dihydropteroate synthase,CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1
Sulfameter,Dihydropteroate synthase,COC1=CN=C(NS(=O)(=O)C2=CC=C(N)C=C2)N=C1
Sulfamethazine,Dihydropteroate synthase,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
Sulfamethizole,Dihydropteroate synthase,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
Sulfamethoxazole,Dihydropteroate synthase,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
Sulfamethoxazole,Bifunctional protein FolC,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
Sulfamethoxazole,Glutathione S-transferase P,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
Sulfametopyrazine,Dihydropteroate synthetase,COC1=NC=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1
"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",Carbonic anhydrase 2,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OS(=O)(=O)O2
Sulfamoxole,Dihydropteroate synthetase,CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1
Sulfanilamide,Dihydropteroate synthase,NC1=CC=C(C=C1)S(N)(=O)=O
Sulfaphenazole,Dihydropteroate synthase,NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=NN1C1=CC=CC=C1
Sulfapyridine,Dihydropteroate synthase type-1,NC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1
Sulfasalazine,Arachidonate 5-lipoxygenase,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,Prostaglandin G/H synthase 2,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,Prostaglandin G/H synthase 1,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,Peroxisome proliferator-activated receptor gamma,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,Inhibitor of nuclear factor kappa-B kinase subunit alpha,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,Inhibitor of nuclear factor kappa-B kinase subunit beta,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,Cystine/glutamate transporter,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,"Acetyl-CoA acetyltransferase, mitochondrial",OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,Thromboxane-A synthase,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfasalazine,Phospholipase A2,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Sulfathiazole,Dihydropteroate synthetase,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1
Sulfinpyrazone,Multidrug resistance-associated protein 1,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1
Sulfinpyrazone,Canalicular multispecific organic anion transporter 1,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1
Sulfinpyrazone,Solute carrier family 22 member 12,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1
Sulfinpyrazone,Nuclear receptor subfamily 1 group I member 2,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1
Sulfisoxazole,Dihydropteroate synthase,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
Sulfoxone,Dihydropteroate synthetase,OS(=O)CNC1=CC=C(C=C1)S(=O)(=O)C1=CC=C(NCS(O)=O)C=C1
Sulindac,Prostaglandin G/H synthase 2,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
Sulindac,Prostaglandin G/H synthase 1,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
Sulindac,Aldose reductase,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
Sulindac,Mitogen-activated protein kinase 3,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
Sulindac,Peroxisome proliferator-activated receptor delta,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
Sulindac,Prostaglandin D2 receptor 2,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
Sulindac,Aldo-keto reductase family 1 member B10,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O
Sulodexide,Antithrombin-III,
Sulodexide,Heparin cofactor 2,
Sulpiride,D(2) dopamine receptor,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
Sulpiride,D(3) dopamine receptor,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
Sulpiride,Carbonic anhydrase 2,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
Sulpiride,Carbonic anhydrase 3,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O
Sulthiame,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C(C=C1)N1CCCCS1(=O)=O
Sumanirole,D(4) dopamine receptor,CN[C@H]1CN2C(=O)NC3=CC=CC(C1)=C23
Sumanirole,D(3) dopamine receptor,CN[C@H]1CN2C(=O)NC3=CC=CC(C1)=C23
Sumanirole,D(2) dopamine receptor,CN[C@H]1CN2C(=O)NC3=CC=CC(C1)=C23
Sumatriptan,5-hydroxytryptamine receptor 1F,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
Sumatriptan,5-hydroxytryptamine receptor 1D,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
Sumatriptan,5-hydroxytryptamine receptor 1B,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
Sumatriptan,5-hydroxytryptamine receptor 1A,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
Sunitinib,Platelet-derived growth factor receptor beta,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
Sunitinib,Vascular endothelial growth factor receptor 1,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
Sunitinib,Mast/stem cell growth factor receptor Kit,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
Sunitinib,Vascular endothelial growth factor receptor 2,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
Sunitinib,Vascular endothelial growth factor receptor 3,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
Sunitinib,Receptor-type tyrosine-protein kinase FLT3,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
Sunitinib,Macrophage colony-stimulating factor 1 receptor,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
Sunitinib,Platelet-derived growth factor receptor alpha,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
Suprofen,Prostaglandin G/H synthase 1,CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1
Suprofen,Prostaglandin G/H synthase 2,CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1
Suramin,P2Y purinoceptor 2,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O
Suramin,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O
Suramin,Follicle-stimulating hormone receptor,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O
Suramin,Ryanodine receptor 1,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O
Suramin,Prothrombin,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O
Suramin,"Phospholipase A2, membrane associated",CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O
Suramin,Complement control protein C3,CC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O
Susoctocog alfa,von Willebrand factor,
Suvorexant,Orexin receptor type 1,[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2
Suvorexant,Orexin receptor type 2,[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2
Synephrine,Alpha-1A adrenergic receptor,CNCC(O)C1=CC=C(O)C=C1
Synephrine,Alpha-1B adrenergic receptor,CNCC(O)C1=CC=C(O)C=C1
Synephrine,Alpha-1D adrenergic receptor,CNCC(O)C1=CC=C(O)C=C1
"Synthetic Conjugated Estrogens, A",Estrogen receptor,
"Synthetic Conjugated Estrogens, B",Estrogen receptor,
TACRINE(8)-4-AMINOQUINOLINE,Acetylcholinesterase,C(CCCCNC1=C2CCCCC2=NC2=CC=CC=C12)CCCNC1=CC=NC2=CC=CC=C12
TAK-475,3-hydroxy-3-methylglutaryl-coenzyme A reductase,
TAK-475,Squalene synthase,
TAS-108,Estrogen receptor,OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CC1=CC=C(OCC[C@H]2CC[C@H]3[C@@H]4[C@H](C)CC5=C(C=CC(O)=C5)[C@H]4CC[C@]23C)C(OC)=C1
TAS-108,Estrogen receptor beta,OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CC1=CC=C(OCC[C@H]2CC[C@H]3[C@@H]4[C@H](C)CC5=C(C=CC(O)=C5)[C@H]4CC[C@]23C)C(OC)=C1
TB-402,Coagulation factor VIII,
TBC-3711,Endothelin-1,
TD-2749,5-hydroxytryptamine receptor 4,
TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,Cathepsin K,CN(NC(=O)OC(C)(C)C)C#N
TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,Collagenase 3,CC#CCNC1=CC=C(C=C1)S(=O)(=O)CC1(CCN(CC1)C(=O)OC(C)(C)C)C(=O)NO
"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",Methionine aminopeptidase 1,CC(C)(C)OC(=O)NC1=C(N=CC=C1)C(=O)NC1=NC=CS1
TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,Blasticidin-S deaminase,CN(CC[C@H](N)CC(=O)N[C@H]1C=C[C@@H](O[C@@H]1C(O)=O)N1C=C[C@@](N)(O)NC1=O)C(N)=N
TG-100801,Vascular endothelial growth factor receptor 3,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl
TG-100801,Vascular endothelial growth factor receptor 1,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl
TG-100801,Vascular endothelial growth factor receptor 2,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl
TG-100801,Tyrosine-protein kinase CSK,CC1=C2N=C(NC3=CC=C(OCCN4CCCC4)C=C3)N=NC2=CC(=C1)C1=CC(OC(=O)C2=CC=CC=C2)=CC=C1Cl
TG100-115,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",NC1=NC(N)=C2N=C(C3=CC=CC(O)=C3)C(=NC2=N1)C1=CC(O)=CC=C1
TG100-115,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",NC1=NC(N)=C2N=C(C3=CC=CC(O)=C3)C(=NC2=N1)C1=CC(O)=CC=C1
TG4010,Mucin-1,
TG4010,Interleukin-2,
"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",Coagulation factor X,[H][C@@]1(CCN(CC2=CC3=C(C=CN=C3N)C=C2)C1=O)NS(=O)(=O)C1=CC2=C(S1)C=CC=N2
"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",Coagulation factor X,[H][C@@]1(CCN(CC2=CC3=C(N2)C=NC=C3)C1=O)NS(=O)(=O)C1=CC2=C(S1)C=CC=N2
THIO-ATPA,Glutamate receptor 2,[H][C@]([NH3+])(CC1=C(SN=C1[O-])C(C)(C)C)C(O)=O
"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",Carbonic anhydrase 2,CC1=CC=C(CNS(=O)(=O)C2=CC=C(S2)S(N)(=O)=O)C=C1
THYMIDINE-5'-THIOPHOSPHATE,DNA polymerase I,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(O)=S)N1C=C(C)C(=O)NC1=O
TM30339,Neuropeptide Y receptor type 4,
TNP-470,Methionine aminopeptidase 2,[H][C@]1(CC=C(C)C)O[C@]1(C)[C@@]1([H])[C@]([H])(OC)[C@@]([H])(CC[C@]11CO1)OC(=O)NC(=O)CCl
TNX-901,High affinity immunoglobulin epsilon receptor subunit alpha,
TP-508,Fibroblast growth factor 4,
"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",Phenylethanolamine N-methyltransferase,[H][C@]1(N)CCC2=CC=CC=C2[C@]1([H])O
TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE,Ig gamma-1 chain C region,[H][C@@]1(CC[N@@+](C)([O-])CC1)[Si](C)(C)C1=CC=CC=C1
TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE,Prothrombin,NC(N)=NCCCC[C@H](NC(=O)[C@@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H]1CCN1C(=O)[C@@H](CC1CCCCC1)NC(=O)[C@@H]1CC[C@H](CN=C(N)N)CC1)C(N)=O
TRAZEOLIDE,Ig kappa chain C region,[H][C@]1(C)[C@]([H])(C(C)C)C2=C(C=C(C)C(=C2)C(=O)CCC(O)=O)C1(C)C
TRC093,Collagen alpha-4(IV) chain,
TRIAZOLOPYRIMIDINE,Cyclin-dependent kinase 2,BrC1=CC=CC(=C1)C1=NC2=[N+](NC=N2)C(NCC2=CC=NC=C2)=C1
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,Amicyanin,[H][C@](N)(CC1=CNC2=C1C=CC(NNC1=CC=CC=C1)=C2O)C=O
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,Methylamine dehydrogenase heavy chain,[H][C@](N)(CC1=CNC2=C1C=CC(NNC1=CC=CC=C1)=C2O)C=O
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,Methylamine dehydrogenase light chain,[H][C@](N)(CC1=CNC2=C1C=CC(NNC1=CC=CC=C1)=C2O)C=O
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,Cytochrome c-L,[H][C@](N)(CC1=CNC2=C1C=CC(NNC1=CC=CC=C1)=C2O)C=O
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,Quinohemoprotein amine dehydrogenase subunit gamma,[H][C@](N)(CC1=CNC2=C1C=CC(NNC1=CC=CC=C1)=C2O)C=O
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,Quinohemoprotein amine dehydrogenase 60 kDa subunit,[H][C@](N)(CC1=CNC2=C1C=CC(NNC1=CC=CC=C1)=C2O)C=O
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,Quinohemoprotein amine dehydrogenase 40 kDa subunit,[H][C@](N)(CC1=CNC2=C1C=CC(NNC1=CC=CC=C1)=C2O)C=O
TTP889,Coagulation factor IX,
Tacrine,Acetylcholinesterase,NC1=C2CCCCC2=NC2=CC=CC=C12
Tacrine,Cholinesterase,NC1=C2CCCCC2=NC2=CC=CC=C12
Tacrine,Liver carboxylesterase 1,NC1=C2CCCCC2=NC2=CC=CC=C12
Tacrolimus,Peptidyl-prolyl cis-trans isomerase FKBP1A,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC
Tadalafil,"cGMP-specific 3',5'-cyclic phosphodiesterase",[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1
Tadalafil,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1
Tafamidis,Transthyretin,OC(=O)C1=CC2=C(C=C1)N=C(O2)C1=CC(Cl)=CC(Cl)=C1
Tafluprost,Prostaglandin F2-alpha receptor,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1
Tagetitoxin,DNA-directed RNA polymerase subunit beta,[H]N([H])[C@H]1[C@@H](OC(C)=O)[C@@]2([H])O[C@](CS[C@@]2(O)C(=O)N([H])[H])([C@@H]1OP(O)(O)=O)C(O)=O
Tagetitoxin,DNA-directed RNA polymerase subunit beta',[H]N([H])[C@H]1[C@@H](OC(C)=O)[C@@]2([H])O[C@](CS[C@@]2(O)C(=O)N([H])[H])([C@@H]1OP(O)(O)=O)C(O)=O
Tagraxofusp,Interleukin-3 receptor subunit alpha,
Tagraxofusp,ADP-ribosylation factor-like protein 2,
Talampanel,Glutamate receptor 1,C[C@@H]1CC2=CC3=C(OCO3)C=C2C(=NN1C(C)=O)C1=CC=C(N)C=C1
Talampanel,Glutamate receptor 2,C[C@@H]1CC2=CC3=C(OCO3)C=C2C(=NN1C(C)=O)C1=CC=C(N)C=C1
Talampanel,Glutamate receptor 4,C[C@@H]1CC2=CC3=C(OCO3)C=C2C(=NN1C(C)=O)C1=CC=C(N)C=C1
Talampanel,Glutamate receptor 3,C[C@@H]1CC2=CC3=C(OCO3)C=C2C(=NN1C(C)=O)C1=CC=C(N)C=C1
Talarozole,Cytochrome P450 26A1,CCC(CC)C(N1C=NC=N1)C1=CC=C(NC2=NC3=CC=CC=C3S2)C=C1
Talazoparib,Poly [ADP-ribose] polymerase 1,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1
Talazoparib,Poly [ADP-ribose] polymerase 2,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-1,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-2,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-3,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-4,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-5,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-6,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Neuronal acetylcholine receptor subunit alpha-4,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Neuronal acetylcholine receptor subunit alpha-7,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Glutamate receptor 2,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,"Glutamate receptor ionotropic, kainate 2",CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-1,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-2,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-3,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-4,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-5,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit alpha-6,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit beta-1,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit beta-2,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit beta-3,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit delta,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit epsilon,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit gamma-1,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit gamma-2,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit gamma-3,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit pi,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talbutal,Gamma-aminobutyric acid receptor subunit theta,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O
Talimogene laherparepvec,DNA polymerase catalytic subunit,
Talimogene laherparepvec,DNA polymerase catalytic subunit,
Talmapimod,Tumor necrosis factor,[H][C@]1(C)CN(C(=O)C2=C(Cl)C=C3N(C)C=C(C(=O)C(=O)N(C)C)C3=C2)[C@]([H])(C)CN1CC1=CC=C(F)C=C1
Talmapimod,Mitogen-activated protein kinase 14,[H][C@]1(C)CN(C(=O)C2=C(Cl)C=C3N(C)C=C(C(=O)C(=O)N(C)C)C3=C2)[C@]([H])(C)CN1CC1=CC=C(F)C=C1
Talmapimod,Interleukin-1 beta,[H][C@]1(C)CN(C(=O)C2=C(Cl)C=C3N(C)C=C(C(=O)C(=O)N(C)C)C3=C2)[C@]([H])(C)CN1CC1=CC=C(F)C=C1
Talmapimod,Cytochrome c oxidase subunit 2,[H][C@]1(C)CN(C(=O)C2=C(Cl)C=C3N(C)C=C(C(=O)C(=O)N(C)C)C3=C2)[C@]([H])(C)CN1CC1=CC=C(F)C=C1
Talnetant,Neuromedin-K receptor,CCC(NC(=O)C1=C(O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C1=CC=CC=C1
Talniflumate,Prostaglandin G/H synthase 1,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OC2OC(=O)C3=CC=CC=C23)=CC=C1
Talniflumate,Prostaglandin G/H synthase 2,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OC2OC(=O)C3=CC=CC=C23)=CC=C1
Talniflumate,Chloride channel protein ClC-Ka,FC(F)(F)C1=CC(NC2=C(C=CC=N2)C(=O)OC2OC(=O)C3=CC=CC=C23)=CC=C1
Talviraline,Gag-Pol polyprotein,[H][C@@]1(CSC)N(C(=O)OC(C)C)C2=C(NC1=S)C=CC(OC)=C2
Tamatinib,Tyrosine-protein kinase SYK,COC1=CC(NC2=NC=C(F)C(NC3=CC=C4OC(C)(C)C(=O)NC4=N3)=N2)=CC(OC)=C1OC
Tamibarotene,Retinoic acid receptor beta,CC1(C)CCC(C)(C)C2=C1C=CC(NC(=O)C1=CC=C(C=C1)C(O)=O)=C2
Tamibarotene,Retinoic acid receptor alpha,CC1(C)CCC(C)(C)C2=C1C=CC(NC(=O)C1=CC=C(C=C1)C(O)=O)=C2
Tamoxifen,Estrogen receptor,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Estrogen receptor beta,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Protein kinase C alpha type,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Protein kinase C beta type,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Protein kinase C delta type,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Protein kinase C epsilon type,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Protein kinase C gamma type,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Protein kinase C iota type,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Protein kinase C theta type,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Protein kinase C zeta type,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Androgen receptor,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Potassium voltage-gated channel subfamily H member 2,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Nuclear receptor subfamily 1 group I member 2,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Estrogen-related receptor gamma,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamoxifen,Sex hormone-binding globulin,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
Tamsulosin,Alpha-1A adrenergic receptor,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O
Tamsulosin,Alpha-1D adrenergic receptor,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O
Tamsulosin,Alpha-1B adrenergic receptor,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O
Tanaproget,Progesterone receptor,CN1C(=CC=C1C1=CC=C2NC(=S)OC(C)(C)C2=C1)C#N
Tandutinib,Receptor-type tyrosine-protein kinase FLT3,COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1
Tandutinib,Platelet-derived growth factor D,COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1
Tanespimycin,Heat shock protein HSP 90-alpha,[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)C(C)=C([H])[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(NCC=C)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC
Tanespimycin,Heat shock protein HSP 90-beta,[H]/C1=C([H])/[C@]([H])(OC)[C@@]([H])(OC(O)=N)C(C)=C([H])[C@]([H])(C)[C@@]([H])(O)[C@]([H])(C[C@]([H])(C)CC2=C(NCC=C)C(=O)C=C(N=C(O)\C(C)=C\1/[H])C2=O)OC
Tapentadol,Mu-type opioid receptor,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
Tapentadol,Sodium-dependent noradrenaline transporter,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
Tapentadol,Kappa-type opioid receptor,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
Tapentadol,Delta-type opioid receptor,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
Tapentadol,5-hydroxytryptamine receptor 3A,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
Tapentadol,Sodium-dependent serotonin transporter,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
Tapinarof,Interleukin-6,CC(C)C1=C(O)C=C(\C=C\C2=CC=CC=C2)C=C1O
Tapinarof,Interleukin-8,CC(C)C1=C(O)C=C(\C=C\C2=CC=CC=C2)C=C1O
Tapinarof,Interleukin-12 subunit beta,CC(C)C1=C(O)C=C(\C=C\C2=CC=CC=C2)C=C1O
Tapinarof,Interleukin-2,CC(C)C1=C(O)C=C(\C=C\C2=CC=CC=C2)C=C1O
Tarenflurbil,NF-kappa-B essential modulator,C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
Taribavirin,Cytosolic purine 5'-nucleotidase,NC(=N)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Taribavirin,RNA-directed RNA polymerase catalytic subunit,NC(=N)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Taribavirin,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,NC(=N)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Taribavirin,RNA-directed RNA polymerase L,NC(=N)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Taribavirin,Inosine-5'-monophosphate dehydrogenase 1,NC(=N)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Tariquidar,Multidrug resistance protein 1,COC1=CC2=C(CN(CCC3=CC=C(NC(=O)C4=CC(OC)=C(OC)C=C4NC(=O)C4=CN=C5C=CC=CC5=C4)C=C3)CC2)C=C1OC
Tartronate,"NAD-dependent malic enzyme, mitochondrial",OC(C([O-])=O)C([O-])=O
Tartronate,"NADP-dependent malic enzyme, mitochondrial",OC(C([O-])=O)C([O-])=O
Tasimelteon,Melatonin receptor type 1A,[H][C@@]1(CN=C(O)CC)C[C@@]1([H])C1=C2CCOC2=CC=C1
Tasimelteon,Melatonin receptor type 1B,[H][C@@]1(CN=C(O)CC)C[C@@]1([H])C1=C2CCOC2=CC=C1
Tasonermin,Tumor necrosis factor receptor superfamily member 1A,
Tasonermin,Tumor necrosis factor receptor superfamily member 1B,
Tasosartan,Type-1 angiotensin II receptor,CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C2=N1
Tasosartan,Type-2 angiotensin II receptor,CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C2=N1
Taurine,Alpha-ketoglutarate-dependent taurine dioxygenase,NCCS(O)(=O)=O
Taurine,Choloylglycine hydrolase,NCCS(O)(=O)=O
Taurine,Glycine receptor subunit alpha-1,NCCS(O)(=O)=O
Taurine,"Glutamate receptor ionotropic, NMDA 2B",NCCS(O)(=O)=O
Taurine,Glycine receptor subunit alpha-2,NCCS(O)(=O)=O
Taurine,Glycine receptor subunit alpha-3,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit alpha-1,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit alpha-2,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit alpha-3,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit alpha-4,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit alpha-5,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit alpha-6,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit beta-1,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit beta-2,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit beta-3,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit delta,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit epsilon,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit gamma-1,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit gamma-2,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit gamma-3,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit pi,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid receptor subunit theta,NCCS(O)(=O)=O
Taurine,Gamma-aminobutyric acid type B receptor subunit 1,NCCS(O)(=O)=O
Taurocholic Acid,Gastrotropin,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O
Taurocholic Acid,Bile salt-activated lipase,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O
Taurocholic Acid,Bile acid receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O
Tavaborole,Cytosolic leucyl-tRNA synthetase,OB1OCC2=CC(F)=CC=C12
Tazarotene,Retinoic acid receptor RXR-beta,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1
Tazarotene,Retinoic acid receptor gamma,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1
Tazarotene,Retinoic acid receptor beta,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1
Tazarotene,Retinoic acid receptor alpha,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1
Tazemetostat,Histone-lysine N-methyltransferase EZH2,CCN(C1CCOCC1)C1=CC(=CC(C(=O)NCC2=C(C)C=C(C)NC2=O)=C1C)C1=CC=C(CN2CCOCC2)C=C1
Tazobactam,Beta-lactamase TEM,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O
Tazobactam,Beta-lactamase SHV-1,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)[C@](C)(CN1C=CN=N1)S2(=O)=O
Tecadenoson,Adenosine receptor A1,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N[C@@H]3CCOC3)N=CN=C12
Tecastemizole,Potassium voltage-gated channel subfamily H member 2,FC1=CC=C(CN2C(NC3=CC=CC=C23)=NC2CCNCC2)C=C1
Technetium Tc-99m arcitumomab,Carcinoembryonic antigen-related cell adhesion molecule 1,
Technetium Tc-99m ciprofloxacin,DNA gyrase subunit B,
Technetium Tc-99m ciprofloxacin,DNA topoisomerase 2-beta,
Technetium Tc-99m nofetumomab merpentan,Epithelial cell adhesion molecule,
Technetium Tc-99m nofetumomab merpentan,B-lymphocyte antigen CD20,
Technetium Tc-99m tilmanocept,Macrophage mannose receptor 1,
Tecovirimat,Envelope protein F13,FC(F)(F)C1=CC=C(C=C1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O
Teduglutide,Glucagon-like peptide 2 receptor,
Tegafur,Thymidylate synthase,FC1=CN(C2CCCO2)C(=O)NC1=O
Tegafur-uracil,Dihydropyrimidine dehydrogenase [NADP(+)],O=C1NC=CC(=O)N1.FC1=CN(C2CCCO2)C(=O)NC1=O
Tegafur-uracil,Thymidylate synthase,O=C1NC=CC(=O)N1.FC1=CN(C2CCCO2)C(=O)NC1=O
Tegaserod,5-hydroxytryptamine receptor 4,CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
Tegaserod,5-hydroxytryptamine receptor 2B,CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
Tegaserod,5-hydroxytryptamine receptor 2C,CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
Tegaserod,5-hydroxytryptamine receptor 2A,CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
Telaprevir,Genome polyprotein,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1
Telaprevir,Solute carrier organic anion transporter family member 1B1,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1
Telaprevir,Solute carrier organic anion transporter family member 2B1,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1
Telapristone acetate,Progesterone receptor,[H][C@@]12CC[C@](OC(C)=O)(C(=O)COC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
Telbivudine,Protein P,CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O
Telcagepant,Calcitonin gene-related peptide 1,[H][C@]1(CC[C@@]([H])(N=C(O)N2CCC(CC2)N2C(O)=NC3=C2C=CC=N3)C(=O)N(CC(F)(F)F)C1)C1=C(F)C(F)=CC=C1
Telcagepant,Calcitonin gene-related peptide 2,[H][C@]1(CC[C@@]([H])(N=C(O)N2CCC(CC2)N2C(O)=NC3=C2C=CC=N3)C(=O)N(CC(F)(F)F)C1)C1=C(F)C(F)=CC=C1
Telcagepant,Calcitonin gene-related peptide type 1 receptor,[H][C@]1(CC[C@@]([H])(N=C(O)N2CCC(CC2)N2C(O)=NC3=C2C=CC=N3)C(=O)N(CC(F)(F)F)C1)C1=C(F)C(F)=CC=C1
Telmisartan,Type-1 angiotensin II receptor,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O
Telmisartan,Peroxisome proliferator-activated receptor gamma,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O
Telotristat ethyl,Tryptophan 5-hydroxylase 2,CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=CC=C(Cl)C=C2N2C=CC(C)=N2)C(F)(F)F)=C1
Telotristat ethyl,Tryptophan 5-hydroxylase 1,CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=CC=C(Cl)C=C2N2C=CC(C)=N2)C(F)(F)F)=C1
Temafloxacin,DNA gyrase subunit A,CC1CN(CCN1)C1=C(F)C=C2C(=O)C(=CN(C2=C1)C1=C(F)C=C(F)C=C1)C(O)=O
Temafloxacin,DNA topoisomerase 4 subunit A,CC1CN(CCN1)C1=C(F)C=C2C(=O)C(=CN(C2=C1)C1=C(F)C=C(F)C=C1)C(O)=O
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-4,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-6,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit beta-1,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit beta-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit beta-3,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit gamma-1,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit gamma-3,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit delta,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit epsilon,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit pi,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit rho-1,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit rho-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit rho-3,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit theta,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Translocator protein,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-1,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-3,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-4,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-5,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit alpha-6,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit beta-1,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit beta-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit beta-3,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit delta,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit epsilon,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit gamma-1,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit gamma-2,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit gamma-3,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit pi,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temazepam,Gamma-aminobutyric acid receptor subunit theta,CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1
Temocapril,Angiotensin-converting enzyme,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)C1=CC=CS1
Temsirolimus,Serine/threonine-protein kinase mTOR,OCC(C)(CO)C(=O)O[C@@H]1CC[C@@H](C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC
Tenecteplase,Plasminogen,
Tenecteplase,Fibrinogen alpha chain,
Tenecteplase,Urokinase plasminogen activator surface receptor,
Tenecteplase,Plasminogen activator inhibitor 1,
Tenecteplase,Plasminogen activator inhibitor 2,
Tenecteplase,Tetranectin,
Tenecteplase,"Keratin, type II cytoskeletal 8",
Tenecteplase,Annexin A2,
Tenecteplase,Calreticulin,
Tenecteplase,Calnexin,
Tenecteplase,Prolow-density lipoprotein receptor-related protein 1,
Teniposide,DNA topoisomerase 2-alpha,[H][C@]12COC(=O)[C@]1([H])[C@]([H])(C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@]2([H])O[C@]1([H])O[C@]2([H])CO[C@]([H])(O[C@@]2([H])[C@]([H])(O)[C@@]1([H])O)C1=CC=CS1
Tenocyclidine,"Glutamate receptor ionotropic, NMDA 2D",C1CCN(CC1)C1(CCCCC1)C1=CC=CS1
Tenocyclidine,"Glutamate receptor ionotropic, NMDA 2B",C1CCN(CC1)C1(CCCCC1)C1=CC=CS1
Tenocyclidine,"Glutamate receptor ionotropic, NMDA 2C",C1CCN(CC1)C1(CCCCC1)C1=CC=CS1
Tenocyclidine,"Glutamate receptor ionotropic, NMDA 3B",C1CCN(CC1)C1(CCCCC1)C1=CC=CS1
Tenocyclidine,"Glutamate receptor ionotropic, NMDA 3A",C1CCN(CC1)C1(CCCCC1)C1=CC=CS1
Tenocyclidine,"Glutamate receptor ionotropic, NMDA 2A",C1CCN(CC1)C1(CCCCC1)C1=CC=CS1
Tenocyclidine,Alpha-7 nicotinic cholinergic receptor subunit,C1CCN(CC1)C1(CCCCC1)C1=CC=CS1
Tenofovir,Reverse transcriptase/RNaseH,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O
Tenofovir alafenamide,Reverse transcriptase/RNaseH,CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)OC1=CC=CC=C1
Tenofovir disoproxil,Reverse transcriptase/RNaseH,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C
Tenofovir disoproxil,Protein P,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C
Tenoxicam,Prostaglandin G/H synthase 2,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O
Tenoxicam,Prostaglandin G/H synthase 1,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O
Teprotumumab,Insulin-like growth factor 1 receptor,
Terazosin,Alpha-1A adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Terazosin,Alpha-1B adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Terazosin,Alpha-1D adrenergic receptor,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Terazosin,Potassium voltage-gated channel subfamily H member 2,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Terazosin,Potassium voltage-gated channel subfamily H member 6,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Terazosin,Potassium voltage-gated channel subfamily H member 7,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Terazosin,Transforming growth factor beta-1,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1
Terbinafine,Squalene monooxygenase,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12
Terbutaline,Beta-2 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1
Terbutaline,Beta-3 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1
Terbutaline,Beta-1 adrenergic receptor,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1
Terconazole,Lanosterol 14-alpha demethylase,CC(C)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1
Terfenadine,Potassium voltage-gated channel subfamily H member 2,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Terfenadine,Histamine H1 receptor,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Terfenadine,Muscarinic acetylcholine receptor M3,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Terfenadine,Muscarinic acetylcholine receptor M1,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Terfenadine,Muscarinic acetylcholine receptor M5,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Terfenadine,Muscarinic acetylcholine receptor M4,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Terfenadine,Muscarinic acetylcholine receptor M2,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
Teriflunomide,"Dihydroorotate dehydrogenase (quinone), mitochondrial",C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F
Teriparatide,Parathyroid hormone/parathyroid hormone-related peptide receptor,
Terlipressin,Vasopressin V1a receptor,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
Terlipressin,Vasopressin V2 receptor,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
Terlipressin,Vasopressin V1b receptor,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate,Cathepsin K,[H][C@@](NC(=O)OC(C)(C)C)(C=O)C1CCCCC1
Tert-Butyloxycarbonyl Group,Gag-Pol polyprotein,CC(C)(C)OC=O
Tertomotide,Telomerase reverse transcriptase,
Tesaglitazar,Peroxisome proliferator-activated receptor alpha,CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O
Tesaglitazar,Peroxisome proliferator-activated receptor gamma,CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O
Tesamorelin,Growth hormone-releasing hormone receptor,CC\C=C\CC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(N)=O
Tesevatinib,Receptor tyrosine-protein kinase erbB-2,COC1=C(OC[C@H]2C[C@H]3CN(C)C[C@H]3C2)C=C2N=CN=C(NC3=CC=C(Cl)C(Cl)=C3F)C2=C1
Tesevatinib,Pro-epidermal growth factor,COC1=C(OC[C@H]2C[C@H]3CN(C)C[C@H]3C2)C=C2N=CN=C(NC3=CC=C(Cl)C(Cl)=C3F)C2=C1
Tesevatinib,Ephrin type-B receptor 4,COC1=C(OC[C@H]2C[C@H]3CN(C)C[C@H]3C2)C=C2N=CN=C(NC3=CC=C(Cl)C(Cl)=C3F)C2=C1
Tesmilifene,Histamine H1 receptor,CCN(CC)CCOC1=CC=C(CC2=CC=CC=C2)C=C1
Tesmilifene,Multidrug resistance protein 1,CCN(CC)CCOC1=CC=C(CC2=CC=CC=C2)C=C1
Tesofensine,Sodium-dependent noradrenaline transporter,CCOC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C
Tesofensine,Sodium-dependent dopamine transporter,CCOC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C
Tesofensine,Sodium-dependent serotonin transporter,CCOC[C@H]1[C@H]2CC[C@@H](C[C@@H]1C1=CC(Cl)=C(Cl)C=C1)N2C
Testolactone,Aromatase,[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H]
Testosterone,Androgen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Testosterone,Estrogen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Testosterone,Mineralocorticoid receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Testosterone cypionate,Androgen receptor,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1
Testosterone cypionate,Estrogen receptor,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1
Testosterone cypionate,Mineralocorticoid receptor,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1
Testosterone enanthate,Androgen receptor,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Testosterone enanthate,Estrogen receptor,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Testosterone enanthate,Mineralocorticoid receptor,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Testosterone propionate,Androgen receptor,[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Testosterone succinate,Neocarzinostatin,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCC(O)=O
Testosterone undecanoate,Androgen receptor,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
Testosterone undecanoate,Estrogen receptor,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
Testosterone undecanoate,Mineralocorticoid receptor,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
Tetanus Immune Globulin,Tetanus toxin,
Tetomilast,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CCOC1=C(OCC)C=C(C=C1)C1=NC(=CS1)C1=NC(=CC=C1)C(O)=O
Tetra(Imidazole)Diaquacopper (I),Azurin,[OH2+][Cu-4]([OH2+])([N]1=CNC=C1)([N+]1=CNC=C1)([N+]1=CNC=C1)[N+]1=CNC=C1
Tetra(Imidazole)Diaquacopper (Ii),Azurin,O.O.[Cu+4].[N-]1C=CN=C1.[N-]1C=CN=C1.[N-]1C=CN=C1.[N-]1C=CN=C1
Tetrabenazine,Synaptic vesicular amine transporter,COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1
Tetrabenazine,D(2) dopamine receptor,COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1
Tetrabromo-2-Benzotriazole,Casein kinase II subunit alpha,[H]N1N=C2C(=N1)C(Br)=C(Br)C(Br)=C2Br
Tetrabutylammonium Ion,pH-gated potassium channel KcsA,CCCC[N+](CCCC)(CCCC)CCCC
Tetrabutylammonium Ion,Ig kappa chain C region,CCCC[N+](CCCC)(CCCC)CCCC
Tetracaine,Ryanodine receptor 1,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
Tetracaine,Ryanodine receptor 2,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
Tetrachlorodecaoxide,Macrophage erythroblast attacher,O.O=O.[O-][Cl]=O.[O-][Cl]=O.[O-][Cl]=O.[O-][Cl]=O
Tetrachlorodecaoxide,Scavenger receptor cysteine-rich type 1 protein M130,O.O=O.[O-][Cl]=O.[O-][Cl]=O.[O-][Cl]=O.[O-][Cl]=O
Tetracosactide,Adrenocorticotropic hormone receptor,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O
Tetracycline,30S ribosomal protein S7,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O
Tetracycline,30S ribosomal protein S14,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O
Tetracycline,30S ribosomal protein S3,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O
Tetracycline,30S ribosomal protein S8,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O
Tetracycline,30S ribosomal protein S19,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O
Tetracycline,Major prion protein,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O
Tetracycline,Multidrug translocase MdfA,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O
Tetracycline,Protein-arginine deiminase type-4,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O
Tetradecyl hydrogen sulfate (ester),Endothelial protein C receptor,CCCCC(CC)CCC(CC(C)C)OS(O)(=O)=O
Tetraethylammonium,pH-gated potassium channel KcsA,CC[N+](CC)(CC)CC
Tetraethylammonium,Neuronal acetylcholine receptor subunit alpha-9,CC[N+](CC)(CC)CC
Tetraethylammonium,Calcium-activated potassium channel subunit alpha-1,CC[N+](CC)(CC)CC
Tetraethylammonium,Potassium voltage-gated channel subfamily A member 1,CC[N+](CC)(CC)CC
Tetraferric tricitrate decahydrate,Iron(3+)-hydroxamate-binding protein FhuD,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O
Tetraferric tricitrate decahydrate,Transferrin receptor protein 1,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O
Tetrafluoroaluminate Ion,UMP-CMP kinase,F[Al](F)(F)[F-]
Tetrafluoroaluminate Ion,Protein RecA,F[Al](F)(F)[F-]
Tetrafluoroaluminate Ion,Acetylglutamate kinase,F[Al](F)(F)[F-]
Tetrafluoroaluminate Ion,Ribokinase,F[Al](F)(F)[F-]
Tetrafluoroaluminate Ion,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,F[Al](F)(F)[F-]
Tetrafluoroaluminate Ion,Myosin-14,F[Al](F)(F)[F-]
Tetrafluoroaluminate Ion,Guanine nucleotide-binding protein G(t) subunit alpha-1,F[Al](F)(F)[F-]
Tetrafluoroaluminate Ion,Myosin-11,F[Al](F)(F)[F-]
Tetrafluoroaluminate Ion,Guanine nucleotide-binding protein G(i) subunit alpha-1,F[Al](F)(F)[F-]
Tetrahydrocannabivarin,Cannabinoid receptor 1,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1
Tetrahydrocannabivarin,Cannabinoid receptor 2,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1
Tetrahydrocannabivarin,G-protein coupled receptor 55,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1
Tetrahydrocannabivarin,5-hydroxytryptamine receptor 1A,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1
Tetrahydrocannabivarin,Transient receptor potential cation channel subfamily V member 2,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1
Tetrahydrocannabivarin,Transient receptor potential cation channel subfamily M member 8,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1
Tetrahydrocannabivarin,Transient receptor potential cation channel subfamily A member 1,CCCC1=CC(O)=C2[C@@H]3C=C(C)CC[C@H]3C(C)(C)OC2=C1
Tetrahydrodeoxyuridine,Cytidine deaminase,[H]N1C(=O)CCN(C2C[C@H](O)[C@@H](CO)O2)C1=O
Tetrahydrofolic acid,"Aminomethyltransferase, mitochondrial",NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,"Serine hydroxymethyltransferase, mitochondrial",NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,"Serine hydroxymethyltransferase, cytosolic",NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,"C-1-tetrahydrofolate synthase, cytoplasmic",NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,Methionine synthase,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,Formimidoyltransferase-cyclodeaminase,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,Cytosolic 10-formyltetrahydrofolate dehydrogenase,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,Bifunctional purine biosynthesis protein PURH,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,Serine hydroxymethyltransferase,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,Methylenetetrahydrofolate reductase,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofolic acid,"Methionyl-tRNA formyltransferase, mitochondrial",NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Tetrahydrofuran-2-Carboxylic Acid,Bifunctional protein PutA,OC(=O)[C@H]1CCCO1
Tetrahydrofuran-2-Carboxylic Acid,Quinohemoprotein ethanol dehydrogenase type-1,OC(=O)[C@H]1CCCO1
Tetrahydrooxazine,Endoglucanase 5A,OC[C@H]1ONC[C@@H](O)[C@@H]1O
Tetrahydrooxazine,Beta-glucosidase A,OC[C@H]1ONC[C@@H](O)[C@@H]1O
Tetrahydropalmatine,D(1A) dopamine receptor,COC1=CC=C2C[C@@H]3N(CCC4=CC(OC)=C(OC)C=C34)CC2=C1OC
Tetrahydropalmatine,D(2) dopamine receptor,COC1=CC=C2C[C@@H]3N(CCC4=CC(OC)=C(OC)C=C34)CC2=C1OC
Tetramethylammonium Ion,UDP-glucose 4-epimerase,C[N+](C)(C)C
Tetrandrine,Multidrug resistance protein 1,COC1=CC=C2C[C@@H]3N(C)CCC4=C3C(OC3=CC5=C(CCN(C)[C@H]5CC5=CC=C(OC1=C2)C=C5)C=C3OC)=C(OC)C(OC)=C4
Tetrastearoyl cardiolipin,ADP/ATP translocase 1,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)COP(O)(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC
Tetrathiomolybdate,Amyloid beta A4 protein,[S-][Mo]([S-])(=S)=S
Tetrazolyl Histidine,Myoglobin,[H][C@](N)(CC1=CN(C=N1)C1=NNN=N1)C=O
Tetrodotoxin,Sodium channel protein type 1 subunit alpha,[H][C@]12OC3([O-])OC(C4C(O)[NH+]=C(N)NC4(C1O)[C@@H]3O)C2(O)CO
Tetrodotoxin,Sodium channel protein type 2 subunit alpha,[H][C@]12OC3([O-])OC(C4C(O)[NH+]=C(N)NC4(C1O)[C@@H]3O)C2(O)CO
Tetrodotoxin,Sodium channel protein type 3 subunit alpha,[H][C@]12OC3([O-])OC(C4C(O)[NH+]=C(N)NC4(C1O)[C@@H]3O)C2(O)CO
Tetrodotoxin,Sodium channel protein type 8 subunit alpha,[H][C@]12OC3([O-])OC(C4C(O)[NH+]=C(N)NC4(C1O)[C@@H]3O)C2(O)CO
Tetryzoline,Alpha-1A adrenergic receptor,C1CN=C(N1)C1CCCC2=CC=CC=C12
Teverelix,Gonadotropin-releasing hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](CCCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
Tezacaftor,Cystic fibrosis transmembrane conductance regulator,CC(C)(CO)C1=CC2=CC(NC(=O)C3(CC3)C3=CC=C4OC(F)(F)OC4=C3)=C(F)C=C2N1C[C@@H](O)CO
Tezacitabine,Ribonucleoside-diphosphate reductase large subunit,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)\C1=C/F
Tezampanel,Gamma-aminobutyric acid type B receptor subunit 1,[H][C@]1(CCC2=NN=NN2)CC[C@@]2([H])CN[C@@]([H])(C[C@@]2([H])C1)C(O)=O
Tezampanel,"Glutamate receptor ionotropic, kainate 1",[H][C@]1(CCC2=NN=NN2)CC[C@@]2([H])CN[C@@]([H])(C[C@@]2([H])C1)C(O)=O
Tezosentan,Endothelin B receptor,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=NC=C(C=C2)C(C)C)N=C(N=C1OCCO)C1=CC(=NC=C1)C1=NNN=N1
Tezosentan,Endothelin-1 receptor,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=NC=C(C=C2)C(C)C)N=C(N=C1OCCO)C1=CC(=NC=C1)C1=NNN=N1
Thalidomide,Protein cereblon,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
Thalidomide,Tumor necrosis factor,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
Thalidomide,Nuclear factor NF-kappa-B p105 subunit,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
Thalidomide,Fibroblast growth factor receptor 2,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
Thalidomide,Prostaglandin G/H synthase 2,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
Thalidomide,Alpha-1-acid glycoprotein 1,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
Thalidomide,Alpha-1-acid glycoprotein 2,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
Thenoyltrifluoroacetone,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",FC(F)(F)C(=O)CC(=O)C1=CC=CS1
Thenoyltrifluoroacetone,Liver carboxylesterase 1,FC(F)(F)C(=O)CC(=O)C1=CC=CS1
Theobromine,Adenosine receptor A1,CN1C=NC2=C1C(=O)NC(=O)N2C
Theobromine,Adenosine receptor A2a,CN1C=NC2=C1C(=O)NC(=O)N2C
Theobromine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CN1C=NC2=C1C(=O)NC(=O)N2C
Theophylline,Adenosine receptor A1,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Adenosine receptor A2a,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Adenosine receptor A2b,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,"cGMP-specific 3',5'-cyclic phosphodiesterase",CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Histone deacetylase 2,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Copine-1,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Minor histocompatibility antigen H13,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Nodal modulator 1,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Poly [ADP-ribose] polymerase 1,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Protein RIC-3,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Theophylline,Tubulin monoglycylase TTLL3,CN1C2=C(NC=N2)C(=O)N(C)C1=O
Thiabendazole,Fumarate reductase flavoprotein subunit,N1C2=CC=CC=C2N=C1C1=CSC=N1
Thiamine,Thiamin pyrophosphokinase 1,CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N
Thiamine,Thiamine transporter 1,CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N
Thiamine(1+) monophosphate,Thiamine-phosphate synthase,CC1=C(CCO[P@](O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N
Thiamphenicol,Dr hemagglutinin structural subunit,[H][C@](CO)(NC(=O)C(Cl)Cl)[C@]([H])(O)C1=CC=C(C=C1)S(C)(=O)=O
Thiamylal,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O
Thiamylal,ATP-sensitive inward rectifier potassium channel 8,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O
Thiamylal,ATP-sensitive inward rectifier potassium channel 11,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O
Thiarsa Dihydroxy Cysteine,Arsenate reductase,[H][C@](N)(CS[As](O)O)C(O)=O
Thiarsahydroxy-Cysteine,Arsenate reductase,N[C@@H](CS[AsH]O)C(O)=O
"Thieno[2,3-B]Pyridine-2-Carboxamidine",Trypsin-1,NC(=[NH2+])C1=CC2=C(S1)N=CC=C2
"Thieno[2,3-B]Pyridine-2-Carboxamidine",Urokinase-type plasminogen activator,NC(=[NH2+])C1=CC2=C(S1)N=CC=C2
Thiethylperazine,D(2) dopamine receptor,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thiethylperazine,D(1A) dopamine receptor,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thiethylperazine,D(4) dopamine receptor,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thimerosal,Methionine synthase,CC[Hg]SC1=CC=CC=C1C(=O)O[Na]
Thimerosal,Cystine/glutamate transporter,CC[Hg]SC1=CC=CC=C1C(=O)O[Na]
Thimerosal,Sodium/potassium-transporting ATPase subunit gamma,CC[Hg]SC1=CC=CC=C1C(=O)O[Na]
Thio-Maltohexaose,Cyclomaltodextrin glucanotransferase,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(S[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]4([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]5([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]6([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]6([H])O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
Thio-Maltopentaose,Cyclomaltodextrin glucanotransferase,[H][C@]1(S)O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]4([H])O[C@]([H])(CO)[C@@]([H])(S[C@@]5([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]5([H])O)[C@]([H])(O)[C@@]4([H])O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
Thiocamphor,Camphor 5-monooxygenase,[H][C@@]12CC[C@@](C)(C(=S)C1)C2(C)C
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit alpha-1,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit alpha-2,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit alpha-3,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit alpha-4,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit alpha-5,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit alpha-6,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit beta-1,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit beta-2,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit beta-3,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit delta,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit epsilon,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit gamma-1,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit gamma-2,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit gamma-3,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit pi,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Gamma-aminobutyric acid receptor subunit theta,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Glycine receptor subunit alpha-1,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocolchicoside,Tumor necrosis factor ligand superfamily member 11,COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C2CC[C@H](NC(C)=O)C3=CC(=O)C(SC)=CC=C3C2=C1OC
Thiocoumarin,"Nitric oxide synthase, inducible",CN(C)CCCOC1=CC(=O)SC2=CC=CC=C12
Thiodigalactoside,Heat-labile enterotoxin B chain,[H][C@]1(CO)O[C@@]([H])(S[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Thiodigalactoside,Lactose permease,[H][C@]1(CO)O[C@@]([H])(S[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Thiodigalactoside,Galectin-1,[H][C@]1(CO)O[C@@]([H])(S[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Thiodigalactoside,Neurocan core protein,[H][C@]1(CO)O[C@@]([H])(S[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]([H])(O)[C@@]1([H])O
Thionicotinamide-Adenine-Dinucleotide,Glyceraldehyde-3-phosphate dehydrogenase,[H][C@]1(COP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])([N+]3=CC=CC(=C3)C([S-])=N)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Thiopental,Gamma-aminobutyric acid receptor subunit alpha-1,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Gamma-aminobutyric acid receptor subunit alpha-2,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Gamma-aminobutyric acid receptor subunit alpha-3,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Gamma-aminobutyric acid receptor subunit alpha-4,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Gamma-aminobutyric acid receptor subunit alpha-5,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Gamma-aminobutyric acid receptor subunit alpha-6,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Neuronal acetylcholine receptor subunit alpha-4,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Neuronal acetylcholine receptor subunit alpha-7,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Glutamate receptor 2,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,"Glutamate receptor ionotropic, kainate 2",CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Fatty-acid amide hydrolase 1,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thiopental,Muscarinic acetylcholine receptor M3,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
Thioproperazine,D(2) dopamine receptor,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thioproperazine,D(1A) dopamine receptor,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thioproperazine,5-hydroxytryptamine receptor 2A,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thioproperazine,5-hydroxytryptamine receptor 1A,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thioproperazine,Alpha-1A adrenergic receptor,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thioproperazine,Alpha-1B adrenergic receptor,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1
Thioridazine,D(2) dopamine receptor,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1
Thioridazine,D(1A) dopamine receptor,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1
Thioridazine,Alpha-1A adrenergic receptor,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1
Thioridazine,Alpha-1B adrenergic receptor,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1
Thioridazine,5-hydroxytryptamine receptor 2A,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1
Thioridazine,Potassium voltage-gated channel subfamily H member 2,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1
Thiorphan,Neprilysin,[H][C@](CS)(CC1=CC=CC=C1)C(=O)NCC(O)=O
Thiothixene,D(2) dopamine receptor,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
Thiothixene,D(1A) dopamine receptor,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
Thiothixene,5-hydroxytryptamine receptor 2A,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1
Thonzonium,V-type proton ATPase subunit C 1,CCCCCCCCCCCCCCCC[N+](C)(C)CCN(CC1=CC=C(OC)C=C1)C1=NC=CC=N1
Thonzylamine,Histamine H1 receptor,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1
Thonzylamine,Muscarinic acetylcholine receptor M1,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1
Thonzylamine,Muscarinic acetylcholine receptor M2,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1
Thonzylamine,Muscarinic acetylcholine receptor M3,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1
Thonzylamine,Muscarinic acetylcholine receptor M4,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1
Thonzylamine,Muscarinic acetylcholine receptor M5,COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1
Threonine Derivative,Peptidyl-glycine alpha-amidating monooxygenase,[H][C@](C)(O)[C@@]([H])(N=C(O)[C@]([H])(CC1=CC(I)=C(O)C(I)=C1)N=C(C)O)C(O)=O
Threonine-Aspartic Ester,L-asparaginase 2,[H][C@](N)(C[C@]([H])(O)O[C@]([H])(C)[C@]([H])(N)C(O)=O)C(O)=O
Thrombin,Proteinase-activated receptor 1,
Thrombin,Proteinase-activated receptor 4,
Thrombin,Coagulation factor XI,
Thrombin,Coagulation factor XIII A chain,
Thrombin,Coagulation factor XIII B chain,
Thrombin,Fibrinogen alpha chain,
Thrombin,Fibrinogen beta chain,
Thrombin,Fibrinogen gamma chain,
Thrombin,Coagulation factor V,
Thrombin,Coagulation factor VIII,
Thrombin alfa,Coagulation factor XI,
Thrombin alfa,Coagulation factor VIII,
Thrombin alfa,Coagulation factor V,
Thrombin alfa,Coagulation factor XIII A chain,
Thrombin alfa,Coagulation factor XIII B chain,
Thrombin alfa,Fibrinogen alpha chain,
Thrombin alfa,Fibrinogen beta chain,
Thrombin alfa,Fibrinogen gamma chain,
Thrombomodulin Alfa,Prothrombin,
Thrombomodulin Alfa,Coagulation factor V,
Thrombopoietin,Thrombopoietin receptor,
Thymectacin,Thymidylate synthase,COC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(\C=C\Br)C(=O)NC1=O)OC1=CC=CC=C1
Thymidine,Thymidylate kinase,CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
Thymidine,Uridine phosphorylase,CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
Thymidine,Thymidine kinase,CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
Thymidine,Thymidine kinase,CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
Thymidine,Nucleoside-specific channel-forming protein tsx,CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
Thymidine,Glucose-1-phosphate thymidylyltransferase,CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
Thymidine,"Thymidine kinase 2, mitochondrial",CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
Thymidine monophosphate,Thymidylate synthase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
Thymidine monophosphate,Thymidylate kinase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
Thymidine monophosphate,Thymidylate kinase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
Thymidine monophosphate,Thymidine kinase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
Thymidine monophosphate,Thymidylate synthase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
Thymidine monophosphate,DNA topoisomerase 1,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
Thymidine monophosphate,PCZA361.16,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
Thymidine monophosphate,DNA polymerase III subunit epsilon,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
Thymidine monophosphate,Glucose-1-phosphate thymidylyltransferase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(O)=O)O2)C(=O)NC1=O
"Thymidine-3',5'-Diphosphate",DNA topoisomerase 1,[H][C@@]1(C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(=O)NC1=O)OP(O)(O)=O
"Thymidine-3',5'-Diphosphate",Thermonuclease,[H][C@@]1(C[C@@]([H])(O[C@]1([H])COP(O)(O)=O)N1C=C(C)C(=O)NC1=O)OP(O)(O)=O
Thymidine-5'- Diphosphate,Nucleoside diphosphate kinase A,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-(Dithio)Phosphate,Nuclease P1,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(S)=S)N1C=C(C)C(O)=NC1=O
Thymidine-5'-Diphospho-Beta-D-Xylose,"dTDP-glucose 4,6-dehydratase",[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)O[C@@]1([H])OC[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O)N1C=C(C)C(O)=NC1=O
Thymidine-5'-Diphospho-Beta-D-Xylose,"dTDP-4-dehydrorhamnose 3,5-epimerase",[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OP(O)(=O)O[C@@]1([H])OC[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O)N1C=C(C)C(O)=NC1=O
Thymidine-5'-Triphosphate,Thymidylate kinase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,"Thymidine kinase, cytosolic",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,Anaerobic ribonucleoside-triphosphate reductase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,Ribonucleoside-diphosphate reductase 2 subunit alpha,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,DNA primase/helicase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,Thymidine kinase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,Glucose-1-phosphate thymidylyltransferase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,Glucose-1-phosphate thymidylyltransferase 2,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,Glucose-1-phosphate thymidylyltransferase,CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymidine-5'-Triphosphate,"Thymidine kinase 2, mitochondrial",CC1=CN([C@H]2C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O
Thymine,Deoxyribodipyrimidine photo-lyase,CC1=CNC(=O)NC1=O
Thymine,Thymidine phosphorylase,CC1=CNC(=O)NC1=O
Thyrotropin alfa,Thyrotropin receptor,
Tiagabine,Sodium- and chloride-dependent GABA transporter 1,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1
Tianeptine,Glutamate receptor 1,CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O
Tianeptine,Mu-type opioid receptor,CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O
Tianeptine,5-hydroxytryptamine receptor 1A,CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O
Tianeptine,D(3) dopamine receptor,CN1C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=C(C=C(Cl)C=C2)S1(=O)=O
Tiapride,D(2) dopamine receptor,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,D(3) dopamine receptor,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 1A,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 1B,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 1D,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 1E,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 1F,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 2A,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 2B,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 2C,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 3A,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 3B,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 3C,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 3D,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 3E,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 4,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 6,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,5-hydroxytryptamine receptor 7,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,Alpha-1A adrenergic receptor,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,Alpha-1B adrenergic receptor,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,Alpha-1D adrenergic receptor,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,Alpha-2A adrenergic receptor,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,Alpha-2B adrenergic receptor,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiapride,Alpha-2C adrenergic receptor,CCN(CC)CCN=C(O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
Tiaprofenic acid,Prostaglandin G/H synthase 2,CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1
Tiaprofenic acid,Prostaglandin G/H synthase 1,CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1
Tibolone,Estrogen receptor,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC(=O)CC3)C[C@@]([H])(C)[C@@]21[H]
Ticagrelor,P2Y purinoceptor 12,CCCSC1=NC2=C(N=NN2[C@@H]2C[C@H](OCCO)[C@@H](O)[C@H]2O)C(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=N1
Ticalopride,5-hydroxytryptamine receptor 4,CO[C@H]1CNCC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC
Ticalopride,5-hydroxytryptamine receptor 3A,CO[C@H]1CNCC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC
Ticarcillin,Penicillin binding protein 2a,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](C(O)=O)C1=CSC=C1)C(O)=O
Ticlopidine,P2Y purinoceptor 12,ClC1=CC=CC=C1CN1CCC2=C(C1)C=CS2
Tideglusib,Glycogen synthase kinase-3 beta,O=C1SN(C(=O)N1CC1=CC=CC=C1)C1=C2C=CC=CC2=CC=C1
Tifuvirtide,Plasma serine protease inhibitor,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O
Tigapotide,40S ribosomal protein SA,
Tigecycline,30S ribosomal protein S9,[H][C@@]12CC3=C(C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Tigecycline,30S ribosomal protein S12,[H][C@@]12CC3=C(C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Tigecycline,30S ribosomal protein S13,[H][C@@]12CC3=C(C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Tigecycline,30S ribosomal protein S14,[H][C@@]12CC3=C(C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Tigecycline,30S ribosomal protein S19,[H][C@@]12CC3=C(C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
Tildrakizumab,Interleukin-12 subunit beta,
Tildrakizumab,Interleukin-23 subunit alpha,
Tiludronic acid,V-type proton ATPase catalytic subunit A,OP(O)(=O)C(SC1=CC=C(Cl)C=C1)P(O)(O)=O
Tiludronic acid,Tyrosine-protein phosphatase non-receptor type 1,OP(O)(=O)C(SC1=CC=C(Cl)C=C1)P(O)(O)=O
Timolol,Beta-1 adrenergic receptor,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1
Timolol,Beta-2 adrenergic receptor,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1
Timolol,Endolysin,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1
Tinzaparin,Antithrombin-III,
Tinzaparin,Integrin alpha-4,
Tinzaparin,Stromal cell-derived factor 1,
Tioconazole,Lanosterol 14-alpha demethylase,ClC1=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=CS1
Tioconazole,Lanosterol 14-alpha demethylase,ClC1=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=CS1
Tiotropium,Muscarinic acetylcholine receptor M3,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
Tiotropium,Muscarinic acetylcholine receptor M1,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
Tiotropium,Muscarinic acetylcholine receptor M2,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
Tiotropium,Muscarinic acetylcholine receptor M4,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
Tiotropium,Muscarinic acetylcholine receptor M5,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
Tipifarnib,Protein farnesyltransferase subunit beta,CN1C=NC=C1[C@@](N)(C1=CC=C(Cl)C=C1)C1=CC2=C(C=C1)N(C)C(=O)C=C2C1=CC(Cl)=CC=C1
Tipiracil,Thymidine phosphorylase,ClC1=C(CN2CCCC2=N)NC(=O)NC1=O
Tipranavir,Pol polyprotein,[H][C@@](CC)(C1=CC(NS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)=CC=C1)C1=C(O)C[C@@](CCC)(CCC2=CC=CC=C2)OC1=O
Tiratricol,Thyroid hormone receptor beta,OC(=O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1
Tirofiban,Integrin alpha-IIb,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O
Tirofiban,Integrin beta-3,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O
Tisagenlecleucel,B-lymphocyte antigen CD19,
Titanium dioxide,Macrophage receptor MARCO,O=[Ti]=O
Tivantinib,Hepatocyte growth factor receptor,O=C1NC(=O)[C@H]([C@@H]1C1=CNC2=CC=CC=C12)C1=CN2CCCC3=C2C1=CC=C3
Tixocortol,Glucocorticoid receptor,[H][C@@]12CC[C@](O)(C(=O)CS)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Tixocortol,Histone deacetylase 2,[H][C@@]12CC[C@](O)(C(=O)CS)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Tizanidine,Alpha-2A adrenergic receptor,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
Tizanidine,Alpha-2B adrenergic receptor,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
Tizanidine,Alpha-2C adrenergic receptor,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
Tizanidine,Nischarin,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
Tizanidine,Alpha-1A adrenergic receptor,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
Tizanidine,Alpha-1B adrenergic receptor,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
Tizanidine,Alpha-1D adrenergic receptor,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1
Tl-3-093,Pol polyprotein,[H][C@@](CO)(CC1=CC=CC=C1)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(C)NC(=O)OCC1=CC=CC=C1)C(C)C
Tl-3-093,Gag-Pol polyprotein,[H][C@@](CO)(CC1=CC=CC=C1)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(C)NC(=O)OCC1=CC=CC=C1)C(C)C
Tmr,"Actin, alpha skeletal muscle",CN(C)C1=CCC2=C(C3=CC=C(C=C3OC2=C1)N(C)C)C1=CC=C(C=C1C(O)=O)N1C(=O)C=CC1=O
Tobramycin,30S ribosomal protein S12,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
Tocainide,Sodium channel protein type 5 subunit alpha,CC(N)C(=O)NC1=C(C)C=CC=C1C
Tocilizumab,Interleukin-6 receptor subunit alpha,
Tocofersolan,Multidrug resistance protein 1,
Tofacitinib,Tyrosine-protein kinase JAK1,[H][C@@]1(C)CCN(C[C@]1([H])N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N
Tofacitinib,Tyrosine-protein kinase JAK2,[H][C@@]1(C)CCN(C[C@]1([H])N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N
Tofacitinib,Tyrosine-protein kinase JAK3,[H][C@@]1(C)CCN(C[C@]1([H])N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N
Tofacitinib,Non-receptor tyrosine-protein kinase TYK2,[H][C@@]1(C)CCN(C[C@]1([H])N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N
Tofisopam,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1
Tofisopam,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1
Tofisopam,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1
Tofisopam,"cGMP-dependent 3',5'-cyclic phosphodiesterase",CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1
Tolazamide,ATP-binding cassette sub-family C member 8,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1
Tolazamide,ATP-sensitive inward rectifier potassium channel 11,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1
Tolazoline,Alpha-1A adrenergic receptor,C(C1=NCCN1)C1=CC=CC=C1
Tolazoline,Alpha-2A adrenergic receptor,C(C1=NCCN1)C1=CC=CC=C1
Tolazoline,Histamine H1 receptor,C(C1=NCCN1)C1=CC=CC=C1
Tolazoline,Histamine H2 receptor,C(C1=NCCN1)C1=CC=CC=C1
Tolazoline,Alpha-2C adrenergic receptor,C(C1=NCCN1)C1=CC=CC=C1
Tolazoline,Alpha-2B adrenergic receptor,C(C1=NCCN1)C1=CC=CC=C1
Tolbutamide,ATP-binding cassette sub-family C member 8,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
Tolbutamide,ATP-sensitive inward rectifier potassium channel 1,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
Tolcapone,Catechol O-methyltransferase,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O
Tolfenamic Acid,Prostaglandin G/H synthase 1,CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O
Tolfenamic Acid,Prostaglandin G/H synthase 2,CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O
Tolmetin,Prostaglandin G/H synthase 2,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
Tolmetin,Prostaglandin G/H synthase 1,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1
Tolnaftate,Squalene monooxygenase,CN(C(=S)OC1=CC2=CC=CC=C2C=C1)C1=CC=CC(C)=C1
Toloxatone,Amine oxidase [flavin-containing] A,CC1=CC(=CC=C1)N1CC(CO)OC1=O
Tolrestat,Aldose reductase,COC1=C(C2=CC=CC(C(=S)N(C)CC(O)=O)=C2C=C1)C(F)(F)F
Tolrestat,Alcohol dehydrogenase [NADP(+)],COC1=C(C2=CC=CC(C(=S)N(C)CC(O)=O)=C2C=C1)C(F)(F)F
Tolrestat,Aldo-keto reductase family 1 member B10,COC1=C(C2=CC=CC(C(=S)N(C)CC(O)=O)=C2C=C1)C(F)(F)F
Tolterodine,Muscarinic acetylcholine receptor M3,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
Tolterodine,Muscarinic acetylcholine receptor M2,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
Tolterodine,Muscarinic acetylcholine receptor M5,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
Tolterodine,Muscarinic acetylcholine receptor M1,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
Tolterodine,Muscarinic acetylcholine receptor M4,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
Tolvaptan,Vasopressin V2 receptor,CC1=CC=CC=C1C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC[C@@H](O)C2=C1C=CC(Cl)=C2
Tolvaptan,Vasopressin V1a receptor,CC1=CC=CC=C1C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC[C@@H](O)C2=C1C=CC(Cl)=C2
Tonapofylline,Adenosine receptor A1,CCCN1C2=C(NC(=N2)C23CCC(CCC(O)=O)(CC2)CC3)C(=O)N(CCC)C1=O
Topiramate,Gamma-aminobutyric acid receptor subunit alpha-1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Sodium channel protein type 1 subunit alpha,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,"Glutamate receptor ionotropic, kainate 1",[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Carbonic anhydrase 2,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Carbonic anhydrase 4,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit alpha-1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit alpha-2,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit alpha-3,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit alpha-4,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit alpha-5,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit alpha-6,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit beta-1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit beta-2,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit beta-3,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit delta,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit epsilon,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit gamma-1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit gamma-2,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit gamma-3,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit pi,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Gamma-aminobutyric acid receptor subunit theta,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Carbonic anhydrase 1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Carbonic anhydrase 3,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiramate,Glutamate receptor 1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
Topiroxostat,Xanthine dehydrogenase/oxidase,N#CC1=NC=CC(=C1)C1=NNC(=N1)C1=CC=NC=C1
Topotecan,DNA topoisomerase 1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O
Topotecan,"DNA topoisomerase I, mitochondrial",CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O
Torasemide,Solute carrier family 12 member 1,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1
Torasemide,Solute carrier family 12 member 2,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1
Torcetrapib,Cholesteryl ester transfer protein,CCOC(=O)N1[C@H](CC)C[C@H](N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C2=C1C=CC(=C2)C(F)(F)F
Toremifene,Estrogen receptor,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
Toremifene,Sex hormone-binding globulin,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
Tosedostat,Leukotriene A-4 hydrolase,CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C1=CC=CC=C1
Tosedostat,Puromycin-sensitive aminopeptidase,CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)C1=CC=CC=C1
Tositumomab,B-lymphocyte antigen CD20,
Tositumomab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Tositumomab,Complement C1r subcomponent,
Tositumomab,Complement C1q subcomponent subunit A,
Tositumomab,Complement C1q subcomponent subunit B,
Tositumomab,Complement C1q subcomponent subunit C,
Tositumomab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Tositumomab,High affinity immunoglobulin gamma Fc receptor I,
Tositumomab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Tositumomab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Tositumomab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Tosyl-D-Proline,Thymidylate synthase,[H][C@@]1(CCCN1S(=O)(=O)C1=CC=C(C)C=C1)C(O)=O
Tramadol,Mu-type opioid receptor,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,Sodium-dependent noradrenaline transporter,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,Sodium-dependent serotonin transporter,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,5-hydroxytryptamine receptor 2C,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,Kappa-type opioid receptor,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,Delta-type opioid receptor,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,"Glutamate receptor ionotropic, NMDA 3A",COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,Alpha-7 nicotinic cholinergic receptor subunit,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,Muscarinic acetylcholine receptor M3,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Tramadol,Muscarinic acetylcholine receptor M1,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C
Trametinib,Dual specificity mitogen-activated protein kinase kinase 1,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1
Trametinib,Dual specificity mitogen-activated protein kinase kinase 2,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1
Trandolapril,Angiotensin-converting enzyme,[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O
Tranexamic acid,Plasminogen,NC[C@H]1CC[C@@H](CC1)C(O)=O
Tranilast,Hematopoietic prostaglandin D synthase,COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC
Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,Urokinase-type plasminogen activator,[H][C@]1(C[C@@]1([H])C1=CC2=CC=C(C=C2C=C1)C(N)=N)C1=CC=CC=C1
Trans-O-Hydroxy-Alpha-Methyl Cinnamate,Chymotrypsinogen B,[H][C@@](C)(CC1=CC=CC=C1O)C(O)=O
Tranylcypromine,Amine oxidase [flavin-containing] A,NC1CC1C1=CC=CC=C1
Tranylcypromine,Amine oxidase [flavin-containing] B,NC1CC1C1=CC=CC=C1
Trapidil,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cGMP-dependent 3',5'-cyclic phosphodiesterase",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"cGMP-specific 3',5'-cyclic phosphodiesterase",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trapidil,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta",CCN(CC)C1=CC(C)=NC2=NC=NN12
Trastuzumab,Receptor tyrosine-protein kinase erbB-2,
Trastuzumab,Epidermal growth factor receptor,
Trastuzumab,Complement C1r subcomponent,
Trastuzumab,Complement C1q subcomponent subunit A,
Trastuzumab,Complement C1q subcomponent subunit B,
Trastuzumab,Complement C1q subcomponent subunit C,
Trastuzumab,Complement C1s subcomponent,
Trastuzumab,High affinity immunoglobulin gamma Fc receptor I,
Trastuzumab,Low affinity immunoglobulin gamma Fc region receptor II-a,
Trastuzumab,Low affinity immunoglobulin gamma Fc region receptor II-b,
Trastuzumab,Low affinity immunoglobulin gamma Fc region receptor II-c,
Trastuzumab,Low affinity immunoglobulin gamma Fc region receptor III-B,
Trastuzumab,Low affinity immunoglobulin gamma Fc region receptor III-A,
Trastuzumab emtansine,Receptor tyrosine-protein kinase erbB-2,
Travoprost,Prostaglandin F2-alpha receptor,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F
Trazodone,5-hydroxytryptamine receptor 2A,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
Trazodone,5-hydroxytryptamine receptor 2C,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
Trazodone,Sodium-dependent serotonin transporter,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
Trazodone,5-hydroxytryptamine receptor 1A,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
Trazodone,Histamine H1 receptor,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
Trazodone,Alpha-1A adrenergic receptor,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
Trazodone,Alpha-2A adrenergic receptor,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1
Trehalose-6-Phosphate,HTH-type transcriptional regulator TreR,OC[C@H]1O[C@H](O[C@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
"Trencam-3,2-Hopo",Neutrophil gelatinase-associated lipocalin,NC(=O)C1=CC=CC(O)=C1O
Treprostinil,Prostacyclin receptor,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1
Treprostinil,Peroxisome proliferator-activated receptor delta,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1
Treprostinil,P2Y purinoceptor 12,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1
Tretazicar,Oxygen-insensitive NAD(P)H nitroreductase,NC(=O)C1=CC(N2CC2)=C(C=C1[N+]([O-])=O)[N+]([O-])=O
Tretazicar,Ribosyldihydronicotinamide dehydrogenase [quinone],NC(=O)C1=CC(N2CC2)=C(C=C1[N+]([O-])=O)[N+]([O-])=O
Tretinoin,Retinoic acid receptor RXR-beta,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinoic acid receptor RXR-gamma,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinoic acid receptor gamma,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinal dehydrogenase 1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinoic acid-induced protein 3,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Nuclear receptor subfamily 0 group B member 1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinal dehydrogenase 2,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinoic acid receptor responder protein 1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinoic acid receptor alpha,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinoic acid receptor beta,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Lipocalin-1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Odorant-binding protein 2a,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinol-binding protein 4,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Retinoic acid receptor RXR-alpha,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Cytochrome P450 26A1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Cytochrome P450 26B1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Cytochrome P450 26C1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Tretinoin,Hematopoietic prostaglandin D synthase,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
Triamcinolone,Glucocorticoid receptor,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
Triamterene,Amiloride-sensitive sodium channel subunit beta,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1
Triamterene,Amiloride-sensitive sodium channel subunit alpha,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1
Triamterene,Amiloride-sensitive sodium channel subunit delta,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1
Triamterene,Amiloride-sensitive sodium channel subunit gamma,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-1,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-2,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-3,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-4,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-5,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-6,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit beta-1,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit beta-2,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit beta-3,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit gamma-1,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit gamma-2,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit gamma-3,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit delta,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit epsilon,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit pi,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit rho-1,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit rho-2,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit rho-3,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit theta,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Translocator protein,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-1,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-2,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-3,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-4,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-5,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit alpha-6,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit beta-1,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit beta-2,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit beta-3,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit delta,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit epsilon,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit gamma-1,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit gamma-2,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit gamma-3,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit pi,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolam,Gamma-aminobutyric acid receptor subunit theta,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12
Triazolopyridine,Mitogen-activated protein kinase 14,CC(C)C1=NN=C2C=CC(=CN12)C1=C(N=CO1)C1=CC=C(F)C=C1
Tricarballylic Acid,"Aconitate hydratase, mitochondrial",OC(=O)CC(CC(O)=O)C(O)=O
Trichlormethiazide,Solute carrier family 12 member 3,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl
Trichlormethiazide,Sodium/potassium-transporting ATPase subunit alpha-1,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl
Trichlormethiazide,Carbonic anhydrase 1,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl
Trichlormethiazide,Carbonic anhydrase 2,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl
Trichlormethiazide,Carbonic anhydrase 4,NS(=O)(=O)C1=C(Cl)C=C2NC(NS(=O)(=O)C2=C1)C(Cl)Cl
Triclocarban,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,ClC1=CC=C(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)C=C1
Triclosan,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Enoyl-[acyl-carrier-protein] reductase [NADH],OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Enoyl-[acyl-carrier-protein] reductase [NADH],OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Nuclear receptor subfamily 1 group I member 2,OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Androgen receptor,OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Nuclear receptor subfamily 1 group I member 3,OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Peroxisome proliferator-activated receptor gamma,OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Triclosan,Thyroid peroxidase,OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
Tricosanoic Acid,Lipase 3,CCCCCCCCCCCCCCCCCCCCCCC(O)=O
Tridihexethyl,Muscarinic acetylcholine receptor M3,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1
Tridihexethyl,Muscarinic acetylcholine receptor M1,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1
Tridihexethyl,Muscarinic acetylcholine receptor M2,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1
Tridolgosir,Alpha-mannosidase 2,[H][C@@]1(O)CN2CCC[C@@]([H])(O)[C@]2([H])[C@]1([H])O
Triethyl Phosphate,Parathion hydrolase,CCOP(=O)(OCC)OCC
Triethyl Phosphate,Parathion hydrolase,CCOP(=O)(OCC)OCC
Triethyl Phosphate,Cellular tumor antigen p53,CCOP(=O)(OCC)OCC
Triethylene glycol,"Acetolactate synthase, catabolic",OCCOCCOCCO
Triethylene glycol,"Arabinogalactan endo-beta-1,4-galactanase",OCCOCCOCCO
Triethylene glycol,Phosphoserine aminotransferase,OCCOCCOCCO
Trifluoperazine,D(2) dopamine receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Trifluoperazine,Neuron-specific vesicular protein calcyon,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Trifluoperazine,Alpha-1A adrenergic receptor,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Trifluoperazine,Calmodulin,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Trifluoperazine,"Troponin C, slow skeletal and cardiac muscles",CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Trifluoperazine,Protein S100-A4,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
Trifluoro-thiamin phosphate,Thiamine-phosphate synthase,CC1=C(CCOP([O-])([O-])=O)SC=[N+]1CC1=CN=C(N=C1N)C(F)(F)F
Trifluoroacetonyl Coenzyme A,"Citrate synthase, mitochondrial",[H][C@](O)(C(O)=NCCC(O)=NCCSCC(=O)C(F)(F)F)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])OP(O)(O)=O
Trifluoroethanol,Alcohol dehydrogenase 1C,OCC(F)(F)F
Trifluoroethanol,GTPase HRas,OCC(F)(F)F
Trifluoroethanol,Alcohol dehydrogenase,OCC(F)(F)F
Trifluoromethionine,Methionine--tRNA ligase,N[C@@H](CCSC(F)(F)F)C(O)=O
Trifluoromethionine,Methionine aminopeptidase,N[C@@H](CCSC(F)(F)F)C(O)=O
Triflupromazine,D(1A) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Triflupromazine,D(2) dopamine receptor,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Triflupromazine,5-hydroxytryptamine receptor 2B,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Triflupromazine,Muscarinic acetylcholine receptor M1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Triflupromazine,Muscarinic acetylcholine receptor M2,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
Trifluridine,Thymidylate synthase,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(C(=O)NC1=O)C(F)(F)F
Triflusal,Prostaglandin G/H synthase 1,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O
Triflusal,Nuclear factor NF-kappa-B p105 subunit,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O
Triflusal,"Nitric oxide synthase, inducible",CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O
Triflusal,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(O)=O
Triglu-5-Formyl-Tetrahydrofolate,"Serine hydroxymethyltransferase, cytosolic",[H][C@@](CCC(O)=N[C@@]([H])(CCC(O)=N[C@@]([H])(CCC(O)=O)C(O)=O)C(O)=O)(NC(=O)C1=CC=C(NC[C@@]2([H])CNC3=C(N2C=O)C(O)=NC(=N)N3)C=C1)C(O)=O
Triglyme,Outer-membrane lipoprotein LolB,COCCOCCOCCOC
Triglyme,Profilin-2,COCCOCCOCCOC
Triglyme,Outer-membrane lipoprotein LolB,COCCOCCOCCOC
Triglyme,Uncharacterized protein,COCCOCCOCCOC
Triglyme,Serine acetyltransferase,COCCOCCOCCOC
Triglyme,Tyrosine-protein kinase Fyn,COCCOCCOCCOC
Triglyme,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",COCCOCCOCCOC
Triglyme,"Transcriptional regulator, GntR family",COCCOCCOCCOC
Triglyme,"ABC transporter, periplasmic substrate-binding protein",COCCOCCOCCOC
Triglyme,Transketolase,COCCOCCOCCOC
Trihexyphenidyl,Muscarinic acetylcholine receptor M1,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
Trihexyphenidyl,Muscarinic acetylcholine receptor M2,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
Trihexyphenidyl,Muscarinic acetylcholine receptor M3,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
Trihexyphenidyl,Muscarinic acetylcholine receptor M4,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
Trihexyphenidyl,Muscarinic acetylcholine receptor M5,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
Trihydroxyantimonite(Iii),Arsenical pump-driving ATPase,O[Sb](O)O
Trilostane,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N
Trilostane,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N
Trilostane,Estrogen receptor,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N
Trilostane,Estrogen receptor beta,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N
Trimebutine,Mu-type opioid receptor,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent L-type calcium channel subunit alpha-1C,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent L-type calcium channel subunit alpha-1D,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent L-type calcium channel subunit alpha-1F,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent L-type calcium channel subunit alpha-1S,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent L-type calcium channel subunit beta-1,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent L-type calcium channel subunit beta-2,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent L-type calcium channel subunit beta-3,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent L-type calcium channel subunit beta-4,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Calcium-activated potassium channel subunit alpha-1,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Calcium-activated potassium channel subunit beta-1,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Calcium-activated potassium channel subunit beta-2,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Calcium-activated potassium channel subunit beta-3,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Calcium-activated potassium channel subunit beta-4,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Intermediate conductance calcium-activated potassium channel protein 4,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Small conductance calcium-activated potassium channel protein 1,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Small conductance calcium-activated potassium channel protein 2,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Small conductance calcium-activated potassium channel protein 3,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent T-type calcium channel subunit alpha-1G,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent T-type calcium channel subunit alpha-1H,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Voltage-dependent T-type calcium channel subunit alpha-1I,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Muscarinic acetylcholine receptor M1,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Muscarinic acetylcholine receptor M2,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Muscarinic acetylcholine receptor M3,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimebutine,Muscarinic acetylcholine receptor M4,CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
Trimetazidine,"3-ketoacyl-CoA thiolase, peroxisomal",COC1=C(OC)C(OC)=C(CN2CCNCC2)C=C1
Trimethadione,Voltage-dependent T-type calcium channel subunit alpha-1G,CN1C(=O)OC(C)(C)C1=O
Trimethaphan,Neuronal acetylcholine receptor subunit alpha-10,O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1
Trimethoprim,Thymidylate synthase,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC
Trimethoprim,Dihydrofolate reductase,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC
Trimetrexate,Dihydrofolate reductase,COC1=CC(NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)=CC(OC)=C1OC
Trimipramine,Sodium-dependent noradrenaline transporter,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Sodium-dependent serotonin transporter,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Sodium-dependent dopamine transporter,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,5-hydroxytryptamine receptor 2A,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,5-hydroxytryptamine receptor 1A,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Alpha-1A adrenergic receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Alpha-1B adrenergic receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,D(2) dopamine receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Alpha-2B adrenergic receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Histamine H1 receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,5-hydroxytryptamine receptor 2C,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,5-hydroxytryptamine receptor 3A,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,5-hydroxytryptamine receptor 1D,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Alpha-2A adrenergic receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,D(1A) dopamine receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,D(1B) dopamine receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Beta-1 adrenergic receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Beta-2 adrenergic receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Beta-3 adrenergic receptor,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Muscarinic acetylcholine receptor M1,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Muscarinic acetylcholine receptor M2,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Muscarinic acetylcholine receptor M3,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Muscarinic acetylcholine receptor M4,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,Muscarinic acetylcholine receptor M5,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trimipramine,5-hydroxytryptamine receptor 2C,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12
Trinitrotoluene,Pentaerythritol tetranitrate reductase,CC1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O
Tripelennamine,Histamine H1 receptor,CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1
Triphosphoric acid,Poly(A) polymerase alpha,OP(O)(=O)OP(O)(=O)OP(O)(O)=O
Triprolidine,Histamine H1 receptor,CC1=CC=C(C=C1)C(=C/CN1CCCC1)\C1=CC=CC=N1
Triptorelin,Gonadotropin-releasing hormone receptor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O
Tris(Hydroxyethyl)Aminomethane,Alpha-amylase 1,NC(CCO)(CCO)CCO
Tris(Hydroxyethyl)Aminomethane,Alpha-lytic protease,NC(CCO)(CCO)CCO
Tris(Hydroxyethyl)Aminomethane,"Chlorocatechol 1,2-dioxygenase",NC(CCO)(CCO)CCO
Tris-Hydroxymethyl-Methyl-Ammonium,Azurin,C[N+](CO)(CO)CO
Tris-Hydroxymethyl-Methyl-Ammonium,Thiazole tautomerase,C[N+](CO)(CO)CO
Tris-Hydroxymethyl-Methyl-Ammonium,Pantothenate synthetase,C[N+](CO)(CO)CO
Trodusquemine,Sodium-dependent noradrenaline transporter,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)NCCCNCCCCNCCCN)[C@H](C)CC[C@@H](OS(O)(=O)=O)C(C)C
Trodusquemine,Tyrosine-protein phosphatase non-receptor type 1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)NCCCNCCCCNCCCN)[C@H](C)CC[C@@H](OS(O)(=O)=O)C(C)C
Trodusquemine,Sodium-dependent dopamine transporter,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)NCCCNCCCCNCCCN)[C@H](C)CC[C@@H](OS(O)(=O)=O)C(C)C
Troglitazone,Peroxisome proliferator-activated receptor gamma,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Troglitazone,Plasminogen activator inhibitor 1,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Troglitazone,Long-chain-fatty-acid--CoA ligase 4,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Troglitazone,Equilibrative nucleoside transporter 1,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Troglitazone,Estrogen-related receptor gamma,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Troglitazone,Steroid hormone receptor ERR1,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Troglitazone,Peroxisome proliferator-activated receptor delta,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Troglitazone,Peroxisome proliferator-activated receptor alpha,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Troglitazone,Glutathione S-transferase P,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
Trolamine salicylate,Prostaglandin G/H synthase 1,OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O
Trolamine salicylate,Prostaglandin G/H synthase 2,OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O
Troleandomycin,50S ribosomal protein L32,CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O
Troleandomycin,50S ribosomal protein L4,CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O
Troleandomycin,Nuclear receptor subfamily 1 group I member 2,CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O
Tromethamine,S-adenosylmethionine decarboxylase proenzyme,NC(CO)(CO)CO
Tromethamine,Vascular endothelial growth factor A,NC(CO)(CO)CO
Tromethamine,Cholera enterotoxin subunit B,NC(CO)(CO)CO
Tromethamine,Biotin synthase,NC(CO)(CO)CO
Tromethamine,Soluble calcium-activated nucleotidase 1,NC(CO)(CO)CO
Tromethamine,Cytochrome c4,NC(CO)(CO)CO
Tromethamine,Autolysin,NC(CO)(CO)CO
Tromethamine,6-phosphogluconolactonase,NC(CO)(CO)CO
Tromethamine,Lipoprotein NlpI,NC(CO)(CO)CO
Tromethamine,DNA protection during starvation protein,NC(CO)(CO)CO
Tromethamine,Putative glucose-6-phosphate 1-epimerase,NC(CO)(CO)CO
Tromethamine,Endonuclease 8-like 1,NC(CO)(CO)CO
Tromethamine,Decorin,NC(CO)(CO)CO
Tropicamide,Muscarinic acetylcholine receptor M4,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
Tropicamide,Muscarinic acetylcholine receptor M1,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
Tropicamide,Muscarinic acetylcholine receptor M2,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
Tropicamide,Muscarinic acetylcholine receptor M3,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
Tropisetron,5-hydroxytryptamine receptor 3A,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C1=CNC3=CC=CC=C13)N2C
Trospium,Muscarinic acetylcholine receptor M1,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1
Trovafloxacin,DNA gyrase subunit A,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O
Trovafloxacin,DNA topoisomerase 4 subunit A,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O
Trovafloxacin,DNA topoisomerase 2-alpha,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O
Trypanothione,Trypanothione reductase,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)NCCCCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@H](N)C(O)=O)C(O)=O
Tryptophanyl-5'amp,"Tryptophan--tRNA ligase, cytoplasmic",N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12
Tryptophanyl-5'amp,Tryptophan--tRNA ligase,N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12
Tu-514,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,[H][C@]1(CC(O)=NO)CO[C@]([H])(CO)[C@@]([H])(O)[C@]1([H])OC(=O)CCCCCCCCCCCCC
Tubercidin,Purine nucleoside phosphorylase DeoD-type,NC1=NC=NC2=C1C=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Tuberculin Purified Protein Derivative,Toll-like receptor 2,
Tubocurarine,Neuronal acetylcholine receptor subunit alpha-2,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3
Tubocurarine,5-hydroxytryptamine receptor 3A,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3
Tubocurarine,Acetylcholinesterase,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3
Tubocurarine,Neuronal acetylcholine receptor subunit alpha-7,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3
Tucatinib,Receptor tyrosine-protein kinase erbB-2,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1
Tulobuterol,Beta-2 adrenergic receptor,CC(C)(C)NCC(O)C1=CC=CC=C1Cl
Turoctocog alfa,Coagulation factor IX,
Turoctocog alfa,Coagulation factor X,
Turoctocog alfa,Prothrombin,
Turoctocog alfa pegol,Coagulation factor IX,
Turoctocog alfa pegol,Coagulation factor X,
Turoctocog alfa pegol,Prothrombin,
Turpentine,Mitogen-activated protein kinase 1,
Tyloxapol,Lipoprotein lipase,
Tyrosinal,"Tyrosine--tRNA ligase, cytoplasmic",[H][C@](N)(CC1=CC=C(O)C=C1)C=O
Tyrosinal,Pseudomonalisin,[H][C@](N)(CC1=CC=C(O)C=C1)C=O
Tyrosinal,Tyrosine--tRNA ligase,[H][C@](N)(CC1=CC=C(O)C=C1)C=O
Tyrosinal,Tyrosine--tRNA ligase,[H][C@](N)(CC1=CC=C(O)C=C1)C=O
Tyrosine,"Tyrosine--tRNA ligase, cytoplasmic",N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
Tyrosine,"Tyrosine--tRNA ligase, mitochondrial",N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
Tyrosine,Tyrosine 3-monooxygenase,N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
Tyrosine,Tyrosine aminotransferase,N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
Tyrosyladenylate,Tyrosine--tRNA ligase,[H][C@](N)(CC1=CC=C(O)C=C1)C(O)=NS(=O)(=O)OC[C@@]1([H])O[C@@]([H])(N2C=NC3=C(N)N=CN=C23)[C@]([H])(O)[C@]1([H])O
Tyrothricin,Acetylcholinesterase,
Tyrothricin,Beta-galactosidase,
Tyvelose,Tail fiber protein,[H][C@]1(O)C[C@]([H])(O)[C@@]([H])(O)O[C@]1([H])C
U-Pi-a-Pi,Ribonuclease pancreatic,[H][C@@]1(C[C@]([H])(OP(O)(=O)OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])OP(O)(O)=O)[C@@]([H])(COP(O)(O)=O)O1)N1C=CC(O)=NC1=O
UBIQUINONE-1,Photosynthetic reaction center cytochrome c subunit,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,Reaction center protein H chain,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,Reaction center protein L chain,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,Reaction center protein M chain,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,Thiol:disulfide interchange protein DsbA,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,Disulfide bond formation protein B,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,NrfC protein,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,Thiosulfate reductase,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-1,Hypothetical membrane spanning protein,COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Succinate dehydrogenase flavoprotein subunit,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Succinate dehydrogenase iron-sulfur subunit,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Succinate dehydrogenase cytochrome b556 subunit,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Succinate dehydrogenase hydrophobic membrane anchor subunit,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,"Cytochrome c1, heme protein, mitochondrial",COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Cytochrome b,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,"Cytochrome b-c1 complex subunit 1, mitochondrial",COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,"Cytochrome b-c1 complex subunit 2, mitochondrial",COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,"Cytochrome b-c1 complex subunit 6, mitochondrial",COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Cytochrome b-c1 complex subunit 8,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Cytochrome b-c1 complex subunit 10,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Cytochrome b-c1 complex subunit 7,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Cytochrome b-c1 complex subunit 9,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Photosynthetic reaction center cytochrome c subunit,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Reaction center protein H chain,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Reaction center protein L chain,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Reaction center protein M chain,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Disulfide bond formation protein B,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Cytochrome b,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Ubiquinol-cytochrome c reductase iron-sulfur subunit,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Cytochrome c1,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Reaction center protein L chain,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Reaction center protein M chain,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UBIQUINONE-2,Reaction center protein H chain,COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O
UC-781,Gag-Pol polyprotein,CC(C)=CCOC1=C(Cl)C=CC(NC(=S)C2=C(C)OC=C2)=C1
UDP-alpha-D-glucuronic acid,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O
UDP-alpha-D-glucuronic acid,UDP-glucose 6-dehydrogenase,O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O
UDP-alpha-D-glucuronic acid,UDP-glucose 4-epimerase,O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O
"UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE",Lysozyme C,O=CCCCC=C(CCC=C(CCC=O)C=O)C=O
"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",Light-harvesting protein B-800/850 beta 1 chain,CCCCCCCCCCC[N+](C)(C)[O-]
"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",Light-harvesting protein B-800/850 alpha chain,CCCCCCCCCCC[N+](C)(C)[O-]
"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE","Dihydroorotate dehydrogenase (quinone), mitochondrial",CCCCCCCCCCC[N+](C)(C)[O-]
UP5,UMP-CMP kinase,[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)N4C=CC(=O)N([H])C4=O)[C@@H](O)[C@H]3O)C2=NC=N1
Ubenimex,Bacterial leucyl aminopeptidase,[H][C@@](N)(CC1=CC=CC=C1)[C@]([H])(O)C(O)=N[C@@]([H])(CC(C)C)C(O)=O
Ubenimex,Leukotriene A-4 hydrolase,[H][C@@](N)(CC1=CC=CC=C1)[C@]([H])(O)C(O)=N[C@@]([H])(CC(C)C)C(O)=O
Ubidecarenone,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O
Ubidecarenone,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O
Udenafil,"cGMP-specific 3',5'-cyclic phosphodiesterase",CCCOC1=C(C=C(C=C1)S(=O)(=O)NCCC1CCCN1C)C1=NC(=O)C2=C(N1)C(CCC)=NN2C
Udp-Alpha-D-Xylopyranose,UDP-glucose 6-dehydrogenase,[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])OC[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])O)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
Ulapualide A,"Actin, alpha skeletal muscle",[H]C(=C([H])C([H])(C)C([H])(OC(C)=O)[C@]([H])(C)C(=O)CC[C@]([H])(C)[C@]([H])(C[C@]1([H])OC(=O)C[C@@]([H])(O)CCCC(=O)C[C@]([H])(C)C2=COC(=N2)C2=COC(=N2)C2=COC(=N2)\C([H])=C([H])\C[C@]([H])(OC)[C@@]1([H])C)OC)N(C)CO
Ularitide,Atrial natriuretic peptide receptor 1,CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O
Ulimorelin,Growth hormone secretagogue receptor type 1,C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](CC2=CC=C(F)C=C2)C(=O)NCCCC2=CC=CC=C2O1
Ulipristal,Progesterone receptor,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12
Ulipristal,Glucocorticoid receptor,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12
Ulipristal,Androgen receptor,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12
Ulixertinib,Mitogen-activated protein kinase 3,[H]N([C@H](CO)C1=CC(Cl)=CC=C1)C(=O)C1=CC(=CN1[H])C1=CC(=NC=C1Cl)N([H])C(C)C
Ulixertinib,Mitogen-activated protein kinase 1,[H]N([C@H](CO)C1=CC(Cl)=CC=C1)C(=O)C1=CC(=CN1[H])C1=CC(=NC=C1Cl)N([H])C(C)C
Ulobetasol,Glucocorticoid receptor,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
Umeclidinium,Muscarinic acetylcholine receptor M1,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
Umeclidinium,Muscarinic acetylcholine receptor M2,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
Umeclidinium,Muscarinic acetylcholine receptor M3,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
Umeclidinium,Muscarinic acetylcholine receptor M4,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
Umeclidinium,Muscarinic acetylcholine receptor M5,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
Undecyl-Beta-D-Maltopyranoside,V-type sodium ATPase subunit K,[H][C@]1(O)[C@]([H])(O)[C@@]([H])(CO)O[C@]([H])(O[C@@]2([H])[C@]([H])(O)[C@@]([H])(O)[C@]([H])(OCCCCCCCCCCC)O[C@]2([H])CO)[C@]1([H])O
Undecyl-Phosphinic Acid Butyl Ester,Gastric triacylglycerol lipase,[H][P@@](=O)(CCCCCCCCCCC)OCCCC
Uracil,Dihydropyrimidine dehydrogenase [NADP(+)],O=C1NC=CC(=O)N1
Uracil,Uracil-DNA glycosylase,O=C1NC=CC(=O)N1
Uracil,Uracil-DNA glycosylase,O=C1NC=CC(=O)N1
Uracil,Ribosomal small subunit pseudouridine synthase A,O=C1NC=CC(=O)N1
Uracil,Uracil-DNA glycosylase,O=C1NC=CC(=O)N1
Uracil,Pyrimidine-nucleoside phosphorylase,O=C1NC=CC(=O)N1
Uracil,Uridine-cytidine kinase-like 1,O=C1NC=CC(=O)N1
Uracil arabinose-3'-phosphate,Ribonuclease pancreatic,[H][C@]1(CO)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@@]([H])(O)[C@]1([H])OP(O)(O)=O
Urea,Arginase-1,NC(N)=O
Urea,Carbonic anhydrase 2,NC(N)=O
Urea,Catenin beta-1,NC(N)=O
Urea,Sulfoxide reductase catalytic subunit YedY,NC(N)=O
Urea,Structural polyprotein,NC(N)=O
Urea,Dihydrofolate reductase,NC(N)=O
Urea C-13,Urease,N[13C](O)=N
Urea C-14,Urease,N[14C](N)=O
Urelumab,Tumor necrosis factor receptor superfamily member 9,
Uric acid,"Glycogen phosphorylase, liver form",O=C1NC2=C(N1)C(=O)NC(=O)N2
Uridine,Nucleoside-specific channel-forming protein tsx,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine,U6 snRNA-associated Sm-like protein LSm6,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine 5'-triphosphate,Genome polyprotein,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine 5'-triphosphate,Genome polyprotein,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine 5'-triphosphate,Uridine-cytidine kinase 2,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine diphosphate glucose,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine diphosphate glucose,Galactose-1-phosphate uridylyltransferase,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine diphosphate glucose,UDP-glucose 4-epimerase,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine diphosphate glucose,UDP-glucose 4-epimerase,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine diphosphate glucose,Glucose-1-phosphate thymidylyltransferase,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine diphosphate glucose,DNA beta-glucosyltransferase,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine diphosphate glucose,WbpP,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine diphosphate glucose,Glycogenin-1,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine diphosphate glucose,Glycosyltransferase 6 domain-containing protein 1,OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O
Uridine monophosphate,"Beta-1,4-galactosyltransferase 1",O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Galactose-1-phosphate uridylyltransferase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Thymidylate synthase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Bifunctional protein PyrR,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Bifunctional polymyxin resistance protein ArnA,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Interferon-stimulated gene 20 kDa protein,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Orotidine 5'-phosphate decarboxylase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Uracil phosphoribosyltransferase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Uracil phosphoribosyltransferase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Ribosomal small subunit pseudouridine synthase A,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,U6 snRNA-associated Sm-like protein LSm6,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Glycosyltransferase 6 domain-containing protein 1,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine monophosphate,Uridine-cytidine kinase-like 1,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O
"Uridine-2',3'-Vanadate",Ribonuclease pancreatic,OC[C@@H]1O[C@H]([C@H]2O[V](O)(O)(=O)O[C@H]12)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Histo-blood group ABO system transferase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,UMP-CMP kinase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Pol polyprotein,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Galactose-1-phosphate uridylyltransferase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,UDP-N-acetylglucosamine 2-epimerase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,UDP-glucose 4-epimerase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Spore coat polysaccharide biosynthesis protein SpsA,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,DNA beta-glucosyltransferase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,UDP-galactose 4-epimerase,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Glycogenin-1,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Glycosyltransferase 6 domain-containing protein 1,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate,Exostosin-like 2,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O
Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,UDP-glucose 4-epimerase,[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(F)[C@]([H])(O)[C@@]2([H])O)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
Uridine-5'-Diphosphate-Mannose,UDP-glucose 4-epimerase,[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine,UDP-N-acetylmuramate--L-alanine ligase,C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@@H]1NC(C)=O)C(O)=O
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine,UDP-N-acetylmuramoylalanine--D-glutamate ligase,C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@@H]1NC(C)=O)C(O)=O
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate,UDP-N-acetylmuramoylalanine--D-glutamate ligase,C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@@H]1NC(C)=O)C(=O)N[C@H](CCC(O)=O)C(O)=O
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@@H]1NC(C)=O)C(=O)N[C@H](CCC(O)=O)C(O)=O
Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]2([H])F)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,Glycosyl transferase,[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])F)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester,LgtC,[H][C@]1(COP(O)(=O)OP(O)(=O)O[C@@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])F)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(O)[C@]1([H])O
Uridine-Diphosphate-N-Acetylgalactosamine,Histo-blood group ABO system transferase,CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylgalactosamine,UDP-N-acetylglucosamine 2-epimerase,CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylgalactosamine,UDP-N-acetylhexosamine pyrophosphorylase,CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylgalactosamine,UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase,CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylgalactosamine,UDP-glucose 4-epimerase,CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylgalactosamine,WbpP,CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylgalactosamine,Exostosin-like 2,CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylglucosamine,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylglucosamine,UDP-N-acetylhexosamine pyrophosphorylase,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylglucosamine,UDP-glucose 4-epimerase,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylglucosamine,UDP-glucose 4-epimerase,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylglucosamine,Bifunctional protein GlmU,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylglucosamine,Bifunctional protein GlmU,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylglucosamine,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridine-Diphosphate-N-Acetylglucosamine,Exostosin-like 2,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
Uridylyl-2'-5'-Phospho-Adenosine,Ribonuclease pancreatic,[H][C@]1(CO)O[C@@]([H])(N2C=CC(O)=NC2=O)[C@]([H])(OP(O)(=O)OC[C@@]2([H])O[C@@]([H])(N3C=NC4=C(N)N=CN=C34)[C@]([H])(O)[C@]2([H])O)[C@]1([H])O
Urofollitropin,Follicle-stimulating hormone receptor,
Urokinase,Plasminogen,
Urokinase,Urokinase plasminogen activator surface receptor,
Urokinase,Urokinase-type plasminogen activator,
Urokinase,Tissue-type plasminogen activator,
Urokinase,Plasminogen activator inhibitor 1,
Urokinase,Plasminogen activator inhibitor 2,
Urokinase,Plasma serine protease inhibitor,
Urokinase,Low-density lipoprotein receptor-related protein 2,
Urokinase,Suppressor of tumorigenicity 14 protein,
Urokinase,Nidogen-1,
Ursodeoxycholic acid,Aldo-keto reductase family 1 member C2,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
Ursodeoxycholic acid,Bile acid receptor,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
Ustekinumab,Interleukin-12 subunit beta,
Ustekinumab,Interleukin-12 subunit beta,
Ustekinumab,Interleukin-23 subunit alpha,
V1003,Kappa-type opioid receptor,
V1003,Mu-type opioid receptor,
V24343,Cannabinoid receptor 1,
VGV-1,Gag-Pol polyprotein,
VIR201,Interferon gamma,
VP025,Interleukin-1 beta,
VX-148,Inosine-5'-monophosphate dehydrogenase 2,
VX-148,Inosine-5'-monophosphate dehydrogenase 1,
VX-702,Tumor necrosis factor,NC(=O)N(C1=CC=C(C(N)=O)C(=N1)C1=CC=C(F)C=C1F)C1=C(F)C=CC=C1F
VX-702,Interleukin-6,NC(=O)N(C1=CC=C(C(N)=O)C(=N1)C1=CC=C(F)C=C1F)C1=C(F)C=CC=C1F
VX-702,Mitogen-activated protein kinase 14,NC(=O)N(C1=CC=C(C(N)=O)C(=N1)C1=CC=C(F)C=C1F)C1=C(F)C=CC=C1F
VX-702,Interleukin-1 beta,NC(=O)N(C1=CC=C(C(N)=O)C(=N1)C1=CC=C(F)C=C1F)C1=C(F)C=CC=C1F
VX-765,Caspase-1,
VX-765,Interleukin-1 beta,
Vaborbactam,Beta-lactamase,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1
Vaborbactam,Carbapenem-hydrolyzing beta-lactamase KPC,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1
Vaborbactam,Beta-lactamase SHV-1,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1
Vaborbactam,Beta-lactamase TEM,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1
Vaborbactam,Beta-lactamase,OB1O[C@H](CC(O)=O)CC[C@@H]1NC(=O)CC1=CC=CS1
Valaciclovir,DNA polymerase catalytic subunit,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1NC(N)=NC2=O
Valaciclovir,Thymidine kinase,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1NC(N)=NC2=O
Valbenazine,Vesicle monoamine transporter type 2,COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1
Valdecoxib,Prostaglandin G/H synthase 2,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
Valdecoxib,Carbonic anhydrase 2,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
Valdecoxib,Carbonic anhydrase 3,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
Valproic Acid,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",CCCC(CCC)C(O)=O
Valproic Acid,Histone deacetylase 9,CCCC(CCC)C(O)=O
Valproic Acid,"2-oxoglutarate dehydrogenase, mitochondrial",CCCC(CCC)C(O)=O
Valproic Acid,"Succinate-semialdehyde dehydrogenase, mitochondrial",CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 1 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 10 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 11 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 2 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 3 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 4 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 5 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 7 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 8 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel protein type 9 subunit alpha,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel subunit beta-1,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel subunit beta-2,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel subunit beta-3,CCCC(CCC)C(O)=O
Valproic Acid,Sodium channel subunit beta-4,CCCC(CCC)C(O)=O
Valproic Acid,Histone deacetylase 2,CCCC(CCC)C(O)=O
Valproic Acid,Peroxisome proliferator-activated receptor alpha,CCCC(CCC)C(O)=O
Valproic Acid,Peroxisome proliferator-activated receptor delta,CCCC(CCC)C(O)=O
Valproic Acid,Peroxisome proliferator-activated receptor gamma,CCCC(CCC)C(O)=O
Valpromide,"Limonene-1,2-epoxide hydrolase",CCCC(CCC)C(N)=O
Valrubicin,DNA topoisomerase 2-alpha,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1
Valsartan,Type-1 angiotensin II receptor,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O
Vandetanib,Vascular endothelial growth factor A,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
Vandetanib,Epidermal growth factor receptor,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
Vandetanib,Protein-tyrosine kinase 6,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
Vandetanib,Angiopoietin-1 receptor,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
Vandetanib,Proto-oncogene tyrosine-protein kinase receptor Ret,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1
Vanillic acid,Chorismate pyruvate-lyase,COC1=CC(=CC=C1O)C([O-])=O
Vanoxerine,Sodium-dependent dopamine transporter,FC1=CC=C(C=C1)C(OCCN1CCN(CCCC2=CC=CC=C2)CC1)C1=CC=C(F)C=C1
Vapreotide,Somatostatin receptor type 2,[H][C@@](N)(CC1=CC=CC=C1)C(O)=N[C@@]1([H])CSSC[C@]([H])(N=C(O)[C@@]([H])(N=C(O)[C@]([H])(CCCCN)N=C(O)[C@@]([H])(CC2=CNC3=CC=CC=C23)N=C(O)[C@]([H])(CC2=CC=C(O)C=C2)N=C1O)C(C)C)C(O)=N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(O)=N
Vapreotide,Somatostatin receptor type 5,[H][C@@](N)(CC1=CC=CC=C1)C(O)=N[C@@]1([H])CSSC[C@]([H])(N=C(O)[C@@]([H])(N=C(O)[C@]([H])(CCCCN)N=C(O)[C@@]([H])(CC2=CNC3=CC=CC=C23)N=C(O)[C@]([H])(CC2=CC=C(O)C=C2)N=C1O)C(C)C)C(O)=N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(O)=N
Vapreotide,Substance-P receptor,[H][C@@](N)(CC1=CC=CC=C1)C(O)=N[C@@]1([H])CSSC[C@]([H])(N=C(O)[C@@]([H])(N=C(O)[C@]([H])(CCCCN)N=C(O)[C@@]([H])(CC2=CNC3=CC=CC=C23)N=C(O)[C@]([H])(CC2=CC=C(O)C=C2)N=C1O)C(C)C)C(O)=N[C@@]([H])(CC1=CNC2=CC=CC=C12)C(O)=N
Vardenafil,"cGMP-specific 3',5'-cyclic phosphodiesterase",CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1
Vardenafil,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1
Vardenafil,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1
Varenicline,Neuronal acetylcholine receptor subunit alpha-4,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
Varenicline,Neuronal acetylcholine receptor subunit alpha-7,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
Varenicline,Neuronal acetylcholine receptor subunit alpha-3,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
Varenicline,Neuronal acetylcholine receptor subunit alpha-6,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
Varenicline,Neuronal acetylcholine receptor subunit beta-2,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
Varespladib methyl,Group 10 secretory phospholipase A2,CCC1=C(C(=O)C(N)=O)C2=C(OCC(=O)OC)C=CC=C2N1CC1=CC=CC=C1
Varespladib methyl,"Phospholipase A2, membrane associated",CCC1=C(C(=O)C(N)=O)C2=C(OCC(=O)OC)C=CC=C2N1CC1=CC=CC=C1
Varlitinib,Receptor tyrosine-protein kinase erbB-2,C[C@@H]1COC(NC2=CC=C3N=CN=C(NC4=CC=C(OCC5=NC=CS5)C(Cl)=C4)C3=C2)=N1
Varlitinib,Epidermal growth factor receptor,C[C@@H]1COC(NC2=CC=C3N=CN=C(NC4=CC=C(OCC5=NC=CS5)C(Cl)=C4)C3=C2)=N1
Vasopressin,Vasopressin V2 receptor,
Vasopressin,Vasopressin V1a receptor,
Vasopressin,Vasopressin V1b receptor,
Vatalanib,Vascular endothelial growth factor receptor 3,ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1
Vatalanib,Vascular endothelial growth factor receptor 1,ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1
Vatalanib,Vascular endothelial growth factor receptor 2,ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1
Vecuronium,Neuronal acetylcholine receptor subunit alpha-2,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1
Vedolizumab,Integrin alpha-4,
Vedolizumab,Integrin beta-7,
Veglin,Vascular endothelial growth factor A,
Velaglucerase alfa,Glucosylceramidase,
Veliparib,Poly [ADP-ribose] polymerase 1,C[C@@]1(CCCN1)C1=NC2=CC=CC(C(N)=O)=C2N1
Veliparib,Poly [ADP-ribose] polymerase 2,C[C@@]1(CCCN1)C1=NC2=CC=CC(C(N)=O)=C2N1
Velusetrag,5-hydroxytryptamine receptor 4,CC(C)N1C(=O)C(=CC2=CC=CC=C12)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@@H](O)CN(C)S(C)(=O)=O
Vemurafenib,Serine/threonine-protein kinase B-raf,CCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C1
Venetoclax,Apoptosis regulator Bcl-2,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1
Venlafaxine,Sodium-dependent serotonin transporter,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
Venlafaxine,Sodium-dependent noradrenaline transporter,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
Venlafaxine,Sodium-dependent dopamine transporter,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1
Verapamil,Voltage-dependent L-type calcium channel subunit alpha-1C,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent L-type calcium channel subunit alpha-1D,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent L-type calcium channel subunit alpha-1F,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent L-type calcium channel subunit alpha-1S,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent L-type calcium channel subunit beta-1,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent L-type calcium channel subunit beta-2,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent L-type calcium channel subunit beta-3,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent L-type calcium channel subunit beta-4,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent T-type calcium channel subunit alpha-1I,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent T-type calcium channel subunit alpha-1G,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent N-type calcium channel subunit alpha-1B,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Potassium voltage-gated channel subfamily H member 2,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Sodium channel protein type 5 subunit alpha,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,ATP-sensitive inward rectifier potassium channel 11,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Sodium-dependent serotonin transporter,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Alpha-1A adrenergic receptor,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Alpha-1B adrenergic receptor,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Verapamil,Alpha-1D adrenergic receptor,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
Vercirnon,C-C chemokine receptor type 9,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC1=C(C=C(Cl)C=C1)C(=O)C1=CC=[N+]([O-])C=C1
Verdoheme,Heme oxygenase 1,CC1=CC2=CC3=[N+]4C(=CC5=C(C=C)C(C)=C6OC7=C(C=C)C(C)=C8C=C1N2[Fe]4(N56)N78)C(C)=C3CCC(O)=O
Vernakalant,Sodium channel protein type 5 subunit alpha,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
Vernakalant,Potassium voltage-gated channel subfamily A member 5,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
Vernakalant,Potassium voltage-gated channel subfamily D member 3,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
Vernakalant,Potassium voltage-gated channel subfamily H member 2,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
Verpasep caltespen,"Keratin, type II cytoskeletal 7",
Verpasep caltespen,E3 ubiquitin-protein ligase UBR4,
Verubecestat,Beta-secretase 1,CN1C(N)=N[C@@](C)(CS1(=O)=O)C1=CC(NC(=O)C2=CC=C(F)C=N2)=CC=C1F
Vestipitant,Substance-P receptor,C[C@@H](N(C)C(=O)N1CCNC[C@@H]1C1=CC=C(F)C=C1C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
Vicriviroc,C-C chemokine receptor type 5,COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C1=CC=C(C=C1)C(F)(F)F
Vidarabine,DNA polymerase catalytic subunit,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Vidarabine,Thymidine kinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Vidarabine,Thymidine kinase,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Vigabatrin,Gamma-aminobutyric acid type B receptor subunit 1,NC(CCC(O)=O)C=C
Vigabatrin,"4-aminobutyrate aminotransferase, mitochondrial",NC(CCC(O)=O)C=C
Vilanterol,Beta-2 adrenergic receptor,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl
Vilazodone,Sodium-dependent serotonin transporter,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
Vilazodone,5-hydroxytryptamine receptor 1A,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
Vildagliptin,Dipeptidyl peptidase 4,OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N
Viloxazine,Sodium-dependent noradrenaline transporter,CCOC1=CC=CC=C1OCC1CNCCO1
Vinblastine,Tubulin alpha-1A chain,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vinblastine,Tubulin beta chain,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vinblastine,Tubulin delta chain,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vinblastine,Tubulin gamma-1 chain,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vinblastine,Tubulin epsilon chain,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vinblastine,Transcription factor AP-1,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vincristine,Tubulin beta chain,CC[C@]1(O)C[C@@H]2CN(C1)CCC1=C(NC3=CC=CC=C13)[C@@](C2)(C(=O)OC)C1=C(OC)C=C2N(C=O)[C@@H]3[C@]4(CCN5CC=C[C@](CC)([C@@H]45)[C@@H](OC(C)=O)[C@]3(O)C(=O)OC)C2=C1
Vincristine,Tubulin alpha-4A chain,CC[C@]1(O)C[C@@H]2CN(C1)CCC1=C(NC3=CC=CC=C13)[C@@](C2)(C(=O)OC)C1=C(OC)C=C2N(C=O)[C@@H]3[C@]4(CCN5CC=C[C@](CC)([C@@H]45)[C@@H](OC(C)=O)[C@]3(O)C(=O)OC)C2=C1
Vindesine,Tubulin beta-1 chain,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@@H]5C[N@@](C[C@](O)(CC)C5)CCC5=C4NC4=CC=CC=C54)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(N)=O
Vinflunine,Tubulin beta chain,CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)C1=CC(OC)=C(C=C41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CC3=C1NC1=CC=CC=C31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC
Vinorelbine,Tubulin beta chain,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(CC(CC)=C2)CC2=C1NC1=CC=CC=C21)C(=O)OC
Vintafolide,Folate receptor beta,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C1=CC=C(NCC2=CNC3=NC(N)=NC(=O)C3=N2)C=C1)C(O)=O)C(O)=O)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vintafolide,Folate receptor gamma,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C1=CC=C(NCC2=CNC3=NC(N)=NC(=O)C3=N2)C=C1)C(O)=O)C(O)=O)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vintafolide,Folate receptor alpha,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C)[C@@]1([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)CC[C@H](NC(=O)C1=CC=C(NCC2=CNC3=NC(N)=NC(=O)C3=N2)C=C1)C(O)=O)C(O)=O)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC
Vinylglycine,1-aminocyclopropane-1-carboxylate synthase-like protein 1,N[C@@H](C=C)C(O)=O
Vinylglycine,L-amino-acid oxidase,N[C@@H](C=C)C(O)=O
Vinylsulphonic Acid,Phosphonoacetaldehyde hydrolase,OS(=O)(=O)C=C
Virginiamycin M1,Streptogramin A acetyltransferase,CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)C2=COC(=N2)CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C
Virginiamycin S1,60S ribosomal protein L37,[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)CCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N(C)C2=O)C1=CC=CC=C1
Vismodegib,Smoothened homolog,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1
Vitamin A,Dehydrogenase/reductase SDR family member 4,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinol-binding protein 3,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinol-binding protein 1,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinal dehydrogenase 2,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinal dehydrogenase 1,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,11-cis retinol dehydrogenase,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Aldehyde dehydrogenase family 1 member A3,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinol dehydrogenase 13,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinol dehydrogenase 12,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinaldehyde-binding protein 1,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Lecithin retinol acyltransferase,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Short-chain dehydrogenase/reductase 3,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,"All-trans-retinol 13,14-reductase",C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinol dehydrogenase 11,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinol dehydrogenase 14,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Retinol dehydrogenase 8,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Apolipoprotein D,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin A,Hematopoietic prostaglandin D synthase,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
Vitamin B6 Complexed with 2-Amino-Hexanoic Acid,Aspartate aminotransferase,[H][C@@](CCCC)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)C(O)=O
Vitamin B6 Complexed with 2-Amino-Pentanoic Acid,Aspartate aminotransferase,CCC[C@H](NCC1=C(O)C(C)=NC=C1COP(O)(O)=O)C(O)=O
Vitamin D,Vitamin D3 receptor,
Vitamin D,Vitamin D-binding protein,
Vitamin E,SEC14-like protein 4,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,Arachidonate 5-lipoxygenase,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,SEC14-like protein 2,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,SEC14-like protein 3,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,Protein kinase C beta type,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,Nuclear receptor subfamily 1 group I member 2,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,Protein kinase C alpha type,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,Diacylglycerol kinase alpha,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Vitamin E,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C
Voacamine,Multidrug resistance protein 1,[H][C@@]12C[C@H](CC)[C@]3([H])N(C1)CCC1=C(NC4=CC(=C(OC)C=C14)[C@@]1([H])C[C@]4([H])C(C(=O)OC)[C@@]([H])(CC5=C1NC1=CC=CC=C51)N(C)C\C4=C\C)[C@@]3(C2)C(=O)OC
Voclosporin,Calcineurin subunit B type 1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
Voclosporin,Calcineurin subunit B type 2,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
Vofopitant,Substance-P receptor,COC1=CC=C(C=C1CN[C@H]1CCCN[C@H]1C1=CC=CC=C1)N1N=NN=C1C(F)(F)F
Voglibose,"Maltase-glucoamylase, intestinal",OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O
Volixibat,Ileal sodium/bile acid cotransporter,[H][C@@]1([C@@H](O)[C@](CC)(CCCC)CS(=O)(=O)C2=CC=C(C=C12)N(C)C)C1=CC=CC(NC(=O)N[C@@H]2O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](OCC3=CC=CC=C3)[C@H]2O)=C1
Von Willebrand Factor Human,Coagulation factor VIII,
Von Willebrand Factor Human,Collagen alpha-1(I) chain,
Vonicog Alfa,Coagulation factor VIII,
Vonicog Alfa,Collagen alpha-1(I) chain,
Vorapaxar,Proteinase-activated receptor 1,[H][C@@]12C[C@]3([H])C[C@@H](CC[C@@]3([H])[C@H](\C=C\C3=CC=C(C=N3)C3=CC(F)=CC=C3)[C@]1([H])[C@@H](C)OC2=O)NC(=O)OCC
Voretigene neparvovec,Retinoid isomerohydrolase,
Vorhyaluronidase alfa,Transforming growth factor beta-1,
Voriconazole,Lanosterol 14-alpha demethylase,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1
Vorinostat,Histone deacetylase 8,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
Vorinostat,Histone deacetylase 1,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
Vorinostat,Histone deacetylase 2,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
Vorinostat,Histone deacetylase 3,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
Vorinostat,Histone deacetylase 6,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
Vorinostat,Acetoin utilization protein,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
Vortioxetine,Sodium-dependent serotonin transporter,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1
Vortioxetine,5-hydroxytryptamine receptor 3A,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1
Vortioxetine,5-hydroxytryptamine receptor 7,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1
Vortioxetine,5-hydroxytryptamine receptor 1B,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1
Vortioxetine,5-hydroxytryptamine receptor 1A,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1
Vortioxetine,Beta-1 adrenergic receptor,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1
Voxilaprevir,Genome polyprotein,CC[C@@H]1[C@@H]2CN([C@@H]1C(=O)N[C@@]1(C[C@H]1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1)C(=O)[C@@H](NC(=O)O[C@@H]1C[C@H]1CCCCC(F)(F)C1=C(O2)N=C2C=C(OC)C=CC2=N1)C(C)(C)C
WAY-151693,Collagenase 3,COC1=CC=C(C=C1)S(=O)(=O)N(CC1=CC=CN=C1)C1=C(C=CC=C1C)C(=O)NO
WRR-112,Cruzipain,[H][C@](O)(CC(O)=O)C(=O)N[C@@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C
WRR-112,Cathepsin F,[H][C@](O)(CC(O)=O)C(=O)N[C@@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C
WRR-204,Cruzipain,[H][C@](CCC1=CC=CC=C1)(CCS(=O)(=O)OC1=CC=CC=C1)N=C(O)[C@]([H])(CC1=CC=CC=C1)N=C(O)OCC1=CC=CC=C1
WRR-99,Cruzipain,[H][C@](O)(CC(O)=O)C(=O)N[C@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C
WRR-99,Cathepsin F,[H][C@](O)(CC(O)=O)C(=O)N[C@]([H])(CCC1=CC=CC=C1)C(=O)NCCC(C)C
WX-UK1,Urokinase plasminogen activator surface receptor,Cl.CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC1=CC=CC(=C1)C(N)=N)NS(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C
Warfarin,Vitamin K epoxide reductase complex subunit 1,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2
Warfarin,Nuclear receptor subfamily 1 group I member 2,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2
Willardiine,Glutamate receptor 2,N[C@@H](CN1C=CC(=O)NC1=O)C(O)=O
Wortmannin,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C
Wortmannin,Serine/threonine-protein kinase PLK1,[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C
Wortmannin,Phosphatidylinositol 3-kinase regulatory subunit alpha,[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C
Wortmannin,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",[H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)C2=C3C(=CO2)C(=O)O[C@H](COC)[C@]13C
XEN2174,Sodium-dependent noradrenaline transporter,
XL019,Tyrosine-protein kinase JAK2,
XL228,Tyrosine-protein kinase ABL1,
XL228,Abelson tyrosine-protein kinase 2,
XL228,Proto-oncogene tyrosine-protein kinase Src,
XL228,Insulin-like growth factor 1 receptor,
XL281,RAF proto-oncogene serine/threonine-protein kinase,
XL281,Serine/threonine-protein kinase B-raf,
XL418,Tyrosine-protein kinase BTK,
XL765,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",
XL765,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",
XL765,Serine/threonine-protein kinase mTOR,
XL765,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",
XL765,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",
XL784,Disintegrin and metalloproteinase domain-containing protein 10,
XL820,Platelet-derived growth factor receptor beta,
XL820,Vascular endothelial growth factor receptor 2,
XL820,Mast/stem cell growth factor receptor Kit,
XL820,Platelet-derived growth factor receptor alpha,
XL844,Serine/threonine-protein kinase Chk2,
XL844,Serine/threonine-protein kinase Chk1,
XL999,Receptor-type tyrosine-protein kinase FLT3,
XL999,Platelet-derived growth factor receptor beta,
XL999,Vascular endothelial growth factor receptor 2,
XL999,RET proto-oncogene,
XL999,Fibroblast growth factor receptor 1,
XL999,Fibroblast growth factor receptor 3,
XMT-1001,DNA topoisomerase 1,
XTL-6865,Genome polyprotein,
XV638,Gag-Pol polyprotein,[H][C@]1(CC2=CC=CC=C2)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)C(=O)N(CC2=CC(=CC=C2)C(=O)NC2=NC=CS2)[C@]([H])(CC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O
Xaliproden,5-hydroxytryptamine receptor 1A,FC(F)(F)C1=CC(=CC=C1)C1=CCN(CCC2=CC3=CC=CC=C3C=C2)CC1
Xamoterol,Beta-1 adrenergic receptor,OC(CNCCN=C(O)N1CCOCC1)COC1=CC=C(O)C=C1
Xanthine,Purine nucleoside phosphorylase 2,O=C1NC2=C(NC=N2)C(=O)N1
Xanthine,Xanthine phosphoribosyltransferase,O=C1NC2=C(NC=N2)C(=O)N1
Xanthinol,60S ribosomal protein L3,CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Xanthinol,"NAD(P) transhydrogenase, mitochondrial",CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Xanthinol,Glyceraldehyde-3-phosphate dehydrogenase,CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Xanthinol,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Xanthinol,"2-oxoglutarate dehydrogenase, mitochondrial",CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Xanthinol,"Malate dehydrogenase, mitochondrial",CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C
Ximelagatran,Prothrombin,CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(\N)=N\O)C1CCCCC1
XmAb 2513,Tumor necrosis factor receptor superfamily member 8,
Xylarohydroxamate,Glucarate dehydratase,ONC(=O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O
Xylazine,Alpha-2A adrenergic receptor,CC1=CC=CC(C)=C1NC1=NCCCS1
Xylazine,Alpha-2B adrenergic receptor,CC1=CC=CC(C)=C1NC1=NCCCS1
Xylazine,Alpha-2C adrenergic receptor,CC1=CC=CC(C)=C1NC1=NCCCS1
Xylitol,Xylose isomerase,OC[C@H](O)[C@@H](O)[C@H](O)CO
Xylitol,Xylose isomerase,OC[C@H](O)[C@@H](O)[C@H](O)CO
Xylitol,Xylose isomerase,OC[C@H](O)[C@@H](O)[C@H](O)CO
Xylitol,Xylose isomerase,OC[C@H](O)[C@@H](O)[C@H](O)CO
Xylitol,Hyaluronate lyase,OC[C@H](O)[C@@H](O)[C@H](O)CO
Xylometazoline,Alpha-1A adrenergic receptor,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
Xylometazoline,Alpha-2A adrenergic receptor,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
Xylometazoline,Alpha-2B adrenergic receptor,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
Xylometazoline,Alpha-1B adrenergic receptor,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
Xylometazoline,Alpha-1D adrenergic receptor,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
Xylometazoline,Alpha-2C adrenergic receptor,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C
Xylose-Derived Imidazole,Exoglucanase/xylanase,[H][C@@]1(O)CN2C=CN=C2[C@]([H])(O)[C@@]1([H])O
Xylose-Derived Lactam Oxime,Exoglucanase/xylanase,O\N=C1/NC[C@@H](O)[C@H](O)[C@H]1O
Y-700,Xanthine dehydrogenase/oxidase,CC(C)(C)COC1=C(C=C(C=C1)N1C=C(C=N1)C(O)=O)C#N
YKP-1358,5-hydroxytryptamine receptor 2A,
YKP-1358,D(2) dopamine receptor,
YSIL6,Tumor necrosis factor,
YSIL6,Interleukin-6,
Yohimbine,Alpha-2A adrenergic receptor,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,Alpha-2C adrenergic receptor,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,Alpha-2B adrenergic receptor,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,5-hydroxytryptamine receptor 1A,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,5-hydroxytryptamine receptor 1B,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,5-hydroxytryptamine receptor 1D,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,D(2) dopamine receptor,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,D(3) dopamine receptor,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,5-hydroxytryptamine receptor 2A,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,5-hydroxytryptamine receptor 2C,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,ATP-sensitive inward rectifier potassium channel 1,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,ATP-sensitive inward rectifier potassium channel 10,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,ATP-sensitive inward rectifier potassium channel 11,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,ATP-sensitive inward rectifier potassium channel 12,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,ATP-sensitive inward rectifier potassium channel 14,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,ATP-sensitive inward rectifier potassium channel 15,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,ATP-sensitive inward rectifier potassium channel 8,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Yohimbine,5-hydroxytryptamine receptor 2B,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Z-Ala Prolinal,Prolyl endopeptidase Pep,[H][C@@](C)(NC(=O)OCC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(O)=O
Z-Pro-Prolinal,Prolyl endopeptidase,[H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1C(=O)OCC1=CC=CC=C1)C=O
Z-Pro-Prolinal,Prolyl endopeptidase,[H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1C(=O)OCC1=CC=CC=C1)C=O
Z-Val-Ala-Asp fluoromethyl ketone,Caspase-1,CC(C)[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)CF
ZEN-012,Tubulin beta-1 chain,
ZEN-012,Tubulin beta chain,
ZEN-012,DNA topoisomerase 2-alpha,
ZEN-012,Tubulin beta-4A chain,
ZEN-012,Tubulin beta-3 chain,
ZEN-012,DNA topoisomerase 2-beta,
ZK-805623,Trypsin-1,CC1=C(F)C(OC2=CC(=CC=C2)C(N)=N)=[NH+]C(OC2=CC=CC(=C2)C(N)=N)=C1F
ZK-806711,Trypsin-1,[H]N=C(C)N1CCC(CC1)OC1=CC2=C(C=C1)N=C(C)N2CC1=CC2=C(C=C1)C=CC(=C2)C(N)=[NH2+]
Zafirlukast,Cysteinyl leukotriene receptor 1,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C
Zalcitabine,Reverse transcriptase/RNaseH,NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1
Zaleplon,Gamma-aminobutyric acid receptor subunit alpha-1,CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N
Zaleplon,Translocator protein,CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N
Zalutumumab,Epidermal growth factor receptor,
Zanamivir,Neuraminidase,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
Zanamivir,Neuraminidase,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
Zanamivir,Sialidase-2,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
Zanapezil,Acetylcholinesterase,O=C(CCC1CCN(CC2=CC=CC=C2)CC1)C1=CC2=C(CCCCN2)C=C1
Zardaverine,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",COC1=CC(=CC=C1OC(F)F)C1=NNC(=O)C=C1
Zebularine,Cytidine deaminase,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC=NC1=O
Zenarestat,Aldose reductase,OC(=O)CN1C(=O)N(CC2=C(F)C=C(Br)C=C2)C(=O)C2=C1C=C(Cl)C=C2
Zeranol,Estrogen receptor,C[C@H]1CCC[C@H](O)CCCCCC2=CC(O)=CC(O)=C2C(=O)O1
Zeranol,Sex hormone-binding globulin,C[C@H]1CCC[C@H](O)CCCCCC2=CC(O)=CC(O)=C2C(=O)O1
Zidovudine,Reverse transcriptase/RNaseH,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
Zidovudine,Telomerase reverse transcriptase,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
Zileuton,Arachidonate 5-lipoxygenase,CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1
Zimelidine,Sodium-dependent serotonin transporter,CN(C)C\C=C(\C1=CC=C(Br)C=C1)C1=CC=CN=C1
Zimelidine,Amine oxidase [flavin-containing] B,CN(C)C\C=C(\C1=CC=C(Br)C=C1)C1=CC=CN=C1
Zimelidine,Amine oxidase [flavin-containing] A,CN(C)C\C=C(\C1=CC=C(Br)C=C1)C1=CC=CN=C1
Zinc,B1 bradykinin receptor,[Zn]
Zinc,Methylated-DNA--protein-cysteine methyltransferase,[Zn]
Zinc,Fructose-bisphosphate aldolase A,[Zn]
Zinc,Elongation factor 1-alpha 1,[Zn]
Zinc,Alpha-enolase,[Zn]
Zinc,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",[Zn]
Zinc,Nucleoside diphosphate kinase A,[Zn]
Zinc,Protein disulfide-isomerase,[Zn]
Zinc,Protein disulfide-isomerase A3,[Zn]
Zinc,Peroxiredoxin-1,[Zn]
Zinc,Phosphoserine phosphatase,[Zn]
Zinc,Triosephosphate isomerase,[Zn]
Zinc,"Elongation factor Tu, mitochondrial",[Zn]
Zinc,Estrogen receptor,[Zn]
Zinc,Interleukin-3,[Zn]
Zinc,Metallothionein-2,[Zn]
Zinc,Copper chaperone for superoxide dismutase,[Zn]
Zinc,Histone deacetylase 1,[Zn]
Zinc,Histone deacetylase 4,[Zn]
Zinc,DNA-3-methyladenine glycosylase,[Zn]
Zinc,Semenogelin-1,[Zn]
Zinc,Superoxide dismutase [Cu-Zn],[Zn]
Zinc,Histone deacetylase 8,[Zn]
Zinc,Apoptosis regulatory protein Siva,[Zn]
Zinc,Glycine receptor subunit alpha-1,[Zn]
Zinc,E3 ubiquitin-protein ligase Mdm2,[Zn]
Zinc,Insulin,[Zn]
Zinc,Utrophin,[Zn]
Zinc,Aspartoacylase,[Zn]
Zinc,Protein S100-A8,[Zn]
Zinc,Protein S100-A9,[Zn]
Zinc,Matrix metalloproteinase-9,[Zn]
Zinc,Tumor protein p73,[Zn]
Zinc,Protein S100-A2,[Zn]
Zinc,Cellular tumor antigen p53,[Zn]
Zinc,Metallothionein-3,[Zn]
Zinc,Programmed cell death protein 6,[Zn]
Zinc,DAN domain family member 5,[Zn]
Zinc,Metallothionein-1A,[Zn]
Zinc,Alpha-1B-glycoprotein,[Zn]
Zinc,Alpha-2-macroglobulin,[Zn]
Zinc,Angiotensinogen,[Zn]
Zinc,Alpha-2-HS-glycoprotein,[Zn]
Zinc,Serum amyloid P-component,[Zn]
Zinc,Apolipoprotein A-I,[Zn]
Zinc,Apolipoprotein A-II,[Zn]
Zinc,Apolipoprotein A-IV,[Zn]
Zinc,Apolipoprotein B receptor,[Zn]
Zinc,Apolipoprotein E,[Zn]
Zinc,Apolipoprotein L1,[Zn]
Zinc,Complement C1q subcomponent subunit B,[Zn]
Zinc,Complement C1q subcomponent subunit C,[Zn]
Zinc,Complement C1r subcomponent,[Zn]
Zinc,Complement C1s subcomponent,[Zn]
Zinc,Complement C3,[Zn]
Zinc,Complement C4-B,[Zn]
Zinc,C4b-binding protein alpha chain,[Zn]
Zinc,C4b-binding protein beta chain,[Zn]
Zinc,Complement C5,[Zn]
Zinc,Lys-63-specific deubiquitinase BRCC36,[Zn]
Zinc,Complement component C8 alpha chain,[Zn]
Zinc,Complement component C8 beta chain,[Zn]
Zinc,Complement component C8 gamma chain,[Zn]
Zinc,Complement factor B,[Zn]
Zinc,Complement factor H,[Zn]
Zinc,Complement factor I,[Zn]
Zinc,Clusterin,[Zn]
Zinc,Ceruloplasmin,[Zn]
Zinc,Carboxypeptidase N catalytic chain,[Zn]
Zinc,Carboxypeptidase N subunit 2,[Zn]
Zinc,Dermcidin,[Zn]
Zinc,Desmoplakin,[Zn]
Zinc,Coagulation factor XII,[Zn]
Zinc,Coagulation factor XIII B chain,[Zn]
Zinc,Prothrombin,[Zn]
Zinc,Ficolin-3,[Zn]
Zinc,Fibrinogen alpha chain,[Zn]
Zinc,Fibronectin,[Zn]
Zinc,Gelsolin,[Zn]
Zinc,Hemoglobin subunit alpha,[Zn]
Zinc,Hemoglobin subunit beta,[Zn]
Zinc,Haptoglobin-related protein,[Zn]
Zinc,Hornerin,[Zn]
Zinc,Insulin-like growth factor-binding protein complex acid labile subunit,[Zn]
Zinc,Ig alpha-1 chain C region,[Zn]
Zinc,Ig mu chain C region,[Zn]
Zinc,Immunoglobulin kappa variable 1-17,[Zn]
Zinc,Ig kappa chain V-III region GOL,[Zn]
Zinc,Immunoglobulin lambda variable 3-21,[Zn]
Zinc,Inter-alpha-trypsin inhibitor heavy chain H1,[Zn]
Zinc,Inter-alpha-trypsin inhibitor heavy chain H2,[Zn]
Zinc,Inter-alpha-trypsin inhibitor heavy chain H3,[Zn]
Zinc,Inter-alpha-trypsin inhibitor heavy chain H4,[Zn]
Zinc,Immunoglobulin J chain,[Zn]
Zinc,Junction plakoglobin,[Zn]
Zinc,Plasma kallikrein,[Zn]
Zinc,Kininogen-1,[Zn]
Zinc,"Keratin, type II cytoskeletal 1",[Zn]
Zinc,"Keratin, type I cytoskeletal 10",[Zn]
Zinc,"Keratin, type I cytoskeletal 14",[Zn]
Zinc,"Keratin, type I cytoskeletal 16",[Zn]
Zinc,"Keratin, type II cytoskeletal 2 epidermal",[Zn]
Zinc,"Keratin, type II cytoskeletal 5",[Zn]
Zinc,"Keratin, type II cytoskeletal 6A",[Zn]
Zinc,"Keratin, type I cytoskeletal 9",[Zn]
Zinc,Alpha-1-acid glycoprotein 2,[Zn]
Zinc,N-acetylmuramoyl-L-alanine amidase,[Zn]
Zinc,Serum paraoxonase/arylesterase 1,[Zn]
Zinc,Pregnancy zone protein,[Zn]
Zinc,Protein S100-A7,[Zn]
Zinc,Selenoprotein P,[Zn]
Zinc,Alpha-1-antitrypsin,[Zn]
Zinc,Alpha-1-antichymotrypsin,[Zn]
Zinc,Kallistatin,[Zn]
Zinc,Corticosteroid-binding globulin,[Zn]
Zinc,Heparin cofactor 2,[Zn]
Zinc,Sex hormone-binding globulin,[Zn]
Zinc,Serotransferrin,[Zn]
Zinc,Transthyretin,[Zn]
Zinc,Vitronectin,[Zn]
Zinc,Amyloid-like protein 1,[Zn]
Zinc,Amyloid-like protein 2,[Zn]
Zinc,Amyloid beta A4 protein,[Zn]
Zinc,Poly [ADP-ribose] polymerase 1,[Zn]
Zinc Substituted Heme C,Cytochrome c,[Zn+4].[H]\C(C)=C1\C(C)=C2[N-]\C\1=C([H])/C1=C(C)C(=C([H])C)\C([N-]1)=C([H])\C1=C(C)C(CCC(O)=O)=C([N-]1)\C([H])=C1/[N-]\C(=C/2\[H])C(C)=C1CCC(O)=O
Zinc Trihydroxide,Glutathione S-transferase Mu 1,O[Zn-](O)O
Zinc acetate,B1 bradykinin receptor,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Methylated-DNA--protein-cysteine methyltransferase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Fructose-bisphosphate aldolase A,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Elongation factor 1-alpha 1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Alpha-enolase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Nucleoside diphosphate kinase A,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Protein disulfide-isomerase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Protein disulfide-isomerase A3,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Peroxiredoxin-1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Phosphoserine phosphatase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Triosephosphate isomerase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Elongation factor Tu, mitochondrial",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Estrogen receptor,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Interleukin-3,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Metallothionein-2,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Copper chaperone for superoxide dismutase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Histone deacetylase 1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Histone deacetylase 4,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,DNA-3-methyladenine glycosylase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Semenogelin-1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Superoxide dismutase [Cu-Zn],[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Histone deacetylase 8,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Apoptosis regulatory protein Siva,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Glycine receptor subunit alpha-1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,E3 ubiquitin-protein ligase Mdm2,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Insulin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Utrophin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Aspartoacylase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Protein S100-A8,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Protein S100-A9,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Matrix metalloproteinase-9,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Tumor protein p73,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Protein S100-A2,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Cellular tumor antigen p53,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Metallothionein-3,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Programmed cell death protein 6,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,DAN domain family member 5,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Metallothionein-1A,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Alpha-1B-glycoprotein,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Alpha-2-macroglobulin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Angiotensinogen,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Alpha-2-HS-glycoprotein,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Serum amyloid P-component,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Apolipoprotein A-I,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Apolipoprotein A-II,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Apolipoprotein A-IV,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Apolipoprotein B receptor,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Apolipoprotein E,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Apolipoprotein L1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement C1q subcomponent subunit B,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement C1q subcomponent subunit C,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement C1r subcomponent,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement C1s subcomponent,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement C3,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement C4-B,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,C4b-binding protein alpha chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,C4b-binding protein beta chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement C5,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Lys-63-specific deubiquitinase BRCC36,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement component C8 alpha chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement component C8 beta chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement component C8 gamma chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement factor B,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement factor H,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Complement factor I,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Clusterin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Ceruloplasmin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Carboxypeptidase N catalytic chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Carboxypeptidase N subunit 2,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Dermcidin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Desmoplakin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Coagulation factor XII,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Coagulation factor XIII B chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Prothrombin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Ficolin-3,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Fibrinogen alpha chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Fibronectin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Gelsolin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Hemoglobin subunit alpha,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Hemoglobin subunit beta,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Haptoglobin-related protein,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Hornerin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Insulin-like growth factor-binding protein complex acid labile subunit,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Ig alpha-1 chain C region,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Ig mu chain C region,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Immunoglobulin kappa variable 1-17,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Ig kappa chain V-III region GOL,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Immunoglobulin lambda variable 3-21,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Inter-alpha-trypsin inhibitor heavy chain H1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Inter-alpha-trypsin inhibitor heavy chain H2,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Inter-alpha-trypsin inhibitor heavy chain H3,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Inter-alpha-trypsin inhibitor heavy chain H4,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Immunoglobulin J chain,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Junction plakoglobin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Plasma kallikrein,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Kininogen-1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Keratin, type II cytoskeletal 1",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Keratin, type I cytoskeletal 10",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Keratin, type I cytoskeletal 14",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Keratin, type I cytoskeletal 16",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Keratin, type II cytoskeletal 2 epidermal",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Keratin, type II cytoskeletal 5",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Keratin, type II cytoskeletal 6A",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,"Keratin, type I cytoskeletal 9",[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Alpha-1-acid glycoprotein 2,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,N-acetylmuramoyl-L-alanine amidase,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Serum paraoxonase/arylesterase 1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Pregnancy zone protein,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Protein S100-A7,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Selenoprotein P,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Alpha-1-antitrypsin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Alpha-1-antichymotrypsin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Kallistatin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Corticosteroid-binding globulin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Heparin cofactor 2,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Sex hormone-binding globulin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Serotransferrin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Transthyretin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Vitronectin,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Amyloid-like protein 1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Amyloid-like protein 2,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Amyloid beta A4 protein,[Zn++].CC([O-])=O.CC([O-])=O
Zinc acetate,Poly [ADP-ribose] polymerase 1,[Zn++].CC([O-])=O.CC([O-])=O
Zinc chloride,B1 bradykinin receptor,[Cl-].[Cl-].[Zn++]
Zinc chloride,Methylated-DNA--protein-cysteine methyltransferase,[Cl-].[Cl-].[Zn++]
Zinc chloride,Fructose-bisphosphate aldolase A,[Cl-].[Cl-].[Zn++]
Zinc chloride,Elongation factor 1-alpha 1,[Cl-].[Cl-].[Zn++]
Zinc chloride,Alpha-enolase,[Cl-].[Cl-].[Zn++]
Zinc chloride,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",[Cl-].[Cl-].[Zn++]
Zinc chloride,Nucleoside diphosphate kinase A,[Cl-].[Cl-].[Zn++]
Zinc chloride,Protein disulfide-isomerase,[Cl-].[Cl-].[Zn++]
Zinc chloride,Protein disulfide-isomerase A3,[Cl-].[Cl-].[Zn++]
Zinc chloride,Peroxiredoxin-1,[Cl-].[Cl-].[Zn++]
Zinc chloride,Phosphoserine phosphatase,[Cl-].[Cl-].[Zn++]
Zinc chloride,Triosephosphate isomerase,[Cl-].[Cl-].[Zn++]
Zinc chloride,"Elongation factor Tu, mitochondrial",[Cl-].[Cl-].[Zn++]
Zinc chloride,Estrogen receptor,[Cl-].[Cl-].[Zn++]
Zinc chloride,Interleukin-3,[Cl-].[Cl-].[Zn++]
Zinc chloride,Metallothionein-2,[Cl-].[Cl-].[Zn++]
Zinc chloride,Copper chaperone for superoxide dismutase,[Cl-].[Cl-].[Zn++]
Zinc chloride,Histone deacetylase 1,[Cl-].[Cl-].[Zn++]
Zinc chloride,Histone deacetylase 4,[Cl-].[Cl-].[Zn++]
Zinc chloride,DNA-3-methyladenine glycosylase,[Cl-].[Cl-].[Zn++]
Zinc chloride,Semenogelin-1,[Cl-].[Cl-].[Zn++]
Zinc chloride,Superoxide dismutase [Cu-Zn],[Cl-].[Cl-].[Zn++]
Zinc chloride,Histone deacetylase 8,[Cl-].[Cl-].[Zn++]
Zinc chloride,Apoptosis regulatory protein Siva,[Cl-].[Cl-].[Zn++]
Zinc chloride,Glycine receptor subunit alpha-1,[Cl-].[Cl-].[Zn++]
Zinc chloride,E3 ubiquitin-protein ligase Mdm2,[Cl-].[Cl-].[Zn++]
Zinc chloride,Insulin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Utrophin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Aspartoacylase,[Cl-].[Cl-].[Zn++]
Zinc chloride,Protein S100-A8,[Cl-].[Cl-].[Zn++]
Zinc chloride,Protein S100-A9,[Cl-].[Cl-].[Zn++]
Zinc chloride,Matrix metalloproteinase-9,[Cl-].[Cl-].[Zn++]
Zinc chloride,Tumor protein p73,[Cl-].[Cl-].[Zn++]
Zinc chloride,Protein S100-A2,[Cl-].[Cl-].[Zn++]
Zinc chloride,Cellular tumor antigen p53,[Cl-].[Cl-].[Zn++]
Zinc chloride,Metallothionein-3,[Cl-].[Cl-].[Zn++]
Zinc chloride,Programmed cell death protein 6,[Cl-].[Cl-].[Zn++]
Zinc chloride,DAN domain family member 5,[Cl-].[Cl-].[Zn++]
Zinc chloride,Metallothionein-1A,[Cl-].[Cl-].[Zn++]
Zinc chloride,Alpha-1B-glycoprotein,[Cl-].[Cl-].[Zn++]
Zinc chloride,Alpha-2-macroglobulin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Angiotensinogen,[Cl-].[Cl-].[Zn++]
Zinc chloride,Alpha-2-HS-glycoprotein,[Cl-].[Cl-].[Zn++]
Zinc chloride,Serum amyloid P-component,[Cl-].[Cl-].[Zn++]
Zinc chloride,Apolipoprotein A-I,[Cl-].[Cl-].[Zn++]
Zinc chloride,Apolipoprotein A-II,[Cl-].[Cl-].[Zn++]
Zinc chloride,Apolipoprotein A-IV,[Cl-].[Cl-].[Zn++]
Zinc chloride,Apolipoprotein B receptor,[Cl-].[Cl-].[Zn++]
Zinc chloride,Apolipoprotein E,[Cl-].[Cl-].[Zn++]
Zinc chloride,Apolipoprotein L1,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement C1q subcomponent subunit B,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement C1q subcomponent subunit C,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement C1r subcomponent,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement C1s subcomponent,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement C3,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement C4-B,[Cl-].[Cl-].[Zn++]
Zinc chloride,C4b-binding protein alpha chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,C4b-binding protein beta chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement C5,[Cl-].[Cl-].[Zn++]
Zinc chloride,Lys-63-specific deubiquitinase BRCC36,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement component C8 alpha chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement component C8 beta chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement component C8 gamma chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement factor B,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement factor H,[Cl-].[Cl-].[Zn++]
Zinc chloride,Complement factor I,[Cl-].[Cl-].[Zn++]
Zinc chloride,Clusterin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Ceruloplasmin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Carboxypeptidase N catalytic chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,Carboxypeptidase N subunit 2,[Cl-].[Cl-].[Zn++]
Zinc chloride,Dermcidin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Desmoplakin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Coagulation factor XII,[Cl-].[Cl-].[Zn++]
Zinc chloride,Coagulation factor XIII B chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,Prothrombin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Ficolin-3,[Cl-].[Cl-].[Zn++]
Zinc chloride,Fibrinogen alpha chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,Fibronectin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Gelsolin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Hemoglobin subunit alpha,[Cl-].[Cl-].[Zn++]
Zinc chloride,Hemoglobin subunit beta,[Cl-].[Cl-].[Zn++]
Zinc chloride,Haptoglobin-related protein,[Cl-].[Cl-].[Zn++]
Zinc chloride,Hornerin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Insulin-like growth factor-binding protein complex acid labile subunit,[Cl-].[Cl-].[Zn++]
Zinc chloride,Ig alpha-1 chain C region,[Cl-].[Cl-].[Zn++]
Zinc chloride,Ig mu chain C region,[Cl-].[Cl-].[Zn++]
Zinc chloride,Immunoglobulin kappa variable 1-17,[Cl-].[Cl-].[Zn++]
Zinc chloride,Ig kappa chain V-III region GOL,[Cl-].[Cl-].[Zn++]
Zinc chloride,Immunoglobulin lambda variable 3-21,[Cl-].[Cl-].[Zn++]
Zinc chloride,Inter-alpha-trypsin inhibitor heavy chain H1,[Cl-].[Cl-].[Zn++]
Zinc chloride,Inter-alpha-trypsin inhibitor heavy chain H2,[Cl-].[Cl-].[Zn++]
Zinc chloride,Inter-alpha-trypsin inhibitor heavy chain H3,[Cl-].[Cl-].[Zn++]
Zinc chloride,Inter-alpha-trypsin inhibitor heavy chain H4,[Cl-].[Cl-].[Zn++]
Zinc chloride,Immunoglobulin J chain,[Cl-].[Cl-].[Zn++]
Zinc chloride,Junction plakoglobin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Plasma kallikrein,[Cl-].[Cl-].[Zn++]
Zinc chloride,Kininogen-1,[Cl-].[Cl-].[Zn++]
Zinc chloride,"Keratin, type II cytoskeletal 1",[Cl-].[Cl-].[Zn++]
Zinc chloride,"Keratin, type I cytoskeletal 10",[Cl-].[Cl-].[Zn++]
Zinc chloride,"Keratin, type I cytoskeletal 14",[Cl-].[Cl-].[Zn++]
Zinc chloride,"Keratin, type I cytoskeletal 16",[Cl-].[Cl-].[Zn++]
Zinc chloride,"Keratin, type II cytoskeletal 2 epidermal",[Cl-].[Cl-].[Zn++]
Zinc chloride,"Keratin, type II cytoskeletal 5",[Cl-].[Cl-].[Zn++]
Zinc chloride,"Keratin, type II cytoskeletal 6A",[Cl-].[Cl-].[Zn++]
Zinc chloride,"Keratin, type I cytoskeletal 9",[Cl-].[Cl-].[Zn++]
Zinc chloride,Alpha-1-acid glycoprotein 2,[Cl-].[Cl-].[Zn++]
Zinc chloride,N-acetylmuramoyl-L-alanine amidase,[Cl-].[Cl-].[Zn++]
Zinc chloride,Serum paraoxonase/arylesterase 1,[Cl-].[Cl-].[Zn++]
Zinc chloride,Pregnancy zone protein,[Cl-].[Cl-].[Zn++]
Zinc chloride,Protein S100-A7,[Cl-].[Cl-].[Zn++]
Zinc chloride,Selenoprotein P,[Cl-].[Cl-].[Zn++]
Zinc chloride,Alpha-1-antitrypsin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Alpha-1-antichymotrypsin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Kallistatin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Corticosteroid-binding globulin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Heparin cofactor 2,[Cl-].[Cl-].[Zn++]
Zinc chloride,Sex hormone-binding globulin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Serotransferrin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Transthyretin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Vitronectin,[Cl-].[Cl-].[Zn++]
Zinc chloride,Amyloid-like protein 1,[Cl-].[Cl-].[Zn++]
Zinc chloride,Amyloid-like protein 2,[Cl-].[Cl-].[Zn++]
Zinc chloride,Amyloid beta A4 protein,[Cl-].[Cl-].[Zn++]
Zinc chloride,Poly [ADP-ribose] polymerase 1,[Cl-].[Cl-].[Zn++]
Ziprasidone,D(2) dopamine receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,D(1A) dopamine receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,D(1B) dopamine receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 2A,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,D(3) dopamine receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,D(4) dopamine receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 1A,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 1B,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 1D,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 1E,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 2C,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 3A,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 6,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,5-hydroxytryptamine receptor 7,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Histamine H1 receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Alpha-1A adrenergic receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Alpha-1B adrenergic receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Alpha-2A adrenergic receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Alpha-2B adrenergic receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Alpha-2C adrenergic receptor,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Muscarinic acetylcholine receptor M1,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Muscarinic acetylcholine receptor M2,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Muscarinic acetylcholine receptor M3,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Muscarinic acetylcholine receptor M4,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Ziprasidone,Muscarinic acetylcholine receptor M5,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
Zk-806450,Trypsin-1,CC(=N)N1CCC(CC1)OC1=CC=C2C(=C1)N(CC1=CC=C3C=CC(=CC3=C1)C(N)=N)C1=C2C=CC=C1
Zofenopril,Angiotensin-converting enzyme,C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1=CC=CC=C1
Zofenoprilat,Cytosol aminopeptidase,C[C@H](CS)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1=CC=CC=C1
Zoledronic acid,Farnesyl pyrophosphate synthase,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
Zoledronic acid,Geranylgeranyl pyrophosphate synthase,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
Zolmitriptan,5-hydroxytryptamine receptor 1B,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12
Zolmitriptan,5-hydroxytryptamine receptor 1D,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12
Zolmitriptan,5-hydroxytryptamine receptor 1F,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12
Zolmitriptan,5-hydroxytryptamine receptor 1A,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12
Zolpidem,Gamma-aminobutyric acid receptor subunit alpha-1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
Zolpidem,Gamma-aminobutyric acid receptor subunit alpha-2,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
Zolpidem,Gamma-aminobutyric acid receptor subunit alpha-3,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
Zolpidem,Gamma-aminobutyric acid receptor subunit gamma-2,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1
Zomepirac,Prostaglandin D2 receptor 2,CN1C(CC(O)=O)=CC(C)=C1C(=O)C1=CC=C(Cl)C=C1
Zonisamide,Sodium channel protein type 1 subunit alpha,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel protein type 2 subunit alpha,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel protein type 3 subunit alpha,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel protein type 4 subunit alpha,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel protein type 5 subunit alpha,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel protein type 9 subunit alpha,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel protein type 11 subunit alpha,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel subunit beta-1,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel subunit beta-2,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel subunit beta-3,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Sodium channel subunit beta-4,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Voltage-dependent T-type calcium channel subunit alpha-1G,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Voltage-dependent T-type calcium channel subunit alpha-1H,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Voltage-dependent T-type calcium channel subunit alpha-1I,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 1,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 2,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 3,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 4,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,"Carbonic anhydrase 5A, mitochondrial",NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,"Carbonic anhydrase 5B, mitochondrial",NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 6,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 7,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase-related protein,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 9,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase-related protein 10,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase-related protein 11,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 12,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 13,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Carbonic anhydrase 14,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Amine oxidase [flavin-containing] B,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zonisamide,Amine oxidase [flavin-containing] A,NS(=O)(=O)CC1=NOC2=CC=CC=C12
Zopiclone,Gamma-aminobutyric acid receptor subunit alpha-1,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Zopiclone,Gamma-aminobutyric acid receptor subunit alpha-2,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Zopiclone,Gamma-aminobutyric acid receptor subunit alpha-3,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Zopiclone,Gamma-aminobutyric acid receptor subunit alpha-5,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Zopiclone,Translocator protein,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
Zosuquidar,Multidrug resistance protein 1,[H][C@]12C3=CC=CC=C3[C@H](N3CCN(C[C@@H](O)COC4=CC=CC5=C4C=CC=N5)CC3)C3=CC=CC=C3[C@@]1([H])C2(F)F
Zotepine,D(1A) dopamine receptor,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12
Zotepine,D(1B) dopamine receptor,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12
Zotepine,D(2) dopamine receptor,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12
Zotepine,5-hydroxytryptamine receptor 2A,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12
Zotepine,5-hydroxytryptamine receptor 6,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12
Zotepine,5-hydroxytryptamine receptor 7,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12
Zotepine,Sodium-dependent noradrenaline transporter,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12
Zotepine,Sodium-dependent serotonin transporter,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12
Zucapsaicin,Transient receptor potential cation channel subfamily V member 1,COC1=C(O)C=CC(CNC(=O)CCCC\C=C/C(C)C)=C1
Zuclopenthixol,D(1A) dopamine receptor,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Zuclopenthixol,D(1B) dopamine receptor,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Zuclopenthixol,D(2) dopamine receptor,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Zuclopenthixol,Alpha-1A adrenergic receptor,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Zuclopenthixol,Alpha-2A adrenergic receptor,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Zuclopenthixol,5-hydroxytryptamine receptor 2A,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
Zuclopenthixol,Histamine H1 receptor,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1
[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,Trypsin-1,CCOC(=O)CO\N=C(\C1=CC=CC=N1)C1(CC1)C1=CC=C2N(C)C(CNC3=CC=C(C=C3)C(N)=N)=NC2=C1
[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron,Subtilisin Carlsberg,[H][C@](N)(CO[B-](O)(O)[C@]([H])(CC1=CC=C(Cl)C=C1)N=C(C)O)C(O)=O
[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,Chymase,[H][C@@](C(=O)NC1=CC=C2C=CC=CC2=C1)(C1=CSC2=C1C=C(Cl)C=C2)P(O)(O)=O
[(1S)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron,Subtilisin Carlsberg,CC(=O)N[C@H](CC1=CC=C(Cl)C=C1)[B-](O)(O)OC[C@H](N)C(O)=O
[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID,Beta-lactamase TEM,CO\N=C(/C(=O)NCB(O)O)C1=CSC(N)=N1
[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,Beta-lactamase TEM,CCOC1=C(C(=O)NCB(O)O)C2=C(C=CC=C2)C=C1
[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,Beta-lactamase,CCOC1=C(C(=O)NCB(O)O)C2=C(C=CC=C2)C=C1
[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,Beta-lactamase TEM,CCOC1=C(C(=O)NCB(O)O)C2=C(C=CC=C2)C=C1
"[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid",Carboxylesterase,[H][C@@]1(CC(O)=O)NC2=CC=CC=C2CN(C)C1=O
"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",GTPase KRas,CC(C)=CCC\C(C)=C\CC\C(C)=C\CONC(=O)CP(O)(O)=O
"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,CC(C)=CCC\C(C)=C\CC\C(C)=C\CONC(=O)CP(O)(O)=O
"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",Protein farnesyltransferase subunit beta,CC(C)=CCC\C(C)=C\CC\C(C)=C\CONC(=O)CP(O)(O)=O
"[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",Tyrosine-protein phosphatase non-receptor type 1,[H]N(C)C(=O)[C@H]1CC2=C(CN1C(=O)OC(C)(C)C)C=C(C=C2)N([H])S(O)(=O)=O
"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",Phenylethanolamine N-methyltransferase,[H][C@]1(CO)CC2=CC=C(C=C2CN1)[N+]([O-])=O
"[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID",Type I polyketide synthase PikAIV,[H][C@](C)(C(=O)C[P@]([H])(O)=O)[C@@]([H])(O)CC
"[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID",Type I polyketide synthase PikAIV,[H][C@](C)(CO)C[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C[P@@]([H])(O)=O
"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",Tyrosine-protein phosphatase non-receptor type 1,CNC(=O)[C@@H]1CC2=CC=C(NS(O)(=O)=O)C=C2CN1C(=O)OC(C)(C)C
"[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid",ActII protein,[H][C@@]1(CC(O)=O)CC2=CC3=C(C(O)=CC=C3)C(=O)C2=C(C)O1
[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,Tyrosine-protein phosphatase non-receptor type 1,OP(O)(=O)C(F)(F)C1=CC=C(CCCCC2=CC=C(C=C2)C(F)(F)P(O)(O)=O)C=C1
"[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate",Lipase EstA,CC1(C)OC[C@@H](COP(O)(=O)CCCCC=C)O1
"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",Kinesin-like protein KIF11,[H][C@@]1(NC(=S)N(C)C(C)=C1C(=O)C1=CC=CC=C1)C1=CC(O)=CC=C1
"[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate",Lipase EstA,CC1(C)OC[C@H](COP(O)(=O)CCCCC=C)O1
"[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",DNA polymerase III subunit beta,[H][C@]1(CC2=C(Br)C(Br)=C(O)C(OCC)=C2)SC(=S)N(CC(O)=O)C1=O
[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,Cruzipain,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)C(=O)CO
[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,Cathepsin F,[H][C@@](CC1=CC=CC=C1)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)C(=O)CO
"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",Cruzipain,[H][C@@](C)(NC(=O)[C@@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)\C=C\C(=O)C=O
"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",Cathepsin F,[H][C@@](C)(NC(=O)[C@@]([H])(CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)\C=C\C(=O)C=O
[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,Chymotrypsin-like elastase family member 1,[H][C@](NC(=O)OC(C)(C)C)(C(C)C)C(=O)NC1=CC=CC(Cl)=C1C=O
[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,Cruzipain,[H][C@@](CCC1=CC=CC=C1)(N=C(O)[C@]([H])(CC1=CC=CC=C1)N=C(O)OCC1=CN=CC=C1)C(=O)CO
[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,Cathepsin K,[H][C@@](CCCC)(NC(=O)OCC1(CC2=CC=C(F)C=C2)CCC1)C(=O)C(=O)NC1=CC=NN1
[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,Casein kinase II subunit alpha',CC(C)NC1=CC2=C(C=NN2C2=NC(=CN=C2)N2C=CC(CC(O)=O)=C2)C=C1
"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)","Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",OC(COC1=CC=CC(=C1)C1=CC=CC(=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O
"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",Coagulation factor VII,NC(=O)NCC1=CC(=CC=C1)C1=C(O)C(=CC=C1)C1=CC2=C(N1)C=CN=C2
"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",Tissue factor,NC(=O)NCC1=CC(=CC=C1)C1=C(O)C(=CC=C1)C1=CC2=C(N1)C=CN=C2
[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid,Triosephosphate isomerase,ON(CCP(O)(O)=O)C=O
"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",Neprilysin,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@@]([H])(S)CCCCC)C(O)=O
"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",Thermolysin,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@@]([H])(S)CCCCC)C(O)=O
"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",Thermolysin,[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=CC=C1)NC(=O)[C@@]([H])(S)CCCCC)C(O)=O
"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",Urokinase-type plasminogen activator,[H][C@@](CC1=CC(=CC=C1)C(N)=N)(NS(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C)C(=O)N1CCN(CC1)C(=O)CCN
[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,Geranylgeranyl pyrophosphate synthase,OC(CC1=CC(=CC=C1)C1=CC=CC2=C1OC1=C2C=CC=C1)(P(O)(O)=O)P(O)(O)=O
[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",OC(CC1=CC(=CC=C1)C1=CC=CC2=C1OC1=C2C=CC=C1)(P(O)(O)=O)P(O)(O)=O
"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",Stromelysin-1,[H][C@](CC(=O)NC1=NN=C(S)S1)(NC(=O)OCC1=CC=CC=C1)C1=CC=CC=C1
"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",Cyclin-dependent kinase 2,NC1=C(N2C=C(C=CC2=N1)C(=O)C1=C(F)C=CC=C1F)C(=O)C1=CC=CC=C1
"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",Thyroid hormone receptor beta,OC(O)CC1=CC(Br)=C(OC2=CC(C(O)NCCC3=CC=CC=C3)=C(O)C=C2)C(Br)=C1
"[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine",Trypsin-3,NC(=[NH2+])NCCCOB1OCCO1
[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,"Phospholipase A2, membrane associated",CC1=C(CC(N)=O)C2=C(C=CC(OCCCP(O)(O)=O)=C2)N1CC1=CC=CC=C1
[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium,ADP/ATP translocase 1,CCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-]
"[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]",Xanthan lyase,C[C@@]1(OC[C@H]2O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]2O1)C(O)=O
"[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine",Trypsin-3,NC(=[NH2+])C1=CC=C(COB2OCCO2)C=C1
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,Cyclin-dependent kinase 2,CC1=C(SC(N)=N1)C1=NC(NC2=CC=CC(=C2)[N+]([O-])=O)=NC=C1
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,Cyclin-A2,CC1=C(SC(N)=N1)C1=NC(NC2=CC=CC(=C2)[N+]([O-])=O)=NC=C1
[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,Tryptase beta-2,NCC1=CC=CC(=C1)C1CCN(CC1)C(=O)C1=CC(CCC2=CC=CC=C2)=CN=C1
"[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID",Ig kappa chain C region,[H][C@]12C(=O)N(C(=O)[C@@]1([H])[C@@]1(CC[C@@]2([H])CC1)NC(=O)OCC(O)=O)C1=CC=C(NC(C)=O)C=C1
[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,Stromelysin-1,OC(=O)CNS(=O)(=O)C1=CC=C(C=C1)N1CCC(CC1)C1=CC=CC=C1
"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",Serine/threonine-protein kinase Sgk1,OC(=O)CC1=CC=C(C=C1)C1=CNC2=NC=C(C=C12)C1=CC=C2C=CC=CC2=C1
"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",Trypsin-1,ClC1=CC=C2C=C(C=CC2=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1CCN(CC1)C1=CC=NC=C1
"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",STE20-like serine/threonine-protein kinase,[H]C1(CC#N)C=CC(C=C1)=NC1=NC2=CC=CC=C2C(N=C2NNC(=C2)C2CC2)=N1
"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",Calcium/calmodulin-dependent protein kinase type II subunit delta,[H]C1(CC#N)C=CC(C=C1)=NC1=NC2=CC=CC=C2C(N=C2NNC(=C2)C2CC2)=N1
"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",Serine/threonine-protein kinase 26,[H]C1(CC#N)C=CC(C=C1)=NC1=NC2=CC=CC=C2C(N=C2NNC(=C2)C2CC2)=N1
[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,Calcium/calmodulin-dependent protein kinase type II subunit beta,CNC1=NC(NC2=CC=C(CC#N)C=C2)=NC(NC2=NNC(=C2)C2CC2)=C1
[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,Proto-oncogene tyrosine-protein kinase Src,N#CCC1=CC=C(NC2=NC3=CC=CC=C3C(NC3=NNC(=C3)C3CC3)=N2)C=C1
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,Mitogen-activated protein kinase 1,CC1=CC(NC2=NC(NC3=CC=C(CC(O)=O)C=C3)=NC=C2C(N)=O)=CC=C1
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,Insulin receptor,CC1=CC(NC2=NC(NC3=CC=C(CC(O)=O)C=C3)=NC=C2C(N)=O)=CC=C1
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,Insulin receptor substrate 1,CC1=CC(NC2=NC(NC3=CC=C(CC(O)=O)C=C3)=NC=C2C(N)=O)=CC=C1
[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,Trypsin-1,C[N+](C)(C)C1=CC=C(CNC(=O)C2=CC3=C(C=CC(OCC4=CC=CC=C4)=C3)N2CC2=CC=CC(=C2)C(N)=N)C=C1
"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",Gag-Pol polyprotein,[H][C@]1(CC2=CC=CC=C2)N(CC=C)C(=O)N(CC=C)[C@]([H])(CC2=CC=CC=C2)[C@]([H])(O)[C@@]1([H])O
"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",Serine/threonine-protein kinase Chk1,CC(C)(C)NC1=NC(N)=C(S1)C(=O)C1=CC=CC=C1
"[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid",Coagulation factor VII,NC1=CC=C2NC(=CC2=N1)C1=CC(CC(O)=O)=CC(=C1O)C1=CC=CC(=C1)[N+]([O-])=O
"[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid",Tissue factor,NC1=CC=C2NC(=CC2=N1)C1=CC(CC(O)=O)=CC(=C1O)C1=CC=CC(=C1)[N+]([O-])=O
"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",Mitogen-activated protein kinase 14,[H][C@](O)(CO)COC1=CC(=CC=C1)C(=O)C1=C(N)N(N=C1)C1=CC=C(F)C=C1
[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,Mitogen-activated protein kinase 14,NC1=C(C=NN1C1=CC=C(F)C=C1)C(=O)C1=CC(OC2CCNCC2)=CC=C1
[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,Estrogen receptor beta,OC1=CC=C(C=C1)C1=CC2=C(O1)C(CC#N)=CC(O)=C2
[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,Nuclear receptor coactivator 1,OC1=CC=C(C=C1)C1=CC2=C(O1)C(CC#N)=CC(O)=C2
[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,Estrogen receptor,OC1=CC=C(C=C1)C1=CC2=C(O1)C(CC#N)=CC(O)=C2
"[5-hydroxy-6-methyl-4-({[(4E)-3-oxo-1,2-oxazolidin-4-ylidene]amino}methyl)pyridin-3-yl]methyl dihydrogen phosphate","2,2-dialkylglycine decarboxylase",CC1=C(O)C(C\N=C2/CON=C2O)=C(COP(O)(O)=O)C=N1
[Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine,Glycylpeptide N-tetradecanoyltransferase,[H][C@@](CO)(N=C(O)CC1=CC=C(CCCCN2C=CN=C2C)C=C1)C(O)=N[C@@]([H])(CCCCN)C(O)=NCCC1CCCCC1
"[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde",Gamma-aminobutyraldehyde dehydrogenase,C[N+](C)(C)CC=O
[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,Peptide deformylase,OCN(O)CCCC1=CC=CC=C1
[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,Peptide deformylase,OCN(O)CCCC1=CC=CC=C1
[Methylseleno]Acetate,Monomeric sarcosine oxidase,C[Se]CC([O-])=O
[Methyltelluro]Acetate,Monomeric sarcosine oxidase,C[Te]CC([O-])=O
[Methylthio]Acetate,Monomeric sarcosine oxidase,CSCC([O-])=O
"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",Dihydrofolate reductase,NC1=NC2=C(N=C(CN3C4=CC=CC=C4C=CC4=CC=CC=C34)C=N2)C(N)=N1
[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,Caspase-3,[H][C@](O)(CC(=O)N(N)CC(O)=O)C(=O)N(CC1=CC=CC=C1)CC1=CC=CC=C1
[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,Trypsin-1,[H][C@](NC(=O)OCC1=CC=CC=C1)(C1=CC=C(C=C1)C(N)=N)P(O)(O)=O
[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,Prothrombin,[H][C@@](N)(CC1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCCNC1=CC=NC=C1
[Pterin-6-Yl Methanyl]-Phosphonophosphate,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,NC1=NC2=NC=C(CO[P@](O)(=O)OP(O)(O)=O)N=C2C(=O)N1
[Pterin-6-Yl Methanyl]-Phosphonophosphate,Dihydropteroate synthase,NC1=NC2=NC=C(CO[P@](O)(=O)OP(O)(O)=O)N=C2C(=O)N1
"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",Beta-hexosaminidase,[H][C@]1(CO)O\C(=N/OC(=O)NC2=CC=CC=C2)[C@]([H])(NC(=O)CCC)[C@@]([H])(O)[C@]1([H])O
"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",O-GlcNAcase BT_4395,[H][C@]1(CO)O\C(=N/OC(=O)NC2=CC=CC=C2)[C@]([H])(NC(=O)CCC)[C@@]([H])(O)[C@]1([H])O
"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",Beta-hexosaminidase,[H][C@]1(CO)O\C(=N/OC(=O)NC2=CC=CC=C2)[C@]([H])(NC(=O)CCCC)[C@@]([H])(O)[C@]1([H])O
[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,Interstitial collagenase,[H][C@@](C)(NC(=O)[C@]([H])(CC(C)C)NC(=O)[C@]([H])(CC(C)C)CC(=O)NO)C(=O)OCC
"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",Tyrosine-protein phosphatase non-receptor type 1,NCC1=CC=C(NC(=O)C(O)=O)C=C1
[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,Prothrombin,[H][C@](CCNC1=CC=[NH+]C=C1)(NC(=O)CNS(=O)(=O)C1CCCCC1)C(=O)N1CCCCC1
[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,Beta-lactamase TEM,OP(O)(=O)CNC(=O)OCC1=CC=CC=C1
[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,Beta-lactamase TEM,OP(O)(=O)CNC(=O)OCC1=CC=CC=C1
[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,Beta-lactamase,OP(O)(=O)CNC(=O)OCC1=CC=CC=C1
"[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate",1-deoxy-D-xylulose 5-phosphate reductoisomerase,OP(O)(=O)C(NC1=CC=C(Cl)C=N1)P(O)(O)=O
"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",Tyrosine-protein phosphatase non-receptor type 1,[H][C@](CC1=CC(Br)=C(C=C1)C(F)(F)P(O)(O)=O)(C(=O)C1=CC=CC=C1)C1=CC=CC=C1
acetylleucyl-leucyl-norleucinal,Proteasome subunit alpha type-7,[H]C(=O)[C@H](CCCC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O
alpha-D-Xylopyranose,Chondroitinase-B,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,Exoglucanase/xylanase,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,Chondroitinase-AC,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,Beta-amylase,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,"Endo-1,4-beta-xylanase A",O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,"Endo-1,4-beta-xylanase A",O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,Beta-xylanase,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,Aldose 1-epimerase,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,"Endo-1,4-beta-xylanase",O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,"Endo-beta-1,4-xylanase Xyn10C",O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,Reducing end xylose-releasing exo-oligoxylanase,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,"Endo-1,4-beta-xylanase",O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,"Endo-1,4-beta-xylanase",O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,Beta-xylanase,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,"Endo-1,4-beta-xylanase",O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-Xylopyranose,Lactase-phlorizin hydrolase,O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O
alpha-D-arabinofuranose,Ribokinase,OC[C@H]1O[C@H](O)[C@@H](O)[C@@H]1O
alpha-D-glucose 6-phosphate,Aldose reductase,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose 6-phosphate,"Glycogen phosphorylase, muscle form",O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose 6-phosphate,Hexokinase-1,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose 6-phosphate,Glucose-6-phosphate isomerase,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose 6-phosphate,Maltose-6'-phosphate glucosidase,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose 6-phosphate,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose 6-phosphate,Phosphomannomutase/phosphoglucomutase,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose 6-phosphate,6-phospho-beta-glucosidase BglT,O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose 6-phosphate,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],O[C@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
alpha-D-glucose-1-phosphate,"Glycogen phosphorylase, muscle form",OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
alpha-D-glucose-1-phosphate,Phosphomannomutase/phosphoglucomutase,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
alpha-D-glucose-1-phosphate,Maltodextrin phosphorylase,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
alpha-D-glucose-1-phosphate,Glucose-1-phosphatase,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
alpha-D-glucose-1-phosphate,Glucose-1-phosphate thymidylyltransferase,OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
alpha-D-mannose 6-phosphate,Phosphomannomutase/phosphoglucomutase,[H][C@]1(O)O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
alpha-D-mannose 6-phosphate,Cation-independent mannose-6-phosphate receptor,[H][C@]1(O)O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
alpha-D-mannose 6-phosphate,Cation-dependent mannose-6-phosphate receptor,[H][C@]1(O)O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
alpha-D-quinovopyranose,Pancreatic alpha-amylase,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
alpha-D-quinovopyranose,Cyclomaltodextrin glucanotransferase,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
alpha-D-quinovopyranose,Alpha-amylase,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
alpha-D-quinovopyranose,Aldose 1-epimerase,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
alpha-D-quinovopyranose,Cyclomaltodextrin glucanotransferase,[H][C@]1(C)O[C@]([H])(O)[C@]([H])(O)[C@@]([H])(O)[C@]1([H])O
alpha-Ketoisovalerate,"Branched-chain-amino-acid aminotransferase, mitochondrial",CC(C)C(=O)C(O)=O
alpha-Ketoisovalerate,2-isopropylmalate synthase,CC(C)C(=O)C(O)=O
alpha-Ketoisovalerate,3-methyl-2-oxobutanoate hydroxymethyltransferase,CC(C)C(=O)C(O)=O
alpha-Ketoisovalerate,Deacetoxycephalosporin C synthase,CC(C)C(=O)C(O)=O
alpha-L-iduronic acid,Chondroitinase-AC,[H][C@@]1(O)O[C@@]([H])(C(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O
alpha-L-methyl-fucose,Chondroitinase-AC,[H][C@@]1(C)O[C@@]([H])(OC)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
alpha-L-methyl-fucose,Mannose-binding protein C,[H][C@@]1(C)O[C@@]([H])(OC)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
alpha-Tocopherol succinate,SEC14-like protein 4,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,SEC14-like protein 3,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,SEC14-like protein 2,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,Nuclear receptor subfamily 1 group I member 2,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,Protein kinase C beta type,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,Arachidonate 5-lipoxygenase,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,Protein kinase C alpha type,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,Diacylglycerol kinase alpha,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-Tocopherol succinate,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1
alpha-maltotriose,Maltose binding protein,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
alpha-maltotriose,Alpha-amylase 2B,[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O[C@@]2([H])O[C@]([H])(CO)[C@@]([H])(O[C@@]3([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
benzyl (2-oxopropyl)carbamate,Replicase polyprotein 1ab,CC(=O)CNC(=O)OCC1=CC=CC=C1
beta-(1->4)-galactotriose,"Arabinogalactan endo-beta-1,4-galactanase",[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O[C@]3([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]3([H])O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
beta-D-Galactopyranuronic acid,AlgQ1,O[C@@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)C(O)=O
beta-D-Galactopyranuronic acid,AlgQ2,O[C@@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1O)C(O)=O
beta-D-Ribopyranose,Ribose import binding protein RbsB,O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O
beta-D-Ribopyranose,D-ribose pyranase,O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O
beta-D-Ribose-5-phosphate,"ADP-ribose pyrophosphatase, mitochondrial",[H][C@@]1(O)O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@@]1([H])O
beta-D-Ribose-5-phosphate,D-ribose pyranase,[H][C@@]1(O)O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@@]1([H])O
beta-D-arabinofuranose 5-phosphate,Ribose-5-phosphate isomerase A,[H][C@@]1(O)O[C@]([H])(COP(O)(O)=O)[C@@]([H])(O)[C@]1([H])O
"beta-D-fructofuranose 1,6-bisphosphate",Pyruvate kinase PKLR,O[C@H]1[C@H](O)[C@@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O
"beta-D-fructofuranose 1,6-bisphosphate",Glycerol kinase,O[C@H]1[C@H](O)[C@@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O
beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose,"Arabinogalactan endo-beta-1,4-galactanase",[H][C@@]1(O)O[C@]([H])(CO)[C@]([H])(O[C@]2([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]2([H])O)[C@]([H])(O)[C@@]1([H])O
beta-D-galactose 6-phosphate,6-phospho-beta-galactosidase,O[C@@H]1O[C@H](COP(O)(O)=O)[C@H](O)[C@H](O)[C@H]1O
beta-D-glucose 6-phosphate,Glucose-6-phosphate 1-dehydrogenase,O[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O
beta-D-glucuronic acid,Hyaluronate lyase,O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O
beta-D-glucuronic acid,Chondroitinase-AC,O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O
beta-D-glucuronic acid,"Xylan alpha-1,2-glucuronidase",O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O
beta-Hydroxyasparagine,Mannan-binding lectin serine protease 2,N[C@@H]([C@H](O)C(N)=O)C(O)=O
beta-L-fucose,Acetylcholinesterase,C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O
beta-L-fucose,"Alpha-L-fucosidase, putative",C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O
beta-L-methyl-fucose,Mannose-binding protein C,[H][C@@]1(C)O[C@]([H])(OC)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
beta-Naphthoflavone,Estrogen receptor,O=C1C=C(OC2=C1C1=CC=CC=C1C=C2)C1=CC=CC=C1
beta-Naphthoflavone,Steroid hormone receptor ERR1,O=C1C=C(OC2=C1C1=CC=CC=C1C=C2)C1=CC=CC=C1
beta-Naphthoflavone,COUP transcription factor 1,O=C1C=C(OC2=C1C1=CC=CC=C1C=C2)C1=CC=CC=C1
beta-Naphthoflavone,Aryl hydrocarbon receptor,O=C1C=C(OC2=C1C1=CC=CC=C1C=C2)C1=CC=CC=C1
beta-Naphthoflavone,Cytochrome P450 1B1,O=C1C=C(OC2=C1C1=CC=CC=C1C=C2)C1=CC=CC=C1
beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,Prothrombin,[H][C@@](N)(C(C1=CC=CC=C1)C1=CC=CC=C1)C(=O)N1CCC[C@@]1([H])C(=O)NCCC
bis(4-hydroxyphenyl)methanone,Lanosterol 14-alpha demethylase,OC1=CC=C(C=C1)C(=O)C1=CC=C(O)C=C1
bis(4-nitrophenyl) hydrogen phosphate,Uncharacterized protein PA1000,OP(=O)(OC1=CC=C(C=C1)[N+]([O-])=O)OC1=CC=C(C=C1)[N+]([O-])=O
cis-Vaccenic acid,Peroxisome proliferator-activated receptor delta,CCCCCC\C=C/CCCCCCCCCC(O)=O
cis-tetracosenoyl sulfatide,Antigen-presenting glycoprotein CD1d,CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(O)(=O)=O)[C@H]1O)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC
dATP,DNA polymerase beta,NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
dATP,Protein RecA,NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
dATP,Protein RecA,NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
dATP,Anaerobic ribonucleoside-triphosphate reductase,NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
dATP,Ribonucleoside-diphosphate reductase 2 subunit alpha,NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
dATP,DNA primase/helicase,NC1=NC=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1
"deoxycytidylyl-3',5'-guanosine",Ribonuclease pancreatic,[H][C@]1(O)C[C@@]([H])(O[C@]1([H])COP(O)(=O)OC1([H])CC([H])(OC1([H])CO)N1C=CC(=N)N=C1O)N1C=NC2=C1NC(=N)N=C2O
"diethyl [(1R)-1,5-diaminopentyl]boronate",Trypsin-1,[H][C@](N)(CCCCN)B(OCC)OCC
difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron,Peroxisome proliferator-activated receptor gamma,CCCCCCCCC1=CC=C2C=C3C=CC(CCCCC(O)=O)=[N+]3[B-](F)(F)N12
"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",Estrogen receptor,[H][C@]12O[C@]([H])(C(C(=O)OC)=C1C(=O)OC)C(=C2C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",Nuclear receptor coactivator 2,[H][C@]12O[C@]([H])(C(C(=O)OC)=C1C(=O)OC)C(=C2C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
dioxothiomolybdenum(VI) ion,Xanthine dehydrogenase/oxidase,S[Mo](=O)=O
"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",Dual specificity protein kinase CLK1,CCOC(=O)C1=C(\C(=C/N)C#N)C2=C(N1C)C(Cl)=C(Cl)C=C2
"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",Dual specificity protein kinase CLK3,CCOC(=O)C1=C(\C(=C/N)C#N)C2=C(N1C)C(Cl)=C(Cl)C=C2
gamma-Aminobutyric acid,"Glycine amidinotransferase, mitochondrial",NCCCC(O)=O
gamma-Aminobutyric acid,Gamma-aminobutyric acid type B receptor subunit 1,NCCCC(O)=O
gamma-Aminobutyric acid,Gamma-aminobutyric acid type B receptor subunit 2,NCCCC(O)=O
gamma-Glutamylcysteine,Glutathione synthetase,N[C@@H](CCC(=O)N[C@@H](CS)C(O)=O)C(O)=O
gamma-Hydroxybutyric acid,"Solute carrier family 52, riboflavin transporter, member 2",OCCCC(O)=O
gamma-Hydroxybutyric acid,Gamma-aminobutyric acid receptor subunit beta-1,OCCCC(O)=O
gamma-butyrolactone,O-GlcNAcase NagJ,O=C1CCCO1
humanized SMART Anti-IL-12 Antibody,Interleukin-12 subunit beta,
iCo-007,RAF proto-oncogene serine/threonine-protein kinase,
indane-5-sulfonamide,Carbonic anhydrase 2,NS(=O)(=O)C1=CC=C2CCCC2=C1
keyhole limpet hemocyanin,Interleukin-2,
"lambda-bis(2,2'-bipyridine)imidazole osmium (II)",Azurin,C1=CN(C=N1)[Os++]123[N]4=CC=CC=C4C4=[N]1C=CC=C4.C1=CC(C4=CC=CC=[N]24)=[N]3C=C1
"lambda-bis(2,2'-bipyridine)imidazole ruthenium (II)",Azurin,[Ru+3].[N-]1C=CN=C1.C1=CC=C(N=C1)C1=CC=CC=N1.C1=CC=C(N=C1)C1=CC=CC=N1
liposomal prostaglandin E1,Platelet glycoprotein Ib alpha chain,
m-Chlorophenylpiperazine,5-hydroxytryptamine receptor 2C,ClC1=CC(=CC=C1)N1CCNCC1
"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",Disintegrin and metalloproteinase domain-containing protein 17,[H][C@@]1(C[C@]1(CC1=CC=C(OCC2=CC(C)=NC3=C2C=CC=C3)C=C1)C(=O)OC)C(=O)NO
methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate,Caspase-3,[H][C@@](CC(=O)OC)(NC(=O)OC(C)(C)C)C(C)=O
"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",Lactoylglutathione lyase,COC(=O)C1=C(C)C=C(OC2=C(O)C(O)=CC(C)=C2)C=C1O
methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate,Histone deacetylase-like amidohydrolase,[H][C@@](CC1=CC=C(Br)C=C1)(NC(=O)CCCCCCC(=O)NO)C(=O)OC
methyl L-phenylalaninate,Fimbrial protein,[H][C@](N)(CC1=CC=CC=C1)C(=O)OC
methyl L-phenylalaninate,Prothrombin,[H][C@](N)(CC1=CC=CC=C1)C(=O)OC
methyl beta-D-glucopyranoside,Endoglucanase 5A,CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
methyl beta-D-glucopyranoside,Endoglucanase F,CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
methyl beta-D-glucopyranoside,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
motexafin gadolinium,"Thioredoxin reductase 1, cytoplasmic",[Gd+3].CC([O-])=O.CC([O-])=O.CCC1=C(CC)/C2=C/C3=N/C(=C\N=C4/C=C(OCCOCCOCCOC)C(OCCOCCOCCOC)=C/C/4=N\C=C4/N=C(/C=C\1\[N-]\2)C(CCCO)=C4C)/C(C)=C3CCCO
motexafin gadolinium,Ribonucleoside-diphosphate reductase subunit M2,[Gd+3].CC([O-])=O.CC([O-])=O.CCC1=C(CC)/C2=C/C3=N/C(=C\N=C4/C=C(OCCOCCOCCOC)C(OCCOCCOCCOC)=C/C/4=N\C=C4/N=C(/C=C\1\[N-]\2)C(CCCO)=C4C)/C(C)=C3CCCO
motexafin gadolinium,"Thioredoxin reductase 2, mitochondrial",[Gd+3].CC([O-])=O.CC([O-])=O.CCC1=C(CC)/C2=C/C3=N/C(=C\N=C4/C=C(OCCOCCOCCOC)C(OCCOCCOCCOC)=C/C/4=N\C=C4/N=C(/C=C\1\[N-]\2)C(CCCO)=C4C)/C(C)=C3CCCO
nocodazole,Hematopoietic prostaglandin D synthase,COC(=O)NC1=NC2=CC=C(C=C2N1)C(=O)C1=CC=CS1
nor-NOHA,Arginase-1,N[C@@H](CCNC(=N)NO)C(O)=O
o-Bromophenol,Thymidylate synthase,OC1=CC=CC=C1Br
"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",Histo-blood group ABO system transferase,[H][C@]1(O)C[C@]([H])(O[C@]2([H])[C@@]([H])(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]2([H])OCCCCCCCC)O[C@@]([H])(C)[C@@]1([H])O
octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,Histo-blood group ABO system transferase,[H][C@@]1(O)C[C@@]([H])(O[C@]2([H])O[C@@]([H])(C)[C@@]([H])(O)[C@@]([H])(O)[C@]2([H])O)[C@]([H])(OCCCCCCCC)O[C@]1([H])CO
octyl alpha-L-altropyranoside,Aquaporin Z,[H][C@]1(O)[C@@]([H])(O)[C@]([H])(CO)O[C@@]([H])(OCCCCCCCC)[C@]1([H])O
octyl beta-D-galactopyranoside,Aquaporin Z,[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCCC)[C@]1([H])O
omega interferon,Interferon alpha/beta receptor 2,
omega interferon,Interferon alpha/beta receptor 1,
p-Chlorobenzoic acid,4-chlorobenzoyl CoA ligase,OC(=O)C1=CC=C(Cl)C=C1
para-Coumaric Acid,Photoactive yellow protein,OC(=O)\C=C\C1=CC=C(O)C=C1
para-Coumaric Acid,PPH,OC(=O)\C=C\C1=CC=C(O)C=C1
para-Coumaric Acid,Prostaglandin reductase 1,OC(=O)\C=C\C1=CC=C(O)C=C1
para-Coumaric Acid,Tyrosine ammonia-lyase,OC(=O)\C=C\C1=CC=C(O)C=C1
phenyl ethenesulfonate,Tyrosine-protein phosphatase YopH,C=CS(=O)(=O)OC1=CC=CC=C1
rNAPc2,Coagulation factor X,
rNAPc2,Coagulation factor VII,
rNAPc2,Tissue factor,
rhIGFBP-3,Insulin-like growth factor 1 receptor,
scyllo-inositol,Glucosylceramidase,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
scyllo-inositol,1-phosphatidylinositol phosphodiesterase,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
scyllo-inositol,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
scyllo-inositol,1-phosphatidylinositol phosphodiesterase,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",HTH-type transcriptional regulator EthR,CC(C)(C)OC(=O)N1CCC(CC1)C1=NC(=NO1)C1=CC=CS1
"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",Queuine tRNA-ribosyltransferase,CC(C)(C)OC(=O)NCC1=CNC2=C1C(=O)NC(N)=N2
threo-3-methyl-L-aspartic acid,Methylaspartate ammonia-lyase,[H][C@@](C)(C(O)=O)[C@]([H])(N)C(O)=O
trans-2-hydroxycinnamic acid,Major NAD(P)H-flavin oxidoreductase,OC(=O)\C=C\C1=CC=CC=C1O
trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,Poly [ADP-ribose] polymerase 1,CCCN1CCC(CC1)C1=NC2=C(N1)C(=CC=C2)C(N)=O
trans-urocanic acid,Urocanate hydratase,OC(=O)\C=C\C1=CNC=N1
tributylstannanyl,Nuclear receptor coactivator 2,CCCC[Sn](CCCC)CCCC
tributylstannanyl,Retinoic acid receptor RXR-alpha,CCCC[Sn](CCCC)CCCC
trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-),Myosin-14,CN(CCO[P@](O)(=O)O[P@@](O)(=O)O[Be-](F)(F)F)C1=CC=CC=C1[N+]([O-])=O
tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate,Dehydrosqualene synthase,[H][C@@](CCCC1=CC=C(C=C1)C1=CC=CC=C1)(P(=O)(O[K])O[K])S(=O)(=O)O[K]
undecan-2-one,Acyl-coenzyme A thioesterase 13,CCCCCCCCCC(C)=O
{(1s)-1-Benzyl-4-[3-Carbamoyl-1-(1-Carbamoyl-2-Phenyl-Ethylcarbamoyl)-(S)-Propylcarbamoyl]-2-Oxo-5-Phenyl-Pentyl}-Carbamic Acid Tert-Butyl Ester,Gag-Pol polyprotein,[H][C@](CC(=O)[C@]([H])(CC1=CC=CC=C1)N=C(O)OC(C)(C)C)(CC1=CC=CC=C1)C(O)=N[C@@]([H])(CCC(O)=N)C(O)=N[C@@]([H])(CC1=CC=CC=C1)C(O)=N
{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,Prothrombin,[H][C@@]1(COC(=O)CC2=CC(Cl)=CC=C2)CCCN1C(=O)CNC(=O)OC(C)(C)C
"{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide",CHRNA7-FAM7A fusion protein,ClC1=NC=C(CN2CCS\C2=N/C#N)C=C1
"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",Casein kinase I isoform gamma-3,COC1=CC=C(C=C1)\N=C1\NC(N)=C(S1)C(=O)C1=CC=C(OC)C=C1
{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid,Alanine racemase,[H][C@@](C)(NCC1=C(COP(O)(O)=O)C=NC(C)=C1O)P(O)(O)=O
{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER,Genome polyprotein,[H][C@@](CC)(C=O)[C@@]1([H])N(CC[C@]1([H])NS(C)(=O)=O)C(=O)[C@@]([H])(NC(=O)OC(C)(C)C)C(C)C
{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid,Threonine-phosphate decarboxylase,C[C@H](CNCC1=C(O)C(C)=NC=C1COP(O)(O)=O)OP(O)(O)=O
"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",Aldose reductase,OC(=O)CN1C=C(CC2=NC3=C(S2)C(F)=CC(F)=C3F)C2=C1C=CC=C2
"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",Aldose reductase,OC(=O)CN1C=CC(=O)N(CC2=NC3=CC(Cl)=CC=C3S2)C1=O
"{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid",Peptidyl-prolyl cis-trans isomerase FKBP1A,[H][C@](CCC1=CC(OC)=C(OC)C=C1)(OC(=O)[C@]1([H])CCCCN1C(=O)[C@@]([H])(CC)C1=CC(OC)=C(OC)C(OC)=C1)C1=CC(OCC(O)=O)=CC=C1
{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,Leukotriene A-4 hydrolase,[H][C@]1(COC2=CC=C(C=C2)C(=O)C2=CC=C(C=C2)C2=CSC=C2)CCCN1
{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid,Tyrosine-protein kinase Lck,[H]N([H])C(=O)C1=C(OCC2CCCCC2)C=CC(=C1)[C@H](C)N([H])C(=O)[C@H](CC1=CC(=C(OCC(O)=O)C=C1)P(O)(O)=O)N([H])C(C)=O
"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",Tyrosine-protein phosphatase non-receptor type 1,[H]\C(C[C@](CC1=CC=C(C=C1)C(F)(F)P(O)(O)=O)(N1N=NC2=CC=CC=C12)C1=NC2=CC=CC=C2S1)=C(\[H])C1=CC=CC=C1
"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",Aldose reductase,OC(=O)COC(=O)C1=C2C(C(=O)N(CC(O)=O)S2(=O)=O)=C2C=CC=CC2=C1
"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",Receptor-type tyrosine-protein phosphatase beta,CC1=NC(=NO1)C(CC1=CC=CC=C1)(CC1=CC=C(NS(O)(=O)=O)C=C1)C1=NOC(C)=N1
"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",Tyrosine-protein kinase Lck,[H][C@@](CC1=CC(=C(C=C1)P(O)(O)=O)P(O)(O)=O)(N=C(C)O)C(O)=N[C@@]1([H])CCCCC2=CC(OCC3CCCCC3)=C(C=C12)C(O)=N
{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,Receptor-type tyrosine-protein phosphatase beta,COC(=O)C(CC1=CC=CC=C1)(CC1=CC=C(NS(O)(=O)=O)C=C1)C(=O)OC
{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,Peroxisome proliferator-activated receptor delta,CCCC1=C(OCCCOC2=CC=C(OCC(O)=O)C=C2)C=CC(C(C)=O)=C1O
"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol","Fructose-1,6-bisphosphatase 1",CCOC1=C(OCC)C=C2C(NC3=CC=CC(=C3)C3=CSC(CO)=N3)=NC=NC2=C1
"{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid",2-dehydro-3-deoxyphosphooctonate aldolase,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CN(CC(O)O)CP(O)(O)=O
"{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid",2-dehydro-3-deoxyphosphooctonate aldolase,[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CN(CC(O)O)CP(O)(O)=O
"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",Cyclin-dependent kinase 2,FC1=CC=C(NC(=O)C2=NNC=C2NC(=O)C2=C(F)C=CC=C2F)C=C1
"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",Tyrosine-protein phosphatase non-receptor type 1,OP(O)(=O)C(F)(F)C1=CC=C(CC(CC2=CC=C(C=C2)C(F)(F)P(O)(O)=O)(N2N=NC3=C2C=CC=C3)C2=CC=C(F)C(F)=C2)C=C1
"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",Aldose reductase,OC(=O)CSC1=NN=C(O1)C1=CC=C(O1)[N+]([O-])=O
{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,Tyrosine-protein phosphatase non-receptor type 1,OP(O)(=O)C(F)(F)C1=CC2=CC(=CC=C2C=C1)C(F)(F)P(O)(O)=O
